>OMIFANIC_00001 hypothetical protein
MYVCNIVPSPASYAKNYYLAEDKKWLFTLWTTL
>OMIFANIC_00002 hypothetical protein
MIYQLISYLKFLTRATNQHGVHSPFVYKLITECFYDRSEYAAYKILADHRSHLFNDLDAI
EVLDFGAGSRVFKSNVRKISAIAKNAGIRKKRQQLLYRLVNYLEPATILELGTSVGLSTM
ALALGNKEATVTSLEGCPQTSKKAQQYFDRFQMHNIDLHNVEFENYLSNSTEIYDLIFID
GNHSKEKTIAYFNSLRKHVNNNSLIIFDDIYWSKEMTAAWKEIIADDSVTVSIDTFQWGL
VFFRKEQKKQHFNVRM
>OMIFANIC_00003 Energy-dependent translational throttle protein EttA
MIFRKNLRVAFISQEPDLNPELTVEETIFSSENHILKIIANYEKALQNPDDSENYQIAFD
AMDAHNAWDFETLYKQILFKFKLEELDKKVGALSGGQKKRLALTNALLMQPELLIMDEPT
NHLDLEMIEWLEGFFAKANITLFMVTHDRYFLERICNEIIELDEGKLYAYKGNYSYYLEK
RDARIENEATETAKARQLYNKELDWMRRQPKARTTKSKSRIDDFHDIKARAHQRRNEHEI
QLELNMERLGTKVVELHGISKAFDEKSLFSKFSYNFLRGERLGIIGKNGTGKSSFLNIIT
GSLKPDSGKVVIGDTVKFGYYTQHGITIKEGQKVIDVIREYGDYIPLKKGRQISAQQLLE
RFLFDRKKQYDYVEKLSGGERKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLENFLLD
FPGCIIVVSHDRYFMDKVVDHLFVFKVGGIIEDFPGNYSDYRTYTDSMSTNNEPSIDRAP
KKKNTWKDGRTGVKLSYNEQKEYQKLEKEIAKLEDERESLQNMFATEGWDGEEIDKQSRK
LQMLIDNIDEKTERWFELSAKMES
>OMIFANIC_00004 hypothetical protein
MMEIALWISIFFITFCIMEFMAWFTHKYVMHGFLWSLHKDHHRKDHDSWFERNDTFFIFY
AVVSMSFILLAGNSEFWYGYPIGFGIMAYGATYFLVHDIFIHQRFKIFRNANNWYARGVR
RAHKMHHKHLGKEDGECFGMLWVPFKYFKK
>OMIFANIC_00005 hypothetical protein
MGQLSEISDGDATELLKMAIRLPDALKTEREEIDQSEFNQIIEAVDAALEAINNYRSSEG
KALETEFLQRVINIGELLDKVIEMDPQRIDNVKERLRRAISELKESVDENRFEQELIYYL
EKYDITEEKVRLKNHLDYFKETLETHASNGKKLGFISQEIGREINTIGSKANFAPMQQLV
VQMKDELEKIKEQALNVL
>OMIFANIC_00006 Guanylate kinase
MRGGKLIVFSAPSGSGKTTIVRHLLEQEKLNLAFSVSATSREPRGEEKDGEDYYFISAAK
FKKHIKDGDFLEWEEVYRDNFYGTLHSEVNRLWAHGKNVIFDIDVVGGLRIKKKYPEKTL
AVFVEPPSVDELKIRLKKRKTESDEKINMRIAKASIEMATASQFDHIIVNDNLDKALEEA
ERLVAQHIDKEENESKAREEE
>OMIFANIC_00007 Nicotinate-nucleotide adenylyltransferase
MAKGKKIGLYFGTFNPIHVGHLVIANHMVEYSDLDEIWMVVTPHNPHKKKNSLLDDIHRL
TMVRIALEDYPKLNASNIEFDLPQPNYTVNTLAHLEEKYPENNFCLIMGEDNLKSFHKWK
NYEVILERYPVYVYPRISKGKVETRFDDHPAITPVNAPIMELSSTFIRKGIKEGKNVRPM
LPHSVWKYLDEMNFYR
>OMIFANIC_00008 hypothetical protein
MKTVKLFFGVALATIMFTSCYTEVIVEDPYVDPVPSITLRELVSSYELWYVDINRSSGNG
YIPFMQKAFTVSFQNGTLYANNNLVGIGEQGYGFGIDVGFFDTHNFVLDVSHDIDGFYSF
EVTQLNNNEIELYYRPLQLSYILVGYQRSTFDYDALFYDNIHYFIQEYVAWEKTYTSPYG
DPNEFDYENFLQFLPGGGNGNFRSSEDPNGTNINYIYWDYTGNYNVDDVPGDRYLKYLTL
DYDYMGNEYFELSVINDHTIELFHEFSGTLYRFTGKGYIQYRSSEGKLRKSKKDIEKEMI
KISKF
>OMIFANIC_00009 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MSKTPKFAVIGGGSWATAIVKMLCENLDEVGWYMRSVYALEHIKKEFHNPNYLSSVEFHL
DQLRLSNDINEMVDYADYLIFAIPSVYVEQELQKLTTSLKGKVIFTAIKGIVPESSLIVG
DHFFTHYDIPFKDIGVITGPCHAEEVAMERLSYLTIACADEKKADLVASVLRSDYIKTTT
SDDIIGTEYAAMLKNIYALAAGIAHGLGYGDNFLSVLMSNAIREMKGYVKKVHKMKRDIN
GSAYLGDLLVTGYSIFSRNRMFGNMIGKGYTVKSAMMEMSMVAEGYYATKSAYELNEARG
KEKAKTPIINAVYSILYEGKNPKKVIEKLTEKLN
>OMIFANIC_00010 hypothetical protein
MRKDIVIPEVKDVYVAAVYEFNEDFNTHDWNAYIINDGMDALETVLIVSQGYDDKDLTAP
MRHSLQLLPAKGYAKIEFLDVSVLRLDNFFTITYFIGDKLYDKRFELPANSVIEDNRVPL
PVMDQKGVLAR
>OMIFANIC_00011 Phenylalanine--tRNA ligase alpha subunit
MIDKIKEHIAEVEAFTAKTREEVESFRIKYLGKKGLLNEFFAEFKNVSKDQKKEFGQVVN
TLKSAAQEKVNSLKNTLDASEESSGVYGDLSRPGEPIKLGSRHPVSIVKNKIVSIFSRIG
FNVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTNPDVLLRTHTSSVQVRYMENNK
PPIRTISPGRVYRNEAISARSHCFFHQVEGLYVDKGVSFADLKQTLQYFTTEMFGKSKIR
LRPSYFPFTEPSAEVDVYWGLETETDYKMTKGTGWLEIMGCGMVDPNVLSNCGIDPKVYS
GFAFGMGIDRVALLLHQIPDIRMLSENDIRFLEQFKSSL
>OMIFANIC_00012 hypothetical protein
MARDEVLKNRWEQVVKTLGDRFADGEVLDLDAVIYLVGIQELGQLHRKFRKDDKIDLMHI
AICRLLEPYGYYSFDYFDEEGWPHYRIEEQLPSLKAGEQSVLMKEAIVHYFLEKEVIE
>OMIFANIC_00013 hypothetical protein
MNLIDIVLGVILLIAFYMGYKRGLFVALAGLIGLVAGVYGAIYFSDFAAGYISQWFDWSE
QTVNLVAFAITFLAIVFLISAAGKFLTKIADFAMLGILNKLLGGVFNALKYAFIISVVFM
FVNASETYSILSEEKRSDSVLYTPVASLAPLVLPHILIEVNNFRDDSEENNSKADETSAI
E
>OMIFANIC_00014 Bicarbonate transporter BicA
MFKNIFTNIRGNLFGGITAGIVALPLALAFGVQSGLGPDAGLYGAIFIGFFASLFGGTNT
QISGPTAPMTALSMVIIAGIIGANDGDVAKALPFILMVFLLAGLIQILIGVVGWGKYIKY
IPYPVVSGFMTAIGVIILVTQVLPVLGYYAENDSEFINEFKPQAEEILLDNILKDEAEEG
ILVLEDFKETVRRADEITEEEIIREASALAKNKSSGVIGSLNTVSRAVKNVRWLEVALAF
LTIFLIYTFRRITKKIPATLIALLVVSAGAILLKLDYQPIKEIPAGFPMPNLDIFANFSV
SQISPYIFTAITLAFLGAIDSLLTSIVADNMTKTKHKPNQELIGQGIGNSLAAIFGGLPG
AGATIRTVVNINSGGTTKLSGMVAAVLLVVILLLLGPIASQIPAAVLAGILVTVGIGVMD
YKGLKAIPNMPISEVIVMLVVLVLSVFWNLIYAVGIGLVLASLIFMKKLGDATAARSQII
PLSDADENDIPWKDERGFPKELKEEVYIKHLDGPMFFGNTNDFHELAKGIPDTASHVIIR
MDKVPYMDQSGLYAMEETLYRFSKTNITAVLVHLERQPRVMMESIDIIPDLLPPERIFED
FDEVLVYLNENVEDVV
>OMIFANIC_00015 hypothetical protein
MKINVATYFFLFVLLVGPYICAQNETSFNLGKEAYKTENYQEAISQWQEILNAGEHSAEL
YFNLGNAHYKLNNIGPSIYYYEKALQLDPYDLDIQNNLAFAENARVDAIEPLPQNVFKTW
YRSVSGVFNYNGWAINAAIFSFIFVLLFLLYYYSASERKKRILFAASIATLFFLVASITL
AFMTYSDYQKNNPAIIYSEKVEVKDAPSVGGEVTFVIHEGTKVQLLERDDEWVRIRLEDG
KDGWVPLTDLKEL
>OMIFANIC_00016 hypothetical protein
MKPTYFIYIFFFLFSLGLTQAQVRFETKVSKSKLGVNERLRVDFEMNQDGDNFNPPSFSG
FRVVGGPNQAISNSYINGKRSYSKTYSYYLTPQKRGKFTIGQATIDIDGETYKTLPVSIE
VTAAVERPKDGDNAEYVASENVHLVASISDTNPYLNEAITVQYRLYVSNDVNLTRGFREI
DTPKYADFWSQTISNRGNFTVYDGEYNGRTDYRYIIVQTTVLYPQKTGKLTIEPLTLDVP
IDVETNKRDLFGRRLMTRVNKTISAGNKTIDVKPLPAEGRPDNFNGAVGDFTFDVQADRS
SLDANEALQLTVKVSGKGNLKLFDLPSVKLPAALELFEPERDNKVSTQTDGMRGSISETY
TVVPQFKGDYPIRPLSFSFFDPKTEKYRTLSSDEIVLNVVNGPVTSATTSETTTNGKNPV
TVFNEEQFKYIKLNTTLKPVVTSDFFQSGLFWSLVGGPFLLIPLFIFIGRKRKKRLRDIQ
GNKLRRADKLAKKYLTEAKRSLGDKVGFYEAMERALHNYLKAKLAIETSDFSKEKITGLL
HDKGAEETIIATFIEILKSCELARYTPASSVAMKHDYDKAVKVISTIDKQLIR
>OMIFANIC_00017 hypothetical protein
MQRLTNRFYTGIPKGFYILLCVLLANNSVLAQEDKEKEKIEKETTNLLRSATSELESDDF
IDAEVDLRKAISLSPANETGKYNLGNAYYEKELNDEAMRRYVQAAEVAESKPEKHKAYHN
LGNTFMNAKKYQEAVEAYKNALRNNPGDDETRYNLALAKEMLEKNPPQGGDDNKDEENNK
DEENKDENENKDDKGKDQEGDEGDEKENEDKGDEKDENKDGENKDDRGNPKDPNEQKDGE
GEQPKQQKPVPGQLSPQQVKNLLEAMNNEEKKVQDKINARKQKGAKVKSNKDW
>OMIFANIC_00018 hypothetical protein
MYQLEEPIYFYLLLAIPAVVVLFLLVLFWKYRTQKKFADNRLLRKLSPDRSNFKSMLKIS
VFCLALTALAFALVNPKIGTKLETVKREGVDVVFALDVSKSMLAEDIAPNRLEKSKQLVT
QIINSLAGDRIGIIGYAGSAFPQVPITTDFSSAKLFLNGMNTDMVSSQGTAITEAIAMAK
TYYDDEEQTNRVLFIVSDGEDHEGSLAEISAEAASEGIKIYTIGVGTAVGGPIPIKRNGV
LQYYKRDQNNEQVITRLGEDRLKEIASQANGTYIEGNNTKDVLEEVTAILNGMDKKEFDA
KQFTDFKDQFQWFLVGALFLLILDILLLERKTAWVRKLNLFNEKE
>OMIFANIC_00019 hypothetical protein
MDRFEYVNPEFFWLLLLLPALVVWFIWMRHRQTASLTISSLKGFKTGKNWLAKVRPFLFI
LRLLALAAIIVALARPRTVDESTRIKTTKGIDIVMAIDVSASMLARDLRPSRLEALKTVA
ARFINARPNDRIGLVEYAGESYTKTPLTSDKSIVLSSLKSLRYNTVIDPGTAIGMGLATA
VNRLKESRAKSKVIILLTDGVNNTGFIDPKIASELAVEFGIKVYTIGLGTNGMAQSPIGI
RPDGSFQYGSIQVEIDEALLQEIAETTGGQYFRATSTTKLNEIYNEINKLEKTDIEEFKY
TNYEEKFRPLALLALALLGLEFLLRYTLFRSFI
>OMIFANIC_00020 hypothetical protein
MPDRIINIRFLSFLTFPLSVVEVKVRNIVLLFLLLSGGWAEAQITSNVDTTNIRIGEEIR
YSVEVMADSTDLVLFPEGQSFLPLEMIESYKVDTTYEQAKYRLIKKYGLTQFDSGSYTIP
PQKIVINDRVFSTDSVKIEVADVPVDTTQQKMFEIKPATEVGSTPFNFMKLLYWLLPLII
IGGIGWYLLRRKKKREAEEEQLPPYDEALASLKELDASNLLSSNRSKEYYSQLTEIVKRY
LDREIDDTALESTSDELIERLQLHKDAGNFEFDTETISKLDAILKRADLVKFAKMEMAQG
QSSSDRNTIEEIITETHEVVPEPTEEELLQNELYAQEQRRRRRNKRIIYGAATGMLAVII
AVVILASTYGWDYLKDNVIGHPTKDLVEGQWYRSEYGIPAVIMETPVVLKRQDVQLPPEM
QEAVQSSRFFAYGSILDRFYLVVNTTIFNQPIDGELEKVLEGALATFEAQGARNLVVKTE
SFETDNGVKGIKAYGSFESENPFVKGNNDTQNYEMLVFGQQGALQQIIISSLDSDRYAEE
LVDRIRNSIELEVQPTKQKQQ
>OMIFANIC_00021 hypothetical protein
MDTKELLKKVRKIEIKTRRLSDHVFGGEYHSTFKGRGMTFSEVRQYQFGDDVRNIDWNVT
ARYNEPFIKVFEEERELTLMLVVDVSGSEFFGTDKQFKNEVVTEIAATLAFSAMQNNDKT
GLILFTDEIELFIPPKKGKFHVLRIIRELIEFHPKSKKTDVAQALKYLTNVMKKKAIVFV
LSDFITDGYHDTLKIVAKKHDVTGIRVYDAKEEAIPNLGMVEMLDEETGEHLLVNTGSNA
VRRNYHRYYRERVDYYQEAFTKSGAGAIDCRVDESYVKKLLGYFKRRA
>OMIFANIC_00022 hypothetical protein
MEEVTTALDIGALNEKIEKESAFVDILTLEMNKVIIGQKHMVERLLIGLLGRGHILLEGV
PGLAKTLAINTLAQAVHGSFSRIQFTPDLLPADVVGTLIYNMKLNDFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQERQVTIGEDTFILDEPFLVMATQNPIEQEGTYPLPEAQVD
RFMLKTVIDYPKIAEEQLIIRQNLKGAYEKINPVVTLEQILRAQQAVREVYMDEKIEKYI
LDIIFATRTPEHYKLSEIKPLIGFGASPRGSINLAMASKCYAFIKRRGYVIPEDVRAIVH
DVLRHRIGLTYEAEAENVTSEDIINKIVNVIEVP
>OMIFANIC_00023 Oxidoreductase YdhF
MKLTYSSIIQGCMGWGVWGAKLSENEMTDRIHHCLENGITTFDHADIYGDYTTEASFGNA
FSASNLAREDIQIISKCGIQYVGNTRDNEIKHYRYDADYIVWSAEKSISDLNSDYLDLLL
LHRPSPLMQPDEVAKAVDKLISEGKIRSFGLSNFTPSQTALIASKSKVSANQIEFSLTAI
EALWNGSLDDMMLNDITPMCWSPLGSVFKEDNEQTRRIHKVLDDLNQKYNATKDQLLLAW
ILKHPSGIHPVIGTATPERIANASKAASIDLSEIDWFRMLVSSQGHKVA
>OMIFANIC_00024 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MENKLALITGATSGIGRATARIFADNGVNLVICGRRIDRLESLKDELSEKVKIHSLVFDV
RNKELVFNSIQGLPEDFTQIDILVNNAGNAHGMDPIQSGSTEDWDAMLDINVKGLLYVSK
AVLPGMLERANGHIINIGSTAGKEVYPNGNVYCASKHAVDAINQGMRLDLNGKGIRVAAI
NPGLVETEFSEVRFKGDTERAEKVYKGFTPLKPEDIADIIWFAVTRPSHVNIADLTVMCL
DQASSTIVNKK
>OMIFANIC_00025 hypothetical protein
MINKRLLIKNLLAHNDESSFYDKKRKIDLGSKEGKAKFLKHICALSNSNPANNSFIVVGV
EDETNEIRGVDFFDDSKIQNLVNAYLSNPPLISYENIMFPHLPDDKVVGLVTIRPTGEIT
SLRKNIWKYWGGSIFLRDGSISMPKDFDIEIRDVNSEIVKAIENKAMNNIEHTLDGVIDF
LNNRHNDLPSDYKVFKEQFVVCWAGIPKQINGNTYYSRVDIELINEQVRLFYSALDEISI
EHTNDYFRILEYVNLGLNQQFKYYPLEEVTIEFRENGSYAMNSELVFEPPRFNKKTLYHI
YNANNALVDKLNKQIPLNPTEEKDLYQLSETYLICYLNDFNDAIDKLTEAKPFLKQMGGN
VYQSFKEAQRILRKVKYN
>OMIFANIC_00026 hypothetical protein
MGIFDTIKEKLSNEFIDIIEWLDYTDDTICHRFERYQNEIKNNAKLIVREGQTAVFINEG
QLADVFEPGTYTLNTQNLPILTTLKGWKYGFDSPFKAEVYFVNTHLFTDEKWGTKNPITL
NDERFGLVEIRAFGTYAFRISDAGKFIIDIVGTDNNFTNFEINEHLKSLIATRFTDTVGE
ANLPIELYAANTTELSETCKEVMQPEFESVGIALEKFFIENVSMPEDLKKEIFEYSRIDK
LDLDKLTKFKTAKAIEAAASNEGGTAGAGMGMGMGFVLAQQMGGMMSPQMGGQQLPSHQH
APTMPPPMPQAVQYFYAANGQQAGPVTFEQLQALFANRTVNRDSLVWKQGMTEWTALKEV
EELKAFLGGSTPPPLPGA
>OMIFANIC_00027 hypothetical protein
MQEAPEKKSELKKSCVNCGAELLYAPGTTELQCEYCGHAQDIPPSEIGFEELELQTYLDS
LGHHSHSQAILMLQCKSCGANQHIEENYKSLHCVYCNSPLIIEDAQKEEWILPGAILPFQ
IDQNNAHRIFQKWVKGLWWAPNKLKKASLDPQNTKGLYSPYWTFDAQLSANYTGQRGDYY
YVSVPYTTTVNGKTVTRMRQERRTRWTPASGRISGFIDDTLIKASKQRSGVIPRKVARWD
LSKLVPFDSSYLSGFVTEKYTIPLKDGHLDAQKEAERIADRWARRDIGGDTQRISSIDMR
LTEETFKHILLPVYISAYRYKGKRYNFFVNGQSGVLAGQRPYSFWKIFLFIIMIIAVLSL
IVYFVNQG
>OMIFANIC_00028 Serine/threonine-protein phosphatase 1
MRTLVVGDIHGGLKGLKQALERVNPTHEDLFIFVGDYVDGWSENAETVSFLLKFSEEYQC
IFLRGNHDDLVYDFLKKNDEKPMWLAHGGQASKDSYAKLSSRELDLHIEFFESLQNYFID
DKNRLYLHAGFTNMHGPQHEFYPNLVYWDRTLWEMACSLDPEISQDNRYYPKRLKLFNEI
YIGHTPVTRLGETIPIRKANVWNVDTGAAFKGPLSIIDVDSKNIWQSDPVWTLYPLEKGR
N
>OMIFANIC_00029 Periplasmic trehalase
MKRRDFAKNISLAGGVIGLGMLSACEQVSDKNSEGKTTDTDSNVPKALADEMYAKALEIT
KSKVRGGVSEPFFKKPFIDAAFSPNIFLWDTCFMCCFAKYHLNELPVYQALDNFYEQMDE
DGYICREYRQDGRPLWSKDHPVSINPPLLALAELEIYKISEDISRLKKVYPILKKNFQFH
VGRYMMEDDLFYGDTLGMGMDNIPRAPRDWEPTEGNGLTHHELGEKLAAMNESAETKLQY
FIEQYVETKQGLWNTQARLVDFSAQMAMYALQLIEIGTLTGNEDDISIFEDIHSRIKLAI
NEKCWNNRDNFYYDLGFDKQVPRRHIGMYWTLLGKLVPADRMKSFLEHLRNPDEFYRKTP
LPALSAADPDYVGWGDYWLGGVWAPTVYMVLKGLSENGEDDLAKDLATKVYRNVATVFEA
TGTFWENYAPDLVSYGMPAKKDFCGWTALIPIAVYKEYIEV
>OMIFANIC_00030 3,6-anhydro-alpha-L-galactose dehydrogenase
MLTATTSFGIEEALEKLGVEDINHGTSTGTNWMPGAGAISSYSPVDGKLIGKVTTTTKDE
YEQMMKTATEAFKTWRVMPAPQRGEIVRQFGEELRRLKEPLGKLVSYEMGKSYQEGLGEV
QEMIDICDFAVGLSRQLHGLTMHSERPGHRMYEQYHPLGVVGIISAFNFPVAVWSWNTAL
AWICGDVCVWKPSEKAPLCGIACQKIAARVFAENNLPEGISCLINGDYKVGEYMTTDTRI
PLISATGSTRMGKIVGRTVGERLGKSLLELGGNNAIIVTPDADIKMTVIGAVFGAVGTCG
QRCTSTRRLIIHESIYDKVKDAVVAAYGQLRIGNPLDENNHVGPLIDKDAVEMYKNALAK
VVEEGGNLVVEGGVLEGEGYESGCYVKPAIAEADNSFEIVQHETFAPVLYLLKYSGEVDN
AIDIQNGVAQGLSSAIMTNNLREAERFLSHAGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKIYMRRQTNTINYTTELPLAQGIKFDL
>OMIFANIC_00031 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MKDLEVQEQPVPFMVFAHWLHEHTSKSRSNYTGACVLSTVGMDGYPNARNVSIKLLEYPY
LIFGTPTNSLKSIEIKASKKVALTFWWEESMRQIRIQGIASELDEETADFVFEKRNKGSQ
VVSLISEQGANLPSWEILQERYRVMFNELKDERIERPEHWKGFKVEPIRYEFMEFRKTRL
HYRRVFHKKKDGWEMKMIQP
>OMIFANIC_00032 3-hydroxyanthranilate 3,4-dioxygenase
MAIPKPFNLTQWVEENRDLLKPPVGNKNLYKDAEDYIVMIVAGPNARKDYHYNETEELFY
QLEGNIEVIIQEDGERKVMKLGPGDMYLHPAKVPHSPSRSEGSIGLVVERKRTDIDAKDG
LLWFCDNCNNKLHEVYFPLHDIEKDFLKHFIDFYGSEELRTCNNCGTVMESDPRFVSQD
>OMIFANIC_00033 hypothetical protein
MVLFATVVSCSKDEAVVVEEADYTIDLNLAQETNWELADAILDLVNQHRVSEGLTELKRD
QTYASAYAVEHTQYMIRKAMISHDNFNVRSKALKERGALIVGENVAYGYETAEDVVFAWL
NSPGHKKIIEGLYTHSGFGIIQNERGDYYFTQLFYRK
>OMIFANIC_00034 Isoaspartyl peptidase
MTKIFSFLFTVVLVFSCGNDKNVAENASTSSEKTSGKNPTFGLVIHGGAGTILKENMSDS
LEAAYTSKLEEAIRVGHKILENGGSAMEAVTKTINVMEDSPLFNAGKGAVFTHDETNELD
ASVMDGATLNAGAVAGVTGIKNPIDLAVEVMNNSPHVMLSGKGAEIFAKERGIELVDPSY
FYTERRFQSLKRIKEREKENKISVANEDTFIKNSKYGTVGCAALDKNGNLAAGTSTGGMT
NKKWNRIGDAPIIGAGTYANNATCAVSSTGWGEYFIRAMVAHDISAMMEYKGVSLQDAAS
DVIQKKLSELGGTGGIVAIDKDGNISMEFNTAGMYRAHMNAQGELTIGIYKE
>OMIFANIC_00035 hypothetical protein
MSSYYAVIFTSLLTDNTAGYSEMAHKMEELAKKQPGYIGFESAREELGVTISYWESIEAI
KKWKENIDHLDAQQKGRDQWYRWYKTRICKVEREYEFERS
>OMIFANIC_00036 putative lipoprotein YfhM
MLQPFPTQQAILRIQRIVLISQFADETAFVLPPFYCTFNTAKPSLMKSLLRLTALAVMIL
LFACKDKTQTSQTDNLFKFKNYISNHTYGNQSIALPIRIELAQPLEQFEITQEIDSDYLK
ILPKTEGTLIVENRTTLIFQPDALLKPDTAYSVTVKLSELYEDIGREFKNYTFAFKTITP
NFKISLDNLQSYSKEWQYVTGYLEAADIIPLETAKKLVSGSQGSKQLKIQWPDDESSARY
FAFTIDSIQRKVDDSEIIVSWDGDPIEADTKGSNTFPIPGQNNFTVVDARNSHSPQASLT
INFSDPIKENQDFAGLITIENAQDLRFEVDGNVLTVYPTARLTGTSRVTIFNGIKNSDGY
GLKKEFSELISFEQIKPAVRLISNGVILPNAVSTPLYFEAVNLKSVNIRIIKVFENNMLQ
FLQTSNLNSTNNYNIRRVGRRVAARTMQLEEEGITTEGLWTAYAVNLSEFFQADPGALYQ
VEFSFDKDNSIYDCSDSDEGNPEDDYIEYADASNLDEDEREERYWDNEIYRWRTYTYNWE
QRDNPCHAAYYNEDRNITANIIGSNLGLIVKKGKNKTYHLATSNLITADPEASVKINLYN
YQQQLVKSTTTDGNGLAVFDSDKAIAFAVAVKGNNYAYVKLDDGNALSLSKFDVSGKELQ
KGLKGFMYTERGVHRPGDSIHLTFVLNDLSNPLPADHPVTLQLKDARGKLVERKVINGKA
SKNGITKDNFYYFPLATEASAPTGNWNASISVGGVNFSKTLKVATVKPNRLKIKLNFDDD
VLDASKPVSGNAEASWLHGAPARKMRIEMDATLRSTATAFDKFNGFIFNDPVRTFEEVDL
PVIDSNLSDDGKINFSEKFNISKKAPGMLRATFLTKVYEGGGDFSIDVFTKNLSPYSHFV
GLRSPKPHRYGSYFTDQKTEFEIATADAQGNPAGNRTVEVQVYRIEWRWWWSRGRDNLSR
YENAKVHRPYKKFNVSTGNNGKGTFSLNIPEDDGGRYLIRIIDNESGHATGRITYFYRNW
WRQPADGDSESTKMLVFSADKDSYEVGEEAKITFPSGSEGRALLSIENGTEVLSTQWIET
KKGETNATVKLTKEMTPNVYVNISLLQPHEQTKNDLPIRLYGVIPILVEDPTTKLSPVLD
MPKVLKPEEKFSINVSEESNKAMTYTIAVVDEGLLDLTRFKTPEIHKAFYTREALGVKTF
DLYDYIIGAYSGSVDNIYAVGGGDEAAGAKNRKADRFKPVVKFIGPFTLEKGKSASHELV
MPNYIGSVRTMIVAGDNRVGAYGKSDITTPVRKPLMVLASLPRKLSPGEKVTLPVTVFAM
EKKVKNANITVNVGDALKPIGGSTKSLSFKEPGEQIVNFEFEVLPASEFQTIEVVATGNG
EKATYEVEIDVENPNPISQKSTLHTLDANASQTITFETYGVAGTNAATLEFSTLPPMDFH
RRMGFLIRYPHGCIEQTTSGAFPQLYLADIFDLTLDKKQKMEKNVKSAIRKLNNFQRPNG
GLGYWPGESEINKWGTNYAGHFMLEAKEKGYALPITFMSNWLRYQKTAARQWRSNSTSYN
SSHIQAYRLFTLALAGQPELAAMNRLRESGNMSNDAKWRLAAAYALAGKKKAANDLAKTA
NINFQPQKYNYYSYGSSFRNKAMALETMVILGDERQREMAISLAKGLSSGNWYSTQESAY
ALLALSKMIGKNGGKAINVSYSLRGDAANVNSDRAIAERDLEVNMGTNTVTISNKKANVV
YVTLSQQGKLPLGDELNEQRNLSVQTQFLDGDEVPLNVSKLRQGSEINMKVTVTNTSNDY
VDNVALTQILPSGWEIVNTSFTELGGGASGVARYTDIRDDRVNFYFDIHRKKTRTFTLKL
NASYLGNYYLPGTQAEAMYDNTYYARNKGRWVVVEK
>OMIFANIC_00037 Penicillin-binding protein 1C
MKNQRAISQVLKSHRRKLIVLGVVFSIWLFCLPAELFDASTSTVVESREGIMLGARIADD
GQWRFPESDSVPYRFEQCILHFEDEYFYSHPGVNPVSMAKALWQNITTDKRRGGSTLTQQ
VIRLSRKNKKRTYFEKVIEIFMATRLEAGYSKKGILNLYASHAPFGGNVVGLETASWRYF
GLPSSDLSWGQSAALAILPNAPSLIFPGKNEQILRSKRDRLLKKLFDKGILDQITYELSL
EEALPGKPLPLPEIAFHLTEKIRKDFPGSRKTTTISIELQKKLNTIATENYFQFKQNEIH
NLAVLLLDVDSREVLAYVGNAPTTSDNNKYVDIIDKRRSTGSVLKPFLYTSMLHSGELLP
HTLVADIPTVINGYSPENYDGQFNGAVPASVALSRSLNVPAVRMLRSYGLDRFHRRLKKL
NFNSIDKPADYYGLSLILGGAESSLWEVTNAYAGMAATLNHFNRTSSEYTGESLKSPVII
RNETLESSKNQSEPVVFNAGAIYQTLDALQKVNRPEGEENWSFFSNSQPIAWKTGTSFGF
KDAWAVGVTSKYAIGVWVGNADGEGRPGLTGIQTAAPVLFDILDVLPQSDWFAVPYDELI
EGDICLKSGHLAGVYCEEVSSQFIPKYGIRTQPCSYHQQVFLDANKQFQVNSSCYTLAEI
KQQSWFALPPVMEYYYAQKHPEYLPLPPFRNDCLQDGERLMEFIYPKRNEAILLAKDFDE
TINDLILKVAHRSAETKLYWYLDSQFIGMTETFHELAIQPISGDYMLTVVDQEGNELKQK
VTIKQTSS
>OMIFANIC_00038 Beta-hexosaminidase
MHRALFSIVLSLLFLLNVSCADKSSEKVIIEPQIIPKPAQMDVGDGVFELTEKTTISFPK
IFSSPSNFLINYLKKGANFELILKEPEKADILIEVDSLIEDEGYFLDVSKKQILIRANSS
TGAFYAFQSLRQLLPPQIESADSFKKKKIHIPVVSITDQPKFTYRGMHLDVARHFFPKEF
IKEYIAYLAMLKMNYFHWHLTEDQGWRIEIEKFPRLTSHAAYRDETLIGHYNSTPQIFDG
KRYGGYYTKEDIKEIVAFATEHHITIIPEIEMPGHAQAAISAYPELGCAGEQVPVATKWG
VFENIYCPNQKTFAFLKGVLSEVMELFPGEYVHIGGDEAPKKQWQQCAHCQKLIKGLNLK
DEHELQSWFIKEIETFLNDNGKKMIGWDEILEGGLAPNATVMSWRGTQGGIEAAKAGHNV
IMTPTSHAYFDYYQSDDQGEPLAIGGFLPLEKVYGFNPVPSDLNNEEAKYVLGAQGNVWT
EYMKTGEQVEYMIFPRMLAMSEVVWSGPSGNKEENYPEFVNRVENFHDRLNAMQVNYANH
LYTIKGAVVKRNDSVFYELSTPTKGKTIRYSLNADASLYDYSEPIPLSEDGTLGNKHIIG
AAVYKNDSILGNRFVQEIKIHKGVKGSVSLNVEPHPSYGAGGKDALINGISGSDTRYGDS
EWLGFWGDDLKILIDLSEERQVNMVKTRFYHAPGQWIYAPKTISVTRDFADGASLNTISP
IEPDPESTVTTVSLKLKTPIDKQIKKLIIRIPNFGVIPNGKQGAGNKAWTFIDEIIIE
>OMIFANIC_00039 Copper homeostasis protein CutC
MIVEICASNFESAKAAEDGGADRIELCEYLEIGGLTPSPKLIEKVLTELSIPVHVLVRPR
KGDFSYSEADWISVLESVEMCHELGCAGIVSGALSSDKSIDKERTGTLVEICKEMDFTFH
RAFDQCRDPLAAFETLLFLGVDRLLSSGQELNAVDGIPLLKRLHVLSDNRMEIMPGSGIE
PANVMHFKESGFHSVHLSAIKKTKPATSFFDTGVSGISDLQTIKEVVQIVH
>OMIFANIC_00040 hypothetical protein
MKFNFNLFLITFVLLIGCKEEHKVQNGDQQFESKVKTVSQIKKELTDDGYQIFDYVDPNS
GDTVIMQQYFIAFLKRGPNRSQDSLGAATLQEAHLNHLGKMYDKGYADISGPFGDDGEIR
GITIYNVPTFEMADSLANMDPMVKVGRLEIEIHPWWAAKGFPLR
>OMIFANIC_00041 Inorganic triphosphatase
MIEIERKFLVNSLDYRKESQSKTTIVQGFLNTHPNRTVRIRIHGEMGYITIKGVSNENGT
TRFEWEDELNVRDARALLRLCEPGIIEKSRYVVKAGEHLFEIDEFSGENEGLIIAEIELS
SEEEEFLQPSWLGNEVTGDIRFYNSQLSKKPYKYWKNEV
>OMIFANIC_00042 DNA polymerase IV
MFEVLPIRKIIHVDMDAFYASVEQLDNPELAGKPIAVGGGGKRGVVSAASYEARKFGVRS
AMSGVLARKRCADLIFIRPRFDRYKEISEQIRKIFLEYTDLVEPLSLDEAYLDVTENKKG
NPSATLIAKEIREQIKERTGLNASAGISINKFVAKVASDINKPNGQKTVPPEEVIDFLEQ
LDIKKFYGVGKVMKEKMYRLGIFTGKDLKTKSIGFLADNFGKSGTYYFNIVRGIHQGEVK
PSRTRKSLAAERTFSENISSEVFMLERLEDIAKEVERRLKSSRVAGKTITLKIKYSDFTL
QTRSRTLPHYVSSKDLIMNNVKDLLFQEKMKDSVRLLGISLSNLNNEDKKEEKPPPDKTI
DVQLKLDF
>OMIFANIC_00043 hypothetical protein
MKKVVFALAAIVLSTVIISCKNEAESTVLQENQEQENTLENPDDLALADVNLETTTGGDY
LYVTASSGLSLREFGNLQSNKLAKMPYGTKVKVIKAEDNVTMTVSGIKGGMDEIEFNHKK
GFAFNGYLSKYFPPELNITVKDYTAELQKFFPDVTYTELKGGTASNPENTETILLPDAEW
HEAFYIAQRLFDFPKEFEFPNPNGKTAETIFDGKPKKGIWTSQLEVARNDEGLEKITYVY
SSKQFDAQVSIEKDEKGMKISRIEKIK
>OMIFANIC_00044 Pyruvate kinase
MPKQKRTKIVATLGPASSDKETIKKMILAGVDVFRINFSHANYDDVKKRIGIIRDLGDEL
HRSTAILADLQGPKLRVGIMKEEIVVEPGDKITFCTGEEFEGTKDRIYMNYRNFPKDVNP
GERILLDDGKLIFEIEATNNKNEVNAVVVQGGPLRSKKGVNLPNTKISLPALTAKDKEDA
IFAVKQEVDWIALSFVRHADDLKELQALIEAHSEYKIPIIAKIEKPEAVKNIDSIVTYCD
GLMVARGDLGVEVPAEEVPLIQKQLVLSAKRSRIPVIIATQMMETMISSLTPTRAEVNDV
ANSVMDGADAVMLSGETSVGKYPVEVIETMTNICKQVEKSELIRVPHEPPQVRTNRYVTK
SVCFHAAKMADEIEARAICTLTNSGYTAFQISAWRPDSHILVFTSNRRILSRLNLLWGVR
SFFYDRYVSTDETVEDINKIALKSGFVKKGDFLINLAAMPIVEKGMVNTLRVSQIK
>OMIFANIC_00045 hypothetical protein
MANYKLILEDDFKDEFTLIAIHCSEDPYKMAYILNRQLSLQLQRKRTDLDFSKKGLEITF
PWYEFEDQLDYTYYDLLANKCKTIAARTVASGGLFGADDSEEIIIEYLIPELKTVDFLMK
ISSDFEDVYIRKLLHDINDINQVISAYAVEVENLKSKNNLIFD
>OMIFANIC_00046 Ribonuclease 3
MASIKDIFNPRTEKDGDFFVAVKKILGFKPGDISIYEEAFTHRSMNETNSDGQRQNYERL
EFLGDAMLGAVIASHLFMEVPSGDEGYLTKMRSKVVSREHLNELGRDLNLINLLKTSIPT
DQFGGNIHGNVFEALIGAIYLDKGYRYCEKFIHRRVIKPYVDIERLEGKVISYKSLFIEW
CQKNKKPFKFMVYDDTGADELKHFAVKLMLENEVVAKARATSKKKAEERAAKRAFYKLQT
AIEKDLP
>OMIFANIC_00047 3-oxoacyl-[acyl-carrier-protein] synthase 2
MELKRVVVTGLGALTPIGNTVSQYWDGLKNGKSGCAPITYFDTEKFKTKFACEIKDYDPK
DHFDRKEARKLDRFAQYALVSSDEAIQDAGINLDEIDKFRVGVIWGAGIGGLETFQNEVI
NFAQGDGTPRFNPFFIPKMIADIAPGNISIKHGFMGPNYTTVSACASSANAMIDALNYIR
LGHCDIIVTGGSEAAVTQAGMGGFNAMHALSTRNDSPETASRPFDATRDGFVLGEGAGAL
ILEEYEHAKKRGAKIYAEVVGGGMSSDAYHMTAPHPEGIGVERVMLNCLRDANMKPEEVD
AINTHGTATPLGDVAELKAISNVFGDHTKNININSTKSMTGHLLGAAGAIEAIASILAME
NGMVPPTINHTTVDEEIDPSLNLTLNVAQKRDIKVAMSNTFGFGGHNACVLFRKLED
>OMIFANIC_00048 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVNEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEEAK
>OMIFANIC_00049 Phosphoribosylglycinamide formyltransferase
MKKRIAIFASGSGTNTQNIIQHFKSSSIGEVVLVLSNKRHAKVLERAENEDIKSLYFHKE
DLYDRDGVLKILKEARIDLIVLAGFLIMFPKHILKEFPNKVINIHPALLPKYGGKGMYGK
YVHEAIVANKEKESGITIHYVNEAYDEGAIIFQAATGITEEDTPNSVAEKVHALEYEHFP
IVIETLLTSEDDG
>OMIFANIC_00050 Ribonuclease H
MAKKQKFYVVWYGNPAGIFGSWEECQRSIKGVKGAQYKSFETFAEAKTAYNKEYSDYKGK
GGKKKKSLTPEELKKIGDPNLYSIAVDAASSGNPGKMEYRGVDTQTEEQLFHQGPFEQGT
NNVGEFLALVHGIAYLKQKNSDRIIYSDSRIAMGWVKKKKCNTKLKQSSKNKKLFELINR
AENWLKKNTYETEVVKWETKAWGEIPADFGRK
>OMIFANIC_00051 putative sugar kinase YdjH
MSKLVIVGTVAFDAIETPFGKTDKILGGAATFIGLAASQCDADGAIVSVVGGDFPKDYIN
LFVQRGMDVSGLEIVEDGKTFFWRGKYHNDMNSRDTLATELNVLESFSPVVPEKFRNSDV
VMLGNLHPMVQLSVIEQMNNPELIVLDTMNFWMDNTLAELMRVISRVNVITINDEEARQL
TREYSLVVAARKIMEMGPKYVVIKKGEHGALLFHKNEIFYAPALPLEEVFDPTGAGDTFA
GGFTGYLAKTGDYSYDNMKNAVIYGAALASFCVEKFGTERLLNLTAKEVRQRLKQFQDLT
QFDIELT
>OMIFANIC_00052 Amidophosphoribosyltransferase
MSDALKHECGIAMIRLLKPLEYYHEKYGTAFYGVNKMYLMMEKQHNRGQDGAGFASIKMD
VSPGERYISRVRSNAAQPIQDIFSQINDRINSEFKSHPEYSGDVAAQKKNIPYIGELLLG
HVRYGTFGINSVENVHPFLRQNNWMHRNLIIAGNFNMTNTTHLFNNLIKLGMHPKEKADT
ITVMEKIGHFLDDAVRKLYKKAKADGLNKMEASPFIAENLNIAKILKKSARDWDGGYAMA
GMIGHGDSFVLRDPAGIRPAYFYNDDEVVVIASERPAIQTVFNVPFEEIREIEPGHAVII
KKSGAVAQEEILSPLERKSCSFERIYFSRGSDAEIYQERKELGRLVMPKVLDAIDRDAEN
TVFSFIPNTAETSFYGMLDAAQNELNKQKNDAILKEGANLTNERLDEIQKHKIRTEKIAI
KDVKLRTFITEDSSRDDLVAHVYDVTYGIVRPKDNLVIIDDSIVRGTTLKKSILKMLDRL
HPKQIVVVSSAPQIRYPDCYGIDMARLEDLVAFQAALQLHKDRGTYDIVEKIYHKAKAEM
TNKTEPPVNHVKELYDPFTDEELSDKIAEIISDNGINAKVKVIFQSVDDLHKACPKNLGD
WYFTGDYPTEGGKKVVNRAYVHFFEGNPERAY
>OMIFANIC_00053 hypothetical protein
MKLVLITLIVINSFLQSNWELKKEKDGIKVYLTKSDDSKIKTFKVETFVKAKPREIADAV
VDLENNYKWFVNVEKAELLEQLGTDEFVFKQVIQVPFPFKDREVIEYCVVKELPNGVVRI
DLKEDSTFIPVSDDYVRMPISRGYWILTPSGDGTDIEYSFLADPGGNIPAWLANQFIVSN
PFKTIKGLREYLKN
>OMIFANIC_00054 Superoxide dismutase [Mn]
MSFELPSLPYAHDALEPHIDTRTMEIHHGKHHAGYTNKLNAAVQGTELDGKSMEEILGNL
DMSNGALRNNGGGYYNHCLFWEVMSPNGGGRPSGELAQAINDACGSFDAFKDAFSTAAKT
QFGSGWAWLCVHKGGKVEVCSTPNQDNPMMPGVTCGGTPILGLDVWEHAYYLKYQNRRPD
YVEAFFNVINWDKVAENYAKNK
>OMIFANIC_00055 ATP-dependent helicase/nuclease subunit A
MKETSSFLIYNASAGSGKTYSLVKAFLKTLLLNSSPDYYKYLLAITFTNKAVGEMKERII
EYLRRFSEAIPDERIPEMMETLSLECNLSVEQLRSKSKSILHHLLHHYAAFSVETIDSFN
HRLIRTFARDLKIASNFEVSLDESELLEQAVDNLLQRAGEDREITEALVKFTLAKTDDDR
SWDISRDITEASGILFKENELDHVQRLKDKSLPEFRKIASKLQSELESITLQIKEKALEI
LELIDESGLQFTDFNRSSYPNHMLKLAEGNDPKFDAKWQETLRDKPLYPAKLLKESAHSA
TVIDEITPALADAFDQTKQLSFRKKFVRSLLNNLTPLSVINLVQQELDVIKEEENLLPIS
EFNRLINAEIKNQPAPFIYERLGERYRHFFVDEFQDTSKLQWENLVPLIDNSLAQEQDDI
PGSLLLVGDAKQSIYRWRGGLPEQFIDLYNCENPFSVSNKDVINLDINWRSCATIIEFNN
AFFTHLSQHFNRPEHEELYTLGNQQKKNYKEGGYVRLEFIDFNKKEDADPLYAERVYQTV
RELLNQGFSLNDICILTRRKKEGIALGEILMEKGLPVVSSESLLLQHSPIVRFLADFLQF
RTQPNNDELKTSLICFMHRHFEINEPLSGFLQSFFPSEKNNFNATLHQYGIDLNIEKTFG
LTLYECCEYALKSLALLPKVDVYVEGFMNIIFDFEQRQTLLTQTFTDYWYNKKEKAAITV
GEGLDALRLMTIHKAKGLEFPVVLFPHADVDIYYEKAAKTWMNARDLVGDDEPFRINFNK
DIAEFNEEGAAIYEERRSRQQLDNFNLLYVTLTRAVEQLYIFSKNVTSNKRDDLKKYNEF
FQSFLKSQDLWEENKNTYEFGSPLRGVEKTKIHTPDEVPLYYQTTFPEDLNLQVASRGAA
LWQTDAEIAISAGTVLHDLMENIRRNEDVDETIEEFKIGSDLEDSELKRIEEMIRNIVTH
PEITHYFDSESVVETERDLITSDGRLLRPDRINFHKDNKITIIDYKTGGKSPKHMQQLDE
YGEALEDMGYSVINKLIIYASEDKISINKL
>OMIFANIC_00056 2-amino-3-ketobutyrate coenzyme A ligase
MYGNIKTHLQRELQEIKDNGLFKKERIITSPQDAVITISTGEKVINFCANNYLGLSSNKE
VIQAAKDTMDTHGFGMSSVRFICGTQDIHKTLEEKIANYYGTEDTILYAAAFDANGGLFE
PLLGAEDAIISDSLNHASIIDGVRLCKAARYRYANSDMEDLEKQLIAANEGGARFKIIVT
DGVFSMDGLVAPLDTICDLAEKYDAMVMIDECHATGFIGETGRGTLEEKGVMGRIDIITG
TLGKALGGAMGGYTTGKKEIIEMLRQRSRPYLFSNSLAPAIVGASIKVFEMLDSDTTLRD
KLQENTDYFKNGMKEAGFDIIDGDSAIVPVMLYDAKLSQTMADMLLEEGIYVIGFFYPVV
PKGKARIRVQLSAAHEKVHLDKAINAFRKVGEKLGVINP
>OMIFANIC_00057 Outer membrane porin F
MKHLNTFLVATLLLLGVGVTNAQDENNPWAIEVGVNAVDVYPVGLDDEGRFPNMIGDAAI
KGDLFDEYFNANDHWNILPSISRVSVGRYIGSGFTLTAAGSVNKITKLGNVKINDVTYYS
ADGEIEYSLRDLIGGPGGWIDPTIGVGGGYTWVDDVGFGTANLLAGMRFWVAENLALSFQ
SAYKHSFEDDYGIIHFQHSAGIMFKFGGKDTDGDGIYDQDDECPETPGLPEFNGCPDTDG
DGIEDRKDACPNTPGLAEFNGCPDTDGDGIADPQDACPTVAGIASLNGCPDADGDGITDA
EDACPNEAGPAANQGCPWPDRDGDGVLDKDDQCPDVPGTVANNGCPEVTVEIIKQLNDYS
KTILFDTGKSTIRQESYAVLQNIVDIMKEYPNTYFVIEGHTDSVGRESTNQTLSDNRAKS
VRDYLVTIGMDASRLSSIGYGESRPIATNNTRAGRQQNRRVEISLKK
>OMIFANIC_00058 hypothetical protein
MQTFLEETIDDLLQKHNDVSQLTIILPSKRAGGFFKNYLRKQIRKTSFQPKIISIEEFVE
IISDLTIIDNTQLLLKSYLVYRNTDAIPEKEEFETYSSWIQTLLNDFNEIDRYLVDPEQF
FNYLGSIKSLEKWSLPEDQTDFIRNYLTFWNSLPAFYQNLRDDLLKDGFGYQGMVYRKAA
EEVEHYISVHGDKPHIFIGFNALNKAEQTIIKELLETSNSEIYWDAESHFFNQSSHSASK
FMSAYFETWKYHINSKPILGNNFDQPKAFRFIEVPQNVAQAKYAGNILARMTREALENTA
VVLADESLLTPLLYSLPSDIESVNITMGVPIQNFPVSLFFQTLLQIHQKHSAKWYYKDVF
RLLNNPMGSKLVPSSAGIIDKISAQNYTYLSLEQIITFADEDDIENLNLLFGNWRDDPKK
ALHNSKILLVNLKKLTKQNAMEKVTVFELYKTFKNIEIQLNSFPYISSIKTIYALFQEAI
SHATVDFKGDAYKGLQIMGVLETRVLDFKNVIMLSVNEGFLPSGKSNTSFITYDLKKEFE
LPLFTDKDAIYTYHFYHLLHRAENIWLLYNNSSEGLGAGEKSRYMLQLDIERHPNHTIEK
QVVSPPISITDSPALSAAKTPAVMDRLKAIAEKGFSPSALTAYIRNPFDFYLSRVLGINE
TEEVEETVDYQTLGTIVHNCLETFYEPLVGVKLEISQLVAMKEKVQEEVTREFERSFLKG
EFRKGKNLLIFEVAKRYIENLINLDITELQNGHRIKLLQIESKLSIPFNLAELPFPVNIQ
GTVDRVDEFDGSVRIIDYKTGNVSQSDVEIINWEELTSDYKFSKAFQILSYAMMIHDQDA
INTSEAGIISFKNLNRGFLKFGTKTSSHGPRNNRISEDTLHLFAAELKKLVLEICDPAIP
FIEKEV
>OMIFANIC_00060 hypothetical protein
MKLFTSIFRKIRSKIDLSEAALFFIGAVAIILFQNQFYQFKVIAPAENIVLLLIAVMAIL
IAAVFQFKLRKIAPGFLLIYCFSLLLSFSALWILREYRFGFNGMRSDAYFNLALISTYYE
NWISSDFSYKGLSSFYPYYYQFFSGKIGSLFQIPPYVMAKLGTLLVLYVIPIISYKFWKR
AIGQGLLAAVLVVVSFLAFPYPYYVKPYKIITILLILPWFYYYFVKMKKGGFLSLMFGGF
LGGMLFGTYYFFFILLVLAVVLYIIYYIFSERKGLRSLYKEHKSQLIIVCWTIVFASPFM
APYVIDLLTHPVDSNQNKFFLANSIRFEWLSLNNWPLVVSIFYFTVTYKDRLSRYLLTIL
GACLIFMLFAYTGLLNNKPVLISHVYPMALMISYIGLVLGIDRLLGAYKPESLKPVLLGL
SCILFYQQGLFFENIQRTKMTDLENSWLPTILFDEKFPVENLRNKVLLTNVDLNCFVPSY
KFLERNAFFSHPSSQITERMKFLYALQFFDDPVFQRFMLQHNRFEKVDYIIFVRDNGKLY
LHVPNFPYQPFIHRVPIDLSALVRSNTEMKQVALQYNNILVYKLAEKPVNSKSFTQLQKK
FIEAFGDDTAITNISGTPVSFDKGDEYLGDFSFQNLELFRKMNETPLKILIEDPKAKLEV
GYYHSQYTDSGIIYVAVEEYYVFRRNFRANEEQAVDLEFNFYTEDSLVQGKKLNWLDKKE
SSYRKDQRVYYYFEIDAGIIDACDKMQFRMTSRRFELNKSIQVDF
>OMIFANIC_00061 TRAP-T-associated universal stress protein TeaD
MKNILVPVGSTENGVNNLRYAVSFAAMSGATVYLINIYKEYSKAGGMTKVTQVAMEDNQA
QLDEVLSRVDTEGVEVIAKPIKGDPYEGIARVSKRLNIDLIIVSSQSVEIRDEVYLGSIT
GRLVKQTDIPMLIIPRDYVFRKAENILLAVKSLSFEKENVLNPLRDILALFSAKLNVLRV
KTPDVADEEDQLDTELKEIMTTYTETENATIYQGVLEHFQSHQPDILCVLRRKRGFFKKL
FEKNAVYKRDFYTTRPLLILCGIQ
>OMIFANIC_00062 hypothetical protein
MIRKAKPLEIDAILAITRACAVKMIADKIYQWNEWYPHREAFETDIRRGELFVITSQDTI
TGCIVISSLKDEVYNPVQWLTEDGLNYYIHRLAIHPDFQHQGFAKKLMDFAEEYIRKNEG
ISVRLDTFSKNTRNQRFYEARGYTRLEEIYFPKQSEYPFYCYELPL
>OMIFANIC_00063 hypothetical protein
MRRWTLHICLILIGFAARGQSCPDLLNPLAGANGVPVDTSISWEEVVGVTGYIISLGTTS
GGTDIINEQPVGSDTTFTPPLGLPESTQIFVTLTLFFFNQDNIVCNSVSFTTENVTTVPE
CATLLTPVNGETNVNVGTIISWAYASRAIGYRISIGTAPGAGDIVDNQNVGNVLSFDPPN
NFPPATEIFVSITPYNENGDAVDCPGASFTTGALGEPPGCTMLISPSNGQINVTLDTVIE
WAPVPNAIGYIVSIGSSPYINDVLDMVIYTTTVINVINFEPNKTYFVRIIPFNEAGQAQG
CIQESFSTILGCGPFFDPVTGELITFFPEITMPDEIGICENDLPTRIEAPDIADGYRWFK
ITANEPETLISDEDYVLISEPGQYRYVAYNLLVQDGFELECPADKEFTAILSGLPSIDFI
NIEEDGELFNISIGVSGVGDYEYSLNSTNAWTDNNIYSALTPGDYIIYVRDKNGCGTVER
AFRLAFPPPGFPPYFSPNGDGIKDLWQYIPPKEDPLPLTIIYIYDRYGKILSYFSIDDPG
WDGLYDGTPMPLGGYWYKALTSDGQAYRGHFSLIR
>OMIFANIC_00064 DNA damage-inducible protein F
MAIPAILSGIAEPVLSSTDAAVVGNIPDYGTESLAAVGIVGSFLSMLIWILAQSRSAISA
IVSQNLGAGKIKELNNFPAQAIYFNIALSIIVLLSTYYFVEEIFGLLNAEGIILEYSIDY
YNIRVWGFPLTLFTFAVFGLFRGLQNTFWPMTIATTGAVVNIGLDFALVYGIEDYIAPMG
IKGAAWASLISQAIMALMALIFILRKTDVSLRLRFPLHPEISRLVQMSINLFIRSIALNA
ALMLAVREATGLGKEYIAAHAIAINIWLFSAFFVDGYGAAGNILGGKLLGEKDYTTLWKL
TRRVNLYNLFVAGVLVLVGLLFYKQLGLLFNKDAEVLAIFYGMFFMVLISQPLNALGFTL
DAIFKGLGEMRYLRNVLLGATIIGFVPVLFLARYMDWGLTGIWMAILVWVAYRAVALIIK
YRNKYLPLVEK
>OMIFANIC_00065 hypothetical protein
MSNIQITKMFTFETGHALYGYDGKCRNVHGHSYKLSVTVIGVPISDSNNVKYGMVIDFGD
LKKIVKEEIVDVFDHATVFNKNTPHVELAEELKSRGHNVLLVNYQPTSEMMVIDFAEKIR
KRLPETIKLHSLKLQETETSYAAWFASEN
>OMIFANIC_00066 UDP-2,3-diacylglucosamine hydrolase
MHIPQGKKIYFSSDNHLGAPTPEASFPREKKFVRWLDSIKHDAAAIFLLGDLFDFWFEYK
TVVPKGFVRVLGKLAELSDSGIPIYFFVGNHDLWMRDYFEKELNIPIYREPKEFNFNDTS
FFIGHGDGKGPGDKGYKRMKKVFTSPFFKWLFRWFHPELGMRLAQYLSVKNKIISGDEDK
KFLGEEKEWLAQYARRKLESSHYDYFVFGHRHLPMEITVGDNSTYFNLGDWITHFTYGVF
DGTKFELLEFKE
>OMIFANIC_00067 hypothetical protein
MKQIIIFLLIVIIGLIGWGQYKKYKRFSLTEYEYKIPENLKNSERKDLLLDYFEAVEALN
GHVITQWSAYRIDVRNPKKDNNRTQAAVSEYRNKRANVKYYEQQLLDPETQKEPSVVSEE
EKKKQLLRKQFYANPSANSLRLREQNAMVFEIQGLLISKGHIIEHDGLFRAETFNALKAF
EEKSGLFPDGKLDAITLEYLLK
>OMIFANIC_00068 Single-stranded-DNA-specific exonuclease RecJ
MRWTLKPKPNPEKVSKLSKDLQVEPVVAGLLIQRGIESYEDAKRFFRPELSHLHDPFLMK
DMDKAVERIEKSIEEGENILIYGDYDVDGTSSVALLSSYLKTYYPNVGTYIPDRYEEGYG
ISYQGIDYAEDNDIGLIIALDCGIKALDKVLYASEKNIDFIICDHHRPGDTIPDAVAVLD
PKRPDCDYPYKELCGCGVGFKLVQALSSRRGLSLNDLLLYLDLVVTAIGADIVPITGENR
VLAYFGLKVINSNPRTGFQAILQQLKKKKLTITDVVFIIAPRINAAGRMKHGNHAVTLLV
EPDLDKAMDYAREIEEFNTERRETDKQITEEALQQIREKHEEDRMTTVVYKENWHKGVIG
IVASRLTETYYRPTLVFTKSGEKLAASARSVRGYDIYNALEGCAGHIEQFGGHKYAAGLT
MFEKDFEKFKVAFERVVSETIDPTLLIPEIKIDAQIRLDQITPRFYRILKQFAPFGPGNM
NPVFMSVDVKDNGTGRCVGEDKSHLRLVVTQGNSKPITGIGFGLGDKEKIACEGEYFKVA
YAIDENEWNGMISLQLKIKDIKL
>OMIFANIC_00069 hypothetical protein
MTSEAININLVKGASFSYFREKQNYNSMPLVTPLSAEHDPETKQLAEFFNETLGFCPNSV
LTMQRRPAISKAFINLNKAVMANEGRVTSALKRMIAWVSSNSTGCRYCQAHAIRAAERYG
AEQEQLDNIWEYRTHPAFSEAERAALDFSLAASLVPNAVDEEIKSRLYEHWNEGEIVEML
GVISLFGYLNRWNDSMGTSIEEGAIESGEQYLGKHGWNKGKHV
>OMIFANIC_00070 hypothetical protein
MKELLSEIRKCTVCAKHLPLGPRPVIEASANSKIIVVGQAPGTKVHQSGIPWDDQSGKKL
REWIGVDNETFYDVDNFGIVPMGFCYPGKGKTGDLPPRKECAETWHDRIFKAFEGVELIL
LIGTYAQDYFFPKEERNLTGKVKNYTDFLPKYWPLPHPSPVNRFWRSRNPWFENDVVPKL
QDKIHEVLQN
>OMIFANIC_00071 Ribosomal RNA small subunit methyltransferase I
MGKLYLVPTPIGNLKDITFRAVEVLKEADLILAEDTRTSGKLLKHYDIQTPMQSHHMHNE
HRTVDAIVSRIQTGDTVALISDAGTPAISDPGFLLTRACIEQGIEVDCLPGATAFVPALV
NSGLPNDKFVFEGFLPVKKGRQTRLKLLAEETRTIILYESPHKLVKTLNQISEFLGEDRP
ISVSREISKMHEETLRGTVTELISHFETHPPKGEIVIVVGGKK
>OMIFANIC_00072 hypothetical protein
MKKKLQKEISELAAELSREGTEFNVRKVKQAIRLIFEKLTVLEYLEGQLEGGDQSFDSKS
FREQNWFVEPEPVPQPEHEDELVEPVMEKIKDIVAQMPEESDQVDELLKEVLPEKKYVKN
DLEEFASNYQETPVFERKEPETAKAVKPPTAIKPETLPKDSVEVDRPKSLNEVVKSGLNI
GLNDRHAFIKHLFNDRTDDYTRVLSQINSMRSFEEAATFIKGKVKPDYNYWLNKDKYAER
FMALVEKSFN
>OMIFANIC_00073 Thymidine kinase
MFLENTVNQKEQFGWIEVICGSMFSGKTEELIRRLKRAKFARQRVEIFKPSVDLRHEEDK
VISHDSNEIRSTSVPAAANIPILADGCDVVGIDEAQFFDDEIVKVCNDLANNGVRVIVAG
LDMDYKGNPFGPMPNLMATAEYVTKVHAVCPRTGNLAHFSYRKGNSDELVLLGETDEYEP
LSRAAYYKAVLREKVKKIDVKDPIELPSKKQA
>OMIFANIC_00074 Alanine racemase 1
MPKASETILEIDLNALDHNYRFITSNLKPTTRVLGVVKASGYGSDGAEIARELVELGADY
LAVAYVNEGVELRDAGIEAPVLVLHPQPVNFDVLIERCLEPALYSARVLKSFIAKAEEHS
QKDYPVHLKFNTGLNRLGFWENDTEWITERLSGTSAIKVKSMFSHLAASEDASEKDFTLN
QIKSFKAITEDMRSKLGYEMMLHQSNTSAILNYPEAEFDMVRTGIGLYGYGNNPSIDTHL
IPVLHLKTVISQIHMIEPGETVGYNRAYAAKGYEKTATLPIGHADGIPRSLGNKKGSVII
SGQKADIIGNVCMDMMMVDVTNIDCKEGDEVIVIGEKMPASELAAAGNTISYELLTALSH
RIKRVVCRK
>OMIFANIC_00075 Large-conductance mechanosensitive channel
MLKEFKNFILTGNVIDFAVAVILAGAVGLVVNGFVADIMMPIVGHFAGGIDFADMKYVLD
EAVTGEDGAVTTPENAIMYGKWVNAIINLIIVGFVLFMIVKAYNKSKKPAEEAPAEPAGP
TQEELLSEIRDLLKK
>OMIFANIC_00076 Aspartate-semialdehyde dehydrogenase
MKVAVVGATGMVGAVMLKVLEERNFPVTEFIPVASERSVGKEIVFKGKPYSIIGLQDAVN
ARPDIAIFSAGGGTSLEWAPAFAEIGCTVIDNSSAWRMDRTKKLVVPEINAHDLTSEDKI
IANPNCSTIQLVMVLAPLHKKYTMKRVIVSTYQSVSGTGIAAVNQLENEIKGVKGEMAYP
YPIHKNALPHCDVFEANGYTKEEMKLAREPQKILDDRSFSISATAVRIPTAGGHSESVNV
EFFNDFDISEIRKILHETPGVTVQDNPDTNTYPMPVYAHDKDDVFVGRIRRDETQPNTLN
LWIVSDNLRKGAATNAIQIAEYLVEKNLVGESVSRA
>OMIFANIC_00077 hypothetical protein
MNSNFTTILRIILALGLLVFGLNKFVGFIPPPELNPEASDFMNSLVDTGYVLYFLGILEV
AIGLLLLLKKWVPFALIVLVPISVNILLFHIFLDLPDILQAIIIVGLNTILIIKYWKAYR
PLFH
>OMIFANIC_00078 Prolyl endopeptidase
MKKSIILPFLALILIACKEEIKKEPIAVNYPETKQVDTVTTYFGTEVKDPYRWLEDDMSD
ETGDWVKRQNEVTFGYLDNVPFREELKQRLETLWNYEKVGAPFKEGDYTYFRKNDGLQNQ
FVIYRYRTGEDPSTAEVFLDPNTFKEDGTISLGGLSFSDNGAAAAYSISEGGSDWRKVLV
MNTESKEIVEDTLMDVKFSGLSWKANDGFYYSSYDKPEGSELSAKTDQHKLYYHKLGTPQ
TEDQLVYGGTADEKHRYVGGYVTEDNRYLVVTASISTSGNKLFIKDLQNPGSGFTTILDH
ADSDTYVMENEGSKLYLATNLNAPNQKIVTVDASNPTPDNWVDFIPETDNVLSPSSGGKY
IFAEYMVDAVSKVFQYDFDGNMIREIELPGIGSAGGFGAKKEETELYYSFTNYVTPGSIY
KFNMENGESELYRKPEIDFNPDDYESNQVFYTSKDGTKVPMIITHKKGIELNGKNPTILY
GYGGFNISLTPGFSITNAVWMEQGGIYAVPNLRGGGEYGKKWHLAGTKMQKQNVFDDFIA
AAEYLIENNYTSKDYLAIRGGSNGGLLVGATMTQRPDLMKVALPAVGVLDMLRYHTFTAG
AGWAYDYGTADDDKEMFEYLKGYSPVHNVKDGVEYPATLITTGDHDDRVVPAHSFKFAAE
LQARQSGTNPTLIRIETDAGHGAGTPVSKRIEQYADIFGFTLYNMGYEVLPEKVNEEVKE
>OMIFANIC_00079 Spermidine/putrescine import ATP-binding protein PotA
MFPDTLLGNNLFLYQNMLKVNIETFSYDQTEILKNIQFELEPGEHLAVLGESGCGKSTLL
HLIYGLLQLEKGSLHWDSKELKGPKFNLVPGEPFIKLVAQEYNVMPFTTVAENVAEHLSR
RDPEEDSIRVQELLEVVNLDEFSETMVKNLSGGQKQRVALAKALAKQPELLLLDEPFSHI
DTFRKNKLRRKLYDYLKEKNIACITATHDAAEALAFSDHLLLLKDGTMEALGSPEQIYGS
VANVYQAGFFDEVNLLPAFLSNSDDRSGEMILFPHMLMYSAEATEIKVIVQKSYFKGSHY
LIYSEWNGQAVFFEHSKRLEKGESLYLTIAE
>OMIFANIC_00080 hypothetical protein
MKKLIYTILIALCTGSAMYSQESSEDYSEKVNSIDSIIETLYGVISGEKGEERNWELFKF
LFTPDAKLIPSGKNADNTYNVRYMTPSDYIELAGKWLIENGFYEKEIYRKTESFGNVTHV
FSTYESYYSSSDKEPFMRGINSIQLLDDGNRWWVVNIYWTAETDEDPIPVKYLPKRN
>OMIFANIC_00081 hypothetical protein
MTNQEIKIKLFSKCKDYISSHRERINMALSGIKNSLNDEGKSTVGDKHHTNRAMLQLERE
NLSHQIVEVEKQEAILNKISLEHLNEIAHLGSLVVTDHANYFMSVSAGAIKIEGKTYYCV
SLESPIGKLMLGRKLGEVAVFNDKKINILEIH
>OMIFANIC_00082 Biosynthetic peptidoglycan transglycosylase
MIKKLFRFLIKTTLWFVVLSIVWVLLYRFLPVPATPLMAIRSFQSETTVYIKHDWVPLED
ISKVMQLAVISAEDQNFTTHNGFDYEAIKKAYKDNKVGKSLKGGSTISQQTAKNVFLWPG
RSWFRKGLETYFTFLIENLWGKERILEVYLNSIEMGEGVYGIQAASKYWFNKDAKNLTKH
ESAAIAVILPNPRNYKASPRTAYLEKRKQWVLRQMNNLGELNINKNDQPGD
>OMIFANIC_00083 hypothetical protein
MNLSYWEQKSWFSDIDFAIVGSGIVGLSCALALRKKHPKKKIVVFEKGILPSGASTKNAG
FACFGSVSEILEDLKTHSEEEVIQIIRGRIEGLKLLRETLGDHEIDYHEYGGYEVFSAAD
EQLYEKCLSNLPYVNNLMKMAFYAEKGVFIVKNDPFSFKNTQKKLIFNQFEGQINTGMMM
QALLKKAAEMDIFVINSVEIESYLPKNGAISIILNKNVEISVKKLLLATNGFAKQLFKEE
LQPARAQVLITKPIKDLKIKGTFHLEKGYYYFRNIDDRILLGGGRNLDFNAEETTELGLT
ALVQNKLDELLSTTILPGTAFEIESRWSGIMGVGGKKKPIVKKIDDHVYCGVRLGGMGVA
IGSSIGKHMAELVDS
>OMIFANIC_00084 Biotin carboxylase
MFKKILIANRGEIALRVIRTCKEMGIKTVAVYSKADEESLHVRFADEAVCIGPAPSSESY
LKIANIISAAEITNADAIHPGYGFLSENARFSKICEEHDIKFIGASPEMIEKMGDKASAK
ATMKEAGVPCVPGSEGVIEDFESCKKLALETGYPVMLKASAGGGGKGMRAVWKEEDLQDA
WESARQESKAAFGNDDMYMEKLIEEPRHIEIQIVGDSSGKACHLSERDCSIQRRHQKLTE
ETPSPFMTKKLRNDMGMAAVKAAEYIKYEGAGTVEFLVDKNRNFYFMEMNTRIQVEHPIT
EQVIDFDLIREQILVAAGVPISGKHYTPNLHSIECRINAEDPYNDFRPSPGKITTLHAPG
GHGVRLDTHVYAGYMIPPNYDSMIAKLITTAQTRDEAINKMKRALDEFVIEGIKTTIPFH
RQLMDHPDYVAGNYTTAFMDDWEMEAPEE
>OMIFANIC_00085 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MELKEIQNLIKFVAKSGASEVKLEMDDVKITIRTGKPEGNGDTHIIQQVPTMPVAAQPQA
APVAPSEPPAPEAPAEKAPVVEEDSNLIVVKSPIIGTFYRKPAPDKPVFKEVGDTISVGD
VLCVIEAMKLFNEIESEVSGKIVKVLVDDASPVEFDQPLFLVEPS
>OMIFANIC_00086 3-oxoacyl-[acyl-carrier-protein] synthase 3
MSKITAAITAIGGYVPDYVLTNEILETMVDTNDEWITTRTGIKERRILKEEGKGTSYLAI
KAAQDLFEKSNTNPKDIDLVIMATATPDMPVAVTGVYVATEIGAVNAFSFDLIGACSSFL
YGMSVAARYIESGKYKKVLLIGADKMSSIIDYEDRTTCIIFGDGGGAVLFEPNEDGYGVQ
DEFLRSDGIGRESLKIDAGGSILPPSAETVANKQHYVFQDGKTVFKFAVSNMADVSEKIM
VRNGLSGNDVNWLVPHQANKRIIDATAKRMDLPEEKVMMNIQKYGNTTSATLPLCLVDYE
NQLKKGDNLVFASFGGGFTWGAIYVKWAYDPE
>OMIFANIC_00087 50S ribosomal protein L32
MAHPKRKISRTRRDKRRTHYKATTPQIATDPTTGEAHLYHRAHWHEGKLYYRGQVVIDAT
EEAEA
>OMIFANIC_00088 hypothetical protein
MEELKEFTIPFIGLKLGEHRFNFEITNTFFEHFGYDEFDNANIKLDVLLDKKSTLLDISL
NFEGPVGVNCDITNEPYDQGLSGTYHFVVKFGEEYNDENEDLLILPHGSHEVNIQQYVYE
SIVLAVPTRKIHPGVGDGTLKSEILEKLEELRPNGSNDSEKENEDTDPRWDELKKLLTDK
>OMIFANIC_00089 4-hydroxythreonine-4-phosphate dehydrogenase
MSKKEKIIVGISIGDLNGIGSEIVLKTFQDNRMLEFCTPVVFASVKLMSYIKKVLELDVN
LYGIDSLDKIVHKKINVLNVWKEQLDIKFGEEDKAIGSYAIKSLEAAVAALKDSKIDVLV
TAPINKSNVQSESFNFPGHTDYLAKELGGESLMLMISDGLRVGLLTDHVAVKDVSTTITR
ELIEKKIKTIYKTLIQDFGISKPKIAVLGINPHVGDQGVIGTEDDEILIPTLNNLRNNGK
LVFGPYAADSFFGSGNYKNFDAVIASYHDQGLVPFKTLTFGNGVNYTAGLSKIRTSPDHG
TAYDMAGKNKANYESFKQAVFSAIEIHRKREEYRLLSKDPLKVNPKKTFAKKK
>OMIFANIC_00090 Riboflavin synthase
MFTGIIESLGTVSEMIKEGDNVHLIINSSLCSELSVDQSVSHDGICLTVVDVMPDNYKVT
AIKETMDKTNLGELQPGSLINLERAMKLGARLDGHIVQGHVDETGICTKVEEANGSWYYT
FTYNTSNDNITIEKGSITVNGVSLTVVNSKLNEFSVAIIPYTYENTNFKQIRAGDTVNLE
FDVIGKYVKRLMNAF
>OMIFANIC_00092 hypothetical protein
MIKIEHIGIAVKDLSAANEIYTKLMGYEQYKTEEVKSEGVTTSFFKCGESKIELLEGTTE
ESAITKFVEKRGEGIHHIAFAVDDIHSEMKRLEKEGFRVLNKEPKRGADNKWVVFLHPKS
ANGVLVELCQDVEASVIQ
>OMIFANIC_00093 Ribosome-binding factor A
MYYFCTMTESNRQKKIGGVLQEDLANELQTMLRDAGQTGVIISVSKVKVTADLSIAKVYV
SVFPPDKAESIVNELNGIKPAIKHRIALITKDQLRKMPDLSFYNDDSLEYIENIEKAVKG
GDNPLENPEILPKRKKS
>OMIFANIC_00094 Lipoprotein-releasing system transmembrane protein LolE
MNFPFYIAKRYLFSKSSNNAINVITIIAATGVVIGAMSLFIVLSAFSGLKDFSLQFTNVF
DSDLKIVPASGKTITFNEELAEKFDKVAEISAYSKIIEERAFLQYKGKNHIAYIKGVDSN
YVNVVPVDSILYLSEWFQYGRNEVVIGTATALKLSIGINDYTNLLEIYVPTPGTGQITEL
NIDRAFTRERAVAVGFYEVNEDVNGKYVFSDFELAQSLLSLDSTVVSSIEIKLQPDTDEE
LVKAKIFEILQGQDILVKNRIQQNDALYKMLNTENIAVYLIFTLVLIIALFNVIGSIIMM
ILDKRKNIKTLFNMGTTLRKIRLIFFLQGTLMTTLGGLLGILLGIIIVWLQMQSPFVYIT
SSLPYPVKLKAINIVVVFVTITLLGIVASKIASNRVKASLLD
>OMIFANIC_00095 putative tRNA-dihydrouridine synthase
MAKIGDIDVGDFPLLLAPMEDVSDPPFRALCKEQGADVVYTEFISSEGLIRDAAKSVMKL
DIYEKERPVGIQIFGAVLESMLRSIEIVEASGPDIIDINFGCPVKKVVSKGAGAGILKDI
DLMVSLTEAMVKHSKLPITVKTRLGWDHNSIKIVEVAERLQDVGCKAISIHGRTRAQMYK
GEADWAPIAEVKNNPRMHIPVFGNGDVNSPERAMEMRDKYGLDGAMIGRASIGYPWFFKE
VKHYFKTGKHCVPPTMAERVEAARRHLTMAIDWKGEKLGVFETRRHYTNYFKGIPDFKQY
RMRMVTSDDSASVFAAFDEVLEKFGDHQFV
>OMIFANIC_00096 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLDATGSVTAREQQAQLLDNMDLERERGITIKSHAVQ
MEYEYEGEQYILNLIDTPGHVDFSYEVSRSIAACEGALLVVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEEVTDDIVDLLGCDAKEVIPASAKTGFGIKEILKAIIERVP
APKGEPNEPLQALIFDSVYNPFRGVETYFRVLNGEIRKGQQIKFMATGKNYFADEVGTLK
LKQLPKQVIKTGDVGYLISGIKDAREVKVGDTITDAKNPTTNMIEGFEDVKPMVFAGIYP
VDTEDYEELRASMEKLQLNDASLVFQPESSAALGFGFRCGFLGMLHLEIIQERLEREFDM
TVITTVPNVSYQAYTNKEPDTPILVNNPSDLPEPSTLNRVEEPYIKASIITKADFVGPVM
SLCIEKRGQITNQTYLTPERVELNFDMPLAEIVFDFYDRLKTVSRGYASFDYSPIGLRAS
KLVKVDVLLNANTVDALSALLHQDNAYDIGKKMCEKLRQLIPRQQFDIPIQAAIGSKIIA
RETVKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRAVGNVEIPQEAFMAVLKLND
>OMIFANIC_00097 hypothetical protein
MNLRRISSVIKTNQIRSRCSYKIFMKFYYTIIALLGIAFLTSCKSDDTGGCVTCSAPQTL
DFVLCEEGDGNASVNGENTGTPYDLYLQDLLDDGADCGG
>OMIFANIC_00098 K(+)/H(+) antiporter NhaP2
MLELAGIIVLGILAQWVAWKLKIPAILPLILIGLFVGPISTLVSEDGSQWIQPIFDGKSG
FFPGQNLFYFVSLAIGIILFEGGLTLRSEEVKKIGPVIGKLISLGSAVTFIGGGVAAHYI
FGLDWRIAFLFSALIIVTGPTVITPILRNIPLKKEVSAVLKWEGILIDPIGALVAVLVFE
FISVGGDAGYTKQALVEFGKIVLIGFSFGISGGYALYYAIKKRFIPHYLLNVVSLSVVLL
IFVESDVFAHESGLLAVVVMGMFLGNSDLPSLKELLYFKESLSVLLISILFILLAANITL
DDLLLVYNWETGILLAVIIFVLRPMAVFLSTTGSSLKTNEKLFISWVGPRGIVAAGIASL
FGTKLVEQGIPGAEYITPLVFAVVLVTVLLNAATARLFASIVGVFLKTSEGIVIIGASKV
SRLIGVYLQKNNRHVVLVDTNSSNIDRAKDLGLEAMNASIHTDDLTDNIELNDVGYLIAM
TGNPEINKQAISKYGKTLGENGSYRLMSADELKSGEIRPGTRNDILTTTHDYLKLVQVVS
EYPSIQDLPINSKDQFLEILNRIEKKDEVVALFLKDEKNNLELITDPENMHVDKGCQIVY
LGKPIDLEGVVQMNNSNESQEDQ
>OMIFANIC_00099 hypothetical protein
MKYHEFNTIGIGVAFSPNLKANIYEASRLAIFFESRLVLIHVGDRSNEKTEIIKSHLMPF
IDRELDYEILFVPGDPVSVILDSVERENIDLLLLGALQREKFLQFYIGTIARKITRKASC
AVLLHINPSVQRVPCKHIVVNGMKSDKSAETIASAFYVAYKLGTDRLTIVEEISQDEVAV
KVEDDKSLRKSALIRDKLRRRESNRVKKIIQEVPQLFKKGVAVTSQPIFGRRGYSIGHYA
ELVRADLLILSAPGKSGLRDRIFPHDNEYILKELPTDVLILP
>OMIFANIC_00100 C4-dicarboxylic acid transporter DauA
MIPKKNAISLFFRVLPKNIFSGFVVSLIALPLGLGLAMASDAPPIAGIIAAIVGGLVVSF
LGGSFVTIVGPGNGLVGVLLVAVTTLGLEGTYAAVICSGGLLLILGFLRMGKLANFFPSS
AIQGMLAAIGLIILGKQFHVMLGNKISREGSIDYLLEMPGTIFAVFKYDNMALVYAAVAG
ILSLLIMAYYPKIRNKYLQLIPAPMWIVLLSIAFSYFMELVIQAPNPIHPEYMVAGIPEP
AEVVSQIPSPDFSLVSGFPFWMSVLALTLIASIESLLSIKAVDKLDPDRRRSNVNKDLKA
LGLATVGSGFLGGINVVTVIARSSVNVNNGASNRSSNFFHALFLTVFIVLFSTQLTRIPL
PALMAILVFTGYKLASPSTIRKIFNIGKEQLLIFFTTLVVTLYVDLIVGIIAGVVVTIII
HSFVAKSISLFFSNVQKPNVLMYKEMDSGSYYVSVKHFSSFLNFYKLKQKLDIIPEESDV
VIDFSLCEFVDHTVMESLNSYQNVFAKRGGNFEVIGLDLHDTESEHPFALRRLIPGFQFI
QKNLTKRQSTLKEVAEDYDLNYAFDSVEDVRFIEDFIFFRTKQIQRVYNQLFNDIASFRI
FDLTFSEGAFIAREVVRTTMLHIELERDLPVFTLDREGFLEKVYAFAGFKDIPIDNHTDF
SKRFYLLGEDEGSIKEFFTDDLVHFFESNPYYHIESNGHSLLLFGKERLAGIKEIKAMLD
FGKRLKDVIDSEYFS
>OMIFANIC_00101 putative quorum-quenching lactonase YtnP
MKLFPIESGNFKLDGGAMFGVVPKTLWSKTNPADKNNMIDMAARCLLVEDGKRLTLIDTG
MGNKQSDKFFGYYYRWGDHSLDTSLKKYGFHPDDITDVFMTHLHFDHCGGSVQWNKGRTG
YEPAFKNATFWSNARHWDWAVHPNRRERASFLKENILPMEESGQLKFVPDPKTDYVEKSE
LNFGIFFADGHTEKQMLPHIQYKDKTIVFVADLLPTAGHLPIPYVMGYDTRPLLTLPEKE
KFLNAAADNNYYLFLEHDAHNEIITVKHTEKGVRLDESFTFNELFN
>OMIFANIC_00102 Thermophilic serine proteinase
MVAFALATLLASCGNSVAPIVSTPIENIDTLPLKTAPLTDEGFKTWASADLLSDTIPGMS
VDRAYAEILKGRKGQKVIVGVVDSGVDIEHEDLKNVIWVNKDEVPGNGKDDDKNGYVDDV
HGWNFLGDIVGENMEYVRYMKKLGPKFDGKSENSISAADRADFAIYQKAKAEYEKEYQEV
LANKNRYDQILGQLKPAHQAIAKKLGKEDYNQKDLAAISDPSPSEQQQIGMLNQMLNYGD
TVPEVIKELNGGIDYFSGRLDTHFNMNKDFRMKLNNDPDDFSTKYYGNNDVDGPDPKEED
AQHGTHVAGIIAAQRNNGVGMNGVANNAEIMVIRTVPDGDEYDKDVALAIRYAVDNGAKV
INTSFGKYFSTHPEWVRDAIKYAASKDVLIVNAAGNEGLNLDTIEVFPNDQTMTGPEIAN
NVLTVGALSYKYGSEMIASFSNYGKSNVDVFAPGVKIWSTTPLDTYEYLQGTSMAAPAVA
GVAATIRSYYPKLSAAQVKQAIMDSGLTSKSPVILAGESSNQDNFSNVSKSGKMVNMYNA
LILADKMSRK
>OMIFANIC_00103 Aminopeptidase N
MKQAIKFLLLWLSVFPALAQNSTSYWQQHVDYTMEIDMDVETFQYKGKQTAVYTNNSPDV
LNRIFYHLHFNAFQPGSDMDIRSRTIADPDGRVGDRISKLSPSEIGYIRPTVLRQDGVPL
KYVVAGTVLEVTLNKPLQPGESTTFYMEWDAQVPVQIRRSGRNNRDGVALSMTQWYPKIA
EYDFQGWHADPYIGREFHGVWGNFDVKITIDADYTIGGTGYLQNAEEVGHGYGPEGLKPM
KPKNGKYTWHFNAPNVHDFTWAADDEYIHDKLEGPNGVVLHFLYKNNPEIIENWKKIQPK
TAELMQFFNENIGPYPYKQYSVIQGGDGGMEYGMCTLISGGTRYRGLLGTTSHELAHSWF
QFVLATNESKHEWMDEGFASYISARAMGAVNNEVKANPWGGSYRGYRYIAKSGNEQPQST
HADRYAINRVYGVAAYSKGAVFMAQLGYVIGEKNLDKTIKKYFNDWAFKHPTPNDFIRVA
EKVSGFELDWYLTDWTQTTNTIDYSIENVQSDKDGTYIFLERIGLMPMPIDLEIEYSDGS
RELFYIPLQMARAEKPAENDSLRRTVMADWSWANPEYKIFVAGNKSINKVMIDPSGLMAD
INPEDNVFITE
>OMIFANIC_00104 Ribonuclease P protein component
MIAALFSEGKSIANYPVRMIFLEQDELDRTKAAFTVPKRNFKRAVDRNHFKRLMREAYRL
HKNKLNPNNGNHFALLFLYIGRKDGGFGEIEKAIVSLLKKLPDLSNR
>OMIFANIC_00105 putative CtpA-like serine protease
MKKRIIIPVVAIAILLTTASFKNDFFEIAKQIEIFTTMFKELNMNYVDEVTPATLMDKAI
KGMLEDLDPYTVYWNEQEVQDARIKNSGTYTGIGASVRTLKDKIVVVEPFKGYPADEAGL
KAGDEIIKIGNTVLSDFDDDAGELLKGASGTSVELTFLRQGKTQSTSLTRKKVAVKAVPF
YKLLDDNIGYIVLTKFNRKTTIETKAALEELKADGATKIILDLRGNPGGLLNEAINIVNL
FVPKGEVITTTKSVIEKYNKTYSTRGDPVDTEIPLVVLVNGRSASASEIVSGGLQDLDRA
VIVGARSFGKGLVQRPKKLTYGTQLKVTISRYYTPSGRCIQALDYWNRDENGDPIRLDPK
EYNSFKTKGGRTVYDGGGILPDIEVETAQFSPITTALLKDNAIFDYATKYYYKNEMADWA
DFKFSEADFQDFLKFLKQNDFSYETQTEKEFAEALRRSEDDDLKKEIESSYRQLKASIDS
AKDKALVDKKAEIMSLLSDEILKRYFYREGLYNYQVKNNSEILTAIEVLNDANRYSRILK
>OMIFANIC_00106 hypothetical protein
MEGFLDFFENMPIWMKAGWIFFVLAVFWILEGNYSQFGFKYRKWRHAKVNFVLLLFVMII
NAVFGIATAGVFVWLAESNFGLLHLFEAPIWVELLLSILVLDLIAQYTVHFLLHKVPAMW
RLHLVHHSDKHVDVTTGTRHHPVDFIIRELFALGAVVIMGMPIAFYFFYRIISVLFTYFT
HANMALPLWLDRGLSYVIVTPNMHKFHHHYQLPWTDTNYGNMLSIWDRIFGTFVYGNVED
IQYGIDVADHRDDESIGVQLGIPFDGSVRKFRQ
>OMIFANIC_00107 hypothetical protein
MIYSEKEENKDKLQESINYLENKGFENIKADLDGYEKPKSYLKKSTNEFIAPDIVAERAG
IKHYFEVGLKSEQKKLLKSKWRFLEVLSRMKEHRFKIITYHGHFRFTNELLKDLNLDKKL
IRI
>OMIFANIC_00108 Ammonia channel
MGRRLNFIVLAVFVLISLLFSAEYEFIQGSGDIDSGDTAWMIVASAFVLLMTPGLAFFYG
GMVSKKSVISTMLQSFVALGVISVLWVVVGFSLAFGESIGGIIGNPFTYFNFKGVTLSPN
ADFSDSIPFLIFALFQLKFAIITPALITGSFAERIRFRSYILFMVLFSVFIYSPLAHMTW
HPDGLLRNWGVLDFAGGTVVHMSAGIAALAGALYLGKRKERMERPANIPFVILGTGLLWF
GWFGFNSGSALGANTDAVVAFANTNLASAASMITWIFLDRFQNRKMSSLGACIGAIVGLV
AITPAAGFVTLGQSIFIGFVAAIVSNFAIRLNKKSEIDDTLDVFPSHGVGGIVGMILTGI
LAKDVGLIYGETSTFMYHMLALLLVALFTFTGSWILYKVTDLLLSMRVREDQEYRGLDAS
QHGENIN
>OMIFANIC_00109 Acetyltransferase
MEIVVKTFDSLSLKELHDLLQLRSEVFVVEQDCVYQDIDGKDEKALHVLGFSNGTLAAYT
RCFAPGIYFKEAAIGRVVVSKHFRGKDYGHIIMKESLDAILKYYQTETVKVSAQTYLKGF
YNAHGFESTGEEYLEDGIPHIAMIKTPA
>OMIFANIC_00110 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGHNHSHHHQHDHSDVKGRNLLISIFLNIIITVAQVIGGIVSGSLALISDALHNFSDVLS
LIISYVANRFAKKKASFNRTFGYKRAEIIAAFVNAATLLVVAVYLIYEAILRFFNPQDIK
SGLVIWLALLGILANGLSVLLLRKSSRENMNMRSAYLHLLTDMSASVAVLVGGLLMKYFG
WFWVDSVLTVLIAVYLIIMGYDLLRSSFRVLMLFSPEDVDLEKLRSAISAHPEIKNVHHI
HIWQLNEQENHLEAHIDFHNDITLSEFDAILDEVELILHDEFGINHVNIQPEYQKDDPKE
IIVQD
>OMIFANIC_00111 Putative sugar phosphate isomerase YwlF
MKIAIGNDHAGTDYKNKIINYLESAGHEVQNFGTNSSDSVDYPDFVHPVAKAVSENEVDF
GIIICGSGNGASMTANKHQKVRSALCWTKEITALAREHNDANILSIPARFTSEPQAIEMV
KTFLETPFEGGRHQRRVDKIACV
>OMIFANIC_00112 hypothetical protein
MEQFETIAIFTYPSEYAVLRLLLEHNEIRHVFQNETMISVLPFHSNAIGGIRLKVHLEDI
PKAKEIIENLNNSANLRIV
>OMIFANIC_00113 Ribonuclease R
MPKRKKRRRKKNRIENLTESILKILRQNHSQPYNYKQIASKLGLDDPSSRNQIVKKLKQL
QAKGTTQEIERGKYILTPSVNYHTGVIDLTTRGEGYVIVEGMEDDIFIKHKNLNKALNGD
VVEVYVFKRRRGGKLEGEVSKILQRKRKEFVGTIQVSEKFAFVETTGYKMYTDIFIPKSK
VHKAENGDKVLVRIEGWEEHSDSPVGTVIKILGKPGEHHTEIHSILAQYGLPYEFPEEVE
AYANSLDTSIHASEIRKRRDMREILTFTIDPKDAKDFDDALSFEKLENGNYEIGIHIADV
SHYVKPGSILDDEAYERATSVYLVDRVVPMLPEVLSNNACSLRPKEEKYTFSAVFEINDK
AEVLKKWFGRTVTYSDARFAYEEAQHVIENPKDQSHEIPANISITGKKYVVNNAIAEAVL
EMDRLAKILRKKRMSQGAISFDKVEVKFKLDEDNEPEGVYFKESKEANKLIEEFMLLANR
SVAEFIGKHREKKTFVYRVHDEPDDEKIAQLENIIKRFGYKLNTSNRQSTAASLNKLLED
VHGKKEQNMVDTLTIRSMSKAVYTTNNIGHYGLAFDYYTHFTSPIRRYPDVMVHRLLQQY
LDGKPSAKEETYEEKCGHSSDMEYLASSAERASVKYMQVKYMMDHQDQDFLGVISGVTEW
GVYVEIISNKCEGMVRLQDLKDDHYRFDRDEFAVIGDRTKNVYQLGDEVYVKVKNADLIK
KHLDFTMLGHRKEIEQTL
>OMIFANIC_00114 hypothetical protein
MMKNILLLLIIAIAFTTQAQQTISRDVGEFSVLKVFDLIEVNLIQSDDNRVVIKGENTEN
VKLVNDNGVLKIRMELEERFDGNNTFVEVYFNQIDVIDANEGAYIVVNETIDQNTIELRS
QEGGRIKIGLKANHVKIRAVTGGIVEASGISESQEIKLNTGGIFEGRYLHTKDTSIGITA
AGEAEVFATEKVKVRVTAGGDVIIYGNPQKVDKKSIAGGRIKVMN
>OMIFANIC_00115 hypothetical protein
MYFYVMFDGLLYAVLYGVVLAFMVGPVFFTLIETSITKGFKAGLFFDLGAITADIIFIVI
ALYGTSKILEKVRDDPALLIFGGVILIAYGVISYIRTAKSFIKIVREHYAVKVKKDLGGL
FLKGFLLNFVNFGVLAGWIGTIIMANALTSSDRGVVLFLVTVLVAFFLTDLLKISLAKKL
KSRLTPRFIFRTKKWVSILIIGFGVLLLVEGIFPDEVQKGLDRIPSVNNPIENKVN
>OMIFANIC_00117 Dihydroneopterin aldolase
MSSIRLKNIRIFTNHGCLTEEEKIGSDYLVNLTVKADLSKAAASDHLKDTVDYVHLNRIV
KEQMAIRSKLLEHVGQRIINTIFQEVPVVRAVKVRVSKVNPPIGGDVAEVSVTMSSER
>OMIFANIC_00118 Glutamine--tRNA ligase
MSKEEPLNFIEHIIENDLDSGYSDKSLRFRFPPEPNGYLHIGHASAICLNFGLGEKYNAP
VNLRFDDTNPTKEEQEFVDAIKRDVSWLGYTWDEERYASDYFQQLYDWAVQLIKDGKAYV
DSQSSEAIAKQKGTPGEHGQDSPYRDRPIEESLELFDKMKNGEVGEGEHVLRAKIDMASA
NMLMRDPVMYRVLHKHHHRTGTDWKIFPLYDWTHGESDYIEQISHSFCTLEFLPHRELYD
WFLDQVYSTDKLRPKQREFARRNMSHTVVSKRKLARLVEDGVVDGWDDPRMPTISGLRRR
GYTPQSIRNFAERIGVGKRENLVDVSRLEYNVREDLNKKATRVMAVLNPVKLVITNYPEG
KTEWLEAENNPEDESAGSRKIPFSRELYIEREDFKEEANRKFFRLTLEKEVRLKSAYIIK
GESVIKDEEGNILEIHCTYDPESRSGSGTEASKRKVKGTLHWVCSAHAIPIEVRLYDRLF
TDPSPDTHKGKDFMEFLNPNSLQVVRAYGEPSLADLNEEDKVQFQRLGYFTVDRDSTKDR
KVFNRTVPLRDSWAKLDTNS
>OMIFANIC_00119 hypothetical protein
MSLITEIKESIITKWIVLYYTFFFILGSYLLLQLLFTTLQFLLFNDPEQTVTIQGFYVVI
GEAQYQIWDIAQFHIAIVLSSCIALGLIIITVKLLVKTNPLHYLGFRSISNEHHIWFLYS
FLVLVAGVVLHEFVISTSDVLITAEKPIEKFLVVLGLGVFGPIFEECLYRGFLLKRMDDI
LKQRQRWITITATAFLFSVFHFQYNPVELLYVFSIGMFLALMRFKTGSLWFPIVFHIVGN
LYAILTIIL
>OMIFANIC_00120 hypothetical protein
MKIFKLVTVVLLGTLLMGQTYGNEISNNPGDQTNCISPFSSVNDSPGKDYDFSYLKPGET
ADITGYGSAGKAFTYRITRTSNGIDVAIYSDTIRNVDPRTVITFKGPKGVTNTTTLGQIS
SQRCGWLCVIAHVFCVKIHLGPPGNTWEWDCDTTNED
>OMIFANIC_00121 hypothetical protein
MSARKHMQKRITWIDQARGFSIFLVVYGHNFPTNEPYIYSFHVPLFFFIAGMFHPKKIDF
AVLKRRAKMLLIPYFIWAVALFLFWWALGRNYGNSIELNLSPLKNFIGVFYAQGGSDYMD
WGIPLWFIPCIFLVFVLRAITQKISNKFIEHLLLLVIFTIGFAWPRFFEIHLPWSLDVAA
VALGFYVAGEVLKNYMIELSKMRSAYFFLFALIINIMAFYYNPEKVDMYRSIYGNEVLFF
VSGFAGSIAFVLFFKIVPVFAFLSYLGRHTIVLLATHIRMLTVIKMIAFFIFGVTVFNFT
EAEKLLLSAAQVIMVIPIIWFVNKYAPILDGKVKKN
>OMIFANIC_00122 Phosphoethanolamine transferase EptA
MLLYWMEKLKRIKPVIVFHLVLNAIIVVFITGASYYHVPLEGLKDHAIYFLHLCALQSTV
AGILYVLSLFKWTFRVVFSILFLSYCGFSFWAYSQDISITRSLIQGVMETKPDIAIDLIT
IPYFIFYLVAIAVLIFILNWHGRLNRRKGFRIFIVPAVALIIMFFVFERKQYGIFKFRLP
YNVVVALDDYYEQPPFKLEQKIPPVHSGTDSLKVVFVLGETVRADHLGLNGYNRNTTPLL
SQRKDIISYSNLFTSKTITATSLPQILTDQLLTDTIGSYTSLYSVVNDGGFKTTWIGNQT
MEKSYLPIVETNRDIILVDKYKSVFSFDKELDGVMLKPIDSLLRLNDKQLITIHMIGSHW
WYENRYEDRHRKFTPVIDSKYIPSLTKEQVINSYDNTVVYLDYFLNEIITRLEKERLPTF
MIYVSDHGEILGEGGKWLHAQEDDALKNPGYILWFSESFRQWYPGKVTAIEQLKNSEITT
DVIYPTLLDLLDLQVSEGK
>OMIFANIC_00123 Modulator of FtsH protease HflK
MGGFFVFAIPIGIILFFLLFSALFIVKQQTAAIIETFGRYSSIRNSGLQFKIPIVQRIAG
RINLKIQQLDVLVETKTKDDVFVRLKISVQFQVIREKVYDAFYKLQSPQDQITSYVFDVV
RAEVPKMKLDDVFERKDDIAIAVKSELNDAMIDYGYDIIKTLVTDIDPDVQVKAAMNRIN
AAEREKVAAEYEAEAERIKIVAKARAEAESKRLQGQGIADQRREIARGLEESVDVLNNVG
INSQEASALIVVTQHYDTLQSIGEETNTNLILLPNSPQAGSNMLNDMIASFVASNKIGEE
MRKKNEADPNMGTKRSKTRRKPPSSDDPDVTY
>OMIFANIC_00124 hypothetical protein
MSLKNLTFVTFTLLFIVTSQAQKNYDSYNRLGLQAGFTLFDIETSDLTTKQTAGFMGGFT
TRGSFYEGFDLIYGINFFSNNIEILAVSKGLENSIPIEEFLDYTINAVQINFLGSYNIVR
HHFSLEFGPVLNVNGKMKLNNEDRYERYILDGDASGDASASGPIRAGDVQDISKVNFRVM
GGATAGLENFRLWGQYQYGVTNMLKNLNDKGLGKTDFKGNSSTFIFGAVFFF
>OMIFANIC_00125 Glutamate--tRNA ligase
MAQKVRVRFAPSPTGPLHIGGVRTALFNYLFAKKNQGDFILRIEDTDRNRYVEGTEDYII
ESLNWLNIPFDEGPGKEGNYGPYRQSEREHLYKEYADLLISEGKAYYAFDTAEELAKHRK
DHEAEGKTFIYNWHNREKLNNALVLNSEETQKKLDAGDPYVIRFKSPQDTAITLTDIIRG
EISIDSNTLDDKVLFKSDGMPTYHLANIVDDHLMEISHVIRGEEWLPSLALHQMLYDAFG
WSAPEFAHLPLIMKPVGKGKLSKRDGEKLGFPVFPLEWKPENAAPSAGYREEGYLPEAVV
NMLALLGWNPGTEQEIFSLEELVSAFDLGRVHKGGAKFDPEKTRWFQHHYLQMMDESILV
SQFNQLLSTKGISDTSISANIVPLLKERATFVEDLWEQGSFFYEAPRNYDEKASMKAFKE
DTKEILSKALGLMQNVDTFSAENISESIKGWITSNQIGFGKVMMPLRLALVGEMKGPDVF
KIAALLGQEEVINRIQAAINFID
>OMIFANIC_00126 Alkane 1-monooxygenase 2
MKDLKYLAAYSIPIVAIIGLYLEGIWTFLTPVYAFGFIPVLEIILSQDPANLTQEEASEK
KKKRLFDVLLYLNLPIVYSIIGYFLYSLTWANYSNFEIVGLIFSVGIVLGGNGINVAHEL
GHRTTQWEKTLGKILLLPALYMHFFIEHNFGHHKNAATAEDPASAKYNQSVYSFWVSSML
HQYFNAWKIQKELLKREGRGFFSNKNDMFWYSIFQFAYLGVIFIIMGGMAALIAMAIALT
AAVLLETINYIEHYGLSRKKLASGRYERVQEIHSWNSNHVLGRIMLYELTRHSDHHYKSS
KKYQLLDCHESSPQMPFGYPTSMMLSLLPPLWFKIMNKRIPVEMRT
>OMIFANIC_00127 hypothetical protein
MSTFSIIQQKLEQFIKKYYTNELIKGAILFFAIGLLYFIVTLLVEYFLWLDPFGRTVLFW
LFVGVEATLFIRFIAFPLAKLFNLQRGISHEEASRIIGNHFPQVSDKLLNVIQLNQNQRE
SELLMASIDQKASQLQPVPFKRAVDFRKNARYLKYAAIPIVIFALISVLGDKDIFSSSYE
RVVNYDTAYEPPAPFSFLVTNESLRAIENKPFTLKIRTEGEVIPENASINYNNEVYYLQQ
TAPGIFEYTFLQPTEAVSFVLQANKVVSKEYTIDVVKTPSLRALEMVLDYPAYTGKRDEI
LKSTGNATIPEGTRVKWKVNALNTTSVSLKTRDTMFGFNETAAKESIVKEQHFELDRRVY
RKLDYAITTSNDNLKEYENISFTLGVIKDEYPEIDVQSKQDTTNSQIVYFLGQVSDDYGL
SKLRLVFYPIGEEDKAESASLPVNKTTVDQFVFTFPGELPLQDGTAYEYYFEVFDNDAIH
NFKSSKSGVFAFRKLTKDEIENEQLQNQENTIKDLDKTLDELKQQDKKLEELSKLQKEKK
ELNWNDKKKLENFIKRQKQQEEMMKNFSKEMKENLENFQPENEEEDPFKEQLEKRLDENE
ERLKENEKLLEELEKVQDKIEKEELTEKLEKLAKQNKNQEKNLEQLLELTKRYYVAKKAE
KLAEEIFKLGEEQEKLADSPEEENTKEAQEELNEKFEEYKKEMDELQKENEGLKSPMEIP
QDESGEKKVDEEQQKATDNLQQQKQQDAQKNQKKAGQKMKQMGQQMQAAMMQGQMETISE
DVEMLRQILDNLVVFSFEQESLMEDFKVTDYGNPVFGKKLNVQNDLKLNFQHIDDSLFAL
SLRQPMISEPINESITEVQYNIDKALERLAENQMRQGISSQQYSVTGANELAILLSELLG
NMQNQMQMSGQGSGQGQGQGQGQGQGKGFQLPDIIKKQESLSEEMQKGMGSKPGENSGGS
EGESGGESQGEQGENGRQGEGKDGEGGKSGNGEGGNNGDGNGDSDGEGGENDNEDMNGLL
YEIYKQQQQLRQQLQDRLSKEGLKGKGGDILRQMEQVEQQLLDKGFNERTLQQMLNLKYE
LLKLDEADFEQGQESRRESQTNRNKYQNTLRLSPEDVKKYFNTTEILNREALPLRPEFKE
KVQSYFKKNNG
>OMIFANIC_00128 Endoribonuclease YbeY
MVNFCSENEFILDQEAEVSDWIRGTIMSEGYKLGEITFVFCDDSYLLEINKEFLQHDTYT
DIISFDYSLGKEVHGEIYISIERVQENAVEFETQFRDELHRVIIHGVLHLCGYNDKETND
KVLMRTRENECLLARNFL
>OMIFANIC_00129 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFEKEYDVIVVGAGHAGSEAAAAAANMGSKTLLVTMNLQNIGQMSCNPAMGGIAKGQIVR
EIDALGGYSGIISDKTAIQFKMLNISKGPAMWSPRVQSDRMKFSEMWRFMLEQTPNLDFY
QEMVSGIIVEGSRVTGVRTSLGLEIKGKSVVLTNGTFLNGLIHIGEKQFGGGRAGEKAAT
GITKDLVELGFDSGRMKTGTPPRVDGRSLDFSKMIIQPGDEEPQKFSYLDSTEPLKEQLP
CHMTYTSTHVHDLLREGFERSPMFNGRIKSIGPRYCPSIEDKINRFAEKDRHQLFVEPEG
WNTVEYYVNGFSTSLPEDVQFKALKECEGFENVKFFRPGYAIEYDYFPPTQLKHTLETKL
VEGLFFAGQINGTTGYEEAASQGLMAGMNAHLKIQDKDPFILKRNEAYIGVLIDDLITKG
TEEPYRMFTSRAEYRTLLRQDNADFRLTPKSYELGLASEERMKTMERKRKKSDEFVNFFK
KTSVSPNEANPILEANDSAKVKQSDKMFKLFSRPEIDMEDMKHIASVSSYIDENDLDTEV
LQQAEIQIKYAGYIEKEKNNADKLNRLEGIRIPQNFDYSKLKSLSYEAMEKLKAIQPATI
SQASRISGVSPNDISVLLVYMGR
>OMIFANIC_00130 Ubiquinone biosynthesis O-methyltransferase
MVDPDKASEFMVVKDFLVSGESFQLMHHPELDMLFTFPQPSADRLSEYYESEQYISHTDS
GKGLIAWLYQIVKGYSLRKKVKLIDRINSGPGSLADIGAGTAAFLDAAKRRGWDVSGIEP
NAKARGFAKEREIDLQESISNLTGMQFDVVTLWHVLEHLPDLENTILKISELVKPEGHLI
IAVPNFKSYDAHYYKKYWAAFDVPRHLWHFSGTSVKKLFEGKLDFVQTKPMIFDSFYVSL
LSEKYKNGNSFSLRALGIGLWSNISAWRSKEYSSRVYLFRKAN
>OMIFANIC_00131 DNA polymerase III subunit gamma/tau
MDFSDVIGHNHLKSYFLKTIDNGRVPHAQLFVGSTGSGLLSMALAYSQAMLCSQFDPSSS
QYTSCANKVKKLMHPDLHFVFPVNTTSTVKKHAVSSQFLEEWRGFVKSNPYGSLFEWLQL
LGIQNKQGIINVDEAAEIMKTLALKSYEGGYKIMIVWMAEKMNTACANKILKIVEEPPAK
TVLLLLTENEESLLTTIHSRCQKLHFPLLSEEDIASQLIDFKGVEVNLAKRIAHRSAGDY
NMALHILEHNADDLEFENWFVSWVRMAFRAKGNKGAISELLKWSETLAGQGRETQKKFLA
FCIEVFRQAMLKNYSADSLLYFEAEDPSFDITKFAPFVHQNNIFEIMKELEDAIYHVERN
GNAKIIFSDLSIRLTRLIHRKELV
>OMIFANIC_00132 Phosphoglycerate kinase
MKTVNDINFENKKALIRVDFNVPLNENLEVTDDTRIRAAKPTIISILESGGSCILMSHLG
RPKNRENEFSLRHIVDKATQVLGVQVNFVDDCIGEKVEDAVNNLEPGEILLLENLRYYDE
EKQGNRDFAEKLSRLADYYVNDAFGTAHRAHASTAVIAEFFPENKCFGLLLASEVENLNR
VLANGEPPITAIIGGAKVSSKITVIENILDKIDHLIIGGGMAFTFVKAQGGHVGSSLVED
DKLQVALDIMKEAERKNVKIHLPSDAVIADSFSNQANTGISPVGQIPDGWMGLDAGPETN
AAFAEVISQSRTILWNGPVGVFEMDSFAQGTVKLGLAIADATEDGAFSLLGGGDSVAAVK
KFQLDNKVSYVSTGGGAMLEMLEGKVLPGIDALLD
>OMIFANIC_00133 Membrane-bound lytic murein transglycosylase D
MKPTFFLVVFLCVGMSFLNAQEEGDKEVLQKKTIQVTDSITIPVKIGDLTQNTLVTNVKD
SVVFSLNDMESARLIDSLWLKELYSTGRFEEMYGTILDEDYEPVEYEELPTEVLKQRLQE
LNARTPFNVEYNPSLESVIKGYLKNRRRTMARLMALSDYYFPMFEEQLDKHGLPLEMKYL
AIVESALDPRARSRVGATGLWQFMYSTGKIFGLEVNSYVDERSDPVMATEAACQYLKSLE
KSLGDWDLALAAYNSGPGNVSKALRRAGGHTNYWNIRHHLPRETAGYVPAFLATMYIFEF
AEEHGFKSSGPKFPYIATDTVRVKNMIALEHVAKVTNLEMEELTFLNPSYKHEIIPVVKD
EDYVLRLPVDAVGKFVANEEAVYAYAAAEFNSKEKPLPQYFEQSDRIRYRVRSGDYLGKI
ASKYGVTVSQIKRWNSLRSTRLRIGQRLTIYPRGGGRKKSSGSKATVSNTSGAKTYTVKN
GDSLWSISQKFPGVTVDNIRKWNDISGNKLKPGMKLKIQKG
>OMIFANIC_00134 hypothetical protein
MKILRIALAGLVFALTSCENSGEQNAYLLKSLGNINTLQVIIENDLWNGEVGEEIRGFFA
APIDGLPQDEPLFSMNQMPPSTYTDFARKYRTFLHVTIGDTTGVAIKKNPYAKPQIGAFI
VGKDIADIKRLLEKNYQQIISAFKKSEIIEKQRRIKISLKKTDSLKKFFGVNMRLPSAYR
SALETEDFIWYRKALKSGETNIIVYQVPLGLIRSDSTSVADIITIRDSIGGDYMPVEEGG
RFITEEAYAPYIFKTKIDDRFAYETKGIWEVKTQFMGGPFINYAVRDSINNRYLIIEGFV
YAPATSKRDLQFELEAILRSMKFE
>OMIFANIC_00135 Sec-independent protein translocase protein TatAy
MTALFLPLAIGPWQIVLIVVIVLLLFGGRKIPELMRGLGSGIKEFKEASKEDPSDDKKIE
E
>OMIFANIC_00136 Glycyl-glycine endopeptidase LytM
MAEKEKRTKKIKKKLLHKYRLVVLNEDTFEERFSFKLNRLNVFVFSTIFAVFLIAITTLL
IAFTPLREYIPGYSSTALKKEATDLAFKTDSLQQVIDINQSYLASIRKVLSGDVKTVDFN
KDSIIEIANANANQGDLDLSPSKEDSLLREKVFQEDKYNPLVDPEAVNIVLFPPVKGTVS
EAYNPQEKHYAMDIVTTKDAPVKATADGTVIFAGWTSETGYVIILEHRNNLISVYKHNAS
LAKEQGDLVKAGEVIATSGNTGELTTGPHLHFELWSEGYPINPANFIDFD
>OMIFANIC_00137 hypothetical protein
MSLKAIAARIFAGTIAKRNRKWSSRPIETQQKVFDSLISQASSTVFGKDHHFSSIKSYQD
FTQNVPIRDYEELRPYVDRMVAGETDILWPGKPIYFAKTSGTTSGAKYIPITRASMPSHI
RAARDAILTYIHETGNTDFVDGKMIFLQGNPVLKEQNGVKLGRLSGIVAHYVPKYLQKNR
LPSWETNCINDWETKVDVIVEETKDENMTVISGIPSWVQMYFEKLIDTSGKKVGELFQNF
SLFIYGGVNYEPYRAKFESLIGRKVDSIELFPASEGFFAYQDKQEEKGMLLLLNSGIFYE
FVEADKFFDENPKRCMLNEVKLGVNYVMIISTNAGLWAYNLGDTIQFTSLSPYRVIVSGR
IKHFISAFGEHVIGKEVEQAMRLAMQDHGFTISEFTVAPQANPADDGLPFHEWLVEFENI
PCDISEIEATLDKHMQDQNNYYYDLVSGKILRPLKIKPLTKNSFTLLMKKAGKLGGQNKV
PRLSNDRKIADGLHELQP
>OMIFANIC_00138 hypothetical protein
MTRLISHKRTRAQESSGAIERMYITMRHLFNRGFYKPMGISGETLRESLLILSPEIYGSI
TEDKIELEGLLYVIDRLPYGIEECRFINLTSDEGYKNSHFKPIIPAKRRRNCYRIDDEQM
NIEITRGRSEIYDILTHLTFLYIESHKIMKQVMINDEGEVIRDWKKLEEAVLIKKNLSQK
DKEIALTHTANFLGRTFEEVNKIYSLFECESIKNRFLNIIYFLGKRAMEEVMTDSQRLIT
FSPVLRERLGHHIHGEQWALKVKKTLKNNGLLSRPLHIISANMHSVLNSLYAPKALANEL
KNEDGIAIFEKLSNSKSKLQQKVNKYALENGMTYIEDESGANINVQIFDSDYFYEGPVDM
VKEDKPVILVMDYAFGEQAYETMDELLKPFIASGSRELLNLISISIMGKAGILSGKKGDI
MIPTAHVFEGTADNYPFKNKLKKSHFGDVDIDVCEGTMITVLGTSLQNRDILKFFHTSTW
DVIGLEMEGAHYQKAIQSASKIRGSISPKVTVRYAYYASDNPLKSGSTLASGGLGTAGVK
PTYVITEKMLKQILV
>OMIFANIC_00139 dTDP-glucose 4,6-dehydratase 2
MKYDNILITGGAGFIGSNYVSYLLESTSADVYVLDKLTYAGDMHNLESVSNKSNFFFIQG
DICDKEFVDEMFEKHQFDQVVHFAAESHVDNSITGPAEFIQTNIVGTFNLLQSAYTTWME
GPGKMKEAFQHARFLHVSTDEVYGTLGETGLFTEETPYAPNSPYSASKASSDFIVRSYFH
TYQLPVVTTNCSNNYGPNQHKEKLIPTIIRKALAGEPIPIYGDGTNVRDWLYVLDHCKGI
KLAVEKGRLGETYNIGGKNERQNLYIAETICKIMDELEPREGSYSEQISFVTDRPGHDFR
YAIDASKIEKELGWKAEENFESGILKTIKWYLQHKERL
>OMIFANIC_00140 Glucose-1-phosphate thymidylyltransferase 1
MKGIVLAGGSGTRLHPITLAISKQLMPVYDKPMIYYPLSTLMYSGIREILIISTPQDLPL
FKKLLGDGSKYGCSFHYAVQEEPKGLAEAFIIGKDFIGKEKVALILGDNIFYGSGLKELL
ISNNDPDGGVIYAYHVHDPERYGVVEFDDQGKALSIEEKPENPKSNFAVPGIYFYDNTVV
DIAAGIKPSARGELEITDINNEYLKAGKLNVSILDKGTAWLDTGTFASLMQAAQFVEVIE
ERQGLKIGSIEEAAYEMGYIDADQLKKLAEPLLKSGYGKHILHRK
>OMIFANIC_00141 dTDP-4-dehydrorhamnose 3,5-epimerase
MEKILTPLKDCFALKPRIFSDERGTFYETYNENTFKASTGIDLNFVQDNQSTSSYGVLRG
LHFQKGKMAQAKLVRVIAGKVLDIVVDLRPESGTFGKSYAIELSDKNHLQLFVPRGFAHG
FVTLSDRSVFAYKCDNFYNKSSEGGIIYNDATLNLDWHLPEEDLIISEKDLQLPGFEQAI
S
>OMIFANIC_00142 dTDP-4-dehydrorhamnose reductase
MKQILVTGANGQLAKCIKDAANNYSGMELHFVTRKELDISNAAAVSVWFENKSFDYCINT
AAYTNVEKAESEKDAAFATNAEGVKNVANACKKYGITLIHISTDYVFDGNKTSPYSEEDK
TNPINVYGASKLKGEENITASGCKHLIMRTSWLYSQYGHNFFNTVLRFASEGKPLTVTTE
QTGVPTNANDLADAILKIVMGNAEAHGIFHFSNRGNATWYDFAEAILEFTGQLAGAKLAK
TNHYRTFAKRPKYSILNTKRFSEAFGIVPLPWRESLKELVKINLTKKRN
>OMIFANIC_00143 hypothetical protein
MAQNNQEEVDLFVVLQRLNKLYHRFLSGIYKGIRFIIKNWIVLTILIVGGYFLGGVWKTS
LPSTKESVLIVQNNFDSSNYVYNAVELLNMKYSQRDSNFLSKHNFDTEEPDLFSIEIEAI
VNIFELLEKQETNDRNLESYLSRVGFEEDPLISELYTPEYRYHRITIHTHKASLQTPKKV
LDYLNSNEIYNKTREVVVEETRLRIQRNDTSIKYIDDVFIELAGKNDQDDKQTGEVNFKV
QQHDNLHHLMEKKREIIEENEMLKKELIKYDNVVTLINEPYFYGKTSFLDKKKIILPVLL
VFLYVGFFVVRNMYRKGRMYSKQEE
>OMIFANIC_00144 hypothetical protein
MTRVQSVIKIFPEIEAKLLTVMLTTYTNDATG
>OMIFANIC_00145 hypothetical protein
MMLLDKLKDLLSNKMVFQSINVLGLRVAGMLLFFALTLFLTNNFEASLVGQYDFSRALLI
FLGGICVFGMHQSVIYYAGYLKAKESLAYMKRLYKKMVVIVFSIAFVFFLAVLGIAPSFI
DGLFDKEVSQLVTYSVFALFFYGITLLNIDVFRAIQKIYVSEFYRNVMRYAVFFGAIIYL
YYSGNPQFLVEVFLLNFAFLAMLSTGYLLFYFSKMNIEKVSEVITYKQILKRSGPMAISA
ITYLLMQSVDVILLSKYSSFERVAFYSVAIKLTTVLSLVLASVNTVYAPSFAEWYNLNDL
SSLREGLKRSTRLIFLFTFPAIIVVLVFSKMILGFFGPDYIEAQWALIILLIGQAVNALC
GSVGVYMNMTGKQVIFQRILVTAFSINIVLNLILIPVYDLLGAAIATTISTVFWNVVTTA
YIYKKDKMITFLTIK
>OMIFANIC_00146 hypothetical protein
MKQVLVDFFVIGVARGGTTSLYNYLQQHPAIFLPKVKECNFFSEVDSLDKEVYLKPEKNK
EYHMKIIQDEAVYFSLFDNALDSQLKGEISPSYLWDRNTAERIFNHNPNANLLISLRNPI
ERAHSHYLMNYQTGHEKESSFEDALKAPKNNIWGGGNMYLEMGMYYEQLKPYYDRFNSEN
IKVIVSEEWTRNNGEALNEIYNFLGLQSFDALEVDTAHNAAKQIKNKGLLAFLRLEKIKR
PLKWLLPEKAKDKLKDRWFYKEGEKQCLDPETYRRLEDHFREDIRKTEDLTGLDLSGKWR
IRNNSNLKTIE
>OMIFANIC_00147 hypothetical protein
MISPKHKTLFVHIPKVAGQSIETIFLQDLGLSWDERHELLLRKKKNNEAGPYRLAHLKAK
EYLEYNYIDKETFDSYFKFSFVRNPYKRLLSVYNYLGYSRIISFTDFVGKVVKKALERDD
FFYSPQYEYLYDEGKLMMDFVGKLENIKVDMKQVLIKTRLAGKEIPHVNKSEKGLKRGLA
ALIKTPRLWTRIKFRSLFSTRRKLNLNEEERALVYELYQKDFEYFNYEP
>OMIFANIC_00148 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MNHKKNILFISIACDMYGSSKVLLSLVLQMKQDSEEYNPIVCLPPEEGPLRQNLINAGIQ
IIEMPVVKLTRSMLKSLNFIGLFREYFRAKKVFRQETRGITVDAIQSNTLATMFGAMYCK
FRKTKHVIHVHEIMDRPKIASFFFKMVLKYCCDEIVYNSEATAEFYNGMAPTLKNKSATI
VNGVDRNRGVISEEERSKIRTEMFRSSPEEFIIGLLGRFNRLKGHQVTLETFKEIYEEYP
KLKLCFIGSPPPNQEHFLVNLRERIASMGLDKRVQIMGFQDDVFAILEALDLVVVPSTEP
ESFGLVVVEAMLAGTAVIGSDIGGISTIIDHGKTGLLFEPNDKNEFKNAIVSLLNDGSLK
AMMEKKAMDKAKIAFSSEAMFQKFNLLYRKII
>OMIFANIC_00149 hypothetical protein
MGQWFYKICLVVLIWSIQTANIELSFGIAAFVTLASFRTKLSSQALLLIIILFFLVIIGS
ISVFSPENDYYFFLKDLIYFTRPILVILAGYFLTMRFKNKMSFLNIIVLMGFYFAFVHAL
SFIIYFNIIPGHTSGIRNIFGRYNHVETAALLLIICVKDLPVKRSRYKFFYQAFVACLVL
SFLLYMSRTMIMVVFVGSLAYYGYLKLNRKGTIALVSFMIVGAGFALFLQAYDPPTENPG
VVDGLLLKIKNSVNESFSLGNINVQDLDRRELWKHWRAYEAFKVYQEIEAEKLWVTGQGF
GSTVDIGFEARLDGELTQHLSLTHNGFAYLFLKTGVLGLLIYFVMILYLYSFSYSPRRGT
MADIGNNLLVATTFYILITSFVVTGIFKPYDMATLLIGAAFALKQLKPSEDSDTGDQRDT
>OMIFANIC_00150 hypothetical protein
MKIAILGTRGIPNTYGGFEQFAEFFSVFLKEKGHDVYVYSSSSHEYQDKEYKGVKLVHCK
DPEHKIGTVGQFIYDFNCIHDARKRNFDIILQLGYTSSSIWRRYLPRKSMIVTNMDGLEW
KRTKFSKKVRRFLKYAESLAVKGSDHLIADSLGIQDYLKQKYDVESRYIPYGATVFSNPD
ASVINNYGLKPFKYNMLIARMEPENSIEIILDGVVSSGSEETFLVVGKHDVNKFGVYLKE
KFRANENIKFLGGIYNQDHLNNLRHYSKLYFHGHTVGGTNPSLLEAMGSNSLIAAHNNKF
NAAILGEDAFYFSSADEVASVLKKVLSKNDYQDALIHNAEKIKTMYSWELINKTYLDFFE
EKYATYK
>OMIFANIC_00151 hypothetical protein
MQRISKIVSSPQAYWVLLSALLISLPLPYGFSTGILIALLASSLLSARYHKLSFQKIYLV
PILFYVLMVCSLFWTSSVENSLRGLERQLAMVLIPAAFFLMPELSIKIRDKIFYAFAVAL
TMFAIFFIGAAFIEYLENSNINRFFYHALVSPLELNAIYLSVMVSLSGLFLLFNQPKSLT
TILLLLIHAIFLILLASKVIIVITALVAVFGIVRTFKRSRILLLLPVLLIGVILLMVTSN
PVRERFEREFTVSDVKEVMECERFDKVYDWTGTTIRLFQARIFVEMLDEDSAYLTGYGIN
NSKHKIIEKQKQYNLWQGYYEYNFHNQYIQAFAELGIFGFIFLLILLGSIFKEYLRTKDM
LFLSLFLVMLVVFLTESYIWRQRGLYHFLVFFCLLFKVSAIPSKSGTES
>OMIFANIC_00152 hypothetical protein
MKVLLRAIYPYIYLLLFLTIPFDNYVRVLPNILMAALLAIFPFIVTRNDLTKLRKAPTIA
FLIFLIYLVINSLVFNRIDEDFVTIKKIGLAVGLAILYIPVQDRRKISLAIIFSSLAAIV
FSIVKIVIIINVSEDIALGYSREVIEALLIDRLYLGMLSILSVLVSYQAITKRFHPNNQY
HLINIIINVLFVFLMVSKIAIVVMGALFVIRLFYSKKKMFRVFAVIIAIASATVLFVSIR
NIDNNHASVTTVNPADRSFLENTVTWELRTTVWKCGYQVARAQGVIFEGLGFNETRESLI
DCYENTIENNWKKNKYVEMGYNSHNQFIDLYLNYGLFALILFVAFLLIAFVKCKKHYFAM
AMLVTMVSYLLVENVFHRQIGAYYIGFILIVLLSRNFLGQINSVKED
>OMIFANIC_00153 UDP-glucose 6-dehydrogenase TuaD
MKIAVIGTGYVGLVTGTCLAETGNDVICVDIDTEKIEKMRQGIVPIYEPHLDVLFERNIK
AGRLQFTTSLDEGLEHGDIIFLALPTPEDEDGSADLSYVLNVSEEIGKRITRYKVIVDKS
TVPVGTAEKVHAVISENAKTEFDVVSNPEFLREGLAVDDFLKPERIVVGSSSERATQLMK
KLYGPFVRSGNPIIIMDEKSAELTKYAANSFLATKITFMNEIANYCEKVGADVDKVRVGM
GTDSRIGKRFLFPGIGYGGSCFPKDVKALIHAGSLVDYEFQILDSVVRINHIQKRILIPK
ISEYFNNELKGKNVAIWGLAFKPETDDIREAPSISVMEELLSKGASLSVFDPEAMPNIKK
QFGDKLTYADSMYDAIENADALVICTEWSIFRSPSFSKMKSLLKEPVIFDGRNIYQVEEM
AKEGFKYVSIGRNEAN
>OMIFANIC_00154 UDP-glucose 4-epimerase
MNNKKKRVLITGAAGFLGSHLCDKFIEEGHDVVGMDNLITGDLKNIEHLFKRPDFEFYHH
DVTKFVHVPGNIDYIMHFASPASPIDYLKIPIQTLKVGSLGTHNLLGLAKQKKSRILIAS
TSEIYGDPLVHPQSEDYYGNVNTIGPRGVYDEAKRFQESITMAYHRVHGLDTRIARIFNT
YGPRMRLNDGRVIPAFIGQALRGEDLTVFGDGKQTRSFCYVSDQVEGLYRLLMSDYELPL
NIGNPDEITILDFAEEIIKLTGTEQKIVFRELPKDDPLQRQPDITRAREVLGWEPKVSRT
EGMKKTFEYFKNLTDEELYNSEHKDFTKHNRL
>OMIFANIC_00155 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MIYRTGRYSGYLRPISYLIDLAIIHVLAYQFFSSSFHFINYVVFITVAWIVISLRSRFYE
IFRFTRLTTILSLVGKQGVLFLLLVFAFFGFYRELQVEPLSIFRYVLLVILYITIVKVGI
YYLLKKYRVILRGNLRRVVIVGLNQKTDQLRKFFDDNPEYGYKLLNIFDLSGPEKVSIED
CLEYINENKIDEIYSSVGELSNEELTKLIDYSDNNLKILKFLPDNKEIYSKRLDFTYYGY
LPILSMRKIPIEEPFNKFIKRGFDILLSLIIIVGILSWLTPLLGLIIKLESKGPIFFKQK
RNGLDYQEFYCYKFRSMRPNPMAHLHQVQKNDPRVTKIGRIIRKTSIDELPQFINVLKGE
MSVVGPRPHMVSHTHMYAERIDKFMVRHFVKPGITGLAQVSGYRGEVEDENHIINRVKYD
IFYLENWSLFLDLKIVFQTVYNAIKGDKRAY
>OMIFANIC_00156 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MQLKETKEHTNDKSSPLISIITPLYNAESFVSETIKSVLNQTYSNWEQIIVNDASTDASL
SIVKRFAQNDERIRIEDLSNNKGAAYCRNLATDLARGTYIAFLDSDDLWHTEKLEKQVAF
MIKNKCDVSYTSYLHIDESGNSLNKRILALPKLSYKKQHCNNYIGNLTGMYNAEILGKIA
SPDIRKRQDWAVWLEAIKRSGKPALGLQEDLSLYRVRRDSMSSNKAKLVKYNYSFYKDYL
GYSSIKSGWNLMKFFYEYFFVRPRYIQKL
>OMIFANIC_00157 Phenylacetate-coenzyme A ligase
MNLFELSLKLNGFPITEAKRALEDIKDIPENKFEEYVIRSRQDILFYHLNNNPFYKKFIA
DRNTVEWSQIPVMQKSDLQKPLKERLSHGFSEKKVYVNKTSGSSGHPFIFAKDRYCHALT
WAEILDRFGWFGIDFHSSYQARFYGIPLDTIGYKKERFKDWLGKRYRFPIFDLSEAKLGQ
FLEHFRSKKFDHINGYTSSIVLFAKFLKSKNITLTDVCPTLKYCIVTSEMLYPDDKKLME
NIFGVPVINEYGASELDLIAFTNAEGQFVLNSETLFVEIVDENDQPVPHGTQGRIVITSL
YNKAHPMIRYDIGDTGSIEPGSGFKDPVLRELVGRTNDVALLPGGKTVPGLTFYYVTKSV
IEDDGNVKEFVIEQADLDRFKIRYVSDRELTANETETIKNALYTYLENDLKLEFERKDIL
DRSKRGKLKQFTSLL
>OMIFANIC_00158 Phosphoribosylamine--glycine ligase
MNILILGSGGREHTFAYKISESENCTKLFVAPGNAGTHAIATNLPISVNDFEAIRSAVLE
HNIEMVIVGPEDPLVSGIADYFAKDDRLKEVMLIGPSSRGAMLEGSKERAKEFMMRHNIP
TAAYASFTRETLVAGKKFLDTLQPPYVLKADGLAAGKGVLILNSLEEAKHELENMLAHSK
FGEASTKVVIEEFLDGIELSVFVLTDGKNYKILPTAKDYKRIGEGDTGLNTGGMGAVSPV
PFADEELMRKIKERIVIPTVNGIAEEKIDYKGFIFIGLIRVNNEPYVIEYNVRMGDPETE
VVLPRIKTDLVELMRATSQQKLDEISLEIDKRSATTIMVVSGGYPEAYDKGKVISGISEI
QDSIVFHAGTAVKDGDIVTNGGRVIAITSLDEDFRKAIKKSYQNIEKLSFDRMYYRTDIG
FDLS
>OMIFANIC_00159 hypothetical protein
MKDFFYGIETLFVDYFFAPFDALRAIEMDSWWISNVMSWLFFALGLVAFFYWMRKLAEVN
TRGEEDRSSTSHSFLG
>OMIFANIC_00160 hypothetical protein
MLTSFFSKSNPVNFLILGAVMVIAYIIYQFTTLNSGLELLDIIGVIAISALLVFTILLLD
FIVRKNNLTRKNTLSVFIFIAFTLMVPSVFGNTEILIAVVCCLFAMRRVFSFTSEKNTEK
KILDASLWLLLASFFYFYSFLFFAAVYFAILRNPKTSFRFLFIPPIAILAAFSIATSYFY
LTENSFDWFWSIVTPVGLDFSAYNSFGLLIPSALFLSAIFWIGLYRLFKVSRIMRKERPN
FVVLLVILVCSVAVSIVSPQKDGSELYFLISPLAITMADYIENREEKYISEIFIWVLMLL
PVALIFM
>OMIFANIC_00161 hypothetical protein
MFSDKANQIFQKVIEFYHVLDRVDQPFSNPYDNESQLIEHLLYRKCWIDTVQWHYEDIIR
DPNIDPDAALTLKRKIDASNQDRTDTVEYIDGYFLDKYRDVTPQENATINTESPAWGIDR
LSILALKIYHMNEEASRTDASPEHINACKAKLDILLEQREDLSTAIDQLLYDISEGSKYM
KVYKQMKMYNDDEMNPVLRNQK
>OMIFANIC_00162 hypothetical protein
MTLPTHILVIRFSALGDVAMTVPVLRVVTAAYPEIKITVVSKNQYAPLFDDVPGVQFLEA
DVYGRHKGFGLFKLASEAKELGIDAVADLHNVIRSKIVRSTLWGRGIKTTAIDKGRAEKK
KLTVGQNRELAPLKSTHQRYADVFMELGLKIDLDTHVFPAAKDISPRIHHFFGSQPKKAI
GIAPFAAYTSKMYPLQMMKEVIARLDSLGDYKIFLLGAGAEEADILKSIELEHKNVLNVA
DQLTFGEELSLISNLDLMVSMDSSNGHLAAMYGVPVITMWGVTHPCLGFTPFEQPAENQL
LTDREKFPLIPTSVYGNSFPVGYENAMETITPSVVIAKIQEIIEH
>OMIFANIC_00163 1,2-phenylacetyl-CoA epoxidase, subunit E
MSDFHLLKISEVRKETPNSVCITFKIPDELVKEFEYTAGQYVTIKHRHNGSEIRRAYSIC
SSPGSGKLSIGIKKVKNGAFSPYANVDLKTGDTLEVMPPEGNFVLMPDPSHAWNYLALAA
GSGITPVLSIITTALEEEPNSTFSLIYGNQSLEETMFANEIAQLKALYPERFFAEYIFSR
RKEDVGLTGRIDRSTVNYLLKNKLVQDEFDAYYLCGPEEMIHSISELLQEKGARKENIHF
ELFTTTEEGELEEAHEGFTKVTITLDDETETFTMPQDTSVLQASLDHGLDAPYSCQGGIC
STCIARITGGKAEMRKNQILTDDEIAEGLILTCQAHPSSPTLSIDYDDV
>OMIFANIC_00164 hypothetical protein
MKGIYKITIFLLAVILLAACSRKKNTFLSRNYHAVTGEYNALYNGGVALESGKQELALTY
RDNFWEILPVERFELEDDKSLPGESQNPDFNRAEEKAAKAIQKHSIYLDGKEYNPQIDEA
YMMLGKARYFDKRFIPALDAFNFILNKYPTSNNINRAKVWKAKSNIRLNNEDIAIENLKK
MMKTEELDDEELAESSVILAQAFVNLDSIDAALPYIKLASEYTRDNELRGRYAYIKGQIY
NRLDLKDSANMAFDEVIELNRKSPRVYMINAYIEKARNFNYDKEDRVAFLELLFDLEENR
ENRPFLDRIYNQIGEYYKSTENIDTAIIYYNKSIKNYKDDRVMQSVNYSTLAEINFDKAL
YKRAGDYYDSTLTFMDPKTRPWRRVKKKRENLDDVIKYEDIATLNDSVLRLANMSESEQL
AFFTEYTDRLKQKAIDDSIAAVKLEKQIANNEFYQKNKTGNNKEQSGGKFYFYNSTTVAY
GKQEFRRIWGDRKLEDNWRRSDRKTSGITEEVVVEEDTPISENERFKPETYIALIPSDEK
VIDSLTKERNFAYYQLGLIYKVKFKEYGLAANRLEKLLTYNPEDRLILPSKYNLYKIYQQ
LERPALADKYKNDIINNHPESRYAEILLNPDAMLATDESSPEFKYKALYAEFEAQNYQQV
IETAEEYITLYNGNDIIPKLEMLKATALARQDGFEAYKKALNFISLNYPNSEEGKKAQEI
FSTVLPKLAVKDFVPDDASEEWKVVYEFNVTERESAEKLTEKLDKFLTERRYDTEMSTSI
DYYNPETILVIIHGLNTKLGARGIAEVLNEDKKYKIKKPFFEISSPNYKIVQIHKNLDEY
LKADTVE
>OMIFANIC_00165 hypothetical protein
MFSDKKDKKNMEPTASQNRINEGTKLKGDIQSKGFFRIDGVIDGNVNTPSKVVLGKTGVI
TGTLTCENADIEGTFDGKLDVTGTLTLKATARITGDVVVGKLAVEPGATFNASCVMKGSE
KGKATSASDNASAETKKSQNHPFDRTQRIQKPKTEQQT
>OMIFANIC_00166 hypothetical protein
MTEPKESKNQKRNSRLNSYARFSGIAFQMIVIILLGTLGGLKLDEIYPNEYSIFTIICSL
LAVGISMYFVIKQVTDFSKKQDKDS
>OMIFANIC_00167 hypothetical protein
MKRDLPFFLIKLIGITALLFGIHYYVFTVLFSDIVLYFPLWVIYLFNAGLVLLVFLIIRI
QMARGYTKTYNLFLILTISKMALAIVFLLPLFAGKAENAVVDVSNFFIPYFLFLVFEIFQ
LNIFFKKEETN
>OMIFANIC_00168 ATP synthase subunit a
MKTTNFTIVRSLFIGLFFILSATSVLGASSTSSSKEEGEEKEFDVTEMIMHHIKDSHDFH
ILDWNGHAVSFPLPVILWTDNGLVSFMSSEFHHDDAGTVVVEKNGQKFVKYHEEIYYASE
TANADGAYIMLEEGDHPSNAHPIDFSITKLVFSMFLSIVLILLIFGVSARKYDKVGVPRG
IAKFTEPLVVFIRDEVAIPNIGEKHYHKYMPFLLTLFFFIWINNLMGLIPFFPFSANLSG
NIAFTLVLAFITFTITTLKGNKDYWKHIFWMPGVPVFLKPFLALIEFAGIFIKPVSLMIR
LFANITAGHIIVLSLISLIFIFGTVWISPVSVFFSVFISVIEVLVVAIQAYIFTMLSALY
IGSAMEEHAH
>OMIFANIC_00169 ATP synthase subunit c
MSSLALIQEAVSYAPFAAIGAGLAAIGAGIGIGRIGGSAMDAIARQPEMQGKIQASAIVL
LAFVEAVALFAVVVALIAK
>OMIFANIC_00170 ATP synthase subunit b
MDLVTPDIGLIFWTFISFAVLFFLLKKFAWKPIVGTVNDREQSIREALASAEDAKKEMEN
LSADNERILKEARLEREAMLREAREIKAKMIAEAEDDAKAKADKLVANAKEAIEIEKKAA
IAELKSQVAVLSVDIAEKVVRTELSDKDKQLKLVENMLDDATLN
>OMIFANIC_00171 ATP synthase subunit delta
MKGSKAAIRYAKALLQQAKEVKAADKVFADMQAVAHTLKDSKELRSVLKSPVIKASDKKE
ALLEIFSSVSEDTKNVIGVLVDNQRVAILGAVADSYVYLYNEAKGVKVASVTTAIPLSAA
IESQVLAKVKELTGSNTVTLENTIDESIIGGFILRVGDLQYNSSIANNLNKLKREFTVN
>OMIFANIC_00172 ATP synthase subunit alpha
MAEVKPAEVSAILKKQLSGFEATASLDEVGTVLTIGDGIARVYGLSNAQYGELVEFENGL
EGIVLNLEEDNVGVVLLGPYTEIKEGATVKRTQRIASINVGEGIVGRVVNTLGEPIDGKG
PISGETFEMPLERKAPGVIYRQPVNEPLQTGIKSVDAMIPIGRGQRELVIGDRQTGKTTV
CIDTIINQKEFYDAGEPVYCIYVAVGQKASTVANIARVLEEKGALAYTTIVAANASDPAP
MQVYAPFAGAAIGEYFRDTGRPALIIYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERAAKVIDDDSIAKNMNDLPEPLKGKVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVAGTLKLDQAQFRELEAF
AKFGSDLDAATMNVIEKGKRNVEILKQAQNDPFTVEDQVAIIYAGSKNLLRNVPVNKVKE
FERDYLELLNAKHREALDVLKQGKLTDDVIDTLSTVAKDLSARYN
>OMIFANIC_00173 ATP synthase gamma chain
MANLKEIRNRISSVGSTMQITSAMKMVSAAKLKKAQDAITAMRPYANKLTELLQNLSATL
DADSGGKFANHRDMKKVLIVAITSNRGLAGAFNSNIVKEARRTAEEDFAGKQVDFVTIGK
KGNDIISKSETVIENNNAIFDDLTFDNVAAIAEFLMDQYAEAKYDKIVLIYNKFKNAATQ
IVMNEQFLPILPPDSDGADSKGVADYIFEPNKEKIVEELIPKSLKTQLFKAIRDSVASEH
GARMTAMHKATDNASELKDDLTLEYNKARQAAITGEILEIVGGAEALAG
>OMIFANIC_00174 hypothetical protein
MKTHKNLAGTISLAMIIILFAQCGGGKTENGKPQLDQNPPFKILDAYYQDWVAGIPEGGS
GTNIYISLGDISEDVVIDKIYFRKMISDAKLSPQTKNQYIGYFRKDQRQDIIMDIDPVKE
AQNIPREPFPFELKDDEAVIAYRHENEMKYTRVSDLRMEELLAYPSTKPKDDN
>OMIFANIC_00175 hypothetical protein
MSIFKKLFKQTFIYGLATVLPRALGIVLVPLYVSVLGKEQYGVYATLMAFLILGNVLLSY
GMETAFFRFINKHEDQKKLVQSTALTSVALSTLLFLSITLFFNTSLAEFLDFRKEFVTHG
LIILALDALAVLPFAWFRANEKPMRYAVIKIFNVLINLSLNLFFFLVLPSWARNDPGSFW
DAILLTDTRVAYVFIANLIASAITLIIVSPLYVRIGFRFSSAIWKGMLRYALPVLIAGIA
FSINEAFDKILLRYLLPSDIAEAEVGVYAACYKLGVFMTLFATAFRLGIEPFFFNHAKSE
NAKETYATITKYFTIFGSGILLFVIVYIDLFKRILIPDPKFWEALVIVPVILLANLCLGI
YHNLSVWYKVTDRTRYGAVISVIGALITLSLNLALIPIISYKGSAIATLAAYGSMMVISY
ILGQRNYAVPYDLKKIGGYLMLSVGMSVLSFYVFEGNLIIGTALLLVFLLWIIIAEKTQL
MRLLKR
>OMIFANIC_00176 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MKVKIVNKSEHPLPHYETIYSAGMDLRANVPEPSTLQPLERAIVKTGLFIELPIGYEAQV
RPRSGLAAKHGITVLNSPGTIDADYRGEIGVILVNLSKEPFTIENGERIAQLVIARHERA
IWEEVEELSETDRGAGGFGSTGVQ
>OMIFANIC_00177 Glucose-1-phosphate thymidylyltransferase 1
MAGRGSRLRPHTLTVPKPLIPVAGKPIVHQLVTDIAGILKEDIEEIAFILGDPAFFGDDV
VESLNALAGELGARCSIYRQLVPKGTGHAIMCAEPSLSGPAVIAYADTLIRADFDLDKDA
DSVIWTKKVANPEAYGVVKLNELNEIVELVEKPSEFVSDQAVIGIYYFRDVAVLKNELQY
VLDNNIVHGGEYQINDGILRMIKAGKIFKTGTVSEWMDCGNKEVTLETNAKMLGFLAESN
TQLISEKISLDNSIIIEPCFIGDGVVLKNATVGPYVSVGQGTIIEDSIVKNSIIQTEAVI
KNATLDNAMIGNYATFDGNFTNLSIGDYSELK
>OMIFANIC_00178 Lipopolysaccharide assembly protein B
MTYKYSYILVILFGMIFMPEVAMAQEDDDAPTDDLGNVSDAFQENFFEGLKQKGIENYEL
ALTALRKAEMAAKGDAVNIAVVHFEMGKNYSKLKQYEDAEMMYNQVLESQGERLDVLEAL
YDVYYEQQDYTAAIPLVEKLTKYDADYREDLANLYHRTEQYEKALELLDELDEDWGESAM
RNALRRQIYKVTGNTEGAITNLEDKIDKNPQKEQDYLNLIFLYSEQGKTEKAFETAKELL
KNQPDSELVHLALYKFYLDAGDIEKALNSMDVVFSSTEVDKDSKYRVLGDFIGYANENPG
YETQLEAIVDKFSTENSGQVYEQLGLYFFAQGQKEKALQFYEKGMANDPDNYSLVKNTLL
LQIEFGRYQEAAANSSLSLEIFPAQPLLYLINGVANIEIDQLDQAIESLETGLDYLLDDL
KMEKDFYEQLSIAYARKGNDTKAASFSKKASEINIAN
>OMIFANIC_00179 hypothetical protein
MKRVIIYLFALLLLLTSCKGLKGVNGSETANAGLQAKEIIATHKLASPKFNTMAGRIKVE
YEDEKKSQSITVSLRMEKDKKIWIKASIIGITLAKVMITPDSVSYYETLSNSYFDGDFTL
ISEWLGTEVDFEKTQAILLGQTMFELNKSTYTSQVVNNQYKLLPKQQLENFIHSLFLNPS
NFKVASVSVAQPWEDRMLTVYYGPYQMIEGGYFPSELSINTIEGDDRTRIDVTYRKIDLN
VDVNFPFNIPRGYEQIDLGR
>OMIFANIC_00180 Murein hydrolase activator EnvC
MMRLKFILTVLCCFVLASASVQGQSKKQQELEAKRQAILEEIKQINTLLFKTRGEKKSVL
TQVEDLDQRIRATENLIRVTNQQANLLTREINDNLNKIESLREELKALKEDYAAMIKKSY
KSKSQQSRVMFLLSSEDFLQAYKRLQYMKQYAKHRKEQGERIKDKTEELQALNTGLIEQK
NQKQLLIDQNKQTRVTLAKEKKDQETLIASLRKDEGKFASQIRSKQREADAIDKQIDAII
KAAIAESNKSAGTKVTKGTVETFALTAEAKALAASFSSNKGKLPWPVEKGVVIRRYGNQR
HPQLPNVTTFSSGVEIATEKNAKARAVFNGEVFQVQRSKQGIMAVFVRHGNYISVYYNLD
NLLVKKGDKVTTKQEIGTIFTNGLSGKTVLKFLIYQNSTRMNPADWVYRM
>OMIFANIC_00181 C5a peptidase
MEKFTFFSINRKSVSFWVLALACTFVFAQNNYTITFQDETIEMPENINTFEWSQMPDYAH
LRDGYIGWVQFYETPTQTVQDQFAANGLDLISYIPHHTYLFRFPETTSVSFLQNNGVRSI
VPVQGRFRLSENLKNGNIGDWAIEGDFYIVTLQFYPYVDAQYVINDLAAKQISVKEQYTG
SNNIDLIIPNDCLESLVDQPYVKWVEVIGPPGETEAEVSKSLMRSSGLDTQTPSGLSYDG
EGVGVLTRDQGPVFQHVDFAGRLTNVPPFNSGTHGIQVTGGFAGAGNIRPDARGSAAGAT
IFATGYNSTFLDNNTVTLINSGDVQITNSSYSDVCNGPYSSKSQTVDTQIHDIPTLQHVF
SAGNSNGSNCGYGAGSQWGNITGGHKAAKNCVTVGATSALGNIAGFSSRGPAFDGRIKPD
VAGHGASFLTTNPGNSYTVINGTSYSAPATAGVMAQLYQVYMEANGGSLPQSALIKAALL
NCATDFGNPGPDFIYGWGIVNGLRSGQLIEDGNYLSDDISQGGTNTHTINVPSGTAQVRF
MVYWSDEPATPGSNPALVNDLDLEVVDPSNNTLLPFLLDHTPDPNLLNLPAGNGADHLNN
MEQVLIDAPAAGSYDIEISGFNVPIGPQEYFVVYDFIEENITVDYPNGGEKISAGGVVNV
HWDAVNTTQGFTLEYSDDDGASWTTFANPGANFRSYSWNTAGLGIAGNGEMKVRVTSGSF
SDESDESFSFADVPDNLEVVEVCETEATFEWDAVDGAEFYDLYLLGEKYMEIVGTSETNS
ITIPITDPDAELWMAIAARNETEGWEGRRSWALRYGGGILDCDLGFDDNALASNVILSPN
PASDQVTISLIDASFNSFEVTVLNSLGQTLQTVSEDNGSSSTVLNVSNYRTGIYFVTIEV
DGLSTTKKLVIR
>OMIFANIC_00182 putative acyl-CoA thioester hydrolase
MLAKNPKDSKTTITDLVLPSETNPIGNMFGGELLARMDRAASIAARRHSRRIVVTASVNH
VAFNKMIPVGSVVTVEAKVSRAFNSSMEVFMDVWLEDRESGMRTKANEGIYTFVAVDEIG
HPVPVPPLVPETELEKERFEAALRRKQLSLVLAGKMPPQKATELKALFD
>OMIFANIC_00183 hypothetical protein
MIGEQVKIILFSVVNKIAGHLLNSTEKTYKFVSMQLETYIKDLLYRYECVILPGFGAFLT
HYRSARIDGVSHTFYPPAKSVSFNRQLQTNDGLLANYIAAADSCSYETALQRIRNFSSRL
SRKLHEGQAISLNGIGDFQMNKEGSVQFVPSASENYDTASFGLASFISPEISRQVQTTQS
EVEPVDKTPILFTPGKRTSVPYMKYAAIGLIAIALSSLGGMKLYEDKVQKHNFSEREKAD
ALVENQIQEATFIISDPLPAMQISVPKEYGRYHIVAGAFRIEANAYKKLDQLADKGYTGR
IIGKNKYGLHQVIYSSHQDRLEALRELRIIKRTENSDAWLLVKSLGTK
>OMIFANIC_00184 DNA processing protein DprA
MLSKNELRCLLALQRVPNLGDASVKKLIKHVGSAEGVFKEKKQRLLQIEGIGAFRFRDFQ
PKIILDEAEEELKFIEDNDIQYHHFLNPEYPSRLKHCIDAPILIFSKGKFNLKNKYIISI
VGTRNATSHGKRACEKLISELAPLNPIIVSGFAYGIDIAAHTAAIKHGLQTIVCLAHGLD
QIYPKTHKKYVPQILDNGALFTEFWSSDSFDRTNFLKRNRIIAGMSEATVVIESAEKGGS
LVTADIANSYNREVFAIPGRPNDMFSLGCNNLIKTQQANLLSSAADLIYVMGWDLDKKPA
KPVQTQLFSNLNEDEEKIYNYLKGKEKELLDQISIQCELPSHKTASVLFNLEIKGLVRPL
PGKLFQAI
>OMIFANIC_00185 Tryptophan--tRNA ligase
MARILTGIQSTGTPHLGNILGAILPAIKMANNPSNQSFLFIADMHSLTQIKEPETLKQNT
YSTAATWLAFGLDTDKTVFYRQSDIPQVTELSWYLSCFFPYQRLTLAHSFKDKADRLEDV
NAGLFTYPMLMAADILLYDADIVPVGKDQMQHLEMTRDVASRFHAKMGETFVLPDVKVQE
HTKLVPGTDGGKMSKSKDNIIDIFLPDKKLRKQVMGIQTDSTPLEDPKDPDTCNVFALYR
LIASEDETATMRANYLNGGYGYGHAKQALYDVLLDQYSVAREKYTHFMNHTDEIEAILAS
GAAKATVVANGVLDRVREKLGY
>OMIFANIC_00186 1-acyl-sn-glycerol-3-phosphate acyltransferase
MRFFRNIFLLFYRVWFYILVTVPILLLFPILIVSIAYERWYPFFFRLARLWAKFILFGMG
LYPVVKRDTKIKKGRSYMLVANHTSMTDIMLMLYLSRNPFVFVGKKELAKIPLFGFFYKR
TCILVDRGSAKSRHEVFVRAQRKLQQGLSVCIFPEGGVPETHVLLDEFKDGAFRLAIEYK
IPLIPLTFHDNKKRFSYDIFSEGGPGKLRVRIHEEIPTGILEQEDKRMLKNQVRAIILDE
LENPSL
>OMIFANIC_00187 hypothetical protein
MKEKKQIDKLFQERFQNFEATPPPDAWTNIQAQLKKEKEDRKVIPIWWKLGGVAALLALL
LTIGNSVLNNGDDPIQVTDENTKTEKVSNDASKDVLTDAKSQDSEIATEKDSEKVENIAD
DQKVYTNNESKEAVLNQDSQDESTVAVENKSSEKKKSNVQKDPILRDKEIINDLNEKKDA
VVDAVSKEKVSDKKITDKNQLDKVTDPETNKIETEKIAKTGVDQKEEKTTDPLIKKETEI
IEKKAEEAVAVEEDAEVDEEEVKEEEKKSIFDAIEENEEIEDAVAIKEGPKDRWEVSPNV
GPVYYSSFGNGSSLDPTFADNSQSGDVNFSYGAAVSYAISEKLSIRTGINNVNLSYSTGD
VELGIGPPTAGLQSVNYGRSSGQVLIAVDKGSLRPSSEGDFGVITPKAGGADAFINQSIR
YYEVPMELKYALMDKKFGINMIGGFSTLFLGDSEVSVEAGEFRSVLGEANNLNSLSFTTN
IGLGFDYKISKRLKFNIEPMFKYQLNPYSDSSVDFNPFYMGVYTGLSFKF
>OMIFANIC_00188 ECF RNA polymerase sigma factor SigW
MTLEELIIQCKKQDATAQEELYKKYSNTLFSICLKYSPNYAEAQDNLQDSFLTIFNRIEQ
FKGKGSFEGWIKRITVNTALQKYRKKRAFDITNEGQIEDEDVEVEDNSIPLDFLLKIIQE
LPDRYRLVFNLYVLDDYSHKEIAQMLGISDGTSKSNLARARMILKQKIEIYNNEQA
>OMIFANIC_00189 Protein RecA
MSNEKEAKLKALKLTLDKLDKTYGKGTVMKMGDTAVQEVEVIPTGSLGLDIALGVGGYPR
GRVVEIYGPESSGKTTLTLHAIAEAQKKGGIAAFIDAEHAFDRYYAEKLGIDIENLIISQ
PDNGEQALEIADNLIRSGAIDIIIIDSVAALTPKSEIEGEMGDSKMGLHARLMSQALRKL
TGSISKTKCTVIFINQLREKIGVMFGNPETTTGGNALKFYASVRLDIRRSTQIKDSNSEA
KGNKTRVKVVKNKVAPPFKTAEFDIMYGTGISKVGEIIDLGVAFEIVKKSGSWFSYDDTK
LGQGRDAVKTLLEDNPELMEELEQKIKEAIEAVQA
>OMIFANIC_00190 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNTLSAKERAALLEEAGEDRLTLSFYQYAKIGNPELFRNHLFIAWNDMDVLGRIYVA
NEGINAQLSVPAKNFETFKKFLDGIYFLKDVRLNIAIEQDLKSFLKLKVKVRHKIVADGL
NDDTFDVRDKGIHVNAEKFNELIEDPDTVLVDMRNHYESEIGHFQGAITPDVDTFRDSLD
IIEEDLSEHKEDKNLVMYCTGGIRCEKASAYYKHKGFKKVFQLEGGIIEYARQVQKKGLE
NKFLGKNFVFDHRRGERISQEIIANCHQCGKPCDTHVNCANEACHLLFIQCDECADKMEN
CCSEECVEVIHLPYEEQKKRRSGTHNSNKIFKKGRSEKLKFKK
>OMIFANIC_00191 hypothetical protein
MGCTSCATGADGQPKGCRNNGTCGSDGCNKLTVFDWLSNMSLPGDQKPFNAVEVRFKNGR
KHFYQFLENLSLSIGDVVATEASPGHDIGIVTLTGELVRVQMKKKNQPSDISALPKIYRK
ATQKDIDIWQKCRNKELDVQKQSREIAMALGLKMKISDVEYQGDGSKAIFYYTAEERVDF
RQLIKDFARAFSTRIEMKQVGFRQEAARLGGIGSCGRELCCSTWLTDFRSVNTSAARYQQ
LSLNPQKLAGQCGKLKCCLNYELDTYLEALDEFPKTDIKLKTEKGTASCQKIDIFKRLMW
FAYDNDGMNWHQLQVDKVNEIAAINRKGKTVTSIEEYIEDLVIPDSKLFNNVVGQDSLTR
FDQPQRRRKKRRNKSRNRNRNRNTQKNG
>OMIFANIC_00192 Gliding motility lipoprotein GldH
MGKAIILMLFCGLLISCNQAIVVSDTHTMPGYWDKDEKIEFIIPQLDSLKQYNVFVNIRN
TNDYPFNNLFIIVSMEFPYGKTIVDTLEYKMAYPNGEWMGEGIGNVKDNKLWYKENVSFF
EDGNYNITITHAVRNNGEVEGVSRLEGITDVGYSIEEVTQD
>OMIFANIC_00193 Penicillin-binding protein 1A
MAKARTTKKKKADQGVRKHIRTFWKIFGGLIALILLVFILASWGVFGSLPDETSLENPEK
NLATQIIGSDGETLGTFYKENRTPVKYEDLPDHLVNALIATEDVRFYDHSGIDAKGTVRA
FVFLGTKGGASTISQQLAKLFFTEQVSRNKFQRGLQKIKEWIIAIRLERRYTKEEILTMY
FNEYDFLNQAVGIQSASMIYFSKQPSEISTVEAATLVGMFKNSSLYNPLKNPIGVKNRRN
VVLAQMAKYDYITDEVKDSLQALDLNIRYSPQGHDEGIATYFREYARAFMADWVKENPKS
DGSKYDIYSDGLKLYTTIDSKMQAYAEQAMDMHMEKLQEEFDSQNKKNKTAPFRDITPEE
TNKILDAAMRRSDRWREMNKQGKSEKEIIDSFKEERKMRIFSWKGDIDTVLTPLDSIRYY
KGILQASLMSMNPQTGEVKAWVGGIDYKHFKYDMVKTGQRQIGSTFKPFVYATAIDQMHM
SPCDTLPDTPYTIPQGKYGLLEPWTPKNSGAISGKHLSLRSALAQSINTITARLIDRVGP
EPVIELVNKMKVDTEDIPPVPSIALGTPDVTLYEMVGAYSTFANQGVYIKPTLIQRIEDK
NGTVLYQNVPETKDVISDETAYVTVSLMEGVTQSGSGSRLRHTWRGGDPVYKKAVTGYPY
GFTNPIAGKTGTTQNNSDGWFMGMVPNLATGVWVGGEDRATHFNSTSYGQGATMALPIWA
LYMQKCYEDESLNISTSEFEKPSKISIATDCEKWKAENSGGEIPDEFDL
>OMIFANIC_00194 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MINKTVASVQEACEGVKDGMTFMLGGFGLSGIPENSIAELVRRGVKNVTCISNNAGVDDF
GLGLLLQQRQIKKMISSYVGENAEFERQMLSGELEVELIPQGTLAQRCQAAQSGIPAFYT
PAGFGTEVGEGKEVREFNGKMHLMERAFNADFGFVKAWKGDEAGNLIFKGTARNFNPNMA
GAATITVAEVEELLPAGSLDPNQIHIPGIFVQRIFKGAHYEKRIEQRTVRKKE
>OMIFANIC_00195 hypothetical protein
MKLNFTCSIWNEKNKFRPIAPNRGELQMKMGDDVNVNCVQCGSLEKKHLNDIYAVVDYRI
ILVGVILGIIVTVPLWMYYGAIAAVSGMIPILIYGYENKTGHAFNYYRIKRK
>OMIFANIC_00196 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MLDKNQIAQRIAKEVKDGYYVNLGIGIPTLVANFVRDDIEVEFQSENGILGMGPFPYEDE
EDPDLINAGKQTITALPGASFFDSAMSFSMIRGQHVDLTILGAMEVAQNGDIANWKIPGK
MVKGMGGAMDLVASADNIIVAMMHTNRAGASKLLRKCSLPLTGVDCVKKIVTNLAVLKIE
NNKFVLLERAPGVSVEEIKTATEGELVIEGDIPEMKL
>OMIFANIC_00197 Glutathione import ATP-binding protein GsiA
MLNINTFGFMLKKLVLEIENLSIAFGNKNKRVEVIHDISFTVSENEIIGIVGESGSGKSV
TSLAIAGLLPRHSSQLKGSIRFENTELLELSSKEFQKIRGKEIAMIFQEPMSALNPSLTC
GFQVSEIIRHHLGYSVSEAKKETLKLFSRVRLPRPKELYGRYPHQISGGQMQRVMIAMAI
ACKPKLLIADEPTTALDVTVQKEILQLLKDLQKETGMSLLFISHDLSLVSEIADKVLVMY
QGNIVEQGSVLQIFKTPHHSYTRALLAARPVLDKRLLKLPTIASLEDKTFKPKEVTPAQR
ALRHKRLYTSTPLLEVKNVEKEYYSSAGLFTPKKVTKAVNDVSFSVFEGETLGLVGESGC
GKSTLGKAILLLDKATAGNIKYRGKELGRLSKAEIRNLRKEIQLIFQDPFASLNPRLTIG
QAILEPMKVHQIGSGRQEREKKVRELLIRVGLDESYFNRYPHELSGGQRQRVGIARTIAL
APKLVICDESVSALDISVQAQVLNLLNELKEDFGFTYIFISHDLAVVKYMSDQLMVMNAG
KIEEIGDADEIYANPARDYTKKLIDAIPKGI
>OMIFANIC_00198 Bifunctional protein pyrR
MKGFFFAVSFKFHKNPYFCTLNKIQIYCMSQKVLLNATEVHIALHRLACQLIENHDTFSN
TVLIGIQPRGVHLAERLKSMLEIDYKVRDIKLGYLDITFYRDDFRRSDKPLEANTTEIDF
IVENKKVVFIDDVLYTGRSIRAALTAIQSFGRPTEIELLTLIDRRFSRHLPIQPDYRGRQ
VDAINREKVKVCWKEQDGEDAVYLINN
>OMIFANIC_00199 Aspartate carbamoyltransferase
MSELSVNHLLGIKYINEDDINLIFETADHFKEVINRPIKKVPSLRDITIANLFFENSTRT
RLSFELAEKRLSADVINFSAASSSVKKGETLIDTVNNILSMKVDMIVMRHPNPGAGVFLS
KHIDASIVNAGDGAHEHPTQALLDCYSIRERLKDVAGKKVVIVGDILHSRVALSNIFALQ
KLGAKVKVCGPKTLIPKYIEKLGVEYEGNLRKALEWCDVANMLRVQKERMEISYFPTTRE
YTQQYGVNKALLDSLGKEIVVMHPGPINRGVEITSDVADSKQAIILEQVQNGVAVRMAVL
YLLASKIQHNEN
>OMIFANIC_00200 hypothetical protein
MKIENFENYVVLADDHNNLKEFASFLEFQIIKKFKGQNVVIDLTDYHALELEELLYFLKT
SNIHRKTKQSFVLVTATLDPDTIPRELIVVPTLQEAGDIIEMEEIERDLGF
>OMIFANIC_00201 Ribonuclease BN
MKLTILGCHSATPRTSAHPTAQVLEMKGHLFLIDCGEGTQVQLRRYKVKFSRIKHIFISH
LHGDHFFGLVGLVSTFRLLGREADLHIYGPKGIKEAIVLQLKLGKSWTDYNLIFHELESK
SAHVIFEDESLTVSTIPLDHRIYTNGFLFREKPGERKLNLDAAVKAKIDTSYFSKLKQGF
DVENRKGEMIDNKLVTLDPDPPKSYAFCSDTSYYPEMAAQIQDVTVLYHESTFLESHQHL
AEATKHSTAREAALIANKASAGTLILGHYSGRYKDLEEFRKEAMEVFDRVELAEDGKVYE
W
>OMIFANIC_00202 hypothetical protein
MKFRNIIFDRMRASLYCVLLLAASILSVAQTTVDLDSRQPPCTFISESNAFENGLLSPSE
GTQTVANDILVAAGDVFTLSEIEVNFFSVSIITDADITYYEDDNGLPGSVLNTMTDVTPT
AVFDIGSFGIFIWKAIFDVPQFDFVGQAGEETRYWISITVSNMDGDDEVYWETKSVGQQG
FQPAINDNGTGWMLVDTSNGQHVEGVYEFIGECSLGINTVAQQNVTVFPNPATDLVQCVN
CQDITKATIYNLTGQQMAVLTDLSGEINIGFLLHGMYFFELVGSDIKKTVSLLKI
>OMIFANIC_00203 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MHHKNSKTRKLRYKVKLMKEDLHGYRRNYDKGELTKTSVDPNPLQQFRTWFYEAMDTDGV
DEANAMSLTTIGTDGFPKGRMVLLKKYDEYGFYFYTNYNSEKGRAIAENNKVSLTFFWPI
LERQIIIQGTAEKTSKIDSDNYFQSRPKGSQLGAVVSDQSEIVTDREIMEERLHELEEEY
ENKEIPRPDYWGGYLVRPLRIEFWQGRPNRLHDRIQYILNEDFDWIINRLQP
>OMIFANIC_00204 hypothetical protein
MKTLYMARHAKSSWKYDLPDHQRPLKKRGHKDASLVSEKAKTDHKPPEKIISSDANRAQT
TAMYFKKAFGVSDENYILNHDLYDFSGQSVMEIIKGLDNSLKRVMIVGHNHAFTSIVNML
GNEYIDNLPTSGFVIIKFPVDSWSEITTGKTKTLLFPRHLKE
>OMIFANIC_00205 Exopolyphosphatase
MLNIEKYAAIDIGSNAIRLLIATVIEKGPSKVQFKKTSLVRVPIRLGADVFLKDNISEEN
YLRMVDAMNAYRLLMKTHNVVKYRACATSAMREADNGEEIAKRIKKETGIDIHIIDGKDE
AAIIATTDLYDLIDNDKAFLYVDVGGGSTEFTVFANGKVITSKSFKLGTVRILNDMVRES
IWDDVKDWIKKNTRKYDKINCIGSGGNINSIYKLSEKKIGKPLSYFYLAGFYEELKSYTY
HERIFELQMNPDRADVVIPATRIYLSAMKWSKSKNMYVPKIGLSDGIVKSLYNEKIARQI
EIRK
>OMIFANIC_00206 hypothetical protein
MEKEKKDLNKKMLGLKLPTDPRWVNIVEKNIEEILTDHAYCEQKAASTAISLIVTFPEYT
ELVREMIDLVEEEMSHFKMVHDLILERGFVMGRDRKDYYVSRLTQFFPKGGSRSTQLVHR
LLYAALIEARSCERFRLLSEELKDKKLARFYRKLMISEANHYTMFLGFARKYGESVEQVN
EKWQALLSFEAEIMKDLGKEETIHG
>OMIFANIC_00207 DNA polymerase III subunit tau
MAGFYICLSMEHFIVSARKYRPTQFEDVVGQQAITNTLDNAIANNHLAQALLFTGPRGVG
KTTCARILAKKINQDGTEREDEDFAFNIFELDAASNNSVDDIRNLIDQVRIPPQVGKYKV
YIIDEVHMLSSAAFNAFLKTLEEPPKHAIFILATTEKHKIIPTILSRCQIFDFRRINVKD
IKQHLARVAEAEGIEAEDDALHIIAQKADGALRDALSIFDRVVSFSGKNLTRQAVTENLN
VLDYTYYFSITDLLLENNIPQLLVSFNEILSKGFDGHHFIMGLASHFRDLLVCKNEDTVE
LLEVGDTVKTMYLEQSSKTSADFLIEAIELANSCDLKYKSSRNPRLLVELCLMQLGSITQ
KDEKKKTNAKRFVIPPSFFKDVAVKQQPKVENTPSPTEVKDDSGSFPEVNNKPEPVISEK
KNVTVVQERVIERPQILAERNAKKVSALSLKSIQKKQQLKKELIANQPNEDNLPATEFSE
KEMQTAWDDYAKKVEMDGKYNLLSHLTMGTPKLEGSVIHLVFPNDTIKVEVERAKFELLG
FLREKLQNYEIDLSIEVNEAETKRYAYTAREKFEKLKEKNPLIDKLRQEFDLEI
>OMIFANIC_00208 hypothetical protein
METSENSFLDVGFANFQFYDIYVIATVGEGVVLGKEEMAKFYEVFENQYGDKPFGYISNR
KNDYTINPLYYKEIEKYNINIVGVATLCYSKESYDMALFAEQFFSWPHAAFYTLEDCISF
ITEQYKKEKKAGL
>OMIFANIC_00209 Ribosomal RNA small subunit methyltransferase D
MRIVSGKFKGKRIIAPKKLPVRPTTDFAKEALFNILNNRYDFGELRVLDLFAGTGNISYE
FASRGTKEILCVDAHYACVKFIQQTAMSLEIPITTVKSDVFKYLRIQQDAYDIIFADPPY
DFSSDQLEELVSLSFGNNLVREEGCLIIEHTKHLDLSEISHFQESRKYGGSVFSFFT
>OMIFANIC_00210 hypothetical protein
MKLIPVVTGQKFMTQTTTSSLHTIPNKRLSVQVALTGLSFLVTNSAKTEVLHFSAKEFEK
ARTPEELLIDVEAFVNAEIEDPTLFESVTVLYSNAEYTAVPSALFDETKASDYLKFNSKI
LANDFIAWDELAERNMHLVYVPYVNINNYLFDTFGSFQYFHTTSVLLNTLPVGTKFSEEP
TVHIHVEKTNFQIIVQASGELKLCNSYHFVTPEDFIYYILFCFEQLQINPDTVKLVLLGN
INREDELYSMVYTYIRNVELMEDDLSKLNIENTFAHQYMLLKSV
>OMIFANIC_00211 hypothetical protein
MIIYIVIGIILSIGLVLFLEKFVPKKFNPIISIILWAVIVYLGYLLYNSIQGPIEFNKVK
EARYAKVIKNLKDIKAAQLAFQEINGGFMGDFDSLVRFIDTAQFAVIQRRDTSYPDVEKN
VAFGLDPQDGGYFVEEVIIDTLGFTPVKDSIYKGTDRYKTMMNIPVENVSEQFELKAGKL
DKNGTIYSVFESRVAKDVILADLDKDLLAQEKQVISVDGVNGPYIKVGSMDEVDTSGNWP
KIYDTDDNQ
>OMIFANIC_00212 ATP-dependent RecD-like DNA helicase
MDVSGFYSLLKSDFKFTATSKQDITLQLLSRFVLSNVKNEVFLLKGYAGTGKTTIVGTLV
KNLWKAKKSSVLLAPTGRAAKVISSYSGKEAFTIHKKIYYPKSNKSGGVSFTLQPNKHRN
VIFIVDEASMIPDVNQDSKLFENGSLLDDLMQYAYSGHNCKLMLIGDTAQLPPVKLDVSP
ALDKRILENHYNKEVIEIELDEVVRQEQDSGILFNATKIRNRIEDELFEAFKLSIQSFPE
VTRPEDGQEIMDAINDCYTQLGNEETVIIVRSNKRANLYNQNIRSRILFQEEELSAGDYL
MVVKNNYFWVKPHTEAGFIANGDIVQVLEIFGFKDLYGFRFAEVKIQMVDYPKMAPFETV
LLLDTLTSETPSLSYDDSNRLYQEVVKDYADVKSNYKRFLSVKNNKYFNALQVKFSYAIT
CHKSQGGQWHTVFVEQPYLPEGVNKDYLRWLYTAITRATKKVYLIGFKNEFFDDSL
>OMIFANIC_00213 3-deoxy-alpha-D-manno-octulosonate 8-oxidase
MIPARYGASRFPGKLMQDLGGKPVIVRTYEAAKDTGLFDEVYVVTDSEIIFNEIELHGGQ
AIMSKKEHDSGSDRIAEAAENMDVDIVVNVQGDEPFTSKDGLEQVLNVFKGADADRIDLA
SLMTEIHDWKEISDPNCVKVIVDKDNFAQYFSRSPIPYPRDKNAAVQYYKHKGIYAFRKQ
ALMDFYRLPMRSLEAAEKIECIRYLEYGKNIKMAVTATQGIEIDTPEDLKRANKILKEEK
KDTVNNKYRNFPMVPKVVFGEGSFDQLSSILAPQRKDKAPFIFLVDDVFENNPKLVDRIN
LRFNDKLLFVSADEEPKTSQVDEIVEDIKSEFTYKPSGIIGIGGGTILDLAKAVAIMLTN
KGSASDYQGWDLVPNKAIYHVGIPTISGTGAEVSRTTVLTGPVKKLGINSDYTPFDQVIL
DPDLTKGVPRNQWFYTGMDCFIHCVESLNGTFLNAFSQSYGEKAYDLCKEIFVDSKLSVE
ESRGKLMMASWHGGMSIAYSQVGVAHAMSYGLGYVLGTKHGIGNCIVFDHLEEFYPDDVA
LFKEMVKAHNIDIPKGLCKNLTEEEMNTMIDIALSLVPLWENALGDNWESIATRDKLRSL
YLKM
>OMIFANIC_00214 hypothetical protein
MILTKFIFHRLLGWKIEGDFDRNILKSVVIVVPHTSWHDFYIGAFARKLLRTEINFVAKK
ELFKWPFGAYFRWMGGTPLDRSGGMNKVEAIASIFSEKKEFRMALAPEGTRKKVDRWRTG
FYFIALEADVPIIPVAFNYKIKTVKIGQAFYPTGNIEADLDELHQFYDGVVGKIPAKT
>OMIFANIC_00215 putative transcriptional regulatory protein
MGRAFEFRKARKMKRWAAMSKAFTRIGKDIVMAVKEGGPDPDANSRLRAVIQNAKSVNMP
KDNIERAIKRASDKNQGDYKEVLFEGYAPHGIAVLIETATDNNTRTVANVRSYFNKCDGN
LGTSGSVAFMFDHVCNFRINAEGNDMEELELELIDFGVEEIFEDEDGVLIYAPFESFGAI
QSFLEERSIEILSSGFERIPQVTKTISPEQAADVEKLLEKIEEDDDVQNVYHTMDENSSG
A
>OMIFANIC_00216 hypothetical protein
MRKPLSFLLLLLLFFTNNLYSQQFNNALEYLEFVSNEQEIITRNTWKYTKAIAHSKRDRT
IASKRSSLIKSIERALTKINKANAFEGDDFKENVLKNLELNKSLLQQDYAKIIDMKAVAE
QSYDAMEAYMLAQELADKKMAQAQQEFEVHYYQYAREHNINIIESESDLGKKMKISSEVF
DHYNDLYLMFFKVNMNEVYLYDALERSDVSAIEQSAGALSESAKEGLKKLDTVSLYKKDR
MLVDATRKAFEFFEDEADNKIPVLTDFLIANEDFEAIKSKLDGTPERKRTKAQIDAYNEK
VSLINKAVENYNKTNAALNKKREAVLGNLNAAYERFLAKHIPKD
>OMIFANIC_00217 Tail-specific protease
MLKNYCLIIVCLFSLSASAQTDPPFCDQMAALKLLIETQHYRPKPLDDALSSGIYKLFIQ
RLDEDKVLFNDKDIAEIRKDSLKFDDYLRDNNCGFIGKYIKTLRWRIAETKQVIDSYKNT
EFDYSGKDTLKYYRTRESGYFDDDIAMKKYWSKRLRFEILSKISEEDSILDRLEMNFDIL
ENEVRPLIFEKLSCQLDEMENGYGGLERFVTETFLNAYTNYQDPNSTFFNNTDKTMFENS
VSTSMMTFGLYTEKNEDGEIVISYVTPGGAAYFEGSIEEGDVIRSLTAGTNIVETNCISN
EEITAFLSDNNNKRITFRIKKKDGTIKSVMLTKKAEKAAENLTRGYVMSGEFPIGYINVP
SFYTDFESPHGMGVANDIAKEIYKLKKENIQGLVIDLRFNGGGSMKEASDLCGMFIDRGP
VSILKYRNGETFTVRDANRGTVFNKPIVVIQNSYSASASEYFTSVMQDYNRAVIVGTPSY
GKSSMQTIVPLDKNREELGFCKITTDLFYRVTGKSNQSKGVIPDIFFPSMYDGLDVNEQF
IDFSLPNDSVQIKVKHQPKRKIPLKLLREKSEYRMYIDEGFQKIKRLNKTLLRNYIQKDT
IYSLTLKNVYGDLRGYNDLWKDFIGYFEERKGILTVKNTASTEELLKYSDEDKKVNALSI
DEISNDIFIEEAYHIIADINNIN
>OMIFANIC_00218 Putative pterin-4-alpha-carbinolamine dehydratase
MKALSEADIRKRLQSLEGWEYNDNAIHTAFEFENFKEAFTIMTRIAFEAEKLDHHPDWSN
VYNQLHISLYTHSENGVTEKDLELAETINRLVS
>OMIFANIC_00219 hypothetical protein
MGASGYIGNALYRELDSYFDVYGTYCTQDGLYADNQVFYQFDAEKNSVLPLLEKLKPRYI
ISSFSSQYQASMKVHQDLVSYCELLPESRVIFSSSAEVFDARKKFPAYEYDKPLSESTEG
RQKLTLEKLLLEHIPFQTTIIRMPVVLGINAPLILQLRQAIKHKAAFEVFPKRIISASTA
AKIGQQVHYIINKDLTDIYHLSSSDVIHHDDIFREIAMKISDSLPVFKKVFSSNEDEYQA
ILPKENLLPKPYRITIAEVIESSTLHDEIISIKK
>OMIFANIC_00220 Aminomethyltransferase
MKDTALSHIHKVLGAKMVPFAGYNMPVSYEGVNAEHETVRNAVGVFDVSHMGEFLITGPN
ALELIQKVCSNDASKLVDGQAQYSCFPNADGGIVDDLIVYRLDAEKWLLVVNASNIDKDW
EWISSHNSMNAEMRNLSEDFSLLAIQGPKAVEAMQSLTSEDLSSIKFYTFKVSDFAGIEY
VIISATGYTGSGGFEIYCKNSEVEQIWNKVLEAGKDFGIKPVGLAARDTLRLEMGYCLYG
NDIDDTTSPLEAGLGWITKFTKDFINSDALQQQKTEGVKRKLVAFELNERGIPRQGYDIV
DQDGNSVGKVTSGTMSPSLNKGIGMGYVPVELSKPGTAMGIQIRKNIIPATIVKLPFYKG
>OMIFANIC_00221 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MIVFNKDGNLQKTICRMKVFSATQLHEADKVTTEKDGITPLDLMERAGTMVFNWLHQRMQ
GAQVPVHIFCGIGNNGGDGLVVGRLLIEHGYSVHIYIANFTDKRSKCFLLNYDRIKKVTS
SWPTLMTSEADFPEIHQDDVVIDAIFGIGLNRAPEGWVKKLIQYLNNEKAFRLSIDIPSG
LHANKPIADKEAVLRANHTLTFQAPKLAFFLPESGQFVPYFETIDIGLDPEFLHQTEPLA
RLISKAEAQQFYKQRKKYSHKGDYGHVVAIGGSHGKIGAVVLASKAAYRSGAGLVTAFIP
SCGYETLQTAVPEAMAVTDKDEEIISDISGIPEATAFAVGMGLGTDERTVDALKKFFKET
KAPMVIDADAINCIANNKELKTLLPKQSVLTPHPGELRRLIGDWSDDYDKLAKTKAFAKE
HECIVLIKGANSITVSEDKLYVNTSGNPGMATGGSGDVLSGMIAGLLAQGYDPLSAAIFA
TYIHGSAGNIVSQTNGFEAVMAGDIADHIGKAFLILFEPDAPVQTDADEEA
>OMIFANIC_00222 Thiol-disulfide oxidoreductase ResA
MKKLILALCAMAIFACEDDSPKDYVTFSGEIKNKNSDSIRIYNRNYSKTIAVNDDGTFSD
TLKVETGNYTFHDGGEATSLFLENGYDLKLTLDTEMFDETVIYTGVGAENNNFLAASALK
MESLLDIDTDNLDEQKLNAVLDNARTKYTEFVDSAVNVDSMIISSSRDDLDATLQSFQRY
YGGIIALRKEFPKGSPSPTFEGYENFKGGTTSLADLKGKYVYVDVWATWCAPCKVEIPYL
KELDEEFKDKNIAFVSMSIDDAKRHKDSWEKAHESWKKMVEEKELTGVQIMAPNGWQSDF
VKAYKINGIPRFILIDPEGNVVDPDAPRPSNPKLKEVLKSLI
>OMIFANIC_00223 Histidine ammonia-lyase
MQNTHYVSSDILDLPILKEIIEEGRKLELSEEAILNINKSHDYLHKRIGQDDSVIYGLNT
GFGALCNVKISSENLSKLQENLVMSHACGTGDFVPKHIIRLMLLLKIQSLSYGHSGVQLG
TVQRLIDFFNHDYLPVIYTQGSLGASGDLAPLAHLSLPLIGKGEVYVNDEIIKTEEVLKK
HNWEPITLQAKEGLALLNGTQFMSAYGTYILLRAHKLSYLADVISALSVDAFDCNLSPFD
PLVHLARPHRGQVKTAERMLYLLEDSEIGRSEKDNVQDPYSFRCIPQVHGASKDTIVFAH
KTFKTEINSVTDNPNIFVADDKIISGGNFHGQPLALALDYLSIALAELANISERRTFQLV
SGLRGLPDFLVNNPGLNSGFMIPQYTAASIVSQNKQLATPASVDSIVSSNGQEDHVSMGA
NAATKCLRILENLETVLAIELMNASQAIHFRRPKKTSPFLESFVASFRNAVTFVDEDRLL
ADDIHTAIGFIQDMSIDGEILFN
>OMIFANIC_00224 hypothetical protein
MLPSEKHIVTFDFGVAELHQNYMLMVMNEGITVNSSINAQLTDLAAEHFKERPFGYITYR
KNSYSVDPNVYNETSKIKMLVAFAIVSDEDIRRTTAKVEEIFLDKPLKVFKRLKDAVIWV
EKIVALS
>OMIFANIC_00225 RNA polymerase-binding transcription factor DksA
MKDTAQIKQRINEEIKATKELVLKYRELTKPIAPENAIGRISRMDAINNKSVNDAALRKA
ETKLKNLEVALSKVDDPDFGICLKCKNEIPLGRIMLLPHAVTCVNCAK
>OMIFANIC_00226 Negative regulator of genetic competence ClpC/MecB
MDDNFSPRVKDVIAYSKEEALRLGHDFIGTEHLMLGLLRDGNGKAVTILNALDVDLNHLR
RKVEILSPANPSPGTSTNDKKNLHLTRQAERALKTTFLEAKLFQSSSINTAHLLLCILRN
ENDPTTKLLNKLKVDYDGVKDQFKLMITNDEDYIEGPTSESFPNEDESAGDEETSKENLF
SGSAGKGSKKSKTPVLDNFGRDLTSLAEEGKLDPVVGREAEIQRVSQILSRRKKNNPLLI
GEPGVGKSAIAEGLALRIIQRKVSRILYDKRVVTLDLASLVAGTKYRGQFEERMKAVMNE
LEKNDDIILFIDEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKD
GALERRFQKVLVEPTTVEETIEILQNIKDKYETHHNVSYTDDALEACVKLTNRYMTERFL
PDKAIDALDEAGSRVHITNINVPEKILEIEQKLEEVRELKNSVVKKQKYEEAAKLRDDEK
NLEKELATEQESWEKESKLHKETVDEENVAEVVSMMTGVPVNRIAQTESNKLAELPDRIK
GKVIGQDEAVSKVVKAIQRNRAGLKDPNKPIGSFIFLGQTGVGKTQLAKVLARELFDSEN
ALVRVDMSEYMEKFAVSRLIGAPPGYVGYEEGGQLTEKIRRKPYAVVLLDEIEKAHPDVF
NMLLQVLDDGYLTDSLGRKIDFRNTIIIMTSNIGARKLKDFGQGVGFGTAAKESQADSHA
KGVIENALKKTFAPEFLNRVDDVMVFNTLEREHIHAIIDIELEKLYERISDIGYKLILSD
KAKDYIVDKGFDKDYGARPLKRAIQKYIEDALAEEIINSNLREGDSISMDLDEKSNELKI
KIKKQKKTTES
>OMIFANIC_00227 DNA gyrase subunit A
MAEGEKLIPINIEDEMKSAYIDYSMSVIVSRALPDVRDGMKPVHRRVLYGMHELGVRANS
AHKKSARIVGEVLGKYHPHGDTSVYDAMVRMAQEWSLRYMLVDGQGNFGSIDGDSPAAMR
YTEARMQKISEDMLSDIDKETVDHQLNFDDTLHEPTVLPTRVPGLLINGASGIAVGMATN
MPPHNLTEVIDGTIAYIDNTDIEIDELMQHVKAPDFPTGGVIYGYEGVKDAFHTGRGRIV
MRGKANFEEVNGRECIIVTEIPYQVNKANMIKKTADLVNDKRIDGISNIRDESDRKGMRI
VYILKRDAIPNIVLNMLYKYTELQSSFSVNNIALVNGRPRLLNLKEMIHYFVEHRHEVVT
RRTQYLLRKAEERAHILEGLIIASDNIDEVIALIRASKNADEAREKLIETFELSEIQAKA
IVEMRLRQLTGLEQDKLRTEYDELMNTIEDYKDILAKKERRMQIIKDELEEIRTKYGDER
RSVIEYAGGDVSITDLIADEKVVITISHAGYIKRTSLTEYKKQNRGGVGQKASATRTEDF
LEHLFVGTNHQYMLFFTQKGKCFWMRVFEIPEGSRTSKGRAIQNLINISPDDKVKAFICT
QDLKDEDYINSHYVIMATKKGQVKKTPLEQYSRPRTNGINAITIKEDDELLEAKLTTGDS
QVMLAVKSGKAIRFEEGKTRPMGRNASGVRGIRLGHKDDEVIGMIAIEDAETEILVVSEN
GYGKRSSIEDYRITNRGGKGVKTINVTEKTGNLVAIKNVSDSDDLMIINKSGIAIRMAVE
DLRVMGRATQGVRLIKVKEDDAIAAVAKVMHDEDDVDENGDETSEGENGTTLDTNESNTE
NNE
>OMIFANIC_00228 Photosystem I assembly protein Ycf3
MKKQLLLAGLFCISAIAFGQKKEIKKAEKALKAGNASEAISYINQAEGLLSNADGAMKSQ
FYMLKGKAFLAEAGTTDYGKLKTAAEAFKMANESGAAGKTADEVAIGMQNLRVALVNSAV
ADQNAKNYAGAAEKLYTSYTIQKDTSDLYYAAGNAVNAKDYEKALMYYKDLLDQGYTGIR
KEFVAIEIETGKEVVFASESDRNTNMLTGKYTNPTERMSQSVRGDVLQKVTLIYISRNEN
EKALALMKEAREANPDDKSLLRAEADMAYKMGDMEKYSSLMEEIIAADPNNPELYYNLGV
GSANKGDKEKALSYYKKALELDPDFTNAKINIAATILAGEGPIIEEMNSLGTSNADYDRY
DELKEVKNGLYREAMPYLEAASADKPDNLELIRTLMNIYSQLGEDDKHKAAKAKLDALEG
GE
>OMIFANIC_00229 Gamma-D-glutamyl-L-lysine endopeptidase
MKYGLCNLSIVPLRAESSDQSELVSQILYGETFKVLERRKKWSKIRLQFDSYEGWIDNKQ
FTEISKEDFKKLNELPVQLSSDLVNFITTRENQLIIITIGSNVAASDFLAHQYEGNKVES
SLTKEAIIDTALLYLNAPYLWGGKSPLGIDCSGFTQMVYKLCGYSLLRDASQQASQGEAL
SFIEESEPGDLAFFDNEEGIITHVGIIMEDHHIIHAHGKVRIDRLDHTGIFNAEKRTHTH
KLRVIKRIV
>OMIFANIC_00230 Acetyl-CoA acetyltransferase
MNKKVVIVSAARTPIGSFMGSLSSLSAAHLGSVAIKGALSKINLDPSLIEEVFMGNVVQA
GVGQAPARQAALGAGIPDSVPCTTVNKVCASGMKAVMHGAQAIALGDADIIVAGGMESMS
NIPHYMHLRTAHKFGPKSMEDGMQKDGLVDAYDKQAMGVCADLCASEYEFSREDQDAFAI
QSYERSAKAWSEGKFANEVVPVEVPQRRGEPVIVSEDEEYKNVKMEKIPALRPAFTKEGT
VTAANASTINDGAGAVILMSGEKAEELGLKPLATIKSYADAAQEPKWFTTAPAKALPKAL
AKAGLSQDEIDYFEFNEAFSVVGLANMKILGLDDSNVNVNGGAVSLGHPLGCSGVRILIT
LLNILEKNDARYGAAAICNGGGGASAMVIERN
>OMIFANIC_00231 Cyclic-di-AMP phosphodiesterase PgpH
MNKRLSRFSKKQSLVYKVFLFIASTLLVIYLLPRGGQFKYDFQKGKPWQYENLYAPFSFT
IKKSEEALENEKADLRKLVVPYFDLDIRVIDQNKTKLRQLLSESYVDTLYTIRESAIYDI
GSSIIDQVNIHGLSDEIHAYSQDQLVYLKNGNEVDEITYGQILKMDELDDRVLNLINGAS
NSESVRNLLEILLKRSISPNVTFNNKLTEAAIESELKDISPNRGIIEKDGRIIAKGEVVE
GDTFQILNSLKAEYQSEVWSESNRVWLLVGYALLVSLVFLMLFLFLNKYRKEIFSNNTKV
TFIFFNIVLMVFLTTFIVKLDAAFVYVVPLCILPLILKAFFDPRLGLFVHVLTLLLLGFI
VPNSFEYLFLQIIAGIVTILTVSELYRRANLFISVGQITLIYIVGYFAFFIIQEGNIQTL
ELETFGYFILCGLATLFAHPLIYFYEKLFGLVSDVSLLELSDTNTKLLKELANKAPGTFH
HSLNVANLSEAAANEIGANAMLVRVGALYHDIGKMINPTYFTENQLNAVNTHNELAPKES
ARIIIDHVIKGIEIARKNNLPDRIIDFIRTHHGTNLVYFFYSKEKEISGEADPKDFMYPG
PIPFSKETAILMMADSVEAASKSLKEPTSSKIDAFVEKIVSVQMENGQFLNANITFKEIQ
TIKKVLKKKLNNIYHLRVEYPE
>OMIFANIC_00232 Glucosamine-6-phosphate deaminase 1
MKNIKYQPAGQFESTRFEKIHNVEFNSHIEASLVVASEIAALIRKKETAGETCLLGLATG
SSPIKVYDELVRLHKKEGLSFKNVVTFNLDEYYPMEKQNFQSYYHFMHEHLFDHVDILPE
NINIPNGELEFDEIHQYCIDYEEKILEMGGLDFQLLGIGRTGHIGFNEPGSHINSGTRLI
TLDHITRVDAADSFLGIDNVPRKAITMGIASVRNARRIVLLAWGQHKAGIIKVTVEGDIT
SEVPATYLQQHENTTFVLDYEAGSQLTRNKTPWLVGPCEWTSALKSKAIVWLCGQTGKSI
LRLTDTDYNNHGMSGLLAQEGSAYNFNIEMFNKLQHTITGWPGGKPNADDSKRPERAQPA
SKRVIVFSPHPDDDVISMGGTLDRLIEQGHDVHVVYQTSGNIAVSNEEALKFAEIASALD
TESDLKDEILKELVSGKEHQADSTNLRRLKGLIRRSESYAATRYLGLKDENAHFLNLPFY
ETGKVKKNELSEADIELMIGVISKIKPHQIYAAGDLGDPHGTHKVCLEALFESLNRMKSE
SFMKDCWVWLYRGAWHEWQLHEIDMVVPMSPDQIVKKRHAIFYHQSQKDRVMYQGDDDRE
FWMRAEERNKTTASNYRAVGLADYAAMEAFVRYHF
>OMIFANIC_00233 hypothetical protein
MPEKKPDQVVFNEETQTYDASLKPYPTNLGAPAIALVETVAWKRLNAKRANEHLKSSFEE
IKYKYEKLVEKMELNELVYNAKFSFEPIVGNIYHLYRNKSEIPFLSILSPEECHFDHLGS
FRLTSEKLWEAIED
>OMIFANIC_00234 GTP cyclohydrolase 1
MKNQESLVTSLLKGNTLNGFNHEEIGDDHLYTGIETPMKDNAFDMSDKEKKERISILFAE
IMDVMGLDLTDDSLKGTPDRVAKMYIEEIFSGLNPANKPKVALFDNKYQYNQMLVEKNIT
FYSNCEHHFVPIIGKAHVAYISSGKVIGLSKLNRIVQYYAKRPQVQERLTNQIAMDLQEI
LDTEDVAVIIDAKHLCVSSRGIKDDTSSTVTSFYGGQFNTPQKIAELQNYLKD
>OMIFANIC_00235 HTH-type transcriptional regulator GlnR
MDQSDNQAYKRTEPLYTLSVASRLSNTPTHSVRQYIDKGLILPFKTKNKRHLFSDVDISR
LKCIRKHLDEQGLNIAGINALFALVPCWIIKPCSIEDRENCDAYSEIKKPCWQASNKGPE
CKNTDCRLCSVYQLPEKCVNLKDFIKKITNT
>OMIFANIC_00236 Sulfurtransferase TusA
MSTINIEKVLDLKGLLCPIPVVKISNAIKEIEPGNVIEATATDPGVMMDIPAWCASTGNE
LDSMEEAGGVITFRVKRLK
>OMIFANIC_00237 hypothetical protein
MDSQSFMHFVEYELQAIAITWMVVMYTIKAVQLSRLPMPWEKEKPKGSGTKGILRSYGSI
FMPWSVESSRKHMGRWIGFSLYHVGCLVAIVNTFTYTFTPGMMTPTVKIVFSALIAPAIF
IGFIKFYNRLSRPELRHISTPDDYFSLLSLQLFFFTGIMALLLDTVFWRSSYYIITAAFL
FYVPFSKISHYIYFFFARFLTGKRYGWRGIIPQK
>OMIFANIC_00238 Lactate utilization protein A
MDTREKVIQELDKRYNRLVGTSATNLCTHCGWCIESCHIFKATGNPEHSPVAKAEKVRRV
LKRKHDWLSRLFPKWTGAKDLTESDLDEWIEAAFKNCTLCERCVINCPMGVETPQILATA
RGVLTAMGKSPEILNQLTDAAIAREEKMEMMEGFFRKQIANLEKQVQERMNDSNARIPVS
EEADILYVPLSGAHTMVPAALIFNAAKANWTMSLFEASNYGVFVADIPKAKKVVERVLKE
AKKVKAKTLVVTECGHAYGVLKWEAPKWFGKQFDFEVKSLLEVMNDYIQEGKIVLDPSKN
SEPVTYHDPCNIGRKGGIFEEPRNVIQASSKEYKEMTPSKVENFCCGGGSGMVACSEWTE
DRLLYGTVKVEQIKKTNAKKVVTACDNCLHQIKELGEKNNLNISVSNVSEHLANALVFS
>OMIFANIC_00239 hypothetical protein
MEENRPKRMAIIASQGTLDWAYPPFILASTAAAMNMEVTIFFTFYGLTLLKKKVKGKVAP
QTNPAMPMRMPFGPNWFQKLTWPIPNVIMGNVPFFENMATGLMKKTFKNKKVMSIEELRQ
MCLDLNVKMVGCQMTMDVFGFKKEEFIDGVDIGGAATFLNFASDADIQLFV
>OMIFANIC_00240 hypothetical protein
MKTKYLILILILFLSTPNIYTQDLMDALKQTAEMHNEQHGDDSGDDRELSEEERERIQNY
WKEKTKDTGEFIESLNKPYHQCLALMGLYSYHFQTLLIAAEEEENCKMKYDLYGIALLMN
ISGTFLIPCTEGFYNLPEEDQKSIFHDFLNSLYQCNYSGDSSGPIAWTPLAKKAPKTAKD
IHLGFFQAMCYNDEVGNYTVLKKVYYYIFEWEAIMLHTLVIGRKMEALGCG
>OMIFANIC_00241 hypothetical protein
MNYERASKKGARFFFGSKRSDSFVGFQHGVLSGSRVERVILFDDHGVLSGSRVERVILFD
DHGVLSGSRVERVILFDDHGVLSGSPKVIRYFQHGMLSGSPKVIRYFQHGVLSGSHLQSL
SQQGLSNIVTYIISIVTIVIYFPVHCYYFYFMIPLMLLTIGISPIA
>OMIFANIC_00243 Serine/threonine-protein kinase pkn1
MIYTLFERRFIINAFILLNLYSCGRNNDKNDDSVSSKIVSSKFECYPYNGRPYYLKKVQD
SLLAIDSDIRKDKSFASIIEGMSLIPGGEFMMGAVGDLALEREYPKHPVQVSGFYMDAHE
VTNAEFGKFVEETGYKTIAERPIDWEEMKKQIPPGTPKPAKVLLEPGSLVFTPKPGITNL
QDFSQWWSWINFANWQHPNGPHSNIDGKENHPVVHIALADAKAYAKWAGKRLPTEAEWEW
AARGGLEDPVYPWGNCDINDTPYKANFFQGTFPANNSEGDLFKETAPVGSFEPNGYGLFD
MAGNVWEITSDLYDELYYRSLSSTEMSIDPKGSEKSFYPDNQYSEHTVLKGGSFLCNDSY
CASYRVSARMPLELDAAMNHVGFRCVIDVEQ
>OMIFANIC_00244 hypothetical protein
MTGIILFQFVISIYSGTKESRKATLSPPFLFLQDYWRDPEVGPVLNESRKATLSPPFLFP
QDYSRDPEVGPVLEKNQQPAVALFFYSLYFEKHVFRVRE
>OMIFANIC_00247 hypothetical protein
MKNVLWILMMLSGLAYGQNDCNYKINVDTNDELFKLTQEQLMDYELSSTQSAFIYFSLMR
ESELYSLVLQISLNALEMPPIMCFDNKSRVTFKLEDGNFVSLPYLDEVNCGRQTDHEDQL
DNSTSEAAFFMNDESMLKLKASPIETMRITSMNSNFDFKLKSVLSNPAIEQPIYPKEYFI
SSLSCLESSNAKN
>OMIFANIC_00248 hypothetical protein
MNKSILKPEVQEFIINFSGDLSKLAFSGSPFHDITTRELLEQIKSRQKAKTKIPTWVNAE
NIYYPPTLNLEQTSSEITAEYKSKLVHGKQVADITGGFGVDSFLFAKQFEYVDHFEVNPF
ISEIAKHNLDQLGCKNIQFLAVDGIEGVDDRHYDLIYIDPSRRHDAKGKVFFLEDCLPNI
PEHLEYLMERTSALLIKTSPMLDISIGIKALKYVNEIHILAVQNEVKEVLWLLKKPTSLE
PRITTVNMTNSNDESFSFKYGDLGVATYSGPLTYLYEPNAAILKSGGFSVISERFGIAKL
GKHTHLYTSDELMDFPGRRFRIENIVAYSKKDMRAGITFDKANIAIRNFPESVEALRKRW
KIKDGGENFVFFTTAGSNEKMMLLCKKITT
>OMIFANIC_00249 tRNA (guanosine(18)-2'-O)-methyltransferase
MQHSHESTPFSKRDFPIVLICDGVNGPANIGSLFRISEAFGVSEIIFGNAEIDLDSSRMK
RTARDTHLKVSCSISEDLHETTKHLREGGYLIVALEISKHSKPIKDFKWNRSEKLAMIVG
NEANGISEDILSTADMVFHIELFGENSSINVAHATAIALYQLTGL
>OMIFANIC_00250 hypothetical protein
MRLGVLIGIMSITLSLNAQQIAVLKYGGGGDWYSNPTALPNLARFCNQQIDTAIDAKTET
VSPGSIDLFNFPFVHMTGHGNVFFTSEEAENMRNYLLSGGFLHIDDNYGMDQYLRKELVK
IFPDKELKELPGDHPIFSYKYKFPEGLPKIHEHDSGRPQAFGIIHEGRLVLLYTFESDLG
DGWENLEIHNDPEEVRLKALRMGANIVKYAFEN
>OMIFANIC_00251 Ribosomal RNA small subunit methyltransferase E
MQLFYHPDITAESKEIIFNKDESRHISRVLRKKPGDELNITNGRGSIFTAGLTVVEPKQA
IARIQGSKEIGPLPYQLHLAVAPTKLNDRYEWFLEKATEIGVTEISPIICEHSERKVIKP
ERFERILQSAMKQSLKAWIPKLNPAVTFSEFLRQENKVSVRCIAHCEDSEKKSLKHTISP
GESVILLIGPEGDFSSDEIRQAISRGYSEVHLGNSRLRTETAAIVACQSVAFINEV
>OMIFANIC_00252 hypothetical protein
MDQKSHHIVKRIRAALNPWEDHITEKRMFGGHCYLYNGKMCVGETKHRLMARVLSDHMEE
VLAMPNVHPMDFTGKPMKEFIFVSEDGFDTEGKLQQWIEYGIAHAKSKTE
>OMIFANIC_00253 tRNA N6-adenosine threonylcarbamoyltransferase
MAFTQGPGLMGSLLVGASFSKSFAMGMDIPLIGVNHMQAHILAHFIKTEEQKAPNFPFIA
LTISGGHTQLVKVTDYFEMEIIGETLDDAVGEAFDKSAKILGLPYPGGPLIDKYAQMGDP
NRFPFPKPKVGPLQFSFSGLKTAVLYFIEKEVKANPNFIEENLYDICASIQYTIVDYLMD
KLKNAVKKTGIREIAIGGGVSANSGIRKALREAEETLGWKTYIPKFEYCTDNAAMIAMVG
ELKFKQEIFSASNAMSYARMKF
>OMIFANIC_00255 hypothetical protein
MPRGHTDKKLLIRGLKYMAFVIPLLVLTTYLFTLAFLNKDTKILYIVLPVAIVGMAATIW
LGFKGIRTIMRAVFK
>OMIFANIC_00256 N-acetylmuramic acid 6-phosphate etherase
MTFRKTTEEPSNYDHLEQMSIHELLVSINSEDKTVASAVKKSIPQIERLAENVSEQLKKG
GRLFYIGAGTSGRLGILDASECPPTFGVPHGLVVGLIAGGDTAIRKAVEFAEDSKEQGWK
DLDDYKISKKDIVIGIAASGTTPYVLGALEGCNLRGIPTGCITCNEGSPLAKTAKLPVVV
VVGPEFVTGSSRMKAGTAQKLVLNMISTTAMIQLGRVKGNKMVDMQLSNNKLVDRGTKMV
MDALDISEDKANELLLKYGSVRKAIEAYNNA
>OMIFANIC_00257 Glycerate 2-kinase
MNVLLIPDAFKDSLSANDVSDAMRRGVLEFNPQSQILHIPASDGGENFLNSVKHYIDSLA
EKECETVDPLGRPIRAGYLYSETTKTAFIELAKASGLELLTYAERNPLQTSTIGTGIQIR
DAMQIGATTIYIGIGGSATNDAGMGIAQALGFQFRDAEGNILNAAGSNLSSVHLVIEPEN
NFSNISFFAINDVLNPLFGPNGAAFTYAKQKGASSEDTMKLEQGLRQFSEVIHSELKKDF
ANLPGSGAAGGAAFGLKSFLNAEYISGVSFILKLARFQKLIFSEKIDVIITGEGCIDQQT
AFGKLVYGVANEVRDKNIPVLAICGKLNLHPREVKSLGLHKVAQLYHPDQEDGYSFTHAT
ELIQQRTLDLLKELDLR
>OMIFANIC_00258 hypothetical protein
MKKTIRTYLSGITAVLFSVVFIASCEDVVDVDLPTEEPRLIIDALIRVDTSKVFTDVVVK
VAETGSFFGTVPPAELQQITITNSETGVGEVLIEQEPGTGIYRNPDPFPTAELLESEWLL
QIDYEDQIYFAYAQFTPSVPIDSAVQGDGILFDEDDTEVIIAFTDSGERDDFYLFDFDFA
NYLVTKDEFYQGQLFEFSYYYDDLLVAGDTVNISLMGVDEDFYNYMDQLITQSEEGFGPF
ETPSLTVRGNIINATDMDNNNNFNNLNNTDNFALGYFAIVQEFKETVIIEDRAP
>OMIFANIC_00259 TonB-dependent receptor SusC
MKKLNFTLLVLCATLSFSQQKYTLSGTVSEDETGETLIGVNVIIPELKSGTITNEYGFYS
ITLPEGTYVVTYSSLGLTTQSITVNLTENVRENIRLASDTEQLDEVVIEADVERASIKTP
QMSVNTLTAGTIKNIPVVLGEADVVKSILLLPGVTNAGEASSGFNVRGGAADQNLILLDE
ATIFNSSHLFGFFSVFNPDAIKDVKLFKGGIPARYGGRISSVLEIFQKEGNSKELKINGG
IGAVASRLLAEGPIVKDKAAFLVGGRGSYAHLFLPLFDIDNRAYFYDLNTKINWRINERN
SIFLSGYFGRDLFSINDSFVNVYGNALGNFRWNHIFSDKLFSNLSVIYSDYYYGLELDFV
GFEWNSGIQNFNIKYDLKHYFSDGFQVNYGINNIYYRFNPGKIEPNSPDSGILEEQLIKK
YANEFAAYVDVEHTLTDRLRVQYGLRLSHFIRFGQDELNVYANNNPVEFDKSLLIYKGAE
PVDVINPGRSDQLASFTNLEPRASVSYIINDDTSIKASYTRISQYLHLLSNTSSPTPLDV
WTPSGPFVEPQLLDQYAFGFFRNLWDREFTIETEVFYKGIQNRIDYIDGANLIANNEIEQ
VILNGEARAYGWEFLFRKNTGKLQGWLAYTLSKSEQRTPPRNSEEIGINNGVWYNTPFDK
THDIALYGNYNLNDTWSFNGNFVFQTGQPTNFPIGQFEFQGLVIPYYGLRNSTRLPDYHR
LDIAATLTPKKNKGRNWQSEWVFSIYNVYNRRNAASINFRQNQDTGINEAVRTSIFGIVP
SVTYNFKF
>OMIFANIC_00260 Isocitrate dehydrogenase [NADP] 2
MTKTAKIIYTMTDEAPFLATHSLLPIVKAFTSPSDIQIETRDISLAGRILANFPEYLSDN
QRINDALGELGELAKTPEANIIKLPNISASIPQLTSAIAELQKKGYAIPDYPDDPQTDEE
RKIRAVYDKVKGSAVNPVLREGNSDRRAPKAVKNYAKKNPHSMGAWSPDSKTHVSTMSHG
DFRHNEQSVTIEKAGNVSIVHTDKVGNKTILKKDIAVLDGEIIDATVMQKKELLSFLAEQ
VQDATEKDVLFSLHMKATMMKVSDPIIFGHAVRVYFSDLFDKYEKTFEKIGVDVKNGFGD
LISEIQKLSESERNEILSEIDRIYASNPDLAMVNSDRGITNLHVPSDVIIDASMPAMIRN
SGQMWDKNGDTKDTKAVIPDSSYAAVYQATIDFCKKHGAFDPSTMGTVPNVGLMAQKAEE
YGSHDKTFEVPSNGKITVLDQDLTTLMEHEVSEGDIWRMCQVKDLPVQDWVKLAISRARA
TGAPAVFWLDEDRAHDAELIKKVNRYLKNHDTSGLEIKILSPEKATHYTLERVRKGEDTI
SVTGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVQQFVKEGHL
RWDSLGEYLALAVSLEHLGTTYDNAKAILLSETLDDATEKLLENRKGPSRKVNELDNRGS
HFYLAMYWAEALANQDKVMALKDRFTPVAEQLKNNEDKIVQELNDAQGDPVNIDGYYWPD
TNLVNAEMRASETLNSIISGIA
>OMIFANIC_00261 50S ribosomal protein L19
MESLVKFVQDEFVTKKEFPKFNAGDSITVYYEIREGNKTRTQFFKGVVIQVKGTGTSQTF
TIRKMSGTIGVERIFPLNMPALQKIEVNKTGSVRRKRIYYFRGLTGKKARIREKRS
>OMIFANIC_00262 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITVLPELLKSPFEASILKRAIDKGLVSIYTHNLRDYASNKYKQVDDYQFGGGAGM
VLMIEPIDKCISKLKSERGYDEIIYMTPDGDTFSQSIANELSLKGNIIILCGHYKGVDQR
VRDHFITREISVGDFVLSGGELAAAVVCDAVIRLLPGVLGDETSALTDSFQDDLLAPPIY
TRPANYKGWKVPEILTSGHTAKIEAWREEQALKNTEDKRPDLLEE
>OMIFANIC_00263 hypothetical protein
MDHLTKLEELLDQANLNIKDGLYDEATNKLEKILDMDPNFGKAYNHLGYLYEVKFKEYEK
GETLYKLCLEKSPMYPAVYYNYSILLSTLGKWDDLKNLLDKAINVPGITKSTIWNEYAIM
YEQQGKLDEAIEHYRKAALNTLDKAVLERAKSSIERCQMKKELM
>OMIFANIC_00264 hypothetical protein
MKIKTATSEDLDILTLLFDRYRVFYKQESNLSAAREFLKDRLRKKDSVIFLAVDENGAGL
GFAQLYPSFSSVAMQRVYILNDLFVSKEARGKGIGEELLEHSKNFAKANESRGLTLETAV
DNPAQNLYERLGWVKDTKVFHYTWETDKSI
>OMIFANIC_00265 scyllo-inositol 2-dehydrogenase (NAD(+))
MKRRSFIKKSAAAGAAFTIVPSFVLGRNHIPPSDTLYIAGIGVGGRGGGVVNELYSSGKV
KFVAFCDVDQKRAASTFTNHPDVKRYMDFRKVYDNHLKDMDAVMVATPDHTHAAIALPFM
KEKKHAYVEKPLTHNIFEARLMATTAKEMSITTQMGNQGASGEGIRQAQEWINAGVIGKV
HRVDCWTNRPVWPQGFKKIDKGEPVPETLNWDLWLGPASMRPYNSSYLPFKWRGWWDFGT
GAMGDMGCHIMETPFKTLGLKFPYEAEASCTTIWSGDFVEADYSEACPPSSVVRLKFDNE
THGDVSLNWYDGGIMPDLPSELKVGEEPGGSGGGSIFHGSEGIMITDTYSRNPRLLPSER
MMDFTPPEPTIKRVETDHAGEWVNACINGGATSSPFSYGGPLTEAVLMGNLAIKAFQYKT
LKEGKKAGDWDPYDYPGRRTIQWDGDAMKVTNYDHANNWVKREYRNGWEL
>OMIFANIC_00266 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MSFDEVYEKELSFQTDRRKATVEFIKIVSDLWYDRSIELVLFRNQLIDRNASEILSLHEY
AGEFVQKPISIFDSVEIAQAILKLNLPPAKLDIGRLTYEYHLEDNDHEDAMRFVSHKLKD
AKETSNIVPKDVILYGFGRIGRLLARELMTRTGQGSQMRLRAIVTRGNVDKTVLEKRASL
LQHDSVHGDFPGIVRTDLENSALIINGTTVHMISANAPEDIDYTQYGIEDALVIDNTGAF
RDKEALGRHLKAKGVSKVLLTAPGKGVPNIVHGVNHGEYHPDEVDIFSAASCTTNAITPV
LKAIEDSFGVVQGHLETIHAYTNDQNLVDNMHKKYRRGRAAALNMVITETGAGSAVSKAL
PSFEGKLTSNAIRVPVPNGSLAILKLELENKTSKNALNTVMKKYALVGDLVEQIKYSLNN
ELVSSDIVGSSAPSIFDSNATIVSNDGKNVVLYVWYDNEYGYSHQVIRLAKYISKVRRYA
YY
>OMIFANIC_00267 Periplasmic pH-dependent serine endoprotease DegQ
MKQTVRLFAVALIAGAITLWGYKLLEDDNPVIITANQENPTFIPTNYTSELNDTGIDLTK
AAEKTVNAVVHVKNTTISRRPTNIMEYFYGGGEPRAMVGAGSGVIITPDGYIVTNNHVIA
NASQLEVTLNNNKIYEAELIGTDAKTDIALIKIEPDEDLPFVPFGDSNEIRIGEWVLAVG
NPFNLTSTVTAGIVSAKARDLNEFDRNPQSFIQTDAAVNRGNSGGALVNIRGELVGINTA
ITSETGSYVGYSFAVPANIARKVIEDIIEYGDVQRGILGIQGQTLNSKIAQKLGLNESEG
VIVGGIEDGSGADKSGIREGDIIKGLDGYKVGKFSDLSGYLGSKRPNDVVDVTVIRNGKK
KVIPVTLIKLETYEIEELGLELKNASQEDLKKYGVDGGVMISRALTKDMQRYDLDGILIT
KINDQPVRSIDDAKRIMNRRNTNEDIKLTFYDRDGDLNTFIFR
>OMIFANIC_00268 Diaminopimelate epimerase
MAIEFYKYQGTGNDFIIVDNRNDKFPKNNTKLIAHMCDRKFGIGADGLILLENHDTADFN
MVYYNSDGNLSSMCGNGGRCITHFAKFLGIIENQAVFEAIDGMHESSVDAETISLRMNDV
NSLQVNGASIYLNTGSPHHVTLVDDLTVFDVFNEGKRIRTSIYGEEGANVNFVEKVSESV
FAVRTYERGVEDETLSCGTGVTAVALAMHETMNTTSEEITLKTPGGELKVRFIKTENGYT
DIYLIGPAIQVFKGIWE
>OMIFANIC_00269 Spermidine N(1)-acetyltransferase
MNTLSGNKIILRALELTDLDFLYQLENDESVWEVSNTSTPYSKYVLKQYLENAHRDIYEV
KQLRLVICTSEKMKPIGFIDLFDFEPRHSRIGVGIVIFKDTDRRKGYASEALKLVADYSF
SHLKVHQLFANISEDNHVSIKLFEKLGFELSGSKREWIISEKGFKNELFYQLIHDKKS
>OMIFANIC_00270 Endolytic murein transglycosylase
MTKNLKRVIWSVLVLGVIAMAIFAWFVYSAVLSPNTAFTNDEAHIYIRTDANFADVMEEL
RPLLKDAVSFEAVANRKGYPENIKPGHYVINKGMNNNDIINTIRINNTPVKVKFNNQERL
ENLAGAVSKQIEADSVALLNAMSDREFLAEIGQTPESALAIYLPNTYELYWNTSATDFCK
RMKSEYDSFWNESRTSKARSIGLSPEQVVSLAAIVQKETAKVDERPRVAGLYVNRIKRGM
LLQADPTVIYAKKKAENDFDQVIKRVLYRDLELDSPYNTYKYTGVPPGPISMPDMSSIKA
VLDHENHDYIFMVADISNPGYHKFAKTLAQHNRNRAEYVRWINGQGVNR
>OMIFANIC_00271 hypothetical protein
MVKIAKNERSILNTEGKLCKINITTCFTIVYTIIIVHFLTR
>OMIFANIC_00272 hypothetical protein
MRRKLLRISLLVSVAIGVLSVFSFNENKAITYFNNDGLELFFTVPTEAEANFDNKELELN
HNLFLGKTYVGFKEALGFKESRNNYKTINEYGYMGKYQFGRGTLNMIGIYNSKRFLNDAK
LQEQAFTAYTSRNKWILRRDIDRYVGRYIDGVKVTESGILAAAHLAGAGNVKKYLRSGGE
IGFSDAFGTSIRYYLKKFSGYDTSWVEADKRAKVL
>OMIFANIC_00273 Ribosomal RNA small subunit methyltransferase I
MVSEKGNLYLIPCTLGETPPLEVLPFLVKKAVEEIDYYIVEHEKNARRFIKSIVPRKSQP
DLHFKLINKYTDESEIPDMLAPCHQGLDVGVISDAGCPGIADPGAAVVEEAHKQGIRVVP
LVGPSSILLAMMASGFNGQNFAFNGYLPIDKRERRKEIKRLERLSQEFHQSQLFIETPYR
NNQLLESIISTVQGQTKICLACDITLPTEFILTLTAEEWKNKKVDLNKRPTIFIIQK
>OMIFANIC_00274 Aldose sugar dehydrogenase YliI
MKTIIPYLLSLLIFSSATSQIIEVEQFNTGASFDQPVDLQNAGDDRLFVVEKAGIIKILN
SDGSINGSPFLDINSIVINPQGTNDERGLLGLAFHPDYDTNGFFYVNYINNSGNTQVSRF
SVDPGDPDIALPGSELQIISYIQPFQNHNGGSLAFGPDGFLYIASGDGGSGGDPGNRAQN
TTLLLGKLLRIDVDNPGGGNNYGIPTDNPFFGHPTNAEEIWAYGLRNPWKFSFDRTADNL
WIGDVGQGDVEEINKQPVTAAGLNYGWRCYEGSQPFNTAGCPPVGDLTFPEAEYSSSSGS
GNCSVTGGYVYRGSMWPGLQGLYFAADVCSGKLFTVDGDGNLVDRGGFGGTWVSFGENID
KELFVVDIFGDVYRIIDEDIAGASDFEFETFKLTPNPATDLVSLTFDNGSFQSVRVMNLT
GSIILSEENIETQQYDLDVSQLRSGLYLVSVETESGAQLINKLVVR
>OMIFANIC_00275 Low molecular weight protein-tyrosine-phosphatase YfkJ
MVCLGNICRSPLAEGILRSKVNITKITVDSAGTGGWHVGEQPDPRSIKVAKKYGLDITYQ
RGRKFSTYDFETYDHIFVMDNSNYQDVIKLAKNNDEIAKVRLILDEIFPDENVDVPDPYY
GGAFGFENVFKMLDEACEKIAARL
>OMIFANIC_00276 Chromosomal replication initiator protein DnaA
MSKTAESVWNNCLSFIEDNISSQAYKTWFEPIKAVKLTDNALSIQVPSKFFYEWLEEHYV
KLLKVALTKELGSTAKLVYVIKMENTYGNKQPFTEKIPSTNRSQVQSQEVDVPLKNKSPE
LKNPFVIPGIRNVKIESQLNPGYNFDNFLEGESNRLARSAGMAVANKPGGTSFNPLLIFG
GVGLGKTHLAHAIGVEIKDKYPEKTVLYISAEKFTQQYIESVKKNSRNDFIHFYQIIDVL
IVDDIQLLSGKAGTQDVFFHIFNHLHQNGKQVILTSDKAPVDMIDIEQRLLSRFKWGLSA
ELNHPDYDTRVAIIKNKLYRDGVEMPEDIVEFLANNIKTNIRELEGAIISLIAHSSFNKR
EITIDLAKKIVDNYVKHTKREVSIDYIQKVVSEYFQMDVDTLQSKTRKRHIVQARQLAMF
FAKKFTKASLASIGSQIGQRDHATVLHACKTVDNLSSTDKQFRKYVEDLNKKLTL
>OMIFANIC_00277 Acyl-CoA thioester hydrolase YbgC
MKKNITKLRVRYGETDQMGVVYYGNYAQYLEQGRTEWLRELGFSYRWMEENNVKLPVIKL
VIDYKLPARYDDEIFITTTLRKLPTVKIEFDYEIHNADGDLLVTASTTLVFVDMHTNKLK
RAPDYLIKKLQE
>OMIFANIC_00278 IMPACT family member YigZ
MASEKDTYKTIATAGEETMFKEKGSKFFGYAFPVTSEEEIRGQLDTLKKEHYSARHWCYA
WQLGKGYERYRVNDDGEPSNSAGAPIYGQIQAFGLTNVLVVVVRYFGGTKLGVGGLIQAY
KTSAKMALEASRLITRTIDENFIVQCAYADLNSVMRVVKNEQLKIVGQKMEMDCKIEISV
RKKDSDRIFDTFRNLQNIQIRRR
>OMIFANIC_00279 hypothetical protein
MIFLLLSVLSSTVIFVTFKLFDRFKVNTLHAIVVNYIVASLCGIIAFEGVVDPIDIVNKD
WFVYTAVLGLLFIIIFNLMAITTQRSGLSVVSVATKMSLVIPILFGLLYYKESLGIYKFI
GIILALVAVYLASIKTRSGLRINRSNLIYPFLVFLGSGIIDTSLKYLEDTHVAKNEVSIF
SSMIFATAAVTGLFILIWQMIKGSFRFEVKNVIGGIALGIPNYFSVYFLVKALRSDILES
SGIFTVNNVAVVMTSTLVGILLFHEKLLVKNWIGIALAVISIFLVTLNSW
>OMIFANIC_00280 Riboflavin biosynthesis protein RibD
MSRCIELAKKGLGTTYPNPLVGSVIVYNGRIIGEGWHYKSGEPHAEVHAIQNVIHSNLLS
EATLYVNLEPCSHFGKTPPCVDRIISEGIKKVIIGSTDPNPKVSGRGIAKLLDAGCDVTT
GILKEECDALNKRFFTFQKKKRPYVILKWAQSEDGLLAPALRDEKKEPVWITNDISKQFT
HRMRAEEAAILVGTNTVVDDNPSLTARNWEGTSPHRIIIDRSSRIPLNSNVLDDSVPTLV
ISEEKVKAGLNLTYEAIDFNNPVAKQICDLLYRYELQSLIVEGGSRTLQTFIEENLWDEA
FVFQGPLKFNQGVKAPELPGTLITETRFKQDRMQHFKNPLS
>OMIFANIC_00281 hypothetical protein
MKLPVIRPIEKRDNAQLQYLIRSILEDFGVPKIGSAYADAALDDMYGYYLKEKAAYFVID
HGERIIGGAGIAQLDNYNGPICELQKMYFLTEARGRGLGTRMMELCLQKATEFGFEKVYL
ETMPYMIAAQKLYERSGFEYIDGPIGDTGHYACQTHMMKTL
>OMIFANIC_00282 Release factor glutamine methyltransferase
MNIAKLKERFKSELSGIFPPEEIDSFFVMLGESLLGYSRIALALNASEEIRPEDLLKFND
ALERLKNEEPIQYIIGVTEFYGLPFKVSPETLIPRPETEELVEWIIRQNKEQADILDIGT
GSGCIAITLAKNLKESVVSALDVSVEALKVAAYNAQHNKVSIDFITKDILAIDKLPSQYD
IIVSNPPYVRNLEKKTMSDNVLQFEPSAALFVPDDDPLKFYRKISSLAKTHLKEGGSLFF
EINEYLGEELVALLKNFDFKNIELGQDFRGKDRFIKCTRSLNE
>OMIFANIC_00283 LOG family protein YvdD
MNKLEKICVFCGSSDGNDTSVTSSAVELGEIFAQENITLVYGAAKIGIMGTIAKTVLDNH
GKVIGIIPEFLKKKEVVHLGLNELITTRNMHDRKLKMQEVSDGFIALPGGLGTLEELFEI
LTWLQLGLHSKPIGLLNVNGFYDDLLQLFETMVRKGFVSMNNYEMLLVDSDARRLLEKMA
HFKAPDIPHWLNEERA
>OMIFANIC_00284 Aquaporin Z
MSSTKKYLAEGLGTFALVLFGCGAAAVAGVSQTGPDGIGLLGISLAFGLAVQQLWLFIVA
PVAGGIFAAVVRKLFIDD
>OMIFANIC_00285 Alpha-amylase
MKTKFLIIFLLIFSMSAGITAQVNVEQKANFVGEVTSMEYVTSLASRTSDWIPSDNSVKE
AKDKRSLANQIVAGQDPQTEDDYYVRNRHEMEQSVRMAPASLVFDAYASGSQPTDPSLAI
GPNHVFVVYNTGFTIFDKSGNTLVPQTAPNPAIFPSGGCCDLTVSYDNAADRWVLTFLGN
GAQIAVSDGPNPVTSGWYVYNISSINDYQKLSVWSDGYYMTDNTSSSNRVWALERDAMLL
GDPNAQIIGFNLPGISTSGFYSPQALNVTDGNLPAAGGATIVYLQDDAWNGVSNDHIKLW
TIDVNWNSPGSSTVSAAQEISATPFISVFDNGSFSNLRQPGNGRPINVDALQATIMNQAQ
FRKFTNHNSAVFNFVVDADATSGELAAVRWYEFRQSGDNQPWSLYQEGTYTAPDGRHAWN
ASLAMDGNGNIGMGYTSMSGPNTPGTVYISSYFTGRSSSDPLGVMTAAEGLIANGNAKIP
GTRYGDYSKIDVDPSDNSSFWFINEYMNGSRRGVVGKFTVQVAPPDTEAPTIPTNLTASN
ITSSGATLTWNASTDNVGVTQYNISIDGNPVGTSATTSFNVTGLSPLTLYNAAVSAQDAA
GNVSGEATTSFTTLEGGGGNGEIAAYYFETGFDGWIDGGNDCARQATANSFEGTYSIRLR
DNSNSSNAVSPTLDLSGNTQVSIEFHTYAKSMENGENFFVEFYNGSSYQVIGDYASGSDF
SNDSFFTDTIVLDSGTYNFNANNRFRIRCDASANNDQIWFDQVIITGDGTEALPAIPGET
ITRTPEAIQAQALATSDNIKLYPNPVNSTLSIEILEGNFDQVTVYSTSGELVKTFYNVSD
FLQLDVSDFTTGMYFVRFVTGKLAVTKRFIKK
>OMIFANIC_00286 DNA ligase
MNPEQQIKELREELREHNYKYYVLDNPVISDYEFDLKLKQLQELEAAHPEFYDPNSPTVR
VGGEVTKNFNTVTHEFRMYSLDNSYSKDDLLDWVKRIRKLVDGEIQYTCELKYDGASMNL
TYENGKLIRAVTRGDGFQGDEVTTNVKTIKSVPLQLKGDYPEKFEMRGEIVLPFEGFKKM
NLERIDIGEEPYRNPRNTASGSLKLQDSSEVARRPLEFLWYSMKANRLPVATQYESLQKA
REWGFKVPEVAKLCKNLDEVLEFIEYWDVHRHEMPYETDGVVIKVNQLQQQEELGYTAKS
PRWAMAYKFKAESAVTVLNKITYQVGRTGAITPVANLEPVQLAGTIVKRASLHNADQIAK
LDIREGDTVFVEKGGEIIPKITAVDTSKRAPSTPPTQYIEHCPECETPLERKEGEAQHYC
PNTDGCPPQIIGRIQHYISRKAMDIEGLGGETVALLVTNGLIKNYADLYDLTMEQVIPLE
RMAEKSAENLVKGIGASKQIPFERVLFALGIRYVGETVAKKLAKHYKSIDALMEASAEML
VNVDEIGERIAESVITFFASEDNKTIIRRLKDYGVQLEISAEKLANQTDKLQGNSFVVSG
VFEQVSRTELKKLIEDNGGKVSGSISGKTSYVVAGEKMGPSKRTKAEELGIPIISEEDFL
AMIS
>OMIFANIC_00287 hypothetical protein
MVTLGFLVDEALIPELEVFDSFALDYELQPKDVKVFSFQEVKKKTPSLRQNQVNNKDFSW
KGEIHNQNAVEFLDKSFDVLVGYYQGKHEFMDLMISRSNAAFKVGFPGGDERLFDLIIAM
DPKRVNNFKEELKKYLTVLGKMA
>OMIFANIC_00288 4-hydroxy-tetrahydrodipicolinate synthase
MKELTGTGVALITPFKEDNSLDVDGLTRVVNYQIENGIDYLVLLGTTAESATLSNSEKQL
VIETVTSANARRLPMVLGIGGNNTQAVIDEVESRNLEDFTAILSVSPMYNKPTQEGIYQH
FAAIAAKSPKPIIVYNVPSRTGSNVLPETISWLARDFNNIVAIKEAAGDIVQAMRMIDST
PDDFMVISGDDMVTLPMILAGGSGVISVIGEGFPRELSKMVQLGLAGNASEAHKIHYQMM
PAIDYIFAEGNPAGIKAVFKALGICDEFVRLPLVSASSSLKARINDFVAQNS
>OMIFANIC_00289 Outer membrane protein assembly factor BamD
MFYKMIRTSLLVLITVLSFTSCSEYQKVLKDDDASRKFAMADSLYEKGKYKKALKLMEQI
VPVYRGKPQAEKLMYMYANTFYNLEDFYLAGYQFERFETSYPKSDSLEVAAYKSARSYYE
LSPRYSLDQKDTYKGLERLQSYIDKYPNSPFRTEANSLVSELREKLETKDYEVAKQYLNI
EDYKAAIEAFDNFITDHPGTSLRKEAFYGRFEAAYKLAINSLPSLVKERLEIAKGHYNSF
NKYYEDSELTEEAKKIMADIEERMLTEEPTSK
>OMIFANIC_00290 hypothetical protein
MTDIKNSDAPINTKTIDKNLIDQPTDNIYEAISIISKRAAQINGDIKKELLEKLDEFATY
NDSLEEIFENKEQIEVSKFYEKLPKPHALAIQEWLEDKIYYRNTQDEELED
>OMIFANIC_00291 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLSGKNILLGVTAGIAAYKSAFLVRLLIKQGASVKVVMTPSSKEFVTPLTLSTLSKNE
VFSSFTNEEDENAQWNNHVELALWADLFIIAPATVNTLSKMANGVCDNLLMATYMSAKCP
VYYAPAMDLDMYKHPSTKETFDKLTSFGNIQIAATSGELASGLIGQGRMAEPEDIVSFVE
KDLLKGLPLRNKNVLITAGPTFEAIDPVRFIGNHSSGKMGYALAEAAAGLGAMVTLISGP
VSVSTDHSFIKVISVTSAEEMYHATHEHYGAADIAILSAAVADYRPAEVSSEKIKKKDDE
LHIKLEKTKDILATLGEKKKDQYLVGFALETENELENAKTKLKKKNLDLIVLNSLRDKGA
GFKGDTNKVTLINKDNKISPFTVKPKTEVARDILEFIIDEIHV
>OMIFANIC_00292 hypothetical protein
MYRILLAIALIFSVVTVQSQELNATVTIDAEQTGQPNLQVFRTLESQLTEYINNTKWTDK
IFKNQERIDCNFTLIVSGFESDSFSATLQVQASRPIYGSTYDSPIYNYNDRQCNFDYIEF
QPLVFNINNFDSNLMSVLAYHVYTVIGLDADTFEDNGGQEYFDIAKQIVNTAAASNYAGW
RGTDGTQSRFRYNDAIISNVYKEFHDAMYKYHREGLDLMSDEPKRAKQNIITAITLLKNI
NDRRPNSFLLRTFFDAKSDEIQDVFSGGPSVEITRLIENLNRMAPTKRSNWSEIKF
>OMIFANIC_00293 DNA repair protein RecN
MITNLAIKNYALIDDIRVDFSSGLTIITGETGAGKSILLGALSLLLGKRADLSSVKDPSK
KCVIEADFAIAGYDFEAIFTENDLDYDPNTIVRREILPSGKSRAFVNDTPVTLSQLQALG
VRLVDVHSQHETLVLSSESFQLEVIDALAGNDSVLERYRDQRNNVIKITEQLKQLEEQKE
TANRELDYNTFLFNELKEAALDGIDLQELEEQYETLNNIEVIQESLANAIGFFSEENSGT
INTAKQARMALSRIQEFSAEFGEHWERINSSIIELEDLLESLHDSAMKLDADPQKLHEIN
DKLQLVYKLQQKHTAADISELLEIQLQLEGKINATIDMDERIDSLKQQLIEGTEKATSSA
EILHENRILAIPLLKEKLERILKELGLPNARFQFEIAMQDTFRTHGMDTLELLFTANKGL
NFGPLKKVASGGELSRIMLAVKAVLAKYKQLPTIIFDEIDSGVSGEIANKMAVIMGEMSK
SMQLMSITHLPQIAAKGDRHVMVYKEDIDDVTVTRLKELDNDERIVEIAKMIGGKNITEA
AIANAKELLN
>OMIFANIC_00294 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MSYNLLKGKKGIIFGALDENSIAWKTAERVFEEGGTFVLTNAPIAMRMGQIKELAEKTNS
EIIPADATSLEDLENLVEKATEILGGKLDFVLHSIGMSVNVRKGKHYTESNYDWTHKGWD
VSALSFHKTMQVLYKKDAMNEWGSIVALTYMAAQRVFPDYNDMADNKAYLESIARSFGYF
FGRDKKVRVNTISQSPTPTTAGQGVKGFDGFISYAEKMSPLGNATALDCANYTIAMFSDL
TKRVTLQNLYNDGGFSNMGVSDLVMDTFQGED
>OMIFANIC_00295 Green-light absorbing proteorhodopsin
MDTFSNFISLVPKLAPDDYVGFTFFVGCMAMMAASAFFFLSMNSFDRKWRTSILVSGLIT
FIAAVHYWYMRDYWAANAESPTFFRYVDWILTVPLMCVEFYLILKVAGAKKSLMWKLIFL
SVIMLVTGYFGEGVDPDNAQIWGLVSGIAYFAIVYEIWLGGAAKLAKAAGGSVQRSHKIL
CWFVLVGWAIYPIGYMAGTPGWYEGIFGGLSMDVFYNIADAINKIGFGLVIYNLAVQQTA
EQKA
>OMIFANIC_00296 hypothetical protein
MNFNKIAIFVTLFSLWLTNYFSGSGQEIVAFSLIFSVGILHGSNDLAIMNKLQSVSGIRK
IATILGSYILIVVIAGGLFYLLPKLALAGFILFSAYHFGEQHWEDTISKASVRLIKLSYL
SYGMLILCLLFYMNTAETQDIITALTGQLIPQTWFLYGLVTAGVVFVFSMLYFLLKKYIE
YSRLLFEAFLLLVLSIVFKYADLIWAFAIYFIYWHSIPSIFGQLKYLYGDVSFGSFKRYL
KSSSLIWVISVSSMLLLFYLFRDNEEVIMPLFFAFLGAITFAHSFIISKMFAAGK
>OMIFANIC_00297 Aminopeptidase S
MKHLLIITLSLLTISCNSAQTASQQTIMTRVDYANTITAEELKTHLYTFASDNMEGRMTG
TDGQKLAAEYLRNFYMDNGISSPIEENNYYQPIPASYLGRRITTDSENIVAFIKGSEKPD
EVIVLSAHYDHVGKREDGTIYNGADDDGSGTVAMLEIAEAFQQAVNDGNGPKRSLLFLHV
TGEEIGLYGSKYYTENPLFPLENTVCNLNTDMIGRIDPDKEGEPDYVYLIGSDRLSQELH
DVSEAVNSQYVNLELDYKFNAENDPNRFYYRSDHYNFAKNNIPVIFYFNGVHEDYHQPTD
TPDKIEYDLMTKRTQLIFQTAWEIANREGRIRADKS
>OMIFANIC_00298 hypothetical protein
MIMVIFSLFAPSVLHLIVEESELITVIDTTEEENKKENKKENNKELEEKDVFMQDLENFE
SIYNGIQFAKASNYLDGSCQHHSEIFLPPPEQRS
>OMIFANIC_00299 Bicarbonate transporter BicA
MFKNIKSDLPSSIVVFFVALPLCLGIALASGAPLFSGLIAGIVGGIVVGSLSGSAIGVSG
PAAGLAAIVLTAIATLGGFENFLLAVVLGGIIQIVFGVLKAGVIGYYFPSSVIKGMLTGI
GIIIILKQIPHFFGYDANPEGDFAFFQVDGENTFSEIFKTMNAISLGSTIVAVVGLGILI
LWEKVLSKKSKIFKLVQGPLVAVIFGIVFFSLTGGTSLAIASENLVSVPAPEDASSFLAQ
FTFPNFAAITKPEIWITAFTIALVASLETLLCVEATDKLDPEKRVTPTNRELLAQGTGNI
LSGLIGGLPITQVIVRSSANIQSGGKSKSSAIIHGFFLLISIILIPTLLNKIPLSVLAAI
LLVVGYKLAKPALFKKMYALGWKQFVPFTVTVGGIIFTDLLVGIGLGLGVGIIVILIKSY
QNSHFLHIEDKSNGKHKIKMTLAEEVTFFNKGAILKELDSLPRDTYLELDVRQTRYLDND
IIEILEDFAYKAKERNIDIKIISEGGTVENPPSFIEYFKLLPKTA
>OMIFANIC_00300 hypothetical protein
MKKNNIVVLINLDKPQLNIVQNSINVAKSMNAAVTFLYVKKAVDVVQNENHLSAIKTLTD
AHMKIDGKMRELLEPFQQSTDTELRSKIAIGNVKNHIAKHLNKLNPDLVILGKRSKKILP
WEGDRLTQFVVNEFNGPVLISATDQVLELNEQLSLGLLSASGSDAPKGIVEDLLKISSQP
VKSFKIVNKASDAQTSSTMPFKTVEYAFEPGDNAVKNLSKYVHRNNVNLLFLDRDNVTQR
NRKASSTNLHGVINQLPSSLLLA
>OMIFANIC_00301 ECF RNA polymerase sigma factor SigE
MKNEKDSCKEEVFNALYRDYAQSLRNFVFFKCTDSAQSHDITQEAFIKLWKNCAKVTPSK
AKSFLYTVANNLFLNSVAHQKVVLNFRKTKGSGLDEQSPQFLLEEKEYGERLFKAIDNLT
EMQRTAFLLSRVEGKKYKEIAEILNISEKAAGKRIHDAMEALRRQIDKI
>OMIFANIC_00302 hypothetical protein
MPTNMEKKDLLNKWLNDELTPEEFEVFRTIPEFSSYQKIDAFVKEIELPVHNVEAGLEDL
KLRNQIPSVKKDSKVISLSSVLKVAAILVLLLTSYYFISNYTINENTELAQTEIVTLPGN
SIVVINEDSELSYKRFNWGNNRVVDLEGEAYFAVEKGSAFTVQTAQGTITVLGTKFNVSS
KERDFIISCYEGLVRVDQGDLSIELPAGRAIALGRGDFELNDIHTTEPGWLYNESTFDDT
PILAVLGVLKTEYGIQLTTENIDVNLRFTGGFPNDDLEAALQAITVPLHLNYSIENKDAV
TIYGEGSSE
>OMIFANIC_00303 hypothetical protein
MQLLFTAKAVQNKTIILLFILFFLSDIHAQNTSTNEVPVITILKNSEKRFNLSFSYNKRE
LRGIKCEAPSGSATLEETLQAITENCTLQFYRIDERYIAVQVGNDPLISVCGTLIDTATG
APLIGASVISQSTQTSTDSGGVFNITAVPGDATISLYHMGFKVKEIKAEELSTENDCPLV
FTEQRFNYLPTVLLSSYLTKGISKNAEGSVSISNKNFEILPSLIDPDVLKIAQILPGIES
FNETASDINIRGGNNDEVLLLWDGIRMYQSGHFFGLISAFNPNLTQDVTVYKNGTHPRFG
ESVSGVISMKSDSEIPEKVKGAASIDFISTQFYAKIPASETFAIHLSGRTSINTGLGNPV
YNQFFKRVFQNTVVTNFQTNTTEGLRSTDEAFNFYDINGKAIWQLSNKDKLEYNFLTIFN
KLQFTERITGETSLSKNESELKQQSLVHGITWVRDWSNKLSSKLVYNSIDYVNNGANQNV
DTGQTQSQRNDVVESKLMMELFYTFNSDLSVNAGYQHAETVIENESSPFVVNEIFTTRDK
LVTNGFFIHSKWKLFSKNSILTAGFRYTDYPNLDQQFLEPRLNVYQKINSELSVTASAEQ
KHQAIIQTTDIRNNLLGIENQRWIILGSESTPILENNQIALGTTFKKDDWTFGIEGFYKK
VEGVNTANQGFRNQLVDAEALGSYEVTGMEASISKKTEHLDAWLSYTYMDNEYTFDSLIP
VSFRSNYDISHALSLALSYTWKSLLFSIGTSYHSGIPYTTPVDGNAIIVENDDATINFNE
PNNATLQDFFRTDFSAGYTLPLDKTFTGKINIGLVNVFNRKNSLDSYYVLDEDQNGNVIL
NRVEQFSLGFTPNISFKLLF
>OMIFANIC_00304 Arginine--tRNA ligase
MVLQEKLTTHIKKATSDIYGVSPESVEFQATRKEFEGDITVVVFPMLKVIKGNPVQIGES
IGTYLTEKVDEVSGYNVVKGFLNLVLSDSYFLEFFSNISNFSSYGIESTGTEAMMVEYAS
PNTNKPLHLGHMRNILLGYSVAEILKAAGKKVYKTQIINDRGIHICKSMLAWKRYGNGET
PDSSGIKGDKLVGNYYVKFDKVYKEEIEELKSQGKPEEEAKATAPSLMEAQEMLRKWEAG
DPDTVGLWKTMNGWVYDGFDKTYTSMGVDFDSYYYESDTYLLGKDNIEEGLAKGVFYRKE
DGSVWCDLTEEGLDEKIVLRSDGTAVYMTQDIGTAIQRVKDHPDINGMIYTVGNEQEYHF
KVLFLILKKLGFSWAKNLYHLSYGMVDLPSGKMKSREGTVVDADDLIEEMSKTAKDISEE
LGKIEEFSEDEKKELYHTIGMGALKYYILKVDPRKGILFNPKESVDFQGNTGPFIQYTYA
RIQSILRKATSLDEGSFENISLHPKEKELLKQLMIFPETIQAAASNYSPALIANYTYDLV
KEFNSFYQNVTILGAESPSEKNFRVQLSNAVAEVIKSAFSMLGINVPERM
>OMIFANIC_00305 hypothetical protein
MLLNVSYNNKEVYRKIDEAVGKPYTIAERLKRKGIGAGRLVITQASVQINNLLILDNYRN
VCSVEMRPKGIIVGFRSLLESYALVIPYYKLSLYKGRAEEYSIHMDTYFIKILVKAKDKY
THRFMAKILTEKASQQPAHPSDLI
>OMIFANIC_00306 hypothetical protein
MKILLTGANGYIGMRLLPLLLEQGHQVICAVRNAARLSVSRQTRSRIQVIEIDFLDDNAQ
GVIPGDIDAAYYLIHSMSSSTSDFDEKEEHSARNFNKYISETNCKQVIYLGGIVNEENLS
KHLWSRKNVEEILKSGSFSLTVLRAAIIVGSGSASFEIIRDLCEKLPVMITPKWVKTRCQ
PIAIRNVIEYLTGVLGEERFYNESYDIGGPDILTYREMMKLYAKIRKLKLYIIDVPFMSP
KLSSYWLYFVTSTSYKLALNLVDSMKVEVITRDTRLQEALQIDPISYAEAIKLAFKKIEQ
NQVLSSWKDSMVSGRFRQDLNEYIKVPKYGCLIDEQTIKITDPERVLNNIWTIGGKKGWY
YGNFLWKIRGFIDKLFGGVGLRRGRTHPDKIFEGDALDFWRVILADKEQKRLLLFAEMRV
PGEAWLEFDIDENNILHQTATFRPKGLWGRIYWFLMLPFHYFIFGGMIRRIAKS
>OMIFANIC_00307 hypothetical protein
MQQITNSILMIRPVAFRMNEETAVNNYFQEDIDLKNSEINKKAQNEFDAFVEKLRAVGVN
VIVESDDALADTPDSVFPNNWVSFHSNGDIAIYPMFAENRRQERRDEVFMRLEDEGFRIT
NIIDYTSAENEGVFLEGTGSILMDRVNKKAYCALSPRADEELFIEFCEDFEYTPVVFTAY
QNVDGQRMPIYHTNVMMCLAENFCVICLDSIDDPAEKKNVIQHLKQNDKEIIDISESQMH
QFAGNMLQVKGAAGNRYMIMSLAAHKSLNKDQISKIEKHCAILSSDLETIETCGGGSARC
MMAEVFLPKE
>OMIFANIC_00308 hypothetical protein
MKKIITIVILLCAIATYGQGRIDGFYKGKNNGAVVLGLGFEDGKKYFAGGSGKLDLTRSV
SYGNIFGAYGLTEDLDVNISIPYIVSDDNADFQDISVYLKYRLFQIQGEKGNFEISVAGG
FSTNLTDYDLGGLNDIGQQATILDGKGLIHYKWNSGWFATAQSGFSFKVDPTPNSMPLTV
KAGKATAKWYYDVYYDFQHSFGGIDYLGTPRPQDFREFGVDFQKTGGTVYHSLSDTFGIY
ASLSYVFDGRNIFKGPGYGAGLVYNFSTKK
>OMIFANIC_00310 hypothetical protein
MFFVYIIESQKDGSYYIGQTSDIEKRLMSHNSGQTRSTKGKIPWNVVYTEEYSNRKDAIV
RERFLKKQRNREFYKRLIKQMP
>OMIFANIC_00311 hypothetical protein
MKIEKQINEITGFKNLELLATQVVEGFISGLHKSPFHGFSAEFAEHKIYNTGESRKHIDW
KLYAKTDKLYTKRYEEETNLRCHLVMDNSSSMHYPKLKEFNINSLNKIGFSVLAAAALMN
LLKRQRDAVGMSIYSDEYEFYASEKGSERHHQMLLGKLNEAIVQPRESKQTRTYAHLHLI
AEKLKRRSLVFLFTDMFQSDMEEQKLFEALQHLKYNKHEVVLFHTFDKEKELKFDFSNRP
KRFVDVETGEHVNLYADNIKESYETAVAKYFNELQLKCGQYGIKYVRSDINEGFNKILTT
YLVERSKFD
>OMIFANIC_00312 hypothetical protein
MDVWKTGMDLVEKIYGLIAEFPSEEKYGLSNQMKRAVVSIPSNIAEGAARKSNKEFSHFI
SISLGSLAGLETQYLLAIRLRYIDENTDINEMLESMRRLLIGTRNYLNK
>OMIFANIC_00313 ATP-dependent Clp protease proteolytic subunit
MEKTNKVQDKIDNQLLEERKVFLWGMVDDESAKHVVDRLLYLDSLSNEEIKFYINSPGGF
VTSGFSMYDTMKAVKSPVSTICTGLCASMGSILLSAGEKGKRFIQPHARVMIHQPSGGAR
GPASDIEITAQEILKTKELSAEILADNCGQPYEKVMKDFNRDHWMGAEESVEYGIVDGVI
E
>OMIFANIC_00314 Thioredoxin
MALEITDATFDETVLKSDKPVVVDFWAAWCGPCRMVGPIIDQISDEYEGKAVVGKVDVDA
NQEFAAKYGVRNIPTVLVFNNGELVGRQVGVAPKNVYTEAIDSLLN
>OMIFANIC_00315 DNA polymerase III subunit alpha
MYLIFDTETTGLPKRYDAPLSDSDNWPRCIQIAWQLHDDMGNLLENEDYLVQPEEFNIPY
DSEKIHGISTELAQQQGKPLDEVVQRFLETLEKSKFVVGQNVDFDINIMGAEFYRLGIEN
ALASKPVLDTCTETTAQLCQLPGGRGGKFKLPTLTELHQFLFDQPFAEAHNATADVEATT
RCFLELIRRQIFTVEELDVQPDYFEEFSEVNPRTIELTGLKHINLKKASDKIRQELEDAI
QTEEISSEAIDENIAVLQETSFAHLHNHSQFSILQSTSSTHDLVRAAVKDEMPAVALTDS
GNMMGAFHFIKAVNDYNKSLTEEDKHKELKAILGCEFFVCEDHTNKSHKDNGYQVVFLAK
NKNGYHNLAKMASIAYTDGFYYVPRIDRNVIERYKEDLIVLTGSLYGEIPSKILNIGEKQ
AEQALIWWKEQFGEDLYMEIMRHGQEDERRVNGTLISMAQKHNLKLVACNNTYYIDKEDA
NAHDILLCVKDGEKQATPIGRGRGYRYGLPNQEYYFKTQEEMKKLFEDLPEAISNIAEVI
EKIEPFTLMRDVLLPNFDIPKEFYNIEDADGGKRGENEFLKHLAYVGAEKRYGELTDEIK
ERLDFELEVIANTGYPGYFLIVQDFIAEARKMGVSVGPGRGSAAGSAVAYCLGITNIDPI
KYDLLFERFLNPDRVSMPDIDIDFDDEGRSRVMDYVIEKYGANQVAQIITYGTMAAKSSI
RDTARVLDLPLNDADRIAKLIPNMTKLNKIFGLSDSELRSKFRSDELPKVNELLNLAEGE
DLEAETIKQAKVLEGSVRNTGIHACGVIITPDNITNYVPIATAKDSDLYVTQFDNSVVES
AGLLKMDFLGLKTLTLIKDTVKIVKHKHDVDLDPDNFPLDDEKTYELFQRGETVGIFQYE
SVGMQKHMKDLKPTVFADLIAMNALYRPGPMEYIPSFIRRKHGEEEISYDLPAMEEYLKE
TYGITVYQEQVMLLSQKLASFTKGEADVLRKAMGKKQKAVLDKMKPQFIEQAAANGHDPE
ILEKIWKDWEAFASYAFNKSHSTCYAWIAYQTAYLKAHYPAEYMAAVLSNNMNDIKQVTF
FMEECKRMGLEVLGPDVNESFYKFTVNDSGAVRFGMGAIKGVGGNAVATIVENRKDGKYK
SIFDLAKRIDLRAANKKAFENLVLAGGFDSFDTHRAQYMHTDGDGIMFFEKVLRYAARYQ
ETQNSSQVSLFGDASEVQIPEPEVPPCEEWGTMKKLKQEKEVVGIYISGHPLDDFKTEID
SFCSCKVSDFNHLERFVNRELTFGGVVSDVQHRESKAGKGWAIFTVEDYDDSFEFKIFGE
EYLKYRHLLIPNSFIYARVFVREGWVNRETGKKGDPRLQYSNIQLLHDVMGLQAKKLTLQ
IPIDNLQEDTINELKELLKMHKGDKQLHITMYDMEDKLKLNMPSRKQKVEISKELLEELK
EMELKYKLN
>OMIFANIC_00316 hypothetical protein
MKRIILTIFALSFAFLGCEDIEDNSPAIQGEIDNVFFKALDVRGQENENGSFTLKGENQD
QELTLNIRSSDPGTYPLGPGEANFAIYEDGEGNEYETSPSGEGKIVITDHCESCETLSGN
FNFVAINTGVDTVYVQKGFFFEVSYNLGGIQGDTSDGYMNAKVDGEPFETMIVSGEEIGG
AIVFNGFVDNQNITIKIPVSAASGNYSVNDSGFSASYTLDGVVEVAESGLISVNFINTTT
RRALVFFNFNTATREITNGESRVNY
>OMIFANIC_00317 30S ribosomal protein S16
MPVKIRLQRHGKKGKPFYWIVAADSRAKRDGKYLEKLGTYNPNVNPAEINLNVDGAVQWL
QNGAQPTDTARAILSYKGAMMKKHLSEGVRKGALTEEQAEEKYNNWLEEKAKAVEAKRSK
LADVKAKAKADALAAEKAVNDARIAEAEAAEAEAVAEEAAAEEVVEEGAEASAETTEETT
KEEE
>OMIFANIC_00318 Ribosome maturation factor RimM
MQKKDCFFVGKIVKKYSFKGELLVKLDTDEPKQFLKMESVFVEKHKNLIPFFIESVSLHK
SSLLRIKFEEVSTEADAEALLGSELYLPLDLLPELSGNQFYYHEIIGFKIVDTSFGEVGT
ITGVNDSTAQALFEIDREGVEILIPVSDEIIKEVDRTTKTILIEAPEGLIDIYL
>OMIFANIC_00319 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MSKPFHFKEFSVSQDRCAMKIGTDGVLLGAWTSIDNNPQSILDIGSGTGIIALQLAQRSA
APTIDAVELDDNAYEQCSENFEASPWPDRLFCYHASIQEFASEIDETYDLIVSNPPFYRE
DFKSAAPARDTARFTDTLPFEHLMVCVAHLLSENGKFSLILPQKEQLRLTELATKQRLHP
KRICEVRGTPNSEIKRVLMEFSNMRPAKIISEELTIEIGRHEYTPKYINLVKDFYLKM
>OMIFANIC_00320 Caffeyl-CoA reductase-Etf complex subunit CarC
MKPDLFESPDYYNLDDLLTEEHKLIRSAAREWVKRDVSPIIEEAAQNAEFPKSIIPGLAE
IGAFGPYIPVEYGGSGLDQISYGIIMQEIERGDSGVRSTASVQSSLVMYPIWKYGSEEQR
KKYLPKLATGEWMGSFGLTEPDHGSNPAGMVTNFKDKGDHYLLNGAKLWISNSPFCDVAV
VWAKNEEGRIHGLIVERGMEGFSTPETHNKWSLRASATGELIFQDVKVPKENLLPNKSGL
GAPLGCLDSARYGIAWGVIGCAMDCYDTALRYAKERIQFGKPIAAFRLQQKKLAEMITEI
TKAQLLAYRLGQLKNEDRATSAQISLAKRNNVDMAIKIAREARQILGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGLDITGHNAFK
>OMIFANIC_00321 hypothetical protein
MSSRKRFSRAYTTAPRIPFDNTSKFIIFSDCHRGDNSFADDFANNRNTYFHALQHYYNEG
FTYCELGDGDELWENLEFKNIFEAHKNVYTLMMNFYQECRLYRLLGNHDMVYKNERYVAK
HLHSYFNKVIGEDVPLFPGINFTEGIVLEHSQTGQEVFMLHGHQADFMNYAGWKLNRFMV
RALWRQLQIFGIGDPTSPAKNYRELKKVERRTKEWIIENDNIFTITGHTHRPRFPEPGEI
AYFNDGSCVHPRSITGIEIENGEISLIKWHITTAVDGTLKVNRKLLEGPNKLIDYKTN
>OMIFANIC_00322 hypothetical protein
MKKKITLILLLVGITGLAQVKGNGTIKTIIVPAKNISEIEMELYAKVIVNANATEEIIIT
ADENLLPLISSEVKDEKLLIEQKEWIRPSQKILITVGAPNIRKVSVGVHETVFVNNLNSD
EILLLAPIGKIIANGRTKLLTINSKKGTIDASDLEARNANVSITGSGKVIVNVSDTLARD
LDSKARLEYANEPMKIIGEPTAIEMNRNKTDFANARFIDISIKNNSWNRRNFVVEGPKKN
GSTFSYGFPMMPGSVKKERWTVGTKVYRKKSMGKRELLLTIKAADEGKTLKLFD
>OMIFANIC_00323 hypothetical protein
MKTMLVKLITPVTQTKWYADLLLAIPRIICGLLLTIDFGSSKFGLPWSPAEKNLGFFEVV
HWFPEDVAAYGGLFAAFPVFFAWMGAFSEAVGGVFLALGLKTRVASFLIMCTMLVAIFFQ
KWGGGTWGMLPAMGFLWLSVFTLILGSGRFGLDYLFAKFLTINNK
>OMIFANIC_00324 HTH-type transcriptional activator Btr
MSVNYFLSFPDFNIWSTPLLILVLQGLVLIGLLLFRYFRKRNVSDLFLALILVIVCYEQI
CYTVGFMGWYHAFPNTKINYWLIPMALALAPMIYFYVKTSTTSDFKFRKIYWLHFIPAMA
LVLYRLSIYTYDSLQPGFNDTQNGYLKIHLDEPIIQPILMFVEFAALLLYLAFTFQMFLN
YRKKIKLFFSNTFKYELNWILTFLVIFSLLFIYEAVQDVIGTLITELHYTQRWWLNLLLA
IATIYIGVKGYFTDTEKLKNLNFNVVAMPSQSTVAKDKPAVSNEELNKLKNFMETEKPYL
DPELNLNDLATLINMNRAQLSQLINSGFQKNFNDFVNEYRIEAVKDLLSKGKQKKLSLLG
IAYECGFNSKATFNRVFKKLTNTSPTDYLNSIS
>OMIFANIC_00325 hypothetical protein
MESLASNNNTFVHSGTVSRISGNSVFVSLDPNIHCDSCRAKSACGISDSKSKEIEITDPS
ASFTINEHVEVVINRALGLKAVFWAYLFPFILLTCVLVIASSFLPEWQAGLLALGILVPY
YALLHYTKSFFKRKFKISVLKLV
>OMIFANIC_00326 Electron transport complex subunit RsxB
MMLSILHSTILLGSIGTVAAVILFVVSKKFYVYENPLIGEVEDILPAANCGGCGSPGCKA
FAENLVNSDDISELFCPVGGNDVMKQVSQLLGKEVAEQDPTVAVLLCQGACDVRPKTTIY
QGPRSCAISSLVYGGETDCQYGCLGDGDCVDVCDFDAMYMNEETGLPVIITDKCTSCGLC
VKACPRDIIEMRPRNKRDLKIFVGCLNQDKGGIAKKACAVACIGCSKCEDICPKDAVIMT
DNLAYIDPVACSLCRKCVEVCPTHSIIETNFPPKKVKIKKPEKPKAAPIAKTEINPEKPS
TDA
>OMIFANIC_00327 Electron transport complex subunit RnfC
MLKTFPKGGIHPAENKITSSKAIRRMPVPKVVYVPIAQHIGIPSEIVVDRKDKVEIGQII
AKSGGYVSSNIHAPVAGTVTKLDMMVDTSGYKKQCIVIRTDQKNESNFETPEFPLKKEIT
MDQKDILQHITDSGIVGLGGATFPSHVKLDLKNDNLIDCLIINGVECEPYLTADHRLMLE
KADEIVVGIQILMHALHIQRAVIGIENNKRDAVEVLKKAAQDDDRIKVAALQVKYPQGSE
KQLIKAILKREVPKGGLPMDVGVIVHNVGTIFAIYQAVQHDRPLIERVVTVTGKKIENPS
NFWVKIGTPIKDLVEEVGGIPEGTRKIVNGGPMMGKAIKNTDVPITKGTSGILVISEEEA
SRKESKNCIRCSNCVFVCPMGLEPHLLMNLSEKGFYERAKAEDIMTCIECGSCSYVCPSH
RPLLDYIRFGKNIVKKLEAAQN
>OMIFANIC_00328 Electron transport complex subunit RsxD
MTDERIIISASPHVHSDSTSKKLMYDVLIALIPAFIVTLYVFGISALIMTSVAVISCILF
EYLIQKYLLKTAVTVSDGSALITGILLAFNLPSSLPLWMVITGSFVAIGIAKMSFGGLGY
NIFNPALVGRVFLFISFPAQMSSWPVPVENNMTLVDAISGETTLGIIKEGLMYGETMSTL
SMQIPSMTELLLGFTSGSAGEMSALALILGGLYLLIRKVITWHIPITILVTMAVFTGIFW
LVDPEQYANPLIHILSGGAVLGAFYMATDLVTSPMTKKGMIIFAVGIAVITVVIRLFGAY
PEGISFAILIMNAFVPLINSYFKPRRFGNKIKAKIV
>OMIFANIC_00329 Electron transport complex subunit RnfG
MGKKKSTFINMTVTLFVITIVAGVSLGFINDITKGPKAQAKLERKINALKSVLPEFNNNP
VESVKRVKSDLAKDSIEIYTAYMDNKQTGTAVVGSSEKGYGGLVKVMVGFNPDGSIKNIT
VLEQKETPGLGTKMKDEKFIRQFRGKHPSVFNLKVRKDQGDVDALTGATITTRAFTEATQ
MAYDVFVENQTQPKN
>OMIFANIC_00330 Electron transport complex subunit RnfE
MAEQLSQKQNFLKGIIKDNPVFVMLLGMCPTLGVTSTAYNGLGMGIATMFVLLMSNIVVS
LVKSQIPGKVRIPAFIIVIASFVTIVEMVLEAFIPFLYEQLGIFIPLIVVNCLILGRAEA
FASKNNLISSIVDALGMGIGFTIALTVLGASREILGSGSLFDFKMVPEDASTLILFILPP
GAFIALAYLSVVFNKVSTKIN
>OMIFANIC_00331 Electron transport complex subunit RsxA
MEYVVILIAAVFVNNIVLSQFLGICPFLGVSSKVSTSVGMSGAVLFVMTIATLVTYLLYQ
FVLVPTGLDYLRTITFILVIASLVQMVEIILKKVSPALYQALGVFLPLITTNCAVLGVAI
LALGLENGSLLKAVFFAIANSIGFALALILFASIREQLELADLPEGMKGVPINLLVAGLL
SLAFLGFTGLV
>OMIFANIC_00332 2-oxoglutarate oxidoreductase subunit KorB
METTAEKKYTYKDFESDQEVRWCPGCDDYVILRSMQKALPEMGVNKEDVVFISGIGCSSR
FPYYMDTFGMHGIHGRAPAIATGVKLAKNDLSVWVITGDGDSMAIGGNHFIHVLRRNIDL
NIVLFNNEIYGLTKGQFSPTSLVGQKTKSSPYGNTQPPFSPGELALGAHARFFARIGGNT
PKEMTEIFVQSEKFSGTSLIEVLQNCPIFNDGAFSEFTDRKVREDRQLFVKHGEPMIFGK
ERDKGLVLNGLKLEVVTIGENGVTEEDILVHDAGEADPTLHQMLVRSTYPLVTGIIRKFE
DVTFEERENKQREEVKLNSKFKKTKDLFFAGDVYEVT
>OMIFANIC_00333 2-oxoglutarate oxidoreductase subunit KorA
MDVVEKNRAAEKLEAVVIRFAGDSGDGMQLTGTQFSDTSAMFGNDIATFPNYPAEIRAPQ
GSLYGVSGYQVHIGSVEISTPGDEVDLLVAMNPAGLKTNLHAVKPGHTIIVDTDAFTKKN
LEKAQYDSNPLEDGILANYRVIEVEMTSLTKAALKDIEGLDNKSITRTKNMFALGMVYWM
YNRSTDHTIKFFQNKFKNRPEIIEANTKVLNTGFYFAETLELIPNAYTVSPAKMNPGTYR
IIMGNRATAWGFLAAAEKSGLELFLGSYPITPASDILHELSKHGHFGVKTFQAEDEIAGI
SSAIGAAFAGDLAITTTSGPGLALKGEALGLATMIELPLVVVNVQRGGPSTGLPTKTEQS
DLLQALYGRNGESPVIVIAASTPANCFNYAYEAAKLTLEHMTPVVLLTDGYIANGSAPWK
ILSVDDMPEIKNNIYKSNGDTWHPYDRNEDTLARRWPVPGTPGMEHRVGGLEKDRVTGNV
SYVPENHEYMTKVRAEKIKRVQNYIPDLKTEFAETGDLLVVGWGGTYGSLHSAVKYMHEE
GYSNIGYAHFNYINPLPKNTEDILKRYKKIVVCELNNGQFAKVLKINFNDFEFTQFNKIQ
GLPFGNGELMEKFKQLIK
>OMIFANIC_00334 Ferredoxin
MAIKITDECINCDACVTECPNNAIYEPDDNWSYSDETSLSGMVTGLHGEEIDADAENDPV
SEEFYFIVTDKCTECKGFHDEPQCAAVCPVDCCVPDEDHVESEEELLNKKAWLHGE
>OMIFANIC_00335 Pyruvate-flavodoxin oxidoreductase
MEKASGKLICDGNEAVARVAHKTNEVCAIYPITPASPMGEHVDVFSAKGEKNIWGNIPRI
VEMQSEGGAAGAVHGSLLGGALTTTFTASQGLLLMIPNMYKIAGELLPTVIHVASRTVAT
HALSIFADHSDVMAARQTGFAMLFGGSVQEAQDFALISQVATLRSRVPFMNVFDGFRTSH
EISKIEPISDEIIRKMMPEDKIMEHKARSLDPDHPTIKGTSQNPDVFFQAREAANTYYNN
TPEIVQDTMNEFYELTGRRYSLFYYVGHPEAEKVVIIMGSGQGPVMETIDTMVKDGEKVG
AIIVRLFRPFSLEHFIDALPTTVKKVAVLDRTKEPGSTGEPLYLEIVSALSESKRDMESI
IGGRYGLSSKEFDPAMVKSVLDELDKENPKNHFTIGINDDVSHTSLDIGKRLHTVKSTFN
CMFYGLGSDGTVGANKNSIKIIGETTDNHVQGYFVYDSKKAGAQTVSHLRFGPEPIYSTY
LIHKADFIACHQYNFIEKYDILKSIKKGGTFLLNAPFSKDEIWDRLPKKMQEEIVENELE
FYVIDATKVAHEQKLGKRTNTILQTCFFAISGILPKDEAIQKIKDAIVKTYSHKGESIVK
KNFNAVDASLANLQKVDYPKTITSDKALKPIMTGDADPFVMEVLGKILAGRGDELPVSAF
PVDGTFPVGTTQYEKRGIADYIPVWDDIELCTQCNKCIAICPHAAIRAKVVPNDELADAP
ASLKSVAAKGRPFNKEEDSYVLQVSPEDCTGCDLCVAVCPAVSKEIDDFKAINMHRKLDV
ENEENPNWDYFTKLSNYDRSALQITNVKGSQFLEPLFEFSGACSGCGETPYIKLLTQLYG
DSILIANATGCSSIYGGNLPTTPYKANEDGRGPAWANSLFEDNAEFGLGMKLALTKKQEI
AIQLLKSIESELDSELVQSILENPEETEEQKAKKIVDINTLQSQLETLEDNPDARKLGQM
SEYLRRKGVWILGGDGWAYDIGYGGVDHVLASGEDINIMVLDTEVYSNTGGQTSKATPLG
ASAKFSVSGKRTSKKSLALQAVSYENVYVAQVAIGAKDLQTLKAIEEAEAYPGPSIIIAY
SHCGEHGYDLADGAVQQSKAVNSGYWPLFRFDPSKPKGKKFRLDSKEPSIPLEDFMYGET
RFTRVVKEDKELGASLLEQAQEEVQTKWERLELYKNM
>OMIFANIC_00336 hypothetical protein
MEKDISKYFKDAAVKLKEANQELYKPAEDVVSYLVCQKSQHAIENYLKGYLLKHEIDPSG
FDSIESMYHECLKINKEFEKVDLSDFTCNYIETDMAYCNDINEVSHCYELADGLNTLLRK
EKIIA
>OMIFANIC_00337 Fe/S biogenesis protein NfuA
MTKKELQSKVEIALDEIRPFLQSDGGDIKLLSIDDGKIVKVQLEGACVGCTVNQMTLKSG
VEMTIKKHAPQIESVINVE
>OMIFANIC_00338 Iron-sulfur cluster carrier protein
MSFNKQDILKALETVTVAGEGKNMVESGAVRNVMTFADEVVVDITIATPAMHIKKRAESD
IIKTIQEKVNKDAKVQVNIKVEAPVKENPNLIKGEPIPGIQNIVAVASGKGGVGKSTVTA
NLAVTLAKMGFKVGVLDADIYGPSIPIMFDVAMERPLSVEIDGKSKMKPIENYGVKVLSI
GFFTEPDQAVIWRGPMAAKALNQLIFDAAWGELDFMLIDLPPGTGDIHLSIMQSLPITGA
VVVSTPQMVALADARKGVAMFQQESIQVPVLGIVENMAYFTPAELPENKYYIFGKEGAKN
LADDLNVPFLGEIPLEQSIREAGDVGHPAALQTATKTEKAFEEVTKRVVEETVRRNEALP
PTEAIKITTMAGCSAVKK
>OMIFANIC_00339 DNA base-flipping protein
METESFFSKVHDVAKLIPYGRVTSYGAIARYLGAAGSARMVGWAMNASHKDPDVPAHRVV
NRKGLLTGKHHFAGTNLMQQLLESEGIVVIDNQIQDFDRLFWDPMKEL
>OMIFANIC_00340 hypothetical protein
MTFIANFIIGFLAAFVGVIPPGLLNMSAAKISMKEGRKKGLLFSIGVCVTVMIQTYVALI
FARFLDQHPEYVDFLQKVALGIFICITIYFLFIAKDTGRPIPQDMNRSKTNRFFAGMLLA
VLNLLPLPYWVYISITFSGFGWFTFEQPGIWAAVLASGLGTFAMLIVYVQFFRRKEEKPR
ANLNMNYIIGFITAVISIITFVKILNDF
>OMIFANIC_00341 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFKENETFVNVIQPERQDILSNSFSLKGKWAKEFFKNEKPIVLELGCGKGEY
TINLARRYPDKNFIGIDIKGARLWRGAKTALEEEMANVGFLRTQIELLDLIFERNEVDEI
WITFPDPQIKYKRTKHRLTNQQFLELYRRILVPEGIIHLKTDSEFMHGYTLGLLHGLGHT
VEYAHHDVYSNEYTPPEVTSIQTYYEGQYLEEGKKITYIRFKLK
>OMIFANIC_00342 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MNPSKKPKTILVAPLHWGLGHAARCIPIIRSLLEQGYNVVLASDGGALSLLKHEFPYLDS
LELPSYAIEYPKKDSNFKLKLLMNLPHIGKTISRERKLIKKLVKDGRIDGIISDNRLGVY
SKKIPSVYLTHQLNVLSGNTSWFSSKAHQKVIKKFNECWVPDIEGAGNLSGKLGHLKKPT
FSIKYIGPLSRMIRRELPVKYDFMCLLSGPEPQRSILERKFIETFSVLDKKVLIVQGVVD
VQKTKEIQGNITLINFLTTKDLEKVINESEIILSRSGYTTIMDIAAMRKKAYFIPTPGQY
EQEYLANRLKLQRVVPSCKQEDFSIEKLNEISEFKGFKDVDSNYKPEYLFRLFQSK
>OMIFANIC_00343 Alkaline phosphatase synthesis sensor protein PhoR
MTTTSFKKTYKFAGYTSGAITVVFTLALAGFFYLTDSLNYWVLAAFAAGCYILSFFIIQY
RVERYIYKRVQKIYDDVALLDASTFSQPQITTDMETLTREVERFAQDKKLEIEALKIREN
YRKEFIGNISHELKTPLFTVQGYILTLLDGAMKDKNVRKKYLVNANKGVERLIYIVKDLD
MITKLEVGDLNLYKEEFNIIELAQNVFDLLEMKTAKKNIELTFDKNYSNSIMVMADRERI
QQVLSNLLVNSIKYGKEGGTTEVSIEDLIKNKVIVRITDNGEGIAEEHLPRLFERFYRVD
KSGSRKEGGSGLGLAIVKHIVEAHKEQIYVESQIGIGSEFSFTLEKAK
>OMIFANIC_00344 Transcriptional regulatory protein SrrA
MKKRDTRILLVDDEPDILEILGYNLSSEGYQIITAENGVEAITKAKKHKPHLIVLDVMMP
EMDGIEACEKIRAVPELSETVITFLTARGEDYSQVAGFEAGADDYITKPIKPKVLISKVK
ALLRRFKETSDEDGTMKIGNLTINREEYKILKGKQEIILPRKEFELLALLASKPGKVFKR
EDILDRVWGNEVVVGGRTIDVHIRKLREKIGDERFKTVKGVGYKFVV
>OMIFANIC_00345 hypothetical protein
MSLTSIFNIDTPEEFRKLALETFLYQYNNVPVYRKFCETLGTEIDSIDSITGIPFMPIQF
FKSEKVISNGHSAQMVFHSSGTTGSNTSKHFVADIELYEKSFTRTFEDNFGNPQDLAILA
LLPSYLERQGSSLVYMVDSLLKASRNPRSGFYLKDTESLTRMLQELEETGQKTLLIGVSF
ALLDLVEDQKFQLKNTIVMETGGMKGRRREMIREELHEKLKTGFGVSRIYSEYGMTELLS
QAYSKGDGIFQCPPWMKILTRDTEDALSYVHNKTGGLNIIDLANRYSCSFIATQDLGKCY
PDGSFEIIGRFDTSDIRGCNLMVL
>OMIFANIC_00346 hypothetical protein
MNLSPKKHANGCLWLVVMAIVLTVSFGVITVSLDLPILLSLVLSVTGSVFIALKLVGRPK
LSSLIGGAVIAIIVIGILVAGISFLFSMFEPPVTSTVFEVEESVQKTYRFEDNDSVEVYA
ANRFWRDNMGNDFNAVLAVRVKDYQKLKNHINGYRPASRINFWGDLYDYIERTDRPALDI
ILESFSMIQNEKKLNKMEFAEMVVTCIQDIPYSLVFQEDCLDSTNYEYDIRKLLEDCPEC
CIGNIMYGIQNPVSFMKNLKGDCDTRTVMIYSILKSFGYDVAILNSEYYRHSILGINLPA
SGKAKVYKGKKYALWETTAKYYSAGSLPATYSDISYWDIVLTSK
>OMIFANIC_00347 hypothetical protein
MNTKLLTLAIIEVLISIGVTVAIVFISFKILKLLFFKTTELSKNNMAFTIFTSGIVLSIG
LILSEILPSITNVIRLNTTQTEVIETSTIISYSGLYLAIGFILAVIINASAFLLFSILTT
GINEFKEIQQNNVSVSILVVSILLSITLIVKESIALLISALIPYPELTNYL
>OMIFANIC_00348 Tyrosine--tRNA ligase
MALKNFVEELKWRGMIHDVMPDTEEHLMEQMRSAYIGFDPTADSLHIGNLVPIMMLAFFQ
RCGHQPVALVGGATGMIGDPSGKSSERNLLDESALRHNQECVRKQLSQFLDFSSGNTNQA
VMLNNYDWMKEFTFLDFIRDVGKHITVNYMMAKDSVKNRISGEETEGMSFTEFTYQLVQG
YDFLHLFRNHNCTLQMGGSDQWGNITTGTELIRRIGGGKGFALTCPLITKSDGSKFGKSE
GGNVWLDAKRTSPYKFYQYWLNTSDEDAEKYIRIFTFLDKETIDKLIAEHKQTPHLRLLQ
KRLAKEVTVTVHNEAEYENAVKASEILFGKSTSEDLKSLDEATFLDVFDGVPQGEVSSEE
ISSGMDIIASLAERTGFLKSNGEARRALKENSISVNKEKVNDSYTIGSNDLINGKFILLQ
RGKKNYFIIKAV
>OMIFANIC_00349 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MVLVTGGTGLVGSHLLYFLLKKGIDVRAIHRKSSKLEAVRRVFSYYTKDADSLFDKIEWM
EANITDIPALEDAFHGVTHVYHSAAYISFHPKHFRKLKKANIDGTANIVNLSLAHKVQKL
CHVSSIATLGSTIDGSLISESTPWNPEEDNNVYAITKYGSEMEVWRGTQEGLDSVIINPG
VIMGSGHWHSGSGAIVKMVAKGTKYYTEGGVSIVDVRDVVHAMIKLMDSDIINERFVLAG
ENITYKVLLSQLANSLGVSAPKKSISKWKLDGLRKLDWLSSKLSGSRRRLLKSTVDSMYK
KSYYDGSKISKFVDFTYTNSEETLRRVGKNYLKD
>OMIFANIC_00350 hypothetical protein
MRLVLVVISLLFLAGCQNVEKPEEPQDLIPKELMVDILTDAYISNAAKSVNNKVIRQKGI
KLDSLIYKKYGIDSLQFVESHAWYNADLDLYNEIFKEIEDRLEAMKKKVDSASFPGKSNI
KRKQDSLRDAKGLIDPAESE
>OMIFANIC_00351 Allantoinase
MSTILIKNANIVNEGKIVQGDLMIENDTIVEVGGSISVKIADTKVIDADGQYLLPGMIDD
QVHFREPGLTHKATIETESKAAVAGGITTFIEMPNTVPQATTIELLEEKFSRAAETSWAN
YSFMFGGTNDNLEEILKVDKTKVAGLKLFLGSSTGNMLVDDPTVLEEIFSKTDLLISVHC
EDESTIKKNLAKYKKQYGEDIPIEMHPKIRSEEACYISSSGAIELAKKTGARLHVFHLST
KKETELFDKKKPLSDKKITAEVCIHHLWFSEEDYATKGTHIKWNPAVKTSEDREGLMKAL
NDGRIDVIATDHAPHTQDEKNSVYTEAPSGGPLVQHALVALFEMYHQGNISMETIVQKTA
HNPAILFEIKDRGYIREGYKADLVLVDINSPWTVSKENILYKCGWSPFEGRTFRSRVTHT
LVNGCLAYENLKFPNRSKGERITFNR
>OMIFANIC_00352 Polyprenol monophosphomannose synthase
MSNALVVIPTYNEKENIERLVRNIISLQRSFNILVVDDNSPDGTGAIVKSMHNEFSNRVF
LLERAGKLGLGTAYIAGFKWALERDYEYIFEMDADFSHNPNDLIRLYNACNKEGFDMSIG
SRYVKGVNVVNWPMSRVLLSWLASKYVRLITGMRIYDTTAGFVCYRRHVLEKINLDKIRF
VGYAFQIEMKFKAYLAKFKITEVPVVFTDRTRGESKMSGGIISEAIFGVIKMKFRSLFGS
TDFNEI
>OMIFANIC_00353 hypothetical protein
MDYITRDMVSNDWITFLLLGCVVLYSVSKYLYPQRFQEFILLPITNKYFLVQGKNNEIQH
PFNILLFISQVISVSLLIYLIIKVSSPETVSSNPWIYIQISTAYAAFVLVKYYLEKIVSV
IFSLEPLLNQYLYEKITYRNLLSIVVFLGNLVFFFIYEPTLTVLLTFLGIMVIMNVVSII
YSYKTNGKLILRNFFYFILYLCALEISPYFILYKLFIGQGDF
>OMIFANIC_00354 hypothetical protein
MKVKTILVSQPEPKVENSPYFDLIEKQKVKIDFRPFIHVEGVSSKEVRSQKVDLGDYSAI
ILTSRNAVDHFFRIAEEMRFKVPDSMKYFCQSEAVAYYLQKYVVYRKRKIYVGKRTFQEL
TPLIKKYKTEKFLLPSSDKLKPEVPNILDELTVNWKKATFYKTVVSDLSDLRDVYYDILV
FFSPSGIKSLLENFPDFKQNETRIAVFGNTTIQAATDNGLRVDIKAPTPDTPSMTMALEK
YIKAVNKK
>OMIFANIC_00355 Phosphoenolpyruvate carboxykinase (ATP)
MIDHNQTSKSISIEKYGITDARVKYQLSSQELHNETIEKGMGREADTGALAINTGEFTGR
SPQDRFIVKDDITRDRIWWGSINKPFDSDKFDALYEKITAYLSGKDVYVRDSYACSDPKY
RTNIRVMNEYPWSNMFVNSMFLRPEDSELSNFEPEWIVVNAPGFMADPEVDGTRQHNFAI
LNFTRKVAIVGGTGYTGEIKKGIFSALNFILPVFKNTLPMHCSANVGKNEETAIFFGLSG
TGKTTLSADPDRKLIGDDEHGWTAENTVFNFEGGCYAKVIDLTEESEPDIYRAIKPGAIL
ENVIMDNNGHVDYADTTITQNTRVSYPLEHIDNIQIPSIGHNPKNIFFLTADAFGVLPPI
SRLTPGQAAYHFISGYTAKVAGTEEGIDEPLPSFSACFGAPFMPLHPTKYAEMLSAKMQE
AGVNVWLVNTGWTGGPYGTGERMKLRYTRAMITAALDGKLDNVSYHEHPIFGLNIPQECP
NVPSEVLNPKGTWADKEAYDRKAKQLAKSFKDNFEQFAEYANEEIMAGAPKTE
>OMIFANIC_00356 hypothetical protein
MIQFDKKITVTASFLGALTIAIGAFGAHGLEKLVDTEAIASFETGVRYQMYHTIALLVIG
FATAIPVSTRKWVFRLFVAGIIFFSGSIYFLALKSVLPLSVSFLGPVTPIGGLLFILGWL
RLAYGLLTNNKG
>OMIFANIC_00357 hypothetical protein
MRNILIIGAGRSATSLVQYILNKSQEEDLLVTIGDISIQNARKLAAGHPNAEATLIDIHN
EQERREIVSDSDIVISMLPARYHIEVARDCLEFGIHLVTASYVSDEMQSLHRKAKAKGLV
FMNEIGVDPGIDHMSAMQVIDRIRDNGGKMLMFESFTGGLVAPESDDNLWNYKFTWNPRN
VVLAGQGGAAEFIQEGTYKYIPYHRLFRRTEFLQVEGYGRFEAYANRNSLKYRDIYGLED
ILTLYRGTIRRVGFSKAWNIFVQLGMTDDSYMIPHSEDLSYRQFVNLFLPYSPTDSVELK
LRHNLKIDQDDLIWDKLVELDIFNGEKTIGIKDATPAQALQKILMEKWTLQEDEKDMIVM
YHKFGYELEGKKKQIDSNMVIKGEDQTYTAMAKTVGLPVAIAALKILNREITTPGVLRPI
AKEIYDPILKELEDYGITFNEHFTNYLGYNPDNVGG
>OMIFANIC_00358 hypothetical protein
MMGYYILAGVIFLVSMLVSNRLKSKFKKYSKVQLQNGMSGKEIAEKMLRDNGIYDVQVVS
VQGMLTDHYNPKTKTVNLSEGVYLQRNAAAAAVAAHECGHAVQHATAYGWLQMRSSIVPM
VGIASKLSNFVIMAGLVLTFSGIAFGNWIFLVGIGLFAMTTVFSFITLPVEYDASNRALA
WLQNNNMVNQQEYSGAKDALKWAARTYVVAALGSLATLIYFISIFLGGRD
>OMIFANIC_00359 Leucine--tRNA ligase
MADVKTISGVFTGAYAIHPFSGEKIPVWIGDYVLAGYGTGAVMAVPCGDQRDYDFAKFYN
IPIPNIFEGVDISEEAFADKDNTVIANSEFMNGMNHKDATRKVIEELEKKGAGTGKINYR
LRDAVFSRQRYWGEPFPAYYKDGLPQMIETEHLPLVLPEVEKYLPTEEGDPPLGQADVWA
WDSGKNEVVSNELIDNTTVFPLELNTMPGWAGSSCYMFRYMDPHNENELASKAALAYWQD
VDLYLGGSEHATGHLLYSRFWVKFMYDRGHLPVDEHAKKLINQGMILGESAFVYRIEGEN
KLVTESKKGEQTVQPIHADVSMVNLSNELDIEAFKKWRPEFENAEFITEDDGTFKVAREI
EKMSKSKYNVVNPDEICHRYGADTLRMYEMFLGPLEQAKPWSTAGITGVHSFLKKLWKLY
HSGADGTFGVSVEEGTKDNLKTLHKTIKKVEEDIENFSFNTSVSTFMIAVNELTAQKCFT
RKVLEPLLILISPYAPHIAEELWNKLGHTESISAAPFPIFDESHLVESTKEYPVSFNGKM
RFKLELPLDMSKDDIEAAVMAHEKTAHYMEGRTPKKVIVVPGKIINIVG
>OMIFANIC_00360 Methionyl-tRNA formyltransferase
MEVGSELVLETVLLIAEGEVKTEIQPSAKELKGAPKLNNENTKIDWTRPAMEIDALIRGL
NPYPAAWCYLENDGERLKIKIYDVALKLEEHDHEIGTLFSSKKDLHVAVENGFLEIQEIQ
LPGKRRMKSSDLLNGYSFDADAKVV
>OMIFANIC_00361 DNA-binding protein HU-beta
MNKSDLIDGMAEDAGITKAAAKKALESFLGNVEGSLKRGNRVSLVGFGSWSVSRRAAREG
RNPQTGKTIKIAAKNVVKFKAGSDLSSSVN
>OMIFANIC_00362 hypothetical protein
MTTLRPDKGVLLVAEPSIIGDVSFNRSVVLLAEYNESGSVGFILNKPLKYKLKDFIPEIS
SDLEVYNGGPVEQDNLYFIHKVPELIPDSVEISNGIYWGGDFNAIMGLLKEDVLKKEQIR
FFLGYSGWSNEQLESELEVHSWVVVPNIYENKILGKSNNNFWKEKMLEFGGDYLIWSNAP
EDPTYN
>OMIFANIC_00363 Aminodeoxychorismate lyase
MKTNYNGTFTDAENASISVNNRGLHFGDSVFETLRYSGGKIFFWEDHYFRLMSAMRILRM
EIPMDFTPEQLEAEIIKTITASDAEKVTCRVRITVWRQWGGKYNPSNQDIEYMIQLEKLD
APFYTISDEPYEIELYKDHYVNSGLLSTLKTNNKIINVLGSVFATENGYENCLLLNENKM
VVEALNGNIFLVNGYKIKTPPLEDGCLKGVLRKQIIDIIGAIPDYVLEETTVSPFELQKA
DEIFITNVIGGIQPVTKYRKKTFDNTVAKELLAKLNVKARLG
>OMIFANIC_00364 hypothetical protein
MKKKSRKSFKRKKFPEEYKISDPQLAKNFHRPLKWLNRLLDALIEILDNHLREGVPITPG
TEDIIPLLKEYKMRAIREGFLGYFPESDYIFSAYYRHLEALNRRLLKAKLLAHDRRACLA
ELVKARDRKQWIPNLFLDYMGIEFSTWYHGCYALDKVIERLEDAIDNETISQDDLIEKVV
DILSEYNDLRGSTAGEDAWDSPGDVTDDIRDDFNNMKDRIRFLLEQVRSGDWDINNDEDK
AKIKRILRELRVIKHRILRHLGDFGGKSILDWYKKLYEMDIHIDNAIDMWKDGKKLTDWD
PELVEIYIRMAERAKIRFLRLFPLYLGMSVSFFYKELYLMDLHMDQAKAMMDANDIRDAL
RELRHVRIHKHKIERILEES
>OMIFANIC_00365 Sensor histidine kinase TodS
MKYYQFIVLSFVMSFAHSQDRKQITFSQLSVNEGLSQNSVVSIAQDTIGYLWFATQDGLN
KYNGLEFEYYPILFDDVTKENYSRLGKVFINSANEIFVIGKGGQLQKHNTKTDSFEPVLR
FEDVSTLEEGKDKSVWIGTYSNGLYQINSESKDTLAFLQNESALTAIYDLYNYETKMVVA
SSNSIYIMDEEGSGLIKTIERDHTNFSSLAEANNKLWIGSFGKGLFYSSALDSLSIFNGF
SESDALPGDLNILSLLRDQQQRLWVGTYGDGAYLIDFKSEQIQHFVAEPRNPKAIHYNDI
LSIYEDHTGTIWLGTDGAGLSYYDENLSKFNVLTNYQTPIYTDIDVIRAITKDKNGNLWL
GSSGKGLTMVTPDQSEFKTFVHDPNDTGSIVSNRIMSLMSNDDELWIGFQDEGLSVYEGG
NSFKHFSGSSSPPLMANTIWCFLKDSQNRIWLGTRDNGLIQFDMNKGVIAQHIYDPNDNN
SVSSNNIRVIVEASDGNLWLGTENNGLNKFFVAEGNFRRYTQVSIANIKSLYEDKDKLWI
GTNGNGLLSMQLNNSELTSYTTNEGLPNNVVYAVLPDEQGNLWLSSNRGITKLNADNRKE
VEITNYDIYDGLQALEFNTGAYYKDDDGLLYFGGLKGINWLNPKEITNNTAPPRTIIYKL
DLFNEEIALDSERKFNSGENTISFTFAGLHFSQPERNEYRYILENYEDSWTGPTKNNYAH
YTNLPPGEYTFNVVSSNYDGVWDSTPASYSFTISKPWFLTNVAKISYILLGIALLYLIYL
YFKWRWSMQLKLRLEHEETERLQKLDDLKTKLYTNISHEFRTPLTLISGPVQQLLNTAGL
SEKDKQSLSIIEGSSERMLRLINQMLDLSKLEERSVKLRVTRNDLKPQLIQIVESFMLRA
NEKAITVHKDIQEFNESWYDRDIIDKIVTNLMSNAIKYAPENSDVNLAAKQIGDNLLLRV
SNANTSLSESHLPKLFDRFYQHDKTSPGTGIGLSLIKELITLCGGKIRALKDKENEICFE
AIIPVSRGSYNANTVIPEDTSYDFLHNEAEELFTNEDETPVMLVVEDNIELRSYIGALFR
GSFEVLQAGDGNEGIKLAIARVPDIIISDIMMPEKDGIELTNTLKTDVRSSHIPILLLTA
KTGTSNELKGLSSKADDYITKPFNAEILKQKVRNYIEMRKALQKRYSQHLYLKPKDISVT
SVDEQLLEDIQKIIDTRITEPDFTVGPFAEELGLSRMQLHRKLKALTGLSASEFIRSQRL
KSSTKLMETSDRSISEIAYSVGFNSPSYFIKCFKEAYGLTPTEYIKNL
>OMIFANIC_00366 hypothetical protein
MLLLLDETITFVINFNYFPMATNKGEFIGNVTSKYPEIYLAIDDLKDGYYIFHIIQNEKV
IKSFEIEKKQL
>OMIFANIC_00367 Stress response protein NhaX
MKNILVAIDFDENLDFLIRHAKRFAKAFNAKIWLMHVAAPDPEFVGYDVGPQYIRDSRAG
ELREEHRVIQEQTDWLKKEGCDAEGLLIQGATIELIMEESKKLHIDMIMTGHHERSFLYN
AFVGSVSAKIMKNSKIPVLIVPFK
>OMIFANIC_00368 1,4-dihydroxy-2-naphthoyl-CoA synthase
MSTPNWKTAKEYSDITYKKCDGVARIAFNRPEVRNAFRPKTTSELLDAFHDAQEDTSIGV
VLLSAEGPSPKDGVYSFCSGGDQAVRGHQGYVGEDGYHRLNILEVQRLIRFMPKAVIAVV
PGWAVGGGHSLHVVCDITLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFF
LGRNYSAQEAFEMGMVNEVVPHDELESTAFEWAQEILAKSPTSIKMLKFAMNLTDDGMVG
QQVFAGEATRLAYMTDEAKEGRDAFLEKRKPNFEKKWLP
>OMIFANIC_00369 Aminopeptidase E
MRNLLFILGLLSSITLLAQQPYKFNTVIDLETTPVISQGRTGTCWSFSSTSFLESEIIRL
TGTEIDLSEMYTVRNTYPKKAQNYVMRQGKAQFSEGGLAHDVMNSVRDFGLVPQETYSGM
FEEQTGHNHAELSAVLKAMVETYVDNPGRKLSKKWDDAVEAVLDVYMGENPKVFNYKGKQ
YSPETFLEMTKIVPDDYVTITSFSHAPFYSEFILNIPDNWSYGSMYNVPLDEMITTIDNA
LEKGFTVELDCDVSERTFSSKDGVAVIPRNSNNNIKALQGVYPEMNISQEYRQDEFENFT
TTDDHLMHITGLLRDQNGTKYYKVKNSWGTDESRNANGGYVYFSESYMRLKSISIMIHKD
AVPQATAKKLNL
>OMIFANIC_00370 hypothetical protein
MKIVYFILLLIPMALFSQDDFSTRYYTINSESLPQLDELTVYNLKPVTPFEKIGLNNFQM
NVNNYRSSVDMVSAVEQESDYVPANVNVQEIQSEFYSFGAQKNYLTDGKTRVKNSVYKEM
RGLDLLDPCPPFGICARCAPYRVGRGF
>OMIFANIC_00371 Lipopolysaccharide assembly protein B
MDNRLLTVIFLLNISIIFSQNNVIPIVEEGIAYHDRGEFDKAIEIYKTALEIDPESAMVF
YEIGLSYYHKGDYKAAIKYYDKVLKKNEKYLLPATINKGLSLDNLGKSKAALKLFKRAVN
EFKNEPRLHYNLGYQYYQKDDMENAIREVSKSIELDPEYSTSHLLMGFLQFSQNNRVQAL
LSYHYFLLLEPGSDRAEGAFYDINSIMGGNISVAEDDPKSINISLSANLNSEFSASELLL
ALLVAQNNEKKNKDKTEEELFIENTTKFFKHLGELKADNNNPRGIYWNLYIPFFEGLAES
GHMTAYFHHITENIIEDSAVWIENHTIEMFAFEKWLDR
>OMIFANIC_00372 Conserved virulence factor B
MLQLGQNQQLTILRETDPGLYLGSPEGDEVLLPHKYKPEQFEIGDPIDVFVYLDHEERPV
ATTLEPYVKLNEFGFLQCSDVNKFGAFMDWGLEKQLFVPFKEQARPMKIGNWYIVYLYLD
DQTNRLTGSSKTNKFLNNDQVTVSKFDEVDILVTHITEKGANAIVNGIHKGLIYIEDIFE
DIRTGDRLKAYVRKVRQDNKIDIVLQTPGYKSIEPNANYILDELKAAGGFMPLHDKTDPE
VIKNELGISKKSFKKAIGSLFKDKQIRIKEDGIELI
>OMIFANIC_00373 hypothetical protein
MELTNPHNYSSSAALEHVLKIDIVTIYFYEGIVVVEAEEGITLSYKTGFQFWFSV
>OMIFANIC_00374 hypothetical protein
MVFGLKYIGHRPFAYITYRVNYHSVNPNDYIYLDKNPTLKGLAIVSPNDIGKQNVELEQN
FFKKPMKIFYSISKAHHWVTQILQAYNS
>OMIFANIC_00375 hypothetical protein
MMTAAPNKSTKSSIDFADTPRKVLNTELGNIYIYDQYVIMEGKENVNISIRNGMPILLKV
VKAVGLRSVVYISNRINTYSVDPNDYKYLEMIPNLTGIAVVAYNDYAANTAMLEEKFFRK
PFKVFTSMNDAKKWANYVIEGLIIV
>OMIFANIC_00376 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MNFSSKRLSQTITQLCLVKEIDHVVISPGSRNAPLTIGFTEHPFFKTFSIVDERSAAFFA
LGIAQQIKKPVALVCTSGSAMLNYYPAVAEAFYSDIPLVVISADRPEYLIEVGDGQTIKQ
ENVFANHILYSANCKEGDEFQIHNETEVNIALNTSLELRGPVHINAPFDEPLYERRNDLQ
VRPQHVPIRIIEESIPDFEELQSLWNTSGKKMILVGAMSPGSLNSKIAERLASDGEVLVL
TETTSNVRHPNFVPAIDQLISALENKEFEELRPDLLITFGGMIISKRIKAFLRKYPPRHH
WHVDTKKAYDTFFILSQHVKMSPNRFFKNLLKEIEPSKPAYRDTWLAIKNHRLKKHAEYL
EVIPYSDFKVYYNLFASIPKNYQVQIANSAAVRYAQLFDLDESLKVFCNRGTSGIDGSTS
TAIGAALGSNTRTVLVTGDLSFFYDSNALWNAYIPKDFRIIIINNAGGGIFRILPGAKET
DHFKTYFETTHSLNAKNISEMFGIGYLAASDEKQLMECLEDFYSESDVPRILEVFTPAEL
NDKILVDYFEFIR
>OMIFANIC_00377 Salicylate biosynthesis isochorismate synthase
MKQDPVLNSILSHYQKKLPFAVYALPGEGIISVLLQQNARLYKNDNWQESGFTMAPFNPD
ISANFIPVSKSKCLKSEFIGKPVLNKSFELIQSDSDREDHIARVKNAIGLINASELEKVV
LSRKQEIKLNEFRITDLCASLFSEYPSAFRYLWYHPKTGLWCGATPELLLNVKENLFETM
SLAGTRAIQLNGGQEWTQKEYMEQQIVTDAILEALHPFARSLQTSEAYTVTAGNLEHLRT
DISGTLTTRKELSGLLNVLHPTPAVCGKPRSKALEFIRSTEGYDRSYYTGFVGSVGAESE
QISLFVNLRCMALNGRTATIYTGGGITADSIPESEWIETCKKQETMLKLLSLFL
>OMIFANIC_00378 1,4-dihydroxy-2-naphthoyl-CoA hydrolase
MKNSKEETLKALAAMCRNTLMETLEIEYTDVSEDALVARMPVTSRVHQPDGVLHGGATVA
LAESVGSAAAVLFLEGNEVSIRGIEISANHVKGIRDGYVYAKARILHKGRTTQLWSIPIV
NENDELISMVKLTTITLKK
>OMIFANIC_00379 hypothetical protein
MALEKRVSYNATAAYYTVNTLSEKTKNIWLVFHGMGYLSRYFTRYFSDLNSEENFIIAPQ
APSKYYIGPEFKHVGASWLTREDTSEETKNVLNYIDAVCEAEPISSDSRFIVLGYSQGVS
IASRWLASRKIQCDHLILHSGGIPKELKPEDFDYMHPETDVTYIYGDKDEYITEARKTEE
TLRGSNLFRDKLKIEVFDGIHEVSGEFLQKIAHN
>OMIFANIC_00380 hypothetical protein
MKKSISSLLLLLMTVVLSAQVAPAEKQALLDFYHSTHGDQWNQSWDITMPVTDWQGVTVE
NNTVTGLSLLFNNISGTLPESLGKLKNLRILELSFNRISGELPASLGNLDHLEMLAFNGN
ELSGNIPETLGKLKDLKQLHLSSNYLTGTLPGSLKYLKNLEVFNVFDNKLSGELPSEMSQ
LTNLKEVMIAENNFSNTEHFSVILMSNTAKLDFNDTGIVPAAKSVIAIETSDDNE
>OMIFANIC_00381 Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase
MYNQSRVIIENITPLINCGEFPLKSVVNEIIPVTADIFADGHDVIAASVLFKHEKEKSWK
ETRMHPAENDQWNSSFQVNKQGFYQYKIQGWVDHALNWQHGIQRKIEDGQTVNSELLEGA
MLLEVIIEGAAKNDKTFLLDCIASFRHPGAYEKATEMAQSDKLHRLLVKHPTKLLHNESQ
VFTVYVDRLKARYSTWYEFFPRSASDEEGKHGTFKDCERLLPRVASMGFDTLYFPPIHPI
GEVNRKGKNNTTVAKKDDVGSTWGIGSKLGGHKDIHPELGSLKDFKDLVKAAEKLGIEIA
MDFALQAAPDHPWVKDHPEWFKWRPDGTVQYAENPPKKYQDILPIHFESGDWKNLWKDML
DTALYWIEECGIKVFRVDNPHTKPFYFWGWLISEVKKKHKDILFLSEAFTRPKIMHQLAK
QGFTQSYTYFTWRNSKHELIEYMEELTKTDQQYFFRPNFWPNTPDINPWSLQSGNEAMHL
QRYFLAATLSSNTGVYGPVFEQMVSAALPGREEYLDSEKFQIRHWDWEKQNKLTTLITKI
NMIRKEHTSLQQTKNIQFLSIENEQILAYHKYSDDREDETLMIVNLDPHYPQNGWVQLPM
GELGVQEGQRISVTDLITGSSYHWDKEWNFVELHPALPFHLFKIGK
>OMIFANIC_00382 Maltokinase
MAKLETSKTKKRSNFDLPWEELMDNDDFVNMFLSEVLEDYIQKQRWYGGKSSKLKYIELT
EYFRIQRKEEMYYGLILEVNFEEAFYQHYFIPIAFVTDEDYATNDRILPISIQGTEGYII
DAINLDAFRKVVFERILNAMPNDTTRVQYHKGERLKETEFKSSRNMGMEQSNTSVIINDT
CVIKFFRRIYANKNPDYEMSLFLSDKKGFKNTPAYLGSLNIIDTDNLVITIALMQEMVEN
KGDAWEYTLDKLDGIFNNLSQKNINIDALPVTPMFERLPLKDVPHEIIDWAGLDIFQKLQ
KLAQRTAEMHIALGSEFEDTNFTPQHFNMDYEVWLKNRLLYQFQNRLNIVENNMHKLKGD
TLRLAKQFLEHKNEIRKRFLAYDWTKLKGERIRVHGDYHLGQVLVTDNDFYILDFEGEPE
STIRDRVVKQPPLKDVAGMFRSFHYAVYATIFNNGDKYPFPQEQLYKAGECLYRYFIGVF
LYTYTRLVQEANLNIGYNQERIFMLKYAMLEKAVYELGYEMNARPLWAVIPLEGIASIMN
EDQKI
>OMIFANIC_00383 1,4-alpha-glucan branching enzyme GlgB
MSKVITHSLFTEFDIDLFRAGKHFRLYEKLGAHLTELDGQKGVYFAVWAPSAKAVSVIGD
FNFWIEGEHPLNIRWDSSGIWEGFIPGVEKGSKYKYKIHSHHGDVKTEKADPFAARCEHP
PNTASIVWDTTYVWRDKSWMNKRKDINRLDKPFSVYEMHIGSWMHNAEEDRPLTYLELAK
ELTAYLKKMNFTHVEFMPVMEYPYDPSWGYQLTGYFAPTSRFGKPEDFMYLVDELHKNDI
GVILDWVPSHFPEDAHGLGNFDGSHLYEHPDRRKGYHPDWKSLIFNYGRNEVRAFLISNA
IFWLDRYHADGLRVDAVASMLYLDYSREDGEWEPNQFGGRENLDAISFFKELNEEVYGSF
EGVQTIAEESTSFPMVSKPTYIGGLGFGMKWMMGWMHDTLEYFKKEPIYRKHHQNDITFS
MTYAFTENFMLPLSHDEVVYGKQSILGRMPGDEWQRFANLRLLYGYMFTHPGSKLLFMGG
EFGQGEEWNFQQSLDWHLLEHDYHKGIQKLVAEVNKLYRKEPALHQKQFVGDGFEWIDYN
DAENSVLAYIRKGEKEKDDVILIANMTPIPREDYRIGLPASGKYKLIFNSDDPNYGGSGY
KIARQYTTDDKEWQFRKQSVALKLPPLSIIALKRVQTTKKS
>OMIFANIC_00384 Oligosaccharide 4-alpha-D-glucosyltransferase
MIVNTELEQKGNQFPSLINSFIKKKDKFLITTQNGVLLQITVIRDSVLRFRYAPTGSFPK
DFSYAISDDVVRGYNHLEYSEKPKKYIIKTSKLELHIDKTNLKKTIYDLDGKVINQDELG
FHWEYSYEHGSDIVKMSKTEQKMECYYGLGDKPTHFNLKGKRVQNWVTDQYAFGKDQDPL
YKAIPFYIGLHHDISYGIFFDNTFRTFFDFAGERHHVTSFWAQGGEMNYYFIYGPKMGDV
VRSYTDLTGKPDLPPLWALGYHQSKWSYYPEKNVREIAAKFRDLKIPCDAIYLDIDYMDG
FRCFTWNEKYFPDPKGMVDDLLEDGFNTVAIIDPGIKIDMDYDIYREALEKDYFCKRADG
PLMRGKVWPGECNFPDFTNPEVRTWWSGLYKELIEDIGVKGVWNDMNEPAVMEVPTKTFP
LDVRHNFDGDPCSHSKAHNIYGMQMAKATYEGVKQFAYPKRPFIITRAAYSGTQRYSSSW
TGDNIASWEHLWIANQQVQRMAISGMSFVGTDIGGFAEQPTGELFIRWIQLGIFHPFCRV
HSSGDHGDQEPWAFDEDVTNIFRKFIEIRYKMLPYLYTAFYQYVEEGTPMVQPLVLFDQE
DHQTYYRTDEFMFGSQILVCPIIEPNSKGRRMYLPKGKWYNYWTYEVIDGGKEVWVDADI
DSIPLFVKEGAIIPKYPVQQYVGEKDFDEIELEVYFKEGKENSVLYEDAHDGYDYKKGRY
SYRTFKLTGYKNELIIQQHKEGKYITPYDKFKLDLKRLPFEIGIIEVDNKETNLSELKVN
GNTSLVVDKNFTELHLIGK
>OMIFANIC_00385 hypothetical protein
MKTIRLLFFTFLLFSISLNAQDKKEDKPTTADKEFHNLKWRNIGPFRGGRSVASSGVVTQ
PGVWYMGSTGGGVYKSTDDGINWKNISDGFFKTGTVGAIAVSESDPNIVVVGMGEHAARG
VMTSMGDGVYKSTDAGKTWKHIGLDYTRHISDVIIHPTNPDIIFVAAQGAQYGPSDDRGV
YRSSDGGMSWEKVLFVDNNTGASSLSMDMTNPRILYASMWQHRRYPWTMESGGESSGLHK
SVDGGTTWKPMKAGIPDIIGKSGISVSRANPDRVFAVIEAEGDKGGVYRSDNAGKSWKQV
NKNRVNIARSWYYMEIFADPQNENIVYVCNAPVMKSIDGGKSFSGVSTPHGDNHHLWIHP
NNNQVMINSNDGGANVSNNGGRSWSSQRNQATAQFYRVTTDNLFPYNVYGGQQDNSAIAI
ASRTNHGGIDWKDWYSVAGCESAFLAFDPDNPVVVYGGCYQGIIDRWMKDIDQGKAINEY
PELGLSKAPKDAKYRFNWNAPIISSPHDRNTIYHAGNKVFKTTDGGISWTPISPDLTRNE
KDKHGPGGKPFTNEAAGGENYNTIMAFVESPHEKGVMYAGTDDGLLQLTMDGGINWKNIT
PKNLREGIINSIEISPHDAATAYITVMRYKSMDLKPYVFKTNNYGASWTKITNGIEGEHT
FVRVVREDTKRKGLLYAGTETGLYISWNDGATWESFQLNLPVVPINDLVIQDNDLIAATA
GRSFWILDDLGAIQNKDKKGDAITLFKPRETYLFFGGMSSNPTIGKNPPSGVIFDYYIKE
AIDSVPVTLEVLQNGEVIRKMTSKPDKDFKSWPGGPSKPAVLPAKSGFNRFYWNFRRDDM
PTVSKVFVFGNLGGSHVGPGTYTFRLTQGDASSESTVTIKPNPNIDASAADFNEQQRMLV
EIESIVKDIHESVNDMRSAKSQLTSYSKLLKDNDKAEELVRKGDSLQKRITSWEENLIQA
KQKTFQDVINYNNKLNSELLFLKGFIEGPIPQVTQGSKQRFADLKKDWSTYEQERNTIIN
TEMAAFNAMFKELDIPAIILDKE
>OMIFANIC_00386 hypothetical protein
MYDIETYFLVFIIIQFFHSIEELSTGFHKKCPFFKMKFGSFLAFEILFIMFWTAVYLLEQ
FPFREKLMGYFILLMLANGIWHITWWGISKKYVPGIITAPLFVIAFIGYYSHLI
>OMIFANIC_00387 hypothetical protein
MKNLRYYILPGLVLFFGIISTQIINAQVIDYTEYSGVVTDSNTNDPLISVSIKLTNSNLG
SITNDEGAFIIKVPNDRGITAIEFSLLGYESKSIPLSRLSSGKNRIKLNLKVTELSQVNI
SSFRNAKALVKAVFDKKAQNNLNRASIMTAFYRETIKRRNRNVSLTEAVVNLYKEPYSSS
VKDVVGLHKARKSTDYRRLDTVALKLQGGPFSTLYLDIMKYPEYIFTPVTMDEYEFSFGD
PTTINNKPVYVVNFKQKAVINVPRYYGSFFIDAETLALRSASYSLKLTGMKDSANKMFVK
KKPRDIDVTALSASYKVDYREKDGQWYYGYGSVNLSFKVKKRRKLFNSVYTLASEMAVTD
WEENTTGVRLKGKDRLKPTVIMTDAVSGFKDPDFWGPYNVIEPEKSIESAIDKIQRKLRR
NGST
>OMIFANIC_00388 hypothetical protein
MKQYIKILFGTFILLTGTITAMGQEVGYVNSIAVVNSMSETKVAMAQIDKFKKDMNADYE
AKVSAFQSKLAEAQRKAQNGEYSPVQQKEVETALSSEEQSLRKLEGESLQKIKEKEQALY
SPIYDKVNKVIATVAKENNFKVVLDSSAGIVLYAEEATDLTQRVIDKVKQ
>OMIFANIC_00389 Carboxymethylenebutenolidase
MKKLRKEDIKQEVFDLYDDYAHNKIERREFIQKLSLFAVGGITIPSLLSFVLPDYVNTLL
VKPDDPRLFSDYITYNSAKGGGEIKGLLSYPTDNTGTMPGIIVVHENRGLNPYIEDVGRR
AALEGFISLAPDALTPLGGYPGNDDDGRALQRQRDRDEMLEDFIAAYAYLKQHEKCNGHV
GVVGFCFGGWISNMMAVNLPELGAAVPYYGRQPVDEDVPAINAPLLLQYAGLDKRVNEGW
PSYEAALKKHNKEYVAHIYPEVNHGFHNNTTPRYDEKAAKLSWERTIAFFKEKLK
>OMIFANIC_00390 Glycerophosphodiester phosphodiesterase
MQKTIDLQGHRGCRGLMPENTIPGFLKALEIGVTTLEMDLFISKDHKVVVSHEPYFSHLI
ATDPDGKSISSKNERLYNLYEMNYDEIMQYDVGLKPHPSFPRQEKLHAIKPLFADVVRAA
EQAVDQNAYQKPFYNVEIKRVPWQDEVYHPHVREFVKLVVEAIWNTGIENRIVVQSFDPQ
SLQRVREIDPKIGLVLLVGNDRSPEENLSSLGFTPKVYSPEYSLVNEGLLIFCKENNMEL
IPWTVNNKQQMIRMIELEVDGIITDYPDILHEAIEVMNVTMK
>OMIFANIC_00391 Beta-1,4-mannooligosaccharide phosphorylase
MKILSTVLVLMLLLSCTENISEDRTEDPSWAFPYFKKMDSLNPILKPSADLSFTDPITDT
LVQWEERNVLNPTAVVLNDTVFLLYRAQDVQGTSRIGMAVSTDGLNFVKLAAPVFYPDKD
DMKVYEWNYKKDGSKQENSEDCYFCYFDGVEDPRIVQSESGDYFMTYTSYDGKTARLSIA
SSPDLRSWTKHGLVMKDSVFRDTWSKAGAIIAEQQGSNMVAKRINGKYWMYFGDTNLFMA
TSDDLINWKVALNEESGKRISVLHPRMGYFDSRLVEPGPYALLKDEGVVLIYNASNASNF
NDPALPKFTYAAGQALFDASEPYKMIDREESYFIHPDKDYEKVGEVNEVCFVEGLVYYKE
KWFLYYGTADSKIAVAVYDPGINE
>OMIFANIC_00392 hypothetical protein
MEMKYYVYGMLMGIGMGVAIGVALDNVAIGIAIGAGVGVAFGAAFAGANQKKKDDENEPE
S
>OMIFANIC_00393 L-fucose-proton symporter
MANTTSSKRYYHIVVLVMVIFFAISFITNILNSIIVDVKESFDLSLSLAGLLPFSFFIAY
GVMSIPAGFLSEKYSDKTLLSVSFAVIIMACIAFAVFPGYLLFSFTLFFLGCSMAVLQVI
INPMLRAAGGEEHFAFNSVLAQLVFGLASFASPYLYIYLVNENDSQGGLAGSLRNLVPNE
LPWVSLYIVFSLLAFVLFIIVRFTSYPEYTKKETERSGDRRSYFQLLKNKWTLLYFFGIF
CYVGTEQGIGNWISEFLNQYHGLDAQTTGANTVSYFWAMLTIGCVLGLLLLKFIDSRKIL
IGASIITIACLFVAIFGSSGVALIAFPMLGFFISVMWSIIFSLGLNSVRDHHGSLSGILC
TGIAGGAVMPLIVGFLGDNFSLKTGIIFLVLPLVFIMSIGFWAKPLVNNSTIQIKKKTAS
>OMIFANIC_00394 Glucokinase
MNGEYLGVDLGGTSFNIGRVKSGMVIDEVGSDIISQGKATEVLATLTSAIDQVITPEVKG
IGVGVPGIVDTKNGIIYDIQNIPAWKEIQLQHILEDKYEIPVVLNNDANCFALAEKKFGK
GQIYENFVGLSIGTGLGMGIIINDQLYDGVMCGAGEIGMLPYKDGIVEQYAASFFFAREY
DRTAKEMHEAARDKELIAIEAFDEFGIHLGEAIKIILFMYAPQAIILGGSISKAYQYFEK
TMKHTIADFAYPKQLNNLNIVVSTHPNLPVLGASALCLDNTH
>OMIFANIC_00395 hypothetical protein
MKALHSFIVLCCLLYSFPALAQSSASLTELLERKNKTTHECVTAVFSPEEMAILRAHYGR
DSETPVVDMRVGGSDIFGIENVSQTYGKFDKGNPAAFTPIADSPIVDPNFEGAGAVNGNG
SKAYVVDNNNNLYELVLLTGVYTLLGAISGVPAGESITGLEFNPLDGILYALSTNAVVTT
LLIINLVAIAAVVVGVTGMVLGIALAATLSGQFFALDIDSDSIFSLSLITGLAVLVGTIG
FDANFGQGMALSYIAGVILLAAFNNTVFDSELRIVNIATGLTTLIGIILVAATSQFSWIG
NPDPTLSVSENLNRLFNIYPNPAGDSIFLEAGERIESVSIFDMYGRRVMYQPVDATNSQL
DISYLSSGQYLCSAVVNGQAGMYKIIKQ
>OMIFANIC_00396 hypothetical protein
MNSSDFYFELSANGEQTSFETVDGVSTEPVLKHALLPGEHPFKYRLPSLPKAKSIVLKNG
KSVSGSKLMQWCAPASEEGDLPKKGSVLLYLKDSSGKPLVEWTLHNAFPLNHHAKKEAGK
LPATVIEDLELGYSFYTFAKK
>OMIFANIC_00397 hypothetical protein
MNIRILSMAIICLCFQFSVLGQENPTEEVNTQIWQAFKTAYEARNSEAFKAIHTKDVLRI
NDGGIKTADLYFKSIDNWQTPNNDTGLSIDFAFENRQYFRNTGYETGYYRVIAFRNEKKR
DTFYGQFHVVLKKVAGQWKIAQDFDTETVGGRKIDKTFFEGASLLELN
>OMIFANIC_00398 hypothetical protein
MKQNNLLKALLFLFVITSFAATAQLNTPRGSQKASVSQTVGITKIYVEYSRPSVNGREIW
GNLVPYGMNNLGFGTATESPWRAGANENTIIKFTDDVTIGGKDVKAGKYGFHVIVNENDT
ATVILSHNHGAWGSYFYEPSEDALRVDVTTETIPHTEQLTYNFVDVTPNSATLALDWEKK
RIPMKMEVDVTSIVMADIRQKLQNQEGFNIQTWEQAAAYAMNNGGNLDEALGWIDGAIQG
QFFSQKNFNNLSVKAQILNMQGNSVESEAIMNEALDIATVFETHGYGRTLIGQGNKEKAL
EVFKMNASKFKDTWPTDYGLARGYSANGNYSKALEHLKIALKRVPDAQNKNIILTNIAKL
EKGEDIN
>OMIFANIC_00399 hypothetical protein
MKLIFTLLLSVISIGGIAQSTFMHPSPDRPIQNRNVVTPITATISYQGYDEAQAYFGEGE
YEIFLDNVDGILDKPIIVLDGFDPGDGRDITGLYNSLSFGGNNLADIVRDEGFDIVVLNA
PQYTTGGKDIDGGADYIQRNAMVLVELINLMNDQKVGDEELVVLGPSMGGLIARYALSYM
EQNSLDPETRLYISFDSPHRGANIPISLQYLINYLAQELGDPDALAIVENVLNSAAAKEM
LYDHLLAHLQAGSTYLQDPTKLLPEGAPDFRDAFQGELDALGFPQTVRNVAMVNGSSQGT
TTGDPGMLVVDTTLDFGSGATADVALRFTPEAGLTNTSTSFDSFLFGIPIGSFDASARSF
AFTDGVDASPGGTSNISAALEGGGTNPVIQDFIDALNQDEYSFIPVLSALAIDNENDWYV
APDIGGIHNSAFVNTYIPSENESHVEITAASAQFALDEIRGIILAAPEFDLSKRYQLAMN
PVEETIELQLDLGMDYSSADLKVFNVTGQELLSLNVTSPSNRITISHNLGSGLYFLNIQD
ETGRYSLKLLVR
>OMIFANIC_00400 hypothetical protein
MKQFFLKTFVIISVVLLVSCAQGGPTDVTEDIRTANIEFVDAFNANDAARLTAVYTSDAT
IYPPNSEAISGSEGIEAFWKAGFEAGISSGVLDTQKATAYGDTAVENGTFKIMAADGSMI
DQGKYMVIWKMVDGAWKYHQDIWNSSMPLPEPPADTVAEMADTDEETSE
>OMIFANIC_00401 hypothetical protein
MKSIFYTVLVFCFVFLTSFTPNNDDFQGQAFYYSKSKMELGNWGARMSEAQKKQVYQRLK
NRLEKTYILTFNKEESIFDEADKLDAISGATDSWGNNFSRGKQYKNVKEDLLVQSQEFYG
KKFLVKDKLQAIEWKMGSESKQVGQYTCFKATASIPTDELTWYDFSWGDLRRDSANDTAD
ATTGEDVEPEIDMTEVEAWYTMQIPVRHGPGEYWGLPGLILEVSAGNTVMLCSKVVMNPK
ETIKIEAPDKGKETTKKEYQTTVRFKMQEMRDNRGRRRN
>OMIFANIC_00402 hypothetical protein
MIIVSSVCAALFFLLGSYLLLSKRGNRKANMFLGLFFLLWGIDFIDGILLLNGSFISNPN
WAFWTDPFVFLYGPLLLWYTKSIQFSEFRLSIKSLLHLLPFILFMLILLFSYHLQPTAVK
SEILSEVISFEPTSGSMVFLVAVYIQFFAYIVASRLSIKAAYQELKGYYSNITLEWLYLI
LNSFSLIVILSIVASLLQVFVNKIHFQFALPVLASVIVIFMARIIFKVLDQPSLLTAGKM
TSGRELHLDKNELTGIASAIRRALDDSKVYLDPDMNLEKLAIHVNSSPKKVSSVINNHFN
KNFFDLMNSYRIEEAKRIFEENKDPRLTVLEVMYEVGYNSKSSFNTQFKAKTGLTPSEYK
RQHN
>OMIFANIC_00403 hypothetical protein
MEANITEYSDQLTLKKQLLYHFYPGILIALGYIILSDVFVANGYPGMAALLAVELLILAP
IAILHLGFVGKSRSGSFSIRSAIRYTEKLSFRQYAFWTILGVVGCLLIYVPLYPVGLYLK
ETVFNWLPEWYFNPAYGASGPEVVANIFLVAIVIDGIVGPVAEELFFRGYLLPRMAYLKG
WAPVLNGLLFGLYHFWQPHNYFAIIAVGIILSYIVWRKKNVYLGILIHCIINILGAIGGY
LAASSGELILR
>OMIFANIC_00404 hypothetical protein
MSISSVERNVSKGRRAGSQKLPQVTKGMNQDMKFQKLIYWSLSIEIY
>OMIFANIC_00405 hypothetical protein
MDKEHPNIAILKKFDPRNIATAAHILAKDAEFHFFNPLLPEIKGTYVGLEGFRDFFQKMG
EISHRSFNVNPVSITPVGDELVVVHSKNTMILEDREMEVDAVIVWRIVNGKITEVWDIPS
VHTARVMELEAVT
>OMIFANIC_00406 hypothetical protein
MDSAFFYAVNPEVAQTLTHRADAGNISGNWTEIDHPLLNNNPNGIVVLTHNWGVSGAPSN
VLMDKAVGVWYTGSNWAVFTEDLSAMPVDIEFDLMIFDPTLGTEDTTIEGLSYGPNPFTD
IVNIQAKEPITSVTLYNVLGTEVSQFTGEGNAMGINLSNYASGVYIARIVVGNTTQTVKL
IKQ
>OMIFANIC_00407 2-oxoisovalerate dehydrogenase subunit beta
MIKEETKLLKTKTLNKETLIKGFQNLCTAKALTFLYEENFKTVSKYVHATSRGHEVIQTA
VGMQLKPQDYAFPYYRDDAMLLAIGMRPYDLMLQVLAKRDDPFSGGRTYYSHPSLKDEDK
PKIPHQSSATGMQAIPATGAAMGFWYKEAEGLDVNDEKPIVICSLGDASVTEGEIAEAFQ
MAALKQLPILYLVQDNGWDISATAAETRAQNAFEYAAGFHGLEAVSIDGTDFEQSYKTIS
EVINTIREERRPFLVHAKVPLLNHHTSGVRMEWYRDDLEESQARDPYPKMKALLKKSGLN
DNEIQALENEQINIVRSDFKKALKAEDPRPEDLFTHDFAPTAILEESGDRSPSGADKVVM
VDCALFAIEELMRTHNECLLYGQDVGGRLGGVFREAATLAQKFGDNRVFNTPIQEAFIVG
STVGMSAVGLKPIVEVQFADYIWPGLNQLFTEVSRSCYLSNGKWPVSMILRVPIGAYGSG
GPYHSSSVESVVSNIRGLKIAYPSNGADLKGLIKAAYHDPNPVVIFEHKGLYWSKVPGTK
GATSVEPAEDYVLPFGKAWVLQEIWKQEEEETLAIITYGMGVHWAINASEELGLEDKIEI
VDLRTLHPLDYNTVFNSVKKCGKCLVVTEEPTENSFSRALQGRIQEECFQELDGPVMIIG
SENMPAIPLNSTLEQAMIPSVKKVKKKITEILKY
>OMIFANIC_00408 Branched-chain-amino-acid aminotransferase 2
MMEITEQIKINKTTNSRLAALDFNSIPLGRTFTDHMFICDYENGQWQNPRVEPLKDIPTH
PAAMALHYGQAIFEGMKATLDQEGNPMLFRPDQNAARLNFSARRMGMPEFSVELFVEGLK
TFVDMEREWIPPQEGSALYIRPFMYADEPFIGMRAATSYKFMIIASPSGPLFSKPINLWA
EKQFIRAVEGGTGEAKAAGNYAAAIRPTEIAKEKGYDQVLWLDAVEHRYIQEVGTMNIFF
KIDGKIITPSLDGAVLSGITRMSVIDLLRSKEYLVTERPITLDEIIEAEKDGSLEEAFGT
GTAVGIAYIDTIGYDDKVIRISEEHPLGLEVNDTLNRIKTAKEQDSFGWMVKVI
>OMIFANIC_00409 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSQFEFKMPRMGESITQAAIIKWFKGVGDTIELDEILLEVATDKVDSEVPATVSGEIVEL
LYKPNDVVDIGEVIAIIRTNGEVPEPSSRAKKAKPTEKGKAISERKRKPKPKTQTAFKVN
ENVYISPLIDSIARTHHVSYEELARIPGTGKEGRLRKSDIMNYLAEGRPFQFAQPVADSS
GFKVPDLQFDKGKGKIVEMDRMRQMIADHMVFSKHTSPHVTAYVEADLTEMVNWRNKVKS
GFLKKYNEKLTFTPLFIECIAKAIKAFPMINSSLDGKKIIVKDHINIGMATALPSGNLIV
PVVRNADKLDLVSLAAATNELVVKARDGKLAADDTSGSTFTISNVGTFGSLMGTPIINQP
EAAILATGIIKKKAEVMEREDGDQIEIRQMMYLSLSFDHRIVDGYLAGSFLRRVADEMEQ
FNQKRKI
>OMIFANIC_00410 Carnitine operon protein CaiE
MIYSFKGHIPVVHESSFVHPLAAVTGNVIIGKDCYIGPGAAIRGDWGEIILEDGVNVQEN
CTVHMFPGKSILLKAGAHVGHGAVVHGANLGANCLIGMNSVIMDGAEIGDECIVGAMSFV
KAESKFEARKLIVGNPAKAIKDVSEEMIAWKTAGTRLYQQLPSDCHETLKAVEPLRSIPE
NRPKQEDFYKTLEEFRRN
>OMIFANIC_00411 putative polyketide biosynthesis enoyl-CoA hydratase PksH
MTEPYVKEDIQNGISTIEFFHPAHNSLPGDLLAKLAATIKGAGENDEVMVIVLKSGGDRT
FCAGASFKELININDADSGRVFFSGFANVINAMRKCPKFIIGRIQGKTVGGGVGVASATD
YCMATKYASIKLSELNVGIGPFVVGPAVERKLGLSGMSQIAIDANSFYDAAWARQKGLFA
QVYDSTEELDEAVAAFAGQLCGYNPEAMKEMKKVFWKGTEDWDELLAERAAISGRLVLSE
FTKETLKRFK
>OMIFANIC_00412 Bifunctional protein PaaZ
MNKTQHYVTGSWIDGSGEGAPVFDSVTGEQFTSVTVEGLDVPSILEYGRDKGEALRKMTF
QQRGLMLKKLAMYLNKKKEQFYELSYRTGATKVDSWIDIEGGFGNLFANASLRKLFPNQS
YHVEGEPIDLSRGGRFMAHHIMVPKRGVVVHINAFNFPVWGMLEKCAVNWMAGMPAIVLP
APQTAYLAEAVVREIVGSGILPEGSIQLISGTAKNILDTVQSQDVVTFTGSASTGKILRK
HPQLIEESVPFTMEADSLNASVLGEDAVPGTPEFDLFIKEVRKEMTVKAGQKCTAIRRII
VPEKMVEDVQIELGKQLDKVTIGDPRLQEVRMGALVSDAQRKSVREQVEKIAKTAEIVYG
DLDVVETIGADSKKGAFLKPILLRENNPFKNEAAHITEAFGPVSTLMPYKDLNEAITLAQ
MGKGSLVSSIATYNDNIAKEYVIGAASHHGRILVLNRENARVSTGHGSPLPTLVHGGPGR
AGGGEEMGGMRGVKHYLQRCAVQGTPTTLTEVTGIYQPKGAYKEAEQHPFKYHWEDIEPG
MSLKTHKRTITDGDIVNFANLTWDHFYAHTDITSLDGSIFEKRTAHGYFLLAAAAGLFVY
PNKGPVAANYGLEDCRFLRPIYHNDTIYVRLTCKQKIDREQRGTELPSGIVKWYGEVFDT
DDELVAVVTVLTMVQKKQNTFVEMTSEKIDECLAKLTEDSKPTWGNLTPQHMLEHLEYTY
RIAAGEIQDFEISTPERVLEKVHATLYNYKKMPQGYDFPLREEAEMDKLKHPDLATAKVK
FLEARQDYLDYFEENPDARTKNVVFGELNRFEWYLLERKHLNHHFEQFRLI
>OMIFANIC_00413 Beta-ketoadipyl-CoA thiolase
MKEAFIIDGIRTPIGNYKGTLSKVRTDDLGAMVIKEVAERNPDIPQAAYDDVIMGCANQA
GEDNRNVARMALLLAGLPFTVPGETVNRLCSSGLSAIIHANRAIKAGDGDLFIAGGVENM
TRGPYVIAKPSTAFGNDSKMYDSSFGWRFVNAKMHELYGTDGMGNTAENLVEKYNITRED
QDAFAYWSQMKASAAQKNGRLGMEIVDVEIPQRKKDPIIFSNDEFVKPGTTKEVLAKLRP
AFKKDGSVTAGNSSGLNDGAAATIIASEDAVKKYNLHPLARIVSSAVIGVEPRIMGIGPV
EASNKALAKAGLAMEDMDVIELNEAFASQALACIREWGLADDDPRINPNGGSIAIGHPLG
VTGARIALSAALELRQQNKRYALITMCVGVGQGYAAIIENVNL
>OMIFANIC_00414 Acyl-coenzyme A thioesterase PaaI
MLEGTLIPHKMLSQDAFSQWLGIEILESEIGRCQVAMTVRDEMLNSMGNAHGGISYSLAD
TAFGFAANSHGLMAVSIETSVNHIDEIKAGDYLVAEAIIDITKTKVGFNVIEVRRGEEIV
ALFKGMVYRSSIEWK
>OMIFANIC_00415 3-hydroxyadipyl-CoA dehydrogenase
MIKNVGVIGSGTMGSGIAQVAATAGCKVNLYDTNPEALDKAKTNLEKILDRLVEKGRIDS
REKSRIRENISYVDSLESLSDSNLVIEAIIENLQIKQQLFRDLEALLSKKAIIASNTSSL
SIASIASALKSPKRGIGIHFFNPAPLMKLVEVVPAVQTSEKIKQTTIETIESWGKIVAVV
KDTPGFIVNRVARPFYGEALRIYEEGIADVATIDWAMKSIGGFRMGPFELIDFIGNDINY
TVTETVFEAFYYDPRYKPSFTQRRLSEAGYLGRKTGKGYYNYEEGASNPAPDENVGQAQK
IFDRVLVMLINEAADALFWNIASAEDIENAMTKGVNYPKGLLAWADEKGIDWCVSKLDEL
YDEYREDRYRCSPLLRRMNKEQRTFY
>OMIFANIC_00416 1,2-epoxyphenylacetyl-CoA isomerase
MSASVIKSIENGVAWLKLNRPDVFNSFNREMALLFQSELDACASDNSIRAIVVTGNGKAF
CAGQDLKEVTTPELNPGFRKILEEHYNPIIRKIRSIDKPVIAAVNGVAAGAGANIALACD
IVIASEGSSFIQAFSKIGLVPDSAGTFFLPRLIGFQKASAFMMLGEKVSARDAEKLGMVY
KVESIETFMDAVEKTATTLAQMPTKALGLTKQLLNASMNNTLEEQLDMESKYQIESAQSE
DYAEGVAAFVEKRKPVFKGK
>OMIFANIC_00417 Putative 1,2-phenylacetyl-CoA epoxidase, subunit D
MNIDLQPNIDKELIPILDEVADPEIPVLTVLDLGVIREAIMKDGKVLIKLTPTYSGCPAM
DVIGDDLKAAFKKNKMEAEVELVLSPAWTTDWMSENGKRKMEEYGIAAPLDETADKEALL
GNKRIVKCTNCGSTNTKLVSQFGSTACKALFQCEDCQEPFDYFKCLK
>OMIFANIC_00418 1,2-phenylacetyl-CoA epoxidase, subunit C
MKNQDLYNYILGIADNSLILGQRLGELCGHGPNLETDIALTNIALDLFGQTRSYYQYAAR
IAGDGKTEDDVAMLRVERDYKNVLLVEQPNTHFGHVIARQYLFDVFHLLLMTELQNSKDE
TLAAVARKGIKEVSYHQRFSGDWLKRLGDGTEESRTKMQEAIDHFWPYTAELFDTTESDQ
KMIKSGIGVDVSLLKESYYKEVTETLEEATLDVPENPYFKKGGKQGIHTEHMGFLLTELQ
YMQRTYPNMSW
>OMIFANIC_00419 1,2-phenylacetyl-CoA epoxidase, subunit B
MKKEWPLWEVFVRSKNGLEHRHFGSLHAADAEMALENARDVYTRRNEGVSIWVVESKYIT
ASNPEDHGELFEPAQDKVYRHPTFYNLPDEVKHM
>OMIFANIC_00420 1,2-phenylacetyl-CoA epoxidase, subunit A
MSEKEVKNMEEIFEARIARDEKIEPKDWMPEKYRKTHIRQISQHAHSEVVGMLPEGNWIT
RAPSLRRKAALLAKVQDEAGHGLYLYSATETLGISREELYDQLHSGKAKYSSIFNYPSIT
WADIGAIGWLVDGAAIINQVALCGTSFGPYARAMVRICKEESFHQRQGYEIMLTLCNGTP
EQKEMAQDALNRWWWPSLMMFGPRDEDSPHTAQSMKWKLKRKTNDELRQQFVDQTVPQAD
ILGITIPDPDMTYNPETGHYEFGEIDWDEFWQVVKGHGPCNKERMEARVGAWERGSWVRE
AAMSYAEKQEKKKIAKAS
>OMIFANIC_00421 1,2-phenylacetyl-CoA epoxidase, subunit E
MARFHKLKVKDIYKETDDCSVVTFDIPEEIKDDFKFRQGQHLTLKAEINNENIRRNYSLC
SSPFDDEWRVAVKQIPEGKFSSYVNNELSIGDFVESLAPSGRFGVDVNSAVAKNYLFFAA
GSGITPILSMIKTHLSQEPGSTCKLFYVNKTAKSIIFKEELEQLRNAFFGRLEIYYFLTR
EKRDIELFNGRFDDDRMKVLCSTFIDIPDTSEVFLCGPEDMVNYVSDYLVNAGLPQELIH
FELFVKGLSEEDKARMERLSKQNVEGVELTIIDGGKEFHFTMTKDYDNILDAALGAGADL
PFACKGGVCSTCKCKVLEGEVEMKVNYALEADELAQDFVLSCQSVPVSDKIKVDFDV
>OMIFANIC_00422 HTH-type transcriptional repressor KstR2
MKTATRKDEIIAAASSLFKEKGYSAVSMRDIAQEMGIKAASLYNHISGKQEILSTLVLFL
AKEFTRGMHSVMISERSPLDKIRDIIELHIDITVNHSEALAALNNDWMHLEDQDLSDFVK
MREDYEENFRTIVKEGIKAGDLKPRHPEVILFSILSTLRTLYLWYQKRGKLDVNILKKDM
VAVLLKGIV
>OMIFANIC_00423 Phenylalanine-4-hydroxylase
MGSSYESNELIDRLPPHLKQFIKPQNYEDYTPVNQAVWRYVMRKNVDYLSEVAHESYVEG
LRKTGISIDRIPSMYGMNRILKEIGWAAVAVDGFIPPNAFMEFQAYKILVIASDIRQLEN
IEYTPAPDIIHEAAGHAPIIASPDYAEYLRRFGEVGAKAITSAHDNEIYEAVRELSILKE
AHPSSVQDLENKITLAEKKVNELQQKKVAPSEMALIRNLHWWTVEYGLVGSVEDPKIYGA
GLLSSIGESTWCMKPEVKKIPYSVDAAYQEFDITKPQPQLYVTPDFAYLQEVLEEFANTM
AVRKGGWRGLKKLIGSKQIGTIELSTGLQVSGIFTRMIQNEDNEVVYFETKGETALAYRE
KEVIGHGISRHTNGFRSPLGKLKGINLSIENMGPRDLQAYNFYDGKPISFEFESGITVDG
LNVTGMRNLSGKLMLIQFTDCTVKYKDEVLYSPEMGDFDMAVGKEIVSAFAGAADYHSFN
VLSHKLSETETVRTQLSSAEEELNDLYRKVRDFRESNEAQDISVLKNIFDTVQEQFPQDW
LLSLEILEEVVNSSGTYSEDIEKHLDQLKNKRPEVALLIDNGLSLLKK
>OMIFANIC_00424 Thiosulfate sulfurtransferase GlpE
MGLFSFLFGNKTKKIQEFVSRNAVIIDVRTKAEFSSGAIPGSKNIPLQQISVRIKDIKKW
DKPVITCCATGMRSGSAAGILRSHGIEAMNGGGWANLEQKL
>OMIFANIC_00425 TonB-dependent receptor SusC
MKKLLLLAVILLTTIVSAQSIKVRGVIKDTLNNPLEFANVIATVQESGDVEGYGITNQDG
LFQLSLPKGATYNLRASFLGYTTVSKTLEVPEDAENMRIDFVLRAITTELDGVEIVYEMP
VTVKGDTIVYNADSFTSGDERKLGDVMKKLPGVEVNDEGEIEVEGKAVTKVMVEGKDFFD
GDSKLATKNIPADAVDKVEVLRNYNEVDQMRGLGNDQDNVAINIKLKEGKKKFWFGEVTA
GAGIDSDEDPRYLVHPKLFYYSPEYSINIITDFNDIGEVPFTWRDYFNFTGGFRNFNRGG
GTQFNISQSDLGFAVAQNNRANAIETKFLAGNFSWRANKSLDLSGFTILSDNSTNIVNNS
IRRYISTGFTETTESVNDQQSQLAMLKLSSVYKPSTDFQLDYDVLAKVSNQTEDDRTLSV
FGPDGRNDIQEELDNNPYSINQNVNAYYTLDDKNIFAGQVQHLWQDEDPFYKAITDSLPF
RNLLPVMPDNRFDINQQRNVKSNKIDGKIDYYYVLNNISNLNFTLGNTYSRQQFDSNIFQ
ILNSGSTVDLDETNEVDGETTPLVNDVSYAFNDVFLGLHYKVKTGEFIFTPGLTLHNYNL
KNEQLGTSVTQNDWMVLPDFNAIWNIKKSESLRFNYAISAEYTDINNYAEALIFNNYNSL
FGGNRNLENALSHQYSLTYFSFNLFNYTNISGSLNYNRRLEGFKNNSQIVGINRVGTIIN
IDSDFPDETFSAFFRFSKTVKKIQFNLNGNISLNKSNNLINDVITQSESFTQGYRASVRS
NFREWPNFEVGYRLTVNQYDNGGLEQTFYTQRPYANMDINFLKHFSLNATWDYFNYSDEA
GTVDNTYSFLNSTLYYQKGDSSWEFSVQATNILDTEFTNNDSFNEQFNTTSQYFVLPRIL
MFVVKYDL
>OMIFANIC_00426 hypothetical protein
MKALSLLTIILLSFTGISQNISGVAYYESKTTVDMDNFGNREMSEDMKRQIMDRMKNYLE
KTYILTFNGNESIYKEQEKLEAGAGRGGFAMMMGSFSAGKQYKNIKNNQILEEREFFGKE
FLINDTLTNLDWEITKESKQIGQYLAIKATAIKPIDENDFSMARRRNRDRDRDTDKKEDE
ETEGEKAVDSTNNEPRDPFDEIEIPKTVQVTAWFTPQIPVGNGPGEYAGLPGLILELNAY
RTTLLCSKIVLNPEDADVIEAPNKGKEVTREEYNKIVKEKMDEMRENFRGRGGRRGGRRF
GG
>OMIFANIC_00427 hypothetical protein
MKIQITLTLVLSLFITTLFGQEFKGVATYKTDRKVDLRMDSTSMMDSEMHGQLQAQLRKQ
FQREYTLNFNANESIYTEVEKLDAPSPAISGGINIVVAGNTDILYRNTAENKIVRETEIM
SKPFLIKDVPEKRKWELTKETKSIGEYTCLKATSTEEIEEQIFSSELDSVTTATRLVTTT
AWYTLDIPVQHGPDEYWGLPGLILEISDGDQTILCSKIVLNPEKADEIIAPKNGKVVTRD
EFREIQDKKMKEMQEQFESSGRRGEDGNRMMIRIGG
>OMIFANIC_00428 Sensor protein SrrB
MNNLKYKGILYFIAAVILTTLCIQVYWNYKNYQIGKQQLINDVQTSLDNAVDNYYTSLAK
SRSFNILADSAHFSRKHWLDTEFHISDSIVDKGRFELNVSKVPERISVLKTSRDLDSGKV
NITIIDTLGPQLNRIAFMDSLSNPVEMLSSKIMLSFQEDTLSLKKMDSLLLDELERKNIN
IDYGLTHQGTFNKKQTLRPEIIEQSRLSTASTSQFSFYDNKLTIHFSNITLSILKKNLVG
IILSFILVAGVILCLLYLLKVIRHQKQLSELKNDLISNITHEFKTPIATIGVAMEAIRDF
NTEQDPDKNLRYARISQEQVDKLNGMVEKLLETATLDSENLELNYETIDLVSLLENTTLK
EIFISSGKNITFHTSEDSILHPIDVFHFENALNNIIDNAVKYGGEEISVTIKKINGGTEI
KISDSGNELTDQHKKHLFEKFYRVPKGNTHDVKGFGIGLYYTKKIVEKHGGTIDLHLNKL
TTFKIVLPDDPKN
>OMIFANIC_00429 Response regulator SaeR
MTQKTKILLAEDEPSLGQIVKESLETRGFEVVFCKDGKEAESKYHEYEPHLLVLDVMMPK
MDGFTLAKEIRRHDKNTPIIFLTAKSQTHDVVEGFTIGGNDYLKKPFSIEELIVRIDNLL
NSERVANAEEESAIGQYLFDPKKQTLQFNKEEPVSLTYRESQLLFYLNKNRNEVLDRSFI
LKKLWQDDDFFSARSMDVFISRLRKKLKKDETVQIVNVRGYGYKLIC
>OMIFANIC_00430 hypothetical protein
MKSLAFLFVFFVFNLSAQELKKADSRPLDAETFVGVDSYNNTYFIKDMVLHKTGPLGEFV
FRDYQLGPVSSVDIINPLNVVVFYQEVNTVVLVDNRLNEIERINFNNLEEFVNVGAASNA
GNNRLWIFNIDTQQLELYNYRGGGKILISQPISDDVLSMASDFNYCYLLTSKAIQKYNIY
GSFLSELAVDDFQKIVQQNERLIALKNNELYYQALIDEDAVLLLSPIKLPLSENNIKDLQ
LTQEFLYIYDGLNIHSFTLTQPKQ
>OMIFANIC_00431 Deoxyadenosine/deoxycytidine kinase
MHVAIAGNIGSGKTTLTRLLAKHYRWKAHYEDVEDNPYLDDFYNQMERWSFNLQVYFLNS
RFRQILDIRQSGKNIIQDRTIYEDAYIFAPNLHAMGLMTNRDFENYRSLFDLMESVTKGP
DLLIYLRSSIPNLVQQIHARGREYENSISIDYLSRLNERYEAWIQEYDKGNLIVFDVDNI
NFVDNPEHLGEVVEKIDAEIHGLFQEK
>OMIFANIC_00432 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MMEQNIIYVPIALSLLGLIFMLIKMRWVKKQASGSERMQFISKSIKEGALAFLHAEYRLL
LIFAIIAAGLLFFISTQVESTSWLIVPAFIFGAIFSASAGNIGMRVATEANARTAEAAKT
SLPQALKVSFGGGTVMGLGVAGLAVLGLSLFFFFFVGQFMGNPDGSFYDNMTVVLEALAG
FSLGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVA
GMGADLFGSYVATVLASMVLGNYVIRDMSIGSQFTDAFNNMGPILLPLVIAGVGVLASII
GTFLVKIKNNDAREPQVQRALDMGNWTAIILTLIASWFLINWMLPETMTMNFFGEGAKDI
PSRHVFYACMIGLAVGALISFVTAHYTSLGKKPVMDIVKNSSTGAATNIIAGLAVGMKST
FFSVLLFAAAIYGSYELAGFYGVALAASAMMATTAMQLAIDAFGPIADNAGGVAEMSELE
PHVRERTDILDSVGNTTAAIGKGFAIASAALTALALFAAYVTFTGINGINIFRADVLAML
FVGGMIPVVFSALAMKSVGKAAMEMVKEVRRQFKEIPGIMEGTGTPEYAKCVDISTKAAL
REMILPGLLTIVTPVLVGLIFGPEPLGGYMAGVCVSGVMWAIFQNNAGGAWDNAKKSFEA
GVMIDGEMTYKGSEAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLVGLVIAPILGAGHG
HEDQAMNNSEEMIFIDEDGNKTVLTDKEANKMIGEKSEVSKEVKVEMSSEGDLTTGTVTI
ETARDGETTTETKTFTGTDEEVKAQIEAFKDANVNIEKGEKVIQEVIEEVEEVEENN
>OMIFANIC_00433 TonB-dependent receptor SusC
MRKFLLLLLLSTPLLILGQTKVSGIVNDEYGDPVAFANVIFKDSNEGTITNEDGRFYLES
NESFDALWVSFVGYELTTVPLSKKITYDLSIVLKEEASALDEVVVYSGKTSKKDNPALVI
LRKIWENRRENGVKKFKQYEYDKYEKLEFDLNTIDSGLIKSKVFKGMEFVWEQIDTSKIT
GNSYLPIFINEAISKVYGDNLLKGEKEILEGNKNSGFENNQTLIAFIKDLYKEYDVYDNY
MKFFDKAFTSPLSKTGIDVYNYVLLDSAYRDNKWCYNIVYYPRRKNELTFKGDFWVNDTT
WAIKEINLQASKSANLNWVREVYIEQEFDVLNDSIFLITRDYFLSDFSLKKKEGARGIYG
KRTTLYDNYEFDKQKDKKFYGEQTDPYAYEIYNRPDDFWEQKRMESLSKDEKGVYKMLDT
LKEIPRFKSLYNIAATLASGYYEVGNIDVGPVFSVFGFNEAEGLRIRLGGRTYFSQNDPW
RLEVFGAYGFRDERFKYGISGKWLLDRKSRLTIFGGNRKDVEQTGASLTNSNDVLGRSLA
SSALITVGANDRLMNLNLSTLGFSVEPAKNLLFRVTGSYRTLRSATDTFSIDYIDENGDI
QSEISQPEIRFTLGYTPKRKTSGYGVERTIINDGDFASFFAGYTYGMKDILGGDFEYSKL
QALYTQPWNIGGIGRLWSTVEVGKIFDPVPLGLLSPVPGNQTLFSIYNTFSNLDFYEFVT
DTYTSLHLRHNFGGRIFSRIPLLRDLDLREIVGFRAIYGSISDENIAINASNIVYQAPED
IYWEWSVGVGNIFRVFRLDFNFRGNYLGNPDARKFGITGEFGFSF
>OMIFANIC_00434 2-oxoisovalerate dehydrogenase subunit beta
MKTLQFREAVQEAMSEEMRRDESIYLMGEEVAEYNGAYKASKGMLDEFGAKRVIDTPISE
LGFTGIGVGSAMNGNRPIIEFMTFNFSLVGIDQIINNAAKMRQMSGGQFNIPIVFRGPTA
SAGQLAATHSQAFESWYANCPGLKVVVPSNPADAKGLLKSSIRDDDPVIFMESEQMYGDK
GEVPEGEYLIPLGVADIKREGTDVTIVSFGKIIKEAYKAAEELSKEGIECEIIDLRTVRP
MDHKAILDSVKKTNRLVILEEAWPFGNVATEITYQVQSQAFDYLDAPIVKLNTGDTPAPY
SPVLLQEWLPNSNDVIKAVKKVLYK
>OMIFANIC_00435 Electron transfer flavoprotein subunit beta
MKIAVCISHVPDTTSKINFTDDNTKFDTNGVQFVINPNDEFGLTRAMWFKEKQGASVHVL
NVGGPETEPTLRKALAIGADEAIRVNTVATDGYSVAKQLANVISEGGYNLVIGGRESIDY
NGSMVPGMIAKLNGANFVNTCIGLEIDGTNATAIREIDGGKETIKTSLPLVIGGQKGLVE
ESDLRIPNMRGIMQARSKPLHVKEPIDTTGETQSVQFQKPAPKGAVKLVDNADELINLLH
NEAKVI
>OMIFANIC_00436 Electron transfer flavoprotein subunit alpha
MVLVYTESEGGKFKKIAHEAVSYAKGIADMLGTTVIAVAVNANDANELGNFGASKVLNVT
NDSLTNFNAEAYADAVSEAAKNEGAKVIVLTSSANSKFMAPLVAISLNAGYVPNVNGLPE
STAPFKVNHSVFTNKAFATTEITTDVKVIGLAKNAYGVNENTTSVNIEAFSPDVSNGNSE
TVSVDKATDKVTIADAEIVVSAGRGMKGPENWGMIEELAEILGAATACSKPVSDMGWRPH
SEHVGQTGKPVASNLYIAIGISGAIQHLAGINASKVKVVINNDPEAPFFKSADYGIVGDA
FEVVPQLTEKLKAFKAQNA
>OMIFANIC_00437 hypothetical protein
MSLIRLNIKGISYSQTQNGAYALILSEVDGDRKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKNFADHFDIIVKQVIIHKLVDGVFYSSIICERDTIEEIIDARTSDAIALALRFKA
PIFTYKNILDKAGIYLKTQKKSEDISEEEEAVIEELLTGDDKESVAPKVSENYSKFSMKE
LNEMLDQAVAEENYEKAAAIRDEISKR
>OMIFANIC_00438 hypothetical protein
MVKVSFINSPFSSNFTWNISARSGQAPKTKLAPTSARERKATTFSENHSKIVATKGTFST
RMAKMSCRARPENTNFQSIFRRLLLNR
>OMIFANIC_00439 hypothetical protein
MSSAGTPMIQAIGANMFPSIYCIESSLYRPSVAAAILSFKPVDDPTRSAEIQFSTAMSEV
NTSSIAPTFTASLMPSVVPFDMASSTLEPIFSRAMFNLVFTLSTSGYSILAIMIAAGADM
IEAVNKCLAKITRSASLSPPRKAIKAANTPPAIVAIPPTIKHNISLFVIFSRYGFTTRGA
SVCPIKILAAAAKLSAPDNRMVLLIIQANAYTIFCRIPR
>OMIFANIC_00441 Proline--tRNA ligase
MAKNLTTREEDYSKWYNELVLKADLAEMSGVRGCMVIKPYGFAIWEKMQAELDRMFKETG
HQNAYFPLFIPKSYFSREASHVDGFAKECAVVTHYRLKTDESGKEIVVDPEAKLEEELIV
RPTSETIIWDTYRKWIQSYRDLPILVNQWANVVRWEMRTRLFLRTTEFLWQEGHTAHATE
DEAIAEAEQMMNIYAEFVENYMAVPVIKGLKTESERFAGALETYCIEALMQDGKALQAGT
SHFLGQNFAKAFDVKFADKDGGLDYVWATSWGVSTRLMGALVMTHSDDNGLVLPPNLAPD
QVVIVPIYRNEEQFAAVSEIANNLMKELKAKGIRVKFDNRDTHKPGWKFNEYELKGVPVR
VGIGPKDVEKGTVEIARRDTLEKEFVANEQVVSKIESLMQEIQENLYKRAFKFRQENTTE
VETYDEFKEVLDGKGGFVLAHWDGTAATEERIKNETKATIRCIPLDDNVEAGSCMVTGDP
SPRKVLFARAY
>OMIFANIC_00442 hypothetical protein
MQTKIYAMKKSLPILVLGVVAFVLTACGTYNNGYGDTDGIYTSDTATTESGEVEETTDKS
NYYKQYFQSRQNDYANLPEEDLVFTDIESYSSNDTIDEDGNIVIMEREYQDGYGGWGDNT
TDVTVNIYGNAGWGGYWGGYWGWNHWYNPWWYGGWGWGYNYWSPYWGIGWGWGPFWNAGW
YGGWYGGFYPYYGGYYGYNNIAYNRGRRNLDYNRGRSVYNSRRDYNSGRSSLNSRRGNYS
RSEFNRRSTNYRRNNVNANRRSSNRVDARRNVNTNRRSTRPNVNTPSRSSRPSVNRNSTR
RSNNSVRRSGGSRSSGSFRSSGGGTRSSGSRGGGGSRRGGRG
>OMIFANIC_00443 hypothetical protein
MKKILFLLIAGCALTFSNAQNITDGLRYGVDRTTGTARYTALSGAFGALGGDLSAIGINP
ASSAVFITNDLSFSLGVLDRENNSVYFGTESRGIDTDVAVNQAGAVFVFLNPNENSDWKK
FTVGLNYNATQNYDDDIFISGNGNTSIAQYFLTLAQGIPLNLLQLQGSESISNLYSFLGE
TEGVAAQNAFLGFQGYIIDPLDPSNPNNTQYVSNIAPGRFGQDYYVASDGYNGKYTMNFG
AQYTENIYMGINLNFHAIDYIESNFLFETNSNPGSSVNRVEFENNLSVLGNGFSLQIGGI
AKVTDELRLGITYDTPTWYEISEETTQFLRTRRMEDGSNITTVVDPNVLNVFADYELRTP
GRYSASAAYVFGKEGLISLDYSYKDYSQTEFSSDFSGEFAALNSAISNSLKGSSHIKVGG
EYRIDELSLRAGMQYEESPYENKTTIGDLTGFSLGLGYDFGDYNFDIAYARAEQDSRRQL
YEVGLTSASDIETTFNNIIFTLGISL
>OMIFANIC_00444 hypothetical protein
MIKKVTIDGETYNIKKFKTPGLFQGLVYRFLRKSKACRSFEHAFRLIELGINTPFPVCYS
EIFSGGLRESYYISRHMDYDFDFRVLNHNPKWPNRNEILRQVARFTFKLHENNINFLDHS
PGNTLIIDKGDGQYDFYLIDLNRMRFESMSFDKRMHNMRRLWLSKNMINIMSETYAELYG
KTYEQTHALMTKYSRAFQKKVNSKKLRKRRRRK
>OMIFANIC_00445 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MTELQKHIEKAWEDRSLLTETATINAIREVVRLCDEGELRCAQPTDDGWQVNEWVKKAVV
LYFPIQKMKTMEAGIFEYHDKIPLKKGYEAKGIRVVPHAVARHGAYISKGVIMMPSYVNI
GAYVDEGTMVDTWATVGSCAQIGRNVHISGGVGIGGVLEPLQAAPVIIEDNCFIGSRCIV
VEGVRVESEAVLGANVVLTASTKIIDVTGDEPVEMKGRVPARSVVIPGSYTKKFPAGNYN
VPCALIIGTRKESTNKKTSLNDALREYDVAV
>OMIFANIC_00446 Putative pre-16S rRNA nuclease
MGRILAIDYGTKRTGIAITDELKMIASGLTTVATEDLMSFLQTYFEDETVELVLVGEPKQ
KDGTHSAVEEEIKNFLTEFTDKYPDMKVIRVDERFSSKRAFQAMIDSGLKKKKRRNKALI
DEISATILLQDYLYNN
>OMIFANIC_00447 Peptide deformylase
MILPIVAYGDAALRQETKEIDKDYPKLDELIENMFETMYAARGIGLAAPQVAKSIRLFIV
DATPFEDDDDLTEKEREYVSTFKKVFINAKIVEEEGDEWAFNEGCLSIPDINEDVFRKPQ
ITMEYMDENFKKHKETYDGIVARIIQHEYDHIEGILFTDKLSPLKKRIIKGRLANISKGK
IDVAYRMKFPMAKKKR
>OMIFANIC_00448 hypothetical protein
MSLEKILSISGKPGLYELKTQTRSGFLAESLLDGKKISVSGRHNVSLLSEIAIYTLTEEV
PLSKVFSKISNKENGGPAINHKSSRDELEEYFFEVLPDYDEDRVYASDIKKVVQWYNLLQ
KNGMAQFLDEDTSEEE
>OMIFANIC_00449 Nucleoside triphosphate pyrophosphohydrolase
MNSREEQLKALNRLLTIMDELREQCPWDKKQTMESLRHLTIEETYELGDAILNNDLHEVK
KELGDLLLHIVFYARIGSETKDFDIADVANDICDKLVSRHPHIYGDISVADEEEVKQNWE
KLKLKEGKKSVLEGVPKSLPALVKANRIQDKVAGVGFDWEEPQQVFEKLKEELEELQHEV
SEGNKRGIESEFGDVLFSMINYARFLKVDPENALERTNKKFMKRFQYLENKSKELGKPLK
EMTLAEMDVYWEEAKQG
>OMIFANIC_00450 hypothetical protein
MNHCLLCHSESTALFFEGNSHLFYKCSNCGTVFRDPDTFISVEDEKARYLTHNNDVEDER
YQQFVSPITASVLKDFTSKATGLDFGAGTGPVITKVLKDNGYHIELYDPFFHPDNTVLER
TYDYIVCCEVIEHFHNPLEEFKLLKRLLNPGGKLYCMSDILVSIQEFDKWYYKDDPTHVI
FYSEENLQWIRKASGFSNVFIDNRLIIFPV
>OMIFANIC_00451 hypothetical protein
MSDKKLQEENLSNNPESEQKVQVTPETTEEQVAVVTGEESEETPEKTSTENLEETTEDKS
EETTEEKTKEPPVVSKTEEEKHEDEEEEIASSDDHHKEEEHEEEENKDYHSLSKKQLIVE
LESLLKSKPVQQIKQDVEEIRSEFNAKFNEELEHQKEEFLAGGGNIIDFHYTTPVKKAFN
SLFFDYKEKRNAYYKNLKKDLHANLEIRQALIDELKGLLNAEENINTTYKHFKDIQERWH
TAGPIPRDKYNLIWNTYRHHVENFYDFLHLNREFRDLDFKHNLEQKIKLITRAEELQQEE
NISKAFRELQMLHKMWKEDVGPVAKEYRDDVWEKFSAATKIIHDRRFHYLKEMESAFEDN
LVAKQKIVSEIAEVRANTKPSHQNWQKAIKKVQELRDQYFEIGKVPRADNKEIWNSFKEA
TRAFNKEKNNFYKNQKKEQYTNLEKKRELIKIAEENKDSEDFEVVTPLMKKIQADWKKIG
HVPRKDSDKIWKEFKDACNYYFDRLHSLKDEANKEENVHFETKTKLLEEVKKLKLSGKKD
DDLSLIKEKINEWKKIGRVPFRKKSIEQQFNKALDSLFSKLDMNKNEAEMIKFENKLNTM
VSQEDERKLKNEHFFISKKIDEAKNEIRQLENNLGFFQHVDESNPLVKEVHQNIARHKEQ
LEVWKAKLKRIKKARNS
>OMIFANIC_00452 Shikimate dehydrogenase (NADP(+))
MIGKDLSHSFSRTFFTHKFDKDKRKHSYHNFELDEIDEFPGLIRNIKGLKGLNVTIPYKE
TIIPYLDKIDKEAEKIGAVNTIKFRKNGKLIGYNTDHYGFAKALSDIFPIKEKTALILGT
GGASKAIKYVLETMDFNYEVVSRQESPDTITYEELDEEVISNHLLIVNCTPLGTAPNIEE
CPKVPYRYITKDHVLFDLIYNPAETEFMKRGFLKGARVSNGRKMLEYQAKKSWRIWKS
>OMIFANIC_00453 hypothetical protein
MYEKRSIWDKIWLVMKGLAMGAANKVPGVSGGVVAFVAGFYEEFIYSLQKINRKAFKLLF
NGRYKSFFKYINGQFLGLLFLGMVISYFSVSKILDYLIVHYELYVWSAFFGMIVGSIYYM
AKDYGEWNRKHLGDLLFGIIAGLSISFLEPATQNGNLFFVFFCGIIGVSGMTLPGLSGSF
ILILLGNYVLLLVDSVNALFDTLADLVNGDTSFLTDPARIQLLKVLIVFSLGSLVGLVSL
SHLLAYVLKRYKKATYAVIIGFITGSLGVVWPWKNKKFEYDESGNILYDANGAAIIKDYE
RFWPSEFTLQTFWAILFIIVGILIVLSLDWYQKHRTPRNG
>OMIFANIC_00454 hypothetical protein
MPSRNFLQYLLISAKGVAMGAADVVPGVSGGTIAFISGIYEELIETIHKLNLGFFKIWKK
GGFKAAWRAYNLSFLFALFSGVIISILSLAKLIAWLLANHPIMVWAFFFGLVIASILFVG
RQITAWKAQTVIAMVIGAAFALYLTLAKPIGSPDSAWFLLIAGFVAIIAMILPGISGAFI
LLLLGAYGPVIDMLSQLSEGITTLNGPMAANALMRIGIFVIGAILGLKVFSRTLNWMFKH
FKNLTLAVLTGFMIGALNKIWPWKKVIQYRTNHKGLEVPFIEESVLPSGYEGDPQLLYAV
LFCVIGFLTIFILERISVNKKTA
>OMIFANIC_00455 Beta-barrel assembly-enhancing protease
MHSSPNEYNNFSLSRFESMLKTNNVLFFDSGEFEEIIQHYLENGKIALAKKAVKLGLEQH
PTSTNLKLFQVEMFIFENELDTAEELLDSLQPLEQSNEEIYIQKANILSRRDQHKEAIRL
LEKALEITNDESDVLSLIGMEYLFIEDFENAKFNFMKCLEQDEADYSALYNIIYCFDYLE
QHEAAIDYLNDFLNKNPYCEVAWHQVGKQYTNLEEFKKALAAFDFAIISDDSFIGAYLEK
GKVLEKLGKINEAIESYTITLGLEEPTSFALLRIGKCYEKLGNSELALRFYNKCVEEDAL
LDKGWIAITDFYFKRKNYQKALYYIDKAINIDSENVLYWKRYAKINNQLNLFEEAEHGFR
RSIELGNYELDTWIARADILLQLGEFEAAINNLHQAAEFYAESAEIEFRLAGVHYLLNED
TKGEYHLKNALKFEPEYAMIIEEIFPSIYDRKSVKELIKNQQNPSL
>OMIFANIC_00456 Acetylornithine aminotransferase
MKEEGNMNEDFLKYQAQTTPHPLAMEISHAKGCYIYDAQGKAHLDFIAGVSACSLGHCHP
RVIEAVKKQVDTYSHVMVYGEFIQEPALELTRILAELLPDPLETTYLVNSGTEAIDGAIK
LARRATGRSEILYAERAYHGNTYGALSVMGFEERKTPFGPLLPDCHPIRFNMEDDIEQIT
DKTAAVILETIQGGAGFIMPKGDYLIKVKQRCESVGALLILDEIQPGFGRTGKLFGFQHY
NVVPDILVMGKGMGGGMPIGAFTSSRAHMSLLKDNPKLGHITTFGGNAVIAAAALATLKE
ITETDLIDSTHRKEELIRSILNHSLINEIRGKGLMLAAMVNSPEIASEIILGCKDQGLIL
FWLLYEPCAIRITPPLTISEEEIRKGCAIITDVMDKVAEKYI
>OMIFANIC_00457 LPS-assembly protein LptD
MKISKYITLFFLLLETVSFAQDDPEKTKVSVESGYLEVKPEFPDAIIYTKDNSGQVYILH
EGVEMWCDQAYVYLKDNFVKAYGKVRIMQGDTVSMRSKYAEYNGNTQFAFASGDVVLTEP
KTTLRTDTLYFDRIKQQAFYRSGGTVRDTASTLTSRIGRYYANSKKYQFLSKVKIVNPKY
TVNSEQLDFYSESGGAYLYGESTIVSETSTVYCERGYYNTRTDKGYFVKNSRVDYNNRIL
YGDSIYFDRNTSFASATNNIRVLDTINRSIIRGHYAEVYREKDSVFITKRAVAVTLRDND
SIYVHADTLRVTGKPENRIIRGFYRARMFKRGVPPDEPTSGKCDSIFVDQKAGITKLLRN
PILWSGENQMTGDTIHILSNSETEKLDTLKVFNNAFLVQKDSAGYNQVKGERLIGLFTNN
ELDTVNIIKNTEVIYFSRNDKQELVGINNTVSSSIQMYLEAQQITGIRFNKQAKGKVYPP
SQLPENARILPGFIWRGDERLFEVKDLFKGKPAPLLPKIKGIPLPEDEGEFFDDIPEEDI
ELPEASKLRAKDLQNRKADPKAETRDNIEEDEGGG
>OMIFANIC_00458 Adenylosuccinate synthetase
MAVDLLLGLQWGDEGKGKIVDVLTKNYDIIARFQGGPNAGHTLEFDGIKHVLHTIPSGIF
HDNAINLVGNGVVIDPVIFRKELDNLLQFNIDFKSKLLISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGIRVGELELDGWQKKYRALANKHEAMIDFYKVEIQY
DLAEMEAEFFEAVEVLKSLTFIDSEEYLHQAQKAGRTILAEGAQGSLLDIDFGTYPYVTS
SNTTAAGACTGLGVAPGKIKEVFGIFKAYATRVGSGPFPTELFDQYGETMGRVGKEFGAT
TGRPRRCGWLDLVALKYAVQVNGVTQLMMMKGDVLSGFDKLKVCTAYQYKGEKIEHLPYN
IEAENVTPVYTEMKGWEEDLTKMRDESEFPSALNDYINFLEKELEVPIKIVSVGPDRTQT
IHR
>OMIFANIC_00459 Ferric uptake regulation protein
MLLGMTAKTDQNNQAIVKNVFTTFLEEKGHRKTPERFAILQEIYDHNDHFDIESLYINMK
NKNYRVSRATLYNTIELLLECGLVRKHQFGQNQAHYEKSYFDKQHDHVILANGEVIEFCD
PRIQNIKKTIEEVFDIEITNHSLYFYGNRKTSDPKSYSGRDNS
>OMIFANIC_00460 GTP pyrophosphokinase
MTEEVLEAEKKELTRQYKELLKISYRTLTAADKRLIRSAFDVAVDAHKDQRRKSGEAYIF
HPLAVAKIVASEIGLDATSIAAALLHDVVEDTEYTLADIEQLFGEAVARIVDGLTKISKM
PYEKDVSMQAENFRKMLLTLHEDIRVIIIKIADRLHNMQTMDSMPEHKQVKIASETLYIY
APLAHRIGLYNIKTELEDLGLKYTEPNVYEDILSKIKESKEQQDAYIQDFSKVIKDSLDA
EKLNYEIKGRPKSIFSIRRKMLAQNVSFDEVYDKFAVRIIYKSDHENEKFIAWKIYSIVT
DHFRPNPTRLRDWISSPKSTGYEALHITVMGPQGRWVEVQIRSERMNEIAEKGYAAHYKY
KNDEKEDIGLEDWLNKLQETLESAEVSAVDFVEDFKLNLYSKEIFVFSPKGDLYSLPKGG
TALDFAFHIHTEVGLHTRGAKVNGKLVPLSHVLKSGDQVEIMTSEKANPTANWLNYATTG
RARSKIKSSLKEEKKEIAAEGKVVLARKLKSLKITLDEKTINQLVVYFKLKTSLDLFYRV
GAGIIDNKKLKDFAASRSNAFVSFFKNKIRKPGQPQDVDRDEITEKFDQLVFGKEEEKLD
YKIANCCNPIPGDDVFGFLTVNEGIKVHKQNCPNALQLQSNYGYRIMLAKWIDSTQSDFR
VELNISGIDTMGLVNEVTKIISNNLHINMKSVHFDSNDGVFNGKIIVVVKNKNILNNLVE
KIKNINGIDKVKRA
>OMIFANIC_00461 Protease HtpX
MSPKMLFYIIISILVINFIIDKVLDYLNARHFNDLLPQEIADVYDEEAYKKSQLYKKVRY
RFGLLTSVISIIATLLFFFLDGFQYVDNIAHSFAESPIVVALIFFGIIAIAASILSLPFS
YYSTFVIEEKFGFNKTSRKTFILDKLKGILMTAIIGGPLLALIVWFYEWAGSEFWLYAWG
MITVFSIVMNMFYARLIVPIFNKQQPLEAGVLRTKIEEYAQEVGFRLDKIFVIDGSKRST
KANAYFSGFGSEKRVTLYDTLVNDLEDEEIVAVLAHEVGHYKKKHILINLFASVLTTGFT
LWILSMFVGNPLLSEALNVSQPSFHVGLVAFGILFTPISEVTGLVMNYLSRKFEYQADNY
AKTTYAGPPLISALKKLSKNSLSNLTPHPAYVFAHYSHPTLLQRFRNLNK
>OMIFANIC_00462 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MRKSISSVQNPLVKKISLLIEKSRERRKTGTFVIEGKREIHLATKGDYSIKTVLICPDIY
SDNISEFTSEDTEIIEISIEVYQKLSYRKTTEGIIAIAEVNELSLDALQFTKEKPLVLVA
EAPEKPGNIGALLRTADAAQLDAVIIANPKTDMFNPNIIRSSVGCLFTNNVATGDTDEII
RFLQKNKIDIYAATLQASVPYQTCDFTRSSAIVVGTEDEGLSESWRVHSTQNIIIPMQGE
IDSMNVSVAAGILIFEAKRQRNFEV
>OMIFANIC_00463 hypothetical protein
MYSGSFLIFGVTNLLSMKTFYLLFVASVLMYACKEQNKDPQPVIHDTISISEETARIMNY
PVLFKEVLKAHGGLERWSEMKNLCFEFSKLNGAETHTVSLPDRRTKIESEKWSIGFNGKD
IWLLQNQEEAYKDNPIFYHNLMFYFYAMPFVLGDKGLSYEEVKGTELDGDVYEGIKISFD
PGIGNSPNDEYIIYYHPETHQMEWLGYTVTYNENTSSDEWRFIKYSEWQEVNGLKLPKTL
TWYNVENGKPIQARNNVNFEKVTITETKLDDSVFEIPEGSKVINR
>OMIFANIC_00464 hypothetical protein
MKKLLCLSLVILIVSNCTKGSKDQTFSKLIADSPSIEGKKEYLQSPFVTAGDRVYMVGHQ
DGSFPELGWHIKGEMGGIWNHPIKLMDGFEIELLTDGKTIRLNSADSFVNYPFANKHVYK
LDSLNVEIERWQFVPDGKQGIVVQLVIKNKGEKRVKVRFIGHSDLRPTWLGERTDMIDSK
DNGVYDQKMGIWKIKDSLNSWHTIFGSDLGFEQETTPVEINNETNGSTNAIEDVIFLFHD
RTHIINYFIAGSYTSEEDAINTYKDISENYIEQLTDKKQRYEDLARRTKLTVPDKEIEQA
FEWVKYNCDWLVRTVPEVGTGIGAGIPDYPWWFGVDSEYALQGYMAIGQKEAVYRTIKLL
DSVSNAVNGNGRIIHEMSTNGAVFNPGNINETPQYATLIWKIYQWNGDKEFLRAYFPTIK
KGLDWLMTEKDADGNLFPDGFGMMEIHGMDSEMIDVAAYTQKAFKDASFIADALGEFNLA
QDYYDMSEKLQQKINEEFWSDEFHSYADFIGTDEQALHLIEDAIVRADTLNKPWAVDELK
KTKEAILKNPSPTPRPFVLHHNWVVNTPMEVGLASPDKAVKALATAEKYVNPFGVFVTGI
DRDESAGSDDGSFKGSKIFSYTGAVMTLPTGVQIVSENNYGRPDMALNYMKRMTRTFSYA
LPGSIYEVSPDYGMITQAWNVYGFAVPIVEQFFGIQPDAANKKVTISPQMPSSWDEASLE
NVMIGNNEVSIYFSVENGLKLVRVEQSKTDWQFELRLSRSKASNIAGREGSMELIDNPEE
SFYIIKSSDKYVVIEYNE
>OMIFANIC_00465 Imidazolonepropionase
MKAIKQILIAIITCVGLQSFAQQMPAPAQSAAITITGATAHIGNGSVIENSIIVFENGVI
TAVGNSGTPTKGRIIDASGKHVYPGFIAPAKSLGLVEVNAVRASNDQDEIGDFIPNIRSL
IAYNAESKVVESMRPNGILVGQVTPQGGRISGTSSIVQFDAWNWEDAAVKVDDGIHMNWP
NSFSRGRWWLGEPRGWKPNKDYSKRLDEIKNYMANSRAYGMSEDQPMNEGFAAMQGLYDG
SKKLYIYVQGEKEIIDAVTLCKDSGIKDPVIVGGNEAHKIIPFLKQHNIPVLVRQTHSRP
SRDDDDYDLPYRLPKLLVDGGLLVGLQNANMSNFQTRNLPFYAGQLVGQGMDKETALQLI
TGNTAKILGIDGTHGTLETGKSATLFISEGDALDMRTNLLTNAFIDGREISLETHQTELW
KRYMEKYSRE
>OMIFANIC_00466 D-hydantoinase
MKKLSLLILVFFVMSIVQGQEYFPKNDGVKENNTNYTAFTNATLYITPTQVVKNGTLLIR
NGKVVASGKSVTIPKNSVIHDLEGKHIYPSFIDPYTGFGVEKPKRKPGQGRSPQYDASRK
GFYWNDHIMPENKAISKFKYDEKKASEFRKAGFGVLNTHIMDGIARGTGVLVALNDEDDA
ATRILDNASAQFFSFDKSVTSRQSYPSSLMGSLALLRQLHWDLDWYANGNTETRDRSLDA
LITNKSLPSIIEAGDKTNNLRADKISDQFNLNYIIVGGGDEYELIDEIKATNARYIIPVN
FPDAYDVSDPYATKYISLEDMRNWNQAPGNPKALIDNGISFALTTFDLKSPSAFKGKLIK
ALNYGFDSTRALEALTTIPAQYLGKSNEIGSLQTGRYANFLITSGDVFNKETTLYENWVQ
GRKHVINDMSQKDIRGKYTLNAGGKTYDLAISGEMSKPKAEVKIGETEFPAKLEYKDNWV
MLSFTNKDKTESYRSTAIVPSDGKNFSGKFVLPTGVETSFTAVHTGDTEVSENKGKKDKD
TKPEVVPVTFPNVGYGSLNKPQSQNTLFRNATVWTGESTGVLSNTDVLVRNGKISKIGKN
LSASGATVVDATGKHLTAGVIDEHSHIAALSINESGHNSSAEVKIEDVVDPEDVSIYRNL
AGGVTSIQILHGSANPIGGRSAILKLKWGENAENLIYDNSPKFIKFALGENVKQSNWQSF
SRFPQTRMGVEQLYVNYFNRAKEYEAKKKSGQPYRYDEEMEVLVEILNGERFISCHSYVQ
SEINMLMKVAEKFGFRVNTFTHILEGYKVADKMAAHGVGGSTFSDWWAYKFEVNDAIPYN
AAIMASQGVTVAINSDDSEMSRRLNQEAAKGVKYGGMTEEEAWKMVTINPAKLLHIDDRT
GSIKEGKDADLVLWSDHPLSVYAKAEKTMIDGAVYFDLEQDKAKRQAIKAERSKLINMMI
SEKNGGGKTRPPAGKDKIRFECETIN
>OMIFANIC_00467 hypothetical protein
MQRKRTRLIIALLLPIQVLALQILKNYPQFVETYYSQGFYPLISKISRYIFGWIPFSMGD
LFYLLISILAIRWLFKNIRRVRYEAVRFFIDIVATLSIVYFMFHILWGLNYYRQPLHKTL
ELDYEYTTEQLIQTTKRLIAKSNDLHRSLGYPDSVKIDLPYTQREIFKKSLDGYKTLSKE
YPDLTYNPKSLKKSGWSLGLTYMGYSGYYNPFSGEAQVNNLIKTYKFPVVSCHEEAHQIG
FAAENEANFIATLATINNSDPYIQYSGYIFALRYCVNELARRDIDKYKELIETINPGILA
SYKEMRDFWQKYKNPFEDFSKGFWDQFLKANNQSKGIMSYSYMVALVVNYFEDKPF
>OMIFANIC_00468 Cytosol non-specific dipeptidase
MNEAIRNLEPQQVWNNFADLNAVPRASKKEERVIAFMKKFGEDLGLETEVDHIGNVIIRK
PATTGMEGKKAIVMQSHLDMVHQKNNDTEFDFDTQGIDMMIDGDWVRAKGTTLGADNGLG
VATIMTILQSDSIPHPDLEALFTIDEETGMTGAMELKGGVLKGEILLNLDTEEDDEIGVG
CAGGVDVTATGTYNTVNVSGNVKAFTVKVKGLQGGHSGMDIIKGLGNANKMMNRMLYATR
DLMEISEINGGSLRNAIPRESIATVVVPAEKETEFLTEFDAMKKAIINEYTLLEPELSIA
AVETAVPALIMTTEGKNKLLNALHAAHNGVFRMSPAIADLVETSNNIAKVTVKDGNIKVE
NLTRSSVESSKEDLAHSLRSVFELAGYEVSFTGSYPGWAPNMDSPILKVMDKLYERMNGH
KANVAACHAGLECGILGQNYPGMDMISFGPTIKGAHSPDERASISSMQKFWAFVQEILKH
VPEKTA
>OMIFANIC_00469 putative peptidyl-prolyl cis-trans isomerase
MKKLSLLLILLVTLVVTTACEDKYPDLPEGVYAEFITNKGTFVAKLFNDQTPLTTANFVT
LAEGNNEMVDSIYLGKPYYNGLIFHRVIKDFMIQGGDPNGDGSGNPGYRFPDEFVDSLKH
DRKGLLSMANSGPETNGSQFFVTLKETPWLDGKHTVFGEVVMGQEVVDSIGNTPTTKPGD
KPVDDVVMEEVNIIKKGDINVVAFAEELKKIEAEREARKQELERLAIDKAVSFVNMKQEA
ETLESGLQISYQTRGEGPKPKEGEDLLINYSGYFTNGQLFNTSYLEVAELYDTVDQNRKA
QGRYTPILTNTNDTRLIQGFREALQNMSIGDKVTVFIPAHLGYGEAGNRPYIPPNTDLVF
ELEMLEKTDE
>OMIFANIC_00470 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MNPRSILLFFLGCILLASCKTPEARKPVQQSSGSFIKESAKRNKVIYKKEEERIATIMAA
NPENNYLSSDRGFWYYYNVKDSLNIPTPEYGDIVTFTYNVKSLDGISILSESETGLQTYK
IDQSNQDLISGLRDGVKLMKVGEQVTFFFPSYKAYGYYGLEDKLGTNVPIQSTVTLKSIQ
QSQ
>OMIFANIC_00471 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MNEATTAKVKELLATPKKIVVVGHKNPDGDAVGSCLALAHVLNSLEHEATVVMPNDFPDF
LKWLPDCDSILIHDKAVEKSKKLISDADLIFTLDFNALDRTGEMEIPLKETTAKYVLIDH
HQQPDDYAAAVYSDTAMSSTCEMVYHFLDAIGALHLITSEVATQLYTGIMTDTGSFRFPA
TSATTHRVIAHLIECGVKNTEIHQNIYDTNTPDRIALLGVALQNMKILPEYRTAYITISQ
KELDDHRFKKGDTEGFVNYALSVTGVVFAVIFIENRQEQIVKISFRSKGSFSVNEFARKY
YSGGGHTNAAGGKSTKSLRATVTEFISILPSHKNELTDES
>OMIFANIC_00472 hypothetical protein
MRLPVLFLAILALFSCGNPSEVKQANTPENIFTEDNASNFTLVFASCNHQDRPQPLWQPI
LDTNPDVFIWGGDNVYADTDDMEKMKADYDKVSANPLYAKLKEQTAITGTWDDHDYGKND
AGVEWEKKDEAKEILLDFLGVSNDDPRRSREGVYFSETFNANGGSIKMISLDTRYFRSPL
KKSDDLGRRYDSWGMDHQGTMLGDAQWKWLEEELKDDSADFTLIVTSIQFLSKEHGWEKW
FNFPSEVEKMRELLKGAKARNIVLLSGDRHMAEISVDDESGLGYPLIDFTSSGLTHTWPH
FSTEGNEYRVSNIIKRLNFGVLFFNFENRTVTFEIRGRNNFIFERFTQQY
>OMIFANIC_00473 Nucleoside diphosphate kinase
MRTDRTFTMLKPDSVEKGHIGAILEKINAAGFKIVAMKLTQMTVDDAKEFYAIHKERPFF
GELVEYMTRGPIVAAILEKDNAVEDFRTLIGATNPEEAAEGTIRKLYAASIGENAVHGSD
SDENAAIEGAFHFAGRDTF
>OMIFANIC_00474 hypothetical protein
MPKRHGENTSLGDVLKEFIEANRLQSGLDKISVKDAWHSVMGEAISKYTTSVKLERDTLY
VGLSSSVLREELSYGKEKIVKLLNDAMEKDLIKKIVLR
>OMIFANIC_00475 hypothetical protein
MQSDGDIAVSSNVLSTFYLSLNKLRSIAQLFNHMNYKKSQTGWIVIGIMVPILVLLYLSY
VHQWGDNPLPLLPFAIIAIVLIIAAALFYQLTVEVDRTTVKVIYGIGLIRIKFKIDELLS
THVIRTPWYYGYGIRITPKGMLYNIQGSKAVEIKFISKGKHKSVMIGSPEPEKLQRAIDH
NFRKRAWT
>OMIFANIC_00476 hypothetical protein
MKQLLHVLTICLIVSCSNQDPNDQKTRLGGYWVIEKVEMPGGSEKLFQLSTTIDFIEVTG
DSGVRKKVQPKVDGSFLANDSAEKFDLMIENDSLHMYYKTPYDSWKETVLRARDSVLVVL
NQDGKIYTYTKFGGLSVPEE
>OMIFANIC_00477 DNA replication and repair protein RecF
MILQSLKLINYKNFESESFDFDPRINCFVGNNGIGKTNVLDAIYHLSFGKSYFNPITSQN
IKHGEDFFVLEGLYSKDDKDEKIVISAKKGQKKIIKRNGKAYERFSEHIGFLPVVIISPA
DRDLIIEGSETRRKFIDGVISQGDVQYLRDLISYNKVLSQRNSLLKYFAANKTHNQDTLD
IYNEQLDNYGTEIYKKRLEFLEEFTPIFLKRYQSISGRMETVDLMYKSQLAEADLKSLLE
DNINKDKFTQYTNYGIHKDDLLFQIEGHPVKKFGSQGQQKSYLIALKLAQFDFVKAHSGQ
LPILLLDDIFDKLDEQRVGQIIRLVDEENFGQLFISDTHPERTEEVVKEVHQSYKMFRL
>OMIFANIC_00478 hypothetical protein
MATYKKRGYKPKNKAEKQAQLEDGSTTAEVFKSLDEGASKTEAWVEKNQKYILGVVGAIA
IAVLGYIAYQQFIQEPKEIEATNEMFKAQEYYELAQSAPARDSLYNLSLNGGEGKYGFLD
IIDNYGGTSAGNRARYYAGMAYLNLKDYQQAINFLDDYKGSDEMTGPLAKGAIGDAFVQL
GQNDEALKYYEEAANMRENSVTSPRFLLKAGITALNLGQADVALAHFKAIEENYPEAPEA
AKAIIYVGKAEAMQ
>OMIFANIC_00479 6,7-dimethyl-8-ribityllumazine synthase
MATENNNLSAYDKTAIPNAKDFRFGIVVSEWNAEITNGMFQGAFDAILDCGGIKENIVRW
NVPGSFELIYGCKKITQSYDMLDAVIAIGSVIQGETKHFDYVCEAVSQGIRELNVQGEIP
VIFCVLTDNNMQQAIDRSGGKHGNKGTEAAIAAIKMAQLRKDARF
>OMIFANIC_00480 hypothetical protein
MKISFLKRIKPNNRYNYTPRYYKGKDEETTPYEMGTKFDKFVDTYNKNDFGAHWRDARKN
MRNRGNVEFNRTVLIIMAVLILIFLWIIDFDLSIFTQ
>OMIFANIC_00481 DNA mismatch repair protein MutL
MPDIIQLLPDHVANQIAAGEVVQRPASVVKELLENAIDAGATKISVVVKDAGKTLVQVTD
NGVGMSTTDARLSFERHATSKIKTAEDLFNLHTKGFRGEALASIAAIAHVELKTKTEEAE
IGTKICIEGSTVVSQEAEVVPQGTTIAVKNLFYNIPARRNFLKSNPVETRHIIDEFHRVA
LAHPQVAFSMVHNGSDVFNLPPSNIRQRIVNIFGSKTNQKLVPVTEETEIVKVNGFVLKP
EFARKSRGEQFFFVNDRFIKSPYLHHAVSSAFEGLIRDRMHPGYFLFLEVKPTTIDINIH
PTKTEIKFDDEHSIYAMLRSTIKHGLGQFSVAPVLDFNKDSSFDTPYEYSKKSPVLPTIE
VDRDFNPFKEGGAKSGGGFTKYKDKSTNWESLYVGLKGELSGSTDETDVTQIEFESEEVT
GRLFDTNETDSGQLTFQLQQKYIISPIKSGLMVIHQHLAHQRILYEELLRNMTVKEAVSQ
QLLFPMEIELSKPDMEILQKVREQLEHTGFHFESFSEEKISISGIPVGLNDSSAGKVLDQ
LITDIRDEVPDASFSLNDLLAKSMAKSMAVRTGTALNKAEREHLVNRLFACKEPSVSPDN
TQVLITLDVTELDKRFM
>OMIFANIC_00482 Rhomboid protease GluP
MGRISETIKVLIIINVIFFIGTLLNQDLAYGLFSLFYYENPNFQFWQPLTHMFMHGGLWH
ILFNMYALWAFGTPLEMRWGRSKFLFFYFSAGLGAALVHTIANYYNFQEGVDTLIAAGAT
QADITEFLSNPANGVYKMYQAYHVPAVGASGAIYGILVAFAMMFPNIELMLIFLPIPIKA
KYFVPVIILGDLIFGITGSPLGIAHWAHIGGALIGFIMAWYWKKNSFDNTRIY
>OMIFANIC_00483 Rhomboid protease GlpG
MAATGLTYKYKTADMVMKLIIINSLLFLAFRLVAFFMQIRIADLTNWLTLPENTSEFITQ
PWAFITYSFVHFGFFHILFNMIWLYMFGRIILNYFSGKRLLTIYLLGAIVGGLFFVFSYN
VFPVFENDRGFLLGASGAVTALMAFIATYSPNTQLRIFTFNIKLWHIAVFLIVADLVRIS
TSDNPGGLLAHLGGAVFGYFYAVQLAKGKDIGKWFENILDWFANLFKSRKQKPFKKVHRT
DKKGAGIKDIDKTEHQRKVDAILDKIGKSGYDSLSKAEKDYLFKAGKED
>OMIFANIC_00484 hypothetical protein
MLWGSRLAVLLLAITFVVPYLAPKNFPNLSLASLIVSPLIFINLLFLIYWILRKWKKAIF
TGLILFIAYLHFGPFIEFSSEGDVSEYRESLTLLSYNVRLFNAYEKDVDTVEVSEVISEM
IDAKNPDVISMQEYYLPNSADFSDYPYQFIHFHDENKLGHAIFSKYPIVNKGAFDFQSYN
NSIYADVVKGKDTIRIYNLHLQSLGVLPNVEYLQDGDKERIRKRMSINFEKQQVQVKKIL
AHKTTSPYPVLLSGDFNNTPFSYIYRNLKADMKDSFLERGNGIGTTFKFDFYPMRIDYIL
MSKTFEVVKFETLEKSFSDHKPVCATVGWPVKAD
>OMIFANIC_00485 hypothetical protein
MVAIVAAGEVVFEVQDNYQKQTYRNRAYIAHANGRLLLNVPIKHSKGGARQKTKEVMPED
NFPWQDQHWKSLQTAYRTSPFFEFYEDELEPLFTKKVNGLLEHNLEIFDVLLELLGHSVQ
ISQTKTYESHPEITDLRYLVEAKKQKDYSFTAYTQVLQTHHGFLSDLSVLDLLFNEGPNA
LHYLEEQSLDI
>OMIFANIC_00486 Signal peptidase I
MTITGWLLLFLIIQVIHFLGTWKLYIKAGRKAWEAAVPIYNAVILMKIINRPWWWTILLF
IPIVNLIMFPVIWVETIRSFGRNNATDTALVLITLGLYIYYISYTQEVSYIDDRDLKPRT
STGEWVSSILFAVVAATIVHTYFMQPYTIPTSSLEKTLLVGDFLFVSKFHYGARAPITPV
ALPMVHDTLPLVKSRSYFKGPDYPYFRFPGFEDIERNDIVVFSWPVDTLVDILRPNKGTY
IKPLDKKTNYVKRCVGLPGDSLEVKNGYVYINGQQNKLPGRAKLQFAYRVYSKKSLVLTD
NQGKFTNIPTPFVSQRYDISDIYVSDLDRDKNLIVHVAQLTNETAEKLKNNPDIVQITRA
LMDETVSDPGIFPHTPMYPGNTDNFGPIYIPEAGKTVAITPQSIPYYRRIIEVYEGRELG
ISNKISQKGTQVMLNGEPISEYTFKMDYYWMMGDNRSNSQDARSWGYVPFNHVVGKPVFV
WFSWNSNGQGISNKIRWNRLFTTVHGDGEPVSYFKYFLVLLAGWFVFDFFRKRRKKTAKK
>OMIFANIC_00487 4-hydroxy-tetrahydrodipicolinate reductase
MKLALLGYGKMGKTIERLAIDAGHVVIFKADKEFEDGDLKAADAAVEFSTPNAAFTNIKR
CIEAGVPVVSGTTGWLDEYSEVLKLCEERNGSFIYASNFSIGVNLFFSLNEYLSKQMQSH
KEYKASIEETHHTEKKDAPSGTAISLAESILKYSDKVGWKLDNARDDELRVHSKREGDIK
GIHEVTYGSEIDQISIRHEAFSRDGFAKGAILAAEWLQNKKGVYSMKDVLGLE
>OMIFANIC_00488 hypothetical protein
MRSRLLYILLIFLATTFFAQAQDSLNVAKEEILVVKDTISKQSYDPLAPSRAAFYSAVLP
GLGQAYNKKYWKIPIIYAGMATGVYFYIQNDKDYDRFRDAYKRRLAGFTDDEFYGNGDTP
VISDDRLIDAQRSAQKNKDISIIVSLAFYLVNIIDANVDAHLSQYNVSDDLTLSPNLYVD
PVHTQANYGLSFKFNLK
>OMIFANIC_00489 putative chromosome-partitioning protein ParB
MAKATKKQALGRGLSALLKDPANDIKSADDKNADKVVGNIVELDLDTIEVNPFQPRTSFN
EESLRELASSIRELGVIQPITVRKLGFNKYQLVSGERRYRASKLIGLKTIPSYIRIANDQ
ESLEMALVENIQRQDLDPIEIALSYQRLIEEIQVTQEALSERVGKNRSTIANYLRLLKLD
PIIQTGMRDGFISMGHGRALINVEDPDKQLDIYEKILTKKLSVRETEALVRGTKSPDSKP
KTDSKSIPSYAMEAKQELSDLLNSKVQVKVSGSGKGQFVVPFTSKDEFLRILNQIKGEK
>OMIFANIC_00490 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANATSGLGIDVENVQHGT
YHLIEHTVSAKDAIVETSSPNLDLIPAHIDLVAIEIELVDKDKRESMLKSAIQGLKDHYD
YILIDCAPSLGLLTLNALTAADSVIIPIQCEYFALEGLGKLLNTVKSVQKIHNPDLDIEG
LLLTMYDSRLRLSNQVVDEVKKHFDEMVFKTIIQRNVRLSEAPSFGESIISYDAGSKGAN
NYLSLAQELIEKYA
>OMIFANIC_00491 hypothetical protein
MRLQRFLKLKYLGILVLVGVISAGIWYSQLSNRHKAIVKTRLLHGFRIIDHDWEISYNDN
SIALESPDLLVDNIYQSMDGPQAILNLELNPDKNSLKWITGFKAEVYREGTSEHNNDFLC
HTNIDFFNGVHYKNLKLPKRINSQYPRLGTLSNGINELKFPEGFGFPMAGNDAFIIASRT
LNHNIEDAFFKVKHQIEFTTENADARLKPLMPKALVLVLDYDHENPDNPEPSDDPNLCLP
LDLKNHSFPNAEGVRFAAHWVLPKGEHLYKFDVTYQLQLKDDTQIHAMAAHLHPDAQEFT
LYDLTEDKPVYTINCENYDEKIGLKNVPTYSSSEGLQIYADHEYELQLLTNNPSDEFRDM
MAVLFVYLYDREMDEHLQATSYLQ
>OMIFANIC_00492 putative 2,4-dienoyl-CoA reductase
MDLKAKMLRDDALKGKTIVVTGGGSGLGKSMTTYFLELGANVVITSRNMEKLQTVKTELE
AQTGGNVLPVQCDVRHYDQVEAMVEASIKEFGSVDVLLNNAAGNFISPTERLSANAFDTI
IDIVLKGTKNCTLAFGKRWIAEKETNKVVLNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGMRFNAIAPGPFPTKGAWDRLLPGDLKEKFDLAKKVPLKRVGEHQELANLAA
YLVSDFSAYLNGEVITIDGGEWLKGAGQMNLLEEVPEQMWDMLEAMIRAKKNK
>OMIFANIC_00493 hypothetical protein
MSFQKGIEEKVKQLTVEDVSKAIKKYFKPLSQWTVVNAGDFKNMLEVKNTSLKN
>OMIFANIC_00494 Methylmalonyl-CoA mutase large subunit
MDRKNLEHITLDTIPNIRRENENELFNTAEDIRVQKYYDARVLSEIEHLDFVAGIAPNLR
GPYSTMYVRRPWTIRQYAGFSTAEDSNAFYRRNLAAGQKGLSVAFDLATHRGYDSDHERV
VGDVGKAGVAIDSVEDMKILFDQIPLDKMSVSMTMNGAVLPIMAFYIIAAEEQGVSPAAL
AGTIQNDILKEFMVRNTYIYPPAPSMKIISDIFEYTSEKMPKFNSISISGYHMQEAGATC
DIELAYTLADGLEYIRTGIAAGMDIDSFAPRLSFFWAIGMNHFMEIAKMRAARMLWAKLV
KQFDPKNPKSLSLRTHCQTSGWSLTEQDPFNNIARTCIEAAAAAFGGTQSLHTNALDEAI
ALPTDFSARIARNTQIYLQEETHITKTVDPWAGSYYVESLTREIAEKAWSLIQEVEELGG
MTKAIEAGIPKLRIEEAAARKQARIDSGQDVIVGVNKYRLEKEDPLHILDVDNQKVRTGQ
IERLERIRAKRNTEEVNAALTKLTQCAKTGEGNLLALALDAARARATLGEISDALEKEFG
RYKAQIRSFSGVYSKEMKKDPSFEKAREMADQFAELEGRRPRIMIAKMGQDGHDRGAKVV
ATGYADVGFDVDIGPLFQTPAEAAKQAMENDVHILGVSSLAAGHKTLVPQVIDELKKQGR
EDIMVIVGGVIPAQDYQFLFDAGAVAVYGPGTKISQAAIEMLEILIDSVA
>OMIFANIC_00495 Methylmalonyl-CoA mutase small subunit
MSKLFEEFEGVSAKAWKQKIHLDLKGADYNDTLIWQSPEGIHVKPFYHPDDFEGRFDDIP
GHPKKWEVVQDVFIDDENTANSLAKDALNRGAEAIFFTADKVFDRKKVFKGIDFSKGTIY
FDLRFLNKEFHNELMTFLTEKKACVFYNIDLIGNLARTGNWYTNLKEDHIVLDQLVEKFP
SEALLSVDAALYQNAGANIVQQLAYAIAHANEYLNHFQDKKDLLINFKTAAGNNYFFEIA
KLRALRKLYSVLGHEYEMNPVCNILSTPSRRNKTIYDYNVNMLRSTTECMSAILGGANAI
SNLSYDTIYQKSNEFGERISRNQLLILKSESYFDAVSNPADGTYYIESLTAQLAESALKL
FKEIEAGGGFLKLLKEGTIQRKIKESARKEQQLFDDGELVLLGTNKHPNPADLMKETLEL
YPFVKMKPRKTLIEPVIEKRLADSIEKERLENENQI
>OMIFANIC_00496 hypothetical protein
MGKFSEIKKKKWFIIVSSTYVLILIFFIVWMIFFDTNSYFIHRELDQDIKGLEENKEFYK
EEIVKDKAFIEKMKDSSEMEKFAREKYYLKKDNEDIYIIEHEDSLKNKTNDE
>OMIFANIC_00497 Uridine kinase
MLTIGIAGGTGSGKTTVVQQIIEQLPEGEVCLISQDSYYKDTSHLSFSERESINFDHPKA
IDFDLLSRHLQELKKGISFEQPVYSFVDHNRTSETITTHPKKVVIVEGILILTHPEIRDL
FDIKVYVHADSDERLIRRLKRDIIERGRDLDEVLTRYQSTLKPMHQEFIEPTKEYADIIV
PTNRFNRVAVELIRNIINQKLGD
>OMIFANIC_00498 Cytochrome c-552
MKSILAIMALTILLSCNSNAKQRASVSSLKPDPKKELDASKERGGLIYTNFCIQCHMANG
KGIPGTFPPLAGSDWLTNKRKESIHAVKYGQTGEIIVNGETYNSVMVSMGLSDEEIADVL
NYVMNSWGNTQLKMVTASEVGEIQK
>OMIFANIC_00499 Aldose sugar dehydrogenase YliI
MEKFAMSLCILLLFMGCKEQSRENDVAIKSEIKRGYTTERIVDNLSNPWGMTWLPDGTML
ITEKRGDILHVKNGKKTKIQNVPEVYNRGQGGLLDIEIHPNYREKPWIYFTYASSEGEGN
GGNTKLSRAMLVEGKLVNIQDLYKAYPNTTRGQHFGSRIEFDNEGYVYFSVGDRGERDVN
PQDIRRDGGKIYRLYDDGKIPVSNPFVNEMNAKAAIYSYGHRNPQGIAKHPETGEIWIHE
HGPKGGDEVNIIKKRANYGWPVISYGVNYSGTKFTEETEREGMEQPLYYWVPSIAPCGMT
FVTSDKYPEWKGHLLVGSLKFNYVELLKLDGNKVVGREKIAEDIGRVRNVKQGPDGYIYI
AVEGDGIYKVVPN
>OMIFANIC_00501 hypothetical protein
MVTYNCKRADKVLTIPILDNDLGQDLEEIFQLFFER
>OMIFANIC_00502 Putative phosphoribosyl transferase
MIAQEIRQAVTIKLGDINLKGDLIIPENPAGIVLFSHGSGSSRLSPRNNYVAEVLQGNGL
ATLLFDLLTEEEERINHMRFDIDLLTRRLIGATKWIKELPETNTLPIGYFGASIGAASAL
RAAAFFKDEVSVVVSRGGRPDLAMKEVDKVTASTLLIVGGNDELVIKFNKKAFQQMQCDA
KLEIIPGASHLFAEPGALEQVAKISANWFNEKLT
>OMIFANIC_00503 Putative phosphoribosyl transferase
MFKSRTDAGLRLAEELMNFKDRNCVVLAIPRGGLPLGAIVAEALNAPLDVVLTKKIGHPF
NKEYAIGAVSMDSRILSNAMEVSDAYIEEETIRIRNVLAKRSEQYYENSRPQDLKGKTVI
IVDDGIATGNTILATIELVYSKEPSGIIVAIPVAPPTAIENLNNSPYLDEVICLETPLNF
RAVGQFYEEFYPVTDENAIRILEECNQAIL
>OMIFANIC_00504 RNA-splicing ligase RtcB
MKKVDKHHIRKLENYLWEIPRSFRDDMRVPARALALESMLDDILKDRSLNQLVNVATLPG
IQEASLVMPDVHEGYGFPIGGVAATQYPDGVISPGGIGYDINCGVRLLTSQLKIDDVRHR
MEDLSKEMYAQIPSGMGKGGQIKLTIDEIDKVLIYGAEWAVSHGYGFKEDLPYIESHGKL
EAADPAYVSEMAKKRGSDQLGTIGSGNHFVEVDYVDEIYDKDISKAYNLFPGQLVVLIHT
GSRGLGHQVATDYIRKMVRAMPKYGIELPDKELACVPLNSEEGQQYFKAMCAAANYAWCN
REVISWEVRNAWKNIFGEQAEPLKLLYDVAHNIAKIEDHLIDGELKKVIVHRKGATRSFG
PGFEELPSEYIDAGQPVIIPGSMGTCSYILAGASAENITFGSCCHGAGRRLSRTAAKKQV
YAPGLKEELRDRGIFVQAGSFKGIAEEAPIAYKDVNVVVETIDTSGVAKKVAKLRPVAVV
KG
>OMIFANIC_00505 Protein archease
MNIEYLPHTADIRMKIQGSSMEELFIHGIQGMNNILKQGFCDPAHQYLHKTSVETASSGY
TNLLIDFLSDVLSYTYTENVMFCQIEFIRFTENLVEAQMLGAPIESFDEEIKAVTYHEAN
IKKNTKGNWETIVVFDI
>OMIFANIC_00506 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MYRTEVFNKNVEVYEAWYDKYHEVYMSELAALREQISKLPENIRGIEIGLGTGRFSEPLG
IKEGIEPSEEMARKAVKRGIEIMEGVAERLPYGDMQFDFVLFVTICHLNNIRLAIKEAHR
VLKPGGAIIIGFLDKDQSIAQQYMEKRDRSTFFRNATFYTVDRIRKLLEENKFKNLEFNQ
TLFGALDEISTIQIPEFGYGNGSFVVVKAVKK
>OMIFANIC_00507 Acylphosphatase
MIKHINLRVYGKVQGVWYRKSTQEKAITLGITGFVKNVEDGSVYIEAEGPDTPLKKLIEW
CKIGPQHAVVTNVEIEESASKSFKSFDIAY
>OMIFANIC_00508 hypothetical protein
MRYYIVILVTLMLVPFSGATQVLEGIDYITPFHEELAAVKKGDQWAFVNTKGDIVIDFRD
NLVWSKAIATETKKGYVRKEPTKYPRFTEDRCLIFKMKDGFKYYGYMDKTGKTVIAPEFI
NARVFDNGYAIVLKVTKEIIGRNEILGKDVISYSYAEQVIDPEGSVKAYLKGPVNLVMSV
ETKKQPPAIKSYIFSPDMVAFHTNDKKWKLIRLDSFK
>OMIFANIC_00509 Calcium-transporting ATPase 1
MIQSPHSITIKEVTAKLACDADRGLSSSEIKNRRRKYGRNILKSTSTRSTWSILLDQFLD
PIIYVLGIAMILGFAFEEWLEGFAVLAVILITVSIGFFMELQAVRSIESLRKLAQISINV
LRNGKIFKIKSPFIVPGDIILLAPGDVIPADARLIWHQSLGVKEAMLTGESDQVEKDTKV
LPIDTPLAEQTNMVFKGTIVLRGNAKAIVSATGNETQVGQISSLTREAEKSRNPLEKRLN
SLSRWLIGLTLILAAIIVISGYIQGKDLSLMIKTGIALAIATIPEGLPIVATIALARGMI
KLSKQKVIIKKLEAVQTLGETTVICTDKTGTLTENKMSVHELLLDNHRIKYEDLMDASFA
KQLEKNRAFTKLMEAGILCNNVQPDVTGLNGDSLEIALIEFAQMSDVDIAMLRKQYMELE
EIPFDAERKMMVTLNQHENEYAVYAKGAAESILDVCDYIIAKEGNVKSLMDKQKWLDLAD
EVASEGLRVLAFAFKDLEKRPATDEFTDKLIFTGLIGFLDPPRKDVKQAIQTYRDAGIKV
VMITGDHPRTARKIAEEIGLLTSGDPAEKVIHGQTILDLESTIPENNASILNASVFARMI
PKQKLDLVKFYQNHNAVVGMIGDGVNDAPALKRADIGIATGIRGTEAAKEVADVILLDDQ
FTSTELAIRQGRNIFGNIRQFVVYLLSCNLAEIIAVTVASLSNLPLPLLPLQILFLNLVT
DVFPALALGMGKGNTDIMKLPPRDPDEPIMTVNHWIITFVYGIGITASVMAITIYAHYQL
RLPSEVVNNMAFYTLILAQLLNVFNIPGRDRSFFKNEVTQNLWIWAALLLSAGIMFIAYT
IPLTNRVLSLVDLSTDQFLLIGLFGLGSLVLIQIMKRLIVITKK
>OMIFANIC_00510 Aerobic respiration control sensor protein ArcB
MDNELKIQDHLSDKIKISDTAQATARASKITLETIAKHFPNGLIAVINGDFLIEYVEGEE
LDKLGLRNVIVSGMCVDDISTFSENQKTRLKKDVLKTLDGVHNTFETEFNNNTYSVNTTP
FTIVGNGKKALLVFYNISRRKKYETKIWKALQKEQELNELKSSFITMASHEFRTPLSAIL
SSVNMIQKLESPEYREKREKYFKIIKANVHNLVVILDDYLSFEKLKDKKEALKKKWIYPD
LFITTLIEQIKPSKKPGQTIRLIKKKSDHKVFTDPILLEHILVNLISNAIKYSSKESVIS
VTVGTIDDSFYYTVEDQGIGIPLDEQKNLFNKFFRAQNANYIQGTGLGLHIAKQYTELLG
GSINFKSMVNTGTTFTVQFPTNQFFAKHEENTVNRGQ
>OMIFANIC_00511 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKILLIEDNRYVRETTADILEFANYDVITAEDGYVGVRKAEEHLPDLILCDILMPALDG
YEVLRILSENVETNHIPFIFLTSKTEKDDVRKGMILGADDYLLKPFEEHELLESIESRLR
KKEVLINRLSISPDITPDLDDSLRDVNLEKYFVKYRTKLYNLKQDLFTDGSKASYVYYIK
NGVVKTYKYTESGKEFVTGMYTSGEFIGQLSLLADESYNTETATAIADARTIEIPRTDFI
DLMRKDKVISKIFTKMVSNELMKERRRNMSMAFASVRQRTAKALLELYNKGIVKDVANSG
TDIPREDFAGFIGTATETAIRMLHKLKDEGLIAMGPGRKLILLNKTRLREIANFQ
>OMIFANIC_00512 Acid shock protein
MSLTTFKRKPWKTMFDKDFFEPNEFFDMRLPSIPFIESRFWNGKWKEPALNIIETDDEFK
VELAAPGFSKKDFEVTIADGCLNISAEKKVTKEEEKMNYKRKEFSYNAFERSLMLPETVK
EEEIKAKYKDGILSFDLYKKEEARKEKPKLIEIA
>OMIFANIC_00513 Hydrogenase-2 operon protein HybG
MCLAIPGKLIEFTAPQDNPFRTGKVSFDGVIKEVSLALIPEVKLNEYVLVHVGTAISIVN
EEEAKKTFEILKQLDELKDLES
>OMIFANIC_00514 Hydrogenase isoenzymes nickel incorporation protein HypB
MCGTCGCSPEENKIVLLDPVKAKSEPEHKHSHDHSHDHSHGHTHEHSHDHHHDHSHSHKV
LEVEADILRQNDLMAAKNRGFFEAKGILALNLVSSPGSGKTSLLERTLSDLKDELSFYVI
EGDQKTQNDARRIAALDVPVVQINTGKGCHLESDTVLEAVRKLEVEDRGILMIENVGNLV
CPSMFDLGESKRVVIISTTEGDDKPLKYPDMFYTSDICIINKMDLLPYLDTDIETIKQNA
LKVNPNLLFFEVSATKGNGMKDWYQWLTEQYESI
>OMIFANIC_00515 hypothetical protein
MKDYETKILLLGIGNSGRSDDGLGWAFLDAMQDKLTSEFDLEYRYQLQIEDAELISNYDV
VYFIDAHLDQFAQGYHLEPCLPLRTESFSTHQLDPRTVVYLCESIYNKRPETFTLGISGV
AFDLNIGISAQAKSNLSNALNFFENSILELTINK
>OMIFANIC_00516 NAD-reducing hydrogenase HoxS subunit beta
MSQKLVIDPVTRVEGHGKVTVHLDDQNKVKDAFFHIVEFRGFERFIQGHPYWEAPVLVQR
LCGICPVSHHLAAGKAIDQIVGLDPGDLSLPAQKIRKLLHFGQVFQSHALHFFYLASPDL
LFGFDADPVKRNVVGVAMDYPALAKKGILMRKFGQEIIKMVAGKRIHGISTTPGGVHKKI
TVKERNRFLDGKELPSIDTMIEWSVEILDFMKEYHKKNSAFLDGFADYPSGHLGLVKKEN
GFLELYDGNLRATDAKGNITLDDIPDVDYAKHFYEGVEKWSYLKFPYLKHIGREHGWNRV
GPLARVNICNGIETPLAEKERIEFKLAGGDINNKTMHTHWARLIEILYCAEMMKNLLEDD
DIISNDLVRKGTRRSEGVGIIEAPRGTLIHHYEVDDKDRITRCNLIVSTTHNNEAMNRAV
RWVAQNEISGQPKVTEAMMNQIEVAIRAYDPCLSCATHALGQMPLDISIIDQYGNILDER
LRN
>OMIFANIC_00517 NAD-reducing hydrogenase HoxS subunit gamma
MTKMVNLKIDGKPIQAEAGMNLVDVAKQNGIYIPTLCYFKELNPLATCRICTVKVNGKEI
TGCTVKVAEGMDIEVTTPELLDNRKAIIEMLYAEGNHFCPSCEKSGNCDMQNLGYDMGIT
VTRYPHVFSDKIVDFNPKRMIMESNRCILCKRCVEEVKTKDGKDVFSFVQRGVKTRVQID
YEQEANLTEAEAIHAMNICPVGAILVKGMIHEQPFGERKYDLLGKDIKPVVKKDPLRQRD
GGKFIVATTSLAGCFGCHMSLLDIDTELLDVLELVEFNKSPLTDIKKFSKQCHIGLVEGG
CSNSENVEVLREFRKKCDILVGFGECAIMGGIPAMRNFVPLKECLDEAYLNGVTTEVGAD
VVPGHEDIPKLLNNVYPCNEVVKIDYYIPGCPPNAQHIWKVVKSILLGEEFSIAHDEFKY
D
>OMIFANIC_00518 NAD-reducing hydrogenase HoxS subunit alpha
MITENKVDRSKLMDVIWDIQRKKFQITHDDISKIAQEFDMSRMELEGIVTFYHFYHRTPC
GKYTIYLNDSIVSEHSGRPEVLHAFEEALGIKLGRITADGTFGLFKTPCIGLSDQEPSCL
INFKPFTNLTPEKVRDIIGRLRNGEKPSKICDKPKTNIRYTPEPERTVFFKPYTTYSSLD
KLNEYEPSEVIELVKKSKLTGRGGAFFPTGLKWQFCSQNEADIRYIICNADEGEPGTFKD
RVLLQEHPELLIEGMILAAYAIGCSQGAIYLRAEYMYLKKELESLLEEYRNNGYLGKDIK
AKKPFDFDIYIHMGAGAYVCGEETALIHSMEGKRGEPSTKEYFPVEKGFNGKPTVVNNVE
TLCAVPRILNMGLDKYLTLGTEQTPGTKLLSVSGDCGKPGLYEIEWGMKLREFLKLIEAR
NTKFILFNGYAGECLSEADFDREISGKNLLADDDLLHFKDTEEYTQKMSGKGLRAGGSVM
IFNKGRDLLHVLKNVADFFVAESCGICVPCRTGNFLLNKKIDRIKLGHGEEKDLEEIKEW
SKIIKTTSRCGLGKMSSTALNDAIFKFPEVFGTILSENTDFNKAFNLDDATIDYDHIINE
MTSDYD
>OMIFANIC_00519 hydrogenase nickel incorporation protein HypA
MHEMSIALSIVKIAETEAKKAKVDSFAAIEMEIGTLAGIEFDALDFVWEAAVRETVLEKA
VKRIKKIPAKARCGDCEKIYSLQFIHDNCPDCGSFLKTIIQGKELRVKSMETF
>OMIFANIC_00520 Uptake hydrogenase small subunit
MGTLHKNKRETYFDNIIGHGYSRREFMKFAAFITAYMGLEHSMIGQVAKALETSYRLPII
WEHYQECTCCSESFIRSDHPIVADIILDNISLDYTETLMAASGHQAEAAKHDTMKKYYGE
YILCVEGSVPLGADGVYCTIAGRTAIDHLKEAAEGAKAIIAWGSCACNGCVQGAKPNPTD
ATPIHKIIKNKPIVQMPGCPPIGEAMAALIVHYVTFGKLPELDRAGRPKAFYGKRVHDTC
YRRPYFDAGLFAESFDDENAKDGYCLYKVGCKGPTTYNACGSMRWNNGVSFPIQSGHGCI
GCSEANFWDHGPFYERLTNVPGFSIENTADKVGKIATGAVVAGLAAHAVAASISKRKEHK
KRYTRGRINEEKIDKNE
>OMIFANIC_00521 Hydrogenase-1 large chain
MANRIVVDPVTRIEGHLRIEAEVKDGKIVDAYSSSTMVRGLENIVKGRDPRDVWAFAQRT
CGVCTTVHAIASVRAVEDALGIAVPPNAEMVRNIMQGALYMHDHAVHFYHLHALDWVDIV
SALQADPGETSKIAQSISNWPKSSPGYFGDIQKRIKKFVDSGQLGIFANGYWGHPQMKLP
AAVNLLGVAHYLEALEWQKEMVKVHTIFGGKNPHPNYLVGGMACAINEDSMGGINAERLA
YVGKLLKQGKDFINQVYIPDLLAIASYYKDWGAIGKGHGNYMSYGDFPTNGYGDPSGFKF
PQGVILNRDLSKIHDVDHRNGDIEEFVNNSWYDNYTEGADTGRHPWDGETNINYTGPKPP
YEQLDVSQKYSFIKTPRWQGKPMEVGPLARLLVGYGRGHEEIQNAVNAALSHLDVPVEAL
FSTLGRTAARGIETQLVADWTLEFYNQLLTNIKNGDSRMANMDLWEPADWPEEAKGIGFT
EAPRGSLAHWIKIKDGKTENYQQVVPTTWNASPRDPNGQMSAYEASLIDTPVADPELPLE
IIRTVHSFDPCLACAVHLYDEHGRHLSQVNQIDSCEI
>OMIFANIC_00522 putative Ni/Fe-hydrogenase B-type cytochrome subunit
MEKTIQTSDFKRVLVWELPVRICHWITALSVIILTVTGLIIANPPVFMSGAEASESYWFG
TVRMIHFITAYIFLVNAIVRIYWAFRGNYYANWRALFPYTKRSWKNVWHVLKVDILLQNE
EEEILKNISIGHNYVASISYLVLFLLALVQIFTGFGLYAATSGWWLPQLFAWVPDFLGGD
APTRLIHHAATWLFIVFTLIHVYLVFYHDWLEGRGETSAMISGYKFVRKERLESDEHI
>OMIFANIC_00523 Hydrogenase 2 maturation protease
MSTYKDNNPSPIAVSSDSFFFEKDKSDCILVMGVGNYLMGDEGIGVHIIQEMSKMDLPDA
VDILDGGTGGLLLLSCFEAYPKIIFIDATMDGKTPGSISIITPKFASDFPNALSVHDVGL
KDMIEAVYLMDEVPEILLITISIQEVKPMTVELSKPVKEAIPRTIDKVLKLAEKLHS
>OMIFANIC_00524 Carbamoyltransferase HypF
MLKTYKLIITGQVQGVGFRPYVYVLAKEFNIKGTVSNNEEGVIIIASGTEEEVHSFYQKL
IEHPPKVARINSHHFQDIELRQFDEFQIIPSKKSGKLNLQLTPDFAICKDCKNDISNREN
RRFHYPFTTCVNCGPRWAITNTFPFERDHTSISEFEMCEQCINEYANPEDRRFHSQTNSC
SVCGIGYKLVDNNEKEMQVTRNQIFSKMAELLSEGEIIAIKNTGGYLLCCDATSEETVES
LRKKKNRPDKPFAVMYPSLELLEQGLRLSQQQKKLLCSPERPIVIIPMKDYKGDVAGKAV
APGLSQLGVMLPYSGIMQLLANELDRPIVATSGNLHGSPILSDEKESTVILRDVADYFFN
HNLRIINPQDDSVVKISERSGIPVMFRRSRGYAPNLFKRTESTTERVMALGGNLKSTIAF
IPNDYLYMSEYLGVLDHYDVYRRFVDTVTKFIRLFEQEPDVILVDKHPAYQSTLYGIELA
KENEVDHYKVQHHKAHFAAVMGEYNLFDHSEPILGVVWDGTGYGDDGAIWGGEFFTFENK
TMDRLSHFEYFDWLAGDKMAKEPRLSLLSITSSEDIPEIAHKFSEQEITIYSSVKEENNL
KTSSVGRLFDAVASLLDICDLNSYEGEAAILLENYVSNYNLDECMTYAPEMEGTIISTRA
IWNNLYSDFRSGTSRERIIVNFLYTLASLVKDVATARNIKNIAFSGGVFQNTILVDMIND
IVGSGHKLYFHRELSPNDENISFGQLMYYIHCTKNTTNS
>OMIFANIC_00525 Hydrogenase expression/formation protein HypD
MKYLNEYRNLEATKNYLKRIEKTVTRPWKIMEVCGGQTHGLIKNGIIDLLPDKVQMIHGP
GCPVCVTPLVLIDKAIALMDQGVIVCSFGDMIRVPGSKKSLLEAKSDGGDLRILYSPLEA
VRIAADNPDREVVFFAVGFETTAPANALSVLHAKNEGLKNYSILVSHVLVPPAMEAILDD
EFCNIDAFLGAGNVCAIMGTSEYHELSTKYEIPIVVTGFEPLDLVEGIFMAVSQLEAGRF
VVENQYARIVKEEGNLAAKEVIAKVFEIGDRDWRGIGTIPKSGYVLRSEYSHFDAELKFG
VESISTKEHATCIAGAILKGIKKPGECSEFGSRCTPSNPMGAPMVSSEGACAAYYHFATN
LNN
>OMIFANIC_00526 Hydrogenase expression/formation protein HypE
MSIELSNYKSINLGHGSGGLMTRELLDEIIFKVFNNPYLNQKHDGSIVKIEGEIAISTDS
FVVSPVFFKGGNIGELAVHGTVNDIAMCGGIPEYLSLAFIVEEGMDMNDFIKIVESIKQT
ADECGVQVITGDTKVVERGKGDKIFVNTTGFGKVHPGANISTDRIKVGDKIIVSGYIAQH
GMAIMSERKGLQFESDIISDTTNLNYLVKDLLDGFGEKIHLLRDPTRGGLSGVLSEIAND
TAKGVSIYEKDIPLEKQVAAACEILGLDPLYVANEGVFVVIVDNEIADEVIDAMRNDEKG
RNAVCIGEISNENPSKVVMHSIIGGKRIVSPLIGEQLPRIC
>OMIFANIC_00527 hypothetical protein
MELTFPFISALLASMLHVITGPDHLAAVTPFALTAKRKAWRIGLAWGLGHLSGMLIIGIL
MALFNELVPIEGISNYSEQLVGLLLIGIGLWVWYKIFSRKKVHKHLHVHAENSPVIHTHA
HDHSDEKVHHHTHEKKSRQSATAAFGIGIVHGLAGITHFLLFLPVLSFESWTDSTNYIVG
FSVGIVLAMTAYALIVGKISSLAQGGHNDTFFKGVRFTAGLFAIIIGIYWLLSF
>OMIFANIC_00528 hypothetical protein
MRNFLSILVFLFSIALYSQAGHIMQGVGSVNMSMGGAATGQPTDISGALHWNPAAISTFD
EDILKVDIGFFFSSPELSSTVPVFNEMGEPTGQFFSGVTEDDRGVSPLPNLAMVWGASDS
KSTFGASAFGISGFGVTFPENASNPINAPQNFGGFGRIESDYSLLQLSFSWAYQLSDQFS
IGLQPNFNYATLELMPNPTANPTAFGYPSTDKATALGFGGQIGLFYDTGVGFKFGTSYKT
VQSFGDFELENTYLNGATATNELALDYPAIWSFGAGFSEGDFDIALDYRLVDYENTDGFS
ETGWTQTASVSGFGWKNISIISAGVQYKGVDKLPLRVGYTYSSNPIESDVAFFNVPATAI
IENAFQFGLSYEVSHCIKLDGMFHYGSSAGATSGPLLNPMFISNFPPYGAIPGSEVSYDM
TTSMVMVGASYTFKTKTEDTD
>OMIFANIC_00529 Sulfide-quinone reductase
MKNLVILGAGTAGTMMSNHLIKKLPKNEWKITIVDQFKTHYYQPGFLFLPFDIYTTKQVK
KKGRKFIPKNATYIQKRIELIEPKENRVILENNEQLSYDILIVATGSKIAPDEIEGMDGP
MWYKNIFDFYTYEGAKALRDKLREWEGGKLVVHITEMPIKCPVAPLEFAFLADSYFKHKG
MRDKVDITFVTPLGGAFTKPTATKTLHYLLEEKNIKEVTDFNIERVDYENNKIIDYADTE
VEYDLLVTVPTNMGDSVIERSGMGDDLNFIPTNKGSLQTLEHENIFAIGDATNIPASKAG
SVAHFEAEILTDNILRYIKGEELKEEFDGHANCFIETGNGKALLIDFNYTHEPVEGTFPF
PGVGPLRLLKESRANHMGKMAFRWVYWNMLIKGVHIPFVSATMSEKGKHYEKVN
>OMIFANIC_00530 Sulfurtransferase TusE
MKKMIEQREIEVNEEGYLLDFSQWDKEIGEKLAEEQNIILTDKHWEVIEYLQDKHRKEEA
LSIRGIKKSGVINIKEFYSLFPGGPLKKSTLIAGIPKPKSCI
>OMIFANIC_00531 hypothetical protein
MSETKVRKMLFILSKATIENAYAAFVMANGARMEGIESEIFFTFFGLEAIQKKKLEHLHV
ATVGNPAMHMPTMLGALPGVEALATKMMKKEMEKLDMPPVGEFLEILSDSGCKLWGCKLA
IDMFHLEREDLIDELDGILTIGDFYNRADKEGTHLLFI
>OMIFANIC_00532 hypothetical protein
MHHFFLETGFRESFKTLVANQKVNTSCFLFLFPQAKQDLENPTKPSLQIKK
>OMIFANIC_00533 Tyrosine recombinase XerC
MAYSAIKLYKENKDGKKFVIIYYKHDGSTLRHRTGIVLPIKDFDKKASRVKPSNHSYESY
NEIISNAHELIEDIILDYVKRNGIKPSGKYIKDQLKAGRKIRKQTLDADLIDCYSDFLNE
KKILFTSPDKSPTSLRDYVSTENALIEYSHVNGPSCPTDLNDMKWLNKFNIFLSKPRPKL
KDYRFKTSEQNDKTRSKRFGVLKNFGDWLLKEKFLNDTEILDNFKVTVQNKSYYTLKLEE
LGLIQNHKFKSIPQQKAIDMFVVACHTGLRYSDVTRINKARIRIHKKVSILILNNQKTKV
KIEVPLSEKVLQILDKYNYNLNLMTSQKTNYYIHKALKNINPFLDEYEYGLEGDTLPKHE
LVTFHTGRRTFITNLVNNNVSLNAIMKMTGHKKISTLQKYINPDYDLVMDNIRIFNDL
>OMIFANIC_00534 hypothetical protein
MTKNEAQIIVDLIHKTEAFPESIVVKKEIQTVVDKYINSLLKHNPKINYSRLKSEVNRKT
NNFIKPFDEAIKRKLRAVFQEHYVTPESKPESEEKRYLIKEVANLLEMTSQNLNRHLRNH
PEINVIEISSRKRYLTESEIEKLKNL
>OMIFANIC_00535 hypothetical protein
MVKKVLQTEFLYIQEGEKTHLPKRFVKVNNICAILYDQLTEIFTTENYGPLTHTEINHPE
IEKVIKELEKENIHILDWLKKNGKKEDITQVLTKHLLMSITSDFLAFIYESLRCAKNGKM
TVAYALLRKPLTDELLILEQLLIDRDDFVHRFFVDGRTKGYDPSPANKKVDKQSVIESAV
SKLYLNPVLVADYIHEVRYDKACGFGLNGLTNQALHIVTNDFHYRTEEQNLNFVFSIEED
IKNYREHYYTIVPYLLIYAISVIDGVVFDLLKDDENQDIRYVKALRRLTGFFLINKHSKT
IDGGTIEGLFKIIGEGMPKDCQSCGHENTIELADFELFFETEVFVCEKCFDNLLATKESV
KTIREFFSGFRKDGEG
>OMIFANIC_00536 hypothetical protein
MPTQRQNYKWRPNDESSTTRMRYDLEASHWYRSFKNAEREHKPSSISADLGVIGLFLSLI
GSLIVLIILSLVQFIKWLRS
>OMIFANIC_00537 hypothetical protein
MIAKKLKFKNVGVHSIRKASAIHVLDKTGSLSMAQYHLTHKRATTTDKYLGVTQASALEQ
LARVF
>OMIFANIC_00538 Inosose dehydratase
MKTIKGPAVFLAQFMDDKAPFNSLDGLCKWASDLGYKGIQIPTWESRLIDLTLAGESKMY
CDELKGKIGEYGLEITELSTHLQGQLVAVHPAYDIMFDNFAPNDCKNNPKKRTEWARNQV
IAAARASKHLGLKAHATFSGALLWHTWHPWPQRPAGLVEMGFEELAKRWLPLLDEFEENG
VAVCYEIHPGEDLHDGVTFERFLKETGNHKAVNILYDPSHFVLQQLDYIEYIDHYHEFIK
AFHVKDSEFNPTGKKGAFGGYGDWKDRAGRYRSLGDGQIDFKTVFSKLTEYGCDVWAVME
WECVIKSPEQGAREGAKFIKDHIIEATQKRFDDFAGSEIDKEKLKKILGL
>OMIFANIC_00539 hypothetical protein
MRKLIHAFMISAVLVSCKENKNDTEENEVAGKYEAVLIDVRNTEIPGDIDPDVLMEDTLL
ADMNLTEKSQFWGEKKDFALFAMGSIKFPESGLYYFRLTSTGKITFKLNNKDLVVNTAIH
DTETNNGEAYLDTGSSIFEYEYYPAFKEPYLVLEWSKDGKTYEVVPTEAFDNLDAFSVAN
WEGETSETEEGKIPDNTLSEKEKEEGWQLLFDGSTTEGWHTYNKPGQIGRKWKAENGALV
FEGRPRFEFYVSGRKIELGPTDKAADGGQDIIYATPFENFELKMDWWISEAGNSGIFYTV
QSDTIYDEIWKTSPEMQVMDNAKHKDGLINKHRAGDLYDLIAANPIRVKKQGEWNSVKIV
KNQGKIEHWMNGIKVLEYDLNSETWKDMFSKSKFKDLNEYASKGPGHIGIQDHDNEVHYK
NIKIRVLE
>OMIFANIC_00540 hypothetical protein
MIRNILLLFLFCSFLSCSQMKDIAKDDQSNQNWITLFDGSSFGNWRGYLSDEMPSEWTIE
DDAMLFTPSDRGGKNIITREKFTNFVLSLEWKVSEGGNSGIFWGVFEDTKFPEPYQTGPE
VQVLDNENHPDSFLREGRRKAGAIYDLVAYPGEFVNPAGSWNLCVVEINYNTSLAKVTMN
NKESVEFPINGPEWKELVRNSKFKDWPGFGIYHSGHISLQDHGNKVWYRNIRIKKLD
>OMIFANIC_00541 hypothetical protein
MPKRISRFFAHHFTTGRTCSMIGIYNKVITQWHDLVSKGVVEMAGELLFGQFGNNVLCKI
GSSHISNEQGIPGDDPMLFAVLINQ
>OMIFANIC_00542 hypothetical protein
MILGLIGGGGSILTVPVFVYLLYINPVTATAYSLFVVGVSALVGALRNIQKGLVDFRTAI
VFSIPAFIAVYITRKFIVPAIPETLFSIGEYTVSKNVGIMLFFAIIMLVASFSMIRSNGK
KDLQVEKVSFNYPLIFIEGFVVGILTGIVGAGGGFLIIPALVLLAKLPMKKAVATSLLII
AIKSLIGFIGDIETMEIDWEFLLFFTGTSVAGIFIGVWLNKFIDGKKLKKGFGWFVLLMG
IYIIFKEFSS
>OMIFANIC_00543 Global nitrogen regulator
MISELKESYGAHFEDALISEINQVGTFKEVGAGQKLMEIGEYIRSMPLLVSGAIKILRED
EDGDELLLYFLERGETCAMTMTCCVGQTKSEIRAIAETDAKLVMIPVQKMEEWTAKYKTW
RNFVFQSYHDRLEELLKTIDSIAFLKMDERLLKYLKEKVHITGEHTIRNTHQEIAYELHT
SRVVISRLLKKLEKLGKIKLHRNSIEVVSL
>OMIFANIC_00544 hypothetical protein
MRLKQIVLRKDVARVRRNYPLAIYIAFISAFMVSYSVVTAIQYF
>OMIFANIC_00545 hypothetical protein
MLRPFIFALLGVIMLISCNQKADTTTPEEEVVTSTYYLIRHAEKDRSDPDNKDPMLTEAG
KARAERWKSYFDTIALDAVYSTSYNRTYSTARPTAGKKGLAVIPYNVQYVFSQDFRNDTK
GKKVLVVGHSNTAPPLANKLLGSDKFPDMEDNDNSSLFVVTITDTKADVEVRTVL
>OMIFANIC_00546 hypothetical protein
MKYILALLICTCLGIQAQTPTYVAAVESFQRSYNEKDADAIFNSFAPLMQQSVNLKTTEQ
IVNSFQSRYGEMKSFDFKQSEGAMETYVAHFERGKQNMQISLNNEGKMRGLLFKPVTESR
PPKFERNTTKLGIPFKGKWFVVWGGDTKAQNYHVSFPAQRGAFDFLILGKGNKTYERSGT
RNEDYYAFGQPLYAVCDAEVHDVITGVEDNKPGDMNPAQPLGNAVILKTSNDEYIFYAHF
EIGTIKVEKGQIVKKGQYLGNCGNSGNSSEPHLHLHIQDGPDIYSDVGAKCYFESILVNG
EVKTDYSPVRLEVIAPPEE
>OMIFANIC_00547 SsrA-binding protein
MPLMAIQKKVQIKNKKARFEYEILDKYTAGIVLRGTEIKAIREGKASIAESFCEFSNGEL
FVINMTVQEYSHATHYNHNPKQERKLLLNRSELKKLEKEVKNTGLTIIPLLLFTTEKGLA
KLEIALCRGKKQYDKRESIKERDTKRDLSRIKKSFNN
>OMIFANIC_00548 TonB-dependent receptor SusC
MRIIGINSFMNQTLLLLFLLFSLQLSAQIAGKVTNGSGEPLPYVNIYLEGTYTGTTSNED
GNYELSVTEEGNYTVVFQFLGFTKVIKEISVDSFPYILNITLKEQTTSLDEVVINTSEDP
AYRIIRNTIAQRKANLDRISEFKADFYSRGLWRVDSIPEKFMGQDVGDFDGQLDSTRTGI
VYLSETISKIAFRQPDDFKETIIASKVSGNDNGFSFNSAMDAEYSFYENTADLNAAIVSP
IANNALSYYRYKLDGVFYEGNKLVNKIIVTPRRPKDRVWTGIIYIVEDDWELYGLDLTTN
GQAIQIPFVKELVFKQNFSFDPKNKFWVKRSQTIDFGFGFFGFNGDGRFIAVYSNYDFTP
QFKERSFTNEVLSFEPEANKKDSLFWKGIRPVPLTDEELNDYIKKDSIQQLRKSKPYLDS
LDQKNNRFGALDILFGYTYRNSFKKWDISYQGPLPGVNFNTVQGWNGGVGLTYFKAFDEN
RTRWLSLFSRIRYGISDDRVRPAGGATFNFNRTNRLQLGVYGGNEVVQFNRSQPISPLIN
TISSLFFERNYMKVYEVNYANVRWSQELFNGLRMSATTGYEQRKPLFNTTDYVTIPNDKV
DYTLNNPRQPINEVLQPDIITHDIIKSSITADISFGQKYYSYPDGKFNIGNGKYPSLRII
FENGAGASIDDYNFSQLRAQLYQRINTGNKGEFIYRLKGGTFFNGDDISFADYQHFNGNQ
TRVGTSFNYTNVFNLLPYYDLSTNQSYFEGHIEHDFRGWILGKIPGINALNFNLVAGAHM
LSIDGNKPYTEFSLGIDNLGWGKFRFLRLDYVRSNYNGVGDGALIFGLKFLNLLD
>OMIFANIC_00549 hypothetical protein
MKLIIKHQRLLVVLILLLTITASAQNTIKPLKGYSNDIGNMVAMLEDLRGRVTRSVANLS
QDETDFLLDDKANRVGALILHLAATEKYYQVYTFENRSFNTEEQKQWEIALNLGDIARET
IKGKPIRYYLDIWNEVRAETKALLKTKDDKWFKSRVNGSSMNNHWAWYHVMEHQANHMGQ
IRLITKRTN
>OMIFANIC_00550 hypothetical protein
MKIMKKDFETKFTGWSFLAAAIMLWLGWALSPHHIGEYIVASDFTAVGEDLWLWIWMYRI
HIFGWVFMGIALFALVAATARKPYRVLILPGAGVAIIGTFTLAIASAYFYNFGAWGVGMT
EGKSATEIQTFMDSILYTNQYVTCFIRFGRVFSAVGLVLLGLSFIKWKLVGQWLGWLTVA
IGLATMVIIMGIPDNYEIYKPMFHVKVIWLLLMGVVILKNGIHLPKEKS
>OMIFANIC_00551 hypothetical protein
MFKDTDNKLVIERLTALWALNECGLGGFMHAVSSPFTGILVGGISILLISLIASNASKVW
PTLIKALSIVLLVKLSVSPHSPVTSYVAVSFQAFLGMLLFSLFSVNRITIVSLGAITFLE
SAAQKLLTLTIIYGQSLWESVDIYSAWVSEKLSFIDYALSSKSLIILFITFYSCAGIVVG
FLIVRIMKLMQSVETTAPYHFSIQNKTREVEKTKSKKRKKLIFFWAITLLIVLLPLLFFS
TEFNGWKGGLYLLSRSLIVLVLWYYVVGPFLLKGLDKLLSKRQSAYQSDIQNTLDLFPHL
RSIIQYAWKDSSSLRGLNRMQHFMARSIVYSIHFKSSNE
>OMIFANIC_00552 hypothetical protein
MIFILKGDIETGKSNALLQWTEGRRDVYGVLSPRNDKGERYVLNVNTKETIAMQAHQGGD
SIISVGRYHFFSSAFIYANSVILNTLKNYKSGFVIIDELGKLEMNSDGLHGSASIAIQKT
NHNNDLHAILVVRTTLLESIREKYNIPNCKVITTEDLISGCLENVTIVT
>OMIFANIC_00553 Sulfoxide reductase catalytic subunit YedY
MKRREFVKKATLSSFTALIGAELVFGSKMLEGYKPLALQDPDPFKMFNKNPEMVVLNDKP
WNIEAQAHLLDDKITPNSCMFIRNNGFVPEGIDPNSWTLTIDGESVVREKTYTLAELKSK
FQHHTYQLTLECGGNGRSEFDPPAKGNQWTVGAVHCASWTGVRLKDVLEDAGIKSSAVYI
GYHAVDKHLSGDPKKEPISRGCPMSKALQDETLLAFQMNGKDIPLVHGHPLRLVAGGWPA
SVSGKWVDRISIRNKVHDGTKMTGTAYRVPCEPVAPGEKVKDEDMCIIESMPVKSLITYP
KTGAMINKGKALKIRGHAWAGELEVAKMEYSIDFGSTWTECSVEKPANRLAWQHFSANVE
FPKSGYYEVWARATDSNGISQPMLLPGWNPKGYLNNACHRIAVKVK
>OMIFANIC_00554 hypothetical protein
MAREDVFREQVKKVYRLLMLILVFSVLTGGVLVYFTVNPGFLDFNQTTAELVEVPVEVDE
DLIENGIHVRTGLVEADGLMEVVNNCTACHSAKIVTQNRMSAERWNATIKWMQETQNLWD
LGGNQEIIVNYLVTNYPPSAKGRRMVLTDIEWYELKD
>OMIFANIC_00555 hypothetical protein
MEKYLDAFVNAFLGTVEWTWKSIIFEVPWYTNFFWGLVVISLVVWLLEIAFPWRKEQSII
RQDFWLDAFYMFFNFFIFAIVISGIYEILGLLFGEFNVTAKSLSLIDITGWAPWLQLLVF
FIILDFVQWFTHVLLHKYPFLWKFHKVHHSVKEMGFAAHLRYHWMENILYKPLKVFGVMI
IGGFEPEQAYIIHFIAIAIGHLNHANIKITWGPLKYIFNNPVMHLYHHAYVLPKGSYGVN
YGISLSLWDYIFKTNYIPEDSGTIEIGFKGDDKFPKDFLHQNLYGFKKGQR
>OMIFANIC_00556 putative MFS-type transporter YhjX
MSNYFSREKSIAKSNYNRWYVPIAALSIHLCIGQIYAFSVFNKPLTKIIGITEQLPEDWK
LTELGWIFTIALFFLGASAATFGKWVERVGPRKTMFVAALCFSSGFLISALGIYLHQLWI
LYLGSGLLGGIGLGLGYISPVSTLIKWFPDRPGMATGMAIMGFGGGAMIASPLSVKLMEY
YASGTSTGVMETFITMGLIYLVLMMFGSIIVRIPQEGWKPKGFNPEKKKQAKLITSENVL
VDNAMKTPQFWLLFTVLLMNVSAGIGVLGQASVMIQEMFSVSSVGAELAVDATAAAMFVG
ILSLFNMVGRFFWSSLSDYIGRKSTYAIFFLLGIALYITVPYAGKIGSVVLFYAAFGIII
SMYGGGFATIPAYLRDMFGTKQVGAIHGRLLLAWSLAAIVGPVTLNYLREYQIEELGIPP
AEVYSLTMYLMAGLLLIGLIANLMVRPVNSKYHDKS
>OMIFANIC_00557 Formate--tetrahydrofolate ligase
MTDLQIAQSVKEEHIRDIAAKLNIKEESLEFYGTNKAKLPLTLIDEKKVDQSNLVLVTAI
TPTPAGEGKTTVSIGLGDAMNINGENALTVIREPSLGPVFGIKGGAAGGGWSQVIPMVDI
NLHFTGDFHAIEKANNLLSALIENNIQTKKRNLGIDPRTVLWKRCMDMNDRGLRNIVAAL
GGKAGGMPRETGFNITAASEIMAILCLSKDFEDLKEKCGNIYVGDTWEGKPVYARDLNAH
GAMAALMRDAIKPNLVQTLEGNPSIIHGGPFANIAQGTNSILATKMGLSLSDYVITEAGF
GADLGAEKFMNIKCREAGLSPKTIVLVATIRALKYHGGKPLNELTNEDTEALKAGFPNLE
RHISSLQSFGVPVVVAINTFSSDTDAEKQALMDHCDTLEVPVALSNGWAEGGKGCTDLAK
KVVEAVKTCKGVFTPTYSLEDSPRRKMEKICSTIYGAENVILTNKANRQLKRFEELGYGK
LPVCMAKTQKSLSDDEKQLGRPRFFDIHIREIEIATGAGFMIPIAGNILRMPGLPATPAA
ENIDIDGDGNITGLF
>OMIFANIC_00558 hypothetical protein
MLYAVLVLNNIIYIQGQAPDKIAILLTGLYQSLGM
>OMIFANIC_00559 hypothetical protein
MNYYFNTTLSNTTFEEAIERTIEELKKEGFGVLTEIDIQSTLKKKLDVDFHKYRILGACN
PPFAYQALQAEDKIGTMLPCNVIVQEKDAGKIEVSAVDPMASMVSVENEALGGIAHEVQE
RLKRVIDNL
>OMIFANIC_00560 hypothetical protein
MENNHINYIEFKAPDLEAVKKFYSGCFGWKFTDYGPTYTSFSESGIFGGFEKSGEAVING
ALIVLYHEDLELILEKITSAGGKVVKPIFSFPGGRRFHFTDPAGNELAIWSDH
>OMIFANIC_00561 hypothetical protein
MLLTDHFKSLLKSFNVTQSTIDTLWGEIETHYSEGHRYYHTLEHLDNVLKELIEVKDSIE
DWEVLLFSLFYHDIIYDTQKSNNELKSAEFAEKRLQTLRVPKEKIEKCKAVILATSSHEL
SDDHDINCFLDVDLSVLGRAREVYEKYSEDIRKEYSNYPDLLYRPGRKKILTHFLGMDRI
FKTKYFSEKFEVQARKNLQWELENVK
>OMIFANIC_00562 Immunogenic protein MPB70
MKKLILILTTILAFGVSQNALAQKQSIVDIAVSNEDFSTLVTALQAADLVGALQGDGPFT
VFAPTNAAFAKIDANTLNSLLEPKNKATLSSILTYHVVPGKLAAADVVAALKKGNGKAEV
KALSGATLTVVQKDGKIWLKDENGNYSQITSTDVMASNGVIHVIGDVVMPK
>OMIFANIC_00563 ECF RNA polymerase sigma factor RpoE
MQEELTLINQMKARDERALSALYDNYSGALYGVIIRICRNEAHAQDLLQETFIKIWQKCD
SYDPEKGRFYTWAYRIARNTTLNSLRNRPDLIQNEDLSVYDNKEEQDDTPIDLTQLNGSI
KKLEAHHQEALGLVYFKGLTHREAHKEMDVPLGTFKSYVRQALTQLRKSYELLLVVGIAL
LERIL
>OMIFANIC_00564 hypothetical protein
MKETHDIIESGILERYLLGELSKDEMASLEYSLEADSELKAHFQQLELDMEKMAMENAVT
PSGNVKQALFRQLEGDTDKKIIKINSRKPTRTYTAIAASLAVLFLLSSFWLYQKMSGIQE
DLRVVREQNDLLLDENEDLVKNYDETIQWLEELNSADTEKLIMKGNDLMPEARAISYVNH
KNKTVILNAAGLPELPADKDYQLWADVEGEMIDMGVIPKDTDMAVMTYIEEAESLNITIE
PAGGNDHPTVSNLITFATIEP
>OMIFANIC_00565 Beta-lactamase
MRFLSILLFSIFLIPIKSDAQILEKIKKTKDKISAVTIDKLSRDPITTSFKDVDKSEVLG
IEFGNDRAYQSFFEQLFDPNRGFTLEPGYYEGTFQSFCIKAGTTPPVEGGGRFYAPIKGP
KADIMTAIIDGYQGNPEITQREVQLLLWAIIAKADFTKMKGPVKVTAIKLLTPSQIARLS
KGALDKLTRNELKKVANETPAVRAILEAEDNLRRKFYAGAKSYQEYEEIAMLAGVEPIVP
GFEAGRWTKHPEGYYIRYFPKGYAQTRTQIYIPESTGTTQFNPSTDIAVPPNRGQRLLQT
NLPTGNPSSNTGGYVNTYPDPFCEPAFDPIVDNAVRKQMIMQNVPGLAVAVFKEGKMIHI
KGYGYSNYYSKTPITTGTKMHWASISKSVTGVAAAQLEERGINNFSVNDKITEYVDRDTW
DKVKYTDTTGIKSEDKRPLDITLGQLLNNTSGIQHYGKGSGSGDDELYAKIPKGDKVHVV
AFERNTDAYGDRDNGPRGWKAKEAVDIFNMSVLNDDPGMRYLYSSYGFVLAGAAVDKVSP
DGYHPWVKENIIKVADLRSMDYCEEKGPGHHMNQDGMLITSDLGCNQPVLPAGGYESNIC
DLAKYAYALSTGKFLDSNKTVLWDNMVTVSRSSSDATRGYSYGLNFEGTGKDLRVWHGGK
HNNVRSHMEFFPADSTGIVLIAPAVYSELPRLARYIRQELSLHPESSNINGDTPRDRCRS
NMENGEDLFHGVWRKTSDDVLIRTGYEKRGFFNQMGFLKNNGYEVVDIETYKNGGKRYWD
AVLKEGQPDSKLVSDLKLSELKDKINSMKGNGYIVTDIESYIAGNSGRLWGAVFSKENKR
NKTAFKMTRQEFLDQHQANVANGYALADVESYPAGNVFHWTGVWVEGGQTKLEVNKKPKD
LFDEMESMRNQSYRISDVEYYMLSNQEWRVAVVWEKSTDDEFITGEVADLDGDGDDDGGS
LTLHEFCDHMSEHELLSSLGYELIDWERIDIEWFDD
>OMIFANIC_00566 hypothetical protein
MDSAGVTNQITNVTWVKNAIRMLFNTRGGKNMTDN
>OMIFANIC_00567 Protein-L-isoaspartate O-methyltransferase
MKDDFKHKGMRKKLVETLIKKGIADESVLDAINSVPRHLFMDSGFVSHAYVDKAFPIAAD
QTISQPYTVARQTELLEVKKGDKILEIGTGSGYQTAVLLEMGAVVYSIERQNELFKKTKL
FLPKIGYRPKKLIFGDGYQGYEEEAPYDGIIVTAGAPSVPKVLLSQLAIGGRLVIPVGRS
LQIMTVYMRKGPKEFDKKEYGEYRFVPLLEDKN
>OMIFANIC_00568 scyllo-inositol 2-dehydrogenase (NAD(+))
MEFYAGISEKNESVNHEHRPHIFFKFYYLCAKQDHMLKAGVLGAGHLGKIHLKLINQSNR
YELIGFYDADTEASAAIEEEFGYKSFPTMESLIEACDMIDVVTPTVAHFDCAEKVVTAGK
HLFIEKPITHTVEEANNLLALARKHKVKGQVGQVERFNPAFMAVKDMIDNPMFVESHRLA
EFNPRGTDVSVVLDLMIHDIDAILSVVDSEVKNVHASGVSVISETPDIANARIEFENGCV
ANLTASRISMKKMRKARFFQRDAYISVDFLEKTCEVVKMKDAPKDPDDFAMILTNAEGIK
KQIYFDNPEVESNNAILDELETFADAIENNTTPVVSLQQGTNALRVAMQIIENFKKL
>OMIFANIC_00569 putative 3-hydroxybutyryl-CoA dehydrogenase
MKNVAVIGAGTMGNGIAHTFAQFDYKVQMIDVSQAALDRGLATITKNLDRMVAKERITED
EKAQTLANITTYTSLEEGVEYASLVVEAATENVDLKLKIFKDLDKFCPEDTILASNTSSI
SITQIAAATSRPEMVIGMHFMNPVPIMKLIEIIKGYSTSGETYATVEEISRKLNKVPVEV
NDYPGFVANRILMPMINEAVETLYNGVAGVTEIDTVMKLGMAHPMGPLQLADFIGLDVCL
SILKVMYDGFKNPKYAPCPLLVNMVTAGKLGVKSGEGFYDYSETRKAETVSKMFQ
>OMIFANIC_00570 hypothetical protein
MPKILPFKAVRPTRDKVCLIASRAYDSYTREERDARLRDNPFSFLHIVNPGFKYHKVISG
KERYKLVRNRYQEFKEDGIFIQDQNPCYYVYKIVNRDGLVFRGIVAATSVEDYKNDLIKK
HEDTIEFRETMFKDYLKTVGFNAEAVLLTYPDNSEIKQIIDEVMVSRAEYEFTTTYKDTH
YLWCVDDTKVVEEIARLFQAMPEIYIADGHHRCSSSYLLAEDLKKENKSHTGKEPYNYFM
SYLIPESDLKIYEFNRLITDLNGMSNEEFLIHLDTMYRIEERGAEYYKPSKKHHFSMYLD
GSFYSLYLRKHNYEISNALDALDTQILHSTILKPILGIEDARNDKRLNYTHGKMDMAFVK
SMVDSGEYKVGFGLLPITVSEMKNIADEGHTMPPKSTYIEPKLRSGVTIYEF
>OMIFANIC_00571 hypothetical protein
MSISENIKEFKTGLPDGITLVAVTKTKPVSEIMEAYETGQRVFGENKIQEMEAKWRKMPE
DVEWHMIGHVQRNKVKYMAEFVSVVHAVDSLKLLKEINKQAAKHQRVIHCMLQLKIASEE
TKFGMHEEDAKALLNSEELKALENIKVVGLMGMATFTDDEEQIRGEFQRLKNLYDSLKER
YNFSELSMGMSGDYKIAIAEGSTMIRVGSAIFGARNYG
>OMIFANIC_00572 DNA polymerase III PolC-type
MYAIIDIETTGGKYNEEGITEIAIYKFDGDKIVDQFSSLINPERRIQPFVVNLTGINSEM
LRNAPKFYEVAKRIIEITDGTTIVAHNAQFDNRILTTEFDRLGYNFEKDTLCTVELAKKL
IPDLPSYSLGKLVRSLGIPLSDRHRAQGDAKATVTLFKMLLAKDVSKEIIQKSVRKDPKR
QLEPKLLDIIDKAPAETGVYYMHREDGTIIYIGKSKNIKKRLVQHFTNDSRKSKQIQLNV
AAVTYEKTGNDLIAQLKESQEIKRNKPVYNRALRRTMFTYQLTSYTDSSGYINLKVEKAN
LEKEAIITFTNYQQARSSLHRITEANQLCQKLTGLYKTEKSCFLYSIKECYGACVEIEPT
DTYNDRVRTFIEKNSYDNKHMLIIDKGRDVDERSVILIENGQYKGFGFYNLNYQINNIEI
LRTIINPVENDRDSQHIIQNYLRKNKVLNIVKLPEEAAI
>OMIFANIC_00573 Cyclic nucleotide-gated potassium channel
MNSKPHAAWRRQLHDIIYEADTPMGKLFDVILLILILLSVFFVMLESVTGMPDYIYRWLY
YGEWVITIFFSFEYIARIITVKKPSRYIFSFYGVIDFLSTIPLYLSFILVGSNYLLTVRA
LRLLRIFRILKITRYIKESNKLTRALLHSRAKILIFLFAVLIVCIIAGTLMYLIEGEESG
FKNIPASIYWCIVTLTTVGYGDIAPITPIGQFLAAIIMIMGYGILAVPTGIISAEYAKSD
EYVHVNSFACPNCNSSKHRDDAEFCHRCGEKLHPDEF
>OMIFANIC_00574 tRNA dimethylallyltransferase
MPSPNTLICVIGPTAIGKTALAVELAKAFDTEIISADSRQFYKEMTIGTAVPSKEELAAI
KHHFIQTKSIKDTYSVGDFEREALDLLSELFQKKDVVVMAGGSGLYLDAVVRGLDDFPEV
TPEIRNQLKDELEQGGIEYLQSELKEVDPESYARIDIQNKQRLIRALEIYRGTGKPYSSF
LNQKSTKREFNTVFIGLTTERTIVYARINERVDQMISSGLIEEARSLYPFRHLNALQTVG
YKELFQWFDNELTKEEAIAEIKKNSRRFAKRQGTWFRKNEAINWFDYRTKPKEIISFLKE
KKGL
>OMIFANIC_00575 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
METENKKILLVEDDPNFGTVLKDYLAMNDYDVTHAKNGMEGFEKFKKDDFDLCILDVMMP
YKDGFTLAKEIREKNEDVPIIFLTAKAMKEDVLKGYKVGADDYLNKPFDSEVLLMKIKAI
IQRKATDSIADSKQFEFEIGNFHLNSKLRFLTFNKEEPIKLSPKENELLRLLALHKNDLM
PRELALTKIWRDDNYFTSRSMDVYIAKLRKYLGKDNGVEIINIHGEGFRLVVKDEVDQ
>OMIFANIC_00576 Sensor protein kinase WalK
MLKSYFWDMNKRLFILLIALMSLSLLGIIFVQGYWISNSYRDKEEQINYNFRQVLNEVAK
EVQVGEIEDYYRIYSGLADSLETPENINFSELVYTTQSDKSNETYIFSDGILEEDYKLSS
SFLDTEIDSILFKRIINTKSTTKVISGLDGSGTVSQMVESFSRLKDYERSSFENAFKNIS
SRTPIHKRVSVEEIEELLQKGMEKRGLKSDVEFAVYSNGLSTRVHSRNFEFDADKILATP
IFVNEEMKIGYNLLVNFSEKKKTALRSIMGMAILSLIFTSVIVLAYSSALSQIFKQRQIS
QIKSDFINNMTHEFKTPIATINLALDALKNPKAKGDEEFVDRYLEMIRDENRRMHAQVEN
VLRISKLEKNQLDLPKDRIKLHDVVQNAVSHVSLIVEDRNGYIKTHLGALKSSVLASESH
LTNVIVNILDNAIKYSEDEPKIDVYSENVKDSIIIKIRDQGIGMTKSVQKKIFEKFYRES
TGDIHNVKGHGLGLAYAKRILDDHDAEIYVESEKGKGSTFIIKLHLIS
>OMIFANIC_00577 Dephospho-CoA kinase
MRIIGLTGGIGSGKTTVAMMFSELGIPVYIADVEAKALTNRSKVIRRKLIELLGPEAYSN
AAVNSSFVAEKIFNDPELLQQVNKIIHPKVAAHFKRWLKKQDSPYVIKEAAILFENGGYK
QCDKSILVTAPLGLRMKRLLARDKSSKREIEARMANQWSDSKKKKLADIIIENIDLEDTQ
KQVNEIHKELSRSR
>OMIFANIC_00578 hypothetical protein
MAPKKYNTKKIRTFLLFLGVACIIWVLTKFSKEYTATITGNIEYTGLPENSVLNEENADE
LSFEVTANGFKFLQYQLNTPQIRIPLGSYTLTENDNVILESRDLNRLITTELGNDVSISN
LSLSQLVVSLDRVASRKIPVVAKMNLTFREGFRTVGGPLITPDSVMIFAPGDVLSEIDSI
ATSELALTDVHESVGMNLKLDVPENSKYRVEPAEVDLQLKVTEYTQKTVSVPIEVINVPS
GTTLKIIPKTLTISFDVAMEKFNDISATDFTMICDFAQKNAEENFMLVEMTKQPEAIFNV
EFSEKKIDYLIFK
>OMIFANIC_00579 Putative glycosyltransferase EpsH
MELSFSFIVPVFNRPQEIRELLESFSSLEFAGAYEIVIVEDGSTDTSKEVVESFDSLLNI
SYYYKENSGPGDSRNYGMARAKGNYFIILDSDVLLPPHYLDTVSNYLSNKYYHCFGGSDA
AHSSFTPVQKAINYSMTSFLTTGGIRGNKRQLSKFEPRSFNMGISREAFEKTQGFAKIHP
GEDPDLSHRIRKAGFETTYIPNAQVYHKRRISWSKFYRQVMKFGLVRPILSKWHPDSAKI
TFWFPSLFVLFVMASILFSFIVNWLFILPVLLYLGIVFVDATVKNVSISIGLLSILAVFV
QFFGYGLAFLKSTLYIRVLNKQPEKQFPQLFFK
>OMIFANIC_00580 hypothetical protein
MKNLKFILPLALIALVVSISLTSCEQREDWRFPELGNGGFIKFVTQPETWTGSDVSDGTS
IVKYHIGADPAESAFEAFVEDPNGNIANVDFFVMGDFEGAPDDALPFGSTTSFPYDVSFT
TADMAALFGVDATVFESGDFFEFMTVINTTDGRTYISRVAECDECPLEAGDPNGSGVWNG
GTIDAVLLQGGDTGDNFLLPAVWYRVKYLAE
>OMIFANIC_00581 Putative TrmH family tRNA/rRNA methyltransferase
MKKESLIFGIHPVLEAVRSGKPIDKLYIQKGSTNDKIDAILKLIDTDAVSINYVPVEKLD
RLIRSNHQGIVASISPITFKSLEVVVEGLLESKEDPLFLILDQVSDVRNFGAILRTAECT
GVDAVIIQKKGGAPVSGDTVKASAGAIFNLPICKVDHIKDAIFYLQGSGIKTIAATEKTD
NSIYDIDLTGGLAIIMGSEGKGISKSVLSIVDQSASLPLLGKINSLNVSVASGVILYEVI
RQRMH
>OMIFANIC_00582 hypothetical protein
MAKKNKLEFTSDVIIYPLIMVLSLWVVFWAEFRFGWHLKYYGIYPQKLEGLRGILFGPFL
HSDLQHLFNNSIPLMVLTTALFYFYRDIRWRVLILGALLTGLMTWIIGRPALHIGASGIV
YLLAAFLFFKGIFSKQYQLTALAFVVVFLYGSLLWYVFPIDPKISWEGHLSGFAVGFVFA
LLFRSNPIPKRKFAWEEESYDPENDPFLRHFDEEGNFIENLPEEEPASEEPKNIIIRYTI
RKSRDDKKDSSD
>OMIFANIC_00583 Replication-associated recombination protein A
MHKPLAERIRPSSLEDYISQEHLVGPNGALTAQFNSDMLSSMIFWGPPGTGKTTLASIIA
NTSERPFYTLSAVDSGVAAVREVINRAKKSDDLFAVKNPILFIDEIHRFSKSQQDSLLGA
VEKGWITLIGATTENPSFEVIPALLSRCQVYVLKPFSKSDLEALLERAIKTDEVLLQKKI
NLKETEALLRLSGGDARKLLNILELVVLSEKSDDVEITNDIVQNKVQKNTVLYDKAGEQH
YDIISAFIKSIRGSDPNAAVYWLARMIEGGEDVKFIARRMLILASEDIGNANPTALVLAN
STFQAVNTIGYPEARIILSQCAIYLASSAKSNASYKSIGAAQQTVRQTGDLSVPLSIRNA
PTKLMKELGYGEDYQYAHNYEGNFVPHEFLPEEIKGTTFYKPGKNKRESALRNYLKDLWK
DKYDF
>OMIFANIC_00584 hypothetical protein
MIKKIALLLLLSSFISTTYGQKSASDYSYIVVPELFEFLFEEDQHQLNSMTKFLFNKYGF
NAYFPSELPNVKRCDGLQAEVLGKPGFVYTRITVIIKDCYGEEIHRSEEGKSKYKEYKKA
YQDALRKAFTSIEGLGVRQKEVVAYEDDLSTYDEVNDETAKKSSGTDAKISVLGMTNFPG
SKFTSYELGGKSYLLRKTMEGYSFYEESEDAPNGLLLKGVIVIKEDKAIYTSTEGVEHNA
GFMESGDFILESAGSIIRYNAAN
>OMIFANIC_00585 hypothetical protein
MRNVLTLTLALGLSVCFAQNKQLLYGFDEVPQSLMLNPGTKVPQKKHFGIPFLSQLHING
GSSGVSVFDIFGESNVDINTRIRNKIFELKNSDFFTATEQLEIINFGWRANNEIYFSGGI
YQELDFISYFPRDLAILAWEGNRDYLDYPFNLGEISATADLLTVYHFGANKQLTKKLTAG
LRVKLYSSMLSARSVDNQGTFVTTLGGPDSPNIYEHTVTNANVTLNTSGIASLDGMDSSE
IPGEIIGRAFFGGNFGLGVDLGATYDINNRLSASASLIDVGMIFHGKDAETYEATGTYTL
DGIELIFPPLSAGQPTLPYYDNLEDELEEEIPIDTITSGYTQFRPLKVNAALKYSFGKTV
GKGAECDCRNMGGGIDRAQAVGAQFYSIFRPKGPQMAGTLFYYRRLWDFLAAKATYTVDS
YSYSNVGLGMVTDLGKFNFYIAADNLLHYGNLAKAKSVSLQLGFNIKIDEE
>OMIFANIC_00586 hypothetical protein
MKKNLLKPLTVIFLCFVAFACVKDTDFDQAEEIALTPVVELDLIYFNIEAGEFYDEVNNI
PIPTLTDTTEIRFLDDTEIQESLRRADFFFKFTNSIPRNFQVDFQFLSEQNDTTYATQTS
VAEGSVQTPVITEFEEIIEGDDILQVTMANRIVVSVTIPDANPDLEGTLNLQSKTTYYLE
IRDRE
>OMIFANIC_00587 Pyrimidine 5'-nucleotidase YjjG
MPDTITDVFFDLDHTLWDFDRNSALAFSRLFRTHAIEIELSEFIEVYEPINFAYWKLYRE
DRVSKQELRRGRFRDAFEPFGMSYSIAQLDAMAVTYIDELPKDNHLLNGAWEILEYLNPK
YQLHIITNGFAEVQALKLQNSRIAHFFDTITSSEEVGLKKPHPVIFETAMDKASVPPRRS
IMIGDTFEADILGAEQVGMDTLFFNYRNDNVPETYKVVNDLTEIKSHL
>OMIFANIC_00588 hypothetical protein
MLLIFTQNLTPRIDFIFKHICQRILGLEIGFTSVIEEFIGHQGPKLSYTKQPMGNELFVQ
SYGLLEQVGVEDLEINVKPWEDTYGFFAVGEKSALPFDIFSSAFFLLSRYEEYLPHVKDE
LGRFPAIESLGYKSGFLMQPVVDMWAYKWKQVLQRAFPNMAFPKRQSVVHSLLKIEQPYE
FINKGFVRSGAGYARDISKFRFRTVFKRTRVLLGVNKDPLNVYDWIISVSKSGENKLTAF
FLLGDHPNLRHGFNSRRKRFKSLLKYISDYNDVGLLFSYHALSDLEALKYEKKQLEDITH
RRLASAMNADYLVMLPELYRIFVEQEIETDYSMVYEDTPGFRAGTCTPFLFYDLDYEIKT
PLIIHPIAFTTEGFNKKYESDSLQRISALYDLVMELNGTFSVFFNIQDFSEQKSNAIWRN
LFSEKLNPNA
>OMIFANIC_00589 hypothetical protein
MYTNKSSFTIKSWNEDDRPREKLLNKGRTVVSDAELIAILIGSGSRAESAVSLSKRILSA
VEFNLNALGKLSIKDLCSFNGIGKAKAVTIIAALELGKRRRIQAALDLKKIASSADAFEI
MQPVIGDLHHEEFWIIYLNNSNKVLQLSQLSKGGITGTLVDIRLAFKEALNVGAVSIILA
HNHPSGTLKPSESDTKLTAKIRKAGESLDINILDHLIITEKAYFSFADEQML
>OMIFANIC_00590 hypothetical protein
MSNARHNNSYEMGSENAELRFVATFPKIIN
>OMIFANIC_00591 hypothetical protein
MKSLLDQETFKEVKDRLNKLNENSERQWGKMTHGQMAKHCQRPLEIMLGHNNYNLKPNWL
VNVFFKKSMYNDKLWRKNLPTVKRFKETKERDFAAEKAKLNTMLDELGSQLNKESWGDHP
AFGKLTNEQWGKMQYKHLDHHLRQFGV
>OMIFANIC_00592 Protease synthase and sporulation protein PAI 2
MYPPPHHQTNDRRKMIAVMKAFPFALLVTASKDHPYITHIPIIYNETSGRLVAHIDATNP
QVETLNDGNAATVVFKGPDTYISPSVYSTEQLPTWNYIIVHITGVIHRITDPKAVKKTMI
DMTDFLEGNDPKFVLKKDNPKMDRMVNYIKAFEIEITNWEGKFKLSQDKIPQDYELAKEA
LIQNTQRDYKEFINSIYKNL
>OMIFANIC_00593 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MRVHFIAIGGSAMHNLALALHEKGYAVTGSDDTIFDPSKSRLQKKGLLPEAFGWFPEKIN
PDLDAVILGMHAKADNPELLKAKELKLIIYSYPEFLYAQSKDKTRVVIGGSHGKTTITSM
ILHVMHYHEREVDYMVGAQLEGFETMVRLTEDADFMVLEGDEYLSSPIDRRPKFHLYKPN
IALLSGIAWDHINVFPTFENYVEQFRIFLDQITKGGAIIYNEEDPAVKKVVEETTNTIKK
YPYGTPAYQVQDGTTLLETPEGPMPVEIFGKHNLNNLEGARWICQLMGIDVDDFYEAIAS
FKGASKRLEKLGETSTAVAYKDFAHSPSKVKATTEAVKDQYPNRHLLACLELHTYSSLNP
EFLVEYQGALDAADTAVVFYSPHAVAIKKLDPISKEQIARAFQRDDLIIYTDPSEFKEFL
FAQDLGNNALLLMSSGNYGGLDFDEVKELITDSYK
>OMIFANIC_00594 Lipopolysaccharide assembly protein B
MKKLLFFLLFPGLLWAQTTFQEAEAFFDNEQFNKAKPLFQKFLKENPNHTKTREYLGDIA
GYAKNWDEAISYYEPLVEEDPRNANYHFKCGGAMGMKALEISRIRALGYIGDIKRHFETA
AKLDPKHIEVRWALVEYYIQLPGIIGGSERKAIKNANELLKISPVDGYLANGYIAEYTDR
PEDAERFYKKAIKVGGSPHTYEKLTNLYEKNEQPREAMQTAANSLKKHKRNSLNYQIGKI
AAQYNLNAELGIDCLQAYIKNYSVRDGVPKDWAYYRLAQIYKNIGRKDKALQWIDKALTD
RPDFPEAIQERHHILSL
>OMIFANIC_00595 hypothetical protein
MKSAMALFGILLLVSCGATVGVDYDEQIDFSEYTTYNFYPSIKSGLNELDDKRISKIADS
LLQMKGLTRSEDPQLFVNFFASEVLTNSRNTIGVGVGGGGRNVGVGVSGGIPIGGKIINQ
QLTVDLIDVARDDLVWQAVVDGEYKEKASPKQKEAYYNTVLSKILKKYPPGKNKREKK
>OMIFANIC_00596 GTPase Obg
MTEGNFVDYVKIHVTSGKGGKGSAHLRREKYIPKGGPDGGDGGRGGHVILKANKNLWTLY
HLKFKRHYKAGHGMAGGKQTSTGADGDDVYIDVPLGTAVKNTDTGELLKELMEHGDEMII
ALGGKGGKGNAHFKSATRQTPRYAQPGLEGEEGNFTLEMKVLADVGLVGFPNAGKSTLLS
VLSAAKPKIANYEFTTLKPNLGIVEYRDYQTFVMADIPGIIEGAAEGKGLGHYFLRHIER
NSTLLFLIPADADDIRKQYDILVDELRRYNPELLDKERLVAISKSDMLDEELKTEMKEEL
DRDFKDIPYLFISAVAQQGLQELKDKLWDMLNTDEKI
>OMIFANIC_00597 Adenylate kinase
MKNIVLFGPPGAGKGTQAEVLKEKYQLVHISTGDVFRYNIKNETELGTLAKSYMDKGHLV
PDEVTINMLNAEVEKNADANGFIFDGFPRTEAQAVALAELMEEKESQINAMVALEVDDEV
LVGRLLERGKSSGRADDANEEVIRERIAEYYRKTDILKNYYQKQDKYYGVDGVGSIKEIT
ERLSTVIDRL
>OMIFANIC_00598 N5-carboxyaminoimidazole ribonucleotide synthase
MYLCAMANYFSSEFTLGILGGGQLGKMLLYETRKYDIKTKVLDSSAEAPCRISCDTFVQG
DLMDYQTVYSFAQDVDLLTIEIEGVNVDAIEKLESEGLKVYPSSQTLRNIQNKGVQKQFY
TANEIPTSPFQLFDSLAELKNAVISNKRVVPFVWKSTTGGYDGKGVSIIRSAADLNALSE
GECIAEDLIPFKNELAVIVARSPKGEVLTYPVVEMEFHPEANQVEYVLCPARIDEEVAKK
AREIAEKVSIAYGHVGLLAVEMFQTNDDDILVNEVAPRPHNSGHYSIEASYTNQFEQHLR
AILDLPLGKTDSKVGGIMVNLVGAEGFTGDVVYENIEQIMAMDGVTPHIYGKKHTRPFRK
MGHVTIVNKNLAEARKIAEAVKNSIKVISK
>OMIFANIC_00599 N5-carboxyaminoimidazole ribonucleotide mutase
MSKVGIIMGSTSDLPVMQDAIDVLKGFDIEVDVDIVSAHRTPDKLFDYGRNAHERGISVI
IAGAGGAAHLPGMIASLSPLPVIGVPVKSSNSIDGWDSILSILQMPGGVPVATVALNGAK
NAGILAAQIIGSADKCVLDKVLAYKEGLKLKVEEGAKKLKS
>OMIFANIC_00600 Oligopeptidase A
MNPLLKKFTTAPFSKINNEHYLPAFKDLIQHTKVEIDAIVINDEKPGFKNTIEALERTGE
QLDRVSSIFFNLNSAETNDEIQKIAQEVSPLLTNFNNDLLLNEALFKKVKAVHDSKDELE
LSHEQAMLLDKQYKAFARNGANLKEADKLKLREIDAELSKLTLKFGENVLAETNVYELHL
TSEEDLKGLPDGAKEAAAHIAKDRGKEGWVITLDYPSYIPFMKYADNRKLRKQLSLAFGS
RAFKNNDHNNETNVLRIANLRHQRALLLGYDSHAHFVLEERMAETPQKVTSFLNELMEKA
KPAALQEFNELEQFAKELDGIDELQKWDSAYYAEKLKQKLFDLDDEKLKPYFELEKVIAG
VFSVANKLYGLNFTETKKVDVYHEEVKTYEVTDAEGAFVSLFYADFHPRPGKRNGAWMTS
YRSQQIKNEVNDRPHISIVCNFTKPTPSKPSLLTFNEVTTLFHEFGHALHGMLANTTYSG
LSGTSVYWDFVELPSQILENWCYEKETLELFAKHYKTDELIPMEYVEKIKDSSTFHEGMQ
TLRQLSFGLLDMAWHGADPSEIENVKAFESKTFESTRLYPDTPETCMSTSFSHIFQGGYS
AGYYSYKWAEVLDADAFEYFQQEGIFNKTVATKFKDYVLSKGGTQDPMELYVKFRGQKPN
PDALLKRAGLLKN
>OMIFANIC_00601 Bacterial leucyl aminopeptidase
MKKIILLSFTILLNICVFAQDTDRFYATMARQDARELKADAPDQIDILAEKGYEAVVFMS
PSAAELLHGRILVHGPGYIFKSSYDEAISSINKTITTTSSRMVFNITEDEKVNEALALMS
VQNIEDHIIELENYGTRYHTLAPGTQSAIDLKAKWEAMAALYGRTDVSVRLYNHNNTPMP
SVIMTITGAQFPDEFVIVGGHLDSTSNQGNNDAPGADDDASGIATITEAIRTLFEADFVP
QRTIEIMAYAAEEIGLVGSGEIAQEYSSNNVNISAYVQFDMTNYNGSANDVYLITDFTNS
SLNGFLMQLMDHYNASGAHQFTYGTSLCNYGCSDHASWHNEGYMAAFPFEASFGQHNPNI
HTPNDTFSISGTADHALKFAKLCVEFLVETAKHNGLIGVSEVSEELYDIYTSNNTLYYNF
DQYDATIDSIVIYDIAGRAIVAVDDPENEGNISLGHLSSGIYIVNVQTTYTEFVNKKIKI
D
>OMIFANIC_00602 RNA polymerase sigma factor YlaC
MGNELLHPENWVDRYSDYLYNYTIVRVNDHEIAQDLISETFLAGLKSKDNFKGDASERTW
LISILKRKIIDHYRKINSNKGKAEIRVKYTDEDSEGDWLEERVKDPFDRTAEDLLENEEL
GLAILKCMEGLDERQAKIFKMKTIENFDTEAICNEFNITPSNLWVIIHRARRSMAMCLEK
NWF
>OMIFANIC_00603 hypothetical protein
MNLGILFKCNEAAHICDKSQYKESSFIERLLMRMHQWMCAVCREHSSENTKLTEIIQKAD
LKTMPEKDKIELREVIQQEISK
>OMIFANIC_00604 hypothetical protein
MKYLKAVFNFYLDSSIHVALAVCSLLYLTVFEYDIEITQELVGFVFFGTITAYNFVKYAG
VARFHHRSLTEKLRVIQVFSLLCFGMLIYYFTLLPFTLYWIMACLAGVTFLYAVPILGRR
TLRKLSGLKIFAVALVWAGITVLVPWLAVAESITTDVWLTFVQRFLIVVVLTIPFEIRDL
RFDETALGTLPQKLGVITSKWLGVIVMYAGFSLDLFKDEFSCAHSSAFAITCFLCALALW
GANEVQKKYYASFIVESIPIVWVGLFYLLKYYFEISC
>OMIFANIC_00605 Glycine dehydrogenase (decarboxylating)
MNTDSFARRHIGPRKRDLPKMLEAIGVESMEQLVFETIPHEILIKDKLALDEAMSEQEYL
EHINRLAKKNRVFDTYIGLGYNEAYLPAVIQRNILENPGWYTAYTPYQAEIAQGRLEALL
NFQTMVSDLTGMPIANASLLDEATAAAEAMTLLFAVRERAQKKNNVVKFFVSDEVLPQTL
SLLTTRSKPVGIELVVGDHRDFDFSSEFFGAIVQYPGKSGIVFDYVEFIEKAKAAEIKVA
VAADILSLVKLKSPGSIGADVVVGTTQRFGIPLGYGGPHAAYYATREEFKRHIPGRIIGV
TKDLDGNRALRMALQTREQHIKRDKATSNICTAQVLLAVMAGMYAVYHGPNGLTYIADKV
HNAASTLADGLEQLGLFQTNSSYFDTLAIKTESEKIRPIAEAQKVNFYYPDAETVQISVN
ETTTLLEVNKIIGIFAEAIGKEPIEFSELQQGNAIPNEVARSTTFLQNEVFNTYHSETEL
MRYIKKLERKDLALNHSMISLGSCTMKLNAAAEMLPLSDARWGNIHPFVPTEQAEGYQIM
LKKLEDQLTEITGFAGTSLQPNSGAQGEYSGLMVIRAYHESRGDSHRNICLIPSSAHGTN
PASAVMAGMKVVVTKATEEGNIDVEDLRAKAIEHQDNLAALMVTYPSTHGVYESDIIEIT
GIIHEYGGQVYMDGANMNAQVALTNPGAIGADVCHLNLHKTFAIPHGGGGPGVGPICVAE
QLVPFLPTNPIIPTGGEKAITAISAAPWGSALACIISYAYICMLGEKGLRKSTEYAILNA
NYIKERLHGHYEVLYTGEQGRAAHEMIIDCRPFREKGIEVVHIAKRLMDYGFHAPTVSFP
VAGTMMIEPTESESREELDRFCDAMIAISKEIESVNKDDEHNLLKNAPHTQAMVTADNWE
FPYSRKTAAFPLDYIADNKFWPTVRRVDDAYGDRNLICTCEPIESFMEA
>OMIFANIC_00606 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MSTKITGVGSYIPKGIAPNDQFEQHSFYNEDGTKFGHENTVIIEKFKAITGISERRYIQD
DKTTSDIACFAAEKALEDAGLDKEELDYLIVAHNYGDVKHNTHQSDTVPSIASRVKHLLK
IKNPRCVAYDVLFGCPGWIEGVIQAHAYIKCGMAKKCMVIGAESLSRVIDQHDRDSMIYS
DGAGATVIEDTGDDGSGILSHLSATYAYDEAHFIYFGESNKQELNDARRYIKMYGRKIYE
FAITNVPGAMKECLDDSGCDISEVKKVFIHQANEKMDEAIIKRFFRLYGEEAPEDVMPMS
IDKLGNSSVATVPTLYDLVVKRELDDHQVNPGDVIIFASVGAGMNINAVVYKV
>OMIFANIC_00607 hypothetical protein
MYEGEFPKKRYKYTFNFLQQFVSREDKILDLGISNPFSEILRDKGYNVSNTAGEDLDLDT
TAVKTTDYDVVTAFEIFEHMVSPFNILQDIQANKLIASVPLKLWFASAYRSKTDDWDRHY
HEFEDWQFDWLLEKAGWKIKKREKFTNPVKKVGIRPILRRFTPRYYLIYAERAK
>OMIFANIC_00608 hypothetical protein
MNISIVIPAHNEEAYLDKTLDSLVSQTLLPKKIIVVNDNSTDNTQQIIDSYSGKYEFIHG
VSHKAGSDHVPGAKVIEAFNRGLSELDSDYDVICKFDADLVFPIDYLQKLKVTFQSSESI
GMAGGFCYVEKNGSWHIEGLTGKDHIRGALKAYRKECFQQIGGLKRAMGWDTIDELLALY
HGWEVRTIDALQVKHMKPTGTSYSGRSGRLQGTAFKKMRYGFLLTLIASAKLSLKKRNFS
YFLDCIKGYFSGDGDFMIGKDEGRFIRKLRWRNIRKKLF
>OMIFANIC_00609 Alkaline phosphatase
MRYLLILILIGASTLAWSQSPENSSPERPKNIILLIGDGMGMSQVSVSFYFNENESNFNR
FTNIGLIRTSSSAQLITDSAAGATAFASGIKSYNGAIGVNPKTESVPTIFELMSKNNYAT
GIISTSSVVHATPAAFYAHVFSRRMYEVIAANLAESEVDFIAGGGSKFFNARTDGKNLYD
LFAARDFEIHTESIPETLSGKKQLIILAEDGMPKMIEGRGDFLPKSTDLAIDYLSKNKEG
FFLVIEGSQIDWAGHDNNADYLIGEQLDFDKTIGVALDFAKENGETLVIVTADHETGGLT
LSADGNDYNKISPIFSTGGHSATLIPVFTYGPGASSFNGIYENTEIFHKMMALLNKK
>OMIFANIC_00610 putative phospholipid ABC transporter permease protein MlaE
MIVVRALKDVGSYFLMLKRVFSGFTKGSILRELIFKEIDDLIIGSLGIVSFISFFVGGVI
AIQTALNLENPLIPKSLIGFATRQSMILEFAPTFISIIMAGKMGSFITSSIGSMRVTEQI
DALDVMGVNSLNYLVFPKVVALMFYPFVIALSMFLGIFGGFLAGVYGGFTSPGEFVTGLQ
DSFDPFHLTYAFIKTFIFAFILATVPSWQGYFMKGGALEVGKASTNSFVWTSVLIILANY
IVTTLLLS
>OMIFANIC_00611 putative ribonucleotide transport ATP-binding protein mkl
MIRVEDIHKSFGEHEVLKGISTVFEKGRTNLIIGASGSGKTVLLKCLLGLFHPEQGRIYY
EDKSIQDMNDDEKRDLREHIGMLFQGGALFDSMTIEENVMFPLRMFTKKKRIEMLDRVNE
VLARVNLENVNNKYPAEISGGMKKRVSIARAIVNQPKYLFCDEPNSGLDPNTATVIDNLI
QEITKEYNITTVVVSHDMNSVMEIGENIVLLKNGVLVWEGSNEDIFKSNNKDVTDFVYSS
DLFKKIREVQLKEG
>OMIFANIC_00612 hypothetical protein
MKNLLLIGIALVVSSMSFAQVTFTNQGNLLANYPDNSETAVDMNGDWMDDYVRVSANGVG
IDYQVGDGTFNSVFYPVTIANVPNWSVAAGDLDENGYNDLVLGNGQRVSFLYANANGTAY
TETTFPEFIFSQRSTMNDIDNDGDLDSFVCHDIDLSHPYRNDGTGTMTLDQTLIVTLDRP
GNYAAIWVDYDNDGDSDMYLTKCRGGAAPGDPNRDNAMYTNNGDGTFTENGLDINMRDNA
QSWSTVFEDFDNDGDFDAFIVNHDFQNRFMLNDGTGMFTDIIGTTGIDPNDLGAWENQAG
DFNNDGFVDIFSELSKELYLNNGDLTFTGIDLSFDEGAIGDFNGDGFLDVVNNGNLYIND
GNPNNWVKIGLEGVQSNLNGIGARIEIYGDWGMQIREVRSGQGFSHMNSLVAHFGIGTAT
TIDQIVIKWPSGVVDTYDDPDTNVQHIYVEGGSLGSDDFLANTINVYPNPTSDMINFSLN
GLEDTTVNVVDVAGKIVMNTVISSENNIDVSSLKSGVYFVQMEVEGRQASYKFIKK
>OMIFANIC_00613 hypothetical protein
MNTSNNRPNSTPTEEEQFEHLKLSTWASIKKFFSELLDIRSETDRDATITAVKKDISFKG
HNAWILIFSIFVASIGLNVSSTAVVIGAMLISPLMGPIVGVGLAVAINDVETLRRSLINL
GVMIGLSVLTAFLYFKISPLTEETPELLARTYPTILDVLVAIFGGLALIVAKTKSGTIAS
VIFGVAIATALMPPLCTVGYGLAIGNLNYAGGAIYLFSINTVFIALSTFIVAKLLRFPLV
RYANSRRRRLISRVASLIALIVMVPSVILFLNLLDKQVYENRTKEFVRDVINYDGAEVVK
YTFDYPSKEIEVYLIGRLVPQGQLNKWQTALGETEQLEGSKLNIYQGSDQSGELAEKISG
DLKEDILEDLYVNNQKELRDKDLRIEFLEDEITKLKIDEIEFATLSKEVQLNYDKLISFS
YSKRVMTNFTQIDTIPVFEVDWDRSVNSRTRRSNNEKLANWLKFKLSLDTLLIEER
>OMIFANIC_00614 Alginate biosynthesis protein AlgA
MKKDYYAVIMAGGIGSRFWPVSTSGFPKQFHDMLGTGHSLLQKTFSRITNGIPKENIRVL
TNERYSDLVLEQIPGMTGEQLVLEPAMRNTAPCILLSALKIHKENPNALMLVAPSDHWIE
DEAAFMSDVISCFEDCRANDKLVTLGINPSFPNTGYGYIESDQSDASEIKRVLQFREKPD
YETAKEFLAAGNFLWNAGIFIWSVRSIIKAFSEHLPDMYDLFHSGEVQLNTSQEKKFVEE
NYASAENISIDYGIMEKAGNVFMKKASFDWNDLGTWGALHDKLEKDEHGNAIVRAVPYFR
DSEGNIVYTSTKKLVVVDGIKDYIIVDKDNVLMIYPKEKEQNIKKLLAEISHTFGENYT
>OMIFANIC_00615 Protein SprT
MTDLLEKYIPRGAVKPVFELIKRYNVHLKIVNERVTRHGDYKKLPNGGHQITVNANLNVY
RFLITLIHEIAHLVAFNEYGRSIKPHGKEWKHIFRQFMLPFIRPEIFPSGLLPLLAIHFK
NPKASSDTDSNLSLALKEYDPPNDKNYIFEIPYGATFRLYNGKLFKRGNKRVKRYECLDL
ASGRIYLFNPNAEVEFIK
>OMIFANIC_00616 Fatty acyl-CoA reductase
MNKNVVITGTSRGIGYELVALFAKAGHNVLALSRNDKPISDLGMSNCYCFPCDITRKADV
QKVTEFIAEQWRKVDILINNSGYLVNKPFEELDAEDFQRSYEVNVFGAVSMIKVVLPFMN
KEGHVVNISSMGGVQGSAKFPGLAAYSSSKGAILTLTEVLAEEYKETGPAFNALALGAVQ
TEMLEEAFPGYKAPVTAKEMAQHIMEFSLNGHNLYNGKIMQVSSSTP
>OMIFANIC_00617 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEIITMPRLSDTMEEGTVASWLKKVGDKIEEGDILAEIETDKATMEFESFYEGTLLHIG
IAEGETAEVDKLLAIIGEKGEDISELLKGDAPSQDAPETEASDSAEENTAATVTTEAEEL
PEGVEIITMPRLSDTMEEGTVASWLKKEGDTVEEGDILAEIETDKATMEFESFYSGTLLR
IGIQEGQTANVDALLAIIGPAGTDVSNIDISARSPEPEEAPVNTTEPESTQKVEASAATS
TRTSVIPAQVSATNGRIFASPLARKLAEEKGIALASIQGSGENGRIIKRDIENYQPGFAA
ASAYVPVGEESFEEFANSQMRKTIAKRLGESKFTAPHYYLTVELDMDNAISSRNAINSDP
NVKISFNDMILKASAMALRKHPQVNSQWADKVTRIAKHIHLGVAVAVDDGLVVPVLKFAD
NMTFSQIGAAVKELAGKARDKKLTPDEMQGSTFTVSNLGMFGIKEFTSIINQPNSAILSV
GAIVQKPVVKNGAIAIGNTMTVTLACDHRTVDGVTGAKFLETLRQYIENPVTMFV
>OMIFANIC_00618 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKITKQTYLQWYEDMLFWRKFEDKLAQVYIKQKVRGFLHLYNGQEAVLAGALHAMDLGK
DRMITAYRNHVQPIGMGVDPKKVMAELYGKGTGTSQGLGGSMHIFSKEHRFYGGHGIVGG
QIPLGAGLAFADKYHDRDAVTLTYMGDGATRQGSLHETFNLATLWKLPVVFCVENNGYAM
GTSVERTASHSEIWKLGLGYEMPCKPVDGMKPEVVAKEMDEAIQRARKGDGPSFLEIRTY
RYRGHSMSDAQHYRSKEEVAAKQEEDPIDYVLNHIYEKKWATEKEIGAIEKRVREHVSEC
EKFAEDSPYPEKNVMYDTVYEQEDYPFLPHKL
>OMIFANIC_00619 Cytidine deaminase
MKKHKLETYLEVYDSISELPDTIQNLINKAQQARDNAYAPYSHFKVGAALQLASGVIITG
NNQENAAFPSGLCAERVAVFHAGSNYPGETILHLALTVKSSHKEIDTPTPPCGACRQSLA
EYEVEQESPIAIYFMGETGKVVKADAVKDLLPLVFDSSFLE
>OMIFANIC_00620 hypothetical protein
MKKFFIPIFICLFTFKAVAQDNSTANQRVITTAVPFILIAADARAAGMGDIGVATSADAF
SQQWNPAKYAFAISKQGVGITYTPYLSQLVNDIFLGNLTYYNRINERSSIAASLRYFSLG
DIELRQTIEQDPLIQSPNEFTFDVSYALRLSERFSMAVAGRYLRSDLRIQASTEDASAAS
SFAVDIAGFYQSEEIAYDSFDGRWRAGFNISNIGPKIKYDEVGQENNLPTNLALGGGFDF
ILDAYNKIGINAEVNKLLVPTPQDFDGDGDIDAEDDEEYESISFFSGIFKSFGDAPDGFS
EELKEFTWALGAEYWYQDVFAFRTGYFNESDLKGSRKFLSLGAGFRYTAINIDISYLFST
SKVRSPLEGTLRFGLTFNFGDEYDEY
>OMIFANIC_00621 hypothetical protein
MMRKVVLLFVLFSLPVMLFSQSKTIVVDWEDKQTKQPFLPKKSEVSTSKKARKDVSSLQL
GEDRVIYSQIWPDTREVNPNSVRITGIVYGTLSNSELAKINKALVPNNLSYTLKSTYSRN
KLFSVLTMAPVISQNGVLRKIQSFTLSYSYGAARAGNKRIPITNSVLASGSWYKFKIENT
GIHRVDKAFLSDLGMNTDGIDPRTLKIYGHGGDPLPEINDNNTEYDLPQNAIQVVGEEDG
SFDASDFILFYGKTAGFNEENPTNINPYSDDTYYYVTAGGSPGLRVQTMVEPTGTPNLNI
STFNDYQFHEVDELSPALVGRKWFGNRFDIENEQSYEFSFPNIAPGTEIELDIKAAAASD
ISTSMAISVNGTSVDPLMFSAINDPKLLDLRDFEGNIPAGSETVTVDLVYNNSGNPASIA
YLDYIRVGAIRQLTGTDGQLPFRYNEAELQSGIGEYQISNAGQFTQVWDVTEKSNITSKI
NEGGASVLSFKAFMGSAREYVAVNPNNYFAPVEGPQSLVLNQDIKGTIFNDESGNFKDID
YLIVTAPFLLQPALKLARHHKDLNGLNVKVVTTDKIYEEFSSGKQDITAIRNLVKYVYDN
ASSQEKQVKYLCLFGDASVDYKNRLSGNNNIVPVYHRYDRDFEVSTYRSFMSDEYFVMMD
GQDGSMMTSDMSDIATGRILADNVNLANSLIDKIIEYSGTESYGNWRNNFVLVSDDADDR
GDSRLQFDLDALGDEISSEKPFINVKKIHMDAFEQQTSAGGNRYPEVNEAMSNAIEVGAL
VLNYFGHGGEDGLAKEFVFTKDQAIELQNKGKYPCVITVTCEFTKFDNPLRITAGELTYW
NRQGGAISLITTTRSISVGTGVEYNQELAPELFGFGTNIINPPAEALRRARNIITNNDKY
VVFYVGDPAMHLAFPKQKVRLTTLNGVPIEQSTDTLQALSRVRLGGEVVDEQGNLLSNYN
GRLEGKVYDKNVQRQTLGNDGARDQNGDLIILDFITLGEILFNGQATVTNGTFEFEFVVP
RDIQIPVETGRVSLYSQRNLELEDQTGYDLRLRVGGLNENAPEDNQGPLISLFMNDESFV
SGGITNNEPILIAKLEDENGINTASGIGHDITAIIDGDESNPFVLNEYYQAEIDDFTRGK
ATYKLRDLEKGLHTLTLKAWDVYNNSSTMDIQFVVAGNDELEVTRVLNYPNPFVNYTEFW
FNHNRPFEPLEVQVQVFTVTGKVVWTKNQIVNTDGFLSRDIVWNGLDDFGDRIGKGVYVY
KLTVKSTLTNQQIEKFEKLVIL
>OMIFANIC_00622 Hercynine oxygenase
MNLRKTLALQLSIAVVAVALFASCNKSRDYKNSSRATGWKMNAKEGGLQYNAKAKEQETG
PGLVFIEGGTYTMGRVQDDPMHDWNNTPNQQHVQSFYMDETEVTNLMYHEYLEWIKGVFP
PSDDQYRKIYEGALPDTLVWRNRLGYNEVMTNNYLRHPAYADYPVVGVSWIQAVEFSNWR
TDRVNELILEQEGFTTRNARYDVEAGQTFSTDTYLNAPTMTYGGSDSITRGGKRSEALLK
RNEDSTGLYVQRKDGLLLPDYRLPTEAEWEYAALGLVGLRNYNVYRGRKKYPWDGQYTRS
GKRRSRGDQLANFKQGDGDYGGIAGWSDDGADITAEVKSYEPNDFGLYDMAGNVAEWVAD
VYRPIVDDEFNDFNYYRGNVYTKNYIGDDGKVKVVTADSIVFDTLSNGKIIARNLPGEIL
QVPVDEEETYLRTQFSESDNRDYRDGDPRSTRYYQSFSDVEDGETSDTKRMYNSPKHAVY
ADSLGQLERQYDKASNRTTLIDNEVRVYKGGSWRDRDYWLDPAQRRYFPQDMATDYIGFR
CAMSRVGSKSKKGKRPRH
>OMIFANIC_00623 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MKIETLHSHFLKSSGICTDTRKIKKNCLFFALKGENFNGNEFAQEALDKGAYKAVIDDIS
AHKNTGETILHGNALSLLQKLATFHRNYIKVPIIALTGSNGKTTTKELINAVLSQKYRTS
ATQGNLNNHIGVPLTLLSMDQETEMGIVEMGANHLKEIALLSSITEPDFGLITNFGKAHL
EGFGGVEGVIRGKSELYTHIRDHDKMVFVNGNDSKQMELTGDMKRITFGSGDFDYNVVLK
NASGELLLQYEGIDIQSNLIGIYNFHNIAAAIAIGSYFQIDNEQIKTAIEGYVPLNNRSQ
LIQRDGFNIIMDAYNANPTSMMAAIENFQQAAGDQKIMILGDMFELGKSAAEEHQHIVNY
LEAHPFGQAFLLGSNFNRTTSTKDHIRTFNSFEDFKKEWVNLDLTGTNLLVKGSRGMALE
RVLELI
>OMIFANIC_00626 Folylpolyglutamate synthase
MYQRVGKAAYKADLSNTVLLADHLGNPESSFKSVHIAGTNGKGSTSHMLAAILQHAGYKV
GLYTSPHLKDFRERIRINGDMIQKEFVTGFIGLHREFFEENSLSFFEMTVGLAFEYFRDE
EVDIAVIEVGLGGRLDSTNIITPEVSVITNIGFDHMNFLGNTLEEIAIEKAGIIKEGVPV
VIGEIQKETRYVFEQVAEQNLAPICFAEEQDLPNYKTDLRGAYQQKNLRTTLAIIRVMRE
LHWNIPIDAAEKGLLTVSQTTGLRGRWEIIEDKPKVICDTAHNREGLEMALEQLRAEQYE
KLFIVLGVVDDKDLEPILPLFPGDAVYHFCKPDVPRGMDAKKLKLKAAEFKLFGEAFNSV
KEALRSALEKAGKEDVIYVGGSTFTVAEVI
>OMIFANIC_00627 Xyloglucanase
MRYHIFLSLLSILIIVSCNHRTEDISAKSPELLPADFMFDQRAYPTGEIKTDAYRKAIQW
KKEQLQQRSPAGNGWEFAGPVNIGGRITDIEIPSNDAQTYYVGAASGGIFKTTDAGASWV
PVFDDQEMLSIGDIEISKVNNDVIWVGTGEVNAGGGSLAYDGDGIYKSEDGGITWQSKGL
PDIGSVGKVLIDPTDENTLFVAAMGPLFRNDNNRGVYRSTDGGSSWEQKLFVSDSTGVID
MAIHPVNGDIVYATAWERIRRPNNRQYGGETSGIYRSLDGGDTWNELTNGLPAAASQKGR
ISIDISQSNPNVLYSRYANASGSIQGVYRTDNGGDSWTAVNSNQLTNIGFHWWFRGIFVD
PTDENTIYNVDFVVEKSTDGGQNWSTAFPNVHVDQHALAFNNLVAGQVLLGNDGGFYKSN
NGGNSWVKDETLPITQIYRTHVDFQNDNKIYVGTQDNSTMRTNTGSTDDWEIITGGDGFQ
PLVDPTDTNVIYALSQRGNLVKSINNGASFFSVMNGISGADRKNWDTPIVFDPADSQILY
YGANRLYKTTNAAGNWTPISPDLSNGPYPGNLTFGTIISIDVSPLDSNIIYVGTDDGNVW
VTENGGVDWTLISDSLPNRWVTKVLASRNQLNEVYVTFSGYRYGEDEGHVYKSNNAGGTW
FDITGLLPDIPINDIVQDANGFLYVGTDVGVFASATEGNFWEVVGDNMPSVVVTDMHIHD
PSEYLYAGTYGRSAYKMDISDIILSTEDISTYAEIAVYPNPAVSIVNIDMGGSHKENEVS
LADIHGRILRTRQFRNKTQFEVSDLPSGIYFIRITSEGSEITKKLIVN
>OMIFANIC_00628 hypothetical protein
MSLLDTKHKRKSMTITVILHLIILFLIFFVIGLKYMDPPLERGIAVNFGTTDEGSGNVQP
SEPIKTAPKNTNPEPVSQPKAEIKEEVVTQENEDAPVIKNEKPQKEVKETPVKEQPKKEV
KPDPKPDKSTTDALSSIINGPKNDGKAKGSEGNDDKAGDKGNPNGDPNASGYYGTGKGLD
GDGNYLLGGRKALNKEKYIQDCNEAGTVVVSIEVDRSGKVINATPGVRGTTNNSRCLLEP
AKRAALATRFNSDNKAPAKQIGKIIYRFRLSN
>OMIFANIC_00629 hypothetical protein
MNLRGRNKISPEFSMSSMTDIVFLLLVFFLLTSPAITPDALDLILPKAKGKSTNQQKASV
SITKDGAYYVNKERVSEYSIEKELQGILAGQDEPTIILRAEEGVPIEDAVFVMDVANKNS
YKVVLAVRPN
>OMIFANIC_00630 hypothetical protein
MLNFFIQEGQDLAQDLEPVVSEEKTLSVLELIMNGGLGAQIIIALLFVLLFVAVYIYFER
WFAIKAASHLDNNFMNQIRDNVAGGNIQAAKILCTQQNTPVSRLTEKGISRIGSPLEDIN
TAIENAGRLEVYKLEKNVSILATIAGAAPMIGFLGTVIGMVLAFHQLATSSGQAEMGSLA
EGIYTAMTTTVAGLIVGIIAYIGYNHLVVRTDKVVHQMEATAVDFLDLLNEPA
>OMIFANIC_00631 Na(+)/H(+) antiporter NhaD
MESIIILIFVIGYLSITLEHPLRLDKTVPALIMAALIWAVLAVGFHSGWFSVIDTHEEVF
NFASGGVEAEHGFENTLLHHLGKTAEILIFLIGAMTIVEIIDLHRGFEVLKGAVRTKSKR
KLLWIIGVLAFVLSAIIDNLTATIVLVTLLRKLIHNKNERLWYAAMVVIAANAGGAWSPI
GDVTTTMLWIANKVSALGLIKLVVIPSIVCFVVPFFVAGYLKPFKGNIEVDASEDVIAER
LLSSKTMLFLGLGMIVSVPVFKTFTHLPPYVGMMLALGVVWLVSEYIHPEEDFSKERRHL
YSAHKALSRIEISSILFFLGILMAVAGLESLVYSTVEVVVNGVPQEVEVGTLRYLAEVLQ
AAIPNQDIVVMLLGVLSAIIDNVPLVAASIGMYEAPLDSPLWHFIAYSAGTGGSMLIIGS
AAGVAAMGMERIDFIWYLRKVAWLAFIGFAAGAVAFLLFRDMIIG
>OMIFANIC_00632 Anhydro-N-acetylmuramic acid kinase
MEKSRYKILGVMSGTSLDGIDLAECQLAYSDESGWSYNLGVANTIPYPAEWKSRLSDAVN
FSEGRLRTLNENYTRYLSNVISEFINRNKIAGLDAICSHGHTILHQPQKGITLQIGNLPE
IATYVNETVVCDFRVQDVELGGQGAPLVPIGDRLLFSHYDYCLNLGGFANISSEGEHGRI
AYDICPVNIVLNHYSEKLGKPYDEGGRIAASGVVNEKLLQQLNDLQYYRTDPPKSLGLEW
VTREVFPVINNMGILGKDIIATFTEHIAVQLAAQFQKGAKVLITGGGAYNDHLIERLKFH
RQVMIELPSQKIIEYKEALVFALLGVLKLRNEVNCLSSVTGARNDHSGGVIYSKK
>OMIFANIC_00633 Acyl-CoA dehydrogenase
MFSIPKTIQTMDFNLSEEHLMIRDAARDFAKSELLPGVIERDTHQRFPTEQVKKLAELGF
MGMMVDPKYGGGGMDTVSYVLAMEELSKIDASASVIVSVNNSLVCWGLETYGTESQKEKY
LTKLAAGESIGAFCLSEPEAGSDATSQRTTAIDKGDHYILNGTKNWITNGGSADYYLVIA
QTDRDKGHRGINAFIVEKTWDGFEVGPKEDKLGIRGSDTHTLNFNDVKVPKENRIGEDGF
GFKFAMKTLSGGRIGIAAQALGIAAGAYELARDYSKIRKAFGTEICNHQAIAFKLADMHT
EITAARHLVLQAAWDKDMGNNYNMSSAMAKLYASKVAMEVTVEAVQVHGGNGFVKEYHVE
RLMRDAKITQIYEGTSEIQKMVISRGLLKD
>OMIFANIC_00634 hypothetical protein
MSDDFDLLETESNSKQEKVDVNWGKAVDQMKSKLAQEDDPEMRQKILNATLDDVVGMAEK
DRASLLDAIKDLTDYQEEVGIIFEKFSTLNAAEQKVIDSAQSNLERAKLALEDAEKVKDN
WWNNLWGRKSKIKKREAELEAAQKERDAADMKAKQMFQERIETADIQTLLSELSYKSQAA
VSRLKNREIEIREVEDKLQDAIVEASKNHTKALEKKKETEDKLEEHYALLKQARQELEEI
SDKQSTAYSEAIGKITQLEQKVEELEGLKNAYTTLAASKDSFVHKHNLTIKVLTSLRSNL
QSHRAKLKSDTDERLKYYDGYVVALKARTDQEFAAILEHLGVKTDEHIGQTLAAMHSASA
KARQEMMDNIPVHEKVMQGVYSSYAESLQEIREKDAQIQKDFANRYGIDMKEIFEEYYAS
STGDGGNAPEGDEPSETPEEPAPGDDDLLG
>OMIFANIC_00635 hypothetical protein
MSINQIVTPLDSAVLETKEQYSVYFKIVKHAFESLMKSITENDMCNALEVSFIEQYCELL
AYSLESFRVKYLYDEEEKMKIDLTESGFPNYLEFRYLINDLELKNEHISRLPNPEELKAE
FLETLLKQKQPVPKRRLEQAASIVYYTSVERNYIFKKFVQGKIITIKNNPEAPYLVSWSF
YDVSYNRPFICFMYFDLYKTDLKEYTKKIYEVLEAVADRNMNLDNLAYALDKRLPKVLPK
KFRKIDLGPLHNVFAKDELTITHVVLEGIVNKVLDLSTYAISLTIDDLVSTGKITEGSLF
NRQHLQIWETHKPKKYVFCPHRLIQLLYDRIPEEIHKLAKEPIEIPALKI
>OMIFANIC_00636 hypothetical protein
MEHNTTFPIKIAELDALREEATSYLKGVQWDQSYKAKNRDKSVKDDSILLYLSKATGNST
SNVTSVSKSILALKKRLLPESVAIPLKLNRALFALQEGLTMGIWLKDSYGDASGLSALNE
RKSTLDGSQRREFDSKQHTATAYMLFGTAYRILYDLKPVASDDLSVLKNKFAGIPEISLM
SPIKGISCMLFYFDKYLNHPEIITRDSDVVDFAVVFFEAVIAEIQLRLGSLEYTETITDR
TYKLENSDFAVSGWENIYEGTAKSVEFNKIQFEEIVGNRDAKHFARRLTERLLSYDFTVK
KNPFQELGGFMPVFMGYGIPGTGKSMLIAAIATRLKEHCDNLDIPFLFHPMPDTLISTFQ
GGSAEKMVQWMKPLQDPGKLIFAPIDDAENNLQERTAQGVSAGVKEVIGVFLRYTEGAYA
VNYGNSSIGLFTNLPEMLDKAVISRVQGRFKIDGARTIPDFVDQDYLWWRKIEKTMPGFV
NMQGPEKYSYLSEQGLAKNLGEILRHTEKPTEERVLAIYEQIEEKHEESEHLFYAELYKS
IQKAFPFFSSRDIRNIQSAVSLRLTDFDLPKEWFENGDTYFRKDYDTKYGMLQELMKQNM
KGLSFSDIRRQEVIRYLDNVATIADTDFKRKVDQRLHDMNVQMEARRRFEDEEN
>OMIFANIC_00637 hypothetical protein
MDKLKAAGLYGRELITVSGSLAERYNGCLTILGMEPTALKAFHIDGIGWSPEIAEEKENP
FYLNIGEANSNAIVISPNQEGNPVHMPFHSFDRDIMTTVFAAYAKEIRDITKDAAICIHL
DQHIDTYYEPFDLLRYKQLTVSFRILNDLAKKQKEQMELVDEFNTANNFINREIHNKLLD
SARKYGDLRDRKLELDPLKLKISSFYTMAFGGIFVLRDFINDIIVFESEETFNKAIKDTV
HDVTLFHIGHNELTSTLVNHLIAEFDIKKAAKTKRYERIKKHRFVQELKNCKHPIPEVLE
SPMLFKKYLNEMDVDTKKRIMSVERYNQRKIVERELKIDDVVDPLYVKALLQPHSSLEEE
HNELIWKLLTKIVPVDPLHLYWYDKKQFYETYLTWPDGYQDWVIDRILKNN
>OMIFANIC_00638 hypothetical protein
MTLEIIVFVIAILFGIIIYWRESKSNRLYRFFNHVMHSRELQMTSENRKGFVHKQVFLMR
LVWITLLFVLIGALISFATPINVIFFQYFVSAIVGTLIGTYIASAFIFTSEGLRKDNLKK
NFEKAVEKGKDFVEDIREDLEPEPTAEEKQEQEPEESSKKSARDRLKDKGMIN
>OMIFANIC_00639 hypothetical protein
MIKAYWNRGRKQRRVVVIGGIILVLLLFFLRDDYQPALLFVRKYIFMLLICGLFLGFTIS
KFRSAPSAGRRLLIMLGIIAFFATLWFFGSKLQLYSYMQTYNVFRNLNKVEIHELPLTRN
ERIQPYNNIVTMAYESIGETQEVSPPQLVRVDSSNQWTMAVQPSKEYTWQRISDDTEEIF
TVESTSPFPRFSGENRVPVIFSIGESLAFSRNTYNAVVQRFNFFQLFTLEPSEVFYMKND
NGKWVQVVSLIKWKGFFFPYPSYGGVMIVDPGEHDFSDYLERITIGKGTYIPPEEIKNYP
FLTKQNTLAEKVSRLQAQSLQFLGGFTDPLPWNMETAVKIPDLKDDENMQPFVTDFDFDT
METDAYSGLYHWFGLEPVGEERTSLSFSVMIPADGTDKLYYYNHAAKKEGLAGVSAMPLK
VIESRKEYDWNVNKPVEFRPFVKEIGGRKRMFVFCTVAAKREDSKKFDGSATPDLALVDT
EYRDVVWIDAKHPSQWESAILEQLGETWKSSENLKDEDIWPNRIEIDLNEIKEMDSIMFN
SISEKLKEAVLDSINN
>OMIFANIC_00640 hypothetical protein
MSMRLIYQMLRVSFAIVWFVNGFYCKILGLIPRHEFIVAKILGFKYAEQLTLGIGFAEVL
MGFWILSGNKPKFNAITQIVLVLSMNLLEVILVPELLLWGSLNLLFAVLFVILIFVNEFI
IAKRVT
>OMIFANIC_00641 hypothetical protein
MNKTLLFFFFFCTTAVVFSQNYSRGSSGNVPKTKAPIELYQIVSADRDTTVVDTSLTIAK
DYKFNYLRRDDFELMPFVNVGQTYNSLGYSFDKSNLKPLFVAQSHHFNYMEIEDMQYFRV
PTPLTELYFRTAFEQGQQLDAFLTVNTSEQFNFSIAYKGVRSLGNYQQMLTSTGNFRFTT
NYHTKNKRYKVRAHVAAQDILNQENGGLNANSIALFEAADPEFEDRGRLDVNFENAENKL
EGLRFYADHEYEIISQRDSTSYNVLNIGNRISYEDKFFEYRQNAPFSGFGESYESSDLLK
KTKLEDFNVEGYARLENSILGEIGAFIGYTDYNYGYNTVLELAEGRITNRLKGNIVQFGA
SYKKQYRGFELSGNGKINIAGDFDGNYLNAAASFSFNEENKVRASATIHSVAPNFNFLLY
QSDYVNYNWQNSFENVKTQELKFEMKSKKLLDATVSYTGIDDYTYFAVKANDSTPTPQQF
DERVDYLKVKAEREFRYGRFALMNTVMFQQAVSGEEVFNVPEIVIRHSLYYEDEWFKKAL
FLQTGITVKYFTEYNMNAYDPVLAEFYVQNNEKLGAFPLVDLFFNAKIKQTRIYFKYEHI
NQLFNSSNSHFSAPGYPYRDAVIRFGLVWNFFL
>OMIFANIC_00642 Ribonuclease HII
MLDLKIHSQLLECGTDEAGRGCLAGPVTAAAVILPDNFTHPWLTDSKKLSEKKRLELRPI
IEAQALACAVTHVMMDEIDKVNILNASIMAMHRSIEKLKLLPEFIAVDGNRFKPFGKIPY
QCVVKGDGKYLHIAAASILAKTYRDDYLSELHDEFPAYNWRKNKGYPTREHREAIKKFGP
TPYHRKSFRLLPEQLRLEI
>OMIFANIC_00643 hypothetical protein
MIPAYFCSVRTLKKIGLTIVFLSFVIGCDSTTDSKYELEDFIPGDPSIVVSIANIEILQN
DLDQNEVFKNIEKNELHRLLSGEHAIVKLIKPKSKSLIGLYKKDSANYDFTLVTKQDSTL
FSPDSIGDVISETLSYGEVSLNRVQIENETAFTMVRDSFFLISSSQQLLQETLSEADTEQ
SNLSKVIDLGDEAELLIIRNKEKIRLSDSLTEALADQLALNISIAADGIRASGVALNNDT
LPQLIDVFKGQNPQTNAIAAAHPVDAETSLTFTFNNPDSLFNNLKTFRADFSDLATHPIF
ETITEVCDLQFKNDRAIIMHSIDAALTNEALIPYLSENSSFRDVDVYDFSNPEIFINQFA
PLVNKTRPILAFRLEQFFVFTESMLTAEKIITGFKSNNVLMNSTFFKNASRDLATASSML
LMQFNEEVSRGIANAIYGDMDMIRRSESLKDYRLSALQFSYDRNFAHVNYVCTETVASKQ
ITGSVTQVSSNSLDTDVLIDPQFFSNHRTGGKDIVVQDMANKLHLLSSNGKLLWSKNLQD
PVLGKIHEVDILRNGKKQLAFTTKNKLHVIDRNGNTVKPFPINFKDEITQPLSVFDYDNN
RKYRFAIVQDEDVLLYDSKGKIVTGFKFKGAGSKIVLPVQHMRMGNKDYILVAEEKGRLH
VLSRVGKSRISIDKRFKFSDIPIAEEGSNFVVITSNKTKESISQRGKVSSQKLNVSDSYS
FNIDFKTKVTLDDNLLRINGILVELPFGIYTQPALYRANRQTYITLTETQENKVYVYNTS
GELISGFPIYGTSTAEIAGRNRTKSMRLLVKGENNEVILYEVQ
>OMIFANIC_00644 Sensor histidine kinase TmoS
MHRVYIVLSLFITSFLYAQDDGVFTNNISEEDSVTIANWRIKMAQNINPNPDSAFFYSRK
IKRLTVERKYGPGIIDADYLIGQCFKRMQQNDSAIVYFKGALEMAEKIDYPIGAARAYNS
LCRTYYLMGKMEESIEACEKAIATTLTYDDPNNMIFADSHTALATAYARQNKLDEAIKKL
LVVDSVHKLEALRPDVIAAAYQNLGNIYLDLEDYNASEKYYLRANREFEKLGGNATYYLN
TTHINLGQVYLNKNNLNKADSLLSLSYEFFSAIKDERTVGEISTYLGQLKMKQNKSAEAE
TFFNEGFDIHKRNNRTYEASLNALELAKLALRQQQTSRAISYLKEAEDLNRSSKNSQVAL
ETYNLLSRSYAQNNNYRRAFNYKEMAAALKDSLQGIQSSEKIKEIEAIYQTESRDREIAL
LTSQKQLVEAQKKNQRNVLLGGLGLMTLAGLFFFFQYRNRIRTNSKLKELDKAKSTFFAN
ISHEFRTPLTLIKGPVEDQLDSEALTKNDRKNLLIARANTQRLESLVEQLLALSKLESGN
LMLKVQPGNLSGFIAAQAEAFSFSSKEKNINLEISLDSKNEETEWFDRDAMEKILFNLLG
NAIKYTNEGGRIRVSGAREQEHYMFHVENTGNFLSEGQQARIFERFYQSDSENPGTGIGL
ALTKELVDLHKGTISVESAEGDLTRFSVRIPINRSVYSEAEILSEELQKSETTVETVSEA
IAEQQFTTPEDAPILLVADDNAEIRHYVSSIFESTYQIKTARNGKEALELALEEIPDIVI
SDIMMPELDGLGFTEKLKENEFTSHIPIILLTAKSDDKDKLDGVHSGADTYITKPFNAQL
LKATVSNLIENRRKLQSRFAQEVLLRPKDIAISSADEQFLERLQKVMDEYLTNPDFSVEQ
FSKEMGVSRMQLHRKLKAITGQATSEFLRSQRLKLALNLLKEKKATISEIGYTVGFNDPS
YFTKCFKQEFGTSPSDYFSS
>OMIFANIC_00645 hypothetical protein
MSKERKVYEGNVELEPFTQIYLNINHLAEGIYTLKITHKNKVIKQTTFKK
>OMIFANIC_00646 hypothetical protein
MKKIGILLIFIGSLLPGLKAQVGIGTTSPEPSSILDVASTDKGLLVPRVSLGDVSDTMLD
GTNTAATGLLIWNINAAVTGGDGIGYYSFNGTSWEKISTGTGNDAVVLKVTSSTVSSSLA
QGTNMILFLNSISNNIGGGSYDTTTGTYTVPTDGIYEIRTSFNVSLPAPNYEMLLSNRLF
LNGVYHTTTLEQRGSLVNTSYGITYSTTFTEEFSAGDLVQMRSTNFSTVTIYGGANTGGR
STWLTIKKID
>OMIFANIC_00647 hypothetical protein
MKTVKYILILFFLLLGTQADAQIFKKLSKRAERAAERTVERRVERETRKSTDRALDSVID
APKKDRKRDKRKSKKDEEAIIDSTNDSIPAPNLNTKS
>OMIFANIC_00648 hypothetical protein
MRNLKVLLFIVLFGAFSSTSIAQPYTLDEKITPHRLELKEDKKVKGATAVATNATIKDEA
QYFYVAGCNMFQFIDVYIFSNFGSPNFKADLVRNTWGDVETSASTGSSKNGIINFKLRAE
GDFGFKVYPGGELINYTIVVYASPVIQEYMGSAFKKASNSDVKGAEDGSAGSGGSSSGSS
NMVLYIVLGIALLVIGFMAAKLMSKNKASIILLVLGLSFPSNICAQGAAEQNLEIEIEEV
DLDDIRTRQYEERLRELGGEIFDGAGDAIDEGLDRLGEVGDIIEDDDRYRMVRDLYDSYV
GLGDCINSVPPPGMPRIPSFCETEECGTCFTTARDAFNQNRYTFERLKTIYSCTKTFTDA
ALSFGDNVSGIHGVSGLAWQSERRKIEKSIKNLQKTYDNKYRELLQAQKNALMQLNDCEA
QHGIPDWYDRFGYMYYEFTALNYKRPD
>OMIFANIC_00649 Outer membrane porin F
MVFILCLAACKNSTEEQETAEAKVNETILDIEPEIEIPEEVLEEETEGSEETEAVPKSIF
DIDMSMVYIKKEDLDESEMSKLHEILDNNPELTETNLITDIDTEYGLNLQSLKSHLSKSD
ETFKAVRDILELNVAPASISMGYEIDGRERIREFTGSPTGGFMEDMTEYYMFKGRSAGKN
ALRRLGVASDDNVVPILLEYFEVSSDELDLLKSFPGTERHSNSLAAKAAINFELSSRVTD
HLKSSKCSEGFKYAIKFFEKRQIKESKRFMLNAKKAKDAFYKLNPGWYGEDDDIGITYID
SRKKYIYLPFGALSFADMVISHDTGTEGSNSEGVLGEPDMALENFRLKDPRIGNLGINGV
LTLEFTNNALTDVNGPDLYIFEMGKIEPTRLEISKDGEDWLDIGKIEGGTAMVDIAEFVK
PGETFNYIRLTDLDTWSTVPGADVDAVAAIGGALRLNIDSAVLFDTAEYQLKESATSELE
KLLEAVKEIPEGTIIVEGHTDNVGSPQSNLKLSENRAKEVSAYLKSNLPEDYKYAIKGYG
ETRPVVPNDSDENRQKNRRVEILVVPGNEKK
>OMIFANIC_00650 hypothetical protein
MKKTLITFVAICLGGFYTNAQSDCSKFYPFSEGAKSQLTMYNAKGKSQGMVEYHVSGIES
KDGGTAATMTMNLIDKKGNELKGSNYELLCKDGIVSMDFKSLMRPGMLDAYGEIDHEITG
TNLDFPNKLSVGQDLPDAEILIKLSMSGMNMNMSTLITDRKVLDKESVTTPAGTFECYVI
SQNTQIKSMASNMKRSSKQWIAEGVGVVKSEDYNKKGKLDTYSILTSFTK
>OMIFANIC_00651 Octanoyltransferase
MNKKVVIKDLGRWDYKETWDYQETLFKEILDIKIKNRREDAGLATPNYFLFVEHPHVYTL
GKSGDYDNLLMPEDKLAEIGATFYKINRGGDITYHGPGQIVGYPILDLENFFTDIHKYLR
FLEEIIIRTLAEYHIKAERSKGETGVWLDVDTPFARKICAMGVRASRWVTMHGFAFNVNS
DLGYFDHMIPCGIKDKAVTSLNVELGKSEISITEVKEKLLKHFSELFEAVIVQKETV
>OMIFANIC_00652 hypothetical protein
MKKLFFFIIASTTLLSCQFTETMVMNEDGTGRMSLSMDLSEMMAFGGEMSQDSTFTRQDT
IISFKDVFEEKKDSIAKLSKAEQKRLKAMENYNIHMVSDPEENKLVMDIFTDFKDISEAN
DLMKGFEQTEGLLPGNESSADDSDDGPEPEILGVSYSFKRGVFKRDAFIKDEERHKVQMD
SMKQAESFMNSMMYRLKYTFPKKIKNSSVEDATYSLDGKTIEIERSFLDYFKNPDVLDLE
IELEN
>OMIFANIC_00653 hypothetical protein
MSFWRVLLSILFPPLAVIDKGCGSVLIVLILTICGWIPGVIAALIILNNPER
>OMIFANIC_00654 hypothetical protein
MRSYLILFSILILTACKDNQPQNTEEEPATVEVIDDKLLGKISKDDLMEPVFAEWFQPAY
ESYEVNTEFVNSYKADLKTYEIEVFMGTWCEDSQREVPTLFKILEAADFPMEQFRMVAID
DEIDNYKRSPDGDEEGKNIHHVPTIILKRDGEEINRIIEYPVRTIEEDLQLIMEGNYTPY
YYAADMVHGKLNEMGLESFKENMEALAAEFNGKTRDVYELNTYAKTIFRQGKKEEGIQVA
TLNTMIYPENPNAYAGLGSRYTDMDRNQEALEMFEKAVELAPDDSEFKALLEEVQAKL
>OMIFANIC_00655 hypothetical protein
MDVFSLMFSSRTLLAGGLFAVYRYSGKSFHWKFSSLKHLAEARDLSFAIPAPGPHKLPNE
LILGWDDLRHRS
>OMIFANIC_00656 hypothetical protein
MEVKRITEEPLSSLEADILDILKGNYKPNYYGVSSVDELLKEAGLEKFDKKSRKLISELK
GTIKNRYELNTYAKVLFYSDRKKQGLAVFELNTLLFPDEVGTYLSLANSLGVLRYHSEAI
IQYEKALEIDPENEEALRSRDYIKSKISN
>OMIFANIC_00657 Lysine--tRNA ligase, heat inducible
MQLSELELIRREKLSQLRNLGIDPYPAALYPVDTTSEKIKQEFEEGKKVNIAGRLMSRRI
QGKASFAELQDADGRIQVYFNRDEICPGEDKTHYNEVYKKLLDIGDFIGVEGELFTTQVG
EKTVMVKDFTILSKALKPLPQPRVDTEGNTHDAFTDAEQRYRQRYVDLVVNPHVKEVFVK
RTKLFNAMREFFNQHGYFEVETPILQPIPGGAAARPFVTHHNTLDLPLYLRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYHWMMEFCEQLLEFSALQVN
GTTEATFGEHVIDFKAPYPRVTMTDAIKQFTGFDITDKTEDELRAAAIGMGVEVDDSMGK
GKLIDEIFGEKCEGNFIQPTFIMDYPKEMSPLCKEHRSDPELTERFELMICGKEVANAYS
ELNDPIDQRERFEDQLKLADRGDDEAMFIDNDFIRALEYGMPPTSGMGIGMDRLVMFLTN
NASIQEVLFFPQMKPEKPQVALNDEEKHILELLRKKSPVYLVELKAETGLSNKKWDKAIK
HLTRNNLAKVEKTDDGLFVKVV
>OMIFANIC_00658 hypothetical protein
MALLANFENIIFNEHLGDDQGDLVTFNGMTFVGDQSKLANFNIERKPKGKGYLLLHLWSV
QDIHHRIEINNINVSNTAEFPQQSGSEKSAIWSIPIDENVLKKDNNTLQIKRSGDDNFHV
YSVIVNWKEEVNLNNTVRPGFFGRLFNRG
>OMIFANIC_00659 hypothetical protein
MNKYPLSNYHFQVLWGGTRIGFTEVTGLTIEHTAIDFREGITLDDEISKMPGIQKYSNVV
LKRGIVSGDNEFYEWVNTIDNNEVERRNVVISLLNEDHEPVMVWKLEKAWPVKLVGPTLS
SESSEVCMESLELVYEKITIETP
>OMIFANIC_00660 hypothetical protein
MRLTFYSCLLIFVLTVILLVTGSSALGWTILEDPYIPLGNVLTWLAVIALPTSLYLGIKH
FRSPMTKLDKIYKAIVIVSIMLGVLWYPVTWYLADNFSGSFGGNGVFRGSARAGEYFWYY
TYAIIGLPLLLLLSYFLFRLHGKFRK
>OMIFANIC_00661 Choline-sulfatase
MQFIMNLKRILFRFLIISLPLLLVSCEEREEPNIVFIIADDMYPHMFNNISDTTADGEKP
NLTPALDRLAQEGVWLDNMKVVSPLCTPSRYNVLTGNFASRATNSASENTAKRNDGQRVI
QWNSFIVPGNERTMGNYFQALGYKTGFVGKNHVIESPAQIGGNTQPDLNANIKDPKVKEA
LRYRYAELQKDIQASGFDYADGLYHNNTNWSGVKALNSHNMDWIAEKGIEFIDQNKNKPF
MLYFAATLPHGPTNARQSWEADRRLTPLGRIENAPNVLPRYKGELPEKHDSILAKYPGME
ATIRSYESINKRLAEKGQHGRDKANLLWLDDAVGALFNKLEEENLLDNTIIVFFNDHGQE
LKGTLYEGGVNSQAYIWKKGGFEIGNVMETPVSNVDFLPTLLDLAGYKQDLNNFDGYSFK
PALEGKEYTGRTSMYHELGYARAIVKDNLKYYTVRYPEWAMNLSYEKRLEMLNKQNAFKE
KFGLPSLTADPMAPFGHLVMIPGGELVENPAYISMPNYTEPNQFYDLTIDPEEKNNLFND
PRYADKVIELREELRKKLEKLPGNYPIDQGLTNNTFKN
>OMIFANIC_00662 hypothetical protein
MLTRLKSFQRISFPKLKALDEYCAIRFVKLVKIYCDDPKAVTSLPFKEKVEYSFERKDAR
EEDIFVMSFYAWLKSKMELRPIYEITLELVRME
>OMIFANIC_00663 hypothetical protein
MLLPILALGAFFAVSESNDTYSETARLLNPSDGCVFMTVMGEQSSEEFNMYKSDENLMLS
VRDGLSWLAEAQLPNGGYGAGSHSAQHVRDPHAVKADPATTAMVAQAFLRSGTTIKSGKY
AKNLKDAIDFLLETVESAPKKSAFITDVRGTQIQTKLGENIDAVLTAQLLSNLLDRNLKG
IDKKRVERCLDICVGKIEAGTDATGRQSGAGWAGVLQSGLATSALEAAQVVGADVDEEVV
ERSKNYQKDNYDEKTGNVKTDDGAGIMLYAVSGSVRSSAKEARKAEAAINKAKKEGKLDK
NAPVSAENLRKAGYSESEAMGYATSYNVYQSAKKTAQREDVLNGFGNNGGEEFLSFLQTG
ESLLVNRDKEWKDWYDDMSGRILKIQNQDGSWNGHHCITSPVFCTATSLLLLTVENDIDF
LSKVGE
>OMIFANIC_00664 Chitinase A1
MKNIRVALLLVLGLTILSCGSDDSNPGDFDNQNPTAPQNLTVSNIAINSIELTWDASTDN
VGVTGYNIYRNGSLAISDNSGTTAVVTNLDEETLYSFYVTAVDAAGNESVASNTTSGTTE
GTPLVLTSRLSELGFFQGPMEDLTPADDVQLYEIRTTLFTDYAAKQRLIKMPVGQSMRYI
NTDLLPSFPNNTLIAKTFYYYIDERDPSLGKQIIETRVFLKLESGWMATDYVWNAGMTEA
FRDDVGGTVPISYIDENGITNNVDYIIPSNTDCFTCHNKYNKTVPIGMKLRNMNFTPTYI
GYNQLIYFTDNGLLLGVSDPTTISALPDWLNGNLTLEERSRAYMDVNCAHCHSPGGSVPP
TYNIDFTYETDFNETGIYPNRGEIEARFESTSPIYRMPQLGRTVVHQEALVMLRDYLESL
>OMIFANIC_00665 hypothetical protein
MKNALIICSLLICFTAFAQRPEGNNDRPPRPKMERPDYTPEQIAELQTKKLTLMLDLNES
QQSKIKTLELEAAKARELKWSEKEPSEKPSDEERFNMRSEMLDNKIAHKNSMKSILTKSQ
FEKWEESLLVKGKGRHKKGHHGRKSGKTH
>OMIFANIC_00666 hypothetical protein
MKNLLSVLAISCMMLFGMGNITAQSLTQDQDRPEVIAKTKVADLSSKLDLSGDQQRALFR
AYTAHESNYRKHVKGQDIASPKVQADKKKFDAVLKDAVKKSLNEAQYKKWLSLQEM
>OMIFANIC_00667 Glutamate-1-semialdehyde 2,1-aminomutase
MIYQRSSALFKEAQQVIPGGVNSPVRAFKAVGGEPVFVEKAEGAYLYDADGNKLIDYIAS
WGPMILGHAFQPVIEAVVAKAEKGTSFGMPTEIETEIAALAISMVPGIDKIRFVNSGTEA
CMSAVRLARGFTKKDKIIKFAGCYHGHSDSFLIEAGSGAVTFGVPNSPGVTQGTARDTLL
ATYNDLNSVSELISENKDEIACVILEPVAGNMGCIPPANGFLEGLRKLCDANGILLVFDE
VMTGFRLAPGGAQELFGVRADIVTFGKVIGGGLPVGAFAARNEIMNFLAPVGPVYQAGTL
SGNPLAMAAGLAMLKNLKESKEVYRSLEEKTKYLHTGLTTALNEHNVVHTINRLGSMISV
HFTQNEVVDFTTSAEGNNEVFRKFFHGMLNQGIYLPPSAFESWFLNDALSYEDLDRTIDA
CRIIAKTL
>OMIFANIC_00668 Exo-glucosaminidase LytG
MLNRTIILILAVGLLASGCKSKKRLAEEKKSNRTEKVVISKKRDNSKTTIKKPPANASYA
EVVSIYIDNYSRIAREEMLQYGIPASITLAQGILESGAGKGELTKKANNHFGIKCHTGWN
GERVYHDDDKRGECFRKYKDPKYSFRDHSLFLTQRSRYKDLFKLKKDDYKGWARGLKKAG
YATDPRYPDKLISIVERYKLYEYDEMVLGNRANPVNPDDSKINTYSIIKGDTLYSIARRF
NLTVETLKEYNGLESNDISVGQVLYLHPVKNQ
>OMIFANIC_00669 D-cysteine desulfhydrase
MMETGKEAILTFGGAYSNHIAAVAEAGRLLGIKTVGLIRGEELKAIIPSNPTLQFAAKCG
MKLVFMTREDYRQKENYDILRRYVAKLSDYYIIPEGGTSELAVKGCEEILTSNDSQFDYV
CVSVGTGGTLSGIVNSLRPHQTGIGFSALKGTFQKETITKYCDNTNFDITDAFCFGGYAK
IDSELVRFINKFKSTTGVLLDPVYTGKMMFGILKLMEDGYFKKNSRILAIHTGGLQGIVG
MNLQLKKKNLPQIEL
>OMIFANIC_00670 hypothetical protein
MFIIVGIFLNNQLMTITLLSRKFLLILFCILSTAMLNAQVGINTTSPASGSMLDVNSNNK
GILLPRIALTATNSSSPITPAPTTSLLIYNTATAGAGATAVTPGYYYWSGSAWIPILSND
WKANGNAGTTPATNFVGTTDNIGLSFRTNNTEKFRITNNGALRAYTDGTSALPTLTWASD
TDTGLFRSNNDEISIATNGTAQLSIDGNGNIRANNAGTAANPLFGWTGDPNNGFYSPGAD
EFGLVTNGTERFRIPNANQVHAMSNGTNTLPFYTWDSDTDTGIWLSSADRLNVSAGGVEF
IEFRGDGNDQVVINDPNADINTRIATSGNNTTLFVDGEFDNVGLGTGTPDNSAQLEMSDT
DRGILINRVALTSRTNASPVTSPANGLLIYNTASANSGDNEVIPGFYYWNGSEWVAMGGT
GGRDWSLEGNAGTNPNINFIGTTDATDFVLRTDDTERMRFLDIGTAGMGSAPYTNVVLRV
NNPAHPFGVVSETGSNGAAIWGADSGTGIGVRGENTGTGIGLYGYAANSHGAYTYTTYTG
SAFLIGGIQAWGGGANGANGVLAVANQQASSASNMGLRAVSGSTTSISSGQILNVGVNTN
ATDLALYALTEYPMTSSSSIEAARFQSNYSGSPINSDSRDARAQLAGYTNASQAGGGSMY
YGGYFYSGGTSVNASFAYSGARFNGINYKIIGNGAVSTIVEDTNGDRKVMFAAEAPEVLF
EDYGTGQLVNGSATIPIDPIFSNNIVVDQSHPLKVFIQLEGDCNGVYVTNKSATGFTVKE
LQSGNSNVSFSYHIVANRKSETGRSSDGGSNYSDLRFPDAPSELAPDTLESNSIEKHTPE
DSVVSATGNSKMKK
>OMIFANIC_00671 hypothetical protein
MLYTFPIKAFSKDSTKTVIDVTELFEKDVKALGMNANSRKRYKANRLEANKSFIEDVKSY
PLNIEARHVKTYAAAEPPSNRSTGSISIEINNSMILLPAEPMRRRFFDERVGWFARGQTD
YGQEAQRSKQVTYLDRWRLEVRDEDMDKFRRGELVVPKKQIVYYIDRATPEKWRKYIKQG
IEDWQVAFEEAGFKEAIIAKDPPSPEEDPEWSPEDVRYSVVRYLASPIPNANGPHVSDPR
SGEILESDINWYHNVMSLLRGWFFVQTAAINPDARRPEFDDAVMGRLIRFVSAHEVGHTL
GLPHNMGSSVAYPVEKLRDAEFTRKFGTAPSIMDYARFNYVAQPGDNGVALMPNIGVYDK
YAIKWGYKPIPDANTAGDEKTVLNQWIREHEGDPMYRFGHQQVGDVVDPSSQTEDLGDNA
MIASDYGIANLKRIVPNLIDWTTEAGEDYDDLGEMYGHVISQFRRYMGHVSNNIGGVYEH
YKTADQDGAVYTHVPKAHQKEAMAWINDRLFKTPEWLIDTDIFGKIEYSGSVERIRSVQE
RYLNTILSLGKMQRMIENEALNGNQAYKLTDMMRDMRNGIWTELSSGRTIDTYRRNLQRV
HIDRLAYLMTAKDQSKRRGSAYFKSTAVKTNQSDIRAVARAQLNTIQRSARNAVGRTGDY
MSRIHLQDVVERVDNILNPND
>OMIFANIC_00672 hypothetical protein
MKRLVVLICVLATFSLSAQQGPRHKQGKAGMGMMKNLSPDEAATLKTKKMTLDLDLSEAQ
QDKIYKIQLKNAQERQTRMEEIKKLREEGEMKKPSKEERYTRMNEGLDKQIAHKKEMKAI
LDQDQFEKWERGRKRHSQKRKGMKNQRSKRSRR
>OMIFANIC_00673 hypothetical protein
MKRILSLCIFSLALIIGTSSVNAQEKYKKMDEVIKMEANELQKVLNLDGDQTALLARSMY
AKEKAYTDINTNKKLDEKEAKVLIEKVDMNFKSRLQSILSEEQFAAYSAYQAKKKAKPKY
>OMIFANIC_00674 Exo-glucosaminidase LytG
MKQLLALILVLICFSCGSKRKIITKKDRNEETEVPVKSDAPDRTIEDVKSDRPVITSTES
YIETFKDIAISEMELYSIPASITLAQGILESGSGKGRLAVKANNHFGIKCHDWTGARIYH
DDDRSQECFRKYKNPSQSFRDHSEFLAKRKRYSKLFNLSMKDYKGWARELRRAGYATDKR
YPQKLISLIERYDLDKYDRKSAGISAAAKREHIVMAGDTLYSISKRYGVSVEQIKSLNKL
SGNDIDIGQVLIISSAE
>OMIFANIC_00675 1-aminocyclopropane-1-carboxylate deaminase
MPVTNVHIIDKLFLKPEYLNNSGVSGNKYRKLKYNLEAMQLLKAGVLLTFGGAYSNHIAA
VARAGHEEGYETIGVIRGEELADQIYDNPTLAQARDYGMKLKFISRKEYRNKDSAEFLDP
LEKEFGPYYYLPEGGTNALAVKGCEEILTTDDQDFDIICCPVGTGGTMAGIINSSHAHQT
VLGFPALKGDFLKRDIAKFAKRDNWRLMTSYHFGGYGKINEELISFINRFLEDFGIPLDP
IYNGKMMFGIFDMLEKGELNRNLKILAVHTGGLQGIQGMNKVLQKKKLPQLKVL
>OMIFANIC_00676 hypothetical protein
MLPHAPEVNCSIKFLFAEIPVIVIGKGPPVTVKVYQPSCLKDAGHADAETKGDSSVVFLI
>OMIFANIC_00677 hypothetical protein
MIFRHSVKHDQITPGVIVGDVVDETQLMPEIKTG
>OMIFANIC_00678 hypothetical protein
MKKILLFALLALAVLSCKKDDDTNNNCIEPLSISVDQINSESALVLWDPGNETAFEIEYG
LTGFSTGTGTVAQTSQTNFFIDGLNPMTTYDAYVRSNCGSDGFSNYLSVSFTTLEPVNPC
NTPTDLFLIDVSSSTVTFGWSENNETAWEIEYGLSGFTLGTGTVVQTSQSNFQITGLQSS
TTYEIYVRANCGTEGFSEYSDQLVVTTDP
>OMIFANIC_00679 hypothetical protein
MELKQIDRVETITKQDFLKNFFKPQKPVIIERFIEDWPAFQKWNLDYMSEIAGEKEVPLY
DNRPVDYKDGFNEPHAKMKMSEYIDLLKREPTKFRIFLWNVLKEVPELQNDYRWPDFGLK
LMKGLPMLFFGGENSYTFMHYDIDLANIFHFHFHGKKQVILFDQDQNDYLYKIPHSLITR
EDIDFADPDYEKWPALKKANGFVGNLEHGNVLYMPEGYWHYMRYLTPGFSMSLRAIARNP
KNLGKAVYNVFVMRHYDNLMRRMKGQAWIDGKNEKAITRTHSKLGIEH
>OMIFANIC_00680 Regulatory protein RecX
MRNYKTYSVEEAKSRMERYCAYRERCHKEVHQKLVEMRMIPEAVDLILHHLITQNYLNET
RFSQAFVRGKFRIKKWGKHRIIRELKSRNISKYNIKLGLKEVPEEEYLTVFHELSEKRWQ
QLASEENLQKKKKKFTDYLIYRGWESQLIWEKLMELVS
>OMIFANIC_00681 Ribonuclease G
MSYELFIRSSSQEVDFALLKDGKLIELHKEEEDTKFAVGDIFLAKIRKTVPGLNAAFVNV
GYEKDAFLHYHDLGPKVLSLLKFVKRVSTGKLKEYSLKDFPFEKEIDKNGGINHAIKSNQ
SILVQIVKEPISTKGPRISSELSIAGRYIVLVPFSDRVSVSQKIESKEEKDRLIRLIKSI
RPKGFGVIIRTVAEGKKVAELDRDLQNLTDRWMAMCKKLQRAHHPSKVLSELDRGASILR
DIFNDAFSAIHIDDETLYLQIKDYVQEIAPKQESIVKLYDSKVPIFEKFGIERQIKTSFG
KTVSGSKGAYLVIEHTEAMHVIDVNSGNRSNKSKNQEDTALEVNLIAASEVARQLRLRDM
GGIIVVDFIDMGHAANRKKLYNHLREEMNDDRAKHKILPPSKFGLIQITRQRVRPEMNIK
TAEENPNLGIEGEIEAPIIVVQRITEELERLFKKDYKKITLNTHPFIAAFLSKGFPSVRT
KWFMKHKKWVNIQPRDAYTYLEYHFIDKDGNQIK
>OMIFANIC_00682 DNA-binding protein HU
MTKADIVAKISEKLGMEKGDVQATVETFMEEVKSSLESGDNVYLRGFGSFIIKKRAEKTG
RNISKNTTIKIPAHNIPAFKPAKIFVEGVKTNVEVK
>OMIFANIC_00683 Adenine DNA glycosylase
MIKNQSDFSNILIVWYLQNKRDLPWRNESQPYYIWLSEIMLQQTRVAQGLPYYLKFIKAF
PTIADLANASEEYVLKLWQGLGYYSRARNLHYTAKEITFNRNSEFPDTYKELLELKGVGD
YTASAIASICYNEPTAVVDGNVYRVLSRVFGIETPINSSSGVKIFKDLAQELIDAERPGT
FNQAVMEFGARYCIPQKPDCENCVFSDRCEAKRTGSVSKLPVKIRKQKIKHRHFNYLVIL
SDKQEATVLQQRRHKGIWQSLYEFPLIETDSEVGESEIAERAEFKAYWGKNGTKELLLFN
ESPIIHKLSHQHLHTKFWVVKTAEQLPEPVPISEINNYPVPVLIENFISEFSPFQN
>OMIFANIC_00684 Single-stranded DNA-binding protein
MSGTLNKVMLIGHTGDEIKMHYFEGGGCIGRFPLATNETYTNKTTGERVTNTEWHNIVMR
NKAAEICEKYLKKGDKIYIEGRLKTRKWQDDQGKDRYSTEVQCTEFTFLTPKAEGGAMPQ
QTSGAPATQQPATPQPQVEEHIGEEDDDLPF
>OMIFANIC_00685 Magnesium and cobalt efflux protein CorC
MDIEPPSLFFIALVNITHIVGIVLLVVLLICSALISGAEVAFFSLSPTDFETTEDKSPPK
QLKIVQRLLLRPKKLLATILIANNTINIAIVLLFESLSSLWFKGWDYSINLYLFDVSAIF
ILKIGLATFLILLFGEILPKVYASRNKLQFSTFMAYPLNALDRLFAPLSLPMRSATIYIE
NRFGKQKSGISVDQLSQALELTDEHDTTQEEQKILQGIVTFGNTDTKQVMKPRMEIFALS
EDINYKDIMPEIIENGYSRIPVYKDSIDNITGILYVKDLMPHIDKKTLEWNKLTREAYFV
PENKKLDDLLNEFKDMKMHLAIVVDEYGGTSGLISLEDIIEEIVGEISDEFDDEDLVFSK
LDDNTFVFEGKTPLKDFYKVIQLEDTTIFEETKGEAETLAGFLLEISKGFPKKDEVINFH
NYAFIIEAFEHRRIKQIKLSITP
>OMIFANIC_00686 hypothetical protein
MRYLFLLVVLIGFVSCKDDVIVKPSAMMRLEYPDPVYKLIEPDCPYGFEKNDQASLQLKK
NCWMNLEYPEMKATVYLTYQQIRNNNLDSLLRDAQKLTYDHTIKAQSILEQPRVDSVNKV
YGMFYMINGDAATQSQFYVTDSLKHFITGSLYFESKPKFDSLYPAVVYLREDIRRIMETV
YWRN
>OMIFANIC_00687 putative inner membrane transporter YedA
MGNNKLKWVYLIILSLIWGSSFILIKKGLIGLTDYQLGSLRIVLTSIILFSVGFKSIREI
KKKHWIWVAISGFVSSFFPPFLFAIAQNHIDSGITSILNSIVPLNTVIIGALLFAIGVTR
RQIWGVLIGLAGTLMLIYGGMMITDGGTIENSLPGETNYLYSGLIILATIGYAFNVNIIK
KYLNDISALAVTTGNFIFVFLPSLVILYYSGFFEEIMRSQQMQLASGYVLILALFGTALA
KVIFNRLVQIASPVFASSVTYTMPIVAVGWGLVDGESFGFLQLIAAGVILFGVYLSNKRQ
KLN
>OMIFANIC_00688 hypothetical protein
MGKIYSTYGTGTAVVLVAYFLLTKLIGLHQYPVLSAANGVIIGAGIFFALKKYKSTVEAF
KYQDGFQLGLFTGGLATIIFSTFMALYIFIVDTEFAKAILDSWNLNFNKGSLILIISLVI
MGFATTFVLTLSFMQLLKESWNPKR
>OMIFANIC_00689 50S ribosomal protein L21
MQCIGVGDRTKNKLINRYAMYAIVEIAGQQFKVAKDQKVFVNRLATEEGKKVSFDNVLLI
GDGDKVTIGAPAINGAQVGAKVVKHLKGDKVIVFKKKRRKGYQVKNGHRQSLSEIVIESI
VASGAKPAKKAEPKKAAPKAKAEKPAAKAAPKKAAPKKAEPKKPAAKAAAPKAKAPAKAK
AAPKKAAAKKDDLKKIEGIGPKIAETLTAGGIATFAELAKSKPAKISEIIAGVRGNHVPD
TWPEQAKLAADGKWDELKALQDKLDGGKK
>OMIFANIC_00690 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIYGGQAAIAGNIIVRQRGMEHHPADNVYAGKDFTLH
AQVDGTVKFTKKKNNKSYVSIIPSAQA
>OMIFANIC_00691 Adenosylhomocysteinase
MSTKTMPYVPFKVKDISLADWGRKEIELAEAEMPGLMSLREEYKDEQPLKGARIAGCLHM
TIQTAVLIETLIALGAEVTWSSCNIFSTQDQAAAAIAAAGIPVYAWKGMTEEEFDWCIEQ
TLFFGEERQPLNMILDDGGDLTNMVFDKYPELASGIKGLSEETTTGVHRLYDRMKNGTLV
MPAINVNDSVTKSKFDNKYGCKESAVDAIRRATDVMLAGKRVVVCGYGDVGKGTAASFKG
AGSIVTVTEIDPICALQAAMDGFEVKRLETVVEKADIFITTTGNKDIIQGKHFEAMKDKA
IVCNIGHFDNEIDVAWLNDNHEKVEIKPQVDKYSVNGKDIVLLAEGRLVNLGCATGHPSF
VMSNSFTNQTLAQIELWKNSDQYENKVYMLPKHLDEKVAKLHLEKIGVELTELREEQAEY
IGVKVEGPYKPEYYRY
>OMIFANIC_00692 hypothetical protein
MPLYKTITVNEDTKVLIWKIEESFDELSNGISLTENCRNRVDGMKSDLHRRGFMSIRHLL
AEEGYTDHDLYYDENGKPHLGDDKHISITHSFIFSAIIISTNEVGIDIEKQRPKIIRIAH
KFTPIEDYRNLPNDEIIMRKLTMVWGAKESLYKSFAAPGLSFLQHIYVEDFILEEMQTTA
IVSFNGKVELYHVNMLEFEGFTCAYALLSKVV
>OMIFANIC_00693 Geranylgeranylglyceryl phosphate synthase
MMGSRNIYNTILEAVTAKKKLLAILIDPEKFDLEKASEFLRNLPSETTHLFIGGSTVPRG
LTHQVVETIKLYTAKTIVLFPGDVSQITESADALLYLSLFSGDNPEYLVGQQIKAVPLLR
SIQIEIIPTGYILVDGGNGSAVATVTRTRPIPQHEIQRIVDTAVAAELSGKKLIYLEAGS
GARIAIIPEIISEVKKELQIPLIVGGGIRTADQVRAAYDAGADMVVIGTAFENGNSLKLK
N
>OMIFANIC_00694 Nicotinamide riboside transporter PnuC
MGEIFEFFFGQYANYETIDIILEIIAVIFGFLSVWFSKQNNILVFPTGMISTAIFVYLLL
KWALLGDMMINAYYFIMSVYGWYVWTRKVDETHVTPISYTTKKEHLYSVLIFVATLVFVY
VVYKTFDKWNNWTAIVDTFTTAVFFVGMWLMAKRKIENWLYWIVGDIISIPLYFYKGFTF
TSFQYLIFTIIAIFGYFAWKKYLNKNLQTA
>OMIFANIC_00695 Trifunctional NAD biosynthesis/regulator protein NadR
MEKILKQEPSDCVKIVLFGPESTGKTTLASELADYFNTEWVPEYMREYLQKKWDELGERI
SWEDLLPIAQGQISAENETAKNANGILFCDTDLRELKVYCEYYYDGKCPEEIRNAVENNS
YTLYLLTDIDSPWVADDLRDRPEDRTTLFRIFEKELIENGLNYHVLNGSRTEKFNKAVAL
TKKLVGR
>OMIFANIC_00696 hypothetical protein
MLKKEDLQQIKEYGLPLQKVYQQLETFSLGIPPVNIVTAASVGNGIEVIPKESHQKLVDL
YEDRKDKLDIVKFVPASGAATRMFAFLYNFLEHYDPEAETLGKFLKRQPSPALETFMKYM
KDFAFINDVRKKIRQNYPDYKKSTTGQRMTWFIQTMLEPKNLNYSNLPKGLIPFHKYSKY
YTTAFEEQLYEAAFYAAAHDDAYLHFTFSEKHVPFFKKEFETVRKRVSKKTKTDFHISYS
FQKPETDTLAVTMDNNPYRDSKGKLVFRPSGHGALLENLNDIDSDLIFIKNIDNVVTEEY
VETIAFYKKLLAGKLLWIQKKVFHYLLDLEKEEVEEEVLREIRSFMWNELSIKDIPIDQD
KMMNILNRPIRVCGVVKNTGAPGGGPFWVREEDGKVSLQIVEKSQIDMDDPHKSAIVNDA
THFNPVDIICGVRDFKGKKFDLRLFSDPRAGIIANKSDGGTPIKALELPGLWNGGMAKWN
TAFVEVPLVTFNPVKTVNDLLSKEHRPNA
>OMIFANIC_00697 Peptidyl-tRNA hydrolase ArfB
MESEQVIKELRFKAIRSSGPGGQHVNKSSSKIEVQFNIENSEAFSEKERERLRDRLAKRI
TSDGLIILQCGETRSQHRNKAIVVQRLLDLLAQNLKVKKKRKKTKPSKTAIEKRLKVKKQ
QALKKSSRRPPKIE
>OMIFANIC_00698 Vitamin B12 transporter BtuB
MKLLSFIVLFFVGFTLVWTQEKTVDSTQVENLDEVLVQAIRVKEDAPITHSNVDKEELQK
RNLGQDIPLLLNYLPSVVTASDAGAGVGYTYIRVRGSDASRVNVTLNGIPFNDAESQGTF
WVNLPDFASSVQSLQLQRGVGTSTNGSGAFGASLNILTDAISEKAYVELANSFGSYNTRK
HTVRFSTGLLDDHIEFSGRLSNITSDGYIDRATSDLKSYFLQAAYKDRNTLLKLITFGGR
EETYQAYFGIDGETLAIDRTFNPAGIYTDDNGNIRFYDNEVDNYAQDHYQALWNQRFNNK
WRTNVSLNYTYGRGYFEQFVEDGDLEFHGITPIEIGGETITTSDLVRRRWLDNDFYAVNA
NVSYTESEFDITSGAFYSFYDGDHFGEVIWSRFAGNAEIRDRYYFGIGEKSEFTVFSKAN
WQIDSQWSVFADLQGRFINYETTGITADKFPLNVDETYDFFNPKAGISFEFNSNNQFYAS
FGRANREPRRSDFEQGIFTPESLNDYELGWRYNSEKVQVNSNAYFMDYRDQLVLTGAIDD
VGAPIRATSGKSYRLGLEVDAEIIIGPKLKIRPNIALSTNKNVDFVTSRDGSLVNLGSTN
ISFSPDLVAGNIIEYNPVENLQIAFLSKYVGEQYMGNIDSEVSKLDSYFINDLNLIYRLE
NVPVAREITLSAIVNNLFNVEYVSNGYFFTFDDDFSDPGTITTIEGAGFYPQATTNFLIG
ATVLF
>OMIFANIC_00699 hypothetical protein
MKMKLFAMCVLILLASCKSDDGGVQDDNPFLIDPIVNLNLNLNLPQYDPLKFPGNSIIIN
QQGIKGIVIYNVNNSLYTASELSDPNHPPSGCSRMTIEGIIASCPCEADNNEYDIVTGQH
KTNTNSYPMQQYRAIRTGDNLQVSN
>OMIFANIC_00700 Transcription elongation factor GreA
MSKVSYYTAEGLKKLRDELNQLKDVERPKASQAIADARDKGDLSENAEYDAAKEAQGLLE
MRISKMEETLANARLIDESALDTSKVLVHSTVKIKNQVNGMEMTYKLVAQSEADLKTGKI
SVDSPIGKGLLGKEVGDTAEIQVPNGTMKFDIMEISRD
>OMIFANIC_00701 putative HIT-like protein
MSTIFTKIINGEIPSYKVAEDEHFFAFLDINPNTRGHTLCVPKQEVNKLFDLDKDTYEGL
MRFSYKVAKAIERSVPCDRIGMAVIGLEVPHVHVHLIPINEMKDMTFQHKTPVPAEEMKA
LAEQIQQNL
>OMIFANIC_00702 hypothetical protein
MPETSHILHTAKLKNNCPECSLADSLELTFTQIENENRFYSKASKNINSVMRCNSCDTTI
YPVSWNEDLERVYEYNRKLAKPKPTGIKLKPLAYFIIILDAIIIGIVIYLLK
>OMIFANIC_00703 Sporulation kinase D
MLYIYRTSYPIGTVMKKYLSMQNKKAVLRWFFVFLSIFIISLILWNTYVFFNELKDNERS
KMQIWAAAQNEFAQTDLESDEDISNIVLQVLQSNITTPMVVYSHKEDSYDVRNIEENETD
PEKLRENRKQLAEQFTSEYKPIPIRFNDEILQTIYYGNSPIINKLKYYPIALILIIVLFF
TALYFFFQTSKSSEQNKLWAGMAKETAHQIGTPLSSLVGWAEILKEEKVNASYIEEIEKD
IDRLKTITERFSKIGSVPALTKTDIVAETRQSFDYLKSRTSKLIEFDLHLPVHPVFVELN
PQLYGWTIENLVKNAIDAMKGKGKISISIEATSRHARLLISDTGKGIQKRNFRKVFTPGY
TTKTRGWGLGLSLVRRIIEEYHLGKIRVLKSTIGEGTTMEILLKIIR
>OMIFANIC_00704 Flavoredoxin
MITIDPKEIPTPKLHGYLLGAVSPRPICFASTVDSKGSVNLSPYSFFNVFSANPPVMIFS
PARRVRDNTTKHTLENVLETKEVVINIVSYEMVQQMSLSSTEYPKGVNEFLKAGFTEVPS
DVVKPPRVKEAPVQFECKVNEVIALGNHGGAGNLVICEVMKIHLHEEILDENGRIDPLKI
DTVARMGGNWYSRAKAGLFEVEKPLRTLGIGVDALPESIRLSTVLTGNDLGILANVEALP
EGVNDEIKPSDETQKKAQEYLKTGNVMEAWKILQQ
>OMIFANIC_00705 hypothetical protein
MEVQGKIKMIDETKTYGNNGFRKRELVITTEEQYPQHIMIEFVQDKTELLNSYQVGQNVK
VSINLRGREWVNPQGETKYFNSIQGWRIENIDQAVSGDMPPLPPEDAFEPANDLNEEDHD
DLPF
>OMIFANIC_00706 Leucyl/phenylalanyl-tRNA--protein transferase
MQFLTEEIWFPPVNEATSEGLLAIGGDLSVKRLKLAYQSGIFPWYGDAQPIMWWSPDPRM
VLFPDSLYVSKNLRKKIQKEHFTVTFNKSFKEVIHHCANVKREDQGGTWITDEMLTAYTE
LHNHGMARSVEVWNGNKLVGGLYGIDLQAQRIFCGESMFSLESDASKVALYYLVQEIRKL
KYQFIDCQMYTEHLARMGAREIPRSEFLKYLQ
>OMIFANIC_00707 hypothetical protein
MNSIEQIRQWMDNNPTSLAFIKYLLWVIVIIALIQFFRSLLRRRLPDTRTRYKTQKGVEV
IGYVFLVLLSLSYFTGNIKDFTLAVGLFTAGVAITLQELILSIAGSVYIFFVKVYKPGDR
IEINGIKGDVIDIDSIYTTMMEIGEWVSSDNYSGRIVKLSNAFVFKGPVYNYSQDFPFIW
DEFNIPIRYESDVELAKSIIIKVASEQLSDYVNTSLDKWKSVVRRYYIEDALVAPTLAIS
LTDNWIQFNLRYIVDYKKRRFTKHRLNELIALEIENTNGKVKLASTTIEIVRIPTLQMDK
EAK
>OMIFANIC_00708 Peptidylarginine deiminase
MKRFYPNFILVLMLALLTTVSFSQDKGILPAGLTEAEREIISDYSFTGNRFTPPPSGPVR
AAAEWEEVEYLLITWQPSFPNILRQIVAAAVQECKVIITTQNEASVSNYLQSNGVDLTNV
IFMDEPWNSIWIRDYAGNTIYSDDVGERALTDWIYNRPRPLDNVMPSAHAALVGVPIYIT
DTAPNDLVNTGGNYMSDGLGNAFASELVLNENEAGNPYGVSAKTEAQVDNIMQEYMGIDT
YIKMTPLPYDVINHIDMHMKLLDEETLLVSKYPEGVADGPQIAENIDYVLDNFQSVFGTP
YRVKWIDAPPSPSGSYPDTGGYYRNFTNAIFINKTVLLPLYRPEVDGPALAQWEEMMPGY
NIVGIDVDNPGENLIALFGAIHCITHTIGVADPLWIVHQPVYSADTNTDVTLDAMVKHVS
GVTSADVIWREVGDTNWNQATMTNVSSDNWTTDISIADTDVEYYIEAEANSGKVLSRPIV
APEGYWTIGAGVLGTGDLTNYNISGPYPNPTVGSVSFNLNNLSGPVSVRVQNILGQVLMT
EVVINGNGVFNLDLNPGWRGTLFVTFEGEFGRATKKVIKL
>OMIFANIC_00709 hypothetical protein
MKRHFIFIFLLVVCISANGFAQSSTDVNKDVDRTAVYEQVVKEGYGTPKIYKALGNAHYF
EGNYTDAKKWFEKLFESETLEDPMLKFRYKQTLKALKLDPANNTYLNPTMAGSN
>OMIFANIC_00710 DNA-3-methyladenine glycosylase 1
MTKTRCAWCGDDPLYVAYHDIEWGVPVQDDRLLFEFLILETFQAGLSWITVLRKRENFRR
AFDNFDYKKVAKYEQQKIDSLLLDAGIIRNKLKVKATVTNAIAFMEVQRKFGSFSDYIWR
FVNGKPIVNSFKDMAEIPANTSLSDEISKDLKKRGFKFVGTTVVYAHMQATGMVNDHVTG
CFRFNEINRL
>OMIFANIC_00711 hypothetical protein
MEIKQQNKVALVKEKLSETIDYKTYKNVVSELAKKGLSTSPEQTEANSNFTKLNDARMRR
LDKTIKVPDEIAEKFENFSGNHTWLVITESWCGDAAQSIPAMNRLAELSEGIDLRLIYRD
THPDLMDVFLTNGVRSIPKLIVFDNTTDQILSEWGSRPSAATKLVNDYKAEHGVLTPEFK
QDLQVWYNKDKGQSILQDLAELI
>OMIFANIC_00712 hypothetical protein
MKFDYSYRAFIITSLLFGCLFLILYSAKLGAGFPVDETSYDVEYADELPIPEEELAKLTP
AEQRAIETNKAFNEAEKFISDLETSESEIDDKLAELDAAINDTQFVSEEGIKEAREKLKE
AREIALKRKKQKKAETGSGNRNTTISYELVNRRSLHIPNPVYTCDRGGIIVINIQVNALG
KVTKTGYNKKASSTQNGCLIESAIIYAKKARFNTAAAVETQKGTITYNFPGQQ
>OMIFANIC_00713 tRNA pseudouridine synthase B
MTAEDYLEGQVILIDKPLNWTSFQVVNKIRWIIRKEFGIKKTKVGHAGTLDPLATGLLIL
CTGRFTKKIETYQAQEKEYTGTITLGATTPSYDLESEIDQRFDVTKITSKDIHEATTKFI
GNIQQQPPVFSALKKDGKRLYDYAREGKEVEIPTRTIHISEFEITGIDLPDVKFRVVCSK
GTYIRSLAHDFGKALDNGAHLSELRRTRIGDFIVENAISIEEFAKQITS
>OMIFANIC_00714 Undecaprenyl-diphosphatase
MDIWDAIILGVVQGFTEFLPVSSSGHLELGKAILGDTSVPEESLLFTVVLHFATALSTIV
VFRKDVWEIISGLLKFKWNEETKFSLKIIISMIPATIVGVLFEEELEAFFGGKIAFVGAM
LIVTAILLWLADRAKHTGKKVTNSNAFVIGIAQAVAMLPGISRSGATISTSVLLGNDKSK
AARFSFLMVVPLIFGKIAKDIYSGELSGESTDFTVLGIGFIAAFICGLLACTWMITLVRK
SKLSYFAIYCVLVGITAIVTSFYVS
>OMIFANIC_00715 hypothetical protein
MGEKKRKEAAKINSFVFEKKNYKFMLIGAAFIALGFILMAGGGSDDPNVFNPEIYNWRRI
RLAPALILIGFGFEVYAILLNPNKEK
>OMIFANIC_00716 hypothetical protein
MNSTIKKLALILTTSFLLSGCLIQDPKPEDCVTKEITVTAIEEGTSFDIVIKEKKDDFYY
INRGLEQGLTIEGLKEQIMNKKVNLQLYKFWFGTSEHISQLTVDNNVLFTEFD
>OMIFANIC_00717 Cell division protein FtsX
MATAFEKYQKRRLISSYFSVVISIGLVLFLLGLLGLLVLNSKRVADHFKEQVPIVIFLKD
TAKEVEINQLKQSLELADYTRYANYVTKEEAAEAHMAEIGEDYVDYLGENPLQNNIDVRL
RADYVTPEKVEEIITELKSKPFVDDVGYDKPLIEQLTKNVQRISFWVLVVAGIFLVIAIL
LINSSIRLSVYAKRFTIKTMQMVGATKRFIRRPFIWKSVRLGILGSILAMGGMAFILYYL
NKTFPELGLTQDTVLIVSLFVFIFLMGLIITWISTFFATQRFLNLRTDELYY
>OMIFANIC_00718 Photosystem I P700 chlorophyll a apoprotein A2
MKTLLKKSILLSLVLLFTGLTFAQKKEIEKADKEFDKYSYIDAREIYLKVVEDGYTSAQI
FKNLGDTYYWNSEYDSAAKWYQRLVNEFPNEADAMYYYRAAQSLKSLGQDDVAGELMEAY
IRKGGDPKIIQATNTSFMEYEVELQKVSVNTENSDFGSAFYGDKLVYASATVQTEGDKIH
EWNQQPFLDLFEADMDENGMLSNPTKLNGEVNTRFHESSAVFTKDGNTMYFTRNNFIDGK
KGRDKEKTIRLKLYRATKSSETYWTNIEELPFNSEEYSVAHPALSLDGKKLYFSSDMPGT
TGMSDIWYVNILEDGAYGSPMNVTVLNTEARESFPFISENNNFYFASDGRGGLGGYDVFM
VPLGESGIPNGEIKNLGAPTNSNKDDFGFIINEQKRIGYVSSNRDGEKGSVADEIYRVQE
RCEVTIAGTITSDVDNKPVANATVTLLDENSIVVKTMTAGPDGTYSFDGMAECSSVYVVR
AIGDGCEYNEKLVTTPNVSGTVMADLVLECDPCAPNDLGCRLKLEPIYFDFDRYNIRPDA
EIELAKILAALRQYAELVIHIESHTDSRGNDAYNEALSEKRAQSTLEWLVSKGIDRNRLS
AKGYGEYQLTNQCSNGVECTEEEHQLNRRSMFIIQN
>OMIFANIC_00719 Isopentenyl-diphosphate Delta-isomerase
MQEEMVILVNEKDEQIGLMPKMEAHQKAILHRAFSIFIFNDKDELMLQQRALHKYHSPGL
WTNTCCSHQRDGETSLEAGSRRLQEEMGFTTPLKETTSFIYKAPFDNGLTEHEFDHVMVG
RYNDEPVINKDEVNAWKWMLLEDVKKDIKLNPENYSAWFKIIFDKFYEHLSL
>OMIFANIC_00720 6-carboxy-5,6,7,8-tetrahydropterin synthase
MSLTVFRKAHFNAAHRLYRKDWSEERNEEIFGKCNNPNFHGHNYELEVGVTGEVDPETGY
LIDMKVLKDLIREEVEDAFDHKNLNVEVPEFANLNPTAENIAKVIWEKLRKRLDSDFKLS
VKLYETPRNFVLFTG
>OMIFANIC_00721 Putative peroxiredoxin bcp
MALKIGNSIPEFSLKDQHGNLFESKSLIGKTSSVIYFYPKNFTPGCTKEACEFRDRYEAF
TDMNAKVIGISRDSTVSHRRFANQYNLPFTLLSDKNNEVGKMFGVKKSFLGLLPGRETYV
FDKQGKLIFTFNSLDAKPHITKALQQLTQLNE
>OMIFANIC_00722 putative mannose-6-phosphate isomerase GmuF
MSKALKLYPLKFTPVLKSKIWGGDKLTSKFEKGPYKDGIGESWELSGVSGSISEVQNGIL
KGTNLQELLRSHGEDLLGKRVYKLYGEDFPLLVKFIDAKEDLSVQLHPDDKMAASHHNSF
GKTEMWYIVDTNPDARLIIGFNRKMDKHLYRKNLSEGTLPATLNSEEIKPGDAFFIAPGT
VHAIGGGTLLAEIQQTSDITYRIYDWDRPDVDGNMRELHTELALKAIHYNAPNARLDYED
EENSIVKLCTSDYFETNKLKLTKPLHRDTSGLDSFRVYLCVDGDILIETHSDSVSLSAGE
TVLIPACIDKIILKTASATLLEVYIP
>OMIFANIC_00723 hypothetical protein
MASVRDLKRDINYVLGDIIEAVYIWELTNPEKDTKKSEKIIDEAIDTFDDLIAKVNAKDV
ENRKNHFKAINQELEDRGRKLIDKINALS
>OMIFANIC_00724 hypothetical protein
MRYFGLILGLMIVLTGCSRSENQMQLSGTVKGLKKGTIILQKIKDTVVVSVDSLVVDGDP
NFLFTEEINSPEIYYLYLRLENGTLLDDRIPFFAEPSEIKIETSLKKFGNDVSVSGSVNQ
VKLDTYKQLMRRFNNRNLDVIEQRLKARQDGQDSLAISLSAQQDKILAGKYLATVNYALQ
QKDFEVAPYLMLSEVYDANLKYLDTVYKVLSPKIKDSKYGEELYSYIEERRKDETN
>OMIFANIC_00725 hypothetical protein
MQETASEIIKDTTPLITSDTIVFGLLMICLGLIFYTSSQKKGFWYKFYKVVPALFMAYFV
PALLTTSGLIAPEWTTVDDAGVATEGETSLYFMSSRYLLPAALVLMTLSIDLKGVFNLGP
KAVIMFLTGTAGIILGGPVAILVVGAIYPDAIATPLTPVPGVGETNEIWAGLSTLSGSWI
GGGANQTAMFEIYGYNPKLFGQMVFVDIVVANIWMALLIIGIGKAVRIDKWLNSDTSAIE
RLKEKVSQFSKKVERNPSFSDLMILAGIAFGTVSIAHFGAGYISGYFESMVNSMPQGLSR
NMLSFMSSSFFWMISIATVIGVLLSYTKARDYEGAGASKFGSVFIYILVASIGMKMDLTL
IFENKMLIVIGLVWMAIHAGLLILVAKLIRAPYFFLAVGSQANVGGAASAPIVASEFHPS
LATVGVLLAVFGYAIGTLGAVACTFLMQLASAA
>OMIFANIC_00726 Esterase EstD
MGQIDESKIDFDHFIEDAVAVLNFFTNDERFSKVYLLGHSQGSLVGMIAGQQGADGFISV
AGAGQAIDDVIVDQLAKQAPGLRDNARQSFDDLRVNGVAQNYSPGLSSIFRPALQPFIYS
WMKYDPKEELAKLEVPVLIVNGDKDLQVQVSEAELLHSSKPSASYEIIENMNHIFKEIAG
NDLENQKSYNEYNRPVMPELIELISTFVSAE
>OMIFANIC_00727 hypothetical protein
MYSDKCIKELTFEGKYISGEAKNVLTDPYTNKYIIKGSTGIGGTTAILNNTQGNYIIVSP
NLGMIKSKEKHRVTYDSDKQFFIYSESKDNWVETLDYIQASEDPNVIINTTPDQIAKAPS
ERLKWLVEIPLFIDDVHLYVQDAGYRDNVGHMIEMVYHEWKANYTLSTATPIHNFWDIPN
DIDLEYYKVSPIVVPNKHIDVSYDRKDINRFVYEQYEMGRLVAVFTNDKRIHTSFRDLRV
SNLVGDTLRVKIAPYDRGISTQELNYAETDVLILSSSYFAGYDIQHDCSILIVSDQSNDA
WKVNVNNIVQAYGRCRNKVHQALFINLQNSHRDSSQGQISSLQTTLDLYPHYDAFQKKVD
LYTGLLNDSELKYQDEFNRYFVNYSYVNRPKLMGDLIDVVDDYYLYNKEAFTKILSSYNF
EIANYVSEYEKIIGKIGIDFSDRIKNLIQLSPDDLSRDYSNIKYNIRNKREGTYTPKLAL
EYLTAYLIVITQPNELIKKLDNKRIYAKEFYEYMQKFLSINGSTKYLLRPPTKKFITNNS
HYENQHSREALKECSTQTDDWHMLYAIYQVSKNQFSTRIDRNLKIEHAIHNEDIYNWYRK
SGCNRTKLTRAKIIKSLKDDNVTLTDRELNRLNRKIVENFNELNNDKSFGQYYNPKYLKR
LMTQVMLFCLTNGKCGGVKIKDYREYNPFTALPKSLRSIIPIKYVEIDLSSANAQFVDML
LDTQLADEVYRNIMKHYKLSRNQAKWKYNSALNNYKMSISSASEFYQNAGYPEDKAVLLA
RMTARTIKGEFFNIMTQYEQVIINLYNEMIDDIGFRFHDALVVRESHLWDKNYVLPMRLR
TKKDKCMDDIFSDLEMPKDRVIQFHIGYYNNPSINYTGSITNEVHDADLPLVEIE
>OMIFANIC_00728 hypothetical protein
MIYKATINGQNIVIYLDGSMFYNGTTKQELTPYVREDGIEVIDIGDIQLPVEGVLATARK
EMGMED
>OMIFANIC_00730 hypothetical protein
MLTKYLPAFIILSLLAEIFGTVGGFGSSVFFVPVANYFLDFQAVLGITALFHVSSNITKI
AFFKKGIDKKIILTLGVPAVLFVILGAYVSKFFDPVILTYILGGFLVTFSLLFLIFNQLE
VKPKTPNAIIGGVLSGFSAGILGTGGAIRGMTLAAFKMSKDKFIATSAVIDLGVDSSRTV
VYYFNGYMKMELLYLIPILIVIGILGTWIGKRILKYISHEQFRYIVLFLILGIGIASIVT
NPG
>OMIFANIC_00731 Lipoprotein-releasing system ATP-binding protein LolD
MDIVLEARHIDKYFTKPVEFHVLKDINLEVKKGEFTSVMGKSGCGKSTLLYILSTMDTDY
KGELFLNGELTTGLDSNRLAHIRNKYIGFVFQFHYLLSEFSVLENVMLPAKKLGEKSVEE
IKEDAMLKLKMLEIDNLAMKRANRISGGEKQRVAIARALINDPLILMGDEPTGNLDSQNA
ENVFRIFKKLSDEQGLSLLVVTHDIDFADKTDRIILMGDGTILD
>OMIFANIC_00732 Lipoprotein-releasing system transmembrane protein LolE
MNQKKVLFTIAKTHLLTKFRQTATAALGVTFGIGAYITLVCFMTGLNKMLDDLVLNQTPH
VHIYNEIEPSEKQPVSLYKEFENALNTVHSIKPKQSQVRIHNALPIIDHLRKDENVLCAL
PQVRTQVFYVAGSIELGGTITGINIREEVEYFNFGDYVVDGDPVDLKNTDNSILLGAGIA
ETMSLHIGDRVQITSTGGTIFPLKIVGIFQSGIADVDNVRSFTTIKTAQRIVEGSDNYIT
DINLKLNDISQAPTIARTIERQFDLKAIDINEANAQFETGTTIRNLITYAVSITLLIVAG
FGIYNILNMLIYEKMNDIAILKATGFSGKDVQLIFIMQALIIGIVGGILGLFLGMGLAHL
IDGIAFETEALPTITTYPVNHNPWFYVIGITFAIVSTFLAGYLPSQRAKRVDPVKIIRGQ
>OMIFANIC_00733 Putative efflux system component YknX
MRSFLVFLMFISLVCCDSKEDRIQPKRTDLTESVYASATVQPDSLYKVYAAVSGILDDIL
VEEGDTVVIGEPVVKIINTNPALSSENAKLAYELAKSNYSGNSAILKTLEEEIAAARLKL
SNDSVNYCRQKNLWDQQIGSKAEYDTRKLAYDLSKNTVARLENNYSRTKEELETQFQQAG
NQYKSALVTTGDFTVKSKINGTVYSLLKNPGELVSTLEPIATIGSTNDFIIELLIDEVDV
VKVRKAQKVIVSLDSYGNRVFTAIISRILPAKDMRNQTFTVEAIFEEEPGILYPGLSGEA
NIIIAVKEDVLTIPKLYLIDENKVKTEDGIVEIETGLQDLEKVEILSGISEDDWILKPAQ
>OMIFANIC_00734 Uracil phosphoribosyltransferase
MIIHNFEQPPSLLDQFISEIRDKTIQTDPMRFRKNIERIGEILSYEMSKTLDYKISSIET
PFGIKEMPILQDQLVLCSVLRAGLPLHQGILNYFDRAENAFISAYRYHPEGGDDFEVIVR
YFASPKLDNKVLVLTDPMLATGKTLENVFKTLRSHGNPKKIHILSVIGSEEGVQYVSKVF
PESTEFWTAAIDKTLTAEGYIIPGLGDAGDLAFGEKL
>OMIFANIC_00735 hypothetical protein
MKIVFTFIVGIHALIHVMGFLKGFGYAEIGEISKAVSRLEGILWLTTSLLFMSGIILMHY
NNLRWKWLLLLAVLISQALIITVWPDARFGSLPNLLIALVLLFGYSENVFRVRSEKLAKE
ILVSSETLSLNNTIEDRINNKPPIVQKWLRASMHDSSYISSVRLQQKGRMRTKPQARWMP
FTAEQYISIPAASYIWTTEVELFSDIDLTGRDKLESGEGETSIKLMGLIPIVNEKSNPKI
NSGSLMRYLAEICWYPTAALDNRIHWESVGDTSAEASMMMNGVTVTGTFYFTPDGNFEAF
ESQRFYGGGDNSNLETWHIEALDYDTFHGVQIPNKAEITWKFLEGDFKWLELEVIDIDYN
TTEVY
>OMIFANIC_00736 hypothetical protein
MQYDTGHILSIFRKVHLEYKFNITGMTISIQYVKMPTSETLTAFTEKRLNKLASKYSWLI
NANVYFKLEKDAVGKKICEIELSLPGPKIFATSVEDNFEVAVKETITDLNRQLRKRKETT
YNH
>OMIFANIC_00737 Universal stress protein/MSMEI_3859
MKTLLVPIDFSDHSEYALEVAAKIAKRHDSSIVALHMMGLSQAVLTKDDSQEVFEAMYYM
KLAEKRFKDFLDRDYLEGIEVQTTVQNYKLFHEIDQVAQEFKADLIVMGSHGSSGLREVF
VGSNTEKVVRNSEIPVLVVKNKMGDEAMNKVVFANNFDNENVSSFLKARKLFSTLDVDMQ
LVYINTPGDGFKSTQEMEEKVADFFVEANVNGEYSVNDVKYFSAYSIEEGIFAYSNKVNA
DLIAIPTHGRKGLAHFFTGSISEDLVNHSDLPVITFKM
>OMIFANIC_00738 Purine nucleoside phosphorylase DeoD-type
MSNHLEAKPGEIAESVLLPGDPMRAKWIAETFLKDAHCYNDVRAMLGYTGTFKGQRISVQ
GTGMGIPSALIYCHELINEYGVKNLIRVGSAGSYQPDIKLRDIVIAMAASSTSGINNSRF
INADYSPTANFELLMKAANYARDHGIPIKAGNVLSTDEFYEDDFDAYKLWAEFGVLCVEM
EAAGLYTIAAKHNVRALAILTISDSLVTKQRSTVEERESTFTNMVKIALNTLID
>OMIFANIC_00739 Deoxyribose-phosphate aldolase
MKPLNRYIDHTLLHPAASPEAIVALCDEAKAYNFYAVCVNSCYVYLAAKELKKSGIRIAS
TVGFPLGAASTKSKVAEARKAVKDGADEIDMVLNIGFLKSELHKNVKEDIEAVKKEIGKK
TLKVILETCYLTDEEKKIACLIAEKAGADYVKTSTGFGTGGASKEDVTLMKATIGESMKI
KAAGGISSASEAIDYIELGVMRIGTSNGIRLMEGINTTE
>OMIFANIC_00740 Thioredoxin C-1
MKTTFKDIIESNKIVLVDFSAEWCGPCKVLGPILKEVKDEVGDTVKIIKIDVDKNQQLSA
QYKVMGVPTLILFKDGVQAWRQSGVMQKQELLDLLQSKAS
>OMIFANIC_00741 hypothetical protein
MKNLLIALSVSMLLFGCKDDPKKELTDEIPFEETDETLPDTIMATENDLDLQKQIDVEIR
KKTLVEKEDERDELQDLIISKRFLRDEDLYTIDFKYPYLNENLKESYVNFNEYIAETYLD
IAGVEAQILEDKELLCDTLRINKFREKRYVDYKVYNVNEKLVSVLFYKENFYSGTLHPSY
TFDCLNFDLDRSVFMIYEDFFIEGSEEELRKILNEILVAKIESGEVYYDCWGISEEDFFE
YKDNFVVDDKMVEYYFDDCVICPTYTGNFSVEIPLEELLPVLRRYNLNPLQL
>OMIFANIC_00742 hypothetical protein
MTYTEKPQIAFYQKVGELFYAVAAADKVVREVEYKALKKLVREVWSKYDDSLDDFNTRAI
FQMEVVFDWFDYEKMDADACFESFENYVKEHPLLFTEERKQLIFQTANEIADAFSGKNKS
ELIILGKLHLLLAA
>OMIFANIC_00743 Sensor histidine kinase ResE
MEVFNSSSDIYQILTEAISEGIVVVNEKQIIVATNQSLNSLFGYKKDELVGKSLNTLIPE
KYHHNHSSHFKSFMNESTKRQMGHGRDLYGLKKDGSTFPVEAGLNPFEIYGKRYVMALII
DITVRKEQELEIQELNTELEGKIAERTKALNESILKLQKEVEKRKQAENKIKESLRKERE
LSDLKTKFLSLVSHEFKTPLSGIFTSATLAGKYTKEEQQEKREKHIKTIQNKVKYLNNIL
DDFLSIERIESGKVNYKYSNFPISKVINEVIYGANMLLKEGQIINYPEGIDTIVISFDEK
ILELTLTNLVNNAIKYSSENTTIDIRVTEEGDQLIIEVEDEGMGIPAAEQKHIFNRYFRA
ENALLNQGTGIGLNIVQNHLENLDGTITFTSEENKGSTFKVTIPTMGNL
>OMIFANIC_00744 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MIKNILLIEDDSALRENTAEMLELSGYTVITASNGRIGIEKAKENHPNVIVCDIMMPEVD
GYGVLESLSHDAETQHIPFIFLSAKTEHKEVRKGMDLGADDYLTKPFEEDELLSAIESRL
AKSQLLLQAMESNVSKEERKEDVETIRNLNELKNFFDDNGEIVNYNKGEVIYKEGGHSNN
IFLILKGIVKSHKMDENGKELITELHKPDDFLGFTSFEDAIPYQESATAVEDVELAVISK
NVLKNILSKSNAVSLELMNVLTENLSEIKEQLLQMAYSSVRKKTAATILQFAEILNKNQN
DNIKISRHDLASVAGIATESLIRTLSGFKKDGLIEIEGRNIRITDLDGLRHIE
>OMIFANIC_00745 hypothetical protein
MTMKRILIPTDFSHNAWNAIEYTMAFFNKRPVHIHLYHIAYSGRINGEDDLYSNGVAIIE
KGGKTKEKQLIALQRKIETLYPRTQATIDVRVAQSRFIEGIKSAVEELNIDLMVMGTKGA
SGLKEVTIGSHTGAVITRVKCPVLVIPERAVFESPKNIVFPTDFNMIYKQRILDTLFDVS
DVYDSSIKVLRVANNEYPLNAEQEKNRNFLRDILEERSYSFHCIKSPRLEEGLQSFIDLM
DVQIIAMVAKNLNFFQRLLFKPTVAKISYHTEIPFLVLHE
>OMIFANIC_00746 hypothetical protein
MSHAIELGILWEAIPFFSIIFKTKNSMKISAMFLLVLTSFILLTVVLFSAMNLPFGWVFL
LTTFGQVMLVVTVYKVLRDNYTTDKTFEDFYEDHPITEKYR
>OMIFANIC_00747 hypothetical protein
MRKVLIPTDFSDNAMNAIKYAMELFKYDRTDFYIMHAYGDDLYSSKDGVDRESLNVAREE
AMKNTNTDLEKVIAHMKEVSPNPRHNYFPISVFGALVDEANEIAELENVDVIVMGTKGKS
DDRNLTFGSNTLQVIKYVKCPVLAVPAVFKDIQPANVLFATDYMLPYQRRELKLMSTIIQ
NFAAKLKVLHISKFDELSFRQQDNKAFLEYCMEQIKPDYLQLAGTDITNVINNAVESYDI
DLLVMINSRHSFLEDFLYTSKVEKIGLEIKIPFLVLQNLPRN
>OMIFANIC_00748 hypothetical protein
MRRILLPTDFSENALNAIRYAVQLFKNSSCEFYLLHTYTPAAYNVGSMADSYSALELQKV
TKQNAERSMDEVEETIRAEFKNKNHHFHKIVTFNLLVHEIQDIVETKGIDLIIMGTQGAT
GAQEVFLGTHTMYTIKKVKCPVIAVPSGFGYETPKEILFPTDYSLSTSNPYLSLIREISD
LHTARLNILNAYYGEPLDKDQKQVKAYLDAYFKDNSHLFHIAENTDVQGAIEKFQVKHKI
NLLVMIHNRHNFFENLLFKPVINEIAYHTNIPFLVIPSEERMMH
>OMIFANIC_00749 hypothetical protein
MQHILVPTDFSENAYKALIYTTKLFGKNPCTIHILHSIEEQASRLTSRVDIGKSERVIDE
LYDEADRKCEAVKSRLIADTKGCGHTFDVISTAMSLPRAMNRICAQRDVDMVVMGTKGQT
GAKEVILGSNTVNVLRRIKKIPVLVIPVETEFEPISRMAFATSFKQNYDPSDLDELIYLA
KLHNSDVKIFHIYEDKQITDAQRDHLDQLLKLMEGVKCDVDWIDSDTEKTRAIADYIDEK
NIDLLAIIYYKYNFIVQLFRESIVKKIGRNPTTPYLVIPAS
>OMIFANIC_00750 hypothetical protein
MRRKILLPTDFSRNAWDAITYAVDLFKNEACDFYILNVYNFTGYAMDNIIVAQPNNEYAE
AVREKSMKGLERILQQLSFRDEGIDHTYFTISKNDNLMDAIKEIVKLKDIDLVVMGTKGD
TDAINVSFGSNTVMVMEKERNCPVMAVPPQVQYSAPSEIVFPTSYKTHFKKRELAYLIDI
AKITNAPIRVLHVETEDQLDEKQLNYKKMLEEYFEDIDHSFHNLEKNDIGEAIQLFVQSR
GSGMIAFINRKHTFFGSIFSRPLVKELGIHSKVPVLAMHDFRN
>OMIFANIC_00751 hypothetical protein
MTEEVSIDVIKSSGEKVQFSLDKLRASLRRSGADKKLIKTIINVVRDELYQGISTKEIYN
RAYSLLKRKESIFASKYKLKKAIYELGPTGFPFERFVGALLQYSGYDVQVGKFINGKCVT
HEVDVIARKNSEYVVAECKFHSDEGRKCDVKIPLYINSRYKDILGFQKVDTPTEGWVVTN
TRFTRDARDYGTCAGLYLLSWDHPEGNSLRERIDRLGLYPITVSTLLTKREKQFLLSRDI
VLCRQLYKDDFYLDHLGVSEKRKENIMNEVNMLCNL
>OMIFANIC_00752 Ribonuclease
MRTAKIHFLGAARTVTGSKFIVETPEINIMIDCGMFQGLKELRERNWEPLPFNVSSIDVV
LLTHGHLDHTGYLPRLVKQGFRGKIIATRPTLAVTKIILEDSGKIHEEEAEKANKEGYSK
HRPALPFYTIREAEATQNFFSPVSKDEWIELSDHCKCRFRYNGHIIGSTFIDLQIFDKLF
VFSGDIGRTNDHLLYNPEKPEWADYLFVESTYGNKLHPQDSVTETLASLVTKTIYKRGTL
IVPSFAVERLQVLMYLMWKLFRENRIPNIPIFIDSPMGNNVMSVFERFPEWHKLPPNDFK
AIQNRMEIITSYRETWETIDDPRPKVVIAGSGMVTGGRVLTYLKQLVDEPNTDILLVGFQ
AEGTRGRQLLEGAHELKIFGKYYPVKAEVHHVESLSAHADQGEIIDWLSEVKNIPEQTFL
IHGEHTAQEALRTKIADIFGWRVNTPHLFENVTVMI
>OMIFANIC_00753 Acid shock protein
MSLIKFRRRMPLIDRGIPTWFDTSDIFDEDFFEKGKSLPPMNVKETEKTFDIELAIPGFS
KDEIEISLENDVLQVSAEKEKETIEEDVEGYTRKEFSYNSFERKIKVPNTVNQEKEVKAT
YNNGVLNLQLVKEDLAIEQPKKKIEIK
>OMIFANIC_00754 hypothetical protein
MHINPTSIKYIEWRSPEGLHEDSVTCISELRFLKDEIQFLSDLIKSHTLEILSENLFEES
KEIAIELSKQKKRVKPMIKKLVKHSNVLETLIDDIDIPDEEDEYKAEHYQLMFEAATCLS
NFKKLKRRVFSLIKAILKEKKKRKLLKP
>OMIFANIC_00755 hypothetical protein
MKKVFLLFISAAFLWSCSSSRLIDQWESPDTPVYESNKILVIGMSADTELRRTFEDKLAS
ALEKEKIVAVRSIDFFERSFTDTDKTEEDLNTIENQLIESGFDSVLISKVTGTEAKVTTV
QAMRGFVDDFQNFKDYYRTNQDLYRKNATESYTVYHTETSIFCICPGEEREMLWRGNIDV
VDPYNRERNINDYVRTLLKTLEKNELVIVRE
>OMIFANIC_00756 D-lactate dehydrogenase
MKLLVYSAKDFEIPFLKKGNTKGFEVIFSPDRLTTNTAMKALGFDAISIFSADDASINVV
EKLHDFGVKYIALRSTGYDNVHLKTARKFNIKVANAPGYSPYAIAEHAMALLLSLNRKIV
LANNQMKMQDFTLSNLVGFDLFGKRVGVLGTGAIGSVVVKILHGFGCEVFANDLEPDLEL
QKKYDVTYLSKHEMQQKCDVLIICLPLTSETHHLIDDSVLSGMKDGAYIVNIARGAIVET
KAILKALDSGKLGGYASDVYEKEGGVYFYDRRGDLIKDPLLKELVNHPNVLLTPHQAFAT
REALQKIAETTFYNLNCWRQQQTPDFEL
>OMIFANIC_00757 hypothetical protein
MKNILLPTDFSQNSYHAMDYAMKYFTGTKINFVVLNIQKSSEYIMDDLMTASPGTSVHEA
ISGDNTEKLRELVDRYKENYADEDFSFESIFDFDVFIDAIAQTVVSRKIDLIVMGTNGAS
GAREAVFGSNTLQVIRSIKCPVLAIPEDYRFQSPEKVMLTVIKERYPSSNAIQSLQQLFQ
LHDLQLHVVHITDNTITDRGTGEAEISKLFPKTNISHHYLEDIPVPMAISSFTQLMKVDM
HCILVEQKSFLDRFIHGSDTSRISYSTEVPLLVIHN
>OMIFANIC_00758 hypothetical protein
MILERAILFPGAFKYACLDIDNNQLNLIWNHLYLVHNPEI
>OMIFANIC_00759 hypothetical protein
MQENFALRKMKRDIGFVLIQFVLFALYIINFKIIDYKIDLPSWIDIFLLILGFVAAVIIT
MGVINLNENLTPFPSPRRNSSLVSNGIYRHIRHPIYTGIIALMFTYGLYSGSMGRLVITV
ILIVVFYFKTELEEKLLIKRFPEYRDYRKVAGRFFPRVARK
>OMIFANIC_00760 Thioredoxin reductase
MSDQIERVKCLIIGSGPAGYTAAIYAARADLKPVLYTGLEPGGQLTTTTEVDNFPGYPEG
VDGPTMMVQLQQQAERFGTEVRIGMVTSVEFSDEVGGIHKAVVDNTKEIEAETVIISTGA
TARYLGLPSEQRLRGGGVSACAVCDGFFYKGQDVAIVGGGDTAAEEATYLANICNKVTML
VRRDVMRASKAMQHRVTAAKNIDLRYNSEVDEVLGDMVVEGLRIKNNVTGETEEIPITGL
FIAIGHTPNTGIFKGQLEMDDTGYIITNGKNTKTNKPGVFASGDVQDKEYRQAVTAAGTG
CMAALDAERYLQTIEAEVTT
>OMIFANIC_00761 hypothetical protein
MKVLIFFLLTLSFGIHAQVDRDSELFKTLQQKDSLIFKRGFNHCELEVFIDFIAEDLEFY
HDKAGITNNKAAFVKQFKNGICGNPDFSARRELIQGSLEVYPLYDNGNLYGALQKGIHKF
YAKPKDKPEITGSTARFTHLWLLLEGEWILKRVLSYNHLIK
>OMIFANIC_00762 hypothetical protein
MKTLQILIAFVAAATLSSCNFDISIGQVDGNGNVVTEERNVADFSKVKGSAGIDVYLTEG
NESKIVVEADENLMELIETTVEGGKLRIRSNQNIGRAKSKKVHVTYVNLTSIEASSGADV
IGNSVIKSESLDLDSSSGADLELEILSKEVFAVTSSGSDMKLSGKATTLRAKASSGSDLD
AKELIVATCNADASSGADIKVNVKDRLTAEASSGGDVHYYGDPAAVSNNSGSTGSVHKM
>OMIFANIC_00763 hypothetical protein
MKKTVNINLAGTFFHIDEDAYAKLQRYLEAIKRSLSDPQGSDEILRDIEARIAELFSEKI
ENNSQVISIKELDEVIAVMGQPEDYMVDEEIFEDTPPSAKRKTRSSYKQLFRDIDNKFIA
GVSSGLGHYLGLDAIWVRLLWVLLTVFSSGVFVVIYILFWILVPAAESTSDKLKMTGEPV
NISNIEKKFKEGYETVADKVKNADYDKYGEKVKSSGTSFFDALGNILLTILKIFVKFFGI
ILIITALSTLVGLIVGLFTLGSVDIWGQGELLDYFTAVDTSNTPIWLLSLILLFAVGIPF
FVLFILGLKLLISNLKSIGTTAKIVLLVLWVASLVGLGIIGVRQATQQAYNGDFIAQNEL
QVIPGDTLALAMRADDRYSYNVYRGGGIRIEFDENDEKIIYSNDIRLIVRSTTDPTAKLV
IERHAKGSSYNDAKERAEAIDYNYSFENGTLLLDGFFTTDFDNKYQDQEMDLILYLPEGS
VLIADDNTYSFHRNYASSRDILNNGDEGQYLRILKNKTECLDCPEGENEFETSTEVEGWE
QEVIESVDDDDAMPSENISEDIIPDEIEETVVETDSTEFNNDQIN
>OMIFANIC_00764 hypothetical protein
MKIENTKAQMRKGVLEYCILSILKDGEAYTSDILETLKDAKMLVVEGTIYPLLTRLKNAG
LLSYRWEESTSGPPRKYYELTETGKIFLNELNTTWSELQKAVNRVTSETIKK
>OMIFANIC_00765 hypothetical protein
MSTLINLVIAIAASLLTLTGVLRDTPEVPETQIMQCKQNVEDIDTHFIIENEELSQLIK
>OMIFANIC_00766 hypothetical protein
MEPNPSENQKQLGALIHLSTFSKFFFPFGNFLVPLILWSFNKDKSFVDEHGRQAINFQLS
ILVYSLVIGLICIPFFLIFATDFISLVEAIEHTVDHVSVNNATNLSGFVILFSIVALLLF
GLFLFELYAVISATMKAARGELYQYPLSIPFIKTNIKNQSTHEHSN
>OMIFANIC_00767 hypothetical protein
MLKYFEMPMKPSAINVFLMFKLPAAYFTGVRVKSISEESCTTSVRHRWINQNPFKSMFWA
VQGMAAELSTGALVMSVIKDSGKPISMLVANNKASFSKKATGRITFSCNDGLKIRDAMER
AIETGEGQTCRMHSTGRNKEGIIVSEFDFEWTVKLKNS
>OMIFANIC_00768 hypothetical protein
MARAMFDYTKAVLKKVSFDVNLFCKELKKAMKRLLPYEIEELKIWVDALVRQNPQLNQCL
ILLNP
>OMIFANIC_00769 Hydrogen peroxide-inducible genes activator
MTITQLKYVLAVAEHKNFTKAAEKTFVTQPTLSMQIQKLEEELDIQIFDRSKKPIELTAV
GNKIVNQARSIVNEAERMQDVVDQEKGFIGGEFKLGIIPTVMPTLLPMFLRNFTNKYPKV
QLNIEELTTDEIISKITDGHLDAAIAATPLYHEKIKERVLYYEPFVGYIPPSHRLSEKKK
IERTDLDIEDILLLEDGHCFRDGVINLCKSSKLNGNDSFQLQSGSFETLIKLSDEGLGMT
LLPYLNTSDVSEAQKGNLRYFTDPPPAREVSIIYSKSELKMQIINALYDLIAAVVRGAIA
FQDVKIIPPTK
>OMIFANIC_00770 hypothetical protein
MKTILITITLALTSLFINAQDDPGTDTVAMEGISITVNVPVSGDKGNVIFGLFTEENFMT
GAPVQGLESEIVDGKASVTFTNVTPGTYAVTLLHDTNGNKRMDYDANGMPLEMYGVSNNI
MSMGPPLWSDAKFEVENEPLTLDIIM
>OMIFANIC_00771 hypothetical protein
MGLTFITSGLRKMPGVKFTQLPVDNPVGLFFEGMYETGFYWNFIGYFQIVAGIILMTPWL
KRLSPLLIFPVTLNIFLVSVSLNMKGTPLITAMMVLANLYLILWHLRSYTPLFKLKGS
>OMIFANIC_00772 hypothetical protein
MFKFLKSLYLTSRFFYSLAVIVVLFLISYWTTTLYAIVWLIVLGLVLLMLMEIFMLFSGK
GLDGSRILPDKFSNSDENEVIVQLKNHYSFDVTVDLIDELPVQFQKRDFLQQTRIAGKHS
KTLQYTVRPVERGEYVFGNLNCYARSVIGLVRRRYTFSNEQMVKVYPSFIQMKKYDFMAI
DHRLSYAGLKKLRRIGHTMEFEQIKEYVLGDDVRTVNWKATAKHAQLMVNQYQDEKMQPV
YSIIDTSRIMKMPFNELKLVDYAINSSLAFSNIALKKGDKVGLLDFSNKIGNYLPAKAKK
THLNGILESLYNVDTKFLDSSFGKLQAFVKQNITQRSLLLLYTNFEHISSLRRQMPYLKA
IAKKHVLVVIFFENTELKQLIEDKAETIPEIVDQTIARQFEFDKKVMVLELQQRGIQTVL
TAPEDLTVNTINKYLEIKARGLL
>OMIFANIC_00773 ATPase RavA
MENPEENNNELHFSSRIPLEELKKCVESIKAQLNKVIIGQEEFIELLIISLLANGHVLIE
GVPGIAKTITAKLFAKTLKTDFSRIQFTPDLMPSDVLGTSVLNMKESEFEFKKGPIFSNI
ILIDEINRAPAKTQAALFEVMEERQITMDGQKYDMEYPFMVLATQNPIEQEGTYALPEAQ
LDRFLFKIRVGYPTLDNEVDILKSHHDRKLTAPESLISGVLTPENLRTFREQVQSVLIED
KIFSYIAQIVDKTRNHPHLYLGGSPRASIAIMNASKAFAALNGRDFVTPDDVKKSLAPVL
RHRIILSPEREMEGMAPEAVIDMISQSIEIPR
>OMIFANIC_00774 hypothetical protein
MSKFQRLVFFGLIIIVSALVYLETSKPEPINWFPSYTTSAKIPLGTYVLDELLAERLQDQ
YIRTNNSPFERFRDSSFKGTYFFVNDDVSFETAEVNRLLDWVQEGNTVFVSANYHSYELL
DTLKLAIRNDWVSGKLVSEPLLNLTNPKLRSPEPYHIEHDFTVRYFEEIDTLNQVALGEA
QIYNDTLEMTDPKINFIKAPIGKGNIYLHTQPEIFTNYFLLWKDHAEHTENVLSYINNDE
ILYYDNHYKSGKPINLSPLYILLNNKYLKWAYYFVLIAALLYVLFEGKRKQRSISVIKPL
KNQTYEYTRTIAGMYIDRKEYHDVARKQIALFMDYIRTHYRIPTNVINSKFFNTVAARSG
NTVEDTRELFIYTEKINNQPIISKQELKELHHKIETFKNKLDGKS
>OMIFANIC_00775 hypothetical protein
MRILSLIIFIFLLFAEGKAQDQTGETIKPVVVYDEDRNVEPLDLDENTIDELKKDDDFNY
EEIEAADTIWEKLLRWMGEMWDSFWRWLLGDYEAIGFLAFIIKLLPYLIIAGIVFFVIWL
FYKLNPGARFLKSKEKPEVFFTEEEEIIRSKNIQELIQKALEDKNFRLAIRYYYLLVLRK
LTNAEIITYEFDKTNSEYVSEISSEAISGQFSKVTTLYDYIWYGSFDVTETDFGIAQKSF
NTLVQQIPEGHE
>OMIFANIC_00776 hypothetical protein
MDEFIQFKRSRDLGRIITDIFKFLRHNYKVLFGLIFRIAGPALILLVVAYVFYMESAMNA
FDPYASDPDLSGGFVSLLGSLLVFLLAAGLYYALLYGTVLNCIKSYVNNKGVIDKTEVIS
GVKENFWGLIGLSILNGLIVGAGLMVCFFPGVYLGVVVITTYMIMVFEKRGASDSISYSF
ELIKGQWWTTFATLIVVWVIYYVVLFIFQVPQYIYFFTKEFTVSETYIEGSPVEAFDWID
MALSSFGVIAQYLLQTFLVLASAFIYFNLNEKKNFTGTMETIESLGNREE
>OMIFANIC_00777 hypothetical protein
MKINYEGTMREAAFAKQNKDKWLKFENVLRNNIQISPDELSALYVEITDHLSYAQTFYPN
SNTLRYLNGLSVLAHQKIYKTKRESRSRIITFFTQEFPLFFSQYQKQLLISFLTFALFTV
VGAYSSATDGNFVRLILGDGYVNMTLDNIEKGDPMAVYKEMGEMNMFLGITINNIRVALF
AFGLGIFFSLGTLFILMRNAIMLGSFQYFFYDHGMLWESARTIWIHGTIEISVIIVAGAA
GLVFGNGLLFPGTYSRLQSFIRGAKDGVKILISTIPFFIIAGFLEGFVTRHTEMPDWLAI
LIIGGSLFLILFYYVIYPIKLKKKHGRIHTI
>OMIFANIC_00778 hypothetical protein
MDKFQIETAQNVNIRQNVAGVGDRILAYLVDSIIIGIYIIIMVILFSWLEMDDDLSFIVI
MTVGLPVFLYHLLFEMFWNGQSPGKRVMKLRVVKVDGSKPAFSNYLIRWLMRIVDLTLTS
GALALVTILLNGKGQRLGDIAATTTVISEKPTMSLAQTLLVDIPEDYEPMYPQVTVFNDN
EMQTIKSVYNDAKYDGNHNVILKLAAKVSDVMEIKYEGSPMAFVNKVIQDYNFYTQR
>OMIFANIC_00779 Peptidyl-prolyl cis-trans isomerase A
MKYLSFYTLILFSIFTACEDNKKTSVEKTSDPSSDIIVVDSLIKDEVPEKVQENEGIKDT
TYPLLTNENVVDFLTEYGKENPETRVRISTTHGDIDIELYRDTPLHRANFIYLVKQNYFY
GTFLHRVVPNFIIQAGNSDNRTTTRKRAQIGKDYLLPAELNNNRIHQYGTISGAKEYREN
PDKRTAPFEFFIFLGPKSATGHLNGKYTIFGRVTGGMEVVKKIANMPSDDGDWPLENIYI
EAKILP
>OMIFANIC_00780 putative Nudix hydrolase NudL
MPLPGEDSHMEMAPMERLLELKRLAHMAQSAKKAGVLMLFYPSELNQTHFVLILRKTYKG
VHSAQVGFPGGKFEEVDTTFQDTALRETQEEVGVPSHTISVIRELTELFIPPSNYIVKPY
LGLTAVNPTFIPQESEVEDIIEVPLTEFMDDGILIKKNLSTSYAKSIDVPAFKLQEHIVW
GATAMMLNEVRQLFKKSL
>OMIFANIC_00781 hypothetical protein
MGLFKKNPFGHILFLKKWLIRILGALTHRRFKGFNQLQIEGSEIITQLPENNVLFVSNHQ
TYFADVVAMFHVFNASLSGRVDSIKNIGYLWNPKLNIYFVAARETMQSGLLPKILAYTGS
VSIDRTWRAEGKEVNRQVKMSDVSNISKALNDGWVITFPQGTTKPWKPIRRGTAFIIKEN
KPLVVPIVIDGFRRSFDRKGLRTKKKGILQSMEIKQPLDIDYENDSIQDIVKKLEYAIEQ
HPSFLKVIPEEELLIREELNKERQWRKEKKQKKIKEEKELGEN
>OMIFANIC_00782 hypothetical protein
MDELEVLKKEWQTREQEFPKLSSKEIYPMLLRKSSSLVKWIFYISIAELILWTSLAFVAP
ESSKQINEAMGLKTTLLVVSVIGYVITFIFIYLFYKNYKSIQVTDSIKNLMASILRTRKT
VRYFVYYNIGAAILLLTFTNIYYYSKKETLYETFSKYSEDYAAIPSESFTTIFFTAQIIV
GVLLILFLIVFYRLVYGILLRRLKRNYKELKKIEI
>OMIFANIC_00783 ECF RNA polymerase sigma-E factor
MTKELEHNFVAQLEENQNIVHKICRLYTNDSDSHNDLFQEITIQLWRAYPKFRGDSKFST
WMYRVALNTAITLYRKSKRRVQTQNYEGVSFKISAEAYDDTVEQQLKLMYKAVKNLNDID
KALVFLYLEDKSYKEIAETLGISEVNSRVKMNRIKEKLRKILNP
>OMIFANIC_00784 NADH dehydrogenase-like protein
MVFYAKGFTYCNFILYNSSMNIPNTEKPRIVVIGGGFAGISFIRKLKNIQAQVVLFDRNN
YHTFQPLLYQVSTAGLEPDSIAYPLRKIFRKHDDFHFRMAEVEGIDTESNTVKTTVGELS
YDYLVIATGTRTNYFGNTSIETHSMPMKNVPQALNIRSLMLQNIEKADISDDPEERKCLL
NFVIAGAGPTGVELAGALAEFRKSILKNDYPFIEREDMQVHLVEGSERVLSPMSSFASEK
AKRFLEAMGVKVHLNTLVKSYDGKTVSTVDGRTFEAATFIWAAGVTGAPVKGINGSALLE
KQNRYKVNEFNLIEGYNNIYALGDIALMKTSAYPSGHPQVAQPAIQQGRRLATNITRALK
GKEMKPFEYRDKGTMATIGRNKAVADIKKMHFGGAFAWLLWMVVHLFFLVGFRNRVVTFF
NWTYNYINYDKAARLIIRPFRRP
>OMIFANIC_00785 hypothetical protein
MKTDLYTKSVLTVIAICLTVNLIGQLDLIPKAHASESNPSEVSTEYAVVPISDMETMDVR
IVDINTYDELNVNLKSVDTYDEVKVNIKSIDTSDELDVNLDEIGGGWVTNGGPIKVKLD
>OMIFANIC_00786 Adenylate cyclase 1
MTSYKTRLLWQYFRKSFWILIIWVIISNLIFFLEYFSLVSNQYLSSEYDFKSAFTANMIV
SVSAGVVGGFVTLHLMEYWLRKFAFWKALSLMVIAYTAAAVFVSTIGASYAISEQYGLPL
FHPDVQEDLLLFFGSWVFVKNFIIWLLIVIGTLIVLMVNDKYGPGVFRDYLLGRYFRPKN
ERRIFMFTDIKDATAIAEKLGENKYFHLLKDFFKDIAPAIVQSRGEVYQYVGDEVVISWK
MKPGLKNGNAIGCFFRMKQLLAAKAHTYEERYGLVPNFKVGYHFGPVMVGELGQIKRDIA
FSGDVLNTTSRIQAKCNELGVEILASKEFSEIAYQLPMGITPKEMGNQELKGKKQKLSLV
TYVLDHSVHPS
>OMIFANIC_00787 hypothetical protein
MTISEKVNAYISKHNRWSRQLEQLREVFQRTELLEEVKWGSPTYTLNGKLVAGFAAFKNH
YAIWFHQGVFLKDTDKKLINAQEGKTKALRQWKFEAGDIIDQDIILKYIQEAIENSLAPK
EIKPERKTALMVPEFLQKALNTDSKFKQSFDGLTPGKKREYAEYIDSAKREVTKLSRLEK
ITPMILEGKGLNDKYKKC
>OMIFANIC_00788 hypothetical protein
MTRLYTFLLSIMLFGAVSAQDTFSIIAVDPTTGEVGSAGASCVTGVGSQGIIDIITDIIP
GRGGVNSQAYVCIPNVNLQNAIIRMEMGDSPTEIIDWLIANDACGSQNFDPAFRQYGIAD
FDGNGDPRTAGFTGNMTDDYKEDRQGATFSVQGNILLNQTVIDNMENNFNNTTGTLADKL
MAALQGANFPGADQRCLSAGTSSTTAYLLVYKEDDLPGEPYLRLNVGQQPSGTEPIDILQ
DLYDNFLAVEDNQVKERLQLYPNPANDIIFIERQASLTIDSLEIFDVNGKKVSETISMDT
SKLQYEININNLQSGIYFLRVHSPEGNATLKFVKN
>OMIFANIC_00789 TonB-dependent receptor SusC
MDIWDVKQSIKEMNLPKNTLAVLIILTLFTCCFSHFGFAQTTISGIVTEKNGTPIEGANI
YLDGTYDGITSDVDGKFNFQTSETGVQTLIASYLSFETFMMAADVSQMNNLTIALREDVN
SLDTVVISAGTLEASDNSKVSVLKPLDVVTTASALGDFVGALQTLPGTTTVAEDGRLFVR
GGDAGETQIFIDGIRVFTPYTPTTNNIPTRGRYSPFLFDGITFSTGGYSAEYGQALSSVL
LLNTIDEPDQDKTEIALMTVGGGVGNTQKWEKSSLSFNTSYINLAPYLAIYPDRNDWEKP
FEALAGETVFRNQFESGILKVYAAFDSSNFELTQEDINFAEGLKFKLKNYNFYTNASYTG
YLNQSWRIETGGSYTRARNDVGIMTDDIDNTENSAHFKLKFRKRFSNRVKLSFGAEQFLT
DFVEEFSNQFVSERYGFNNGISAAFSELDVVFSRKFAIKVGARGEHSQLFDQFTFSPRTS
LAYKTGKNSQLSVAYGDFYQQPMNDILKFSNTLEAQKTQHYILNYQYVAENRILRAEAYR
KDYSSLVTYDDEFPFFDSNYANNGEGYAQGFDLFWRDNKTIKNVDYWVSYSFLDTERLYR
NYPVEATPSFANKHNLSAVAKWWIEDWKSQIGFSHTFSSGRSYTNPNLPGFLQERTKSFN
SLSVNWAYLISQQKILYVSINNVLGTKNINGYQYASMPDANGNFDRRALRPAADQFFFVG
FFWTISEDRSDNQLDNL
>OMIFANIC_00790 hypothetical protein
MQTLLLYIMLLLTGMLVHAQNTVEVSLRDFNHNKGHVRVGLYNDADQFLDKTFKSKRTEI
KGKAAKVTFTDLPDGIYAISCYHDEDDNGELNMFLGMIPSEPYGTSNNARGFFGPPKWED
ARFELRDGEVRKLDINM
>OMIFANIC_00791 hypothetical protein
MKKLILILIAIVSVNTFAQSKYQQGMEKAFELWKADKPWEAANLFERIAQAENENWLPPF
YVAQINVFSSFNEQDKEKMVAQMDKARNFLNDAKARTENNAEVVVLEAQLLTAWVVYDGQ
QYGMKYSPKIAELYQKAFEIDPENPRVVLGKAQWDIGSAKFFNQPTDVYCDDIRKAIELF
GKEEPAGEFYPTGGGEYAEQVLQENCEE
>OMIFANIC_00792 Sensor histidine kinase YpdA
MRFFKELGKAFFVGTLIFLVVGIIEYTTGSFKWDGPTLIKSFLYNQLYTVILYMSNAAFF
IYLVRKYGKQILSTKYLVRGILGGIIITLVALWFIRVITVVIIEGQGFFEFVNSDKLVDY
APSLLIALVVITVFYLFYYYKHRQEFKVKEQKIIAKTASAQFDALKNQLDPHFLFNSLNV
LTSLIEENPEAATRFTTSLSKVYRYVLEQKNKDLITIEEEIKFAKLYMSLINMRFEDSIV
FTVPNRLSNPEAKVVPLSLQLLLENAVKHNQVTPAKKLHITIFEADGNLVIKNNIQPKSV
VKESSGVGLQNIRQRYSLLTDRPVRIQKEDREFMVSIPLLTRSTMTMKTQATYISGKRLE
RARKKVEELKGFYIHFSIYLIMVPVFIFLNMKSTSFPWALFPIGGWGLGVLGHASEVFAW
NPFFGKDWEERKIRKFMDEDS
>OMIFANIC_00793 hypothetical protein
MRTFNQIDESKYQRAKNRVEKLKGFYTHLFIYLVFVIFFIYLNIISTRFPWAIFPIAGWG
IGIVGHASEAFGWNPLFGKKWEERKIREFMEDDEVYF
>OMIFANIC_00794 hypothetical protein
MDFNNQDRENKYLKAKERVEEIKKFYSGLIMYVAFITFLAALNYYTNEWSYMWFLWVAFG
WGIGLFFHAAKAFRWNPFLGKDWEERKMKEFMDDEDKNQWK
>OMIFANIC_00795 hypothetical protein
MEIKTAILKPTDQEKYDNARKKVNAIKGFHSHLTAYIIINIVLLLLQADVISAIADRDID
AHFERWLEWNAWGTAILWGIGLLIHGLYVYRDNFKFLKSWEERKIKEIIEKEEAEERKKY
E
>OMIFANIC_00796 hypothetical protein
MEAFNEDNDKYKRAKKRVEEIKGFYIHLTVYILVNTFLYLSAAGLFRSNIESLDFPRFGQ
LSTPFFWGIGLLFHGLYVFQFKSGFIKRWEERKLKEFMDKDREDLDKFDQNPFE
>OMIFANIC_00797 Sensory transduction protein LytR
MNVLIIEDEKPSARRLQRMLERQNVEVSHMLHSVSESVEWFVNNDHPDLIFLDIQLSDGL
SFEIFDEVEVKSAIIFTTAFDEYALQAFKLNSIDYLLKPIDEEELEAAIAQYKAQAPQKQ
DVQLNFDDIRKLLANPVERQYKKRFTTKIGQHIKMITVDEIECFYSENKGTYAHTYEGRD
YLLDTTLEELVDELAPEIFFRVNRTFIVNINAIRDIISYTNSRLQLKLNSFKEQEVIVAR
ERVKDFKLWLE
>OMIFANIC_00798 hypothetical protein
MNPSAVNWIPKYLHILKKNTEEVNLTNSERLYDALKQTGFIYGVSLDTIPKEFSSTYKLT
REEFTKVNLFHALMFTYRYEKNKEMPNPAIKSIINFYDAMDKGRTGFLKKLTLSPSYSQK
LEKILAARLQETNTFLNRGVTGILTYALLYVDVLAYKYALQQPDSFRKYAEQVEITVITA
CYLALNSKKKKNKYDKLLIELFQSSAHYLSEKSPSNTVTIETLPLLKQASILEKRYILDI
CTITVWDDHSMDEEEFSFLKELTEYLDLPDDYLSNSLAQLALFMSKHKTSVKLFEYANPV
KLFYKQSTATVKLLILRNKKRLQKELEESGELLVLLTKSTSRELSHEEKTKVKQQLLDIC
KTIPSLTIFLLPGGTVLLPILIKFIPRLLPSSFRENRIDNN
>OMIFANIC_00799 hypothetical protein
MKKTKLFAAIMCSSLLILSIVFVAADHIDAPAVAGTTTDIADLYAFEGDNPNNTVFIATL
QGPLTPGVVTENAAFDEDVLVEFNIDNTGDLIEDLVIQAIKRGDSMYFFGPAQPAQTGLS
SEVAVFSERTAVKISDSTDVQIVTNNGMSFFAGPRRDAFYFDFNRFNEVISGTAAPDGFL
PPGTAEDFFEALNVLAIAVEIPNSMLGTAPQHIANGIGGVANLAPSYNVWVSAKRKQ
>OMIFANIC_00800 hypothetical protein
MKIYKIKLVFIAICASVLFAQCDDDENGNVIMQETCDDGILNGDEEGIDCGGSNCEPCVG
ALDFSGTYVQEDIMGRPGINTVFSGTDDVKNMFNTSLVTDRAAFQPTFEATLEAYHDVYG
DALGTPIDYETNILGFDAVTFTTVLAEFDALQVSPNGPTSYYDPNISGAVLTGRTLSDDV
IDISLTLMFGGMSGTRFDGNNDTPQLTSDGVDSGDRDFSLPFPYLEPPIQE
>OMIFANIC_00801 Beta-barrel assembly-enhancing protease
MSMKRFIYFFGIVLLLASCRQETSREQITDPIDYNKYLATASNPTYDEALNEVEFWSKRL
RPDSSGVGDLGPLAAAYTKLFQATGNASYLSDAESLYMKAMAISANNKDIYARGLARTYI
SQHRFKEAEEILRESYQGISSKRATEFMLFDALMELGNYDEAETFLKKLQNTSDYNYLIR
KAKWSDHKGDLTNAINYMETAKDIAESRDSKTLKIWTYSNLGDFYGHDGRIRDAYLNYLK
TLELQPDNAYVKKGIAWIAYSYEEDVEEVRRILDSVMVNHKVPDYYLILADMAEYEGNEK
LMNSLLDKFIETASSNVYGAMYNTSLIEVLTESRPEKARRMAEIEIENRPTPEIYALLAY
TMAMTGDKEEAGEIIDSHVRKKTFEPMSLYFSASVYKLNGNTKELKGVKKELEEASFELG
PVLVKKIKEL
>OMIFANIC_00802 hypothetical protein
MKKILSHIAIMTLSLLINSAIGQTDVAKIEVFIGEQVQLGNITKNYADWEYTSGHVSSSS
GINHLYFRQTLHGIPVKGSESSLHLDSSDNIISSDLNFLNEDIDLTSESKNTTIDVLSAL
NTAVSSLQKVPMKEFEIIEYLDNGKTRISDGGIFSNDLVPDLYYVLSEKKNLLLVWNFDL
KDESEHDYWAVQVDATTGALLGMEDFILYCNIDNDGSVSDIPEFVGPLNRDEQNGGCSEC
YEVFNLPVENAYYGERTIVEQPAHPIASPYGWHDINGIPGAEYTSTSGNNFDVNGSSGHV
TDVGESLDFTGFTFDTFWTPQNPSIDAAITNLFYVLNSMHDIMYVYGFDEVAGNFQVNNY
GRGGMEEDAIKVQSQNEGHCGSSYWPTNDGDRPRIIYGVCINKDASVDSDVIIHEYMHGL
TTRLAGGASIICLRNEENLGEGFSDWYSKVLTIKPGDRGPDPKGFGNYITNKGPDGIGTN
KYYYSTDMQVNPSTYANINDDHRVHAIGAIWANILWEVTWQLIDAHGFDPDLFNFTGTPE
DAGNIRAIAIVTESLKLMACEPGFVTARDAIIQANNYLYNGESDCLIWDAFSKRGVGVNA
DEGSATYVGDEIVDFTPMPRDIVFDYDESVCVGVRQIYQGGGLPHGGVYSGTGITDYGDG
KYFQIDPEGLPLGTYEITYQTEDTDCYNGGTAIGYFHIEEDTEPPVPACLEEIAHLIEVS
DEYLLWDYRDQLYYEDNCSDVEVTQDPPPNTPVEPGLIPLRFKFEDQGGNVAFCDVMLNL
AARLGTIEDNPYKVLIFPNPTKGTVYVQIYPGEELFNAIIYDISGRMVKSYDLRQTVSQT
ELNVESLTEGVYFVKFAFGDGEVIEQLIKR
>OMIFANIC_00803 hypothetical protein
MKRFITMLLLMVCLVISSQAIAQNGTTQINNYFDHLLENNELQAQDVQWEITSQNTSSVS
GVQHIYFRQIVNGIPVYGTESGMHLLPNGKVLQANDRFISNTQSRTSGNAVPSLTAEQAV
QAAASQLNYNLSESLNVLERKNNITQETRLSGGGISLSDIPVKLMYQLNNNNELVLVWDL
SIESSEVQTEWFSVRVDAASGIIVDKVNWIVSCSFEHDHSTHDKEVLDYNANLFDIPNYD
ALVANAEAGCSECYQAFAMPIESPYFGAFTNEVQPADLTASPFGWHDTDGAAGAEFTVTR
GNNVNAYEDGDNPGYQPDGGSTLEFTGYPFSQIYSGANQYEDAAITNLFYWNNIIHDVMY
QYGFDEASGNFQENNYGNGGAGSDSVNAEAQDGSGTCNANMGTPADGGNPRMQMYVCGDK
DGDFDNLVIVHEYSHGTSNRLTGGPGASGCLQNSEQMGEGWSDYYGTVMTIEPGDTGTDA
RAVGTYLFGQGPGGNGIRPFPYSTDLAVNPQTYDDIKTASIPHGVGSVWATMIWEMTWAL
IDEHGFDADFYNFTGDVNQDAGNIQAMALVTEGMRLQPCSPGFVDGRDAILAADLAIYGG
ANECLIWDAFAKRGLGVSADQGSSSSRSDGTEAFDTPSGVAEFTAPEDVCASEPVLTGLG
GGTPSGGVYSGPGVTDDGNGVTYSFDPAVAGVGVHTISYEVQASNCSVASTATDDIEVLA
VPNGPTTTGASDICVGDAVTVSATPNDPANVIRWFDDPVAGNFLFEGNDYTFNPTTNTTL
WAQENPPGALSQLVISEITLETPDQLEITNVGVATDYSGYTVAVSEEPYSDINTQNSVEQ
TLGFMGQNSVVEYNDDGGANYWGDNIWWNNTGNGWIIIIDTAGNVVESVFWNFSAAEIAG
LNVTINGFNVTAADLDWTGIGADLTEECNGSFRRTGETDSAADWSGVCETSSYGVYNEDI
GLGFTGCLASRTETVVTVDAIDPEVTCPADITETVNSGELFTIPDYTPLATATDNCTGAP
VLTQDPAAGTQVGAGVTTITIEAADAAGNTASCTFELEVVEILGNGDNELFNNILLYPNP
TRGEITLVNNSSETLVSATITDVNGRTIQTQNLTNAGTTTSFSLEMLSTGMYFVQIQTTN
ATVVKRVVKQ
>OMIFANIC_00804 hypothetical protein
MSRPKNKLELTSLSRENYEKLLNLINSYSEAEQNADFPPGTLNRNIRDVIAHLHHWHMML
LRWYDEGMKGLKPDMPAKGYSWKMTPELNRDIQKMYAIKTLSQVLTLFGDSYMKVRDIIV
THSDEELFTKKLYKWTGSTSLGVYLVSNTSSHYDWAIKLIKRSKK
>OMIFANIC_00805 hypothetical protein
MNIKTTITAIFFIFSFSLGFSQDKSAEIVETLEGHWEGVFMKQNSHQKFDVQFYRKDSSF
TSLQTIREWHPQFGEFEIPLNIDSLGTIRLNTGYGKALLKLDRRNLEMVGYIENSIPIMN
VHLKKVPDPPSPNYEVNEIKVSNSDVSLNGHLHRPMYEKARTAIIVVGGRSCYAGSTKYD
LTAKILREYGVAVLVFDKRGTGKSTGNCDIATIDDLASDVLACKRYLENHPDSFENIGVI
GSSAGGWVMLKAQENDPFDFLIGVVGPSTSVKDQQLQSAEYGAVEYDLSDAALANLKTYT
ELLFEAKANRENFKAINGLLANAEKEGWRDLLDDTDIPDSVDAIDQLWVRRHNYDPSGTL
KNLDVPLLSIFGEKDWIVPYKENIEALNQSFPGNRKKLLTTLVAPDAGHGTEVEGKNITF
SDNNSYWRYFRISPQVTIEIIDFLKRHAFIE
>OMIFANIC_00806 Putative antitoxin YwqK
MKKLLLLLLILCGLPLIASGQVSLKDVVEDKKDMADSYYGIFKYKGKPFTGEATEYYENG
QMKSSRNYKDGMYQGYWTEWYSNGNMKFRGDRYKNKGEGLTKWWHENGQLKKMGTYNLDK
QHGAVLRWYDNGNLQQIRYYINDIANGNWTTFDKNGDVLDEGNDMNRYYRPFFGNDTAPE
GFEETSPSFTADGNTMVFARYTDWVKKVPYIAYKNGKTWKKEKLPIADTLYNLAISAEGN
RIVFKKFEYSGEDEISRTFVVDRINGSWGSPKEVDNLFNINAGYFQFTKEGVLYMFARKP
RNGIYYSEPTTDGYYSKPKWLSDEVGLEKSDSFDVHIHPEKNKLIITQAYSTEKYPNRGA
IGMYYYKKKNGEWVREKRIPLGYAWGACITPDGKFVFVRNGNLQFVNLTELEIDW
>OMIFANIC_00807 Serine/threonine-protein kinase pkn1
MKSSYVLKICIAVIGIIVLTAFHSTKNENDMSKYKSAEMVFIQGGSFFMGQVDGEADEKP
SHKVNLSDFYIGKFEVSVADYRLFCETTNRIMPKEPKWGWYDDHPIVNTTWYDAIDFITW
LNAETGENFRLPSEAEFEYVIRNGGKEGVYPWAQGKPINENIADESYGTQYSGKRIWNGY
TDGFVHTSPIGAYPPNEVGVCDINGNVWEWVSDWFQDYSDAIKQDPEGPESGKHKVGRGG
SFNADPWHCRSASRSYVLPSFTGPGFRLARDID
>OMIFANIC_00808 putative N-acetyltransferase YsnE
MIRLKLTNSDDKDFIELVESLDRELAVRDGDDHAFYHQFNAIDMINNAIVAYEDKVSVGC
GAIKEFDGLSMEVKRMYTLPDYRGKGIASKIVLRLELWAKELGYPFCVLETGKQQPEAMA
LYKKQGYEIIPNYGQYAGVTNSICFKKKLI
>OMIFANIC_00809 hypothetical protein
MPDNFEIDYTFGDHHYFYSIDTKDPDGHTLELTTLVVDEESFF
>OMIFANIC_00810 hypothetical protein
MKPLYQLFVLAGLGIFAYFYFFNFDNMSETELVNSVMYWYVPLAFGLYGLIAFRIKKRMP
ETENNVLKYVFSGKDQVILILMILLGLSGLIGLLVLLLPLLIFNVRRPGYDLSVALVGAF
LLLILLAVFFKVLWPSL
>OMIFANIC_00811 Superoxide dismutase-like protein YojM
MKKIAMSLMLASLVLVSCKDDKKKLDSEEATDTEVVEEVEEVEEMEVKKVTMTLASKSGS
SATGTVTFTEQEGVVAMEATLSGLTPGTHAIHIHEKADCTAEDGTSSGGHWNPTFAPHGK
WGAEEGFHKGDIGNVEADENGNASIAMKTDEWCIGCGDENKDILGKAIIVHQGTDDYTTQ
PTGAAGARVSCGGIIE
>OMIFANIC_00812 hypothetical protein
MVSEIFEVTITGTHGVKLPESAAAPFYKAGHKRVKMTAWFKDKHIGFHGALHLNKGNFVI
SFGKRYQKELGVGFNDYFDLQLAEDTSKYGVEMPEELSAVLESDPMAADVFEDFTDGKKR
SLIYYVLRFKNSQTRIDKSLIIAENMKHGISDPKELIRDRR
>OMIFANIC_00813 hypothetical protein
MNLQKVTFENESGQQLSGRLELPADEIPHNFVLFAHCFTCNKNLGAVRNISRALSSKGFG
VLRFDFTGLGESDGDFEDTNFSGNVADLIAASDYLAENYKAPTLVVGHSLGGAAAIFAAA
EITSIKAVATIGAPSNPVHVTHLLKSSLEEIENEGVAVVNLSGRDFTIKKQFLDDLKTKS
LPDVAQGLRKALLVMHSPQDTTVGIKNAEEIYIAARHPKSFVSLDGADHLLMRREDSEYA
GLVIAGWASRYVDIPKETNIKSSHDTVASLSGSKGYTTQMKIGNHYMLADEPESVGGNDF
GPNPYEFVSAGLSACTAMTVQMYVRRKGWDLQNIEVHTSYSKEHAIDCENCEADSARIDT
FQREIKFEGDLDEKQVARMLEIADKCPVHRTLHSETQVLTKLII
>OMIFANIC_00814 hypothetical protein
MRKVIIVFTIVLGFQNYTASAQETGEDDFGFWAMYFGTNRVSEKLSIHTEAQFRFYEVAS
NFNQMLLRTGLNYHISDKAMATIGYGYIETDPTFPEPDGEQNISENRIYQQFVLRNNVGK
IKFSHRYRIEQRFISNPVTGNDTQHRARYFLRVTYPINDTWFLTAYDEVFINLQEPIFGQ
NRLYGAIGYVANKNVSVQVGYLKNHFTGSNFDRLQIGIFWNTDLRKKQESSD
>OMIFANIC_00815 Dipeptidyl aminopeptidase BIII
MKKLIMMFALFTLLLACKEAVEKETAEVIIPDQYTIEQFMDNENAFGNGFSPDKSKVLMT
SNRSGIYNMYTTPIGGGELAPVTQSDSASVFGISYFPKDDRILFRMDGNGDEIYKIFMKD
GEEIKRLTPAENVRALFRGWSRDENSFFYGSNERDPRYMDHYEMSLEDFSSKMIWQNDEG
MNFGGMSPDRKYIALTKSINTNDSDLFILNTETGEKSKVNDTISGNTPQDFTLDGKYFYY
STDKGAEFSYVMRYNLEDGSKELVLGKDWDISSYYFSRNDKYQITFSNEDAKTVMVVTEV
ATGDVVEFPSFENQEISSASFSMDESMALLRVGGSHTPTNSYSYNLETQELNQLTDVLND
EINGTHLVSASVVRFKSFDGLEIPAIYYKPHQASAENPAPALVWVHGGPGGQSRQGYNST
IQYLVNHGYAILAVNNRGSSGYGKTFYKMDDQNHGDKDLKDCIAGKDWLKTQEDIDGEKI
GILGGSYGGYMTMAALTYAPEEFQVGVNIFGVTNWIRTLKSIPPWWESFKDALYTEMGDP
NTEDSIRLRQISPLFHTEKVTKPLIVLQGAQDPRVLKVESDEIVEGVKNNGVPVEYVLFE
DEGHGFVKKENQIEAYGRIKEFLDKYLKGEGQESMDSAQTESTETK
>OMIFANIC_00816 hypothetical protein
MTKIFFLSFLFISTTLLSQNVPMDLMKDLKPRNIGPGGMSGRVTSIDVVNNDPDIMYVGT
ASGGLWKSSSGGIKWHPIFDDQPTASIGAVAIQQSNPSVIWVGTGEGNPRNSLNGGFGVY
RSLDGGKTWKSMGLEKTRHIHRIIIDPTDPNTVYVGAIGSPWGIHPERGVFKTADGGKTW
NKILYTNDKSGIADLVMDPTNPNKLIAAMWEHKRDPWFFKSGGEGSGLYITHDGGDTWEK
RTDADGLPKGDLGRIGIAIARNKPNIIYALVEAKKNALYKSKDGGFKWKKINDKNDIGNR
PFYYSEIYVDPQNENRVYSVFTYVNVSEDGGKSFDQLMPAYGVDNGVHPDHHAWWIHPED
GSFMIDGNDGGMNITRDGGKTWRFIGNLPVAQFYHIAVDNEFPYNVYGGMQDNGSWRGPS
YVWRSQGIRNSYWQEISFGDGFDVVPDPDDSRYGWSMSQQGFVSRYDWKIGNNYSVRPTH
PDPEMKLRFNWNSAINIDPFNNNVIYFGSQFVHKSIDKGLTWEIISPDLTTNDPDKQKQH
ESGGLTMDATGAENYTTILVIEPSPLEQGMMWVGTDDGRVHYTQNGGVNWIEVSKNLKGL
PEGSWIVQIKASNKKKGEALLVANDYRRFNYTPYAYRTTDYGKTWERIVDGNDVISYALS
IVEDPEEKNLLFLGTDDGLYVSINAGSNWTKWTNGFPTTSVKDLVIQSREHDLIIGTFGR
AAWVLDDIRPLRELASNNSLLSQDVRIFDPPTAYRASYKQPTGSRFGADALYNGENRPRG
ATISYYFKKPVEDKNVEKEDEDEDDDKNMDETTPDETEGKHKDSLYMRFYDGQNLIRTLK
RKIPDSSGMYRWRWFMNEAGVTRPSRRIREVKNEPGGIGVKPGIYRVELSYLESKSVTNI
KVESDPRLKVTQKAINDRYAYGKKLQEMTGVAAEVVKQLVESKNTVEDFQKKLKKKDKEK
YKEDLKSGKEVIKKIDNLIALYLGKEDKRQGITRNPEVTVMQRIGTANRYVRSRPDGLTA
TEERLLEQAEDQFNAAIEETNNFFVTKWAEYRSKLEQMDLSPFKETKTF
>OMIFANIC_00817 hypothetical protein
MKKKPRPSGFVFTKHVPKEQSPFERLFEIFQELITHTSGDFDEAIDWLRQLDEEYNITTP
DYTIDDFIEDLKKKGYIKEEIVPDGSGKGNGEGTSKMTEKLEQALRKRALDQIFGKLKRS
GAGNHKTKNTGRGDERSGEFRKYQFGDALDRISMTESLKNAQINHGIGDLHLTENDLVVE
QTMYKAQMSTVLMIDISHSMILYGEDRITPAKKVAMALSELITTRYPKDTLDILVFGNDA
WPIKIKDLPYLNVGPYHTNTVAGLQLAMDMLRRKRNTNKQIFMITDGKPSCLQLPDGQYY
KNSVGLDPHIVNKCYMMARQARKLHIPITTFMIAQDPYLMQFVDHFTEANQGKAFYTGLK
GLGEMIFTDYETNRRKKIR
>OMIFANIC_00818 Magnesium-chelatase 38 kDa subunit
MKIENIRTLGELNKAGYEYKTVKEELRRNLLQKLMKKEPTFEGIHGYEYTVIPELERAIL
SKHNINLLGLRGQAKTRLARQMVSLLDEYIPVVSGSEIHDDPFHPISRYAMELIAEKGDE
TPIEWVHREERFAEKLATPDVTVADLIGDVDPIKAANLKLTYADDRVIHYGMIPRANRSI
FVINELPDLQARIQVALFNILQEGDVQIRGFKLRLPLDIQFVFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPEDIETARIITEQEAADAMAEKHHVFVPELAKDILEEISFQARESEFI
DAKSGVSARMSITAFENLLSTAERRALQNGESETTVRLGDFTGIVPSITGKVELVYEGEQ
EGASQVAQQLIADAVKSQFEQYFPKIEKLQKETEADPYTDIVAWFFEQSGFELLESLSNE
EYAMQLNRIAPLNNLIDDNMPDIDDRDKAFVKEFVLWALVEYRKLSKYNLSDGMRFKDVY
GGYISDL
>OMIFANIC_00819 hypothetical protein
MSQDLHITGSVIDENNEVIAFATTYIIKASDSTLVKASITNNNGYFKIGPVQSGEYLLKV
TYVGFQDYLSDKIILNQSLDMGVVNLTTEAEALGEVVVKYEKPIVEVQADKTVFNVDKTI
NATGSNGFELLRKAPGVIIDNNNSIIVEGKSGVQIYIDGRPALLRGQDLINYLETLQSTD
IDSIEIITQPSSRYEAAGNAGIININLKKNKSLGTNGSITAGYIQGRFPRVNSSISLNNR
GKKTNLYGTYSNRFGDSYGFINLNRMQNGTRFDARTTSKFDSNNHNLKSGFDYYLNAKNT
LGIIFTGNLNNGISKSESRTPIIPSGQNIPSEVLLAQSNADNVSSNYNVNLNYKFADTLG
HDLNVDLDYGRYTSDRENFQPNYYVNGTETDTIRSSIARFITPIDIDILAGQLDYEQNGL
GGKISAGGRVSYVETANTFNFFDVINGMDVFNTEQSNIFNYTEQINAGYVNYNIKWAKWN
LQVGLRVEQTISEGELQSTQQNSNELVKRNYTDYFPSGGLTYQVNRKNSLSLTYSRRIQR
PSYQSLNPFQYKIDELSFRQGNPFLQPQYTNNLRLAHTWNYRLTTSLSYSYISDFFAQVT
EAVGDNQNFIIQRNVANQRIYNLGVSYPTKINEWWNIYFSLNAFHSEYEATSPDFIPVEQ
TTLSFYGQNTIKLPSEITMEVSGWFSSPSIWGGTYRTKSLGSLDIAFQKKFFNDRMTARI
AFSDILYTIPWRGETQFGDLSIMGDGGSDSRQVRFSLNYNFGRSEIKKARKRKTGIEDEQ
NRIDN
>OMIFANIC_00820 hypothetical protein
MVINIWIKTALFQNIKKRKDDEWFYRPMNVTGHLSAYKTIRRIRIALVAVIKYIWTNRNF
YDTLSNFNPYFNYIITAV
>OMIFANIC_00821 D-aminopeptidase
MIRFLILILTSIILLLPFKGFSQTGMEALDAIIENQIKGIQPGLTVGVVKDMKIVYERYA
GFSNLAHQIPVDSSTRFNIASNAKQYTAFMILYLEDLGKLKITDDFRKYLPEYFPEIKSP
ITIGNLLNHSSGIRDFYELMSLEGRTWWKHVGLDNNDALELLRKQTALNFEPGSQHLYSN
SNYTLLTEVVKSVSGQSFPKAIATLFDSLGMPNTRFQTNYMSVIPNKALPYSDWGDGVWK
QYPMVTNLYGDGFLFTTLRDQLKWEMQIQEMYSDIDPVELLAKSQKPIPGSEIENYGFGI
EFGNYKGKQIVYHEGATGSYSAYFIRIPSETVSVVVMTNNGSVWSEGLAKEILDEVVVFN
AEEDHPGMPSAIGARPGLEALPGDYLLKDGTLIKLYLEKRKLFRSIYNREPVEIVHEKGN
VFRYATIENLKMVFVANATNSYDFELYMPGTPVRIAPRLPEQSILDNWENADGTYVNSEL
GVKFQMQYKEGRTFEISMRDNSYTAELLRNDWIQMGDYKLNIERNKSGEITALLLDQNRL
RNVRFSKRL
>OMIFANIC_00822 hypothetical protein
MKKLIIITISLISLSIYGQPASTSASEVENGLQQKQQLAEKSIVKNLPLESIGPTIMSGR
VVDFAVNPENPVEFYVGYASGGVWYTKNNGTSFEPVLDSSPTQNVGSLSVDWKNKVIWVG
TGEVNSSRSSYAGIGLLRSEDGGKSWQNMGLRDSHHISKIMINPNNTDEMIVSAVGHLYS
KNSERGVYKTMDGGKTWNRTLFVNDETGIIEMDVDRNNFNLMYAAAWDKDRKAWNFRGNG
TGSAIYKSTDAGNTWAKITVDGSGFPTGEGVGRIGVAVVDANTVYAIHDNQFRREESGEK
ESDDGILSKDDFKTMTVSQFLELDNNRLKDFLRQNGFQEKYRPENVKNMVRSGSVKPVDL
ARYLEDANTMLFDTPVIGAEVYKSTDGGKTWNKTHDGYLDGIYFSYGYYFGKIHVDPNNR
DKIYIYGVPILKSADGGKSFESIGAENVHGDHHALWINPEMPGHLIDGNDGGVNISYDDG
ETWIKNNAPAVGQFYTVNVDNEKPYNVYGGLQDNGVWKGAHNATMNYRWQQSGQNPYKSI
MGGDGMQVQIDSRNTNIVYTGFQFGNYFRLNLENEEQTYIQPKHELGENPYRFNWQTPIL
LSSHNQDILYLGGNKLMRSMNQGNDWDAISGDLTKGGKPGNVAYGTLTSISESPFQFGLL
YAGSDDGLLHLTQNGGGNWINISTTFPKDLWVSRVIASEHKKERVYVTLNGYRWDDFKAY
VYVSENYGQSWTDISSNLPASPVNVIKEDPANEDLLYLGADNGAWVSFNRGKSWEVFSGG
LPNVAVHDLVVQKRDKDLVLGTHGRSFYRADIEVLQQMTSTGMNEILLAEIPSIRYSRRW
GSSFSPWSETFEPLRNIHFYSPLGGNIKIRVADESGNSLNELTIDADKGINIAEYNLSVS
EKGVKALKKNGIELKKADNGMYYLPKGSFQITVLNDDGAATTSMEVK
>OMIFANIC_00823 hypothetical protein
MFGFNSFEPYFCASEIFEKKTIMGLIKSSIARKVAMALSGLFLVFFLGQHFVINISSVID
PDTFNSWSHFMGTNGLVQFVLQPVLIFGVVFHFVMGFILELQNRKARAINYKSFKGNLSA
SWASRNMLISGVVVLAFLGLHFYDFWVPEIVHKYIETHPEDPTRYFPELVHKFESPVRVG
LYALSFVLLIFHLWHGFASAFQSVGFNNKYSVGLTKFAKFYAVLIPIGFVFIALYHHFNQ
IPH
>OMIFANIC_00824 Fumarate reductase flavoprotein subunit
MSILNSKVPSGPLSEKWTKHKNDINLVNPANKRNIDVIVVGTGLAGGSAAATLAELGYNV
KTFCYQDSPRRAHSIAAQGGINAAKNYQGDGDSTYRLFYDTIKGGDYRSREENVYRLAEV
SANIIDQCVAQGVPFAREYGGLLDNRSFGGVLVSRTFYAKGQTGQQLLLGAYSAMNRQIN
RGKIKSYTRHEMLDLVIVDGKARGIIARDMVTGELERHSAHAVVIATGGYGNVFYLSTNA
MGSNVTASWKIHKRGAFFANPCYTQIHPTCIPVSGDHQSKLTLMSESLRNDGRIWVPKKQ
EDAEAIQQGKLKPVDLAEEDRDYYLERRYPSFGNLVPRDVASRAAKERCDAGFGVNKTGE
AVFLDFAAAIMRYGKEVAAVEHIENPSEEKIRELGEKVIETKYGNLFQMYEKIVDENPYK
TPMMIYPAVHYTMGGVWVDYNLETTIPGCYCAGEANYSDHGANRLGASALMQGLADGYFV
LPYTIGDYLADDIRTGPISTDLPEFAEAEKNIQEQLDKLINNEGSKSVDHFHKRLGKIMW
NKVGMSRNEKGLKEAISEIRELREAFWKDVRVPGDANEVNPELEKAMRVADFLELGELFA
IDALHRNESCGGHFREEYQTEEGEALRDDENFMYTAAWEFKGDPGKAVLHKEELNYENIE
VKTRSYK
>OMIFANIC_00825 Fumarate reductase iron-sulfur subunit
MKLTLKIWRQKNAQTKGNMQTYPIDGIEGDMSFLEMLDVLNTQLIDKGEEPVVFDHDCRE
GICGTCSLQINGEPHGPDRLITTCQLHMRKFNDGDTIVIEPFRAKAFPVIKDLMVDRSSF
ERIQQAGGYISVNTSGNTIDANAIPIEKEHADESFNAAACIGCGACVAACKNASAMLFTA
AKVSQFALLPQGQVEASRRVLNMVEQMDKEGFGNCTNTGACEIECPKGISLENIARMNRE
YLSASLKG
>OMIFANIC_00826 Autoinducer 2 sensor kinase/phosphatase LuxQ
MRKAIFHLLVFLFVAPAISQDATNPPTISEQKEQFKTLKVTSDQFYNGGNYRKSLETNIE
LLKIALKIDDAFYKQQGYRLLAYDYLAMSDTLMARENFTKSIRFANESENDTAKAYMYMD
MANIYSTIEPSYKKAMDHHNKSVDQLRKINDSVNLAKAHFNTVLTAFENGKYKEGYAHLL
RARKMEKFEPHPSFGVALDNLMGEYYYSKENYELAQKYLRKAAEVAEREKFSLELENAYF
YLSECLYNLEEYQEAFLIKDKYEEHSIQNMENALYAENDETSARFAIEEYRKEVQAAELQ
NSLQAQIVENKSMLNNVLLIVSFCILFLLMVLYLAYRKRKELVAELRVKNTEYLMAKEET
ERLSKAKTNFFSTVSHELRTPLYGVIGLSTLLLEDKGLKSHEKDLKSLKFSADYLLALIN
DVLHLNKIDSKTVENDKAYFNIREQVKTIVSSFEYMRVQNSNTFYIDIDKDIPKLIRGNS
VRLSQILMNLIGNACKFTEQGDIYVSAGLKEITSNKATISFAIRDTGIGIAEGKQNIIFD
EFSQGNNLNYNYQGSGLGLPIVRKLLSLSNSEIHLESKLGEGSTFSFDLAYDILNKAYKK
EPVHALDTQGLKDKRILIVEDNRINQTVTRKILEREGVVCTIAENGEIAVAVEREKEFDL
ILMDINMPVMNGLDATRGIRKNNKAIPILALTAVEIEEMRFSIYDSGMDDIIVKPYDITK
FTQTILKHLHGRDSRSDISKLQAM
>OMIFANIC_00827 Methionine aminotransferase
MISKLPKVTTTIFAVMSKMAQEYDAINISQGYPNFNSDPKLIDLVSEAMRSGFNQYAPMP
GDGLLRERIAEKINNTYGSSYSPDADITITAGATQAIFTAIAATVHKGDEVIVFAPAYDC
YEPAIELFGGIPVAIQMKPPSFEPDWKEVADRISAKTRMIIINSPHNPSGMLFSKADMLE
LQRLVLEHDLYVISDEVYEHIIFNGNDHQSAARFPDLAERTFITASFGKTFHNTGWKMGY
CVASSHLMQEFRKVHQYNVFSVNHPLQRALATYLEDPETYLGLSGFYQAKRDHFLKLISG
SRFKFVPSKGTYFQLLDYSGISTKGDIEFSEWLTKEKGLATIPTSVFNRGGEDFRQLRVC
FAKTDETLEAAARIINSL
>OMIFANIC_00828 hypothetical protein
MSDAIFNTIRNGDNKALDSLLKKDPSLVNVKDERGSSPLLLATYYGFEDITETLLSYPQD
VNAQDGSGNTALMGVCFKGYVGIATKLIERGADVNLRNYNGGSAIIFAATFGRTELVKLL
LEKGADAGNKDDGGKTALDHARMQGLTEVISLLEQYT
>OMIFANIC_00829 2-oxoglutaramate amidase
MNELSVGIIQSNLHWENPEANRDMLEAKISSFEPDTNLVVLPEMFTTGFSMNALELAEKK
EGTTLEWMRSIASNQDIAVTGSLIVREKRKFYNRLYFVFPDGSYHWYDKKHTFTLAGEHR
TYAAGKEKLIIDFHGWKICPLICYDLRFPVWSRNTEDYDLLIYVANWPKKRISAWDALLR
ARAIENMSYCIGVNRIGVDGNNHEYIGHSAVYNVLGDLISNSDNEIEFTEKVVLSKDHIL
NTRKQLQFLNDRDAFSLI
>OMIFANIC_00830 hypothetical protein
MKRRLYFIPFIFIGILLMANCAKKGRPSGGPRDTIPPIIVRSVPENFTTNFGETEIRIFF
DEYIKLKDLGENLIISPPMKYAPIITPLNTSKMLRIRILDTLAENTTYSINFGKSIVDNN
EENEFEFFKYVFSTGNYIDSLKVTGAVRDAKLRTAEFPVTVMLYEVNESFKDSTIYSEKP
MYITATRDSSNTFEITNVKEGKYILIALKEKSNDYTFQPKTDKIGFLNEQITLPTDSTYN
VTIFKEIPEYKVTRPSHLSKYHIVFGYEGDPKNLEITPLSELPNDFVSTTLRDMERDSLH
YWFRPEITADSLLFQVRNEEQLDTVEVRMKNLFADSLIVQGYKLGTIIPRDTMSLKTTTP
LVSIDNEMIGIMDKDSLNIPFTTRVHPENNLAQILFDRTEEQRYKVDLLPGALTDFYTNV
SDSLSYSVESKSNSDYGTIPLTIDNVKAYPIIVELVSEKNIVMDSVMMTESAPMSFDYII
PGNYYIRIIFDSNSNGRWDTGSFLERLQPEEIVYYPNKIEVRANWTLNTNFILD
>OMIFANIC_00831 hypothetical protein
MLNLLFPKICHGCEDILQSTENVLCTQCRHDLPLTRFHLHGSEGMKRVFYGLIPVENATA
LLHFQKKGITQQLLHNLKYRGQEEIGAFLGDWLGAELAENPKYVSIDLVIPVPIHNRKRR
KRGYNQVTGFGKQIASALGAEFREDILLKVSKTSSQVLKKRLTRFQDEQIFRLQERNLLR
DKHVLLVDDIVTTGATLENCARQLLDKTNARLSVATMAIA
>OMIFANIC_00832 hypothetical protein
MTAENNSTKFKVLIGILSALLIALAVYTVTLYNDSKNTVSGLEQQKSDIEGELEDLIANY
DEVIQDNELKDKDLLAARERIELLLDSVKDAEANVALIKRYKVEIGRLKQERKILFRKAD
SLIAANKQLAMERDSTNVVLNETIRVVDSVSEQNIAMAETIKKGSVVNAVDLRGEAVIVR
SSGKIVDTRRSSRADKVRACFTLTPNDIAESGDRLLYVQVINPKNNLLGKKSTMEFEDGI
LNYSEVTKVFYENEELDVCILVDAIEEDLIEGRYTINVFDGARQIATTAMELK
>OMIFANIC_00833 Glycine--tRNA ligase
MANNEDQFKKVISHAKEYGYIFGSSEIYDGLSAVYDYGQQGVELKNNIREYWWRSMVYMH
QNIVGIDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLVEDHAEKLENKAKKE
IAKAKKRFGDAFDEEQFVTTNPRVLKYRAEKQEILDRMARLLEEEDLAGVKALIEELGIA
DPVSGSRNWTEVRQFNLMFGTKLGASAESATDLYLRPETAQGIFVNFLNVQKTGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVRPGEEMKWYEYWKETRLNWHLSLGLG
EENYRFHDHEKVAHYANAATDIEFNFPFGFKELEGIHSRTDFDLKAHEEYSGKKLQFFDP
EMNESYVPYVVETSIGLDRMFLAILSTSLQDETLEDGSVRTVLRLPAILAPVKAAVLPLV
KKDGLPEIAHDIIDDLKWDFNVIYDEKDAVGRRYRRQDAAGTPFCITVDHQTKEDQTVTL
RNRDTMEQQRIPMSEVAKHIQNSISYKEWLT
>OMIFANIC_00834 hypothetical protein
MILIRTFLALLIATIVSCNSSAKTTEENANDNTSEMKVEAMKMKEAGYTSGTIVYSDEEG
DCPYTIQVDGEDNDYMFDPINLDESYKKDGMRIWFKYGGLRMMNRCVKANPVNILEIQER
M
>OMIFANIC_00835 hypothetical protein
MKFKNYFALMICLVLSMSLSAQVNEIVPNEPQGPATVGTFDSMIIVPSLASRQGMLAAPD
NSIREAQDRRSLRPEGLIGPDPQTTNDFLASNPHPSSQTIDSAPPFLIFDAFTSNSSPTD
PTMAVGPNHVMVTWNTAFAIYDKSGNLLQGPLSPAAIFASSGCCDLTVTYDTNADRWVLT
YLGASNSIAVSDGPDPINDDWFVYSQSFNDYQKLSVWSDGYYMTQNTQGSNKVFALERDE
MLAGNPSAQIISFNLPGILGTNPFFSPQFLNVSDGNMPAPGGATVLFLQDDAFSGISSDH
IKYWTIDMNWGASTGTISAATQIPATPFISVFDNGNFNNLSQPGGGAAIDALQNTIMNMA
QFRKFSGHNSAIFNFVIDTDASGGELAGIRWYEFRQTADNQPWTLYQEGTYTSPNGKHAW
MGSMIMDQNGNIGLGYSSMAGPTTVDPLDFRVGSYYTGRFDGDALGTMTVIEEPIEVSTN
NVPNLRYCDYNKMTIDPSNDTEFWFINEIMNGPRKGIIAAFQLEPPQPNDIGMLTIDQPV
DGPLTAAEEIVVTIRNYGSNDITDPEVQYTIDGGAAVVEDYSGTIVAGTTESYTFSQTAD
LSIPETSYVIEAKTNLAADSNTSNDTATKTVTNTTLGIVDNLINNSDLYVVTEPNNRFEI
VLVTGFDEVASLNVFNQLGQQLSSNELEKQGDRYVYRLNMSSYSAGVYLIQIGDANTNTY
RTAKIVVR
>OMIFANIC_00836 hypothetical protein
MKLIYTFLACLFLASLGANAQETDLTKPFYKGTIGNVTYVPPINSRLADIPAYVDSNEEA
QDGRSSRVKVIPGKDPQTQDDFFFRNQDPLTQKLAGRAPSIVFDAYASGSQPTDPSLAVG
PDHVLVVFNTGFIVYDKAGVAQSGQMPPNPTIFPSGGCCDLTVSFDTAAQRWIVTFLGGG
AQIAISDGTSTDPLATGWFVYNINQINDYQKLSVWSDGYYLTDNTGSANKVWAMERDEMI
LGNPAAQILGFNLPGIVTSGFYSPQVLNVTDDNMPSAGGATVVYLQDDAWSGVSNDHVKL
WTIDVDWGAGNGTVSNPPLELTATPFISVFDGGSFSNLAQPGGGADIDALQATIMNQAQF
RKFGGHNSAVFNFVIDTDASGGELAGVRWYELRQPGDGQPWSIFQEGTYMAPDGRHAWHA
SLMMDAQGNIGMGYSSMAGPTTPNPLNFRVSSYYTGRFSADPINTMTIAEELIASGNQNI
PGLRYGDYSKIDIDPADDKTFWFINEYMNSGRKGVVGVFKIAPDFNNDVGAVDIVSPVDG
ILTNAESVEVTIFNFGLDPQSNFPLELRVDGNLVATETFTGTVAPTMSASFTFAQTVDLS
IPGQTYTLEVRTDLSGDEDANNDSVTKDVTNVFANDIGVIEILEPTSGEGLGNETVTVRI
ENFGAAPQSNFDVSYSIDGGADVTETVVGPIGPGATLDYSFSTLADLSVEGTYEFLASTE
LAADSDTSNDSTTKTVINLSCSSETNDTNFSIGPNAGTVTNSVITYTNDIMVNDVNVNLN
INHTWVGDLTISLIAPDNTTVVLADGVCGNCDNMVDVTFDDEAADPITGATDPITGPYQP
EGNLSDFDGISTIGDWTLRIVDNANQDGGNLLDWTLQLCGDIILGTEEFANTTDLLVLDQ
GNNQFKLLLPTTEVTDQLTFSVINMLGQTLSSYRLENENGTGYEYDLDMSYVSAGVYIVR
IGNSEFGGTKRIIVK
>OMIFANIC_00837 hypothetical protein
MKHFLIILLLITPFLGNAQEIPSNYKTKRIAVSDTILVDSIALNPSRFEILLKDGNKVDS
NDYTIDFNTGLLVPSEILRERADTITINYLRYPDYLTRDYYVFDPKSIIESTGSIEKLYS
LQESGTKRNYTPFEGLNTVGSISRGVTVGNNQNAVVNSELDLQITGRLSDKVSIRASIQD
ANIPTQEGGYSQSLDEFDQIFIELFSDNWNIRAGDVDLQNTNSYFSRFTKKVQGISLAGK
LNHDTGASSSAFASGALVRGVFQRSQFTGQEGNQGPYKLVGPNGELFILIVSGSERVYVN
GLLLKRGENADYIIDYNAGEIKFNPTFPITANMRIVVEYQFTDRNYSRFIGYGGGNYSTD
KFDLGVYVYSENDAKNQPLQQNLSEEQVSILQDAGDDMDAMTAPSAVPDTFSENKILYRK
EILNGVEIFVFSNNPEDELFNVRFSLVGPNQGNYILSDLSAINRIFEYVPPLNGVPQGEY
EPVIRLNAPVKLQIAGVNGSYHPSESTKIDFEVAGSQNDLNLFSDLDDGDNDGFAARLAA
KQTLLKTADTLSLTGHGSLDFVNRDFRTIERLYNIEFTRDWNLIDPMGDQRFIIAGMELS
KPRLGIAGYEYQNLNFSENFKGNRHVLNAGLRPGKFRINSSSSYLNSESDSLDSKFIRSF
TNAVYQLNKAWVGAKVNLEDNQVSTVRNDSLTGVSQRFISYETYVGVGDSTKVFTEAGYQ
YRVNDSVQNNMLTKVNTSNTYYIKSRVINTPESQLSIYANYRDLKDEKNDSDDDERSLTS
RLIYNQRLFKGGIRWNTVLESNSGVIPQQEFTYIQVEPGQGIYTWKDYNNNGIQELDEFE
IAQFQDEAEYVRVLLPNQIFVKIRENKFSQLLTLNPQAWTSEEGFKKLLSKFHNQTSYLI
SRKTRRNNDDFEINPFKDGGDDELGLSLNFRNVLFFNRGKQNLTTSYTFIATSANNLLSV
GLQQNDLQSHQFNFNHKIWNNWLVTLKGSFGNNSSSSENFPSRNFDLDSYTFNPKLSYLF
NKQTRFDVFYQFANDENTLGGMEQLDSQKTGVSFAYTNAQKISITAEFNYINNDFTGSAF
SPVAYQMLEGLQPGSNFTWSLLFQKKITKYLDANLSYFGRNSENSSTIHTGSIQLRAYF
>OMIFANIC_00838 Exodeoxyribonuclease
MKIISYNVNGIRAAMRKGLMEWLKAADPDVFCIQETKATQDQVEVNEIEAAGYPYHYWYS
AQKKGYSGVAIFCKKEPDHVAYGTGIDYMDFEGRNLRVDYDGLSVMSLYLPSGTNIERLD
RKLTYMADFQTYVDDLKKELPNLVISGDYNICHEAIDIHDPVRNKNVSGFLPVEREWIGK
FIDSGFIDSFRYFNKEPHYYTWWSYRANARANNKGWRIDYNMIAQPLQEKMKRAVILPEA
HHSDHCPLMVELSL
>OMIFANIC_00839 putative lipoprotein YiaD
MFKKIFFGIILISISTSCVSSKIYEDLQDRYDALKAENESLMAQLDANGGNGEEYSITKL
RTEVDKLNAENTRLKMEMSALQNNLDRLQSSYDALEANSSSALTENLERNRKLLEDLEAK
ENRLAEEEARLKTLQKELASRSAKVDELEGIIAAKDAKMKALKDAISAALVNFEGNGLTV
EQRDGKVYVSMENKLLFDSGSWAVNSRGSEAVVQLGKVLAQNKEIAVLIEGHTDNVSYGG
SGNITDNWDLSTKRATAIVNILTQNSGIPKDNLTAAGRGEYAPLAPNSTADGRSKNRRIE
VILTPKLDEIAKLLNEI
>OMIFANIC_00840 hypothetical protein
MKKLKFAPALLLVLVLTSCSTVRVVSDYDREANFDQYKTYAFYKPGVDKAEISDLDKKRI
LRAIDAELSAKGLNKGESPDLLVSIFTKERERVDVYNNNFGWGWGWNPWWYGGWGNTVST
STEGSLYVDLIDAKTNELVWQGIGTARLITSGNIDKKEERIREIVREIMMQYPPGSGQN
>OMIFANIC_00841 Urocanate hydratase
MTFSEEIIQGIPDWLPKPKPYDSTINHAPKRKEILSDFEKELALRNALRYFPPNQHAILL
PEFREELETYGRIYMYRYRPDHKIFARSISEYPGKSEQAKAIMLMIQNNLDHAVAQHPHE
LITYGGNGAVFQNWAQYRLVMKYLSEMTDEQTLVMYSGHPLGLFPSHKEAPKVVITNGMM
IPNYSSQDDWEKFNALGVTQYGQMTAGSYMYIGPQGIVHGTTITVLNGFRKINKDPKGGL
FVTSGLGGMSGAQPKAGNIAGCVTVCAEVNKKATHTRHSQGWVDEVISNLDLLAERVIKA
CEDKETVSIAYDGNVVDVWEHFAEKNIKIDLGSDQTSLHNPWAGGYYPVGLTYEEANEMM
ANNPDLFKEKVQESLRRHAAAINKHTDKGTYFFDYGNAFLLEASRAGADVLSDDPQREFK
YPSYVQDIMGPMCFDYGFGPFRWVCASGKAEDLAITDEIATEVLEVLKIDSPGEIQQQLA
DNIQWIRGAQENKLVVGSQARILYADSDGRSKIASAFNKAISQGKIGPVILGRDHHDVSG
TDSPYRETSNIYDGSRFTADMAIHNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGMVLD
GSKEAQRRLENMLFWDVNNGIARRSWARNEEAVFAIKRAMQNNPSLKVTLPNFVDNKLFK
>OMIFANIC_00842 hypothetical protein
MFVLVNRFLLRKNFLGISLWPFIILKRKELKLNKVFINHEKIHLRQQIEMLVIPFYIWYV
VEYIIRLVRYRNRKHAYRNISFEREAYSNEKDLDYLKKRSFWRFLFYI
>OMIFANIC_00843 hypothetical protein
MRNLRRLLLMIVLLGTYSMFSQVNSNNTTEPADEKKSANILYEMSSVSNSVDGDGVEDRT
TGTTEYSMSTKNNAALESESNQQEVDPAMVEVKISMKSVDSSSIKKTRFRKEH
>OMIFANIC_00844 hypothetical protein
MKTITLKKVPKLFSTCLFLFMTTALFAQVGINTITPGDGSIMEVNSSDKGIFIPRVDITD
LSTIAPVTGIPNNPADLLAAEGLLVYNTNTTTGPGFFYWGGTTWTAVNPGSVPEPAIDSV
TLTTDETLDGTGYTDIPGMSLTFTARKTSVMVNLTASGFGTTNSVSIAYLRVYNVTSTSV
LGGTLEKVQSHLEKGPPGAFSVYTTTWSSSYSTLLTGLTIGNSYTIKVQGYAEPVTTGGS
AVIRPVTVPDSNHLTLSVTQ
>OMIFANIC_00845 hypothetical protein
METMFINTPGSLADKLVAALQGAKRVGGDNRCTSSGISGRAAFVKVLLPADPNDNSPSVD
ISLYPNISWIEPIDELQCAYDSAYSPPTCRRTVTSFPYTMDFEDELWIKDENNCSPSNAT
NSWIRSRHATPSGSTGPSSASQGQLYMFVEADQGTNDRAIMTSPCFEIPTGDTTVITFDY
HMFGASMGTLNLTVNDGSGWSTLWTKSGSQGNSWNLQEQVDLTSYAGSTIRLRFDGTTGS
GTTSDMAIDNIRIGTPPPPPPAVSCTNTVDVFDYAEGFEGNIGLWVQASGDDGDWIRNSG
GTPSGNTGPSSASEGSEYLYIEASSNGTTGEIGANATAILESPCFDLTYAQAADFTFDYH
SYGGDAGTISLQASEFEGVWSEIFNVTGVNNNAWVPTTVSLTAYLGKIVKLRFVGTTGNG
FASDLAIDNTALVVSCPNSSIYSGGSWIGGAPTLGTEVTITDSYTTAANGGSIDACQLII
GPGATLRISQGDYLNVNGDITNNGTLIVEHEGIVVQQNPNASVNNNGTINVELSTPPLEK
RDFMIMGSPMTAETRNGVFTNSYNVQEYTPANFIPNVNVPAGGTNFADDNLDDWNPATGA
IVPGDGYLVYPQAAYNDPAYDGPPPVTELVFNMTYSQGTLNNGTVTRPIVYNGGSNPDGT
PNVLANPYASPIDASTLIADNALINEVYFWEHLTEPSAGIPGANNINVSMDDISMYNGTM
GVPAANDPGTSTMPNGVISTGQGFGIKAFNNGNVSFTNSMRLTSGNTTLRTSTEEIDKLV
LKVRNEQYGIGGYTGIGFRTDATAQLDENMDSNRLATMVSLYSHLEDGTEQLGIQTRESF
NSDIKIPMGFASQVEDVTTYVISIAGLEGANLSNTRVYLIDNQENSITDLTLENYEFKSN
KGTFNERFTLQFEEENILGQTTNTLDSVTVYPNPIEDVLNIQSDGILMNTIQIFDVRGRS
MAQQIVNNQNTVMLDISSYPSGVYFVRIETEVEIITKKIIKK
>OMIFANIC_00846 hypothetical protein
MPGHNILTENIFHTITTKNGVEKVSLKEYSITTDNDVVVGIEMVEFYGDELYLSVSATPF
GGTAYLRERSQSGWDVRWNFGLAFGLLSSYPQSGTKP
>OMIFANIC_00847 1-acyl-sn-glycerol-3-phosphate acyltransferase
MVFGFLLLVFDPIQRISLNLFGYQAHKNSVDYFNLLVVRILHILGTTYSIKVPDYMPDNA
AIIIISNHQSMWDIPPLIWFLRKLHPKFISKIELGRKIPTISYNLKYGGSVLIDRKNPKQ
ATEQIEKIGKYIQQYKRSVVIFPEGTRSRTGIPKPFKRKGLLTLIEHAPEAWILPVSISN
SWKLQRYGMFPIPVGTHLILKAHSAIKVAGNDPSELIDHVERLVISEIETIPGDPTN
>OMIFANIC_00848 hypothetical protein
MYPEELVKPMREDLTSIGFAELRTADEVEQALAKEGTTLVVVNSVCGCAAANARPGARMS
LQNAKTPDHLVTVFAGMETEAVDAARAQMIPFPPSSPSMALFKNGELVHMLERHHIEGRA
ADMIADNLKGAYNEFC
>OMIFANIC_00849 Chaperone protein DnaJ
MFRWLGAILGYVFYRFPGAIIGFLIGSLIDSMGGKKSTGGYGRVFQQQRRDQVSPADFEL
NLLSLASLVIKADGAVSQVELDYVRQYFVQAYGKERANATFRVFNDVIKTREVSAQRIGG
LLRRRMRYESRLQVIHFLFSIANADGYVSDGELRIINNISVNLGIQNADFESIKAMFFKN
PDSAYKILEIDRTATDSEIKAAYRRMAKKYHPDKLQHMDEAYRKGAGDKFRKVQEAYEQL
QKERGF
>OMIFANIC_00850 Iron-dependent repressor IdeR
MYSLAEENYLKAIYHLEQEAKGEVSTNAIADRMATKPSSVTDMIQKLADKKLLSYKRYKG
ALLTPEGRKIAAGVIRKHRLWEVFLVEKLDFHWDEVHEIAEQLEHVHSEKLISRLDQFLG
NPDFDPHGDPIPDKHGNIKRTEKKLLSELDKKQRGVCVGVKESSSDFLQYLDKKKITIGT
KILVLGKEFFDGSMVIQVGRDQFFISKKIAENLYVQTN
>OMIFANIC_00851 hypothetical protein
MFKPTSAMRNRAILILICLGGTVKMLAQEKEVTEPLVTDRPDATEASTTVPKGALQIETG
AFYTSFEENEIKEEVLGLNTTLVRYGILENLELRLGWNFEEGRTTINGMELDDVTSGMSP
LLAGIKVNITEEKGLMPEIALIGHIFLPFTASSDYRPETTATDFRFSLSHTLSEKSSLGY
NIGAQWGADSPEAAYIYTLAYGYSITDRFGFYAELYGDLPEDSRANHFWDAGLTYLLMNN
LQLDATVGSGITDGQDLLLSAGVSYRIPK
>OMIFANIC_00852 Zinc transporter ZupT
MLDQLVEFAREKPILAAFYASLFTWGLTAAGAALVFLFKKASRAVLDAMLGFTGGVMVAA
SFWSLLSPAIENSEGEGFMKVIPAATGFLLGALALFGMDKLLPHLHINFKKSEAEGVKTN
WHRTTLLVLAITLHNIPEGLAVGVLFGAAATMVGVEQTEMIIAAISLAIGIGIQNFPEGF
AVSMPLKREGVSRLKSFWYGQLSAVVEPIAAVLGAVAVSVFTPILPYALAFAAGAMIFVV
VEEVIPETQRDKYTDLATMGFIGGFIVMMSLDVGLG
>OMIFANIC_00853 hypothetical protein
MKYFIAICLFTFFGTSYAQEEKVETPQIAIRIDLGETINLEGAQITFAEVLEDSRCPTDV
QCVWAGRARVLILVSEPDKPEVSKEVIFGQVMQNEVKDMLLLLKEEYVIKAINIAPYPKE
PGEELEYSILIRKSKKKDQ
>OMIFANIC_00854 hypothetical protein
MQTILVIITFTLAVGFLLKKFLWTPVFETRKKTVTTLDGDRIKCGNKDCGCH
>OMIFANIC_00855 Fe(2+) transporter FeoB
MARQINVALIGNPNTGKTSVFNRLTGLNQKVGNYPGITVEKKEGVCKLTRNLKAHILDLP
GTYSLNASSLDENVVIELLLNKNDKDFPDVAVVVTEIENLKRNLLLFTQIKDLGIPTILL
INMADRMKRKAISLDIKKLESRLETRIALISSRKNEGFEELKEIIANYSSLSLNPCLNAS
RIEPEYFNRLKKAFPNQDLYKLWLVITQDVNFGKLERGDMSGIATFQTESKSTLKRMQQR
ETITRYKFINDVLKESMIIDTANAKDFRSVLDRVLTHHIWGYVIFFGILLLIFQAIFDWS
TYPMDFIDGAFASLSEWLKSTLPPGDFTSLIAEGIVPGLGGIVIFIPQIAFLFLFVSILE
ESGYMSRVVFLMDRIMRRFGLSGKSVVPLISGTACAIPAIMATRNIESWKERLITILVTP
FTTCSARLPVYLIIIALVIPEQRILGIFSLQGLTLMFLYLLGFASAIFSAWLLNKVLRIR
SKTFFVVEMPNYKVPIPKNVALTVVEKTKSFVLGAGKIILAISIILWVLASYGPGDFNNA
QEIVTAETSSENIPEEELETRIASFKLEHSYIGIIGKGIEPAVRPLGYDWKIGIAIVSSF
AAREVFVGTLATIYSVGSEEEETIKNRMAAEVNPVLGTPRFNFASGVSLLLFYAFAMQCM
STLAVVRRETNSWKWPLWQLVVMSAIAYVVALGAYQFLS
>OMIFANIC_00856 Fe(2+) transport protein A
MLTIANLQKGERAKIKDFSVESVPLKLLEMGCLPGNEVELVQQAPFSDPLYLNINGSHLA
IRKETAEQIEIELI
>OMIFANIC_00857 SCO1 protein 
MLTFFAKYKFFGIVLLVLSAIIITIMYQALDPKEVLPVYQPNRVSAELVDSTVQYVKKYH
TITNFSLTNQNGKTVTQKDYEDKIYVADFFFTTCQTICPIMTDHMVAIQKELQNDNEVML
LSHSVTPEIDSVAQLKKYALEKGVNDNKWNLVTGNKKEIYDLARKSYLAAKDVPYSEYDL
IHTENFVLVDKKKRIRGFYDGTNPEDIEKLLDDIKVLKEE
>OMIFANIC_00858 Putative zinc metalloprotease
MSPFAVKAIQLLLSLSILIVLHELGHFIPAKLFKTRVEKFFLFFDVKFALVKKKVGDTVY
GIGWLPLGGYVKISGMIDESMDKEQMAQPPQPWEFRSKPAWQRLIIMLGGVTVNIIVGFV
IYMGILYFYGRNVTTNEELPNGFAVVDEFKAFGFQDGDKILKVNNEEFPYVTNINRELFL
RDVNNITVVHPGGAEETINLPEDVGSYMFDNDILLPFKEREEPVLDTVVAGFPALAAGFK
KGDRMLSVNGEKIDYWYEFQEKLRDRKSEENVIEIDRSGVVQSINVTTNENGQIGVDNVS
NTRKLEFSLGESITGGVSFGYNILKDYVKQFKYVFTSKGATQIGGFGAIGNLFPSQWSWV
AFWQTTALISIILAFMNVLPIPALDGGHVAFLLYEMVTGRKPGDKFLEYAQMVGFFLLIA
LVLFANGNDIYRWLFK
>OMIFANIC_00860 hypothetical protein
MKNVILIVLLAIGASGFAQDPEMIGTWYLRAFTADLSDPVFITNNDAPQNPTLIVYSDYS
FEGIGACNTFTGQFQYDPVEEVYFHTSFIPTTDDCGDPGYNTFEDGYFAHFDDTLGLFLR
YVPIGSGLLLLEIESPGFGMEFQDTVFLGVDENPISLINIYPTITSEYVNVSKPTSIAIE
KAIVYNSLGQPVLSVSENIERIDVSSLSKGMYFLQIDSEEGSMTKKFIKG
>OMIFANIC_00861 Tyrosine phenol-lyase
MNLPYAEPYKTKMVEYIKPSTIEERRKWIKEANYNLFNLSSDKVFIDLLTDSGTGAMSDK
QWAEMMLGDESYAGSQSYLKLKDTVKRITGFPYFLPTHQGRAAENVLFSVMVKEGNIIPG
NAHFDTTKGHIEFRKATALDCTIDEAFDPYVDHPFKGNIDLEKLEHAFRNNPNDKIPFVV
LTVTCNTAGGQPVSIDNVKKVSEVCKKYNTPLIIDAARFAENAYFIKIREEGYADKSIKE
ISRELFSHADGMTMSAKKDGLVNMGGFIALRNEELYKQATVFNIMFEGFLTYGGMNGRDM
GALAVGLDEATEFDYLETRINQVAFLGKQLVDYGIPVLQPFGGHAIFLDANKFVPTIPRD
EYRAQALAVELYIQGGIRSVEIGTILADRDPFTHKNRYPELEMVRLAIPRRTYSLNHMRY
IAAVLKKIYDSRDQAKRGYKIVDEAPIMRHFTVKLEKIPSIL
>OMIFANIC_00862 hypothetical protein
MNNNIQVSTKRAITAIFIAWLLFIGVDFLFHAAILESLWKEEIPAIKPLDDLAILIPAGY
ASFLLLTTLIGFVFFRIFKTKPSLKEVFKFGLIFGLLFSAANITGLFSYVAIPLKQLLIF
NLVYFIEILVVAIAIYHLAYSIKRKKVVWLSFLIFFGLVILAIVIQNITANL
>OMIFANIC_00863 hypothetical protein
MLNFWEIIFLFFAFQAVLLAIELKENAMSTKFGMYLLGIIGIMCVVGGILQFDKANPASV
QSIVYSFTGLLLFISFTLLFFSFDKSIRTDKRF
>OMIFANIC_00864 Multidrug resistance protein MdtC
MEPLVVAKQEAIRQTIEFAVSGDRIPLVTLKQIGRQIENDLRALPGISQINIDGYPEEEI
EIAVDENSLLAYNLTFGEVASAVSRTNILTTGGTIKTNSEEYLIRANNRSYYGQELSNVI
VRANADGETIRLKDVAIIRDRFSETPNANYFNGDLSVNVTITSTNNEDLISSAETVKAYI
DDFNDKYNNVSLNVISDSSITLTQRTRLLAKNAFSGIILVLFFLSLFLNTRLAFWVAFGL
PVAFLGMFMLAPYFNVTINVLSLFGMIIVIGILVDDGIVIAENIYQHYEKGKSPIRAAVD
GTMEVIPPIVSAIITTIIAFGIFLFLDGRIGDFFGEVSVIVILTLSVSLVEALIILPAHL
AHSKALRKQQKPKTRMAQLFSKLRYLNQFGDKIMSYMRDKWYGPALKFTLKYKMLTFSFF
VMALILTFGSIGGGIVRSAFFPQIASDRVSVNLSMPNGTNERTTDSIISFIESKAREVNE
EITKEYLEGTDKVLVENIIKKVGPGASAASLTINMLPGEERPDEITSGLVTDRLREKVGP
VYGVESLVFGSGGNFGGRPVSVSLLGNNIQELKAVKEELKSEMVSNPLLKDVTDNDPAGI
KEIRLELKESAYLLGLNLRDVMTEVRAGFFGTQAQRFQRGQDEIRVWVRYDRENRSSLVD
LDNMRINTPMGSRVPLNEIANYTIERGDVAINHLEGQREIQISADLKDPANTSSTDIMSD
IKNVIMPEILSKYPTVTASYEGQNREANKLQKSINAVGLSALLLIYIVIAFTFRSFSQPI
LLILLVPFSLTAVAWGHWLHGFPINILSMLGIIALIGIMVNDGLVLIGRFNNNLRDGMLF
DKAIYEAGKSRFRAIFLTSLTTMAGLAPLIFEKSRQAQFLKPMAISIAYGIGFATFLTLL
MLPLFLSVNNKLKVGTKWLATGDKITKEEVERAIKEQIEEREFEEIQEVISEETKIEAE
>OMIFANIC_00865 Outer membrane efflux protein BepC
MRRLLTLNRTLLLAGLTLLGSGHSFGQSDELLTKLTKDEAISTMLENNFGIKIANNAVRV
ADNNQNILNSDYLPTISGTAGATYDNTSSETSFNGALDNEGNPRPDITIDEAETRRYNAS
LNLDYTLFDGLGRYYNYKSLKEQYNLSQLEARETIELTTLQLISVYYEVARQMENVSVLE
DALAISKQRELRAGYQFDYGQVSKLELLNARVDVNTDSINLLVARQQLVNTKRDLNLVLN
RELETKFTVDTTATFISLLKMNEFAAAASENNVSLLQSDKNIELSGYDVKRAKAVLLPSV
GLTGSYGWNRSENPAGVFFPGTTGISNTLNVGLNLRWNLFDGGQSITTVKNARIALENQN
LLKSQLSEQVFRDLANARGNYETALYIYRLQEQNVLTNEDNFRRSQEQLKIGQITSVEFR
QAQLNLLNALNVKNAAKYSAKIAEAELLQLTGQLLNTDF
>OMIFANIC_00866 hypothetical protein
MLLDPSVSQTYVEDCEVCCNPIELTVVFENESLMKFEAADIEQ
>OMIFANIC_00867 hypothetical protein
MLANTNFSDNTIGYILDGVMDMKSLNNFWYEILEKLAHHDKVNLYVEDENLDSFTLNIIL
IVTLFPLEYADKFDKIVFVAPGRKHNALEKLKSLLKRVTIKNFEVKDKKHARNWLLSN
>OMIFANIC_00869 hypothetical protein
MYGAVKRFGVMPYQSFPEETIRQISEYLYDYDIEEPEWFAEHHGQGMGKGSGQGKGEGKG
MENHNCSENCSGNCKGMQMRKGQGKGMGKGKGMGKSRS
>OMIFANIC_00870 Thiopurine S-methyltransferase
MQFIEGYWNHRYLQGETGWDIGYVSTPLQAYFDQLTYKDLRILIPGGGNSYEAEYLFKQG
FTNIYILDISVIALQNFQKRVPDFPLEQLLHQDFFDLNDRFDLIVEQTFFCALNPSERSR
YVVKMHSLLKENGKLAGLLFNIPLFEDHPPFGGNEQEYRQLFSEYFSIDIMETAHNSIPK
RAGNELFIKLQKK
>OMIFANIC_00871 hypothetical protein
MKIRYSLLSVFLIATASLSQEVRTISKPDLLQNVLQNGNTLKIQAQHVIEAKGDLNQANA
VFLPSISASYTGMTTTNPLMAFGSKLNQEVLTASDFNPQLLNDPLRTDNFATKLEVRQPL
INLDGIYQRKAAKSKFEAAQFQESRSREYLELQVDEVYMQLQLAYKMKEVIELSKTASEE
NLRIANNSFKQGLLQRSDLLAAEVQVLEIENRMAYAQSNIENISGHLSVLMNDTSDAVYR
PSESLEPVNENIATHTLPSERADLRAMLASSKAYEQQYQSNKMSFLPRLNAFGSYELYDN
EFLQADANGYLVGAQLSWDLFDGNKRFGKAQKSKAAYERSAIEYDQYLAESKLELEKAHR
MLSDAANDLALSKKALEQYEESLRIRKNRFREGLERTSDLLFSEAKFAEKQLEYYQTVFQ
YNYAQAYLRFLTKK
>OMIFANIC_00872 Multidrug resistance protein MdtA
MKKITISILITTLFLSCGERSQTATEMNTATLKVQTQQVDNSEDSSFLSTSGIVEALNNA
QLSTRMMGHVEKIYVATGDKVKKGTLLLRVNSTELSAKNAQANAMIAEATAAYRNAEKDL
QRFQALFNDNSASQKELDDMRSRFEMAEARLEAAKQMKNEVGAQFAYTNIRAPFNGIVTG
VFTDEGDLANPGVPLLAIEGPGTFEVTTRVAENDIQKIKKNTKAAIVVKALDTTLSVTVS
EVSSSAAISGGQFVVKVIVDKTIEGLKSGMYATVQFPVEDGLTETPVLIPLEAVVQRGQL
RGVYTVSEQNTALLRWLRLGRSYGDQVEVLSGLESDESFIVSADGKLFNGVKVEIQ
>OMIFANIC_00873 Swarming motility protein SwrC
MKEGLAGKIAKGFIGSKLTVLLMIVFMVIGVYSSFLIPREEEPQIDVPIADIFVGYPGAS
PTEVESRVIKPLEKLISNIKGIEYVYSTSTKEQGMVIVQFYVGEDIERSLVKLYNEINKH
MDLMPEGVTFPLVKTRAIDDVPMLGLTLWSENYDDYQLKQISQELTNEIEKINDVSATQR
IGGRERQLRIVLDRDKMAANGLDFLSIAEMIKSNNQQLQSGTFNTNDEEFSVMTGRFLED
KEDVESLIVGTNENQPIYLKQIAEVIDGPEIPKNYVSLGYGKASELIEDYPSEYPAVTIS
VAKRKGADAMKISDIILEKVAHLRTTLIPDDVHVEVTRNYGETASQKVSELLMHLIGAII
AVTLVVMLAMGWRGGLVVFLSVPITFALTLLSYYILDYTLNRITLFALVFVTGIVVDDSI
IIAENMHRHFKMKQLPFKQAALYAINEVGNPTILATFTVIASVLPMAFVSGLMGPYMSPM
PIGASIAMLLSLFVALTITPYLGVLFLREKDKGDSKSKKHKPLGDTFIYRIYEKLERPLI
ENPKKRWLFLGLTFLLLLGSVGLFFTKSVAVKMLPFDNKNEFQVVIDMPEGTTLERTAVV
AKEISQFIAIQPQVVNYQSYVGTSAPITFNGLVRHYDLRGGSNMADIQVNLTDKHDRSEQ
SHDIAKGFRPGIQEIAAKFGANVKIVEVPPGPPVLSTIVAEIYGPDYGEQIAVADGVRQL
LHNTNDVVDIDWMVEADQKEYGFVIDREKATLYGVSPKQITHSLNMALSERPVTSLYDED
ASNQVGILLALEEKEKSDLLDIKGIMVRSANGNMIPVGDLIEIKEGVIEKSIYRKNQKRV
VYVMADMAGELESPVYAIMGISDELEKIPLPKGYTMDELYIKQPDFEDNYTVKWDGEWQV
TLEVFRDLGIAFAGVIIIIYILIVGWFQNFKAPVVMMVAIPLSLIGIVLGHWLMDAFFTA
TSFIGMIALAGIMVRNSVLLIDFVNLRLAEGIPLKQAVIEAGAVRTTPILLTAGTVVIGA
FVILFDPIFQGLAISLMGGTIVSTVLTLLVVPLVYYLIEKKKHS
>OMIFANIC_00874 hypothetical protein
MKLLIVTSVSEFNTEVRALFRKAEIERYSESDIEGFKNATPFMMRSGWFEGSGQGTESDM
FFSFTEPEKVEVLFGLIEEFNSMLETDNPVKAVVVPVEKFI
>OMIFANIC_00875 Inner membrane protein YgaP
MRERYIRIIAGTLILISIILAATVNINWLWFTAFVGVNLFQSGITKWCLMDDILKKFGVK
>OMIFANIC_00876 Catalase-peroxidase
MDPVYEPISRHFYENPDEFADAFARAWFKLIHRDMGPKDRYLGPEVPQEELIWQDPIPAV
DHELINDGDIAALKANILASGLSVSQLVSTAWASASTFRGSDMRGGANGGRLRLEPQKNW
EVNDPAQLAKVLDTLERIQKEFNDTNSGKKVSMADLIVLGGCAGVEQAAKNGGHNVTVPF
TPGRMDASQEQTDVESFAALEPRADGFRNYVKTKYMASAEDMLVDRAQLLTLTAPEMTVL
YGGLRVMGTNYDHSKHGVFTNKQGSLSNDYFTNLLDFGITWSATDDSQEAFEGRDRKTGE
VAWTGTRCDLIFGSNTELRALAEVYACEDSEKKFVNDFVAAWNKVMNLDRFDLK
>OMIFANIC_00877 hypothetical protein
MELRTDPRVKDVFDSYPELARDRLNHLRDLILATASEIDGIGTLEETLKWGEPSYLAKHS
STIRIDWKEKSPDQYAIYFKCTSKLVPTFKIIHKNKFNYEGNRAIVFSLDDKIPEAALKQ
CIGMALTYHKVKQLPLLGA
>OMIFANIC_00878 hypothetical protein
MSDKSEFVDIYSGSEVRVILLKGLLEKSEIDVVVQNDYQSGITAGFGGGTINTVRLKVHE
SDLEKTKPIVEDFIKNQE
>OMIFANIC_00879 hypothetical protein
MRYFVEHNSIVKKIWGKSDTILFIFAGAAAEFALNKAVDWLYFTGKLPSDPLGRLFSTVR
YAKLIVFAPMDEANQAIDTMDRIHKSVEQSRGSTIPDWAYRDVLFMLIYYSIAAYELLER
KLTDNEKEEVYNVFYRVGVRMGLKELPANYIDWLPVRNDHLVQDLYRSEYTIDLFKQYKK
HLGPVRYKLLKEAQKLVVPKRVKELMHFSSFSLLSPFVPLYKFCRVLKLDSVIKSILLPS
QYKRQINDLDVMRN
>OMIFANIC_00880 hypothetical protein
MINKSFCIHIYLLLFLFIFIAACNGQDKKNKSEETSVGSDTITKDTTSKVIRNSTLDYEN
PFNPPTINDSLFFIEGQLCQHLRKIFQDSRGNLWFGTNVYGLMRYDGKKLEYFSEKDGLG
GGRITGIIEDNTGNLWIGTYSGLTKFDGETFTNFSKQDGLLNTEIWSLLLDSKGMFWIGT
TEGVFRFDGEKFTPFSIPKADVKDAITVYSFNRVSNMMEDKNGLIWFGTDGYGICKYDPS
VALKQSGNSFTHLTKEDGLPGNNISGILEDKNGNIWIGTMFGGVSKFDGKTFTNFTQNGV
VSGIEVGGFFEDSGGYIWFAAENEGVYRYDPEASTRTTGVSFTKFNSKNGLQSKGVLCIY
EDKQGRFWLGGWGGLFRYNPSAALRADGNLFFSVTRNGPWK
>OMIFANIC_00881 hypothetical protein
MKKLVTVMVITGILFSCNSTDKTENKNQESTESETVEIDLATKEENEQFIEIDSDEALIA
TALMAAPEESREGCTVIGYNMAGEFVTLKEGTNEFICLADDPKKIGFSAACYHKDLEPFM
ARGRALKNEGKTGGEIFDIREEEVKSGKLSMGKPGATLHIYFGAKSLYNPETSVVAGAQY
RYVVYMPFATSESTGLPENPIAPNHPWIMNPGTHRAHIMISPKKDSEE
>OMIFANIC_00882 hypothetical protein
MRPETDIADSEYEAILKVGKIDQAQVHRIRVEQAENFDFKLNNYCAIIAGGSPFDVSCPE
ENKGEMQNRVESFFNSLFNQIIPIDFPFLGACSGNGLLGSYCGTTISGKYSEPVGAVTVT
VTKEGAEDPILNGLPQKFSALVGHKEACDELPQNAVLLASSELCPIQMFRIKNNIYATQF
HPEADAEEFILRISAYKDHGYFPPEDADTLVSSLKDIQTPVAEKILNRFVDRYSNH
>OMIFANIC_00883 hypothetical protein
MLKEIIENCPKEVDLTNDTHSELIIQTTTSILDEGYSISEIEQIEEHLINENDRSHIFIL
LCLKIAKSKILASRVNTPLFISVVFAVYKEHNRIKKSSEHPHGEDFLIKKIKQLEWLFED
QQHVNWELIIVDDGCPENSGKIAQHIIDANQLNDKARVLFLSEAIKRNDPPVRSIRSTNE
SQKGGSIVYGMWDAVQQKRSKDQIVIYTDADLSTHLGQLMLLVDPLLNQNKWVAIGSRRE
PDSVVIKKGSRNDRGKLFIYLWKRLIPNLGDIIDTQCGFKAFRAEIIPEIIDRLIEKKFA
FDIELLLRAELLKNGAICKVGVAWIDSEEASTTTDLQPYLPMLKSIVKMYRQYFSRDPIS
DEFADFIESLSEKEFKSILNNIPQKITKREPDEFTKYDEVRVADFMKY
>OMIFANIC_00884 hypothetical protein
MKTMTCRQLGGACDLEFHANSFEEISEMSKQHGMEMFQKNDEAHLEAMNKMRELMQSADS
DAMKNWMKNKREEFDALPDN
>OMIFANIC_00885 hypothetical protein
MINFFRKIRQKLLSENKFSKYLIYALGEILLVVVGILIALQVNNWNIAKKDRIREVKYLK
NIELDLHKDLKSLSYNLDFRRKKYIGTNKLIDQINGMPIEDVTELSYNVLNTLMAERFTP
NNATYTELSNSGNLNLISNDSIKILLLELEELYKTNNFGIDHETFDYREYISKPLLKYID
TDQLIPVFKGEKTITEQNITKDNFSDLFQSLDYKNGLIITNWITQDFIALYESIDSKSKK
IIDMLRVEIENNKNKPL
>OMIFANIC_00886 hypothetical protein
MKTRLACSLLMIFGIVSTTCLAQRDLINDEFPEAKQEIMQTFGAIAQSIKDGDIEKLISY
HAYSPKFTEFKNGELRNDGTANETHERNVFGSVTEVVKFDAKDLQIAVYGEVANVTFHSD
FHLKFGEDLVVVNDQITLLFVKTKDGWKMVHEHHSPLSKS
>OMIFANIC_00887 Putative malate transporter YflS
MKEPSNNYWKIRWIKRIITLVIGIIIWHLPIPWDLSPASWYLFTIFITAILGVLIDALSI
FTASVLALVAAVILGVLTPEKAFSGFSESFILLILAAFLVAKGVIKSGLGRRIAFLLIRR
FGKSTLNLGYCIVATDTLLGPAIPSNTARSGILYPITQALSLDTGSHPTPESRKKTGSYL
MMTAISGHTISSALWFTGMAANPVGAGIAAQFGVNMNFGNWVFVASVPCLLALIAIPFVL
YKLFPPENKHTPEAPEMAGKALHEMGPMSKQEWIMGITFFGMILLWAFSPILNLNLAIVA
FLGLSILILSNVYTLEDIRQGAGDALETYVWFAILYMMSTALNEMGFMKTLGAQIATYIS
DFNWITVYILLTILYVIIHYLFVSQTAQLLALYAVFLQVAVNAEVPAALMAFMLSFATNY
FAVITPQASSSNVLFAGSGYLSSKDIYKQGAVITILNTAIFLLATPWIIWSSSL
>OMIFANIC_00888 hypothetical protein
MKEFKMMSPKWILLMVTVIIISCNSVEKESELNVSEATVVLVKYKAQPEKGSEAVSELTR
LIEKVELEPNFLNLKLHVDPADETNILLYEVWSDVDYYNSAHMNTAHLKEFIENSRNFLA
GPPEISFWNVENEFKPSK
>OMIFANIC_00889 hypothetical protein
MIKFFRHIRQRLLSENKLSKYFLYAIGEIMLVVIGILIALQINNKNEARKDRAIEVNYLK
NLKADLLIELENNEGFSVYRFEKSRSCTNLLNMAIPKTVEDVKEYTDVYEKVFIWHSFVP
NNNTFKELLGSGNLSLIKNDSIKNALLELDNFYADISGGEYHMRREYEKFLYDRSVENTL
SLAFFNDSEPKYGFPDRLKIEDIPKSKHEQLITDAQWLYEDQTFNNGIRLAMMNNGFLAD
IHRNMNQNIQKLLELIDEEINK
>OMIFANIC_00890 hypothetical protein
MRKRIKKILASIGLLNIAKKIRYRIYQHKKQWQLNFGDLNVIYDTTDSYSNRWFYPRYAH
GGIHEPGATKIFMDNIEKHSKILDIGGHLGYFTCIAGKLAAKGSVYVFEVDPKCLHLINK
NLRANNLTNVVVNNLAVSDKNETIKIQQYESPNPGLVINNNSGDNFIEVKSIRIDDFISQ
NNIKPDFIKIDVEGAEWNVLNGMKHFLAQDNNVVLLIEIHTKHLRQYFNADYSDCIDLLL
KNGFRLKKVDHRLADGSFLNVDRKTILEGNTMLLCEKHNQTMIRPTSNE
>OMIFANIC_00891 hypothetical protein
MIKFFRKIRQRLLTENKFSKYLLYAFGEIILVVIGILIALWVNKWNQENNEHRIGEDLLT
RIHRDLVQDTINFRSVIVRNEALREDLKELLADLYDGVDNMEEVQDMSKTWDQMLDQAFS
PNDNTYQSMLSSGTLGLIQNPELKEEIVDLYSEYDQSRALLLSIGEWMIGIASTMDSETD
FIKFGSDVSDIFKTQEMLNENDFAFLNEKDSPKFKLFIRAMSSVAFYQKVNNTYRSALIK
KCDTVLKSINKELNK
>OMIFANIC_00892 hypothetical protein
MNNIRHIHEVIFLIEKNNEQWTAEQLTEAISTAWGADIHFASCSGNAFPKEYALDFLINR
QKAALTEAGKVVLHPSMQICDGHQDFQGK
>OMIFANIC_00893 hypothetical protein
MNKRISRHIAYWILILLFLTLFFGYKWDNHILAFYFSSLLLPIAIGTSYFFNLYLVPNYL
LTGKYWNFTLYFIYMLVVSLYLEMLVSLLSFVLIANYKVDVMGLESISIFILGVNLYLIV
FVTSFIRIVLQFREKSQMVNSLRSELEKKQKDRIQIRANRKNHHIPLDELLYIESLDDYV
KLVLIKSEITTREKITKLHSKLPDKFLRIHRSFVVNKEKVQSYSKSQVMINDLSIPIGRT
YKKSAVEALHGHKPGRE
>OMIFANIC_00894 hypothetical protein
MLDLFYEGGPLFMGLLTIILIIMFVVSVMNGIPVLKGNITDHDTIRRKIGTIKSVGLLAL
IMGILGQLIGLFSAFRAIELKAIEVSPSLIAGGFKVSMITTMYGLIIYILSLLIWFGFNM
KLEKK
>OMIFANIC_00895 hypothetical protein
MNIHIETDRLILRDMEEYDVEGIFALDSDPDVHEYLGKNPITTMKQAREVIDYVRNQYKK
HGIGRWAVIDKKTNDFIGWSGLKFETTVREEFDYYDLGYRFRKKYWGKGIATETAIASLK
YGFEKLKLDEISGAADVDNLASNKILQKVGLKYVETFNYEGIPHHWYTLKRSEWLEINSH
H
>OMIFANIC_00896 Dipeptidyl carboxypeptidase
MTKFHGSIRLTLLLAAVILIVSCKQEKDEPMAMVDNVLLKEWDGPYGGVPDFNQMKVEDV
KEAMLQGMELNLKDIDAIANNEDAPTFENTIEAMERAGEELDRGFTYYGILRSNMSTPEF
REIQTELAPLFSEFRSKITQNEKLFQRIKAVYDASLENPLPADQQRVVHLTYQSFAMNGA
ELDADKKERYAAINKELSSLYTKFSNNVLHDEENYVTYLNKDQLGGLSEGYIKSAARTAS
EKGQEGKYAVTNTRSSMDPFLTYSTERELRKQVWTNYYSRGDNGDEYDNNELIAEILKLR
RERVQLLGHKNYAEWRLQDRMAKTPENAMELMEAVWPAAIARVAEEVADMQAVADASGDN
ITIEPWDYRFYAEKVRKEKYDLNSDEVKQYLQLDKLTEAMHYVAGRLFNFNFTPVPEGSV
PVYHEDVKVWEVTDRTSGENIGLWYLDPYAREGKRSGAWANTFRSHSTFDGKKNVLGTNN
SNFVKPAPGEALLVSWDDATTFFHEFGHALHYFSSNVRYPTLNGGVRDYTEFQSQLLERW
LSTDEVINTYLVHNETGEPIPAELVTKIKNAATFNQGFATTEYLASALMDMKLHLADPAG
IDVDKFERETLAALNMPKELPMRHRTPHFGHVFSGEGYATAYYGYMWADVLTADASEAFA
EAPGGFYDEEMADKLVKYLFAPRNSMDPAEAYKLFRGRDAKIEALMRDRGFPVTSE
>OMIFANIC_00897 hypothetical protein
MDKALQTMIDNMPEKTGKALEEWFEILKDKSFAKHSEAVKFLKTEHQVTHGFANTIVSLS
KAQNSPEVDLVSEQYKGKEALYPIYKKLVAFVNTLGKDVTISPKKSSVSIIRKRQFVLIK
PATKTRIDLGFKLKDKPTTARLGGSGPFGSMCTHRVQLHDVNDVDDELKSWINEAYEKSV
>OMIFANIC_00898 Thermostable beta-glucosidase B
MSCRIAAIVLFLMSTTLLMAQSTIEQEIDALLAKMTLEEKIGQMNLYSGFYDATGPAPQG
GSAATKYEHLKKGWVGSMLNVRGAEETRKLQEIVVNESRLGIPLIFGLDVIHGQKTLAPV
PLAEAASWDMELVKKSAAIAANEAAAEGVHWTFAPMVDISYDPRWGRVMEGGGEDPYLGA
KIATARVKGFQGDDLSSTSTIAACAKHFAGYGFAEAGRDYNTVDIGTYTLYNRVFPPFKA
AVDAGVRTFMNGFHLLNGTPVTGSAKLQREILKGKWGFDGFVVSDWGSVAEMIAHGHAKD
STHAAQIGVKAGSDMDMASGSYLKNLVGLVKDGKIDEANIDEAVRRILKVKMELGLFEDP
YKYSNLEREKERIYHPDHQAGVLEMAKKSIVLLKNEGNLLPLSKDQKGIVVIGDLADDKD
SPLGSWRLASENNTAVSVLEGMDAITKEYQYVQGPKVFLEASFLQHVKINETDTNGIKEA
VEAAKNAEVVVMVLGEHGFMSGESRSRTNIDLPGLQLKLLKEVYEVNQNVVLVLMNGRPL
ALPWEAENIPSILETWQLGSQSGNAIAQVLFGDENPSGKLPMTFPRSVGQVPIYYNAYST
GRPVNKEGNVFWSHYADEENSPLYAFGHGLSYTTFDFSNLNINANDPKNIRVSVTITNSG
ARAGEEVVQLYLHDPVSTLVRPVKELKGFRKIALEPGDSQTISFSLTDKELGVYNRDYEW
VVEAGEFRVMVGGSSEKGLTGSFEVR
>OMIFANIC_00899 Beta-1,3-xylanase TXYA
MNNSPLIILTAILFLVNLVVAQKFEPEDGKCLVFIGQDLEATGGLDGYNSGYTDYFRTPA
GITAHTNLSPGNESYGYYNKGLDGIRTKANWGAGDSCADFYLQDSTYQNSAIAIGLSFVN
NEKNVAKGKHDHLIKELAHWIKSAQRPVFLRIGYEFDGWDWNHYKKKHYLKSWQRIHSIF
KDLQVENVAFVWQSKGTGSNQEVLEEWYPGDDLVDWVGYSYFGNPDQEMLIFARKHNKPV
IIAEATPVREIENLYFDSDVKKEKLEKIIWEEWFVPFFNTIKNNSDVIKAFSYINSDWSS
QPMWINNPVFQKVDSRIQKSKYISEKWQKEMEDLRYLNASDNFWN
>OMIFANIC_00900 hypothetical protein
MEKTNVLVKTFFLSLVLTLFFGCKGDNEKNKTARESTDDWQMDFFDDFDTFNEDNWQDQM
IWVNNEDQCYVPDGQFNTREVSNGTLKLRVVDLGEKRPCDNLDVKTGAQHPETQYVAGRI
ISKNRKEFIKGKWTVRLKVENSGQPGMFPAWWLLGALNNEPPVEDEDETVCWPLTGSGEI
DVFEHHSDGGPDHYAARAIVSLGECQSGDWQGKMLVQEATLDEYHDYSVEWDGNDLVFRL
DETEVYRAEDQGGNYPEPLFAILNFAKINDSPMTQTWEMEVDWIKHEYRK
>OMIFANIC_00901 hypothetical protein
MKTIATYIVVALVMQPLFLMYCQNNTDDIIKAYDLRMDGRTEEAITVLSEIIDSDPSNAM
AHFELARSLENDKKNDHIIMALDYDPENLAYKFYQANLQMLEAYKGMKTNNKELITNNLD
LCKETLKSILAIKPDCKESLFFLIDIYGSIPEDMGGNIDMAEKYLKTLKDVDPLYAAHGE
LILKFKDGDVDMVKYWKDYIATIDDSNEAHIKLGKAYLMNNDMEKAKECFNTVMKSDPNQ
TILHLDVARAHLYTAMRGGDKSDEALQKFKENIQLYIDAEIKKPKLIEAWCYGWLGMVES
RQGNKELADMYAAKAEKLIPNYPRFTAIPSIDAPPNVKTYKYKSYFSPF
>OMIFANIC_00902 hypothetical protein
MHLHALENDPEYIELQTEMVRMQNWLIETNNRLIIICEGRDSAGKGGAIMRFIRYINPRH
YRVIALNKPTQPERGQWYFQRYIQHFPSPGEIVFFDRSWYNRAVVEPVMGFCTKEQYDNF
IKQVVQFENMIVEDGILLFKLWFSIDKDEQKIRLEERKVNPLINWKLSTVDMQAQMKWDE
FTKYKELMFQKTASKTSPWIIINGNNKDLARKEAMRFVLRNINYSQKALTKAKLDYDPEI
VQIKS
>OMIFANIC_00903 Bleomycin resistance protein
MLTDINPKLPMRDKSVTREYYSNRLGFKEFGSVDFDGYLMMEKDQIQIHFFEFKELKPKK
NYGQVYIRTDNIDEFYKSLLETQTEIHPQGKLENKPWGQKEFSILDPDNNLLTFGQNI
>OMIFANIC_00904 hypothetical protein
MLLFSIVLNLKSNRFYKMKTVILITIITLTFIGCKENQSQKQSSNEITEPKGIENVAYKW
GEMALTATANDTERFQPRPTVTSRYLGLIFVAVFDAWSRYDEKAIPVYLNDVERRPEKER
SLKNKEIAVSYAAFRAMNEYYYSDKKIFEDFMRELGLDPNNESLDPNTPEGIGNLAAKAV
IEARKGDGANQYGEEEGSNGEPYFNYVGYEPVNSADKNVDPNRWQPKYFSDGKGGKFAPG
CLTPYWDKVKPIALKSGDQFRPGPPPMIGSEQLEQEVQEVIEMQAKLTDYQKALVEFMRD
GPQSVQQAGHWLKFAQDVSRRDNHTLDQDVKMYFYNQVVAMDAFIASWDSKMFYDYARPY
ALVHEYYDNQKIKAWGGEGKGMVEMDGKQWRPYSPETFLCPPFPSYVSGHSTISGGCAEA
LKIWTGSDKFGSDAQLVAGAMTEPDNLGDTITLEFPTFTETAEMAGISRVLGGYHIQADN
VAGLELGRDVAKEVWKFYKKHVGEE
>OMIFANIC_00905 hypothetical protein
MQKKYSIKFLITASLAFFLSSYVLNAQSCNSELRVVKNRNARSAMENDPTRFQMELTNNS
SSSQTYEIQYKVFEDPCEVVGASNSSNRSTDLNVAIYSRKVRTNSITVPARSKQTFLAEV
SVNIGSKLNAWKCVRLTAVSNACSEQETQQLLKVYVSDPTEH
>OMIFANIC_00906 Peptide chain release factor 3
MSLAKEIARRKTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEIE
RQRGISVATSVLAFEYKDIKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQT
EKLVEVCRMRNIPMIVFINKLDREGKDAFELLDEIEQKLHLKVTPLSFPIGMGYDFKGIY
NVWEKNVNLFSGDSRKNIEETIEIEDLASPELEELIGPEVAETLREELELVHEVYPDFDR
AEYLEGHLQPVFFGSALNNFGVRELLDCFIEIAPAPRPKASDTRLVEPGEKDFSGFVFKI
HANMDPKHRDRLAFVKIVSGTFERNTPYLHVRNGKKMKFSSPNAFFAEKKQIVDISYPGD
IVGLHDTGNFKIGDTLTEGEIMQYKGIPSFSPEHFKYINNADPMKSKQLEKGIDQLMDEG
VAQLFTLELNGRKVIGTVGALQFEVIQYRLEHEYGATCRYENLNVHKACWVEPEDENSEE
FNEFKRVKAKFLAKDKRGQLVFFADSAFTLQMTQSKFPSVKLHFVSEFETAE
>OMIFANIC_00907 hypothetical protein
MKKIITLCIVCLATISTGWAQGVGIGTTNPQEALHIAGNNSTVRLEGLNNINNPKNKGGA
DLYNVVVDSNGNLTLLDISGEMSSEATVSSPVVLQTMADSGKNSNELYTKTFTLTQRAYV
VVTYYISMEFESYDGSAKIVDGRTKIANNYWYLGNGLAPDTSKKYGMTTTVYTNANCDTA
SGYIYNSRTVTMPLDAGTYSVHLNGEVYGGGMTADAAFRVTFGDYDRLDLSVIYL
>OMIFANIC_00908 hypothetical protein
MKKIVTLCLLCATTVFSWAQVGIGTTNPQEALHIAGNDGSIRIDGLNSSNNTKNMGGTDM
YNVVVDADGNLALADVSGELSSEASMVSPVVIQTAANSGMNSNELYSKTFTLTQRALVVV
TYHISMEFENYDGSDKVDDGRAKIAHNYWYLGDGTSPDTSKSYGMTSSVYFSSSTDTASG
YIYNSRSVTIPLDAGTYSIHLNGAVYGGGLTSDAAFRVTFGDLDRLDINAIYL
>OMIFANIC_00909 hypothetical protein
MKFYAPQFQRVTSLWMFTVLALYFFSIKSIAQTQKPSVQSGVTFSWSDTQIADSDPATIS
AITINGTIYSNFAAPSTYALTRLGPDGHHENNIILNGVNVNTNSSDPNWNSDAIAAFQDK
NLNHYFHSNDNGRDICGDFVTAGTTDAQIQSLYYSPGIPSNDGGILAISERNANNCYYVA
VYGTPVGGGPDQFLGDTFVRNNSTQWGPLFSAPPFGVDYWNSGRVVENGGTLGIAIFVLD
DLAPVGSVITRVDLMASTQDHGDGKVFIAQRYAKPKTETSCMDQEFNGTVDNGSAPVGST
YSLLSGPTPAGESFTFNSDGSYSYTPSAGYLGDVTFDYEVCLPAPNSGICDSATLTINYV
TYPNNGCPCNSGGADAPLLQNN
>OMIFANIC_00910 hypothetical protein
MRFKELFILLLFVSGSIDMTSQVGINTTNPQEELHVAGATANARVDGLNATNNAENLGAG
LTTRVYVDADGDLVLGDSGSTIEILVDSENYLEDVENSTNIINQVGTSIGYNTAGTPANI
PAATFTLTKNAILEINYSVSYSVYKTSNPNGRIDDRHARIVQTALFFRQNTIAGPAVVND
VDGNPINGGPWCIDVNPAGTVCLETGGMIGLNGQFYTNGNGSRGAYQNFRNTGTDYVKLG
PGTYVAMFAGQLAVGNVGGTGAVKMYLGSGDDDLQIIAYYYE
>OMIFANIC_00911 hypothetical protein
MIKYIITISFTFFVMLGYAQVGIGTLNPQEDLHIAGASATIRIESLNSINNPTYNDGIKL
SPAYVDGNGTITIGNGTGPGGQLPLNFLIEVPDFIPNDPYGFGNTGTSVFNDNTQTSVDG
QVTTVTFTAPQEAIVEIKYGITLFITSSDLSMAPPYFYVTYDQAVSVMTYFKVDLNNDGL
SGVELTKDYGQKAQSYTTFDQGTAGYPYMNGQAYLKVPAGTHTLYFYGRVNDALTFNTGV
GFGGAQDYLKIRVYN
>OMIFANIC_00912 hypothetical protein
MEMKVWFILILISGYGLSAQVGINTTNPQQALHISGSSETVRIESLNSTNNSYNGGDVNG
DLDLTNDTFPLYVDENGNFTLELKTYVSSEDLDAFDDTALPTSAVELLSTNGAGEISTTI
KTYSITVTRASILEVKYSLSFDVYLNSSKTVITDNLARLIETHIEVTGQTRHYGPSNKCY
TSGTLNSVTGTMFNSNTAYITLPSAGSYDISFIGRVLSDVKGGGPGDPAQQTYVEFATGN
DFVFMRLH
>OMIFANIC_00913 hypothetical protein
MAKENKPKQGQINIELDAEVAQGIYSNLAIINHSQSEFVIDFVTIMPGVPKSKVKSRIVL
TPQHAKRFLKALNDNLQRFENAHGEIKDYQQPPMPINFGPTGEA
>OMIFANIC_00914 DNA-directed RNA polymerase subunit beta'
MARNKENTAQKFNKISIGLASPESILAESRGEVLKPETINYRTHKPERDGLFCERIFGPV
KDYECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPVAHIWYFRSLPNKIG
YLLGLPSKKLDMIIYYERYVVIQPGIATNEEGEPVQKMDFLTEEEYLNILDSLPQENLYL
EDSDPNKFIAKMGAECLIDLLNRIDLDTLSFELRHKANNETSKQRKTEALKRLQVVEALR
DANKNRENRPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLME
IKAPEVILRNEKRMLQESVDSLFDNTRKSSAVKTDSNRPLKSLSDSLKGKQGRFRQNLLG
KRVDYSARSVIVVGPELKLYECGLPKDMAAELYKPFVIRKLIERGIVKTVKSAKKIIDKK
EPVVWDILENVLKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFNADFDGD
QMAVHLPLGPEAILESQLLMLASHNILNPANGSPVAVPSQDMVLGLYYMTKLRKSTDDEQ
VLGEGLTFYSPEEAFIAYNEKKVDLNAEIKVRTKDFNEEGELVNQIITTTIGRVIFNDKV
PEEAGYINEVLTKKSLRDIIGDILKVTSVPTTAEFLDEIKDLGYKFAFEGGLSFSLGDII
IPAEKQTMIDSANSQVDGIIANYNMGLITNNERYNQVIDIWTATNAELTELSMKRIREDQ
QGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSSSGGGEIIENPILSNFKEGLSIL
EYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIINEEDCGTLRGIEVSALKKNEE
IVETLKERIVGRTALNDVVHPLTKETLVASGDHISEEIAEAISTSPIEMIEVRSALTCEA
KKGICSQCYGRNLATNKMVQRGEAVGVVAAQSIGEPGTQLTLRTFHVGGIAGNISEENKL
VTKFAGKAEIEDLKTVKGEDSEGKTVDIVISRTSEIKLIDEKTGITLSTNNIPYGSSIYV
KKGQKLKEGTVVCQWDPYNGVIISEFAGKIKYENIEQGITYQVEIDEQTGFQEKVISESR
DKKKIPTLHILGKKDEVIRSYNLPVGAHLMVDDGDKIKIGKILVKIPRKSAKAGDITGGL
PRVTELFEARNPSNPAVVSEIDGVVSFGKIKRGNREIIIESKLGEIKKYLVKLSNQILVQ
ENDYVRAGMPLSDGSITPEDILRIKGPSAVQQYLVNEVQEVYRLQGVKINDKHFEVVVRQ
MMRKVRIVDSGDTTFLENQLAHKYDFIEENDKIFGMKVVENAGDSEHLKEGQIITPRELR
DENSILKRADKAIADARDAVPATATPILQGITRASLQTKSFISAASFQETTKVLNEAAVS
GKVDTLEGLKENVIVGHRIPAGTGMRNYDTIIVGSKEELEEMTREKQEVNYN
>OMIFANIC_00915 DNA-directed RNA polymerase subunit beta
MNFSSVQNKPEYPDFLDIQIKSFQDFFQLETKSEERGNEGLYKTFLENFPITDTRNQFVL
EFLDYFVDPPRYSIQECIERGLTYSVPLKARLKLYCTDEEHEDFETIVQDVYLGTIPYMT
PSGTFCINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEFATDINSVM
YAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEVKATKTGLKKFMGRKLAARVLKTW
HEDFVDEDTGEVVSIERNEIILDRDTVLEKEHIEEILESGSKTILLHKEDNLLADYAIIH
NTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIINKLFFSDQRYNLGEVGRYRMNKK
LGLDIEMDKQVLTKEDIITIVKYLIELINSKAEIDDIDHLSNRRVRTVGEQLSSQFGVGL
ARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNPLAEITHKR
RLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLSVYAKVNNLGFIE
TPYRKVENGKIDLKNEPIYLSAEEEEEKLIAQANIPLKKDGKIDSDRVIARMEGDFPVVE
PSTVNYADVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLRAQSPIVGTGLER
QVASDSRVLINAEGDGVVEYVDANEIVIKYDRTDDERLVSFDGDSKTYNLIKFRKTNQST
SINLKPIVKKGDRVTKGQVLCQGYATEDGELALGRNMKVAFMPWKGYNFEDAIVISEKVV
REDIFTSIHIDEYSLEVRDTKLGNEELTNDIPNVSEEATKDLDEHGMIRIGAEVKPGDIL
IGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLRGVVIDKKLFARAIKDKRK
RAKDKEDIAELEAKYDAKFDSLKDVLVEKLFAIVGGKTAQGVMNDLGEVVFPKGKKYTLK
MLNAVDDYTHLTGGTWTTDDATNHMVKDLMHNYKIKENDLQGNLRREKFTISVGDELPSG
ILKLAKVYIAKKRKLKVGDKMAGRHGNKGIVARIVREEDMPFLEDGTPVDIVLNPLGVPS
RMNIGQIYETVLGWAGQKLDRKYATPIFDGATLDQINELTDEAGIPRFGHTYLYDGGTGQ
RFDQPATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQRFGEMEVWALE
AYGASSTLREILTVKSDDVIGRAKTYESIVKGEAMPDPGLPESFNVLMHELKGLGLDIRL
EE
>OMIFANIC_00916 hypothetical protein
MDTHQKGNSRRTFFQQLILGSAGLYLFPYLQSCDNGKYPDMIKGSGNPPFNVWEEMIYAL
ENSPDHYLARRDNLVSAGDINAMRDFVVNDIGLLPSDKGYFRSIAAGLLYGPDAALRCGL
ATPREKAEILSKMLQEAGVEARVVLETVDMSEEEVKSILFNPGKAAFEPAAKDSDLKRWK
KELGSNPENGTVVVMESPVEKATIFADGLLEKLDDKYKQVETESKFYFSNSGVPTVLYME
EGVEKYAHLFDPSVPLGSLHPSNKDNYTKDAKPLRSIEEEVSVTIKSTNAFDGTKEIELI
KGSWKASDLVGNQVKVSFLNNMTFEDQAVKSVSDISTFTPCLALQAIHKDRKYMEERSFL
GEPITLEGEKVFSEFGLQSKGDEQQGDIRDVVSLEIKAFPKTYPKVRLEIFPKDNEGKIV
EGIKAGNFTIRDNNKLVTGLLRQNIVAPRIMLLYDTSLSMPNQYRDEGIVAFLEETQTAI
RETYPHARIKLQETGSRIYTAHLKAAQTESDLILYATDGHNSDSFNPDDKPIFESGPPTL
YLYTRDTDKYIQAIADNTGGMIIPAEDQQATILQIRETINSLEFPPYVFNYNSVEIDKDH
LVEVSAKKNVLSASANFRFASKSSNAVGKRLTGIYMDIKIGNRSPIRRVLAGWDNYLDSY
ADPTPEMANAVHELLLGGVVIAFEREGASESIRLSEYLKTLMSNKAWFEAVQAGDNAMAL
EKLSQGTFDYPAILLNTMQPIKNNISKESITYPSGYRVGIIKFKPAYFSEASEVTFDYLP
TSEYKSLTPSGRNAFIETTRKTAQLALLEEEIFDKTAMSELKNSKLVLNQDVSREEEYSS
RVLAESYRYFREKVFRGGVLKLFDASAVIKSFWRIDPKTGELYGVLPDGTGGGGNSHYEQ
LQHLQAVVDEYEKVVARMNLGMGIAGVGGLAVGIVATYSLTLVRLYAFASEAIILMDASN
LDDQIAQALQELACNVYKEILYATLGPVGEGMNGIENLIGSIGGDFSFVSC
>OMIFANIC_00917 Chaperone protein ClpB 1
MNLNNFTIKSQEALQQAQQLAQSLEHQQIENEHLLKAIFEIDENVTPFILKKLNVNLSLL
QQVLEKHLESLPKVSGGDIMFSREAGKTVNEASIIAKKMNDEYVSIEHLLIAIFKSKSTV
AQSLKDQGVNEKGIRAAIDELRKGDRVTSASAEDTYNSLNKYARNLNQLAIDGKLDPVIG
RDEEIRRILQILTRRTKNNPMLVGEPGTGKTAIAEGLAHRIVDGDIPENLRSKEIFSLDM
GALIAGAKYKGEFEERLKAVIKEVTGSDGNIVLFIDEIHTLVGAGGGQGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVMVNEPDTESAISILRGIKEKYETHHK
VRIKDEAIIAAVELSQRYITNRFLPDKAIDLMDEAAARLRMEINSKPEELDVLDRKIMQL
EIEIEAIKREKDEAKLKTLRSELANLKEERNELNAKWKSEKEVVDNIQNAKKEIEEFKLE
AERAEREGNFGKVAELRYGKIKETQERLNELENQLAQYPEGTSMIKEEVTNDDIAEVVAK
WTGIPVTKMLKSEREKLLQLESELHKRVVGQEEAIVAVSDAIRRSRAGLQDAKKPIGSFL
FLGTTGVGKTELAKALAEYLFDDENAMTRIDMSEYQERHSVSRLVGAPPGYIGYDEGGQL
TEAVRRKPYSVVLLDEIEKAHQDTFNILLQVLDEGRLTDNKGRVADFKNTIIIMTSNMGS
HIIQEQFENLKDLDTAMETAKVEVLGLLRQSVRPEFLNRIDDIIMFTPLNKQDIKEIVGL
QLKGVTKMLSKQGVTMDATDEAIAYLAEKGYDPQYGARPVKRVIQKEVLNELSKEILAGK
VKTDSIILIDSFDDNLVFRNQNDLVKS
>OMIFANIC_00918 hypothetical protein
MGLFGLFGSKEPSEKKEKKEIPWDRLTRIEQLDEIVEISKSVPVAIFKHSTSCGISRMAL
RQFEGSYDLEANQMRLFYLDLLSYREVSNEVSIRFQVIHQSPQLIVIKNGIAVHSASHHG
IMTSRLQDFI
>OMIFANIC_00919 hypothetical protein
MRTTITLILATLLLGGCNSVKRNQKFLARGNYDQAIGLAIKKLQKDKNLARNEEHIILLE
EAFKKAVAEDQRRINFLKKENNLESKRNLYYKYVGLERRQQHIRPLLPLYIASEGRNARF
KIKDYTNETLAAKKVLGDALWSLSVQYLDNNNKMQARNAFNLLNELQDLRGSDTGLTSMI
EDAIYIGTDFVFVTLNNRSGQIIPRELERELLDFNTYGLDDFWTEYHDERSQGIDYDYGI
ALNFRQIDFSPERISEREERRTKRIKDGWEYKRDKDGKIINDREGNPVKIDIYRTVSAVL
TITEQFKAATVGGNVVYRDMNQGRDINKFPLGTEFIFENIFATFRGDERALSDDDLVLTE
NRFVPFPNNAQLLLDASDDIKGRLKDILRNNKI
>OMIFANIC_00920 hypothetical protein
MPLSANNTDRHSWLKVPENSDFPIQNIPFGVFLTRDDIITIGTRIGDTAIDLGALHQLGY
FKGIDLTDDIFLQDTLNDFIADGRKTWRLVRNRVSEIFMIDNPALRDHEEHKKRVLFAMD
EIEMQLPVDVGDYTDFYASKEHATNVGSLFRDPENALLPNWLHIPIGYHGRSSSIIPSGT
AIHRPVGQTKPGDDGIPGFGPSKLLDFELEMAFITTASNKLGKRIPIDEAEDYIFGLVLF
NDWSARDIQAWEYVPLGPFLGKNFASTISPWIVTLDALEPFRVSGPEQQPKPLPYLQQRG
NKNFDIKLQAVIQPEGKEESVVCNSNFKFMYWSMAQQLTHHTVNGCNLRSGDMMGSGTIS
GPTKDSYGSMLELSWRGQNPVSLSDGSTRKFIEDGDTVILRGYCKNDEVRIGFGDCSGKV
LPSNTL
>OMIFANIC_00921 Serine hydroxymethyltransferase
MIARDEQIFELIEAEKQRQLNGLELIASENFVSDQVMEATGSVLTNKYAEGYPGKRYYGG
CEVVDEVESIAIERAKTLFGAEYANVQPHSGSQANTAVFAACMNPGDKFLGFDLAHGGHL
THGSSVNFSGKLYDPVFYGVEEETGRLDYDKIEAIAVAEKPKMIIAGASAYSREIDYKRF
REIADKVGAILLADIAHPAGLIAKGIISDPIPHCHVVTTTTHKTLRGPRGGLILMGKDFE
NPFGITLRSGKLRMMSSLLDSGIFPGNQGGPLEHVIAAKAIGFGEALTDDFLHYMVQVKK
NAAVMAQAFVEKDYKIISGGTDNHMMLIDLRNKNITGKEAEEALGKADITVNKNMVPFDD
KSPFVTSGIRIGTAAITTRGMMENEMAQIVELIDEVIMNFEDEARLETIAVKVNAMMEGR
PLFQA
>OMIFANIC_00922 hypothetical protein
MKALAFILVLAFTSPQGHSIDFGTDTGGNDWQVVNDDVMGGRSTSTAYLKDSGLYFSGYV
SLENNGGFASVRSPYQNMDLSPYKTVTIRHRGSSRKFALSFDRHTVWYKPNYKHEFVPSE
EWQETTIALKDFKESQVGRYNGETMSEDTQAKIIRMGIILYDKKAGPFTLEVDYIRFD
>OMIFANIC_00923 hypothetical protein
MKGSIHSVKALECLPQTGVGIIYSPAIAAIDFPMGLIDTLEIEPQTLCIRNSNDVLQIPS
NVFEDIMALPYNKLVHSIGAPVGGTLPPKQDQLDLIKYSSELFNSPWVTEHLSFNATTEF
NTGFFLPPLQTEKGLEATIRNVRILQEKIGRPIAVETGVNYLKPNNMEMNDGAFVSALAK
ATNCGILLDIHNLFANQLNGRQSIVDFLKEIPLDQVVEMHIAGGTELNGLWMDSHSGPID
KRLLALTSEVLPDLSNLKAITYEIFDSYIPVVGDALIISEMETVRDLWEGRKIHYKAVNN
EQLPKSVYNVQKLNREFEPNEWETLLSKEVIGRSHESEGDTQQERFEIYKKLIKEFRASM
VARIFKLTTRYMMLVLGPDVFTTILQHFWQNYPPEQLSYKEAKNFADYLQKKDYKLPWLD
RLLRYEVAVLDTLMDEQLRIVEFDADPTPMFNALSQGKLPETIGALGEYEVEITPEMSNT
DWLVLEN
>OMIFANIC_00924 hypothetical protein
MKSRQRKGSGAVRLSIPAKVAYNAEAFQRSIYDLLDELGCPKCFSGVDCYFTTIRDYVLD
PKEQSIQPLAFGDPTPQPSKLAATSTLSVGVSKDASYDIGKIDLAIKDIFEEIGCLACCS
GHDIFFQNQFDFNF
>OMIFANIC_00925 hypothetical protein
MSILTTDRLQIRPYTLGDAAFVLELLNSPEWMANIGDRGIKTLTDAENYIETKYLPQYSE
YGYGAYVTEKIGTDEIVGTCGIYNRPDLDHPDIGFALLPQYAKQGYAFEAAYAVKEYAKN
TLKFETLYGITLPSNTNSIRLLEKLGFNNIDRIRIEGDPEELLLFSISF
>OMIFANIC_00926 hypothetical protein
MKYLYGIAVLACVILWSSCRNDFETVASTGNLEFSRDTVYLDTVFTNIGSSTYNLKVYNR
SDDDINIPTITLGDGEASSYRLNVDGIPGKSFENITILAKDSIFVFIETTIDINNFPNPD
NAFLYTDEILFDTGGNQQDVDLVTLVQDAVFLFPERSADGTVETLNLGVDDEGNDILVEG
FFLDDTELNFTNEKPYVIYGFAAVPSDKTLTIDAGARVHFHADSGIIVANMGSIQANGAP
STDPELMENEVIFEGDRLEPSFANVPGQWSTIWLTQGSINNVFTNTTIKNSIVGILNDNS
PVSLTNVQIYNSANVGLLGRTATVVGNNLVINNSGQASLACSLGGDYIFNHSTFANYWVN
NFRTFPAVLIDNVLQVSETEVVVADLVRAEFNNCIVYGNEQREIGFVNEPSALFNFKFNN
CLIRFEDPNGEFTDIPEYQFQNNDLYSNIVRNQDPVFFDVELNDFNIETGTSGADGIGLP
GVGPVLDLNGTQRGANPDAGAYESIVFPDPGGTP
>OMIFANIC_00927 hypothetical protein
MSFLKFFIIIILVVSPVACGDNEPSAKKLFALEFDGAKKGHKVTEPFNISVKSRKGNIID
SVAFSIDNRKIPASNGNSVQTIDVSEMNLGIRVVTAKIFSEGLSYELADKVILLASETPK
LFTYKIIESYPHDINAYTQGLEFHNDTLYESTGQYKRSSLRKTNYITGEVLQNVSLGDGF
FGEGLTILNNKIYQLTWQENTGFIYNLETMENTGTFVYGESQEGWGLCNNSQVIYKSDGT
ERIWSLNSETLAEEGYIEIYTNTAKIPKVNELEWVEGKIYANIYQKDAIAVVNPDNGAVE
GVINLKGLKEKVKQHEKLDVLNGIAYKGEPNILYVTGKNWDSLFKIEIVEK
>OMIFANIC_00928 Fe/S biogenesis protein NfuA
MHQFSVDIQPTNNENIVKFIANSFLTQAKSFEFNNIDDAKPSPLAQQLFHLPFVKTVYIS
QNFIAIEKFNIVEWAAVQDEVAASITDYLNSGKPVVIEDTIPAKVPVSVYAESTPNPGVM
KFVANKPLAEGTFEFKNIDEASLAPIAKELFTFPFVKEVFISANYISVMKYNVAEWEEIT
MELREFIRSYIENGKPILDDSILSKQSDKKDSLEESDIVKSDLDKEIISILNEYVKPAVA
SDGGHIAFDSFDEETKTVRVILQGACSGCPSSTVTLKNGIETMLREMLQGRVSYVEAING
>OMIFANIC_00929 Calcium dodecin
MAVLKVIEVLSNSNVSWEDAARNAVKHAGKSVKNIRSVYIEDQSAIVNDNDITEFRVNVK
ITFEVN
>OMIFANIC_00930 hypothetical protein
MRSILFALLIIALCYSCNSSKKDMSENHKYTNELIHETSPYLLQHAHNPVNWKAWNEETL
NLAKAEKKLIILSVGYAACHWCHVMEKESFEDSTVAAVMNDNFINIKVDREERPDVDQIY
ISAVELMTGRAGWPLNVITLPDGRPVWGGTYFRKEDWIKSIEKIQELYEDEPQKLIEYAD
RLEEGIKSMDLVTFNTGDVDFVNYDSSMLIENWSRNFDNRFGGYNRAPKFMMPNNYHYLL
RNAVANQDKDLLEYVTLTLDKMAYGGVYDHIGGGFARYSTDDRWHVPHFEKMLYDNAQLV
SLYSDAYAITKNPLYQEIVRETLTFIKEELTHESGAFYSSLDADSETETGELEEGAYYIY
SKTELEALLGSDFELFKSYYNINSFGKWENDHFVLIRTKSDQEITEEFSISYEVLESKKK
NWKSMLLEYRNQRPRPRLDDKSLTSWNGLMLKGYVDAYKVFQNEGYLEVALKNARFIIEN
QLQPSGALYHNYKDGRSTINGYLEDYAAVIESFIALYEVTLDEKWLGYSVDLADYCFEKF
YNSDKGMFYFTSEDDPKLVTRNIDYRDNVIPASNSIMAKNLFKLSHFYEKPKYAETAKQM
LKNVQPEMEQYPGGFSNWLDLMANYQNDYYEVVVMGEAALEKVNEINANYIPNKLIAGST
SSSNSYLLKGRFSDGETLIYVCVNNTCKLPVRDTKRALSTIKAN
>OMIFANIC_00931 hypothetical protein
MRRILVVLTLALFSLVSNTASAQGVFNDPETDNYISQKSITMPSHGYTYTGSPYANKAFK
PGFVFKNGVILASNVALRFNAARDQFEIKKSLNTSNYAAKVLVQSEDIYVKINNRLFVYI
NKNEENNTGGYYEVLHDGERLSLYKKLSKEFIEGKKAVNSIAADILPMYKEKVELYFMNA
KNELTELPGSRNGKINSFSSNKKLIKQHIRDKKLNVNKQYDLIKLMNYYDSL
>OMIFANIC_00932 hypothetical protein
MKKIALHTLILSLLLCISAQAQIWDREFVSGLNQIDQNNKRQTKFDKYTLEEDVIGTPYN
HPNYLIGNVYRGNALFATNVALRYNAVADEIEIKESLDSADEDTRVLPKDPEIFAKIEND
IFVFVPFQGKIEDGGYFHVMFEGKKLDLYKKLIKKVIAGRKASSSFTQDVPTEFRDESQY
FLVTKNGRFFQLPDDKNKKFDIFGANKQKVLNYAKDNGLNPGKEADLLKIIKYYDGV
>OMIFANIC_00933 Urease operon transcriptional activator
MRLNLFVFIALISSLSSAQELTDFYLEESPIDSLIVLFDINAEDSVIAERIARKYISKAK
VINDSTKMARGYTRLSFISKHREALKYLDTAITLSRNSDHPNFPTVPYLFKSDYLYENEE
YERSLQSALTGYQYAREKSQIGHQITALHQINDINEMWGDYEKSLDAHRLTYKLLQQNKD
SDQYEQNYLSSLEGLGRSFVNLKQPDSALYYFREGTSEALKTGDSATYYAFVSRSGTALY
VKGNYEEALDSLYKADTYRNEFNNYYLPYYYYYVGSIYNSQGEVDEGMMYYRKIDSLYEA
RSIVYPELPEVYDKLISYYKEKGEYETQLNYLYKLVVVLRIIESKKRNINEKTVTDFEIP
KLVEEKEQLIADLEEKNKISTTSLGWALGFLALSFGLVFYYFRRQNQYKKRFENLMENKG
PEVEVEPSAIEDVGISPEIIESIMERLKKFELDKEFLSQRISLSEMAKSFESNSTYLSKV
INLKKGKNFSQYINDLRIDYAVEELKDNSTFRKYTIKAIAHECGFKSAESFSKSFYKKHG
IYPSYYLKQLQQSQK
>OMIFANIC_00934 hypothetical protein
MKKKFVLLTILLASVLFQAAAQNFGGDPTQLRAFTNSLHQVDEFIKRQNMGIDFADKESY
TGTPYNHPSYLPGNVYKGKELLATNVALRYNAIADEMEIKESIETIDADAKALTKSPDIY
VKIVNDIFVFVPYDGGIEGGGYFQVLTEGNKVDLFKKIKKDFSAAKKATTSITRDIPAKF
TDKPVYFLVTKEGKFYELPSSKKKKLKVFSDNANLVKKYVNSNNLDLNDEKDLIRVIKYY
DGV
>OMIFANIC_00935 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MATILCLETATTNCSVALSVNGSVIAFKEDRSSAYTHAEKLHPFIEDVLSQAGISKTNLD
AVAVSKGPGSYTGLRIGVSAAKGLCFALDIPLISIPTLNSMIVPVTLASDFKIPLLDARR
MEVYSSVFNSKNEEVRETRAEILTEGSFSEYLDKGKVIFLGSGSDKFQKIINHPNAIFMP
EAIPSSVDMAEIAERKYKKSDIEDVAYFEPYYLKDFISG
>OMIFANIC_00936 Macrolide export protein MacA
MKKKTLIIIISAIVVLLLLLVVAKKKGWIGSDSDTTKVEMTEITLMEIIETVAATGKIQP
EVEVALSSEVSGEIIELPIKEGQQVKKGDLLVKINPDLIQAAVSQSQAGLQNVRAQLSQA
EANLNNAQLNYNRNKELFEKGVISKSEWDRSVNEYESAKANKEATYYSVQSAAANLKQSR
DNLERTTIYAPMDGTISKLSVELGERVVGTAQMAGTEIVRVADLTNMEVEVDVNENDIVK
VSLEDSTIVEVDAYLKREFKGVVTEIANSAENAISVDQVTNFKVKVRIVPESYADLTEGK
PDYYSPFRPGMTATVDVITEKKSNITGVPISAIVIKTDTSCTKSFKAKKKKTEGEQEKFE
CVFVKEGDEAKIRVVTTGIQDDSNIEITSGLEEGDVVITGPYNTVTKTLDCGDMIAEAED
EEEEKDEE
>OMIFANIC_00937 Outer membrane protein TolC
MKKQIIILILLLAATNMFAQKKWTLRECVIYALENNISVKQSELDLEATNAEKLSAIGNF
LPSINANANVSENTGLSLNPTNNELENTTFLSASGAINVGYTLFDGLRNFRSAQRAKISK
LAAEHRLDKMKDDISLFVANAYLQVLLNKANLEVLVAQNNVTKEQITRTQDLVDAGVLPR
GDLLEIQATDASEIQNIVTAENVVQISLISLAQLLLIKEYETFDIEDEGYDIVDDGVASK
SVDEIIANAKETRSEIKIAESDVALAEKDLQLSRGSYYPTVSAFFGYNTRYADNDPLMTP
FSEQLYLNDGIGYGLQLNVPVLNGLNVRSNVKRNRVNLERTRFQLEQAKLDLESNIYQAY
VDVQGAFKAYEAAEKAFESQELAYQYAKDRYDVGLTNAFDFSQSKLRFDNASIEVNRTKY
DYIFKLKVLELYFGIPATELKF
>OMIFANIC_00938 Macrolide export protein MacA
MKKTVTIIILVAIVISFTAALYYLYSKNQEDPVVYETEQAEVGNIIKKTVATGSIVPKEE
VLIKPNISGIIDEIFVEAGEQVEAGDLLAKVKVIPNVSALTSAKNSINSSRTQLETARLA
LENERNIFKRQKDLFDKGVISANEFDNAQLAFNQAQQRFNQEKVNLSGAQQNYDIVKTGT
TSGLGSAATTEIRATVSGMVLDVPVKVGNQVIEANNFNDGTTIATLADVDQMIFEGKVDE
SEVGKITENLPLEITVGAIENATFDAVLDYIAPKGVSENGAIQFEIKGTLKKKDTTFIRA
GLSANASIILARADSVLTVKEALVQYDPETQEPFVEIETGDQEFERREIELGISDGINVE
VKNGISKEDLIKVWNQIKPAVQFGRN
>OMIFANIC_00939 Macrolide export ATP-binding/permease protein MacB
MFNRDRWEEILEALSSNWFRTVLTAFGVLWGIFILVILLAAGKGLENGVKADFGDIATNT
MFMWTQTISKPYKGLPKGRRFSYKISDVQAIKDNVPNMRFISPRNQLGGFGGSNNVVRGL
NTGAFNVYGDYPEIIEQQPMDITSGRFINYGDIDEKRKIAIIGEGVKTSLYEFGEDPLGT
YIKINGVNFIVVGTYKKKSQGGDSEEDQKEIYVPFTSFSQAFNRGDRVGWMAITAEDGSS
ITQLKEQIFDVIKQRHTIHPEDDRAIGNFDLYEQYSRIERLFFALKIIAYFVGTLVLLSG
IIGISNIMLIVVKERTKEIGIRRALGATPWSIRGQVLLESIFLTIISGMMGISLGALVIY
AINKVLDASGPVDMFSNPSVDIGVVITALIILIVSGLFAGFIPAQNAIKVKPVDALRTE
>OMIFANIC_00940 Macrolide export ATP-binding/permease protein MacB
MFNIERWQEIFDTIRKNKLRTFLTGLSVASGIFILVVLLGFGQGMTNGVAKEFEQDATNR
IAVWTGVTTVEYKGLNPGRFIELKNEDYDLLIKKYEDDIEFKSSVFRIWNGIATYKNESG
NYRVEGVYPDYQFIENASLSAGRFLNYDDHNGNEKVIVIGHKVYRDLFGKKEAIGEQVQI
SGINFKVVGVFTDPGGEREESKVFLPLSTSQRVFAGGNTIRNLGFTLKPQRTFQQAVRQS
IIFTNEIQSFLQERHIVAPEDESAIDTWNSLEEAKRYYDLMDMIKLFFWVVGICTIVAGV
VGVSNIMLIIVKERTKEIGIRKAIGAQPWSIIGMILHESIFVTAIAGFLGLIFSMALLEV
VGPNVEIDYIVNPSVNFNVALTTVIVLIVAGALAGFFPAWRAARIKPIDALRDE
>OMIFANIC_00941 putative ABC transporter ATP-binding protein YknY
MNFTKESGKPRYFVIELIKMIEIKDLHKSYVMGENSLHVLKGIDFTVKEGELVAIMGSSG
SGKSTLLNILGMLDEADKGSYYLDGKPIKNLSEKIAARYRNKFLGFVFQSFNLITYKSAL
ENVAMPLYYQGMKRNERNKKAMRYLEKVGLADWATHLPNELSGGQNQRVAIARALASEPK
VLLADEPTGALDSTTSYEVMRIIQSINDEGKTILIVTHEDDIAHMCKRIVNLRDGVIIKD
SKINQVRTKSATHV
>OMIFANIC_00942 hypothetical protein
MKLKIFLIILFVIFASFPMEAQCAMCRAVLESEESGGAAAGINKGIIYLMIFPYLLIGGV
GYAIYRMRQKAKDED
>OMIFANIC_00943 hypothetical protein
MSKDKVSKKYTTWIWILSIAIPVVVALLFSVKIPGVERLGFLPPIYASINALTSILLIVA
VIQIKKGNRKTHERLMKFCILLSALFLIMYVAYHMTSDSTPYGGEGILRYLYFVILISHI
FLSIGVIPFVLITYVRALTGDFQKHKKIAKFTFPIWLYVAVTGVIVYLMISPYY
>OMIFANIC_00944 SCO1 protein 
MSKNYSYIGISFIILVFGIWAIPKIVDNFSKPDLAVIGTVPEFSFTNQNRNTISNEDYKG
KVYVAEFFFTTCPSICPIMNRNMVRIQNEFYGNPDLGIASFSIDPEYDTPEILKSYAESY
EITNPSWHLLTGEKAKIFELANAGFNLYVGENSEVEGGFEHSGYFALIDQEGNIRSRIDE
NGNPIIYYDGLEAEGIQMLMEDIELLLKN
>OMIFANIC_00945 hypothetical protein
MQVKKYLVLGVLFLLPLSMYIFFASGKDNFGRLPVLTENITEIDKFNAEDNDTIRLKNSI
TILGFFGNDPLANKVNAFNLAHKIYKKNRGFNDFQIVILQPEGTEAPSKELKKKLSEIAD
TDRWKFVFGSPEEIKEVFNSLKSDYLLMPDNGSPYVFIIDKNGNLRGRDDDEDVGKLYGF
DARDFAEINNKMDDDVKVILAEYRLELKKYKADREI
>OMIFANIC_00946 hypothetical protein
MAHDHKLAIFRGLITFKSNERKIWGVFAFLSVVTVVEVALGIIKPEVLTENRFLAMKLLN
WIFIVLTLVKAYYITWDFMHMRDEVKPLRRAVVWTAIFLICYLVLILLIEGDYIYEVYKN
NYMKFTF
>OMIFANIC_00947 Cytochrome c oxidase subunit 3
MDATVAQTGTEGKTWGGGNRPLNASYGKMMMWFFIVSDALTFSGFLASYGFSRFKFIDSW
PIADEVFTHFPFLHGVDAPMYYVAFMTFILIFSSVTMVLAVDAGHKMQKNKVIIYLFLTV
IGGLIFVGSQAWEWATFIKGDYGAVETNGGKILQFLDKDGNRVAIGEFATTLPSTSVTHT
EGNGIWYMEGGTETSFNYEEVKAGFLANENLLIRDQELVPDMAALRASDLEADKQEVARL
ERSYINLDEIGEKAIYSREMSVSKLVNDGKLVVEGANLKHNEYGTPLFADFFFFITGFHG
FHVFSGVIFNLIIFFNVVIGTYERRGHYEMVEKVGLYWHFVDLVWVFVFTFFYLV
>OMIFANIC_00948 Cytochrome c oxidase subunit 3
MDYTEGSEDLKRQRAKKMMLWFGIVSLSMSFLGFTSAYIVSSKREDWLDDFQIPQAFYIS
LAVIIASSITMHLAKRNIKKENNGTGMLFLWTTLVLGVVFVWLQLQGFDEIIGIFGYNPT
GPTSNITYTYIFLIATVHIAHIVVALIALLVVIYNHYKQKYTKGKTLGVELAATFWHFVD
ILWIYLFFFFYIVR
>OMIFANIC_00949 Protoheme IX farnesyltransferase 1
MPTAQSQSFPVSVVKNFTEITKMRLSVSVVFSSIAGYLLGTDSINFFTLFILGVGGYCMV
GASNVFNQIIEKDRDALMDRTKDRPIPAGRMGVTSAFILACLLTLIGIAILYIINPMTAL
FGAISIFMYVSMYTPLKTKTPLAVFVGAFPGAIPFMLGWVAATNDFGIEPGTLFMIQFFW
QFPHFWAIGWFLFDDYKKGGFFMLPNGKRDKGTAIQIVLYCIWTVLASLIPAVGVTGSLY
LTPFSAVLIAVIGIWLIYYAVRLFKLRTEKAAKQLMLVSVSYITLLQLIYVLDKFIR
>OMIFANIC_00950 Hydroxyacylglutathione hydrolase
MRVLSLSTLLFFLGFFISPAQDSGETNTTSSNPARTISLVKVADSIYMLQGKGGNIGVSF
GNDGVLMIDSQFAPATPEIIDLIASLSDKQVQFLVNTHHHGDHTGGNANMTDNGAIVVAH
DNARKRLVNVEKQKIYKAQEEEFKKLVDQLEDEGNTEKAQAKAKEGIQSESSFDPSLYKF
PVITFSDNMTFHYNDETIMVFHLHNAHTDGDALVYFTESNVLHTGDTFFNGKYPYIDMNS
GGTYDGYIDALSKILALTDDETSIIPGHGPVGSKADVKKTYSMMKALKDRVAYYYVQNNS
KEEILANKEITKEYDALGYGDGYVSTEKFVSMIYKLTEAKYGDVSKKN
>OMIFANIC_00951 hypothetical protein
MKIVASILFCLFIIPSFSQTNISSFEKYPVFPECAAVEIDQLENCFNNTLQSFVYSNFVV
PEVVSSENYKGTLAVFFEINKEGSFRVILVDAVYEELKEEANRVFGLLPKIQPATYNAKP
AYVQFTLSLNIPLEAPVPVEIESKITSETQPDEVVLNEYDNIEKLPYENEEYTSQINIPL
SHHNYSLFDPALNRIGQNNHTAQKPYVYAEVNRYYNFEAENDKILKNKTSWFGRKFWNEH
MVTIKGKDYWITLDPGVDLQVGKDTDADIDTYNNTRLVYTQGGIGKNFNFFAVIYESQGR
FADYFNRFAEARRPDGGNPAIIPGRGIAKEFKTDSYDYPIATGHISYSPSKTFNFQLGHG
KNFIGDGYRSLLLSDNSSPYPFFKVNTTFWKLKYTNTWMSLRDVRSAVTADGSFRTKYIA
NHYLSYNITKRLNIGLFESVIWQNDNDRGFDFNYLNPIIFYRAIEFSTGSRGGNAIIGLS
SKFKFTDKVNAYGQLIIDEFSSSDISGGNGSYKNKIGYQLGAKYYDAFSVDGLYLQAEYN
RVRPYTYSHNTVVLNYGHNNQSLAHTLGANFSEFIGIARYQKGRIFGDAKVVVAKRGFEF
NTPEDMNFYGGSIYGTEDDRISDNGNDLAQGNTTDFLHAELQAGYLLNPATNLKIYASVI
FRDFKPELNTDNVFENQTTWVNFGIRTDLFNWYYDF
>OMIFANIC_00952 hypothetical protein
MKPSVQYFQSDRPKKLSKREDKKSVNHRWNSRLYFQLGLIISLGITILVVESTVGLSLIK
EVAVGKDPVMDPPTVTYTVEKPKPVVVQKEKVVKQKPLVRKRTISTVVAVAKNLPTIVET
PLAPTDVPKTNTVAVVKPTPPPVNTNPENINSVEFVPVFPGCEYLGSNEARKQCLSDKIR
SFISKKFDTDEFSYLDSGTVFRIDVQFKIDQNGNVKEVRSRAPERSLENEAVRVINLLPT
IQPGMQGDKPVEVIYRVPITFKTN
>OMIFANIC_00953 hypothetical protein
MIEVVEDEEDVEETIIESTETDTEEEIVEIEEIEEVVEEEIADVPFAVIENVPIYPGCES
AGNNNAKKKCMSEKIQKFVQKKFNNELANDLGLDAGRQRISVQFKIDRTGNVTGVRARAP
HPKLEQEAIKVVKQLPKMTPGKQRGKAVGVLYALPIVFEVQN
>OMIFANIC_00954 Sodium/glucose cotransporter
MIDLSTLDFIIIIALFVVILSIGFYVGKTSGKNSSQYFLSGRNMPWWLLGLSMVATTFST
DTPNLVTDIVRTNGVSGNWVWWAFLVTGLLTVFVYAKLWRKSEVKTDIEFYELRYGGKPA
RFLRGFRAIYLGILFNVLAMAGVTLAAIKIGEIMLGLSPLTTVVIAGLITAVFSAIGGFK
GVVYTDFILFFVAMSGAFGAAYYIVGIPEIGGLEALISHENVQDKLNILPDLDDRETLIA
LLVIPLAVQWWSSWYPGSEPGGGGYVAQRMLAAKNENHAIGATFFYNIMHYALRPWPWII
VALASLVVFPDLASIQEAFPNVSEDKLGHDLAYSAMLTMLPSGLLGLVLASLSAAYMSTI
STHLNWGASYVVNDFYAQQIKPSATEKELVNVGRLTTVLLMIVSATIALLLTNALQLFDI
ILMFGAGTGLIFILRWFWWRLNAWTEISAMVASGVISILIAFTPLGDVLFGDGGVFPAYA
RFPFVVFSSMAIWLTVTFITKAEKKEVLYRFYKKTQPGGPGWKKVLEEAKRDNEEIIQTT
GAWSVPSGILAMLIGCVFIYSAMFTTGYFIYGENSKALGLLALCALSGFLLIRVWKRIKG
KVL
>OMIFANIC_00955 D-glycero-alpha-D-manno-heptose 1-phosphate guanylyltransferase
MTKTLIILAGGTSSRMKRSESARLSDSVKHQADTISKALIPVNNRPILDYLLYNAKMAGI
KNVIIVTGADNSMFKDRYGKESKGNAFHGLTISYAIQHIPAGKNKPMGTADAVHQALEQY
PGVQQEFFLVCNCDNLYSVESFNTLIENNDSNAFINYDRDTLKYSAERIANFAITRVNAD
GYLMDIIEKPSDIDMARNKSGGDSTRVSMNLWKFYGPQFYAFLETCPVHPERDEKELPTA
VLNMIKVYPRCMKAISFSEHVPDLTGKEDIAVLNDYLSTHYSHLDWTN
>OMIFANIC_00956 Galactokinase
MTPFISKAPGRICLFGDHQDYLGLPVIACAINRYIQIKGSSNNTNLFKISMPDLKLEFVL
PLDKNDKPLKKGDHLEAVMKVVNRYGCIPDQGYDIEILGDLPINAGLSSSSAMVVAWVQW
LLAKFGSYHELSPTLIAKLAYEAEVLEQNSPGGKMDQYTSAIGGIIYLETDEESNFRKLE
SELDSLIIGESGIPKDTVGMLDDLKNKALTAISLIKSHNPKFDIHEADLTDYENYKEILP
EPMRPYLFAAIMNHLITKQALAEFQQKNPDNRKLGELINAHHEILRDILQITVPKIDAMV
HAAIRAGAYGAKIVGSGGGGSIVAIAPEDKEDWIVSAMKEAGAIAAYPVNVANGAHIIK
>OMIFANIC_00957 Alpha-N-acetylgalactosaminidase
MSSRRDFVKKTTIVGAGIALAPGITYSAIRSPMDKLNVALIGVGLRGTNHLVNLLQRKDV
NVTAICDIDPGRIVIAKEHMSKAGYPAPKVFGNDEYDYRNLLKDNDIDAVIISTPWLWHT
RMAKDAMKAGKYTGVEVSAANTMEECWDLVNTHEETGSHLMILENVNYRRDIMAVLKMVR
ENVFGELLHFRCGYQHDLRFVKFNDGKTPYGKGAEFGEKGISESKWRTQHSLLRNGDVYP
THGVGPIATMCNINRGNRFVSMTSHATKAIGLNKYIVKVGGPDHPNAGLNWQQGDVITST
INTAKGETIIVTHDCNSPRPYSLGFRVQGSEGLWEVDGSRIYIEGKSEPHRWDDAKPWLD
KYDHPLWKKYGEYATGSGHGGMDFFVLNAFVESAKQNIAPPLDVYDAAAWSAITPLSEAS
IANNGEPQDFPDFTRGLWVSRKPYNWIKDSY
>OMIFANIC_00958 hypothetical protein
MFLRSFVALLSIVITLVGCAETESFSAESVINEAIEAHQMDLINGREISFQFRDHQYKMY
RDSNLYVYSRIKDSITDILHSRKGFNRVINGTPVLVADSMAAKYSASVNSVLYFFQLPFV
LNDAAARKEYIGRTTIEEMEYHILKVTFNEEGGGEDFEDEFRYWINTETFEIDFLAYSYL
TDDGGIRFREAFNKQRFDGILFQDYRNFKPASLQVPLDSLPVLFERQELKLLSKIENKDI
QVVKQ
>OMIFANIC_00960 putative epimerase/dehydratase
MKKRILIIGACGQIGTELTERLRRIYAPHKVIASDIHEGNETMMKSGPFEVLDAMDYESL
ENVVINHEISEVYLMAAMLSATAEKFPMKGWNLNMNSLFNVLNLAKEGKIEKVFWPSSIA
VFGPTTPKVNTPQHTIAEPTTVYGISKLTGERWCEYYHKKFGVDVRSLRYPGLISYKTLP
GGGTTDYAVEIYHKAVKHKKYISFLNKGTTLPMMFIDDAINATIGIMEAKPEEVKLRSSY
NLAAISFDPEEIAASIKQHIPDFQIYYEPDFRQAIADSWPNSIDDTKAREDWGWSHTYDL
KEMTEVMIENLQGSLLKASD
>OMIFANIC_00961 hypothetical protein
MRIRNVLYLLSAFLIFSLLFSSCGKSEEKPAELFEEAQDFSNGFGDKTMLFPKLISAAET
EVSSWSVFEDFQNEMKTLNGSTLAELRVKSERLRLHTDSLRKKIPEALATQPIKSRLLVV
DSRVNLLDQEINKSPIDSLTLEEHLRELTTATVNFYLQINEKLQKDKIDQEREEDEKKEL
EKQKRFLDSVYQAELKDQEN
>OMIFANIC_00962 Neutral endopeptidase
MKTNYLKSILAATIAVFAIASCADKDGKMAANDEGPHGLILANMDTTVSPKNDFYNYVNG
TWMKNTEIPDDQVRWGGFMVLRKSTDKDVLEILATAKESEKYAPDTDQAKAIMIFESELD
TVARDAAGIEPLKPILEKIESISSVEEFQKVMTENAITVSQPFLGIAAFSNPSNSAMNSG
YILPGGLGLPDRDYYTNTDEASKKIREQYTDHITRMLQFLGDSEEEARAQAETILAFETK
LAEPRLDKVARRDFRNFNNPRSMEQLQEMVPQLQWKQALKDLGVTKDVDTVLVMQPAYMQ
VLEQIMEEGDIDTWKTVMRWSTLNNSAGMLSTEINKANWDFYSKTLRGAKKQRPADERAL
ATVNNTVGEALGKLYVDEKFPPEAKAKAELMIDNVIAAYKDRIQTLEWMSDSTKTKAIQK
LDKFTVKIGYPDKWKDYSTMNVKPENGYFENIVAVGEWQLKDNLDRVDEPVDRTEWGMSP
QTVNAYFQPFNNEIVFPAAILQPPFYDYKADEAVNYGGIGAVIGHEISHAFDDSGSRFDG
DGNLVNWWTDNDLKEFTERGSELVEQYDNIEVLDSVFINGKFTLGENIGDLGGILGAYDG
LQRFYKENGRPDNIDGFTPEQRFFMSWATVWRTKQTDKYTQEQVKTDPHSPGRYRATQPL
MNVDAFYEAFDIKEGDGMWIAPEDRVRIW
>OMIFANIC_00963 hypothetical protein
MSKTVAMAGMGWLGLPLARHLKTLGYSVKGSVTSEEKANSLRKNGFHAITMIVTEGGVTG
PIQLLLADTDYLVIMIPPGLRRHTGADHVLKMSYLLSEIEKSSVRNVILVSSTSVYGDGQ
GMVTEQEVPKPETLAGKQLLQVEQLFFTSERLNTTIVRFGGLFGGSRQPVRYLAGRKDLS
NGDAPVNLIHRSDCIGILTEIIKQEAFGHIFNAVLPSHPKKREYYSDIASKLDLVPPQYS
EGDSEEIFKQVDSVNLDTILDYSFKHSL
>OMIFANIC_00964 hypothetical protein
MKRLSAVASLLIILGLIYYSFSSLMPSERTGPDSPETEFSTSRALATLKEISKAPHYYAN
EEHTRVREFLINEMQKMGLEVETQKDYVLSPHWGRQKVGDSVIAIPAGYHMDQPRNIMAR
LKGSGDGKALILLSHYDSAKVPSFGASDAGSGIVTILECLRAYQASGKTPANDIIILFTD
AEEIGLDGAKLFVNNHPWAKDAALVLNFEARGSGGPSNMILETNGGNANLVKAFIEASPE
YPVASSLMYSIYKMLPNDTDSTIFREDGDIDSFFFAFIDDHFDYHSANDTVENLDVESLQ
HQGSYLLPLLHYFSDADLQYLKASEDHVYVNVPLFKMIHYPFSWILPMLILAILIFAGLI
FYGIKQGDITGKGVGRSFAATFISLVICGLLGFFGWKLLLSIYPEYNEIQHGFKYNGHSY
IAFFVLISLAVTFGVFRRFGKDQKIAGMYIAPLTIWMLINILVYVVIKGAGYFIIPFFFG
LISLWILIRQDKPNLLLMALITAPAIILFAPLVQFFPVGLGSDHVFISCIFTVLLFGLVY
SVIGFYKAKRWIALLCLIVGLGYFIQAHNRSDFSDERQKPNSLIYYQNADKGKSYWVTYD
RMLDDWTKGYLGESPEAASKYLESASGSKYNTPYRYASEAPQKQIASSEIILRTDSLNDR
GREVSFTIRPKRKVTELFVFSDTTNTYSSLKFNGVEAVRDDAGTIHANVLNKRLMRYFMA
EDDSLNITYSTPDRESYEFTILEFSFDLMDHPQFTINKRPAHMMPKPFVITDAIAVKRSF
NINELTVKTNDTLDMVNLIIEEIDE
>OMIFANIC_00965 Inosine-5'-monophosphate dehydrogenase
MSIKSYIGKRAKPTKGSTENIKVSDYMTTNLITFRPNQSVLEVMNTLIKKRISGGPVVND
KNELVGIISEGDCMKQISNSRYYNQPLQDFKVEQHMNTNVDTIDGSMNVFDAADKFLTSK
HRRFPIVENGKLVGQISQKDVLKAALQLKGRNWK
>OMIFANIC_00966 hypothetical protein
MERLCPECGEKIIGRSDKKFCSDACRNSYNNRLNKDRKNLVRNINNRLRKNYRILEQLNS
KDKTKVKKESLLKHGFSFEYFTSEYRTQAGSVYKYVYDQGYLPLENDWYLLVRREN
>OMIFANIC_00967 hypothetical protein
MKKALLLTLFLPFCCFSQNYVDLLRIGYGQTFNNDFENSDSSTQVRSFEADLTFPIELNK
NNVLITGAAFSRNNLQLFPEAEFTSLLSTTLKLGVVSTYNEKWSSTLVLLPKIASDYKNI
SGDDFYMGAFAILKLKKSENLIYRFGAYASAEAFGIFSTPIFGWYYLSPNGRFEMDMSLP
ISADMNYCMGATTIGIDYFGIGRSFNITEDNTPEVYVDLSSLDFASYIQFNTLGNSVLLR
AKFGYSSNDYEVYPQGQEIDFGLSAFSFGDDRTQLNPKVRGGLFLKFEAIYRFQLKKENE
ETDSP
>OMIFANIC_00968 Isoleucine--tRNA ligase
MSKNFKEYKGLDLPQLAEDVLAFWKEERIFEESIAIREGAEPFVFFEGPPSANGLPGIHH
VMARAIKDIFCRYKTQKGFKVDRKAGWDTHGLPIELGVEKELGITKEDIGTKITVEEYNE
ACKKAVMRYTDIWNKVTDSYGYWVDMDDPYVTYKSKYMETVWWILKQIWDKELLYKGYTI
QPYSPKAGTGLSSHELNMPGTYQDVTDTTVVAQFMAKDETLPGFLKGYGDVHLLAWTTTP
WTLPSNTALTVGPKIDYVFVRTFNQYTFKPTNVVLAKSLVGYQFSGKFVEVENENELDSY
EEGAKKIPYFILKEFKGAELEGIRYEQLLPYALPNDNPENAFRVITGDFVTTEDGTGIVH
TAPTFGADDAKVAKEATPEVPPLLVKDENDNLVPLVDLQGKFRPEMGEFAGKYVKNEYYD
EGEAPEKSTDVELAIKLKIENKAFKVEKYVHSYPNCWRTDKPILYYPLDSWFIKVTEFKD
RMFELNQTINWKPKATGEKRFGNWLANANDWNLSRSRYWGIPLPIWRTEDGKEAKCIGSV
EELETEMHRSVEAGFMDKVLFEDFVPGDYSEENYEKVDLHKNIVDEIILISDSGKPMKRE
ADLIDVWFDSGSMPYAQWHYPFENKEKVEKTWRKADFIAEGVDQTRGWFYTLHAIATMIF
DDVAYKNVVSNGLVLDKDGQKMSKRLGNAVDPFETLKKYGPDATRWYMISNANPWDNLKF
DSDGIAEVRNKFFGTLYNTYSFFSLYANLDKFDYAEAEIPLAKRPEIDRWILSELHTLIE
KVDEAYSDYEPTRAARAISLFVQENLSNWFVRLSRRRFWKGSYGEDKISAYQTLYTCLEA
VTRLGAPIAPFFMDRMYKDLTSGVVKHGENSVHLSNFPVGDPSYVDRELEQKMHRAQTIS
SLVLSLRQREKIKVRQPLQKIMIPVMDPAERHAIEAVSDLIKSEVNVKEIELIDEGSGIL
VKQIKPNFKKLGPHFGKDMKAVAQVITTFGQDEISQLEKDGEISVLINEKNTTLTIDDVL
ISSQDIEGWLVANADGITVALDVTITPKLKNEGIARELVNRIQNLRKDSGFEVTDRVEVI
IQNDAQLQPAVAENLDYIKQETLTEVLQFESDVANGTEIAFDNVATRLQIKKY
>OMIFANIC_00969 General stress protein 16O
MAKDVKNRYSDKELDSFRKLIQEKIEKAQEQLELIESAYKNDSNNGTDDTSPTFKAFDEG
SEVMSKETSSQLAIRQEKFIRDLKNALIRIENKTYGICRVTGKLINPERLKLVPHATLSI
EAKNMQK
>OMIFANIC_00970 hypothetical protein
MQNLIFHIFVVFLITSQICAQKTIQKQWIVSAVDTVLIASDQIYNVRITSGSKETINLTT
SVEGEVYETVVVKELISGKTLQIGTGHSPYFSPKNDKLAAHKVLSVEMVLTVPPNVAVVV
HSKNTSVIAEGTIAYLETVLEKGHCTLQDFKGDARLFTVFGDISVAVHPGVGGRAISKEG
VTNELKLEGDYFIEAESINGLVSLVRQE
>OMIFANIC_00971 Phytochrome-like protein cph1
MNFLAQKRSRILSQNNISQKSLPPDTASPENFYYREIAKLTGSGGWSVNFREKKSFLDSE
SKRILETPKDFNPSLRSALDFYAPDYKDRAAAIFMECSEGHSFSTTLKMQTYTKKEFWAR
AIGRPIFDEYGEVIGIQGIFQDISDDKQKEIELLKSLKIIESQNTKLNNFANIITHSLRS
HSSNLQMTLHLLKDATDSADKKELTQGLHQISESIATTVGHLAELGSIQTKAQEPKEMVF
FEKSLENVKNTIRRTLTDTRSEIFTDFSEIPSIPYIPSYLESILLNLITNAVKYRHPERS
PVIEIYSYRENDCTFLMVKDNGLGIDLEKHGNRIFNIYQTFHNHKDAEGVGLFLVRNKIE
SLQGTISVQSEVGKGSTFTIRF
>OMIFANIC_00972 hypothetical protein
METTNTPSGTPPDNNLVWAIICTVLCCLPLGIVAIIKSTKVKELWLQGDHAAAQKAADDA
KKYSIWGMVIGGVFVLLYIILVVVLGVAGSGF
>OMIFANIC_00973 5-formyltetrahydrofolate cyclo-ligase
MDKSQIRKKYKEKRRLLSRNDIDSLSLEIANLSLNMPIWDKTYYHLFLSIEGKKEVNTEY
LLHILQGKDKSVVISRSDFKTFEMNHFLLQENTPIKISEIGIPEPTDGIVIEPSLLDVVF
VPLLAFDDSGYRIGYGKGFYDRFLSKCRPDCIKVGLSFFESERQIIHENIDFPIDHCITP
KKIYGFKNSNLYL
>OMIFANIC_00974 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MKKTKAKDIVLFKEVIPPGSSKELNLSFAKLHTNTPIDVPIFVERSLYEGPTVLFTAGIH
GDEVNGIEIVRQLVSKGINKPKIGTTITIPIINIFGFLQKVREFPDGRDLNRSFPGSKSG
SLAARVAHKLMNHIIPHVDYCLDFHTGGSSRFNAPHIRVEKGDEELIKLAGIFNAPFILQ
SKNLKKTFRYACSKKGVPMLLFEGGKSNSIDNVVSNTGVNGSKRVLHHLGMLNSKFKVSS
PKNNSLIITHSIWVRAHASGMFKPAVKVGSHVKQGEVIGHITDPYGKIHYWIKSTNNGYV
FNVNESPLVYQGDALFHISTGVT
>OMIFANIC_00975 Ribosomal protein S6--L-glutamate ligase
MNIAIISRGESLYSTRSLFKAGESRNHVMEVLDPTRCTQAIENGKPVLYFNNELIADLHA
VIPRIGASNTYFGAALVRHFQSMGVFCVVRAEPILQSRNKWTCNQILAHAKIPVPETVLG
TAGNVEAMLGIFGDPPYIIKILQGTHGQGVILAETYQSALSTVETLLTAKVRFVIQEFIA
ESDGSDLRVIVVDGAVIAAMKRQSRAGEFRSNLHRGGSSQEIKLTYAEENLALRAAKALR
LGVCGVDILQSNRGPLVLEVNSTPGLEGIETTTGISIASKIISYIERNKRK
>OMIFANIC_00976 UvrABC system protein C
MPGRKLPVHFCTIFKTRGIFDTMAEASVKLQISTLPESPGVYQYYDKDGKLLYVGKAINL
KKRVASYFTKQHDNARTRLLVKKIADIKHIVVATETDALLLENNLIKKYQPRYNVMLKDD
KSYPWICIKNERFPRVFSTRRLVKDGSEYYGPYTSMKTVHTLLELIRGLYQLRTCNYDLS
AEKIKAGKYKVCLEYHLGNCLGPCEDKQTLEDYNENIDAIRNIIKGNFKESLNRFKKQMK
SYAANLHYEDAQRVKEKIDILENYQVKSTVVNPKINNVDVFSIVSDESYAYVNFLQISFG
SIIRSHTMELKKKLDETDEELLELSVVELRQRFNSQSKEIFVPFVIKTESGVKVSVPKLG
DKKKILELSVRNAKYFRMERFKQAKIVDPDRHEKRIMAQMKKDLRLSQEPRHIECFDNSN
IQGTNPVAACVVFKNGKPSKKEYRKFNIKTVVGPDDFASMEEVVYRRYKRLLDEEQPLPQ
LIIIDGGKGQLSSALKSLERLGLRGKIAIVGIAKRLEELFYPDDPIPLYLDKKSETLKII
QQLRNEAHRFGIDFHRNKRSKEALNTELESISGIGEKTVIELLKHFKSIKRISEAAFEEL
ANVIGADKAKKIVTHFQQTQ
>OMIFANIC_00977 putative NTE family protein
MKLRVLLILFLIGSSWCFAQQGDSDPKVGLVLSGGGAKGLAHIGALKIIEDSGIEIDYIG
GTSMGAIIGALYASGYTAHQLDSIFEELDFDELIQDEIPRKAKTFYEKTETDKYAVTLPF
DGFKVSFPSGLSKGQNVYNLFSKLTSHVSDVNEFNELPIPFFCMATNVETGEKVMLESGY
LPQAISASGALPSLFSPVIIDEQVLVDGGVKNNYPIEELKAKGMDIIIGIDVQDSLKTRK
DLNSAFDVLVQINNFRTIEEMTEKRRKTDIYINPNIDKFTVVSFDEGRKIIDAGEAAAVE
FKDQLVEIASRQKERDRIKPEIFSETSIFIESVEISGNVNYTRAYVLGKLKLRVPDEISY
ELLNEGINNLSATGSFQDINYRIVETSPGIHKLYFDLIESDSRTLLRLGAHYDDLFRTAA
LINVTRKRLFTNNDIASLDFVVGDNLRYNFNYYIDKGFYWSIGFNSRYSFFEKDVKIEFI
SPEMITEPRFDINELQLKYGDLTNQLYVETLFRRTFLAGAGIEHKWLRYLSETIGIDENN
EPRTIFENTNYFSTYGYLKYDTFDNTFFPSRGLFFEGDFHFYLFANGNNEAFEEFSIAKA
NIGYAIGLLDNITVLLTTEGGFKIGGTNTRSLDFFVGGYGFLQINNIIPLYGYEALSLRG
DTYLKSSVTLDYEFIRKNHLNLSANISNVGDRLFETGNWIDEIDYSGYAIGYGMETFFGP
LELKYSYSPEIDNSEWYVRLGFSF
>OMIFANIC_00978 Homogentisate 1,2-dioxygenase
MPLYHKLGKIPPKRHTQFRKSDGSLYSEQLFGTIGFDGMYSNLYHEHRPTQVIDIRDQYS
VAPKVAKANNLKSYRFRGFQVAPEKDYLESRKVILTNSDCNIILAAPKDSLRDYFYKNTD
ADELLFIHKGSGTLRTFMGNLEFNYGDYLLIPRGMIYQIDFDSEDNRLFIVESYRPIYTP
KRYRNWFGQLLEHSPFCERDIRKPDKLETFDEKGEFLMKVKKQDEIIEMVYATHPFDVVG
YDGYNYPYAFSIHDFEPITGRIHQPPPVHQTFETDAFVVCSFVPRLYDYHPESIPAPYNH
SNIDSDEVLYYVDGDFMSRNDIDAGHISLHPAGIPHGPHPGATERSIGQVKTDELAVMVD
TFKPLQVTEEAMKIADDTYYQSWLE
>OMIFANIC_00979 4-hydroxyphenylpyruvate dioxygenase
MSKEVKSVDYGLEKIFEGAQDFLPLLGTDYVEFYVGNAKQSAHFYKTAFGFQSFAYKGLE
TGSKDEVSYVLKQDKIKIILTTPLNSKSPINDHIVKHGDGVKVIALWVDDARKAWEETTS
RGAKSYMEPFVEKDDEGEVVRSGIYTYGETIHMFVERKNYNGVFLPGFRKWESDYNPTST
GLKYIDHMVGNVGWGQMNTWVKWYEDVMGFVNFLSFDDKQIHTEYSALMSKVMSNGNGRI
KFPINEPAEGIKKSQIEEYLDFYEGSGVQHLALATDDIIKTVAQLKARGVEFLPPPPQQY
YDDIPGRLGTHMEMMKEDIKELQKLSILVDADEEGYLLQIFTKPLEDRPTLFFEIIQRMG
AKGFGAGNFKALFESIEREQAARGTL
>OMIFANIC_00980 hypothetical protein
MKRLITLFLFFSFSTVFAQKQAYGDGEWFKFRVHYGFVTAGYAILQVENDYLDGRSVYHI
KGEGKTTGVSKFFFRVEDYYESYVDKYNDRPYRFIRNIDEGGHTKDIQIDFDHDSGKALV
HNKKHKTKEVVPFPRDAQDMVSAFYYLRNNLDVTNISEGDTVSMNMFFDKENYKFRLKFL
GRETLKTNFGKVSCLIFRPYVQAGRVFKEKESLTLWVSDDDNKIPLLIKADLAVGSLKAT
LTEFKGLKHSFKIIVD
>OMIFANIC_00981 Tryptophan 2,3-dioxygenase
MEIQPETKELLKQLKEKYDAIDQDLDTHLEGLLYGEPITYWDYIQTDALLNLQVQRTTLP
DEMVFIMYHQINELLFKMILWEIHQVSHKEDLSMAFFSERLMRISRYFDMLTSSFEIMTE
GMEVAQYLKFRNTLTPASGFQSAQYRKIEFASTDLINLIDARFRDTIDRETPYEHALEHL
YWQAAGKNYKTGKKSYLLSAFEEKYKNEFIAFTKEYNTINLYAKFKSLPETVKQDPKLQN
AMRHYDHTVNIKWVMAHYNTAVKYLNHGNEPEEATGGSDWAKYMLPKYQRRIFFPEVWTE
EELKNWGHDV
>OMIFANIC_00982 Murein DD-endopeptidase MepM
MRKLTYLLPVFLLFAACSTDVKEEIVEAEEAPPALIEEYGFLLNDFNVIRDTIRPGDTFG
AILDANGVTQDKIFEVATKFQDSFDVRRIVVGKPYVLLNSKDSLNRTQVFIYEKNKVDYA
VVDFRDSISSFNSKKPVNFVEKSASGVITSSLYQTMEDNDLSPYMSERLANIYAWTINFF
AIQPGDRFRVIYTEKYINDTIPAGLDEIKAAYFEHKGKPLYAFNFVGDTVNQIPDFYDEK
ADNLRRAFLKAPVRFSRISSRYNLKRRIKYYGYKLRPHKGTDFAANIGTPILATADGTVT
KSERRGGNGNYVKIRHNSTYETQYLHMKSRNVRVGDFVRQGDVIGWVGMTGNTGGPHVCY
RFWKNGRQVDPFKQDLPASKPLSEDLQPEYFEFIAPLKEKLDCISY
>OMIFANIC_00983 TonB-dependent receptor SusC
MKKLLLLVFLFGSFTAFSQGTVTGTVQDADLGGTLPNASVVESGTTNGTISDFDGNFTLS
VSSDSGQLQISYLGYVTRLIPFTLSNGTANLGSISLEGDAATLGEVVIIGTGVIDLADDR
QTPVAVSTITAQEITSKAAGNVEFTEAMKNTPSVYVSNQAGGFGDSQIFLRGFNDTNTAF
LLNGQPINSQEDGRMFWSNWAGMADVANAIQVQRGLGSSKLAISSVGGTVNIISKTTDQS
QGGFVRFLAGNDSYFKGTASYNTGLSDSGWAFSVLIDHWQAHRKYAIGTAGQGQNYLFSV
GYKPNETHAFNFLITGAPQWHDQNFSNDLDEYELYGEKYNSNTGFLEGERYTERRNFYHK
PVANLNWDYTISDNADLSTVAYASWGRGGGTGMYGRGSRVRLGINGEIDFDQIVMNNMDI
ADENGVGAFDDARIRRSSMNNHNWYGLLSSLNLEASENWNINVGFDGRLYQGDHFRQVND
LLGLSGLEENGQVFSNEFEADPWKTLFDRAEEGDRIDYDYSENINYLGGFGQVEYATDKF
SIFAQGAFSTQSFEREERYDLENAGMSEKLNKTGYNIKGGASYNITENHSIFANAGQFSR
QPFLDNIFRDIRGSNDIAMPEVDNEEILGLEAGYRFQNSNLRVNVDVYRTEWGNRFVPTS
GEDNTDPDNPVFFTDRFTDVTQVHQGVEFDFEYRPNYGNWRLRGYGSIGNWKFDGETPFT
RQNDDTSEFIITDGMLDLTGTKVGNAPQTSFGAGLSVRLCDGLTVDGDYNIYTDLYGFVN
PDDVIEAAQMGMRYQAERLPAYTLGDAGITYRFTLGEQRLTFRGNVYNVFNDSYINQRDR
FGYYLGVGRTYNASLRLNF
>OMIFANIC_00984 hypothetical protein
MYTTVQFIHSWWAYLVLFMLVIATINSLAGLVGKKEYHPRDFRIALFTLIVTHIQFLIGL
ILYFISPMGMKNISNVGMSEVMKNGEFRLYAVEHPLIMIIVVVLVTIGYSKHKKRLVSGP
KFRALTIFYGLAALFALSRIPWAQWFD
>OMIFANIC_00985 hypothetical protein
MRTPYCFIILSFCCSITFHAQQQRTFKIHTIAFYNLENLFDFKDDPFTFDDDRTPEGKDH
WTEKNYRAKLQNMARVISEIGKDATGQSPTIIGVCEIENRTVLEDLINEDPLGKEGYGIV
HFDSPDRRGIDVALLYRKNVFTPSHYKSIELLLYNEQDRKKRIYTRDQLIVSGMLDGERI
HIIVNHWPSRSGGEARSRPKRLKAAWLNKRIIDSLWSLDPYAKIVSMGDFNDDPGSQSIK
KVLQTLHDRNTNELKRLYNPMEYMHKKGLGTLAYRDGWNLFDQIIISSELIKREYDSYRY
YKAGIHSNTKLITSSGRYKGYPFRSFTDSGFTGGYSDHFPVYIYLIKEIDSSEGLSNQSN
H
>OMIFANIC_00986 Maltose O-acetyltransferase
MPVRMGNNVMLGPNVQIYTATHPLEAKLRYSGREYAKPVTIGNDVWISGGAIICPGVSIG
NGSVIGAGAVVTRDIPDNVFAGGNPAKVIKKIKNDS
>OMIFANIC_00987 hypothetical protein
MKILLRILFLIIFFITGSMTLNAHPAWGIVIDAEANIYFADIFHNGRGSVWKLHKNGTLE
LLLKDFHSHNVSLDHDGNLVTAHGEQHHTMVRLLGNKVSDTIYTSENFEEFNGGNCTYTI
DGDIIFGISNYLWRIDKDGTKSKLSDFRFEWNQTIFSDGEGNYYAPDIGRDNGAVIKIDK
LGNSMVVATNLISRLDREYDRHNDVLLGIGKDDQGSLYIAETAGKRIIKFSETGEKETFY
TSGGDWFPNGITFYSGEAYILEVKMDNGYEGPRITKLLKDGTSEVIFNYDTHKNPVTSGS
SKNRDEEELNLIWFYLGLALIIIVVLLLYRRLNIPASHLRGGN
>OMIFANIC_00988 Outer membrane protein MIP
MKTSILLFAFVWLLSIPVSYAQQIELPSGIVYTLIESGSETIPDTNRVLVRYSYTNSKGE
VHRENVSKERPMIIPKSFLNNQENNIYEILSRLNVNDSISASMAVDQIYSMVPEGVDPKA
RWNVNLKVTGSMSPAEYKAYRKQQIVDMRPADDKDGIKQLAKDIDLIEEYLKVNKIDALR
TPSGLFYSITTKGNGDTVKKGDTIRTNYTGFLLDSGFHFDTSIEEVAKQHNLFNPDFTYE
PFKTVIGESKVIDGWDEAFQLLNQGSKATLYIPSMLAYGPRKLSEDIPANSVMVFEVELV
EIIRN
>OMIFANIC_00989 Arginine deiminase
MPKLEDAYDPKSAEHIKAGTYPSEEAMVREMEGVVDVLSKHGVHVFRPHTLENYNQIFAR
DISFVIENKIIIANILPDREREVDATEHVWSHVEKSFRVILPDDCHVEGGDVMPWGDYIF
VGTYRGDDYADYITARTNMEAVEALEQLFPHKIVKSFNLRKSNTNAKENALHLDCCFQPL
GKGKAIIHKESFLEEEEYEWLVNFFGKENCFNISTDEMARMYSNIFSISPDVVISEKNFT
RLNDWLRSEGFTVEEVAYGEIAKQGGLLRCSTMPLVRE
>OMIFANIC_00990 Citrate synthase 1
MSKTATLTIDGASYEFPIIQGTENELAIDIKSLRGTTGGVTTIDPGYKNTGSCESAITFL
NGEEGILRYRGYAIEELADKADFLEVAYLLIFGELPSAETMEKFHGDIKAQSRVDEDVKK
ILDGFPKTAHPMGVLSSLTSALVAFNPSSVNVDSEDEMYNAIVRILGKFPVLTAWTYRKR
AGLPLDYGDASLGYVDNFLKMMFKHPNDEYKSNEIVVDALDKLLILHADHEQNCSTSTVR
IVGSSHAGLFVSISAGINALWGPLHGGANQAVIEMLEAIKEDGGDTKKYMAKAKDKNDPF
RLMGFGHRVYKNFDPRAKIIKKAADSVLTDLGVDDPVLDIAKGLEKEALEDSYFVDRKLY
PNVDFYSGIIYRAMGIPVEMFTPMFALGRLPGWIAQWREMRLRKEPIGRPRQVYIGENLR
QFKDIENR
>OMIFANIC_00991 Enolase
MSIIIDIHARQIFDSRGNPTVEVDVVTENGFVGRAAVPSGASTGEHEAVELRDGGKNYMG
KGVLKAVENVNGKIAGTLLGVSVFEQAEIDKIMIELDGTKNKSKLGANAILGVSLASAKA
AAHELGMPLYRYVGGVNATTLPVPMMNIINGGSHSDAPIAFQEFMVMPVKAESFTHAMQM
GSEIFHSLKKVLHDRNLSTAVGDEGGFAPALDGTEDALDTIGLACEKAGYKLGDEVMIAL
DCASAEFYVDGKYDYTKFEGEGGSVRSSKEQADYLAELCEKYPIISVEDGMDENDWEGWK
YLTERVGDKVQLVGDDLFVTNVERLGRGIDEHIANSILIKVNQIGTLTETIDAVSMAQNA
GYTTVMSHRSGETEDNTIADLAVALNCGQIKTGSASRSDRMAKYNQLLRIEEQLCDVAYY
PGRKTFKV
>OMIFANIC_00992 Carbamoyl-phosphate synthase small chain
MKYQKRKKAIVLLADGTIFYGKAVAGKEGSSFGEVCFNTGMTGYQEIFTDPSYYGQLMVA
TNAHIGNYGANSEEVESEGVKIAGLICRNFSYNYSRPAADESLEEFLDKNNLLAISDVDT
RALVNYIRDNGAMNAVISTEVDNIEGLKAQLAEIPDMNGLELASKVSTKEPYFFGEPNAT
YKISALDIGIKKNILRNLAQRDCYIKVFPYNATYEEMREFQPDGYFLSNGPGDPEPLTES
FETAKQIIDSDAPLFGICLGHQVIALANGISTYKMHNGHRGINHPVMNLLTGKGEITSQN
HGFAINREEAEAHPEVEITHVHLNDNTAAGIKMKNKPVFSVQYHPEASPGPHDAEYIFDQ
FITTIKNNKLETA
>OMIFANIC_00993 50S ribosomal protein L17
MRHGKKVNHLGRKTAHRKAMLANMACSLIEHKRINTTVAKAKALKQFVEPLVTKSKVDTT
HNRRIVFSRLRQKEAVTELFREVATKVGDRPGGYTRIIKLGNRLGDNAEMAMIELVDYNE
LYNAGKPSKKKSTRRSRRGKGAKAVAPAIDTKANKEEE
>OMIFANIC_00994 DNA-directed RNA polymerase subunit alpha
MAVFSFQKPDKVIMINSTDFEGKFEFRPLEPGYGLTIGNALRRVLLSSLEGFAITSVRIE
GVDHEFSTIAGVVEDVTEIILNLKQIRFKRQIDEIDNETVTVSVSGAQQLTAGDFQKFIS
GFQVLNPDLVVCNMDAKVNLNFEITIEKGRGYVPAEENKKANAPLGTIFTDSIYTPIKNV
KYSIENFRVEQKTDYEKLVFEIITDGSIHPKDALTEAAKTLIHHFMLFSDERITLEADEI
AQTETYDEESLHMRQLLKTKLVDMDLSVRALNCLKAAEVDTLGDLVSYNKNDLMKFRNFG
KKSLTELEELVNVKGLSFGMDLSKYKLDKD
>OMIFANIC_00995 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGDDKSFEKRNYPPGQHGNNRRRGKKSEYAIQLAEKQKAKY
TYGILERQFRNMFKKATSSPGITGEVLLQLCEGRLDNVVYRMGIAPSRRAARQLVSHRHI
TVNGDKVNIPSFQCKPGDVIAVREKSKSLEAIENSLANASHVYEWITWNSETMQGTYVSV
PQRLQIPENINEQFIVELYSK
>OMIFANIC_00996 30S ribosomal protein S11
MAKTKGTRKRKVNVESVGEAHVTASFNNIIISLTNKNGDVISWSSAGKMGFRGSKKNTPY
AAQLAAEDAVTVAKDAGLRKVKVYVKGPGNGRESAIRSIHNAGIEVTEIIDVTPMPHNGC
RPPKRRRV
>OMIFANIC_00997 30S ribosomal protein S13
MARIAGVDIPKQKRGVIALTYIFGIGKSRALDILEKAGVSEDKKVNEWNDDEIGKIREAV
GSFKIEGELRSEVQLSIKRLMDIGCYRGIRHRTGLPLRGQRTKNNSRTRKGKRKTVANKK
KATK
>OMIFANIC_00998 Translation initiation factor IF-1
MAKQPAIEQDGTIVEALSNAMFRVELENGHIVTAHISGKMRMHYIKLLPGDKVKLEMSPY
DLTKARITYRY
>OMIFANIC_00999 Protein translocase subunit SecY
MKFIETIKNVFKIEELRNRIVVTLGLLLVYRFGAQVTLPGIDASKLAEFAGKFDAGGIGG
LLNAFTGGAFANASVFALGIMPYISASIVVQLMQIAVPYLQKLQKEGESGRKKINQITRW
LTIGICLVQAPSYLAGLPALGVPSEAFIMVQQGMGTMFYVSSVIILVTGCVFAMWLGEKI
TDKGIGNGISILIMVGIIATLPQSFIQSVAARLQPGAGDVIMILIEVVIWFIIILASVML
VMAVRKIPVQYARRTASGGYEKNIFGARQFIPLKLNASGVMPIIFAQAIMFVPSAVASLS
DSEFAKGIQATFSDIFGLWYNVVFAILIIIFTYFYTAITVPTNKMADDLKRSGGFIPGIK
PGTDTAEFLDRVMSQITLPGSLFLALIAVAPAFVVKLMGVQQGWALFFGGTSLLIMVGVA
IDTMQQINSYLLNRHYDGLMKSGKNRKAVA
>OMIFANIC_01000 50S ribosomal protein L15
MDLSNLKPADGSVNRQGKRLGRGQGSGKAGTSGRGHKGAKSRSGYSKKLGFEGGQMPLQR
RVPKFGFTNINRKEYQGINIDTLQKLVDDKKIKDAVDFDTFVSLRLAGKNEMVKILGRGE
LKAKLKVSAHKFTASAKEAIEAAGGEVVTL
>OMIFANIC_01001 50S ribosomal protein L30
MAKIKVTKVKSAINRTQNQKRTLEALGLKKIGQTVEHDDTRNILGMVNKVKHLVSVETA
>OMIFANIC_01002 30S ribosomal protein S5
MYQDYKNVELVKPGGLELKDRLVGVQRVTKVTKGGRAFGFSAIVVVGDENGVVGQGLGKS
KDVASAIAKAIEDAKKNLVRIPLNRATLPHEQKGKYGGARVTLLPAAPGTGVIAGGAVRA
VLEAVGVHDVLSKSQGSSNPHNVVKATFDALLQLRSAQIVAKQRGISLEKLYKG
>OMIFANIC_01003 50S ribosomal protein L18
MALSKNDRRDRIRFRIRKTVSGTAQRPRLAIFRSNKEIYAQLIDDVTGTTITAASSRDKD
LKASKVNKTDAAKLVGKAIAEKAQKAGVETVSFDRGGYLYHGRVKSLAEGAREGGLKF
>OMIFANIC_01004 50S ribosomal protein L6
MSRIGNNPVAIPEGVTVEVKDNVITVKGKLGELTQEFDGVSVKVEEGNVMISRPSDAKDH
RAKHGLYRSLIDNMINGVSTGWTKELELVGVGYRASNQGQKLDLAVGFSHNIVLDIAPEV
KVETFSEKGKNPRVKLTSHDKQLVGQVAAKIRAFRKPEPYKGKGIKFVGEQIRRKAGKSA
>OMIFANIC_01005 30S ribosomal protein S8
MTTDPIADYLTRVRNAVKAGHRVVEVPASNLKKEITKILFDQGYVLSYKFEDDKGPQGTI
KIALKYDKLTKDPVIKKMQRISKPGLRKYAGSTDMPRILNGLGIAIVSTSAGVMTGKQAE
SQNVGGEVLCYVY
>OMIFANIC_01006 Alternate 30S ribosomal protein S14
MAKESMKAREVKRARMVAKYAEKRKALKEAGDWEALQKLPKNSSPVRMHNRCKLTGRPKG
YMRQFGVSRVMFREMANKGLIPGVRKASW
>OMIFANIC_01007 50S ribosomal protein L5
MGYIPRLKEEYKSRVVNALTDEFGYRNVMQVPKLEKIIVSQGVGAAVADKKLIDNSVEEL
TNITGQKAIATISKKDVANFKLRKGMPIGTKVTLRGERMYEFLDRLITTAIPRIRDFNGI
KATGFDGRGNYSLGVTEQIIFQEIDIDKVKKIEGMNITFVTSAKTDKEAKSLLTELGLPF
KKN
>OMIFANIC_01008 50S ribosomal protein L24
MGKLKIKSGDNVVVTTGEHKGSEGRVLKIFRDKNKAIVEGVNTVKKHEKPSAANPQGGIT
EKEAPIHISNLALIDPKSGEATRVGYRMEDGKKVRFSKKSNQVL
>OMIFANIC_01009 50S ribosomal protein L14
MIQQESRLKVADNTGAKEVLCIRVLGGTKKRYASIGDKIVVTVKDATPNGTIKKGSVSTA
VVVRTVKEVRRPDGSYIRFDDNACVLLGPQGEMRGTRVFGPVARELRDKQFMKIVSLAPE
VL
>OMIFANIC_01010 30S ribosomal protein S17
MEKRNLRKERIGVVTSNKMEKSIVVAEVKKVKHPMYGKFVLKTKKYVAHDEKNDCNEGDT
VKIMETRPLSKTKCWRLVEIIERAK
>OMIFANIC_01011 50S ribosomal protein L29
MKQSEINQASSAELQEKLAETRQAYSDLKMAHTISPLENPIQLRAHRKTIARIATELTNR
EEQ
>OMIFANIC_01012 50S ribosomal protein L16
MLQPKRTKYRKMQKGRMKGNAGRGNQLSYGTFGIKSLDSKFLTARQIEAARIAATRYMKR
EGSIWIMIFPDKPITKKPLEVRMGKGKGAVEYYAAVVKPGRILFEVSGVTMETAKEALRL
AAQKLPVRTKFVVSRDYQG
>OMIFANIC_01013 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWESNWYGGNDYGDKLAEDDKIRKYIHARLSKASVSRVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKITGKEVQINIHEIKRPELDAHLVAASIA
RQIENRISYRRAIKMAIAAAMRMNAEGIKIMISGRLNGAEMARSESYKDGRIPLSTFRAD
IDYALVEAHTTYGRLGVKVWIMKGEVYGKRELSPLVGLAKKGGKGGSGRGGNKSRRRK
>OMIFANIC_01014 50S ribosomal protein L22
MGVRKRERAEAIKEAKKTQYFAKLNNCPTSPRKMRLVADLVRGEKVDKALNILRFSPKEA
SRRLEKLLLSAIANWQAKNEDASIEDADLFIKEIRVDSGTMLKRLRPAPQGRAHRIRKRS
NHVTMVLGANDNTQS
>OMIFANIC_01015 30S ribosomal protein S19
MARSLKKGPYVHYKLEQKVQQNVESNKKTVIKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHAGAKNKGKK
>OMIFANIC_01016 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGFDAITTDKPEKSLLAPKKRSGGRNSQGKMTMRYKGGGHKR
KYRIIDFKRNKEGIPATVASIEYDPNRTAFIALVNYQDGEKRYVIAQNGLQVGQNIVSGD
KVAPEIGNAMTLANIPLGTIVSCIELHPGQGAVLARSAGAFAQLMARDGKYATVKLPSGE
TRMILATCKATVGAVSNSDHQLLVSGKAGRSRWLGRRPRTRPVVMNPVDHPMGGGEGKSS
GGHPRSRNGIPAKGYRTRSKNKASNKYIIERRKK
>OMIFANIC_01017 hypothetical protein
MSITFALIKETKNPPDKRVVLSPKMCQEVMKEHPDARIIVESSDIRVFKDAEYEAMGIPV
VADISEADVMIGVKEVKTEALIPRKKYFFFSHTIKKQPYNRALLKAVLDRKIELYDHELI
TRQNGARLIGFGRYAGLVGAYNAFLALGLRDGLYDLPKVETLHDLEELKRELDKIKLPQN
LRIILSGTGKVAHGGREILDHLKIREVTDADYLSQTFDEPVYCLIDVTEYNRRIDGKPMD
KYEFYDDPSGHESDFMRYARVSDMFIAGHYYGDGAPYLFTREDARDPDFKINLVADISCD
IDGPVATTIRSSTIADPFYGYDPETETETSYNAPGAIMVMAVDNLPCELPRDASFGFGEM
FLKWVIPAFFNGDKDGILHRAKMTTDFGTLTERYAYLHDYAEGLG
>OMIFANIC_01018 hypothetical protein
MKVSFKKRYFIPFLLVLVCEIAIAIFHFHRFVRGFLGDVLVIPLLYFFLRTFSNLRRNKT
LVLVLIFGCIVEILQLIDLAVLFNIQSNVLTIILGNTFDWTDLIAYVLGGIIILLLEKLK
LL
>OMIFANIC_01019 Inner membrane protein CreD
MEQKRSKFGNWMRNSITARMLVVGFLLLVLLIPLQFVQLLISERSLRQQEVIREINSKWG
NEVLLSGPILKIPYKTVVEQRSYDSNSKVMQTTAQTVVKNAYLLPDSLAIDADVESLKRN
RSIYESVVYTGDMDFSGNFPAIDFSEMDIAAEDILWDKITLEIRTSNLKGIRNSVAVRLG
NESLTMTPKYNESYLNIIESTSLGINYSEFTDAIDFTFQIKINGSESLKFVPLGKETSVS
MDSDWHSPSFDGSPLPDEETKNISAEGFHADWHAFQINRQFQQKFLETLPELQSFGFGTN
FIIPVDEYQKSERTSKYGFMVIGLTLLVFLLIQLVSKIYIHPFQYVMIGLALVMFYTLLI
SISEHSSFLKAYAIAGGSVLALITIYSRAILKGFKFPLLVCGSLASLYGFIYVIIQLENY
ALLVGSIGLFIILAIIMFASRKIDWGND
>OMIFANIC_01020 hypothetical protein
MNYRKQLIVRLFKMSEKFYTRHFKKNKQAWNITRSELLTYPTNSFGHSLGKFLSHNKFEL
IPKVERHDAYHVLTGYGTKVEDEIALQYVCFGNGKRSPYLFGVMFLGTLLLPDYLSYYLR
SFKIGRKAHAFHHWDFSKILHSSLDEMRLSIFPKHYIETLNSSCYLAP
>OMIFANIC_01021 hypothetical protein
MGIIDNINKLFDHRIRLGIMSILVVNESADFNRLKELLDVTDGNLASHLKTLEKESYILV
EKQFIGRKPNTRYSATVLGKAKFKKHIEALEKLLKK
>OMIFANIC_01022 hypothetical protein
MSEQDYLNDISEIKDLMNRSSRFISLSGLSGIFAGIYALVGAAVAYWLVTNSGSEYLILD
GKIFRLVLLDLFLIAFFSVITAIFLTTRKARKNGENIWDASSRRLIINFLIPLVAGGAYI
LIILNQQKYGQTAALMLIFYGLALVNASKYSIGHVRYLGITEIILGLICALFPGYGFWLW
VFGFGIMHILYGSIMFVNEKKT
>OMIFANIC_01023 Inosine-5'-monophosphate dehydrogenase
MDERTPISSIMTREVVTLNNTDTLEMAEHLFKSKKIRHIPIVRGPHVIGILSYTDLLRIS
FADAFSEDTHEVDTSVYTLFTIEQVMARNLVSVNSNTTIKEVAEIFAVREFHALPVVDDN
RLVGIVTTTDLIKFLLAQF
>OMIFANIC_01024 hypothetical protein
MNPAEEYILNANEPFRSILLHLQVLIESTIPELELLYKYKIPFYYLDGKKAFLYLNQTKN
YVDVGFWHGAHLTRHTDKLISENRKHMKSLRYFALEDIDDSVLIEVLKEAYSVRDRKYYN
>OMIFANIC_01025 2-dehydro-3-deoxyphosphooctonate aldolase
MNLASIPKIKHTDADNFFLLAGPCAIEGEDMAYRIAEEVVSITNRLNIPYIFKGSFRKAN
RSRIDSFTGIGDEKALEILQKVSEKFDIPTVTDIHESEDAALAAQYVDVLQIPAFLVRQT
DLVVSAAETGKVVNLKKGQFMSPESMKHAVKKVTDSGNEKVMVTDRGTMFGYQDMVVDFR
GIPTMRSFATTVLDVTHSLQQPNQTVGVTGGRPEMISTIARAGIATGVDGLFIETHFDPA
NAKSDGANMLDLSQLEKLLTDLVAIRRTVNQL
>OMIFANIC_01026 GTP-binding protein TypA/BipA
MNIRNIAIIAHVDHGKTTLVDKIMHHCSLFRENEKTGELILDNNDLERERGITITSKNVS
VIYKDTKINIIDTPGHADFGGEVERVLNMADGVLLLVDAFEGPMPQTRFVLQKAIGLGLK
PCVVINKVDKENCTPDEVHEAVFDLMFELGAEEWQLDFPTVYGSAKHNWMSEDWQKPANN
IEPLLDMVLEHIPAPIVREGSPQMLITSLDYSSFTGRIAIGRLHRGILKENMQISLVKRD
GTISKSKIKELHTFEGLGRKKVTEVHAGDICALVGLEGFEIGDTVADLENPEGLTTIAID
EPTMSMLFTINDSPFFGKDGKFVTSRHIKERLDRELEKNLALRVEPTDSADKFMVFGRGV
LHLSVLIETMRREGYELQIGQPQVIIKEINGVKCEPVEQLTIDLPEDVSGRAIDMVTLRK
GEMQGMEAKGERMICTFVIPSRGIIGLRNQLLTATAGEAIMTHRFLEYQPFKGGIPERQN
GSMVSMENGTAIPYSIDKLQERGRFFIDPGESIYEGQVIGENSRQDDMTVNVTKTKKLTN
VRSAGADDKARIVPAIKFSLEEALEYIQKDEYVEVTPSHLRLRKILLKEVDRKRNKL
>OMIFANIC_01027 hypothetical protein
MNFLYFDPGLGAMIAQAVIAAAAGVLLFSKNVMYKVKSFFGMIKDEGDSFDSIDIDEQDT
EKDDKE
>OMIFANIC_01028 hypothetical protein
MTKNNHHEASFRDPSGYMFFDNDVLRRAINPIYFEQYEALNKSGLFNALVKKGLLIPHQE
TEVSSDKIVITPEPIPFITNPYEWSFEQYKHAALLTLQIQKFALSRGFILKDASAYNVTF
HKGKPVFIDTLSFDFYEEGSPWRAFKQFIMHFFGPLVLAHYHGAEILKMMQTHIDGIPLK
LIVSLLPGKSRFSSTLYTNIHLLAKLESKHSDDYKAETKIAKLSKKAQNNMLENLFNYIK
KMDLKESSEWGDYYDKTNYNTDSFNAKKELIRSWVKPLAPQRLIDVGGNDGTFARTVIEE
VPHVIVTDIDSNAVAHNYLQARDKNEENMLAFVCDVLQPAPGIGFNNTERESLIERLQNY
APDITMALALIHHITLSGNVPFEKSAEFFAKFSKYLIIEFPKREDSWVESLLVRKREFIN
HFDFYNEKEFEKGYLKYFTLEKKEEIKGTQRVLYLLKRS
>OMIFANIC_01029 hypothetical protein
MGNNRSKKTGIKSRTGWLARFLKSDKDVPVLAAVAAGLYPIFFYFTNNYTLINTWRHVAY
FAVAFVCVPVVVFFVAHRISRLSVFEKIKKYVLPFLNIFVFLFLLKVCLYAGLQKKLIVL
ILVVSAIFAFFLYKHLKKVIVIQLLLAAIGIYTLVPTVITQLNYSDEWMKQPDNIEDAVF
TKKPNVYVIQPDGYLNFSELNKGYYNYDNSKFESFLAENNFTNYPNFRSNYASTLASNSA
TFVMKHHYYNRGTSFSEAINARNVIVSSNPVLDLFKKNGYLTHLLVQKPYLLLNKPEIGY
DKSNFSLDDVAYIGTGLGPSQDLLPYLKQYMEEDPDTPKFYFMEIFNPGHIHNRKADSRG
VDGERELWIEGLEWANTVLTETISHIKEEDPNALIIIMADHGGFVGLNYSKEIYYKTQDR
DIIYSIFSSQLSIHWPEGEAPEVDKSISTAINLFRVVFSYLCDDPSFIDHLQDDGSYVIL
NKDAPQGIYQYIDDNGKVVFKKR
>OMIFANIC_01030 hypothetical protein
MNKLTAFFQNKKLFPAFVGFASGLYPIIFYYSNNFSLINSWRHLGFFICLFLFVPMVACY
LGFRIFNMEMFKRVKKFLLPFLSVSFFLVFLEISLFASLKVWLTLGIIVIAVIAAILLHR
HLKKIMIIQFILAFLGLFTLVPTLIKQFSYSDEWMVQPDNIEEGVFKKKPNVYFIQPDGY
VNFSELDKGFYQIDNGEFKSFLEDEGFKLYDNFRSNYNSTLLSDMATFAMKHHYSNSGFN
FTEVINAREVIVGSNPVINLFKKNGYKTHFIAEWPYLIANQPEIGYDFSNFSNKDVSLIG
TGYSKAKEIFEPLIQSIEQDSLQPKFYFVQMFMPGHVPAQKEDTKGAKIEKELWIQRLDS
ANIALTRAVKIIKERDPNGLILIMADHGGYVGMDYTLQIRRKSEDRNWVYSIFSSQLAIR
WPDNQAPEYDVKFKTPVNVFRILFSYLTENESYLNNLEEDASFLKIEIDAPKGVYKYIDE
SGNVIFKKI
>OMIFANIC_01031 hypothetical protein
MDYHSDRFQDFSLLIYKEDLLIALLPANLVDNEVISHQGLTYGSFVLQEKCKLLDAFHAY
KKMLEYLHSEGVTTLNFRVIPTFYNNLPADELEYFLYKSGATLRKRDVLMVIDYANKLRF
QKNRREGINKAVRNGLTVTIDDNYETFWNEILIPNLSKKHGVSPVHTLDEIKLLAGRFPD
NIKQVSVYTKEGKMVAGTTVFLTRTTVHPQYVSGNPDKNFYGSLDLAYHYIINECWQDKR
YFDFNISSEDDGTVLNEGLIFWKETCGARTWKADNYLVDTASYKQLNLLLK
>OMIFANIC_01032 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIPFLDLHMVNLRFETEFKSKYEEFMNSGRYILGEQVDLFEKEFADFCGTLECIGVGNGL
DALRLILEGYKSLGKLNPEDEVLVSSNTYIATILAIKQAGLIPVLVETDPQTYNFELSDL
EDTLTKRTRAIMPVHLYGQISPMKEILAFASQYDLLVIEDAAQAHGALDTDGKLAGNLGH
AAGFSFYPTKNLGALGDGGAITTNDSKLAEVVRKLRNYGTSSKYVNDILGFNSRLDELQA
VFLRTKLPYLNADNKRRMEIAKRYLSEVENEKITLPVHTGETDHVFHLFVVRVKDRLEFM
EYLKDNGIGTLIHYPIPPHKQQALEEYAHLSFPVCEQIHREVVSIPMSPVMMDNEVSRVI
SILNSY
>OMIFANIC_01033 Lipid III flippase
MKIPDFIRANVLLKMTSLNAAVITVRLIVSLFIQRLLAEIVGEAGISKIGQLRNLTQILT
SISSVGIFNGIVKYVSEYKEDKEQLKRLFSTAFLLVVIGVIVSGTLLFFGADGISNYLFS
STDFSYLIKLVAVIVPFIGIQRVFNGVVNGLSMYKKFAKIDLFAYLLSAILTVILLLNYN
IEGALIAIALTPVIQLTVLLIIFFSVLKEYVHFKKISMKAPMGKSLLAFTLMSFVSTVLL
NYVEIDIRTMIVNRITEEDAGIWTAMTFISKNYMVFSGAIFTLYVLPKFASIHTRSGFNR
ELLNIYKTLLPIFGVGMILVYLFRNLVIDIIYPDFTAMAPLFKWQLMGDFVRLASVVLAH
QFLAKKLVRNFIFTEILSLALFYGLARYFTTTHGVEGVVIAHFIRYIIYFFVVFFLVFRY
FKKQVPST
>OMIFANIC_01034 hypothetical protein
MRTFAQALLFSEYNKDMKILLVGEYSRLHNSLKEGLLVLGHNVTLISTGDFFKKYPSDII
LKRKFDRGFAKKIKVGIFKLTGIDITSYLLKKQFFKHSKHLKGYDVVQLINESPFAVDPK
IETELISFLKEYNKKLFLLSCGTDYLSVQFAMSDTLPYNILYEYKSGNIPATQFRFILKY
TKPEFKKLHEHVFSVIDGVIASDMDYHLPLKDHPLYKGLIPNPVNITRLPAMPQYSEGPI
VIFLGINRDNYHSKGIRFFEEALEIVSEKYSDKIEIQVVENLPYTEYIERFNKAHILLDQ
VLGYDQGYNALEAMAKGKVVFTGADELFENYYNLTNPVAVNALPDPQQIAGKLEELILHP
ERITEIGRNAREFVEREHDYKLIAERYTSVWNAN
>OMIFANIC_01035 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MAGGGAERSCAMLSEMLVALGHEVHIAILNDAVDYPYSGTLFNMGHFKEDKDSLGKRYKR
FRLLRRYLLKNEIEVVIDHRPKNQYYRELFYHHYVYKGLKRIYVVHSSNPVLYLTQHPKK
FVKLLNKNAANVAVSKYVEDEVLRPIGVQNTRTIYNAFHPSWAEKKNLFPAELENRTYIL
SYGRIEDSVKDFSFLIRAFNESKLWMQQVKLVIMGEGSDKENLQELAANLEAAGHILFLP
HISEPFDIIKKARFVSLTSHFEGFPMVLVESLSLGTPVVSLDIVSGPGEIIQHKKNGLLV
AKREVSLFAEAMRNMVENDSLYQDCSQYARKSVVQFSFDSISKEWNKLITDVVR
>OMIFANIC_01036 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MSYVDIDTISLLEIPKISDPDGRGNLSVIEKNVLPFIIKRVYYLYDVPSDSSRGGHAHKE
LKQFIIALSGSFDVVLDNGRTRRTFTLNRPNKGLLIPSGVWRELENFSAGAVCLSLVSEH
YNEDDYIRDYDDFVSSK
>OMIFANIC_01037 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MSRFSVIIPLYNKSNDIQSTIESVLDQDFSDFEIVVVNDGSTDDSEAKVKAISDDRIKLF
SKENQGVALTRNFGVEKATADYITFLDADDLWYPNHLKDLDTLTRSHPQTKWFATAYEKR
FNSKLSVPLDAPVMKQSNWYGIVDNYFENCLVDSIAWTSAMCFKKEFFLELNGFDHNITN
GAGEDTDLWIRAALAAPMGFCTNISAVYNLEGSNRISLTPTLHRVFMDPDNYEEAAKKDI
YLKKYLDRNRYSFAMQHKLVGDKESCKRFLHKIDYDNITAKQRLLLKLPNVFLKILIWVQ
ERFASGGIRLTSFR
>OMIFANIC_01038 hypothetical protein
MSKSLSILIPTYEYDVYTLVERLHAQAMKAAFTFEISVLDDCSPNPPPANEKINSLAHCN
YSQLPQNIGRSAIRNLLAEKATFDTLLFLDADTMIFRKDFIETYLDAIDADTQIIYGGIV
YQKEVPPADEKLRWVYGNKREALPVSERIKQPHLRFLTLNFLIKKSVFSTLKFNEKIPNL
RHEDTLFALDSKKKNIRVRHIDNPVVHLGLESSEVFLRKSNEAVDALKLFVQEGLINAEE
TSLSKKGEQIKGGIMGALVKLVYALFKKPMEKNLLSASPSLKIFDLYRLGYYLQKSEN
>OMIFANIC_01039 Peptidoglycan O-acetyltransferase
MLFNTIDFAIFLPVVLILYWAIARRSIQLRNVFLVIVSYVFYSFWDWRFLSLIFASSLLD
YFVGRKLSVTKDKLMRKVWLGVSLFFNLGMLFTFKYFNFFVETFVDTFALFGTKFNYNSW
QIVLPVGISFYTFQTLSYTIDIYRKRIGPTHDIVAFFAFVSFFPQLVAGPIERASNLLTQ
FETRRVFNYSRSVSGLRLILGGLFKKMVIADNCALFVNNIFEQYEVASGSTLLMGAVFFA
FQIYGDFSGYSDIAIGSARLMGFDLMKNFNYPYLAQNMSDFWRRWHISLSTWFRDYVYIP
LGGSLVSKARLTINILIVFLLSGLWHGANLTFVFWGLLHAIFVLPVLLFFKNKNVSFSKN
KKLPTLKEFLNITGTFFVVVIAWVFFRAETITDAFEYLSIVFSSSLFTMPVVSRGALLLL
LGYMVIEWIQRHQDHFMDITNLRNRFLRYIVYLVAVFCVFYYAGDVQPFIYFQF
>OMIFANIC_01040 hypothetical protein
MKQLTVKIVIFLVPVILSWATVEIFYRTVDTNYSRKHEVIQKHYDSAEVLVLGSSHSYYG
INPDFFTRNTYNFSNISQSLYFDELLLEKHIDSMLNLKAVILTIGYFTLSQEDDGSEDRW
RKYFYDQHMDLDVPSVSRLDPKKYSLALSRRFNRSVDLIYKYIKNGTIITHVSNGYGIQD
STDIVSNKDEVSLNIARKHENGSMDFKVNKERLKRIIATCRGRRVKVYLVQMPAYPTYYN
ALNRDKWKMINRVLEDLDRTSEYVKHINLSRYQIFTRDDLRDADHLTNEGAAKCSKLLSD
IIETNL
>OMIFANIC_01041 Cell division ATP-binding protein FtsE
MGKPVLFLKEASIFQRENLILSDVTLEVKKGEFVYLIGKTGTGKSSFMKTLYGDLPLQKG
DGEIVGYDLATLKESDIPFLRRKLGVVFQDFKLLNDRTVKDNLWFVLTATGWKDKAEMDA
RIDQVLDKVGMKTKSFKYPYQLSGGEQQRVAIARALLNEPELILADEPTGNLDPQTSVEV
MEVLQEINKNGNTILMATHDYALILKYPSKTLKCDDNQVFEVVQKTV
>OMIFANIC_01042 Cell wall-associated protease
MKVRYILSFLLLFAAILNAQEVPDEDRYYFYVTIKNAENLVFSKNEDGTLSLSAPTSIEE
AAIYNSYKIYEFERAFPGSRRSLLQEVYRVVTNRVELIGSLWRTFPEKYTKVDQFYPNET
AFYPNDYGTTSPKKNLGKNLPLYDLDLINAAEAWGITRGSEKVVVGISDARVDSTNAEFK
GRVTYLKYSNSTRGQQCAHGSNVAAISIARADNAYGRPGICSDCSVISNGYGSFKYIEEL
VAAGARVINASWATCKMGKFHKEIEKRINELYEDGIIIVAGAGNAKNCNGDDDFPPDDYA
YPASFEKVISVTGVFSRFDSHLDSTFMDKDGYKSAQRLKDRHAKVHAIVNSGKVIPKYVK
YAMQYNKSIDICAPAQSYLLGNELCDNEAVFGGATSSTAPYITGVIGLMWSVNYCLDAYE
TESILKLTSAAIDHLPGNERFKGQLGSGRVDAYKAVKMARDMKELMGNVNVSGRDFSRFH
FRLKNSPYNITVENQTFRDSSSVAFTARHGIVLKPGTRLAPDKNGYVSLGIDPALPIGEC
EPKPPKKYESLYEEQTNRPVNTGNLYNFGVNYSSKNKQLAIRVKAASLLRMKGVYYTVKV
FSPDKRLLKEKRFTLPEDGSMNIDVNSYEFSDVLITCGTRKENHRINTRAKGN
>OMIFANIC_01043 hypothetical protein
MKNIMILCCLLIATAGTAQRNTFKNITEKKGMIGIGTKSPDELLTVKGKIHTQEVLVDLN
GAVAPDYVFEHYFLGSSESKSDYNMLSLSEVASYIAANHHLPGVPSAKTIYEEGLSLKAM
NLILLQKIEELTLYTLEQQNEIETLKQAVTNLQNK
>OMIFANIC_01044 Lipopolysaccharide assembly protein B
MFRNLIITAFFVCFSFSVLSQQTAIFTNDLEAFNKAIELYNNEQFLAAQSLFDRVKNQVN
DETIKGDCAYYIANCAVRLNQQNADQLMESFVEEFPTSIKRNDAYINVANFYFENGRYSY
ARKWYDKVDETSLGRSERERFNFNNGYAYFKNKRYNEARKYFNRVSDSQKYGSQAKYYLG
FIAYEGDEYEQANELFQEVKGDERYAEGLSYYQADMNFKLGNFQKAIDMGLEQYDSASPK
DRSELSKIIGESYFNLGKYNEAIPYLTQYMGKRGKWTNTDYYQLGYAYYMQKDYENATGE
FNKIVDGDNAVAQNAYYHLAESYMKLDRKQQGLNAFKNASEMDFSDEIREDAWLNYAKLS
YEIGNSYQPVPQVLLTFIETFPKNKNNEYLKDLLIDSYITSKNYREAIELLENNKSFENK
LAYQKVAFFRGLELYSEGRYNEAVSYFDKSLKEPRDAIYTARAIYWKAESDYNNSDFNDA
LVGYKQFLQLPQASQTPEYGNSRYNLAYNYFKLKNYSEAISNFKGYVESSTSDGARKQDA
HLRLGDSYFVTSQYWPAMENYNEAITLGSPDEDYAAFQKAISYGFVDRINQKLKGLEEFN
SAYPRSIYGDDALYELGNTYVALERNDDAISTYDKLVRDLPKSSYVSRALLKKALIYDNT
GRSNDALSIFKRVANDFPGTDEALQGVASAKLIYIDQGRVGEYADWVGTLDYVEVENAEL
DDATYTAAEKPYLENKLNQAKSRFEEYVSGFPNGRHAMKAHFYLGQIYFGDNEGEQAIPH
FKFVVDRERTEFTEQALARVSELFLAEKDYENAITYLKRLETEADFPQNIIFAQTNSMKA
SYELKRYEDAVSYAEQVLRNDKIDNAIKSDAQVVIARSAMQTGEEEKAKSAYAEVAKIAT
GQLAAEALYFDAYFANNEGKYEASNASVQKLAKDYSGYKKFGAKGLVLMAKNFYALDDAY
QATYILESVITNFTDYPDVVEEAKAELAVIKAAQSKTNASVETGGN
>OMIFANIC_01045 hypothetical protein
MLKDIFSKLFALLIGTQSYSERLVRIVLIITLSLLCITIASAQEKDLGTEVVNIVKPYTP
AISDAFKVRETPVLNDSVTTQKKEVAYEIFSVPVASTFTPAKGKAANVEKAKPIKLYDNY
ATLGFGNYTSILAELYSNFQISRTDNAGFFLRHNSSQGGIDDIRIENKYYDTRLDGNYTS
RQKGMTYAVDAGIEHQIFNWYGLPEFFDSSSGEIVDGIDAQQTYFSGYAGGSIAVEDSFF
EKIGANLRFLTDSYSSSEFNITAQPEFAFPLTQFTLKVDGDINYLTGSFDQGLFGANGMS
YSHLNIGVSPALVYVDEDLTLSLGVAGYVGLDTENSNSDFFIYPRINASYRLVDELLIVY
GGADGGLQQNTYYDFKEENPFVAPALGIMPTSELYNAFGGLKGKLSNSVGYNVRASYGKE
ENKALFQINPVIDVIPDEGFDYGNSFGLVYDDVNTLSVFGELKVEIDEAFSLGVSGEYFS
YSMTNEPEAWNLPDFEVTVFSNFDITEDIYGGGAIFYVGERNILFTGDVGIFGDGMVRFG
TLDSYIDANLHAGYRVNERLSIFVKGSNLLGENYEKWQNYPVQGIQGLLGATYKFDW
>OMIFANIC_01046 N-substituted formamide deformylase
MKKLVLLSLLPLFCITLSCSSEWIPVDLLVQNATVYTVDETFSTVDGFVIKDGKILETGN
VEQLVSKYNPSEIYDAGGKTIFPGLIDAHAHLYGLGNSLQIVDLVGTQSYDEVLERVVSF
QQEKNVDFIEGRGWDQNDWELKEFPTKDKLDSLFPDTPVVLRRIDGHALLANTKALDLGG
VTPETSMDGGEVIVKDGELTGILVDAPMSLVYTNAPEVSVETAARSLVEAEEICLSLGLT
TVNDAGLPRKVIEMIDSLQRRDEMKLRVYAMVANFEENLDYYLNKGIIKTDRLNVRSVKV
YADGALGSRGAAMKAPYSDQPGHYGAMITTEAQMDSLAKRIADAGYQMNTHAIGDSANVA
VLRAYSRVLEGKTDTRWKVEHAQVVSISDFDYFSKNIIPSIQPTHATSDMYWAEDRVGPD
RIKGAYAYKTLLNKAGIVALGTDFPVEKVNPMHTFYAAVARKDLENYPDGGYRMEEALSR
EEALRGMTIWAAYSNFEEMEKGSIEDGKFADFVVLDQDIMKVHEDSIPNVRVLATFVNGE
LVYGN
>OMIFANIC_01047 hypothetical protein
MFAKKNKGTIMKNFPIKLLLCSLLLLLFTACQSDDSGETNNERTENLKALGTSAEDILSD
DFYTRLVVEIVYSNGFRPKQLTIDTFRTFLNQRLNKPGGISIVETVIDPPQGEPYTISEI
RDIESNVRTRYTNGNEIAVFIFFANGNSSNDTDTSVTLGSAYQNTSLVIYEETLQSLPQD
LFLMEATTIRHEFGHILGLVDITGDDIHPEGHIDPDSSKHCLVEGCLMYFASTIPSNITN
PMVSDIPALDPLCIEDLQVKGGL
>OMIFANIC_01048 hypothetical protein
MKIRFLFLTLFFTFCFSSIGQEDPFQQDIIEYLNNNGTRDQYSGAFESMFDVLKQQFSAS
EVPQSVWKELQNDKEKSLDEIVNLLTFAYRNHFTHDEINTMNEFFSTDAGKQMLKDPSQL
STAQNDEISTFFKSDIGIKIEEKKPELSKDIMEISEHWSRDLFAAKMKNLIELGYSTGH
>OMIFANIC_01049 hypothetical protein
MDDIFGRALLDYYNNKYTEDLITETSISEPDEIPLPYLFRGFDEMPMIEQTALLTSRGAV
LDVGCGAGNHSLYLQNKGFEVTAIDESEGAVKVASQRGVNKTLNCSLLDFEGTFDTILLL
MNGTGIFSTVEEVPKYLQHFKKLLKPGGQILVDGSDLQYMYDQTEEGAIWVPGDRYYGEL
EFIISYKGESTAPFPWLYLDERLFEILANENGFDLSIIERGENFDYLARLSVR
>OMIFANIC_01050 hypothetical protein
MEEILKQLPQRAKDTHKENKKFFAKLRKKPPKHLDTLMQALHEEEFQRTDCLDCANCCKT
TGPLFTDRDIERISRHFRIKPQKFIETYLRIDEENDYVLQSVPCSFLGTDNYCSIYEVRP
KACREFPHTDRKKFQQISNLTLKNVAICPAAFNIVEEMKRRLE
>OMIFANIC_01051 hypothetical protein
MILGSNNAPGDKEFEIHGYTMRFTFFKNTLFLLVLICFSCGSGSKSENASNGNDIAIHDS
LAIEGVLKDTNNHSDSQELTMGAQRFQEYEELLRGKNVGIVANQTSVVTYRSEPDNSYRE
INVEMHLVDFLLRKGIRVKKVFAPEHGFRGEADAGEAVKDGLDTNTGLPIISLYGKNKKP
SQEQLGGLDVIIFDIQDVGARFYTYISTLHYVMEACAENNVSLIVMDRPNPNGHYIDGPI
LEPEHQSFVGMHPVPVVHGMTIGEYAQMINGEEWLKNKAKCKLKVIQMLNYSKNTEYSLP
IRPSPNLPNDSSINLYPSLCFFEGTIVSAGRGTDMQFQVFGAPELPKEYFPFTFTPQSNE
GAKYPKFKGEVCNGLDLRETKKLDRLNLEWLIEAYVGYGKKPNFFNSFFTKLAGTGKLQN
QIESGYTYPEIRANWIRDLKDYDLMRKEYLIYK
>OMIFANIC_01052 Lipoprotein-releasing system transmembrane protein LolC
MMLVSIATGVGLQKKIREKVSAFNGDIVITIFDTNFSNDSQIPISKNQDFYPDFNLVEGV
NHIQITALKGGVIRTASDFEGVVVKGVSDDYKWQNFEEYLVDGRLPDFSEDLNSDVLISQ
YLVNRLGLKLGDRIVTFFINADSSKPPRSRGFDIVGIYNSGFQQFDEQFLIADIRHIQRL
NKWDEDQIGAFELFVDDFDEIENIGRRVYQETASTLDTQTIRQKYGSIFEWLDLFDFNIA
LIIGIMILVAGINMITALLVLILERTQMIGILKALGSDDWSVRKVFIYNAMYLICVGLLF
GNVIGIGLLLIQKYFKVFPLNPDTYYVTEAPVYLDIGYILLLNAGTFLLCLLMLLIPSWI
ITRISPVRAIRFE
>OMIFANIC_01053 Putative cystathionine beta-synthase
MDYAENILETIGNTPLVKINKLTAELPCMVLAKYETFNPGNSVKDRMALMMIEDAEADGR
LKPGGTIIEGTSGNTGMGLALAAIVKGYKCVFVISDKQSKEKMDVLRAVGAEVVVCPTDV
APDDPRSYYSVSRRLAEETPNSWYVNQYDNPSNCKAHFKSTGPEIWEQTDGKVTHFVVGV
GTGGTISGVGSYLKMKNPNVKVWGVDTYGSVFKKYHETGIFDENEIYPYVTEGIGEDILP
KNVNFNIIDGFTKVTDKDAAVYTRLLATKEGMFLGNSAGAAIKGVLQLKEHFKEGDIVVV
LFHDHGSRYVGKMFNDDWMREKGYID
>OMIFANIC_01054 hypothetical protein
MKEDFLHYVWKYQKFDTRNLKTVTGESVIVHSPGMHNSNSGPDFFNGQLEIDGQMWAGNI
EIHLKASHWYNHKHQEDSAYNNVILHVVWKYDTPVKRTNTSEIPTIELKHWIPATTRSAY
KKLFDRANRWIPCEPDFYRVDVFTYKNWLDTLFIERMEHRTDQFAARLEQLNNDWEALLF
HLLSEYFGTKVNSDSFGSIATSVNYSLIRKCAGQPGHLEALLLGQAGLLNQQGGDSYYEK
LREEYVFLKNKFKLRNEHVIPPKFFRLRPMNFPTIRLSQLSMLYSKNQQLFSNLIEASSK
GEYYALLKFEASEYWKDHYNFGTQSVSRSKLMSNAFIDLLLINVVLPLKFFYMRTHGQFN
DNEFMDLAQSLGAEENGIIRKFAELRPKATNVLESQALLQLKSEYCEKKQCLRCAIGNWF
LKR
>OMIFANIC_01055 hypothetical protein
MLQLVYKIRHYLEKHGFYVSSRLADRLGMRAKSVRLFFIYISFATLGVGFAIYLTLAFWL
KLKDLVYTKRTSVFDL
>OMIFANIC_01056 Voltage-gated potassium channel Kch
MKRLFKSEIFGALFLVLGAFVTGVLGFKFFSDYSWIDAIYMTVITITTVGYGEVHPLSPN
EKIFASLLIISSIFVVGYAIKVISEYFLSQNNIGNFKLKRVKRSIEYMEGHVIVCGYGRN
GRQATEKLMDYNQKFVVIEMDDDIINQHSKDDTLFVQGNAVEDETLIEARINQASSLICA
LPSDADNLFIVLSARQINPNLKIISRATEETSFKKLKLAGADNVILPDKIGGDHMANLVV
TPDLVEFLDNLSVSGEKDSINVEQIGFENVCPDGAEKSIRELDIRKKTGCSIIGYKGPDG
EYVVNPEPSLKIEKESKLILIGRPDQIRNLMELYNV
>OMIFANIC_01057 Amino-acid carrier protein AlsT
MKKFLLSLFSLLIPYITFAQDMEEIGFDQKIDEAFEPVSSFFTEVIFFEIAGIPFVLVLL
VASAAFFTLAFGFPNIRFFGKAINTVRGKYDDIEHHGLGDERAAVDGDIRDTIRDESKEG
EVSHFQALATAVSGTVGNGNIAGVALAIALGGPGATFWMIVCGLLGMSTKFVECTLGVQY
RDVDENGTVYGGPMYYLSKGLKEKGFATLGKITAVLFAIFCIGGSFGGGNAAQSNQATIV
IKELFSWESTGAGTLVGVVLAIIVGIIIIGGIKRIASVTEKVVPFMAVLYILCCLYIIFS
NYTFIDDAFGLIFTEAFNPKAIGVGSVIGVLLVGFQRAAFSNEAGAGSASIAHSAVKTNY
SASEGLVALLEPFIDTVVICTMTALVIIIFNFGGFFEYGDATGAGVVIIDGVSYEGAGIT
SKAFAEYIPYSKVFLTIAVVLFAVSTMISWSYYGLQSWKYLFGRGKRADLIYKVLFCVFV
VIGAAASMDSIWAFSDAMIFAMVFPNMIGLYFLFPVVKKQLRRYLDAIKLAR
>OMIFANIC_01058 ComE operon protein 1
MNWLKSHLTFDRGQRDGILVLIILNLVLICVILFVDINPEAKLELNSPELLRIKAEVDSL
KLLQKTSTKTANYPFNPNFISEYKAYTLGLTVEEYENLKAFRENNQWINSISDFQRVTGV
SDSLLEMISMNFKFPDWITNPRPKTKSGNYTQATELPYSEKTDLNIATSVELQEISGVGN
VLSGRIISYREKLGGFASDEQLYAVYGLKEEVIERIKQRFTVKAKSTLVTMNINEVSASD
IATIPGIDFELAKEIWEFVRLREGIDDLAQLEKIEGLTPHKLRLIRLYLSTD
>OMIFANIC_01059 Acyl-CoA dehydrogenase
MNELYFTEEHEFFRKSFRDFLQKEVVPHIEKWEKTGHIERFIWEKMGEMGYFGISYPEKY
GGLDLDIFYLVIYLEELQKINSGGFAAAMWVHPYLAMTHVNTEGSEAIKQKYLTTSIKGK
KIGCLCITEPFAGSDVGGMRTTAVKEGDHYIINGSKTFITNGVYSDYLVVSAKTHPELGS
KGISIFIIDRDTPGVSATKLDKLGWRASDTGEIAFDNVKIPVENLMGEEKKGFNYLMQHL
ALERIVMAINAHARSEWAIEYTIQYMKDRTAFGKSIDKFQALRHKVAQMASEVEMCKTFN
YTTAYQIGKKEYVVKEASMAKLVSTRVADEVAYDCLQLLGGYGYIEEYPLARNLRDSRLG
PIGGGTSEILREIIAKIVIDGKEYKPAT
>OMIFANIC_01060 TonB-dependent receptor SusC
MKKYRFIKLVLSVLLGFICTTAFSQTEIKSKVSDFLTFLPIENANVYIKNTTIGTISNTD
GKFVLQVPEEHVNDTLIISSIGYQSFKTVISEFDDSIDVYLEEDIASLDEVVIVAETRPK
TGNDIVLRALEELPDNLPEYPYLQKGFLRHKERNKKEYKWLIESALTIYDSSFASGSRRN
LKINVDENRKSYDLRDIDSLFTYSSYLKSTGMNINARSQKLRRDTIRTASLVKAIKWNDE
RVNGLENLFKGKLNLVRNSNMKKALFGEGMLDKHQFRLDTILVDDGRKIYKIEIAKSKDF
IGLNTPNIYNEGFEARGWIYIYWDNFAIKRLEYELVAASDVQKRRSKSLFDTQVNHKLVI
TYKEYGEKMYPNYFYYETPKLVKIGDRSSEREQKEKELGIDKDEQFYYTIQEILFTEIIQ
DPIAVEQALQQEWTSDIFSPRPYNEEFWERYNVLLESEEEEQLIQDLSRRATLYKQ
>OMIFANIC_01061 30S ribosomal protein S21
MPSLKRGGDDTMLIIPVKDGENIDRALKRFKRKFDRTGTMRQLRKRQQFTKPSVKRRAQI
QKAQYIQHLRDQEEI
>OMIFANIC_01062 Tyrosine recombinase XerC
MPFSEFSNYLTLEKNYSKHTIMAYLKDLESFAEFAFEGYEVRSIKEIPYAIIRSWVVSLV
NEGISNRSINRKVSSLKSYYKFLLKTKQIEANPLAKHKALKTSKKIQVPFSEKEIADVLE
LLKEAEGFEGIRNKLIVELFYSTGMRRAELVNLKYSDVSLTQSTLKVLGKRNKERLIPLL
PSVLSTIESYMAARNELEMIRDEDYLLLSKKGVKIYETLVYRIINSYFSLASEKVKKSPH
ILRHSFATHLLNEGADLNAVKELLGHSSLASTQVYTHNSIAQLKEVYRNSHPRNTK
>OMIFANIC_01063 Ribosome hibernation promoting factor
MKVTVQAPNFAADEKLIMFIERKLNKLEQFYDRIIFADVFLKVQKTREKENKSVEILLTV
PGGDLIVKKEARTFEAGTDECMQSLERQLKKRKEKLRAKAS
>OMIFANIC_01068 Elongation factor Tu
MAKETFDRSKPHLNVGTIGHVDHGKTTLTAAITKVMADAGYSEASSFDQIDNAPEEKERG
ITINSSHVEYQTANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFMNKVDMVDDDELLELVEMEIRDLLSFYEYDGDNGPVIAGSALGALN
GEEKWVETVKELMEAVDTWIEEPKREVDKDFLMPIEDVFSITGRGTVATGRIETGVANTG
DAVDIIGMGAEKLTSTITGVEMFRKILDRGEAGDNVGILLRGIEKTDIRRGMVICKQGSV
TPHAKFKAEVYVLKKEEGGRHTPFHNNYRPQFYVRTTDVTGNIILPDGVEMVMPGDNLTI
TVELIQAIAMNVGLRFAIREGGRTVGAGQVTEILD
>OMIFANIC_01070 Protein translocase subunit SecE
MVDYIKESYNELRNHVSWPTWAEAQRLTVIVAVFSIVLALAVFGVDKVFSNIIELYFNWI
KS
>OMIFANIC_01071 Transcription termination/antitermination protein NusG
MTETKSTKKWYVVRSVSGQENKIKTYIESEVKRLNLEDYIEQVLVPTEKVIQIRNGKKVN
KERVYFPGYIMIQANLGGEIPHIIKSINGVIGFLGETKGGDPVPLRQAEVNRMLGKVDEL
TVQDENVNIPYVIGETIKVIDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSYMQ
VEKV
>OMIFANIC_01072 50S ribosomal protein L11
MAKEVGKVVKLQVRGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKQGKILPVVITV
YKDKSFDFIIKTPPAAVQILEAAKVKKGSGEPHVNKVASISWDQVRTIAEDKMPDLNAFT
VESAMKMVAGTARSMGVKVKGKGPF
>OMIFANIC_01073 50S ribosomal protein L1
MARLTKKQKEAKGKVEDRTYSVSEASALIKEISKVKFDATVDLAVRLNVDPRKANQMVRG
VVTLPHGTGKDVKVLALVTPDKEAEATEAGADYVGLDEYLTKIKGGWTDVDVIVTMPSVM
GKLGPLGRILGPRGLMPNPKTGTVTMDVAKAVSDVKAGKIDFKVEKTGIVHAAIGKASFD
AEKIAGNAKELLTTLVKMKPQSAKGVYIKSIYMSSTMSPSVEIDTKRFSDQ
>OMIFANIC_01074 50S ribosomal protein L10
MTREEKSQVIENLTAELADNTTIYLADISGLDAKTTSNLRRACFKAGVRLSVVKNTLLSK
AMESSEKDFGVLSEVLKGNTSLMFSETGNAPAKVIKEFRKKSERPVLKGAYIEEAVYVGD
EQLDNLVNIKSKEEIIGDIIGLLQSPAKNVISALKSSGGTIAGIVKTLSEKEG
>OMIFANIC_01075 50S ribosomal protein L7/L12
MADLKDFAEQLVNLTVKEVNELATILKDEYGIEPAAAAVAVAAGGGAAGGDAAEEKSEFD
VILTAPGGSKLAVVKLVKELTGAGLKDAKELVDNAPSPIKEGVAKDEAEALKAQLEEAGA
EVELK
>OMIFANIC_01076 hypothetical protein
MFKLESDANTVMVIVVPTSSQVTSVMSTASMVIPQASKESGPPGISTKNASPSELFRVTV
QLAGSNCPLNPGTKLLIVVVAAPKRPSTEDERNPNTSPGARLISPLFPLWSLAPPGSVSS
VKTPFNRYPKLSNAGPSGVV
>OMIFANIC_01077 hypothetical protein
MLNKIFTVLFVFGLFSCANESSEAKKTGEFTDGATTLFTQIPAEQSNIIFRNKVEETMEF
NFLNYPYLYAGAGLAVGDVDNDGLQDVYLISNQGPNKLYKNKGDLTFEDITVASRTQDYK
GFSTGATMLDINSDGWIDIYVSKAGSLGNDEERRNKLFVNQKDGTFTEAAAQWGLDDPGY
TTQVYQLDYDKDGDLDLYVLNYRYDFKNNTKISGEIQSQIEEITSDQLYRNDGTRFTKVT
GEAGVYNKSWGLGGAVGDFNDDGWDDIYIANDYLEPDIMYINQKDGTFKDEIKQRMNHIS
FNSMGVDYADLNNDMLPDLVTVDMLAENYARSKENMASMSTEGFENMVKVGYHHAYMANT
LQYNKGNGKFQETAQLSGIVKTDWSWAPLIVDLDNDGLKDIFISNGVVKDYTNQDFRKDL
RARNARGEAMTLDAVLDLMPSEKLNNYFYKNNGDLSFTNTIEEWGMDDPSFSNGAVYADF
DNDGDMDIMVSKSNDELGLYRNNSNTNYVQVTFKGPKDNPLGIGAAAQLKNSKGEQFQKL
YLARGYQSSVPNVLHFGLGDDPTLDELVITWPDGKVSKIQDPKSNSLIEVDYSTAVAAAS
APKPSTLKANVDIAQLGIDYVHQENAFNDYSLQLLIPQKQSTKGTGIVSADVNNDGRMDF
FVGNAKDAAAALYLQGENGSFTRSSQNLWNSEAKYEDANAVFFDADGDGDQDLYVVSAGY
DLEKNSPLLQDRLYRNDGNGNFSKNTAALPVMLTSGKAVVAGDYDKDGDMDLFIGGNVIP
AEYPKPPRSYLLSNEGGKFKDVTSANNSLSEIGMVSQALFTDYDNDDDLDLMVVGEWMRP
TIFNNNSGTFAQAEGVSGLDKTEGWWFSVTAGDFDGDGDEDYFFGNIGKNNKFQPKKEKP
IYIYGKDFDDNGSYDVALSKINDGRLVPVRGKECSSEQNPYLLDKIATYKEFAQLEMKDI
YGEDKLKDAFKLTVYMFETVYAENKGNGDFEISKLPNAVQTGPTLSLLSADVNKDGHLDV
MGVGAIYDAEVETIRYDSNYGYVLLGDGTGNFTVSQEYDPFVDSDAKDLEALTINGVTCY
AVVSNNAPLEVFTFQP
>OMIFANIC_01078 hypothetical protein
MPPPRFTTGELREGDVNFCYGSRDGQLWPILNRIFKLDLPFETTEIAVEKRKKFLLAHQI
GICDIVESARREKIDASDIGMKDVQLRELLTLITRYPKIDTLLFMGGNSKNGPEYFFRRL
LKKYDLNLKPVSSEVPRIHEFLLPASNRVIRTISLIAPSGAANRAVGSLQKYKDLKNKNP
EMTTVDFRVLQYSEFFKN
>OMIFANIC_01079 hypothetical protein
MKIVISPAKSLDFETKLPTPMQTEACFLSEAERLNKLLKKKSARSLKKLMGISENLAQLN
YERNQEWSVPFTPENARQAVYAFSGDVYRGMDVYTLPEEKIEYMQNTLRIISGLYGILKP
LDLIQPYRLEMGTSMKVGVKKNLYEFWKKKITDKLNEDLADDEVFVNLASNEYFKAIDTK
ALKVPVVTCVFKDFKNGEYKNIMTFAKLARGYMTRYIIDNKCTAIDDLKGFNYEGYGFSE
SMSSEAELVFIR
>OMIFANIC_01080 Ribosomal large subunit pseudouridine synthase D
MAEEITNPDQEPTGNDDLFEHYRFVADKGQQPLRVDKYLMNKIQNATRNKIQKAAKDGNI
HVNDSPVKQNYKVKGGDVVQVLFEHPPYEFLLTPEDIPLNIVFEDDALIVVNKPAGMVVH
PGHGNYSGTLINALTFHFDNLPNNSSNRPGLVHRIDKDTSGLLVIAKTEEVMTHLSKQFF
DKTTEREYVALVWGNVEEDSGTIEGNIGRHPKNRLQNTVFEGDDAVKGKPAVTHFKVMER
LGYVTLLSCRLETGRTHQIRVHLKYIGHTLFNDERYGGDAILKGTHFSKYKQFVDNCFKI
LPRQGLHARTLGFTHPISGERLQFEAPIPEDMELCIEKWRNYSKHVIE
>OMIFANIC_01081 hypothetical protein
MTFLKFLTTKTFLKQLLFALLAVIILTFLILWWLRSTTNHGQKIEVPNLAKLQLDAVEDK
LDEMDLTYEILDSANYNPEYPRFSVIEQIPKAGNFVKEDRKIYLYLNPSGYRKIKIPPVV
GKTLRQAEPTLEAMGFEIGKKSYRPYIAKDEVLELRHKGTKVEPGDELSKTAVIDLILGD
GSGSLNRNAEAESDGDSEGTTDETNGGGDN
>OMIFANIC_01082 D-alanine--D-alanine ligase B
MTKKHIAVAMGGYSSEAEISRQSGEIVCNNLDSEKYKVYPVHILNEGWFYLNDQSEKIRI
DRSDFSFKAGGEKIIPDVVFNTIHGTPGEDGYMAAYWDLLGIRQTSSGFYPAALSFNKRD
CLSVLKHFGIHCANSYYVNQGTDYDLETIVKTTGLPCFVKPNRAGSSFGISKVHDMEDLQ
PAIEKAFKEDPEIIIETALNGTEVSVGAFRKQGEIIILPPTEIVSENDFFDYEAKYLGKS
QEITPARISDEETVAVQLEAKRIYHLLNMNGVTRSDFIIQDGVPFFIETNTTPGLSSESI
VPKMAREAGMTLTEFFGILVEEALAKK
>OMIFANIC_01083 Phosphopantetheine adenylyltransferase
MIKAVFPGSFDPITLGHVDIIERALPLFDEIIVAIGINAEKKYMWSLDDRKAFLEKTFAR
EPKIKVATYTGLTAEFCKKVKARYILRGLRNTSDFAYEQTIAQANDNAFGVDSMFLMGSP
EMSYISSTVVRDIARHGGDYSSFVPPGVQ
>OMIFANIC_01084 Putative SOS response-associated peptidase YedK
MCYDIKASLEAQLSKARRRGDKNAIEEIRRKLIPFTDLPLHHASGFSHPKLLIYPDRSPD
YPEIATWGLVPHWVKDKLQLKKYWNNTLNARGETIFEKPSFRNSARNNRCIIYVDGFYEH
HHYKGKTYPFYIYKKNGEPMALAGLWSEWLDDETGEMLNTFSIVTTEGNKLLSKIHNNPK
IKGPRMPLILPKEIEDKWLEPVHDELDIKAIESLIESYPDNMLETHTVNRLRGKDYPGNV
EEISDKFDYEELIY
>OMIFANIC_01085 30S ribosomal protein S20
MANHKSALKRIRNSETKRLRNRYQHKTTRNAMKKLKELTKKKEAEKMLPEVVSMIDKLAK
RNIIHDNKAANLKSQLTKHVASL
>OMIFANIC_01087 hypothetical protein
MKHGLSSLIEGGKISIKIFKEDEKLKFEIADTGVGATHKESLLNKGIGLMNTNLRLQKMY
ASGLEILDNSPSGLKIKFSI
>OMIFANIC_01088 Sensory transduction protein LytR
MYKVIVVDDEVAGRKLITEYLKDFPSLIIVAEANNGVDAVKVINRFKPDLVFLDVQMPGL
TGFEVLSHLEELPKIIFSTAYDKYALKAFDVHAIDYLLKPYTKDRFKLAIERVSFSENQK
GIAPLAEDLLLKSARYPERILVEYNKKLITVATAEIIWVEAFGDYSKLHTMEDTYVSNYG
ISQLEEKMDPKLFLRVHRSSIININSIKQLDKYSKSYDVTLQNDDVVRVSRGYMPAVKKL
IY
>OMIFANIC_01089 hypothetical protein
MSEFFSDISLAYIPLLFILGATTFTLSTISGGGGAMMQIPILNFLIGTSQTAPVINLGAL
ISRPSRIIIFWKHIEWKVFWYFVPAAVIAALIAGYLFSKVQIVWVQIIVGLFLVSTVFQY
KFGKQARSFPVKLWYFTPLGFFIGIVGTFTGGMGPILNPFFLNAGITKEELVGTKAAQSL
FLGLAQVSSYSFFGLLNRELWIYGIALGLGATLGNFIGKRILSRMSKLSFRRWVIVIMVL
SGFVLIVKALWDVV
>OMIFANIC_01090 hypothetical protein
MVKAKYQSVLDLGEQLKIQDGDVQIKGHQLEVRGTAATQYHKDLIWDEIKKVGGENPSDI
MADIKVADTSVYARHTVESGESLSKIAKHYYGDPMKYKAIFEANRNILKNPDLIHPGQDL
VIPNL
>OMIFANIC_01091 hypothetical protein
MHLAQLNIAEAIASMDSPEMADFVNNIERINTLAESSQGYIWRLTDEGSDNSYSMQLFDS
EFIVTNMSIWKDKESLFDFVYNTGHVEIFKRRKEWFHKMAKSHMVLWYINEGHIPDIEEA
KERLRYLREQGESAYAFTFKSMYREEDAKKL
>OMIFANIC_01092 Protein TolB
MHIRSLALILALLALTPNFGQKKKKKDKKEEDTSWNVANPGDDFNYKSHKFTTDEGTWMN
LDVSPDGQTIVFDLLGDIYTMPITGGKATSIRTGIPWEIQPRFSPDGQKIAYASDAGGGD
NIWTMNLDGSDAKQVTKEKFRLLNNPMWTADGNYLIARKHFTSQRSAGAGEMWQYHVSGG
NGLQLTKRKNDQQDVNEPFTSSDGRYLYYSEDMYPGGFFQYNKDPNDQIYVIQRYDFETG
KTERVTGGPGGAARPTVSRDGKKLAFVKRVREKSVLFIHDLETGEEWPVYDKLNKDQQEA
WALFGVYPNFNWMPNNEEIVFWSGGKINRISIKTLEVKDVPFEIDVTIDLAETVHFNTRI
DNDRFTAKVIRNAVTSPDGRFLIFNALGYIWSKELPNGNPKRLTTGTDLEFEPVISPDGN
SVVYVSWNDLEKGAIFKLPLSGGSPTRLTSEKGIYRTPSFSPDGQSIVFRKENGNNQQGF
TFTKEPGIYIMSANGANMKKVINKGEYPVFSKDGKRIFLQTGGTYFGNLTKKLISVNLEG
KDEKEHVSSKYANRIVPSPDNKWIAFSNLHKVYIAAMPNHGKMLELGPKTKSVPVQQIAK
DAGINIHWSPNSQQVMWTLGDEYFSNRLNEKFIFLPGAVDESAKMPDSGIKIGLTAPVDK
PTGKIALTNARIITMEDDVVIEGGNIIIEENKIVAIGQMIPIPGDAMIYDLQGKTIIPGM
VDAHAHIGAFRYGLTPQQYWPFMANLAFGVTTAHDPSANTETVFTLSELQKTGSLVGPRL
YSTGIILYGADGDFKAVIDNLDDARSSIRRTKAFGAKSVKSYNQPRREQRQQVLKAAREE
GINVVPEGGSNFFHNITMVIDGHTGVEHNIPVAPVYKDILEVWGKSGTGYTPTLIVNYGG
LNGEYYYYERDDVWANERLQKFTPRAVLDSRSRHRTKIPQGEYQNGHILVSQTAKKLSDA
GVKVNMGAHGQLQGLGAHWETWMFAAGGMTNMEALKAATINAAEYIGAGEDIGSLRVGKM
ADLVILAENPLENIENTQTVEMVMINGRLYVADTMNEVGNHPKERLPFWWEQNKYNQAFP
WHAETQSFLDGGCGCQTGH
>OMIFANIC_01093 hypothetical protein
MDEKPELYFPRDVEWREWLEINHSNYPQGVYLIFYKLENGVPTMRWEDAVKVALCFGWID
STVKSLGGGKRQQYFCPRNPKSNWSALNKKYIKELNEAGLIHESGWKTINKAKETGTWTA
MDHVENLVIPSELQHAFDANPEAFENYNNFSRGYRKSYLAWLHNAKRPETRAKRIGEIIR
LCELNIKSPQ
>OMIFANIC_01094 hypothetical protein
MKYKVVVWLLLFTALGYSQTFTKRDSIFGSITPERAWWDLKHYDLNVSVFPDDRKITGTN
TITYTVIDEAKELQLDLQRPMTLLNVTQKGKELEVRSEGMFYYIRLKEKQKIGETYTLSV
QFSGTPVVAIRPPWDGGFTWEKDSNGKHFIANANQGIGASIWWPNKDHAYDEPDNGTDLT
ITVPSDLTAVGNGRLIDTKDNGDTTTWHWRVVNPINNYGINVNVGDYVHFSEKYNGENGE
LDLGYWVLRENLDKARKQFKQVPMMMEAFEHWFGPYPFYEDSFKLVEVPYLGMEHQSSVT
YGNRYQNGYLGSDLSNTGWGLKFDFIIIHEAGHEWFANNITNTDVADMWIHEGFTAYSEN
LYLDYHFGAEAASAYVIGTRRGIRNQSPIIGQRDVRNHGSTDMYYKGANILHTLRQLLED
DAKWRNMLRGLNTEFRLQTVSSKQVEEYLSNQMGKGLTEFWDQYLRTVQIPKIEYKLDAG
KLKFRYTNIIENFDMPVIAIVNGKEEWIFPSSTWSEKEFNETISSFAIKKDFYVTSEKIE
D
>OMIFANIC_01095 Bacterial leucyl aminopeptidase
MKIAISLLFFLFISLNYAQTDPKLYDIIAEVSAERLESDIAKLAGFGTRHTLSDTVSQTR
GIGAARRWIKSEFDKISASCNDCLDVFYQKDLVKQGENNRIVKDVWVVNVAAVQKGTKYP
NRYIIMSGDIDSRVSDPTDFTSESPGANDNASGMAGAIEAARVLSKHKFESSIVYLGLSG
EEQGLFGGKGFAKYAKENDWEIIGVLNNDMIGNIKGVNGVVSNRDFRIFSEPVPPTETER
QRNRRRFYGGEVDGISRQLARYVHKITKTYMPEMNPMLIYRLDRFGRGGHHRPFNDAGFP
GIRIMEAHENYTQQHQDIRMEDGIEYGDKLKFVNFNYAKKLTAVNAISMASLASAPPPPA
NVEIGGVVEPSAKFKWDKVDGAAGYKIYWRDTTSPSWDHSRYVGDISEYTLEGIVIDNYF
FGIASVSADGHESVVVFPSGVFRN
>OMIFANIC_01096 hypothetical protein
MFRHSFKALFILFEIVAHSQPNTEVYIADISITEELIEVGNVVNISNDEGYDNQPSFQSD
NLVLFSGNNKGQTDIAQYNIRFNMKFWYHKGSASSQYSPQRIPNSQHVLSVHLDTNGRQR
LFHHHLTSLEYKEAHPDVRVAYFAMYNENILLGSVLGEENLDLVVANIETKQVDTLAYNS
GRSFHKIPESKSMSYTFVNEEGNHDVYQLDMDSFESFFVTQLPIGVQDHVWLNGTTLLIG
SGSRLYKFDLFGDGTWTEVADLSEYKMDNITRLAISPDGTKLAIVAEPLQ
>OMIFANIC_01097 hypothetical protein
MEEMNYIYVNSLILCKMKNYCLFILCFLFLASIAAQDLQVVETYPAPQSMIASPAGEILV
TFNQEPDMTSINPGSFRVFGKWSGPMEGTYNLSAGTNTVKFSPQRPLFYGEWITVRLSGD
IQSSSGMPLSNGFNYEFWTKSLPASLDLEYGGEINMRQSGEGALTCYGAYAGDVNNDEYS
DLVVITEDSDDIRVMISDGSTGYGPFVIIEMPPGLGPSTNEGADFNRDGLIDMAIGSTYA
NNVNIQLGDPVTFFNSQMNYQASEGVRGLAVADLNGDGWDDIVTANRADSNMSILMNDGT
GLFQPAVNIDSGFDGETSIATTDLNNDGFTDLLVATHDDNNVVSLLNDGSGNMTVTSNAG
VGGGPWMLAIGDINGDGFVDAITANRFTNDVSVVFSDGSGGVDLDRHYSVNTFPVAIDLG
DIDGDGDLDFISSNVLGGDYTLMENDGTGQFINARVYPSPDMSACAVIHDRNNDGAMDIT
MIDEAADVVILYNNTLLLNNEDRLRENHLSLYPNPFYDTINASGDIHGEVKLILYDAQGR
LLLSENMSVSKRFDLSDYALSEGSYIAHLFYNDTSQKIKLIKISH
>OMIFANIC_01098 putative acyl-CoA dehydrogenase
MSETTELKKDILRGGQFLVKETSCNDIFTPEDFSEEQKMMRDSVIEFVDREIWPNKERFE
KKDYAFTEEIMKKAGELGLLGVAVPEAYGGLGMGFVTTMLVCDYISGATGSIATAFGAHT
GIGTMPITLYGTEEQKQKYVPKLATGEWFGAYCLTEPGAGSDANSGKTKAVLSDDGSHYK
ISGQKMWISNAGFCSLFIVFARIEDDKNITGFIVENDPSNGITLGEEEDKLGIHASSTRQ
VFFNETKVPLENMLSERGNGFKIAMNALNVGRIKLAGACLDAQRRVTENAVKYANERIQF
KTPIAKFGAIKAKLAEMATSAYAGESACYRASKNIEDRIAIRMAEGNTHHEAELKGVEEY
AIECSILKVAVSEDIQNCSDEGIQIFGGMGFSADTPMEAAWRDARIARIYEGTNEINRML
SVGMLVKKAMKGHVDLLAPAMAVADELTGIPSFETPDYSELLSEEKAMIAKLKKVFLMVA
GSAVQKFGPQLEEHQQLLLASADILIEIYLAESTVLRAEKNAKRFGEDAQKEQIAMAKLY
LYNAVDKISQKAKEGIVSFAEGDEQRMMLMGLKRFTKYQNMPNVVALRNLIAEKVTSENT
YPF
>OMIFANIC_01099 hypothetical protein
MHNFKNLNIWIKSMELVSENYNITNSFPEMERYGLANQMNRSAVSIPSNIAEGSSKGSDK
HFNQYLETSLGSAFEWETQLTIAYKQNYIEEDVFKTSEEKIIQIQRMISGFQKGLKKD
>OMIFANIC_01100 3-ketoacyl-CoA thiolase
MPFKSRLPNLNTNISILNTIKMKTAYIVKAYRTAVGKAPRGLFRFKRPDELAAETIEYMM
KELPQFDKTRIDDVIVGNAMPEAEQGLNMARLISLMGLKIEDVPGVTVNRYCASGIETIA
MATAKIQSGMANCIIAGGSESMSYIPMGGYKPTPDYEIAKEGHEDYYWGMGLTAEAVANQ
FKVSREDQDEFAYNSHQKALKAQAENKFKEQIVPIEVEHTFVNSEGKKETKNYTVAKDEG
PRADTSLEVLGKLRPVFAANGSVTAGNSSQMSDGAAFVLVMSEEMVKELNLEPIARMVNF
AAAGVEPRIMGIGPVKAIPKALKQADMKQDDIDLIELNEAFASQSLAVIRELGLNQEIVN
VNGGAIALGHPLGCTGAKLSVQLFDEMRKRNMKGKYGMVTMCVGTGQGAAGIYEFLN
>OMIFANIC_01101 hypothetical protein
MHKIKDLKIWGKSIALAKSVYSIAAELPAEEKFGLVSQLKRCAISIPSNISEGAGRNSKK
EFQHFLSIANGSSYELETQLILIIELQLISEDKIKPVLNKVSEIQKMNYAFQKSLTES
>OMIFANIC_01102 putative 3-hydroxyacyl-CoA dehydrogenase
MSKRRIEKVAVIGSGIMGSGIACHFANIGVQVLLLDIVPRELNDKEKAKGLTMDDKIVRN
RLVNDALTSAIKSRPAPLYSKDFANRITTGNLEDDISKVKDVDWIIEVVVERLDIKQQVF
ENLEKHRTPGTLITSNTSGIPIKFMNEGRSEDFRAHFCGTHFFNPPRYLKLFEIIPGPDT
KDEVLDFLNGYGEKFLGKTSVVAKDTPAFIGNRIGIFGIQSLFHLISEMGLTIEEVDKLT
GPVIGRPKSATFRTVDVVGLDTLVHVANGIYENCPDDEEHDLFKLPAFINTMMENKWLGS
KTGQGFYKKVKKEDGSSEILSLDLDSMEYRSKKRASFPTLEMTKSVDKVIDRFKVLASGK
DKAGEFYRKNFGAMFAYVSKRIPEVTDELYKIDDAMKAGFGWEHGPFEIWDAIGLSEGLQ
LIQDIGKEPAAWVVEMKDAGKESFYTVKDGATYFYDIPKKSHEKVPGQDAFIILDNIRES
NEVYKNSGVVIEDLGDGILNVEFQSKMNSIGGDVLAGVNKAIDLAEKDFEGLVVGNQGAN
FSVGANIGMIFMMAVEQEYDELNMAVKYFQDTCMRLRYSSIPVVVAPHGMTLGGGCEMTL
HADRVVAAAETYIGLVEFGVGVIPGGGGSKEMALRASDTFQKNDVELNRLQEYFLTIGMA
KVATSAYEAYDTGILQHGKDIVVVNKDRQIATAKSVAKMMADQGYTKPIQRNDVRVLGKQ
ALGMFLVGTDSMEAGHYISEHDKKIANKLAYVMAGGDLSEPSYVSEQYLLDLEREAFMSL
TTERKTLERLEHMIKKGKPLRN
>OMIFANIC_01103 Organic hydroperoxide resistance transcriptional regulator
MKEKTIDYILRATWMAVTKMYNEEAGKKDSTMATGFALISIDPEEGTPSTALGPKMGMEA
TSLSRTLKNMEEKGLIERRPNPLDGRSVLIHLTDFGREMREYSKGVVLRFDEVVKESISE
EDLQTFKQVANTILDLVTSKKIYSTEKI
>OMIFANIC_01104 Long-chain-fatty-acid--CoA ligase FadD15
MTEVKRLFDFPYYQLENFPLDAALVTKKTGEWIKTSTQEYLDKSNAFSRGLIKLGVKPDD
KIALISMTNRTEWNICDIGVLQIGAQDVPIYPTISEEEYEYVLNHSECKFCFVSCVEVLN
KIDKIKQNVPSLQGVYCFDELRDCAHYSEVIKLGEENPDLQPEVEKRKEAISENDLATLI
YTSGTTGKPKGVMLSHKNIASNAIYSAERLPIDLGKTKALSFLPVCHIYERMLLYMYQYC
GVSIHFAESLETISDNLKEIKPEVMTAVPRLLEKVYDKIYTKGTELTGIKKSLFFWAVSV
GLRYEPYGQNGWWYELKLKLARKLIFSKWQEALGGNLKAIASGSAALQARLARVYNAAGI
PVMEGYGLTETSPVVTVNDMRNGGFRIGTVGKPIKETEVKIAHDGEILIKGPQVMQGYYK
DPDLTSDVLKDGYFHTGDIGEIDDDGFLKITDRKKEMFKTSGGKYVAPQIIENAFKQSRF
IEQVMVVGEGEKMPAALIQPNFEFIHDWNERKGKGLPEDPEQMVKDPKLIKRIQKEVDHY
NERFGKWEQVKKFELTPDIWSIDEGHLTPTMKMKRKVIKQKYIDLYNRIYERETD
>OMIFANIC_01105 Phosphoribosylformylglycinamidine synthase
MIHFFGDVENTVFAVESTGELSARTTEKLNWLFGNQPKLEQSAIADFFVGPRAAMVTPWS
TNAVEITQNMHIEGIVRIEEYHHVNEDFSDYDPMLSQKFSRLDQDMFDMHIDPEPIREIE
DITAYNSQEGLALSKDEVEYLEQLSEKLGRKLTDSEVFGFSQVNSEHCRHKIFNGTFEID
GEIMPSSLFKLIKKTSATHPNDIVSAYKDNVAFVKGPEVEQFAPKTPDKPDYYYKTPFQS
VISLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGKGSLPLAGTAVYMTSYSRLAENRP
WEKAMEERPWLYQTPMDILIKASNGASDFGNKFGQPLIAGSVLTFEHEEDARKLGFDKVI
MLAGGIGYGKASQAIKDTPEKGDKIVILGGENYRIGMGGAAVSSADTGEFESGIELNAVQ
RSNPEMQKRAANAVRGMVESEENPIVSIHDHGAGGHLNCLSELVEETGGHIDLDKLPVGD
PTLSAKEIIGNESQERMGLVIGDKDIAELRRIAERERSPMYEVGQVTDDNHFCFESSSTG
AKPMDFALEDMFGSSPKTLMRDKEIQRDYRNPQYDSSRLREYVSQLLQLEAVACKDWLTN
KVDRCVTGRVAKQQCAGPLQLPLNNCGVMALDYNGKDGVATSIGHSPVSALVDPVAGSRN
SITESLTNIVWAPLEKGLKSISLSANWMWPCNNEGEDARLYKAVEGVSEFAIELGINVPT
GKDSLSMKQKYKDDVVLAPGTVIISAAGHCSDVKKVVEPVLQKNKGSIYYINISQDDFKL
GGSSFAQILNTIGSDVPTVKSASYVKKVFNTLQELIIDGAIAAGHDVASGGLITTLLEMC
FADNDLGATLDLSQLGDSLPEMLFAENCALLIQAVNDNTVEKALSDHDISFNKIGTVTSG
KELIIRHNHAVEEFDVSEFRDVWYRTSYLLDQQQSGPDKAKERFDNYKNQPLKFKFPDHF
TGKLPVIDPSAPRIKAAIIREKGSNSEREMAYAMHLAGFDVKDVHMTDLISGRETLEDIK
FIAAVGGFSNSDVLGSAKGWAGAFLYNDKAKKALKEFFAKDDTLSLGVCNGCQLFIELGL
INPEHDRKPKMLHNDTNKFECSFTSIKIQENDSVMLSSLSGSTLGIWSAHGEGKFSFPLS
EENYRIVGKYGYEGLPANPNGSDFNTAILTDTSGRHLVIMPHLERSTFPWNWGYYPSDRN
DEVSPWHEAFLNARKWLESK
>OMIFANIC_01106 hypothetical protein
MKIEKLFLLLALIFSVGVNAQETFPPTDIITGTYLGKTGRLDEFPTIDLTESRNTVPTMV
LDQLVNTSGEVVPTTTIIQNLQTEPGQIEAMPLEQNFIGASAGEAGGVFPPDPTGAVGPN
HYMHSVNLLVKIFDKTGNLLLGPTSIAAFLGISNSPGDPIVLYDQLADRWVMSAFGSLNN
SLVIGVSETGDPTGAYNVWQYQFPGFPDYPKYSTWHDGYYGTVNLGGQTTRGFVMERDVM
LAGGANPQILIFQLPQVIVNPNQVKSPVAANLTGTTIDTNAPGLITYLQDDGWTSAITFD
HLKVWEIEMDWNNPSNSTISAPQEIPTDPFDAGELFGNGNGALRQPNTSQRLAAHGGIIS
FNSNYREFGTHDSWLITFNTFIDGNQTGGIRWIELRKNGANPWAIFQEGTYSIADGHSRV
MSSAAMDALGNIAMGYTTGSTGLAPSLRYTGRFDGDPMGTMTVAETTIINGPGVRTNSNR
YGDYAHMTMDPDDLTFWFTSDYFSSNNQWRTQIASLKINPGFTDDVGINNILEPNSGVLT
SSEAVQVSIRNYGSAPKTNIPLELRVDGNLVANETFTGTIPGSDTAIYNFTQTLDLSNTG
QTYSIEVRTNLPGDEFANNDSFTKEVTSLFANDTGVLEITSPVSGTNLNSNETISVTVRN
FGATPQSNFPVQYTINGGDPVVETFTGTLTSEDEASFDFATTGDFNELGTYTIVASTNLS
GDEQPSNDEATAIVESLLCQPAMSCSAGDGFRLVSIAEINNPSGCEGYGDFTNLLANLGQ
GSSNDLTLTTGRGNQYVSVWIDFSDNYSFSGSERLINNFVIAPGQGTGEFTETLLLEIPA
DAPTGEHIMRIKSNRNNPVPGDACQETTFGETEDYLVNIGILGVSDEQISQSELIVLSKD
NNQFEVKLHSEFDEAVYLGVYNMLGQEIGFNKSIPKIDGAYRANLDMSQMSSGVYLLRIG
GQTTTSYQTARIIVK
>OMIFANIC_01107 Ribosomal RNA small subunit methyltransferase B
MIPLPTNWSSMKLHRNLVFATVDSLHQIFNEKKQADKVLKNTLKRDKRWGARDRSFIAET
TYDIVRWKRLYAEIAEVKEPFDRPNLFRLFTVWAVLKGIKLPDWPQFEGTPARRIKGKFD
EFSRTRKIRESVPDWLDELGEKELGKRWEKEIHALNSLADVILRVNTLKTNIKKLQQALS
EENIETETLKGHPFALKLKERANVFITKAFKDGWFEVQDASSQKVAQMLDPKPGMRVVDA
CAGAGGKSLHLAALMENKGQVVALDIYENKLTELKRRARRSGAHNIETRLIESTKVIKKL
INKADGVLIDAPCSGLGVLRRNPDTKWKLSPEFLESIQKTQREILESYSRMVKPGGKLLY
ATCSILPSENENQVAWFLSAEAGKDFTLLKEEKVSPAQSGYDGFYMALLQKKNNE
>OMIFANIC_01108 Ycf48-like protein
MRYFFAFLVAISIGSCGLNGSKEFTTVEIIPVYQDSLSIRAIVPLDEQRVWFAANSGRVG
LIDSVTPKLATIKYEDSLLAFRSIASIRNAVFVLSVANPAVLYKIGFDGESATNIEEVYV
EKGEKVFYDAMAFWNDSEGIAMGDPTEGCLSIILTKDGGNTWKKLPCSVLPRVEEGEAAF
AASNSNISLYGDHAWIVSGGKRARVFHSADKGNTWEVFDTPIIQGKAMTGIYSVDFIDEE
TGVIFGGNWEDKDFNEGNKAITNDGGKTWTLLSNGAGPGYRSSVRFIPGMNGKGIVAVGS
PGISYSPDAGESWTELSKEGFYAIEFVNDTLAFASGRNKISKLIFK
>OMIFANIC_01109 hypothetical protein
MKNLIILLLLVSTAVQAQRGNNERIKALRTAHITQALDLSSAEAEKFWPIYNKHTAQMET
LRKQERREIMMVVNGDVSSVSDADANELIDKILSFKVSQIEHQKALVEELRGVIPPQKIL
RLNKAEEDFRKILMEQLKQRRGNNRKQ
>OMIFANIC_01110 hypothetical protein
MEEKKNISGLQPPEGYFENFEDRMMLKVMEDSLPKSNGFKVPEDYFGQFEGRMIDAISET
DAPKVVSLFRKQAFWYAAAIAASLALIVSLYNGFGSELSIEDLSASAVEEYIDEGGMGID
SYDVIALLEEEDINELTIPSDEISEESLENYLIENIDETSLLIE
>OMIFANIC_01111 ECF RNA polymerase sigma-E factor
MAQEQALVSALKSDMNKEEAFRNLVSQYKERLYWHIRNMVLNHDDADDVLQNTFIKVFRN
IDSFKGDSKLYTWMYRIATNEAITFMNKRAKRNNITLEEVKERAIENLESDVYFEGGAIE
INLQRAIATLPEKQQLVFNMKYFEDHTYEELSEILETSVGGLKSSYHIAVKKITAYLKSN
ETF
>OMIFANIC_01112 Lipid A export ATP-binding/permease protein MsbA
MHYFRKILKYALPYKRYAWLNIISNVFYALFGTLGMISLFPMLRVLFDTTKQLNTKPEYT
GLMNIKDYAEDYLNYFVTQKANAGADDVLLFMIVLVISMFFLKNLFGYLAMFFITFLRNG
VLKDLRNDLYKKTIDLPVSFYSEKRKGDTIARITNDVQEIQHSFLSILELFVREPLTILF
AIVTMLLISVELTIFVFIFIPVSGLIISLIGKSLKRKSERVQREQGHVISVLEETLGGLK
IVKGFNAENIFFERFKESTSRLFHFANKLLNRQNLASPTSEVLGIIVIAALMWYGGRLVL
VEGSLDAELFIVYLALAYQILTPAKAISKASYSVKKGNAAAERVLEILETESAIKDKPGA
VDKSDFNENVAIDNISFKYKDEWVLQNFSLNVPKGSTVALVGQSGSGKSTIANLVTRFYD
VDKGAIKIDGVDIRNMTQYSLRGLLGLVTQDSILFNDTVKGNLLVAREDASDEELKEALK
VANAWEFVSELPDGMDTNIGDSGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDTES
ERLVQVALENMMRNRTSIVIAHRLSTIQNADNIVVLSKGEIVEQGKHRELLEKEGVYQSL
VEMQSLV
>OMIFANIC_01113 Phosphoglucomutase
MIYVDPKILDRVNQWLTPVFDIETQHTIKEMIAYDPEGLEDSFYKSLEFGTGGMRGVMGV
GDNRINKYTLGKNTQGLSNYLYKQFPNEQLKVAIAYDCRHNSKELAKVVADVFSANDIEV
FLYSDLRPTPELSFSVRHLECHCGIVLTASHNPPEYNGYKVYWQDGGQLVPPQDGEIIAE
INGLQYAHIKFDGKADLIHYIDQDIDKAFAAASLENGSFSTPQAAKDKLKIVFTSLHGTS
ITMIPQVLDKAGYKNLHIVEAQAKPDGDFPTVESPNPEEPEALKMAMELAEEEDADIVIG
TDPDCDRLGIAVRDEMGKLVILNGNQAMVVMCHFLLEQWKKTGKLNGNQFLASTIVSTPM
VKVITESFGVKYKEGLTGFKWIAKMVKDFPELEFIGGGEESFGFMVGDFVRDKDAVTATL
LACEIAALKKQQGSSIYGYLQELYKEYGYYLEQLVSMVKKGKKGAEEIIAMMRSLRENPM
KEIAGSKVVRIEDYESGKATDILNGKVTEMDIPRSNVLIYFTEDGSKIAARPSGTEPKIK
FYMSVHGSGNNESIMAELHQKIERIKTELQL
>OMIFANIC_01114 Dodecaprenyl-phosphate galacturonate synthase
MNISIVIPLLNEEESLNELYHWIADVMQSNGFLYELLFIDDGSTDDSWKIIRELAVKHPE
VKGIRFLKNFGKSQALHAGFALAEGEVVVTMDADLQDNPEEIPELYGMITKEGYQLVSGW
KKKRYDSVVTKNLPSKLFNFAARKTSGVKLHDFNCGLKAYHRDVIKTIEVTGEMHRYIPV
LAKNAGFNKIGEKVVQHQKRKYGTTKFGAERFIRGFLDLITISFLSRFGKRPMHLFGAWG
AVMLFVGFCFAVYLGIDKLFINPGGRLLTERPQFYLALTAMILGTQLFLAGFLGELILRS
KAGTHNYIIKEDINFND
>OMIFANIC_01115 hypothetical protein
MDTPKASIKKIALNYGLILALASIGWSVVLFVLDEHIERPWWSGVISFALMVVIIIYGLK
AFKKDNGGYMSLGEALKAGLAISLIAGVVGVIFNFIFVTYIDPDVVQKTLELTEERMYEQ
NPNMTQEQAEMALSMTEKFMSPGIMAALGIIATLFFGFIISLVGGLIMKNSRPEH
>OMIFANIC_01116 50S ribosomal protein L31 type B
MKKDIHPENYRLVAFKDMSNDDVFITKSTANTKETIEVDGVEYPLVKMEISRTSHPFYTG
KAKLIDTAGRIDKFKNKYKKFSKEVAKEVAKEEE
>OMIFANIC_01117 hypothetical protein
MFEGFFYLALNSEQILMNYILFDGSVRDQLLPFTYTRPVADIRIGILTIREKWEKYLGYT
TTTVTEDHLISRWPLVELEENVLINASFLPSQELVSRIKALQVNQAIFHSDEPVAFFSTE
GQEVDFNNFEVFEYSEDDILRIEYTWDIFSKNHEAIKRDYELITKGRSSQPIPETTVAFH
ADQIFIEEGAKLPLCSLNASDGPIYIGKNSEIMEGAMIRGPFALCEGSTVKMASKIYTGC
TIGPYSKVGGEVNNSVLFGYSNKGHDGFLGNSVLGEWCNIGADTNTSNMKNNYAEVKLWD
YNTERFAKTGLQFCGLMMGDHSKCGINTMFNTGTVVGVSANIFGSGFPRNFIPSFSWGGS
HGMTAYKTAKAFETAKAAMARRNVDFSEEDAKILEHVFEETAKFRRY
>OMIFANIC_01118 Heme-binding protein A
MEHIRSIVTYIFSAYCILLLLVCCKKDSLDNTDHLVFRYNEHSNIPTLDPAFARNPQIIW
PTNQLYNGLVELDDSLNIQPDIAKSWKINDTTLTYTFNLRNDVYYHKSEAFAPDSTRVVM
ASDFVYSFDRLTDPMVASPGSWVMSTVESYEAPNDSTFVIRLKQPFPAFLGLLSMRYCSV
VPQEAVDFHAGEFRRNPVGTGPFQFKLWEENVKLVLRKNPLYFETDEEGIQLPYLEAVAI
TFLPDKQSEFLQFAQGKIDFVSGLDNSYKDEIITTTGALQPKYKDQVKLITAPYLNTEYL
GFFMGADTPEIKSNLLRQAVNYGFDREKMVTYLRNGMGIPAEHGFIPKGLPGFDEIQGYT
YDPDKARSLIDQYKSETGDMNPEIVIGTNSQYLDICEYVQRELEKLGVTVTVDVMPPSTL
RQMKSSGELDIFRASWIADYPDAENYLSLFYSPNFTPNGPNYTHYKNETFDSLYVQALNI
SNIEKRQQLYTQMDSIVVADAPVVPLFYDMAIRFVNKKVSGLGINPQNFLVLKRVKKEP
>OMIFANIC_01119 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MNASKKVAFYTLGCKLNFSETSTIARDFSSEGFERVDFSEKADIYVINTCSVTENADKRF
KTIVKQAQKANPEAFVAAIGCYAQLKPQELADVHGVDLVLGATEKFKITDYINDLSKNDF
GEIHSCEIEDADFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDTLQNVLK
NAAEISAQGIKEIVLTGVNIGDYGKGEFGNKKHEHTFFELCAALDKVPGIDRLRISSIEP
NLLKNETIDFVARSKTFVPHFHIPLQSGSNELLRLMKRRYQRELYVDRVHKIREVMPHAC
IGVDVIVGFPGETEAHFLDTYHFLNELDISYLHVFTYSERDNTEAAEMEGVIPKAIRHKR
SKMFRGLSVKKRRAFYEQQIGSIRTVLFEGENKEGYIHGFTENYVKVKAPWNPELVNTLH
QIELTSIDEDGLVRFNFTEAEVLRQS
>OMIFANIC_01120 hypothetical protein
MIEDVEITDNEFLRQFELEVGDNMARIEYALQDRKIFLTKYDMPSDMEDQGFRDIFIKAV
FDEVKDRGISLVPTSPEIAGFMRKNRRKYRDLLPVGISI
>OMIFANIC_01121 Quercetin 2,3-dioxygenase
MKKILHPAATRGTADYGWLQARYSFSFANFFDPNRIQFGKLRVLNDDIVAPAMGFGKHPH
QNMEIVTIPQEGALKHRDSMGNEGIIESGDIQIMSAGSGVEHSEINARTNESVKLFQIWV
FPEEEGVTPRYDQKKIAPLLKPNEISTVVKPKSEAGESELWVHQQAWFSLGEFSETTKTT
YSLNNKTNGVYIFVIDGTIVADNETLNKRDAIGIWDTDTVTITAGKESRVLLIEIPMN
>OMIFANIC_01122 hypothetical protein
MSEQKTQVYFIPGMAAGKEIFKNIRLPEDRFEIHVLEWLIPEKNESMVSYASRMAAEIKG
ENVVLAGVSFGGVVAQEIAAFVNPRKLIIISSVKSPGELPLRLKLARKTGAYKLVPTRLM
LSADDLTKFSIGPRSKKRLKLYQDFLHVRDKRYLDWAIKNMVCWQQKEPYRKIIHIHGDK
DIIFPIKNINDCVVLEGGTHVMLLNKGKQLSQKLLAVIEE
>OMIFANIC_01123 Membrane-bound lytic murein transglycosylase D
MSILSKIGLVTVLFGVSSLCVNAVQQEPGAEKKIEKSTHDYNVYAIPIPESMDFAGEPVP
LDNPDIRERLDRELLVNTYWQSNGLLIFKRANKYFPIIEPLLEKHGLPDDFKYLAVAESA
LENNRSPAGAAGFWHFLKGTGREYGLEINEYVDERYNLEMATKVAAEYLKRSKNKFGSWT
LAAAAYNAGNGGIQKQINRQKSTNNYYDLLLNNETSRYVFRILAFKEILSNPEKYGFNFE
KEDLYAPIPTYKVKVDTAVTDIPGFARQFGINYKILKLHNPWLRETYLRNSSRKEYFIEI
PENGYYKSGE
>OMIFANIC_01124 hypothetical protein
MRMTTILSLIIIGLLAGILSGFMGVGGGVIMIPLMILFLGYDQHQAQGMSLAVLAVPVTF
VAAYTYHKAGHAIDWRYALVIALFFVAGGFLGSKFAVSLNQQVLKKIFALILVVAAVKLF
FSK
>OMIFANIC_01125 hypothetical protein
MGKYLLILFLLLPTAAFSQDNAPKPLFADVIGQNIKKYKKKAKYAYRKKEFNRAQFLFDS
LVDHVIKDSYMNNFKVRKVTGRTTEMYKFEKPVYLITSAFWVATSSGEIPALNTIADRYH
DQVDIVVLFWGPREAIVKLKKHYSRNITLLYVDELENTNDFTIKSMKHSLGFPTTFIMDE
SKRILDVRRNINHRYEKDYTTSYNEHYQTFMNGLSLILNKDKTEKIGLMRNQ
>OMIFANIC_01126 hypothetical protein
MFNKYIKLVLAALSIGAAVWQFYETNTGNGIMLILLALIFVFLYYKNELILLAFLQLRKQ
NFEGAKKWLDRIKNPESALVTKQQGYYNYLNGLMVSQTNMNDAEKYFKKAEKLGLSMSTD
MAMVKLNLAGIAMTKNRKREAEMLLREAKKLDKQNMLDEQIKMMKQQMKRAGQPRQQFGR
GGRGGKGFR
>OMIFANIC_01127 hypothetical protein
MKNPFYILLLVFSFGISTIHAQHELAYSLKVGDSFRIAQKAIQNIKMTMDDQDHNLTNTL
EGSFQFKVQDELAGSYIIETFFEEIKLKTESDILGTLNDVDTSRESDADDMEANIFKGLL
DSPFYMTLRKDGKIVKLEGADQLLESMLKSGGIEDASTKELVKQRVEKQFGAESLAASME
QMTYMFPQRSVGVSDSWNNEFTGDLTALNTWTLDYHDASEFKISCTSTIKLNTGEDTVAM
ELEGIQNSRAVISTESGFLKTLDVEQKASGTTIMNDMGGAEVDTTIDATINYKRI
>OMIFANIC_01128 Carbamoyl-phosphate synthase large chain
MPKNKALKSILIIGSGPIIIGQACEFDYSGSQSLRSLREDGIETILINSNPATIMTDPTM
ADHVYLLPLTTKSIVKILKEHPQIDAVLPTMGGQTALNLCIEADEKGIWKDFDVAIIGVD
IAAINITEDREQFKNLMNEIGIPVAPAKIANSFLKGKEIAQEFGFPVVIRPSFTLGGTGA
SFVHTEDQFDELLTRGLEASPIHEVLIDKALVGWKEYELELLRDNKDNVVIICTIENMDP
MGIHTGDSITVAPAMTLSDTCFQRMRDMAIKMMRSIGDFAGGCNVQFAVSPDEKEDIIAI
EINPRVSRSSALASKATGYPIAKVASKLAIGYSLDELENQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGSERTLGLQMKAVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKSYTNY
DQIIDKLTYASWDRVFVIYDAIQLGIPLSRIHEITKIDMWFLKQYEELYELEKEISGYTL
DTLPRELLLEAKQKGYGDRQIAHMLKCLESQVYNRRDELNIQRVYKLVDTCAAEFKAETP
YYYSTFESEMHTADGEEYAENDSVVTDRKKIIVLGSGPNRIGQGIEFDYCCVHGVLAASE
VGYETIMINCNPETVSTDFDVADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLDRYGIKIMGTSYKALDLAEDRGSFSTLLKENNIPYPEFGTAETTDEALQLADELDFP
LLIRPSYVLGGQGMKIVINKQELEEHVVDLLRKIPNNKLLLDHYLDGAIEAEADAICDGE
NVYIIGIMEHIEPCGIHSGDSNATLPPFNLGEFVMQQIKDHTKQIALALNTVGLINIQFA
IKDDQVFIIEANPRASRTVPFIAKAYGEPYVNYATQVMLGHKKVTDFDFNPQLEGYAIKQ
PVFSFNKFPNVNKQLGPEMKSTGESILFIDSLKDDEFYELYSRRKMYLTR
>OMIFANIC_01129 hypothetical protein
MKHILLYALILAAPLVSAQVGIGTTAPMETLHVNGTVRIESLTPDEPNRVIGVDLKGNVS
EVGVGDNLLLQDGTLHSNGSTKYFVQTITTTTTTSGQEFHNVDLELETTNKDIVVFRLNG
ANHNYEFSGLSGGTDGKHIILLNTSANNFKISNESSNSSPENRIITLTGGFEQTSGEGLV
ELVYDGVSQRWIILSFRN
>OMIFANIC_01130 hypothetical protein
MKNIILLAAAVCVAFSANAQISTPQISDFEDGTVQGWTNGAASPNQPTNIPTGGPLGADD
NFLEEISAGGSGAGSKLVIQNDDSDWTGDYLGAGVGLFSADVKNGGTEDLFLRVALQGGS
DNTRMYTDNSFTLPASQTTWTSFDLVVDNSANWTIVSGASTVEQVLQDVSQIRILSSQSG
GFNGDAVAGVLHIDNITADDIFIGFDDNIFNNLVTYPNPVSDILNIESTVRMDNYQIFNV
AGQLVSVGELEEQFLQVSNLSEGLYFLKLSNVSGSRTIKFVKR
>OMIFANIC_01131 Amicyanin
MKKYLLTMAVMATLTISAQTTFDITWEIGVNGAPASPTVETGDTVRWTWGDALPHSVTSL
AGSQQTFDSTILTGMGTEFSFTFTEVGTNDYQCDVHPGSMFGTVTVEEVLSVEDKFVKSL
SFYPNPAKDQLNIFSLFRIDSYALYNVAGQRVMHNTDDGNFSTLEVSSLQPGIYFVRVTS
GDMSHTNKVIIQ
>OMIFANIC_01132 hypothetical protein
MKSFNTLVYGAALLLILHGCTAKDLDELVPVQQEIPTDFVTFEDVRFVFDNMCQQCHSNP
PQNGAPMPLVTYNNVKSAVETRGLLDRVSRQEGEQGLMPLGGPRLPQATIDLLFQWNEDG
LLEN
>OMIFANIC_01133 hypothetical protein
MKKIFFVLSMISLLTLSTHAQEKLKTKTGEITFEASVPSFEEVKATNENVSAILNSETGE
FAALALVKGFRFKVALMEEHFNENYMESSTYPKAVFKGIIQNFDSSSVTNSPTELVINGS
VTMHGETKELSTAVKLWKEGSTIVLSTSFVMKPGDFNIKIPAVVSNKIAEEVTVDAQFSL
TK
>OMIFANIC_01134 hypothetical protein
MKKKSILVIVIGIVVLAVIGYNYLYQDHREISSEKPMAELSSESISEIFKNDAANDLLNA
TVSVKGVISEIDESTLTLDGKVTCSFADIPSDYRVGDSINVKGRCIGYDDLFEIVKLDQC
SIQN
>OMIFANIC_01135 hypothetical protein
MKKIIVILSFLFPLISFAQDDLLDELESEVTEDTTVDAAFKGLKVVNFESTKLAHKKEFY
FIVSHRFGTVKNGFDDLFGLDEAVTQLKFIYGLNDWLNVGVARSSFQKTYGAHVKYRLIQ
QQQNGFPFTIVGYNLLAINSGLDEDLYTNFEFSDRITYTSQVLLSRKVSERLSLLLAPTY
IHENLATRSVMILADVTTLNFDEENDQFAVGVGGRLKLTTRWSINMDYGIHMNRNDNSNF
KNPFSVGVDLETGGHVFQMHFTNAQPMFEDGFIVRGAGDWSDGDFYFGFNLSRVF
>OMIFANIC_01136 hypothetical protein
MNETFLFLLLAGICLLIGAFIGNLIARLKQKAETGKMEERIEQSDIQHERLQERFQNILN
EREDIRKQKDFLNSELVKRNTEFDNLEKENRKQQQEVEKLQEKFTKEFENLANKILDEKS
SKFTRQNKENLELLLNPLQEKIKTFEKKVEDTNKESVGRHSELKEQLKHLSELNRQISKE
ADNLTKALKGDSKMQGNWGELILTRILEKSGLEIGREYTIQDSHTDESGKRLQTDVLIHL
PDGKKMIVDSKVSLVDFERFVSEEDEDKKQLHLKNHIASIRKHVDDLSGKKYHYLMDESP
DTVFMFVPIEPAFAIAAANEPRIYEDAFNKQVVIVTPSTLLAALRLVDNLWQNDRQTQNA
LAIAKEAGALYDSFTNLTDELIKVGKQIGTVQGTYESAMKKLTGRGNLIRRVENLKKLGA
KASKHIDEKLLKRAEEEGEE
>OMIFANIC_01137 Fe(3+) dicitrate transport ATP-binding protein FecE
MATEGKHSAIAVSGLEIGYFRKKKKIPIVSGIDFSLNSGKLITLVGANGIGKSTLLRTLS
GMQPKLDGKILIGEKDLSDYSSLERATQLSVVLTEAPASGNLTVRELISLGRQPYTNSFG
VLSEKDKEIIQNALEITETAVLENRKCFELSDGQMQRVVIARALAQDTPMIILDEPTTHL
DLYHRAYILKLLKKLTSEEGKTVLFSTHEIDLGIQLADVMIVMSEDEIYVDEPCKLIEQG
RFNSLFPEDTIHFDTNTGRFTIKN
>OMIFANIC_01138 Hemin transport system permease protein HmuU
MDTNRSYTVWFIVLFAGLVLLFLLNVSLGSVKIPLEDVLSALSGNGASKSSWEYIITDYR
LPKALTAILAGGGLAVSGLLMQTLFRNPLAGPFVLGLSSGASLGVALLILGAGAFGGFLG
SLLLSQWSLVIASALGSFLVLLAVLAVTLRVKDSMAILIIGLMFGSVTAAVVAVLSYFST
AEKLQQYIFWSFGSLGNQSWSGILILALCCILGIIIAFASCKSLNALLLGENYAKSMGLR
IKRTTLLIILATSILAGGITAFAGPIAFVGLAVPHLTRQLFTTSNHFVLLPAVLLSGAIL
MLICDTVAQLPMSEETLPINAITSLIGAPVVIWLLVRKRKLLF
>OMIFANIC_01139 hypothetical protein
MHRLFLFLAVLLLISCKDIQKSPSIVQESNHTPEVKYAEGFDFSKKNNHTIIRVSNPWPG
ADQTFEYLLGHADSSIDYAGTEEGLGVERIIDIPVTSMVVTSTTHIPSLDMLGVTDQLVG
FPNLDYISSESARKLISEGKIKELGQNESINTEVLIDLQPDVVISFAVDGTNKAVENIQQ
AGIPVLYNADWTEKHPLGKAEWIKFFGVLFGKEKEADSIFNVIETEYLTARALAKKATSR
PSVLSGAMYKDVWYMPQGDSWAARFIADANGEYLWQETEGTGSLSMSLESVLEKGQNADF
WIGPGQFTTVAQFNDAHSVYEEFLALQNGNVYTFTANKGETGGILYYELAPNRPDIVLKD
IIKILHPDLLPDHKLYFFSKVE
>OMIFANIC_01140 hypothetical protein
MKKKIILLVLIVSTLFTSCFEDNDDVLQVASTLDIQNFIYRGLNFFYLYKADTPELANDA
FASQGDLDAFLSTFDSPESLFDFLKSPQDRFSILVDDYVALENALAGVTKNNGMEYGLIR
YPNDPSLVFGYVRYILPNTDAEAKGLDRGIIFNTVDGTQITENNFRDIFEPDTYTIGLAT
FDGTTITPTGDSVELTKSEYTENPVFIATTLDISGQKIGYLMYNSFTRDFDPELNAAFAQ
FSADGVSDVILDLRYNSGGSVESASDLSSMVTGQFNGQVFYTEQWNEDRQQDYASDGLFN
QTISNGDAINSLNLNRVYIIATGRTASASELVINGLDPYIDVVQVGGTTEGKFQASFILY
DAPAPNFSRSEANPDHTYAMLPLVFKTANANGVTDFVDGLVPDIMLDEDYTNLGVLGDLN
EPLLAAALADIFPAPLPVIPYQSGLEEISDSKASSPIHQIMIAEK
>OMIFANIC_01141 ECF RNA polymerase sigma factor SigK
MKQKEFLTTVMPFKDKLYRLAKRLLVSNDEAEDAVQEIYLKLWKGRDKIGNYKNPEAFAM
TMTKNFCLDRLKSKQAGNMKIVHSNFQNSDNVERKVEAIDGVSLVFQIMETLPEQQRMIV
QLRDVEQYEFAEIAEMLESNETAIRVALSRARKVLREEMIKKYNYGIS
>OMIFANIC_01142 hypothetical protein
MESARIERLLDAYFEGNTTLAEEGTLRDYFTKGNVAAHLESYTPIFQGFVQAKEEVSVKE
VTLPESGFRIKGWWYSIAATFLVAVTVGSIVFSNSGLTDEEQEALAAIKETKEAMMLLSS
NLNKGTENVVFLNEFTKGSSNIKYINQFTETKNRILK
>OMIFANIC_01143 hypothetical protein
MKKLVIVMLVMLVPFIGSAQTFDSYEGEKDVTSIVVTKNMFKLLAEIDLESDDPEVKEYL
ELVNNLDNIKIFVTENADIASRMTADVKKYVSSAKGLNELMRVKDEGKNIKFYSKEGKSS
SYVSELLMFMEGDIDGKEGSMIMSITGNIDLKKISKLTKDLNVPGSDELKKIENKQ
>OMIFANIC_01144 hypothetical protein
MVLVRFIVGLSLAAISLVSCADGSSLQRYLVDKQDDDKFLKVDIATSLLESDDADFTEEQ
KEILETIKKVNVVAFPLKGKNAEDYTAERAELAKILDNEKYVLLGKVSSNGSMMTMKYLG
EEDAIDEVIIFASDDERGFAVFRLLGDNMKPGQMLKLMNSINSGDFDVSALNGIGDIFSE
SGGETDNNTELIDEIAD
>OMIFANIC_01145 Adenylosuccinate lyase
MSSRALQAISPIDGRYASKTQSLVPFFSEEALIKYRVQVEIEYFIALVELPLPQLKEFDS
SLFADLRRLYTEFSSEDAQRIKDTEMVTNHDVKAVEYFIKEEFDALGLEQYKEFIHFGLT
SQDINNTAIPLSLKDAMNEVFVPGFFEVKDKLKELAGEWADVSMLARTHGQPASPTRLGK
EIEVFVVRLEEQFDLLNDIKSAAKFGGATGNFNAHKVAYPEIDWKAFGTEFVQEKLGLHH
SFPTTQIEHYDHMAALFDCLKRINTILIDLDRDIWTYVSMDYFKQKIKKGEIGSSAMPHK
VNPIDFENSEGNLGLANAVFEHLSAKLPISRLQRDLTDSTVLRNIGVPMGHTIIGFQSTL
KGLNKLLLNEAKFKEDLENNWAVVAEAIQTILRREGYPNPYEALKGLTRTNDAITRDSIQ
DFIGTLDVSEEIKEELRAISPANYTGI
>OMIFANIC_01146 hypothetical protein
MTNSELKKQLSYHRAYRDNRLKAAEWVIDNPDCIPELLRYCFEDTSELSYKAAWAFEFVF
IEDPGYLYPYFDYFFEKLPTVKLDQIARPMSHICERLCIRYYKKQDTELRNYLTEEHKNI
MTECAFDWLITDQKVACQVRAMTCLYYLGTQFDWIHPELEQILQERIHSGSAGYKSRAKK
TLQQIAKKR
>OMIFANIC_01147 NAD-dependent protein deacylase
MKISILTGAGMSAESGLKTFRDSNGLWEGHDVMQVASPQGFARNPELVLEFYNQRRRQLL
QVNPNKAHIALAELEVDYEVTIITQNVDDLHERAGSKQVVHLHGELLKVRSTFDENLILD
WHDDLNLGDLCEFNHQLRPHIVWFGEAVPKMDVAIDYVQDSDIILIVGTSMQVYPAAGLI
QYTRSDAHVYFVDPKPAMHSSDRITVLAESATSGVPKVIEMIRKMHS
>OMIFANIC_01148 tRNA (guanosine(18)-2'-O)-methyltransferase
MDSALFEYLQTYLTERRKQLFREVLNERTRHFTVVTEDVYQLHNTSAVMRSCDVFGIQDL
HVVEELEGKRVDKEIAMGAQKWVNLHRYNTIVQCMDKLKREGYQLIATTPHNDSMMLQDF
DVRRKTAFFFGKEDVGLSETVLDGADGFLKIPMYGFTESLNISVSAAIVLQEVVTRMRQQ
NIDWRLTEEEKRKLEMEWTKRSIKSVEAIIDHYYKNKN
>OMIFANIC_01149 hypothetical protein
MYILLSILGAIVAIFIILMIAAPKKYHLNRSIVINRALPDVFKYIKYVKNQDEWSPWKKK
DPDMKQTFTGDDGTVGFVSHWEGNKDVGTGEQEIISIEENKRLETELRFFKPWKSQSDAY
IEVDEAEGGTRVTWGFAGVNKVPFNVIMMFMNMDKAVGKDFEEGLGDLKRILES
>OMIFANIC_01150 hypothetical protein
MEHNIFAWVEIPVTDMNRAINFYEAVLDVELKLVDFGGVQMGWFPFSENAEAIPGATGTL
IKHETYIPSQEGTLVYIHSKDVQIELDRIEAAGGTIYQPKTQISPEHGFMGVFIDSEGNR
VALHSRN
>OMIFANIC_01151 Non-canonical purine NTP pyrophosphatase
MKLVFATHNENKFREVKAQMPDHVELLSLSDINCFDDIAETEKTIEGNALLKARYVKDHF
GIDCFADDSGLEVAALNNAPGVYSARYAGPEKNADSNNRKLLEALQKETNRAARFKTVIA
LIMNGEEHLFTGLCPGRIIEAPRGEGGFGYDPIFQPDGFEKTFAEMSLSRKTEIGHRGNA
IRQLITYLRM
>OMIFANIC_01152 ATP-dependent RNA helicase DeaD
MPTFQSLGLEDQFLQAISDLGFKSPSEVQERTIPILLDQETDLVSLAQTGTGKTAAFGFP
MLQKINADSRTTQGLILSPTRELCLQITNELVAYGKYVNGLNVVAIYGGASITDQARKIK
KGAQIIVATPGRMKDMIGRGMIDISKIEYCVLDEADEMLNMGFYEDITDILSHSPEDKST
WLFSATMPKEVATIARKFMHTPIEISVGTKNVGAENVSHEYYLVNARDRYAALKRLADAN
PDIFSVVFCRTKRDTQKVAERLIEDGYNAAAIHGDLSQNQRDMVMKSFRTRQIQMLVATD
VAARGIDVEDITHVINYQLPDEIETYTHRSGRTGRAGKSGVSMVIVSKSEHRKIRTIEKI
IQKKFEQKEIPSGMEICEKQLFHLASSIKDTEVNHDIDPYLDGINEVLTEFSKEELIKKV
FSVEFTRFYNYYKNSKDLSIAAGDSDRGSDSPSIRFFINLGGKDDFDWMSLKDFLRDLLQ
LGKDDLYKVDVMDSFSFFNVDEKHKDMVLHAFESFKLNGRQITVEISKDGKRKGGGRPSR
KGRRDFKKKGRSFGNDSSKFKGKNRRKKRGPSEKGTGGRRRRR
>OMIFANIC_01153 hypothetical protein
MKKLLILLLLISCSFAYAQDDTVINGTVLNDATDQPLENVNIVNLNSVKGASSDAEGKFR
IKAAVNDTLYFSYLGFKSIRVRVTNDWMKYGDIRIKMTELGIALEEVVIRPVELTGYVEV
DAKLIPIYDNYRYRISGLSTGYEGGKTKPGAVSSVLSAIFNPADFLYNIFGKRPKQMRKL
RQMKEDDEIRNLLAGKYDRETLMAVLQLERVDIDEIVNRCNYSADFIRTASDLQILDAIS
ECYEEYKVLNRKKGKG
>OMIFANIC_01154 hypothetical protein
MSSFYSFKESINSLESILPGKKIRNPYFKLNIIHLTILMFLLASINTIEAQCTEMSCLPT
PAASGANGPDPCNAKLYCSNSGAVQTGLINCTNAADTDGCGVNADAASSAASTYASADAS
VVELFSGGQYNTGTYLQWIVFATPPTVKGTKIQGVGAVDSWWLFHAGSVTVPGDYATVEA
ALTDPARCDSFDSSNLVIGSNANQYEPWLNENAVIAENVYNIYYIALFWDTPTNGSLNFK
VKECELGCPDVFISCPENDVQAACQSQAEIDLAFDNWKSQFTFTGGEEPVTEIFLVNGNP
VDINSLQAPDRCGGTITVTYEVSDNCPNFETCTSTFTVEEVQDFTVPADTGSTLECAPSD
MPTPPTVMDACGVTITPTGPTTGGTYDGCEGTIIYTWNYAESCGVFNHDWTYTYTIDYTQ
GVTAPMDESSTVECPAEAVDPGPPATVQDACGRDVIPVLVGSTSTPDPVTCEGTVVWTYR
YTDCTGQGTDDWTYTYTIDITTPPNAGMDDGSNVQCLDDATEPTPPSGVTDVCDRPIVPT
GPVVNTVFDGCRGTRTYTWTYTDCSGLSDDWVYTYTIEDTINPEIVNLPEPEPLCNDQFP
PYLEAEWTDNCATGGPLQSGGPVITMLDTCTEQAVYTFYVEDDCGNSDTETVTVIREFDL
IENCETAFARLSPNNPPSQCFLDDDDYNFNRWGWTNYIADEGTYTMDLWAGAAHCDTSRG
ELVGTVTVMYYDDEVDVEYQLTGNYVMSEAHINIGCDKYPTKRNGQPTVAPGQYNFNSGS
LNYVQNYTLEDVDVTGPFWIIAHGVTCELTCECSGLPGAPNSDTSTEDPINCTPAPFGES
TSTSVDQTRELDWNLDFTMYPVPFDNYLNVAYNLEYDSNILIEVFDIRGRLIQTAQSDYT
QGRRAVTRLDLGGTANEVLFIKVTTDRSVGMKKVVANNYIKD
>OMIFANIC_01155 NAD(P)-dependent benzaldehyde dehydrogenase
MKKIIEAQRDFFKSGTTRNISFRKKQLKKLRNLLKDNEDRLCEAIHADFSKSEFATVATE
LEIINKDIRIALASMNDWSKRQRVSTNLLNFPAKSYIVPEPLGVSLVIGAWNYPYQLSLA
PAIAAIAAGCTVIVKPSEIPGRTSALMAELINNNFNPEFFTVVEGGVPETTELLQQKFDK
IFFTGSTGVGKIVYKAAAEHLTPVTLELGGKSPAFVTGDCNLKMTVKRLIWGKFLNAGQT
CIAPDYILVDEKIEDRFLELCVKEIEKRKYEIDNNNYVQIINDANLERLSSMIDPEKVFF
GGKIDRVKRTISPTLLSNVSFEDTIMEDEIFGPLLPVISYTDLDKAIEQVKSLHRPLSCY
VFSSNNKVKRDVMEQISFGGGAINEAVMQITNPNLPFGGVGSSGMGKYHGEAGFRTFSHY
KGILSKPTWFELNIKYAPLSNSKLWWIRKVFKL
>OMIFANIC_01156 Ribosomal RNA large subunit methyltransferase H
MKITLLAIGKTDNRELQQLIDEYQRRLIRYVPFSFEIIPDARNTKNLSEAQQKQVEGSEI
LRKVQTSDHLVLLDEEGKSFSSVEFSAYLQKQMNSGLKNLVFAVGGPYGFSEEVYQRANG
KVSLSKMTFSHQMVRLFFVEQLYRGFTILRNEPYHHR
>OMIFANIC_01157 Nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISKKQFQKEIDLIIANAIREDVGDGDHSSLACISEDAEGTAKLLVKDEGIIAGVDFARQ
VFEFVDTGLKMDIKIPDGTEVSNGDICFYVSGSSQSILKAERLVLNAMQRMSAIATKTNK
YVKLLEGTKTQILDTRKTTPGIRALEKWAVKIGGGENHRFALYDMIMLKDNHIDFCGGIE
KAIQQTKAYLKDQKLNLQIICEARNLMEIQQILDAGGVYRILIDNFNYEDTKKAVSLIGD
LCQTESSGGITLETARHYAECGVDYISSGALTHSVHNMDLSLKAV
>OMIFANIC_01158 hypothetical protein
MSKEVEEKLLSIPVINVIVRIFRRIILPGFNGLSLYDLLEIYITGIIKGTFSSRASSIAY
SFFIAIFPFLLFILNLISYIKVEGFQQRFLTFIEELLPPKTHDFFYPVIEDIAINQRTGL
TYFVLFLSLFLAANGVNAIFSAFEGSYLVKINRAFFKQFFISIAVAICLSVLMLVTIGVI
LYGEYIISELKGSDFISDDIFWINVFQVVVFVGMVYVIIAGLYHFGVKKGRHTRFFSIGA
LMTTLLFLLTTYLFGIYINNFSNYNELYGSIGALMIMLFYIWINSNLLLLGFELNISLQR
LKEKRQPEE
>OMIFANIC_01159 hypothetical protein
MKKLFIITALLCSVVVSSQEVTGKWKTIDDNTGEEKSIVEIYEENGRVYGKVVEILVDGR
QNATCRNCEGEDEDKPILGLTIIRGLEEDGDEYNSGKILDPESGKLYKCYIELEEEDKLK
VRGYIGFSLLGRTQYWFRAE
>OMIFANIC_01160 Primosomal protein N'
MKVVHFVNGLFYFYTVYFIDVILPIPLKQTFTYSVNVDEARFLRQGMRVAVPFGKSKVYT
GIVYRVHQQAPTSYETKSIDQILDEEPVINSFQLKHWEWMASYYMCTLGEVIRAALPSAF
LLESETVIRLVSKNNLTDSVFSDEEFLVYEALQHQSSLHINDVRSILDRRNVVKVIQQLL
QKEVIEVEETVFEKYTPKIVRYIRLAPEFASEDNLQILLESLTRAPKQKEVLMTLFMLTA
QQNKPVSSVQLQKKSNSNASVLKTLIGKGIIEEYFIQKDRVQYTGPEGADTKELNEAQVQ
ALSEIKESFKENEVTLLHGVTSSGKTEIYVELISELLKTGKQVLYMLPEIALTTQLISRL
QHYFGECISVYHSKYTLNERVEVWNNVLNGKSKAQIIIGARSALFLPFSSLGLIIVDEAH
EPSFKQYSPAPRYHARDAAVVLGNLHGAKTLLGSATPSLESSYNAQTGKFGHVKLTRRYG
DVLMPEIELIDIKEKHRKKRMSGLFSDRLLEEMKECLETGDQVILFQNRRGYSPFVECTT
CGVSPQCPNCDVSLTYHQYKNELRCHYCGYHMAMLISCMACGSETLDTKGFGTEQIEKEV
KKLFPSHAVVRMDQDTTKGKHAYSKLIEAIENREADIVVGTQMLAKGLDFRNIGLVGVMN
ADNLLNFPDFRAHERSFQLLQQVAGRAGRTEKRGKVLIQTYNPYHRILQQVSVHDYDGMY
KDEAEQRYQYKYPPYYRTIKITFRDRNYNKMRKAAVWFGALLQTRLKDQVLGPEAPPVGR
IRNLFIINLLIKIPKEQSVPKTKEFIGKAVQSFHSVKDFSTVKLTLDVDNY
>OMIFANIC_01161 Transcriptional regulatory protein YpdB
MDKPILKCAIVDDSTLQRLSIVKLIENHPSLDLVAEYNNAIEAKMGLATTQIDLIFLDIE
MPILSGFDLLDDLTHKPQIIFVTGKTKYAFKAFDYDAVDYLRKPISKDRFLNAVHKAITN
YKLKNDEGFDEEDFIFVKSNLKKRKVFLNELRYIEALGDYVKLVTEHDALVVLSTMKAFE
ALLPSDRFLRIHKSYIVNLDKVERYNSKVIELDKEQLPLSRNRKAELAEALAATMRN
>OMIFANIC_01162 30S ribosomal protein S6
MNHYETVFILNPVLSEEQIKETVKKYEGILVSKGAKMISKEDWGLKKLAYPIQHKKSGFY
HLFEFTVEGDAIDAMEVEFRRDERIMRYLTVKLDKHAIAWAEKRRTRNKQKA
>OMIFANIC_01163 hypothetical protein
MEANEIPTSGILAAIRGMKDRKDRSDVLKEFQGSKILICGTKDTVVPFKDSKRAASFTKS
KLISMASGHMTLIENSKELTEIVHFIE
>OMIFANIC_01164 hypothetical protein
MKSSPKSQRSISSLLCVAFGHDYIITRKVTNHINEYRCSHCGREVAENDTGHLEILTQKL
KNTNSALATFFQKKNRKVSA
>OMIFANIC_01165 hypothetical protein
MKQLSCKIKGHSLSPVSKQPFHIKEYECSRCDQKFTTDGYGRLVKFTRYWKENHEFFNNH
FKNRLLS
>OMIFANIC_01166 Thiamine-monophosphate kinase
MFEDKDQSRTPVSQLGEFGLIEHLTRKFELSQETSVKGVGDDAAVISSEKNKHIVVTTDM
LVEGVHFDLSYMPLKHLGYKAVVVNLSDVYAMNAEATQITISMALSNRFTVEAVEAIYDG
IQTAAKYYNIDVVGGDTSSSVSGLILSITALGNVDKDKITYRSGAGINDLLVVTGDLGAA
YLGLQVLEREKKVFEVNPNAQPDLEPYSYLVERQLKPEARKDIPKLMSDLDILPTAMIDI
SDGLSSEVLHICKQSKVGCNLYEDKIPLDPQVISTCEEFNLDSTTIALSGGEDYELLFTI
RQEDFPKLKANPHFTVIGHITEEKEGVHLVTRDDTKIPLIARGWNALTEE
>OMIFANIC_01167 hypothetical protein
MKILMISAAMMITIISCSKDNSFRIPENAQISNQNDSIQGPVELPFSALCVNGSAGGFGC
NGFNLVSRIELGTMGASSGNDCWGWTDPTTGIEYAIMGLNNGAAFIELSDPANPIYLGKV
PTQSSASPWRDVKVYNNYAFIVSEAAGHGMQVFDLTRLRNVPSPPTNFSADALYSGFGNA
HNIVINADSGYAYAVGTSTFNGGPHFINIQNPLDPQAAGGYGMDSYSHDAQVVTYNGPDT
DYTGREILIGSNENEVVIADITDKENPEGIATISYNQSGYTHQGWFTENQRYFIVGDELD
ELEFGFNSRTLVFDFGDLDNPVLSSDYFGPTTAIDHNGYVKGNKYYLSNYTRGMSEIDIA
GIGSGNLFESGYFDTYTENNAASFNGAWSVYPYFSSGNIVISDINLGLFIVKRGN
>OMIFANIC_01168 hypothetical protein
MKNLILPVLLICSLYMSSQTPCIDGTAGGFSCEGLDLISQIPLSTMGSNRANDSWGWTDP
SDGKEYAIICLNEGTAFIDISDPLNPVYLGTLPTEGSSSTWRDAKTYNNHAFIVSEDPGH
GMQVFDLTRLRNVNNPPVTFTNDVHFTGFGSAHNIVINEDTGYAYAVGTDLFSGGAYFID
IQDPLNPQAAGGYSGEGYTHDAHVVNYNGPDTDYSGQEIMVGSNEDELVIVDVSNKANPI
PISSISYTNVAYTHQGWFTEDQRFFLLGDEADEIDFGINSRTIVIDLLDLDNPQVHFSYS
GPTGATDHNGYVKGDRFYLANNAAGLRVIDISDLENQNMTEVGHFDTYSVNNNSGFNGSW
SVYPYFDSGHIVISDREEGFVLVKESGNLNSQEFDPSEFALVPNPAEDLFTISAISSSLE
KIAITDVLGKTIYSEVINGLQTTTIDVSNLSEGIYFVRINDNTTKKLRKN
>OMIFANIC_01169 hypothetical protein
MIKKLLLLSISIFSTMALAQTLCVGGFAGSYPCNGYDLQSHISLSVFGSFGATDSWGWTD
PMNGDEYAIVALEEGTVFIDISDPLNPVYLGNLTSHTDPSSWRDVKTYNNHAFIVSEASG
HGMQVFDLTRLRNVTNPPVNFTEDAHYNGFGSAHNIVINEDTGYAYGVGTDTFGGGSHFV
NIQDPLNPVAAGGYSNDGYTHDAQVIIYSGPDSAYTGREILISSGGGFEIVSIVDVTDKS
NPVGISTMSYSNSGYTHQAWFTEDHRYLLLGDEFDESNVGFNTRTIVFDLLDLDNPQFSF
DFFGTTTAIDHNGYVKGDRYYLANYSAGFREIDVSDIGNQNMSEMAFFDTYPPDNNASYD
GAWNVYPFFGSGNILISDRSGGFFLVKSSESDTTDPVAVCQNAVISLDENGTAILDPSLV
DGGSSDNSGFFTLSVTPNTFDCNQIGNVNVTLVVTDPSGNTDSCNSIITIVDDLGPDFTC
PSNTNVGYDEGQGYYTLTDFVASGDVTATDNCTVNVVITQDPAPGTQLTEGVYTISFSGS
DDEGNTGSCSFELNVMEILSTDDNFFDSNILLYPNPSDEFIHIESGNNNLQTFSLYNLLG
QEILNYSFDNSTTEKIDISELASGMYLIRINNNTVKRLIVR
>OMIFANIC_01170 hypothetical protein
MKKIVTIITVLISSMMIAQVPCSGGFAAGFPCSNFKLMGQITNAAMDAGGGNDSWGWTDP
QDGKEYALVGLTNGTAFIDISDPTDPQYLGKLPTHTDPSIWRDIKVYSNHAFVVSEANNH
GMQVFDLTRLRNVTNPPVTFTEDAHYNGFGSAHNIVINEDTGYAYGVGTSTFNGGPHFVN
IQNPLNPVGEGGYALDDYSHDAQVVTYSGPDADYTGREILIGSNENAVVIVDITDKSNPQ
PIASTSYGNVGYTHQGWFTEDQKYFLVGDELDEFNVGFNTRTIVFDFTDLDNPQFDFEYF
GTTPAVDHNGYVLGNRYYMANYSAGMRALDISDIGNGNISEYGYFDTFASNDNASFDGAW
NVYPYFASGNIVISGDFGFTLVRDENLSAGDFTNSDFAIYPNPANTVLTISSNNTPIQTV
VIYNVLGQQVMQYAFTETDSETINISSLNAGVYIVQINKTTTKRLIVN
>OMIFANIC_01171 hypothetical protein
MKRLLTYSLVMIFMCGFHACKKDENPEPQMSGTDDDDPPIGTNFEGVIEYVKTFGGSNED
EAAAVVQANDGGYVMVGTTSSTDGDIVDKTTTDPDYWVLKVNAEGVKQWSKTYGGTSPDR
GTGISKTNDGGYILSGHSRSNDGHVGGNEGFHDYWIVKINSVGDIQWETNFGFSGSDQAL
NIIQTSDGGYFATGFLDVTASGGLGNDGRNPEHGVGEYWGIKMNANGEKQWRRYFGGSSN
DRSYDVVQTDDGGFLMIGASESSDFDIVDDKGSYDFWVVKVSAAGDKIWTKSFGGSEIDV
AYSIAKATDGNYIIVGDTRSIDQDVSNPLGNADLWVVKFNKDNGAIIWEKTYGGNQFESA
RSIKRLANGTYLISGSTRSANGDVSMNIGQNDAWVMIINENGTLQYEKTVGGTSLDFADA
AIQTTDDKVIVVGNTESNDVDITLNRGIKDLLLIKVK
>OMIFANIC_01172 hypothetical protein
MRKIALALMTSVFLIGCNNDDDTQPAVVEVSVDFTFTQNWDGDPIENSDFDIPQYTNENG
EMMSISKLVYLISDVTFISLSTGVTYDAGDYNLINVRDQTNLTFTPDIEIPEGDYIVSFT
FGFDDEDNQDGIYQDLNSADGGWNVPMMLGGGYHYMRLEGKFIDDTGSLENYAYHTIRAA
DTSTDPVTLQDTSFEVGLGQITIGSSTNIEVQMNVAEWFKNPNTWDLNVLSTVLMPNFDA
QIMMFENGSTFSNSQGAFSLGSVTQ
>OMIFANIC_01173 Cytochrome c551 peroxidase
MKRSLAYIFICGLMFVSCADDQDDNVNGYTATPLELEIPPLFAEKILPPVIPEDNPQTVE
GVALGRKLFFDKKLSADNTLACAGCHSQANAFTDPRQFSIGIDGIAGTRNSMPLFNVAWN
YNELFFWDGRATSVENQALAPVTDPIEMHNTWSQVATTLQSDARYPVMFEDAFGTQSIDS
VLVTKAIAQFIRTLISGNSKFDRYLAGTEELSPSELSGLNIFLDENRGDCFHCHGNPNNP
LWTDNIFHNNGLDEFHEDRGRGGVTGDPREFGTFKTPSLRNLEYTAPYMHDGRFATIDEV
INHYSEGLVYSETIDPLMKKVDEGGVGLTPEEKADLKAFLLTLSDPEFISNPDFQDPN
>OMIFANIC_01174 Iron-sulfur cluster insertion protein ErpA
MIKVSDHAKSKISQLMSDDGFTVEQDFVRVGVKSGGCSGLSYELTFDKKIGDEDKMFEDS
PVKIVVDKKSFLYLVGTTLEYSGGLNGKGFVFNNPNANRTCGCGESFSL
>OMIFANIC_01175 FeS cluster assembly protein SufB
MGKFTEDDLKKELETKEYEYGFYTDIASETFPAGLNEEIVRAISMKKEEPEWMTDWRLES
FRHWKKMIEPEWANVKYEKPDFQAISYYSAPTTKPKYDSIDEVDPELLDTFNRLGISLEE
QKKLAGVAVDIVMDSVSVATTFKKTLAEKGIIFCSISEAIKEHPELVKKYIGTVVPQKDN
FYAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVIADEGSYVSYLEG
CTAPSRDENQLHAAVVELIALDNAEIKYSTVQNWYPGGKDGKGGVYNFVTKRGLCEKNAK
ISWTQVETGSAVTWKYPSCILKGDNSIGEFYSIAVTNNYQQADTGTKMIHLGKNTRSTII
SKGISAGKSQNSYRGLVKISPRAENARNFSQCDSLLMGNQCGAHTFPYIEAKNKSAKIEH
EATTSKIGEDQIFYCNQRGIDTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISLEGS
VG
>OMIFANIC_01176 hypothetical protein
MKKIFYLFLVTAALISCNNSEEKKTESTEESVETNDDVVDVRMPVYRGEFILTDEAAVLK
GKDFIYGVTLDTMARELAERVAPIKRDEFDMVPVIVTGVVSENPALAEGKEVWEEVITIK
KIINVSARPSEADVKIQDKN
>OMIFANIC_01177 putative ATP-dependent transporter SufC
MLQIKELHASVDEKDILNGINLDVKPGEIHAIMGPNGSGKSTLAAVIAGKEEFEITKGDV
LLNGEDITELDPEERAHRGVFMSFQYPVEIPGVTVTNFIKTAINESRKAQGLEDMPASEM
LKKIKEKADLLNIDRKFLSRSLNEGFSGGEKKRNEIFQMAMMEPKLAILDETDSGLDIDA
LKIVANGVNKLRSKDNAVIVITHYQRLLDYIVPDYVHVLLDGRIVKTGSKELAYELEEKG
YDWIKEEVKA
>OMIFANIC_01178 FeS cluster assembly protein SufD
MNLKNKLLSSYIAYEDHLEADSPINDLKSKAIKIFEAEGFPSKKQEDWKYTSLNSLLKTD
YSLSPRKDHALEFKDVKRYFLHDIDTYKVVFVDGVYSSFLSETTHDKIDVCLLSAALSKP
KYQPVIETYFNKAAKDDSLTSLNTAFAREGAYIFIPKHIEVEKPIEIINFSTGNEAALML
QPRNLIIVGENAHVQIIERHQSLSENPVLTNSVTEIFAEKRAYLDYYKIQNDNETASLID
TTYVDQQEQSNCRVHTFSFGGNMTRNNLNYYQRGERCDSTLKGITILEGKQHVDHNTLVN
HIEPNCESHQDYKGIFGDSSTGVFNGKVVVEKEAQKTDAFQQNNNILIDDKATINAKPQL
EIFADDVKCSHGCTIGQLDEEALFYLRSRGIGQKEARALLMYAFANNVLESVKIPELKRR
INKLIATKIGVNMGFDL
>OMIFANIC_01179 Cysteine desulfurase SufS
MAFNVTQIREDFPILKREVNGKPLVYLDNAATSQKPKQVIDSIVDYYSLYNSNIHRGVHT
LSQEATDAYEASRKKIQKHFNISRSHEVIFTSGTTHGINLVANGFTSFLKEGDEVLVSAM
EHHSNIVPWQMLCERSGAVMKVIPMSEEGTLLLDEYDQLLSDRTKLVFVNHISNSLGTIN
PVDIIIEKAHQVGAAVLVDGAQSCSHIKPDLQALDVDFYVTSAHKMCGPTGIGMLYGKES
WLQKLPPYQGGGEMIAEVTFEKTTFADLPHKFEAGTPNIAGGIAFGTAIDYLNEIGFNAI
AGHEQELLTYATEELLKVPGLKIYGTGREKTSVISFNLEDIHPYDVGTILDKLGIAVRTG
HHCTQPIMDFYKIPGTVRASFAFYNTKEEVDILVEGVRKAQMMLS
>OMIFANIC_01180 hypothetical protein
MKALITICTAALFLISCNETKKVIDVAGNVQLAGNYTITSLGETSVTENAPNITFLALDK
SVKGNTGCNSFFGNYSLDLYALSFIDIAATERACDEPIMTNENMFLQALYNTGSYSLEEN
VLTLFSKNDRSVLLKAQKEVNQ
>OMIFANIC_01181 Cysteine desulfuration protein SufE
MSIAEIQEELIDEFSLFDDWMDKYEHLIGLGKSLPLIDPALKTDDRIIKGCQSKVWLHAA
MENDKLIFTADSDAIITKGIIAVLVRVFSGQSPEEIVKANTDFIDQIGLKEHLSPTRANG
LVSMIKQMKLYAIAFQAQLKK
>OMIFANIC_01182 hypothetical protein
MSTTQIDTTELGEKIVKVLKTIFDPEIPVDIYELGLIYDVFVNEDLEVKILMTLTTPNCP
VAETLPLEVEDKVKSIKILKDAEVEITFDPPWSQELMSEEAKLELGML
>OMIFANIC_01183 Hydroxymethylglutaryl-CoA synthase
MKTGIDAISFYVPSLYVPMQELAAKRDIPYEKLRRGLGLEKMAIPDVNEDAASFAANALL
KLIQDNDLDPNKIGRIYLGTESAVDGSKPTATYAIEAVENMLAEKWGERSFKNCDVVDLT
FACVGAVDAMHNCLDWVQNGEERKAVVIASDLSKYELHSTGEYTQGAGAVAVLITKEPAL
IAFDKTWGVATKSVGDFFKPRRFFNKQQLAKDLLEQFNKDYSEEELNEVIAKTNSGFWNE
KNDLVELFKEEPVFDGQYSNQCYSDRVTEALEHFYEQRSTNYLEEWDYLVFHLPYAYHGR
RIIFSNWLNWIRETGNIDTLTNEIGQPTDDIKSWERLASKSEMYRSFVNEKIEMGERASS
FIGNMYTASIFMALLSLLRSGYNEGVDLTAKKIGFIAYGSGSKSKVFEGVVQKKWKEKIA
KVPVFENLKIRAAVDVELYEKMHSRIQQTPVQQTTGVALSEIEENDTNTKGLRKYS
>OMIFANIC_01184 hypothetical protein
MSDEIVNRVANSKLLTIDLEEYYPEGERLSLDISQWLYEGFVLREKEFRAFVKDFDWSSY
ENTYLAVNCSTDAIVPAWAYMLISLEAGKYAKKVIFGDLSDMETVIYSEIISDLDVDFFR
DKPVIIKGCTHKPIPENAYLLLAQRLQPVAKSIMYGEACSSVPLFKRK
>OMIFANIC_01185 hypothetical protein
MKNLVLLTILLLSPFALFAQDEEQKEKPKDGWTKSGNVSLLFNQAAFNAEWQGGGISNIA
GNGSLVYNMNYRKGKLSWDNNIIADYGLTKLANEDYVQKTNDRLELTSLIGKQIKETNWY
YSGLLNFKTQFDSGFEETERTEIVNGEEITITNRTRITKFLSPAYLLVGPGIMWKKSDNL
KVNVAPASARLVFVDGQFTDPNDPRNRLDANNAYFGVDAGDTLRFEFGAALNGYAKFKVM
ENITLENILALYSNYLEDPQNVDIDYTANLIMAVNEWIKVNLAFQAIYDDNAIQGFQIRE
ALGIGVTYGL
>OMIFANIC_01186 GTPase HflX
MIEKENIAYEKTILIGLITRQQDEDKAKDYLDELEFLAYTAGGKVLKRFVQKLDMPNPKT
FIGSGKMAEVEEFVKENDIGTAIFDDELSPAQQKNIEKILRCKIIDRTNLILDIFAQRAK
TSYARTQVELAQYEYLLPRLAGMWTHLERQRGGIGMRGPGETEIETDRRIVRDRISLLKK
KLAKIDRQMEVQRGNRGALVRVALVGYTNVGKSTLMNVISKSDVFAENKLFATLDTTVRK
VVIGNLPFLLSDTVGFIRKLPTQLVESFKSTLDEVREADLLLHVVDISHPSFEDHIDSVN
QILGEIGCADKPTIMIFNKIDAYKPEVIDADDLVTERTKAHNSLDDWKRTWMAQPSWDAL
FISALNKENLDEFRKVVYQKVREIHVTRFPYNTFLYPEYIE
>OMIFANIC_01187 hypothetical protein
MAKIRKLCYGILYFTRQYISVFMLKKENHNYYSFAFYNLENLFDTRNDPKTLDDDFTEHS
ERNWNDKRFRRKLKKMGSVISQIGFDEINHPPVLIGLAEVENRFVLEELVDSKYLRHKHY
GIAHIDSPDERGIDTALLYRKDHIDIRNITAHTVHVVNEEGIRDYTRDILEVEAMLEDSI
VHILVNHWPSRRKGVEETAFRRMAASQKAVEVVDQIKAVNPHARIVIMGDFNDDPESASI
KNLVSSQFYNPMELLLTKDEGSVTYRGDWYLFDQILLSHNFMQQHGNNFRFQKADIYNPK
NLQEFKGRRKGNPFRTFLGRRYAGGFSDHFPVYAIFSIR
>OMIFANIC_01188 hypothetical protein
MKKDYTFGMLQVFRSFKTAFFSIFFLFFVSNVAIAQGPGCPNVDAGPDIELDCGIDCVDL
TASFLQTGETTSYEVTSIDYAPPFPFTGGTPVSANTDDVWSPIIPIPFDFCFFGETYSEM
IIGSNGVVAFDFTQSDTQPLGFCQWSFEPNETIPDPVELFRTTIFGAYMDINPAVAGSGQ
INFEVFGEAPCRTMVINFPEVPYFSCTNLIMTSQIVMYETTNVIEVYIEERSDQCPTWND
GLAIIGIQNQDGTVGFTPPDRNTGNWQANEEAWRFTPNGTSNVMFSWLDAQGNVLGTDTT
INVCPDDQVSEYTAQAVYTNCNGDIITETDTVTVTKIANFTLDLGGDQSLCDVASYDITA
DVQGIDPSLATYLWNTGETTQTITVTQSGTYSCEVTYEDCTLTDSALIELNESPIIDLGD
DFGTCFDGTIILDASPSNFDPAEATYEWSLNGIVLSGETSPTLVVIEVGTYSVFVTVGTC
TSNDTIVITPRTDLEVSLGDDFKSCPNEPQTLTAETSETDVTFQWLLNEEVLEGETGNTL
EFMLEEGVMGIQTYTVIITKGDCTGSDDIDIETYDIGNCVISQGISPNGSPGFNDELDLE
FLSDRAGGILQLQIFNRLGGLVYQKSNYLNEWVGQSDDGNELPTGTYFYVIDLASEDSVY
GMQATGWIYLNRDAN
>OMIFANIC_01189 hypothetical protein
MKKLSLIVLLLAILSSEFMTAQQDPQYTQYMYNMNVVNPAYAGSKESLSITALYRNQWSG
FDGAPETFTFSAHSPLGDKVGLGLSAIKDELGPVSETNVYADFSYTLEIGGNTKIALGVK
AGATFHDVGLTDLELQDPNDPFFSQDISNTYPNVGAGAFLYGDNFYVGLSVPNLLNSVHL
DENGLKYGSETNHYFGTAGYVFQVSENVKLKPSVMVKSAFDAPVSFDGNLNALFFEKFEI
GASYRLDDSFSGLVGFQVTDNIRIGYAYDYITSDLDAVADASHEVILTFDLFFNKRTLRS
PRYF
>OMIFANIC_01190 Outer membrane lipoprotein Omp16
MKKLFTILLLIAVSTTATTAQNKDTKKADQLYARYQYTDAAAAYQKLLKKGKGSRYVFQQ
LGNSYYFINDTKKAETYYRRVVKGRKLDAEVVYNYAQSLKANGKFSDHNTWMKRFAELKP
DDSRAKEFMKNPNYIPLIMDEVQRWEATNLEEINSEYADFGAFVMGKEFYFTSGRNTKRK
KYGWNEEPYLDIYKAQDVGGTIKNASLLPGTEINTKYHEGTVAISPDGKRMYFDRNDFFQ
GDFDKSEDGVNQINLYYAELIDGQWKGVQSVPWNSDEYSNQHPALSPDGNTLYFTSDMPG
GMGKSDIYRVAINTDGTFSEPQNVGALINTEGREGYPSVDSNGTLYFSSDGRLGIGMLDV
FSAEIGRDGFGNAKNMGKGVNSANDDFAFVFNPATMTGYVSSNRDGGKGGDDIYAIKELE
IACEVTINVKVLNEYTDGPISGARVDMYDEFENSLSSRTTAEDGTSSFTAECDKGHVLQG
IMKDFESNAVVVESANNTEVDVVLRLRPIEEIIVDDRVVLNPIFFDLDKSNIKPQAAFEL
DKLVAIMLKYPNMVIKVESHTDNRGNNEYNLGLSERRAQSTVQYVISKGVDAARISGEGK
GETAPKFDCGANCTKEQHDKNRRSEFIIVER
>OMIFANIC_01191 hypothetical protein
MNSNFLSIPTSFHYTMVLLLLFMLSGSCKNENPLPDPLQAGWDGQAVCEVVQDDTSLRVL
KCSFPPGVGHERHYHKKHFGYTLAGSTFRIKDTTGTREVDIPTGLSFSNEGVEWHEVLNI
GDSTAVFLIVEPK
>OMIFANIC_01192 hypothetical protein
MKRSNPLHPFIILFILVFACVADDEYEVPVIDDAQVTITGSEISIISLKQALIQEMQTNG
NQVLTIETDLYVTGYVISSDEQGNFFEEIMIQDEPADPNAGLRIKIDSNPLFQSYEIGRK
VFVKLSGLTVGIDNGQLTIGLRDGNRIGHLSESRMFDFVARDTIVAVIEALPRLISELNE
DMLNTYIRLNDVQFNRDLVLGDRPLTYAGEPGDQFDGERTLESCTENATIILSTSTFADF
KSQELAPGKGTIEGIFTYNFFGDEFNIVVNNLSSVQLDSPDRCDPLEVDCGIASNPGNII
LFSEFFETMVEGEPINGNGWTNFIESGTETWEAFFDDGANGSLGISARMGAYMSGDDSNI
GWLITPEINFDQQENEVLSFKTSNSFADGSNLELLFSPDWDGNPETVVLATWKLLSSAVI
VQDDDYFGDWIFSGNIDLSCIEGTGHIAWKYAGSGDPDFDGTYELDEIEISRE
>OMIFANIC_01193 hypothetical protein
MEFGLEWQALPVFKFKAAASVGQNVYTNNPLLYLSGDDFDNDPLDDIVEGNDLESLGKRK
VALKNYHVSGGPEQAYQLGIEYRDPKFWWIGATVNHFSNAYLDISFLRRTSDFYTDVDGL
PFNNYSEETARNLLQQEQLQDYFLVNLIAGKSWRIKRYFVGFFASVNNILDSEYRTGGFE
DSRRVSYRQRLEEENRRYGPLFGNRYFFGNGTTYYLNLYVRF
>OMIFANIC_01195 hypothetical protein
MVTIIIIVTIYLVYTGYSYYNTALEERFYHPQHDWFKPSGAYGHGLGIIGTLMILIGVSL
YIARKRYNFMAKYLRLKYLLEFHIFLCTLGPIMVLFHTAFKFGGIVSVAFWSMVAVVLSG
VIGRFIYIQIPRTIEGRELSLQEVKGMKTDLSTVLREDYNLDDSTILLFISFTQVEKDRQ
EKVSPGVLKKALKRSNVPVDQRRSVLKLLKNERTLGKRISRLQTMQKLFKYWHVAHLPFA
LIMLVIVIIHIAVTLAFGYKWIF
>OMIFANIC_01196 Ferredoxin--NADP reductase
MEVIIEEILVYGVVFFLCLGVVFLYMRKLKKKTKETERKVEIAKEEGLFEPVSLHPYINL
NTCIGSAACVSECPEKDILGIANGKATLINSSNCVGHGACFHACPVEAISLRMGTESRGV
DLPHVNQNFETNIRGIYIAGELGGMGLIRNSVEQGQQAIDSILKSKKPNPKGALDVIIIG
AGPAGISATLACKKHKLSSVTLEQDSLGGTVYTFPRSKIVMTSPMNLPLHGKVKLYDTSK
DELLKLWNKVIEEHDIEIREKHKVENIIPQKDDTFKVITTSGEEYIGNNVLISIGRRGSP
RKLNIPGEESTKVAYRLLEPERISGKEIVVVGGGDSAIEASLLLMDENNVRQLVRTETLT
RCKPKNREKITQANADGKVKLIFSSNLVSISDAKCIIKTDTDDEAIEVPNDLVYIFAGGI
LPTAFLEKPGIKITKRFGYIMKKHG
>OMIFANIC_01197 hypothetical protein
MRNRFIHIIFLFVLAVTQSYGQISPGDLTTAHSELEGMSNCTLCHDIGKKVSNAKCLDCH
KEIRSLINSNQGYHANRNVRNKDCFECHSDHHGRNFDMIRFDENSFNHDLTGYALEGKHE
EVDCRKCHTPDNIANSDIRKRKGTYLGLDDACLSCHDDFHQKTLSNDCLSCHNMDAFKPV
ANFDHNETDYPLKGEHINVDCIECHKMTTRNGVKFQEFTDLAFSDCKACHNDPHNNQLKG
ECKQCHTETSFSRFTGKGRFNHNVTDFSLKGQHISIDCFTCHDRSSNPITIFQDNIDIAE
NNCVACHEDQHEGLYGTDCAKCHQESSFLALKDMDFFDHSITDYPLTGEHVDVDCTKCHL
ERFSTPIDFSACNNCHSDYHNGEFADNGISPDCVECHSLDNGFDYSLFTLERHQTTNFPL
EGAHTATPCFACHISEDDERWTFVDLGSSCVDCHTDFHESFISTTFYPDQDCTTCHSNDA
WNIVNFDHNITNWPLDGKHLDVDCRACHFEISENETIISQNFTNLDNQCASCHENVHEDA
FAIDGITDCNRCHVTQSWFPEKFNHNSTAFPLEGRHAEISCAACHEISDDNGQKTVMYKL
NKLECIDCHLQ
>OMIFANIC_01198 hypothetical protein
MYRLSFTIALLLVLLPVMSQSPHGDDLKMDCAECHTPDSWTLNFETLQFDHGTTKFELEG
SHEVTDCKACHTDLTFKDTSTDCISCHLDVHNQSVGNDCMRCHNSDSWLVFNIPELHEQN
GFPLIGAHTNLGCIECHDSASTLVFRPLGNECIECHRDDYMATTNPNHAISGFSTDCIEC
HSPFGIGWDAEGIIHDFFPLTLGHDIQNCTECHTNGDFTNTPTDCFACHSDDYIATTNPN
HQTANFPTDCASCHSTNPGWMPATFDHDGMYFPIYSGAHEGEWNDCIDCHINTNNYSVFT
CITCHEKNDMNDEHEGVSGYVYESNACFACHPNPN
>OMIFANIC_01199 hypothetical protein
MSLKHAYILIALALSSVVFAQDNTLTGTVSFVTSNNVYVKFDDTEVIELGKTLQFSGNDC
LRVTDKSSTSVVCVIINNCEVGQGDSVSYTYVVEAADPSVPEPDDEVGPTGAVALIPADG
DKKSLYQENIRGRVSIASLNTFSNIRNDNNIFRTRFSLDANHIGDSKFSVQSFLVYRNFN
TSSNRYDGRTSIFNVYNLNVRYDAMPSLSVTAGRHINPKASSIGAIDGLQVEKYFGDFYV
GAMGGFRPDFENYGFNSDLLQYGGYFGIETNTKDFYSESTVGAVEQTNAGATDRRFIFLQ
HMSTIASDLNLFGSAELDIFSTMGSNSRLTNLYMSARYRISRAVNVMISYDTRKQIIYYE
TFQTEIERLLDEDLARQGLRFRLNVRPAKMLWLGLSYSRRFQADSQNKSDNIYGYATLSQ
IPGIGGRFNVSYNMNSSNYLTSNIYAISYSREFFENKLSAQVYYRLADYTYDNSISDLNL
NYYGTTLSYRISRTWILSVSGELSRFDQENNYRFYTSLTKRFYSKKKK
>OMIFANIC_01200 hypothetical protein
MIYRNILLLIMFTATLASCNNGPKVITAQVENDTNESVSGIFSETNNENVIPNTQTGSFT
EDLHKVTVNEILPATKYVYLKVTEAGEEFWIAARKQDIELGGTYYYRNGLLKTNFESKEY
NRMFERIFLVSNLVHEVHGNNTGTLKPEFGSDEIETEQKQSIPTHTEEIVQHKGSIKIAD
LVANPANYEGKTVQLTGKCVKINPNIMSRNWIHLQDGSKNDFDLVITSNTFVPEGKTITI
KAKVVLNKDFGAGYRYDLILEDGIILE
>OMIFANIC_01201 Cytochrome c biogenesis protein CcsA
MVPMRKWVLLLFHGAIIIIIIGAGVTRYFGFEGVMHIRENDSSSSFLSSETYLKFDVQKD
NETYSFDEPVLFASLGNNHFEESYLIDGSLIEIVVSDFIPNPKQQIVASSTNGKPVLKLV
VAGTNGREEYYIEEGSTKRIGSMLFNFKDQLIFGAVNLKYEEEELLLNYERELTQTVMAT
QIKDTLNFNGEFLPLALRSLYSDGENNFVFPEFSPSAELEMVSEDPKVKNESVTAVVMEI
SVDGVKKETVVYGNKGLPGNPSTLLFDGIQVNTSYGAREVKVPFAIRLNDFIMEKYPGTN
SASSYASEVTLKDPTENVNMDYRIYMNNILNYSGYRFFQSSFDRDEKGTYLSVNSDFWGT
LISFIGYALLTLGMILTFFSKKTRFYSVLQKIKKLRSQRGTFVLILFLSLGINSFGQAYK
DKAVSKEHAEAFSKIVVQDFKGRMKPMHTLSREVMRKVTRKENWEGLTADQVVLGMFVNK
QDWYDVKLVKLGKHKDIQKLLNVRGNYASYKDFFSEKGEYKLRDEVRRVYGLEPIDRGVY
AKELLKIDERLNILSMLFAGSLLKIVPNPNDPNNTWQAYNSHNHAPDDGHNHSTIADNFF
NAYGTALKQATSSRNFQHAGHLLDELKTFQGAKGGSVMPSEAKINTEIRLNEMNVFTRLA
GLYMILGMALLFFLFLSVFKPNLKLKTVYWVIFSLIALGFILHTIGLGMRWYVSGRAPWS
NGYESMIYIAWTSTLAGILFTRKSFGGLAATMVLAGTILFVSTLSFLDPEITPLVPVLKS
YWLTIHVSLEAGSYGFLMLGAIIGLINLILMIFISEKNKGHVKRIIKEMTYISELTITGG
LFMVSIGTYLGGVWANESWGRYWGWDAKETWALVTILVYAFILHMRLIPKLRGTYAYNLA
TIFGLASVIMTYYGVNYYLSGLHSYATGDPVPIPQWVYIVVSCIIVISLAAFIRKRKFQA
IS
>OMIFANIC_01202 Cyclopentanol dehydrogenase
MSKVVFITGGSSGIGKAIGNYLSEKGYTVYGTSRNPERYESESVFKLLPMDVTDPESISA
ALSEVIEREKQLDVLINNAGVGITGPVEETPDIEIHKAFDTNVYGPIRVMKAVLPHMRKQ
GKGLIINITSIAGYMGLPYRGIYSATKAALEITTEAMRMETKQFGVEITNVAPGDFATNI
AAGRYHAPQLDDSPYKKAYGDTLKMMNDHVDHGENPLQMAKAIHHIIASSKPKVHYKVGA
FLQKFSVVLKRILPDRVYERMLMNHYKLK
>OMIFANIC_01203 Transaldolase
MKFFIDTANLDQIKEAQDLGVLDGVTTNPSLMAKEGITGRDNILKHYVDICNIVDGDVSA
EVIATDFDGIIKEGKELSALHEQIVVKVPMIKEGVKAIKYFSDHGIKTNCTLVFSAGQAL
LAAKAGATYVSPFIGRLDDISTDGLNLIAEIRVIYDNYGFETQILAASIRHTMHVLECAK
IGSDVMTGPLSSIEGLLKHPLTDIGLEKFLADYKKGN
>OMIFANIC_01204 hypothetical protein
MIRKLLLLLLCSPFISCETSLTNGSDETWIGGQIINPKSDYVVVLKDNEVLDTLELDSKN
FFHFKSDSIKPGLYSFRHHEYQIFYLEPGDSLMLRVNTVDFDESLTYSGKGAARNNLLMD
LFLMNEKENTLMPALYRLSPSDFQNKIDSLRDERMALYNDYVENQGLCSDFKKVAMANIN
YDYYSKKELYTSANAMNMNLKSEDFPSDFYSYRDEIDFGNESLRAYYPYYRFLNRYFDNL
AHNQNENTGKYLNRNSFDHNYHKMKIIDSMVECDILKNNLLYTCARRYLVNAKNVDNEKQ
MVAMFKRANTNEKHHLEIEKLADRTMQLTPGKSLPNIMLVSYDNVMKDVHTIINRPTVLY
FWSAESVKHFKNLHSRAAELKSKYPEYDFKGINTDTHFKKWKEVVYKAGYNSNQEYQLEN
IKDAEQKLLINSINKAIIVNENGIIQDGHTNLFSPTIEDNLLGFLNL
>OMIFANIC_01205 putative ABC transporter ATP-binding protein YbiT
MLSVNNLSVQFGKRILFDEVNTQFVQGNCYGIIGANGAGKSTFLKIIAGKREATSGSVHL
EPGKRMSVLEQNHNAYDEYPVLETVVRGNDELFAIKAEIDKLYEDYSDENAEKIGELQVS
FEEMNGWNADSDAAALLSNLGINESLHYSLMGDLDGKQKVRVLLAQALFGNPDLLIMDEP
TNDLDYETITWLENFLANYENCVIVVSHDRHFLDAVCTHISDIDFGKITHYSGNYTFWYE
SSQLAARQRAQQNKKAEEKKKELEEFIRRFSANVAKSKQATSRKKMIEKLNVDAIKPSSR
RYPAIIFDREREAGDQILHIENLAASLDGETLFSNVDINLAKGDKVVVFSRDSRATTAFY
EIINGNINADSGKYQWGVTTAQSYLPLDNEHYFQSDMSLVDWLRQWAKTEEEREEVYIRG
FLGKMLFSGEEALKKSNVLSGGEKVRCMLSRMMMIRANVLMLDEPTNHLDLESITAFNNS
LKNFKGTVLLTTHDHEFAQTVANRVIEITPNGVIDRHTTFDEYMNESKIKELRDKMYAVE
V
>OMIFANIC_01206 hypothetical protein
MLAKTNIETMLHKTRDRRIPSETILAEVSKILEENTHQRDTINENLKKSGSDENDFDVNL
LNADKIFHLKDIKKLCVIYRLRFLDSHFFKGDIPEEAISKIRQLEKEHDTPLSGFKVMAP
AKLLKLENADDPLLFAPIGNDYFYLIHKWGNDLHPFRKLLMWPYKSFENLVFTVFLVSIL
LTAMTPMNMFTHTAHMQEYFLMFLFMFKAVGGIVLFYGFAKGKNFNGAIWDSKYYNG
>OMIFANIC_01207 hypothetical protein
MKLKLLIILTITFFVTGQLSAQKYKNTESTVVTKMYQGIEFSSEKTLLENLSEANGFSVY
AGILEDHSANLFTENFIGTVFVITDTGFERMTEENDSFDYSEPTYRKFQLQYFTVPGRLD
AHSIKKAVLKGGGSARYSTVEGSTLEIKMFGDTLFLYVSEKMKAKITTTDFYHKHGFFHI
VDSPVVPPSTKN
>OMIFANIC_01208 Phenylalanine--tRNA ligase beta subunit
MKISYNWLKQFVNINWDAERTGELLTDLGLEIEGITPFTSVPGGLEGVVVGHVLKCSNHP
NADKLKLTQVDLGNGEPVQIVCGAPNVAKGQKVPVATVGTTLYNPEGEPWKIKRGKIRGE
VSMGMICAEDELGLGQSHDGIMVLDSKLKPGTPASKVFDIENDEVFEIGLTPNRADAMSH
WGVARDLRAGLLQNEIQIELITPSTSSFRVDNRMLKIDVEVADDNLAPRYCGLTISGIKV
EPSPGWLQNRIKSIGLPPINNIVDITNYVLHELGQPLHAFDAMKIAGNQINVKTLPAGTK
FVTLDEVERELHEEDLMICDAEKPMCIAGVFGGIHSGVTESTTSIFLESAYFDPVSIRKT
SKRHGLNTDASFRFERGIDPNACEYAMIRAAILITEIAGGEITSDVVDIYRKKIEDHQVV
LNFDSTNSLIGEEIPRETIKEILTSLEIKVNNVTESGIGLTIPAYRNDVTREADVIEEIL
RVYGYNKVGFSEKLNASISETKKVEDHDIQQHVSAQLTALGYNEMLANSLTAPTYCELSN
SLKEAHNVAIINPLSQDLSVLRQSMLFGAMEALSYNINRKNKDVKLFEFGTTYHNYPKGR
EEKKHLTIIVSGSRREDSWTIPNQRSEFFYFKGIITAVLERLGIDGYSEKPIKTDVFNEG
LILSLGRSTLVEFGLINKAVRGHFDVEAETLFADFNWDLILQKISTENFNLKPIPKYPAV
KRDFALLLDNEVSFGKLREAALQTEKQLLKDVSLFDVYTGKNLPKGKKSYALSFTLQDER
KTLTDKQIDKIMVKLKQRFEKDFGATLR
>OMIFANIC_01209 hypothetical protein
MKVVLKLFIVLFVLGLTSCRDTKKEEAELEAVTEQIESVEEEATNIAEEIDAEAEELEET
LSELDSL
>OMIFANIC_01210 hypothetical protein
MKNISKILIFALVLFLGAGQVTMAQDDASLTKKAAEKKQQVDKKLDKAQAEKEAQMEKME
KEKEKMKEKYDDPNYKSDKMKDKADKMKDKAQSDVDKAKADVEQSATDAASTASDRMEKA
DPSKKTGVEKRKAEVKKMKMSKSESMARAKEKIDMSQKNIKGHQQKLGNAETRISKARAR
VDKAKAEGKLTEEEYKAKMDKINEAEDRLTKFKMALENADTSMKSKKESLDKMNSDSNKN
>OMIFANIC_01211 Cold shock-like protein CspC
MTKGTVKFFNDAKGFGFITENDSQTEHFVHATGLVDEIREGDEVEFELEQGKKGLNAVQV
RVI
>OMIFANIC_01212 hypothetical protein
MFLVVLVYLWSRKNTATNRRRHQRSFRDEYYQKKKEKEKEKKEN
>OMIFANIC_01213 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKIYTKTGDTGTTALFGGTRVPKYHIRIESYGTVDELNSHLGLIRDQEIDNRYKELLMNI
QDKLFTVGAILATDPEKAVLKSGKDRLNIPKISDSDIELLESEMDAMNDALPPMTHFVLP
GGHTTVSYCHIARCVCRRAERLTTLLHSEEPINEAVLRYLNRLSDYLFVLARKLSNDLKA
EEIKWIPEKL
>OMIFANIC_01214 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRTGAPLEVVENLQAIEDEGDSYDSIEEIWPDY
PTDEDYLWNEDEY
>OMIFANIC_01215 Protein translocase subunit SecA
MGLLDSVLKVFVGDKSKKDISEIQPIVDRIKEFGPEMSKLSIDELRGKSNEFRKRIEADQ
AEINAQITELEKEADEMEDIDKKEDIYNQIDRLMDDRYEIETKTLDDILPEAFAVIKETA
QRFKDNETLTVTATPFDRELSGSKEYVTLDGEQAIWKNSWDAAGKEVTWDMVHYDVQLVG
GVALHQGKAAEMQTGEGKTLVATLPMYLNALAGNGAHLVTVNDYLAKRDSAWMAPIFEFH
GLTVDCIDHHKPNSEERRKAYNSDITYGTNNEFGFDYLRDNMAHAPGDLVQRPHHYAIVD
EVDSVLIDDARTPLIISGPVPKGDIHEFNELKPQIQELVDIQRKYLTGVLAEAKKLIKEG
DTKEGGFKLLRVYRGLPKNKALIKFLSEEGVKQILQKTENFYMQDNNREMPKVDAELYFV
IEEKNNQIDLTDKGIDFLSGKDDPDFFVMPEIGTEIAQIEEKGLSPEEEAELKEELFRDF
GVKSERIHTMNQLLKAYTIFERDTQYVVIENKVMIVDESTGRIMDGRRYSDGLHQAIEAK
ENVTVEAATQTFATITLQNYFRMYRKLSGMTGTAVTEAGELWEIYKLDVVEIPTNRPIAR
KDMDDKIYKTKREKYNAVIDEVTELSQAGRPILIGTTSVEISELLSRMLSIRNIQHNVLN
AKLHKKEADIVAEAGESGMVTIATNMAGRGTDIKLSDEVKAAGGLAIVGTERHDSRRVDR
QLRGRSGRQGDPGSSQFYVSLEDNLMRLFGSERIAKMMDRMGLKEGEVIQHSMISKSIER
AQKKVEENNFGIRKRLLEYDDVMNAQREVVYKRRYHALFGERLRVDIANMIYDTAEVIAD
TNKGAQDFKNFEFELIRYFSMSSPISESEFESMGFQEIAGKVYKAAYEHYQDKMARNADM
AFPVIKNVYENHKDQYKRILVPFTDGVKTLNVSTDLEMAYETEGKQLVQDFEKNITLAII
DDSWKTHLRKMDELKQSVQLAVHEQKDPLLIYKFEAFELFKTMIEKVNKDVISFLFKGEL
PQENQQQIQEAREVRRKEKLSEQKDEIPNMDERAAQSRAAGNTQKQTQITETIVRERPKI
GRNERVTIKNVMSGENKTLKYKQAIPLIDKGEWVLIDE
>OMIFANIC_01216 hypothetical protein
MKKVIFLLTVILLIACSENDESVTSQQVELFVDHYKTTSIINGTAFVIYENVAPGNNADK
IYGQINRFNFEPGFTYQLTANKTIIENAGTNAQTVRYDLITINNKEAVSPDAEFRIPLIQ
FFNGRGTATFIRRQADSTFILSNEIPFNCNYFCVDLDRAIERETAIEGTFTHGPEGTYIL
QELAN
>OMIFANIC_01217 hypothetical protein
MEEQFKKKDQILKKLIVEAGSETPSPDFKSRLMAAVQQKADQKVMYKPLISIKIWIGVAA
VFIGIVVISFLFPSTGILPELGVDMSQFQPGFSLPKPEFSKTFVYGIIFMSLFLFQIPFL
KKLVETRYD
>OMIFANIC_01218 ECF RNA polymerase sigma-E factor
MNRHTDQHYIQKTLNGDTNAFSVLIDRYQNLVYTVVLRVVKVKEEAEEVAQDTFLKAFES
LSGYRGESKFSTWIYSIAYRKALDRVRKNSRMKPVELVEDITEKNVEDIDNALHFLELQE
RNHTIRKCIEQLPEKEAAIITFYYFDDLSVREISAITELTEDNIKVKLHRSRKKLFSLLK
QFVLPEISNSNGRAI
>OMIFANIC_01219 hypothetical protein
MGPGEVIIPIVMFGVIFGIFYLFISARNRERLALIEKGADASIFYNKNGRVTPMWKVIII
NLAFLLMGIGLGVLIAEGFSEGLGMDEDVAFPGVIFFMAGLGLFSGFFVTKKIAQNA
>OMIFANIC_01220 hypothetical protein
MEEWGENFGKRMEEFGKRFEEQYGQDMEKWGEEYGKQMEEWAKQFEEGGGNWSKQIMTDP
HGNKSIIIQGDKKGEFKRVKATKTLRIKIPKGAKTEINVRHGEIKMADAYNVRATLNYSP
FTANSIDGGNTLINAAYAPVTVNNWNNGALLVKYIDDCQLNKVNRIDLESNSSNVTINLV
DNVAFLSGSFGDIKIREVSDGFNSVRMDLDNTDAFIVIPNSAFTFDFNGKKSTLLYPRSL
QLDQQKQNGRVIVKGFNRSSSSNRSFTINAAYSNIKLQ
>OMIFANIC_01221 HTH-type transcriptional activator RhaR
MSSQNLSNTYLDSLGYEELLTKFNKYSGDSINLESIARMYLRKARKEGDTIKMARGYDRL
ARIFKPKVNLIFADSVISLTMKHNHITYPAMGYILKGYNYRLIKDAVNASKNYKKADSIA
QIRKNLQQQVHIMQNLISEKITWGNKEDALSLQHSRDRIIKSKTYFNNIKKSTRVNAHID
IKQLYINELLNSNINYIFCHLNLRNYDSTRLYIDKTKELLKEYNWVEKNHYENWIDEVLM
ELFYYESDYNNSIIQAKKLLDKESRLEPHSRMNVNLFKGLSLIRTGQRKLGITYLKKSDS
TVIANEIQLLPNDRKLLVVLKEYYRSIGDAENHISYLNRIVEVDSAMMINYKYFEPNMIR
NFETPQLLLEKETLISSLKYRNRKSKILNLGFIFLLLISLLLLVYYIQRQQLYKRRFDKL
MQQNETSNYNSSNQYAYELSPEVINNILLKMEGFERSKTFLNHEITLQSLAKLFETNANY
LSRVINAKIGKNFSQYINDLRIDYAMTGIRSDKKLRKYTIKAIAEECGYKNAESFSKAFY
KRNGIYPSYYIKKLNKADQKN
>OMIFANIC_01222 hypothetical protein
MNNSASKSLIKVLHIILFMLIIHGPLVIVKSSAANFTEDTIELCLNQFAKELSFIEKKYD
SILLGFNNQLTNITADLVQNNRTRHTLELLVKQFQIRDSVDKFQRMRIADINKVRYIKGV
EIIKILYEKTLALDHHFTTVNTLHDIQKMSNPNNYQEFTLAKGNFSNKADKKKGFDLGAI
LGDNIYTTIIHSMISLFTNDGINKSSKKEMMKEIECILDFTLRINNDLNVVYFESAYLKK
SNEEIIQQIEELFNLYTRPIDYKISLKKCRENDDWLTIQTHLVAYLNRLNYLSSAYQNPI
EAYNMKVDLEFCIDRLTHFIFQYNMFINQSGKFYEKFALMLDSYKNEEACVEKIPEEFVT
LKEKINITIEKFHNTYKPVEINGSKMKQLLYGVGGH
>OMIFANIC_01223 Beta-glucanase
MFNRIFFFSLLMGLTAYAQDPVYELVWADEFEGSGAINGDNWHHQTLLPNGSSWYNGEIQ
HYTDREVNSYVGNGTLKIVAKRETFTDQGVTKDFTSARLNSKFAFTYGKVEIRAKLPTGV
GTWPAMWTLGQNISEPGGFWEPTHGSVSWPACGEIDIMEHWGDNQNFVQSAIHTPSSYGN
TVNKGGTTIPTASSEFHIYTMEWDEDRIVFAVDGVVHYTYNPAVQNPDTWPFDANQYILL
NVAILPNIDPAFSESTLEIDYVRVYREGVLGADGPEANVRASLVNPVGEYLEMEFAESAI
GSELYVYDLSGRLVAYFEINQASLVKDSSHWSSGLYMAHLVGEGSLKVMKIVKE
>OMIFANIC_01224 hypothetical protein
MKTNFRNSSLRFGLFAISASVMLLFSGCSQEEVQLPDNEGQNLTEETTETRASGPSASGQ
GTISLDVIPPVGEGFRHFSFHARVKKNGSVQGSGVLTYVGGQRNLQFDIDCLEVTGNLAV
MTGVVTRDNQFPELEGRLCWFKVIDNGEGANADPDQMALFYTGTDPAVYTCTNNFEVPVY
DIEGGNVQVRE
>OMIFANIC_01225 Proline dehydrogenase 2
MFRDIKSNYICLQYRLIMISKNLFDNTETAFKLKSDSELERAYFLFKMISNEPLVKIGTA
VTKFALNVHLPVEGLIRSTVFDHFCGGVNESDCLPTVDKMFDTGVYSVLDYSVEGKEEEA
QFDRARDKVIELTYFARDKEAMPFSVFKPTGLGRFAIWEKVSAVEELNEEEQGEWQRIID
RYHAICKVAKECDVILLIDAEEYAMQKAADELCESMMETYNTEKVIVWDTLQCYRHDRLE
HLKGRHERAKAKGYKTGFKIVRGAYMEKEHERAEDHGYPTPICKSKEETDDNFNTIMRYI
LDNLEDIYLFVGSHNEMSSYLAMEIMEQKGLLRNDPRIWFGQLYGMSDHISYNLAVEGYN
VAKYVPFGPVKDVMPYLIRRAEENTSVAGQTSRELNLLKTEKQRRGI
>OMIFANIC_01226 3-dehydroquinate synthase
MPKQKNIGNVHCGTAVGKVLSVHLQKVNHSSIFVLTDTNTRRHCLPKFLSEVTFESEPVV
LEMPAGEHHKNIDSCVKIWSELSEKNADRNSLLINLGGGVVTDLGGFVASTFKRGIDFIN
IPTSLLAMVDAAVGGKTGVDLGSLKNQVGVINHPSLVLLDPGYLQTLPEAHLRSGQAEML
KHGIIASEVYFDRTLEFDINKPEAEELIWESVLIKDRVVKQDPLEKGLRKILNYGHTLGH
AIESHALRHNPDNPLLHGEAIAIGMILATYISSEMLGFPKKSLDKITAGILAIFKKQLFS
KTHIKEISDLLIYDKKSSRGKVYFVLLNDFADHKINCEVPDSLISEAFSYYSSHS
>OMIFANIC_01227 hypothetical protein
MMKRIIVDYKKLTPEILALLVEKYPDGYDDDHVIVFKNARNETIEAVEVRTDDTIYLVKV
SSRLVSTMANFDEDDYAEEDLSEPIIELPAKRELEEEED
>OMIFANIC_01228 hypothetical protein
MTVNDLHSSEYSSYFQPYIDKVEQKPLIQCLEEGKLATETFFQDIPTGKQEFRYAEGKWT
PKEILLHLSDSERMFCYRAMSFARSDNANLPGYDENEFALNSNANKRSMDDIIVEFSAVR
AATISLFKSFSDEALMRKGTANNNTLSVRAAGFLICGHEIHHRKVISNRYL
>OMIFANIC_01229 Regulatory protein AsnC
MAKFKLDDTDHQILDMLIENTRTPFTDIAKKLGISAGTVHVRVKKMEEGGIITGSSLTLD
YKKLGYSFIAYVGVFLNKTSQTQFVLERIHDIPYVTVAHVTTGKFNIFCKIRAKDTSHAK
EIIYKIDDIEGVTRTETMISLEESINDKKRLMHSIFKEI
>OMIFANIC_01230 hypothetical protein
MVYIINTNNIWGDFQVYLIDFVYLCHQSPLHFMFTIVNKPLFTFVGSMKIQELYSKHFKC
ELSGRYIHNEHIIPLLENATKIAKIEQIGSSENGLPIYSVTLGTGKKKILAWSQMHGNES
TTTKALFDFLHFIKQKKFYVQDISKFLGDYTFVFIPILNPDGAFTYTRENISGVDLNRDA
LDLQQKESMILRNLFEEFEPDMCLNMHDQRTIYGTTEGKTVTVSFLAPAADPTRTITEAR
KAAMQHIARVNSALQLLIPGQVGRYDDTFNANCVGDACTMAGVPSILFEAGHFPGDYQRE
KTRELIFCALLELFHITNFGTIDIGYKEYFQIPENQVNFKDVIIRNVRLSGHENPVSIAV
QYQEVLRNGKICFDPVVDSIGDLDEWYGHYENDGNKGFALLNYHEKEGIGEKIVTIVDEI
TQNTLFNSANK
>OMIFANIC_01231 hypothetical protein
MVNSQEFAKRLQKILEYYSISATAFSDEIEVNRSTISHLLSGRNKPSLDFVLKVIQHYPE
VELYWLLNGKGSFPAVKSSSEEIKETSSESSLHEPTVISSAENSAKDPISTFQDPDIDRI
VIFYKDGSFKSYKN
>OMIFANIC_01232 hypothetical protein
MQIISSLLLLLLLTSCYEVERNCADFRIGTFKFEAVSGTEVYTTRIERNDSIEIEYYKES
IDTASIRWINDCEYVLRKLNPKSMAEEKAIHIKILTTKGNAYTFEFNEVGKSSKSRASAV
KTSN
>OMIFANIC_01233 hypothetical protein
MFDILTTPDALMALLTLTILEIVLGIDNIIFISLAASKLKKNLQVKATNIGLFLAMLIRI
ILLFGISWLVAMEAPFWHLNLSWLKVGVSGQALILFAGGLFLLYKSVSEIHEKVEDKGHD
EREVRKGRSTTLTKAIIQITLINIVFSFDSILTAVGMTNGVGETPQDALLIMIIAVVVSV
IIMMLFANPVGKFVTKHPTVQILGLAFLILIGFMLIAESAHLSHLIVFDQEIGAIPKGYL
YFTIAFSLLIEFLNMRYRRKTSDIVTTVELDEELDK
>OMIFANIC_01234 hypothetical protein
MNRFKSRAEDPKDKEVVTPKDIELLSNIERLMEEQNELLKNK
>OMIFANIC_01235 Na(+)-translocating NADH-quinone reductase subunit F
MFLASTLGVIIATVVAFLVLTLLLVALLLFTKQKLAPSGPVKITINEEKVIEVPSGGTLL
STLGNQKVFLPSACGGGGTCIQCECHVLEGGGEALPTETPHFTRKELKAGARLACQVKVK
QDMNIHIPEEVFGIKKWEATVVRNYNVASFIKEFVVEIPEDMNYKAGGYIQIEIPPCEIK
YSDIDITAHPEEHDTPDKFQAEWDKFGLWPLVMKNTETVERAYSMASYPAEGREIMLNVR
IATPPWDRAKNQWMQVNPGIASSYIFNCKEGDKVTISGPYGEFFINPSESEMLYVGGGAG
MAPMRSHLYHLFKTLKTGRIVTYWYGGRSKRELFYIDHFRELEREFPNFKFYMALSEPLP
EDNWKVKKDIHDEAGDGFVGFIHQVVIDNYLNHHETPEDIELYFCGPPLMNQAVQKMGED
FGIPDENIRFDDFGG
>OMIFANIC_01236 Na(+)-translocating NADH-quinone reductase subunit E
MEHVELFFKSVFVDNMVFAYFLGMCSYLAVSKKVSTAVGLGAAVIFVLTVTVPLNWLLDQ
YILQEGALSWLGAEYAEYDLSFLSFILFIATIATMVQLVEIVVERFSPALYNSLGIFLPL
IAVNCAILGGSLFMQSREIESFSLALNYGFSSGIGWFLAILAIAAIREKIRYSNVPAPLR
GLGITFIITGLMAIGFMSFGGMLTGGDDAPEVSEAGTAQIENTSEESAKELAQNETSEVS
EITAQ
>OMIFANIC_01237 Na(+)-translocating NADH-quinone reductase subunit D
MAISVIFVLGVGNVVISLLRNVIPSKIRIIVQLIVVATLVIMVDQVLKAYAYELSKELSV
FIGLIITNCIIMGRFEAFALGNGPWKSFLDGIGNALGYGVILIIVGFFRELLGSGTLFGI
KVLGDSVEKTGLYAIGYENNGFMVLPPMALIVVGIIIWVQRSKNKALIEEN
>OMIFANIC_01238 hypothetical protein
MERITLTAGETSLNNENLDIDFNVRTENDDDTFFVNAATDNVGIGLNNPSANTKLEVSSG
TNDAISGYSDNVGGILGRETNISFGSPVQTIQGAGVYANNPNAGYTSMFAQSTGNANVGA
LGSYSDVWIAGYDYVDNARDTYNPPASYSQLNVSTPVLGGYKAAIRAYSNRGSTAGNPGY
TVGVQATAVADNEDGFGITAGYFGNSTYTAGGEFFSASSGGATNAYAMVASYYFGTAYKI
LGFGAVSTIVTDDNNKQRIMYAPEAPEVLLQDYGVGTLVNGTAEIAIDPILSKNIHVDAT
HPLKVFVTLEGDCNGIYVTNKSKNGFTVKELQGGRSNIDFSWQIVATRADDTDGSGRTVS
TYKDLRFPEFNMDNNGKVRTSNGQRISETKAESFTRD
>OMIFANIC_01239 hypothetical protein
MQSNFTQKICFLLMLLALFLSGSNGMAQQVGINTSSPSSGALLDINASDGGFLIPRVELT
GTNDTTTITPNATTGLLVYNTVFAGALPFQVTPGFYYWDSVQWRRIYNQGYTLRYQQTNE
VDADSDPTVYVDLDGLDTGDFNIPFSGEYQLIVRGYLSAGDLTTGSPDGACIGSISLWMD
TNNSGTFTKLDESFLTATSKTVNSTTDFYNMAHSTTIVYNVTLDVVNSYRFKVQGREWDR
NGVDIGVFGRDTSGYIGASGIDDAQRGNMTFTLVRQQ
>OMIFANIC_01240 Gluconate 2-dehydrogenase cytochrome c subunit
MKTSTYFSFYLLFMVLLTSCSEKKQSYASPDPANLSEAELIEKGEYLIENMGCAHCHTPK
RLTEKGPVPDMDRWLMGYPASDSLPKIDPNMIESSPWLLFHPDLTAAVGPWGTSFAGNLT
PDDTGIGNWTLDQFKKALREGKYKGMDQNRPMMPPMPVFSSMKDGDLKAMFTYLKSIPPI
ENVPPSYRPPSQ
>OMIFANIC_01241 Isoaspartyl peptidase
MQPFSIVIHGGAGTLIKGLMTPQLEAEYRKALDHALEVGYGLLADGGTALDAVETAVRLL
EDSPLFNAGKGSVFTAEGTHEMDAAIMDGSNLEAGAVTMVTGIKNPVSLSRDVMEKSNHV
FLAGKGAMQFANSLGYEILSPDYFYDEVRYKQWQGIKDSDDFQLDHSVKKDGKFGTVGAV
ACDAEGNVAAATSTGGMTNKKWGRVGDSPMIGAGNYANNKTCAVSCTGSGEYFIRGVVAY
DVSCLMEFKGLSLEEAASEVIHKRILDIGGDGGLIAVDSDGNIAMPFNTEGMYRAFKTST
GSKEIGIYT
>OMIFANIC_01242 Cyanophycinase
MKAKGILIPIGGNEDKGIETADHYKLEYIEEGILARVVKESGGTRASIVVIPTASNYPVE
VGENYINAFGKLGCDNLRILDIREREQSESSENLEIIRNADCVMFSGGNQSKITKVIGRT
TMHDILTDKYRNGKFVIAGTSAGAMCMAEEMISGGSSTEAFFKGTVKMTDGMGFVPNLII
DSHFIRRGRFGRLAEAVARYPKLIGVGLAEDTGLVIKECKTFEVIGSGMVILFDPRKLKH
NNEEILEEGTPMSLVNLKTHVLANGDRFNLKEKKVKVLPVEAPFV
>OMIFANIC_01243 Cyanophycin synthetase
MKIREINAMRGPNYWSVRRHKLIVMVLDLEEMEDRPSNKIEGFRERLEEMFPTMYEHRCS
VGTPGGFFQRVDEGTWMGHIIEHIALEVQTLAGMDTGFGRTRGYGEKGVYNVVFSYIEEN
VGRYAAKASVRICEALIEGEAYDMEPDIQEMRELREASRLGPSTGSIVEEAASRGIPWLR
LNQYSLCQLGYGANQKRIQATVTSETSSIGVELACDKEDTKYLLERAEVEVPKGDIITRE
RSLEDACDYVGYPLVIKPIDGNHGRGITVDIQNYKEAVVAFHAAKEVSRRVIVEKFITGE
DYRLLVINHVLVAAAKRTPAHVIGDGESTVKELVDKVNEDPRRGYGHEKVLTMITINDLT
KTIIKDAGYAEDSVLPEGEKLILKDTANLSTGGTAEDVTDIVHPANVAMAERISKIIDLD
ICGIDIMTSDISKPLSETGGAVLEVNAGPGFRMHLAPTTGLPRNVAAPVVDKLFPTKGDT
GRIPIVAITGTNGKTTTSRLIAHMAKMSGYRVGYTTSDGVYIQNRLLMSGDCTGPASTEF
VLKDPTVNFAVLECARGGLLRAGLGFKNCDVAVVTNVASDHLGLKGIHTVEQLAKVKGVI
PETVLPDGHAILNADDDLVYGMRRSINSNLALFSLDENNPRIQALQRIGGITAVYENGYI
TLCRGTWKMRIMKAENVPLTFGGKALFMIQNVLAAVIAANVRGISIEDMKAALESFVPSS
SQTPGRLNLFEFQNFKILLDYAHNPAGMLALKQLTDNMEASKKVGIIAGVGDRRDEDTNE
IGSIAAEMFDEIIIRQDKRLRGRSEEELIKLLDDGIKMKDPKKKTTIIPSEKEAITHAVN
NAEKDSLIICCSDVVPDALDLVKKFKHQEATGEKIFSQ
>OMIFANIC_01244 hypothetical protein
MKRLIILVAACIVGHTSQSQVGIGNTDPKSSLDITATNVATPSNTDGILIPRIDDFPVSD
PGVDQDGMLVFVTGNGTPSEGFYYWDQGTMSWVSVGGATSDSDWYEVGTNNPADDISDNI
YHLGNLAVGGNSTSTTSPLLVQGDVSTDLSNILTSVNGAFPSGTYFGMSNSGVLTGAGNY
TGISNSLAGSNDGTIRAVSNSFLNSGTGQKIGIENTFNSADGVRKGFRNYFSAGNSISMG
LENVAPGAFSISGALYGLKNDLSSGGNGQRYGVQTVINTTGSGSKYGEQIIINSSAGGQH
YGVYSDVQKPSGYAGYFIGRTSLGTDPSTGRYLMPAADGTTGQMITTDGSGQLSFSDPAQ
EDIDWYEVGTTTAPNAINDDMFTQGNVVIGATTNPANVKFYVESDPANNTTGIRQSMGAG
TSGLLKGFDNLITANGTTNVYAISNSISGNSTGTSIQAIRNSFSGNGGTKTAMYNSFGAG
FGGSARGSQNEFNSTSITGAIGNYNFFNSIGSTATATGTLNSASSSVSAATLFGTSTTFI
GPTVSGSAYGNYSNIQTSGTDYGVYAQVADNAIDYAGYFVGRASFGTNLATGRYLLPAAD
GAAGQVVATDGSGQLSFVNATADTDDQTIDNFGLLGDTLGLSIEDDGQPVQTVDLSNVNF
NVSNFALAKMTMSANQSLPSFTYTKVNFDSSAIAVGSNFNTTTDRFEVSEDGIYRISASV
KSLSNNVSNAYVELLIYVNGSAVKRHIENHHALGVIYRDVEIVQVLTAGQYVEVYAYTDT
TFTIDSGIQQTTFVVERIR
>OMIFANIC_01245 Transcriptional regulatory protein YpdB
MHSLSIFIVEDEPLIAATIETALQKQGFNVIGDAENYDDALSAIQKQKPDLVLLDIQLEG
ERDGVELAMEFDKKNIPYLYLTSQTDPETVDRVKQTQPLGFIVKPFTEAGLRSNIELAWH
NLSLAGDDYLIIKSEGETYKLNQQDILYLKAFDNYCFVVTKDHKHLVPKTLKHTAEGLNP
SHFAKSHRSYIVNLKKISKMTIDSLFINGTEIPLSSANKEHIKERLRS
>OMIFANIC_01246 putative sensor histidine kinase pdtaS
MPFMIRSILLLSILLVALNSRAQSVDRKYIDSVSVSISKLDKENVRVQLKQLRNKIEVLD
KEDAIPLFEYLLENSVSSFAKMIVCGEYGAYLVTRDIPEKAMEYFTIGLALSEDLNETLD
LMWFHVNLANTYIFQNRPDEAMDHLNSAEPLAVDLELVDAITSINYSKGMVYESIEDYNS
ATERYLKAWDNLNTVDDHPEKGFYLYVLVDYFKRIGEITQQAKFTEILAAYYQKRQPETP
FTHLPMNHIFDTAATEANILRYRDVIRVSDSLGALNALLYSSLSLSDIYLKSNLTEDAID
LLLPIIKSLDTTDRDQQKMALYGKLSSLYETSSDYKNALLYKNLEAELRDTLVSEKTKKN
VAELEVKYDLQTKDRKLEQQAASQKLLYWILGSVFVILGIISFFFVKNRKKNQKLARQKK
LLEATVDEKNVLLKETHHRVKNSFQIVSSLLYLQSENMEDTEAQRAIKEAQNRVKSMVLI
HQKLYNKDQLVGIDTREYFDDLTKEIFESHQDDGNKVDYKLNVESMMLDIESITPIGLIL
NELITNVLKHAFDSLDSERQLDIDFQKDGDELVLTVSDNGKGMPEEVLESSFGIKLMKAL
AKKLKATLQFENAPVKGTVATLNVSRYNLLS
>OMIFANIC_01247 hypothetical protein
MQRRGTLKQIYFQEIHETSMNIYRNEECVNSVKVKLKPGENRKATTEVMAFRPKFDRFA
>OMIFANIC_01248 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MKRRTFIQNASLTGIGVVAGASALSCKEEVTVTENIPATTGGITLPVVVATWNVHDATAK
AWEVLQQGKSSLDAIEAGCMVEEANAEGQSVGLGGLPDRDGNVTLDACIMNRDGNYGAVV
YLQNIKHPISVARKVMEDTPHVILAGKGAEQFALESGFEPEDLLTEASRKAWEKWKETSE
YKPVINIENHDTIGMLAIDSNGDIAGGCTTSGLAYKMAGRVGDSPIIGSGLFIDNEVGGA
TATGLGEEVLKTVGSFLIVELMRQGKSPQEACEEAIGRIVAKNDSIKDFQVGYIAVNKHG
ETGSYSIHEGFWVTKYQNDKNENNPSDFYNKKP
>OMIFANIC_01249 hypothetical protein
MRIAITILFISLLCISCNNSENITVAKKEKSLIEYVNPFIGTGGHGHTYPGATLPFGMMQ
LSPDTRLEGWDGCSGYHYSDDFIYGFSHTHLSGTGVSDYGDILLMPTNEVVFNNGAEGKK
GYRAHFSHDNEEASPGYYKVHLDSTEIDVELTVSKRSGMHRYNFPNGSKRIVMLDLQHRD
KLLSSEIKKINDYEIIGHRHSEAWAKDQRLFFHIKFSHPIISETASTHPLSQTRMVAYHF
DHTSNEPLIVKVGISAVDEEGAKMNLETEIGDKKFEQVKAEAEEIWENQLEKIVIESPNE
DHKTNFYTALYHSMLAPNLYQDTDGRYRGMDLKIHQTNAFDYYTVFSLWDTFRAAHPLYT
IIEQERTNDFINTMLAKYDEGGIIPIWDLSANYTGCMIGYHGIPVIADAYLKGIRDYDAE
KALEAMVHSATRDHLGLASYRKFGFIPVEEESESVSKTLEYAYDDWTIAQMAQAMGKTGV
YEDFTKRAQYYKNVYDPQTNFMRGRFRNTWFGPFDPFEVNFNYTEANAWQYSLYAPQDVK
GQIALMGGKDEFRQHLNDLFSAETETSGRDQADITGLIGQYAHGNEPSHHMAYLYNYVNK
PFMTQEKVHQILTELYTNAPDGISGNEDCGQMSAWYVFSSLGFYPVTPGSNEYVIGTPLF
PKATINLESGKQFTVAAEMINEQNIYIKSASLNGKPLNRTYLRHDEILAGGVLKFEMTST
PSNWGNSDSAAPTSEITEYLITPAPFIAEGDVAFKMQTSISLDNVSKDAEIYYSLNDGEF
KPYSESIKISEATLLKAYAITDGLQSAVMETQFYKIDPNISITLDNEYANQYNAGGNDAL
IDGIRGSKDFRTGAWQGYQDTDVIAVIDLGSVKPFDTVSVNFLQDQRSWIFFPTQVECYV
SDNPGTFYKNLPPQEIDAELPSEESEIKTVQFSMGGYSARYVKIVARNLGDLPEWHLGHP
FDGKAWIFVDEIEIK
>OMIFANIC_01250 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MIVRWIIFIAIYIAIDIYAYQAFRTFTKNNWFSAAYIAISVLLLLAFIYQVTSGDSSRTM
TPWRMYTFGLVVAIFFPKLMLVLIMFTEDVVRVVVGGFAKLGGINDTFFVPSRRKFVSAI
ALGLAAIPFSSLLYGMYRGKYNYKVLSYTLEFDDLPDAFDGYRITQISDVHSGSFDNEEK
VAYGIDLVNQQKSDLILFTGDLVNNMTNEMIPWKDLFSKLKAGDGVFSVLGNHDYGDYVT
WASAEDKIQNLEDMKILQKEMGWDLLLNENRTIERNGERIKLIGVENWGAGGFKKAGDLN
AACEGVGDDEFKILMSHDPSHWQQQVKADARHFHLTLSGHTHGMQFGIEIPGLVKWSPVK
YRYENWAGIYEEFGRYINVNRGFGFIGYPGRVGIWPEVTVIELKKRSHTA
>OMIFANIC_01251 Thioredoxin
MSKFGELIETNVPVLLDFYTEWDEACKEMHAVLRDVAAALGDKARVIKIDVEKNSELAEA
LRVKGLPTLMIYKNGEMKWRQSGEQDANTLIGLVKEFV
>OMIFANIC_01252 Peptidoglycan O-acetyltransferase
MIFSSEIFLFLFLPIFLAFYYLSPKKVKTFVLLIASLLFYTWGEEVLVVVMLTSTVVDFF
SGIIIERGYRKVGLGLSLLTNLSLLGFFKYFNFTFENFNSFISVFGYDPMVLEGVPEIIL
PIGISFYTFQTLSYTIDVYRGQVKANRNFIQFASYVTMFPQLVAGPIVRYADIASQLANK
DISVKNFTIGIERFIVGLAKKVLIANTFATIADGIFAENLNDLSTPMAWLGILAYTFQIY
FDFSGYSDMAIGLGRMLGFDFLENFNYPYIAKSIREFWRRWHISLSTWFRDYVYISLGGN
RRSPIRTYVNLFIVFFVTGLWHGASWNFVIWGLFHGVLLVLERFGFDKVLNKSWKPFQHF
YTLLAVIVGWVLFRAETLGDATTYLAKMFWYTSGDITLNSYLSFLHFDARTVVFIIMATL
FSTPVYRYIDRLVLSPKIVGVRPLFYAVLLLLSIVYVGSESYNPFIYFRF
>OMIFANIC_01253 hypothetical protein
MMKVNRYISIVIFVLILWLPLGMNLIGWDEDPDAKQVEVPKLTFKQTDSAVGIKEITRGL
YKDIMMYKDGIDGYFLETYPLKDISFTSYRDIQREVFGADPIPKKVVEGREGWMFLGNSY
SEVITESIGLELFPPGYLKHIKKTVSDREKWLASKNVAYYMAIAPNKHSVYGEYLPIKYR
DTISKKKQLLELLSDDHRIIDMAKDFSEYKKGDKLFYKTNTHWTDIGAYWGYYNLMLEIK
KGFPEVQILPISAVEREVKTTNSEDLTRMLRIEVGEEVIQLVNNNKQSIGLEKQLPVPDY
YKSNPSTYEYRYKSDVNDLKVLMLGDSFSTALRQFLRESFGEIVILRSYTLSESIIEKEA
PDILIHQFVERGVDMLPVTRK
>OMIFANIC_01254 Peptidoglycan-N-acetylglucosamine deacetylase
MNSLLVKTPGFVQRLYPKRLWAFPNEVNSVFLTFDDGPIPEVTPWVLETLAAYDAKATFF
CIGRNVEKHPEIFDKIISEGHAIGNHSYSHLKGWQTSTSEYINDFEIAEDIIQNQESFSE
DMVKLFRPPYGKLTSTQAASILKKDYKIVMWDVLSYDYDQKISEEKCLDNVKGNLESGSI
VVFHDSLKAEKSLRFALPILLDSIRNKGWMAKSIDNSLFPRDR
>OMIFANIC_01255 hypothetical protein
MSDFNFVKWNRILGWSVFAIALLTYWLTVEPTASFWDAGEYITTASNLEVGHPPGAPLYQ
ILGAFFSIFAMDASSIALTINLMSVFVSAFTILFMFWSLTILLTNVVSKQQEINKNSAMA
ILGSAAVGSLAFAFTDSFWFNAVEAEVYASAACIMSILFYAGLRWEREMNTPRGDRWVVL
IAFIIGLSFGVHFMGLLTIPAIGFLYYFKNYKNITAKNFIVANIVMVAILLFIFKLLLPM
TLKFFSASELFFVNDIGLPFNSGTIIAGLLFIGLFYYGLRQSRKKGFVRLNTLLLCILFI
FIGFSSWLMLPIRANAGVVINENNPNNARELLAYYNREQYPETHLFYGPQFTETYAGLDP
DNPYKDDKPKYEKDEKAGKYVIVNRYENAGQNTDDAHKAFLPRMWSIEHTENYISYIDGL
DFSVKRQYRGEARLIEEVNKFKEAYKEGLVDAEDYNTFLTNFSAYLDIEKPSFIDNMKFM
FSYQFGYMYWRYFLWNFAGRQNDVQGNEDDLNGNWISGIKFIDELFIGSQDNLTTDMKNN
KARNTYYFLPLLLGIIGLVFHFFNDRRTFWVLLVFFLFTGLALKVYLNERPFEPRERDYA
LVGSFYVFAIWIGFGVYALYEIAKEYLKPKMALPIILAVTTLAGPVLLATQNWDDHDRSN
RYTAQSMGKMYLDSCDENAILFTIGDNDTFALWYAQNIEGYRQDVRIVNTSLFQTDWYID
DMKKKAWSSDPIPSQLTHDDYKFGSRDFLFYQETSQDTLDIKRWMNWVANDSEATTIALE
SGQIANSFPSKIIRVPVDKETVLRNGIVPQEDADLIVPYIDIELKGDILYKNRMMMLDII
ANNNWERPIYFSGGSFGDDDYLWMKDYLQLDGIVYKLVPIRTPIDRRNPFDMGRIDTDKM
YDIVMKWDWGNSGSPDIYHDTETRRNGISYRSNLARLAEALINEGKTEKAENVLDLGMEK
MPVKYFEYYSLLEPFILGYYELEKPEKARAIYEEVSQKYQENLLFYSGMKIKRQYSLADE
IISNMERYRSIVDIAIVYDTEEFGKQEATEFNDYLKLFRHFYAENEGIDPDKKPATEDSS
GLQTNGISEDTSETDLP
>OMIFANIC_01257 putative bacterial non-heme ferritin
MHTSIENLLNDQIKYEAMASMQYLAMASWADAEGYGGVANFFYTQSEEEREHMLKLVKFV
NERGGKVIIPSLEQPKDSFDSLGALFQKFLESEVFVTEQINTIIGACLQEKDYNTNNFMQ
WYVTEQLEEEATARTLLDKLNIIGDDKSGYYHFDRDIETFIQAHER
>OMIFANIC_01258 hypothetical protein
MVNQDHLSYSSHFEYHDFSDENRIKIIQHNPEILKQPIAIRGDRTILVETPTDIIKKWTS
>OMIFANIC_01259 hypothetical protein
MKILLTIIISLFVLQSYAQVHKLSSLKKTDTVEKVGTLDSLPVWVHVDRPVPIKKYFHYL
DSLVSRYDSLVSYPVTEHLLVHANPWIIDSLVNTDYYRLIERDSFVYDQKEIVILKTGDS
IVIPDVESANSILKDFKSTWIDVNIPEYRLRIFRDSVEMYTVPIRVGQNRKKFLAMGGRV
TDLRTKTGIGKIIRHERDPDFYNPTNGRRFYLTRRDDDSVTVMPQIPWIETEINGVRNGQ
LIHPTTNPETLNKPYSNGCIGTTEGDAWIIYYYAPLKTAIHIRYELSVLDYKGEAIELKD
IYGFKE
>OMIFANIC_01260 hypothetical protein
MDISNFLTAFWGWYLIIFFVILSFNPKRIKQIFNDLKDQKFTILAAFLAIIIGLLNVIAH
NIWESDHRVVVTMLGWISLFLGLSLFIIPNIVSGWLDYINMKLVQVFYVALLFVGIYLLN
VVYQLVPY
>OMIFANIC_01261 hypothetical protein
MKATYSKLKLWVIAAFFALGSCGPVIFSSRPSAPPPPWFYPNRVETVRYVYFPDYLIYYD
LTFGNYIYLENGIWITVNILPPRFNTVNLRRSRYIRIDNYFGDRIDVYHRDYRSNRGRSN
RTTSGRRNQIP
>OMIFANIC_01262 hypothetical protein
MLTFKNYNIADWFSFYRIAAAPVLLLLAIFDLREIFSWMLLISFSTDAIDGYLARTLKIS
SPRGSQLDSMGDQLTLVMGVVGLFVFEPEFMNNKLQLLLIVFIPYFSQMIIAFVKYGKAT
AFHTYFAKLSAVVQGVFILWALFFEPVLWLFYTVLTVGVLETIEEITLISMHDNWTKDVK
GIYWALKKRRKDKKKDKNRESE
>OMIFANIC_01263 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MGPQKKKKGQKKGQKSRIGIVMRRYSLFTIILLCFAILIVDILSYYWLQRITKLHASTDL
KLVIDILFWFFTIGLMSAIIILKIRMDSISALRRQRLISSLYGLAVASFAPKLIFVIVFS
ILTAINYVFSEEASIIVVPIIGLLSGIIPFVMIVYAIFVSLYRFRLNNVNLIFENLPENF
DGVRIVQISDLHLGSFNRRYHILERAFDKINDLNPDYIFFTGDLVNNYAWELEGWESLFL
KLKANRGKFSVFGNHDYGDYSEWPSEEAKEENLNGIKNFYQATNFKLLLNETHLDRIGDD
QIALIGVENWGNPPFKQYGDLEKAARAAQFAPFRILLSHDPTHWAEEVAGKVDIALTLSG
HTHGMQAGIRYRNKQWSPAKLKYKHWAGLYEEKGQYLYVNRGMGWMGFPGRIGMRPEVTL
FKLKTVLKNEEAELSILDGYPLAEQAPGVA
>OMIFANIC_01264 hypothetical protein
MKFILVPILVFLLLNCGTPPQKSTTVIINSDTTTVVPNTNKEIIIEPAIPEDAVTANYMA
GIPAFYGYVNNVNTVDASTLIKFENDYAPSLEIEESYGAEIMSLRFPEFDSDLLLVTSVI
KDPNFNKYYLYLLKNNEWVQVVNGWAIHKENKPDTLQPISVDPTNPSRMHRYYSVFDLDK
ESELGYTWRLLSERISIQNR
>OMIFANIC_01265 Universal stress protein A 
MKRILVPTDFSKQAENALKIAAKMAAKNEAEIYLLHSTEIPIHLANTGDTQSLPEAIYFI
RLAEKRFEELLKKPFLQNLSIHETIGHGEIYDDIREVVDRHDIELIIMGSHGSSGFKEMF
IGSNTEKVVRTSSIPVLVIKNDHDQFDVRDFVFATDFSEECRKPFMQAQKFAKAMGAHIH
LLLINTPSGFKTTAEARELMEAFVRGSAAVNYTLNIYNDTSVEKGILNFAKEINAQLIGM
STHGRKGLSHFFNGSISEDMVNHANMPVITFKI
>OMIFANIC_01266 Ribosome maturation factor RimP
MREIVAELLKEALEQKPGLFLIDLNISETNQIRVIIDGDEGVKVQDCIDISRAIEHNLDR
EDQDFSLEVHSAGVSEPLTMMRQYKKNIGRKLKVKTSEETIEGNLTKADDTSITLHWKTR
EPKPIGKGKVTVQKEAVIPYSDIVEAKVMITFN
>OMIFANIC_01267 Xaa-Pro aminopeptidase
MLNFVKPGVWEFEIEAEFMHEFLRNRSDGFAYTPIIASGNNANVLHYIQNNQQCKSGDLI
LMDVGAAYANYSSDMTRTIPVSGKFTDRQRAVYNAVLRVKDEATKLLVPGAYWKEYHVEV
GKLMTSELLDLGLIDKADVQNEDPDWPAYKKYFMHGTSHHMGLDTHDYGILWEPIKAGMV
FTVEPGIYIPEEGFGVRLEDDVVVQEQGEPFNLMRNIPIQVEEIEDLMNA
>OMIFANIC_01268 1,4-alpha-glucan branching enzyme GlgB
MAITKQYLKSKPICKVTFTVPASEASEVKVAGSFNEWKADSTPLKKLKNGSFKGTVNLDK
DQSYEFRYVVDGNWTNDEQADSYHWNEFAAAENGVLHV
>OMIFANIC_01269 Branched-chain amino acid transport system 2 carrier protein
MTQSKQIVITAFALFSLFFGAGNLVLPPFLGYNAGVSWFWVAIGFAISAVVIPILAIYGH
ARLQGTMLDFGKKVSPWFAITYSVFVYAISVSLPSPRTASVAYEMAIQPYFEMSAIWLSI
IYFALVLVFVLNRNRIISIIGKYLTPLIIIILLLVILLGLFAETESLRTSVFDNSFTSGI
LEGYQTFDAIGGVVVGGVIVISFALQGKYDYDEKRRMIAKSGLLAGLGLFIIYAGLIALG
AWQSNTEEVTNRTELLSLLSTKTLGNTGTAFLAVLVALACFTTAVGIIAGTADFVKGLFK
NSQMAYIVTAIAGCVIGVLVGQNTVGYIIDIAIPALMFIYPITIVLILLSVLPGKFSTRI
IYRITVLTTVLFSIPDFLSTLDVEFISDESLRSIKGFIPLSGDHMGWILPAMTAFILASI
VSVFGSQKR
>OMIFANIC_01270 hypothetical protein
MEFYADTLNGRITVMQSFAEAPMEVPELIQDRIFNSELKAGSITIKASDDLPTHPVTQGS
NMSLYVVFPSAEMKANVFDKLSVGGQVLFPITENFGMLKDKFGIQWMVVHQDN
>OMIFANIC_01271 Diaminopimelate decarboxylase
MTNQDLLKAIQNFGSPLYVYDTSIMKSQYKRLQYAFKKVTNVKIHYAVKALSNISVLKYL
HSLGAGMDTVSIQEVQLAIEAGVPVEDIIYTPNGVSMTEIEEAASLGVQINIDNLSILEQ
FGTKHPATPVCIRINPHVMAGGHTNISVGHIDSKFGISIHQLPHIKRIVENTGMLINGIH
MHTGSDILDVDVFLYASEILFKAAKQFDKLEFIDFGSGFKVPYKEGDIETNVEEFGEKLS
QRFNEFCQDYGSELTLAFEPGKFLVSEAGKFLVQVNVVKQTTSTVFAQVDSGFNHFIRPM
LYGSQHHISNISNPEGRERFYTVTGYICETDTFANNRRISEIREGDILSFRNAGAYCFTM
SSNYNSRFCPAEVLYYDGDTHLIRERETFEDLIKNQKVLSF
>OMIFANIC_01272 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILHSFGVEIQRGIVATTASEAVDAAKKLTEDTGTGWHVIKAQVHAGGRGK
GGGVKLAKNLQEVEALAGQIIGMNLITPQTSAEGKKVHQVLIAEDVYYPGDSEPEEYYMS
VLLDRAKGRNMIMYSTEGGMDIETVAEETPHLIFTEEIDPAVGLLPFQARRIAFNLGLSG
TAFKKMTRFVTALFTAYIKSDSSLFEINPVLKTSDDRIIAVDAKVTLDDSALFRHKDYAA
LRDEREENPMEVEARAVGLNYVDLDGNVGCMVNGAGLAMATMDLIKQAGGEPANFLDVGG
TADAERVEAAFKIILKDPSVKAILVNIFGGIVRCDRVAQGIVDAYKNMGNINVPIIVRLQ
GTNADIAKDIIDNSGLDVQSAIEFQEAADKVQAVMS
>OMIFANIC_01273 hypothetical protein
MKRFKLFLLALGLVASTTAFAANPAPISEGTNTSKELKKMLKTPEFIVDHDMEAQVLFTL
TEDNEIVILSVATDEEQVASYVKEHLNHKTLKSDLEQGKQYVIPLKIKSRK
>OMIFANIC_01274 hypothetical protein
MDKAKNHALISDLVILAKADDKIVASEYDFILRIADRMKVSKEEVDQLIENPLPSLPLVS
EIERITHFHKLILLMNVDWEAHDKEVEVLRNFGLKLGIRPAAIDRILVRTQQYENRVIPS
EELIQIFQTYYN
>OMIFANIC_01275 18 kDa heat shock protein
MKVVKRNTGWFPSIFDEFFTDNRLDVPNYENFSIPAVNIQENLTNFVIELAVPGLEKENI
AIEVEENVLKVSSEVTSKTETEDTDRKFTRKEFSYNNFSRSFTLPETVDVENIVASYKDG
VLMVTIPKKEEQKALKKMVEIS
>OMIFANIC_01276 23S rRNA pseudouridine(2604) synthase
MHHPDSVRINKAISESGYCSRRQADSLIEEGHVTINGKVATLGDRVMPQDEVKVKGKLIV
GNENLVYIALNKPVGITCTTDRRIPGNVVDFIDHKERIFHVGRLDKPSEGLLLMTNDGDI
VNKILRAGNRHEKEYIVKVDRPITPDFLKRMRNGVPILDTVTKKCEVEQLSRYVFRIILV
QGLNRQIRRMCEYLGYDVQELKRIRIMNIKLGNLKTGEWRDLSSEELNGLKNAVADSQNV
PQADRNRSTGGRRRRK
>OMIFANIC_01277 hypothetical protein
MKGITRLIAVLLISIGSFAQELSCADFKEGTFYIEAVSLGIEFRYDLVRYPDYQEEYYGA
GGPVKVDIRWIDECSYVLTKNPADTDFSEIDKKINGWGGIVVELIRIEENCYYFTSLFRV
SENHSERMNGKICKDEI
>OMIFANIC_01278 UvrABC system protein B
MPSPPIFCIFAASPFLSMNFEIVSDFRPTGDQPEAIKALVGGINSGEKYQTLLGVTGSGK
TFTVANVVEQVQKPTLVLAHNKTLAAQLYSEFKQFFPNNAVEYFVSYYDYYQPEAYIPSS
GTYIEKDLSINEEIEKLRLSTTSSLLSGRRDVLVVASVSCLYGIGNPVEFQKNVIHLEQG
QIISRTKLLHMLVQSLYSRTEAEFHNGRFRIKGDTVDVYPGYADDAFRIHFFGDEIEEIE
AFNPQTNEVIEKYDRLNIYPANMFVTSPDVLQNAIHAIQEDLVKQVDYFKEIGKHLEAKR
LEERTNFDLEMIRELGYCSGIENYSRYLDQRLPGTRPFCLLDYFPDDFLMLVDESHVSIP
QVSAMYGGDRSRKENLVEYGFRLPAAMDNRPLKFEEFEALQNQVIYASATPADYELEKCD
GVYVEQIIRPTGLLDPPIEVRPSLNQIDDLLEEIQKCVEKDERVLVTTLTKRMAEELTKY
LARIQIRCRYIHSDVDTLERVEIMQDLRLGIFDVLVGVNLLREGLDLPEVSLVAILDADK
EGFLRSHRSLTQTVGRAARHINGKAIMYADKITRSMQATIDGTNYRREKQITYNTKNNIT
PTAIKKSLENALTKKKTEQYTFDIAETLAAEAENQYLTKPQIEKKIRDTRKEMEKAAKEL
DFIMAAKLRDKIKNLQKQLEEV
>OMIFANIC_01279 hypothetical protein
MILETKIKELRARFGYTQEELAKKVNVRRETIVFLEKGKYNPSLKLAYNISRVFNTSIEE
VFLFD
>OMIFANIC_01280 hypothetical protein
MLLFISNFMLDLFNIKLKKMKKTKTSLILLLALTVTFSAGLWLYSTMDELTAFEYTAAGA
VFITVIFAVILGLKRLKNEKKGLPADDELSMNIKIKAAASAFTFSIYLWTMMLMFTIDTY
IESHILLGMGILGMGLLFVGFWVYYSKKGVDFGDKN
>OMIFANIC_01281 hypothetical protein
MIISYLLPFYMAFLIMVFKELSLTDFKKVKDRYIWMVLIVAFGVIGYFFYFSFKRKLITE
RKFHPDFTKTRYYQSKSN
>OMIFANIC_01282 hypothetical protein
MKKSRKNFVVDSLAFICFVFLVSTGVILHYILPPGSGHSRSIWGMGRHDWGDIHFYFSVG
FLAILVLHLFLHWRWIVNLIKGRKRKTSGRRAVLGLVGALAILAIALAPILTPVEGTGRG
KMQKKESTHIEESEIKVQGSMTLYEVQESTGVPASFILEQLKITTEIPEDTKLGELKKSY
DFSMDEVRDIIKKYKPSP
>OMIFANIC_01283 hypothetical protein
MRLIAILLLAFIFTSCNQEEKNTSARTNVSQTFNSNSYEDLVALFGEWRTFEKPPVRDGA
PDYTLATFNSRWSEFEDLREKLKAIDTTDWSIPRQVDWMIVWAEMNGYDFNQNTLKPWVR
DPAFYKTVWTYKSDVPAHEGPTHHATTELWTYDFPLTSEERNRLINDLKVIPPLNTQAKQ
NLTGNAKDLWVTGIRDIRNQSEVLVNLKQQKTIIDDNELVAVIEDAIKSTDKLVNWLEEE
AKSKTGPSGIGKENYTWYLQNVHLVPLTWEDEVMILKRELARAWSSLKLEEHRNRNLPEI
KAADSPEAYNKMAEESAQSLMSFLDQQDILTVKSYMEPALREHLGSYIPKEERNFFRIGQ
HYDPRPLYSHFYHWFELARMENEPHDSPIRRGPLLYNIFDSRNEGTATAVEEMFMQAGLY
DDSPRTKEIVFIMIAQRAARGLGSLYAHSNEMTMEEAGGIHSEYTPRGWMKTEKELLIFE
QHLYLRQPGYGTSYITGKYLLEDAMAEYARNQELEGKQFVIKDFFDELNSIGNIPIALGQ
WQMTNSRGHMRGIE
>OMIFANIC_01284 hypothetical protein
MKLYKSVYRKVLWVVFLLPFSLFSQNEISLFEQFNGRYDYLAFGNTMNIGENTGQIPPTD
CVILTESSADYALGAGQTPIAALLYWAGVGTGDLSVELNGTTINAERVFNYELNEDFIYF
AAYADVTDLILSSGPGNYTLSELDLTLLIPFYCTNTTNFAGWAINVIYEDPTLPLNQVNV
FDGLEGVSALNNELTILIDNLLVLDNDGAKIGFTAWEGDESLANNETLQINGNIISNPPL
NPPDNQFNGTNSFTNNSDFYNMDLDFYNIENNIQPGDTSATITLTSNQDLVMINNVITVL
NTELPDATIEIDNAFGADECGDRDITVEYTVYNVNSTDVLPANTPIAFYANTTLIGQSET
TVELPIGGSESGSIDLNIPLSIPPDFELKAFVDDDGTGQGIVQELNEDNNGFIVDFHLLA
FPVIQGLEDLELCDVVGTELFDLTEATGQIDPVNTITYHNSEEDALNDVNPIVNPTTYQN
ITNPETIWIRVSNPDCFVVDSFEIEVVDCPLPDATIDILEPLFACRGRDFTVNYIVFNLE
STGPLPAATPITFYIEGNAVAQSETQNVIPIGGSEEGSATFTLTTEIPNEFILVAVVDDI
GDGTGIIQELNEFNNETESSAVFGTIPPIGELPDLTACNEGFLTATFDLTAQDDLVSSDP
NDIITYYTNEENAIAGVDPIQDPENYMNVVNPQRIYVRLDNIVCFTVGSFNITIENCPPF
IPQGFSPNEDTINDEFEITGLLNVFDNFRLQIYSREGNLIYEGGNDDGFWNGIPNTGLLY
REQIVPVGTYYYVLQLNDEQYPEAFLGFVYINY
>OMIFANIC_01285 hypothetical protein
MLRLLNIELHKLKYNKTVKVISIVYFALICCVALIVSIEFNFGGVKFRVADQGIFNFPFI
WHFNAYIVAWLKIFFAIVIVSIVANEYSYRTLKQNLIDGLSKKEFLASKFLTVVLFSLVS
TVFLFVVSLILGLIFSDYNEMSIIFSDLEYIGAYFLKLLCFFSFCMFLAILVKRSAFALG
FLGLWQVVEGIIAILFQWIKVKDGPDLFKSVYNFLPLDSMSDLIVEPFTRFGAVQSAANQ
LGENFDKSYDVPWYTVLIVLGWTCLFIYWSYLILKRRDL
>OMIFANIC_01286 putative ABC transporter ATP-binding protein YxlF
MNTILTLNNLTKKFGPLTAVDDLSFSIEKGNVYGILGPNGSGKSTTLGIVLNVVNRTSGN
FHWFDGSGSTHQALKKVGAIIERPNFYPYMTAVQNLALVSKIKGVSEDKIEEKLEIVGLA
DRKNSKFRTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHQIREIITKIASEGT
TILLASHLLDEVEKVCTHVVILRKGKSLYTGRVDNMIASHGFFVLQSDNMEMLEAELQKN
TAFSSIKIEGDSLVAYLKQPMDASAFNEEMHAKGISLSHLVKRKESLEEQFLEITQNLN
>OMIFANIC_01287 hypothetical protein
MKKIFLFIFFTSLIFTIEAQNDSTFVDSRPTVLGINFDYGFLLKHTDFLRELDDAYPVAV
GLDWSKHLITRKSWDFCNCFPRVGVSLAYWNWDNPDVLGSGISALGYLEPYMVTHKRTNF
FFRAGMGGVYLSNPYDEETNPLNLSYSTNFAFFLMIGAGINYRINDRLNLRLAGKYNHIS
NGGNRTPNKGLNFPSLSIGINSSLKPIAFPNPGKNGKRKPPDERKRISLVHFSGWSNATV
GDTDKFYVFGFAANYSRWIGGRSALTFGTEWIVDISRKEQIRLAGLNDSYLQGAILAGHE
FWLGRVTFSQVLGVYYFKEYRNTDDVYQRYGLSYSFTKNLFAGMNLKAHRNVADFFDFRI
GYRF
>OMIFANIC_01288 hypothetical protein
MINLYNAHIASLSIHRVGNKSRNEGIILSEETHQAHDELTPLLKEFFLKPFRDKEENYFQ
FNHDQDLEFHELYNIVNNIFDSPETAHEQSKKITRHLFDQSIHPHIKSGEVYVAYLEGLQ
IDNEKVDGIGIFKSELKQDFLQFSEKENQLLANLQQGINLNKLDKGALIFNIKKEEGFKV
LSVDSNRYDARYWLESFLGVDAFEDENFFTKKYLKFCQDFAKDVVLPAEDKKEEVLFMNR
AVNHFAKNDQFEESLFVNEVIDNPDLIPEFRHYKTEKAPKYSIEDLTTFPIANTAVTAAR
KKIKNVINLDTNIQIKMDFINPESAERFVEKGWDEEKQMYYYLVYFNQEQKS
>OMIFANIC_01289 hypothetical protein
MYIQTDARMIYRFRVILDTHEDVFRDIEIEGSSTFEDFHNTITQSFGFGGQEMASFYLSN
ELWDQGEEISLFDMGEKPGEVLVMSDTSLESLIDEDQTRLIYIYDFLSMWTFLVELAEIA
EEEEGRSYPNLMFAHGQIPEDAPEKEFIVENLEGDDEEDDLGYDPEDLDNLDFDTNWN
>OMIFANIC_01290 Heme A synthase
MKKDNKRVITWLLIGCTLIFIMVIVGGITRLTHSGLSISNYKLISGTIPPLNQLEWQEAF
DLYKKYPEYQKLNYNMTLEEFKGIYFWEWIHRVIGRFIGIVFIIPFLYFLIKKQLSRSTI
KKSIILLFLGGFQGFLGWYMVKSGLVDRPDVSHYRLAMHLSTAFLTFAFTLWVALDLIYS
ETKKVENSMRNLIRVGFVILMLQIIWGAFVAGLDAGWIHNTWPLMSDGKLVHETVTLEQS
PVWRNFIEGKSGVQFVHRYLAYIVVVIIAVIWHKARKQTITVLQQNGINWLLGLVFIQFI
LGVFTLILQVPVWLGVLHQVMAFFLLAAMTFTLHRFTK
>OMIFANIC_01291 Multifunctional CCA protein
MSEQYPNALRNPVFRVISKAATTLNLESYVIGGYVRDYLLERGDAKDIDVVAVGSGIDLA
NAVSKLLPGKPKVIIFKTYGTAMLQSGGIEMEFVGARKESYSKDSRKPSVENGTLEDDQN
RRDFTINALALSLNDDDFGRLLDPFNGLEDLQDKIIRTPLDPDITYSDDPLRMLRAIRFA
TQLDFKIEDKSLKSIERNADRIKIISRERIIDEIHKILMSYKPSKGFALLHKTGLLKHIF
PELLALQGIEEVEGQRHKDNFWHTLEVVDNIAKTTDDLWLRWAALLHDIGKAPTKRFDKK
LGWTFHGHEFVGSKMVFKLFKRMKMPLNEHMKFVQKMVLMSSRPIALASDVTDSAVRRLV
FDAGDHVDDLMTLCEADITTKNPKKFKKYRDNFQKVRDKIVEVEERDHIRNFQPPVSGEE
IMKTFGLEPSREIGIIKDAIKEAILDGEIPNEYEAARVFMLKKGKEIGLSVIE
>OMIFANIC_01292 tRNA (mo5U34)-methyltransferase
MSHIPEGLDYTNKPRDYYENERPEMVAYLPNEVKTVLDVGCSNGEFGAGIKRLTKAEVWG
IEPMIEFASEAEQKLDKVLISSVEAAIDKLPGNYFDAIYFNDVLEHLLDPYTVLEKVKSK
LKDDGKIISSIPNIRYFRTFFKLLFKGEWEYQDEGILDRTHLRFFTKKSIWNMYENAGYI
IEKHEGINGSSSLKPLLINIPLLFRAKDMKYTQFATVARKK
>OMIFANIC_01293 Threonylcarbamoyl-AMP synthase
MKAEIEAALSVLKKGGLILYPTDTVWGIGCDATNADAIEKVYKLKKRHESKSLICLVSDF
KMLNQFVENIPEVAYDILKNAAKPTTIVYDDPIRVAENLVPEDNTLAIRVVQNDFCKQLI
RRFRRPIVSTSANISGEATPASYNDIAPEIKHGVDYIVNWGQKNRSAKASAIIKLSKDGA
VQIIRK
>OMIFANIC_01294 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MVDVAVILINYNASDFTLKCITSVIEKTKEAVSYEIIVTDNNSEIADYENLKKNFPTDPR
CKLVRSNLNTGFGGGNMFGARLANARYLLFLNNDALLLNNCLEILTGFMDTNKSVGVSTA
QNYDEHNRLVPSFDHNKGLRRLLFGRGFLQKANLKRYPDRKLNYKNPIKVDWVNGAFLFF
RKDAFEEIGGFDPNVFLYWEEMDLCHRLKRKGYTTMLVPGAKILHYQGVSIGKSKEINKE
AYRSYLYVIRKNFGFLKAFLIQLYLFVVLLLKPKKWYLLGTILEGSSMKNSMRHNQKERF
YEG
>OMIFANIC_01295 GDP-mannose:cellobiosyl-diphosphopolyprenol alpha-mannosyltransferase
MKTVFLESHNIKNKFSGFGQFNYHLIRGLSQVKPEDLSIVLHAKNTEILKNEFGNTFEYR
KYNSLSRHKPFRIKKKYDLWHCMNQNIKIEPFHNIPYLLTVHDIHFITEGSEGLQDKLKA
KFREKLKRATAITYISEFAKKDTHANFEVPDIPEFVIHNGNTITDTKVPESYTPPVFPEK
PFLYSIGDFSERKNFISLVEMLRLLPDYNLVLSGSNSSTYADSLRKKVAEYNLKERVLLT
GKVEDTEKKFYLKHCEAFVFPSLREGFGIPPIEAMRYGKPVFISNNTSLPEIGGEHAFYW
DHYDPEYMKEVFLNGMHAFHEKQTFYEQWYVDRAKSFNWVNTARDYLDVYHKILS
>OMIFANIC_01296 Dipeptide and tripeptide permease C
MATNTLTSNGILSPVIYNTSKALERASYYGIRSLLVIYMVGYFGIDRYEAMNLYGWSMTI
YLIALVLGAVVGDLLLGNKYTAIAGGILQAFGAFIICLPSTATLYIGIGMVFFGSGIYGS
NLFSMIGRYFRKREKILDSGMTVYYTVINVGAFIGTMVIGYLGENNFHLGFIAAGILMVI
SSVMLFFTKDTKTPIEEHDITKKNLPKSVVMVFMAMAITAIFWLVYEIAGSDVFSKSYEL
RELSGSGFLRNIWQSINPVIVLLAGILLSVVWYFIRSNRILKLGVGFLLGATSYFILLTM
PEGYSWLGVAVFLISALLLGFAEILFAPTTLSLLSKYTNPKYLAIIFALYMLPTRILSAI
YGLFSENIYNTPNLGLIIGGIILFILAVGLVIYALVFKESITEKKTS
>OMIFANIC_01297 SPBc2 prophage-derived glycosyltransferase SunS
MQDHIPITALAITLNEAQNIDGFIKSLWFANEVIIVDSFSTDDTVKKAEVHEKVTVYQRK
FDNFSAQKNYAISKASNDWVVFFDPDEEITEALGNEILQTLSNPGAIAYFVKRQFHFMDK
RIKYSGFQTDWVIRLFHKNYCEYNGSLVHETLSAEGKTARLKTRVPHHTYKGIDDYTAKL
HRYSALQAQMLYAKGKRPNLLHFLFRPFYRFWHQYLIRLGILDGKEGFILAYINSFSVFK
RYVNLWLLYRNIN
>OMIFANIC_01298 Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase
MANLPVLMYHHVSVSESRDLTIGTSRLEEQFKWLRDNNFKSWHFSELEELRQLPPGNNVM
ITFDDAYVSFRELALPLLQKYQLKATLFVPLAFLGGTDEWYSGQNPIMTSSELNTLDPSL
VELGHHSFFHKKFHQMSSEEIKEDINKCREVIAKQNLNVSPALAYPYGKYPREKPAKEQF
ITLLKEEGFKFGLRIGNRLNAFPFKNSFEIQRLDIKGEYGLSKFKRKIKFGKVF
>OMIFANIC_01299 SPBc2 prophage-derived glycosyltransferase SunS
MHSLSVIIPAYNEENYIEDALRSVAFADEIVLIDSYSTDSTVEIAKPYITKLLQRKFDNF
SAQKNFALEHVSSDWVLFLDADERVTHSLEDEIKKTIAHPKHAGYKINFPHFYMNRFLYH
HSDDVLRLVKRAGAHFMGSVHEKLHCDGSVGKLKNHMLHYTYKGLEPYIRKKESYAWFQA
EQLYKKGKKATWFHLFFKPGYRFFRSYVVKGGFKDGIPGLTVAMVNAYGVFQRYVKLRLL
HKGMR
>OMIFANIC_01300 Hyaluronan synthase
MQKIDTSIIISTYNSPAWLEKVLLGYNNQTYRMFELVIADDGSGEETKALIDKISDEVFY
PILHVWHEDKGFQKSEILNKAIVKCNTPYIIMSDGDCIPRKDFVEQHVKYREKGYFLSGG
YFMLPMDISELIGRNNIYSEDCFDVAWLKKHGLKSSFKNNKLSAGTVLAAFLNRVTPTNA
SWNGHNASGWKEDIVSINGFDERMQYGGQDRELGERLMNYGVKSKQIRYNAVVIHLDHPR
GYKNQESIDKNRAIRKETHEEKKIWTEYGIEK
>OMIFANIC_01301 Trans-aconitate 2-methyltransferase
MNLIDKFHHWRRKLRWNKQYKSGRWDSLQSEKEIGRYHQIVSYIDEFGPKNPSILDIGCG
DGVLNLRMDQLDYSYFLGVDFSKVSIEKAKKKNFPKSEFIAADAIHFSPGRSFDAIVFNE
AFYYIHDSEKQNVLDRMLEYLNEEGVMIISIYREGTGCWEYFKENPKLRELAFTKVTTDE
ELRYWKIGVYKKT
>OMIFANIC_01302 Lipopolysaccharide core heptosyltransferase RfaQ
MQPKKILVIQNKRIGDVLISSVIANNIKKVFPNSHVTYFVYDYTVGVLEQNPNIDNIISV
REKELKKIPNLLKTMRKIRKGKYDIIFDPYSKFQSRMMCLSSRAEYRIGLKRAHKTLKLP
FYTHPVSFLEKRSKNCGKAIEDRINLISSVFKLENPDYEPKIFLTSQEKQFDALAEVKKP
VIMLGVLGSTPQKSMPYEYVSQLINYITDNYDVSILFNYAPHQKPDADKIFHLCRGKDQI
NLDIYEDSIRGFIKLMNQCDLLVSNEGGSVHITKALHKPTFTMYSPYVNKEHWSSFEDGI
AHDSIHLLEEKPDLFDSFTLEERRRIELNPDELYQQLTPEMILNKLKPFLEHHLKNVRK
>OMIFANIC_01304 Lysostaphin
MKKLLLISIFLLLASEIQAQMSYVGRQYDNGNIHYTGSYSGDKETGLWKYYHENGRLSDI
GRYSNGKKSGVWKYYYENGRLRSSGMYIDGQKTGEWKYYLENGDLDRIGLGSEGEEQKEK
RLLMSDRIVTSRINTNSNINITQAKLDDPNDYVQTSPGPDVEKIVVSEEPQTEENYKKNI
ETADKEELIKKLSEKEKALMTEEAYAEYLKKQLDERSFRVKKLEAIIDLNNDAANKVAAQ
KDEAIKENEKNAAALVEAAKKEAELKDAAMKEATLKEAALKEAALKELALKEAALKEAQL
KEAAMNEAALKEAALKEAAMKELALKEAALKEARLKEAALKEAALKEAALKEAAMKELAL
KEAAKREAIKVEEAKREAARLAEAEKQAALKEAALKEAAKIEAARKEAALIAEAEKQKAL
EEAARREEARVEAAKREAARIAEEEKQKALKEAAIKEAARIEAAKLEAAKLAEAEKQKAL
EEAAKKEAAELEAAKREAALLAEAEKQKALKEAALKEAARIEAAKLEAAKLAEAEKQKAL
KEAAKLEAAKREAARLAEAEKQKALKEAAIQEEIKKEIARKERELKEEALIAEAEKQKAI
EEAAKIEAAKQEAARLAEIEKQKALEEAARKEAAKIELAKLEAAKKEAARIAEAEKQAAL
KAEAAKIAAEREISKESDKVKSNEPNTYTVSSGDYLGKIAARFDVTVSEIKQWNNLTKDR
VNIGQKLIINPQKTEAMVAELNKPYEPVIARGYYRDGQLRDMGVYAEDGQKIGQWEYYHK
NGQIREIGNYSGGVKTGLWKNYYEDGTMESTGAFTNGEQSGPWEFYHLNGKLKSDGSYAD
GKINGEWKFYHENGNLKTAGTYKDFKKTGEWPVYDEEGNLVTTKYY
>OMIFANIC_01305 3-oxoacyl-[acyl-carrier-protein] synthase 3
MPNAFIKGTGSYAPENIVKNEFFESVGSNDEWIYSNLGIKERRISNGETTSDLATKAGQI
AIEDAGLTPLDIDLIILATATADRLAPSCACFVQEKLKAKNAVAFDISAVCSGALFATST
GAQFIKSGMYKNVLVIGADTFSNITDWTRRDAVFFGDGAGAMVLSETEEDKGFIDFLLHT
DGTGKDHFTIPAGGSEEPASGNSINSRRHFFQMNGPEVFKTAVEVVPNCISRILKQNKLS
IEHIKFLLPHQPSIKILQEIARKIGMPFDKVKTNMDRYANTSGGTIPIILDEVHKNNEFN
KGDMLLFAAVGAGWTWGSALYKW
>OMIFANIC_01306 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MLENKVFLITGIADENSLAMYTAKEIINQGGRVICTGLGVSEYHQNLSTKAEAFLNKTYS
DFEKSVQSELGEARVEVLDVTLEDNLDAFARKLQEEGVELHGLLHAIAMDKTIRNKEVKP
LLEVTKEEFCDTMDVSAYSLIRLAHYLLKYDVLKPGSSICSLSYIAAAKVTFHPYRNISI
AKAALERITIELADELGRQHGIRANVIRFSPYMGSKAGNATLSVKDVEISDSMSPLGNAC
PADLAYEIVHLFRPNSRITGEIRHVDGGYHITG
>OMIFANIC_01307 Aspartate--ammonia ligase
MDVKQKDLAGPGISTYEEVSKILPENYSPLLPPLKRMEALYLVKEYIEKGLAEALNIQMV
QVPLIVSKDSGVNDYLDRDGSRTPVEFPAGLGLPKRIEAQIVQAATKWKRMALAQFGCEV
GQGINTDMRAVRKDYFLDHDHSAYVDQWDWEKRISENDRNLEYLKDTVREIWNVIRGAGI
MVKEKFPELNDPRYPDFPEELKFFHAEEILDMYPDLPRKERETKLIQEHHAVFIIGIGSV
LKDGYPHEMRAADYDDWITPTVMKNGEQYYGLNGDILVWNPVTQRRHELSSMGIRVTKET
MIAQLELSGQTAFLELPYHKAILNDEIPLSIGGGIGQARTYMYLLRTAHLGEVTVSIWPD
ELKRICKEKNIEVLE
>OMIFANIC_01308 hypothetical protein
MEFNCYAMKNQEQIVREEMRKLISKTCTNSLSRDHNPYSLFQRTLLKYYFNSADVTIDHS
ASTISLWTSETPSTLGHNLYRLKDAVAVTISYSNLEETLKGCLESGENHTRFYKLLLFQY
NNVSAPLGSNVKSA
>OMIFANIC_01309 Thiosulfate sulfurtransferase PspE
MRSIIQFFIIATISFGFLSCKDAGTKTESKTGAEVSAEGEIITLLNTNEFAQQIEAVGDI
QLIDVRTPEEVAEGTIAGAVNFDFRAEGFEKKLEVLDKSNPVYLFCRSGGRSADAALLLK
DLGFTEIYDLAGGMIDWKEAGKEVVK
>OMIFANIC_01310 Thiosulfate sulfurtransferase GlpE
MLDLTQDEWCEQMVADENAVIIDVRTPVEIADGYIPNALHMNIQNAGSFMAKTQELDKSK
NFYIYCRIGGRSKQACMIMNSMGFQNTYNLMGGFENWQGEKTT
>OMIFANIC_01311 Thiol-disulfide oxidoreductase ResA
MKNKRILFVLSLVITASLALAGFTAGENEDSYGYSIGDYAAEINLLNVDGNMVSYEDYPK
AKGFIVIFTCNTCPYAVASEDRIIALDAEFKGKGYPVIAINPNNPEVQPDDTYELMQAKA
KDKGFTFPYLYDKTNTVYAQYGATKTPHVYLLENTKKGRMVQYIGAIDDNVRTASAVKER
FLANAVNELLAGKEVSVKETKAIGCSVKQ
>OMIFANIC_01312 Sporulation thiol-disulfide oxidoreductase A
MKFLSYVLIGLQVISCVDNKKITSEPEQAAIVESSVESKSNDDLIAELRSGIMVYNFEGL
DRALLQKNNDTTYVVNFWATWCKPCVKEMPYFEKVGAEYAKDKVKVVFVSLDFPDRLEPL
VVPFIEKNKIRSEVVLLDDADANSWIPKVSDEWQGAIPATLMFNNKKRAFFERSFTFEEL
EKEVQSIL
>OMIFANIC_01313 Multiple antibiotic resistance protein MarR
MDIDTAIKTIHKMAISTKTVINIMYTSRIIEEAVSTLLKPYDLTIPQYNVMRILRGQKGK
PASLSTIQERMIDKSSNTTRLVDKLIRKGWVKRSVCEENRRKVDILITSSGLEILKELDP
ITENNNQEILKNLSEEQLLNLNNLLDTLRFI
>OMIFANIC_01314 Protein YceI
MKKVVNSVLILAVAFGSMAFTTPVKKKINPAESTIKWKGEKVLGSHHGTIALKEGYLEMD
GDKITGGRFVVDMTSIENNDLEGGSKGKLEGHLKSDDFFGVKSHPTATLEITSATAAKNG
YDITGNITIKGITESISFNLVKNGNTATAKLAIDRTKFGIRYGSGSFFDNLGDKTISDNF
ELDVKLAF
>OMIFANIC_01315 hypothetical protein
MKRRDFLKNSALASSLFFVPGFIKAMDAQLSLPAGYKRLVIIQLAGGNDGLNTIIPFRND
IYYRERPSIAIKQKHVIALNDELGFHKNLAPLKSLYDAGELTVINNVGYPNPNRSHFRST
DIWHTASASNELLKDGWIGRYLDLFGDKPYNAIEIGNSLSLIMQGKLKNGVVAKDAVMLN
KIAGDPFFKQLLTYNQDQHLSEHNMGYLYQTMIDAKQSADYIYEKTRVSKSTFDYGNSRF
GKQMKTLAEFINSQLDTRVYYAALGGFDTHANQAGQQDELLKTYADGVSTLVADLKSNGT
FDDTLILTFSEFGRRVAQNAANGTDHGAANNVFVIGKNLKTPGFYNQAPDLRNLDANGDL
VFEIDFRRIYANLMEKWLDIPSSSLLSETMEPLHII
>OMIFANIC_01316 hypothetical protein
MELQNIYHLYRRAAFGISPSEANKLVSLTREEVVDNLLADSEKVTPLTIDLPDYEAFFKR
KPLGRRKELQKIIRKNAPKHLDYNKAWLKRLCEPTEALNERMTLFWINHFVCRDQVIYFA
VQYYNLLRTNALGNFKDFIKQVGKAPSMMKYLNTNTNSKDHPNENFARELLELFTVGEGQ
YSEKDIKEAARAFTGYGSKLDGSFILRQMHHDFGTKEFMGWTANLDGDDIVNIICSKRKC
AQFISRKLYAYFVNSSLNDAHIDEMTDVFYEDYDIKKLMRFMLTSDWFYAPENLGAKIKS
PVDLLTSIYRVVPFNFEKPRQQLFVQRLLGQALMEPPNVAGWPGGRHWINTNTLMVRLKL
PSVFLGNGLVPSDSPQYAYMERGSFGDRLSVNENWKAFDAEYGSLDEQELIVALCAGKLE
VGTLRMLEQGVGYSRRELSLQLMSTPEFQLT
>OMIFANIC_01317 Anthranilate synthase component 1
MKYNLTTYSEKLLADTLTPVSVYLRLRDKYPNSLLLESSDYRANDNTFSFICCNPIASIT
VTGEQIIERFPDESKRETKINDETDVPQILETFSATFIAETNSELKFPNNGLFGYMAYDA
VRYFEDISVAKDTSDLDIPDIHYAVYQNIIAINHFNNEAYIFAHCYQTPSNIAEISQLLR
SKNFAEYPFERQGSPTTNLEDKEFKALVTRCKEHCARGDVFQIVPSKRFSQEFTGDDFNV
YRALRSVNPSPYLFYFDYGNFKIFGSSPEAQLVVQQDRAEIHPIAGTFKRTGNDEQDAEL
ARTLSEDEKENSEHVMLVDLARNDLSRHGSDVKVETYREVQFFSHVIHLVSKVTARKNPE
TSTMRIVADTFPAGTLSGAPKHKAMQLLEKYENINREFYGGAIGFMDFNGNFNHAIIIRS
FLSKNHTLHYQAGAGIVSDSDEASELQEVYNKLGALTKAMELAEHV
>OMIFANIC_01318 Aminodeoxychorismate synthase component 2
MKVLVIDNYDSFVYNLVHYLEDLDVEVTVKRNDRFDLDELEHYDKILLSPGPGIPDEAGL
LKDVIRRYAGIKPILGVCLGQQAIGEVFGGSIRNLSEVFHGVATKARILVDDEPMFKGLD
KEIEVGRYHSWVVEKENFPMELEITSIDENGQIMSLRHREFDIRAVQFHPESVLTPKGKK
MIKNWIES
>OMIFANIC_01319 Anthranilate phosphoribosyltransferase 2
MKQVLNRLINHEQLDRTEARNILVSISEGAYNQSEISAFLTVYMMRSIALDELEGFRDAL
LDLCIPFDVSEYNTIDLCGTGGDGKNTFNISTLASFITAGAGVMVTKHGNYGVSSISGSS
NVMEQLGIRFSNDSDYLRRSLEEAGICILHAPLFHPAMKNVAPIRRELGVKTFFNMLGPM
VNPAFPKNQLVGVFSLELARMYGYLYQKTDKNYAILHAIDGYDEISLTSATKVISNDSDT
VLKPSDFGVSKIEQSQIHGGETIEASAEIFMNILKGEGTKAQNDVVCANAGMAISVVEGC
TVSEGFQKARESLLNGNAHKVLETLQKISRES
>OMIFANIC_01320 Indole-3-glycerol phosphate synthase
MTILDKILSYKHQEVSAKKEALPVSLLEQSKYFNRPVQSMSSALRKSDHGIIAEHKRRSP
SKSVINDSVSLQKVVLGYEKAGVSAISVLTDTAYFGGSLDDLLLARQLVSKPLLRKEFIV
DAYQIFEARAYGADAILLIASAMEETKLKELCGVAKELQMEVLLEVHNRNELERSLGVPA
DMMGVNNRNLKTFEVSTAVSKELAAFIPDNFVKVSESGLSSPEAVSELKEYGYQGYLMGE
HFMKNDDPGKAVTQFIQKL
>OMIFANIC_01321 N-(5'-phosphoribosyl)anthranilate isomerase
MKYNVAEVASLKPDYLGFIFYENSPRNFTTEIPKIPEHIAKVGVFVNAPISFIINCAQSH
QLQVVQLHGDENPEFCKTLRRAQNNISTQPLEIWKVFHILDSFDFNQLQPFERYIDAFLF
DTKGTLRGGTGVTFDWEVLKDYKSRKPFVLSGGIGLEEVDRLKEIQATGVDIKAIDVNSR
FETKPGMKDIEKLKYFIDELQR
>OMIFANIC_01322 Tryptophan synthase beta chain
MSYNVNDNGYYGEFGGAYIPEMLYPNVEELRKNYLKITSEDSFKREFDALLQDYVGRPTP
LYFAQRFSEKYKTRVYLKREDLCHTGAHKVNNTIGQILLARRLGKKRIIAETGAGQHGVA
TATVCALMGIECVVYMGEIDIERQAPNVARMKMLGATVVPALSGSRTLKDATNEAIRDWI
NNPTDTHYIIGSVVGPHPYPDMVARFQSVISEEIMQQLKLKEGRENPDYVVACVGGGSNA
AGAYYHYLDNPEVGIIAVEAAGKGVHTGESAATSVLGKAGIIHGSKTLLMQTTDGQITEP
YSISAGLDYPGVGPMHAHLYTSGRGEFISITDEDAMKAGIELSQLEGIIPAIETSHALAI
FEKRPFNPEDIIVVNLSGRGDKDLDTYIEYFKL
>OMIFANIC_01323 Tryptophan synthase alpha chain
MNRIKEKLAQDKKILSIYFTAGYPSLEDTVPIIKELEQSGVDMVEIGLPFSDPLADGPTI
QESSTAALKNGMTTEHLFSQLSKIRETVSIPLIIMGYFNPVLQYGVEAFCKKCSEIGIDG
LILPDLPLAEYKEHYEQIFQENGLVNVFLITPQTSEERIREIDNATDGFIYMVSSASTTG
KTQGFGSVQTDYFKRVADMDLKNPQIVGFGISNSKTFSTATEHAKGAIIGSAFIKMISRD
GRSGIREFINSIRHL
>OMIFANIC_01324 hypothetical protein
MERMFERRIEQTNPTNPTGNINQVTNKVDYNERAIWKQQVKR
>OMIFANIC_01325 hypothetical protein
MNTAIGLYPNPASEQVTLANGSNILLDRAAIYDVNGRLINTIDLTNMGSEMVIDISQLSS
GVYIVQISAENSTTVKRLIKE
>OMIFANIC_01326 30S ribosomal protein S6
MNHYETVFILNPVLSEEQIKETVKKYEDLLVSKGAKMIAKEDWGLKKLAYPIQHKKSGFY
HLFEYTVGGEAINEVELDFRRDERIMRYLNVKLDKHAIAWAEKRRNRNKQKA
>OMIFANIC_01327 30S ribosomal protein S18
MATLQQQAKGKKDGEIRYLTPLNIETTKAKKYCRFKKSGIKYIDYKDPDFLMKFVNEQGK
ILPRRLTGTSLKYQRKVAVAVKRARHLALMPYVADLLK
>OMIFANIC_01328 50S ribosomal protein L9
MELILKKDVDNLGFADDLVSVKNGYGRNFLIPQGYAVLATPSAKKVLAETLKQRAFKEKK
VIEDAQAEADKLNDIEIKIGAKAGEGDKLFGSVTNADLAEALEKEGVTIEKKYISIAGGS
IKRTGNYEATVRFHRDVVTNFAFDVIAEAKK
>OMIFANIC_01329 hypothetical protein
MKYLRLTKEQFEELHEEFARFLATQSITADEWKDIKENKPEVAEAELDVFSDMVWEGILN
NTEYLEKIDAQQLFLFKIEEAEMKLIAIKVNDTSRDITTDEGFQWLLKNYLNDEVDFFEA
SQAYSEDKNEDIFNLLKMGSVISKGEWYQYFRELLYAE
>OMIFANIC_01330 Macrolide export ATP-binding/permease protein MacB
MFGLFRENVRIALDSIKSQILRTILTIVIIGIGIWALVGILSAVKALENTISSDFASMGA
NTFNIQRYEFGVRVQRGNQGETRKINPVISYNDAKEFLERYDFPYAQTSISFRGTSSAEI
KYGNEKTDPDIQVYGINEHYLDNTGTKVDRGRDFTFFDIENNNKVAMIGSDFVNGLFQND
NPIGKTISIRGVKFKVVGLLESKGSTFGNNQDLKVLIPIKIARSLFTQSNINYTLSVKVD
DKAMMAGAQDDAIITFRNIRGLNPVEENNFGLERSDDLINRIASITGVLEVSAWIISIIT
ILGSSIALMNIMLVSVTERTREIGVRKAMGAKRKTISTQFFIETIVIGQLGSILGIILGI
ATGIAFAAIFEFKFSLPWGALIGATIISFLTAVIAGSYPATKAARLDPIESLRYE
>OMIFANIC_01331 Histidine--tRNA ligase
MASKPSIPKGTRDFNPQEVVKRNYIFDVMRKAFKRYGFQPIETPSFENSETLMGKYGEEG
DRLIFKILNSGDYLKKVSDEELAAKDSAAIASKISEKALRYDLTVPFARYVVQHQNEITF
PFKRYQIQPVWRADRPQKGRFREFYQCDADVVGSKSLWQEVELVQLYDSVFTNLRLRNTV
IKMNNRKILSGIAEVIGEEDKLIDFTVALDKLDKIGVEKVKDEMRAKGISEAAIEKLGPL
FNVSGSALEKLNSLKSLLASSETGMKGISELEFILNTIDEIQLKTAQLEIDVTLARGLNY
YTGAIFEVGAPAEVSMGSIGGGGRYDDLTGIFGLKDMSGVGISFGLDRIYLVLEELGLFP
ETVLESTRALFVNFGNKEAMYAMRTINALREEGIAVDLYPDETKMGKQMGYADKRGIPFV
ILAGESEMQSRTYTLKNMKTGEQQTLDIDQLVSELK
>OMIFANIC_01332 Pyruvate, phosphate dikinase
MDVMEAKKTRIFKFGANSADGDSDMKNLLGGKGANLAEMSAIGIPVPPGFTISTEVCTEY
NELGEDALKELLKNDLRDAVASVEGIMGAKFGNDTDPLLLSVRSGARVSMPGMMDTVLNL
GLNDVSVVGLAEKSGNERFAWDSYRRFIQMYGSVVLGLKPESKDDMDPFEEVIDHLKDKR
EITMDTDFSVQDLKDLVYDFKDIVKKGTGHDFPTDPWEQLWGSIIAVFNSWNGNRAMYYR
AMHGYPADWGTAVNVQAMVFGNMGDTSGTGVCFTRDAGTGEDQFNGEYLINAQGEDVVSG
VRTPQQITKIGSERWARLAKIDEAERAANYPSLEELMPEIYKELDSYQQQLEDHYRNMQD
MEFTIQDGKLWILQTRNGKRTGAAMVKIAMDLLDDGMINEEEAMLLIEPYKLDELLHPVF
DPKAIKKANIIAQGLPASPGAATGQIVFFAEDADRFRNTILVRMETSPEDLEGMNKARGI
LTARGGMTSHAAVVARGIGKCCISGAGALKIDYKNRKFTVDGKEFHEGEWLSLNGSTGNI
IEGKVATKDPELSGEFAQLMKLSDKFSKVKVRTNADTPKEALLAREFGAEGIGLTRTEHM
FFESGRINVMREMILAPHEKGRRRALRRLLPMQREDFEGIFEAMEGLPVTIRLLDPPLHE
FVPHQLATQKELAEEMHISLMAVKNKVAELEEFNPMLGHRGCRLGNTYPEITEMQARAII
EAALNLKAKGITVKPEIMIPLVGTVAEFDAQEKVIRTTAEQIFKERKDTIEYLVGTMIEV
PRAAVIAEKIAEKADFFSFGTNDLTQMTYGYSRDDADKFMPIYLKKGILNEDPFKVIDRE
GVGQLVKMATDKGREVKPKLKVGICGEHGGDPSSVEFFCSIGLNYVSCSPFRVPIARISS
AQANIKFGC
>OMIFANIC_01333 hypothetical protein
MFKFKIVLVLLLILGIFNGYGQVDDCDKTKVGVSVDIVDKPDNYEWLENDFGPGDKDEWN
GFTARMLVQILSEYEPNITFFTIGEGSEDYHYHLKASLTLTIVGKEDNNEHTGYFVIAPL
IANADCVPNHNWVLAAEEGEDRDLKQAMKNMVSQFWPMDRNIIAYEKDHPSAPRDPQLTI
DIEKEFISPLDKESRKTKVNAEVYDCRGNLVCDQGGDGQPVYYQDYIERLDLKIGNCEGG
YHLGDFMVIVTYKDCNNEGEYILEKGIEAEKKNIQFKTCQLGGPLVEVEEELIIRGLEIT
VKPDRKELKPDERTKIILTFNETDPDGSKYPVEGKDLNVKINGLENGTLKAENGYTTDSD
GKVVLNYKAGSNDERILVTASYQPEDYPDKAEGKGTVIVKPAEYEAEVTITKNYDKTLNT
DQQDNKGEVRVIHKLNENIHAAATLYLKLTQVADMPVYNQTWEYYKPVSVNITSFSYNSN
ENKNSTGKNYETNIDYTRIVKNREISQKEYTTMVPWILAIDNDTGKVVKIVPGGCTIDYE
IMETKVLNSVIYSKDGPDRDSETTTKTRDKKFVIGPVGEEIPDPTVAQSDTWIKDYIKDQ
GIELPPGVTIPEVSNQETIKEIPPDILVSTGDGKRTMGGSGSRTIPKKLDFGQQVENFSY
TWNMTRVEKN
>OMIFANIC_01334 putative lipoprotein YiaD
MKKLLMLFAMLGLLFAAPVPAEAQILDKISKKVKKKVDRKVDREIDKSIDKGMEETEDVI
TGEDDGTTKEEEKKQGDVPVDEKGQPVETTESQDPELVWSKYDFVPGDKVLFEDNLVGEE
NGEFPSRWDLVKGTVENAEFGRENIIMFRGGNPKIIPYLKNREQDYLPEVFTIEFDLYVN
NVNSFEVFFYDAKNQRKSAEHRSLTASYNGLRLYNIGSYIPDKGSIENKWAHIAVAYTRG
KFKAYINETRLINIPRLEFEPTGITLSAYSATDQYKFYIKNFRLAEGGVKYYDQVLQDGK
IVATGIRFDTGKATLKPESMGVINEIVKLMQKYPEIKFSVEGHTDSDGDDASNLKLSDDR
ATTVANTLVKLGISEERLSTKGFGESVPIDTNQSPEGKANNRRVEFVKVEFN
>OMIFANIC_01335 hypothetical protein
MKKVMIIALAGSLSILSSCAGSVQVDAETICECWKEAESKDPSKTFDDCRELEKEIREKY
KDDDDALQEMEDALNEGCAASR
>OMIFANIC_01336 hypothetical protein
MILLERLLKVAIILIPVIVIPWTGVTDQFYFPKAFVLWLIGISLLCWIVFKGGYTSIINL
PKWLLIPIGVFLFAVLLSASLSPHQQIVWDGLLWRHEGVYTLLCYILLFVLSANLNTVST
TSIFDAIILTSSVVSLIGLLQYYNVQIIPQDTLRYSWTRIYSTIGNANWLASLLLLALPL
TFYKASTSSNHFYKIALLLISACLFATGSRGAYLALFIMAIAIILSKWNSLIRSSRKLIL
PACVVLIGFSITCIPNYYPLQRIYSTSTNINSALVNNDMAAGEYRWHLFSEAVKMIPNYV
FMGSGPDTFGKEFDQESTWHIMERDGIKKSHRVKILKAHNEYLQLAVTIGFLGSLSYIFI
SYSIVFRLLRLRDWRSTAIASGLLAYLIQLLFTNSSIGPAVVFWILLGIGVQKANSGLKK
HIVR
>OMIFANIC_01338 Ribose-phosphate pyrophosphokinase
MPVPIPEPKIFPCKQSQELAQNIADAFGIPLGKVITSTYSDGEFQPSFEESVRGSRVFIV
GSTFPNSDHLMEMLLMLDAAKRASARHITAVLPYFGWARQDRKDKPRVPIAAKLVAKMLE
TAGATRIITMDLHADQIQGFFEKPVDHLFASTIFLPYLKELNLGNLTIASPDMGGSKRAY
AYSKAMESDVVICYKQRAKANVISHMELIGDVSGKNVVLVDDMVDTAGTLTKAADLMMER
GALSVRAICTHPILSGNAYERVENSKLEELIVTDSIPLRQQSPKIRVLTCANLFADVMLS
VNANKSISSKFLM
>OMIFANIC_01339 50S ribosomal protein L25
MKSITINGSKRESVGKSATKALRNAGKVPCVVYGGDEPIHFSADEQAFQNLVYTPDVHTV
VIALEDGTKVNAILQDIQFHPVSDRIQHIDFYQIFDDKEVMLEIPVRVVGNSKGVRNGGV
LRIVTRKLRIKAIPANLPDFIEMDITEMKIGDKKYITSVMSDEYNILHPDNTVICQVRTS
RTAIVDEVEEDEEGLEGEEGLEGEEGAEGAAEGAEAPPAEAPAEE
>OMIFANIC_01340 Peptidyl-tRNA hydrolase
MFAFFRKLFGGIPDTPLTDGDPMKKFLIAGLGNIGPQYKNTRHNVGFQILDQLAEEESLT
WETARLGDVTTYKKKGRTFLLLKPSTLMNLSGKAIKYWLEKEKIPLENLLVVTDDLNLTF
GTLRVKTKGSDGGHNGMQNIQNVLQTTTYNRFRFGISDDFSKGRQVDYVLGEWTAEEAEK
LPERFKKGKQIIESFGLAGVNITMNTFNGT
>OMIFANIC_01341 Riboflavin biosynthesis protein RibF
MKEHTSAMSYKGEKPCVVTIGTFDGVHVGHKAILERLVATARKDGMDSVLLTFFPHPRMV
LQKQSNIKLINTISEKKELLNEIGLDHLIVHPFTAEFSRLSAVEFVRDILVNALNAGKVI
IGYDHRFGRNRTASIEDLKEFGEIYDFEVEEISAQEISEVTVSSTKIRKAIKTGDITTAN
QFLGYPFMLSGIVVKGKSIGRTIEYPTANLQIQEGYKLIPGNGVYVVFSEINGGLVYGIT
SIGTNPTVGGEKQTIETYFLDFDGDLYDKELRIEFITRIRGEETFESVSELKEAIQKDEE
FARNFLKHFG
>OMIFANIC_01342 hypothetical protein
MDKILFRHIDNSGLVLWRVVFGLLITIEGFGAIATGWVKRTLVDPEFTFNFIGFEFLQPL
PGNGMYFYFALMGIFGLGVMFGYRYRFSMAAYALMWTGVYLMQKTSYNNHYYLMMLLCWI
MVFLPANRWFSLDARFNPKIKSPSMPQWVKIFVILQIGIVYAYASVAKLYPDWLDASVAA
LFMSGKKSYWLIGEFLQQEWIHWCIAYVGIFFDLLIVPLLLWKRTRVVAFWISVFFHLFN
SIVFQIGIFPYMSIAFSFFFFSPETLQRWFLQKRNLVYTEGKVVVPKMKPLIISIMSAYL
IVQVALPLRHWFFKDDVLWTEEAHRLSWRMMLRTKRGMLTVWVEDKETKKRERYDFTALL
SPKQNRNVRAKPDLLWQLAQRIEKIELEKGRNVAVYMDVRVKVNNGEFHRLIDLDTDLAA
EEWHHFKHHEWILPSPEDYHKKEDKK
>OMIFANIC_01343 Serine--tRNA ligase
MLQVNEIRENKEVFIQALTKRGLDVRTEFEAVLKADEDRRGTQAQLDDTLSQSNKFSKEI
GMLFKQGEVQKANELKQKSVELKETSKVLQEQLNQATERLQQLLYDLPNIPHESVPAGTD
ENDNEEVFLEGEIPALGDEALPHWELAKKYDIIDFELGVKVTGAGFPVYKGKGAKLQRAL
ITYFLDKNTEAGYTEYQVPLMVNEASGFGTGQLPDKEGQMYHVTADDMYLIPTAEVPVTN
LFRGNLLMHNELPITCTGYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRIEHPDNSYTA
LEDMVEHVKGILRDLKLPYRILRLCGGDLGFTSALTYDFEVFSTAQDRWLEISSVSNFES
FQANRLKLRFKETDGRNQLVHTLNGSALALPRVLAGILENYQTPEGIKIPEVLVPYCGFD
MIS
>OMIFANIC_01344 hypothetical protein
MRIIVLVLLLLMAAPSFGQNELLAKNYFDRGEYEKALTIYDKLYRKNPGRQDFFLYIIQS
NQQLEKFSVAEEMLLKKLNGRRIIPHLYVELGYNYSLQDKDSLSDINYRKAIDFTYDNPV
YAYSIGKNFEEYSLLNEAVEVYETAMARDPNKDYNVQLARIYGELGKLEEMFGTYLNLMR
ENPAYRSIAKRNFSQYVNEDPNNEANIILRKTLLKRSQSNPNVLYNELLSWLFIQQKQFK
KAFTQEKAIYRRNPGDLTGIVDLGLIAIDERAFEEASEIIDFVIENAPTAQAEMQGQQYR
MTILLETATPDEYPKIEKEFESLLDRYGRNGRSYALQLDYNHFLAFSAGKKDKAISNLKL
LVNEELTIYQQARVKMELADVLVFDEKFNQALIFYSQIQKKVKNDILAQEASFKVAKTSY
YKGDFEWAQIQLDVLKKSASQLISNDAMELSLMIRDNSLEDSTQTALKKFARADLLELQK
KYPEAIAFMDDILENHKGEKIEDEALLRQGRLFEKTYQFEKAEAAYQKIIEFYKEDILAD
DAYYRLAKLYENQLGMPEKAKDLYEQIIYDFADSIYFVEARKRFRMLRGDVIN
>OMIFANIC_01345 hypothetical protein
MYIYNVTINIDETVHDDWLHWMKSEHIPAMLDTGKFSKALMTRVLVEEEMGGITYSVQYR
TDSKETLEKYYKENAAILRAQSKPFEGKFVAFRTELQVVTEQ
>OMIFANIC_01346 Protein TolB
MKKYSLLMALLMALNVSAQIPVTKSTETKVEDNGFKFKVIPTRINSSYSDYGSCLFRDKF
ISVSSRKIGVFAKKDPVTKEPFPNLFCSDIGPDWDLNRPLLFSYLLNKNENLGTITFSED
GFTMYFTTNKKGDTQLFQIFRAQMDPKKLGKWENVTPMPFNSNEYSVENPHLSTDGKTLY
FASNMKGSKGGFDIFKVDIAEDGSYGPVKPVPGKVNTASDEKFPYTSKDGKFLYFSSKGH
DNFGGYDLFMSKITEKGFKDIVNLGDSINSISDEIAFISVTDRVAYFTSNRSGGKGGFDI
YRAIGITNDQEVDIN
>OMIFANIC_01347 Ribosomal RNA small subunit methyltransferase A
MNNSVRAKKHLGQHFLHDEGIAEKISNTLSLSSCTNVLEIGPGMGVLTKYLIEKPVKIIA
MELDNESVSYLDKHYPQENLSILEADFLKYNLSTLFEGEEFAITGNFPYNISTQIVFKML
EHRDRIPEFTGMFQKEVAERICEKEGTKRYGILSVLVQAFYDAEYLFTVKPGVFNPPPKV
DSGVLRLRRKKEFNIPCDEKLFFKVVKIAFQQRRKTLRNSLKSLNLSQKLKEDTIFGLRP
EQLSVTEFIMLTKKIEEDAISANN
>OMIFANIC_01348 Magnesium transporter MgtE
MPFQLTTDFLAQVEQLIAIKDGKALRELLQDLHFADVAEILEELKSDEATYLIKLLESEI
TSEALMELDDDVREKILDRLSPKEIAEELKEMDTDDAADVVAELDDEIQQEVIEKIEDDI
LAADIVELLKYDEDTAGALMAKELVKVKETWTVAGCVREMRRQAKNVTRVHSIYVTDKDG
KLKGRLSLKDLLTAPEKAHISEVYIPKVDYVTVNTENEEVARIMHKYDLEAIPVVDEEGL
LMGRITIDDIVDFIKDEAEKDYQLAAGISIDVEADDSIFQLTRARLPWLVLGLFGGLGSV
YIMQGFEEALNNFPILFFFTPLIAAMAGNVGVQSSAIIVQGLANDNVKGSLFQRLLKEVG
LALINGVALGLLVILFGTIVGQDQLVSITISVSMLSVIIVAALVGTFVPIILDKRGIDPA
IATGPFITTSNDIFGIFLFFWISKIILNF
>OMIFANIC_01349 hypothetical protein
MKPEVYSYEITVPSSAIDARDHVNNLAYMQWCLDAAQQHWERNASEAIRQSYVWYVLHHE
IDYKAPAFEGETLQVETWVDSSAGVKSERQYRIFRIKDEKLLIEAKTIWCLLNASTLKPS
KIPSEIRTLFEEK
>OMIFANIC_01350 hypothetical protein
MTPINIKAKLKKFDAQWHPHQIAVVDDMQVILAKIQGEFVWHAHEHEDELFYVQKGTLEM
HFRDKVEIVNEGEIIVVPKGVEHCPKSRGDEEVHLLLFEKLSTKHTGEVVHDKTKTEYPK
I
>OMIFANIC_01351 Hydroxypyruvate reductase
MEILHLDSNHPILIEELAKAGFRNTEDYISPREQIEKVIQNFDGIVIRSRFKIDSDFIDL
ATNLKFIARVGAGLDSIDVDYAKKKNIKMLAAPEGNRNAVGEHTLGMLLSLFNNLNRADR
EVREGKWNRESNRGTELDGKIVGLIGYGNTGKAFAKKMKGFNCTVLCHDIKPNVGNKNGT
QVSLKTLQEMADVLSLHTPWTPLTNKMVNKDFISAFSKPFWFLNTARGKSVVTADLVAAL
KSGKILGAGLDVLEYEKSSFESLFNSEDLPGPLAELIKMDNVILSPHIAGWTVESKEKLA
QTIFEKIMKHFGRS
>OMIFANIC_01352 hypothetical protein
MKKKIHWLFCFFVLSLQAQEIYVVNSINEIKLINTQSLTVTNLVTVDVLEVGYITDIAFT
PDGTLYAVTNGWQIFEIDTSNGEASLITDLPIADPYTALVSNADNQLLTSRTFSEELYSY
DLNTGMLELVDNNISSPGDFTFYKGYLVYPNILNDFIKAYDGNSIINIGCSIPLVYTFVN
DFVDCETNNIYAFDQFANLYRYELETENFELIAEFFDQTGLLNGGATQTEWLASDCPVEP
LETVLCIPLGTKNFNLYGITLKSNPVENTIEFEFTNPMELSYSLFNAEGRLIMEGSIDNN
SFSASRLNTGIYFLQLTNIAGLNVFEGKIIKK
>OMIFANIC_01353 Transcriptional regulatory protein LiaR
MKKTIAVFTLLILALLTLFQLSQYSVTSGSLKIEFVAAGTALLFLVIGFFLNRKASSGDQ
INSEEKKIDNQKIAQLGISNREYEILIEISEGLSNKEIADKLFVSESTIKTHVSNLFSKL
DVKRRTQAIQQAKALNIIP
>OMIFANIC_01354 hypothetical protein
MRKTVIKYGLYSLLAASILFLLAFLIGKGMSYSVQETVGYITMVVSLVFVFFGIRHYRDR
VNNGKVSFGKALFIGFMISLFAGLGFGVVDYIYTTMINPDFAQEYLTTMVADMKATLPAE
EFEVQKANLEQQMEEYGGSGFMAFIMFATVAMIGLVISIISALILQRK
>OMIFANIC_01355 hypothetical protein
MQYDASTPEEYLDLIPEERKAPMKKLREVILENLPKDFEEGMNYKMIGYYVPHSVYPPGY
HCDPELPLPFMNIACQKNFIGVYHMGVYANPELYDWFVTQYAKHCKYKLDMGKSCVRLKK
MDDIPYDLIGELASKMTAKEWIELYEKNYKK
>OMIFANIC_01356 hypothetical protein
MKNRVTGLGGFFFKTKDPDKVKNWYRNHLGLNTDQWGCTFWWKDEEGNKCSTQWSPFKED
TKYFDPSEKQFMMNFRVENLRELLKALEEEGVTIVGEVQEYEYGKFGWILDPEGNKIELW
EPVDTAFE
>OMIFANIC_01357 hypothetical protein
MSEENNKDTFDDAKDSIENAAEKIGEGAKEAAGEIKEEWNQVTRAENKKMLAGILAIVIG
SLGIHKFILGYTQEGIIQIVITIVTCGIGGIIGLIEGIIYLTKSDEEFYETYQVNKKPWF
>OMIFANIC_01358 hypothetical protein
MSEENNDNLGDELKDQANELNEDAKEAAEEVKQEAKSTAEEFKEGWNEATKSTENKKLIA
GLLALFVGYLGIHKFILGYNKEGIILLAGFVIGLLTYCFIIGIFIIMAVAIIPFIEGIIY
LTKSDEDFYNTYQVGKKPWF
>OMIFANIC_01359 Biofilm growth-associated repressor
MGVSKRHLHSIQVNQLADMAKVLSHPARISILNYIGDCDGCLCKDISEKIRLSQPTTSQH
LQVIKKSGLLKSKFEGKSQYYTINKDKLMALKELFSEFFETTEQKCC
>OMIFANIC_01360 hypothetical protein
MKTQEFLSLLKAHQDKSLLFEYTPGQLVGANYHITEVKHLQIDAVDCGANSDNWNETIVQ
LWESPSEIGKTEYMSAYKATGILNKVGRIKPYDLDSEVKIEYGNPLFHTAHLYINDFEIH
GTNLMLKLAVTKTDCKAKETCGVPEAVEADSNSAECCTPGSGCC
>OMIFANIC_01361 Glutaredoxin arsenate reductase
MRIIPLLDKHYPEVAVIYKEGLDTGIATFETEVTDWEAWNKKFLPEGRFVVEIDGEVTAW
CALSPTSKREVYRGVVEDTIYVSSKHQGQGIGRKLLDHLIKTSEQLGFWTVQAAIFPQNI
ASIKLHEDLGFRIIGIREQVAQRDGIWYDNVLMERRSKKVNYMKNVLVLCTGNSCRSQMA
HGYLKTMAAGKANIYSAGIETHGLNPGAVSIMAEDGIDISTHTSNHVDEYAGVNWDYIIT
VCDHANENCPFIPAPNAVRLHHNFSDPSKIKGTDEEIHDAFLKTRNEINDYCRKFIETNL
>OMIFANIC_01362 hypothetical protein
MSFATNLLIGFIALLHLYIMWFEMFAWTTRGRKVFRSFPKELFEPTKPMAANQGLYNGFL
AAGLIWSFFIEDQVWRLNVSIFFLSCVAIAGIYGSITASRKIFFVQALPAIIALSAVLIG
LA
>OMIFANIC_01363 hypothetical protein
MNLHRSFILAILLGLLSIVAWEMYWRSQGRIPNIDDSNSLSSIQRAKLENPTDDQVVFIG
SSRILFDIQLDLWREQTGTDPVMLAFQGASPLPTLRDIVDNTDFKGTLIVGVTEGLFFST
TFPKAPPISRAQERLDHYYDRTYAQRLNHHLSVPLQKNLAFVTVADEFWDSDVDLGTLLW
GQVSDERAGPKPAPFYQFEDVSLDRNVQMTSRTTNDTAYANTIKLAWQDMLSGDMPPPDK
EGTTKFFLEYAEKFLEKGGNMILVRCPSDGWFKEIETMGLPREEYWDSLVIKSKLPSYHY
ADYEQFQDLNLPEWSHLSKEDADYFTTEIIKIFKKDGVLTNSKTE
>OMIFANIC_01364 Peptidoglycan O-acetyltransferase
MLFNSLSFVVFLIVVLVLYYSKIFNWTNKKRMLLLASYVFYGLWNPPLVVLLWISTVVDW
TAGKKLAVLEDKRKRKLWLLLSMLVNLGFLAFFKYGDFLLENFTAMLNAVGVEYTARPMD
IILPMGISFYTFQTMSYTIDMYYKRIEPARTFLDFALYVTFFPQLVAGPIVRAKELITQF
YSEKRATANQFIWGLFLLTIGLFQKVVLADTLLSGAADDVFGSKDILNSLDAWTGTLAFS
GQIFFDFAGYSTCAIGIALTLGIHLPDNFRYPYAAIGFSDLWRRWHISLSSWLRDYLYIP
LGGNRHGITRMYVALMLTMLLGGLWHGAAWTFVVWGALHGIYLVVERLLKGMIKIKIGAW
NGILLALLTYTCVNITWVFFRAREFSTAKNMILSMFFLNDEGEKVLYMFDIVKVLMVITG
LFLCHWVMRNTSMKEVAQKTNPWIFGVFWAVLFFLIVISQGSGEQFIYFQF
>OMIFANIC_01365 Proline iminopeptidase
MNAKFNLTPVTLLIIAILSSVWSCDEKTTVAETAECDLTYFDYSNSEDQFTGGINMIPIT
TPNGIFKVWTKRVGNNPKIKVLLLHGGPGGTHEFFECFDGYFPKEGIEYVYYDQLDSYYS
DQPNDSTLWTTEHFVEEVEQVRKALNMNNDNFYLLGQSWGGILAMEYALKYQKNLKGLII
SNMMASIPAYEKYAEEVLGPQLPKEVYSEIKAMEAKNDFANPRYAELVTEYYYTEHVLRM
PLDQWPESVNRAMKHLNPNIYIAMQGYSEFGVTGDASLKGWDVSQRLKEIKVPSLMIGAT
YDTMDPEYMEWMSEEVQNGTFLLCPNGSHFSQYDDQKNYFEGVIQFIKDVNNESQKSNSN
N
>OMIFANIC_01366 hypothetical protein
MNSHSPENDHEIIRSKKEIFMKSKTKHWTKAELHAYIYLLCADADAVITEDEMQLIRSKV
NPDIFEKIYKEFKKDSGRKRLKKIERNIELHEYSQMELGELRKEMHQIFASDEKFHMKEQ
IIDEILDNILY
>OMIFANIC_01367 hypothetical protein
MKNIFFISIILCLVSCKKNPESNDQLGEVRIEVTGDSKAKSHFEKGLLLLHSFEYEDARE
AFREAQDIDPEMPMAYWGEAMTYNHSLWSEQDFDEAIAVLERLNAFDFEDNCSELEKDLI
SSVMILYKPKTDKVDRDVAYSEYLENLVEKYPNNHEVAAFYALSLLGSVPEGRDDEIYGK
GAVIAQGILKENPNHPGALHYIIHSHDDPGHATMALDAAHAYAKVAPDASHALHMPSHIF
VAMGMWDNVIASNIDSYQASVDRMVRKNLDNDARGYHAFHWLEYGYLQKNQVEQAKKLVR
EMKNFTEEKPSIRARVHMVFLKGTYLVETNEWNSEIAQIPVDISDLNISIRSQYHFLEGM
KAYINTKSKQLDSIIGTMENDLNRESFIVAQGSAKLCSGVSREEANQTDLIESKIRLNQL
KGLRADLDSDPVAAEEHFLKSIELEKSISYSYGPPHIQKPTRELYADWLMGQNRFKEAEA
EYKQALISAPKKRSLLNGILKAEQSL
>OMIFANIC_01368 hypothetical protein
MKNTLYLLLLAFVLTGCKTDHNGEQDKDHDDPVAAVFEANSKTVMANLEGWQNENLDYSM
YAGDFYLYETAFSAEKDSLSLEEMKAYDKEMWANYDFKMVSEAVLLPGVKRASTEPDGSV
RHYPVWEVTKPATDSTEARTGTIRLYESFDFNEEGKILRQQVFGDFTGLMMYLHGEGDMM
EQGE
>OMIFANIC_01369 hypothetical protein
MKTTSRFDQAVQKLYNAFHNNNLHPECAMQCAVGNICDNKDAWKHFSDFHGSLCLNYVGR
VHEGFGRRINGYLPSELLKIEAAFLEGCGYVLPLHHSNPKPENPVDKTILFNGLCASVSV
LCELDGISNVMDTHVLFDYERQAPLMSEALR
>OMIFANIC_01370 hypothetical protein
MKFNLEQAIALLERTPSIVRTLLSGLPEASITKNEGPDTWSPYDVVGHLVHGERTDWIPR
LFIIMNDSDQKTFEPYDRFAQFEESKGMTLDDLLQEFETLRKQNIEQLKDFGLTETEFKR
EGIHPSLGPVTLANLLSAWVVHDQGHIAQISRVLAKQYKDEVGPWTKYMTILKYAPKE
>OMIFANIC_01371 Coenzyme PQQ synthesis protein B
MRLFTSFFLLIILFVSSKNIPATFSEEKYEDHTEVDRRPEMIVLGTMQDAGSPHIACKKD
CCKDFFDNPDPNRKVVSLGFIDHKNKKTFLIEATPDISTQLKHLNRISGFDNELPNGIFL
THAHIGHYTGLMYLGKEAVNAAEVPVYVMPRMKGFLESNGPWSQLVDTGNIKLEEIKNRK
EAGTKSDVSFAPILVPHRDEYSETVGYFIEGPRKKVLFIPDIDKWEKWDIPITEGIKDVD
YAFIDATFYSGEEIDTRDISAIPHPFIIESMALFDSLPAMEKNKIHFIHFNHTNPILDPN
SDAYKTVIENGYHISQINDVFKL
>OMIFANIC_01372 hypothetical protein
MKRNMANADRIIRFIIAAVVAYLYFSGTLTGTLGIVLLVVAAIFLLTSFISFCPLYAIFG
ISTCKVKN
>OMIFANIC_01373 hypothetical protein
MGLVNAKEVAKAINVDKFGFIGTFMGWTLMKMLKIDTMNKIYDRNKHLNDLEFINALLDE
FEINFEIPEEDLKRIPKNGSFITISNHPLGGIDGILLLKLLLEHRSDFKIIANFLLHRIL
PLKPYVMPVNPFEDRKDVKSSVMGFKNALSHLKDGHPLGIFPAGEVSTYRDGKLVVDKPW
EVAAMKLIKKAEVPVLPIYFHAKNSKMFYRMAKFNDTFRTAKLPSELLTQKERLIKVRIG
NPISVSDQAEHEGLDEFTEFLRKKTYVLANPFQKKKRLENIPKTLKIPKAPKKIAGAVSI
EMMETEIELLRREDKRLLQSKNYEVFLAPAQLIPNILQEIGRLREITFREVGEGTNNPTD
LDKFDSYYHHMFLWDGDAKKIVGAYRMGLGSKIFPQFGIDGFYLQDLFRFESELYPMMEQ
SIEMGRAFIINEYQQRPMPLFLLWKGIVHTTLRFPEHKFLIGGVSISNKFSEFSKSLMIE
FMKSNYYDPYVAQYINPKKEFKVKLKDADKDFIFDETEADLNKFDKLIDEVEPGSLRLPV
LIKKYIKQNAKVVAFNVDPMFNNAVDGLMYIRIADLPESTVKPVMEEFQAELEKKYLSKD
EEE
>OMIFANIC_01374 Lysine-sensitive aspartokinase 3
MKVFKFGGASVKDATGVRNLKKVVDTTGEKDLVVVVSAMGKMTNHLEKVVDAYLAKDKGL
SLLISEFREYHQKILGELFPVTGHPVYAKVQKLDTKLVNFLETNRSSQHAFVYDQVVCYG
ELVSTLIISEFLQEEGTENTWLDVRSCIVTNANFRDAKVDWENTQKHITDSVSHTGITVT
QGFLGSEEENNFTTTLGREGSDYTAAIFAYCLNAECVIIWKDVPGVLNADPRYFGNTKLL
HNISYEEAIELAFYGASVIHPKTLQPLQRKEIPLFVKSFMNPGNAGTCVGKGVTLNPETS
CFILKRDQVLISLSSLDFSFMMEDNISDVFRWLHEYKMKVELMQNSAISFSVCVDNRFNR
LDALLAKLRERFSVRWNEGVTLYTIRHARPSEIDSLMENKEVLLKQESRDTVQVIVRE
>OMIFANIC_01375 Phosphinothricin N-acetyltransferase
MELLIRNAIKEDMSSVLKLIVELAVFEKEPDAVEISEEDLIVAGFGDDKQFDCFVAEADG
EIVGMALVYFRFSTWKGRTVHLEDLVVKEKMRGKGVGKALYRRVMEYAAEQGVKRVNWVV
LDWNKPAIDFYEQTGATILSSWWQVEMEELALKKFIEQKE
>OMIFANIC_01376 Fructose-1,6-bisphosphatase class 1
MPQKNQTLGEFIIENQGEFKYSSGELSRLINSIRLAAKVVNHEVNKAGLVDILGAAGDTN
IQGESQQKLDVYANEAFIKTLTNREIVCGIASEEEDHYITIKGRNQNHDNKYVVLIDPLD
GSSNIDVNVSVGTIFSIYRRITPSGTPVTLEDFLQPGSKQVAAGYIIYGTSTMIVYTTGH
GVNGFTLNPAIGTYYHSHPNMKFPEDGTIYSVNEGNYVHFPQGVKDYIKFCQEEEGNRPY
TSRYIGSLVSDIHRNMIKGGIYIYPNTAKNPEGKLRLLYECNPVAFIAEQAGGLASDGFQ
RILDIEPTELHQRVPFICGSRNMVLKAEEFMQNAESQKT
>OMIFANIC_01377 hypothetical protein
MAKKTTPNSNNENLDSSSKIEAIKNLIFGENIEQYDSAFDTLKKDLDKKKKILEDNIDEV
RNELMQSIDSLSTDVNIRITDLEDALNAKAETLTEQKVDRKELGKLLISLGEKISS
>OMIFANIC_01378 hypothetical protein
MVKEDENKLKLLREILLIDDREVARAVSQRLDTISETLDKREKLSKKVDPIIEKRLDEFI
SDIPITLGPTITKTLKDQIENSRDQVVEALYPIMGKMIKRYIQNEIKLLSERINQKVNKT
FSFAKVKRKVRSTFTGVKESDMILAETNKPVVDEIFIIEKGSGLLLGNHSTTETMDKDMV
SGMLTAIKSFVEDAFSGGAQNLEAIEYELYTIHIQNFFSYYIAVVVSGNYTRSFESHLEN
DLLELSKKLTSKITSLSREAVDDILAKHMKEHQ
>OMIFANIC_01379 hypothetical protein
MLSGETIYINKMQEIIASFDGTVSISNNAIYPIEPGDNIFQLHPFFQSLELSILNGNNIY
FTFPCINLLLGERNYYCDVIIKKEKDFMAVLLFNYSDHYREMQEKIQKIKGEKFKS
>OMIFANIC_01380 GTPase HflX
MAAVKKIVLLGHFGVGKTSLVRRYIDSAFSEDYLVTVGVHVKKKEVIVNDEPVTLIIWDI
EGNNSIEKARSSYLLGTQGFIYVFDITRQETYESIEEEMAFLQEHHDQVPVCLVGNKSDL
FTDEFTKEFFKDPEFESCYFTSAKTGDNVEALFLDLAKRTL
>OMIFANIC_01381 Autoinducer 2 sensor kinase/phosphatase LuxQ
MGANLKTEISDRRIQEVELNDEGIIVESDNAIFELAEGSSISDLHPFFEGVLPLLSSLKD
SLKIPCVNVDTVPNPRIVDVDFLRKDKKLYLLLFDFTEHYEASQPLVQEKNVASIAKNRL
AFEKQLLEAKEEFKNNFLSNLNHEIRNPLNNLLGFMELLKETRLDYDQNETLKVMQKTGT
HLKILMDDMLDISKIERGVLDIKDVNFNLGHLINNLHNHFKLKYIDNLVEFNVSIDSNVP
RKLIGDPARLNQILFNLLENAFRNTEDGHIALYVKAVNKTKTTTGIQIIISDSGVGIPDD
KLDKVFDTYFQLQVDKLKPLGEGLGLKIVKDLTESLKGSVQVSSEEGKGTVFTCMFPFKV
RASSREKKTIPKGTGILMSKRILIVEDETTNQMLMMKTFLNNEKGYVIEMAINSEHAFEL
LKNNRYNLIMFKSVLPDIDAIGLIKKIRNHEIDGIANLPILIASGNTLKEEQDAVLKAGA
SAFLPKPYSKNELFKSIEQLIR
>OMIFANIC_01382 hypothetical protein
MAFTELFESGERSRKLSHFASIVRMAMADGVVNDDEKRLLKRFALKLDVSEDEFKKITKN
PKIYPMNPSNSAEDRLERMLDLFKIIFADNEIDDEEKRLVERYAIGLGYTEELAAKLISR
SIRIFKGGLDMEDYRYLLNRK
>OMIFANIC_01383 hypothetical protein
MKKALQISNGIALVSVIIINYLSNTGKMNNTTIGEVSGELTTLFTPAGYAFAIWGLIYLS
LFGFIIYQGRSLFVKVRDDEFVNRTGWWFVLSCIANGAWVFCWLYEFTGLSVLCIFLLLI
SLLKIVVNNNMERWDAPISVIAFLWWPFVIYSGWVTVASIANVSAWLTKLEWNGLGISES
IWTIIMIIIAGVINLLVTWKRNMREFALVGVWALVAIAIANWEGNKAIVFTSIAVAAILF
LSSSIHGYRNRATNPIIKLKQYPHR
>OMIFANIC_01384 putative cysteine desulfurase
MLNCQKHLFNLSEDVTYLNCATMSPFLQSVERIGIENLKRKTNPQHIESHHFFTDRKILK
ERFAALIGAPDPDSVSIIPSVSYGIATVTKNIPFNKGDEIIVLEDQFPSNIYAWKQVEQE
KEISITTILAPPLSEGRGKLWNERLIEAISNRTKVVAIPQVHWSDGTFFDLKAIRKKLNE
FGAYLIIDGTQSIGAIPFSIPDIAPDALICGGYKWMLGAYGLGMAYYSERFYQGSPLEDN
WINHKGSEDFTNLASYNPEFKPKATRFDVGESSNFILVPMLAEAIQQIIDWRPERIQDYC
RDITADGIKSLRDHGYFIEDPDFRAQHLFGIFCTGKRSMKEIKQILTLENIKVSFRGQSI
RISPHLYNTRADIEKLVNCFI
>OMIFANIC_01385 Transcription-repair-coupling factor
MSKALVRSLFEQSPETRELREAIDSSEKNIHVNSLVGSSLSLVVAELFKTSEVPYLLILN
DKEDAAYHLNDLENLLGDQNVLFYPGSYRRPYQIEETDNANVLLRSEVLNRLNSRRKPAI
IVTYPEALFEKVVTRRELEKNTLKLKVGEEVSIDFVNEVLFEYRFKRTDFVTEPGEFSVR
GGILDVFSFSHDEPYRIEFFGDEVESIRTFDVETQLSLEQIKRISIIPNVENKMVEENRE
SFLDYIRSKTLVFLRNEELLTTAIDKLFMKATEAFSEADGAVSMSPPEDLFCTSQLLESQ
LNKFSVVRLSKNNVSTYNCNITFNIVPQPSFNKQFNLLIDNLNANAAEGYINYIFCSSEQ
QAKRFHDIFEDAEQHVDAFETIVFPLFQGFIDHDQKKICYTDHQIFERYHKFELKNSYAK
KQALTLKELTNLEVGDYVTHIDHGIGKFGGLQKIDVEGKQQEAIKLMYGERDILYLSIHS
LHKISKYNGKDGAVPKIYKLGSAAWKKLKQKTKKRVKEIAFNLIELYAKRRLQKGEAFAP
DSYLQLELESSFIYEDTPDQTRATEDVKRDMENERPMDRLVCGDVGFGKTEVAIRAAFKA
VDNGKQVAVLVPTTILAFQHFKTFSERLADMPVNVDYLNRFRSARQRRTVLENLANGKLD
IVIGTHQLVNKSVVFKDLGLLIIDEEQKFGVAVKDKLKTIKENVDTLTLTATPIPRTLQF
SLMAARDLSVITTPPPNRYPVDTQVIRFSEEIIRDAIRYEISRGGQVFFVHNRIENIKEV
AGMIQRLVPEAKIGIGHGQLDGRKLEHLMLAFMNNQFDVLVSTTIIESGLDVPNANTIFV
NNANNFGLSDLHQMRGRVGRSNKKAFCYFITPPFSAMTDDARKRITALEQFSELGSGFNI
AMKDLEIRGAGDLLGGEQSGFINEIGFETYQKILSEAIDELKEKEFKDLYAGTEHELKDF
VKEAVIDTDFELLFPDDYVNNITERLNLYQKLNTLESEDQLQQFEAELLDRFGELPEQAK
DLLNSVRIKWIAISMGLERVVMKKNRLVGYFVSDQQSAYYQSDTFTRVLQYVQSHPQMVK
MKEKQTRSGLRLLLSFEQITSVNKALEVLRPFT
>OMIFANIC_01386 hypothetical protein
MAYHNELGKLGEELAVASLISKGYEILERNFVFEKAEIDIISKKDDQLVIVEVKTRNSAV
FGDPQSFVSKGKIKLLVKAANEYVLRNDLDTEVRFDIIAVLKNKYVEQIAHFENAFYHF
>OMIFANIC_01387 Internalin-J
MKLQILITVALFITTISYSQTTPVPDPAFEAKLISLGIDTNGMNGNILNSDAEGVTNLNV
SDSGISNLAGIEAFVDLLMLDCEDNMISNLDLSFNTMLTFLDCNNNLISSLNINANNDLI
SLNASDNSLTNINLANNLALSDITLQNNQLTDLDLANNLNLYQIVAHDNSLTSITFPASP
TLLEIVWIYNNSLTNIDLTTAPILATLRFEDNDLVFLDLRNGNNTNINTMDARGNPDLQL
ICVDDVVFASNATNWNKDATAEYSETCVLGNNDNSNFDVVIAPNPATNSFYIQLNTNTEI
ETLEWINLAGQKQSLPVAETVDISNFATGIYFLKITLSDGRQHTHKIFKK
>OMIFANIC_01388 putative murein peptide carboxypeptidase
MVTPPFLKPGDIVGIVSTARKISRDELQPAFQLLSKWGLKFILGNTIGSEQDQFAGDDAT
RALDLQTMLDNPKISAIWCARGGYGTVRLIDTLDFKYFSSNPKWIIGYSDITVLHSHLNT
RGIETLHAQMPLEIDKKSYETAESIRNALFGDKNEVSFDNLTKLGRTGKARGELTGGNLS
VLYSICGSRSALKTDGKILFLEDLDEYLYHVDRMLQNLKRNGLFDNLKGLIVGGMTDMND
NTIPFGKTAEEIVADIISEYDFPVCFNFPAGHVHDNRALIFGREAELFVSDNTVDLSFTS
>OMIFANIC_01389 hypothetical protein
MEIAAYMSCNTAPLSPYVPSSGNPWNTSKVKHVFRRLGFGANIMQIDDALMLSPNDFIDD
LVDTAFNLPPASAPFWAYYAVSDFTDFQTENTQYINEWRIETGNHLISENLRGRMAIFWM
NHFVTQLDTINYAPYLFQYYNMLQVNALGNYRDFVRSVGTDNNMLLYLNGFENTNNEPNE
NYARELYELFTLGEGNGYSQDDITETARALTGYNHWTEPGADIYFDASTFDDTNKTIFGQ
TGNWGYDDVIDILFDQRSTEIANHICAKLYRFFVSPDIDAMIQQDIITPLVQTLINNNFD
MVPMLKQLFKSEHFFDERALGVVIKSPLDVILSFANEGSFFYNNFVMNAFVYYAGLMGQA
IYDPPDVSGWQGDETWINSSTLTGRWEFMEVYVTYLFENGYELSLTDLAKELTNNSNDPE
FITRVMVDHFVPKGLNTATDYDIATDIFKWEVPQNYYDNGFWNLDWDSAPYQCLLLLVHI
CRMPEFHLK
>OMIFANIC_01390 hypothetical protein
MCVNNKIPKKEMSKDEKRVHDQEHAEWSRRSFIQALGLVGGGSIMLGNAAVTASKPSPLS
VALAESENDRIMVIIRLKGGNDGLNTIVPVYDYATYANLRPTIRHQQNDLVNLDADFAIP
NYMSGLETMWGEGQMKVVHGVGYPQQNLSHFRSSDIWASAADTVVEPTGWWGRYYEYLYP
DYLINPPEVPPAIQIGSIGNLVFEGQENNYAFTVANPMQLENVAQNGQLHNLLDIPDCIY
GDKLLFMRSTTNTTVTYASVINDAYMNSTNQAPYSNEDLAYQLSIVARMIKGGLGTKVYM
VTLGSFDTHANQPNGHRGLLEDLSDSLQNFYADLEAGGMENDVLCMTISEFGRRPYENGS
NGTDHGAASPVMLFGPGLNGSGFVGTHPDLLNWDNNDNLIPTADFRSVYSSVLTNWFCLD
PSVIDLILLNESYDNLDIGFNCDILSNNDFSNVINFVHAPVYKNDRVYIEMNMTNTSHVD
LKLYDIMGKELGTLKNEVLFPGIHSVDVIAALGSNLSFGQYIYRISMGGQFYSKSLLIK
>OMIFANIC_01391 Methionine--tRNA ligase
MNNPKRITITAALPYTNGPVHIGHLAGVYVPADIYARYQRLIGMDVAFVCGSDEHGVPIT
IKAKREGITPQQVVDKYHAIIKKSFSDFGISFDNYSRTSAKIHHDTASEFFTKLYNDGKF
IEEVTEQLYDEEANQFLADRFVVGTCPKCGYEESYGDQCENCGTSHNATDLINPKSAISG
SKPVTRNTRHWFLPLDQYQDWLNDWILKEHKKDWKANVYGQCKSWIDDGLRPRAVTRDLD
WGIPVPVEGAEGKVLYVWFDAPIGYISSTREWAEREGKDWEPYWKSEDTKLLHFIGKDNI
VFHCIIFPAMLKAEGSFVLPDNVPANEFLNLEGNKISTSKNWAVWLHEYLEEFPGQQDVL
RYVLTANAPETKDNDFTWADFQARNNNELVAIFGNFINRVVVLTHKYYDGQVPSPAEFSK
VDRDTLKELQFAPEVISSSLERYRFREAQGKLMDVARLGNKYLADEEPWKTIKTNEERTR
TVMYVALQIASAMAVLSEPFLPHTSRKLNRILGVSSNDAGQENHIENSWNDISQKQELLP
SGHQIGTSELLFSKIENEQIQQQLDKLAASKKANETMNATVEPQKDTITFEDFTKLDMRV
GTIISAEKMPKTKKLLVLKVDTGIDTRTIVSGIAESFTAEEVVGKRVTVLVNLAPRALRG
MDSEGMILMTETPEGKLVFINPDDDVPNGSSIS
>OMIFANIC_01392 Acetoin utilization protein AcuC
MLKIAWHPIYKHPLPTGHRFPMDKYDLLPKQLLHEGTCTPENFFEPELASDEFILRVHNA
DYVNDLRELNLDKKAIRKLGFPLSEKLVEREYRITQGTIQGCEFALEHGIAMNIAGGTHH
AYTDHGEAFCLFNDQAVGARYLQQKNRGEKILIVDLDVHQGNGTAEIFKNDNSVFTFSMH
GAKNYPFKKEVSDLDIALEDGTDDEEYLSVLRNTIPKLIYDVQPDFIFYLSGVDIVATDK
LGRLGCSIEGCKERDRFVLQLCKDHCLPVQVSMGGGYSSDIRLIIEAHSNTYRVAQEVYF
>OMIFANIC_01393 hypothetical protein
MDKMMYLAAQYLAAAGKSFVEHKPDDSHTNLSLSTEHKSLVTLELGENGDRLLLSYEHFS
LKWISRDGIEITHLHNTRHAENVKWLNEVSQQRIGKSYVFDLHYDLGYDLHEEFKFELEN
KEELKDLYQRRVMANNVLTSFLSRHSLSSEIRIWPHHFDTGAFVTDVGIQKLSIGLGMAI
PDSMSEHYYFYLSGYNGRDGIDTSSFEQLTRGSWKNEGFKGAILPIAEMKEKDAVQFLDE
AMKAYIN
>OMIFANIC_01394 Glutamate synthase [NADPH] large chain
MKKPVAIKIFSQLNDRQPAYAQVKDLDLVIIKYDDNVSVLYGRCLHRGALMADGHIEGDN
LICGLHGWDYRFDTGISEYNNKEVLHKFSTKVKNDQLYVDEAEIDAFLEKYPQPFDRESY
LGAYADTHPEDTEPYTGYIKELARNGLKNIGHHGFSASMGVDRNTLPKWKDIQFLPAQLA
KRPLLDEEEVSTRVVIGPNAQKPLVLDIPLFVSDMSFGALSREAKIALSKGAELSGTGIC
SGEGGMLPQEQESNSKYFYELASAKFGFSWDKLEKVQAFHFKGGQGAKTGTGGHLPGNKV
SKEIAEVRGLKEGETAISPAAFPDLKGLDDFRFFADEVRDRTGGIPVGFKIAASHIEKDI
QFALDVGVDYIILDGRGGGTGSAPTILRDNINVPTIPALARARKYLDKVGAKDITLVITG
GLRIAEDFAKALMLGADAIAVSNSALQAIGCLGMRACGSNNCPVGIATQKESLRSRLVMD
ASAKQLQNYFEASNSLIKVVARACGYDDISKFNHADLSTFNKEMSHLSGINYAGVNEI
>OMIFANIC_01395 hypothetical protein
MTIVNFIINFRLYFCQGKNSIAMRDSNTWMYIVGGIVLLHFIVGFIYLIRKMQPRKEDKL
NKDENSE
>OMIFANIC_01396 Succinyl-CoA:coenzyme A transferase
MRIVTAEEAVSEVKSNDTVFFQGASMTPNLLIDKLCDRYQELENVKIIQIHTEGEARYMQ
APYDDTFNVYSFFVGANVRKGVNTNKGDYIPIFLSEIHWLFRRNTIPLDFAFIQVSPPDV
HGFCSLGVSVDIALPALDKAKKVIALVNPQVPRTHGDGIIHINRIDYGVHIDNPIHYSAL
TEPSEIEFKIGKHVAELVEDGATLQMGIGNIPNATLKNLTNHKGLGIDTEMFSDGILPLL
ELGVITGEHKKIKRGKIVTCFAMGTQRLYDFVDDNPSVHFKEAAYTNDTHRISLQPKVTA
INSAIEIDFTGQVCADTIGPYQFSGVGGQMDFIRGASLSEGGKPIIAMPSVTKKGHSKIV
PYLKTGAGVTTTRAHVHYVATEFGVVNLFGKSLKERARALISIAHPDHQEELNREMFFRF
KLGE
>OMIFANIC_01397 Single-stranded DNA-binding protein
MNALRNKVQLIGRLGQDPEIMTFDDGNKLAKFSMATDDSYKDKNGEKVERAYWHNVVVRG
GLVNVVENYVSKGQEIAIEGKLTNRSYEDKEGNKRYTTEVVCNELLLIGGK
>OMIFANIC_01398 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE
MKKEATSYILGTDKQELIRLGIQHQVWAEEAQHGWAKAGFTAGDTLLDLGSGPGYCTREM
ACIAGESGTVIGVDKSEGYIHHLNELSTLQHLNIKAICADFNEMQLEPNSIDGMYCRWAL
AWLPNPKEILQKVYNALKPGGKMVIHEYYDWSTHQTEPKKDGLSIAIAADLKSFRDSEGE
IDIGRHLPEILSGFGMQVPGVRLMAKIGRPDTLNWQWPKTFYYSYFPRLVEVGYLSETHM
KQAFDDLQELEQTPGSSICCPLMTEVIAIK
>OMIFANIC_01399 hypothetical protein
MENSHQIKTLRIVRAIALSVLLILSILVLLFSLLSGSEAYGGGFSGVMKNSPNSLPWVLF
LIMVIIANKKTVLGGFLIMIFGAIITYFFNFTGGNFFLTTFIICLLIVFLGLVLVFSGLA
LKKLADNEK
>OMIFANIC_01400 hypothetical protein
MKNLIVLCVFLLLSQVIFAQSSPDYNGGLKVKFDEEGKKYLRIISWVQAQAIYNDNVPEE
SSNINFNLRRARIVAYAQINEKFLILTHFGLNNLNAENLSATGTGKDSQLFFHGVWGQYH
IGDHAIGGGLHYWNGISRLNNQSTLNLLPLDNNRQSWSTLGLSDQFIRHLGVFGKGKFGK
LQYRVAINEAITNSLDERDPLDVSGAVYAGRRLLGSKDAGFAYSGYFDLHILDQEANLLP
FKIGTYLGEKKVFNVGAGFFFHPSGAVVASDNGMLNGEDVAIFAVDAFYDAPLGENGGAI
TAYASFQSNNYGTNYLFNVYGTGSMVYAHAGYVLPGELKKTRFQPYISFASNSYDAVDDN
RNIFGIGANAFFSGHNSKLTLEYKNQAFGESETGTVTLQAMIYL
>OMIFANIC_01401 Acetyl-coenzyme A synthetase
MSNYHIKHLEEYFQVYRKSVRDPELFWEEIAEEHFLWRKRWNKVLEWDFSKPEIKWFEGA
QLNITENCIDRHLTSKGEHTAIIFEPNDPSEAAEHISYTDLHNRVCRFANVLKSKGIGKG
DRVCIYLPMIPELAVSVLACARIGAIHSVVFAGFSSTALATRINDCDCKIVITSDGSFRG
AKTIDLKGIVDDALDSCQGVETVLVAKRINSEINMKEGRDLWLQPLLDDASPKCEPEIMN
AEDPLFILYTSGSTGKPKGMVHSTAGYMVYTAFTFKNVFQYHQGDIYWCTADIGWITGHS
YIVYGPLSNGATTVMFEGVPTYPDWGRFWQIVEKHQVNQFYTAPTAIRALAKEPLTHVEK
YNVSSLKVLGTVGEPINEEAWHWYNDHIGKMNSPIVDTWWQTETGGIMISPIPFATPTIP
TFATMPLPGVQPCLMNDDSEEVKGNPAQGKLCIKFPWPSIARTIWGDHQRYKDTYFSTFE
NKYFTGDGALRDMTGYYRITGRVDDVIIVSGHNLGTAPIEDAINEHQAVSESAIVGFPHD
VKGNALYGYVILKDSGTERDRDDLRKEINQLITERIGPIAKLDKIQFTTGLPKTRSGKIM
RRILRKIASKDTSNLGDTSTLLNPEVVQDIMDNVL
>OMIFANIC_01402 hypothetical protein
MKTIKTIKFLGLIVSLLLFFSPGSIVSQDAPEKMYVEIGCLKSKSDNLEAFIKDKGMAFN
REAQAKGMLLDFIVLKVIYPNGEDCKCDYRMVSVYNDMKQLDMFMKPNIGYEIATKAFGG
QEQAQAAWEEWQGVGVDKGSELFELEMSAMPGPSGSDMSIANFVNVKPGMEMEYEKMERE
VWMPVVKEAIKAGMLNDMTIWSRVMPAGEHLDGDYIQVIDINNFAQMGSWEWEEFGKIFQ
KVHPGVDMMEMVKKSNALSTLGHNETVQVVARLSDPN
>OMIFANIC_01403 Propionyl-CoA carboxylase beta chain
MKSKIRQLSERIEQAHLGGGQARIDKQHKKNKLTARERIHYLLDDNSFEEIGIMVTHRTT
DFGMEKEQYYGDGVVTGYGTIHGRLVYIYAQDFTVFGGALSETHAEKICKVMDIAMKVGA
PIIGLNDSGGARIQEGVRSLGGYADIFYRNVMASGVIPQISAIMGPCAGGAVYSPAMTDF
TMMVEGTSYMFVTGPNVVKTVTNEEVTSEELGGASTHSMKSGVAHLTAANDVQCLADIKK
LLSYLPQSNRETPKSLDYELGDEIRPELSRIIPKSTATPYDMRDVIKGIIDEDSFFEIHK
DYAENIVVGFARLGGRSIGIVANNPMFLAGVLGVDSSKKAARFTRFCDCFNIPLLVLVDV
PGFLPGTDQEWNGIIIHGAKLLYALSEATVPRITVITRKAYGGAYDVMNSKHIGADMNFA
WPTAEIAVMGAKGASEIIFRKEIQAADDPEKKLKEKENEYAEKFANPWRAAKRGFIDEVI
LPRFTRHKLIKAYAMLEGKKAKIPKKKHGNIPL
>OMIFANIC_01404 Acetyl-/propionyl-coenzyme A carboxylase alpha chain
MKKILVANRGEIAIRVMKTAKNMGIKTVAIFSEADRDAPHVRFADEAVCIGPPPSSESYL
MGSKIIEEAKKLGVDGIHPGYGFLSENAEFAEEVEKNNITFIGPGSKAIRIMGSKLAAKE
AVKAYDIPMVPGIDKAITDIKHAKEIAKEIGFPILIKASAGGGGKGMRVVEKEKDLDAQM
KMAISEATAAFGDGSVFIEKYVTSPRHIEIQVMADKHGNVIHFFERECSIQRRHQKVVEE
APSSVLTPELRREIGMAAVNVARSCDYVGAGTVEFLLDEDLNFYFLEMNTRLQVEHPVTE
LITGVDLVQLQIEVARGEELSIEQTDIEITGHALELRVYAEDPLNEFLPSVGKLETYILP
EGEGIRVDNGFEEGMDVPIYYDPMLSKLITYGRNREEAMDKMIWAINHYKISGVQTTLSF
GKFVCEHPAFRSGNFDTHFVKNYFSGDALTATSEGEARLASLIALTQYLKDRKNLRIPNS
>OMIFANIC_01405 Glutaconyl-CoA decarboxylase subunit gamma
MSTSYKASVNGTSEFEVSIEELLRLDVISAGENTYHIIQDDQSIIATVKSGDRETKAYEI
RIGTNTYKVVLLDKVDELIREMGLTVGSGLQINSLEAPMPGLILDIQVSAGDVVKEGDAL
LILSAMKMENNILSPRDGVIRTIHIAKGDAIDKGQLLIEFEA
>OMIFANIC_01406 Phosphoenolpyruvate carboxylase
MKYTKEERFDKHVLSRYQIYNSIFMTLPFDAITKTGVLLPLFQEVCETGFNKKLNPTEIV
ESFFKKFTDNPTQEERINLLFRFIQYIERQVVLFDAIEDAAFTTVNNMDGRGTLRNSKEE
AQDRNKMVALKDYLEHFKIRPVLTAHPTQFYPGSVLGIITDLAKAIEETDLELIKKLLAQ
LGKTPFFKKQKPTPYDEAVRLIWYLENVFYHSASDIYNYIKNHIFEGEDPGNEIIQLGFW
PGGDRDGNPFVTTEITLQVAYRLRSTILKNYYRDLRAIRRRITFEGVDVLVERLEAEVYA
NISLQHGKITLNTDTIIEQLTEIKKILERDHQSLFLDMVDELINKVKLFGMHFASLDIRQ
DSRIHAAVFKAISEENPHLLPEDYDEKSDSEKIKILSTLSGNIDAESIEDETAAKTMGSI
KAMKIIQENNGESGCNRYIISNNQTAVNVMEVYAMLRLSDWDKPTADVIPLFETVDDLQA
AATVMETLYTNPEYARHVKRRGNRQCIMLGFSDGTKDGGYLMANWSIFTAKERLTEVSRK
YGICVMFFDGRGGPPARGGGKTHQFYASLGPTIEREEVQLTIQGQTISSNFGTRESCQYN
LEQLLSSGISNAVFTNEDASLSAEERDTMTRLAELSYEAYTNFKNHPKFLPYLEQMSTLK
YYAKTNIGSRPSKRGKESELVFSDLRAIPFVGSWSQLKQNVPGFYGVGYALEKFKEQGEF
EKVKSLYGRSMFFRTLLENSMMSLTKSFFPLTAYMKDDPEFGEFWSEIYREYRRSRDLLL
ELTDYDELMEDSKAMRASIAVREQIVLPLLTIQQFALRQIHSLRQKGTPDKELEVWEKIV
TRSLFGNINASRNSA
>OMIFANIC_01407 Colicin I receptor
MRNCLLIVIALFSFTLSAQQIQVLDAKDRQPLSGVAVYNENTSKNGITDLDGIVDISKFS
DEERITFQHISHLMLTLSKQEIIASGNIVVLQSDASQLAEVVVSVSKFGQQKRDIPQQIV
SVTSADVLFLNPQTAADLLESSGQVYVQKSQLGGGSPLIRGFSTNRLLITVDGVRFNTAI
FRGGNVQNVISIDPFAVDRTEVILGPGSVVYGSDAVGGVMNFYTKNPKFSFEEGIALSGR
VTGRYATANSERTGHVELNIGHKEWAFLTSVTYSDFDDLKMGKYGPDDYLRNEYVDRING
EDVIVTNPDPRVQIPTGYDQINAMQKIRFMPSTSWDFKLGLFYTTTSNYPRYDRLYRTRE
GQLRSAEWYYGPQEWMSGNLQATNKAKSAIYDESILTLSYQRFKESRNDRDFGDVILFEN
DEKVNAYSGGLDFTKKLNKATIFYGLEYVYNKVNSEGKDTNINTGISVPDISRYPDGATW
QSMAAYSSLQLKLNKDLSFQGGLRYNHILVDASFVGPFYDFPFTEANIDTGALTGSAGLA
WQASKILGWKLNFGTAFRAPNVDDIGKVFDSEPGSVVVPNPDLEAEYAYNYELGANLNFS
DVVKIELAGYITQLKDALVRRDFELDGLNEIEYQGELSNVQAIQNAAKAEVYGFEAGVEV
NFNKDLQLTSQYNITDGFEEDDEGNTNPIRHAAPQFGNSHLIWKKGKLKLDAFAEYNGQF
DFEDLAPSQQNNDFLYAKDANGNPFSPSWYTLNLGGAYEINKSLSLNAVLENITNQRYRS
YSSGITAPGTNLIVAATFIF
>OMIFANIC_01408 DNA repair protein RecO
MVVTTNAIVFSSIKYAEADLIVSCFTESSGLKSYLLRSVLKSRKGKVRASYFQPLTQLEI
TAVHRNKGTLERIREVKLIEPYKSLHTNVIKGTVVMFLAELLKTCIQEEEPNPPLFEYLQ
QSLVWLDSHDSIANFHILFLLKLSAYLGFYPDESTLDKKYFNLEEGLFEDFPGGMTSEEG
PHVEAFKGFFGIDFDALTRIKLAKTERSDVLNLILLYYKLHLQAYKNPKSLLVLNQLFN
>OMIFANIC_01409 hypothetical protein
MKQLLATLLLLVSCLSSAQNFEDEWTGYFSYVSIKAISQGNDRLFAVAENAVFSFDLSTR
EINTISSVNGLSGELISSLYYSSNFNLLVIGYENGLIDIVIDGEENILKVVDILEKPTIP
PNRKRINHFNEYNGSLYISTGFGISVYDLERLEFGDTYFIGELGTQISTSQTTISGEFIF
ASSDEGGIRRALVDNPNLINFEEWTPINLGSNWLGIQALGDQVYAMRVDDRLFEFIPGAG
FVPVTDYASQVVDFGVQGDLLTVTTVAAIEAYSEGFVLEASVTNIPGFDVVGQSGYSFNN
FFYYGTEEDGLLAIPFGTNQAEQILPDGPIDNRPYSLDAVPGELWVAFGEVDVNFNPFPL
TNKGISHLKEGSWINFDFEAALETNDIVNVAINPADPTEVFMTSYNKGLLRIVDEQPFLR
YDNTNTNLNSIDPNGTDVRLYGADFDRDGNLWVTQSREEEGLIRITPSLQFQKNDITDII
PNAATSGALGELRISREGYIFFTYDQDGLVAYNPSSGQFKLIEEGIGTGNLPDNNVRAIE
FDNQNRLWIGSLMGLRVFFNVGGLFEEGANVDAQPIIILEDGVPQELLFELTVTDIEVDG
SNNKWISTATSGVFYLSSNGQETLLRFTKSNSPLPSDNVQDIAIDPFTGVVYFATLNGLV
AYNGSSTAPRENLEDVYSYPNPVRPGFEGNVTIDGLTARANVKITDLEGNLVFEETSQGG
SVLWDTTAFGRYKVASGVYLVLITTDDALETKVHKIMIVR
>OMIFANIC_01410 NAD(P)-specific glutamate dehydrogenase
MKQSIKDFIAYVESRNPNEPEFIQAVTEVAEAVIPFIEENEKYQNKMLLERMAEPERVIM
FRVPWQDDQGNTQINKGYRVEYNSAIGPYKGGLRFHPSVNLSILKFLGFEQVFKNSLTTL
PMGGGKGGSNFDPKGKSDSEVMRFCQSFMSELQRHIGPNTDVPAGDIGVGGREIGFLFGQ
YKRLRNEFTGVLTGKGLEYGGSLIRPEATGYGTVYFAQSMLETKGQSFNGKTVAISGSGN
VAQFAAEKAMEFGGKVVTLSDSSGFIYDPDGLNKEKLAYVMDLKNVKRGRIKEYADKYPS
ATYTAGERPWGTKCDVALPCATQNELNKEEAETLVNNGCACVAEGANMPSTPDAIEVFQN
ARILYAPGKASNAGGVATSGLEMSQNSLRLSWSSEEVDNKLHGIMDNIHTACVKFGKDGD
GHVDYVKGANVAGFVKLADAMMAQGVV
>OMIFANIC_01411 hypothetical protein
MMNARSLLLVFFLLVFAKQELHSQLGFSHEIGVITGPVVFYSDFGQRNDFETNKGNIGIG
VGLIHYINFSYRADCNCYTRDVYFNDHFKIRNEIDYHVTNFEHFGQWVDPDRTSLTADQL
RAMKGKSKVFDIGTQLEYFPLSIRDFAAGGYKIAPFGSVGVHWVSFDPEVYTELEGGLNT
PITTPFPKYRDAFQQEGDSTWSIVMSVGVRYKLTELSDLMLDSRWQYYFSNWVDGLNPSE
ENNGGFPVPENKANDWIYWLNIGYIYYLD
>OMIFANIC_01412 Cystathionine beta-lyase
MKFNTKAIHGGQHDIDPAYGSVMPPIYQTSTYSQTTPGGHKGFEYSRSGNPTRAALERAF
ASIENGKHGMAFASGLSAIDAVIKLLKPGDEVISTNDLYGGTYRLFTKVFEQFGVKFHFI
GMENAAQIQSYVNDKTKLIWVETPTNPMMNIIDIKACASVAKKHNILLAVDNTFATPYLQ
RPMDLGADIVMHSATKYLGGHSDVVMGALVVNDDALAERLYFIQNASGAVCGPQDSFLVL
RGLKTLHVRMERHCENGKKIAEYLVKHPKIEKVYWPGFENHPNHDIAKNQMDDFGGMISF
VTRGNNYEKAIRIVERLKIFTLAESLGGVESLAGHPASMTHASIPKEEREKTGVVDSLIR
LSVGIEDADDLIGDLEQAIG
>OMIFANIC_01413 hypothetical protein
MFERCFFTIIVVFGILSCDKQQPMMISPLNFTEKQLPGCDTTSCPEITVNYVEITENSDR
ARQINSAINNFIIEALYLGDETSEPGAKDISDAATQFVKMYRTHSAEFPDMQLEYFVEVN
IAETYKTDDILSLEMHQYLFTGGAHGYGATFFATFDAQTGDEIGVEDLFSDFIGFKKFAE
TEFRRANKIPKGESINATGFWFENDTFYLPEAIGIRDSKLALIYNQYDIASYAAGPIELE
IPLSKLKPYLSISIQ
>OMIFANIC_01414 Regulatory protein Spx
MNTFYYLSTCDTCHRIMQALNLPNSVQLREIKGQPLSKTELMQLYKLSGSYEALFSKRAR
LYKERNLKEADLQENDFKSLLLEHYTFLKRPVLVFDGEIFIGNSKKTVEAASKAVNKD
>OMIFANIC_01415 hypothetical protein
MDKRVLALIAATAASAIYGINHTIAKGLMPDIIGSYGFILLRVGGAAICFWIISFFYQNE
KIDRKDWIRIIACAFFGMVLNMNMFFKGLELSTPINSSVVITLAPVLLLVLSAIFLKDRI
TWIKSLGIGLGLAGALTLILFGLKTQPNAPNIPLGNVLFIINATSYSFYLIFVKPLVARY
SSITLMKLLFLFAFVMNLPIGIEQFSEVAWSSHDFDIIWKLAFVVIGTTVLTYLFNIYAL
KQLSPSTIGAFIYLQPVIAGIFAILTGADTLTPLRALAAALIFTGVFLSTRKTKVKASN
>OMIFANIC_01416 hypothetical protein
MYLKEFEIRWNDLDANRHLANSSYVNYMSHTRMSALIDHGINQSTLAKYNIGPVVFHEHI
YYFKESVHGKIKVSFELGGASEDGMFFKFIHNFYNDKGENLASCDMQGGWMDLKTRKLIA
LPNELLSKMHHMPKSSNFIVLEKKDMRSTRNRPANLKL
>OMIFANIC_01417 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MKKILPKIIGGILNILTPIFPKYTSDFTFNLLSRIKRVPVSEEGQLFFSTGDTTWLQVAG
FKTALHRWGTGSKKILFLHGWMSNSQRWRTYIQALDPSEYTCYSLDAPAHGTSDGNYFNL
EIYRQAYKASLDITGPIDVLVSHSMGNLTAGYQFLSDRSVGVASYVVMGSPSGIEIVFDY
AEETLGLSKRMLKNLKIKTDRVLKVPNRELTMSNFFQHMDKPVFVIHEESDDVTPIAPMK
AAVSGCDQIKTLYTSGLDHTLKGPEVLKAVTNFISEQTKDSNYVLERI
>OMIFANIC_01418 HTH-type transcriptional repressor KstR2
MRDAKATKNTIIKESANLFNTQGYKATSISDITRATGFTKGAIYRHFDSKQDLEQHALRR
LSKLMFEEMSVSIKQAKTFQAKFEAIFSFFENYMNAPLYEGGCPLMNAAVESDDTNPILR
QQAYNMLAQLKASLAKLIKNGIKNKQVRPDVNISYYSTVFIATLEGGIMMSKLERNKKAI
SHTIDHLRGLVDELSI
>OMIFANIC_01419 Putative aminoacrylate hydrolase RutD
MCTTHIEWPNDHIYYEMPIVSSSYQPRGAFRNTHFSTIYSAKIRSIPKLVQSRERLELPD
SDFLDLDFSFAHQATANIAVLLHGLEGNAQRTYIKGQGKVLVENGWDVCAVNYRGCSGEP
NRQYKSYNAGKTDDLEEIIQYLRNKDKYRNIALIGFSLGGNLLLKYLGERTDVPKEISYA
VAVSSPLSLKGSLEALTQFHNWVYRTSFLYHLRKKYMRKVKRYPDLASSSEAKKIKSLLA
FDNIYTAPAHGFKDAFEYYKKNSCLQFLPHVEIPTLILNAGNDSFLSPHCYPRELASKLK
NLYLEIPQYGGHVGFYQPKNTYYNETRALKFLQEQF
>OMIFANIC_01420 Azurin
MKILRFTLFLLAFGITFGCGGEKQKKEEKEEIKIGSNKEKSSEESNAVSIGLSGNDLMKF
DKSEIKVKSGQEVTLTLRHIGKMDIKVMGHNFVLLKPGVSITEFSVKASDAGETSDWIPE
DGKDVIVHTKMIGGGQSTSVTFMAPEVGTYDFICSFPGHSALMKGKFIVE
>OMIFANIC_01421 Hydroxypyruvate isomerase
MKRRQFIKQGALAGSLFSFGGSVVASNLLSEVSTHKQKFNLKYAPHIGMFKNHAGADVVS
QLEFMADQGFVAFEDNEMRNRPLNEQKRMAAAMQRLGIQMGVFVAHTIYWKEPNLASGRK
DWRDEFLAEIEESVEVAQRVDAKWMTVVPGHVDLRLNLNYQMANVIETLKQASAILEPHG
LTMVLEPLNFRDHPGLFLTESPQAFEICKAVDSPSCKILFDIYHQQIQEGNLLPNIEACW
DEIGYFQIGDNPGRKEPTTGEINYKNIFSFIHKRGYAGILGMEHGNSVDGKDGEQRVINA
YREVDNFLK
>OMIFANIC_01422 hypothetical protein
MDRRQALRNLGLGAGAMVATPTVIGLLQSCKSEPKDTYVLQFLSEGEFHALTQMVDLIIP
SDEAIPGALDVGVHKFIDAFWANVTPKTQGEVWEERYEPIQENIKSFFKMFTDEFRNKFK
KELGDGEPEEFDEMLATYLKIPKEEQIEIDISMEDFYEAFAADATTQPDKEAAIFSLIAG
IRSMTIWAWKTSEQIGKNVLWYDPIPGKQLGCIPLDEAGNGNDMAL
>OMIFANIC_01423 Fructose dehydrogenase large subunit
MINPNEMYDAIVVGSGISGGWAAKELCENGIKTLVLERGRMVEHVKDYHTMNMDPWEFEY
KGELPKEERDKQLKQARSGYTTEEAHRHFFVNDLEHPYNETKRFDWLRGYHVGGRSLVWG
RQSYRLSDIDFEANKKEGIAIDWPVRYKDISPWYDKVEEFIGVSGENLGLPQLPDGKFCP
PMELNCAETDLKDKIATNYDDGRVLTIGRTAHITGTQPFYGRANCQFRNRCMRGCPYGGY
FSSNSSTLPAAERTGNLTIRPHSIVAEVIYDKASGKATGVRVIDAETKEEIVFNAKVIFL
CASAIASASILMQSKSDRFPNGMGNDSGELGHNIMDHHFKAGAYANVPGFEDKYYKGRRP
NGIYVPRFRNLGGKTDQKNFKRGYGYQGGARRSHYEEMVAELAYGKNLKESVVKPGKWRM
LLLGFGECLPYHDNKMTLDYNNLDQWGLPTVTFDAEWKENEYEMRKDMVQQAIDMLTKAG
YTDIEPWDDPGAPGLGIHEMGTARMGKDPKTSVCNGNNQLHAVPNVYVTDGAFMTSASCV
NPSLSYMAFSARAANHAAQQLKKEA
>OMIFANIC_01424 hypothetical protein
MNKSILFLLLFSVVLACKEKEPKDEVPESALETTSEKDMAYEPKLSLAQWSLHVRYEAQD
ANPFNFAKDAKELGFDTVEFVTQLYTKQIQELGFQAVIDSLKNENERHGVSCNLIMVDDE
GDLADPDEAARNIAVENHKKWVDAAVELGGHSIRVNTFGSNDPEVWSRTVVDGLKKLSEY
AATKNISVLCENHGWLSSDADKLMAAIAEVNMPNCGTLPDFGNWCVKRAKGERWGECVEE
YPDYYKGIELMMPAAKAVSAKANRFDENGDETRIDYYKMLQIVKNAGYTGYIGIEFESEK
INEPTGIRATRDLIIKAAKKAN
>OMIFANIC_01425 Putative nucleoside transporter YegT
MKALTYVRLSFMMFLEFFIWGGWFVTMGTFLLQTLNASGGDTAMAYSTQSWGAIVAPFII
GLIADRYFNAERILGVLHLVGAFLMYQLSQASSFEGFYPYVLGYMIAYMPTLALVNSVSF
NQMKDPSKFFPFVRVWGTVGWIAAGWIISLFAWDSVAGVADGLLSKTFLMTAIASAILGV
YSFTLPKTPPQAKGEKASIYNILGLDALKLLKDRNFLIFFLSSVLICIPLAFYYQNLSPY
LVESGIENSTLKASFGQISEVGFMLLLPFFFKRFGFKMTIIVGMLAWAVRYLLFAYGDAG
ELAFMIIIGILLHGICYDFFFVSGQIYTDSKAGEKIKSAAQGLITLATYGVGMLIGFYVA
GKITDANLLADGGHVWKSIWTFPAIFAGAVLLLFALLFKNEKIEYKA
>OMIFANIC_01426 Glucose-6-phosphate 3-dehydrogenase
MSKKLRWGVLGGGGESLIGVLHRVAASMFDSYQLTGAVFNPVYEKNLAFAEEIGIPTNRI
YLDFDTMVEAELALPKEERIEVFSVLTPNYLHFPMAKKLLESGFHVICEKPMTMSYAEAL
ELEEIRNKNNNIFALTHTYTGYPMVRQMKKMIAGGAIGKVQKVDAQYYQGWINPIIHDPK
LRATTWRLDPEKSGISCCMGDIGVHAYQMLEYMTGMDIQSVLADLNYLYEDNKMDIDGTV
LLRLGDQVKGVLRASQIATAEENNFSVAVFGREGTLKWEQENPNYLYLLKEGKPIQTLKP
GNSYNSELSLDGTKLPPGHPEGIFDAMGNIYKGVAKAIRGHAFDKAEFPGMRDGVRGMKF
IETVVASHLEGNVWKSI
>OMIFANIC_01427 DNA gyrase subunit A
MTEDEHNEEELNGQPGEEQLTTEGDTAETITRVTGMYRDWFLDYASYVILERAVPAIEDG
FKPVQRRIMHSMKDLDDGRYNKVANIVGHTMQYHPHGDASIADAMVQIGQKDLLIDTQGN
WGNILTGDRAAASRYIEARLSKFALDVVYNPKITEWQASYDGRRKEPINLPVMFPMLLAQ
GAEGIAVGLSTKILPHNFIELIDASVKHLQGKRFQVVPDFPTGGIMDATNYNEGIRGGKI
RSRARINQEDKNTLVITEIPFGTTTTSLIDSILKANDKGKIKIKKIEDNTAAEVEILIHI
PSGISPDKTIDALYAFTNCETSISPLGCVIEDNKPLFIGVNEMLRRSTDRTVELLKSELE
IRLGELEEQWHFASLERIFIENRIYRDIEEEETWEGVIKAIDKGLKPHVKHLKRAITEED
IVRLTEIRIKRISKFDIDKAQQKIDSLEDSIAEVKHNLNNLIDYSIAYFKRLKKEYGKGK
ERKTEIRVFDDIEATKVVIRNTKLYVNREEGFVGTSMRRDEYVTDCSDIDDIIVFTREGK
MMVTKVDSKTFIGKGIIHVAVFKKKDKRTIYNMIYKDGTRGATYVKRFAVTSITRDKEYD
LSAGSKGSKVIYFTANPNGEAEVVTIMLRQSGSIKKLKWDLDFADILVKGRASKGNIVTK
YSVKRVELKEKGLSTLKPRKIWFDDTVQRLNVDGRGELLGEFTSEDRLLIVRQNGTIKTA
IPEVTLRFDDDMNILEKWEPKKPLSAIYWDGDKELFYVKRFLIENPDRDEQIISGHPKSY
LEKLFTDHRPMAEVVFVKERGKDRRQNMEVNLEEFIAIKGITAMGNQLTKDKVLEINALE
PLPYDAPKPIPAEEMDVIDEEAVTSDTSKVKDKKSNPSGKDNPAGDADGEGQTTLF
>OMIFANIC_01428 DNA topoisomerase 4 subunit B
MAQTQYTEENIRSLDWKEHIRMRPGMYIGKLGDGSSPDDGIYILLKEVIDNCIDEFVMGA
GKTIEIRIKDKEVRVRDYGRGIPLGKVVDVVSKMNTGGKYDTRAFKKSVGLNGVGTKAVN
ALSAFFRVESVRDGKMKTAEFELGELKVDSKIEASAKRKGTKVIFIPDEGIFKHYKYRNE
YVAKMLKNYVYLNPGLTIDFNGEKFHSDNGLKDLLEDNMAVEDMLYPIVHLKGDDIEVAI
THHKTQYSEEYHSFVNGQNTTQGGTHQAAFRESIVKTIREFYGKNYDASDVRKSIVAAIS
IKVMEPVFESQTKTKLGSTEMGGDLPTVRTYINDFVKTQLDNYLHKNPEVAEKIQRKIMM
AEKERKELSGIRKLARERAKKASLHNKKLRDCRVHLGDMKKEARLETTLFITEGDSASGS
ITKSRNVNTQAVFSLRGKPLNSYGMSKKVVYENEEFNLLQAALNIEESIEDLRYNNIVIA
TDADVDGMHIRLLLITFFLQFFPELIKEGHLYILQTPLFRVRNKKETIYCYSEEERVNAI
EKLKPKPEITRFKGLGEISPDEFQHFIGDDMRLDPVMLDKAMSIEELLKFYMGKNTPDRQ
EFIINNLKVELDKVED
>OMIFANIC_01429 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNIGVVNVPDNRLVKLEELVEPER
VLPATVEIVDIAGLVKGASKGEGLGNQFLGNIRETDAILHVLRCFDNENVVHVDGSVDPV
RDKETIDIELQLKDLETTEKRTDKVARAAKTGDKEAQKELAALTKVKEGLETGISVRAIE
LNEAEREEYINRMQYITDKPVMYICNVDEAAAVSGNDYVEKVKAAVVGENAEVLVLAVGT
EADITELDTFEERQMFLEDLGLDEPGSAKLIRGAYKLLDLQTYFTAGPKEVRAWTIPVGA
TAPQAAGVIHTDFEKGFIRAEVIKYDDYVTYGSEAKVREAGKLGIEGKEYVVQDGDVMHF
RFNV
>OMIFANIC_01430 hypothetical protein
MKKTILFACAFLVASFAVNAQEDSDVLAANSSKKAVVQKAASSTSPTMDEKSGVSQDQPA
NDMKKVLAEREAKGAKIRAAKKAEAKARQEQAASGKKKVVTQEMLRAEEIEKAKKATKKD
GN
>OMIFANIC_01431 hypothetical protein
MKTITLFGLLLLLVTGMGLAQENKTIKEETTVKRVVKKEGSTVIVQEVEATTSEKGAVIV
ADDEQENQVFSEKTKLEDKEKMVVDETEIDAQNEAMIQSNKLQKEKELQESIEAAKAKAE
KQRKILAEQEAARLKALEENRKKLERRGKGVRKLSKKKKGN
>OMIFANIC_01432 Multifunctional-autoprocessing repeats-in-toxin
MRLLKKVLLFIVATIVIVLMGAYLLQEKFIFLPSKLPQEYVYEFDHDFEELFIETEDGAR
LNALHFKQENPRGIIVYYHGNAGDLSRWGEITSYFLQYNYEVLVMDYRTYGKSTGKISEK
ALYSDAQLFYNKAKELFPEGKIVVYGRSIGTPIAAYVASKNDPKKLILETPFYDFKKLVK
DKFPLVPLGLLKYEFPTAHFADDVKCRIVIIHGTDDGIIPFEMGMQLYSVLPEEERNFIT
VKGGKHNDLITFQEYRLTIYKELL
>OMIFANIC_01433 Multifunctional-autoprocessing repeats-in-toxin
MPVWLHILIWVAVIYIAISIALYYLQDYFLFKPEKLPKDFQFYYEHQKVEEYNIETRDGA
VINGLHFMTDNPRGVVLYLKGNSKSIKGWGKYAVDFTRHGFDVIMVDYRGFGKSIGKRSQ
KAIKHDIQYIYNKIRERVPEKYIILYGRSLGCGFATKLASMNNPRMLVLDAPYYSLTKVT
GRYMPFMPLSVILKYPMPTYKWLKYVKCPIRIIHGTNDKLIPFKSSVKLSKINPERTRLY
PVIGGGHKNLNNFESYHKMLGEIINFVEQKIDLETTSLGVKHSVKK
>OMIFANIC_01434 hypothetical protein
MKTTHFLKVFLLLIVLVAVTSCAPDGVNDKVYGFFYGVWHGICLPFAVIGKIFKMDVGIY
AINNTGAWYWIGYLIGFLIIGGTVAAKKRR
>OMIFANIC_01435 hypothetical protein
MSTECSNILEAALAQPNFSGMLKKGSIEKELVTDLQRILFELGFKKELKCDQYNADGDYG
NVYAREALFKEQKDKDNQ
>OMIFANIC_01436 hypothetical protein
MKRILENALSLIGLFLIAVYVINATEIISLPVEFVRIPMFLLGPIAIIGVTSLEKITDQK
RNLLKFKLLDIIF
>OMIFANIC_01437 hypothetical protein
MLVVQQAGSEIFDSLKENDNANVTFKLTNSVHKGMDIAFDIFYSLGILFYSLSFLKLKKL
GFIIGLVGVASSLGLLVLNLIAFPNPPKSAGLMDLGPITIIWWVLIFTYTNRKKQA
>OMIFANIC_01438 hypothetical protein
MNSLNNKISFLIILLLSSIPSLIGPIANIGQWGGPNSPYLSQILTGIPTMIVGTWTGYKF
IFLKGTNKRVESYNSAISKSLIIFLFTLLACLVSWSVCQEILLVLQKAFGMAEARGHGWF
DGLIGLPIILIFSFIPCLIAAIVNGFVSLLIFKMKKTSYNNM
>OMIFANIC_01439 hypothetical protein
MFINDLRTNQINRVTILSYVRLTNLYSIENNYL
>OMIFANIC_01440 Putative penicillin-binding protein PbpX
MKYKLILLTISICLSNISWAQSSENEITAYLEKVINEYNIPSISAGILVDGKIIWSGAVG
FSNKEKQVEASTETLYRIGSISKVLTTALVLKLVELDKLDLQSPIQEYLPDYPIDKKGPI
KVIHLLSHTSGIDHYKGKETRSFTHYNNLRDATRLFETRKLKFQPGTKYRYTSYGYTLLG
AVIEAATGKSYATNLKELILDKGGMNNTHIEDRFEMKLNQAKLYKKKGNDIILDVDNDLS
NIYPAGGLISTATDLLVFFEAWRSGKLITNKNIQKMVDAIESDGQILDENAGLGWNIWKH
NKHGWVCHRIGGQSGTSALLISYREKGVTVALLSNQAVLEPIWEITNTLIGFGLDRK
>OMIFANIC_01441 hypothetical protein
MELLKIATEWAKAEVFSTRFFIFFAILFLIASIGFWQLGKTGLAKAYIIPTLLAGLLLMT
IGLGLFFTNKSRITQFEKAFKADSLAFYQSEIERSESTLKEYTVVFKVIPVLIIVAALLI
LFLNSPTWRAISITTIAMLIVILLVDGTAHSRIEAYHKELKLVDMKK
>OMIFANIC_01442 hypothetical protein
MIKFFRRIRYDLMSKNKTGRYLKYAIGEIVLVMFGILLALQVNEWNKERNRKKAEQVVIE
QLITDLSKSQYELENIIARDFREARIRAQVLRAFWKDELPDDIENYVWGGAGSRVYSPVL
GTAQSLINSGRLDILSSKELKNNIVAYVEIVGYKLKDINRYEESYFRTGVELLREVMPGP
HESKDYFNARSEAYKNSYQYRENLNWRPAVIDKVPFQSDLEQLFENEKFSSAYSKLYLYH
RNTGWKYEDILDVTNKLLVALYKASNKYQNLGEQLENSEHYLVFDAADLEILQRVDGLLS
TPSKWNKNDDGECDDDSANNSYSLYCALVKASEEVVGSYEDEPNRPAIRMVRFTLNKYQD
RRVIGNTVEDWNNHPDTTFEELKKVLKESIDEVKKQL
>OMIFANIC_01443 Alkaline phosphatase 4
MKSWKKTSLLTTLIILVLLSSVYYIFNMSVSVPSSDIEFSPGQVEGKLNGVYEGQKPKNI
IVFIADGMGFSHLSLALQTQQTENTPSVWQAFDVKGWHDPRSLIGPLTDSEASATAMATG
VSTNFGHIGMSNEGETLENIFEMAWAMNYATGIVTDSYVWDGTPAAFTVHTRNEDDARDI
LTQLANSDLDLLFGELEDVGEDEVPEVEETIAILEKRFQLLDASLKLPTGDAVTSPVAVL
FEEDEIQDLDSEPNLPELTETALEYLTNQGKAFLLLVECEEMDSASHTNNTDRVVKGLQS
LQKTLAMLQEFVEKNGETLLIFTSDHETGGLATLSDYNNYPNMQVRWSTNEHSAAVVPLF
AKGPGAHCFADVHRNWQIGDCLIELISQNTPGL
>OMIFANIC_01444 hypothetical protein
MSHTTYIKSGKLFDSENVFKPVPISSLRLKAYQGKYRLSHKMVIAVTKNGKYLKAKADSD
EYPFLPKSSTVFQGHNVNPQPTYN
>OMIFANIC_01445 Small-conductance mechanosensitive channel
MKTDLGNAFGELYSTFTAMLPNIIVGLVVIILFIIMGKLFHRFIGRRIQRRWEDSIISNF
VSEAAKWSFYIFGFIIALNIVGFGGVAGSLVAGAGIGAIVIGFAFKDIGENFLSGIILAI
KRPFEIGDIIEVDGYKGKVEDLDLRLTHLRNFEGKDIYIPNATIIKNTLINFTRDGFLRI
NFSLGIAPECSIDTTRILIMDYFGTNTQVLKKPAPYVLVEELGEFTIDLQVLFWVNIMNK
NKLPDSYMGHTIRSKVIADIKSVLDSNGIEMPSQVLEHKMYRDHTLKVNKES
>OMIFANIC_01446 Inosine-5'-monophosphate dehydrogenase
MTTSVITVKGNTSVGEIRALMSREGFHALPIVKTMPNGDVTIRGIITATDLCKIMDDILT
AEQILKPGRVHVIPPNTNAQSAAKNMLKHKIHHLVVMEDGKIIGMVSSQDFVTLVANYAL
DTKTDTVI
>OMIFANIC_01447 NADH-dependent phenylglyoxylate dehydrogenase subunit gamma
MTQEIIIAGFGGQGVLSMGKILAYAGMLQGEEVCWMPSYGPEMRGGTANVTVILSDDRIS
SPYLKVYDTAIILNQQSMDKFESAVKPGGVLVYDPNGITHHPTRSDIDIYQVDGYRLASE
MGNKKVFNMILLGGFLKIKPVVKIENVLKGLKESLPERYHHLLPLNEEAINKGMQSIFAY
DVEKQLVLEHA
>OMIFANIC_01448 2-oxoglutarate oxidoreductase subunit KorB
MEVLDIIRPENQVFCKTGLMTDATLTYCPGCGHGTAHNITMEVIDEMGVVEDTIGVAPVG
CSVFAYDFMAVDMTQAAHGRAPAVATGIARTWPDKYVFTYQGDGDLAAIGTAETIHCCNR
GENIVIIFVNNGIYGMTGGQMAPTTLPGMKTSTSPYGREIETMGSPIKMSELIANLPGTY
YVTRQSVHTHKHVRKAKKAIRKAFENTRLKKGLSFVEIVSNCNSGWKMTPNESNIWMEEH
MFPYYPLGDIKVNGKLKQVA
>OMIFANIC_01449 2-oxoglutarate oxidoreductase subunit KorA
MSELRLMKGNEALAEAAIRAGADAYFGYPITPQSEVIEYLMDQRPEKRTGMVVLQAESEI
AAINMVYGAASSGKRVMTSSSSPGISLKMEGISYLAGAELPAVIVNVVRGGPGLGTIQPS
QADYNQAVKGGGHGDYRMYVLAPASVQEMSDFVSDAFDIAFKYRTPVMILSDGLIGQMME
KVVLKDERKRLTDAEIDEKYGSWATTGRKGRERNIITSLYLEAERMEQRVRKLMNKYQRM
EEEDLRYEMIHCDDAEYLFVAYGSSARIAQKAVELGREKGIKVGLLRPITLFPFPKKQLF
ELADQVKGVLSVEMNAGQMVDDVRLAVEHKVPVEHFGRTGGIIHTPEEILEALEQKIVKD
GSIRHHTTREPSLL
>OMIFANIC_01450 NAD(P)H-quinone oxidoreductase subunit I, chloroplastic
MAKVRGAIVVDTEACKGCEVCIPVCGEDVISMSAEVNRKGYHYAYMSNPEACTGCINCAL
VCPDRAIAVYRVKVEA
>OMIFANIC_01451 hypothetical protein
MIEIEEFIDKCPVQTDLTDSDLFRKIENLSQNFKEETLHKLDLQLSASPLATFNAVLAIK
LGKSKFALRHVKKDVHITFLFAIYKEIERMSFPHETPLGEDCINEKIRQIEWLVSDSPNV
TWDLLIVDDGCPEKSGIKAQEIANNSVYRDRIKVLFLQDAIDSKSPLAGGLKDASDSQKG
GSILYGLRYAASLKRKNNIVLYTDADLSSHLGMSGLLVEAIVNEHKSLAIGSRREKTCFT
QRSEFRNNRGKLFIYLRRRLLHPINYISDEQCGFKAFDARFLDSFLKNVIETKFSFDVEL
LLRTELKRPNSIAQIPIAWMDSDEASTTKDLEPYVPMLNRMVDFYEYYLPSNPEAEDFKT
FIQELTDDSWDRLIHNIPDVIKSWDPVEDIQFNEVSTVQLRMCMK
>OMIFANIC_01452 hypothetical protein
MMDHAKIIRELSRNRNVFKELLTGLKQEEYLWKSQPEKWCLLEVICHLHDEEREDFRTRT
RLVLENPETPLPPIDPVGWVQERKYIEQDFENMLGNFLKEREMSVVWLKSLTSPKWDNAY
QHPKFGPMTAKLYLSNWLAHDYMHIRQINRIRFEYLQQWTGEPLTYAGNW
>OMIFANIC_01453 hypothetical protein
MALGKRLLYIFSFIIFLLLIPFIAMQFSDQVNWTASDFLIMGFLLLGFGLLIDLVLRKVK
TKSSRAYLVIGIVVLFLLVWAELAVGIFGTPFGGS
>OMIFANIC_01454 hypothetical protein
MKSPSIYTSQREKRLWIWVVVVFVAIYSGLFLGQPLAKLFSNQQIGIFIFIAGMALVGAT
IILHAFRTRPGKTELTVLLGIIAVYVLFFLRLGLPERSHLMEYSVLAIFVHKAITERANN
GKRIPNPAIVAFLITLLIGVVDECIQLVLPYRVFDMLDIVFNGIAIAMAIGSAILLSRVR
K
>OMIFANIC_01455 hypothetical protein
MKKAGIWIDSKKAMIIEPGAPYIKTIESGIESRERFEGESEQEGRFGTQFLTNEKVKKNR
QQHQVKRFMQSIIDEANDLDSVVLFGPSQMKVKLAKELENLPGNTIDVAGVEAAQKLSNN
QLIAWVKDYFKMPDR
>OMIFANIC_01456 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWRYADGTDLSGDVVLPNGKAVNADETQEPV
SDELYYIVADKCTECKGFHEEPQCAAVCPVDCCVPDEDNVESEETLLAKQSFMHRD
>OMIFANIC_01457 hypothetical protein
MQLQQRINAFIELGKFMSSEAAGMDEVIVSASMHNSWFTNDNISFALKSWSQSLSEINLK
KWLATYEVPQKGPKTVAIVMAGNIPLVGFHDFLSVLITGNNVLAKLSSNDTILLPFLAKK
LIELEPGFADRIEFTEERLSHFDAVIATGSNNTARYFDYYFGKYPNIIRRNRNSVAVLTG
TETPSQLKALADDIFRYFGLGCRNVSKIFLPKEYNFDPFFNAMFSWKDIINNNKYINNYD
YNKAVYLMSDIPLLDNEFMLLKEDTAFSSPISVVFYEYYNSLDTLADYLSENKEHVQAII
SDAELPGAIPFGQAQSPRLWDYADGVDTVSFLLALK
>OMIFANIC_01458 Phosphoserine aminotransferase
MKKHNFSPGPCILPQSVFEKASRAVLDYHGIGLSILEMSHRSKEFVDVMEQARELALEHL
GLQNKGYKALFLQGGASTEFLMVAYNLLENKAAYLNTGTWSNKAIKEAKLFGEVVEVASS
KDANFNYIPKDYSIPSDADYFHCTSNNTIFGTQLQSIPNTEVPIVCDMSSDIFSREMDFS
KFSLIYAGAQKNMGPAGATLVVIKEDILGKVSRVIPSMMDYKVHLGKDSMFNTPPVFSVY
VSLLTLEWLKELGGIPAIEKINNAKAELLYNEIDRNPLFKGFAAQIEDRSPMNATFSLTD
ESAKDRFDTLWNGAGINGLNGHRSVGGYRASMYNALTLDSVQVLVDVMQEAERTA
>OMIFANIC_01459 Hydroxypyruvate reductase
MKVLANDGISQSGINALEAAGFEVITTKVAQEQLENYINEHQIDVLLVRSATTARKELID
ACPSIKVIGRGGVGMDNIDVEYAREKGLHVINTPAASSASVAELVFAHLFGGVRFLYDAN
RNMPLEGDSKFKDLKKAYAGGRELRGKTIGIIGFGRIGQEVAKIAIGCGMNVKASDMYVE
EAAIKLDFFDGQKLTFNIKSEPISEVLKQSDFVTLHVPAQKEYVIGKAEMNLMKDGAALI
NAARGGVIDEEALLETLEEGKLSFAALDTFETEPTPAIKVLMNTSVSLSPHIGAATKEAQ
DRIGTELASQIIDILKPA
>OMIFANIC_01460 hypothetical protein
MAGILDLLKSDLGKQLISGASQETKQPEDKTAQVVQMALPLLMGAMKRNASNPQGAAGLM
GALDKKHDGSLLDNLGGFFEGGVSEEQKIDSLGILGHVLGGSQDNVVGALSQKSGMDSNS
VMQILQVAAPILLGFLGKEKKQQNVSSPGGIEGLLGGMLGGGRKQQRKQQSMIESLLDGD
GDGSIVDDIAGMVLSGNKKKGGLLGSLFGR
>OMIFANIC_01461 hypothetical protein
MKYLLAIFGFMLMIYGCESGKSAMSDTSTSAENTMDTIRIANDSLEYEILIMDLGFNNWL
VTQPPEGYYSQTFLENRNRLFVTEYNRRVQNFQLYDRNLYWQEINYDFNIDYGYEVNYLL
YNYFMFFQERYRQSFVGGRQGPKQ
>OMIFANIC_01462 hypothetical protein
MKKLKERWNIESDWRLFVIFLVFAVIGSTSAKFAGPVMDSFGLFKDTTDWYIYWPVRIVL
IFPIYQVLLVVFGWIYGEYEFFWNFEKKMLRLIGLGFLLK
>OMIFANIC_01463 hypothetical protein
MIFTKDIQKSVSSLLLVLALLFPAGVQMAHTLEGHDHPTCTEYNTHIHEKQLDCSLCDFQ
ISVFDFNPDFSEYLVTSIENFKSEIGRVELNSSSHTGFISLRGPPYLV
>OMIFANIC_01464 putative TonB-dependent receptor
MKFIKIVLLLVVTTYTAKSQNSINGSITSETLGEGLPAAIYFPQLEIGTLADLQGNYTID
NIPSGTYAIVYSFLGYASISEKISFSEATPDITRNVVMKESAVEMDEIIIATPFHKLQGE
NVMKVERVSVKELTNAGATTLSQGITNIAGVESITTGIGIGKPVIRGLSANRVLTYAQGV
RLENQQFGDEHGLGLNAAGISSVEVIKGPASLLYGSDALGGVLYFNPEPFANSGSTNADG
GATYFSNTQGYSFNAGAQTSGEKLKFLARVAHAAHSDYEAGNGMRITNTRFNETDLKTGL
RYQGIKLKSTLRYNYNRANIGIPEEIGEQTTEKTPVEPFQEIDNHILSLENNFFFNNSSL
DVKLGYIFNDRREFEDHEEGETEEGETEEGETEEGPALHLKLNTLNYDIKYNLPDLGKLE
TIVGVQGMFQKNENFGEEILIPDARVNDFGILATTHYHLDKVGIQAGLRYDVRNLESDAS
GSPTDDDFIQALDRNFNSFNAALGAKFDLTEKLVGRVNLASGFRAPNLAELTSNGVHEGT
NRFEIGNPLLDNEQNYQIDISMEYGNQHVEIFANGFYNIVNDYIFIEPTGAQIDGNFVYN
YIQSDSDLFGGEFGLHLHPHPLDWIHLESNYQLVVGELDTGEDLPFIPANSLRNTLNIEF
GKNKVLKQAAAFVTLLNVWDQNSISSFETRTGGYSLVNAGVNGSVNLKSVDLDFSVAVTN
LFDKEYVSHLSRLKVDGVPNIGRNISVSLSAGL
>OMIFANIC_01465 hypothetical protein
MKKIKYKLLRQGILYDAIGMTTAFIPGIGPFLDIFWAPYAAKKMSDMYQGNTGKIAAVIV
FLEEILPFTDFIPTFTLMWIYTYVLSPAPKPVVQTIEVEVNE
>OMIFANIC_01466 GTP cyclohydrolase 1
MGSYKRYEEYDKPVTAELQGHFEEILRGVGEDVDREGIVKTPERAAKAIQFLTSGYNMDP
AKILESAMFDEEYHDMIVVKNIELYSLCEHHILPFFGKAHVAYIPDGRIVGLSKIPRVVD
VFARRLQVQERLTHNILECINDTVKPKGVAVVIEAAHMCMMMRGVEKQNSLTTTSGFRGQ
FEKIETRSEFMRLIGTDLA
>OMIFANIC_01467 Peptide methionine sulfoxide reductase MsrA 3
MEEKREIIVLAAGCFWCTEAVFQRFEGIIEVKSGYTGGHIKNPAYREVCSGRTGHAEGVQ
LTFDPEKISFKTILEVFFATHDPTTLNRQGNDVGSQYRSGIFYSSEDQRQESEDFIEFLE
KERIFNDKIVTEITPLDVFYEAEVNHQEYYNLNKNQPYCQFIITPKIDKIKKFYSDKLKA
NGVL
>OMIFANIC_01468 hypothetical protein
MQATRIESPPKIDGILDDTVWQSLPAYGDFNMYEPGNEGKVDPTYNTEVKMAYDNTAVYV
AAYMMDPDPDNILSQFSQRDEVFVQSDRFSIALNTYNDGINETHFFITSAGTIGDARAER
NRFDFGYNVVFEGRVSRDKKGWYAEFKIPYNALRFPERDIQDWGVNFYRRINRINETHTW
NLIDITTGSESQYSGNVTGVSNINPPVRLTFFPFAQSQVTDFDGETESDFSAGMDVKYGL
SDSFTLDATLIPDFGQVAFDEVRLNLGPFEQTFSENRQFFTEGVELFNKGEIFFSRRIGN
EPSGPLEELGENEEYTEYPSKVNLLNALKVSGRTRKKLGVGVLNAITERTYANVVDTISG
VGRKLLVEPLANYNIFVVDQQFNDNSSVSIINSNVTREGSFRDSNVTGLVFDIADKGNNF
RASGRGIMSNVNEIAERTTGIRTEFDFFRIKGKFRYRFGHDFADTELDINDLGLNFRNNF
NNFTVGASYQIFEPTKSFNEYRFSFTARHRRLYRPSVQTRNSIDVNWFFLTTERFAFGGF
LGFNGDEDDYFEPRVDGRFVTFSSNLGGRIWCSSDFRKKFAYDLGIGQRTWFDDPQVAWF
FDIEPRYRFSDKFLVVLSTDISLREDQFGYIDDNGTDVFMGQRDITNIENVITASYNFDP
YKAIDLRFRNFWSSADYSDDIFFILNDDGTRTQIDYDTTENDPNRNFNIWNLDLSFRWRF
APGSEATLLYRNQIFNLDELATLNYRESLDNLFSQPQQNTVSLRITYFIDYNNVKGLFKK
SS
>OMIFANIC_01469 Lipoprotein-releasing system ATP-binding protein LolD
MIEAKNIHKYYDELHVLKGVDITIDKGEIVSIVGASGAGKTTLLQILGTLDKANEGELLI
NDTEVLSLKRKELAKFRNSTLGFIFQFHQLLPEFTALENVCIPAFIKRTPKHEAVKRAKE
LLEFLGLKDREHHKPNELSGGEQQRVAVARALINNPQIILADEPSGNLDTESAENLHNLF
FKLRDEFGQTFVIVTHNEELAAMADRKFVMQDGKIIS
>OMIFANIC_01470 hypothetical protein
MIRAELKEFLDEKAAFYDDVSFIETDPIQIPHLFTKKEDIEIAAFLTATIAWGNRKSIIN
SATRLMELMDHSPYEFILDYDDTTSERFSGFVHRTFNETDVCYFMRSLQNIYNKHGGLEA
VFNRFARTDSLQPAIHEFKNVFFQLPHETRTEKHISDPMKNSAAKRINMFLRWMVRNNGS
GVDFGIWKSLSPSQLSCPLDVHSGTVARKLKLLKRKQNDGKALAELDAQLRKLDPRDPVK
YDFALFGLGIFEKF
>OMIFANIC_01471 hypothetical protein
MKFKITLVLLSALILSSCSPDNEDYTSSETANNIIVIGGATTTDLTNQSFQTELMAGQNI
YAGIVNVDIKDGVVVVSYSSDTEWEITETHLYIGALNLLPTTGNGNPMIGQFPYADTHPV
GTINVEIVGPTISEGDCVYIAAHAVVVNSDTGDDETAWGAGEPIGGTSWAMMFEYCY
>OMIFANIC_01472 Phytochrome-like protein cph1
MITPTIPANEKERLKALRSYDILHSGKEEAYDQLTELAAHITNMPVSLISLVDKDEVWFK
SAHGLNITSSSRDLSFCSHAVGQKNHMLVLEDIKNHPEFSDHPYANDSNKPIQFYAGVCL
LDDEGHALGTLCVIDNKPNTISDRQIEALQVLAKQVVKLIELNKRNKELHEIQDELKEKN
EDLRQFAGRVSHDMKMPLANMIVTADLLKAKYAGEMNEEATKYLNYLKDSSFSLSDYITG
MLAHYESDRIAENSYEDFDLDHLLEEIVELLNIDHQCEINFPEIDFELNCNRAALGQIFL
NLIGNSLKYNDKDTIIIKIACERTEGMYHFSVSDNGMGIPDDKVDDIFDLFTTVGNLDRR
GRKGNGIGLSTVKKLVEKLGGTIDVSSELGVGTTFHFSIKGN
>OMIFANIC_01473 hypothetical protein
MQFKHPEVLYALFLLLIPILIHLFQLRRFQKIDFTNVAFLKKVTIQTRKSSQLKKWLTLL
LRLLAIACIVLAFAQPFTASRTALNAEKETVLYIDNSFSMQAKGANGPLLQRVLQQLYEQ
TSGETTLSWFTNTETRKDVSIQDFKEEILSVPYVQQQLTPEEVILKAQQLFSNSQNAVKR
LLYISDMQLRAPSLPVIPENITLEIVQPEPVSVNNVSIDTAYVASKNAHTTKLNVIVSGQ
GDIAQTVPVSLYNNGILIAKIAADLSESSGSTISYDIENPAGFNGKLELNDPNLVYDNSL
YFTINVPKKIKVLSINEANSDFLTRLFNQPEFEYKRQRADNLNYNDIPNQNFLILNELRT
IPPSLANALSSFLSGGGSLMIIPSGSANLSSYNNLIGANGVGNFSEKVSQEKKISQIVFA
HPLFESVFEKQVVNFQYPKVNEYFLTNTNATAALRFEDSKPFILQSGNVYLSTAPLNVEN
SNFQSSPLIVPTFYNMAIRSLPLSELYYELGRQNTFAIPVNLTQDEILQLKDSVSTFIPL
QQSKANQVIITTTDKPGKSGNFSVENDGEFIEAISYNYSRIESRLQYLEAENWENARSYN
TVASMFDTIAEENAIRSFWKWFVIFAVVFLILELLVLKFYKQ
>OMIFANIC_01474 Dihydroorotase
MSQLLLKSATIVDTGSKHHLKKRDVLIENGIIRKIAASIKNDTAKVVSLKNLHISKGWFD
SSVSFGEPGYEERETVSNGLRTAAFSGFCHVAVNPNTNPVTDTKAGVQFLKAKAEGSPVN
LYPVGSLTVKSGGKDLAELYDMHNEGAVAFGDYKQPVKNANLLKIALQYCQNFNGLVQSM
PLDQSVARNGVMNEEVNSTRLGLKGIPALAEELQITRDLYLLQYTGGKLHIPTISTKEAV
SLIRDAKKKGLDVSCSVAVSNLVLTDDALEGFDTSYKLLPPLRNEIDRKALIKGLKDGTI
DGVTSDHDPIDIEHKKTEFDHAMFGSIGLESCFGALNAQIGMEASINALVSLTGRFGIET
AAIEENALASLTLFDSDTVYEFSKENILSTSHNAAFLGSELKGKAYGIYSNKKLVLNK
>OMIFANIC_01475 hypothetical protein
MTPPGKSKAIIAYITIVGLLIAISMNKDEPHDFATWHIKNMFGLTLMFFISVAMSYQEYL
LFPGRIFFFGSMFFWLFSLVMAIANKKVGIPFLSDKFDSWFTFLN
>OMIFANIC_01476 hypothetical protein
MSETTSGDGKTIAIVSYLWLVGWVIALIMHNNNKTELGAFHLRQTLGLMILWFVVWVINI
VLALMDIVFVGWIFSLALFVLWLLGFIGAIQGEKKLIPVLGEQFQDWFKGIG
>OMIFANIC_01477 Carboxylesterase 2
MLHGFGSDENDLFSFSSELPSEYTIISLRAPLRMDPFGNAWYSIYFDANEDKFSDDEQAI
ASRELVSKCIDEIVEKYKVNQERITLLGFSQGTILSFAVALSYPEKVTNVIGLSGYVNEG
ILKEGYKNYDFSKLKIYSSHGSVDQVIPVEWARKSKPFFDTLNIPCEYSEFPVGHGVAPQ
NFYEFKEWLTNND
>OMIFANIC_01478 hypothetical protein
MKKRIFMYLFFFAVLFILFQYMNEKTIFESQENKINSLTKQVAESDSINNVLTDKVAELD
YFTLLGNENAMTYIENLGMDAEAAQGLVTEAIYESNFGDVQNPLVPIESQDGKMRINKVK
FLNHRWILADFTDGTYWGEVLIEYFFDDNNQLLLTPIGGTLYPN
>OMIFANIC_01479 Phosphoribosyl 1,2-cyclic phosphate phosphodiesterase
MRVTFLGTGTSQGIPVIGSDHPVCKSSDPRDNRLRVSVMVEWGNLRYVIDCGPDFRQQML
RENVHAIDGVLLTHEHSDHTAGIDDIRPFYFRQGNVPFYAHERVFEALHERFAYIFATEN
KYPGAPAIKEIEISKNSSFSLGNIPVTPVEVMHSGLPVLGFRIGDFTYLTDVKTISEEEI
EKIKGTKVLVLNALRYEPHIAHLNIAEALALVDKIKPKTAYFTHISHLMGFHAEVEPKLP
ENVFLAYDGLKIEI
>OMIFANIC_01480 NAD(P) transhydrogenase subunit alpha part 1
MTIGILKETQQGETRVAISPQIAKQLIGKDFKIIVEEDAGTTSSFKDSDYEEIGAHIEKR
GVVFKESDVLLKINPFDEEDVKLIDKSHVLISQLFHKSNPDLMKAIAATGASAFSLDAMP
RISRAQDMDVLSSQSNLAGYKSVIRGAYEMTKIFPLMMTAAGTITPARVLVYGVGVAGLQ
AIATAKRLGAIVEATDIRPETKEQTESLGAKFIEVENDGEEEASVYAKVASEEYMQKQKE
AVNKSLFKADLVITTAMVPGRMSPVLITKEQVNQMKNGAVIIDLAAAQGGNCELSRMDEI
VVQNGVRIIGTTISPESVSTNASELFGKNLYNFIMHLTEDGKFKWELDEEITDSTLIIQN
GTIRKNGKTITT
>OMIFANIC_01481 NAD(P) transhydrogenase subunit alpha
MTEILDFIRTNLELIYIIILIIFIGVEVIKHIPAVLHTPLMSGANALSGVVIVGAILVML
HADPENYLALSLGFLAVVLGIINVVGGFAVTNRMLEMFKKKK
>OMIFANIC_01482 NAD(P) transhydrogenase subunit beta
MSLALSIVYLFAAVSFIYGLKLLGHPETAKRGNTIAATGMIVAILGTLVLHELTVSPFVY
TLIGIAILLGTIIGWVIAIKVEMTKMPELVSLFNGFGGASAVLIGLVEFGNNIGNTSQMA
TIVAAIFIGGTTFSGSMIAWAKLNGRMWKDIRLPKYNLINNVVLLGLLTFAVFIVLYASD
NSIYAYLLMLVALLYGVLLVIPIGGADMPVVISLLNSLTGIAAAITGVLYGNMVMLIGGI
LVGSAGLILTFAMCEAMNRSLGNVIFGAFGDGGASAEHAHHATSGVIKKTTVSDVAILMN
YSERIIIVPGYGLAVAQAQHAIHELEQILESRGIEIKYAIHPVAGRMPGHMNVLLAETNV
EYDKLAEMEDVNPEFATTDVVLVVGANDVVNPAAHNDPASPIYGMPILDVENAKQIIVNK
RSMKPGYAGIENELFYNQKTSMLFGDAKSVIQELITELKGM
>OMIFANIC_01483 hypothetical protein
MEIILKGDKEFDNIPSVKQKALRINLNEHIYGTFAEIGAGQETVRNFFRAGGASGTIAKT
MSAYDKDFSDAIYGHEKDGRYVTEARLKKMLTHEIDLIEDRISRIKHPDKMFFTYANTVA
TIDFAKRYKGHGWVGIRYQVEPYQDYNDILLHLRFKENDARLQQETLGILGTNLIYGAFY
KYNEPKKLLRYLYDHLHQDQLEIDTINFSGPLFEDVDNRLMSLQLVKNGMTDAVMFSPEG
NNILPAKVLYKKNILALRGSFRPVTNVNMDMFERSIEMFNQEPRVNPDQTQVIFEITLSN
LRAEGEIDEQDFMDRAELLCSLGQTVLISNFKEYYKLVEYFSQYSKNRMGLAMGVNNLVE
IFDEKYYRHLSGGILEAFGKLFFKDLRVYLYPMQNEDGTITTSENLKVHPRMKELYKFFK
YNGKVVDITNYNPNILNVFSRTILGMIANGEEGWDKMLPKGIAEIIKEQKLFGYKPKAMA
KKED
>OMIFANIC_01484 Putative peroxiredoxin bcp
MKTLKAGDKVPNFTVNDQDGNSVSLSDYQGKKLIVFFYPAANTPGCTAEACNLRDNYSEL
QTQGYELLGVSADTEKKQSNFRNKFEFPFPLLADTEKEVINSFGVWGPKKFMGREYDGIH
RKTFLIDENGVVERVIDKVKTKDHAAQILEA
>OMIFANIC_01485 Endonuclease III
MNKQEKVSFVIETLNTIYPEIPIPLDHKDPYTLLIAVLLSAQSTDVRVNKITPLLFEIAD
NPYDMVKLTVEEIRDIIKPVGLSPMKSKGIHGLSKLLIEKHDGKVPANFEALEELPSVGH
KTASVVMSQAFNIPAFPVDTHIHRLMYRWGLSNGKNVVQTEKDAKRLFPMDLWNKLHLQI
IWYGREYSPARGWDLEKDVITNTIGRKTVIREYKKNNTRTKKTLKR
>OMIFANIC_01486 hypothetical protein
MQKMYSETSRPERVNKNNVPKDETIKFLLDYSKALSVIDYNKMKFEALLN
>OMIFANIC_01487 RNA polymerase sigma factor CarQ
MKQRTTTDAHLVSAYMKGNESALCDLITRHKQRIFSFIYSKVYDRDVAEDIFQDTFIKVI
NTLKRGAYNEEGKFLPWVMRIAHNLVIDHFRKNNRMPKFENNNDFNIFSVLSDGNPNVEK
QMIKGQVESDVRRLIEELPEDQKQVLIMRIYKDMSFKEISEQTGVSINTALGRMRYALIN
LRKVISKHNIILTN
>OMIFANIC_01488 UvrABC system protein A
MLNSIFAKFSKSKPKLSTKTLSTKENILIQGAKLHNLKNISVAIPRNKLVVITGLSGSGK
SSLAFDTLYAEGQRRYVESLSSYARQFLGRLNKPKVDAIKGISPAIAIEQKVNATNPRST
VGTSTEIYDYLKLLYTRIGKTYSPVSGEEVKKDSVTDVIDYIKSFDPGKKLLLLSPIHLE
EGRTMENKLQALAQQGYARIKFDDTVVRIDELKGSIPKTIFLVVDRVITQEDEDFYNRLA
DAAEVAFFEGKGELIIEDLDNGGTREFNNRFEADGLTFMEPNVHLFSFNNPYGACPKCEG
YGDVIGIDEDLVIPNTALSIYENAIFPWRGESMGWYRDQLVNNAYKFDFPIHKPWFQLSE
SQKQLVWDGNDYFEGLHDFFSFLESKSYKIQNRVMLSRYRGKTKCSSCNGKRLRPEAFNV
KVNGVAIQELVELPLHKISKFFEELSLNSYDQKIAKRLLLEIRNRLSFLIDVGLSYLTLN
RKSNTLSGGESQRINLATSLGSSLVGSMYILDEPSIGLHPKDTERLISVLQSLRDLGNTV
IVVEHDEDIMKAADAIIDIGPEAGIHGGEVVAEGRYEEILMANSLTAKYLNGTYEIEVPK
KRRKWINSIKLVGARHNNLQNIDVEFPIGAFTAVTGVSGSGKSTLVKKILYPAMLRQIGG
YGEKPGQFTGLEGDFSSIKNIEFIDQNPIGRSSRSNPVTYIKAYDDIRNLYAAQKLSDIR
GYKAKHFSFNVDGGRCESCKGEGEVTIEMQFMADVHLECDTCGGKRFKKEILEVQFEGKN
INDILTLTVDEAIEFFNEHGVTKITNKLQPLQDVGLGYVQLGQSSSTLSGGEAQRIKLAS
FLVKGSSKEKALFIFDEPTTGLHFHDINKLLASFYALLDRGHTVIVVEHNIDLIKCADHI
IDLGPGGGEKGGKVVAMGTPEDVLEISESFTAQYLKSKI
>OMIFANIC_01489 hypothetical protein
MLLEDHVWNTDFYSDPFGGGPIQIISAENYVAGETIINNMSYKSVYIDGVEGSCLVREDG
GIVYRYDMDTSQEYIIYDFTLDVGDTFIIPQVMYNSFCASIEFYNGWDEMTVTDRTTEFI
AGVNRVVVSFDYVSEFGIDCKWIEGIGSNLGFDPVGDIIDIGSRYLVCFTKNGTTYFFNN
ATACDNTMLSVPQHLKNQVVLHPNPVQDISILQLPSELNINSLRIYNITGKLISEENLAN
DYVTINAMNYPSGLYFYQALSENTMIKTDRFIVN
>OMIFANIC_01490 hypothetical protein
MKKSILLVVLFLMGMTTQTFSQRNRNVNHNPGNYDRYYNTHEIRFVENGVLYSVAVDGSF
NFRQMYRPYNSNRGRRNFNTVYYNSAPGAVTYINTRPVEHYRVRYGRYGRIKSIGPTLIR
YRRDGRVKSIGCVAMTYYRGSLSTVGNLQILYNRRGKIRNTIGHVNRYNKKFWHDDWYRY
NRDRDEDDWDDDDWEDDRERRRKK
>OMIFANIC_01491 hypothetical protein
MPNSTNIRGILLTICWLVLVGQDLHSQTSEKQSLLTVLENLETTYDVRFSYSVEELDDIT
VEYSEQATLEASLEFLEGKLPFEFNRIDERYITVVKNSTDYLCGRILAADTGKPLASATV
VSTLTSYGIVTNSDGSFYVPKYLLGEQLVIRYIGYQSWQIAVSDLTTDCETILIPAEVST
LDTVFISNYLVEGMEKSLDGSITINTSEFGLLPGQVENDILFVTQALPGVQSVNETISNI
NVRGGTHDENLILWNDIKAYQSGHFFGLISAFNPDITQDVKIYKNGAPVNYGDGISSVIS
MKSKDKVSSSASGGAGVNLINGSAYGIIPLSNKATLQVSGRSSLNGLWESPVYQTYSEKI
FQDTEVTNTNPDETGIEVAAEERFSFYDFSTRLLWDLNDRDKFRLNFLALNNALEFDETI
IETESSKNSELELRSLLGGISWERTWSESLSTKVLAYGTTYYLRALNKDLLTSQEVFQEN
DVLETGLKLDASLQFTNELSLFGGYQFIETGITNEQEVNLPRFVDFKKEVLRTHAAFAGL
VYKSPSERTNIKAGLRLNYFTELDKFHVEPRLAFNQKLTEELSVEVIGEFRSQATTQRID
FDSDFLGVEKRRWVLANEENIPIITSQQASVGVIYESKGWLINLEGFYKNVEGITASNQG
FQNQFQFERSTGSYLANGVEFAINKINKEYSVWFSYSYLNNQYEFDLFDPSEFPHNLDVT
HAATIAGSYTFNRLKIATGINYRTGKPYTLPLMDNEITMEGLTEIVQYDEPNAERLPDYY
RVDVSAEYLWQISDQVNAKINLAALNVLNTRNTLNTRFVVSQDANGDSVVNQVNTFSIGL
SPNISFRVLF
>OMIFANIC_01492 hypothetical protein
MNENYILHKYLNGEASPKEIEILRSTPEYADYFKIAEAARGFQPPEFSSVGNFEVIQQNK
VKHIATPALSGFNRVIRIAAVMVLIVVSYVFISSLSSTVRTDIAQKETFKLPDGSEVQLN
ANSEIKYKKRNWENHRSLSLAGEAYFKVTKGNTFEVETPQGSVTVLGTQFNVFSRDTIFN
IKCFEGLVSVAFNDTLIKLPAGNKLKVENNKLVVLTSTNSIEPAWIRNESNFENASLATV
LKELEAQYPITITSPKSIANKRFTGSFTHNDLELALKSICDPLRIGYTLDDNEVTLYAK
>OMIFANIC_01493 ECF RNA polymerase sigma factor SigL
MKDPASVCNETIFSSIYNDIAQSVWRFIFYKCGDEAQADDLVQEAFIKLWNNCAKVSKEK
AKSFLFTVANNAFLNEVAHKKVVLKHKQLAPSKVDNQSPEFVLEEKQYHKKLQDAIANLS
EAQRTAFLMNRIDGMKYTEIAEHLNISVKAVEKRMSQALKALRQDFKNI
>OMIFANIC_01494 hypothetical protein
MKKIARLPLLFLFVFGMIFTSCQKEEEIFIDQNGEETITANSILTRLLIRTSQNAGDLDD
IIDGNSCVSVKFPITVIANGQEVILMDEDDIDLIEAIFDQFPNDTDTLEIVFPITVILDD
YTEVVVNSQAELDALIAACESSGGDDSISCLDFEYPITFFIFDNNQQQTGTVTVNSDLEL
YIFLNGIGDDDYFSIDYPINVILEDGSVVTVNNNAELEQLIEDCENNTGGGDPIDPVIFE
QNLTTGVWYITYFFDDFDETANYDGYEFTFATDNTAQATNGTNTVPGTWMFEGGSSPDLT
LFFGTTDPFDELDDDWDILEATNEIIRLRDESGDGSVDYLTFERNPATGGGGGTNDLIDQ
LTDGIWYVTLLNDDGDIETCDYVDYVFTYNLNGTATAVSATTTVTGFWSVELDDGMLDLI
LNFDITADPNFDDINDDWDVTDFNANLISLIDVSGGGGGTDILEFGRAQATGCGGGGSGQ
ALVDALEDGQWFVSEYLDDGIDETMDYNGYTLTFSTGTVVATNGSNTFNGTWAVTDTGGD
LDLTLDFGTQIPFDEFNDDWDVLNFTNSIVELEDVSGGGGGTDNLTFQKL
>OMIFANIC_01495 hypothetical protein
MKKQILNISMMILLAVLVISCSKDDSNDTNDNSNTNQATQANQIAQTGTWRISYFWDTDK
DETSNFTGYEFSFNSDGSLVATNGTDTVNGTWSVTNSSSDVDFNIMFAVPQSSDFEDLND
DWDIISVNDNMMELTDVSGGNGGTDFLTFVKI
>OMIFANIC_01496 hypothetical protein
MKVRYIFATLVLAAFFVNCKSADLLTIHYTDQNNNHYTINSRRLKFDPVSEKESSSGTYS
GGAPAEISLKKTDFRQISELAEKIMIASEGKNNRREMLTSVLTISGKDKTTSAILKKSED
RSKLETLLQKLRQ
>OMIFANIC_01497 Aminopeptidase YwaD
MNKSVLWILALLCANGILAQSEIDKVKATVNKSDIEAHIYFLADDLLKGREAGTPENKIA
AAYLANTLRSYGVKPSPKSGSYYQEISLVKKSAPKSFSLELNDVVHEFKIAVNQAEQNGE
FEGIYLGYGLESDYEGKDLKQRFVIVKSGGPDSKSIRDAFGLQKKKEALAKEAGALGIIE
LVEVSTGVWGRINHYYNSGRLEIASAEDSSEEKDQFAYIWAFDLKGRRASEFKLEPTVNI
NIGMDLGENEEIKTQNVIGVVEGTDPKLKNEYIIYSAHYDHVGIGRPDSKGDSIYNGARD
NAVGTTTVLSMAENLAKYPTRRSALFILFTAEEKGLLGSKYYVENPVLPLEQMVYCFNSD
NGGYNDTSLATIVGLDRTTARKNIVDAAASFGLRAIEDPAPEQGLFDRSDNVQFAAKGIP
APTFSMGFSSFDGDVTKYYHRPGDHADSMDYDYLLKFFRAYVMAGRSIANDPDTPFWAGG
DKYESAGNELYGN
>OMIFANIC_01498 Vitamin B12 transporter BtuB
MTKIGKFTFLFILLNFNFLWGQSGNNKQSLQEVFTYLESTYQCTFTYKDIDLRYHYTTPP
QASDLESTLEVLSKATLFNFTLLADRTIAVSKKQNLIGRCVYITSEFGIPFKDVAVVTPY
QQVVTDNEGRADFELANSSETITIQYTGYQALTTTAENLTTNDCSSFSLLRKVEFLNTVT
LVNYLAKGITKNVNGSLNVNYEEFDILPGLIEPDVLQTIQALPGIQSVNETVSFINIRGG
TNDQNLILWDGIKMYQSGHFFGLISAFNPFLTSEVNIIKNGSSSEYGDGVSGIISMQGDD
AVNTEIKGGWGINAISTDAFVDIPLSAKASLQLAGRKSFNNLVETPTYTEYFDKAFQNTE
VVSNSAAQSSSNDDFTFYDTHLRFVYQPSDKDFLRANFLLLGNQLDFLENAEVDNELQSR
QSELTQENISGGLFYRRNWSELFSTDFQLYGSTYALSATNFDILNNQRLLQNNDVLEAGI
KARAFYQMSSNSVIMAGYQFNETGITNFEQINNPFFERTDKQVLRTNSIFTEATFSPTNW
NTTLIGGVRFNHISKFNEVLIEPRLSINYRFLKYFSLDIAGELKSQTTSQIIDLQNDFLG
VENRRWVLSRENEIPILKGQQLSAGINYSRSGWLVNAEPYIKHIKGITTQSQGFQNQLEN
VRTHGSYTVRGVDLLINKRFKKVNTWFSYSYAENDYTFESLTPSSFPNNIDIRHAVTYGI
NYYVNDFKLSGGFNWHSGKPITRLIQENQIVDGQLNFDLPNASNIDDYIRVDISGTYSFQ
LTEKLNAFAGISFWNLLDTRNELNSFYRINNDGEHEKVTENSLAFTPNATFRISF
>OMIFANIC_01499 hypothetical protein
MKKKDLISKWLNFNLSDEELEAFNDLDASSSYHRIDRAAEYFRAPEYDADTSYLKLQNKL
GHQKKSRPLFTYFSGIAAVLVVAFGLFYLLNSANELEYLAENSTTKEFTLPDTSEVTLNA
GSSISFIEKDWASSRNLKLKGEAYFKVAKGEKFTVQTKQGSVSVLGTQFRVNDREGYFEV
TCYEGLVRVSHGGNELDLQAGNTYKVFGNTIINEVTALAIPSWLENKSMFKSMPYHQVIA
ELERQYDIKISGDSADSAILFTGSFSNKNLDTALQAITIPLNLSYTINGKNVVLKINQ
>OMIFANIC_01500 ECF RNA polymerase sigma factor SigE
MPTPLFKNVCDEQFFSKLYEQYSKDLHDFIYYKYGDSFNPEDKVHEAFIKLWQNCKSVTP
DKAKSFLFTVINNLTLNDIKHQKVVLKHQRSKPKHYTNESPQFIMEENEYLEKYQAALAK
LSEGQRVAFLLNRVEGKRHKEIAEMLNISRKAVEKRIYTALEKLRKEIDGI
>OMIFANIC_01501 hypothetical protein
MKHLLYALMLMVLAGCQKEELTIIEGQDEEAFTQDRVLKNLIMSVASHDGSFDDIVDKSS
CFSIDFPYVCFYNGYPYTVNSIEDLAPFQEGDKLIPEFPVNITFADYIQAEVPNEDAFND
LIAQCENGLLFNQSITCVDIVYPIRISIYNPDNSEFETISFTHDKQTFQSIEDFDASLIA
SIQFPIQIEMPNNVVLTINSNDVLKSEILDMIPFCE
>OMIFANIC_01502 Cell surface glycolipoprotein MPB83
MKNLFKLSLIAFLMIFATSCSDDDNGDVMQNGNDTIAVFVQNNEDYSSLLAALERAGLVE
TLNGATEYTVFAPNNAAFAAFLNANGFASLEDVPVDVLTNILLNHVVAGTNNSGDLTTGY
INSLATFGTTTNNLSLFIDTSAGVRINNVSSVTTPDVAVSNGVIHAVDAVIGIPTIVTQA
TANGDFSILVEALIAASDSNIDYVALLSGSASSPFTVFAPNNTAFENLLTTLGFASLNDI
PQPVLQLVLNYHVIAGANVRAEDLTEGQVATTFQGEDITISLANGPQIIDATGMPSNIIV
TNVQTGNGVIHAIDKVLLPQEVLDIVDPTIAGLAMMTADLSTLAEALSITGLDTVLDDRT
AEYTVFAPGNAAFDTFLGDNGFATINDVPVDVLTQVVLNHALTGIALSGGLSTSYTTTLA
TYGTSDNNLSLYINTDSGVTLNGISNVVTPDVTAANGVVHIVDAVIALPTVVTFAVADPT
FETLVAALTRADQPDFVSVLSTPLGTSPAPFTVFAPTNDAFGDLLVELGISSLDDIDTAT
LTATLNTHVIPGANVRAEDLVDGPVGTLGDDIIIDASNATITDQNGRVSNIIVVNVQAAN
GVVHAIDKVLLPQ
>OMIFANIC_01503 hypothetical protein
MTTIRSTRISSLDVLRGIVMVIMALDHVRDYFHAGAMVSDPSNLETTTPFLFFTRFITHF
CAPVFIFLAGTSAFLYGRNKTRHQLFWFLFTRGLWLIFIEVTLMTLLWWFDLTFSFFNLQ
VIWAIGLCMIILAFLIYIPKKILVLTGLVLIFGHNLLDGIVAQGNSFGAIIWYILHQANF
VKFGDTWVSFLYPILPWIGVIVLGYCFGNLYHKEFHAPARKKWLLSLGIGSIVLFLLIRG
INVYGDLVPWEVQQNGTYTLLSFLNVTKYPPSLLFLLVTLGPAFLFLYLAESVKTKLSDF
FLVYGRVPFFYYVVHVFVIHVAAIVGLILTGKDWQIMILNMDSIMDGSMAGYGYSLGITY
LVWIGIVLLLYPVSRWYMIYKAKNRDKWWLSYL
>OMIFANIC_01504 hypothetical protein
MKSIIFLLLSLLIIACNSGMESDIKKNVEAGDIEETDAAAEKELSETLPITSSTNLNYSE
IVAQKLQEYADLQSLIQKHPEFKTDLELQLATLSSDSILLQVPSDSISITDISQIRPAEI
ISDTVEHIPFSFIISSPTVTRKDSLIAVFTTQEVEIDGQIYVSNKVTFKSLSE
>OMIFANIC_01505 hypothetical protein
MDASDKQFFELLKQAVAATYLKENHASASMEEWKGEEIVGFQEDLFQRTRGRVSEKWFYS
YFKNEPTKLPRIDMLNLLCEYTGHEHWNAFKKLNLDAIKIQYKTKRNRKYLWLFLPVVPL
LIALYYLVNPDNEFQFCMVSEDGGEPITAIQIDVKILSEGQSPIYLKTDSTGCFSYVTKE
KIVRFVVQSPYHKTDTITRNFDANTNAMVLLATDDYALMLRYYSSGNVKELKKRRAQLSE
LIADNARIYQVFPDQTGIELYSKEEFITKLTIPTSSLKNINILDKHYEGDKIVKLKFSIQ
>OMIFANIC_01506 hypothetical protein
MKTNSSKSLLKIVLLIMVFTFLYSCNQGGSYSEDVKMDAVDVDDSFASLEAEENAIASFK
PDATITKTPANLKIIKSASARYKVKDVKIATNQIRAIALQYDAYISDLRYENNLYQKQNR
FTIKVPQQHFDIIMDSIGNVVEFVEYENITTTDVTEEYIDLQGRLETKLEVKKRYEEILR
KNARTVKDILDTEEKLRILQEEIESAQGRLKYLTNKVAYSTIQIDLYETVEYTEEPTSYK
KTFGDKSKDALSFGWKMIESIVLFFIHIWPLLLLGIIVVIVLRRWLKK
>OMIFANIC_01507 hypothetical protein
MRKLALLALVGLFFISCKQGEPRYTQSSAEIDTFKELIAAYEGADWENYTAKFADTAQVY
HNTDDKPMTPAETVEAHKTNTAALSSYGFVPDKGDMEMVTTDEGETWVNYWGLWKGTIAS
NGKEMMTPVHVTAQFVDGKVVKEYGYWDNAPMVAAMEEAAAAEAPDEVKPADEVNPGGAE
>OMIFANIC_01508 hypothetical protein
MKTKHIFNTFLCALLFVTSLGIAQEKTSQTYWIHEDHVKPSMLAEYEAVCKELVMQCKKH
GVDETSWLTLATNDFTYAYVGPIDKMADLDENIFATLSEKMGKEAFSKLFQRMDKCYTDH
VDYIISLDKDLSYQPSGINQMPEGQMYRNNVRYYITPENYAKANEIAKKYKKLFTEKGSK
MYYRVYRSGFGANGTFFMVAIAAESPEDYERMSMENRKLLGEEGAKLNQELLAVMTKMDV
MQGWMRADLSYMGK
>OMIFANIC_01509 Signal recognition particle protein
MFDNLTDKLDKALHVLKGHGSITEVNVAETLKEVRRALLDADVNFKTAKEFTNKVKEKAL
GQNVLTTLQPGQLMVKIVKDELTELMGGDTAGIDLSGSPSVILMSGLQGSGKTTFSGKLA
NFLKSKKSKKPLLVACDVYRPAAINQLHVVGDQIGVEVFSDEGNMDPVAIANKAIAHAKQ
NGYNVVIVDTAGRLAVDEQMMTEIANIHAAIKPNETLFVVDSMTGQDAVNTAKSFNDRLN
FDGVVLTKLDGDTRGGAAISIKSVVDKPIKFIGTGEKMDAIDVFHPTRMADRILGMGDVV
SLVERAQEQFDEEEARKIQKKIAKNQFGFDDFMKQIQQVKKMGSMKDLIGMIPGAGKAIK
DVDIDDDAFQGIEAIINSMTPEERATPAVINGNRKKRIAKGSGTSVQEVNQLLKQFNQMS
KMMKMMQGGGGRKMMQMMNKMK
>OMIFANIC_01510 Bifunctional protein FolD protein
MTILDGRKASNDIKDEIKVAVDGMKANGEKVPHLAAVLVGDDGASLTYVGSKVRACERIG
FESTLVHLPDTTSEEELLLKIDELNNDNDIDGFIVQLPLPKQIDSQKVLMAVDPKKDVDG
FHPENFGKMALGMESFIAATPFGIMELLERHKVETSGKHAVVIGRSNIVGRPMSILLSRK
GYPGDCTVTLTHSRTRNMAEITREADIIVSALGVPNFLKADMVKDGVVIIDVGITRVPDE
SHPKGYVITGDVDFEQVSKKASYITPVPGGVGPMTIAMLLKNTLLARKYRNH
>OMIFANIC_01511 hypothetical protein
MTKPIPQHIIQQIFVLLLILLIGGLIFRELLPYFSGVLGAITIYVIMRGWMLKLMRKGWN
RNLAASLLIIISFVGILLPVTGVIMMLGNKIGNAVQNSEKVVRALKEQLGAWETEFDFDL
ASEIDVSAISSWLTNNLQSVAGSTFDIFIAVGLMYFILFYMFTNRRLVKNTVGDYVPISK
PNLKVIGSEIQAMVRSNALGIPLVALAQGIIALIGFFIFGIQDPFFWFVIVTIGSMIPFV
GTLIGILPVFILELSSGNTFSAWGILLYGLIVVGSTDNIIRLYVLKRLDNVHPLITLIGV
IVGVPLFGFIGLIFGPLLISLFLVIVNIYRKEYLSNTSETIEN
>OMIFANIC_01512 hypothetical protein
MRKVILILSILCIGLISIAGIRSSEEGPKITICHIPPGNPENAHSITISINALPAHLAHG
DSEGACEAQCTLETDPECYCELFPNDPACN
>OMIFANIC_01513 hypothetical protein
MKPNLRPFHLAIPVNEIPKNRAFYRDVLGCKEGRSSDHWVDFDFFGHQLVIHLKEEWNDG
VHSNPVDGKDVPVPHFGVVLDMSSFEQLSGSLEKQNIKFIIEPYIRFEGEVGEQATMFFK
DPSGNALEFKAFKNIDQLFAK
>OMIFANIC_01514 hypothetical protein
MLSSSEKSLYRSELFRHLDGIAVAPVVQALDDKGVLDYLLKEGKCLLSTITEKFNANEGY
LNIGLRMLASQGWLEYDIKREDNTITISTNSKSSIAFSLANSYEDVVNFMKISSEFHPRH
FERDEFSLLNRIFNKYRNGAYASTSNDTLTKEIEFQIEKHIEGVLVGPITVFLGMDGMFH
KYFMEASFSADEFHEDPDSFSKILDFFTYLEWFTKKNGHYRFTNKGLFFARRSTAYGVTV
SYIPTFRRVDELMFGNALIFKSSTSTVSEIHVDREMNVWGSGGAHSAYFKKIDEIIITLF
NKPIEEQPKGILDMGCGNGAFLIHLFEVIEQRTHRGTMLEEYPLFLVGVDFNRAALKATR
ANLVKADIWAKVIWGDIGNPEQLEEDIQANYDINLEDLLNVRTFLDHNRPWSMPQNFSKD
TTSLSTGAFSSGGLRLHNAMVEQNLKEHFENWKKYIGKFGLLLIELHTIDPKIAAQYVGK
TAATAYDATHGFSDQYILELDVFNHVLSEIGLSSDPNHLSKFPKDERATVSIHYLTVNN
>OMIFANIC_01515 hypothetical protein
MKTLLYMCFAIISMMAANAQGTYSVSPENPYGKLNPEAPQELADFAPMIGTCDCISTLRN
PDGTWQEPENIVWKWSYIMDGTAVQDETYKPDGSHAGSIRQFIADSSRWYVHFYSNKLPS
PALPAWEGGKRGDSIVLYREQKAPNGMDGFYRVIFSNINEMSFDWLGEWVDTNESIRYPT
WKISCKKRLAFSEEEKIREKIRAFSAAYMNADAEEIASLYTIDAKIFPGNSNIISGRPKI
EKRWQFAEGVKDLYHKVTPSEIRIIKNYAYDYGYYEGSTTNKKGKKTDFEGKYVIVWRRD
KGEWKIYLDIWNRL
>OMIFANIC_01516 hypothetical protein
MKKLLLLAAAAVILLTQCGKETDPFLIGDGTIGPLNKKTQMRQLDSIFANDSIVKLSPIE
DAPETQGEVEIYEKGGKKLMLLSPEDNEDPNSVITNIQIFDDRYITDKGFGMGSTFGDLK
ANYEIVAIENAINSVVIFIKDSEVFITIDKKLLPESVRYNFNAKIEATQIPDDATFKYFM
VGWDAEEEEDDSSDE
>OMIFANIC_01517 hypothetical protein
MADSQVFFDHINNGYKTKGDAITLGAAMLDGEAVTNALVKIPLKTMNRHGLIAGATGTGK
TKTLQILAENLSEKGVPVLLMDMKGDLSGIAQPSPGHPKIDERHANIGFPFEAKKFPVEI
LTLSKQNGVRLRATVSEFGPVLISRILGVSETQAGIISILFKYCDDNKLPLLDLKDFKKI
LQYATEEGKAEIAREYGRISPASSGAILRKIVELEQQGGDLFFGEKSFDTDDLLRVDENG
MGYINIVRLTDIQDRPKLFSTFMLCLLAEVYSTFPEQGDSGRPELVIFIDEAHLIFKEAS
DALLDQIESIVKLIRSKGVGLYFVTQNPTDVPDAVLSQLGLKVQHALRAFTAKDRKAIKL
TAENYPISDYYKTDEVLTSLGIGEALVSALNEKGIPTPLAATLLRAPMSRMDVLEDDELE
DLLEESKLIKKYNEELDRESAYELLNEKIETANKEEAKAKAKKEQEEARRSTSGRRRTTS
RRRGKSSLEKVLTSPTVIRSVLGILTKMLK
>OMIFANIC_01518 2-iminobutanoate/2-iminopropanoate deaminase
MNRIIRTISLLTFPLFILHCAPNSEEKKAELLQTNSPIFYPSHEPGRANKPFSDAVQVGN
LYFLTGQIGLDHSTGNMVAGGIESETIQTLENIKDVLKQHDLEMTDVVKATVILDTIADF
VAFNSIYESYFPQKPVRTTFAVESLARNAKIEIEVIAAKDQNMQ
>OMIFANIC_01519 7-carboxy-7-deazaguanine synthase
MREDIQKQVDAGLMLPLMEEFYTIQGEGYHKGTAAYFIRIGGCDVGCYWCDVKESWNPAI
HPPTDIKSIVENAVKYSKTIVITGGEPLTWDMRPLTSRLKEEGLDIHIETSGAYPLTGSW
DWICLSPKKIKLPKPEIYPKADELKVIVYNKDDLRFAEEQAANVSENCILYLQPEWSKRD
KVMPLIVDYVMKNPKWKVSLQTHKYLNIP
>OMIFANIC_01520 hypothetical protein
MKQKFILLFALALSVMMSDSLYAQKFSDLDKSPMDVASYPSSYRVSDKAIKVTYSRPQLK
GRELSSLAQPGKVWRTGANEAAELTLYTDMKLGGTTVKAGTYSFFTIPGESEWTAIISSD
VNVWGSYSYDESNDVAKITVPATTAKESLEAFSISFTESDSGVDMHLGWGTTRVKVPFTK
>OMIFANIC_01521 DNA gyrase subunit B
MKDEKEIKVYGADSIQALEGMEHVRMRPSMYIGDIGTRGLHHLVYEVVDNSIDEAMAGYC
DTIDVWINEDNSVTVKDNGRGIPVDIHKKEGVSALEVVMTKIGAGGKFDKDSYKVSGGLH
GVGVSVVNALSGSLKATVHRDGKMWEQEYERGKTLYPVKSVGETDYRGTLITFKPDHEIF
QQTLEYNYETLSNRLRELSFLNKGLTISITDKRNKDEKGEFVHETFHSKEGLKEFIRYLD
GNREPLIADVIAMEGEKNEIPVEVAMIYNTSFNENLHSYVNNINTHEGGTHLSGFRRGLT
TTLKKYADNSGMLDKLKFDISGDDFREGLTAIVSVKVAEPQFEGQTKTKLGNREVTSAVS
QAVSEMLENYLEEHPSDAKTIVQKVILAAQARHAARKAREMVQRKTVMSGGGLPGKLSDC
SEQDPEKCEVFLVEGDSAGGTAKQGRDRMFQAILPLRGKILNVEKAMQHKVFENEEIRNI
FTALGVTIGTEEDSKALNLEKLRYHKIVIMCDADVDGSHIATLILTFFFRYMKDLIEAGH
VYIATPPLYLVKKGSKKEYAWNDQERDALNEEYGGNASIQRYKGLGEMNAEQLWETTMKP
SNRTLRQVTIDNGTEADRVFSMLMGDEVPPRREFIEKNAVYANIDA
>OMIFANIC_01522 Malate dehydrogenase
MKITVVGAGAVGASCAEYIAIKDFASEVVLLDIKEGYAEGKAMDLMQTASLNGFDTTISG
TTNDYSKTANSNICVITSGIPRKPGMTREELIGINAGIVKTVATNLIEHSPDTVLIVVSN
PMDTMTYLVHKTTNLPKNRIIGMGGALDSARFKYRLAEAIGAPMSDVDGIVIGGHSDKGM
LPLTRLAGRNSLPISKFLSEERIQQVLEDTKVGGATLTKLLGTSAWYAPGAAVAGLVHTV
ALDTRKMFPCSVMLEGEYGLNDICIGVPVILGRSGVQEILEINLTEAESAKLAESAEGVR
KTNGLLDV
>OMIFANIC_01523 hypothetical protein
MQNKGLVTMFAIVFGLVSLYQLSFTFIANKVEGEAETYAKTLYDGSQPEERIEAETKYVD
SVANDPVFLGISYNDAKEKVLNKGLDLKGGINVILQVSVRDILEGLANNSKDPAFNQALN
NAEELQKDSQDTYLESFFTAFEAIPGDNRLASTNIFFNKNLEDDIQRDDTNEEVQQVLTR
KVDEAMVSAFEVLRKRIDKFGVTQPNLQRLGNSGRILVELPGAKDIERTKELITKTAQLE
FWDVFKADQLQSFILSADATLKDIITPEVDEEVQDTTATADEDIQDILGGEEVDEQVDPA
KTNPLISKFLSFGQQGLPILGSVRATDTEIVSTYLQTPQVRAQLPNEARFIKFVWGIERT
IETVDGESIVVQDLYALKGSDREMIPPLSGGVVTDAAQSYDQAGRVSVDMQMNGKGAKIW
EEMTGNAFSNQSQIAIVLDDIVYSAPGVTSGPIAGGRSSITGDFTINEGQDLANVLRAGK
LPASADIIQAEVVGPTLGQEAIDSGVLSFLIALGFVLIWMVFYYGRAGLFADVALVLNIL
FIFGVLAGLGAVLTLPGIAGIVLTIGISVDANVLIFERIREELAKGKAQKDAVKDGFNNA
LSSILDANVTTGLTGLILLVFGTGPIQGFATTLLIGILTSLFTAIFITRLFIDSYTKNGK
PLPCSTALTKNLFKNVNINFLGKRKIAYVISGILILASLGSLFTNGLNQGVDFVGGRTYT
VRFDKDVNATNVQNDMIAKFGSAEAKTYGGDNQLKITTKFKVDETGEEVDTEIETMLFEA
LQSNLPSGMTYEDFISDDEGKEVGRMSYYKVSPTIADDIKKSSFWAVLGSLAVVFLYILL
RFRRWQFSLGAVAAVFHDVLIVLGIFSLTYKIMPFNMEIDQSFIAAILTVIGYSLNDTVV
VFDRIREFFNEHSSWKMNRIINSALNSTLSRTLNTSMTTLIVLLTIFILGAESIRGLIFA
LIVGVLVGTYSSLFIATPVFFDTVKKRGIDLSDKKEEEEEEAKK
>OMIFANIC_01524 hypothetical protein
MKRLLMLAAIICLANASGSCNETKEEKSITKEVRFQKEGELTLTKTSNDSVVATLEIEIA
EGEYETQTGLMYRKSMQDDRGMLFIFDDEIRRSFYMKNTEFALDIIFINSENEIVNIQKN
AQPLDQTSLPSAAPAKYVLEVNAGLCDKWTLEAGDRIEWNRL
>OMIFANIC_01525 Prolipoprotein diacylglyceryl transferase
MHFLTFTWNPIEGIDLGFFMIRFYSLSYVIAFIVGWFIMKRFFTNEKISMDKLDSLFIYM
VVAILVGARLGHVLFYEPETILADPLSVILPFKTVPEFEFTGFRGLASHGAAIGIIIALI
YFNRKKLKFPVLWIFDRVVITVAIGGAFVRLGNFMNSEIVGRPSGDFPLGVRLVRNADDM
HPQTAMKITGLKDPNDAYNAIANDPQFAEVLAGIPYRHPTQLYEAFGYVITFLILWYIYW
KTSKKQNPGYIFGWFLILLFSTRVIVELFKEVQVADRESWFLNTGQLLSIPFIIAGIYIL
YNSRKKTFTP
>OMIFANIC_01526 Cysteine--tRNA ligase
MKLYEQQELFIYNSLSKTKEKFAPIHDGAVGMYVCGPTVYSNVHMGNCRTFLSFDLVYRY
LIHLGYKVRYVRNITDAGHLENDGESGEDPILRKARIEQLEPMEVVQKYSLDFHNVMAQF
NAHPPSIEPTATGHIIEQIRIVEKIIEAGYAYEKNGSVYFDVLKFNETHEYGKLSGRQLE
DMITNTRELASQSEKKNPQDFALWKKAEPQHIMRWPSPWSDGFPGWHLECTAMSTKYLGN
NFDIHGGGMDLKFPHHECEIAQAEATNDESPVNYWMHANMLTLNGKKMAKSTGNNILPHE
LFSGENDVLSKAFAPTVAKFFMYQAHYRSILDFSNDALEASEKGYYRLMDAYRNLSGLAI
SESSSFDVNEWRQSCYDAMNDDFNSPILIAQLFEATKLINAIKEGKATITENDLSVLTTT
MHDFIFDVLGLLDLASEGNNDTSKLSGAVELLIALRNKARADKDFATSDKIRDDLKEVGI
QLKDGKDGTTYSLN
>OMIFANIC_01527 GTP cyclohydrolase 1
MDLEKQLREIEALGNDHVGTSTDTPLRDDAFELSDIEKIAKIKQDVRNIMETLGLDLSDD
SLKGTPTRVAKMFVQEIFGGLHPDRKPKASTFENKYKYGEMLVEKNITLYSTCEHHLLPI
VGKAHIAYISNGTVVGLSKMNRIVDYFAKRPQVQERLTMQIVKELQHILQTEDVACVIDA
KHLCVNSRGIRDIDSSTVTSEFGGKFKQKDVRRDFLDYIKLDTEF
>OMIFANIC_01528 hypothetical protein
MKTFISMLVVGMISFLSFAQESHNQTSMVELEDVVVLAVNTSYLATVQDENTPKEVTLLQ
RDAANFDIRSNPDFSEDVTTDTFEMVFRNSKGSIDTFYNKHGKIEASYERFRNILLPRAI
QRQLYQSHQGWTMTGNLYASAYENDDLIDRSYKIQLEKGDDKKSVVIHVKR
>OMIFANIC_01529 hypothetical protein
MLPWHQYLLGIIFVAAGFYHFRKPKLYERIMPPYLPMPSTLVLVSGAIEMILGLMVLNPE
TQVIAAWAIIGLLVIFLPIHIYMLQEEDASLNLPKWVLIIRIPLQFALMYWVYQYTLI
>OMIFANIC_01530 hypothetical protein
MNLFDGIADKKLVLPLQDASITYFPSTFDDDVAWEYFHRLLKETNWQQDDIKIFGKVYPQ
PRLTALYGEEGKSYSYSGITMHPEPFTPLLEEIKQAVESISGTKFTTVLLNLYRDGNDSN
GWHSDDEKELGINPVIASLSLGITRKFHLRHRKDKTLRYSIELEHGSLLLMKGETQHHWH
HQLPKSKRIREPRINLTFRIVKG
>OMIFANIC_01531 hypothetical protein
MKQNTRFTDRDLDRIIEMAWEDRTPFEAITFQFGLKEQEIIDLMRREMKSSSFRMWRERV
QGRKTKHKKLRSTDMDRFKCSRQKQITHNKISKR
>OMIFANIC_01532 hypothetical protein
MRLLPIVLLFICTPLCANDTNTDWGRTGHRATGEIATSYLTKRAQKEISKLLDGASLALV
STYGDEIKSDQRYGEYWAWHFVNYPFGSTYDDHPKSDRGDLIRGIDTCIEVLKNKQSTRE
DKVFYLKMLVHFIGDLHQPLHVGQAGDKGGNDFQVRWFDEGTNLHTVWDTKMIESYNMSY
SELASNRRELSNAQLEIIQQGNVTDWMRESRELCEDIYANTEVGEKLGYNYMYKYVETAK
FQIQKGGIRLARVLNEIFD
>OMIFANIC_01533 hypothetical protein
MKAFQSMETLKSHPAASGIGRHLNFLAASQYFIIPVIKYLLFFFFSKILSFNRGSNFYHI
LIPGLKDHIRIRGIHHYDHIVVDIESFFLLNLGCERGATKK
>OMIFANIC_01534 hypothetical protein
MGQDIRKMMRDYTPETTKLSEGHEARFEARLKALEAKPDRNMFFYLKVAAIVVVLISVGW
FAFYSLNGGIQDNGITAVEEENVTENVAESFTLGDISPDLKKIESYYTTGINVQLASLQV
NEDNKELVDGYMQRLSELDIEYQVLNKELNEVGPNEATITALVDNLQLRLELLFKLKNKL
KELKKQNNENYTI
>OMIFANIC_01535 ECF RNA polymerase sigma factor SigR
MADSFLIEKCRQNDRKAQLELYRKYCDGMYIIANRYMRDAAAAEDALQEAFIKAFQKIDQ
FKGDVTFGAWLKRIVINKCLDVIKARKMEVQSLDDGILHIAEGEEDWDVGDQATMDEVYN
AIENLPENYRVVVKLFLLEGYDHQEISEILGISESASRTNLHRGKIQLKKTLKHLEYGTG
Y
>OMIFANIC_01536 GTPase ArgK
MSKSVKKSDALHEMKGVPQPSSVSSTAAEKVKKSRKKYISPKKLLDGMLSGDKSALSRAI
TLIESTKPKHIKQAKELLEACLPYANKSLRIGITGVPGVGKSTFIESFGKLYTDEGHKVA
VLAVDPSSNLSKGSILGDKTRMEELVKNENAFIRPSASGTSLGGVARKTREAIILCEAAG
FDIIIIETVGVGQSETVVHSMTDFFLLLKLAGAGDELQGIKRGIIEMADAIVINKADGEN
IKAAKLAKAEFNRALHLYPEKESGWTPKAFTCSAYTKEGIDQLLEVVQKYIDLTQENGYL
QKKRLEQNKYWLLETINNSLQSKFYENPIIKEALKDRLLALERNETTPFEAARFLLNLKT
S
>OMIFANIC_01537 hypothetical protein
MALLLVHWWKDDLGVVRVAAAFPILSFLAFVVLIATNQWRGSMKSDAYMIKSLNIDHSSM
QYPYYYWKNISFSGTFYSEGNVELIYLKPKEVKALLEIDQPVYLFVKNKETKEIPDRILK
HFTLVDSNNWRSVYVTTPEKD
>OMIFANIC_01538 hypothetical protein
MRNKLAYIAYIVIPLTFFNISHAQTPIIANDGGHEQWEFILEGTGDVLQIALPIGAGMIT
LIKGDYEGTKQLVFSYGTTLALTYSLKYLIAKRRPEGRHQYDAFPSGHTASAFSGASFIQ
RRYGWEYGWAAYVLAGIVAVSRVEGPDGYHDYWDVLAGATVGLSSTYMFTSKYQDPPLDI
SFASGSGNYVLTIKYQF
>OMIFANIC_01539 ATP-dependent DNA helicase RecG
MNPNFLQTPIEFLKGVGPNRADLLKKELGIHTFQDLINLFPNRYLDRTRYYKIAELEKTN
AEVQIIGKITHIKTVEQKRGKRLVATFTDETGTMELVWFRGQKWIRENLKLNEPYVIFGR
ANWFNDHFSMPHPEMELVKEHEKSLRSAMQPVYPSTEKLSTRGITNRVVNKLMQQLFSEA
QNAFVESLSKPILDSLKLLPKNEALFNIHFPKNASLLARAQYRLKFEELFYIQLQLLRKN
LIHKTKIKGYLFSEVGDYFNSFFKSYLPFNLTDAQKRVIKEIRKDVGSQAQMNRLLQGDV
GSGKTVVAFMSMLIGLDNGYQACLMAPTEILSVQHYNSLFKWCNNLNISISLLTGSTSTS
NRRKIHENLENGSLQVLIGTHALLEDKVKFNNLGIAIIDEQHRFGVAQRSKLWHKNERPP
HILVMTATPIPRTLAMSVYGDLDISIIDELPPGRKSIKTVHRFDANRLKVFRFLKDEISK
GRQVYIVYPLIQESEALDYKDLMDGYESIVREFPMPEYQVSIVHGKMKSADKDYEMNRFV
KGETQIMVATTVIEVGVDVPNASVMVIESAERFGLSQLHQLRGRVGRGAEQSYCILMTGH
KLSHDARTRLETMVRTNDGFEIAETDLKLRGPGDIMGTQQSGVLNLRIADIIKDGEILKI
ARSYAFQTLRDDPNLEKTENNPIKFTYAQLAKYRNIWNYIS
>OMIFANIC_01540 hypothetical protein
MKSYIVYIVSNQYRTALYTGITNNMQRRIAQHYFDSMNARKSFAGKYNCYYLVYYEQFTE
PLAALKREKEIKKWKRSKKHELIIAFNPKWESLNQQIFRIAT
>OMIFANIC_01541 Aminopeptidase N
MEFLIRSSFEMTKFGKTIAAVFYMRQILILLFFFYPIGGIAQQTDVVDFLEIRANLTVIP
FQKSIEGGIHLKFRTLKDVDSVYLDAVNMEKTSLDIDYQSVKVETSNDKFWIIGKFKKNQ
EYKTSFSYQAYPQQTLYFTDDQIWTQGQGKYTSHWLPSIDDMNDKIEFDLNIAVQGRENE
IISNGTLANMQFAGDMKAAEYQMNHPMSSYLAALVIGDFRKKEITSASGIPIELYYKPED
SLKAEPTYRYTKEIFDFLETEIGIPYPWQNYKQVPVRDFLYAGMENTTATIFSEAFVVDS
IGFNDRNYVNVNAHELAHHWFGNLVTETSGSHHWLQEGFATYYAHLAEKELFGDDYFYWM
LYQSAEQLKELSDAGKGESLLNPEASSLTFYEKGAWALHILRELIGDDAFKSAIRSYLEK
YKYRNVSTEDFLAEVRASTAIDISQWEADWLNQSAFKAMQAFNSLSKSDFMDRYFQVSSL
RSGPVSQKIDALRNAIESNNDFIGQEAVYQLSGEDRFVTHFLYEKALDSDNLYIRQAVAV
SMDGVSERLKEKYEGLLHDKSYLTIETALYNLWSSFPDDRERYLNDTERIIGFQDKNVRQ
LWLALAIITEGYRTNEKTDFVKELRNYTGSDYSFEIRQKAFNYINDLGLYDDVVIDNLIQ
ASVHHNWRFRNASRKMLSGKMKDSDIRETIEAKLDQFSEKEKQFLNSKLKTE
>OMIFANIC_01542 hypothetical protein
MRAMVISGGGSKGAFAGGVAQYLMMEKGYDYNLFVGTSTGSLLISHLALNKLEKIKKVYT
SVDQKDIFSHRPFVVKKGKHGEKEIAIAHFRVLRNFFRGSKTFGESYNLRRLISNTLTRK
EFEELKESDKEVVVTVSNLSMNQVEYKSVNDFSYSDFCDWIWISCNYIPFMSLVKKDFNE
YADGGFGSMVPIEEAINRGATIVDVIILETEVTHYNRMPSRNPFSLLTNMHAYMLDRVEK
QNIRIGKFVAGHHDAVINFYYTPTVLTTNSLIFDHKQMTNWWDSGFKHAMNQDQETSEIH
PNDA
>OMIFANIC_01543 hypothetical protein
MEEMSQILGYVAYLLPAIVVGVIAYYFFKGHTSNEEGRRRYLIQKEAQNKVLPMRLQAYE
RITLLMERLDPNKLLIRVKPFSDEIEKYETLLINNIEQEFEHNVTQQIYVTPECWNLVNA
AKNATIHVIRQAAMHEKDGGADEMREYLLRNFMEEITPSQKALAYIKKEVSELF
>OMIFANIC_01544 Glutamate synthase [NADPH] large chain
MEAFLEALKSVPWWAWVLIVLALIAIRDIFFNKRHTIQHNFPIVGHIRYMLESIGPEMRQ
YIVANNREELPFNRIERGWIYASAKNENNYEGFGSDRDFYKPNYIFINNAMLPYKLPTDH
PNSNDPYFVPCAKIMGEGRRKRPYRPASVINVSAMSFGSLSARAIESLNRGCQMAHAYHN
TGEGGLSPYHCTGGDVIFHFGTGYFGVRDSEGNFSMEKMKRLVRDNPQVRAIEVKLSQGA
KPGKGGVLPAAKITHEIANIRGVEKGKDVLSPPTHSAFDGIDGLIDFIEAIAEATGLPVG
IKSAVGKLDSWEELATKMKHSGKGPDFITVDGGEGGTGAAPPSFADHVALPWVFGFSDVY
KIFQNHGLCEKTVFIGSGKLGFPAKAAMAFAMGADCINVAREAMMAVGCIQAQICHNNHC
PSGVATQNKWRQRGINIKDKARRTHFYFKNFRKELLEITHACGYEHPSQITMEDVEFSLG
DRNLLKTLSNSFGYQKTKVPLKSVENYLKCQYLGGNYQPKEAKNIVQRAIEKNEVRY
>OMIFANIC_01545 putative hydrolase YxeP
MIRNIFFLLVLFVVGYAQAQMDKSVLTDIESIEQQVLDWRRYFHQNPELSNREFNTAKKI
ESHLRSLGMEVQTGIAKTGVVGILKGDMPGKVVALRADIDGLPVTERNDLPFKSEVKSTF
LNTETGVMHACGHDTHIAILMGVADVLSKNKDKIRGTVKFIFQPAEEGPPPGEEGGAKLM
IKEGVLKNPDVDAIFGLHINSGTPVGTIKYKSGGTMAAVERFVVTVKGKQTHGSAPWSGV
DPILISAKIIDGFQTIISRESPLVEEAAVITVGKITSGVRFNIIPESAEMIGTVRTLDPK
MRELIMRRMNEMARDIAKAYGGEATIEWQNNTVITYNDPELTAQMLPTLQDIAGAENIIT
MKATTGGEDFSYFQEIVPGFYFFLGGMTPGNTTPYPHHTPDFMIDDSGLLLGVKVMTQIS
LDYLNAN
>OMIFANIC_01546 ATP-dependent DNA helicase PcrA
MQSYLEQLNDAQLAPVLQKEGAMIVIAGAGSGKTRVLTYRIAYLMSQGVDPFNILALTFT
NKAAREMKKRIAQIVGNSEAKNLWMGTFHSIFAKILRFEADKLGYPSNFTIYDTQDSQSV
IRSIIKEMQLDKDIYKYKQVYSRISSFKNSLITVKAYFNNPELQEADAMAKIPRLGDIYQ
AYVDKCFKAGAMDFDDLLLKTNELLNRFPDVLAKYQNRFRYILVDEYQDTNHSQYLIVKA
LSDRFQNICVVGDDAQSIYAFRGANINNILNFQKDYDDVRVYRLEQNYRSTKNIVNAANS
IIEKNKQRLEKVVWTANDEGNKILVNRTMTDGDEGRFVASSIFENSMSNQLRFDSFAVLY
RTNAQSRAIEDALRKKDIPYRIYGGLSFYQRKEIKDVLAYLRLVLNPKDEEALKRIINYP
TRGIGQTTVDRLIVAGSHYDRSMFEVMKHIDKIDLKINKGTQAKLQNFVTMIESFQVLNE
GYDAFQIAEHVTKKTGLVQELKKDGTPEGIARIENIEELLNGMRDFVEEQKELADTTGSL
AEFLEDVALATDLDNEKGDENRVALMTVHLAKGLEFPYVYIVGMEEDLFPSAMSMNTRSE
IEEERRLFYVALTRAEKQAYLTYTQSRYRWGKLIDAEPSRFIEEIEEQFLDYLTPITENR
FKPLIDTDIFGEVDKSKLRLRKPKVGSPPKGPTEAQLRKLRRLKPVSSDTDKNFDPAKAN
LSEGTIVEHVRFGKGKILTIEGVGADTKAEILFENGGLKKLLLRFAKLNVLDS
>OMIFANIC_01547 Threonylcarbamoyl-AMP synthase
MAELIRIYEENPNPKDVKKVVDIIRRGGLVIYPSDTVYALGCDITNNKAMERLAKIKGVK
PDKAKFSFICEDLSNLSDYVRQIDNVTFKILKRALPGPYTFVLPGNNKLPAVFKKKKEVG
IRVPDNEIARALVRELGRPIVSTSIKDEDEVIEYTTDPELIFEKWEKLVDVVVDGGFGGN
IPSTVIDLTGDEPLLIREGKGSLEI
>OMIFANIC_01548 hypothetical protein
MEAHYRFTDEAFEKQFKYCLLHPSYFTHEAHLRLAWIHLYKYGLQQAIKNVTHQLEEFTS
SHGERTKYNTTVTVAAVRAVYHFMLDSESQTFKDFIEEVPRLKFDFKELLGYHYAFNIFD
SDEAKEKYMEPDLLPFD
>OMIFANIC_01549 Motility protein B
MKKLLIFATCVGLLFSSCVSKKQYAELEAKQKETQDLLNTATVKLNSCLTDKAAALTRVQ
SLEERLADMRKTNQDLIQSSKDLTMLTQQGATNLEKSLESLKEKDLKISRLQDALNKKDS
VTLALVTSLKREVGLNDPDIEINVEKGVVYISLSDKVLFRTGSYKLSTRANEILGKVAVV
INGKPDFEAMVEGHTDSVPYKSGVLLDNWDLSVKRSTAVVRKLQELGVKPSQLIAAGRGE
FVPLVDNNTAENRSINRRTKILVLPKIDQFYTMIEEELETLAAEEGN
>OMIFANIC_01550 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MTVAVVILNWNGRSLLEQFLPSVVRYSSEATVYVADNASTDESVSFVSENYPSVKIIRNK
VNGGYAKGYNDALRNLDEDLFVLLNSDVEVTEGWLNPAISLFQKDPDLAAAQPKILDYQN
KSKFEYAGAGGGFIDKLGYPYCRGRIFNTIETDHGQYDDTAKIFWATGACLFVRRNSYGE
AGGFDEDFFAHQEEIDLCWRLQATGSSVMYIGNSVVYHLGGGTLKASNPRKTFYNFRNTL
LMLLKNVKGVKVYGIIFQRLVLDGIAGLMFLLQGKGYHFIAILKAHFSFYSLFPLFLKKR
KKHATNLTYSKIKSIVWKYYISKKRNFNEL
>OMIFANIC_01551 hypothetical protein
MQPLNFPSYKFRFKNRENKPLIFDVVRKKFVVLTPEEWVRQHCVQFLHHQLNFPLSLINV
EKQIKVHSTTKRYDIVVFKPDGSIHLIVECKAPKISISQETFDQVARYNFVLQASYLMVT
NGLTHYYCIMDYDESRYHFLKELPPYDKK
>OMIFANIC_01552 hypothetical protein
MPLEKTKQIIADIQQGKIAPIYFLMGEEPYYIDGISDFIEDTVLSQEERSFNQIILYGRD
VSIDDIVSSAKRYPMMAERQVVIVKEAQDLSRTIDNLLPYAENPQPSTVLVICYKYKKLD
ARKKLSKTIQKTGVLFESKKLYENQVPDWIRRVLAGKGYTISPKASQMLTEFLGNDLGKV
NNELEKLQLILPPGSQITPQLIEENIGISKDFNNFELQNAIGSRDIKKAFTIVQYFGQNP
KNHPLVMTVALLYNFFSKLLKYHALDNPANAARELGVSPYFIQDYQTAALNYPMKKVSGI
ISAIREIDMKSKGVGGANIPQSDLFKELLIRIFD
>OMIFANIC_01553 hypothetical protein
MTSTHHLGLLVLRISASGLMLVHGIPKLLEVLQGDFGFGDPIGVGATLTKILAIIGEVIC
PLLIIIGFKTRLAAIPAMITMFVAAFIVHADDPFANKEKALLFGFAFLVIALVGAGKFSV
DKK
>OMIFANIC_01554 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MSKVKAWVSAARLRTLPLSVSGIIAGSASAYAGDSFRSPVFILAIATTLGFQILSNFAND
YGDGVKGTDNKDRVGPARALQSGLLKAKELKRGMIITSAITLLLASMLIYAAFGKDNFLL
SFIFFNLGIAAIIAAITYTVGTSAYGYRALGDLFVFVFFGMVGVMGCYFLYTQNLGELII
LPAITIGLLSTAVLNLNNMRDRISDSKVNKNTLAVILGGKRVKYYHAFLIFFAFISASLY
IWISFTEWQYFIPLVAFVPLFLNVIKVFKTEDATKLDPELKKVALSTFLFALLLFAMNFI
>OMIFANIC_01555 hypothetical protein
MKITFYGQNSLGLEVSGKNIIVDPFISGNPLSKDKVDIDMLQADYILLTHAHQDHVLDAE
AIARNTGATIVSNYEIAMHYQEKGFNVHPMNHGGNWKFDFGNVKYVNAIHTSAFADGSNG
GDPGGFVIEGEHKNIYIAGDTALTMDMKLIPMRTKLDLAILPIGDNFTMGVDDAIIASDF
VDCDKVLGVHYDTFGFIEIDHDEAKRKFYDAGKDLMLLEIGESIEL
>OMIFANIC_01556 L-Ala-D/L-Glu epimerase
MLTATFQKHILHFKRASGTSRGVLTTKDTWFLILKEDNRIGIGECGMFKGLSADDRPDFE
EKLRWVCENISLGEQQLYAETNEFPAIRIGLETAFRSIKANDPFQLFPSEFSKGAQSIPI
NGLIWMGDESFMKDQISEKLKAGFSCIKMKIGAIDFETELAVLDGIRKEYESSEVELRVD
ANGAFKPFEALEKLKRLSEYQLHSIEQPIKAGQPHEMARLCEETPLPIALDEELIGVANS
EEKRKLLHTVHPQYIILKPTLVGGFRSSDEWISIAEETGAGWWITSALESNVGLNAISQY
TFVKNSKLPQGLGTGSLFTNNIPSPLEVKNGTLRYRPEISWKLNLLNL
>OMIFANIC_01557 hypothetical protein
MYIAQAYNYLHDWWRYLIPVAGLASLFVFNMAIIAIMDIDTEAFMKEQIEAKGSNRVFLE
NMIPFALFLGALFVWVKFVHKQTIRALTTSRKKIDWGRFGFGFFLIFIATVGTTLLSYYT
APENFVVQFDLVPFLILALITIVFIPLQTSFEEYMFRGYLMQGIGVMARNRWVPLILTSV
LFGSLHFMNPEVDKLGNVIMIYYIGTGLFLGIITLMDEGLELALGFHAGNNVVASLLVTS
DWTVFQTHSILKEISEPSTGFHILIPVLIMYPIFIGLMAWRYKWTGWKNKLFGNIEPPPE
EETEITEMFN
>OMIFANIC_01558 2-succinylbenzoate--CoA ligase
MKPTSQSLHPAFKLNGLDFSSAEEVLNFADGLLEDGNDQEASVVRFLEQWLDFNETVSVK
TSGSTGDPKVIELRKEHMINSAKATAAYFKTGVNTRALLCLSADYIAGKMMLVRAMVLGW
DLHIVTPSKDSLTEYDNDYDFVAMVPYQVWHSLESLGKVKKLIIGGGRIPAELETKLQEV
STEAFATYGMTETSTHVAVRRLNGPARSDSFSALPDVKFSVDERNCLLINAPNILDHPLT
TNDVVTLNSPTNFNWHGRYDNVINSGGIKIYPEIVEAKLSSDISNNFLIASEKDEELGER
VIMVYEGNERSAPNLSEAFRKLEPHERPKRVYSLSRFVYTETGKLKRQDVLKVLQKYK
>OMIFANIC_01559 TonB-dependent receptor SusC
MKKLFTTLICLFVLQLTAQTVTVSGTVTDEFNVPLNGANIIIQGTKKGVQTDFDGNYTID
AKIGQRLACLYLGMNDEVIEIKKAGTINIMMTQKAEEIGEVVIRTYGIPKSERIYASPVT
VIDGAEIENKPESDAIRSLVGKIPGARITGTSGAVGSGTNFTIRSSSSITGNNTPLFIVD
GTPFNSGTNDVAGLSGGGAITSSRFLDLDPNNIESVKILRGLSATVLYGQEGRNGVVLIT
TKSGSQKEYELAPNKPYSERYLAAQEEARTRLANERTAMELGYESPYQSLVKSILASKDR
MSTYLKLREANQDDPAFYVDVFDRFKKFDPEFAMGVLNSFVEVNSNDPNLLKVLAYKLEE
QNKSMDAVKIYRKLLKILPDEPQSYRDLALILEDTGNDDEAVKLLFSITQRAGLDREYKT
IIENDITRILSTSEQARETYNLKQSALKDVSRDMRVVIDWNRKDVDLDLKVIDPNLEIAA
PDNPRTRSGGRLLSNNDTGFGPEIFDLEQLQTGSYYLKVGYPLKEGEILDVEGPTYVKLT
IFRNYGRSNQTKEVQLVRISDDRKLQLMDRIAVL
>OMIFANIC_01560 hypothetical protein
MRILLLLFLFGTLTSHSQVLNEWDRAKLKDELLADRFNNVLPAIMDRADMDMWLIISREY
NEDPVMRTMLPARWLNARRRTILVFYRNKEANTIEKLAVARYDIGENIVSAWDKEKQPDQ
WARLVEIIRERDPDKIGINISEHFGIADGLVHTDYDELKEALPDDLEAKLVSAEKLAIGW
IETRTTKEMELYNTLVEITHGIIAEAFSEKVITPGTTTTDDVVWWMRQKVTDMGLETWFH
PTVDIQRSEEALKSHIYSFTKGDKNKIILPGDLLHCDFGITYIGLNTDCQQHAYVLKEGE
TEVPDFLKKAFADGNRVQDIFTDNFKTGRSGNEILLKSLSEGKEEGLRPSIYTHPLGTYG
HSSGPTIGMWDSQGGVPVRGDYPLYPNTVYAIELNTTVTITEWQKDVRIMLEEAGFYGEE
GFRYVNGRQQDIRPIPSKL
>OMIFANIC_01561 hypothetical protein
MGTIKTWNKWANRHSYYPLDLLRVALGVFLFIKGINFMGNAHMLLELVKPLQSIGGEMMM
IHYVAPAHFVGGLLIAFGLLTRWAIIAQLPILIGAVLINFLGEMNATNLILALVVLLICV
FFLFFGSGKHSVDYYLKMQQ
>OMIFANIC_01562 hypothetical protein
MNIKFLFVLIMSVILSGCSTEDNETSTSQNPDPVNNNPTVITAASLVIENTGANGITVSF
SVSEEGSGSGITEVGVVWSSNPNPTINDNKVSYSSAGSYRSQLAFLNDDTTYYMRSYGTN
SGGTIYGTESSISTLPTSQALVYDGDITLTSQQEVIDFGYQNYSKVTGTLAIWGYNYIDS
LTPLQTILRVNKLDISGCLGLENLNGLEHLHTIDGSLTIFANEGLLNFNGLNSLTEIGDE
LDIHNNAHLISISNLLSLTNIPGNLKVVNNDQLPNLQGLQQIDSVGGVVKVSLNDDLTDI
SAIAGIQFIGSTFDITGNQSLINIQGFNQLSSIGLDIQIVNNSSLTQINGFNAVTAGIRE
IEIRGNVSMESLNGFAGLVSVEDKLIIRDNISLTSINAFGNLASLDDYLGISNNTELSTI
SGFNALEVIDADIYFAYNNQIIDLNAFSSLRDIGDLSIVGNQLLVDFCALTPLIANNGVH
YFYVVEGNGYNPTKQDILNGDCSL
>OMIFANIC_01563 putative propionyl-CoA carboxylase beta chain 5
MDITFNKNEDHNKLLASELRKKLGKVMAGGGPKRIEKHHAKGKMTARERITYLLDDNKET
IEIGAFAGEGMYEEHGGCPSGGVVVKIGYVNGKQCIVVANDATVKAGAWFPITAKKNLRA
QEISIENRLPIIYLVDSAGVFLPMQDEIFPDKEHFGRIFRNNAVMSSMGITQIAAVMGSC
VAGGAYLPIMSDEALIVDKTGSIFLAGSYLVKAAIGETIDNETLGGATTHCEISGVTDYK
AKDDKDALDTIKNIVSKIGDYEKAGYNRIEAAKPKEDPFEIFGILPKSRADQYDMHGIIS
RIVDNSEFEEYKKGFGKTILTGYARIDGWAVGIVANQRKLVKTKKGEMQFGGVIYSDSAD
KATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFTIVIG
NSYGAGNYAMCGKAYDPRLIAAWPSAALAVMSGNSAAKVLLQIETASLKKEGKEITPEVE
KELFDRIKARYDDQISPYYAAARIWTDAVIDPLDTRKWISMGIEAANHSPIEKPFNLGVI
QV
>OMIFANIC_01564 hypothetical protein
MMNKNTVLAWATFIMIIVGIGLIVLGAFKYEDVAGWGFASVGIGFFAIAWVFNALKGRV
>OMIFANIC_01565 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMSGVSKTYQNAQTPVLKNIYLSFFYGAKIGILGLNGSGKSTLLRIIAGLD
KNHQGEVVFAPGYTVGYLEQEPQLDESKTVIEIVKEGVSEVVEVLDEYNKINDMFALPEV
YENPDKMQELMDKQAKLQDQIDATNAWELDTKLEIAMDALRTPEGDKQISVLSGGERRRV
ALCRLLLQEPDVLLLDEPTNHLDAESVHWLEHHLAQYKGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLEQKSKRLAQEQKQASKRQKTLERELEWVRMAPKGRQAKQKARL
SNYEKLASADQKQLDEKLEIYIPNGPRLGTNVIEAKGVSKAYDEKLLYEDLNFNLPQAGI
VGIIGPNGAGKTTIFKMIMGEETPDKGSFEVGDTAKLAYVDQAHSNIDSDKTIWENFSDS
QELIMMGGRQVNSRAYLSRFNFSGSEQNKKVSMLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVIISHDRWFLDRICTHILAFEGDSQVYFFEGGFSDYE
ENKKKRLGGDLLPKRIKYKKLIR
>OMIFANIC_01566 hypothetical protein
MLRNIKAIAFDADDTLWVNEPFFRNAEKEFCELMQDYLDEEQCNRLLFEVEMQNLPLYGY
GIKPFTLSLIEAAIRFSDGKVPISAINTLIERGKDMLQEPIELLDGIKDTLQQLNGGYRL
VMATKGDLLDQERKLIKSGLEPYFHHIEIVSDKTEVQYRKLVNHLDVKPEEFLMVGNSVK
SDILPVLNIGAHAFHIPYHTTWIHEEVKEPVEHPNFRLLNSATEMLNHLGVVAQ
>OMIFANIC_01567 Xyloglucanase
MKKNILKSLLTVSIFAICLLFFFSEKQQAIAKDPLMNEYPNEWMYMQRAYPNNFINRNAI
RTAIETSKTILANRGQQSGSDWSLAGPLNTGGRITDVAISPDNDDHLYLGTATGGVFRSY
DRGQNWTPVFDDFAKPSIGDIVIAPSNSQRIYVGTGEANGSATDGAYFGDGVYRSDDGGD
SWINTGLTESNHIGRIVIDPNDPDRVFVAAAGLLYGYNDERGVYRSINAGANWERVLFVT
DSTAAIDVAINPVNTDILFAAMWERTRKPWVRDYGGITSAIHRSTDGGDTWTQLGAVNGL
PGPDPQTGRIGLAISESDPSTIYARYTTNEITNVFDGLYKSTDNGDNWTLVTLNELSNID
ASFGWYFGNIRIHPTNPDEVYVLGQTIYKTTNSGNNWNQVTGMHVDHHALEYSKFNPNFI
LEGNDGGAYISENGGNTWTKFTNLPITQFYNIEVDNQQPERLYGGTQDNNTIRTLSGGTS
DWNSIIGGDGFHVNVDPYNNDYVYAESQYGNLRRSTDGGFSFTNATAGISSGDRNNWNTP
VILSPFDSETLYYGSNRLYSSDKAVFWTVISPDLTDGQHPSGSLAYGTLTAIAASYSNLN
TIYTGSDDGNVHVTFDGGNTWTDISSGLPDRYVTSIATIPADDNTAYITFSGYGELDYDA
HVYKTTDGGQNWIDISSNLPGIPVNDIVYDVVSEMLFVATDLNVWYSNDDGTNWDILGND
LPMTIIRDLKIHVPTNTIYAGTFGRSMHYYDIGNLILSNNAISSTPEAISIYPNPANEEF
SIDHDLNADGTIKLYDVTGKLIQDLFKGRLTETQNRSFKIENLSSGIYLVKIQSSKKAVT
AKLIVN
>OMIFANIC_01568 Dipeptidyl-peptidase 5
MKKVLVLLLLLLASSSQLHAQLQKKFEYLDVFQLEYTGDPQISPDGNYVVYRRTGFDIMK
DRSKGNLWLLSTDERKIHHKLTNFDGNERQARWSPSGDRIAYVRNTDNGSEIFVYWTDSG
ASAKLTQLENSPSSISWSPDGTKIAFTMKVNAKAPVIAKMPAKPKDAKWAKAPRITDRLK
HESDGSGYIKPGFTHIFTIPAEGGSSRQLTSKDRNHSGNLSWSPDGLKIFFSSNLNEDWE
YDFRNTEIYAINTETLQYETLTERPGPDSSPKVSPDGQYIASIGFEDKVQTYQTRKIELM
DSRGGNKQILSKNLDRSAQNIQWANDSKGLYFMYKDKGLTKLAYINLNGKVTDIADNVGG
TTLGRPYSSGSFSVSKNGKIAYTISSSDRPADVAIISKGQKNQKKLTGVNDDLLDYRMLG
SVAEIWYKSSFDGRDLHGYLVYPSDYDVQKKYPLLVENHGGPILNYGPHFSAEMQLYAAA
GYVVFYPNPRGSTSYGEEFGNLLFNNYPGQDYNDVMDGVDELVKQGKVDEEQLYVTGGSA
GGIMTAWIVGKTDRFRAAVVAKPVINWISKTLVADNYYGYANSRYPGQPWENFEGYWKFS
PLSLVGNIETPTMVMVGMNDLRTPPSEAKQLYHALKLRKIETVLVEIPEASHGIAARPSN
LITKIAHTLAWFEKYKE
>OMIFANIC_01569 hypothetical protein
MCKLFFLIIALAPAMAFSQAAEEKLANFGKISTALSITLIIMLGLVVYLMFQREKLLIRN
RQLSARIHKLEEKH
>OMIFANIC_01570 hypothetical protein
MAVNVIPFQQRYARDFYELNIEWLETYFYVEDFDKEVLSHPDKYIIEPGGHIFFAIEGDK
ILGTVALMPYAEGVFELTKMAVLPNQRGKKIGQQLMQYCIDFSIGQKFKKLILYSNTKLE
NAIYIYRKYGFVELELEPDSPYNRSNIKMELAL
>OMIFANIC_01571 Glutamate formimidoyltransferase
MQQQLIECVPNISEGRDSVKINSIANIVETVEGVKLLDIDPGKATNRTVITFVGEPEPVI
EAAFLLIKKASELIDMSKHSGEHPRFGATDVCPLVPIRNISLEETAVFAHKLGERVGKEL
GIPGYFYENAAKEEKRKNLASCRSGEYEGLPKKLSDPDWKPDFGPAEFNELVSKTGATAI
SARDFLIAYNVNLNTTSTRRANAIAFDIREAGRVKREGNPITGKKVLDKNGEPVRIPGKL
KAVKGIGWYIEEYGIAQISYNLTNISITSMHVAFDETCKAAEERGLRVTGSELIGLIPLQ
AMLDAADYFLIKQQRSLGIAESEKIKIAIKSLGLDDLKPFNMKEKIIEYMLDSEEKKLID
LKLNDFADETAGESMAPGGGSISAYVGSLGVALGTMVANLSAHKAGWDDKWETYSKWAEK
GQAYMSKLLFLVDEDTNAFNKIIDGFRMPQGSDEEKATRAEAIETATKYATEIPFQVMET
AHDSMEVMQAMLKEGLQTSLSDAGVGVLCARAAVIGAYFNVRINAKDIKDRKFALEILDK
AKKIYKSTLQIESEAIAYIDTRM
>OMIFANIC_01572 Formimidoylglutamase
MNSLKIYDKEFLDSLTLLRKGETKFGEKVGCIGDLDELKKHKADYVVLGIPEDVGVLANF
GKKGTSEAWDACLRSLLNMQANTLSKPENIIILGELDFRNEMRTAHMLDPEADNFGETIG
KLVEKIDLEVSQIIRTIVAAGKIPLVVGGGHNNSLGILKGSSDALGTPLNVINLDAHSDF
KPLEHRHSGNAFSYAMEKGYIYKYGIFGIHKSYTSQEVYNRMEQFKDRIGFYFFEDVILR
ENPPFKQAVKVAKQFIRDRKFGLEIDVDAIEAFTSSAMTPSGFSMTQARQFARFFSKSPV
PSYIHICEAIPSKSELDTVGKALAYLIVDVTV
>OMIFANIC_01573 Imidazolonepropionase
MNVLLTNIKQLLQVRDSRVTNLKGAAMKELPTLENAWLLIENGVIHNYGDMVATPTGSFD
KTIDCSGKIVLPSWCDSHTHIVFAGNREQEFVDRINGLSYQEIAEKGGGILNSARKLQET
GEDDLYMQSAKRLEEVMKLGTGAIEIKSGYGLTKEAEMKMLRVAKRLDKAYPVTVKTTFL
GAHAVPEKFKDKKEDYIQLICDEMLPAVSAEGLADYVDVFCEDGYFSVEDTDKILTAANK
YGLVPKIHVNQFNSIGGVSVGVKHKALTVDHLEIVSDDDIRELQHSETMPVALPACSFFL
GIPYTPGRALIDAGLPLAIATDYNPGSSPTGNMNFVVAAACIKMNLTPEEAINAATVNAA
YAMGLSKTHGSITKGKKANLIITKEIPSYGFLPYSFGSNCIDSVICNGELL
>OMIFANIC_01574 Cystathionine gamma-lyase
MKSKSPGVNTICTHVGELKDEQYKGAISPLYMSSSYAYEDVDVKRYPRYFNTPNQEGLSK
KIAALEHCEAGLIFGSGMAAISHSMLAFLEKGDHVVVQKTIYGGAFNFMVEEFPKYGIEF
DFTDGFSEADFRNKIRPNTKLIYVETPSNPLMLITDLEMISRLAKEHGLVSMIDNTFASP
VNQIPADFGIDVVLHSATKYLGGHSDLCAGAVAASEEHIQKIWNVGKNLGGSLSDYTVWL
LERSMKTLGIRVKAHNRNAKKIAKWLDKHDLVSQVYYPGLKSHPDHSLAKKQMKGYTGML
SFELIPAVTPEKFMASLKMIKQSMSLAGVESTILSPAKTSHALLSPEERERQGISDRLLR
FSVGIEDKNDLIADLKQALETVVTDQMQNTVV
>OMIFANIC_01575 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAIGAHPDDVEMSCGATLAKEIAAGKKVGILDLTRGELGTRGNAELRKHEAEEAA
KILGVIVRENLGLADGFFENNRAAQIAIIKVLRKYRPEVVFCNAVEDRHIDHGKGSKLVS
DSCFLSGLRKIDTEIDGNAQEAWRPKHVYHYIQWRDLEPDFVVDVTGYMDQKLAAVFAYK
SQFYDENSEEPETPISSKNATDSLRYRNRNLGRLIGSEYGEGFTVERYAAVNSIFDLI
>OMIFANIC_01577 hypothetical protein
MIMGSPMTAETRNGVFVNSYNVQEYTSANFLPHPGVPAGGTNFADDNLDDWNPASGAINP
GEGYLVYPQAAYNDPLYDGPPPVTTLTFPLTYTQGTLNNGTISRSVLYNGGTNPDGTPNI
LSNPYASPIDAGVLIANNALINEVYFWEHLTAPSAGIPGANTINVSMDDISMYNGTMGVP
AANDTGTSTTPNGVISTGQGFGIKAFGSGTVNFTNSMRLTSGNSTLRTSQEEAEKLILKV
ANDSYDLRSYTGIGFRSDGTPELDDNMDSNRLATLISLYSHLEDGSEQLGIQTRESFESG
IKIPMGFASQVEEAALFEISIAGLEGTSLTNASIYLIDNVENTITDLTQTNYQFSSNKGT
FNGRFTLQFEGDILSTNDLALETIGVYPNPTSGQLNIVSPTIGIEMITVYDLRGRKVEEV
SLNGEQSYQVDMSAMDAALYFVTIQTENGSVTKRIVKK
>OMIFANIC_01578 hypothetical protein
MKKLIVVVLIVGTTFIFFGTKKGRVAKNVAISYVISSELVNEEGSVVSDRILLPEGYTRK
TYPEGSFQQYIQQYPLENYGAKIINYNGQEYGYQSGHVGIFSLPVPENGLQQCADALIRI
RAEYLWDKVRKDEIGFNFTSGHYFSWKEYAEGYRPKINGNRVTYFKIATQDVSEDNFYRY
LNLIFMYSGTQSLFDELDPVEDISDVEVGDMLIYPGSPGHVIMVADVAIDEIGNKLFIFA
QGNTPAQSVHILKNPNDKRISPWYDIEMGQYLEIPTYFFNEVKFIRFK
>OMIFANIC_01579 hypothetical protein
MPRPLTEQELHNLAMNIVGKDLEEQGFEFLGVNSKLKKDPQFVALKNKDLHFVVVRAISY
PQDAHSYDPVFMQTIKAHADQFDGKTFYAGVGLGHGSDYGKPVIKDEDYTLVYKGIQEIL
>OMIFANIC_01580 FAD:protein FMN transferase
MRITPLLLLLIIAGACSESEPVSRIFKGDAFGTTYNIQYFAESEFDAKSGIDSVIDVVNH
SVSTYLPDSDISRINRGDTSVVVDDIFRDVYTISEKVFIDSEGYFDPTIGVLRNAYGFGD
VKPLAEISESVLDSLREFVGFNKVKLTSDGKVQKAHPEIYFDFNAVAKGYGIDRIGHFLE
SRGVTNYLIELGGEIRASGLNLSKDQSWVVGVESITSEINDRNYAEAVTISNQGLASSGN
YRKFRIDSISGKKYVHTINPLTGLAQQSDVTSATVIASDCATADAYATAFMAMGLERAKI
LLSGSEDLEAYLTFSDSTEIPQIFMTEGFRKQLKK
>OMIFANIC_01581 hypothetical protein
MENFNLIWIFLVAINMFGQSPNDCTNAILVCGNTSFGLEPDGVGFDEFSLSGNERPPCYS
FNLNTIWLRFVIEESGELTFDLIPESNQADYDFAIYGPNVSCDNLGSAIRCSSTNPQNAG
VPVNTGLNLTETDHFEGPGEDGNGYLQFIDAVAGEEYIILIDRPHGSGGFSMEMTGSAVL
PEQPFAHDVEDVVTCEMDEIVDGSTLFDFDPLIPEIMQGQSNMTVTFHETLNDANIGINP
IISPYMNTSNPMTIYYRIENNNSGCVDINDFEILVEAPFEVTLAEDLFVCENTSEPVILE
TQSGFAYYEWSTGEEGANLNSIEITAGGEYWVNVTDSQGCKVKATTIVNSSEAATITDVS
VEDFRGRDNTVTVTVEGNGEYQYLLDDLLPYRDENFFIDVDRGYHKVKVRDKKGCGIAEI
EVLVLDYPKFFTPNGDGVNDYWQIEGIWEFPGSKIIIFDRYGRILTGIRLDSSGWDGTND
NGVPVPSNDYWFAITMEDGREVRGHFTLKR
>OMIFANIC_01582 Demethylmenaquinone methyltransferase
MQRLFKFFLNLFPRPLLIRLSYLVRPFVAFFLKGSKYLDPIDGKSYRKFLPYGYEKVREN
VLAPGTLSLERHRLCWLYLKNETTLFTAPHKVLHFAPEQAFLKRFRRMKHLDYTTTDLNS
PIADIKADICDLPFDDNTYDFIICNHVLEHIPDHLQAMKELYRVLAPGGTAILQVPYDKN
RKTTFQDDSITDPKERTRIFGQYDHVRIYGMDYFETLASVGFSVDAADYTASLSDDMIDK
YRLAKGELIPICKKL
>OMIFANIC_01583 Methionine aminopeptidase 1
MIKPKTKEEIELMREAALVVSKTLGMLAGEVVPGVTTNQLNAKAETFIKDMGAVPGFLGL
YDCPSTLLTSVNEAVVHGLPTDDPLQEGDIVAIDCGAVLHGFYGDHAYTFEVGEVKPETK
QLLEVTKESLYRGIRQFKKGNRVGDIGYAIQNYCESFGYGVVRELVGHGIGTKLHEDPEI
PNYGKRGRGKKFIEGMTIAIEPMINLGTHKVKQLKDGWTIVTQDGKPSAHFEHDVALVDG
KPELLSTFAYVYEALGIVSDEEKEFRQKELVL
>OMIFANIC_01584 hypothetical protein
MEETYTIAIDFDGTIVEDEYPGIGKPRIFAFETMKRLQEKGHRLILWTYRNGKHLDDAVA
FCEDNGITFYAVNKSFPEEEFDPKYSRKINADYFIDDRNIGGIMGWGEIYQILVRETPPD
LSAKKQKKSWFPF
>OMIFANIC_01585 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MNKKVLLLILDGWGIPKDPSVSAIAQGDTPYVDSLYERFPNAQLRTDGMNVGLPEGQMGN
SEVGHMNLGAGRIVYQDLVKINLAVENDTLKDEKVLTDAFEYAKQNAKKVHFLGLLSDGG
VHSHINHLKGLLSTASAKGVSNMFVHAFTDGRDVDPRSGAGFISSIQDHLQTTGGKIASV
VGRYYAMDRDKRWERVKEAYDLLVHGKGESSENVVRSIQQSYDSGVTDEFIKPIVMMENG
QPVATISEGDVVIFFNFRTDRGRQLTHVLSQEDISEYDMKKLPLHYVTLTNYDDSFTGIN
VVFQKENLKNTLGEVLAERSKTQIRIAETEKYPHVTFFFNGGREIPFDGERRILCPSPKV
ATYDLKPEMSAYEIRDKIIPEIENETADFICLNFANPDMVGHTGDFNAAIKACETVDRCT
HDIVETALQHGYASIIIADHGNCETMRNPDGSPHTAHTTNPVPLIIADSDITAVKDGILG
DIAPTILKLMGVPKPEAMTRESLV
>OMIFANIC_01586 Beta-barrel assembly-enhancing protease
MRSRNSWKIRIFIGLAIVAFAFMRKCSSTETNPYTNREQAIALDPQEEIALGVQSAPQVA
AQHGGLYPDERMQSYVDAVGDKLVANSMATNSPYRYEFHLLADEQTINAFALPGGQIFIT
YALFEKLNEDQLAGVLGHEIGHVLGRHSSERIANTEFWQTVSQGANVGANAGDLIAGIGQ
NTLLTNGRGDELESDDLGVLIMLNSGYDAYEMVNVMKVLKAAAGPNRVPEFQSTHPDPDN
RIERIKESIEKYGG
>OMIFANIC_01587 D-alanyl-D-alanine carboxypeptidase
MKRALFLKTCFYSGLGLSIMPQFSFVSFQNKFSRNQLIGKGNPDISGDSYTTKMHKDASL
AFKRMQAAAAHSGIKIELVSAYRSFERQKEIYEGKYKRFTGQGLSPEQAIEKIIEYSTIP
GTSRHHWGTDIDIIDANAPRPENVLQPEHFHGKGPFCKLKEWLNENATLWGFYEVYTDDP
NRKGFKYEPWHYSYAPVSVPMLKEYRNLDIKRILQEEKIKGSEYFSNSFMERYISENILD
INSELL
>OMIFANIC_01588 Peptidase E
MKNLIVASTSTVHGESYLEYLLSTLVNLYQGTEEILFIPFARPGGISHDDYTATASQAFS
KIDKNLRGIHTFENPIEAIRNARGIFTGGGNTFVLVNALHRSRLMEPLRKVIFGGTPYLG
TSAGSNICGVSMQTTNDMPIIYPPSFKTLGVLPFNINPHYLDPDPSSTHMGETRETRIKE
FHTQNTIPVVGLREGSWLDVRADNILLKGNHSARIFLKDKEPYEVNSGTVIDDL
>OMIFANIC_01589 hypothetical protein
MKKQYLIILLLFPLCIVAQEKILLQGKITNEKDVEGIHILNRSTRFNSVTDIYGNFSITV
KESDTLVFSSVHYNPLEVEITSEIFKEALLIVTLQELINELDEVFLGPDLTGNLRTDIEK
IEVKDPINFQDLGIPGYTGTPQERIVPVTTALFPTSVNIEAVYKHLSGYYRKLRLRRKWD
AENRAVASLIDYYNARFFQEAYNIPKNRLYDFVLFCVESTQIAQDFYAGRYEEVFKTFRD
KSKLYLARMNAKEE
>OMIFANIC_01590 hypothetical protein
MKFLKLTFLIFIFPLLTAATAHKFYVSITKVEYVAEKQSLQIISKIFIDDIEDALQTRYD
EDLRLDPEKETEREETFLKQYIFQKLKIAVNGTPVTFDYIGKEYETDIVKIYLEVTDISE
VKTLEITNKVLMEMFEEQQNIIHYKSGGKRKILVLEKDYPKGMLNFN
>OMIFANIC_01591 hypothetical protein
MKLLKYLFLGLIFIATGSTYAQDTNEDKEERKPGHYNENRFKQLYEEFSTPNVYRTASGA
PGPQYYQQQADYKMDITLDDKNARLYGKETITYTNNSPDILEYLWIQLDQNVRAADSKSP
LIESSGAAPADMAGRFVGQYMGAPFDGGFKIQEVKDGNGKDLPNLINQTMMRVEMPKDLK
PGEKFSFSIKWWYNIPEHTIDRARSGYETFEDGNRGYVIAQFYPRMAVYNDVEGWQNSQF
WGRDEFALPFGNFDVNITVPADHTLDATGKLLNRKEVFSKTMMQRYAKAKKEYTTPVQIV
TEEEAEVASKGFATATKTWKFRAENVRDYGIATSRRYMWDMMAVKVGSREVMAVSVYPPE
GNPLWSDWSTKVVASTLKSYSRMTFDYPYHKAISVHAKNQGMEYPMICWNYGRPDKDGNY
SERTKYGMMSVIIHEVGHNYFPMIVNSDERQWTWMDEGLTTFVQYIAEQDFGEAYPSAIA
PNKKYPSRRGPAKNIVDYMSGDQDYLAPIMTKGLNTYNFGANAYSKPATGLNILRETIMG
RELFDYAFKTYAQRWMFKHPTPEDFFRTMEDASAVDLDWFWRSWFYTTDYTDIGVKEVKK
FYVTSKMNKEVREMIARRGMTESDLPPLVYLVEEGSEDFEESMRTATLDDVTTLNEYIMD
NIPESERANLKKPRYFYEVTFEKPGGIPMPIIAEYTYSDGSTERVTYPPQIWRKNDESVG
KVVASDKEITKIMVDPDEETADIDTSNNSWPKRKKLGEFDTFKNKVKGQ
>OMIFANIC_01592 Sec-independent protein translocase protein TatA
MTAMTILPLFISGAEIAFILFIVLMVFGADKVPEIARGLGKGMRQIKDATNDIKSEITKS
AEKQGIDVDITQDVRKEIDKVKEEVNEVSGSIKRKF
>OMIFANIC_01593 hypothetical protein
MIEQLKVWDRELFIWLNGLGVESYDAYWIFITKIESWTPIFILFLAGIIYYYRWKRGLIL
IGFVLLTFGLTLFLTDFTKEWVGRLRPNNSEQLAGLIRILQKPESFSFFSGHASSSFVVT
TFVFLSIRKFNKWILLAYLWPILFVLSRIYVGVHYPSDIIIGAIVGILMAYFFYYISKLI
LNKIYM
>OMIFANIC_01594 hypothetical protein
MKKPVRLLVSTISLFVLLMTAVSCEIKKEAPQQAISIEEADNLEEEFKRSRSRILDSALG
FQDTRDFWFSLDTLKKYIEYVEYEGKKLGKENLGIRVYFAAYPEDSNYPDPGFATVFLVP
TAEAAPNPLKQGFFPMPVENEVLDSLKAMNFSQGGRPPNDL
>OMIFANIC_01595 hypothetical protein
MNIEYFFFIPLLLELLAAVIGTVTYRKYSESNEKYFLYFLWYTLLVELTGDVVGYLFSAD
NFWVYNGFIITSFLFYFYWYYSILKRKRFRKTIVVFTAVFLIVAAYSLVYEDGSQYHSYT
FLTGASFVLVLTVFHFYNLLNSDEVLIVKYKLSFWISTALLLFYMGMIPLMFLTVYADLN
DVSYLIIILSMNLILYGCYIIGFLWTKKEYNRF
>OMIFANIC_01596 Oxygen sensor histidine kinase NreB
MDEKGVQSFLIIFSLIAFLLALTLIVLFAIFQKRKNRLLREQQDAENRYREEIIETQIEI
KEETLRNISWELHDNIGQLLTLSKIQLQNADNNPNSVQEASETIGQCLEELRSLSKLINP
DTFSNLSLVEALQLEMERFNRMKYLKASLSFSQADFYLDNKVELIIFRMLQEFFTNTIKH
SKADVLKVNVDFKDDILKIEASDNGIGFDTEINNAESGIGLMNIRNRAILIGADVELHSK
EGEGTQLKLTYKKDTL
>OMIFANIC_01597 Transcriptional regulatory protein DegU
MSYSVVVVDDHILLSQAIGGLVDGFDKFSVLYICKNGQELVEKLKNPKNIPDIVLMDVNM
PIMNGIEATSTLYKEYPQVKVLALSIEEDENVILKMLRAGAKGYLMKDVKKTELENALLE
LMEKGYYHTNTVAKVLVDSLSGKESSLDSLKERELEFIRHACTEKTYKEIADEMFLSPKT
IEGYRNSIFEKLNLRNRTGLVIYAIKHKIFIP
>OMIFANIC_01598 Putative O-methyltransferase/MSMEI_4947
MEFLPKKIDAYVVAHSQAEPKLLQELTRETWQKVLAPRMLSGHLQGRVLSMLSKLIKPKN
ILEIGTYTGYSALCLAEGLAEHGELHTIDINEELHAIQRKYFDKSGYGNQIFQHTGNALD
IIPGLDYSFDLVFIDADKRNYPKYLDLLMARLPVGAVILSDNVLWSGKVVETVKEDDADT
KALLQYNKQLNEHPKLESVLLPIRDGLTISRVL
>OMIFANIC_01599 hypothetical protein
MRKKLRINGHSHLLPYPEQIPQFMKDKGIFWVDKDRKFMLQKDWSRPVTDSSFFLNEKLE
WMERYKIDHAVVLNLSQLYGNGLRVEEMKKALRFQNDFNAEVQRDNPSKFTCGFVVHPGF
VRGALWEIERCVEELGMQLLCLPTHYMDTIGTWRCIFDEENEPIFELASKYNLAVEVHPY
DGEKFIKLENTAWRFHLIWMLAQCADAYHFLTLNGYADKFPNMRTCFAHGGQLAQINLGR
RIQGFDGRPDLFEGMVHPRKSVGHKNIFFDTLVHDTGSLKLVVENQTSKQIVMGLDDPYP
LGEMESESQSSYPGKILDLAMERNILTSHECDEIWEDNVIQWLCGDDEVAKADLVKRILG
E
>OMIFANIC_01600 NADPH-dependent reductase BacG
MNLDLTYKNALVCGSTAGIGKASAIELAAMGATVTLVARNEEKLKETIIDLPFEAGQKHD
YVVADFSNSEEVKEKISRACQDKIFHILINNTGGPKGGPIFNAETDEFTTAFEQHLVNNH
ILTQSVVPGMKKADYGRIINIISTSVKQPIDGLGVSNTIRGAVASWSKTMANELGPFGIT
VNNVLPGFTATDRLTDIVANAAKKMSKTEAEASEWMKNLVPARRFAQPGEIANAVAFLAS
EAASYINGINLPVDGGRTKSL
>OMIFANIC_01601 2-aminomuconic 6-semialdehyde dehydrogenase
MEKIINYINGEYCEPLSGDWIDNYNPSIGVVYGKIANSNEVDVAKAYEAAQDAFPSWSNS
TIEKRSRILLKIASLIEENLDRLAHAEAEDNGKPLSLAKAVDIPRASANFRFFGNAITQF
SSEAHESVGLNTMNFTLRQPIGVVGCISPWNLPLYLFTWKVAPAIAAGNTVVAKPSEVTP
KTAYLLGEILTEAGLPKGVLNIVHGTGPSAGQSIVAHPKIKAISFTGGTKTGEHIARTAA
PMFKKLSLELGGKNPNLIFADCDYEKMLEVTVRSSFANQGQICLCGSRIFVERPIYEKFK
KDFVEKVSKLKVGNPFADDTNIGALVSKPHLEKVQSYIEIAKEDGGKILYGGDPVTVNGA
ENGYYLEPAVIEVYDDQCRVNQEEIFGPVVTVMPFDTEEEALKMANSVPYGLSSTLWTSD
VNRTMRVSKKLEAGIVWVNTWLNRDLRTPFGGVKASGVGREGGFEALRFFTEPKNICIKY
SE
>OMIFANIC_01602 2-aminomuconate deaminase
MKSRLVEGKATPRGAYPHVKRVGDFIFVSGTSSRLPDNTFAGVYRVDDMGTMRLDVREQT
RAVLENIKDYLATEGASMEDVCDVTSFLVNMNDFAGYNEVYAEYFSKESGPARTTVAVHQ
LPHPHLVVEIKAMAYKPKEN
>OMIFANIC_01603 Kynurenine 3-monooxygenase
MNNKENILIIGAGLCGSLLALRLAQRGYDVTLVEKRPDLRKIEQDAGRSINLALSDRGLK
GLRLGGVEEEAKNLCIPMEGRMIHHENGNVFLTRYSGRDHEHINSVSRPGLNMLLLDACE
KMPNVKMYFDLGCEDVDLKNASARFKHSNSGELVHFQGDILFGTDGAGSVIRKSMFLNRE
FLFSFSQNWLTHGYKEITIPAAEGGGYRTDKSALHIWPRGEDMLIALPNLDGSFTVTLFL
PFSDSDYCFDNLTTPEIVMEYFNKEYPDAVALMPDLAKEFFENPTGPLGTIKCSPWSTYG
KTLIMGDAAHAVVPFYGQGMNASFEDVVVLDEFIEKYEGDWPKIFSEYEKERKKDTDAIA
DLALDNFHEMKEHTASDLFQAKRKLELQFETELPADYNSKYSLVTFNENIPYSEAMKRGR
AQDKAILNLLADGKLDKSMLLKDKLELVLKETAEILHDDAVVKNL
>OMIFANIC_01604 Kynureninase
MYQNSLEFARRCDTNDPLTDFRNKFHIPKDAEGNELIYLCGNSLGLQPKSTSEYIRKELD
DWAKLGVEGHTEAEHPWLPYHEFLTKNMADIVGARPSEVVVMNTLTTNLHLMMVSFYQPT
AKKYKIVVESDAFPSDKYAVESQLKFHGFDPKDGLVQWTPREGEELCHFEDLEQIMTDQG
DEIALLMIGSTNYYSGQSFPLKKITELGHKFGCLVGFDLAHGAGNIYPDLHETGADFAVW
CSYKYLNSGPGSLGGCFVHKRHANNPKLKRFTGWWGHNKQTRFNMRHEFDPLPGAEGWQL
SNPPILSMAAIRASLDIFAEAGMKNLRKKSLKLTGFLEFLIDQLHDNRIEIITPRDPDER
GCQLSIQVKSANKKLHDKLTEAGVISDWREPDVVRVAPAPLYNSFEDVFHFSERLKHILS
>OMIFANIC_01605 hypothetical protein
MRKFFFILTLFVVGQSVYPQSVARQWNEEILNAIRNDFARPTVHARNLFHSSVAIYDIWA
LFDPDSKPYFLGNTVGEYSCNFDGFSTEEDIVKARHEAMSYAVYGLMKHRFADSPGKEDI
FTSIDALMDSFGYDINFRNTNYKSGNPAALGNYLAEQLIAFGLQDGSNEAGDYENTFYEP
LNDPLDTDITGNPDIMFPNNWQPLKVENYVDQSGNIIPGGQPPFLSPEWGKVTPFSLNSD
QLTVYPKPGFDYLVYHDPRDPPYIQDGLGLDDPYKWGFAMVSVWASHLDKNDPTMMDISP
RSLGNVSIDSYPTDFEDYDSFYTFVEGGDPSPGREINPSTGMPYESQLVPRGDYTRVLAE
FWADGPDSETPPGHWFTILNYVNDQPQLVKKFRGKGDVLSDLEWDVKSYFILGGTMHDVA
ISAWGIKGYYDYIRPISAIRYMADQGQSTDPNDASYDPHGIPLVPNYIEVVKEGDPLAGA
FNENVGKIKLFTWRGPDFIVDPNEDEAGVGWILAEEWFPYQRPSFVTPPFAGYVSGHSTF
SRAAAEVLTLLTGDEYFPGGMGVFDIPKDEFLKFEKGPSVPFQLQWATYRDASDQTSLSR
IWGGIHPPCDDIPGRIIGARIGTDAFSFAESYFVGAILERGRIYPNPTADILNVAFKTDQ
PLEVCIYDTLGRKVYTENAVFDNEDRCSLDISALRDGLYFVSLEWEDRRLFTERLVKK
>OMIFANIC_01606 hypothetical protein
MRFCLIFLLTFVTLISCKESPKNVAVTDAENTEVPLSIAEQIASNYGIDKWKDVSELRFT
FNVTSGERRTNRSYIWNTKTQDVVLMNDSNIIQYNRNDNLDSLQLFADKRFVNDSFWLLS
PFKLVWDEGTSISYEDKVIAPISKESLNKLTIVYSSEGGYTPGDAYDFYYTGDLEIKEWG
YRRGNAEEASMSTSWTKLESFNGIKLNTRHNDSSGNFELYFTNISVKN
>OMIFANIC_01607 hypothetical protein
MDVRKEYTNGDLTVVWKPGLCFHAKECVKGLPAVFNPKEKPWIKAENAGIEELKKTINKC
PSGALTYYLKGEGAPEDEKQNTMSETKVEVLENGPLMVKGTIEITHTDGSKESKTRNTAF
CRCGKTGNTPFCDGSHNN
>OMIFANIC_01608 hypothetical protein
MKVDVTKNLKRRRYETEVNGYTAFIEYIKAKNAIYLTHTEVPVQLEGNGVGKAMVIEVLK
VLKEEGSRVAPLCPFVAAYIKENREWVSLVADGYNVG
>OMIFANIC_01609 (6-4) photolyase
MKKLRLVLGDQLNYQHSWYSKNEEDVVYFLAEMRQETDYVKHHIQKVVAFFESMTSFTEW
LRERGHRVIYYSLDSEDNKQDLQKNLSFLIKDLDIEKFEYQLPDEYRLDQQLREFCESLN
IPSESYNTEHFLSERNDVANFFAGKKEMTMEYFYRSMRKKYEILMVNDKDPEGGKWNFDA
SNRKKWKGSPDIPHERGFRKDISETYNRIKKAGVETIGNIDPSSFNWPTSREECLSVLRY
FCNNLLVHFGDYQDAMHTEEKFLFHSRLSFALNTKILHPMEVIESVIDHWREHKDVIDIS
QVEGFVRQILGWREFMRGVYWKEMPSYATLNKLENTNKLPEFFWTGETSMNCMHHAISQS
LDTAYAHHIQRLMITGNYALLTQCDPDEVDSWYLGVYIDAIQWVEITNTRGMSQFADGGI
IATKPYVSSGNYINKQSNYCGNCQYDVNKKVGENACPFNSLYWNFLDDKKEYFKNNRRMG
MMLNLLKKKSAEEISEIKQRAADIIANPDKY
>OMIFANIC_01610 Cryptochrome DASH
MKNSLVWFRNDLRISDNSVLTGVCADSDKVIAVYCFDPRQYATGDFGFVKTGKYRAKFLI
ETVTDLKIQLSRLNIPLFISLSRPEDYIPGLIEAHDIKRIHFQEEWTRDEKNVEDQLRRA
IPETVEIFRQFDQFLFHPKDIPFENLSQIPEVFTAFRKKLEKYAEVRRVIGTPKALPKEN
LIENRSELPSLTDLGHDDFSSDSRSAFPFQGGETAGLKRIDDYIWESENISKYKETRNGL
VGKDYSSKFSAWLANGSLSARMIYWAVRKFEKERIKNSSTYWMIFELIWRDFFKYVSLKH
GDSIFHLGGILNKDYHWKNDRAILQNWIHGKTEYDFVNANMKELAATGWMSNRGRQNVAS
YWAKEKEQDWRVGASYFESMLVDYDVHSNWGNWMYNAGVGNDPRDRKFNIQRQAEMYDKE
GSFRKLWNR
>OMIFANIC_01611 hypothetical protein
MIHKTNSDILEMDKIERLNLINSCTGYKSANLLGSVSPDGVTNVAVFSSVTHLGSNPPLL
GFVLRPTTVPRNTFDNIKKTGEFTVNHIHSGMIADAHHTSAKYPGHVSEFDKTNLKSKFR
DGFKAPYVEGAKIQLGCRYVNEYAIEENGCLLIIGSIEHIYFENDLQLTDGFLALEKADT
VTVNGLDGYALPKLIDRFEYARPE
>OMIFANIC_01612 Ubiquinone biosynthesis O-methyltransferase
MDFQKEFNTNRETWNKKVAVHAASQFYDLEAFKKGADSLKKYEIAALGNVTGRSMLHLQC
HFGQDTLSWARRGAKCTGIDISEEAIKLAKSLNEELDLNANFVCCNVLDVSEHISETFDI
IFTSYGVIGWLPDLKPWAKMIAERLKPGGTFYMVEFHPIAWMFDYLQEPPIMIYGYQQEE
AIYEEYEGTYAEDAKSKITSKEYGWHHGLGEVITALIKAGLHIEYLKEYEESPYDIFPDL
EKTEDGMFALKDRLYPLVYEIKALNHAL
>OMIFANIC_01613 Peptide methionine sulfoxide reductase MsrA 2
MKRLTTIFITALLFSLQGACQSSNEGNKEAEADAQANLTPVEVPAQNGLERAYFASGCFW
CVEAVYESVKGVKESISGYSGGHTENPTYESSNTGRTGHAEAVEIIYDPEVVSFATLVDV
YFGSQNVTQVNGQGPDRGSQYRSIIFYQNEEQKKIIDEKVAEQEKIHGEGKVAAQIMPFQ
KFWVGEKYHQDYEKLNPNNPYIRNVSIPRLKRFQKKFPHLLKENEEH
>OMIFANIC_01614 Chromosome partition protein Smc
MAKKTETTVEEKLRALFDLQLIDSRIDEIRNVRGELPLEVEDLEDEVAGMNTRMEKLKSD
LEVIETSIKDKKNLIEEAKSLIKKYTAQQDNVRNNREYNSLSKEIEFQELEIQLAEKHIK
EFKAQIEQKNVVIDETKERLKARQDHLKHKQGELNEILSETEKEEKSLLKESEKYEKNIE
ERLVKAYKRIRSNVKNGLAVVQVERGASGGSFFTIPPQVQMEIASRKKIITDEHSGRILV
DPELATEEREKMGKIFAKMK
>OMIFANIC_01615 GTP cyclohydrolase 1 type 2 
MIGWNTALYKTRHTRFIFPAFHKTKVYFFIFTVKYKGMKVKEVMAALEEIAPLSYSEDFD
NTGLLVGDMHRDITGILVTLDTLESVVDEAISNDCNLIVSFHPIIFSGLKKITGETYVEK
VVQKAIKYDIAIYAIHTALDNAWNGVNAMICEKIGLNNRSVLIPQRGTIQKLVTYVPTKE
ADTVREALFEAGAGDIGNYSNCSFNTEGKGSFNPNENANPTLGARGETHFEDEVRIEVTF
QKHRKGKVLQALFNAHSYEEVAYEVTTLDNINQHIGMGMVGTMERTVTEEEFLSHLKSTM
QTDCIRHSELIGKPVQRVAVLGGSGSFAIDTAIAAGADAFVTADMKYHDFFKSEGEILLA
DIGHYESEQFTKELILNVLSKKITNFAPALPQGKLVLSKINTNPIRYY
>OMIFANIC_01616 Tetraacyldisaccharide 4'-kinase
MRNYMYDKGWLKSTEYEIPVICVGNLSVGGTGKSPMISYLVTLLKDEYKVAVLSRGYKRK
TRGYLEVKVDHTAREVGDEPLQFKQNFSNITVAVCADRRTGIEKLKSKADLILLDDAFQH
RKVKAKVNILLTPWDDLYIDDYLLPMGMLREPITGVARADIVVVTKCPDGFPYAKQQEIQ
LRLNLKPHQKLYFSKVAYDNMIYGKSENLTLKYLIDKPFTLVTGIANPEPLVEYLKKHGY
RFTHEKYPDHHDFTDSDINKLSKQEIILTTEKDYMRLQPHIDKFALYYLPIKTIILNEQH
SYFKERIEKALQ
>OMIFANIC_01617 Sensory/regulatory protein RpfC
MARDAISKQKFDEAIVQLINANKIAAEFSDRSYKSALQLEVAELHYFLENYVKADNEADL
ALENLEKENDEILKAHAYNLKGLILTQLNELSKAENFFRRAENIYTSKGTEAQRACVLLG
LGDLERKNGKLTDAINYYNATLAVFEENDMAFQLASAYLSKAEALIELEDPSTEASITAA
AESLSEARVLIGKNAFTKLEVQSYKIASHIALKKGDLAEINTNLHLYETKNDSLQQAYLQ
AIAKGVEIESSVSSLKEKIEEQQTNIDKQQKSINFGRMTTGLSIALIIILSLLTLSLYKN
NNLRAKANELLQDKNIELQLAKEKAEKASLAKAQFLSTITHELRTPLYAVTGLTHLLLEE
DPKPHQKEHLNSLKFSGEYLLSLINNILDLNKLEANKVEIEKTTFSLKKRINDVLIALKK
SADDRKNNLHLEYDETIPDRLVGDPLKLSQILINLIGNSVKFTQNGDVVVRVRKLEEKNS
KVSLHFEIEDNGVGISKKKQKSIFETFSQASLQINRKFGGTGLGLSIVKNLLELMGSKIN
LESQLGKGSKFWFNINLDISEEVKEDINPKNIIYDVDYVALENRKILVVEDNKINQMITR
KILEKNKMNCMVADNGMDAIKLVKENEFDVILMDIHMPGISGIEATQKIRAFNKDIPIIA
LTAVTIDENLDDFYRAGFNEIIPKPFKTEEFFEKIYRSISDKTFPVNS
>OMIFANIC_01618 Glyceraldehyde-3-phosphate dehydrogenase
MDKVVNIGINGFGRIGRTLFRKLIDNPNVNVVAINDISDPKTMSHLLKYDSIHGVLPNEI
GYNADSIILDENKIFFTSEGNIDAIPWGKLDVVVECTGKFKSKEQLQYHIKNGASRVILA
VPPEKDDIKTVVLGVNDQILKPEDHIISNASCTTNNAAPMLQVINELCGIEQAYITTVHS
YTTDQSLHDQPHRDLRRARAASQSIVPTTTGAAKALTKIFPELSTVIGGCGIRVPVPNGS
LSDITLNVKREVTIEAVNEAFKEASQGSLHGILQYTEDPIVSVDIIGNAYSCIFDSGMTS
VIGKMVKIIGWYDNEVGYSSRIVDLILQISRK
>OMIFANIC_01619 Lipoyl synthase
MEVNTVDIQKPQPKPKWLRVKLPTGKKYTELRGLVDKYNLHTICTSGSCPNMGECWTEGT
ATFMILGNICTRSCGFCGVKTGRPQSVDWDEPEKVARSIKIMDIKHAVITSVDRDDLKDM
GSIIWAETIKAIRRMNPQTTLETLIPDFQGETRNIDRIIQVKPEVVSHNMETVKRLTREV
RIQAKYERSLEVLRYLKEQGIERTKSGIMLGLGETEEEVLQTMQDLRNVGLDIVTIGQYL
QPSKKHLPVKEFINPEQFKKYETIGLEMGFRHVESGALVRSSYKAQKHLT
>OMIFANIC_01620 Divalent metal cation transporter MntH
MKLSLKKFGPGFIFAGAAIGVSHLVQSTRAGADFGFGLLWALLLINAVKYPFFQFGPRYA
SATGESLLEGYRKMGKSVIYIYFVLTFATMFTIQTAVTIVTAGIATSLFGFGTPVLWTAV
ITVICFTILVIGRYKLLDSLMKIIVIGLTISTLIAVVFAVDPGAITSFDPILPTETAAVA
FLIAFMGWMPAPLDISIWHSIWTVEKKKLNPSIKPDQSRFDFNVGYITTTALAIGFLALG
ALVMFGANESFSLNSGVFANQLISMYTQSLGDWAKMLIGIAALTTMFSTTLTTLDGSPRV
MHKTQEIIFGKQLKKGYLYWLLILAGGTLIIFFLLLSEMKLLVEIATILSFLTAPFYAFF
NYRLISGKHTPVDARPGNFLKFYSVVSIFILVGFSTWYLSTLL
>OMIFANIC_01621 ECF RNA polymerase sigma factor SigW
MTKNDILQQIRLAKSGNQSAFRFLLDSYWNDVYGFQLKRVKDEYEAEDITIETFAKAFDK
IETFNEKYTFGTWLITISKNIQIDKSRKRKASIHSKTTDTSDEHVHKIADVSPTPEDKLI
TEQHLDELLQFIKQLKPHYQDVINLRYFQEMSYNEISEHLDEPLNNVKVRLLRAKKLLSE
IITQNHSH
>OMIFANIC_01622 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MLLIFLLGLVVLVNSIYYVFFSTFLFHRGRKRSESAQFPVSVLICAKNEMQNLSKHIPLW
LAQDYPNFELILINDASSDNTLEIMNHFADSDPRIKVVDVENNEAFWGSKKYALTLGIKK
ASNKRMLFTDADCRPASGSWITHMASNFSEEKQIILGYGAYDKKPGLLNALIRFETLITA
LQYFSYAYNGIPYMGVGRNLAYTSNLFYANKGFTAHMNVRSGDDDLFVNQAATSTNTSLQ
YHPDSFTYSIPKKSWGSWIKQKKRHSSTAKFYKPKHKFLLGTYYVFNLLFWIIAISALLF
YNWKITLPILLSRFLIQYVVCAKAARKFNELGLVVFIPLLELFLVCVQLFIFISSRKSKQ
HPWK
>OMIFANIC_01623 hypothetical protein
MGLLVITLLLLLLAVAGIAIKIWGKKDGEFAGTCASQSPFLNKDGEACGFCGKTPDQFDS
CTEEAHQSS
>OMIFANIC_01624 hypothetical protein
MKLPFSILPLLIIISVLAACKEDVKSEAELEVAEEVIAEEPKQNTEKKEAISQANSVMAR
VMSTKECMSFARYIVSAEVSDQLMKEEGPYTLFAPSDDAFNSMDEESVKKLPMTENKPLL
VSMVKSHIVEGTYDSVTLIQALKKGAVSLTTISGEQLTVSKKDNDILVTDSKGNIATVGK
SDIQANNGVVHVVNLVLGMD
>OMIFANIC_01625 UDP-N-acetylenolpyruvoylglucosamine reductase
MFIEKNKSLRNYNTFGIDVTARAFVSVESLEDLRTILKDYTPDEVFILGGGSNMLLTAPI
DKLVVHINLKGIEVLSRTEDEVILEIQAGENWHELVMYCIENDFGGIENLSLIPGNTGTA
PIQNIGAYGVELEDVFESCTAIECTTGVLRSFSREECKFGYRNSIFKDEAKDQYIITSVM
LRLTSKNHKINSSYGAISDVLAKRNIENPTIKDISEAVISIRRSKLPDPAEIGNSGSFFK
NPVLSSEEFKKFRSKNPEAPYYEVSATQFKIPAGWLIDQAGFKGKRYGDAGIHKHQALVL
VNHGNASGSEIWNLALKIQKKVKEDFGIYIEPEVNVI
>OMIFANIC_01626 Arginine--pyruvate transaminase AruH
MPESPIRKLVPFAEKAYKANKTVYHLNIGQPDIKSPVAAMEAVSQHSLQILAYTRSEGSE
GYREKIANYYKKQNIHVGSDDIIVTTGGSEALLFAMGSITDVGDEIIIPEPFYANYNGFA
TASGVKIVPVISKIENNFALPPIAEFERLITPRTKAILICNPGNPTGYLYSKEEIKKLAS
IVKKHDMFLVADEVYREFVYDGLKHYSILEEEGMENYGIIIDSVSKRYSMCGARIGCLVS
KNPQVIQTSLKFAQARLSPPTFAQIASEAALDTPQSYFDEVIDEYKDRRDTLIRLLEEIP
GVKVGHPKGAFYCIAELPVKDSDDFARWLLESFDVDGETVMVAPAAGFYSSEGEGMNQIR
IAYVLQKESLVKAVRILKAALEQYPG
>OMIFANIC_01627 hypothetical protein
MEKLANAIRTIFLLAFSLLLFSVVNAQSGFKLPQSSNRDKIPFELVNNLVVIPVEINGTE
LSFLLDTGVSSTLLFSVDDLDSLQLNNAQPVKLRGLGEGGSIDALVSNNNTIKVGEAIDT
NHRIFMVMDKKINFSTRMGVPIHGIIGFELYKDFVIKTDYTSKRITLYRPEKFERKRCKS
CEVYPIVFYNRKPFLSAQIASEHKESDALLLIDTGSSDGLWLFDEEDFITENPKNYFKDF
LGLGLSGNIFGLRSKIRRLALNSFQFEKVTTSFPDSNTVRNIRSLPQRKGSLGSEVLRRF
TVIMDYRKKTMILKKNSRFDDPFYYNMAGLTLEHDGLIPVKEVDYFKIDPVTMATEKREA
SAIFDVYKSPTLQFFLAPKYVVAEVREGSPAALVGVMKGDEVVRINGKASYKYKLYEVIN
LFSSKAGRTISLDILRNGILQKKKFVLREVL
>OMIFANIC_01628 hypothetical protein
MKRLVLIALIALIGHTVQAQAKISFKAETIDYGKIAKGSDGVRVFEFTNTGDADLVIADV
KSSCGCTVPKKPEGPIAPGASSTIQVKYDTNRVGPIRKTVTVYSNADQAIKALKIKGEVL
AEGKSVLEKTK
>OMIFANIC_01629 Valine--tRNA ligase
MSLAAKYSAESVENKWYSYWMEHGYFHSEPDERDSYAIVIPPPNVTGVLHMGHMLNNTIQ
DVLIRRARLLGYNALWVPGTDHASIATEAKVVDKLKREGISKTDISREEFLEHAWEWTHK
HGGIILEQLKKLGASCDWSRTKFTMDDDLSESVIRVFVDLYRKGKIYRGYRMVNWDPEAL
TTLSDEEVNYEEKQGNLYYLQYAIEGSDDFVTIATTRPETILGDTAICINPEDERFTHLK
GKKVIVPICNRVIPIIEDEYVSMEFGTGCLKVTPAHDENDKMLGDKHGLEVIDIFNDNAT
LNSYGLHYKGQDRFHARKEIVKELKELGFLAKIEQYTNKVGTSERTGAVIEPKLSDQWFL
NMKDLSKPALDAVLNKDVNLVPEKFINTYRHWMENVRDWNISRQLWWGHQIPAYYFGDGK
EDFVVAATVDEAVTLAKEKSGNSNLSESDLKQDPDVLDTWFSSWLWPITVFNGILEPDNA
DINYYYPTKDLVTAPEILFFWVARMIIAGYEYRNEKPFDNVYLTGIVRDKQRRKMSKSLG
NSPDPIELINEYGADGVRVGMLLSSPAGNDLMFDLELCKQGSGFVNKIWNAYRLIDGWEV
SSEIEPSETGAIAIDWYKNRFNKTIAEIEDHFGKYRISDALMATYKLVWDDFCSWFLEMV
KPAYGQPIDSTTYAGVISILEDNLKILHPFVPFVSEEIWQHITKRSPEEALIVAKWPEIG
PFDTNLISDFEFAAEVISGIRTIRKEKNIAYKEQIELSAINSENTGTEFDGIICKLGNLS
NLNYVSKPLDGSITFRVKSNEYFVPISGTVNVDEEIAKITEELHYTEGFLKSVQKKLSNE
RFVNNAPEQVVKMERTKEADALAKIETLKASLASLK
>OMIFANIC_01630 hypothetical protein
MAKSDLDIEFRKAVDSINKHTEPFPADVLLRLYAYYKVATNDEDRPSGGKPLINAFKTNA
LFQAQNLSVEEAKQLYIETVKNYFIYRK
>OMIFANIC_01631 Phosphatidylserine decarboxylase proenzyme
MFHREGNKIILIALVLCISLSLLTEMSVENQILKFGIIAVLIILLILILQFFRNPKRNFK
PDYFKVMSPVDGKVVVIEEVFEKEYYNEKRLQVSVFMSPLNVHVTRYPVGGKVVLSKYHP
GKYLVAWHPKSSEENERTTVVVRSSEFGDVLHRQIAGAMARRIVNYAETGQTVTQSSDSG
FIKFGSRVDVFLPLDVKVAVELNQKVKGGLTVLASK
>OMIFANIC_01632 Phosphatidate cytidylyltransferase
MKELIVRSISGVLYISIVIFSLFTSREWFMGLFFILAGITLNEYLRIINLKSLLAYILLA
ALFYFLSYEIFDWNALYLFLILCCFVCFYLMKELFRDSDIAMFGPKKYVTTVFYLIGGFV
FLTLIPMHKGYFNPEAVVGVFILVWSNDSIAYLVGKNFGKKKLMERVSPKKTIEGFLGGL
AGSLIAGFLIFKFFDYYPLWMWIIMALIATIFGTIGDLIESKFKRQAGVKDSGVLMPGHG
GLYDRLDSIIYASPFLYAFIEISEYVS
>OMIFANIC_01633 hypothetical protein
MSLFKRLLNPKGRSEEKAKNSEHSKYFPEETLPIDERFTYNFNRNGGKFLYCENMEEILE
AFDNILLENDWYEQDVFCLDEMLSSRFDGFNLNFVHKPSAKFFLSTCESLVSNNGSILLC
SKQIKEKKLHELPANFVIFATTSQLVENISEGLRKIKSKNKRHIPSNITTIQDFETNKEK
DFMSYGSSTKNLYLLLLEDL
>OMIFANIC_01634 ATP-dependent zinc metalloprotease FtsH 3
MANENKKPEIKKPRFNAYWIYAAIIMIFLGIQFFGGSSWSQPEKTTQAEFENFLRDGDVE
KIEIINKKVAKVYLTPDAKQKPVHSANKTKSFFPSAANEPYYQFEFGDLQNFENNINEIK
VQNSIDTKVVWNTDSNMWGELFLTLLPFIVIIGIWIFIMRRMSAGAGGGAGGQIFNIGKS
KAKLFDEKTEVKTSFKDVAGLEGAKEEVQEIVDFLKNPQKYTALGGKIPKGALLVGPPGT
GKTLLAKAVAGEAKVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPSIIFIDEIDAI
GRARGKANFSGSNDERENTLNQLLTEMDGFGTNTNVIVIAATNRADVLDKALMRAGRFDR
QIYVDLPDVRERKEIFEVHLRPLKKDNTLDTDFLAKQTPGFSGADIANVCNEAALIAARK
EKTSVGRQDFLDAVDRIVGGLEKKNKIITPDEKKAIAVHEAGHATVSWMLEHAAPLVKVT
IVPRGQSLGAAWYLPEERLIVRPEQMLDEMCATMGGRAAEKVIFDKISTGALSDLEKVTK
QARAMVTIYGLNEELGNLTYYDSSGQNEYGFTKPYSEKTAELIDKEISNLIEAQYQRAIE
LLKQNKEKLSELAEELLEKEVIFKESLERIFGERPFKKPVPIVKKEEKTEDEVITPEEPV
EPKS
>OMIFANIC_01635 Ribosomal silencing factor RsfS
MIDRLTGTDELVTQIISGIEEVKGQNIEILDLREIENTVCDYFIICDGTSNTQVNAIVNS
IQKLVSKSIKEKPWHVEGSENAEWILLDYVHVVVHVFQKHIREFYDIEGLWGDAKSVKIQ
TTY
>OMIFANIC_01636 Bifunctional ligase/repressor BirA
MKLIKLSAIASTNSYLRDLGMKMYLEDETVVWAESQTKGRGQRGSSWVSEAGKSLTFSMF
KRFSMLSSEEHIKINLAVSLGISASMNRLKIPQITIKWPNDIMSYNKKLCGILIENQLQG
NSVIGSIIGIGINVNNSVFHNLHNAGSMLMATDIMYDPERVLSQVVADISAQLDRVENTD
FETLNREYHDLMFRKDIISVFEHNDRSLFNGIIRGVSNSGNLRIEMEDESVQEFKVKEIL
LRY
>OMIFANIC_01637 hypothetical protein
MQIESKKVQVQKSAEDLCSYLSDVKNFEQLMPENISKFEVISDNTFVFALKGMPEIGLKV
KEVSSPNKVVLGAISDKIPFQLTGNIEDNGVNSSEAELVFNGEFNPMMAMMIKGPITKFL
ETLVNNMEQL
>OMIFANIC_01638 Orotate phosphoribosyltransferase
MILNKGTAQKTAELLLQINAIKLQPQNPFQWASGWKSPIYCDNRITLSFPVIRNFLREQI
ASQIETLYGKPDVIAGVATGAIGIGMLVADYLNVPFCYVRPEAKKHGRQNKIEGLIEAHQ
NVVVVEDLISTGKSSLAAVEALREADLNVKGMVAIFTYGFEIAEKNFDKADVALHTLSNY
NEIVEQAEKSGYITSEESALLSHWRTNPANWDPKMVVNTEDK
>OMIFANIC_01639 Diadenosine hexaphosphate hydrolase
MYKVFVKDIPIILSTEKNIGKQYTSIPLKFARFKKLIKRINEGELLYVNLYHKNEESLEK
FLRKKLPVVEAAGGLVFNNKREILFIYRNEKWDIPKGRIEKNESHQEAAVREVEEETGIK
GLEVKKYLTTTYHVFKRNGKFKLKITYWFEMYSEYNGVFKPQVKEGILKVKWKNFEKSQK
ALQDSYENIKLLFPKEYLLVHPNDRVS
>OMIFANIC_01640 hypothetical protein
MRKLIPLLVLSVLCACSKSKEETSFDFTTKFEKSGGMETATYDEVVEFYTQLADAHTSVA
IYDMDRTDSGKRLNLVTFNPNRSFESEFSGNDEKLIVLINNGIHPGESDGIDASMILMRD
LAEGKIAPPKNTIVAVIPVLNIGGALNRNSTSRTNQNGPEEYGFRGNARNFDLNRDFIKA
DTKNTRAFIDLFRTVKPDLFIDTHVSNGADYQYTLTHLFTQHNKLGGALGEYMQESLMPK
LEDSLENKEWDITPYVNVFNRTPESGFTQFIDGPRYSTGYSTLFNTIGMMVETHMLKPYK
TRVDGTYTMLNEIITIADADAKNIIAMREEANSRFKTGDQYPLSWKVDSTRSRMLMFKGY
EAELIQSEITGAGRLKYDSLKPYTKEIVYYDQFKPVTYTTIPRKYIIPKGYWNVMELIRL
NKIEYTKAPKDSTITAQVYRITSTETSRRPYEGHYPHYNTEVEMTTEEVSLEAGDYIVDT
NQPGMRYLLETLEPMAPDSFFNWNYFDTILGQKEGFSPYVWEDVALNFLNENPEIRKEFE
DKKLQEPQFARNWYSQLDWIHKKSDFYEKAHLRYPIIRVNE
>OMIFANIC_01641 hypothetical protein
MKKITLLSAAFLVSAFGFAQTETYVSETGGINDPVVYVNQNGGIEADCSLSGPGNAFENG
KSCTQNLGRIVAHDFVVAADEDGLLEVINANVFIGGTGSGVNAAFVDVYVWGDAGGAPDP
GNLITSELGFVPDNQVVVGTNFGFDVWDLTLDITDVALPGQSGVATSYWIGLSVEATDAS
NLFWENSTAGLIGAGEAYDDGGGGGFVIDNTLEGVYTFDVECEPILGVGDNLAELVSIYP
NPATTRINIQVPGNIEITNVALYDVLGKNTGATLVNGSVDVSNLAQGVYILNIQSNRGTL
TQKIVKR
>OMIFANIC_01642 O-acetyl-ADP-ribose deacetylase
MRIEVIHGDITKVNADVIVNAANTSLLGGGGVDGAIHKAGGSEILDECIEIRNKQGGCKV
GEAVITTAGNLNARRVIHTVGPKWNDGIYNEAELLRKCYLNSLKLAEEYKLSVIAFPNIS
TGIYGFPKQKAAKIAHAAVTGYEAMSLEQILFVCFDDENYRLYTKLFSEQ
>OMIFANIC_01643 Transcription termination factor Rho
MFEISELKAKKLPELQDLAKTLGVPKYRSLKKLDLVYQILDYQAANPTAVKAVAVDTPSE
KKETKPQQHQKTDSRTTRQRPQRSDKQRVEGQRSDNRGQQRGQQKKQQGPQAQGKKQDGR
QTQASKKGVDQKKEQQKRDHGKRDGQDKPGKNGNKDNRNRYKEPDFEFDSIIESEGVLDI
MQDGYGFLRSSDYNYLSSPDDIYVSQSQIRLFGLKTGDTVLGEVRPPKEGEKYFPLIKVN
KINGLSPNVVRDRVAFEHLTPLFPEEKFNIAERQSNVSTRIIDLFAPIGKGQRGMIVAQP
KTGKTMLLKDIANGISANHPEVYQIILLIDERPEEVTDMQRNVSGEVVASTFDKEATEHV
RIANLVIEKAKRLVECGHDVVILLDSITRLARAYNTVQPASGKILSGGVDANALHKPKRF
FGAARNIENGGSLSIIATALTETGSKMDEVIFEEFKGTGNMELQLDRKISNRRIFPAIDL
TSSSTRRDDLLLDENTIQRMWVMRKYLADMNPVEAMEFINDRIKSTRSNEEFLISMNA
>OMIFANIC_01644 hypothetical protein
MLQRIQTVYLIISVLIMGALYYWFPTLNDQSGTAIISREEPLVLGLIGISVLLAIISIFN
YKRRKGQFVLNRLNIISNFVLLGVFVYRSLTLSGETLVSEKGIGVLFPIISIVFLVLANK
AIKRDEDLVKSVDRLR
>OMIFANIC_01645 hypothetical protein
MKKILLLSDTHGYIDDLILKHVEQADEVWHAGDIGSIDVSDAIKNIKPLRAVYGNIDNAN
IRSEFPLNNRFLCEGVDVWITHIGGYPGRYSPAIREEIGSNPPRLFITGHSHILKVMNDA
KLGLLHMNPGAIGKHGFHKARTMLRFTISGSEIGDLEVIEYSR
>OMIFANIC_01646 tRNA pseudouridine synthase A
MRYFVDISFNGKNYHGWQIQPDALSIQEVLERTFSTFFRAEIKVAGAGRTDTGVHASQMV
AHFDMNTEIEDMNEVIFRLNSFLPKDIAILDIYPVIDEAHARFDAIEREYQYGILFDKDP
FRVDVAYQIHQMPDIEIMNQAAQLLLGHQDFQCFSRSNTDVKTYYCDVKEASWEYEDYFL
IFTIAADRFLRNMVRAIVGTLLDVGHGKITIEEFQEIIKSKDRTKAGASAPAHGLFLTRV
EYPETIYK
>OMIFANIC_01647 putative ABC transporter ATP-binding protein
MAESGKAFDFNLFRRLLAYANKYRVTFYFVGFAAVIMSGLSILQPFLLQQAIDNSIIPQD
GDGLMFYIILMIVVLCLDVIFQFAFIFYANWLGQSVIKDIRVKLFKLMLSFQMKYYDKSA
VGRLTTRAVNDIETISSIFSQGLFVIISDLLKMLVIMGFMLYQSWRLSLIVFAILPVILY
ATRVFQRAMKTAFEEVRNQVANLNSFVQERITGMKIVQIFTREDTEYKEFQKINENHKKA
WIKTVWYNSIFFPIAEMSSSVAIGLIAWYGGLNAAAGGVITVGLIAMFIQLSQMLFRPLR
QIADKFNTLQMGMVAANRVFGILDTESSIQDHGTVEMCRSEGLIEFRDVHFGYNEGEEVI
KGISFTVQPGETVAIVGATGAGKSTIINLLSRFYEINGGEIRIDGVSSKEYTLSSLRNQI
AVVLQDVFLFADSILNNITLNDPTITEEQVIEAAKEIGVHKFIESLPNSYHYNVKERGTT
LSSGQRQLIAFLRAYVSNPEILILDEATSSVDSYSEEMIQRATEKVTQNRTSIVIAHRLA
TVKKADKIIVMEDGKIVETGTHRELLRKEDGHYRNLYEVQFMAEEIM
>OMIFANIC_01648 hypothetical protein
MNCKNCDHPLSEMDNFCQSCGAKVIRNRLALRNLIESFSEQFLNYDNKFLQTFIMLFKKP
EDVIGTYIDGTRKKYVNVVSYFAIAITYAGLFAFINQKYFPGVYDRLFGAVNQNEAQVQF
TSDMLYLIFEYQAFIFFLMVPVLALMSRLVFLKNKKYNYTEHIVITMYAYAQASLFVTTI
SFIAQFDKQLFFLNSILGLPLQILYFAYILKRMYNLNFVQIFLKTLLFLLILGMFYVLFV
IVLLIYLFAFTDFFQQVIEAEKAKKGVSYIISSAINWTS
>OMIFANIC_01649 Cyclic di-AMP synthase CdaA
MDLFDWTNIRIIDIVDIVLVAILLYYLYKLVKGTVAINIFIGIVILYATWQLTELLEMEM
LSYVLGGFLGVGMIALVVVFQQEIRKFLLLLGSTNFKARKRLFKRLTFFSEDSTAVTNIR
AIINALGKMSSTKTGALIVIQRNQSLDFVKSTGDAMHVTVNQPIIESIFFKNSPLHDGAM
IIEDNTITATRAILPISNDRNIPQRFGLRHRAAIGITEKSDAVSIVVSEENGQISYIKEG
DFVLFEDLEELYSILEKDLS
>OMIFANIC_01650 Dihydropteroate synthase
MYSLNCKGTLIDLSTPRVMGIINVTPDSFYDGGKTMAIRDILVQAEQMLQQGATFLDIGG
YSSRPGADDVSETDELERVLPAIEAILREFPKALISIDSFRSKIARKAVAHGACMVNDIS
GGHMDKEMIKTVAGLQVPYVAMHMRGTPQTMTQHTNYHQVTRDVLHYFSKIISEANKAGI
NDLIADPGFGFSKTRTQNFTLMNELELFQQLEIPLLVGISRKSMIYKTLGVSAKEALNGT
TALHSIALLKGVHLLRVHDVKEAMECVRLVSELSDAQ
>OMIFANIC_01651 hypothetical protein
MSKTSKQYDAVISNCRSLFEKKMKDYGSAWRILRLPSLTDQIFIKAQRIRSLQQNEVRKV
DEGEASEFVGIINYCIMALIQLEKGIVEQPDLELEEALQLYDEKISLTKQLMMDKNHDYG
EAWRDMRVSSLTDLILQKLLRVKQIEDNQGKTLVSEGIDANYQDMINYAVFALIHLNQQ
>OMIFANIC_01652 hypothetical protein
MKALVGVTRIFVGILFIISGLIKLNDPVGFSFKLQDYFAPEVLNLEFLTPFALVIAIFVV
IYEVLLGVMIIIGYAKKFTLWSLLLMIVFFTFLTFYSAVTGKVTDCGCFGDALKLTPWQS
FYKDVFLLVLILISWFGRKHIQPFFSRNIRSLTVFASLVVCLAIMYHVLMHLPIIDFRPY
KIEANITEGMSIPEDAPKPIFEYAWKFNVNGEEKIITTNGDYPQQEGEFIGVETKEIQAG
YEPPIHDFSMERGGNDFTDSFLNAEHVIVVIAYSLSNSEKEGFIPVREVTDEALEKGYQV
IGLSASSEEVTDALVEEYGLNFKFYFCDMTTLKTIVRSNPGILELQKGTIKQKLHWNDAS
ELRLKELPKSKPEMDMALKQKLDSIAELDQRYRKLMYLDTEAERAEAAKQAGFEEEDYSM
ETLWARQSKIDSTNMEFIAGIFDTNGYPGKSMVDTANKAAWYVLQHNPDRIEEYLPMIKT
AGEEGELPFNLVAMMEDRYLMGKGEPQIYGTQGMSYDDERGNLIWPISDPENVNERREQA
GFDNTIEEYAKALFGEDFEYKVLTMEDVKED
>OMIFANIC_01653 Dipeptide transport system permease protein DppB
MGGYILQKIGYALLTLLGVVTVIFLLFTILPGDPARMMLGQNETAEQVAIVKKKYGFDKP
VGKQYLYYINDLSPLSFHSNNAEDYTYLSEDKYSATNLFQIGNTEVVLKLPYLRESFQKN
GKKVSDVIAETLPNTAILAVSAIIIAMILGILLGIISVLFKDGWLDKTIQLVSTLGMSVP
SFFSAIIFAWIFGYMLHEYTGLNMTGSLYEVDDFGEGKYIQWKNLILPAIVLGIRPLAVV
TQLMRNSLLEVLSQDYIRTAKAKGLAFATIIRRHALKNSLNPVVTAISGWFASMLAGAVF
VEYIFGWNGLGKEIVDALNTLDLPVIMGAVLIIATLFILINIFVDIIYGWLDPKISQQ
>OMIFANIC_01654 Triosephosphate isomerase
MRKQIVAGNWKMNCDLAETDALLNDLKKQSIPDSTHVMVAPTYTNLQSAVRSLEDSSITV
AAQNMHQSESGAFTGEISAAMLQSIGVDHVILGHSERRAYFGETNELLAEKVTTALNHNM
KVIFCFGEELVDRQHGREFDVVKDQLKYGLFHVSESDWQHIILAYEPVWAIGTGETASPE
QAQEMHAFIRKTLAENYSPSIAEEVSILYGGSVKPGNASEIFGKADVDGGLIGGASLDAE
SFTAIVNAFQ
>OMIFANIC_01655 Ribosomal protein L11 methyltransferase
MIYLGYHFKVIPRQPGTEILIAELAEAGFESFVETEEGVTAYIQKEDWKEDIFHDVRVLR
SDEFEINYSSEVIDQVNWNEEWERNFDPIEVSDTCVVRAPFHREYSLPYEIVIEPKMSFG
TGHHETTHMMLEYLLESDLEGKTVLDMGCGTAVLAILAEMRGADAIDAIDIDEWCVENSE
ENVARNACKNLQVFLGDSRLLKQKNKYDIIIANINRNILLNDMPVYTYSLKKEGILLLSG
FYLEDLSLITETCNKLQMQYVDNKVRNNWIAAKFVN
>OMIFANIC_01656 ATP-dependent Clp protease adapter protein ClpS
MSTKKKYEEEVLLAEKEATENQIVLYNDDVNTFDHVIDTLIYACDHTPEQAEQCSLIVHY
KGKCTVKTGAFEDLKPRCTILLEAGLSAEIV
>OMIFANIC_01657 hypothetical protein
MRKLRLGLIGSFCLGLLLASCSKDAEFLPEDTDANLTQEVPQEVYDAAAILELNPNFIRY
DDFHFPDGSSEVRLFFEDDIVMTEEQLFTLAKLAQDAGQERQYRTFNLVSQGRNISIIGY
TGGGGYGLSSKERTALQWAVNNYNRLSGVSISFSLTFGTNYQSKDMVVYHNPNQGGAGGS
AGFPSNGLPNKYVQIYGLGGYSTNVNEHVITHEIGHSVGFRHTDWFSRQSCGQNVNEGSA
GVGAVYINGTPSGYDPTSIMLACFSSSEDGEFNGNDITALRNMY
>OMIFANIC_01658 hypothetical protein
MKKIILTIVAIVFTNLMVQAQKADASTTTTTTKKVEQTAYSGADADPDATHPTTTKQKAS
GEENKKALMDVEKQKADYRKQAKAKAKKKKKDDN
>OMIFANIC_01659 hypothetical protein
MKRIILLLVAVVLTAPVLAQMETYVTETGGENNPVVYIDVSNPETNPPCGVNISSNAFEN
GKSCTHSLDRMVANDFTVRQGEDLMLESITVNVFIGATGSGVNASFVDVYYYNDSNGEPG
SIIGSELNVYPYSQVVIGTNFGFDIWQIELDVPDRVFIGPNSASKTYWIGISMEATDGSN
LFWENTTVGLVGSGEAYDDGMGGGGYEIDSTLDGVYFITAECETRLGVDDNFANSVQIYP
NPAADGIVHITSPFSGEIHLVLYDVVGKKVIETVLESDNRLDVSTLNTGVYMLQITQDGV
SAIKKLAIK
>OMIFANIC_01661 Adenine phosphoribosyltransferase
MINLEAFIRDIHDFPKPGVTFKDITPLLMNAEAIAYCASALAELTERQKVDKIVGIESRG
FFFATLLANELDAGFVPLRKAGKLPFDTLKEPYLLEYGMDALEIHEDAIEPGDRVILHDD
VLATGGTAQAACKLIEKLGGEIIQCNFLIELSFLRGYEKIKRQEIRSLLTY
>OMIFANIC_01662 Inner membrane protein YrbG
MSVLFILIGLVLLVVGGEYLVRSSVALSFKLKLSKMVIGLTVVSFATSAPELLVSVNAAL
GGHSDISLGNVIGSNIANIGLVLGITAVITPLAIDQDFYKFNWPVMMFLSVTLFFLLTTG
KELDRLEGGVLLILLLVYLFMLIRRARIMGGINTKTEPEGVDDALSKVSNVKIMLWLFIG
GLALWGGSELLVNGAVDLATKLGVSERVISVTMIAVGTSVPELAASVIAALKKEKAISLG
NLIGSNIFNIASVLGITALIQPITVKSEALLSNDIFWMLGFAAVLIPLAFLPRSFEIGRY
KGVIIVTAYALFISLAFIN
>OMIFANIC_01663 Glutamine synthetase
MSTLRFSAIQETFDHKPVAVKEPKRRSEIFGANVFSENAMRQYLTKDSFKSVMDAIDKGS
KIDRAVADHISTGMKEWAISKGATHYTHWFQPLTGATAEKHDAFFETTGNGHAIEKFGGG
QLVQQEPDASSFPHGGIRNTFEARGYTAWDPTSPAFIYGTTLCIPTIFVSYTGEALDNKT
PLLRSLQTVDKAATAVAKYFDKNVTKVHATLGWEQEYFLIDTALAISRPDLLLAGRTLLG
HAAAKGQQLDDHYFGSIPTRVLNYMRDLENECMLLGVPVKTRHNEVAPNQFELAPIFEEA
NLAVDHNSLLMDVMDKVADRHNFRVLFHEKPFAGINGSGKHNNWSLATDTGVNLLSPGST
PMKNLQFLTFFINTIKAVYEYEELLRASIASASNDHRLGANEAPPAIISVFIGSQLTEVL
DELEKVTNGKLSPQEKTELKLNVVGKIPEILLDNTDRNRTSPFAFTGNKFELRAVGSMAN
CAVPMTVLNAIMAQQLTEFKESVDVLIKDKKMKKDDAIFNVLREYIKKSKNIRFEGDGYG
EAWEKEAAKRGLSNNKTTPEALKAYVSKKTIKLYEDLQIMTKVEIEARHEIQVEEYAMHI
QIEGRVLGDIARNHVIPTAIRYQNILIENVQGLKDIYGNAFKKHAGEQMQLIESISVHIA
EINKGITDMINERKKANKIDDAEKRAFAYCDKVKPYFEEIRYHCDKLELLVDDEIWPLTK
YRELLFTR
>OMIFANIC_01664 Minor curlin subunit
MKKLVLCAFALMLATIGFAQFNDSDVLQVGILNASDVNQIGWINDSDVFQLGILNDSEVD
QMGIDNKSLVVQIGGGNEADVLQMGWLNDSFVFQLGVTNAAAVGQVGWFNDSDVVQLGYD
NGALILQGGIANDSYALQLGGDNGVMVVQGGMINTSTSIQLGHYNLGFVGQLGFANDSDV
WQIGWGNAQWTEQFGVINDSDVLQVGLYNFSYVHQEGLGHMSNVVQLGAGNTSVVTQYDM
GGGGF
>OMIFANIC_01665 hypothetical protein
MKIQLHIWILLLVLLPVFGAFAQTYKNIEIRPRTILIGETNPLNLMTTELLRNNTTPQRR
TSRDVHIRQIGFNNNFTSNVRSAASDILLFQMGNHNDAYLNRSAINIEEQIIQRGNNNVF
YDIGRNWTLYHKGQIYQQGNNQRLLYLGTNSLSERIRVSMRGNNQTVIIRNINRR
>OMIFANIC_01666 hypothetical protein
MIRNLSILKLALWVMVLMSGSITAQIHNTRVAAEIFLEENTEFISVTGFAYNKTEINHSL
RYVMSVISKDPETLNRVKNDQNGRFVLSPGEKRELAKTTLNAKDTTRTILLLLVYDLDEN
LLGKDRIVLNDDSEVKSEVVPLDEANDVLERFAMSDGVELRGIVLEDTKTKPGRDFYSMY
YSAYMANNINGPKIVSINEELTIGNNTRIELYIGDDLIMAFFVQPKNDYMKAMSYEAIKR
TIAYFERLKNDKGLIKFYK
>OMIFANIC_01667 hypothetical protein
MKQLIIILIFSICSSGFAQQLTYTPKNPAFGGDPFNYTWMLNSANAQNPFSEDQFDVEQF
GDFANFDNTFGNQFTNQFGTQTPEIGTSRNGNLEYEVYESTQGLVINILDITTGEYTQII
IPNG
>OMIFANIC_01668 Curli production assembly/transport component CsgG
MRPLLTKLGILTWFVVLSGCGAYFNQPIINEDARIAETTSQTEKLIELPAPEKPIVVGVY
NFKDQTGQYKNIETGSTFSTAVTQGATTILIKALEDSKWFTPIERENFGNLLNERNIIRT
TRQEYLKSDDERNQKLSPLLFAGILLEGGIISYDTNILTGGVGARYFGAGGSSQYRQDRI
TIYLRAVSTSTGEILKTVNVSKTILSQAVDVGIFRYVKFQRLLEAETGFTKNEPTQLAVQ
EAIEKAVQLLILEGIKDQLWKTVDGPEADTALIAQYTEEMELESNTSLYERKFLENDYRH
TINVSAGLAYVDSDYTSGILDYNFELTYKFKIIDRFNIGITSQFFRLNSTSETNHWWIDE
TLFAEYTVLPHDRLTPFAYAGGGFMLFADNSPKKYLQRGDTFLTLKFGAGLEYIVSDKVS
FVLKGDWNPTFTDKIDNEIRGRRDDYFFTFGAGINYHFGSRKKDDNLN
>OMIFANIC_01669 hypothetical protein
MKRTFKYIALIVTAFLFVFSCNEDKIGEDEFGALKGKVVAAGSNEPLPNTRISTNPVSST
VFTDSSGNFLIESILVGEYAVEAKKDGFLTDFAPATINGNLTSNVVFELEVSTFNNRPPT
TPVLLTPEDNEMIQGVEAIFSWESTDPEEDPIEYTLELTNIDTNEVLLFEELADTTLTYS
ELTLGTEYVWHVTATDNINDPVVSEASAFEVMPPPIDNRILFVRKINGNNVIFSADDDGV
EFQLTSSEVNSYRPRRNLSVNKIAYLQSDGANADIFLMNRDGTEKRKVTSTVKPNGFNLN
EINFEWPDDFINIYFPRMDKLYRIQFNGGGLAEVYQTPDGSLISEVAISNNSDLIVLKTN
NLDGYDVRIYTITFAGNETGTILENVNGAVGGLDISVDNQKILYSYDISGFEDASYRRLD
SRMFIYDRVELTTTDISDNRPNGTNDLEPIFSRNEAFVMFTNTSNDGISRNDIFTLEIGT
SSSRTLRHEDAFMPDWE
>OMIFANIC_01670 hypothetical protein
MSKASDNEQTKLLISHCFSTHFSEVYTTVGDINIKEKARLVQAFSNQQITSIPSQA
>OMIFANIC_01671 hypothetical protein
MKKVVLCAVALLFATVGFAQFNDSDVVQIGILNSSDVDQTGLANDSDVNQIGLANDSEVD
QIGIINDSYVAQLGIANTSDNLQVGFANKSVTTQIGALNYSEVDQWGVLNNARVDQVGIA
NYSDVNQYILGNDANVYQRGLFNGALINQVGIINDADAIQLGAFNLSATFQEGLANDTYA
LQVGVGNLAGTHQLGAFNTNTTLQFGLGNWSVTDQHGLANDSDLLQIGVGNGSWTEQYGI
INDSDVLQVGFFNSSYTHQHGLGHMSTVTQLGAGNSSVVNQHNL
>OMIFANIC_01672 Minor curlin subunit
MKKVILCAVALLVATVGFAQFNDSDVVQIGILNSSDVDQTGLFNDSDVNQIGLANESEVD
QLGILNDSYVAQLGAGNNSNVDQRGRRNKSVTTQIGVLNYSEVDQRGRRNVSRVDQAGIL
NYADVNQRGRRNDANVYQRGILNGAAITQVGRRNDADAIQLGALNLSGTLQEGRRNDTYA
LQVGIGNLAGAHQLGRRNTNTTLQFGVGNWAATDQHGIRNDSDLLQVGLGNGSWTEQYGV
INDSDVLQVGLYNFSYTHQHGLGHMSTVTQLGAGNSSVVNQHNGGGGF
>OMIFANIC_01673 hypothetical protein
MKLSNRIYLIALIALSSVGFAVGQTYKNVEITPRALAGGSADQLALYTSQFLRNNTPSAN
SVSNEIFIRQVGNNNQFTSEIRSARSNVSAFQQGNNNEAYVSLESVIVDEFILQRGNNNV
FYDIGSDLKLFHNGQIIQSGSNQRLLFLGNNSLSDRIKVNMRGNNQTVIVRNVKRQ
>OMIFANIC_01674 hypothetical protein
MFKKTHISLGMLFFLISLSNMGIAQIYNTQVAAEIEMNRNSEFIEVAGTAYNKTQINQSL
RYVLSVIKTDPGGNLSKNDQEGRFVLQPGEKKKLSITTVNVDDKTKVIILLLVYDFEEKL
LGKDRIVLNDDSKDKKIVLKPKENTDVRTEFAMSDGVELRGIVLEDTKTKPGRDFYTQFY
SGYMYYSVNGPKIVTIKEELAIANNTKIEVLIGEEMIMEFIVRPQNDFIRGMADLAVRRT
MAYFEDLKKQKNIVKQYK
>OMIFANIC_01675 hypothetical protein
MRQIILILFLSLGTYGFAQQLTYRAKNPAFGGDPFNYTWLLNSANAQNPFSENDLGIEAF
DNLAGFDNLLNNQFNDQFGGQTPPLGTSRNGNLEYEVFESTQGLVINILDITTGEQTQII
VPNG
>OMIFANIC_01676 Curli production assembly/transport component CsgG
MKQIIGKISLVLFLILFSGCGAYFNQPIGNQEARIGENTEQTEKLLKLPLPDKPIVVGVY
NFKDQTGQYKNIETGSTFSTAVTQGATTILIKALEDSKWFTPIERENFANLLNERNIIRT
TRQEYLRNDDQRNQRLSPLLFAGILLEGGIVSYDTNILTGGVGARYFGVGGSSQYRQDRI
TIYLRAVSTSTGEILKTVNVSKTILSQAVDVGIFRYVNFQRLLEAETGFTKNEPTQLAVQ
EAIEKAVEVLIYEGIKDQLWTTLDGPEKDKEVVDQYLLEKELEANTDLYEREFQKHDYRH
SAHASFGLAYVDGDFNTGILDYNMELGYKYRFIHSLSLGLTTNFFRLNSTGDTRHWWISE
AATVEYNILPNDKLAPFIYAGPGVLLFVDDSPELYLQRLDAFFFLKMGAGLEYQASDRVS
FIAKGDWNATFSDKIDNEINGRRDDYFFTFSAGINYHFGSKKSKLKTNR
>OMIFANIC_01677 Protein TolB
MKGSFKYIALITTTFLLLFSCNEDKIGENEFGTLNGKVVAAGTNEPLENVRISTNPVSST
VFTSESGNFTIENIEVGDYSVEAKKDGYLADFAPVTINGNVSSNVVFELEVSTFNNRPPT
TPELLTPEDNEVIEGIEAIFSWNSTDPEGDPIEYTLELTNVETNEVLLFEELADTTLTYS
ELTLGTEYFWQVTATDNINDPVISEVSSFEVMDPPVDNRILFVRNMNGNNVIFSSDDEGN
EFQLTSSEVNSYRPRRNISVNKIAYLQSDGANADIFIMNRDGTGKQKVTSTIKPNGFNLD
EINFDWPDDFVNIYFPRLDKLYRIQFNGGGIGEVYQTPDGSLISEVAVSDNSDMIVLKTN
NLDGYDVRIYTITFAGNETGTILENVDGAVGGLDISVDNQRILYSYDVSGFEDASYRRLD
SRLFIYDTDAMTTTDISDNKPNGTNDLDPIFSPNEAFVMYTNTSNDGISRKDVYTLEIET
SSTRTLIHEDAFMPDWH
>OMIFANIC_01678 Phosphoribosylformylglycinamidine cyclo-ligase
MSQEISKRYAKRGVSASKEDVHKAIKNVDKGLFPKAFCKIVPDYLTNDKEYCLVMHADGA
GTKSSLAYMYWKETGDLSVWKGIAQDALIMNIDDLLCVGATDNIMLSSTIGRNKNLIPGE
VISAIINGTEELIEDLARFGVHIYSTGGETADVGDLVRTIIVDSTVTARMKRSSVIDNAN
IKEGDVIIGLASYGKSTYESEYNGGMGSNGLTSARHDVFHKYLAEKYPDSYDHAVPQDLV
YSGSKKLTDAVEGSPLDAGKLVLSPTRTYAPVIKKILSEINTGAIHGMIHCSGGAQTKIL
HFVDDLHIVKDNMFEIPPLFKLIQEESGTDWKEMYQVFNMGHRMELYVQEDVASEIIAIS
NSFDIDARIIGRVESSTQGKKLTIRSEHGEFVY
>OMIFANIC_01679 Peptide chain release factor 1
MLEKLQIVKQRFDEVSDLIIQPDIISDQKRYIQLNKEYKDLRILMDKREAYIMARERIEE
AEEIIKDGSDPEMVEMAKMQLEESGELIPKLEEEIKFLLVPKDPEDSKNAVMEIRAGTGG
DEASIFAGDLHRMYTKYCEGKGWKVNVVDFSEGTSGGFKEIQFEIEGEDVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATVMVFPEAEEFDVEIDPKDVRIDYFCSSGPGGQSVNTTYS
AVRLTHEPTGLVAQCQDQKSQHKNKEKAFKVLRSRLFDLELAKKQAEDAEKRGSMVTSGD
RSAKIRTYNYPQGRVTDHRINLTLYDLSNIIDGDIQKIIDELQLVSNTEKLKEAGETF
>OMIFANIC_01680 Orotidine 5'-phosphate decarboxylase
MQLDTLISEIRKKQSFLCIGLDVDLAKVPTHLLDRDDPIFEFNKAIIDATNHLAVAYKPN
TAFYEAYGLKGWKSLAKTVNYLNENHPEIFTIADAKRGDIGNTSAMYANAFLKELNFDSI
TVAPYMGKDSVEPFLAVENKHTILLGLTSNEGAYDFQTKMLGDKELYKQVLKTSLSWEHS
ERLMYVVGATKAEYLAEIRNIIPDSFLLVPGVGAQGGSLEEVCKYGMNDTVGLLVNSSRG
IIYASQGIDYAEAAARAAKKLQNEMQRILSRHGHKN
>OMIFANIC_01681 hypothetical protein
MLNWLKKKTEIEKLKLRYQKLMKKSFKAALSDTKKSDEFHQEARYIFNRIKDHESNKR
>OMIFANIC_01682 hypothetical protein
MRYIKIALVFTFVFITTSCAELQGVVGTIPSGQGGIDPVMIGNGLRQALDFGIDKQVTKL
TRKDGFYKNPLVKILLPQELQKVDKTLRDIGLGNLADEGLKVLNRAAEDAVKEATPIFVD
AVKGITFNDAKNILLGPDNAATSYLQNRTNQALYNKFNPVIESSFSKVGADQIWANIINK
YNTVPFVNKVNPDLTDYVTNEALKGVYKMIAVEEKNIRTKINSRTTTLLQKVFALQD
>OMIFANIC_01683 hypothetical protein
MKKIYLLALALFAFTYTNAQIIEDDMEFYNLGEMGTQNPTVWTSWTNDGGASNDGMLVVD
TQASSGDQSLLSPGDEGRDPVLLLGNQTSGDYSLIWNFYIPTGKEGYLNIQGQTPPVGTA
FSGVFNSGNIYFNEANGNPNGITDSNPTSDLSGLTFPHDEWFSVLLYVDVDALTYSFTIG
GVTSPDAAFQDDAVLGGINYFPGASVSEMYIDDVLFDDGLLGANDFDTVALSVYPNPVQD
ILNISTKEAVQNISVYDVLGKLVLQAQPGTVSPTIDMGALSSGAYMVQVTVGNTTKTVKV
IK
>OMIFANIC_01684 Fused isobutyryl-CoA mutase
MQQSPPYKPKNKVRIVTAASLFDGHDAAINIMRRIIQSTGVEVIHLGHDRSVEEVVNTAI
QEDANAIAMTSYQGGHNEYFKYMYDLLQEKGAGHIKIFGGGGGVILPSEIKDLMDYGITR
IYSPDDGREMGLQGMINDLVEKSDFAIGETLNGEIDHLSEKNPGAIARVISSAENFPEIA
KEALDKIHEKNKNIATPVLGITGTGGSGKSSLVDELVRRFLIDFPDKTIGLISVDPSKRK
TGGALLGDRIRMNAINSPRVYMRSLATRQSNLALSKYVSEAIEVLKAAEYDLIILETSGI
GQSDTEILEHSDISLYVMTPEFGAATQLEKIDMLDFANLVAINKFDKRGSLDALRDVKKQ
YMRNHNLWDTPQEELPVYGTIASQFNDPGMNQLYKAVMDLLNEKTDSELKSNYTISNEMS
EKIFVIPPARTRYLSEIAENNRAYDTTVNAQVKVGQKLFGIWKTIESVLGSKPELGKLGL
EIDSESVSEENKEFLRLLLAEFDRVKMDLDPYNWEIITGWNDKIYRYKADVYSFKVRGKE
INIETHTKSLSHSQIPKVSLPKYEAWGDILRWTLQENVPGEFPYTAGLYPFKRMGEDPTR
MFAGEGGPERTNRRFHYVSLGMPAKRLSTAFDSVTLYGNDPDHRPDIYGKIGNAGVSICC
LDDAKKLYSGFDLSDAMTSVSMTINGPAPMLLGFFMNAAIDQNCEKYIKEKGIEKEIEKK
IEKIYKDNGTERPRYQGDLPEGNDGLGLMLLGVTGDQVLPTDVYEMIKTETLSQVRGTVQ
ADILKEDQAQNTCIFSTEFALRLMGDVQEYFIENNVRNFYSVSISGYHIAEAGANPITQL
AFTLANGFTYVEYYLSRGMDINKFGPNLSFFFSNGIDPEYSVIGRVARKIWSKALKHKYG
ANPRAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNAYDEAITTPTE
ESVRRAMAIQLIINKELGLAKNENPIQGSFIIEELTDLVEEAVLEEFDRITERGGVLGAM
ETMYQRSKIQEESLYYETLKHTGEFPIIGVNTFLSSKGSPTVLPAEVIRATEEEKQQQID
TLSNLHKTYEQKADASIKEVQHAAIQNENLFERLMQATKYCSLGEITNALFKVGGQYRRN
M
>OMIFANIC_01685 hypothetical protein
MIPSFPNKLPQSPIYKKAQDIFTLSRHISNYMTDDLAVLQEDGNEDPYIYFGGDIVQQSV
SLVPEILKAESQTYAEEKHKYAASVTKLINRLYKNCERLELTSSNGKDFLPILRGEIKKF
RKLQRHWMLTL
>OMIFANIC_01686 HTH-type transcriptional regulator LrpC
MKIDLLNRKILKCLQENARMSNAEIGRQVGVSSPAVAERMRKMEDSGLINGYKTVVSPFE
AGYQLKAIIILRAFMGKLKPFLEKVKEYDEVLNCYRITGNENIIMEVVLENQKHLESFID
QLIIYGETKTQIVLSHIIANRAIKPV
>OMIFANIC_01687 Isonitrile hydratase
MRLLLILILFVALFSCGHHSEEMNHAAEAISETKKTFPKLDSTRYNVAFLIMDGVYNTEL
TAPYDIFQHTIFREGIKAMNVFTVANTDEAVTSFEGMRILPDFNYTKDPIPKIDILVVPS
AEHHLDSDLEDEVMLEFVRKVDAEALFVTSHCDGAFVLAQAGLLNNSVCTTFPTDIDTMR
EMFPSLDIRKDVLFVHDGKYITSAGGAKSFEAALYLCEFLYGAEIAHSLAGGLVIDWDLS
EVPHTVIVN
>OMIFANIC_01688 Inner membrane transport protein YajR
MVIPFLSLYLVKAKGFTLPEVGWIMSCYGVGSLAGTYVGGWLTDRMGFHKVIVLSLFLGG
LGFIGIQFLDTFHAVCAGIFIAIFLVDSYRPAIFVACDAYSKPENVTRSIALIRLAINLG
FSIGPVLGGLIIARINYSALFWIDGVTCVIAAFLLYIVLKPKKVNKDRDEEEALKEGLPP
FKNFAYMIFFLIMVANGIMFIQYFSVMPLYYKDVHFLSEDLIGALLFINGAVIVLLEMPL
VGWLERIQISRTIATFWGVVFLALSFIVLNMSGWTGVLIIGMLLMTLGEMIGSPFANALA
LSMSPKGRKGSYMGVFSMSFSLSHIIGHNSGMNLVNSFGYDTTWNIMFYVLLGVALLTLF
LYRFLKKSPNFTTY
>OMIFANIC_01689 hypothetical protein
MRIITLIIALLFLLPAGAQSKRKLMREIVAFHESENARFRDPATSPLKLDRIASFKALEV
YPINLKYSVKAKLVRTPDEEPFLLRTNTERLAEYVKYGEAYFEIDGKELMLNLYRDPSGN
ESESNILFVPFTDLTSGDGSYGGGRYLEFKIPEKENFILDFNKAFNPYCVYSDRYSCPIP
PRENDLFVRIEAGVKDYNKY
>OMIFANIC_01690 Putative fluoride ion transporter CrcB
MKHVLLVFLGGGLGSALRYAIGKWLDGIYLQFPAGTFVVNIVGSLVIGVVLGMALKNTSI
SQNILLFTATGFCGGFTTFSAFAYENYALLKNEDFLSFSLYTFGSLALGFGAVVLGIWLS
RLI
>OMIFANIC_01691 hypothetical protein
MKILKYLLFLLLIIIVAGGIYFGTKDGKFDVAESKEFNAPAEVIYNNVKDYKNWAKWGPW
KEEDPSMEFTYAEKTEGEGASYSWTSDVMGDGSMQTIKIIPNKEIDQKIIFNTPIGDSES
DIYWKFEPSEEAGKTKVTWGMKGEHSFMEKVFMAFQSEDFDVAVKRMYDKGLANLETEVE
ESMNAYEITVDGITRHGGGFYLYNTTSSKMTEIGDKMASMMGQLSGFIQENNISMAGMPF
TIYNEVDEQNGTVIFSAAIPVTARVITPQGSPVLCSYMAPVDALKTTLKGKYDYLSEGYA
KAQNYLKENNLMMDPGRKMFEVYANDPGNVPNPANWITEIYIPVLTPSTPGFNR
>OMIFANIC_01692 hypothetical protein
MMSKFFIAIAICSLMFVSCADDKKDDQNKPETAEVVTDDFKYQIDQFADLKILRYQIPSW
NDLSLDEQKLVYYLTQAGLAGRDIMWAQNYRHNLTIRKALENIYTNYDGDKESEDWKNFE
VYLKRVWFSNGIHHHYSTAKLKPDFSAEYLRSLLTATNTSLEGEAFDVIFNDKDAKKVNL
SKDADIVLESAINFYGPDVTTADVENYYGAIEVDSEEPIEIGLNTKLVKENGQLVEKVYK
SGGLYGGAIDKIIYWLEKAKGVAEDENQAKALGLLIEYYKTGSLDTWDDYAVAWVNSTEG
DIDWINGFIEVYNDPKGYKGSYETIVEIKDFDMSKKMAVLSKEAQWFEDNSPLMPEHKKK
EVKGVSYKTVIVAGEAGDASPSTPIGVNLPNNNWIRQKHGSKSVSLGNIINSYNNAGGSG
RLQEFAHDEEEVELEKKYGQLADKLHTALHEVVGHASGQINPGVGTPKETLKSYKSTIEE
GRADLFGLYYLMDPKLQELGLVEDWEATGKAAYDGYIRNGLITQLVRLELGDDVEESHMR
NRQWVSAWAYEKGEADGVIEKVTRDGKTFYDIKDYAKLREIFGMLLKETQRITSEGDYEA
AKALVEDYGVKVDQTLHKEVLERNSKFEAAPYGGFVNPVIVPDMNEDGEITGFSIKQPET
FEEQMLNYSKEYGYLSN
>OMIFANIC_01693 hypothetical protein
MFTTGQLIFAICFVIAFVIIMVISYRRDKKLHRKHYKGSFWILIGFLVFVGLLLMAKWLL
KQ
>OMIFANIC_01694 hypothetical protein
MKNKIAAVHEFHAAFGLGIKNTPTADLGEAKNLLRYKLMREENEEYLEAANDNDLVEVAD
ALGDMLYILCGTIIEHGMQHKIEEVFNEIQSSNMSKLGADGKPIYREDGKVLKGPNYFKP
KIKEILES
>OMIFANIC_01695 Branched-chain-amino-acid transaminase 1
MNITTPSSITVQKTSTSRINDVNFDSLEFGTVFSDHMFSCDYKDGRWQNAQILPYGPISI
SPAAKVFHYGQAVFEGMKAYKDDDGGVFMFRPDENFRRINKSSKRMAIPEFPEELFFGAL
NTLLEMDKDWIKPGLGNSLYIRPFAMATQVGVSASASNEYKFIILLSPAQAYYSGDVKVV
FSEHYSRAADGGVGFAKAAGNYGAQFYPTNLAKEKGFQQVIWTDSHTHEYLEEAGTMNIF
FRINDSLLTAPTSDRILDGVTRKSLLKLAETMGIKAEVRPVKVAEIKEAHANGSLKEIFG
AGTAAVISPISAFSHGEVTYDLPKQEDSYAAMFKSRLMDIQYNRSEDPFGWRYRVV
>OMIFANIC_01696 hypothetical protein
MKKLLLLALALVILAACKTDKKNEEPVVEAETQEMAYQSFGEKITADNVLSSEELMEKYK
HLNIGDSIAVKFTSEVKEVCQNKGCWMKMDMGEEEAMVRFKDYGFFMPKDIAGQKVIVDG
YAFVTEMSVEDQRHYAEDAGKTAEEIATITEPKRTLSFTSSGVLIPEMEPAMEKQ
>OMIFANIC_01697 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKREFLITGDGSVTIHLPEWNEQYHSKHGAIAEAAHVFISSGFEYLFQQNPDSLKELYIL
EMGFGTGLNAYLTLLQTFHKKIKIHYTGVDAYPVDTSEVDKLNYPDLVKGSEALFLKLHE
ISWDENTEITDHFHLLKQKKQFSEVQDENQYDLIFFDAFGPRVQPELWTETIFKAMFRSC
RTGGVLVTYSAKGSVRRAMESVGFKVERLPGPPGKREMLRAIKSS
>OMIFANIC_01698 Epimerase family protein
MNILITGATGVIGTHLVKACLSKGHRIHFLTTRKEKIESKTNYKGFYWNPDTGEVDNQAF
KDVTVIIHLAGASISKRWTKSYKKVILDSRIKTAKLLFTAMQNNEHSVTHFVSASGVSIY
PPSFTKFYTEEDNEVDNSFLGEVVKAWEDAANQFKQLGIKVTKVRTGLVLATEGGALPAI
AAPVRKGVGAPLGSGNQWQSWIHIDDMTNIYLNIIENGWGGTINAVSPNPATNKRLTKLI
AKTLKKPLWLPNVPAFVLKLLLGEMSMLVLQGQLVSSKRLEEAGFSFRFFNLESALDDLL
KD
>OMIFANIC_01699 Protein GrpE
MSKKTKKATAVAEEEIDMNNTETSAKQSKKAEKKISEIEHLSNELQNEKDRYLRLFAEFE
NYKKRTGRERIELFKTASEDVMVSLLPVIDDFDRALKEIEKSHDDNLYKGVELISNKLRE
TLKSKGLEAVGTQKGDIFDAEIHEAVTQIPSPSDDMKGKIIDVIEKGYKLGDKIIRFPKV
VIGQ
>OMIFANIC_01700 Chaperone protein DnaJ
MKDDFYDILGISKNASAAEIKKAYRKKAIEYHPDKNPGDAKAEEMFKKAAEAYEVLSDPD
KKARYDQYGHQAFEGGGFGGGGMNMEDIFSQFGDIFGGAFGGGGFGGGFGGFGGGQRRVK
GSNLRIRVKLTLEEIANGVEKKIKVKRKKVAQGTSFRTCGTCNGQGQVTRIQNTILGRMQ
TATTCSTCGGTGQTIEKKPPNADSQGMLLTEETVSIKIPAGVVDGMQLKVSGKGNEAPGG
KGIAGDLLVAIEEQPHSTLQREGDNLHYDLYISFSEAALGTSKEIDTVTGKVRIKIEPGT
QSGKILRLRKKGVPSINSYGTGDLLVHVNVWTPKSLSKEQKEFFENMRADDHFRPNPEKE
DKSFFEKVKDMFS
>OMIFANIC_01701 ABC transporter ATP-binding protein NatA
MDNLLVADKVSKSFGEFKALNDVSIAVPRGSVFGLLGPNGAGKTTLIRIINQITMPDTGS
VILDGQPLKPDDIRHIGYLPEERGLYKSMKVGEQALYLSQLKGLSKQEAKKRLKYWFERL
EIGDWWNKKIQELSKGMAQKIQFVVTVLHEPKLLIFDEPFSGFDPINANLIKDEILRLRD
NGATVIFSTHRMESVEEMCEHIALIHEANKILDGKLIDIKREFRSNTYEVGLISGDHNSA
KSRLAENFEVFPADFKSINDEFQCKVKIPEATSANDLISLLTTQGQLTHFVEVVPSANDI
FIQTVQNN
>OMIFANIC_01702 hypothetical protein
MNHLSLIIKREYLNKVKNRAFIIMTFLSPLIMVGIFTLVAYLSQLNNDKVRTIAVLDESG
MFSDEFESGDNLKYKLVTGSDLSEAKKAVEASGDYGLLYIAEVDSLDALSENITFYSEDS
PSFILLDNIEDAIAAKANTLKLQEAGLDPAKIESLRIRIEAKLETFGGEKTSKLSTGLKL
GFGGLAGYLLFMFIIIYGNMIMRSVIEEKTSRIIEVIISSVKPVKLLLGKIIGTSMAGVT
QFLAWVILIGVFGMVISAIFGIDAGAMQQQEAMAQAEALSNDGAFVQDIMMELNNLPILN
LVIMFILFFVGGYLLYASLYAAIGAAVDSETDTQQFMLPIIMPLILAVYVGFFTVIDNPH
GTVSQVFSFIPFTSPVVMLMRIPFGVPLWQQILSVVILFATFMGTVWFAAKIYRVGILMY
GKKASYKELIKWLKY
>OMIFANIC_01703 Mechanosensitive channel MscK
MFQKEKVTDSIQEVVKTDIWGSIKEFLNWGFEFGQGENQIKLTIGLLLLIVITFLIVGFI
LNLIRKLFTRKMDDIDTRKFVSVFKFIKYVVYIIVVFAVLSLAGVNITPFLAASAALLVG
LGLALQELFQDLIAGMFIITDKSLLVGDIIQIDDKVGRVIDIKLRTTRALTRDDKVIIIP
NHKFISDSIINYTQNHKTTRESVTVGVKYGTDTRLVEKLLLECAHTQKGVLKKPKPFVLF
NDFGDSALIFTLNFYIGDSFIDPIIKSDIRFRIDEAFRANGVTIPFPQRDVHIYPTQTKD
Q
>OMIFANIC_01704 hypothetical protein
MILGYTSLFGQATDLARIEYTFIPQSNSNNSINRFRGFVNFPIPLEWDGSYLVPGIEYRN
VDLDIEDKVPFDTENLRKFQMFRLGIGYTFKMTEVWRVGMRAGVEIASNFEERTAVSSDL
RFTGAAYLVKDRSRDSTGTKDRFIIGLQYSTNAGRPFPIPVINYFKKFHPDWSYTVGVPK
MNLKHYITKKQTVQSFITIDGFFSNIQNDLPIPDGMGMPKIADNISMTTVMAGLGYEYFF
SKYVLFYFYGAYTGYNEIRLRDTNRNSLYRINEENTFYIRSGIKLKL
>OMIFANIC_01705 Transcriptional regulatory protein ZraR
MPKILIIEDEAAIRRVLVKILSEESDTYQVTEAEDGLEGIEKIKKEDYDLILCDIKMPKM
DGVEVLEAVKKIKPEVPIVMISGHGDLDTAVNTMRLGAFDYISKPPDLNRLLNTVRIALD
RKELVVENKRLKKKVSKNYEMIGESAAITHIKDMIEKVAPTEARVLITGPNGTGKELVAH
WLHQKSDRAGGPMIEVNCAAIPSELIESELFGHVKGAFTSANKDRAGKFEAANGGTIFLD
EVGDMSLSAQAKVLRALQENKVQRVGSDKDIKVDVRVIAATNKNLKKEISEGKFREDLYH
RLAVILIKVPALSERREDIPLLVDYFTKKIADEHGTAQKKFSEKALKKLKEYDWTGNIRE
LRNVVERLIILGSTEVSEEDVKLFASK
>OMIFANIC_01706 hypothetical protein
MEPIEISKYKITSKVSISDLNTHEDFRSDKKTLSSSLRETRKKLGKLQDTLYAHGKYAVL
VCLQGMDTAGKDSLIREVFKDFNARGVVVHSFKVPTDLERKHDYIWRHYIALPARGKFGV
FNRTHYENVLVTRVHPGYIMAENLPGVHSTDDVNQAFWDRRFEQINNFEKTIAENGTLIY
KFFLNLSKDEQKNRLIRRLNKPEKNWKFSPGDLDERELWDKYMFCYEDILNRTSKPHAPW
YAIPADNKPAARLIVASILLQEISKYEDIREPDLDPEVKAKISEYKDRLQNE
>OMIFANIC_01707 Bacterial leucyl aminopeptidase
MRYSELKMKENFLLNNRITLITSLFVILMSSISAQVVNKEDSITIRSLYDAALLNGKSYD
WLDHLSNEIGGRLSGSIEAEKAIRYTESELKKLGLDKVWLQPVMVPKWTRGVKEYAYIET
APGITSTTNICALGGSVATPSGGLKAYVVEVQSFEELEKLGRSAIEGKIVFYNRPMQANL
IRTFEAYGGCVNQRYAGAMEAAKYGAVGVLVRSMNLRKDDYPHTGAMTYGDTPPDQRIPA
AAISTNGADYLSSALKLKSDLKFYFKQSCRTYPDVQSYNVIGEITGSTYPDRYMVVGGHL
DSWDLGDGSHDDGAGCVQSMEVLRLFREIGYKPKHSIRVVLFMNEENGLRGGRKYAEEAR
LRNEKHVFALESDAGGFTPRGFSFDTDEKNFAQIESWKSLFEPYLIHSFVKGGSGADIGP
LKDGSIVLSGLRPDSQRYFDHHHSAVDTFDAVNKRELELGGATMASLVYLMDKYGTKSEF
GVIKD
>OMIFANIC_01708 hypothetical protein
MSFLKAEWRKLALANYEVDPEILKPYLPYKTELDIWNNTCYVSLVGFMFINTSVFGVKFP
YHVNFEEINLRFYVRHNDGKQWKRGVVFVSEIVPKPLISFVANTLYNEHYTTRKMFHKWE
ETENTLETSYGFFEKGRAQSIAVSSSKIALPFPAESETEFITEHYWGYTPNSEKETTEYE
VTHPRWNAYEVLDYNIDFDFELAYGLNFGILNELEPRSVMLAEGSEITVESKKILK
>OMIFANIC_01709 Multidrug resistance protein NorM
MLKQYTKEFRYNYRLATPVILGMLGHTIVALVDNIMVGQLGTAELAAVSLGNSFMFIAMS
LGIGFSTAITPLVAEADGENNFEAGKSSFKHGLFLCTVLGIALFLMVFLAKPLMYYMKQP
EEVVQYAMPYLNLAAISLVPLIVFQAFKQFSDGLSMTRYPMYATILANIVNIFLNYIFIF
GKLGMPQLGVVGAAIGTLAARIIMVVYLWYLLSQHHKSRPFVLHIKLFRLSKKMLNKIMG
LGFPSALQMFFEVAIFTAAIWLSGILGKNPQAANQIALNLSSMTFMVAMGFSVAAMIRVG
NQKGLKRFRELRRIAFSIFLLSTMLAVVFAILFVIFNETLPKLYLDYDNKAEFADNFQVA
TIAAKLLLISAIFQISDTLQVVTLGALRGMQDVKIPTVITFVAYWLIGFPISYYLSMVSD
YGSAGIWIGLLAGLTASGIMLFIRFNYLSKRLILKFSDN
>OMIFANIC_01710 hypothetical protein
MELPKYLLGDNTDFPDAIFVVHTEFPRFVIDLSNDEVEWLEEFDQHDQKELETETENYIR
EASEFYDREVARYGND
>OMIFANIC_01711 hypothetical protein
MIDTLLTYDTELFLYLNNLGTERWDGFWRIVTEKWSSIPVYVILLYLVFRHYGLKGTIII
LIAVALMITATDQLANLFKYGIERPRPCRVEALQQQMRFVADGCGRFGFFSAHAASSMAA
AVFLGLALRKYHKYLPFILLFWAVVVAYSRIYLGVHYPLDIITGMFFGGILGWLFYRLQV
WGQVRFNGG
>OMIFANIC_01712 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase
MKALRKNHLLLLVIACIAIFFVNLDALYVNIMEARNFTSAREMLDDGNWLLTTLNGEPRY
QKPPLPTWITAFSGAIFGLQNIAALRMPAALLGLLLVLISYIFSLKLTRERTYAFVACLV
MATSFYVVSASRDGNWDIYTHGFMMVCIWQLYLFFSSENRIYQHAILAAIFFGCSFMSKG
PVSLYALLLPFLIAYGIVYRYRNFKNRWVPLLLFLVISAIISGWWHWYTYTFDPETVAEI
TKRETSNWTGYNVRPFYYYWSFFTQSGVWTIMAFIGLLYPYLKNRVFDKKAYRFTFLWTI
ISLVLLSIIPEKKSRYLLPVLIPLALNTGFYIEYLFRRFSDLKDKRETWPVYFNFGLISV
IGLAFPFGGYFLLQDQLAGKWVWFILLSLMLFGIGIYMLRHLFQKKIKPVFFGTIFFIAS
IICFGMPLAKTLTVNPEFTSLAELNKWQDKTNVNVYELTYFTPELIWAYGKPIEVLLEDG
KTNIPSDEKFGVLVSRDDQKLFNTSFKDFDTKLVRRYDMNPKAKGDRSHKPRLYRDLYLV
SRR
>OMIFANIC_01713 hypothetical protein
MSDLLIYSIGFTAQILFSGRLLAQWIVSEKKKRIITPSLFWKLSLLASFLLFVYGFLRDD
FAIMLGQSLTYFIYIRNLQLQGEWQRAPAWFRWFLVIFPVVIVIYSYNNGEYDLEQFFSK
ENIPLWLLILGIVSQIVFTFRFVYQWIYSERTRTSQLPVGFWRLSVLGASLILTYAIFRK
DPVLFVGHIAGLIIYIRNIFIWKKQFREST
>OMIFANIC_01714 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MYEFTIIVPVYNEEDNLERVEKELLAYTEIASRKTAVLFVNDGSKDGSQALIEAICNRNE
AFSYILFNENRGLSAAIKAGFDHIETELLGYIDSDLQTAPEDFNLLLEHIGKYDLVTGVR
ADRKDSFVKNMSSKIANGIRRAFTHDGMDDTGCPLKVIKTEYAKRIPMFKGLHRFLPAMI
MLQNGKVLQVPVRHFPRIAGKAKFGLWNRLLGPLMDCFAYLWMKKKYINYEVKQKG
>OMIFANIC_01715 UDP-glucose 4-epimerase
MRILVTGAAGFIGSHTSERLSEMGHKVIGVDNFSDYYDVKLKELNAKALFKKGIPVHKTD
LCVDDLASLFKDRFDYIFHFSAQPGIAVTSTFKDYLDNNFVATQRLMDAIEDLEHKPFFV
NIATSSIYGLYATMTEDEAPKPASWYGVTKLAAEQLVLAYSRRGLLKSASLRLYSVYGPR
ERPDKLYTRLIDCGLNDKAFPLFKGSEKHLRSFTYVQDIVDGIVSVIGKEEVTNGEIFNL
GTEQENSTATGITTVEDILQIKIKIEHKPARPGDQSRTKANIDKARKLLGYNPTTRLEEG
LRAQVDWFKDNFC
>OMIFANIC_01716 putative GTPase
MSKSVKKSDALHEVKGVPQPSSVSLTAADKVKKSRKKRISPKKLLGGMLSGDKSALSRAI
TLIESTKPKHRIEARELLEACLPYANNSLRIGITGVPGVGKSTFIERFGKLYTSKGHNVA
VLAVDPSSKLSKGSILGDKTRMEELVKDKNAFIRPSASGSSLGGVARKTREAIILCEAAG
FDIIIIETVGVGQSETMVHSMTDFFLLLKLAGAGDELQGIKRGIMEMADAIVINKADGEN
IKAAKLAKAEFNRALHLFPEKESGWSPKTLTCSAIKNEGIAEIADLISDYVKITRENSFF
LQRRNDQNKYWLLQTIESSLKNNFYENPEIKKALREQLKALDENKTTPFEAANYLLSLNQ
R
>OMIFANIC_01717 ECF RNA polymerase sigma-E factor
MTDSLLIEKCKQHDRKAQMALYRKYCDGMFIIASRYMKDTATAEDALQEAFIKAFQKIDQ
FKGDVTFGAWLKRIVINKCLDVIKARKMEVQSLDDRVLHIAEGEEDWDVGDQATMDEVYN
AIENLPENYRVVVKLFLLEGYDHQEISEVLGISESASRTNLHRGKIQLKKTLKHLEYGTG
Y
>OMIFANIC_01718 hypothetical protein
MQDNMVEEFNAYRSKMNEKLLEDNNKIIKRIFNLDTNAFTDGALPKRTKELLGLGNSMVL
RCDDCVRYHLEACYKLGIPKDEVVEALSVSLLIGGTIVIPHLRRAYEYWEALEKS
>OMIFANIC_01719 Sec-independent protein translocase protein TatC
MAAAKDTSPGKEMSFLGHLEELRWHLIRSTIAVVVMGTVAFIMKDFIFDTLIFGPTKKDS
FPTYRLLCEGAKLLGFEGSFCDAEFPFRIQSRTPAGQFSAHIWTSITAGFIVAFPYVLYE
FWRFVSPGLHRKERSSARGFIFVASILFFTGVLFGYYVVTPLSINFLGTYQVSDAVFNDF
DLSSYIGLVRACALASGLIFELPIIIYFLTKIGLVTPQFLRKYRKFALVIVLIVSAIITP
PDIASQVIVAIPVVILYEVSIYISKAVIKRQNKKDKAHAR
>OMIFANIC_01720 Arabinose 5-phosphate isomerase KdsD
MNQESKIISVAKETIETESKAISHLADLVDEEFAHAVESIYKSDGRVIITGIGKSAIIAT
KIVATLNSTGTPAIFMHAADAIHGDLGTIQQSDTVICISKSGNTPEIKVLVPLIKTRGNI
IIAITSHKESFLGQQADFVLNAYVEKEACPNNLAPTTSTTAQLVIGDALAMCLLDLRGFS
SKDFAKFHPGGTLGKKLYLRVSDLTSLNEQPQVGPDTDVRRVIVEISEKMLGVTAVVEND
EIIGIITDGDLRRMLTKVDNFKGLTAKDIMTRNPKKINNDAMAIEAMELMDTHGITQILA
EKNGKYCGVVHIHNLTKEGII
>OMIFANIC_01721 ATP-dependent DNA helicase RecQ
MAEIDIYAALKKFFGFTKFKGLQEEVIKSIIANHNTFVIMPTGGGKSLCYQLPALIKEGT
AIVVSPLIALMKNQVDALRSHSHEDGIAHVLNSSLTKTEIKQVKSDISNGVTKLLYVAPE
SLTKEENVAFLNSVKISFVAIDEAHCISEWGHDFRPEYRNLRAIIKRIGDDIPIIGLTAT
ATPKVQEDILKNLGIQDANTFKASFNRPNLYYEIRPKTKNVDADITRFVKQNEGKSGIIY
CLSRKRVEELAQTLQVNGIKAVPYHAGLDAKTRVKHQDMFLMEDADVVVATIAFGMGIDK
PDVRFVVHNDIPKSIESYYQETGRAGRDGGEGHCLAFYSYKDIEKLEKFMSGKPVAEQEI
GHALLQEVVAFAETSISRRKFILHYFGEEFDNETGEGGDMDDNMRFPKKKHEAKDEAKKL
LDVVDKTNEKYKSKEIVNVMVGHVNAMIKSHRTDTQDFFGIGTDKTGEYWMALLRQLLVA
GFLRKDIETYGVIKLNPAGLDFIKNPVSFMMTEDHSFKEANDDTIIVAQKSGGTVADDNL
FKLLKSERKRVADNLKLPPFVIFQDPSLEDMALKYPVSMEELATVHGVGEGKAKKYGSPF
LELIRRYVEENDIVRPDDFVVKSTGINSALKLYIIQNVDRKLSLTDIAAAKGLEMPDFIK
EMEAIVYSGTKLNIDYWLEEILDEDQQEELHDYFIVAETDKIDAAMDEFEGGYDDEELRL
FRIKFISEVAN
>OMIFANIC_01722 hypothetical protein
MKHYALTITVLLNLIFLSHLQGQTNELYDKGIITSGFDSLPYRFTKPKNYDPALKYPLII
FLHGSGERGADNELQLKHGASFFASDSIRDKYPAIVVFPQCDTNNSWHNGTYAFTSGKGQ
YSFPKEIKENISLNLVEILIREFQMQFNIDSDRMYLGGLSMGAMGTYEMVNRNPNKFAAA
FAICGGANPEIAERLQFTGCWIFHGEADDVVPVEWSEHMYEAIKKKSGDVKISIYPNVKH
DSWTNAFNEPELMEWLFSNHKN
>OMIFANIC_01723 putative peptidyl-prolyl cis-trans isomerase
MQDGIYANISTEKGTIKIKLTHDKTPGTVGNFVALAEGNLENEAKPQGTPYYDGLKFHRV
IPDFMIQGGDPNGTGAGGPGYNFDDEFHPELRHTGPGVLSMANAGPGTNGSQFFITHVET
PWLDNKHTVFGYVVEGQDVVDSVAQGDTMQKVEIERIGDDARNWNAVEAFRQFNGAKAER
ETAAKKAQEELLTSISEGFEQTESGLRFQIIQKGSGVKPNAGETVAVHYKGMLPDGAEFD
NSYKRGNPIEFPVGTGQVIAGWDEGIQLLKVGDKARFVIPSHLAYGSRGAGGVIPPNATL
VFDVELMDVK
>OMIFANIC_01724 Putative metal-dependent hydrolase YfiT
MEKDHLKFPVGKFEIPKTISDADLNEAITILEVFPEQLKMLTYNLKDEELDSPYREGSWT
IRQLVHHISDSHHHSYNRIRWALSEDNPMIKAYDQDAFAELEDYKTWPIAWSFIHIEAIH
HKIVNLLRMLTEEQWQRTFRHPEMEKEMNLRELALMYAWHSMHHYAHIKNALDKA
>OMIFANIC_01725 Thiol-disulfide oxidoreductase ResA
MALTPSNMLPLGTKAPNFVLIDTITNKPVSLQQVRGEKGTVVMFICNHCPFVKHVNEEIV
RLCNDYRVTGFGFVAISSNDVENYPQDSPKKMWENARKHSYPFPYLFDEDQEVAKAYDAA
CTPDFYLFDHDLKLIYRGQLDNSRPGNNIPVNGRDLREALDNVLNNAPQRKDQKPSIGCN
IKWKSN
>OMIFANIC_01726 putative chaperone CsaA
MEISWDDFQKIDMRVGTILEVSDFHEARNPSYKLKIDFGKELGVMKSSAQITTLYSKELL
MGKQVIAVVNFPKKQIGPFMSECLVLGAVQGDNVILLHPERNVENGTQIS
>OMIFANIC_01727 Sensor histidine kinase RcsC
MSFLKQNVWTLVIFIIGIIAIFLIDRNQIDNDLQKNKLKIEQVHQRSVSQFTTAINEFAA
MISGMKVFMNESEELPSAEILQHFVQKQLEALQSTDSIAVSFIDSTHTFIYSFTRHELDP
NDLAGVNVSSLRSEEKIAELNDLMKTDSLLLFAPLNLVEGWVGVPLNFRVHREGKTLGYL
APILKFKTLMRGMYSQEISKDFVFRFRWEDEFEFDREQVYNNTKVYNKKKDPEYYGNFNV
DDSDFITSDVKMYGRTISISTAYKNGGVQRNPMIYLLLLGHLVLTGLFYVLNKLRLRSKE
LNRELETANQLLGRRGNLLLEQNKELVSVNKTKDKLFSIIGHDLKQPLHSISGLLHLLEN
ENIEDSTLQNLVIQLKRTTNTTTELLSNLLRWAASQTGDLKYQPGWYNLNFILETVIGAI
KPAADLKSITIKYSKGENVQVYADLNMLSTVFRNLLSNALKYTSSEGTIHLSLELNANYA
IVHIQDNGVGMKPEEVARFYDLESQISKLGTSGEVGTGIGLLLCQQFMEINQGKIEVTSK
ENEGTRFSVYVPLKGVK
>OMIFANIC_01728 hypothetical protein
MYIRYSMKTRLSVFVLLLSILAVSIYSCEERISKNNNTISPDGNWESVGYGRILKIDSTG
SFVLSDVSPFSCLPLMEGNLSDMGENLTLSQDTISLEDGINRYFFTRINELPGSCIVDNT
EITRDPILNFEVLWNTFNDHYAYFELRKINWDSIYEIYRPVISQSTTDVELYRVLDEMIS
AMNDGHVGLDAPDEIVDAAIIKSEYPTEVTIKNYGNHEVAKLVADSYIPEGSSAHKELLR
WGVLENNIGYIQLNQMMGLAEYNISDSLTGRDYWMAYFEQSDQSIDDTSDEVNGIRNSMK
TVMEDIAETEAVIIDVRFNGGGKDEVGMEVLRHFNSNRKTVFTKKARFGSGFTPRIEIKQ
DGTTNYYSKPVFLLISGESASATEIMVLCSLSMDNITRIGSNTEGVFSDVLDKALPNGWE
FGLSNELYEDMNGRNYEGVGIAPDIDLNYPRNKQEFLRYIVNALSKNGDAAIETIIDRYS
Q
>OMIFANIC_01729 Bicarbonate transporter BicA
MIQKTIHNFTRNPKNDILSGLTVALALVPEAVAFAFVAGIDPLVGLYGAFMMGIVTSLFG
GRPGMISGATGAMAVVMVHLIQKGNEVGLGLEAPVENLGLQWLFITLLFVGGIQIVAGIL
RLGKFVRLIPHSVMMGFVNGLAIVIFLSQLGLFKETVNGERTWLQGYDMLIMLGLVLLTM
AIMFGLPKLTKKIPAALTAIIVVAAIVIFGKIDVSTVGSFIRDGGGEGLQGSMPEFQDQI
FALLYTLKGHWDLIFSTAFILAAVGLIESLMTLSLIDEMTETRGSGNRECVAQGGANILN
GLFGGMGGCAMIGQSIINVDSGGRGRLSGATAAIALLCFVLFGAPLIEQIPIAALVGVMF
MVVIGTFAWSSFRILHKIPLSDAIVLVSVSAITVWQDLAIAVIAGVIMSALTFAWKNATM
IRARKSIKEDGTKVYEIWGPLFFGSTTNFLTKFDVNNDPEEVEIDFIESKVSDHSGVEAM
RGIVNKYQAAGKKVTLTHLSPDCKILLLKNNPDFDEVIQDSIDDPRYYVVTDMMDSEV
>OMIFANIC_01730 hypothetical protein
MKNLLLLIGILISLPTIAQDYVVDLNYYLPKDVTYNSAIPTPSTVIGHEVGEWHITHDKL
VQYMYALAEASDRITIENRGATFEGRPILLLTITSPVNQRNIDDIKAQHLALTESGSSTL
NTANMPAVVYQGFSIHGNEPSGSNAGLAVAYYLAAAQGSKIDELLTNTVILFDPSFNPDG
LQRFAYWANMHKAKNINPDPNDREYREVWPGGRTNHYWFDVNRDWLPVQLPESRARIKTF
HDWYPNILTDHHEMGRNSSFFFQPGIPSRTHPLTPQKNQDLTKEIAKYHARAFDQLGSFY
FSEENFDDFYYGKGSTFPDINGGVGILFEQASSRGHAQESSNGVLTFPFTIRNQFTAALS
TLEAAVALRRDLLDYQRDFFDNARIEGASGGAIVFGDEKDAAKAFHLAEILKRHKIAVHE
LKEDFSSNGKNYKNGYSYVVLKKQRQHRLIKAIFEKRTQFQDSLFYDISAWSFPLAFNLD
YIENAPVSRAGKEIIDLQMKTPDTPNVSTYAYLMEWHEYYSPKALNMVLSEGLRAKVAMK
PFSLEGRDYDYGTILIPLQNQKLQMADLTKFLAKVSRETKVPIHGVRTGLANGIDLGSNQ
FRPVELPKVAMLVGDGINPYDAGEIWHLFDTRFDMKITKLDTRNFGRTDLSRYTDIIMPA
SWGNALDKQDAEKLKKWVQDGGSLIAFRNAGRFLDRNEMMKIKFKSRKDTATNVSYEQRG
KYRGAQVVGGAIFEAKLDRSHPIAFGYKNDRLAMFRNTTLFVEPDADSYNNPIQYTSNPL
LSGYISKPNLKDLASTVPFKTSGVGRGQVLYFTDNTNFRAFWYGTNKLLMNAIFFGDKM
>OMIFANIC_01731 hypothetical protein
MSDQYMMEKEEIYSKVMRAGRRTYFFDVRSTKAGDYYLTITESKKFTNDDGSFHYKKHKI
YLYKEDFHEFRDNVEEMIQYIIDEKGEEVISERHQKDYKKEETEVTDMVEEPTDETSTSN
FTDIDFDDI
>OMIFANIC_01732 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKELKYLNHYFIKYRGRLLLGLLITVIARIFALIVPMKVGDIVNLVEQRLNGEITVEQLE
TLLLNSILLIIGATLLSALFTFIMRQTIIVVSRYIEFDLKNEVFQQYEKLSLSFYKQNRT
GDLMNRISEDVSKVRMYVGPALMYSTTTVTLFLVVLSYMIYKAPLLTLYAVAPLPVLSVL
IYKLSAAIHRRSTIVQEYLSKLTTFTQESFSGISVIKAYGLEPRTNTEFVDLSEGSKEKN
IDLAKVQALFFPLMMLLIGLSNILVIYIGGQQYVNNQIELGTIVEFLIYVNLLTWPVAIV
GWVTSIIQQAEASQKRINQFMHEEPAIQNLNPEPSEIKGKISFNNLTYTYPDTNITALKN
VSFSINPGQTLAIVGHTGAGKSTVLELIGRLYDVEEGQLLIDNIPISKLNLASLRSSIGY
VPQDAFLFSDTLSNNIKFGKEDASEEEIIEAAKNAAVHDNIIGFNHGYDTVLGERGISLS
GGQKQRVSIARAIIKDPHILLFDDCLSAVDTETEEKILQNLNKISSDKTTIIVSHRVSSA
KNADMIIVLEEGNIVQQGTHNELVNTDGYYKELYAKQLLEKEM
>OMIFANIC_01733 Leucine dehydrogenase
MITDIVSTNELTKIDPVFGQLSFDNHEQVVFCNDKDTGLKAIIGIHNTVLGPALGGTRMW
KYNSEWEALNDVLRLSRGMTFKAAITGLNLGGGKAVIIGDAKTEKTPELMTKFGEFVHSL
SGRYITAEDVGMETADMDLVRTVTPFVTGISEEKGGAGNPSPITAYGVFMGMKAASKYAF
GTDILEDRTIYVEGIGNVGEALVENLTNEGAKVYIVDINQERLQYVSEKYNVEIYNGSNL
FAEEMDIYAPCALGATINDDTIHQLNAKVVAGAANNQLANEQKHGMMLSQKGIVYAPDFL
INAGGIINVYAELENYGRHEIIRKTENIYNTTLEILQNAETNDVTTHQAAFDIAQSRIDA
RKKEK
>OMIFANIC_01734 N utilization substance protein B 
MLTRRHIRVKVLQSIYAFTRGEQQDIDKQEKFLLFSINQMHELYVLLLQSMVALRDHAEA
HLVKSQQKFLATETEKNPSKNFIDNQLLQLLSKHDDLRRILKNKKLNYWKEDDEYIAILF
NELVSKDFYTEYLSEQNPSFQRDKDFVIRLYKEVIAPNDKLYEYLEDKRLTWLDDYPIVN
TVLVKMLAKVNANNIASTLIPDLYKNEEDKDFAIQLLRKVLLNDEKLTAEIDGKTPNWDK
ERIANLDMIILKMGIAEFLYFPSIPVRASINEYLEISKEYSTPKSSLFINGILDKIVKEF
TENGKLNKIGRGLR
>OMIFANIC_01735 hypothetical protein
MKKSILLIAVLSAFIFTSCKENAADKVNEENVAAAADRDAKSQDFPVMTFEESEFDFGTI
DQGTNVEHVFKFTNTGNAPLVIVDAKSSCGCTVPQFTKDPVAPGDSGEMLVKFNGSGKNQ
VSKTVTITANTENGKESIKIKAFVNAPETVTPAGSNVIQTNTK
>OMIFANIC_01736 hypothetical protein
MEQQSLILLVLMFVVVYFFMIRPQVKRQKQEKKFASELKRGDKVVTKSGLHGKVLDLNDD
GTCVIESGAGKMKFERSAISMELSAKLNAPAKK
>OMIFANIC_01737 Peptidase T
MINNQHLIDRFFSYVTVDTESDPESKSTPSTEKQWNLANALADELRRIGMEDVSIDENAY
IMATLPSNVDHEVPVIGFISHFDTSPDFTGADVKPQIIENYDGGDIVLNKEKNIVLSPEE
FDDLLMYKGQTLITTDGTTLLGADDKAGIAEIVSAMEYLINHPEIKHGEIRVGFTPDEEI
GRGAHKFDVEKFGAEWAYTMDGSQVGELEYENFNAASADVTIQGKIVHPGYAKGKMVNSI
YIATEFLNSLPRMETPEHTEGREGFFHLHTMEGSVDSTKLQYIIRDHNLEHFEARKKVML
KLAHELNTQYKKEIVSVEIKDQYFNMREKVEPVMHIVDLAEEAMKQAGITPIIKPIRGGT
DGSQLSYMGLPCPNIFAGGHNFHGRYEYVPLESMQKAVEVIVNIAQLTAKQNG
>OMIFANIC_01738 Dihydroorotate dehydrogenase (quinone)
MYKSILRPLLFKFDPEKVHHFTFKLIRFSSAIGLGGLFRMLYKVNDPRLEREVFGLKFPN
PVGLAAGFDKDAKLYRELENFGFGFIEIGTVTPRPQEGNPKKRLFRLKKDKAIINRMGFN
NGGVEEAVERLKKNKNVLIGGNIGKNKTTPNEEADQDYIFCFEVLFDHVDYFVVNVSSPN
TPNLRALQDKEPLTKLLKLLKERNSQKTNPKPILLKIAPDLNDEQLLDIIHIVAETEIEG
VIATNTTISREGLTTNDSIVQNIGAGGLSGKPLTRRSTEVIRFLSEKSNRSFPIIGVGGI
HSAEDALEKIQAGASLVQLYTGFIYEGPGLIKEINKALLNV
>OMIFANIC_01739 hypothetical protein
MKKFLPVLLFGLLCGNLMVFSQSEATYSINYTSTWSETTHPHPGGNFPASAHYSKLVGAT
HNDQVVFLEMGSLATPGIEDIAELGSNGVFFSEVNTAISNGAANEIIDGDDLSSSTGEIN
ISNVVTNEDFPLLTLVSMIAPSPDWMIAVNSVELLDTNGDWKPSISIDLFPYDAGTDSGV
DYTSPNLDTDPPEPISSAQGVAPFSNEKMGTLTITLESVLGNDDNSDSFLQVFPNPTDGI
IRITESKGIKSVEVFNVLGAKVLQQNINSNQVQMDISSLRSGLYMFRIESSDGTSVVKKV
IKR
>OMIFANIC_01740 Homoserine/homoserine lactone efflux protein
MIEALYLFSLATMALAISPGPDNIYVLTQSLTNGAKSGIATTAGLISGCIVHTTLLAFGV
SIIITASPVIFFSIKVFGACYLLFLAWKVYKRDANISLDNKVSRKSHWQLFKQGVFMNLV
NPKVLIFFLAFFPAFLWDETGNTVLQFYILGITFMVVSFLVFSGLALLAGSISSYMLTHK
NTGFALKWLQILVFVGIAIYILLPEN
>OMIFANIC_01741 Hydroxymethylglutaryl-CoA lyase YngG
MQGIKDWIPTKEKISYLQSLLRCGFDTIDFGSFVSPKAIPQMKDTAEVLAGLDLSNTESK
LLAIVANVRGAQDAVKFNTINYLGYPFSISENFQMRNTHKTIAQSIEVLKEILQLAGDHG
KEVVTYLSMGFGNPYGDPWNVDIVGDWAERMAEMGVKILSLSDTVGTSTPEVIDYLYSNL
IPKYPEIEFGAHLHTTPAKWYEKIHAAHQAGCKRFDGAIQGFGGCPMAKDELTGNMPTEK
MLSYFTANKVDTNVNTMSFESAHNEATKIFTKYH
>OMIFANIC_01742 Trifunctional nucleotide phosphoesterase protein YfkN
MLLRSIFSFLILSALISCKSQKETLSVLKDDSLITLKFVQLNDVYEIAPLSGGKYGGMAR
VAYVTDSIRRAHPNTYLVMAGDFLNPSLLGTIKVEGERIRGRQMIEVMNAMDFSLVTFGN
HEFDLDEEDLQKRLDESNFQWVSSNVLQKKETGNVPFSMTRGIGKIAIPDVYKLSVSDAD
GTTVSIGIFSVTLDSNRKDYVFYGDIYSEAESAYNQLKPVSEVIIGLTHVALEDDKEFAK
KFQDIDLIMGGHEHNNMRYEIGSTVVAKADANAKTVYIHTVTHNKLSGETNVESVLFPID
ERTPSDPEVEQIVSKWNVVLENEIREVIPDPYEIIYFADPPLDGTDSANRGIQTNMGDII
TAAMAFSYKDEVDAAIVNGGSIRLDDMLAGEVTSIDVFRVLPFGGITLKVDMTGELLREV
LDFGKSKGGTGAYLQRHGISESPTGGWLIKGEPLEEGKRYYTVAISDFLLKGYDIPFLTE
DHPGLLKIYTPKENEIANDIRKAVILYLKSIK
>OMIFANIC_01743 hypothetical protein
MVKRILKLLGYAGIIALVVIQFIRPEKNEAGYEAFKSFETDTKPSNEVVGILKANCYDCH
SNQTNYPWYAQVAPVSMWLDDHVRHGKGEFNVSEWDSYSVKKKDHKLEELIEEVEEGHMP
LDSYTWIHGNLSEEDQTLLIQWATVARLQYKNQLEVSAK
>OMIFANIC_01744 Fe(3+) dicitrate transport protein FecA
MKFRSSLIGLFITCLATAQVQVQDSTDTTQKIPELLDEVLLSSNILGSKFEVKNRTGSAY
FVSPQELQQFGYTDANKILRAVPGVSIYEEDGFGLRPNISLRGSSPERSAKITLMEDNVL
IAPAPYSAPAAYYFPTVGRIESIEVLKGSSQVQYGPYTTGGAINFISKKIPKKFSGNVRL
NMGNYSSRNVEATLGDSGENFGFVTQFFNYSSDGFKTLGDGSNTGFDKTDILGKLRWNTN
KTAKVFQSFTLKLQYSEEDSNETYLGLTDADFEIDPFRRYAASQADNMVNEHTQYQLNYL
IKPNSNISINTTANFNKFKRNWYKLDDIVLDEKVKISEVLADPVSFKNEYRALLGNVDTP
DDAFGVKANNRSYESKGIQSRINFKVGSTWMQDVEIGLRYHEDYEDRFQWKDLYALQNRT
MVRTTVAIPGTDSNRISSAKALAGHALFKLRIDGLTLTPGLRYENIKLLREDFGKEDPFR
TGGELSTRENEVDVFIPGVGAHYRFNNDISLFGGVHKGFAPPGSTEGADPEESLNLELGT
RFYFMGFKGEIVGFYNDYSNLLGSDLAATGGTGSLEQFNAGEASVAGLELLLNYDLLNGE
NTNAKLRLPLTLSYTFTDAQFSSDFDSDDSVFGTVQEGDEIPYIARNQFNVTAALENSVF
NVSMSGRFTDEFRTEAGSGDIPDQFRISGNFVMDLAARYFYNERVTLFANMMNVLDTKYE
VARLPAGLRPGAPFMVNAGIGYTF
>OMIFANIC_01745 hypothetical protein
MNSAKNKSQIYFSKNILTSLFRLNINNLHVKVYKRMAPRVLH
>OMIFANIC_01746 Inosine-5'-monophosphate dehydrogenase
MTAHNNKILGEGLTYDDVLLVPAYSEVLPREVSIQSKFSRNISLNVPVVSAAMDTVTESA
MAIAMAREGGIGVLHKNMSIERQAQEVRKVKRAESGMIQDPVTLEKSATVGDAQNTMREY
SIGGIPIVDDEGILIGIVTNRDLRFERNYGRALSEVMTSENLVTVGAGTSLKDAEIILQE
NKIEKLPVVNDDGKLLGLITFRDITKLTQKPIANKDNYGRLRVAAALGVTADAVERAEAL
VKAQVDAVIIDTAHGHTQGVVTVLKEVKKNFPELEVVVGNIATADAAKYLVDAGADAVKV
GIGPGSICTTRVVAGVGFPQFSAVLEVAEAIKGTGVPVIADGGIRYTGDIPKAIAAGADC
VMLGSLLAGTKESPGETIIYEGRKFKSYRGMGSVEAMKQGSKDRYFQDVEDDIKKLVPEG
IVGRVPYKGELVESMTQFIGGLRAGMGYCGAKDIESLKEDGRFIKITASGINESHPHDVT
ITKEAPNYSR
>OMIFANIC_01747 hypothetical protein
MKTIQILLLFISFTVSAQTAQTKVGTIDIDFVLSQMPEITNVQNAVEAYGKTLDADLSTK
VEGYQKLVEEYTKNDVTYTINQRKTMQDSIINSETDINKYRQNATQLITIKRDEELAPLY
KKIGESLEKVAKSQGYTQVMERNSNLVYIDNNFDLTIAVLKDMGIEVKEKE
>OMIFANIC_01748 hypothetical protein
MELIKLIWDFRGPNAAAIAKHHAIHLNEFIHSEKLQNSMSGTESISEMHHIAFMITEKEL
MQSLRERLKPNRGQLYTK
>OMIFANIC_01749 hypothetical protein
MKYTTEVIIDLPREEVINKLDNPDNMKYWQRGLLNYELLEGSPGAEGAKMKLEYKMGKRE
MAMTETITKNLFPSEFHANYDTKGVHNVQKNFFHDIDGTRTKWVSESEFQFANFGMKLMG
WLMPGAFKKQSQKYLNDFKNFAENGTSVAEQN
>OMIFANIC_01750 Foldase protein PrsA 1
MKRYLVLFFILAFSFGQGFSQKKNDVLLTIDDEPVLASEFIRVYKKNLDLVKDESQKSVE
GYLDLFIDYKLKIAEAYDQKYHERQTYKDEFAKYEEQLSRNYIYDNKLAEDLIKEAYDRG
RDEIEARHILISVEYSDTAQDTLKAYNEIKSIRERAIAGEDFTELAKEYSTEPGASERGG
YLGYFTVFSMVYPFETAAYNTPVGEISEIVRTQFGYHIVKVINRRKKGPEISVSHIMVSD
RDDDSRTFDPEERINEIYKMLNQGEGFEKLAGQYSDDKNSAMRGGKLNKFSKGTLRSQIF
ESYAFGLSNPGDLTKPFKSEFGWHIVRLDKIHNKSTFEELQPQLEKQIKQGARSKVVTSA
ISAKIKDKYGFSEGEPYQKYFEEYLPPEVFARKYKYDSMPPVVNKTIFTVGDKKFTFEDF
AQYIERKQKRIKPGIKMGPLVNNMYREFEVDALKSYFREKLELQNEDYAATINEYRSGLL
IFDLMTENIWRKAKTDSLGLNDFYNTVKEKYKWDKRITGTIVSATSEEYAERARNMLNKG
KTGEEIKEALNEAELVNVIITSGTFEVQDRQLPQGFKVEKGVSNIYNNDGSYVVINIAEI
IPPGIKKLDEVRGKVLNDYQTHLETEWMKSLRNKFTVNVNKKVLKKINKEFKS
>OMIFANIC_01751 hypothetical protein
MRNGIILIFCLALVFSCDYLKPEANKIPVARVNNSYLYEEDIESLISENTPPEDSTLIVA
NFINRWATQQLLIDQAKINLPESQLEEYEKLVKDYKNDLLTEAYKNAIVSRQLDSSISAA
DYNKYYEENKEIFKLNDELLKLRYIHLDENYSNLSQMRNILGRFNSEDQKVLDSLSIQFK
AFNFNDSIWVKKQALMQALPVLRTAASNVLKKSNFAQIQDSLGVYLVKIEDVLKPNDIAP
LSHVRPTIREIILNKRKLDLIKELEKDITKDAVKNNKYEVYNNQ
>OMIFANIC_01752 Chaperone SurA
MKFITISSALSVLLCFGNVKAQVTETVDDTSLEVKAIEETPEIEAVKDTVKPFKRIKAGG
VSAVVGEYVIVEFDIDLSFLELQQQGASIEGITRCQMLGKLMEDKLYTHHAKQDSIVISD
DQINGRLDQQMQYLISELGTEEKVAAYYRKDNIADLRKQLFEVNKQIALAGEMQNKVIQD
VEITPEEIRNFFYSIPEDERPVFGAEVEVAQIIVEPEITEAAKQDAIDRLNVIRTDIVEN
GSSFATKAVLYSKDEGSARKGGLIEGVKRDAPFAKEFKDQAFSLLEGEVSEPFETSFGFH
ILYVEKIRGQQVDVRHILLFPEVTQATLNKAREKIDKLREEIVNDSISFGDAARLYSDQK
ETRNSGGRLMNPITGDTRFDLTKMDPTLSAQVYNLAENEVSKVFTDRDRTGKSSYKILTV
TKRFEEHPADYVKDYEKIKELALKEKQIKAIQEWQEKKIGETYISVNRDYGDCDFSNNWQ
KK
>OMIFANIC_01753 hypothetical protein
MEIATFRTTGKKNKERIFMSDVAAVEQLVSKYNALRQEIKKVIVGQDDVVEQVLLSIFSG
GHALLIGVPGLAKTLLVHTVAEALGLQFKRIQFTPDLMPSDILGSEILDQNREFKFIKGP
IFSNIILADEINRTPPKTQAALLEAMQERVVTVAGHRYELDSPYFVLATQNPIEQEGTYP
LPEAQLDRFMFAINLEYPSFSEEVEVVKTTTGGVTQTVNSLFSGEEILKYQQLIRKVPVA
DNVIEYAVTLVGKTRPKSQAAPEMVKNYIDWGAGPRASQNLILAAKANAALNGKFSPDIE
DVQKVAIGILRHRLIKNYKAEAEGLTIEQIVTSLY
>OMIFANIC_01754 hypothetical protein
MNISNKKRNVGLDVARTFAILLVLFSHTLWISDNYPKVVRAAMKLSGTAGVEIFFIISGF
LIGKIVWREILRSDFSFTNIKHFLFRRWFRTFPNYYLLLFVNVLVWYFIYGEFPEKIYKY
IIYIQNFSDTSMPFYRVSWSLAVEQFSYIIGPFLLYGLILFFPKKNRDKFYLWVTIFILV
CFTLTKVHFYYTQSVANIYEWNESIRKVLIYRLDVVYWGFLLRYFYNKYTVWVHNHERKL
LFTGLFALIFLNILRVPLGITVENTPGFMIIWYLGLHSIAICCLMPYLITMEIRSKIVVK
FFTTISLISYSLYLLHYTIILHSLKTIFPSEELTGIALWLYTFLYWGITILFSYLLYKYF
ERPITDLRDSPRILKFLGYNKN
>OMIFANIC_01755 Aconitate hydratase A
MAFDIDMIKKVYAELPSRVDKAREVVGKPLTLSEKILYAHLWDGSPTTAFKRGVNYVDFA
PDRIACQDATAQMALLQFMQAGKQKVAVPTTVHCDHLIQAKDGAVADLKRANDTSNEVFN
FLESVSNKYGIGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAVGVGGAD
AVDVMAGMPWELKFPKLIGVKLTGELNGWTASKDVILKVAGILTVKGGTGAIVEYFGPGA
KNLSCTGKGTICNMGAEIGATTSTFGYDDAMERFLRATDREEIADEANKIREYLTGDPEV
YENPEQYFDQVIEINLSQLRPHLNGPFTPDLATPVGELGDKAREHDWPINVMWGLIGSCT
NSSYEDLTRAASIAQQAIDKNLKPKSDFGINPGSEQIRYTAERDGLLQVFEDLGATIFTN
ACGPCIGQWDRSDVLGDEKNTIVHSFNRNFSKRADGNPNTHAFVGSPEMVAAIAISGRLD
FDPMHDSLVNEEGEEVKLDEPRGIELPPRGFEVEDAGYLEPDADGSGVNVVVSPTSERLQ
LLTPFEPIKDEELMGVKLLIKAFGKCTTDHISMAGPWLRYRGHLDNIANNTLIGAVNAFN
KKTNFVKSQLDGEYGGVPDTQRSYKAAGIKTIVVGDHNYGEGSSREHAAMQPRHLGVAAV
LVKSFARIHETNLKKQGMLGLTFANESDYDLIQEDDTFNFVDIAEFAPGKPLTIEVVHAD
GGKDTIMANHTYNDAQIEWYREGSALNLIKKQNA
>OMIFANIC_01756 Thiol-disulfide oxidoreductase ResA
MKPFIRKNWFNLLIVVFVGLLIVPHTSIPIKVFFQKLFMTSPSEVDASERKKLTSYQWEL
TGMDGSIIEFSDSEEKVVLLNLWATWCPPCLAELPSMQNLYNTYGDKMDFYFISAEDSET
VRKFITKKGYDFPVYLETQRPPAELQVSTIPTTFLIDAAGEIIIQKTGAAQWDSAEVKTI
IEELLAASE
>OMIFANIC_01757 hypothetical protein
MKFLYLWLNVGSFIIPFIFSFHPRLKFYKKWKSFFLGIIVMMAVFIPWDIIFTENGFWGF
NPDYLTGYYLLGLPVEEWLFFICIPYACIFTHYALLEISPKFRFGHRTTHIIYISLITAL
IIILWYYYDHWYTLLSFVYALLVLAIVFNSKKELLRSFFATYLVILIPFFIVNGILTGTG
IEDQVVWYNNDENLAKRILTIPVEDTIYNLGMLLTVLFVTEASGKVKV
>OMIFANIC_01758 hypothetical protein
MEILFWILIFLTTFCIMEFMAWFTHKYVMHGFLWSLHKDHHRKDHGSWWERNDVFFIFYA
VVSIVCFVLWQYYGFWAGLPIGLGIFAYGVTYFMVHDIFIHQRFKMFRNANNWYAKGIRR
AHKIHHKHLGKDKGECYGMLFPPLKYFKK
>OMIFANIC_01759 15-cis-phytoene synthase
MKEKFDIVSEICSQKVTTTYSTSFSMATKMLAPTIRQDIYNIYGFVRFADEIVDSFHDFN
KEELFNKFEADLHHALENRISLNPILNSFQHTVHNYKIDQHLINSFMDSMRQDLSKSEYR
TTEEYKQYIYGSADVVGLMCLKVFVKGDEAKFEELKEAAMHLGSAFQKVNFLRDLKADYE
TLNRTYFPNTNLSALDENSKKEIIDEIEKDFRKGYEGILMLPAEAKFGVFMAYRYYRRLL
KKLAKTPAMEIKNARIRVPNYEKFGLLTRSYVKYQLKLVK
>OMIFANIC_01760 Dehydrosqualene desaturase
MKDIVIIGSGFSSLAAASYLAKTGNKVTIFEKNNTVGGRARQLSKNGFTFDIGPTWYWMP
DVFERFFADFDKKPSDYYDLIKLNPAYSVYFGANDYITIGDTLDKICVAFEAEEAGSSVK
LKKFMNEALDNYNIAIKDLVYRPGVSPLELVTPVTMKKIGQFFSTISKEVRKEFKNPRLI
SILEFPVLFLGAKPSDTPAFYSFMNYADFGLGTFHPKDGMYSVILGMKALAESLGVRIQT
DQTVEKIVMKGKKAIGIVVNGETVYSDVILSGADYHHTETLLEPKFRQYSESYWSKKTFA
PSSLLFYVGFDKKINGTEHHTLFFDVDFEEHANAIYDDPTWPENPLFYASFPSKTDASAA
PEGKEAGIFLIPLAPGLNDTPEIREEYFDKIMSRFEYLTNQEIKNYVIFKESFCINDFIN
DYNSYKGNAYGLANTLMQTAFLRPKLKSKKVDNLFFTGQLTVPGPGVPPSLISGKLVAGL
IEKGN
>OMIFANIC_01761 HTH-type transcriptional repressor CarH
MSVKTQFSIKDLENLSNVKAHTIRIWEKRYNLLEPNRTETNIRQYDLLNLKKLLNVTFLY
NEGLKISKIARLSESEINKLVLGHGKEKKEEFALNSFKSAMLDFDSELFLKTFDSLAEDK
SFREIFFEIFLPLLNEIGILWQTGTIDPSHERFISELIKQQIVLNTERVQRKKVRHTDFV
FSLYLPYEEIHEIGLLYANYEILNAGYKTIYLGINIPLDSLKFVTRHHKNVKFISYFTVK
PDSQSMYDYTREFNEKIGSDRKYELWLMGYKTSELQGLKLEKNFTIFPSLASLIEKLETL
KKS
>OMIFANIC_01764 Shikimate kinase
MNLVLIGYMGSGKTAVGKALANTLNYPFKDLDLVIEDREGNPISKIFSDQGEIYFRKKES
EILKELIDSQNKLVLSTGGGTPCYGDSMEFLLDHNNVKTIYLKSSLEVLSKRLYSEKNSR
PLISHLKEEEELTDFIRKHLFERTHVYERSSEIINTDGLSIDEVVEEIVLKLF
>OMIFANIC_01765 Bifunctional protein PyrR
MSQQTIILNKTQIAHKLKRMAYQVYETNINESEVVIAGIESNGFRLAKKLKRLVENVSPI
KVTLCKVVIDKSEPTNPIKTSLSKKEYANKSLLLVDDVLHSGTTLIYGVKHFLDVPLKQF
KTAVLVDRNHKKYPVKADFKGISLSTSLNENVAVIFETNNDRAVLE
>OMIFANIC_01766 Heat shock protein 15
MRVDKYLWCLRYYKTRSIATKACKKGAVSVNGNVVKPSREVYPGDSIGIRKEQINYTMEV
LDLPESRLGAKLVDMYRKDTTAKEAFASKELLKYAQGFYRKKGVGRPTKKDRRDLEDFTE
SETD
>OMIFANIC_01767 hypothetical protein
MKKHIRILSVAISVLAVLSSCGNDDGPEDNFIPARDRAEEAPLAQAIIEEYLDTHFYNYE
EFASPSVDFDYQIRFDTIAGENSDKIPLRQQVTSKMVKDRVKDGLEYKLYYLVVEEGEGE
QPEFPDVATISYDGIFINKEEPTLDYTRRFDASTIPVRFDMTAIVNGLQDVLIEFKGATG
IITNPDGSVSFEGYGIGAVFMPSGLGYYVDPPVTSSIPTYAQLIFAFQLYENEMGDQDND
GIPSTVEDLNGNKLEEDDDTDNDGLPNYADTDDDNDGRPTSEEIEIDGDGNITYPDEDGD
GIVDYLDADS
>OMIFANIC_01768 1-deoxy-D-xylulose-5-phosphate synthase
MKKYTDSGKKDTRSGFGAGLTELGKRNKDVVALCADLTGSLKMDEFKANHPERFFQVGIA
EANMMGIAAGMTIGGKIPFTGTFANFSTGRVYDQIRQSIAYSHKNVKICASHAGLTLGED
GATHQILEDIGLMKMLPGMTVINTCDYNQTKAATIAIADHHGPVYLRFGRPKVANFTPED
QTFEIGKAVQLQEGNDVTIVATGHLVWEALLAAESLNEQGISADVINIHTIKPLDKEAIL
RSVAKTGCIVTAEEHNYYGGLGESVARVLSENDPTPQEFVATQDTFGESGTPAQLMDKYG
LNAEAIEKAAKKVMTRK
>OMIFANIC_01769 hypothetical protein
MNKALIFLLLLGSGFYGCGQDLSVSMDYKVVYEIPAPMRNSADTISISFDTEGKYLYSDA
KLLGDDLGRSVFKNPNTDLSPAESSFVLDTKNMEVYFDYSLNRNSIFFKMDIESLIPADE
DPFEGNVEIIMEKTEYDVEIAGSSYPSFLLYPDNEPEEPLTLAIDTSRPVDNSIVLNAFI
QLMLRKTDSKGSMSINIPKGLILGIYTANSIMMEAISVENVATTINISHQFTINE
>OMIFANIC_01770 Transketolase
MPDISYLNELVIQVRRDILRQVHKVNSGHPGGSLGCTEFFVTLFQEIMDRKDGFNMNGIG
EDIFFLSNGHVSPVFYSVLARSGYFPVDELNTFRLINSRLQGHPTTHEGLPGVRIASGSL
GQGISVSVGAAETKKLNNDPHLIYTLCGDGELQEGQNWEAIMYAAANKVDNLIVTVDYNG
QQIDGATDNVLPLGNLKAKFEAFGWDVLEIADGNDISQVLNGMAAAKEKTGKGKPVCVLM
KTVMGNGVDFMMHTHAWHGKAPNDEQLEIALAQNPETLGDY
>OMIFANIC_01771 Queuine tRNA-ribosyltransferase
MRFKLEGKDDNSGARAGTISLGHGDIQTPIFMPVGTVGTVKGVHQRELTEDINPDIILGN
TYHLYLRPQTHILEKAGGLHKFMNWDRNILTDSGGYQVYSLSANRKIKEEGVKFKSHIDG
SFHFFTPENVMEIQRTIGADIIMAFDECTPYPCDYEYAKRSMHMTHRWLDRCIAHLDKTP
LKYDYEQAFFPIVQGSTYKDLRRESAEYIANADAPGNAIGGLSVGEPAEEMYEMTAVVTE
ILPEDKPRYLMGVGTPINILENIALGIDMFDCVMPTRNGRNGMLFTAHGTINIKNKKWEA
DFSVIDEMNLTWVDTAYSKAYLRHLFTVNEMLGRQIATIHNLGFYLWLVREARKHILAGD
FRAWKDTMVNQMDKRL
>OMIFANIC_01772 Lipopolysaccharide export system permease protein LptG
MLSILDRYIIRKYLGTFILLLLLFIPIGITVNLAEKIDKILANEVPFIEVAKYYLDFTVY
FANLLFPLFLFLSVIWFTSKLANNTEVIAFLSSGVSYYRFLRPYIIGATIVCIGALILGM
YLAPMASKGFNEFTYKHLKKGKRDRNQTNVYRQINDNDYIYVSYFNVKEKSGNNFTLEHI
EGNKMTYKISASRIKFNDQDSTYMLVNFRKRTILENEDILEKRARVDTTFTFELEDLTPV
EYIAETLNYGELNNFIRREKERGSSYINRYEVVRYKRWSLPVSAYILTIIAVAVSSMKRR
GGMGVNLAIGIAIGMVYIFFDKIFGTMAEQSTFSPFIATWFPNFVFGILAVYLLRNAKR
>OMIFANIC_01773 hypothetical protein
MQNARLLNYLHLHVIVFIWGFTAVLGALISIDAIPLVWYRMLLATVFILFFLKLRKINLK
YTRRALAGFFIAGLLIALHWLAFFGAIKASNVSVTLAVMSTGAFFTSFLEPLYYRRKIIG
YEVLFGLLVVVGLYIIFQFETGYVMGIILALCSSFLGSMFSVINGKMAKRHRASVISFYE
LLFGMLCITVFLAFNGDFTSEFFQLSNSDWIYLLILATVCTAYAFIASIHVMKWLSPYTV
MLTINLEPVYGIILALLILGDSENMSTEFYYGALIILVTVLANGIVKTRRTIKKRP
>OMIFANIC_01774 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLEFELPIKELQEQYEKACKIGEESDVDVSNTCKQIEIKLEETKKEIYKNLTPWQRVQ
LSRHPNRPYTLDYIKAICGDSFLELHGDRSFKDDKAMIGGLGKIGDQSYMFIGQQKGYNT
KTRQYRNFGMANPEGYRKALRLMKSAEKFGIPVVTLIDTPGAYPGLEAEERGQGEAIARN
IMEMTRLEVPIIVVIIGEGASGGALGIGVGDKVLMLENTWYSVISPESCSSILWRSWEFK
EQAAEALKLTATDMKKLKLIDQIVREPLGGAHSDKEKTYHIVANAIDKAYRSLQNLSPKE
LVDQRMEKYSEMGVFKG
>OMIFANIC_01775 Replicative DNA helicase
MEKLKPHSTYPSRPSQVISLEKGKLPPQAVDLEEVVLGAMMIDKKGVDEVIDILNAEVFY
KESHQHIFEAIHMLFENSEPVDLLTVSSQLKKNSKLDAAGGEFYLVQLTQKVSSSAHIEF
HARIILQKYIQRSLIKISNEIIEDSYDETTDVFDLLDNAEAKLYEITQGNIKRSSETAQS
LVIQAKKRIEEIANREGLSGIPSGFTKVDKLTSGWQPSDLVIIAARPGMGKTALTLSMAR
NIAVEHNIPVAFFSLEMSSVQLITRLISSETGLSSEKLRTGNLAKHEWEQLNVKVKGLEK
APLFIDDTPSLSIFDLRAKARRLSSQHGIQLIIVDYLQLMTAGGSLKGGNREQEISTISR
NLKALAKELNVPVIALSQLSRAVETRGGSKRPLLSDLRESGAIEQDADIVSFIYRPEYYK
IDEWDDEDRTPTAGQAEFIVSKHRNGGLDEIRLKFIGHLGRFENLETFDFPTEIHSRMND
AANDDTFKTDHFPSADEAFGSSMNDDLSPEDDNDVPF
>OMIFANIC_01776 hypothetical protein
MMMRMITLLFLLMFFGQATASYILIPMDAEGQKEHLKAYGITYWTLERQQKVKWLLNYRG
GSFLLPDAEEIRKECQIRGVSFEILSDSKAEQILTEISSPSQNMEAVVLEKAPRIAVYSP
KGNQPWDDAVTMVLTYAEIPYTVIYDEEVLGDQLLLYDWLHLHHEDFTGQYGKFYRAYRS
APWYIEEKRKAETLASKLGYSKVSEAKRDVSLKIRDYVIGGGFMFAMCSATDSFDIALAA
EGVDICEPMFDGDPSEPGYQGKIDFAKTFAFKNFTLERSPMVYEFSSIDMTRDRRIMKET
DYFSLMDYSAKWDPIPCMLVQNHTSLVKGFMGQTTSYRRSTVKSNVLVMGENKTNGEARY
IHGIKGKGFFTFYGGHDPEDYQHRVGDAKTELALHPTSPGYRLILNNVLFPAAKKKKQKT
>OMIFANIC_01777 Outer membrane porin F
MFFRFFYIALMILTTSGFAQPKYKYHYTGSDGQRVYLPLGKISFADQVAHFRIGYPKPIS
IFRDSSQALYQPDYKGYNSPDFISLGCKGSIILKFTDNGFMNMKGYDLIVFEVGPSRERS
LVEVSTDGRKWYTAGITEGGTSKLDFDDRQIDPNLIFYYVRIRDVKDECTGKSAGADIDA
VAAINSVLKLTVNADVLFDVAEHKLKSSAKETLDSLAKAINVVGEATILIEGHTDSDGEE
EYNMKLSENRCISVRRKLQKLLSNEGTYHFEIKPHGEFNPRVENNSEENKQINRRVEIMV
LPPKDYFESIPDN
>OMIFANIC_01778 50S ribosomal protein L20
MPRSVNSVASRARRKKVMKHAKGYFGRRKNVWTVAKNAVEKAMLYSYRDRRAKKRNFRSL
WITRINAGARQHGMSYSQFMGKLKANDIELNRKVLADLAMNHPEAFKAVVDKVK
>OMIFANIC_01779 50S ribosomal protein L35
MPKQKTKSSAKKRFKLTGTGKIKRKHAFKSHILTKKSKKRKLALTHSTTVDKSDESNVKQ
MLRMK
>OMIFANIC_01780 Translation initiation factor IF-3
MIKEDQHRINEKIRAEEVRLVGDNVEVGIYSRQQALDIAEELGSDLVEISPKAKPPVCKV
MDYKKFVYEQKKREKALKAKATKVVIKEIRFGPNTDDHDYQFKKKHAEKFLKDGAKLKAY
VFFKGRSIIYKDQGEILLLRLAQELEDYGKVEQMPRLEGKRMTMFIAPKKK
>OMIFANIC_01781 Threonine--tRNA ligase
MIGITLPDGSVKQVELGTTPMDVAQSISEGLARNVISASFNHETVETSTPLTEDGSLVLY
TWRDDEGKKAFWHSSSHIMAQALEEMYPGIKLTIGPAIENGFYYDLDLNGNSISEKDLPA
VENRMLEIARGKHEFKMRTSSKEDALNFYKGQGNEYKVELIENLEDGTITFCDHDSFTDL
CRGGHIPNTGIVKAVKLMSIAGAYWRGDENNTQLTRIYGVSFPKQKDLKEHLALLEEAKK
RDHRKLGKELELFTFSQKVGQGLPLWLPKGAALRERLENFLKKAQKKAGYEMVVSPHIGQ
KELYVTSGHYEKYGEDSFQPIKTPNENEEFLLKPMNCPHHCEIYKSKPWSYKDLPIRFAE
FGTVYRYEQSGELHGLTRVRGFTQDDAHIFCTPDQLDAEFKQVIDLVLYVFGSLGFEDFT
TQVSLRDPDKPEKYIGDPEVWDKAEEAIINAVQDKGLDYVMETGEAAFYGPKLDFMVRDA
LGRSWQLGTIQVDYTLPERFELKYKGSDNELHQPVMIHRAPFGSMERFVAILLEHTGGNF
PLWLMPEQVSILSLSEKYEKYAQKVLNLLENDEIRALVDNRNETIGKKIREAEMDKIPYM
LILGEQEEKDGTVSVRKHSEGDLGTMSVEEFSELIHSEIEKNSVEFNV
>OMIFANIC_01782 hypothetical protein
MEYETPLSSQANFVGETTDNNIYFVERIIGDSSKLYLTDASGNVIWTQTYFDVTYDEVAE
TSDGGYVLIGEQEVEPDNTDIVLTKTNDLGVVSWTQTFGGPGMDGAGSVLQLSDDGFIIA
AYYDEQIPDQYFRTYLIRTDDQGNEIWSTMLALYSPGHIIECCGGNGYVFSTTWVELFES
KLYFGIQKIDLSGNIIFNKLYRGVQGNGQCVIETQDSGFLLTGSTQGAGGLPSDMRLIKF
DSAGNTTLSTGEIDEISTVLSILPNPAVDFVILRLDETYQGTIEAVRLYNSMSQKIINQE
RISSKEKVLDLTILSNGIYFVDIITSLGDTLTHKLIISK
>OMIFANIC_01783 Asparagine synthetase B [glutamine-hydrolyzing]
MCGIVCAFDLKQPSETLRPQLLSMAKCIRHRGPDWSGIYNDDKAILAHERLAIVDPTSGK
QPLYSEDKKLILAANGEIYNHRDLREPYEGNYQFQTHSDCEVILALYKDKGVSFLDDLNG
IFGFALYDVDNDSYFVARDHMGIIPLYMGWDKHGTFYVASELKALEGVCTRIELFPPGHY
LHSEDGELKRWYARDWMDYENVKDNVTSIDELRDALDAAVHRQLMSDVPYGVLLSGGLDS
SVTSALAKKYADKRVEEDDKEKAWWPRLHSFATGLEGSPDLAAAQKVADHLGTVHHEVKF
TIQEGIDAIRDVIYHLETYDITTVRASTPMYLMARAIKAMGIKMVLSGEGADEIFGGYLY
FHKAPNAEEFHKETVRKLDKLHQYDCLRANKSLAAWGIEGRVPFLDKEFMDVAMRLNPKD
KMITEGRIEKWVLRKAFEDMLPESVAWRQKEQFSDGVGYSWIDTLKEMVEIKVTDEQMKN
AHHRFPIQTPTSKEEFYYRSIFEEHFPSDTAALSVPSVPSVACSSPIALEWDESFKNMND
PSGRAVKSVHDEAYEKS
>OMIFANIC_01784 Pyruvate dehydrogenase E1 component subunit beta
MLFTTFAKSNSQKMHTNPQTDKNLSFDDFKAEVINDYKIAVTSRECSLLGRREVLTGKAK
FGIFGDGKEVPQLAWAKAFKNGDWRSGYYRDQTFMMAIGKLTIEQFFAGLYAHTDIEADP
MSAGRQMGGHFATHSLNDDGSWKLLTNQKNSSADISPTGAQMPRLLGLAQASKIFRNVDG
IKDWTQFSINGNEVAWGTIGNASTSEGLFWETINAAGVLQVPMVISVWDDEYGISVHAKH
QTTKENISEILKGFQRTEKEEGFEIIRVMGWDYAALIETFQKAGALAREEHVPVLIHVLE
LTQPQGHSTSGSHERYKNLDRLEWEREFDCNVKMRDWMIANNMATEEELSEMEKSIKKEV
RDGKKAAWKAFIAPQQKEQQEVLTLMGNVAENSPNKNFIEKIKNDLAAEMEPLRRDIMAS
ARKVLRYVVSENTTERKQLKDWIDNYFEIVQPKYSAHLYSEANNKATEVAEVKPTYPDAA
EQVDGRVILRDNFDHIFTNHPESLVFGEDAGEIGDVNQGLEGLQEKHGVLKVSDTGIREA
TILGQGIGLAMRGLRPIAEIQYLDYILYCLQIMSDDLATLRYRTMGKQKAPLIVRTRGHR
LEGIWHSGSQMGGLIHLLRGMYLLVPRNMTKAAGFYNTLLESDEPAVIVECLNGYRLKEK
MPNNIGEFRTPIGVVETIKEGSDITLISYGSTLRIVEEAVRDLQQVGIDAEIIDVQSLLP
LDLNHDMVKSLEKTNRVLVVDEDVPGGASAYILQHLLDEQDGYQHLDSKPQTLTAKSHRP
AYGTDGDYFSKPSVEDVFEKVYSIMHEVSPTDFPKLR
>OMIFANIC_01785 hypothetical protein
MKFLNDWRLIILLCLTLGLAPYFPEPHLWGKLKWIAGGAHGMKGMDWFDTFWHLLPFLLL
IRLIVVNFIKK
>OMIFANIC_01786 hypothetical protein
MRLGIFIYVILFFMGLSPVLGQHLITIETELDAGKNQLNNSQQVVYKNTSDDILTEIYFN
DWANSFATKTTPLARRFAENFDSSFHFEKDANRGHTNIISVTNASELPLEWERGDEIDIL
KIILDKPIAPGEIYTLNFMYKVKLPNARFTRYGHTREGNYNLRYWYLSPAVYDGEWQAYS
NRHTDDLYLTPSEFKITLTTPSVFKLTTDLRVISEGVSSNKRISVLQGSDRMRADLYLEK
RLNFEAIVTDKLEVITDLKDRKVNSAMRALTIDRITHFLDDRLGPYPFDKMLVSEIEYRN
NPVYGLNQLPDFISPFPDGFEYDMEVLKTATANYLENSLVLHPRKDYWLYGALQIYLMME
YVDRHYPNMKIIGTLSNFWVIRWSHASELEFNDQYPLLYLNMARNNLHQPLSTPKDMLTK
FNKNIANNYYGGDGLNYLSDYLGKEPFEQAVKGFYKKSVLKPTTSEAFRKELNNSTGLPV
DWFFDSYVSKRTTIDFKITKVNKRGDSLDVYVRNRRKHAMPVSLYGINKDSTMFKTWIPP
IDSVSMVTVPAENVKKLVLNKEAKIPEFNQRNNYKTLSGLLNRPIQFRLFQDVEDPKYNQ
LFFMPVFEYNLYDGFTVGPKLYNKTVLPKGIHYKLEPQYGFRSKTIVGNGSIIYTQRYNG
SLYAMRFGLSGSTFSYNNGLFYRRYTPFMTLAFRQKDLRNNEKQYINLRNVNVYRDNDPL
DPDQEPNYSVLNLQYVYSNPNLIHYFRSVLDYQISTNFSKVSATLEYRKLFLNNRQLNVR
FFAGAFLYNNTARGDDYFSFALDRPTDYLFDYNYYGRSEDTGLFSQQIIIAEGGFKSKLQ
PAFANSWITTVNASTNIWKWIYAYGDAGLVHNRGIGGGTEAVFDTGVRLSLVADYFEVYL
PLYSTLGWEPGLGNYDQRIRFIVTLSPKTLLGLFTREWY
>OMIFANIC_01787 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MRSESKHKNWNEVKTNDSWAIFKIMGEFVSGYEKLSRIGPCVSIFGSARTKPDHKYYQLA
QRIAKKITEHGYGVITGGGPGIMEAGNKGAHLAGGTSVGLNIALPFEQHDNPYIDSDKSI
DFDYFFVRKVMFVKYSQGFVVMPGGFGTLDEFFEAFTLIQTHKIERFPLILVGTEFWSGL
MDWIKQTLLEQNGNISIEDLDLVHIVDNEEEVLNILNEFYNKYNLSPNF
>OMIFANIC_01788 UvrABC system protein A
MVKTDDFIEVLGARVHNLKDIDVRIPRENLVVITGLSGSGKSSLAFDTIYAEGQRRYIET
FSAYARQFLGNLERPDVDKIDGLSPVIAIEQKTTSRSPRSTVGTITEIYDFLRLFYARAS
DAYSFNTGEKMVSYSDEQIKQLIIKDFEGKKVSILAPVVRSRKGHYRELFEQIAKQGFLK
VRVDGEIIDIVKGMRIDRYKTHDIEIVIDRLKISEESDKDKRLTETILTAMYHGDDVLIV
HENDTEEVRYFSRSLMCPTSGISYPNPEPNNFSFNSPKGMCPTCKGLGELHEVNIHKIVP
DTSLSIKQGALAPHGPQKSNWVFKQLELIAERFDFKLSDPFESIPEDAKEMIFHGGNEKF
EVASKTLGITRSYKIDFEGVATFLQNTFEANESKSLRRWAKEYMDKISCPDCEGSRLRKE
SLYFKVNGKNIAELAHMDVVELAEWFNDLEEHLSETQLKIASEIIKEVRSRLQFLVDVGL
TYLALDRSSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNQKLIHSLISLK
DIGNSVIVVEHDKDMIEHADYVIDIGPAAGRHGGEIVSEGSPEEIQKHHTLTSDYLNGTL
EIEIPKERRKGNGKILKLEGATGNNLKNVSVEFPLGTMIGVTGVSGSGKSTLVNETLYPI
LNAHFFNGVRKPLPFKKINGLKHIDKVIDINQSPIGRTPRSNPATYTGVFSEIRSLFAKI
PEALIRGYKPGRFSFNVTGGRCETCKGGGLRVIEMNFLPDVYVECETCQGKRFNRETLEI
RYKGHSIYDVLEMTIDEACGFFEHIPKIYRKLKTIRDVGLGYITLGQQSTTLSGGEAQRI
KLATELSKRDTGNTFYILDEPTTGLHFEDIRVLLLVLNKLVNKGNTVVIIEHNMDVIKTV
DHIIDIGPEGGKKGGKIMSLGTPEEIVRRKKGYTASFLKKELH
>OMIFANIC_01789 hypothetical protein
MLLSSVECRPRYTAPLRYLCMRKKSFFKDLYAVIPLVFSGLLCIALIFFLQQKVSSAPEF
AQKLTDFSTIFISISGFLSAIIMVYLAYTAVSLKTTKDIIVDKLSKVTQQMHNFRSIIEI
LLRSKMWLPGLREYIDDEFEGLNFFEVKEFYKGKSKLAIEFLQEHHNYQDTENLYLEMKS
LLMTSPKDKKIPEAIGYPKVYPQDIVQKWLEHKCGSGLWYYFGYKYGVFKEALDYNAVFE
RHQEKVMTLANAIDSAHFEDSSFNEVFFSKLGEYMTKEVVPKLFQFQEKSTRNIPGIIRY
LYIIFLLLVICGLLLPLAVLLFSLPVIALIGSYAFVISTIFFIATTFYQFLFREVNS
>OMIFANIC_01790 Gamma-glutamyltranspeptidase
MRPLHVLLLFFVFLGCKTEPEKKESHTPAKGVIAENAMIVSARDEASRLGIEILKKGGNA
YDASVAVELALAVSYPYAGNLGGGGFMVYRTQYGELGTFDFREKAPLAATRDMYLDEQGE
FQTEKSKKGGLAVGVPGTIAGLFAIHEKLGTLPMEEILQPVIDLANQGYVVTKKQETRFA
EYKAEFEEVTGEPFLYTREISEGDIIKNTALAATLTRISEKGVSEFYRGETAKILVDFIK
DKGGIVTMEDLAVYEAKWREPLVFEYKDLDVITMGPPSGGGVCLAQIMKMLEPYPIAEYP
HNSVKAIQIITEAERRAYADRSYYLGDPDFVDIPIDSLLSDNYLRKRMSTFSFDAATLSE
SIKTATITGYESPETTHYSIVDQFGNAASVTTTLNSAFGSKLYVKELGFFLNNEMDDFSA
KPGQPNIYGLTGGAANAIEPQKRMLSSMTPTIVEKNDELWMVVGTPGGATIITSVLQAIL
NVYEYDMPMQEAVNVPRFHHQWLPDAIRYEYGRFPKELKLQLEALGYPENTEVDPIIGKI
DAILMLPDGTMEAGADTRGDDTAVGY
>OMIFANIC_01791 Acyl carrier protein phosphodiesterase
MNFLAHIYLSGDDEGIMLGNFFADSVKGKKYMNYPVKIQKGILLHRAIDSYTDAHPTVRL
STKRLHENYSHYSGVIVDILYDHFLAKNWDQYHNQPLADYVDDFYELLRNNYEILPTRTK
RLMPYMIADNWLLSYASVKGIGAILAQMNVRTKNKSKMNFAVVELEEYYDEFEAEFTLFF
ADLKAYSENKLEQL
>OMIFANIC_01792 Phosphomannomutase/phosphoglucomutase
MLQIFSSMTLIKSISGIRGTIGGKQGENLTPLDAVMYAAAYGTYIKQQRHKENYRIVVGR
DARISGEMIQQLVMNTLVGLGIHVIDLGLSTTPTVEVAVPLEHADGGIILTASHNPKQWN
ALKLLNHKGEFLNAMAGQQILEIAESRDIEYSEVDDLGKITRNDAYIDMHIDEILDLPLV
NVDAIKKAMFKVVIDGVNSTGGIAVPLLLEALGVHPVKLYCEPTGHFPHNPEPLKEHLTD
LMRMVVDEKADFGIVVDPDVDRLAFVDEKGEMFGEEYTLVAVADYVLGQIPGNTVSNMSS
SRALRDITEKHGGAYKASAVGEVNVVQMMKDTKAVIGGEGNGGIIYPELHYGRDSLVGIA
LFLSYLAELNISVSELRKTYPSYFMSKKKIQLTPELDVDAILKGMEAKYASEEITTIDGV
KIDFAENWVHLRKSNTEPIIRIYTEAYSQEAADALADRFIAEIQEIANQ
>OMIFANIC_01793 putative cysteine desulfurase
MLKTKEILGTEMEAYFAPFRNNILGIDQTFESAFGTKKIVYTDWTASGRLYGPIEDKMIN
SFGPFVANTHTETAVTGTTMTHAYHHARDIIKEHVNAGEDDVLITTGTGMTGAVNKFQRI
LGLKVPEQVKDQLDIKEEDRPVVFVSHMEHHSNQTSWLETIATVVVIPCNEVGLFCIENL
KDLLLKYQNRDIKIASITSCSNVTGIKTPYHEVAKLMHQNNGLCFVDFACSAPYIDINMH
PEDPEESLDAVFLSPHKFLGGPGSSGVLIFNQQLYNNLVPDCPGGGTVDWTTPWGTHKYI
ENIEEREDGGTPGFLQVIRTSLAIRLKEKMGVPNILKREEELLTYVFDRLDGEPKISILA
GEHRERLGVISILIGDLHHDLAVKMLNDRYGIQSRGGCSCAGTYGHYLLEIDHQKSDEII
GKMKAGNIMMKPGWVRLSIHPTTTNEEVIYVCDSLIELANNYEEWSKDYVFDNGKFTHQS
ESLKPYSPLDSDWFDV
>OMIFANIC_01794 Lipid A biosynthesis palmitoleoyltransferase
MQRLVYLIIYPFLWITSILPMGLLYIKSDVLSFIIYHVVGYRKKVVLSNLRLVFPDKSDK
EHKIIARKFYRHLCNIIFESIKTLTISEKEITKRFRFENLELIDELYKKDKSVLLLCGHY
SSWEWSGILGKQMKYKGLAVYKKLRNDSLDGLLKKIRGRYGGEIVSNRKIVPILFRLAKE
NTKCLTLILADQTPKPGAFKHRDTFMGIDVPVFTGSEEIAKKLDFASVYLKVEKVKRGYY
SARFVLLAENPKEFEDYQITRAFLDEIEKQIHKAPEYYLWSHKRWKLRN
>OMIFANIC_01795 Rhomboid protease GluP
MQNIDTATIVIIAANIIFSLKGFSDFSFFEKYKFNIAGIRKGEQIRMFSSGFLHVDYTHL
IFNMLTLYFFANIVINSVGVTRFIIIYIASLIVGNILSFYFHKDEYHYSAVGASGAVMGV
LYSAILFHPGMDLYLFFIPIPIDAWIIGILYLLYSVYGMRFRHGNIGHDAHFGGAIAGYL
LTIAFVPSLLETSLWIVALLAVPIVLLLILHKLGKI
>OMIFANIC_01796 26 kDa periplasmic immunogenic protein
MKTTISIIIFLITSTLMAQNNMKPLVEVSGEGIVRVVPDEVTINLRVENTGNNPKELKKQ
NDRIVNEVLSFIKSQNIDDKYIKTEYIRLSKNYDYNSKSYNYSANQAISVKLTDLSKYKS
LMNGLLESGINRIDGISFSSSKRQTLESEARKRAVAHAKLKAEEYAGVLDQGVGKAISIK
ENLSYSPPSPILRSAMQMDSSGGEQTMAPGEMEVRVTVYISFELL
>OMIFANIC_01797 Thiol-disulfide oxidoreductase ResA
MRRYFALLITIILFSCAEDSNSYKLNGSAEGFEDGTQIIVYSLEDNNQPEAIDTLTVQKG
KFSARYPKTDKLLLGYLSVQNPQGSVVFFPENEDLRAILYKDSMVASYVSGSRQNEMYTA
FKQKIREFNNKKQSNSQRFQQARQEQDNLLATEIQKENVQLGAEETNYKLNFINENNTSL
FSLMLATEMLGRKEMSADQAAEFVKNLPPKTASAQLAAGIKNTIDKMKRADVGGMAPDFA
APTPQGEMLSLKETLGKYTIIDFWASWCKPCRRENPNVVRVYEKYHDKGLNIISVSLDRE
GQKERWVQAIEDDNMNWYHVSNLKFWQDPIARQYNVRSIPATFLLDESGKIIAKNLRGPA
LETKIASLLGQ
>OMIFANIC_01798 hypothetical protein
MKGKTTITQFPLKIEVSFKKLFDSYRASLKGMSGLQRKRAKEILQIADEYPVLSEGFDSE
DALTKYQEQVEFVLEDFFADILASNEIKIATIPYQLEIFRSSERFKDIVSHAGQDFEAQL
TNFDEDESYIMGCAIILNAYYGYRVDFRRPFYYDIPDANGVMRHYKVLYNGDFIDIEKTD
KAIDITPEDVAELIDNFENIELWKSKFPPNSWIFKGFVIANMYDATMDVSLSSFKENLIS
KDSKQEDYVAAFRNIIRSIFGLPSLEVGYAMYDEDEGVFQRPPINGNVKSYMLDGKQSEK
CTATLCPNSYEKLFSKNEFYSISDVAKFHKLYPDNVVYKTLHKQKIGSAIIAPLVSQGTL
LGVMELVSPNAQELNSINANKLLDIMPYLVDSVRQSKEREQNEIELLIQAECTSIHPSVH
WKFKKEAERVIRSKFYEENPSSFHEVVFEDVYPLFGQIDIKGSSTARNDATQQDLVLQLK
LVKQIIEKILNVESLPIYDQLIFRINKYLDEIKDHLEVDTERRVLSFLKNEIVPLYDHLS
KKNDTLAGLIDHYHEEIDNDKGFIYKHRKDYDDSVTQVNKHMAMILDVKQKEAQDMYPHY
YERFKTDGVEHNLYLGESITKDDSFNKIYLYNLRLWQLQAMCEMENSFYHLKEKLPVALD
VASMILVFNTSLSLRFRMDEKRFDVDGTYNARYEVVKKRVDKAHIKGTDERVTQPGKISI
VYSQRADEKEYLKYISFLQHKNLLDSDVEIVKLEDLQGVTGLKAIRVNVLYSKKKDDNTK
EYYTYEDLMNEIGSN
>OMIFANIC_01799 hypothetical protein
MTSLVEKASKYVQQLLQEELPGNCLYHNFTHTRRVFKSTKEIIENSAISEEDTEIILLTA
LFHDTGFVKCNDGHEAESVNIATAFLKEHEFADDKLEKVAQCIMATQMEASPETKLDEII
RDADASHFAKDYFQEASEFLRLELKLKGLAEYSKTKWLAGNIDLLRNTHTYYTDYAKKHW
NPKKEENILTMEAQQKELKGEKKVKEKKLKAKLKSVDPEKAIQSVFRVTLRNHIKLSDIA
DTKANILLSVNAIIISIALSNLIPKLDNPSNSYLIVPTIIFLLFTVTSIVLSVLATRPNV
TSGKFTKEDVNNKKVNLLFFGNFHQMSLDEFNWAMTEMLNDKDYIYSSLTKDLYFLGLVL
QKKYKILRLTYSIFMTGIIVSVVAFAIAFMTI
>OMIFANIC_01800 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKKVYTLIGILQILLISSCATHRVQYAENTNKSVFNSTGKQLEKTIYLIGDAGAAVMGES
TDALKAFKDFVAERNTKGDYTIFLGDNIYEDGMPSAKSENRAEAMHRMDVQIKAVEGFDG
EVLFIPGNHDWYDEGPKSVKRQEQYVEKALGKNTFQPEDGCPIETIDVSEDVVIIAIDTQ
WYLTNWDRYPTMNDECELKTRSEFIDELEGELKKNNEKTIILAMHHPAYTYGPHNGGFSA
EKHLFPFQTKIPLPGIATLIAQVRSQGGVSVQDRYNMRYDELMDRLITLVRGNDRVIITS
GHEHSLQYNEDDGIKQIVSGSGSKNSAVRMGKHAKFTYGDQGFAVLKIYKDRSSEVTYYS
AVDGKAQQLFNTGIYEATVEYDTSGLADAFESSVAASTYAKEATLKGKSYEWFWGQHYRY
VYGKDIQVPVATLDTLYGGLTIDRKGGGHQTRSLRLVDRKKRNFAMRGVKKSATRYLQSV
LFTNTYVEKDFEDTVTEDLVLDFYTASHPFASFVVAPLADAIGVYHTNPLLVYVPKHKAL
GNYNDEFGDELYIIEERPDDGFLNVESFGKPSAIESTSDLRKKLRKDEKYQVDEPAFIRA
RLFDMLLGDWDRHQDQWRWSRFDITEDKKIFRPIPRDRDQVFSNYDGALLDILRLLVPAA
GQLQTFEDKIDDIKWLNSAGIKIDRSFIQTSERSEWIKQADYIVNNLTDEVIENAFLKLP
PEVQDETAEEIKRKLKSRRDNLRDAATRYYEYISRLVIITGTDKDDYFEITRGNGSTKIT
VSRIKDGKVAEPYKERIINSNETNEVWIYGLDDDDQFVVNGKGSNPVFIRIIGGQNNDVY
TIENGRKIKVHEHNNKPNTIVKKRGASVRRSDFYEINTYDYEKLISRSNNILPSIGANPD
DGLRIGITDIYTIRGFKTNPFHQKHSIGARYFFATEGFDLAYNGEFAGVFGTWNLTVGGR
FTSENFTRNFFGFGNNTVNMDDEIDFDYNRVKTAIRSGRVGVVKHGEYGGSFSLTAGVEN
IEVEETEDRFVSEFFMNMPTVFDSKTFARVDVSYQFESYDNAANPARGMFFALEGGVNSN
TDDTERTFGYVNPRLIFFNSLTRDQKLVLKTMAQGQFNIGDDFEFYQAAVLGADTGLRGY
RTQRFSGESALAFGGDLRYSFSRFKTGILPIQLGVFGGYDVGRVWVEGEDSDIWHDDFGG
GIFLNAVDSLFGELGIFNSDDGIRISFGFGVSL
>OMIFANIC_01801 hypothetical protein
MKYLLLLFLGTLTTSSCQDYGSLSFTHSLPKTLKEISGITIARDSSLIWAVNDSGNKAII
YGYQPGSNSIVKTISVDNGFNRDWEDITTDGESTLYVGDFGNNQNYRKDLVIYTVTIPDS
IAHSKVDASKTTFELEDQKKFPPKKKHRNFDIEAFVYSEGLFYLFTRNRSSKFDGTTKMY
RLPAQPGHYTAKLIDTFQTCKDYDDCQVTGASLDRQNGKLALLSYNKVWIFSEYENDEFF
SATVEEIKLKHTSQKESITFKGSNTLFIADERSHMQGGNLYILRLK
>OMIFANIC_01802 DNA protection during starvation protein
MTYLNLDTEKTNTTAHELNILLADFHIYYQKLRNFHWNVVGSNFFDLHAKFEEMYDDAKL
KVDEVAERILTLRFQPLSNYSDYLKKSNLKESESDLNDVEMVKTLIGDHALIISQMRKVI
DKAGKANDEGTIDLIGSYVAEIEKTSWMLDAWTMQASENHPKL
>OMIFANIC_01803 3'(2'),5'-bisphosphate nucleotidase CysQ
MRENLHIAIRAAIDGGLEIMKVYATDFDVELKGDNSPLTIADQNANDVINKFLEPTGIPI
ISEENKQTDYEVRRNWNQCWIVDPLDGTKEFVKRNGEFTVNIALVIDGNPVLGVIYVPVE
KSLYFTSEDITESMKVIVNDPSISIDEILRDARSIKPAEEIVPPVKVVGSRSHLNDDTRK
FIENIEKETSVEIVSRGSSLKFCLVAEGDAHIYPRYAPTMEWDTAAGQAICQAAGIRVVE
EATGTPLKYNKENLLNPYFLVAR
>OMIFANIC_01804 hypothetical protein
MVNYRHESHLRSLLKGISWRIIATTDTVLVALMITCLFGKCSIENALKIGAVEFLLKLLV
YYFHERIWQRYRTGGSVTKLNTIYKSISWRLVATTMTFLISGAILESFDEIALFIALSEL
FTKFVLYYFHERLWLRLPLGRIRNYFVKRFKK
>OMIFANIC_01805 Adenylyl-sulfate kinase
MQENIIPHQFSISQKERSELKGHNSFLLWFTGLSGSGKSTIANAVEKALVSEGIHTYTLD
GDNVRKGLNNNLGFSHEDRTENIRRIAEVANLMVDSGLVVLAAFVSPYRVDRENIKTIVG
AAHYVEIFVNTPLEECERRDVKGLYAKARAGEISNFTGINAPYEAPDDPDVEIDTTQVTV
EEAVTKIMNHIKIKLAK
>OMIFANIC_01806 Sulfate adenylyltransferase subunit 2
MSKYYLNYLDELESEAIFILREVWAQFQNPVILFSGGKDSIVVTHLAKKAFYPSRIPFPL
MHVDTGHNFPETIKFRDDLIDSLGARLIVGSVQESIDSGRVAEEKGKNATRNALQITTLL
DAIEMNNVDCAIGGGRRDEEKARAKERFFSHRDDFGQWDPKNQRPELWNILNGNHFEGEH
FRAFPISNWTEMDVWNYILRENISIPSLYFAHEREVVWRQDSWIPVSEYLKLEEGEDIQK
KKIRFRTLGDITITGGIESDADTLEKIVGEVSAMKQTERGNRSDDKRSETAMEDRKRQGY
F
>OMIFANIC_01807 Bifunctional enzyme CysN/CysC
MNTSTQIDKNQLLRFTTAGSVDDGKSTLIGRLLYDSKAIFEDQLQAVENTSKRKGHDGVD
LALFTDGLRDEREQGITIDVAYRYFTTPRRKFIIADTPGHIQYTRNMVTGASTANAALIL
VDARHGVIEQTKRHAFIASLLQIPHIIVCINKMDLVDYSEDVYEDIIDQFEAFSSKLYVK
DIEFLPISALNGDNVVNRSENMDWYQGAPLLHTLEHMHISSDINKIDARFPVQTVLRPQS
DGFIDYRGYAGRVASGILRPGDDVTILPSGFTSVIKSIDTIDGELEEAYAPMSVSITLED
DIDISRGDMIVRTNNKPQALQEFDAMLCWLNNDPARPRAKYTIMHTSNEQKAMIKEVVYK
IDINSYNREEEDKQLNMNDISRVKIRTTRPLMIDEYRDNRITGSFVLIDDTTHETVAAGM
II
>OMIFANIC_01808 Putative O-antigen transporter
MVKRILQLLKNKENVQLIANFFSLVSIKGFDLLIPLFILPYLVRTLGIDIFGLTQFSLAL
CMYFGAFIHYGYSITAVREIARTRNNKEELSRKYSAFLSVSILLTFASLVVLSFVVWVVP
SLNEYWILHLYTFYFIAMQSLFPSWFFQGMEKMKYIAFINLSTKIMFLISLVMLVKGPGD
YLLVPLLNAFAMTISTLISFWIIHKQFKVAFRRSLYSEMEKVIVDGRHAFISLFAPTLYN
STTMFILGYTSSNLIVGIYASATKLIDALNSVALLLSNTFLPFLSRNIRKHGLFSKIMIL
GGMVLTVIAFIFSEQLILFLYGKENLNVSFYFKILTPMVFFIFVRSAYGPNFLMLIGKDR
VYKNIVLYSCLFFFVMAIIIVPIFEIYGAISIMLGTTFVMAALTFIYFRKFRNVVQ
>OMIFANIC_01809 hypothetical protein
MSKKIFDKLYRHSPAWFQNIIISTYGYLLFKKRYGKVYRQKFDEFQKRDYTSYQAEVENQ
NRELREFLSYVNAHSPFYKDLYSGIDISKIKTVEDLNLLPVVDKEMLRANIEDIYTIEVK
DAISSFTGGTTGKALKVLFTHEDFQTRMAYLDAFKARLGIDPFKVKKATFSGRSLVYNSK
TKIFWRKNFVYRQRLYSTFHLSQDNMPLYISDLNKFKPEVLNGFVSAIYELAEYIEREKV
NLTFVPQAIFTTSETLLPVHRKLIEEVFKCKVYDQYASAEGAPFITECVEGNLHYNLDTG
IIESDEDNNMIVTSFTTKGTPLVRYNIGDRVIFKEGTCSCGSSHPLVASIEGRKVDFLYT
DSGGKISLSHLADVIKGNPNSIIKMQFIQHSKDHIELLIVVDERIYCKEHEDKIRNEMAY
RFGNSMRIDMRIVKDIPKEKSGKYALIKNKVKEDSI
>OMIFANIC_01810 Capsule biosynthesis protein CapA
MKIALLGDIAFFGKFSVENNMELHKYFNKVSHKLKSYDLVIGNLETPFAHDNHGSYGFKS
AYIKSSPKNIELLKLLNIDVVNLANNHIYDFGPKSYELTKSVLDEHGIKYFGIEDKELVI
ETQGNSLALNGFCCYSTNPLGIHSDKADGINELNFATVANILTENAEKNLFNIFSVHCGQ
EHVNYPNYDHVQLARRLSEIAPYVFYGHHPHVIQGIEKVRDSLIAYSLGNFCFDDVYTSK
SKDPLIKQTRNNKESFILELEIDNNKLKGHKVVPIFIGEEEMVVGDLEITEKLSKYSEML
SIDKSEYITHRNSLLHSYISLRKKKRDLNWYLKRLNLNSVGLILFARLNAKKYKRSISLH
LDEK
>OMIFANIC_01811 hypothetical protein
MKNKGLNNFEKGLIFAIVLTPFTLLRIGYIGFGEISLLLLFLAGLQTGYISKLSKDLIFS
RFWIIFLIVSFCGFAYNVIFLNQNTGTFESSLFDFAAYVLIFISCLLVENLYLKDRLNIY
QIIRRVFFLSGFIFTALYALSMIMDSVLGLPLKYFEYFAPFVNNLHQTAMFIAPMPFIGL
FVLEREKKKLTRLVIMVLILILSYLTLETGSFKAMAGLGLGWLIYFLIKFINLFRGNLKK
AFIAIAISMVVLVIALNIETIYNILWAIFSSEDLAEGRTNLYTSAIDVGLTSPVIGLGPG
AHIYQDGQFWDSHASFLTVFLQGGVIGLILFLILFYRLSRNLLQVTSLLAASMPILIYAL
GGDIMRRLPIWLLLLLLNYYIVSEQKKEFINE
>OMIFANIC_01812 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MKEKLVRITTVPISLEKLLDGQLAFMSQYYDVTAVSSEKDNLETYGKAEGVKTFYLPLTR
KITPLTDIKCVIKLYRFLKKEKPLIVHTHTPKAGIVGMMAAAMAKVPLRMHTVAGLPLLE
ARGLKRKILNTVEKWTYRYATHVYPNSNGLEKIILNENFCNESKLRVLGNGSSNGIDSTY
FSRDHFSEDSIQAKKAEIGISKDDIVFIFVGRIVADKGINELVAAFKQLVQEHSAVSLLL
VGPFEDELDPVSDTSRKEIVSNNKIFTTGYLEDIRIYLALSDVLAFPSYREGFPNVVMQA
GAMGLPCIVSDINGCNEIIVEGENGLIIAVKDLDELHSAMKKMVEDEILRNKLKLKARHH
IISRYDRLNMWEIIRHEYGTQQSKL
>OMIFANIC_01813 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MFLILLPVFILVAIFLAISLAGDPFFKQLRPGKNERLFTIKKFRTMNNKRNEQGELLADD
QRLTTVGRFVRTTSLDEIPQLLNVMMGEMSLVGPRPLLPEYLQLYNEDQKKRHVVKPGIT
GYAQVNGRNALSWEKKFEHDIFYVEHVSFKLDMMILLKTIKKVFVREGITQEGQSTTTRF
KGTNKT
>OMIFANIC_01814 Putative acetyltransferase EpsM
MKPITLYGAGGHCYAVVELIRSLGEFDPVLIIDDNPNVGSIFDIPVQPNQPEQINEYLCV
TIGNNVIRKRIVERQKSIYPNFVHDSVVSYPSVTIGEGSVILPNAVLDAGVEINRHCIVN
LNATVSHNTIVNDFCHIAIQAAVAGGVQLGEGVLVGAGSVILPEISIGKWATIGAGAVVT
KDVPDYAVVVGNPATIIRYNPITNE
>OMIFANIC_01815 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MNNRIYLSSPHMGGQEQSFVNEAFDTNWVAPLGPNVTGFEQDLEHYLKEPRHVAALSSGT
GALHLALIMMDVGRGDEVICQSMTFSASANPIVYQGATPIFVDSEEDTWNMCPIHLEEAI
KDRISKGKKPKAIIAVHLYGMPFKAEEICSISEKYEIPLLEDSAEALGSTYKGKHCGTFG
DMAVLSFNGNKIITTSGGGALVTKTEEEKVKAIFLATQARDAAPHYQHSEIGYNYRLSNI
CAGIGRGQMRVLDDHVNLRREMNYFYKEIFKSVDGIEVFTEPGTDYFSNHWLTCILIDSS
KTSFTAEDIRLSLEEKNIESRPLWKPMHLQPVFKDYPFYGNHIAGELFDNGLCLPSGSNL
KNTEKQRIMEALSKFL
>OMIFANIC_01816 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MLTPRRIMRSIYRGDNRLKVLDQRYLPRWIVVLLDIFLVLFSLALVYLIILGTPIKFLDY
VSLPAQGGFILGVNIIFFFVFKTYSGIIRHSTFTDILKLAFSSFCTGASLLIFNFVFEAV
QGEKVFLTTSLVLYALVSFTVMLLFRIAVKESYQFLRNTAAGKLKKRVAIMGVGDQTIAL
GKALTTESDMPFVLVGFLSESFDSKRFKILGKPVIPIKKSFSETIENMELDGVLLISETM
SGKRRNQIIEDCIHHSIEIFNVPNLETWNKKEDIQNQIKPLDIEDLLERNPIEIENELIK
HDLQDKTILVTGGAGSIGSEIVKQVAEFNPELIVILDQAESVLHDLEIYLTQNYPKLNYI
TELADISNMYRMGLLFGKYTFHIIYHAAAYKHVPLIERNPHEAIYVNILGTVNLAILAAS
YEIDKFVMVSTDKAVNPTNVMGASKRVAEMYVQSLQNEKGVSTRFITTRFGNVLGSSGSV
IPHFRKQIAHGGPVTVTHKDIIRYFMTIPEACQLVLQAGTMGNGGEIYVFDMGKPVRILD
LAKKMIQLSGMEPYEDIDIKITGLRPGEKLYEELLNDSSTSLPTHHPKIMVSKTNVEKFE
DLKKKVKEIIKLATRGKNEEVVQMLKEIVPEYISENSEYEILDKPKSDTLEKVKVK
>OMIFANIC_01817 hypothetical protein
MANLKGWDIIKYIFVILIWYMRKVILFSLVIVSFLSCATKKEIIYFQDSSELNDTEIPEI
FEPLIEPNDILHISISSFDETLVMPFNKERIAENNANVDNLALQGYLVDSGGSINFPVLG
SISVGGKSRSEIEQMLKKMLLEYVTDVVVDVRILNFKVTILGEVRNPGVYTIRNERVTIP
EALGLAGDLSEDGDRNNISIIREENGKRIVTKVDITQTDLFSSPFFFLKQNDIIYVEPSL
RGVKKSGFIPDIPALLSLVTVMLSAVIIITR
>OMIFANIC_01818 Tyrosine-protein kinase wzc
MSERETVSSISDQTLGDLTKPYTRYWYWFILGLLITFIGAYLYLRYSTPIYEVQAKVIIK
DEKNSSGFLELSAIPELGNFMSRYGNSKIEDEIAIFTSKRLITNVVDDLNLNTVYRAVGN
VITSELYTRKPFTVQFLKNNSDNDIPFPELFIEIQDETSYSISGNGIGNAGTYKFGERVS
FDFADLIVLPNLEDQALFEKYTDESISVTHSDPESVALGYQENLKLLNEVVNSHVIQFSL
ESPTPEKARDFLDELITEYNDDAVNDRNQITRKTLNFIDSRLQIISRELDSVELDKELFK
SKNRLTDIQTEAAIILESASEFDKRQLNIATQLELTNTMIDYIENEDENELLPTNIGIQE
GDVVSAVNDYNELLLQRNRLLKSSTTKNPVIINLNNQIEQIRSSILQSLINTRNGFQISL
RDLNYGESSLNRKIEKVPAKERIYRDIERQQSIKEQLFLFLLQQREEALISLAANASKAK
IVDNAYISAVPVAPKRLFIYLIAFVFGLLLPFIGIYLKNLFNNKIPNREDLERLLKNVSI
LGEIPKLSKGTQDYITQNDRSIMAESFRIIRTNLQYFMRNKVEVDSDEKTIFVTSSITNE
GKTFVAYNLATTLALTGKKVILVGADIRNPQLHRYLANGDRSLKGLTEYIIDPAIAIEDL
CARSDNHDNLDIILSGAIPPNPAELLLSERTELFFSELKARYDYVIVDTAPSMVVTDTLL
ISSIADLTLYVVRADYTEKKIIGFINETASDKKLKNIAVVLNSVSENNFGYGNKYGYVYG
QERKTFFKRLFK
>OMIFANIC_01819 hypothetical protein
MRFVYLFCLITFPVLSQNSNIITRGEVSASAFFSSEDQSPFWFYTNTSNQFSANTDLAVT
ANFIGAYEFGVNRIFTGISGVYRDGFEDRFQRIDLYVGYNNKWIEATLGARQWDVKLNGL
SATNQNFLWSGNNRPLPGILLEAPEWVKITNGFYLDWRIGHYVLNDERYVNDTWVHFKEL
MLRWDINVKNSLRFKLQHIAQWGGDSPVFGELSRDFETFVDVFLARRGGEGSIVGDQLNA
VGNHIGSYLLEYELRGSYGDFLFYHEHPFEDGSGTRLANFPDGVWGVSFAPESKKIFSRV
LYEFISTRDQSGLREASGFDRYFSNKIYRTGWAYENTIIGFPFFTYDPGVVITEETTPII
NDVVQLHHFGANGYFGKFAWTFKSSISANSGTLRTPFNMDLNNWYNFVSFSYNAEKYGVI
TILAGADFSNIADDNFGAGLEYSYKF
>OMIFANIC_01820 hypothetical protein
MIQEILIAMLWSVSPFGEAKVGIPYGMLQGLNIYLVFIACFVANLLVFPIMMVFLDNVNH
YLLRWNWYKKAAIWVARRAKTGSGNKIQKYGFWGLLLFVMIPLPGTGVYAGSIATYLFKI
EKKKAFTANAIGIFLSSAIIWGTTLLTMQGVA
>OMIFANIC_01821 hypothetical protein
MYTNNIMLTGYWEPTNEMLRPFSKNRALNPTGWIGRNWDNSGFNVYAFFPEFDDDSDGKG
VGIGDLTVDYQDTLNDFYRLVKQLNPCAIISFSRDREHHGWTVETAAKVYPYIQWAAENA
IMPDDERLEPPYRPRHLRWDPIYPPDDSGPSGWRGAPIENILGLGTPNTIFNSTLPIDNI
NRMIDASRLYPARLFSNPQEFDRIGNQFLSNFIACLVMKYQEDHLIGSEGFECGAAGHVH
VGGMVTPEDGTIGTNITLKETIKVLRERLPFTFVTRFRITFHTAEILANSDSAASVRVCI
KRDGAPLAAKRINTSGGDLTQGASTNVEFSFRSFRMDPENPDGLDLAGSGVGGGVEFFNG
IFGKFSIELQIEGQDDWIVDEVILEIKELFHTSSAGRLEPLYRVSDWKTAGKWRQLKRLS
TNTRMRGLPARSRVEFKL
>OMIFANIC_01822 tRNA modification GTPase MnmE
MTHEDTIVALATPAGAGAIAVIRLSGPEAIHIGSVMFESVSGKVLQDQATHTVHLGHIKD
DGRIVDEVLATIFKDPHSYTGENVVEFSCHGSNYIQQEIIQLALRKGCRMAQAGEFTLRA
FLHGKMDLSQAEAVADLIASDSAASHQLAIQQMRGGFSSEIKRLREELLNFASLIELELD
FAEEDVEFANRDEFQKLITRIRNVLKRLIDSFATGNVLKNGIPVAIVGEPNVGKSTLLNA
LLNEERAIVSDIAGTTRDTIEDEITIGGIGFRFIDTAGIRDTSDVIEGLGIQKTYEKMEQ
AQVVVFLLEASKFISQEEALKLEIAKIHNRYPQKAILIIANKVDQVSEEERKKIEKELKV
VSSDSEKSHALVLSAKTGENVDLLKTTLLDFVNTGALRNNETIVTNSRHYDALLKALQEI
DKVQQGIDNNLSGDLLAIDIRQALYYFGEITGEISNDELLGNIFANFCIGK
>OMIFANIC_01823 hypothetical protein
MEVINHSGKRIDNNLLVVTHLSQLLYYITGFGGLVVPLILWLTQKDKVAGMDEHGKAVVN
FQLTLILITIISIPGIFLLGLGILGLIYVGLVGFIIPIVNAVRAGNGESPTYFGTIRFIS
>OMIFANIC_01824 Lipopolysaccharide core galacturonosyltransferase RgtC
MKFSSRFIIYGIALFNIAIHLYAINNLEYHRDELLYFALGNHPDFGYATVPPLIGWVATV
MQSLVGHSLFAVKLFPAILGGALVLVSANIARELNGGTYAQIITAISIVMLPVGLRAFHL
FQPVPIDLFLWTLLLFYTIRYINSEERKYLLFLGIVAGIALLNKYLIGVLFFALIISLLF
SPHRKIFRERFLYYGILIAFLIFLPNLAWQIANDFPVIGHMTALNDNQLVHVDRVDFLMD
QLLMTFSVFFILLAGIIYAMRKSKYRYLALSALIVVSVLFILRGKSYYTMGVFPVLIAAG
CVAVEKVIKNNFLRLVIPALIVLITLPLLPMGLPIYSEAGLVAYFKDLEEDYGMEIGRRF
EDGTIHSLPQDYADQLGWEELTKITNEAYNMIPENERAKAIIYGSNYGQAGAIAVIGKKY
DLPEAVSFHESFFYWIPKQFDPDIEYLVYINDEMGENVRNLFAEIEEIGSISNMNAREYG
TTVYLCSKPRSSFNSFWAEIVEQVDSPF
>OMIFANIC_01825 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQVLGGIINTNNTLPILDNFLFDLDGNSLSVSASDLETTISSRLEVE
SSEKGSVCIPARLLLDTLKTFPEQPLTFTVEDNNTVEISSNHGKYALAYASGEEFPSPVE
LKDPSSTTIQGDILANAISKTIFASGNDDLRPVMSGVFFQFSTDDLTFVATDAHKLVKYS
RGDVSASQNAEFIMPKKPLNLLKSILAGSEDDVVVEYNESNAKFSFNSTEMVCRLIDGKY
PNYEAVIPKENPNKLTIDRMQFLNSVRRVSIFSNKTTHQIRLKIAGAELNISAEDIDYSN
KAEERLTCDYQGDDMQIGFNSRFLTEMLNNLSSENVSLEMSLPNRAGILTPVDGLDEGEQ
VTMLVMPVMLNN
>OMIFANIC_01826 hypothetical protein
MARKQNHTVNLVLLIVAIILLNVLGNFVYKRFDLTQDKRYTLSEAAKETIADVDSPVVID
VFLKGKFPAEFRRLQQETRQLLEEFSDYNSNIRYKFIDPIETEENREAIQVQMRDFGLTA
AQVEVQEGGKISTELVYPWALAYYNDKTVKIPLLKNQLGTTPEERVNNSIQNLEYAFADG
FSKLAKPKRRKVAVLKGNGELDDRFVADFFSTLRDYYFIAPFTLDSAAVAPQKTLTQLNE
FDLIVAASPTQPFSDQEKYILDQYTMNGGSSLWLVDATENRVDTLSGKTFAFGKDLNLND
FFFKYGIRINPNLVKDIYAAPIVLASGNERESQYNRYPWFYNPLSSSANNHPVVTNIEAV
KFEYASAIDTLPNNIRKTVLLSSSPITSIIGLPAEINIDKEIPENLKVINEGPDPSKFTA
GETPLAVLLEGEFTSVFNNRVKPFSYPEDKTSSVSTKMLVVSDGDVIRNQLDRGRPLELG
FDKWTQSFYGNKEFLLNAVNYLLDDSGLINIRTKEIAIPFLDPQKTSEKRSSWQIINLLL
PLGLLAIFGFIFQYIRKRKYRQGS
>OMIFANIC_01827 hypothetical protein
MTAIVKKEINSFFASPIGYLVIGLFLVINGLFIWVFPGGYNIFDSGFADLAPFFELSPWI
LLFLIPAVTMRAFSDELKLGTLELLLTKPLSLRSVVGGKYLGAMILIIIALLPTLLYIFT
ISNLGNPEGNWDLGSTLGSYLGLLFLAAAYTAIGIFASSISHNQIVAFLISVFLCFVLYY
GFEGLSSLDFEFAVEKLGMKAHFESVSRGVLDTRDLIYFLSVSVLFLAFTVFKLRKR
>OMIFANIC_01828 hypothetical protein
MFTRIVKMEFKEAEIPAFLANFELIKDKIRSFPGCCFLELYRDKNVPEIFFTYSKWEDEK
DLENYRNSALFNEVWATTKIKFRSKAQAWSVDTLHKLN
>OMIFANIC_01829 5'-fluoro-5'-deoxy-adenosine synthase
MPIITLTTDFGEKDHFVGGVKGAIYNELDSVRIVDISHSISPFHLTEAAYIIQNAYKSFP
AGTIHIIGIDSGLTPENDHLAVLLDGHYFICANNGIISMLTSEIKPEKIVQINIHDRINS
NFPVLDVFVKVACHIARGGTLEVIGKNITKIKELTGIRPVVNPEGNLIIGNVIYIDNYGN
VVCNITRGLFDKIGKGRPFKIMARTASFSEVYNNYSDAINFELPAEKREEDGKKLALWNS
GGYLELAIYKSNPATVGSASSLFGLEYWDTITVNFE
>OMIFANIC_01830 PhoH-like protein
MNELIIELTEISPRDFFGLQNANIDLLKKYFPKLKIVARGSKIKAYGDEEILEEFDTRLT
MLLEHFAKYNKLDENAIERVLQSKSSADYETPASSGEVLVHGVNGKLIKAQTANQRKLVQ
LSQKNDLVFAIGPAGTGKTYTGVAMAVKALKEKQVRRIILTRPAVEAGENLGFLPGDLKE
KLDPYMQPLYDALRDMIPHEKLDSHIEKGIIQIAPLAFMRGRTLDNAFVILDEAQNTTHA
QMKMFLTRMGKNAKFMITGDPGQIDLPRRVISGLKEALLILKDVDGVGMVYLDDKDVIRH
RLVKKVIAAYKEIENRN
>OMIFANIC_01831 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MSNTITDTNFNFPGQKSVYKGKVREVYRLENDLLVMIATDRLSAFDVVMPKGIPYKGQIL
NQIATKMMKDTEDLVPNWLIATPDPNVAVGVACEPYKVEMVIRGYLSGHAAREYKSGKRS
LCGVSMPDGMIENDKFPEPIITPATKAEKGDHDEDISREDILSRGIVSEEDYLQLEDYTR
KLFQCGTEIAASRGLILVDTKYEFGKTKDGKIVLIDEIHTPDSSRYFYAEGYAERQERAE
PQKQLSKEFVRQWLIGNGFQGLEGQEVPNMTDEYIGTVSDRYIELYENITGETFVKADVS
NIQERIEKNVLDYLTT
>OMIFANIC_01832 hypothetical protein
MKQLLTALFLFLCAHVASQEVDVENKSNFVLTPEFLLGYTAESNENFPDRSLQSQFILNF
GWDHSVNPKEWAQRLKGPKTGISIGYTEFGNKDSLGGAITVMPFIEFGVFKSKRFKTQVG
MGGSYFTKIYDEIENPLNQAMSTDLSWSFRAYLHYELLRTRYIDWRIGLGYSHHSNGHTR
LPNQGYNSFLASVSADIKSRKSMEKDPNPLPGNFTRRINDYISLYGGYGINVLSLAYNDK
RDVYTLSGEYGKVLNGMFKVGVGFYYRFYQHYYDYINDEEFLVREGEEFEDLTENPWWNG
SNLGLHVNGEFMLNHVGFNVQLGVNLHKPAYDIDWRINQGWDNTPREIPPNFMLGEFDSK
FRVKKILSSRMGLKYYVFDTSKEPINNLFLGIHINANGGQADFTDISIGYVYNFNYRER
>OMIFANIC_01833 Amino-acid carrier protein AlsT
MYEEIIAYLESITSQAQSIAWGLPLLILLIGGGLYMIVRIKFLPFRYFGHAIAILRGKYD
DENDTGEISHFQALTTALSATVGMGNISGVAVAIAIGGPGAVFWMWVSAVIGMSTKFFTA
SLAVMYRGKDSNGKIQGGPMYFIVEGLGKRWKFLAIIFSVAGLVGALPVFNVNQLTQAIN
DLVLKPTGMYTGLNSDLTLGIILVLITSLVILGGLSRISNTASKLVPSMVLLYFVMVLII
LGVNYEVVPKYISMIFTDAFSASFYEGDAFLGGMVGGLLLLGIKRGAFSNEAGIGTAPMA
HGAAKTNEPIREGLVAMLGPAIDTLVVCTLTALAILVTGVWETTSANGVSLTASAFTQAL
PGFGKYLLLLCIAIFSISSLFSYSYYGTKCMSFLFGAKNASYYIYIYIASIIVGATTTLD
MMIQLIDTFFAIMALPTMIATIIMAPRVIKEAKRYFNSLKKPKVVP
>OMIFANIC_01834 hypothetical protein
MARKFVIHTVLFFIPVLIGCATVEILTRNLPMRYTYLSDYLQKEQKEIETLVLGSSQTKT
AINPQWLSSPTLNLASTSQHHDTDFKLYTGLKERLPKLKTVIIEVSYSHFELPHNGADFW
KNSIYLEYFEANCFERRTWLKDRFIYLANPPFFSDALYDEYLGPKRETNFNEFGFDLNQF
EGVFSRNNYDEETISEMKFTGNSRENEALFRRNSAYLIEMLKAFDSHGIDVILITTPLYK
NYLDRRNAKISKRRDSMLTVIGERFPNLRLLDLEEDTANNFTTKDFLNQNHLNPEGAKKF
TARLEQMLKERP
>OMIFANIC_01835 Peptidoglycan O-acetyltransferase
MLFNSLDFGFFLVIVFTMYWLIGGKRRITQNLLILIASYVFYGFWDWRFLTLLIGSSLID
YIAAKFIHATQRKGRRKFWLLFSLFWNLGILFTFKYMNFFLDSFHALFSSELLPGEFSIW
NVIIPVGLSFYTFQTMSYSIDVYRGKLKPTNNLLNFLCYVSFFPQLVAGPIERASFLLPQ
FEKERSFDLEDAREGLRQILWGLFKKILVADKLGIAVTMVFDNPEGYGSITLIYAAVLFS
FQVYCDFSGYTDIAIGTARLFGFKLHINFRIPYLAKSMTQFWQRWHITLTKWFTDYVYLP
IVKSYKKPGNWSRVWALLITMSLVGLWHGANWTFICFGVVNGLMLVMERIPLGNSKRTLA
RILPTRSRWITVIYFFALTSISSVFFRAYHIDDAWIILKRIFTLTADNELSLLIGVKISF
LILLIVSELLTRHKEFPLQQLEKRFSRPIRWGIYYVLVVLIIRFYEPLKTFIYFQF
>OMIFANIC_01836 Putative aminopeptidase YsdC
MARSILNKKSLTFLENYLNNAAPTGYEWDGQKLWMKYLTPYVDEFLTDTYGTAVGIINPK
AKYKVVIEGHADEISWYVNYISDNGLLYVIRNGGSDHQIAPSKVVNIHTNKGIVKGVFGW
PAIHTRSRAKEEPPKPENIFIDIGAKDKKEVEKMGVHVGCVITYPDEFHILNKDKFVCRA
LDNRMGGFMIAEVARLLHQNKKKLPFGLYITNSVQEEIGLRGAQMIAERIQPHAAIVTDV
THDTTTPMIDKKKQGHAKIGEGPVVAYAPAVQQKLRDLIINAAEANEIPFQRAALSRATG
TDTDAFAYSNMGVASALISLPLRYMHTTVEMVHKQDVENVIKLIYESLLQIKSGETFSYF
E
>OMIFANIC_01837 hypothetical protein
MSKINLIKIVFGLNVLLTNVMVAQTLQEISQVNKDSVETFYYIIEGDTIPKEYIDLGEVI
LLNKLEFNSKTDRRRYLIIRRKTRKVYPYAKLAAERLTTMTERMKTLKRKRDKKRYTKRV
QKYIEEEFSEKLKKLTRTEGQILVKLIHRQTGRTAFALVKELRTGWRAFWYNTTASLFDI
SLKEEYKPFKVKEDYLIEDVLERSFQSNVLERQKPSFEIDYLDLTAHWNKMSVNK
>OMIFANIC_01838 hypothetical protein
MFGEEIDILRPMFLEIKKHYRSDDFIVMGQVCIDKEFRRKGLFRRLYQEMLKGIQPEFSL
IITEVDSKNSRSTNAHFKIGFQTISNYKSHNRDWVLMKLEKSEIA
>OMIFANIC_01839 Arsenical-resistance protein Acr3
MAKTKKLSFLDNYLTLWIFIAMAIGVGIGYFVPSFPNTVNTMSSGTTNIPIAIGLILMMY
PPLAKVNYALLPKVFKNVKILSISLVLNWIIGPVLMFFLAIIFLKDYPEYMVGLILIGLA
RCIAMVLVWNDLAQGSSEYGAGLVALNSIFQVIGYSFYAWVFITVLPPYFGFEGAIVDIS
IATIAESVAIYLGIPFLMGILSRLILVKLYGEEWYTQVFIPKISPLTLIALLFTIIVMFS
LKGEMIVEIPMDVLTIAIPLLIYFALMFLIGFFISKAMGADYDKNAAISFTAAGNNFELA
IAVAIAVFGLNSGQAFAGVIGPLVEVPALILLVRVAFWLRKKYYTKPTTQN
>OMIFANIC_01840 ATP synthase epsilon chain
MYLEIVTPEASLVAGEVESVTVPGVQGPFQMLNNHAPIVSLLNAGKVLFKGNPAIAEGFE
NKFTKEDDGKWSLEITSGTVELNNNRIIVLAD
>OMIFANIC_01841 ATP synthase subunit beta
MSKITGKVAQIIGPVVDVEFASGDELPKIYDSLEVDNHGNILVLEVQSHIGENTVRTISM
DSTDGLSRGVDAVSTGVPIQMPIGEDIYGRLFNVIGDAIDGIGNLPKAGEDGLPIHREAP
KFEDLSTSTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGLS
VFAGVGERTREGNDLLREMLESGIIKYGDDFLHSMEAGGWDLSKVDKAAMKESKATFVFG
QMNEPPGARARVALSGLTVAEYFRDGAGDGQGKDVLFFVDNIFRFTQAGSEVSALLGRMP
SAVGYQPTLATEMGTMQERITSTKKGSITSVQAVYVPADDLTDPAPATTFAHLDATTVLS
RKIAELGIYPAVDPLDSTSRILAPDVLGDEHYDCAQRVKELLQRYKELQDIIAILGMEEL
SEEDKMAVGRARRVQRFLSQPFHVAEQFTGIPGVLVDIKETIKGFNMIMDGELDHLPEAA
FNLKGTIEEAIEAGEKMLAEA
>OMIFANIC_01842 hypothetical protein
MKTLSDDKSERVFSYLKLLMASLLNRGKQNATEFRNHLQKISCFNCVIRIEKTIFAPLKN
RVLSTTLDN
>OMIFANIC_01843 hypothetical protein
MKSLYKNRLLLASALGLFLFASCENDDIPVVEEEEVIPLVAGSANVANYVSIGNSLTAGL
TDGALFILGQENSFPNLLAQKFAMIGGGDFTQPLMNDNIGGLLLGGVQIQNPRLYFDGAG
PALVNQTPTTEVSNIQAGPYNNMGVPGAKSFHLLANGYGSIGGVQTGQANPYFVRMASNP
NASMLEDAVAQNPTFFSLWIGSNDVLSFATSGGAGVNQTGNPDPTTYGSTDITDPAAFDG
IYNAILGSLAANGSQGIVANIPYVFTIPYFTTVPYNPVPADANTAALVNAGYAPYNVGLQ
QALAAGLITAEEATARTINFVEGQNAVVIEDEYLTDLSALGLPNYRQTTEADLPTLLSAS
FIGTLVNNDPTLINGVTVPLADQWVLTVDEVEEVTVATDAYNASIAAAASANGVILIDAN
AFLQQIFDTGIMFDEFNLNGSLVFGGTFSLDGVHPTARGNAFVANQILLAMDEFLGTNFE
EAGELFKAADFTTIYPEVLP
>OMIFANIC_01844 TonB-dependent receptor SusC
MKAIIALFCLCLSTITLAQTDISGKVVDQSSEPILGANVIVVGTGTGTATDFDGNFTLRV
DQAPPFTVQISSIGFETQTQEITSNNQVLNITLAEGSQLDEVVISASRTPERIFESPVTV
ERFDIQDIKYAPNADFYDGLEAIKGVDINTNSLTFKSINTRGFATFANERFVQLVDGMDN
SSPALNFVLGNLLGMTELDVNSIELLPGASSALYGANAFNGILFMTSKNPFDHQGISAYY
KRGMTSQEAAGDNDFYDMGFRAAHAFTDKFAAKVNVSILHGTDWFAVSEEDVLNPGRTRD
HPNYDGLNVYGDEVATNLRGVGVSLANMGLIPAGSENLLPSEDVSRTGYNERDLTNYNAE
SVKFDAALHYRPWADDFEVIYVGKIGVGSTIYQGANRYSVKNFFLQQHKLEFKNDNFFVR
GYITDEDAGDSYDMRFTGININNAWKDNNTWFGEYAGAFIQATLAGATPDQAHGIGRQTA
ETGRLIPGTPEFQAAFDRVTNDPDISTGSQFKDETQLYHVDANYNFSHLLEDIADVQVGG
SYRQYRLNSSGTIFTDFDGPISYSEVGAYSQIQKKLVDDRLKLTGSIRYDKSELFDGQFT
PRLSVGFTAGEKRNHNFRVSWQTAFRNPTTQDLFIGLDVGRAILVGSAEDNLDRDIRMFP
LSGDGQNITGGTTATITARDAYTNSFSVNSVLTGAPEKAIINPIQPEEADVYEVGYRGKL
FNFIIDASAYYSQYSNFISNENVIVPLYGTVGDNSLSLLALQNGDTKVYQTYTNSDADVK
SYGASIGVSTRVAKKVNLSANYTYADQDFDQEANPDFRTNFNTPMHKAKASVRVTDLFPN
FGVGANFRWSDEYFWQAGFADGIVPSFSVLDAQINYKIPKLKTMIKAGASNVLNEEYFTA
YGTGNIGAQYYVSLIVNNL
>OMIFANIC_01845 Branched-chain-amino-acid aminotransferase
MLQQFDKRNMNIKIFIKDRLYDRAEAKISVFDSAVQGGDAVWEGLRVYPEGIVCLEKHLS
RLYESAKTLAFADIPSMDFIKSAIKQTLEANGMSDDTHIRLTLTRGEKITSGMDPRLNQS
GSCLIVLAEWKPLVYDNAAGIKVISCSQRRNGPQFLDSKIHHNNLLNNILAKIQANVAGK
DAGLMLDERGFVAELNGSNIFMVKDNTIFTPYATACLPGITRGTVISMCKDQGIPLIEAD
LSLSEFINANGVFATGTMGELTPVTEIDGRTISGDNSLMNRVINLFNDKIRNFCEPLS
>OMIFANIC_01846 hypothetical protein
MKVINLISGPRNISTALMYSFAQRKDFEVLDEPFYGYYLKQADLAITHPSHMEIIHNMEV
DEQSVVDYINDIAKETNIFIKGMAHHFLSDEPEYLSDWENVVLVRHPRKLISSFSKVISN
PTLADIGIKKASELVTYLNSIGKAPVVIDSDELMINPEAYLVKLCDLLHIGFDPCMLSWK
KGGIPQDGIWARHWYKKVHQTTGFEIQQKKPAEVPPHLGPLLAEALPFYESLQPYILKNE
>OMIFANIC_01847 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGKREAYPIIINGLKRLEYRGYDSAGIALFDGSEIQLSKTKGKVSDLEARIVK
EITTKGSLGIGHTRWATHGVPNDINSHPHYSNSGDLVIIHNGIIENYASIKQELINRGYS
FESDTDTEVLVNLIEEIKKEEKVKLGKAVQIALNQVVGAYAIAVFDKKKPDEIVVAKLGS
PLAIGIGDDEFFVASDASPFIEFTNNAIYLEDEELAIIRKGRDVKVRNIKDDRLVDPYIQ
ELQLNLEQIEKGGYEHFMLKEIYEQPTVIKDTYRGRLLANKGIVKLGGLEDHIGKFVNAN
RIIIVACGTSWHAGLVAEYIFEDLTRIPVEVEYASEFRYRNPIINETDVVIAISQSGETA
DTLAAVKLAKQKGAFVYGICNVVGSTISRETDSGTYTHAGPEIGVASTKAFTTQITVLMM
IALRIAKEKGTISQRHFMLHLRELDMIPDHVAEALKSDEKIREIAEVFMDASNFLYLGRG
YNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEQMPVVVIAVNSNHYEKVVSNI
EEIKARQGKIIAVVTEGDTTVKNLADYIMEVPKTPEALSPLVTTIPLQLLSYHIAVMLGK
NVDQPRNLAKSVTVE
>OMIFANIC_01848 hypothetical protein
MKIKYTLPKSMAILALIIAFASCEEDFNTIGVNIIGDENFQSEFTDSLSVIAYSRKLLPP
QTNALPVYQLGVYNDPVYGKRTVNFLAQLTLDSPDPDFEIAPIADSVVLYIPYFSTEMTN
NEVVTYDLDSVYGNTPININIYESNFFLRDFDPDTGFQEPQNYYANQRELFENFKGELIH
SINDFTPSEEALVLNDSVSLIPGLRANLSKTFFQEKILDQNGSIQLINNNNFRDYFRGLY
FEVESATDDGNLTIMNLEEANVTIYYTFQTEGTGIAAVPGDTIQRFNGEVQMNFNAISVN
TYDNTIPADISEELANPNITDGEERLYVRGGDGIVSVIELFGPDLDEDGVADELEDLRNE
EWLINEANLIFYVDTDRVTGGEQEPERLVIYDIKNSAFLADISLDITSNLEPVDALNVHL
GRLKRGTDENGEFYKIRITNHVSNLINNDSTNVPLGLIVSHNVLESDFQDLENIQAPGIE
QVPAASIVSPEGTVLHGNLSANTGKRLKLQIFYTKPE
>OMIFANIC_01849 Glycogen synthase
MMKDKRVLYVSSEVVPYLPETEISSMSFEAPRLVNNNSGQIRIFMPRYGNINERRHQLHE
VIRLSGMNLTINDLDMPLIIKVASIPKERMQVYFIDNEEYFKRKATYADEDGNFFEDNDE
RAIFFAKGVIETVKKLNWSPDIIHVHGWLASFLPLYLQKYYENEPLFENSKIVTSLYNQG
FPGTLQKSVMDKILFDGIKEEHIAMLKEPTYENMMKIAIDNSDAVIVGSEEIPKELSAYL
KDLKKPVLKYHNIDEIETAYLDFYQSQVLG
>OMIFANIC_01850 Pantothenate synthetase
MVVYTDKESLTPFILSKKNNSKKIGFVPTMGALHKGHLSLVKTALDQNDVVVVSIYVNPT
QFDNLKDLENYPRIPVKDQQFLEQLSGDIVLYVPDNKDIYGKAVDSMNFRFDGLEHQMEG
AHRDGHFDGVGTILTLLFEIVQPDMAYFGEKDFQQLQIVRKLVEKNSIPVQIIGCPIVRE
NNGLAMSSRNKRLSKKEFKEAAFIYETLSEVRSKFSSTSINKLKLLVKERFLHHDYLKLE
YFEIANESTLVPAIRKRKDNKYRAFIAVHCGEVRLIDNVALP
>OMIFANIC_01851 Aspartate 1-decarboxylase
MQIHVVKSKIHRVKVTGADLNYIGSITIDEDLMDAANIVEGEKIQIVNNNNGERLETYAI
PGQRGSGEITLNGAAARKVAPGDILILITYAIMSVEEAKEFKPALVFPNEENNLLI
>OMIFANIC_01852 hypothetical protein
MFSRMRRTIYSYNLNKSLSKFLQIAIPLGLGIFLVWYVYSLFTPEQVEQIVFHFKNANYW
IVGLAVSMSVISHILRSYRWNFMLEPLGYKPRLMNNFMAVSIAYLMNIFIPKSGEVSRAV
VLSKYEGVPFDKGFGTIISERVVDMILLMIFTLIALFLQFDALYTYITDSIPVMKIITAL
AALAVLGTVFLIFLKKSKGPLAMKIRIFVDGLKEGLFSIIKMKKKGLFILHSLIIWILYI
ASFYTATHALEETSAISAGVVIITFVVGSFTFAFTNSGFGFYPTAIMGILLVFGIASDVG
FALGWIVWTSNILSILFFGAFSFLFLPIYNRNIS
>OMIFANIC_01853 hypothetical protein
MKNLLLLIITVLIGFSSLGQSKIIYEEFSSYKLDDTRRLKIQLPRDYETNTEKVYPIVIV
LDANYLFEPVAGNVDYFGYWEDMPESIVVGVMQGDSRYDDCSYDDTNFMPADQGADFFEF
IGLELIPYIDDNFRTAKFVIAVGHDFTANFINYYLFKDPPLFNGYINLSPDLAPMMDERL
PQRIPSVENKIFYYLATGTDDIKDLMEISEGLNTMLKPLESDSFKYYYDNFEGATHYSLV
ARAIPSAMEKIFSVYRPISKQEFNDVLMKLETPVHLYLLDKYNTIKELFGLTNPIRVNDF
IATATAAEKKKQWESLREIASLAQRQYPDTVMGDYYMARFYEETGEPKKAMRTFQGAFDK
EEVDFITIDLMLDKADKIKEDFGY
>OMIFANIC_01854 DNA repair protein RadA
MAKTKTTFFCQNCGSQYSKWQGQCTSCKEWNTIAEEIIQKAETATWKGGETITSKRITKP
QRIAEISASSESRLDTKNHELNRVLGGGLVPGSLILLGGEPGIGKSTLMLQVALSLPYKT
LYVSGEESAQQIKMRAERIQPDAEQCYILTETKTQQIFRHIAELEPDIVVVDSIQTLQTD
HIESSAGSISQIRECATELIKFAKETATPVILIGHITKDGNIAGPKILEHMVDTVLQFEG
DRNHVYRILRANKNRFGSTNELGIYEMQGSGLREVHNPSEILISKNKEDLSGTAIAATLE
GMRPLMIEIQALVSSAVYGTPQRSATGFNVKRLNMLLAVLEKRAGFKLGAKDVFLNVTGG
ISVDDPAIDLAVVASVLSSNVDIAIDKSLCFAAEVGLAGEVRPVTRVDQRILEAEKLGFG
SIVISKYCKLPKETYKINVIKVTKVNDVVRHLFG
>OMIFANIC_01855 Xyloglucanase Xgh74A
MKKLSYLLVLVIGVCISKIHAQDYLELIHNPTESTTLQEIQQLAEAYFANRDRGRGSGYK
QYKRWEYKMQRNVNSDGRIQNFSKLTHDAIVDLNSPNTGVGRMPANWTAMGPLNYTNGNS
GYNGGLGRVNVVAFHPTNANTIYIGVPAGGLWKTTDGGTSWSPMSDALASIGVSGIAVDH
TNPNTVYILTGDGDGADTYSIGVMKSTDGGATWNPTGLSWGVTNFVRGYKLIMHPTNSNI
MIAVTNAGIYRTTDGWVTSTNVQGGSFRDIEFKPGSPSTVYAVTTNSFYRSTDSGATWSV
TGSGLPAGENRIALAVTPANSNYVYYLAGPGGATGNGTFRGLYRSTDSGSTFSSRSTTPN
ILGSDVNGGGSGDQSWYDLALAVDPTNANNTVTGGVNVWRSTNGGSTHTLSAYWYSPGAS
QYVHADIHDLAYNPVDNKLYCGSDGGISVSSDNGATWTNIWSGLQIMQFYKISGVEADQN
LLVTGTQDNGSNKYTGSTTIQHILGGDGMDNMIDYNNNNILYYSFQNGGLQRSTNGGVTS
TGIKPSGSTGAWVTPYAMDASNPSIIYGGYNDVYRSTNMGTSWTNLGSDGRGALAVGIND
GSRLYASNGNVIQTSANTGGNWTTVTGPWPGGLTITDIAIDPANASRVWITLSGYTAGQK
VYESTNAGASWTNISGSLPNVPALSIAFENTGGSPQDAMYIGMSVGVYYRSDVTSWTLYN
TGLPNVPIYDLEINHTNNKLRAGTYGRGLWETLLFGGSTCDIVSTNVTTTAPSCPGGTDG
TLTITATCTTCTSIQYTITPISPPGPPVVQVGNGVFTNLAANSYNVTIEDSTDSSCNDTW
VNNPVVVAAGTDGIAPALSCPANVNVECGDDTSPTNTGTATATDNCDPNPGVTFSDSSAP
GCGLTEVITRTWTATDAAGNVSNCAQTITVVDTTSPTITCTTNITVNNDPGICEAIVSYT
IPTGSDSCGNVTVTQTSGFSSGSLFPVGTTTNAFIITDDCGNTVGCTFDVTVVDNESPTL
VCPVDQTVDPGLGNPYTVPDYFATGEAVATDNCTSPVTNTSQNPAAGTQLPDGVYTVTIN
ATDAAGNVETCTFELTVEGVLGVRDNTDLSSVILYLNPARDHVMLSNPQNIVLDKLDIFN
VQGQLIKTMDLSNSGTEKVIDVSELASGTYLFVIIGENGQIVKQIIKE
>OMIFANIC_01856 L-glyceraldehyde 3-phosphate reductase
MTFGRQNTEAEAHQQMDYALDNGVNFVDTAEMYAVPFTMETQGLTEKYIGSWLNKTGKRD
EIVLATKITGPGRGIFKDIRKNLDFSKESLEDALHKSLKRLQTDYIDLYQLHWPERSVNI
FGIRDYDHAPNLQWADNIAEILDSLERFVKEGKIRHIGMSNETPFGVMRYMEEHRKGKLK
MVSTQNSYSLLQRRDEVGLTEVLQMEHVGYLAYSPLAFGVLSGKYLNNQKPEGARVTLFP
NYNRYSGNASLLATDEYRQIARNHGLSLTQMALAFVNSRPFVTSNIIGATSIDQLSENLD
SINVSLSEEMIREINKVHGQIPNPAP
>OMIFANIC_01857 hypothetical protein
MMIKKTYLILLLFIGSFVHAQDGIPVYSDYFADNLYLIHPSMAGAAAHNQLRLTARQQWF
DQDEAPNLQTLSFNARLGERSGVGAIVFNDRNGYHSQTGGYLTYAHHIMFSRSEADLNQL
SFGLSAGLVQSRLDETQFDPNDFDPIIAGIIQSSSYFNLDAGVSYNFLNFSGHFTVKNII
FQNRNLFSEKFEPNNQRQYLISAAYAISSGVYSTWAYEPSFMLQWRERTNESAIDVNFKV
YRTMDFGKLWGGISYRRSFDGSEFLDGVEVNTQKLQYWTPIIGVNYNNWMFAYTYSYQAG
NIRFQSGGFHQITLGYDFLGNRPEPYNCNCPAIN
>OMIFANIC_01858 hypothetical protein
MKTLQIVTIVFLIGLSFSCKAETKNEINSIEIAHNSSPVVEKHYIKVALLLDTSNSMDGL
IDQAKAQLWEIVNELSYAKCRNERPNLQIALYEYGNDNLNSRNGYIRKILGFTEDLDDVS
KELFSLTTNGGSEYCGTVIHSSIKQLDWGNDADDLKMIFIAGNEPFTQGKINYKDAALEA
REKDIVVNTIFCGDYKHGISSKWQHGAQLAYGDYMAINHNRHTVHIASPFDDLILQLNIK
LNGTYIPYGSHGRMKIAMQEEQDANAAGYNKANAVSRTVTKGSHLYKNSSWDLVDAEKEQ
GFSYDKLKNEDLPENLQGKSKAEIKAFVAKQRKEREAIQQEIANLNEKRRKFIAEKKSDT
DNGLESAMIQALKKQAEKKDYNWD
>OMIFANIC_01859 Sensor histidine kinase YpdA
MKVISTLLFVLLIAVHPLYSQVQKRSENAFVLKGIVLEEETNDPVARVNVEIPGGSYTTT
NGAGEFAISAEIGDELIIKSDAFETVYYTIKNKQKITIRVRDESIVAEEKMPVTSTSRNE
TENNFNTLIDSAKYFLKKDAKKSIEYVTQSLEAVPGKSSSRRHNSIAFETLGDINLYWDQ
PDLAVDNYKSSISSQSRTDVRIKLGAAFIANNNYQESISLFEELLKVKLSNYQEVEVYEG
LGDTYKAINNQEKSVFNYQQALDIASEHSITPKITDLNSKIGEAYAKGGAPLEAEQYFDN
SLNLAKQENKKRAVVEKNKVADFYNQNQDFDKEIQLRSGLLEELKGIDAGALEDDEAEEI
SPQRQNYKIANAYVAQDKYADAIPFLKKSIEEAGEKEDLVVQKDATRKLSEVYKGIGDFG
KAAENYEKYVEVVDELYVKKEQELSQAARFSREIALKQNRITSLENERVLNESRYKLAFE
NQELIQKNNRTQKWIIGSLILIAILLLLTAYYQYKNVKQQKYANNLLALKSLRTQMNPHF
IFNALNSVNSFIANNDERTANKYLSDFSQLMRSVLENSEEDFIPLANEIELLQMYTELEH
FRFKDKFDYKFSVDENIKMNEFVIPPMLLQPYVENAVWHGLRYKGEKGTLDIKFENISEE
TVRIVIEDNGIGRKKSKEFKTEHQKKQKSKGMGNIQKRISILNEMYKDKVDVEIENVFDN
EEGTRVILMLKKD
>OMIFANIC_01860 Transcriptional regulatory protein YehT
MELLAIIVEDEETSREILKNYIAKYCPNVRLLGEAANVEEALVLIRNNELDLVFLDVEMP
YGNAFDLLDKVGDRQFETVFVTAYNHYAIDALNAHASYYLLKPISIDKLIEAVDYVAEIK
EKENSLQNAVLQPKHQHVEGKITIPQQNGFEVLEISDILYCQADDNYTRIFLKEGKKLVS
KTLKYFEESLSGSGFARVHKSYLVNVNAVVEYRKGKGGSVVLSSGKQIMVSPAKKKALLA
YFS
>OMIFANIC_01861 Glutamate racemase
MKANNPIGIFDSGVGGTSIWKEIHQLLPNESTIYLADSHHAPYGIRTPAEIVDLSIKNTD
RLLEFGAKLVVVACNTATTNAISLLRKKYDIPFVGIEPAIKPAALHSKTGKIGILATRGT
LSSALFSQTSEEFTKDISVVEVVGEGLVPLIENGEFDNPLMEELLRKYTEPMIEANVDYL
VLGCSHYPYLIPKLTEILPKQVKIIDSGIAVARQTKFLLEKHNLIRTDISKPSLEFFSNA
DTATLEFLLADYDDIVIQYRDF
>OMIFANIC_01862 hypothetical protein
MKKFKLLFVAIVMFLGATSMTYAQSKIAHIDTSELVQAMPAMKQAQSQLEKLQKTYDTEL
RAMAKELDAKRTQYGAEAETKTDEENRKRVEEVQGMQNNITAYQQQALQDLQTKERDILQ
PILDSAKAAIQKVARAKGYQYVIDSTEGSGLLLAEGYDLLADVKKELGI
>OMIFANIC_01863 hypothetical protein
MKAKQILLFALAVFCFSFVANAQRGVRIGYIDMEYILENVPEYRESETQLEGKVQRWKAD
IEKKQLAIDQMKLNLANERVLLTKELIEEREEEIQILEEEMLKYQQDRFGPNGDLMIQRR
QLVQPIQDQVFNIVQEIAVNKKYDFIFDKSADIVMLFAAERNDISDQVVRTINRAAKREE
ALSKREKKEIEKREELSVEEEGAISEREQAIEDKKNERARIMEERRRVRDSVRDASRREF
EARRQRLLEERQARRDSILRARSGGGDPPPDGGDGDGDEGNGDGGL
>OMIFANIC_01864 Outer membrane protein assembly factor BamA
MEKRVSNFKTSLLSHTSKTLYCIFLFTILSVFSVSAQDNELDKNKRYTINSISVTGEQTF
NEQTVIAFTGLKKGDRIYVPGEKLSDVTKKLWEQNLFSDIAFYVTNIDGDLIDLELYIVE
LPKMYDVTIEGIRKGKKKDIIKDNGLKRGVKITKNLTTTTKNYITNKFRKEGFFNTKVII
STRPRLDSTGKEIAKDMFINIDKGERVKVTDINIEGNKELSDKKVRSAMKKTKRKNPLRF
YKRSKYTEEGFAEDKANIVKKYKTNGFRDARIISDTLLVKDEKNISLNISVEEGRKYYFG
SIDFIGNSKYTDRQLRQILGINKGEVYNGTLLQERIADDSDPDAADLTNLYQNNGFLAVQ
INPVEVAVRNDTIDFEIRIIERNEFYFDHITVVGNDKTNDHVIYRELRTKPGQKYSKRNV
IRTLRELGQLGYFDAEQLTPNFKKVDEANGLVDLEYSVIEKGASQIELQGGYGGGGFVGT
LGLSFNNFSLKNIFNKDAYRPLPMGDGQKLSLRAQASSFYQTYSLSLVEPWLGGKKPIQF
STSFSHTVQYLYDFISRDVDRSRRFLITGGSIGIAKRLKWPDDYFQFSQAVSFQHFNLKN
YNTGLFTFGDGFANNLAYTVGLSRNNTAINPIYPISGSEFSLTAKLSPPYSLFGSTDFTA
LAEERSLLDPTTVDGNERIAEIDQERFKWLEYYKVKFKGTWYTSLYKNLVLRTNAEFGFL
GAYNQDRGVPPFERFFLGGDGLGAFSLDGREVIQLRGYPNQSLSNNDGNTIYNKFSLELR
YPITLKQLASIYVLTFVEGGGAYNGFRDYNPFSLNRSAGAGIRIFMPAFGLLGIDFGYGF
DPILNGTEKNGWETHFIIGQQF
>OMIFANIC_01865 Isoprenyl transferase
MVENHAIAIFKMSLLNKIDLDRLPQHLAVIMDGNGRWAKQKGLFRSIGHEKGTKAVREIV
EACAEINIPYLTLYAFSTENWSRPKMEVELLMKLLVNSLKKEIKTLQDNDIRLNAIGNLD
ALPKKARTELTDVIEKTKHNSRMTLTLALSYGSREEITKTIKEISLKVKNNLISPSAIDE
SYINNHLYTRNLPDVDLLIRTSGEQRISNFLLWQIAYAELYFTKTLWPDYTKDHLFEAII
NYQNRERRFGKTSEQLQN
>OMIFANIC_01866 hypothetical protein
MRYFAVILVVVLSTFSAHSQTYEVGGLIGGTNFIGDVGRTNYIAPNNFAFGGIFKWNRSA
RHSFRGSIMIARISGDDADSNEERRKQRGYSFDNTVSEISIGLEYTFVEFNVHSGKPVST
PYLYTGLTYFWYEALYKVGDVIRDYDGASAPAIPMVIGYKATVGTKMVLAFEIGARYAFT
DDLDGSNPVKGLEDDDQFKFGNTNSDDWYVFTGVTLTFSFGRKPCYCNF
>OMIFANIC_01867 NAD kinase
MKVGIYGQFYHKYSEQSIQLILNALKKTGIEVAVEKNFLKLIKHHEEIDTNVATFSSFTE
VDHSYDLFFSIGGDGTLLKSITFVRDLGIPIVGINTGTLGFLATIQKEKITESINQIIAG
NFKITERSLLAIETEPGYDEIGELNFALNEIAINRKNTTSMIKVETFVDEEHLASYWSDG
LIVSTPTGSTGYSLSCGGPIMDPGSKSIVLTPIAPHNLNARPFVIPDDSEITLKVSGRAK
SYLISLDSRTATLKDNTVIRIRKAPFSIKLAQLKEDSFIKTLREKLLWGEDKRN
>OMIFANIC_01868 hypothetical protein
MNTTQYIINDISPFDIETAIKEVQVAFNQLTYSHIPVSKEGRYVGCISETDAHCFESEQA
INGVEFALEPFFVTDLTNWLDILEAFAMHGSNIMPVLNSENQYMGYYELSDIMNIFNDTP
FLNEAGGIIVVEKGARDYSFSEICQIVESNDARILGAFISKIENETVQATIKIGHTGMNA
IVQTFRRYGYNVVSKHEEDKFLEDLKERSDYLDKYLNM
>OMIFANIC_01869 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNARGGNLPDVVQVAKDVQKFGAQGVTIHPRPDERHIRYQDAYDLK
PAVYTEFNIEGNPIDRFMELVLEIQPAQATLVPDTVDAITSNAGWDTVAHKGYLKEIISE
LKNKGIRTSIFVDPDPAMIEGAAETGTDRIELYTEEFAHQYGLGNEDAIQPYTECAELAH
KLGLGVNAGHDLSLENIRFFKENVPHLLEVSIGHALICESIYQGLENVVKAYLQKLQ
>OMIFANIC_01870 Esterase YbfF
MILHSQIFGEGKPFIILHGLLGMSDNWRTLGRRFSELGYEMHLVDQRNHGRSFHSHEFSY
DLMAADLKSYFDHHQIENCVLMGHSMGGKTAMRFATLYPEMVSKLFVADIGPKEYPHHHQ
DIFKALLSLNFDEISSRGEAEEVLSEYIHETGIRLFLMKNLYWKEKGVMASRANVEVLND
QIEEVGKALAKDARFEGETLFLGGANSGYIEPMDELLIKKHFPNATVDMVSNAGHWLHSE
NPSEYFEKVSRFLAK
>OMIFANIC_01871 hypothetical protein
MKTILRVLLTALAVVILAKVLPGVAVDGYGSAIIVAIVVALLRFIVKPVLVILTLPITII
TLGLFLLIINAIIIMMADYFIPGFAVDSIWWALLFSLLLSILQSIFHSVLDKKKE
>OMIFANIC_01872 Trigger factor
MNITKKEIDSLNAVVTVEISKDDYSEKVDTILNDYRKNANIPGFRKGHVPMGMVKKQYGK
AVLVDEVNKILQSELHKFLSEEKLDVLGNPLPKNEEDIDWEAGDLSFEFDLGLAPEFEVN
LKGKAVTSYKIVADEEMINNQVKTIRKQYGKLISKDTVEKGDEVTGTFTSEEKEIENKTT
FETDVLKGKKQISAIVGAKVGDKINLKTKGLFKDDHDNQRFLGVEHDDAHGLNIEVTLTI
EEVNKREMADLNQELFDKLFGEGVVTSEEQLKEKIKEDAERQFEQQSDQKLLNDVVESLI
ENTKFDLPSEFLQRWIQKSGEEALTEEAAKEEFERSEKGLRYQLIEGRLRAEHNLQVTFD
ELKEYSRNMICMQMAQFGNMNPTDEELDGITSRIMSNEEEVRRLSEQLNTNKMLQFYKEN
AKLKTKEVTYDKFIKEAYA
>OMIFANIC_01873 ATP-dependent Clp protease proteolytic subunit
MNYTKEFKDFAIKDQGISSTYYDTIVSSMYPVGLTPNIIEERQMNAVAMDVFSRLMMDRI
IFLGTGINDQVANIVQAQLLFLESTDASKDIQIYINSPGGSVYAGLGIYDTMQFIKPDVA
TICTGMAASMAAVLLCAGQKGKRSGLTHSRVMIHQPMGGAQGQASDIEITAREILTLKDE
LYKIIANHSGQTFEQVFEDSDRDYWMKAEKAKDYGMIDEILTRT
>OMIFANIC_01874 ATP-dependent Clp protease ATP-binding subunit ClpX
MSKEELECSFCGRKKAETNLLIAGLDAHICDRCIEQAHGIVIEEALHSTNSELSKELMLK
KPKSIKGFLDDYVIGQEHTKKVMSVAVYNHYKRLLQPKSDEEIEIQKSNIIIVGQTGTGK
TLVAKTIARMLNVPLAIVDATVLTEAGYVGEDVESILTRLLQAADYNVEKAQNGIVFIDE
IDKIARKSDNPSITRDVSGEGVQQALLKLLEGTTVNVPPKGGRKHPDQKFIEVNTENILF
IAGGAFDGIERHISKRLNMQAVGFSASKKEETLERDNMLKYIIPRDLKDYGLIPEIIGRL
PVLTFMNPLDKGTLRAILTEPKNAIIKQYKKLFEMDNIDFVITEEALDFIVEQAIEYKLG
ARGLRSLCEAVLTDAMYDLPGSDEKDLNVTVEYAQEKLNKSTIKKLKAVS
>OMIFANIC_01875 hypothetical protein
MKRLIYIVTIVFFSASLASCGTTVSTIQKEEKVAGYTLKNKKELMQQKILNQKKKTVIAQ
P
>OMIFANIC_01876 hypothetical protein
MPIPIVNSIASWFLKKRFHQIELFLKYPVEVQEELLQNLLQKAKQTEIGQEYDFSSITTY
REFADRLPISSYEDNEARIERARRGESNIFWPKTIKWFAKSSGTTNAKSKFIPVSQESLE
DCHYAASKDLLCMYLNNNQESQLFVGKGLRLGGSKELYEENGTVFGDLSAILIDNMPFWA
EFSSTPSSEISLMADWEIKMQAIVNETIKENVTSLAGVPSWMLVLLNNVMDTTGANDLFE
IWPNLEVYFHGGVSFEPYVDQYKKLLPREGFKYYEIYNASEGFFAIQDQNHSNELLLMLD
YGIFYEFIPMSTYGTPDQKIVPLSEVEKDENYAIVITTNAGLWRYKIGDTVRFTSVNPYR
IRVTGRTKHHINVFGEELIIENAEAALRKVSKLTDTEIVDYTVAPIFMEGKEKGAHEWII
EFKTPPKDFTNFSQLLDKSLQEVNSDYEAKRFNNTTLNAPKIHCARTRLFYDWLKLNDKL
GGQHKVPRLSNSREYLEELLTLNC
>OMIFANIC_01877 hypothetical protein
MKYAGVLTKMQTEIGSPIQYFLVFENDFLNINQLLDKLVSISFIKYQCLNCGLDKKIFRM
GYCYDCFYDVPQAADWVIRPELSKAHLNQEDRDLEYEKKVQLQPHIVYLANSSSVKVGVT
RKSQVPTRWIDQGAHEAIEIVEVPNRYLAGITEVALKDHVSDKTNWRAMLKNDIKDEDLV
DWRSRLESHIPEETKEYFIANNSETNLEFPVLQYPVKPKSLNLDKTPDYSGVLKGIKGQY
LIFEDNTVFNVRSNEGYVVEISMK
>OMIFANIC_01878 hypothetical protein
MKKFLKIIGVLLGLFIIVLIAAPFLFKGTLEDLLKKNLNDNLNAEVAWESMDLSLFSSFP
DAAVKIKNFSVVNNAPFEGDTLASGERLTIDMGITQLFKSGNDPIKINALSLDQALVNIK
VDSLGRANYDIAIEKDTPEENTSEFEDEGFTFELNGYEINNSTINYLDEVSKTFLMLSEM
NHSGKGDFSLDLSELDTETDAVLSLQIGDVKYLTNNLVSLDALIQMDLVNQKYTFLENEA
RINELLLTFDGFVKVNENDSELDLMFKTPSSDFRNFLAVIPKQYVKNLDGVSTTGDFSVN
GMLKGVVDDNLIPKMDIAVKSSNASFKYPDLPKAVRNISIDARLKNETGLVEDTYLNIGG
LTFKIDKEIFSANGSIRNITKNAIVNMVLKGTLNLANIEQVLPLELEQGLSGVFKADVTT
NFDMSSIENEQYQNIRTNGTASLSNFTYKDPDFKNELKIETVSMDLSPGNIKLKELKGST
GETDVAATGTIQNLVPWIMAKQDLKGRFDVQSNTFNLNDFKSADTEVAGGSGASSGTTVS
DDQIKIPDFLDATLDFTANKVIYDDITLTNTKGTVSIREETANLNNVTSDLFGGNAALSG
NVSTKEKIPTFAMDLDLSKINISESFQSLALLKYLAPVAKALDGDLNTKIQLNGFLDKNL
SPDLKSLAGNAAARILTAEVTAARTPILAKIGQQAPFLQLDKLSLKDVSTAFTFNNGKIE
VQPFSFDVEGVNVTASGSHGLDKSMNYSLDMDVPAKYLGTDVTNLLSKLDPLEANSMRVN
VPMGVSGSVTDPKISINMGSAVNSITQKLIEKQKQELTEKGTDILKDLIGGNETTGKDPK
NDNTGTKTDPVNTDPEKIVKGILGDLLKGNKKKDSVKN
>OMIFANIC_01879 hypothetical protein
MFVTHLTLKDRLLAQRIYLILGALFIASLVVSNLIFQKFISFDLFGIYTFEISVGVLPYP
ITFLITDIICEVYGQKKANQVVTAGIFASFFSMGIIYVSSAIPATTWSPVSDALFETVFG
ATAIAVLASMMAYLLAQYIDISIFHFWKRLTKGKHLWLRNNFSTFLSQFVDTFTVLILLC
TFGKIEWKLFGGLLLSGFLFKVIVAATDTPFLYAAVYGMRKRFGLKFGEELDLNNVNVLK
>OMIFANIC_01880 Deoxyguanosine kinase
MNKPLQHAYLSLGSNMGNKFEHLQKAVNCIFEEVGALEKISSVYRTPAMGFEGEDFLNCV
LWVKTGLTPNKILEAVLSIEKSMGRERTTSKSYRSRPIDIDILFVDDIQKKTKKLTLPHP
ELENRRFVLQPMAEVNPQFEHPASRKNMIRLLADTMDESAIEKQSKWLRNPRKDYDLAQY
NYIAVEGNIGAGKTSLASKLAGDFNAKLILERFKDNPFLPKFYEDQVRYAFPLEMSFLAD
RYQQLLEDITQFDLFKDCVIADYDVYKSLIFAKVTLAEEEFNVYKKLFHIMHKELPKPDI
YVYLYQKTDRLIENIKKRGRSYEKNIKEEYLQKIHDGYFEFIKTQHMSNIRIVDITDKDF
VNNRKDYLSILKEMLH
>OMIFANIC_01881 Putative TrmH family tRNA/rRNA methyltransferase
MKHRKLKNSELDRLSASQFKEVDKTPVIIILDNVRSLNNIGSVFRTADAFLVQKIFLCGI
TATPPHKDIQKTALGATESVDWEYAENTLDVVKTLQLQGVKVLAIEQAEEAVLLSDLSPD
DHLTYAVVFGNEVKGVQQEVVSASDSVIEIPQFGTKHSLNISVSAGVVIWDLFSKLKSKA
>OMIFANIC_01882 DNA mismatch repair protein MutS
MAKKVTPLMGQYNSIKAKYPDALLLFRVGDFYETFGEDAVKAAGILNITLTARNNGGDMT
ELAGFPHHSLNTYLPKLVMAGCRVAICDQLEDPKQTKKIVKRGVTELVTPGVALNDDILQ
SKANNFLAAVHFGQEEIGVSFLDVSTGEFLTSEGSVEYVDKLLQNFKPSEILFSKQKRKQ
FSDLFGDNFHTFYLEDWVFQKDYASETLQKQFETANLKGFGVEDLEYGIIAAGAALHYLG
ETRHDKLGHITRISRIAEDTYVWMDKFTIRNLELYHSHQENAVTLLDVIDKTISPMGGRL
MKRWLALPLKNQEQIVQRHEVVSYLLDNPEILEKIQLNTKRIGDLERLISKTATGKINPR
EVIQLKNSLEAVVPIKAQAEHSENGSLKHIGEQLNDCEELREKIKTMLNEDAPVNILKGR
AIADGVSEELDELRAIASGGKEYLDAMLERESERTGITSLKIASNNVFGYYIEVRNTHKD
KVPEEWVRKQTLVSAERYITEELKEYESKILGAEEKILILEQQLFLNLLEWMQQFIGVIQ
HTAGLIARLDCLSSFATQAKLHSYTRPLLDDSFDLDIKEGRHPVIEQQLPPDSPFIANDV
FLDRDNQQIIMITGPNMSGKSAILRQTALIVLLAQMGSFVPAGAVRMGCVDKIFTRVGAS
DNISMGESTFMVEMNETASILNNISERSLVLLDEIGRGTSTYDGISIAWAISEYLHEHPS
RAKTLFATHYHELNEMTETFERIKNYNVSVKEMKENVLFLRKLVPGGSHHSFGIHVAKMA
GMPQQVLHRANRIMKRLEKSHASEELSDEIRKVSKEDMQLSFFKLDDPLLEELRDEILDI
DIDTLTPVEALMKLNEIKRMLQRNASMKSKK
>OMIFANIC_01883 hypothetical protein
MQSDGQTINRTIASNISNNGSYLWNGFATDIGNYLIKISGTDDATPTLITGQTGVFTLKD
CEKPDLQVGVIKLLPQNPGERQNVKFEGYVMNYGENPVENPVVMLKIKRSTGTTIRTFTE
ELDITLLKNQGILYVKEFRAPRHGSYTATFILDAVNGVDEMNENNNEKNKTFIVRPLADL
IVCISNAKRPPVGRSREIRMVVKNIGNFRTSINPVSGIKLRSYVEAKGVKMHDIPPLEPG
ESFTIKRNHKWGLAGTKTLTAKIIYPGDETNSRNNEVQSSFFVRLPHHDTYSAAYKVKCS
TGQDVYNWDDIEN
>OMIFANIC_01884 hypothetical protein
MRNLIILSTVVSMAIACKMDSSESSTGDITVVPIDNPIEGNSSLPRLYSSGEEVYLSLVT
RTDSMNILRFVTYKDSKWNAIQGVAKGSDWFVNWADFPVISKNEDRLVLTYLQKSDTATY
AYDIKVIHRMPVDRENIAFGPAGFLEEKIFTLHDDSTKTEHGFASIVPYAEKSFFVTWLD
GRNTAGSNQDDHSDHGSGAMTIRGAVIDSIGEITREVELDARVCDCCQTSATITDNGPLV
AYRDRTEEEIRDISVVRQVNGEWLEPQTIGHDNWNIAGCPVNGPSVDANKNTVGLAWFTA
TKGEGEVNVSFSVDNGATFQSPIRLDSGNATGRVDIVMLSATEAAVLWIEPDGKDEVIQL
VKITSAGNKGAVVTVAKTSAERSSGFPQLEKFGDRLMMAWTEVSGETSAIKTATLSLDKL
>OMIFANIC_01885 Ribosomal protein S12 methylthiotransferase RimO
MRTKSVKKNKINVVTLGCSKNVYDSEVLMGQLKANNKDVVHEEEGNIVVINTCGFIANAK
EESVNTILEYVQKKEEGEVDKVFVTGCLSERYKPDLQKEIPNVDQYFGTTELPGLLKALE
ADYKHELIGERLTTTPRNYAYLKIAEGCDRPCSFCAIPIMRGKHRSTPIEDLVTEAEKLA
AKGVKELILIAQDLTYYGLDIYKKRELATLLKELVKVDGIEWIRLHYAFPTGFPMEVLEV
MKKQPKICNYIDIPLQHISDPILKSMRRGTTKAKTTRLLEDFRAAVPEMAIRTTLIVGYP
GETVEDYQTLKQWVKDMRFERMGCFTYSHEENTHAYNLEDDVPEEVKMQRANEIMEIQSQ
ISWELNQAKIGQTFRVLIDRKEGSYYVGRTEYDSPDVDNEVLINAEDGYLRTGEFFNVKI
NAAEDFDLYGNVIN
>OMIFANIC_01886 Signal recognition particle receptor FtsY
MSLFKKIFTKDKKETLDKGLEKSKASFFDKLSKAVAGKSKVDDDVLDDLEEVLVSSDVGV
DTTLKIIERIEERVSRDKYLGTDELNQILREEIAGLLSETNSGDATEFEIPEIDHPYVIM
VVGVNGVGKTTTIGKLAYQFKKAGKKVVLGAADTFRAAAIDQLQVWADRTEVPLVKQNMG
SDPASVAFDTLESAVTQNADVVIIDTAGRLHNKVNLMNELTKVKRVMQKVIPDAPHDVLL
VLDGSTGQNAFEQAKQFTAATEVSSLAVTKLDGTAKGGVVIGISDQFQVPVKYIGVGEGI
EDLQVFNKFEFVDSFFK
>OMIFANIC_01887 hypothetical protein
MAKKSVASLQTGSKRLTKAIKMVKSPKTGAYMFVESIMAPEHVNEWLNKK
>OMIFANIC_01888 50S ribosomal protein L33
MARKGNRVQVILECTEHKESGKPGTSRYITTKNKKNTPDRMELKKFNPILKKMTVHKEIK
>OMIFANIC_01889 50S ribosomal protein L28
MSRVCELTGKRAMVGNNVSHAMNKTKRKFNVNLVKKRFYIPEEDKWITLKVSTAALKNIN
KKGISAVIKEAREKGFLKK
>OMIFANIC_01890 Nicotinamide-nucleotide amidohydrolase PncC
MLAEIITIGDEILIGQIVDTNSAFISKELNKIGVQVYQITSIQDDREHILQALKDAKEHA
DLVLVTGGLGPTKDDITKHTFCEFLGDSLIEDPGTLQNIKDIFGKYLQRDPLPANLEQAM
VPSSAIILRNAHGTAPGMWMEKDETVYVSMPGVPYEMKYLLTNKVLPRVISEFNRPHIYH
KTLLTYGMGESNIAERIEQFENKLPDDIKLAYLPSLGRVRLRLSAKGTNQLEMEDRVNEQ
MYALNEILSDIAVGYEDETTIQERISAILEREGYSLSVAESCTGGAIAREITTIPGASLY
FKGSIIPYETQQKVNILGVPAELIEKHSVVSAEVAAAMADRCRSLFNSDIALSTTGIAGP
TRGDGQAEVGTVYIGIATPKGNVVEEFNFGKPRERVITKTTNKAFELLLKEISKI
>OMIFANIC_01891 hypothetical protein
MIKHYSIESLREVAGGDPDFMAVVAQTFLDEIPPDLQAMEDAIKNDNKELAYQFAHKMKP
NLEMFGIEVLKDITTIESWTKTSKNKASVDENVRNVTSTLHAVFKELKADFDLG
>OMIFANIC_01892 Fumarylpyruvate hydrolase
MKIICIGRNYAAHINELENERPKDPVVFLKPDTAILLKKQPFFIPEFSDNVHHEVEILVK
INRIGKHIDHKFAHKYYDEIGLGIDFTARDLQSQLKEKGLPWEKAKAFDGSAVIGNFLPK
NKFESVDNINFTLEKNGITVQKGNTALMLWKIDELIEYISKYFTLKIGDIIFTGTPAGVA
KVAPEDKLTGYIEKTEIFSIKVK
>OMIFANIC_01893 putative ATP-dependent helicase DinG 
MELKLSKPICFFDLETTGTNVATDRIVEISVLKVHPNGNKESFTWRVNPEMPIPAGAAAI
HGITDEMVANEPTFKELAPKVHALMKDADLGGYNSNRFDIPLLAEELLRADVDFDLKKAA
SVDVQTIFHKKEKRTLEAAYKFYCDKTLENAHSAEADTIATYEVLKSQLERYQDLENDVT
FLSKYSSHKNFADFAGYIGFDKEGTEVFAFGKHRGKKVEEVMEKEPGYFGWLLNADFPLY
TKKVLTRIKLSKLNNKF
>OMIFANIC_01894 hypothetical protein
MVCDAKVVITTFVKTDMLRNFIFLFLILTSAQSMSQGLKVLIKEQKSGKRLVLVAENKTQ
DTLNVFLMVNAEGYRRSASKPVIKNIPPLSEIPMITLIEIDEVASRYTFDLVVNEKSSPL
SFSYEEPERDIQRVLQGKLVVFSAEGCGKCDLLSEKLEELRIQHRVFNIKDDEVLYGQFM
SFIERKLTSETKIRFPVVWNRDDVIFGFDDLDSIISRLDH
>OMIFANIC_01895 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MGKFELKLPKMGESVAEATVTNWLKDIGDNIEADEAVLEIATDKVDSEVPSEVDGVLVEK
LFEADDVVQVGQTIAIIEIDGEAGSNGSGDVSAEIPLEVEASAENPRKEVIAQVESRVAE
ARESIESPIENNGDRFYSPLVKNIASEEGISQNELDAVPGTGKDGRVTKNDILAYLKSRT
LETKVSPGVVQGTQVKQETQPTSKPVTPVSVNGEDEIIEMTRMGKLIAHHMVESTQTSAH
VQSFVECDVTNIWNWRNKLKNDFQNREGEKLTFTPIFMEAVAKALRDYPMMNISVDGDKI
IKRKNINLGMAAALADGNLIVPVIKNADQLNLVGMTKAVNDLANRARNSQLKPDEIQGGT
YTVTNVGNFGSIMGTPIINQPQVGILALGAIRKVPAVIETSEGDFIGIRYKMFLSHSYDH
RVVNGALGGQFVKAVADYLEAWDMNREI
>OMIFANIC_01896 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKLSVIILNYNVRYFLEQAVRSVQQAISSIEAEIIVIDNNSSDNSCEMMKELFPNIRLIE
NSENVGFSKANNQAVAEASGEYVCILNPDTAVPHSIFSNCFQYISEYENLGILGVRLIDG
TGNFLPESKRNIPTPKSALTKLLGRGEKSNGYYANNLGDTETGEVPILPGAFMMVKRSIF
NEAGGFDEDYFMYGEDIDFSYKVLQAGYKNHYLGTDGILHYKGESPQNDSAYLDRFYGAM
HIFYRKHFNSNFLVNIMAHTGLSLGKFFRKISLARAKVATSSPSEAFVITDNLNLLKSLS
ETLSFPLKSASKVILNDNDFKDTLFIFDEDYMSYSQIFLVMDRLKNRGNQFRIRPAGCNF
MLGSDKSDEKGTVVVF
>OMIFANIC_01897 Recombination protein RecR
MDFSSKLLENAVNEMSQLPGIGRRTALRLVLHLLKQPQSQTNDLAGALEKMRSEINFCSS
CHNISDLALCEICSNPNRNERLICVVEDIRDVMAIENTSQYRGHYHVLGGKISPMDGVGP
GDLNIPTLVEKVRSGKVDELIFALSSTMEGDTTNFYIYRQIEPFEVLSTTIARGIAVGDE
LEYADEVTLGRSILNRIPFETSLKS
>OMIFANIC_01898 Dispase autolysis-inducing protein
MKKNYAFIILLSILACNISVSQEYLQMIDAGTYPVQDVIDSAEAYFEGRDKGRGSGYKQF
KRWEYNALRMMKEDGYLPTISEELAEFERYNAYLNETASSRQPMNDNWEELGPLDWNTTT
SWNPGVGRITGISIDESNSDHIIIGANTGGVWKTLDGGQNWTPLSDFFSNMSVYAVTIDQ
ADPDIYYFGSSSGLIFKSTDAGATWNVLADISNSLINKIVIHPTNSQIIFACSQNAGIFR
STDGGATWSNTGIDSNAYDVEFKPGDPSVVYASGVGFHKSTDDGATFSQIAGFSSGAKMI
GVSPDDAEVVYVVEADSGTFGGFYVSSDSGDSFTELNHAGVNYFGYSTTGNDNNGQAPRD
MDIVVNPNNVDEVHIAGILTWRSLDGGVSFTCTSDWVIDGAIGADIGYCHADVDIMLFHG
SSLYVGSDGGIFRADDTTNLTANYYTDLTTGIGIRQWYKIGTSQTPDVVVTGGSQDNGSS
FYTAANGWIDWIGADGMEGFVDKDNSDIMYGMIQFGRMYRTENAAGSLINISEPGSGSGE
WVTPFEQDPTLSNTIYVGYNRVYRSNNKGSSWVPISQSFADDLDQMKIAPSNNQVMYASN
ATQLFRTEDGGATNWVQVQSPGGLINSIAIHPQDPYKIAVATGSFNKVLVSNDGGDSWET
YRLNLPEFAARAVVWQDNNGGALYVGMNYGIYYIDDTLTEWQPYSTNLPNVIINELEINY
ADGKIYAGTYGRGLWASPVADDIVLGNNDLVTSETLFVFPNPAGNELRISAGTQINASVR
IFDVTGKLVRYLTEVENKEAIDISGLQPGVYFARIQTDQGSATKKFIKK
>OMIFANIC_01899 Sodium/glucose cotransporter
MEPLHIIYLIVAYFGVLIMVSVFTNKGGSNADFFKAGKRSPWYLVAFGMIGASLSGVTFV
SVPGWVEASKFSYFQVVLGYTVGYAVIGLVLLPLYYRLNLTSIYTYLDGRFGNHSYKTGA
SFFLLSRVVGASFRLYLVAIVLQEIVFNKIRFFGHEGVPFWVTVTITILLIWLYTFKSGI
KTIVWTDTLQTLFMLIAVGVAIYYVSTDLGLDSGTIFSFIAESDMSQIFFFDDWKSGDHF
VKQFLSGAFIAIVMTGLDQDMMQKNLTCRSLKDAQKNMFWFTIVLTIVNFIFLALGLLLT
VFAKENGIDAVRDQLFPTIAMESELGIGIAVFFMLGLIAAAYSSADSALTSLTTSFSIDI
MEIEKKYDAAKQVIVRKRIHVLASLVLIVVIIIFKYLIADATVIAKLFTFAGYTYGPLLG
LYAFGLFTKWKVKDSWVPLVAILTPFVGYLISYLSALWFNFEFQFFILILNGALTFFGLV
LIRRQ
>OMIFANIC_01900 hypothetical protein
MDKTLIIGATTNEDRYSNLVIHRLRAKGYSVQAIGKKSGSVAGVKILNEKVPMNNVHTVS
LYLNAQRQPEYYDYIISLKPKRVIFNPGTENPEFSNLLLENGIEVDVACSMVLLASNQY
>OMIFANIC_01901 hypothetical protein
MKQLFVAVVLLFGVTSYAGIDPDSEIKGKISGRVIDKDLQQPIPYATIVVKTMSGEIITG
GVTDDLGNFKIEDLPEGNSIVNVQFIGYRTFTTEIEVSRRNRNIDLGEIFLEEDVSALDE
VTVVAERSTIQQKLDRKVITIGKDLQTAGPTASDIMNNLPSVNVDQQTGALSLRGNQNVR
VMVDGKLTNVPVAQLLKQIPSTSIKQIELITNPSAKYNPEGMSGIINIVLHKNLNIGFNG
NASVGLTYEEQAKFNSSIDMNYRNGKINLFGNWGHNSSKNENFGNIFRPDDNSEQLFEFL
DDSRSNLVKVGIDFYLNDKNTLSFFTNQNFFDGGTGGLTDIVYYSNSELNQTQDFLQERD
NLSSQYNFNYKLDFDKEGHNIELEADFNTFTGEEDALFQFTGASIIDDYMDFVDTDRERL
TVNLDYVNPLNETTKLEIGGEARLFETNLEYMSTGQTFNSEGELIPTPDTNFDYKRDIYS
AYVTYGKSFDKWSVQLGARFETVDVKADTNTVRSFTNDYMQVYPSAFVTYTPSEANQFQV
SYSRRVDRPGLSQVNPIREWSTPLISSFGNTSLEPQFTNSIEANYTKNLKKGSITGGVFY
RAIEDEINRAVFVDRTDLSKVILTFDNFDNTSAYGIELSSNYRPTNWWNFNFSFDLYTQT
QKGITESLNNPGNDPGIEDIVQEVVEVDNTAWNLRMFNNFKATKNLTFSAFGFYRGQNRG
LQFEVEPMYFVNIGARYNLWEGRGTFSVNYNDIFDTMRFRFDGQRPYAQMGEFNWESNTI
FVGLSYRFGGGKYRAKSRKRRDNDEKSGSGGIF
>OMIFANIC_01902 hypothetical protein
MKKITFLFLMASAMVFAQQPQSFVEQGTQQTISNSNQEAVITSANDRQPLVDTYTTLSDF
NDGVTANCSDPTLTSEDFSSAPAGINTCGPVISSAGDGCFGAGDLEDGFSVEASNGTDIV
AISSGQIGNTDALVGANTFAEFTIINFSPEVYAVAMDIWNNSENTTDVRIYGTGGTLIET
LVLNTPSGTQTFAGFIADEPIERVELEGLAGSGELFGNFLFGADCMVLGVNDNALSQVAV
YPNPASDILNIETPGNIEIVSAYVYDVTGKRMTAPVVNNQLNIADLSNGVYLIQINTNEG
NITRKIVKR
>OMIFANIC_01903 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYTSKISGLGSYVPENVVTNDDLSKLMETNDDWIQERTGIKERRHIVKGDGNTTSVMAVK
ASEIALERAGLTPKDIEMIVFATLSPDMYFPGGGVEVQELMGMDTVPALDVRNQCSGFVY
ALSVADQYIKTGMYKNILVVGSEHHSGGLDFTTRGRNVSVIFGDGAGAAVVTRNEKDEGG
ILSTHLHSEGKHKDELALQGPSTSYWVPEILEKNPQEDIPYYPYMNGQFVFKHAIVRFSE
VIKEGLEANKLSVSDIDMLIPHQANLRISQFIQRKLRLTDDQVFNNIQKYGNTTAASIPI
ALTEAWEQGKIKEGDLIVLAAFGSGFTWGSAIIRW
>OMIFANIC_01904 Dipeptidyl-peptidase 5
MKKIVSLLFAFLIATGTVFAQEKLTYQKPPKQILDLVDAPLAPSVLIDSKGENVILLYRD
AYKSIAELSEPEMRLAGLRINPKTNIGSRTNYYNNIKVKKASDKSTKQVMGLPDKPRLSN
FSISPNEKMVACLNTTSEGAEVWVVDIEKAMAKKLTGPQVNANLRDAINWFSDNNAMLVK
MLPANRKGLINTAEAIPEGPTISTSDGQKAQNRTYQDLLKNPNDEANFEQLAIAEIKKVS
IGGSVMDFLPAGMYRNISFSPDGNYLLVSKIEKPFSYIVPYSRFPYKEIIYDKSGKQLTV
FNDVPLNEVQPKGFMATRKGKRRTSWRSDKPATLYWAEALDEGDPEKEVDFRDAVYSLDA
PFNGKSKVLMKTVQRYSGITWGNDNTAIAYDYWWNTRNTKTYLFNPSESSVTPKVISDRN
YQDRYSDPGDFVTKQNKYGRYVLEMDNNTAYLMGDGYSKDGQFPFIDAYNLKTQETSRIY
KSSYTDKLEDLNSAIDMKEGKILVRIESKNEYPNYYLRNIKKKKNALTPVTSFENPFKSL
ANVHKEVISYKRDDGLELEGTLYLPVGYDKNAKEKMPMILWAYPREYKDKNSASQSTSNP
NEFIYPYWGSPIYWVTQGYVVLDDAAFPIVGEGDEEPNDSFRTQLVANGKAAIDAVDELG
YIDRTRVAVGGHSYGAFMVANLLSHSDLFAAGIARSGAYNRTLTPFGFQSEQRSYWDSPE
TYYTMSPFMHADKMKTPLLLVHGEADNNSGTYPLQSERYFNALKGLGAPARLVMLPRESH
GYRAKESILHLLWEQDVWLDEHVKNKKTIVTPNTLKR
>OMIFANIC_01905 putative protein kinase UbiB
MNTIDSIPTGKISRATKLVRTGVKVGGNYLKYYGEKLVNPEVTKEKLNESNAEDIYDGLK
SLKGSALKVAQMLSMEKNIMPRAYVEKFSLAQFSVPPLSAPLVNKTFKRYFGISPYDLYE
SFEADSIAAASIGQVHKATKDGKELAVKIQYPGVADSISSDLALVKPVAIKMFNLKGKDS
EKYFKEIEGKLLEETNYELELTQSRMITGACSKIDNLTFPKYYEELSNDRIITMDWMDGD
HLSEFVSYNTDKEKSNKIGQALWDFYMFQMHELKQVHADPHPGNFLISEDGQLIAIDFGC
VKKVPQEFYIPYFELADPKNINDPKIFREKLFELEILREDDSEKEANYFSALFYEMLSLF
TQPFQNEIFDFSDATFFGKIADLSEKYSKDTELRKMNGNRGSKHFLYINRTFFGLYNLLN
DLQAEVKITNYQTFK
>OMIFANIC_01906 hypothetical protein
MSAKKSSAKKPVNRDQVIAAYMKYCLENEKNPVSVYKFSNENEITEEEFYSFFGSFDGLR
SAIWNNFFDHSMKLAHKNKEYENFSNQEKMLTFLFTFFELLTANRSYVLFALSEQKDPMK
NMSQLKGLRKHVKEFASELIEEKNDEKQFKVLKHPVSVFSEGAWLQTLFILKYWMEDSSP
SFEKTDVVIEKSVRAIFDVFETTPLESLLDFGKFLWKEQMN
>OMIFANIC_01907 Chaperone protein HtpG
MSYLIKVVFYLNDSRQTITLILSKIYQTMSSGTINVSVENIFPLIKKFLYSDHEIFLREL
ISNATDATLKLKHLANIGEAKVEYGNPLIEVKIDKENKKLHIIDQGIGMTAEEVEKYINE
IAFSGAEEFIEKYKDKNGEDAGIIGHFGLGFYSSFMVANKVEIITKSYKDEPAAHWTCDG
SPNYTLDEVDKAERGTEIILHISDDDTEFLDESRIRELLVKYNKFMPVPIKFGTRTETLP
KPDDAKEDDPAPTMEVDDIINNPNPAWTKQPADLEEDDYKNFYRELYPMQFEEPLFNIHL
NVDYPFNLTGILYFPKLTNDLNIQKDRIQLFQNQVFVTDNVEGIVPEFLTMLRGVIDSPD
IPLNVSRSYLQADGAVKKISSYITRKVADKLKSLFKDNREDFENKWNDIKLVIEYGMLTE
DKFFDKAQDFALYPTVDGAFFTFEELKEKIKDHQTDKDDKLIVLYASDKEAQHSYIEAAM
NKGYEVLLLDSPIVSHLLQKMESKNEKMSFVRVDSDAIDMLIKKEEESISKLNEEEKEKL
QGILTEIIPSEKFSVQLEAMDSDASPFIITEPEFMRRMKEMQQSGGGGMFGMGGLPEMYN
LVVNTNHELVNQILNTKTQKKKERLVNQALDLARLSKNLLKGEEMTAFIKRSYDMIK
>OMIFANIC_01908 hypothetical protein
MKESTSRRLFLRKTAMATTGLAFISSNVVSAFTSEIPYEGYNPYSEEKTDLRTTIFDKHV
RVKGILYDKTGTFPMQGVTIEVWHMSPNSKKYRHRAKFKTNHNGEYSFITDFPNKEIAST
ARIYFKVNSDDDPYFTELAVGENCANITSKHWEENQQLGEKLFPTSEKFLNTTTINFNLK
TN
>OMIFANIC_01909 hypothetical protein
MDGVLAVIWMFGGNFAPRGWALCDGQLLSINQNQALFSLLGTTYGGDGRTTFGLPELRGR
VPMHAGNGPGLTPRPLGQRSGVETVTLTTAQIPGHIHPTQVQVSNTDGEEDTVSGKIISN
HAGAFNEDAVPGQLLGGVNGGSAGGNQSHTNIQPFNTVNFVICLQGIFPSRS
>OMIFANIC_01910 hypothetical protein
MDGVIGVIWMFGGNFAPRNWAFCDGQLLPISQFTALFSILGTTYGGDGRTTFGLPELRGR
VPMHAGNGPGLTPRSLGQRSGVETVTLTTAQIPGHIHPTQVQVNSNDGEEDTVSGKIISN
HAGAFNEDAVPGQLLGGVNGGSAGGGQSHNNLQPFTTVNFVICLQGIFPSRS
>OMIFANIC_01911 hypothetical protein
MQLKIGVLLPRSEMFPTLAMDFLNGLKLVINSGMPQEIDPVLLVEGIGNAVDESLLKTAE
KLILQEDVAVTLAFCGNNQLIEFVSIFNNYKKPLIHIDLGGSVLKDDEQSPYVLHHTLNI
WQSAYASGRYAAQNFGKKGVVISSIYDGGYHMAATFNEGFESEGGKVDHFYVAPMDYKSE
SFETMVEGIKDASPEVIFAIFSYKEGQKVFDVIARSDFNGKIPVLTIPLMTDESFNKRDH
QVENVLSVANWSFDEENENMQEFIENYSNAYENNPNIIALMGYEIGLTLLHCVSSDGKVP
SKLEEALKNKKINSPRGTLVYNERNESEIDSFKVRKFEYNKTVYHNNVIDSLDASFSATL
YETFKDLPNVGWQNPYICT
>OMIFANIC_01912 hypothetical protein
MKKITFLLTLFITLCSVSLGFAQKAVVIGTNHVTNDGFAFLVTQDLANGENVYFTEDEYN
NATNVFATGESVVRFTAGSVITAGTVVYIEETGVSTNTFTNTCTGGGSCGTTAHFGGSFS
LRTGGEAYYSYSDTNFFNYYGFTEIYSVFYTGEVGQPTGGAIPAALDPTPDFPNAIVVDG
FPAVNPGRAEFIFAGAGVRDGRCRDDLEVVGNYLHGQGYQALSTTIFGSFTLACTSPSIT
VTSSPASVAEDSGTPIVYTFTLSAPSAGTTTVNFSVGGSSTFPSDYGQSGAATFLAASGT
VDILNGATTAMVTLTPSTDTDLEPDETVVLTATAGTGYIVGSPSSSTGTITNDDTMAITP
VVAVTGLNNAVAPGIEGFSFVALDDIAAGTEVFFTEEEFQTNTLAFSNTSGEGVVRWTAP
AGGVLRGEVIVATENTPDTFTATCDSGSCGSFTTIVNGFTFASNGEGFFAYSDSDTDPTN
GVTQVHAVLFTGTNATPGGNIPAIEDPAVVYIGAVVVDGFPAVQPQRTEYDPALRGVTVD
QANFQNTTNWLHAQANATLDTTPFADIIIATGPTLPTVTVSVAPASVVEDSGTGMVYTFT
STPAVTADTTINFGVSGSATLTTDYTQTGAATFNATTGTVVILNGNSTATVTVTPVVDAV
VEPTETVDLMIAAGTGYTGGSPNAASGGITNDDTSNSDPLVALMGMAHDSGSADAFSFAA
AQDIPAGTVVYFTEDEFDNTTLLFSSGEGVVQWTSPGGGQIDQGDVIVVTETAPDVFTVT
CSDTSGNGCGGASSIVAGFALATNGETLYAYEDSNTDPTDGVDDIYAVMYTGNSGTPGGN
IPVVEDPSGIYLNALVVDGFPAVAPDKTEYTPASRAIPVDMADFEDPTNYDHAQPYGAGL
STVPFANLSIVDTTPPVITCPADATVECGDDTSPTATGTATATDDTDPSPVITFADTSVA
GCGNTEVITRTWTATDAAGNSASCVQTITVVDTTNPTVTAPADATVECGDDTSPTGTGTA
TGTDGCGGVTIAFADSSAAGCGLTETITRTWTATDDCGNTATAVQIITVVDTTPPAITCP
ADVTLECGSGSGTSGMATGTYTGGTQSWPTTSTGLVATLTADVTGIPATATIDDVNVSFD
IDHSWVGDLEITLISPDGGTVLVLADPTCGGSGNSDNVSATLDDESGVGSVSANCTGGVS
TGGGSDACDADYLTNAAIDGTFDPDNPLSALDGGLALGTWTLEVVDDAGGDAGCIFNFSV
DVSWSDAGGGATDTSPAVTGTATATDVCGTPTVTFTDSVVTGCGNTETITRTWTATDECG
NTSTCDQIITVVDTTPPSITCPADVTVECGDSTAPADTGMPTGTDNCGTVTYTFTDVSAP
GCGLTEVITRTWTGTDECGNMSVTCDQIITVVDTTPPTITCPADVTVECGDDTSSSSTGM
ATGADGCGTVTITEADTSVPGCGNTEIITRTWTATDECGNSTTCTQTITVVDTTPPVVVC
PPDITLECGTGSSGGSTGTATANYSGGTQSWPTSQTGLVATLTADVTGIPATATITDVNV
SFEIDHSWVGDLEITLISPDGGTVLVLADPTCGGSGNSDNVNATLDDESGVGSVSANCTG
GVNTGGGSDACPGDYLINAAIDGTFDPDNPLSALDGGLALGTWTLEVVDDAGGDAGCIHN
FSVTVDWDDAGVPGTDTSPAVTGTATGSDGCGGVAITFSDVSVPGCGKTEIITRTWTATD
DCGNTSTCDQIITVVDTTPPTTTCPTNITVNNDPGICGAVVTYTTPVGTDTCGNTTTTLT
GGLASGSTFPVGTTTNTFLIEDECGNSTTCSFDVTVVDNEPPVANCVAPFTIQLDANGDA
NITPADIDNGSTDNCGIASLSVSPDTFTCADVGPNTVTLTVTDVNGNVSTCTTVVTVEDN
VPPVAVCQDIDVFLDANGMAMITAADVDGGSTDACGIASLAIDIDTFMCDADLGPNNVTL
TVTDVNGNVSTCVAVVTVIDDIDPTIACPADISVNTDPGQCSAMVSFPDALALDNCTVTV
MQTDGLPSGSAFPVGVNTVEFTATDSSGNTAVCSFTITVTDNEPPVAVCQDITIQLDANG
MASITASDIDGGSTDNCGIASISASQTDFDCSDVGPNNVTLTVTDDNGNVSTCIAVVTVE
DVTDPVAVCMDITVELDVNGTVTITPGDVDGGSSDACGIAMLELDIDTFTCADVGENVVT
LTVTDNNGNVSTCTAVVTVEDNIPPDLVCMDITLELDENGFAEITPEDVILSNTDACGIE
TTAVDIFEFDCSDIGTPVTVQVFSLDNNGNISTCLAVVTVVDALAPVVTCPEDQTVDPGV
GNLFYEVPDYFALGEASATDNCTDPVTITSQDPAPGTLLSDGVYTVTICATDDSGNEGCC
TFELTVESILGGNDPAEFGTIVLYPNPATDVIYLSNPKQIELNEVAIYDMTGRLIKTINL
EGMGNEKALDISELASATYMFIINNENGQMTKSVIKE
>OMIFANIC_01913 hypothetical protein
MLPWHQYLLGIIFVAAGFYHFRKPKLYERIMPPYIPMHSTLVLISGAIEMILGLMVLNPE
TQVIAAWGMIGLLILFLPVHIHMLQNEDASLKLPKWVLILRIPLQFALIYWVYQYVSV
>OMIFANIC_01914 hypothetical protein
MNLFDQFGQKMIHLPLEDAEITYYPSFIPADEAINYFEQLFRDTPWQQDDIRVFGKVYAQ
PRLTALYGEEGKSYSYSGFQMNPLTFTPLLLELKEKIEAVSHVNFTTVLLNLYRNGMDSN
GWHSDDEKELGRNPIIASLSFGVTRRFHLRHRNDKSKKFSIDLEHGSLLIMKGETQHNWH
HQLPKSRRIQDPRINLTFRIVKS
>OMIFANIC_01915 hypothetical protein
MIKNMGFTERDIDRIIEMAWEDRTPFEAITFQFGLKEQQIIDLMRREMKASSFRMWRERV
QGRKTKHQKLRENGTERFKCSRQKQITHNKISKR
>OMIFANIC_01916 Elongation factor G
MKVFDNKHIKNVVFVGAHRSGKTTLSETMLFEAGLLNRRGSVEQKNTVSDYHEIEHQRGA
SVFATPLHTEWRNYKINIIDTPGLDDFIGEIISSIRVADTIVTVVNAKHGADIGTEIIWN
YIDRYHKPTVFVINKIDSEKANFEDSVQSLKQLVGNNATLVQYPHVIDGAQCIIDVLKMK
CYKFGPEGGKPEKLEIPDDQKEKAEELHNELVEKAAENDEELMELYFDKGTLNEDELLQG
IKLGMLNHDLFPVFCVSALKDMGTGRLMGFIDNVAPSAADLRPEQSVEGDEIKRSVDAPT
TLFVFKTIYQQNLGKVTFFKVKSGEVNANDKLYNKRTGDLETLNQLFIMDGKVKHPVNKL
TQGDIGATTKLKYTETNDTLNAKEDGPTIKPIKFPQSRIEKTVTAVHAAEDEKLNDALKR
MHAQDPTLKLRYNNETHQTVIGCQGELHLSTIAWALKNIYEVEPKFEIPKISYRETIQRS
ATANYRHKKQSGGSGQFGEVHLKIEPYFEGMAEPEGFNIRGKEEIELPWGGKLVFYNCIV
GGVIDTRYLPSIMKGIQEVMEAGPLTKSHARDIRVMVYDGKMHAVDSNDISFKIAGAHAF
KEAFVNANPKLLEPIDEVTIKAPEAMVGNVMTDLQSRRALIQGIDSEDRYQILRALIPRG
EMTNFSSQLRSLTQGRANFTSVFHSYQAVPTNIQKRLTETKEAVGQDK
>OMIFANIC_01917 hypothetical protein
MQTKVRYLSDLKFNLETWRRELRFHFDEMDTFQEKLEEIAVREFGQDARKSLENFQNRIM
IEKSAIAKLKHRCKNKLRNIHLADLSEDVDGRLRTEQSTLKEDMRTYIKMHYDLKEEMMD
YFAEYLVE
>OMIFANIC_01918 N-ethylmaleimide reductase
MKIENQVLQPYRMGDLELPNRVVMAPMTRSRATNPEHAPEAGLHDIYYAQRATAGLIITE
GAQVSRRGVGYIHTPGIYSDVQVEGWKKVTQAVHEAGGRIFIQLWHVGRISHPDFHKGEL
PLAPSALNPEVKSYTYDGLKDTVTPKEMTLKDIENTKQEFVHAASNAVEAGFDGVEIHSS
NGYLFHQFFSTSSNIRTDSYGGSKENRAKFFFEVIDAMKDVIPENRIGVRFNPSLHGMAG
ISVNEETLPTFDYIIEKLDADYNLAYVHLSEPFSDVSEVPFAETHIAKRYRPKYSGTLMI
NTGFNLDRANKVLGDGDADLVAFGRLFVSNPDLVGRFHEGIEMARWDKDTFYTQGREGYL
DYEAAT
>OMIFANIC_01919 hypothetical protein
MKATKYLVILLLMLTACKTADKGITEAEAQQTRDLIAGGNYELTMDWALPLATNAMNQIS
NANLLPMDSRSGRINLVGTSSYIRSQGDILEVYLPYFGTRQLTVTPGDTNGAIQFEGVPE
RYEAVYNEKKQLTAISFRMKDENEQYDVNVKVFGNKNANVYVNSTHRNSIQYTGKLGVLE
NL
>OMIFANIC_01920 hypothetical protein
MEYVLLALKLIVAISLLNVWLIQYNKPTRWRGGDAKTIVEEFKVYGLPVWFCYVTGFLKV
SLSLVLIASYWFPAWENPAALGIAILLLGSVVMHIKISDPLYKSFPAFLFLVLCVAIYYL
>OMIFANIC_01921 hypothetical protein
MAFKVLLPLTRTFAPMELYFQIFVVSIALAFLAYGYNCLFIASMIEEFNRLGLTPGQRRL
TGILQLFGAFGLLLGFLHPAIGMAAALGLGVLMLLGFRIRLKIKDSVLKAAPSFIFMLLN
AGAAYGFSLRLPA
>OMIFANIC_01922 hypothetical protein
MSKLPDEHKFLDLSDYGRPAARWIAQNLKNTKCTPIGVTWLFILSGTLGVLGMYYGYFWL
AAFFLVLKSVLDAADGELARLKNTPSYTGRYFDSIADILLNALIFGTLYLICDISLIWAI
LGFLGVQLQGTLYNYYYVILRNKVNGDTTSRVFETETPKALAGEDQRKVNALFKIYRLLY
GAFDMIIYRLDTSAPQGKKFPKWLMTAVSSFGLGFQLLLIGLLLILGSKEFIIPFFVAYS
VMIFIFIGIRKSLNT
>OMIFANIC_01923 hypothetical protein
MAPEIQTPEKKQIQFPIQNADPGDAGAHRFVFV
>OMIFANIC_01924 hypothetical protein
MGGLLSRASEVSLFGIELKVGKEQAAKLEIAIQGYKDKINGFSEQVAMQQERIQELEGLR
EQLQQDIENCPEAKESSVMLNAQFTKILESNADLKQRSDILKDTWILQRMNQGDLKIKQ
>OMIFANIC_01925 FKBP-type peptidyl-prolyl cis-trans isomerase SlyD
MSKVKENDVVKVHYTGKLSNGQVFDSSLEREPLEVQLGQGQLIPGFENGLIDMAVNEKKT
ITIEKKDAYGDIHEALFHKVPKSDLPQDIKPEVGMGLVGSNPDGSQQQFRIAKVEADDII
IDANHPLAGQDLVFDLELVEIL
>OMIFANIC_01926 hypothetical protein
MLFIAWEGVAGCNLYGTALNFLKDWYLGMQCFYEFLF
>OMIFANIC_01927 Serine/threonine exchanger SteT
MKKNNSIGVFTATAIVVANMIGAGIFTSLGFQLVDTVNTWSIAILWSLGALMALCGAVSY
AELGTHWKRSGGEYHFISKAFNPLLGYLSGWVSLTIGFSAPVALSAMAMGAYIGPYMEIS
EIVLAIAAILVISMIHSISLKRSSVLQNITTTLKVVLILAFIVAGLTKSPETSAFIMDAG
WKNEILLPAFAVSFVYVTFSYSGWNAAAYIVDEIRDARKNLPAALLLGTVIVSVLYLLLN
FVFLFQNPLDAIQGELEIGQITAIAIFGLTGGKLISFAIALMLISSVSAMVWAGPRVTQV
MAEDHSLWRWFSIKTRNQIPLRAIWLQTTITLILVFTGTFEQVLIYSGFVLQLFAAIAVL
GVFVVRRKNRGVTNGFRSPLYPIPQLIFLLLSGWVLVYLFVAQPLESCLGLLNLLLGFII
YRVDKRVFGVTHD
>OMIFANIC_01928 Protein-L-isoaspartate O-methyltransferase
MKKIITFIVCFVYMTGFAQDDFAEERKQMVKTQLEARDITDPATLQAMLKVPRHLFVPEK
IKKYAYRDGALPIGNDQTISQPYIVAYMTQALQLKPQDKVLEIGTGSGYQAAVLAEIVDS
VYTIEIVKPLGIIADKLLKRLGYTNIYTRIGDGYHGWPEQAPFDAIIVTAAVQEIPPKLL
EQLGEGGRMIIPVGETRVQRNLILATKKDGKINRKKLIPVVFVPFTRDKN
>OMIFANIC_01929 Cold shock protein ScoF
MNTGTVKFFNNAKGFGFITEEGSDKEHFVHVTGCIDEIREGDTVEFDLKEGNKGLNAVNV
KVV
>OMIFANIC_01930 Ribosomal RNA large subunit methyltransferase F
MHPRNIHNDSYDFDALTKAHAPLADFVYQGESGRQTINFAISEAVLHLNKALLKHHYEVP
EWNIPPNYLCPPIPGRADYIHYLKDLITETESPENIKGLDIGVGANCIYPLLANKIYDWK
MVGADTDPAAIASARVNVKAAEVLKDSIEIRRQHNRANIFEGIISEREYFDFSMCNPPFH
TSEEEAVKGTLRKLRNLGNDSPRQTKKEIVHNFGGQANELWCNGGEALFIKRMIKQSVAF
KTQIGWFTTLVSKKDNLNKIYKQLDKLKATHRTIKMEQGHKQSRIVAWRFL
>OMIFANIC_01931 putative MscS family protein.1
MDSIQDILDYVLFSIGSFSFKVHMVVMILLILIITRFILWIIKKMLFRRSYVDEHEKGNI
HAVYQIIRYVLWIVAFGLILETLGIKLTLLLAGSAALLVGIGLGLQQTFNDIISGFILLT
ERSIRIGDVLEVEGNVIKIQSIGIRTSKGLNTDDISIIIPNSLITTNKVINWSHQSDKTR
FRIDVGVAYGSNVDQVIQIMEESAFEHPDVYDRELTEGRLMRFGSSSLDFQLLFFSKNIF
RIGSVKSDIRRIIVRKFNENGITIAFPQLDVHIKQNET
>OMIFANIC_01932 Macrolide export ATP-binding/permease protein MacB
MAWRDAKASRVRLFLFVASIILGIAAVVSIQLFSQNLKDNIQRQSKALMGADFIIDSRQV
PNERAQAIIDSLEPDAKEVNFVSMIAFPKNGGTKLVRVRGLEGAFPFYGTIDTQPESAAA
NYQESGGALVDATLMLQFDVSPGDSIKIGEITLPISGSLKAIPGSTAISTSVAPPVVIPY
RYIEATELLQLGSRKEYQYFYKAPEMDLEALDKTLDPMLDTENADLDTHTSTSQRLGRSY
ENVSKFLNLAAFIALLLGCVGIASSVNIYIKEKLKAIAVLKCMGASRRQSFLIFLLQISG
IGILGGIIGTGIGVGLQELFPYILKEFLPFDVEVRITLPPLIMGVLLGFFMSVLFALLPL
MRTWYVSPLEVLRIGGAPQVKPKKARLVVFILIVLFLYGFSLWLLRDVQYAFAFAIGVLV
TFAILAGISELSMRGVKRYFPKRAGYTLRQSLLNLFRPNNQTLVLIVAIGLGTFLISTLY
FTKDILLAKTSLGQTSENANLIALDVQTNQVDGVLRTFDANDLTAIDNIPLVTMRMHSIK
GKLVNALRQDSTRQVRGWILNHEFRTTYRDSLIASETLVGGEWTPAQAPDEPIKISISDN
IAADARVTVGDTIVFNVQGVLMETIVGSIRQVDWARLQLNFSIVFPKGVLENAPQFNVLT
TYAANEETSAAFQRDLVAEFPNVSVIDLRQVYYIIEDILNKITWIINFMAFFSILTGIIV
LIGSVRTSKYQRIRESVLLRTLGATNNQILRISALEYLFLGVLGSLVGILLALLSSLLLA
VLVFKEPFVPSVIPFLMFLPGISLLVLGIGLSNIQSVLRSSPLEVLRKEV
>OMIFANIC_01933 Lipoprotein-releasing system ATP-binding protein LolD
MPKILKINGLEKRYSSGSKQLTVLQDVSFEVEKGQTFSIVGPSGSGKTTLLGLCAGLDKP
ESGTVELCGYDLNSLNEDERAQLRNKEVGFIFQNFQLLPTLTALENVSVPLELQGARDAS
ESAKMLLEKVGLADRLDHYPSQLSGGEQQRVALARAFSNRPSILFADEPTGNLDEETGEK
VIQLLFELNKEAGTTLVIISHDLDLANRTQQILRLKGGRILTNEPTTTV
>OMIFANIC_01934 Esterase TesA
MKHLPKNIQTILHAVHYSEWNFLKFCYFIFAFVILSCGNGNSTKEKTELDTPITSEATTA
EATSTKTILCFGDSITAGYGLEDSNDAYPGLLQTKIDSLGHDYVVVNSGLSGETTAGGRS
RIKWVLNQDIDIFLLELGGNDGLRGVPLSETRANLQAIIDAVREKNPETKIILAGMELPP
NMGQDYTSEFRSIFADLAKKNDVLFIPFILKNVGGIPELNQGDGIHPTLEGHKVVANTVW
DILETVIEP
>OMIFANIC_01935 hypothetical protein
MFTLVALEYYLSYRKQSNLYHGKDFLASSAIGFGNLFVNALTKVGIFYIVVICYNITPWN
IPHTWWSYILCFFALDFVRYWSHKISHMQRFWWSTHVVHHSSKYYNFSTSFRLSWVQNLK
LVFFIPVFMLSFDPVVFIIVHQLEILYQFWIHTELIRKLPRPIEYIFVTPSHHRVHHAVN
EDYIDKNFGSTLIIWDRIFGTFKEEKEQAIYGITKPVNSYNPVYLVFHAWGDLLQDVWKR
PLKTWTILFGSPTTWERGQMKKAKAKNV
>OMIFANIC_01936 hypothetical protein
MKNLLKYFLGVFILGVLCGNFIVLFSNNDTGAVKCEEITSEEPSEGDANRGKVKLIVAKG
RY
>OMIFANIC_01937 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MRRLSSILIAIFCMTIFLANAQEQKVILITGTASGIGKATAETLIEKGHTVYGGDIQVEA
NLYLNDIGGHALIMDVTKDDQVKTGVQKVIDEQGRIDVLINNAGYGSFSTIENIDIAELQ
NQFDVNVFGYARLQQAVLPHMRKQRSGLVIEVSSVVGEISYPMLGWYAATKHAVEAMADA
LRQEVAPFGIDVVKIQPGAVKTNFPNVALAKLDDADIPDDYKQLAADFKLVVEGTYEYNA
ESTDGTVGFIVQAIESENPKTEYRTTPSAKMAIMVKGSMTEKEHDELNDRQFKEAVLYLR
RAKEASEKKKGN
>OMIFANIC_01938 NADP-dependent alcohol dehydrogenase C 1
MNTTSIKAYGTEAADADLKQLQIERRVPLTKDIEIDILYCGVCHSDLHFARNDWGMTEYP
VVPGHEIVGRVTRVGEGVSKYKAGDLVAVGCLVDSCRSCNNCKNDLEQYCPEWVGTYGGF
DNHLQTNTHGGYSETIVVDEEFVMSVPENLDPAGVAPILCAGITTWSPLRHWKVDANSKV
AVVGLGGLGHMAIKLAHALGAHVTLFSRSPNKIEDAKALGANEVIISTDEAQMEAAMGRF
DLIIDTVPYEHDLNPYVGTLSTDGTLVVVGYLGPLDPMLVTVPMIMGRKSVAGSLIGGIA
ETQELLDFCGKHNITSDIEVIDMQNINDAYERMLKADVKYRFVIDMKSLKS
>OMIFANIC_01939 hypothetical protein
MTYYSVLNVTPNSEEWIPNYIPTASQLVAKHGGKYLSRTLTHEQLEGAEAPAGVRVIIEW
PSKEAATSFMNDPDYAPYLKMRTDGSSSEHFLMLGQDDMAQ
>OMIFANIC_01940 hypothetical protein
MKSLLKYLLGTFAITVLFFSCDPGKTDPVDPCDDPCEYSEPLKRGTVEPREAKGGEYPAF
EPVYDTLNKETKPYYVPIGPVRGNLSPANPEYKVDKQDDGASQAVSFEEYDEIGDAINVS
AVLPEPSVAENGQTVMTTGNTWMSLSLDGGQTFTSVNPTTIFPNDYGGLCCDQVLQYVPE
YDLFVWLLQYWTSGGQNAIRIAVQDTQGVRNSNGTSWTYWDFTNGALASSGTLDYNDMSF
GNQFLYWTSSIGGGANRYVIRVPLQELQAKGTVNYQYTGATTAFWSHVTQNGRNAVFWAG
HQNNSTMLVYSMRDNENFYSWREVNINSWPNGTMSSIAADGNDWLTDASWKTYVRAATMR
DNNAIFAWNASNNANFPNTHVQIAEINTNSWTLVNQMQIWNPDFAFAYPYFETNNKGQIG
IITAFGGDIYDASSGVGVWGDFVIYYPRLSSRSYTNYGHYHTTRKSGTNGDEWVSAGFTY
ETDGSVTPYYVRFKH
>OMIFANIC_01941 Cold shock-like protein CspC
MAKSQQTYSKKEKEKKRRKKREEKQKKKEARKAAAKERGNTIEFAYVGHDGQLTDTPPDP
NLKVEVDVESIEINIPRMEDSDIEPVDPVRKGKVSFYDSSKGFGFIIDAENQEKYFTHVS
GLIDEIAENDKVSFELEKGLKGMNAVKVTLIK
>OMIFANIC_01942 Transcriptional regulatory protein SrrA
MLRIRYIIYALLITLLLYAYGSAVSKVEKQEFSETVKVALRAAGNEVLLSNNDSTSVIQP
VVELESQKYRMSFESDLSFRPGELVTAVSKNFLIASLPDTYRVEVIQCGDGEVAYSFQMD
FLEESTIVACQGRKVPKSCYTIDVKFLNARTPFLGRQTLMYLILVLVLGIFFIEFFLRKR
AQRTAALNDTNYAAVGKFHFYPEQNKLVKEAVEIPLSKKECELLAIFAASPNQVVKREEL
TKKVWEDNGVVVGRSLDTYISKLRKKLQEDDSIKLTNIHGVGYKLEVG
>OMIFANIC_01943 hypothetical protein
MKYLLSCFGILLLLSCNQSNSEPLKELALLSESERIVENEKDYTYYYDSISRDDYQIKLG
VLELSNDEFELVISMKLFRESHYISPNAKRDFKGKFFVEFDDSEDLSFLADMEEIPLSVE
EFDEDPFVDGYVNWVRKATRYVLKVKRNKTDDFGISGNLQFVIEPRCTLEKIPLIIVNQG
GYLKFHVRGC
>OMIFANIC_01944 Cocaine esterase
MKIFRFTSLVIFLIFTQIFLGQAPNDILEKLEEIAIVDQKVMMPMRDGVRLATDIYRPKT
DNQVPIIFSRTPYNFNSWGDGKQRTWTATRAYEAVKRGYAYVVQNERGRYYSEGEWDILG
VPLTDGYDAFSWMKDQSWSNGKIGTYGCSSTAEWQMAVAALDHPSHAAMVPQGYGAGVGR
VGDIMEQGNWYRGGVEQMLFFAWLYGVEHDKFKPRIPAGASQQDLIRISRFYDLAPENPP
VDMSEALNHLPIQDILKNVGGKKEIFDKMVRRKPNHPDWYSGGLYHDDMEFGVPSFWFAS
WYDVSITPNLALFNHVRNNAKDAEVRDNQYMVIAPTLHCGYTRAGKNTIVGERSVGDARL
NYNEQIMAWWDYWLKGEENDFKEKTARVQYYTMGSNKWQSAEQWPPADSKLVTYYLNSSG
DANTLNGDGTLSKKKPSGDNPDSFVYDPMNPVTSWGGNVCCTGNAVKGGAFDQQDMEERE
DILVYTTEVLSEGVEVTGFIESTLYVSSDVKDTDFTIKLIDVYPDGRAYNLDETIQRVRY
REGYDKEVFMEEGEVYQVDLTPMATSNYFEKGHRIRIEVSSSNFPRFARNLNTGGNNYDE
SEGIKANNKVHHSRKYPSQIRLPIRQ
>OMIFANIC_01945 Xyloglucanase Xgh74A
MNSHCHLMKFRPNTVQFLLSLFFATTLTAQDFEALQYRTVGPERGGRVTTVTGTPMEPGT
FYLGATGGGVWKSEDYGTTWNNVSDGFFETPSIGAIEVAVNDPNIVYVGTGSDGLRSNVI
SGKGVYRSIDSGKTWEHIGLREVGQIGALEIDPTNNNVVWVAAIGNAFRSNPERGIYKTM
DGGKNWEKVLFVSDKVGFSDLELLPGNPNIVYAAAWKAERKPWTIISGGKNNEGGIYKSI
NGGKDWIKLENGLPQGLIGKIDLAVSPVDSSILYAVIEAPDDEGGLYKSVDQGKTFKQIS
DNKGLVNRPFYYTNIELDPTNPDIVYSNANPLLKSVDGGKTWDRMSVPHGDNHDIWINPN
NTDLLIQCNDGGANVSMNGGETWSTQFNQPTAELYQVEVDDQYPYWLYAGMQDNSSTIAV
PSFPPYSIQYPGRGWILNTGGCETGPGVPKPGNHNIVYANCKGRFSVFDKRTGTEKGYYV
GASNIYGHNPKDLEYRFQRVAPIHVSPHDPDVVYHGSQFVHKTVNDGLAWETISPDLTAF
EADKQVISGSPITRDITGEEYYSTIYSIRESKLVPGLIWVGSNDGVVSLTKDGGKTWSTI
TPKKLPKGGRVESIEPSHFDPAKAYIVVDRHLMGDPKPYLYKTSNYGENWELISEGIPSD
FNARVLREDPARPGLLFAGTEYGVFVTFDDGKSWKAFQQNLPVTPITDLKIHRGDLVIST
MGRGFWILDNITTLRQAQVNNLTDAAVLFKPDNTIRYRYPKSSWGTFPEYPRPGVIIDYY
IPESINGAVQLEILNERGEAVASISGDSTQLRSSEEKVVDMNMSQTFRFVDKKLESKPGL
HRFLWDLRQKGAWSKEEKRRYKNGPIVAPGKYSVKLMIAENTLEQSFDLLMDPRVIAQGI
TKNDIQKQLTLQNKVIDLLSEARKLQADLEDESKELKGKKAKVKKERLAKVDAVLEQLKN
AEGAYPQQMLVSQIGYLLNMISGADQLPGKDAEQRFTDLLSEFQGIKEKLRMP
>OMIFANIC_01946 hypothetical protein
MKLTTTLFITFLTTVALFGQEANEYFSSMKYRNIGPYRGGRSVSATGVVNDPLTYYMGTT
GGGLWKTEDAGSHWKNISDGFFKTGSVGAVAVSESNPNILYCGMGEHAIRGVMTSYGDGV
YKSNDGGKTWDHMGLEATEQISRIVIHPTNPDIVYVAAQGKYPSPTTERGVYKSTDGGFT
WKKTLYVNSFAGASELSIDYNNPNVLYAALWHHQRTPWKIISGGDGSGLYKSTDAGETWE
RLEKGLPKELGKMAISVCRSNSDKVYALIESDTQTDQSGLYLSNNAGKSWSQVSGDNRLT
QRAWYYTEVFTDPNDDETVYVLSAPSLRSKDSGKTWERITGTHGDYHDLWINPNNSNNMV
IANDGGAAISFNFGKSWSSQDIMPTAQFYRINTDNLYPYNIYGGQQDNSSVRIASMSMGN
YSISVSDWTRAAGGESAFLAFDKDDPKVTIGGSYLGTIEVLHMETKASNKIMAAPIQYLG
KAARDMKYLYNWNAPIIWSQHEPNTIYHCAQLVLKSTDFGKSWSEISPDLTRNLDEKQGK
GGGPYTNEAVGAENYGTISYMVESQHEKGVFYTGSDDGYVYITRNNGQSWQNITPKNLGE
TLVNAIEVSPHDPATVYIATTKYKLGDYTPALYKSNDYGNSWTNISSGIPNGAYTRVVRE
DETKKGMLYAGTELGVYISFNDGRSWESFQRNLPVTPITDLKVHDNDLVVATSGRSFWIL
DNLSLLSQYDPGNQSAKLYEPEPIYYGNWGSSLSGNNDAFTGMQDFEGINPANGIELYYY
LPEVPEDSELTMTVTNSEGKVINSYSSKKDENYIPHQGGGAPRAPTLSYKKGLNRFVWNM
RHEIVPGVPGVYIEAGFRGHKVIPGTYTVTFNYNGQVLSSQAVINPNPKYNIAPAVYQEY
DAFMSEVEGNVTEMHDRVNLLKKAETEISGLLKEFKSKGIHPDLVSEGEALVKELKNWDE
KMVQRRSQAYDDVENFENKFTAEYLFLMNQTSSSLPRVNQPNKDRKSELDAQWQGLRATA
NALLKTKLPLFNKKLWDAGYGAISLE
>OMIFANIC_01947 Signal transduction histidine-protein kinase/phosphatase DegS
MAKLIHFTLAILTFTQFYGQNIDSLKQIIQSSNDIEAKSSAYKAITNYYRRGDSVIFKRY
LTEGIIYAHEINDTETELQLGFLNCKRLYSLGAYKKMITGIDSLIPMSKQLGLNELQGDL
LNYKGNAYSNLSDYTNAAVTFIEYLAVAQALPDNTRPVAMANNNIGMAFLNMERFDQAIL
YLNRSLENQSEFDSDFKAHTYWNLGICYMEKEMYEEALDILKLGVAEAERKGDRYAAAGN
QLCVGSVYLRQDSFEKGITAYREAYEMSTKSNLEPFKVIEALNGLIHAYNQLSRPLEAQQ
YIRLADSITDHHNLSDLRNREFLFQKGANLLQLGRPQEADAVFKRYSRAVDSLQNKENMQ
IIQTKETEFRTKEKERMLELQQADLDFQRLLNILLGVGTVFLVLIAFLVLRQQRLKIRHQ
KQEQELKEALQTVAMNKKLEDQRLRIAKELHDNIGSQLTYLASAAQNIGIGMKKVPSEVT
ENKLKDLSDFSQEAIADLRDTIWVMNRSLISWEDLAERIRYLAHKVSNTTGIQVNVKKEG
DNDTALNPAQTMNIFRIIQEAVNNAVKHAQAKEICIRLEVGPPSFIEIQDDGKGYDSQNI
SSSSSGLRNMQSRADKLDASLDITSSEKGTKVRLEISDLQDAV
>OMIFANIC_01948 DNA gyrase inhibitor
MVTAVSNIRIADLPKLTLAYVRNVGPYMGDTELFGRLFNQVMEWATPKGHMTEATEAISV
YHDDPYTVPIEKQRISVGFTVPEGTVANNNIRIMEIPAGKYVVGSYELLPHEYGDAWMEV
HNFILNEGIQTTNLNFELYKNDPDTHPEGRHIVDICVGMK
>OMIFANIC_01949 hypothetical protein
MRKTNYLLFGLPMLLMLLLSTQCSKEDVPPIVPDTGYNWPSTDRSYWPTDGWRTAPMDEH
QIDPAKMDVADQFAKNDKLAKALLVVKDGYLVFENYYHGGNEEKSSNLWSVTKSVSSALV
GIVKDDSDIASTHQFMTEFMPQYSDFETITLHHTLTHTTGLDWDEEGPRWVEWIFSDDWV
QSALDRGFNSRPGKRWKYSSGNTHFLNSLIYYHTGEFPGVIAKERLFEPMGIEFNLYTRP
FDYIDWNQFREPLHQTWRRDPKDVECASFGLYLTARDMAKFGYLYLNRGRWENKQLISES
WVLDSTAEHETDIYGRYSYGYQWYISLVDGHPAFLASGWGGQIIGVVPSLDLVVVLKYEA
VYPQHPVPGTNHDDMGLFDLVVQAVN
>OMIFANIC_01950 hypothetical protein
MRNIFICVVTLIAFGSQLIGQEISPYIKIGETQETIQQASDKIIATLKDNSFAILGAYHP
SNKSNLKVITFTRSDLKYTVIKVKDRGALAAIYKIGLIKDGDKVIMSYTNPEYILRAYLG
DHYNRYKSTFVKFSSDLEAALSNVGTEFKPFGGTVAADKLKKYHYKIMMPYFTDPVELRE
FASFEEGLATIESNLKAKKGNTKMVYKLVYKSSEVAVFGVGLQSREDGEPHFLPKIGEAH
VAALPYEIILQGNKATILHGKYRIALHWPDLSMGTFMKIMSTPGDIEDTMEALCQ
>OMIFANIC_01951 Ycf48-like protein
MKKHFLLFVLSLFLITSFSHAQKKKTEDKQALDTLNISGLSWRSVGPALTSGRISDIAVN
PVNPFEYYVASSSGGIWKTVNSGVDFTPIFDNEGSYSIGCITMDPNNPNVIWVGTGENNN
QRSVAYGDGVYKSEDGGASWQHMGLKTSEHIGKIIVHPDNSDVIYVAAIGPLWSKGGDRG
LYKSEDGGKNWKAVLTVDEHTGVNDVVMSPANPDVLYASTHQRRRHVFTYVGGGPGSGIH
KSTDSGETWTKIHTGLPGVELGRIGLAVTPADPHLVYAIVEAADGKGGVFATTNRGASWQ
KRGSHVTSGNYYQEIIVDPVDANTLYSMDTWMSVSHDGGKSFKVVGETYKHVDNHSMWIN
PKNTAHWLVGCDGGIYETFDSGKQWDFKENLPVTQFYKVTVDNDEPFYNIYGGTQDNFSI
GGPSRVLTNHGITNLDWFITNGGDGFESQVDPNNPDIVYSQSQYGFLVRYDRKSGEIVGI
QPKERKGEDAYNFNWDSPLVVSRHSPGRLYFAANKLFRSNDYGNSWEVISEDLSRQIDRN
TLKVFDRVLSIDAVMKNGSTSLYGSIVALSESPLDENLLAVGTDDGLIHISENGGQTWRK
IDNVPGVPNRSYVNSIYLSRHDANVVYVAFNHHKYGDFKPYVFKSENKGNTWTRISGNLP
ERGSVYAIEEDPVDKDLLFVGTEFGAFFSPNGGMRWKELAKGLPTIAVRDIAIQERENDL
VLGTFGRGFYVMDDYSALRSVENSVPKEKAKIFPIREALVWEQSSPLGLPGKAFQGDNFY
TADNLGPEAIITYYYGDEYKSIEDTRKKREQELIKEKKDVRYPTYNELKAEREEAKPQLV
FTIRDAKGQVVKKEFQKPTRGVQRFHWNLRYTLQGPISFYEPSFYNPWMPKDEGTLVEPG
MYTIDMQMEQDGEFTPLVPPQSFSVKALDNTVMPAENRAEKVAFQRQIMQLESGVGEMQN
KMGELNEKLKFMKAALKRSEQPLGGLLKQVISIEDQLRDINKSLYGDSVKRSLDMDQPPS
PASRLGTISYEQKYTTSTITKTHRDSYSIAKSELDGIKQRLETLIEGDVKQLETLMKQAG
MPYTPGRGTKQ
>OMIFANIC_01952 hypothetical protein
MKTVKFLTKPAFLLMSLTILLMLPVIGYAQIPDKNQSDLIKPETEITDDIYWAVKAYHPQ
VKLLKVKAIDKDGNIHDVKAIQDSYSTSVLNVKALVDGNRLPIKLIVHGEDRYYPVKAIN
TDGTIMDIKAITDEGFMLDVKGVSKTGNIIHIRALDKDGAQYSVLAVSPLGEINEVQGLK
MLSAPVEMVIKGVKIFAHVKAMKPD
>OMIFANIC_01953 6-hydroxy-D-nicotine oxidase
MTNSIKDLDASVIEEFAAQLRGRLVNPQDSDYNETRKVYNGMIDKHPGLFAMCEDVADVM
AAVNFGRENNVLVAVRGGGHNGGGLGLCDEGLVIDLSGIKFVRVDTSNHTVRVGGGNLWG
EVDHATHPFGLAVPAGIISTTGVGGLTLGGGVGHLSRKYGLTIDNLLEADMVLADGSFVT
VNSTEHSDLFWAIRGGGGNFGIVTSFKFQAHPVKNVFGGPTLWPIEQTEEIMKWYHDFIN
NAPDELNGFIATMVIPGAPFPEELHNKQFCGIVWCYAGDMNMAEEAFKPILAKNPLFAHV
GEMPYPAIQTLFDGLLPHGLQWYWRADFFKELGPEVRAKHLEFGSTIPTPLSQMHLYPIS
GAAARVGADETPWAYRDAKYAGVIVGVDPDPENAEKITNWCKDYWEALHPYSSGGAYSNF
MMEEGQERVQASYKHNYDRLASIKQKYDGNNFFRVNQNIKPKS
>OMIFANIC_01954 Regulatory protein PchR
MPLYMDRHELPDGVTSEHVASMHQADLKVQHLYGCRGMTYWCDEKRRTAFCLIEAPNEEA
IQEMHDHAHGDLPHSIIKVNENIVESFLGRIEDPVNVDDEIFASINEDTYRVIMVVEISN
YFDRVEAEQYTIFTQKFHNSTSKTIKQFNGSIVRKDNNSYLVSFESVSDAVRCALKIQYK
FKYVTPKQDSFNRRLNIGLSIGTPVNGNATIFEDGISLATRMCEILKYPFVISAEVNAMF
ENENRNAVIDKTLVKALTPAEEKFLTHLMDHTELKWKSPSLNVQTFSKDLGYSKSQLYRK
LMKLTGKSPNHFIREFRLHKALDLLHRQEGNISEIAYETGFNSPTYFSKCFLDKYGILPS
KYLQQHIN
>OMIFANIC_01955 hypothetical protein
MSVTIIVMKVMKIYEMADLARQLIFPNILI
>OMIFANIC_01956 hypothetical protein
MEAQTNPSVEELHNFFNGQQLLITYREGEVLYGTYYFLEIHYCPNGYYGLYGNTVKRTVL
DNEQRSNWQEFGTWKITTQNGLNGIYYAATNGGQQFYPMYKLQNGDMFISEGISIVNQGA
AICR
>OMIFANIC_01957 hypothetical protein
MRGSRNNVNKILITLPLAGILLFVVFYVIAALYYPGGSYVAPEQIGFSFEHNYLCDLLDD
VAVNGEINTARLYSRISLGILCGSLILLWAYLPWLFDVKRRIHVLISACGILSMLITVFL
ALGAHDIVVRIAGFFGAIALLLTFRELYKAHYGKLLFLGIVSLVLFLANYYIYETGVLIE
RLPLIQKVTFISCLSWFVILNILLLKKYKIDNN
>OMIFANIC_01958 hypothetical protein
MKKGRLLALLGLAGGAFAYWKYKNLSPEQKEELKQKARKVGKDVKEATLDAEQTISEGLD
KLSDKAKEVFDKATT
>OMIFANIC_01959 Dispase autolysis-inducing protein
MRSFYPLLLVASFIFGATFTTSAQEKSKESDNIYNGLKLRSIGPAFMSGRIADIEIHPDN
ESVWYVAVGSGGVWKTVNSGTTWTPIFDEQPSYSIGAVTIDPNNPDTVWVGSGEDSGGRH
VGYGDGVYKSEDGGKTWKNMGLKDSQHISRILVHPFDSNVVWVTAQGPLWRKGGDRGVYK
TTDGGQTWKKTLGDNEWTGATDLVMDPRDPDVLYAATWQRHRTVAAYMGGGPGTALYKST
DGGNNWTKLTNGIPTSWKGKTGLAISYHNPNVIYAAIELDRRKGGLYRSEDGGGSWNKMS
ETISGGTGPHYYQELYASPHQEGRLYLMDNNLQISEDGGKTFYRMNEKNKHGDNHAIAFR
KSDPNYLIVGSDGGLYESFDLTKTWKYVENLPVTQYYKMAVDDSEPFYNIYGGTQDNSTQ
RGPSRTDNVHGIQSSDWSVILNWDGHQPATEPGNPNIVYAERQQGTLSRIDMSTGEVVDI
MPQPGENEDHERFNWDSPILVSPHSPTTIFFASQRVWKSENRGDDWTAISGDLTKDEERI
TLPIMGKQQSWDAPWDMYAMSTYNTITSLAESPKQQGLIYAGTDDGLIQVTEDGGNNWRR
IAVGNLPGVPSTAFVNDIKADMFNANTVYVALDNHKYGDLNPYLLKSTDKGRTWSSIASN
IPKRTVVWRLVQDHVKPGLMFLGTEFGVYFTINGGGKWTKLEGGVPTISFRDLAIQKREN
DLVGATFGRGFYILDDYTALREMSDATLQQEAKLFSVRDAWWYVPRPQLSFGPGKGSQGD
SHYLAPNPEFGATFTYYLKDAPKTMEQQRKDSEKNKDTEAVSFPGWDALAEEVNEDDPQL
LFVVSDANGAVVRKIHTKPMKGMNRISWDLRYPDLDAIGLNDKNDTGRSAFLAPPGNYSV
EMYLSEKGQTRKLDGPVSFSVKQLYKNSLPGSSMDDVSAFWRSYEATSKSVSRFNMDMNK
AMKRAKAMKIALARSAAKPGTTDNELKSVIKSLQDLSGDFYGNPAKGEIGEKDRPTVGER
MFAIYRGVERATYGPTSLNKSQMQIVEKELNTAVSKLNAAKQKLDGIYTELKAAGAPYVE
E
>OMIFANIC_01960 hypothetical protein
MELEEMQTLWTQMSSQIESQKKLTNKLIMEMTQQKFRNRFYTLSIYETIGAVICFVFAFF
ILLNLDKMNSWYLMACSLVTLLFLIILPVLSLRAIHGMRTLDLSNRSYKETMVDFTRKRK
NMLLFQRIAVMLSVVMMWVSIPVFSMIMNNKDFFAMKHNPWLWVFTAAVTVGVVLFSRYG
YRGYRKVTASAENVLKDLEDQTGN
>OMIFANIC_01961 ECF RNA polymerase sigma-E factor
MSKEESFTRIIRDNEGIIYKITRIYTSTVEDQNDLYQEIVFQLWKSFDSFRGDAKVSTWM
YRIALNTALFHSKRAKKRGYNVSLDGVVLQHENYDPVFEERLKVVYEQIRSLNDIEKGII
LLFLEGKKHEEIASITGFSKSNIGTRIGRIKEKLRKQIIK
>OMIFANIC_01962 hypothetical protein
MMKKLRKKFFNNWDEKLKVWKAKLAVYARASSYAIHR
>OMIFANIC_01963 hypothetical protein
MKKIILLFISFLMLQATAQSTFTAQQWQDDLKFLQHTVHKDYPFLFKKVTSEAFDAAVEK
LHKQIPNLAQHEISIGFARIIGMFKYGHTRMGWHGNPTALRQFPVNLYRFSDGVYVQGVH
KDYSQALGAKVLRVGNMSVEEALKAVYPVVPVENEQFFKAYGFLYLMSPEVLHAQGVVSE
LSDQLELTLEKEGKTFKTTFEVLPAGKMPPRTYGYIQTSDEWLDVRASGETPLYLKQLDK
IYYYEYLPDSKTVYVRQSQIQDDPTEPIPAFYTRVFDFIEKNDVQRLVLDVRLNGGGNNY
KNKAVVTRIIESKKINQVGNFVVVLGRRTFSACQNLVNELDNYTNAVFVGEPTGENINFY
GDNNEVILPNTKTPVYLSFAWWQDKPQWENDDWLAPHIAIDMSFEEYKTNKDPVLEAALS
FDDSDFVLDPMQYMTELYTSGQQEKLATEVPKMVRDPRYKFFNFEGELNEAGYNSIQRGD
PQTAIAIFTFITQLFPESANAWDSLAEGYLEAGDKEKATEYYQKALKMDPDGPTGKNASG
MLRKIEVGSH
>OMIFANIC_01964 Bacterial leucyl aminopeptidase
MKRFLSLGFVLLIGCTSIFAQEKDPVIEAMISEANENSQLKQLGHELMDQIGPRLVGTPQ
MKNAHDWAVAKYAEWGVSARNEQYGEWRGWERGVTHIDMVYPRVQSLRGMQLAWSPGTGK
EGVMAELAVLPRVKDSADFAKWLPSVKGKLVMISMQQPTGRPDYNWEEYATEESFQKMKD
ERDALTKDWRTNMQNTGHNRRTLPAALEEAGAAGIVMSNWSRGFGVNKIFGARTKSIPTV
DLELEDYGLLYRLVESGQKPRIHIVAESKELGSMPTFNTIAEIKGSEKPDEYVILSAHFD
SWDGATGATDNGTGTLVMMEALRILKKHYPNPKRTILVGLWGSEEQGLNGSRAFVEDHPE
IVNGVQAVFNQDNGTGRVVRLSGGGFLHSYDYLSRWLNAVPGEITSEIETTFPGRPARGG
SDYASFQAAGAPAFSLSSLSWAYWNYTWHTNRDTYDKIVFDDVRNNVILTTILTYMASED
PETTSRDRAVLPVSSRTGKQMEWPTPRSPDRKGN
>OMIFANIC_01965 hypothetical protein
MVLHFEELLKQITEFIRNEAKTETVVGEQFKLGEFICVPVIKIGMGFGSGEGEGIEKKTK
TKTGYGMGAGAGMGIEPLGFLVTKGEEISFVEAGKAHGLAAAFEKVPEMIEKIYENRGKE
TETA
>OMIFANIC_01966 hypothetical protein
MAALLVIIILLLLLLGYLLWMPVVLKIDTDTNEYYLQLKGLAKASVLGDDKEVLKVKLNV
LFLNFNFYPLRKRKASKKKKLKAKKGEEDAEKKKRNWTNEGRRAWRVLKTFEIKQLLVEL
DTGDYVLNAKLYPVFFMLNRWQGSFAINFTNRNRLALIVQNRPIYILKSIINI
>OMIFANIC_01967 Protein-L-isoaspartate O-methyltransferase
MYLFKNNSNTHNLKRLVLIMAIFLTAFANCQSDYSERRAKMVRGQLESRGIKDKATLEAM
RKVPRHMFVPENAKGKAYIDAPLTIGKGQTISQPYIVGYMTEQLQLKPTDKVLEIGTGSG
YQAAVLAEIVSEVYSIEIIESLGETAANRLKSLGYDNVEVRIGDGYLGWPEKAPFDAIII
TAGIDHVPQPLIDQLAEGGRLIVPEGARRSTRDLMLLRKKKGKIKRKFLIPVVFVEFQRK
ND
>OMIFANIC_01968 hypothetical protein
MKNWKQLWSEKLSKWNVKLAEFAKASSYAIHR
>OMIFANIC_01969 Modulator of FtsH protease HflK
MNPIVLFSIVFVVFLLLGIRVVFEYKRALKFRFGKYIKTLQPGFRWIIPVVETIQVVDIR
VITINIVSQEVMTEDNVPCSIDGVVFFRINDPEKAVLEVEEYKFAISQLAQAALRDVCGK
VELDTILSKREEMGKNIKEIVEMETMEWGIEINDVKIKDIQLPENMRRMMANQAEAERSR
RARIILAEAEEQAAQKLFEAGQIIDQSPSAIKLRLYQTLSNIASEKNSTILFPFPEEVLP
VKKKKE
>OMIFANIC_01970 Putative NAD(P)H nitroreductase MhqN
MEKTVSEAIAYRRAVRVFKEEPIDTQKVEQCLKNATLAATSSNLQLWEFYHITNPEIIRR
IAVACFNQNASKTAKQLVVVVARKDLWRQRARANLKFIEEGFNNTEMTPRLEKRRKMAQN
YYGKLIPVTYFDFLGIFGWLKFLAFQLVGLFRPIYRQARTSDMRVVAHKSAGLAAQNFMI
SMASIGYDTCPMEGSDTLRVKRILKIPYRAEINMVIGCGIRDEKGIYGPRFRIPFKEVYR
LIN
>OMIFANIC_01971 hypothetical protein
MKTLILITAFFISIQGFAQLNRSYDGTNNNLNNPEWGAADAHFRNFATNAFGDLISEPGG
QDRPNPREISNAIGSQTEFIANELELSDFIWGWGQFIDHDVNLNDDNFDEPNDIPVPMCE
PLFDPNCTGNETLRMFRSKSDPATGTSINNPRKHINDITSYIDGSAVYGSDINRANWLRT
FVDGKLKTSSGDLLPWNTVDGEFDSAIDPAAPFMVLDGFPLPEKFFVGGDIRVNEQPGLS
CFHTLWVREHNRLCDEIKDQNPSWNDEEIFQRARKIVGALIQVVTYEEFLPHIGIQIDPY
AGYDDTVEPNILNTFSAAGYRFGHTMVNGRLVRYEENGDDWVFGAVDLRDGFFNPAILKD
EGGIEPFFRGLAAQEHQLVDPLIMDDIRNFLFGQPGSGGIDLLSINLARARERGIPDYNT
FRTDLSLTPHADFNSLTSDPVLSGNLATVYEGDIGKLDPWIGFMSEDHLPNALVGEGLHE
ILKLQFQALRDGDRYYYENDPAFTTGEIDELKSTKLSEIILRNSSIETLQEDVFIAVPRD
LLAVEFFPFPEVKSIELTAYPNPVQKYFNLVIESSRPSSATLSIYGVSGQIISQQAVQLN
RGRNELNFELSDQLANGLYVVSLDSDNGAGQLKLIKRGR
>OMIFANIC_01972 Sugar transporter SemiSWEET
MDLTNLLGNVAAFLTTISFLPQAIKTIRSGNTKQLSLPMYLLFVSGVLLWILYGLSNNQL
PIILGNGITFLFAGTILTYKLIDLRKK
>OMIFANIC_01973 hypothetical protein
METNQPQIKKFGTFGGVFTPTLLTILGVIMYLRLGWVVGNAGLIGAWLIIIISFLITLCT
ALSMSAITTNIRIGAGGAYAIISQSLGLEVGGSLGIPRYISQGLAVTMYIFGFREGWLGI
FPDHNAFLVDVSAFIGLFTIAYISANLAIKTQYLIMVVIIASLVSIVLAAYDGSMVIASD
EALKWGTFKGAPENDFKGSDFWLVFAVFFPAATGIMAGANMSGELKSPRKSIPIGTLWAI
GVSFVIYMLLAFWLARTATEQELISNYNIIIDKAYVGPLIIAGVLGATFSSALASIVGSS
RILFAMGQHNVLPYSGFLAGQSKNGQPRNAMLVTGILIFGTMLLRNLNAVAPLVTLFFLV
TYAMINIVVIIEQNLGLISYRPIFKVKRWIPWLGLISSVLAMFIINPTISLITIAIVLAV
YWYLSRQNLETPFEDVRSGLFVSFAEWAAKHTWGMKNMQQRAWKPNLMVPVRDLTGARGN
FEFLRNIAAPKGSIKLLGIEPDSENSNMTSELDTLAESFRQRGVFSSWTVINTTEFAKGV
NYGNQALRGAFFRPNIVFLNLQQHDDYETELRPVIRECIRLEIGVLLYQSHAKALLGQRN
TINVWVSNRKNNWSLGWDIGNLDLSTLIAYKLKRNWKARIRLITVIDDDSELENATIFLN
SLTNLARLPETLTQVFVGDFKDVVVKAPQADLNIFGMHADLQFEFVQEMTEKTNSSCLFV
KDSGHESILA
>OMIFANIC_01974 Protein YceI
MKAILFSLLTISFLLPTKSISQTYKVDPTHTAVLMKVQRFGVVNVIGRFGDVTGTITLDS
ENSDALDMNMRVGVESYSANNQGGEDSAKSRAFMDSMNFPEITFKLSNAKEDDGTYTITG
DLTLHGVTKEVEFTAEVTGPKMDLPTRKQSIAISGMLVINRLDFGVGPEMTLPDGTEVIS
NRTEIMMEILGIAE
>OMIFANIC_01975 hypothetical protein
MKSYKAPAAIFLLACFVISGNIYSQVGINTTNPRKTLEVAGDMTILNGLEITNFTPQRDT
DTTTFLIQEGDNSIKSLDVSNPTGVALAYIQEYVIEDPDLDWVKDFDTGIDASNYVVIVT
SASFNQELDLTSNPGVETNSSIPFASAFIDNGTWHLVADYPQAANLDETQMGIWTISTLI
FSNDVSKQFGTVNIPMANTSSGAAASPIIN
>OMIFANIC_01976 hypothetical protein
MRHSILSIFFMVCGLTIGQVGIGTTTPMADLHVAGEMLVQKKFVTGNLNTVSPVDEDFKL
VTRVTNSTPVGQITLLDVDQLNVAPVNTVNYHFTNVYLDNLNDVDLQYDINKYVVGVANF
RYVGDAIKKVPGGDNFSIGHFVVRTFKSGGTWHLEIRNVELDLDPTDSLEYYIQLIVYDK
SYFRDLPTILSNLGGSNVGTASSIPVFE
>OMIFANIC_01977 hypothetical protein
MKKITLLLVFVCCISATMAQVGINSSEPSADLEVDGDVLLDDGLYLEDPGDNTNIRGSKF
LVNTVANELSRYDINLSKYGPINYVEFKFSNLSADGLLDYDTKISTTDYLVSVQGYSCGI
AGAGRTGSIMPHSLISDDNIEGYQIYAYPNLTTKTWFLRAFVNNSEWQKSGATSYINTEI
DMWLNIMIYRKGFIAKEQNNITVDMSNSATGTATLPAGF
>OMIFANIC_01978 hypothetical protein
MSLAIGIWQAVIIIVLILFMLGPVLYLIIKGKNDKKK
>OMIFANIC_01979 hypothetical protein
MPDYPEIRALKDFIRQHSVSVDASPDNQDIFNLVPVIFTIQNKKQHCYIQDEYDYLQLND
PCVKVVLALREFELIEESTDYLNWCTMMGIEANSEVIRNYYQDTVRIIPKFKAYFKRNKI
TSFIPDLDFQLNSGAMQSLRNR
>OMIFANIC_01980 hypothetical protein
MKSNRILTLLFLFSLSYFFGNAQTIEQIREMHNEVPDDPYTTVDKSRQARTPAYKVRTAY
FFTTQVNVDADGNNIVGDAGNETSIAIDPTNPNRIAIGWRQFDDVGSNFRQAGYGYSLDG
GYNFTFPGVLNPGVFRSDPVLDFDSDGNFYYNSLRGTFDCDVFKITDGGTDWGSPVPARG
GDKQWMTLDKSGGSSAGHNYSYWNTSFTTCAPGAFTRSTDGSNSFEDCEVIDNEPFWGTM
KVDGNGDLYMVGRNGTGSGMVVVKSTNAKDPGEVVDWDFVTPVDLDGVVYAQGDVNPAGL
VGQAWIDTDNSGGSGDGNVYVLGSVLRSGGDPADVMFARSTDGGLSFEPPVRVNIDTGNT
YQWFGTMSVAPNGRIDVVYLDTSSAGTGSVDSRLIYCWSDDQGDTWNDYLMISEMFDPTI
GYPNQNKMGDYYDMKSDNDYAHLAWCNTLNGGQDAYYTRISPEGILGVDDIALAEGYGFI
SYPNPFSEETTLQFYTGDDQAARMDVYNMQGQLVNTLFDDINSGTTKVRWDGTNGAGQRM
AEGLYFVALEVEGTRSLQKVILKK
>OMIFANIC_01981 hypothetical protein
MVIFKSLKRIRTYMKKKFWTSDKVVSFVAICISLFTLYIFVKQTNIIEEQSRRSVMPYLM
LESSNNSENNTYSISIVNYGVGPAIVESRVIHYKEKVYDMELYEFLQKQIPEMDSVELLN
TTTLQVGVAIPSSSERNVITAGGDKSSYINFLRIMSKLSEEGFNYEIKYRSIYDEHWMIS
GKDQVPVLQED
>OMIFANIC_01982 hypothetical protein
MKKPLNVFILLVFAVQLTLSAQDRPIKIVDERVNNRLMIYAINENEHDLDVSIKIKGSGF
RQRAGTPRLHRVPKASKINIASLVVERGRVPVYTYELTVNDSLSRRVVRKPSTQVKIDPK
KNILVYLKDGCSTCDSLVSKLDKSYYKYRTMNLQEKPEVKDFLVRTFKYTKTPYDSITNP
IVSLGGTLYSEIENYDQLLEKLNADESEMKEEDETEEKKN
>OMIFANIC_01983 hypothetical protein
MRLNILIGLVFINFSVLTAQIDNRNVQVELDPVEDDFKDPGGVELPALKQPSLSNYDPSL
KPNTNLKIADDEDKVDFTQGDGLMDYTSNIVPKAFKKDKKAKEEFGRDQFLGTVATSGGF
VMVKYRDHEFVDGDRIRIFMNGDVIKSEVSLGGSFKGFTLTLDEGNNQIVFQALNQGSSG
PNTAELHVYNDKGQLISAAEWNLLTGNKATIEVLKQ
>OMIFANIC_01984 Carboxypeptidase T
MKNTRTTTIFLLLFFVLSTSILSQETVYSKVRVSLDNSSEIERLAGLDFDLDHPEFEGED
SLYLYVTEAEITKLRYHNFQFEVVIPNFREYYAEMLMGDAENIQNMTRSDFVADGFDLGS
LGGFYTFAEMEAKLDEMKTNYPNLVTTKSSIGTSIEGRPIWMVKISDNPDLDEPEPAAYF
DGVHHAREPLAMATTINYMFWLLENYETDPMVQFLVDNRELYFVPIVNPDGYVYNEETDP
DGGGLWRKNRNPNGGGLCIGVDLNRNYSFGYAANESCSSPNPCSGVYRGTAPFSEPESTA
VKDFLALIQPNTAFSTHSTAGSYLMPYGFDTSPPDFEIYSEWASAFLDDNDYPYGVTFQM
LGYTSCGTTRDYLHSEGIYGWTPEIDGDGFWPPPSTIFELVDENLRALFYQSWISGAYLD
VQSHTQIGNALPGESFQLVVEIKNTGVGAEAQNVSVILSTSNTNVTVPTANDYGIVSARE
KKDNNASPFIISLDPSFVGSYFDLTITTYQDAVANESIDIPIFVGEGTTLFFDDAENGMS
NWTASGNGISWSEVGDDSYSGDFSFGDSNGGNGENNTSNNFELNQTFAFDIDFRPVVTFA
TKWSIESDDNANFQVSTDGGTNWNTIKEYSKNNDWTVELFDLVAYSGLPDVRFRFTMDTD
GFIPGDGFYFDDFTVKEYDNNTLGNNEFYNEAIAVYPNPFGADGFRIQAPLDVISEISGI
QMNDVLGRTMELQYNVENDAIAVSETASMGPGIYFISLLNSKGSILTVKKLVKL
>OMIFANIC_01985 hypothetical protein
MFYPAKFSILQIPSGVPHPDDNTPVDLTNPADLIIYLVIPVVIVILYLVFIKRKKNISN
>OMIFANIC_01986 RNA polymerase sigma factor SigA
MRQLKISKQVTNRETKSLNNYLQDVSKIDLITAEEEVELARLIKEGDERALDKLVRANLR
FVVSVAKQYQNQGLRLPDLINEGNIGLVKAAKRFDETRGFKFISYAVWWIRQSILQAISV
QARVVRLPLNKIGLINRIRKTSLHLQQVYERQPTVAEIAKEMDEHVDKIKNAMKESNRSI
SMDAPFQEGENDNNLYDVVKSSESPVPDNELMRESLEIEIARTLNTLPDREADVLRLNFG
LADQPAMTLQEIGDTFDISRERVRQIREKALGHLRSKHKSHILKKYLG
>OMIFANIC_01987 Outer membrane porin F
MKNLIALTLLSGTILLTSCVSKKKYVELESQYNTTRSTLTKTQLEKEEIEAKYAKIEERV
ASYNAKINSLTQENVDLETNSLRNYGNVVLSNKDKEQMKQALANVDQNELAEAKTLQDSM
NLIVSYNLKKNLDNNLVAEGEEDDIKIDIDETVVMITISDKLLFNSGSYRVNPKADNLLE
RLANVINSEPAMEVLIEGHTDARTVKKGAYIKDNWELSVQRSTAVIRKLQEQFGVAPEKL
IAAGRSSFAPVSDNDTEEGRSKNRRTRIVILPNLDKFLALLSAN
>OMIFANIC_01988 hypothetical protein
MKIESSKYRGLYRYKISEPFGNFYIFDDYVISEINEGVHFNWELAEIVIEQVYDYFGSRD
IKLSYISNRIHSYSLHPQDWLRFYQERHQLEAFAIVAYNKIGLMNVILEKLFSQTRIRKF
RNLDVAIEWVSEIKIQDQEHSA
>OMIFANIC_01989 Putative ketoacyl reductase
MNDIKGKVALITGGTKGIGYGIAEALMRKGVHVAITGRGEVSAQKSAQELMKSINGTVRA
IGLSADVRDYPSQESAMRAVMAEFGKIDVVVANAGIGHFGSVESLTTKQWQETIDTNLTG
AFYSLKATLDALKESKGYYISISSLAGTNFFAGGSAYNASKFGLTGFTQAAMLDLRKYGI
KVSTIMPGSVATYFNDHVPNEKDSWKIQIEDIGKLVVDLLEMHPRTLPSKIEVRPSIPPS
AKA
>OMIFANIC_01990 D-alanyl-D-alanine dipeptidase
MKMVPIYIITLLTVQLQSQSNLVDIASLSTEFDYEIRYATSDNFIGEVLYDCPKCLLQKD
VANALLKANQYFCELGYRIKLYDCYRPLDIQKKMWAKVPRATYVANPYDKGSIHNKGAAV
DITLVTLEGCYVEMGTDYDYFGREAHIDYFNFPEDIIANRNLLMDGMKKFGFKTIRSEWW
HFSFRKNMSFPTMNEPLPCED
>OMIFANIC_01991 putative zinc protease
MTSCKDNNSNNVAASEFSIEYEKFTLDNGLEVILHVDKSDPIVAVATMMHVGSNREKPGK
TGFAHFFEHMSFNDSENVPVGANRKMIPEWGGSRNGGTWSDGTVYYEVVPKDAFEKILWI
DSDRFGYMINTVTEAALEREKQVVKNEKRQRVDNAPYGYTDEIIRKNLYPEGHPYNWTVI
GSLPDLQAATLEDVKEFYNEYYGAANASLVIAGDIDIEETKQLVEKWFGEIPSGPEIEPL
KPMPVTLSETKSLSFADNFAKLPELRMVFPSVEQYNQDEYALQVLGQLLSGSKKSPLYRT
VVEEGKLAPNVRTYNATNELAGEFVVRVRANEGVALDEVKKAIDKGLNKFESDGFTDNEL
QRIKAELETQLYYGVATVLNKAFQLVQDNEFGNNPGYVSKRAKYLQEVSREDVMRVYDKY
LKGKNYVMTSVVPAASPELAVTGAAEATVWQEEITAMKANEQVAQGEEAVYEKTPSKYDR
SEPAFGEAPLFKMPVVWQSNAENGMKLLGIENSELPIVTFNITIPGGHMLDPEDKSGLAV
FTADLMNEGTVNKTSAELEEAIGLLGSSISINGGLEEITISGSCLSRNFEPTLALVEEML
LQPRWDAADFERLKQEWKTGLKGREANPNAIAALNFNKLIYGPEHIAAIPTTGTLETAEN
VTLDDVKEFYKNLTPVNASLKVVGDIGEEEVRKAMANMAANWSGEAFDKPLMNVASESKE
PTLYFIDVPNSKQSVLYIGSMALSATHPDAAKLDFANEILGGGSSGRLFQTLRIQKGYTY
GAYSRIPSRSEIAPFTISSSVRANATLASLEIIQEMVRDYGTGFTENDVELTKNKIVKQN
TRAYESLNAKLGILTNIDKYGKPRNYIDLEQQELMAMTLDDFKSTIDKYMQEDKMIYVVV
GDKATQLEEVRRLGKKVVELDIFGNEIRELESREL
>OMIFANIC_01992 hypothetical protein
MNISIKSFKIISTLEAISFLVLLGIAMPLKYIWDMPEYVSAVGMAHGILFMMYLVGAWYM
KEKLNWTWRVLCISFACAVLPFGPFYVERKYLR
>OMIFANIC_01993 Miniconductance mechanosensitive channel YbdG
MNREQLIEYAGWLRDLLIEQGMGPFWASIINTVALIIVTTFIAVLIDIIIRKIIVQLFKA
FSNRSKTTFDDYLVKSNFPRYLAHAFPLALVWYLIPVIFADFRAVERHVETLAEAYLVIL
CILVFRSILRTITNYLRATNPKFADKPLESYVQVMMIFAWGAGIFFIVNAIFQYSIASIA
TLSAVSAVILLIFKDTILGFVASIQVSVNDTVRIGDWITFSKFGADGLVTEINLAAVRVQ
NWDNTYTTIPTYSLIADSFQNWRGMQESDGRRIKRSIHIKQSSVKFLSPEEIENFKAITL
VKPFIEHRQRDIDKYNARVEADKSILINGRNQTNLGIFRKYIDAYLHESPAINKDMYMMV
RHLNPTDKGIPVEIMCWSYDKVWQNYEAIQADLFDHFISAAKYFDLEIFELPTGKDIAAL
N
>OMIFANIC_01994 putative acyl-CoA thioester hydrolase
MRFHTRKWIKPEDLNPNGTLFGGRLLEWIDEEAALYAIIQLENPRTVTKYISEINFVSSA
KKGDIVEIGIEVKQFGKSSLTLGCEVRNKMTRQSIITIEKIIMVSLDEAGKPEPHGKTKV
EFVSDRLKED
>OMIFANIC_01995 hypothetical protein
MIMRTIRTLFTCLLVTVFIPVNAQTADEIIANYLENTGGIEAWESIQSMTTTGDAMMGGQ
SYPFVQTMMEDGRMVVNVDLQGMNFVPQAFDGERMWTTNFQSMEAEAMDEETSSNYKNNE
ANDFPEALLNYKEKGYSVELVGEEMMEGTECHKIKLTKNPVMVDGEEKPNVATYYLDKEN
FVPIVIENTVNSGPMAGTVTQTVFSEYLEAGDLFLPYSITQKFNGQAGQTIKITKIEFNA
EVDESLFVMPEATETEEEDKN
>OMIFANIC_01996 hypothetical protein
MKILKTIFVLLLIASVVPASAQTADEIISNYLENTGGAEAWNNIEGIKYAGTANAQGMTI
PIEYYQTKDGKQLLKINLQGQEMTQFSFDGDKMWTTNFMTMLPEEADAEATHNMKNQAMD
FPDPFVNYKEKGYTVELIGDETMEGTETFKIKLTRKPMLVDGVEEPNVTFYYFEKENFVP
IATEAEVKQGPMKGQMLKDTLSDYQEVEGLYFPFAITMGGGQPVTMTEIVINPEIDEAMF
AMPEVEETEDKK
>OMIFANIC_01997 Xyloglucanase Xgh74A
MKKLIILFLAGILFPIELPAQEISLKGKELFGDMRARHIGPALMSGRINDMEMHPTNTRI
LYAGTAGGGVWKSSDGGATFVPIFDDYVQSIGVVKLDPKDPDQTIWVGTGETWTRNSVSV
GDGLYKSTDGGSNWNEIPGFENSERIASIAINPNNTDEVYVGVLGALWSDSEARGVFKTT
DGGKTWEKILYVNPSTGAADVIMDPKNPNVLYASMWQFRRTAWGFNSGGADSALYKTVDG
GKNWNKIHNGFPPGDLGRIAVQLAPSDSSIVYAVLETEDRTKNGLWKSTDAGQSWEHLNA
DFGLTVRPFYFSRITVDPKNPDVVVKGGLNGSISRDGGKTFKNLGNMHSDIHDITFHIED
SDIMYSGTDGGVYRSWNGGTTFEIVENLPLSQFYHISVDDAEPYNVYGGLQDNGSWYGPS
SSPGGVNARDWNSVGYGDGFRVLKHPTKNIIYSEMQGAENVWRYDADRNRTKTIQPLPGK
GDPELRFNWNAPMAVSNHAPDRFYMGSQFVHRSDNMGDSWTIISPDLTTNDPAKQDQSKS
GGLSVDNSGAENHTTIFTIAESPLDENIIWVGTDDGNVQVTTDGGKSWNNVTANLTGIPE
NTWVYHIEASVHGKGTAYAVFDGHTHGDMKPYGLKTTDYGKTWTNIISDDIQENAFVRNI
QEDYENENLLFLGTEFGLYVTIDGGKNWSHFTNNMPPVAVHFIDLQKKTNDIVMGTHGRG
VIIIDDISPLRELNQSVLAKDVHFFKTKPFTMVEDSGFSGNFGAETQFVGGNKSTAARIV
YYLKKRHTFGKMTMEVQDMQGNKVLTLSPGKSKGINVVNWNYNTYAPEMAQAKTLSFGGF
TPPRVPAGQYKIVLKKGKNTYEHLIDLKYDEKSLTTLAERKEQEKFTRTLFDMVEDLAYT
VYELNGIQNKAQEVMDKNPKGKKQAGKVYDALEALKKDLVITTGDNYVASAEPELREKMG
DLYANVASSYDRISGAQKQNFELISEEWSDAKGRYQAIMDKEGKKFMSFLEKNDIAAPKL
KSKEEFLKKD
>OMIFANIC_01998 Succinate-semialdehyde dehydrogenase [NADP(+)] 1
MAEIKSINPYNGNEIETFQTHTPDEIRRILTKADSRFRQWRKTSFEDRSKLMIAAANELR
GNKEEYASLISREIGKPISQAIAEVEKCAWVCEYYAVNAANHLADESIATDARKSYVSYE
PLGVILAVMPWNYPFWQVFRFAAPALMAGNIGVLKHASNVFGSALNIERVFTRAGFPEYC
FTSLLVEKEMVKAIIENPVVKAVTLTGSGPAGASVAMTAGENIKKMVLELGGNNALIVLK
DCDMEATLETCIQARFQNTGQSCIAGKRLLLDEAIADEFLSSLVKKVKALHSGDPTHPET
YIGTLAREDLAEELEAQVLKSIRMGAKLETGGKRNAAYFEPTILSGVTSDMPVFVEETFG
PVLSVTTFRSIDEAIDLSNRSKFGLGVSIFTRDVTAAEKWVHRFEEGAVFINELVKSDPR
LPFGGIKESGYGRELSEHGIKEFVNRKTVYIK
>OMIFANIC_01999 hypothetical protein
MELRDASLVRLRPEIPNATINPAMTSEEIFQNRTLRPVAKLQNELLLEVFRNYVRKHKNV
FYDLSLEKRLDYMENAIHKDMKFRNSLKGIIIGQFTVDEYKEYTLNSSALNKRMMNIVKE
RLKSNVQLLEYQYAH
>OMIFANIC_02000 hypothetical protein
MNPELVFALQLLLAHVITDFVFQSKKWIKQKRKKKARSPFLYIHAVLAGLITYVIVQDWS
MWLVPVIITVTHFFIDLWKLHQESDSLRYFLWDQFFHMLVLVAVWLYATDHFGDLIPFIA
SVLGSEFFLVYVTGYLLVIFPIGFIIGKATQRWQKEIKKEDGLKSLEKAGRYIGIFERIL
VLTFILTDNFSAIGFLIAAKSILRFSDKSKSGARKQTEYVLIGTLMSFALTILIGFLMRV
LIFQ
>OMIFANIC_02001 hypothetical protein
MMKNATIAVITGDLVNSSQFSHTRLQAIIQRLKNEFETIQSEKRANRITFTMFRGDSFQG
IVEDPCEALQISLQIKALINSFNDSGEVAGNTVPIADVRISIGIGEASYDLDAINVSNGE
AFQFSGRTLDSMKAEHVKMALRTANAQINDEFRVHMKFLDSITDRWSMASAEVVYFLLKR
YKERQIAQKLNRSQAAINHRKKAAGWDEIQLLFDRYEQVIKKQFV
>OMIFANIC_02002 hypothetical protein
MGTILTKDIFSFLKQLKKNNHRDWMQEHKKQYQANEKHLKQFYADVEASLNETDDIAKVK
VFRINRDIRFSKDKTPYNVHRSVSFSRAGAHRRGGYYLRLEPGNSLMAGGFFGPEPADLL
RIRQEFDMDASEIRKILNKKSFKDAFGGFNQEFAVKTAPKGFSKDHPNIDLIRLKSYFVS
HDFTDKEVMSPDFKDNLVHHFKLLRPFFDYMSEVLTTDLNGVSLLKE
>OMIFANIC_02003 hypothetical protein
MTTTKPNTGFWIIAVFAFLWYLFGVYQYLLSTVWYDDTVKATMSEGLINIVDGLPSWYNY
VFALAIFSGVVACLLMLARKSLAIPLFGISLLAVLVQMCYWLLATDVMEVEGLKAAIMPL
LVIIVAIFLYFYSKGASQKGWLR
>OMIFANIC_02004 Cobalt/magnesium transport protein CorA
MTKPARKNRKLNINIIPRRKAENQIPGAVKYRGRKKDKITKLEIIDYSKSHFDTFYIEEV
QDAFKFRSTDQVTWINVDGLSNTDQIELLGTHFQLHPLIQEDIVTTTQRPKMDEYDDYLF
LVFKMLHYNERAELIFEHVSMVLGKCYVLTFQEADGDVFDGVRERLKNDKGRVRSSGSDY
LMFALMDAVVDNYFTVIETLSDKIEILEDQLFENLASDNIAFQIQDLKKEVLKIRRAIVP
LREVINRLEKTDTELIEQRTNNYIRDLYDHIIQVSESIDLYREMTWGLMDMYMTTISNRM
NEIMKVLTIMASIFIPLTFMAGIYGMNFENIPELKYKYGYFVLWGLMILVFLGMLLFFRR
KKWI
>OMIFANIC_02005 Phosphoribosyl-AMP cyclohydrolase
MKIDYNKYSDGLVPVVVQDVLSRNVLMLGFMNEEAVRQTLDTKRVTFFSRKKESLWTKGE
ESGNFLNLVSITQDCDNDSLLALVKPEGPVCHKGTDTCWGERNIPQFGFLSYLENVIQER
KDNPEMENSYVASLFRKGVNKVAQKVGEEAVELVIEAKDDNDLAFLNEAADLLFHTMILL
QTKGFHLRDVDKTLRSRHKFE
>OMIFANIC_02006 Imidazole glycerol phosphate synthase subunit HisF
MLTKRIIPCLDIKDGRTVKGINFINLRDAGDPVELAEVYSESGADELVFLDISATEENRK
TLADLVLRVAARIRIPFTVGGGISSVEDVDLLLKNGADKVSINSSAVKRPELINELSGRF
GNQCIVVAIDAKKIDGNWKVHLIGGKVPTEVDLFEWAVEVERRGAGEIMFTSMDHDGTKN
GFANEALAKLSELVNIPIIASGGAGIDQHFADTFIDGKADAALAASVFHFKEIDITELKQ
NLKEQGIPVRL
>OMIFANIC_02007 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIEGKCVRLSKGDYNTKVIYNEDPLEVAKEFEDHGIEYLHLVDLDGAKSNGI
INHRILESISGKTKLKVDFGGGLKKDEDVRIAFECGAYQITGGSIAVKSPDIFMNWLNKY
GRERIILGADAKDEKIAISGWLEASEEELVPFIKDYVARGVKYVICTDISKDGMLEGPSF
KLYEKIIGKVEGLALIASGGISEFSELNKLSEIGCEGTIIGKAIYENRISLKQLEKFILN
AH
>OMIFANIC_02008 Imidazole glycerol phosphate synthase subunit HisH
MKIVQIDYGAGNVKNIQFAFERFGFSPILSSDPDEIMGADKVIFPGVGEASSAMKKLRHS
GLDRVIPNLTQPVLGICLGMQLLCDISEENNTRGLAIFNQQVKRFSNAVKVPQIGWNSIH
ELRSHLFDGVRENEFMYLLHSYYVPLCEETIAVSDYEIPYSAAIQKNNFYGVQFHPEKSS
VAGELILKNFLAL
>OMIFANIC_02009 Histidine biosynthesis bifunctional protein HisB
MKKKVLFIDRDGTMIRETADEQIDSFEKLDFYPKALSVLRKIAEQLDFELVMITNQDGLG
TESFPEDTFWPVHDFILKTFENEGVVFDEIFIDRTFPHENANTRKPNTGLLTKYFSEEYD
MENSFVIGDRLTDMELAKNLGARGIFINDNTQLGNSEITVNRDELGSVISFEGNDWDDIY
TFIKLGSRKAATSRKTNETDISIQLNLDGTGQSDINTGIAFFDHMLDQLSRHGLMDLKIH
VKGDLEVDEHHTIEDTAIALGEVFAQALNSKLGIERYGFCLPMDDSLAQVAIDFGGRNWL
VWDAEFKREMIGKMPTEMFYHFFKSFTDGAKANLNIKAEGTNEHHKIEAIFKAFAKAIKA
AVRRDPEKLLLPSTKGTL
>OMIFANIC_02010 Histidinol-phosphate aminotransferase
MNKRVIDLNSLVRPSVRSLKPYSSARDEYTGTTSEMIFLDANENPFDNGVNRYPDPHQRT
LKSLLAELKGVPEESIFLGNGSDEVLDLLFRAFCEPGKDNCVTLPPTYGMYNVLAGINNV
ENRGVLLTSEFQPDLQAISSKWDEQSKLLFICSPNNPTGNTATRGSVEQLLNEFNGLVVI
DEAYIDFAGSDSWLDDLKNFSNLVVVQTFSKAYGMAGIRLGACYASPEIIEILNRIKPPY
NVNELTQQRALKRLGNKILIENEIHSIKEQKDILSKQLLEVNFIEKIFPSEANFLLVKVD
NADARYQQLVDCGLVVRNRSNQPLCENTLRITIGTPEENELLIKKLQTI
>OMIFANIC_02011 Histidinol dehydrogenase
MKKIKYPKKEDWNIMLKRPSQTVDDIEKTVIEIFSEVNTKGDKAVKKYTELFDGIVLQSL
AVTQDEIDASVNMIDTGLKESIQLAKNNISLFHEAQRTQRVELNTMEGVSCWQEKRPIQK
VGLYIPGGTAPLFSTVLMLAVPAVLAGCEEIVLCTPPDSEGRINPAILYTAQLCGIKKIY
KVGGIQAVAAMTFGTETIPAVYKIFGPGNQFVTVAKQLATKFGVAIDMPAGPSELLVFAD
ETANPAFIASDLLSQAEHGSDSQVILVTTSEALLDNVLKEIDDQLQLLPRAEIAQNAINN
SKVILVEDSETALNLINEYGPEHFIVSASDEDFFATNILNAGSVFIGDYTPESAGDYASG
TNHTLPTNGYARQYSGLNLDSFMKSITFQKITKAGLKKLGPAVELMAAAEGLQAHKNAVT
LRLKEIIENE
>OMIFANIC_02012 ATP phosphoribosyltransferase
MKLKIAIQKSGRLHDESLKLLKDCGISIDNGRDQLKAAAKNFPMEIYYLRNGDIPQYLKD
GVVDCAIIGENLLIEKGNDIAITEKLGFSKCRVSLAVSKIFEYDNIKDLEGKRIATSYPV
TTGNYLKEQGVNAELHIINGSVEIAPNIGLADAICDIVSSGSTLFKNNLKEVEVIMKSQA
VLAASPQISESLREILNKFRFRIQSVLKGRDYRYVLLNAPNENLQKIIDILPGMKSPTVL
PLAEEGWSSIHSVVNQDMFWEVIDSLKTAGAEGILVCPIEKMVM
>OMIFANIC_02013 Outer membrane porin F
MKNFLIAFLVFLVWSFFGLWLYSWLQPDNEELPETTEVAIKNSEEGTNETKVDTPSEIKG
TPLVIGNDSTEIVEAYKEEFISAPTTGLRAISETDDIIFFYPEGFIIRKNSQLVDVPSNL
VDFKYKLNTYILEHPDTELHITSQYSPGENIESPNLGIKRGQVIKQLLVETGISSEKIVI
KPFITQIAFSTEDTFRHSFSFTFKPLNNERIEALKKQIPETRVVYPEFSYQGILVNEDLL
KLRQEVSDIIKENPNLHLEVVGHTDNVGNAIDNYTKGLEYARQLRWFLVNKSGIDRNKIT
AVSKGESEAIAGNGTEKGRNLNRRLEVKFYLDTDE
>OMIFANIC_02014 50S ribosomal protein L21
MNNISEFIQELPEFTGIFILMLSTFLIGYFAASWFQRNKFKKIITRLKKEINALKSPMKQ
EKDIDTLFSEIKPRIIEVVKQTQEEIEEEEEEELEEEEYRKFEQMTPPKSIAEKARTTFV
NYSIDRPELDFESFGYADHDQKDDLTQIMGIGPYIEQKLNEIGICNYSQISKFKETDIRV
ITELIDFFPGRIERDNWVGQAKALTKVS
>OMIFANIC_02015 hypothetical protein
MKKFLLLFTLLINISVSAQDPIFDPSMTITEFGIVSSPIGEEVDKVIDGTSSTKFLDFEL
GDGIGFTVDLGGASRTAISMDITTANDFPVRDPIDFEVFGSNNGSSFTSVATGTIDCISD
RFFTRSYTFTNTTAYSFYRLNFSAPCDPSGGTGIPSIQIAEVQLFEEVLAINDNPLSENI
VKVYPNPSSGILTVNYSGNDKIQSVKIISVSGKIVQEISNRAFNSEQTLDISSLGTGIYF
LRISSAASTITKKIIRH
>OMIFANIC_02016 hypothetical protein
MDKLPKIGIPLIIVIIILVIAFAKSAVTIGSGEAGVLYKTFDDGVVTDKPPLGEGFHLIA
PWNKVIIYEVRQQELFEKMKVLSSNGLEIQIDASAWYQPVYNDLGNLHQSLGENYLQRVI
QPAIRSAARSVVGRYTPEQLYSSKRDAIQDEIYTETKKILEAQYVQLNEVLVRDVTLPGT
IKDAIERKLKQEQESLEYEFRLVTAAKEAEKVIIEAQGKADANRILSASLTDKILQDKGI
EATIKLAESPNSKVIVIGSGDSGMPIILGNQ
>OMIFANIC_02017 hypothetical protein
MTAETILYIIIAAVIAFAVAVFMYGYKAQQSGKQRWLYGILRFLSLFALFLLLINPKLKS
ETYSVEKPKLPVLIDNSSSITELNQASNVNDILSQLRSNSDLNDKFDISYYTFGNNLNSN
DSLSFSERNTNINKALSSLNSVFKSDTAPAVLITDGNQTLGTDYEFGTSGFKNSIYPIIL
GDSTQYTDLRIEQLNTNRYAFLKNQFPVEVILVYNGATSANSQFVITQGGTTVFRENVAF
TELNNTRALSFTLPANSVGLQRYTAQLIPLGEEKNKTNNVKRFAVEVIDQATNVLIVSKL
IHPDLGALRKSITSNEQRTVTFKNPAEALPLLNDHQLVILYQPDGTFANLYEEIEKLKKN
TLTFAGMETDWDFLNAIQQNFEKDATYQSELATAILNMNYGTFAVEDIGFDDFPPLRTAF
GALEVTIPHESLLDQAIDGFASESPLLATMELNGIRDAIWDGEDIWKWRAQAYLNTGSFE
PFDDFIGKLVQYLASTKRRSRLEVTSETFYYNNSSIKISAQYFDSNYVFDPRASVTISVT
NSETEEQRTFPMLLKGNFFEVDLSSLAAGDYRYSVAVRDEAVSRVGNFTIMEFNVEQQFL
NADVTKLQRLATNTGGQAFFATEGELLTGALINDNRFQSVQKSEQKIVPLIDWKYLLGLI
ALLLSLEWFIRKYNGLI
>OMIFANIC_02018 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKTAIITGGSRGIGKGIVETFAKHGANVAFTYNSSQEAAEAIAEEASKEGVKVKA
YKSNAASFNESQELAAAVLEEFGSIDILVNNAGITKDNLLMRISEEDFDKVIEVNLKSVF
NMTKAVQRAMLKQRKGSIINMSSVVGVKGNPGQTNYAASKAGIIGFTKSVALELGSRDIR
CNAIAPGFIETEMTGKLDEAVVQGWRDAIPLKRGGTPEDIANACVYLGSDLSAYVTGQVL
NVDGGMLT
>OMIFANIC_02019 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKDSKIIVQGFTGSEGTFHSGQMIEYGTNVVGGVTPGKGGQTHLDKPVFNTVEEA
VKNTGANVSIIFVPPAFAADAMMESADAGIDVIITITEGIPVADMIKVSAYLKDRDCRLV
GPNCPGVITPEEAKVGIMPGFVFKKGKVGIVSKSGTLTYEAADQVVRQGLGITTAIGIGG
DPIIGTTTKEAVELLINDSETEAVVMIGEIGGQLEADAAHWYKNSGSSKPIVGFIAGETA
PAGRTMGHAGAIVGGSDDTAQAKKKIMRECGIHVVDSPAEIGKRVAEVLK
>OMIFANIC_02020 hypothetical protein
MSNNAKEIVRSFYKSDILNDDTVLERYMHKDLVLIWNSADGLSIMNYDDLVEFFAEVRRS
YNDLRIEVSHLLQDDNHITIRYKYYIRTMENPDEELGIAHFIAIWEVKDDKLYRGYQVSQ
PVTDKDDTTESYHRVKV
>OMIFANIC_02021 UDP-3-O-acylglucosamine N-acyltransferase
MKFSTPQKLEDIAQILDCEYEGDADFPVLGMNEIHVVQSGDIVFVDHPKYYDKALNSLAT
TILINKKVDCPPGKALLISEDPFRDFNILTNHFNPFEQARAAIAENAVIGRHTVIQPNTF
IGNNVQIGNDCVIHSNVCIYDDTVIGNNVTIHSGTVLGADAFYYKNRPESYDRLISGGNV
VIKDNVDIGALCTIDRGVSASTIIGEGTKLDNQVHVGHDSVIGRRCLIASQVGIAGCVLI
EDMVTIWGQVGITSGVTIGEKAVISAQSGVSKSLPGHKSYFGTPADEFRKKYKEIASIRL
IPDIIDKLDKIQ
>OMIFANIC_02022 Elongation factor P
MATTSDIRKGLCIKYNHDIFKIIEFLHVKPGKGPAFVRTKLKSVTTGKVIDNTFSAGHKI
DDVRVETHKFQYLYNEGDTYHFMNTEDYSQIQLQKDTLDTPELMKESEVVTVIINTEDGM
PLSVDMPAHVILEVTSTEPGVKGNTATNATKPAIVETGAKINVPLFINEGDKIKIDTDKG
QYQERIKE
>OMIFANIC_02023 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTIHNNVVIGEGTWIGSNVTIMEGARIGKNCNIFPGA
VISAIPQDLKFNDEDTTAEIGDGTTIREYVTINRGTVDRGKTVIGKNCWIMAYCHIAHDC
IVGDNCIFSNNSTLAGHITVGDYVVLAGMTAVHQFCMIGNHAFVTGGSLVRKDVPPYVKG
AREPLSYVGINSIGLRRRGFSPEKIREIQNIYRILYQQNYNTTQASEIIEAEMEATPERD
EILQFIKNSKRGIMKGYFSSN
>OMIFANIC_02024 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MTECLVKQRTIGKEVSLTGVGLHTGKEVTITFKPAPENYGYAFVRVDLEGNPVIEADANF
VVNTQRGTNLEKRGVKIQTSEHVLAALVGMEVDNCIVELNASEPPIMDGSSKFFVEAIEK
AGLVEQDAPREEYIVKEVISYMDEESGSEITIIPSEEYQVTTMVDFGTKVLGTQNASLKH
LSDFKDEISDARTFSFLHEIEMLLENGLIKGGDLNNAIVYVDKELSPETMEKLREAFKKD
EISVKPNGILDNLTLHYPNEAARHKLLDVVGDIALVGTRIRGKVIANKPGHHVNTQFAKK
LSKMIKIDKRNKVPTFDLMKEPVKDVNEIMAMLPHRPPFLLVDKILELSDTHVIGLKNVT
MNEPFFVGHFPGAPVMPGVLIVEAMAQTGGILALSTVPDPENYLTFFMKINNVKFKQQVN
PGDTLVFKLELITPIRRGIVHMSGNAYANGKLVTEAELMAQIVKTKNI
>OMIFANIC_02025 UDP-3-O-acylglucosamine N-acyltransferase
MKFTATQIAGILNGEVEGNAEVEVSKLAKIEEGSKGSLTFLANPKYTQYIYTTEASVTIV
DRDFIAENHLSTTLIRVEDAYKAFSQLLEYYNQVKMNKSGIEQPVFISDSAEIGDNLYLG
AFSYIGENVRIGENAKIYPNVYIGDNVEIGDNIVVFAGAKIYSESIIGDNCVIHSGAIVG
ADGFGFTPNDEGEYSKVPQTGNVIIEDNVDVGAGTTIDRATLGSTLIKKGVKLDNQIQIA
HNVEIGENTVIAAQTGIAGSTKIGKNCMIGGQVGIVGHLTIGNNVRIQAQSGIGRNVKDD
EVLQGSPALKYGDYNKSYVHFKNLPKIIERFNTFEKNQNND
>OMIFANIC_02026 hypothetical protein
MKQPPKLTLVNDPIYGFITIPGPLIYNLIEHRYFQRLRRISQMGMSYLVYPGAHHTRFHH
ALGALHLMTQAVSVLRKKGIEISEDEEEALCVAILLHDIGHGPFSHAMENSIAENVTHEY
LSLLFMQVLNSEFNGKLDRAIAIFKNEYPRKFFHKLISSQLDMDRMDYLKRDSFYTGVAE
GVISSDRLIAMLHVKDDQLVIEEKGIYSVEKFIVARRLMYWQVYLHKTGIVAEQLLVKLL
QRAKELVQSGDKLPGSDPLLYFLKNQVNTKTFSKETLDIFSKLDDYDIISAMKLWMDYDD
FVLRNISKMLINRELLKIKLQNDPFAEKEVNSKKEILQKKYNITDHEATYFVFTGHISNQ
AYSMEKDTINLLTKEGIVKDVVKASDQLNLKALSEKVIKYYLCYPKSDY
>OMIFANIC_02027 Transcriptional regulatory protein ZraR
MSDIKVLWVDDEIDLLKPHILFLENKNYTVTTAQSGTEALEEMQKDRFDIVFLDENMPGL
TGLETLAEIKERQDSLPVVMITKSEEEYIMEEAIGSKIADYLIKPVNPNQILLSLKKNLD
HSRLVSEKTTSSYQQEFRKIAMDMSMINTFEGWAELYQKLVYWELQLEDIEDSGMFEILE
SQKTEANNQFCKFIDKHYPNWFSGEEEAPIMSHTLFKERVQPELESGTPTLLVVVDNLRY
DQWKAFEPFLSNIYKKESEELFYSILPTATQYARNAIFSGLMPSEMEKQHPDYWLNDPDE
GGKNMYEKEFLQSQLNRLRLDLNWSYHKISSLKQGKRLVENFKSHKDEDLTVIVYNFVDM
LSHSKTEMEVIKELASTDKSYRSLTLSWFKNSPLMEIIQQASHLGFKLIITTDHGTINVK
NPSKVIGDKNTSLNLRYKTGKSLTYEGKDVFAAVDPGKIKLPSIHMSSSFIFAKGDLFFA
YPNNYNHYVSYYRNTYQHGGVSLEEMVIPFAVLAPK
>OMIFANIC_02028 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MELTYTLQDLPEVAEKVLTGSSSKTLLFYGEMGTGKTTLIKEIAKNLGVEEAVNSPTFSI
VNEHILNSEKLYHYDFYRLESLDEALDIGIEDYLYSGHWNFVEWPEKVEALLPGESTKIE
LIKNENGSRTLNIMPVK
>OMIFANIC_02029 hypothetical protein
MKLTKYLMIVALFGAGLFISCTPESIEDEQTEQQIERPDIPQNG
>OMIFANIC_02030 hypothetical protein
MNKPNNKSKDQTFLKTGRSNLFIGGIIVFVIACSPFLFYAYESFPSDKSTWETSLFTIST
SYASVAHLAWYFLSKAIPLGLFLIWFFTCKHWWHWIILVPIAMYAFQLWGIINESNDLDE
LEIYYIIPLMLVVVPAVYLIRAKIFSKVRGTDLKSFEKELMEQKSTWGQIKDLFR
>OMIFANIC_02031 Alanine dehydrogenase 2
MSKPKSPFTKAQLLPQEEKLEVARQKGELFIGIPKETYFQEKRICLTPDAVTAITANGHK
VLIENGAGLEAGFSDQEYNEAGAVLTNDTKKVFGCPMILKVEPPTLEELELIKPKTVLIS
ALQLKTRQQDYFDTLAKKKITALGFEFIKDEDHSYPAVKALSEIAGTASILIASELMVNA
KKGNGLLFGNISGVPPVEVVVIGAGTVGQFAVRSALGLGANVKVFDSSITKLRKLQTNVG
QTLYTSTIQPKNLLKALRRCDVAIGAVRGTNRSPIIVTRTMVENMKRGAVIIDVSVDMGG
CFETTEMTSHDSPTQIKYDVIHYGVPNIPARYPKTASISISNIFTPYLLEIAESGGLENA
IRYDQGLKHGLYFYRGILTNKAIAEWFDMSYSDINLLIF
>OMIFANIC_02032 hypothetical protein
MKLIQRVAWYSGGFIVGIIVLMFFLSGKKTSCDYGPNARTLKNIRSKEMKISEDVRQMLS
DHDLDSTAILEVFLKGDVLFSESNTSMDSCKVYVVKGLTKGKELKVFVSNCNKDAKVSEV
IITGQD
>OMIFANIC_02033 hypothetical protein
MKYSMTIIFVSFAVIFSSFKILKETPYTDANSSEPTLTTITVTSPTGGQDYCFKQQQTIT
WLTSGGTVSTVSIYLMQPDGQTINRTIASNISNNGSYLWNGFATGLGNYLIKISGTDDTT
PTLVTGQTGTFTLKDCIKPDLNPQLSSITPLTRWRKRFEITISNIGTKVVQNPTIKIEID
RPGNLPTSNFTTTLNETIDINERVPFSKGIKMREPGNYTITTILDPNDLIDEVDETNNSH
TISLDVPPVPELIVYISNGKRPPVGREREIRIVVKNVGTGETHPNASFQIRSYVKQKGVK
HYDIPQLDMGETFTIKRKHKWGLSGTKSLNAKILYVGLEMDANNNFVESSFFVRLPHHDR
YSLAPKVKCSTGETFRNWDGIEN
>OMIFANIC_02036 hypothetical protein
MNNKSIKTNTKFRQTDKKKRIVKGVLLTALLVATPFLFYFYKHAPAESSEWNTWLGTVRS
GGFGSVQSYMHALFTKLTFILLTTIWFLTSKNWWKYAILIPLTMFLFQLSGVINYKIQYI
DEFDFWYSLPVILPILFFLIYISYRIRKRSDDGEDLKEQVDEEISNIFSDNL
>OMIFANIC_02037 hypothetical protein
MKKLMFTLALLGLALTASCTPESIAGDEQQIDKDKYEVPPNG
>OMIFANIC_02038 hypothetical protein
MITFDNKMIKKLIAKLRSVERKRLIIYIVVYFLWGILMHNVGQWLEIAKFTFWWQVISTY
LLYMIPISILLRGYSFFTQYAYGLVAMAVLEFGGYTLKTSYIYPDNILEQFFGVHTFALG
MAMFFALYFPVGNWAVHRIYLLFIDDSGRK
>OMIFANIC_02039 hypothetical protein
MYIPGTDKLDSVLLGSLGESIVATLPEGNPAKLHVPTVPSGGGALPANVVVSTGARSA
>OMIFANIC_02040 hypothetical protein
MVPDTEVFGSFASMNPTVVGPDSWVHVPIPAVAGTAFNVIVEN
>OMIFANIC_02041 hypothetical protein
MKKLVTLVFGILLMSIPAQAASSEASSASYYEYDGNAYIFIEGAVEFSVFPDGQFDFVYL
GRDARGNVNVNINTNNVNLNFNSGYNYDPFVQYDDYGAVIQIEDIPIYYDNYGRIIQAGN
TEIRYNNRRIVRVGGLRVFYNYYGNFSYCTGFINLWTPRYIYRPWHVWYVRPFYTSCIVY
DYPYRQFYRPHRYPYNYHRQHYRGRRVAYNNGRRNFYRPGSRVHYRDGRTAVNRDYNPNR
RNSMVSANSGRRDGLVDRKNNRNRNNKVDRSSSLNRKNAVSKRSDNIANNRGRPVSNKAI
NRGAPTTNRKSSLNTNKRGNNRKATVNRGNTNTRPSVNSNRKVTRSRPAVSSNRGNTKRN
SSVNRSTPSRNKSVVSNRNNRTKSSSRSYKSSNSSKVNRNATASRSRSSSNRSANVSRSK
SSSKRSSGTKRSNSRQGRRGF
>OMIFANIC_02042 hypothetical protein
MKRVLIITYYWPPAGGPGVQRWLNFVKYLKDFDIEPVVYTPENPNYPIVDPDLLKVVPEG
VEVLKQPIREPYRLAKVFSKKKTQQISMGIISEKNPSSLEKMMLYVRGNYFIPDARVGWV
KPSVAFLKDHLTDNTFDAIITTGPPHSLHLIGLRLKKILGVKWIADFRDPWTTIHYHKSL
RLSRSSEAKHKKLEAEVLRNADRIIVTSNSTGGEFSEITDSPITVITNGYEVTEAIIPKP
DKEFTLAHIGSLLSERNPEILWQVLNELCNENEKFQNLLSINLAGVVGDDVMQSLKEYDL
EDKVKLIGYVSHSEAKQLQHNAQVLLLLEMDKPETRAIIPGKLFEYLIAKRPVIALGPEG
SEIQEILKETNAGCFFTTSDKQAVKEQLLQYFNAYELGDLQVQSKGIDRYSRYELTRSLS
KVINGL
>OMIFANIC_02043 hypothetical protein
MQRIKDFLPHLIVLVLFLIASLAYFNPVLQGKKIFQSDIVQYTGMAKQQNDYRKASGEET
YWTNSAFGGMPTYQLGAKYPHNYIKKLDLTLRFLPRPADYLFLYFISIYILFLVLKVDFR
LAFLGALAFGFSTYLIIILGVGHNAKAHAIAYMPLVLSGVILTFRGKYLWGFILTTIALA
LEFVANHFQMTYYLLLLVLCIGVAYLVDAYRKKMLPHFFKSVAIMLLGVLIAVGLNATNI
MATKEYADTSTRGKSELTILPDGSPKQDGDGLSYEYITEYSYGPLETFNLFIPRFMGGGT
SEPLPQDGETLDALIRLGASPQEANEILGQLPVYWGDQPIVAAPAYIGAITIFLAVLALF
LVKGRIKWWITAAFLLSLFLSWGRNFSFLTELFIDYIPLYDKFRAVSSIQVIIELVVPIL
AVVGLHQYFNDFVKEEARKKALLWAVGITGGIALVFLLFKSAIPGLDFASPYDQELRDQL
GTPLVEAIRDDRASLFVTDTMRTLIFVLLAAVALWMFLKEKLKQNTVIAILAVLVIIDLV
GVNWRYVNNDDFVNARIMNQPFQKNPADIQILEDEGHFRVYDITTNPFSSGRASYFHNAL
GGYHAAKPGRMQDLDDYFLADGDIGILNMMNVRYIIGQSPNGGPVAQRNPFTNGNAWFVE
NVLIAENANEELLLLDSLDTKKTVVIHNEFKEGLPLDNIVRDSTATIDLTEVRPDYMVYE
SSSKSPQLAVFSEVYYPKGWNAYLNGEAVEYIRANYVLRAMALPAGNHKIEFRFEPKVIQ
TGSTISLSSFILLILILAGGLWYYRKQEKNDSEETV
>OMIFANIC_02044 hypothetical protein
MITFLKTVLVILLVYLGLKFLLKLLKPYIMRFILKKAGKQFEQSFGANPFQQNPPEQKEG
SITIDKMPSKNTKATSTVGEYVDYEEID
>OMIFANIC_02045 hypothetical protein
MTRIKILFLAALFLVNFGTISAQYTDMINTNRPGVSQGAFSVGKNVLQFETGFSYGKEDH
RLLSTETNVWAIDYSVRYGFFREELEVSLIGIFQSNNITDTRGAVPFEFTQSNFRSNTLG
AKYLIYDPYRKMEEKGPNLYSWKKNFKFQWADLIPAVSVYAGANFDFSDNPFTPEPETTI
SPKVVVSTQNNLVGGFVFVTNIIADRITTDFPSYGYIITLTHATNDYFSIFLENQGFKSD
FYADQLLRGGAAALINANLHVDASVTLNFKDTPSVFYGRIGVAYRFDMHGEDEYIEEKGK
SGRKKKRAEKGTSKKKNKRKNRKRKDDFIEDDGDGGGLQF
>OMIFANIC_02046 hypothetical protein
MIEITEVTNKKELKKFVTFPFKLYKKNKYWVPPLIKDEMETLDLTKNPVAKNAEATYYLA
YKDGQLAGRIAVIVNHLEINDQGKKKIRFGWFDVTDDIAVTKALLEKVFEKGRSLNLDYA
EGPVGFSNMEKAGILTRGYDEMNTMITWYHHPYYAEHFEKLGFKKQATWVEFRLRIPPEI
KDKVAKFSGIVKKRYGLSVIRFKNKKEILPYVDSMFDLLNKTYNTLQTFVPIQQYQIDYY
KEKYFSFIHPDYITCIKDKEGKLIAFSVVMPSFSKALKKANGKLLPMGWWHILQAQKKND
LAAFYLIGIDPEYQGKGVTAIIFEEMQYLFNSKGIDTVETNPELIENTAVQLLWKDYDPR
QHKERSTYRIDL
>OMIFANIC_02047 hypothetical protein
MIFDFRNGMNRNFLYPFFFIFIFLSTSFSFSQDFTAVDTKVRSYPETRLNSVHELAGMIN
QDFSSNIEKVRAIYTWITSNVAYSYDARSTMSITYYSEEERIRKMQRYQDVFANITLKSK
KAVCHGYSLLFNELCEQLGIESRVIRGFGKSYVSDIGAEYVSNHAWNMVTIEGKDYLIDA
TWGAGSMNGNHFKREVTYLYFLTPPEFFIKNHYPDNFSDSLLEEHVNKRSFLMNPVVFEK
ALSQYALINPGIGVLRMKSIEQFEIESKRPIGKIRYYMDGNFHDVESLLIQNNRYSFKID
LNGHYDRELLIYLNDEAAFGFKVRP
>OMIFANIC_02048 Putative pyridoxal phosphate-dependent acyltransferase
MRDLFDKIYKDKGPLGKWAEQAEGYFVFPKLEGPISNRMGFNGKEVITWSVNDYLGLANH
PEVRKVDAEAAAQYGSAYPMGARMMSGHTDLHEQLQKELAAFVSKEAAYLLNFGYQGMVS
TIDALVSKDDVIVYDVDAHACIIDGVRLHLGQRFTYKHNDMESIEKNLKRAEKVAEKTGG
GILLISEGVFGMRGEQGKLKEIVALKKKFNFRLFVDDAHGFGTLGKTGAGAGEEQGVQED
IDVYFATFAKSMASTGAFIAGDEEIINYLKYNLRSQMFAKSLQMQLVAGALKRLDMMRSS
TEFKDKLWENVNALQGGLRERGFDLGTTQSCVTPVYLKGSIPEAMALVKDLRENHGVFCS
IVVYPVIPKGLILLRMIPTASHTMEDINETLEAFSAIRERLENGTYKRLSAAVAAAMGE
>OMIFANIC_02049 Putative cystathionine beta-synthase
MKEAIKAHENVLELIGKTPLIKLNNITIGMKGDYFAKVEAFNPGHSAKDRIALYIIEKAE
REGILNPGDTIIETTSGNTGFSIAMVSILKGYKCILAVSSKSSKDKIDMLKSMGAQVYVC
PANVAADDPRSYYEVAKRLHTEIAGSVYINQYFNTLNIDAHYHTTGPEIWEQTGGQITHL
VACSGTGGTISGISRYLKEQNSEVQVIGIDAYGSVLQKFHETREFDKNEIYPYRIEGLGK
NLVPDATDFDSIDRFIKVTDEDSAIMAREIAKTEGLFVGYTSGAAMQGLKQLEEEGFFDA
ESKIVVVFPDHGSRYMSKIYSDEWMQKQGFGEAQNTEAVNIQYVK
>OMIFANIC_02050 Protease 2
MMKYLIVVCMASLIFATSCDKEKNTENNMELQPPKADKIAKNLEMHDDVRVDEYYWLNQK
DDPEVIDYLERENDYYAKMTADTDEFKEALFEELKGRIKEDDESVPYLYNGYYYITRYEK
GKNYPVYTRKKGNLDAEEEVLFNVNEMAEGYAFYNLRGINISPDNKWAAFGVDTLSRRKY
NIHIKNLETGEVLDEVIPLTTGTSTWANDNKTLFYTHKDEQTLRSSKIYRHVRGTDIEND
VLIFSEDDETFGTYVYKTKSKKYLVIGSYSTLTSEFQILKADDPEGQFKVFQPRVRGLEY
NISHFGDHFYILTNKDGASNFKLMKTSENTTEQENWEEVIAHRDDVLLEDVETFRDFLVI
SERSNGLNKIKISRWDESTDPYYLPFDNETYTAYTMQNMEFDSEVLRYGYNSLTTPASVI
DFNMNTRDKEIKKEVEVLGGKFDKNNYESKRVWATGEDGTKIPISMVYRKGMEQNGDNPL
LLYGYGSYGSTIDPYFSSQRLTLLDRGFIFAIAHVRGSEYLGRQWYEDGKLLKKMNTFTD
FVDATKYLISEKYTSTEHMYASGGSAGGLLMGAILNISPEFYNGVVAAVPFVDVVTTMLD
DSIPLTTGEYDEWGNPNKKEYYEYMKSYSPYDNVKKVDYPNIFVTTGYHDSQVQYWEPAK
WVAKLREYNTSDNVILFHTNMEAGHGGASGRFEALKELAMDYAFLLSLEGIKE
>OMIFANIC_02051 Nucleoid-associated protein
MFGDLMGMMGKLKETQQKVEATKKRLDTVLIDEKSNDGLLEVTITANREIKSVIIDDRLL
DDKEQLEDYLILTLNKAITKAGNVHETEVAAVAKEGMPNMKGMDGLFK
>OMIFANIC_02052 Disulfide bond reductase DsbH
MKYILIIAFMGLSAITYAQDNDNALAWYTNLEEAQKVSKKEKKPILLYFNGSDWCAPCKM
LKKDFFDTSEFRDRSEEFVLVMIDYPRRIDILSEEQFAYNKRLVAKYNKARTFPKILVLN
NKGKPQDEISGYSSLRDTSNHFAFLDRNK
>OMIFANIC_02053 Outer membrane porin F
MNKFFLLGLSLLVASVTFAQDLPTNPEPGKCYVRCTTPDVYVNETVQVMTKPAYKKLRTV
PAQYETVTERVMVKAPGKKLRVIPEKWGTETLTYVKKQAGSTLSVSAASFSSDSETLEIK
PAYAQWELGAPAPDCASSNPNDCRYWCYKGYPAEYTTISITRLANDASANRASVPEKMGS
YTKRIVTEPARVVEEDVPAEYANITKTVLVKDAEVIEETVPAVYKTVTKEVLQTKGGLTT
WKEVECELVEYQALPINWNLGSATLTSQAKNLIDTRLMPVLAQNPGVKLEIASHTDSRGT
SSSNQDLSERRAQAVVNYLQTKGVNPSLLVANGYGENRLKNRCSDGVSCTEREHAVNRRT
EFRLINN
>OMIFANIC_02054 hypothetical protein
MFELKQSGDKYHFVLKAGNGQVILSSQMYASKASAMNGIESVKKNCGDDNCFEKKTAKNG
KFHFNLKSTNGQIVGSSQMYAAESGMNNGIESVKKNAPGADVKEAE
>OMIFANIC_02055 L-allo-threonine aldolase
MITDLRSDTVTRPTPGMLEAIINAQTGDDVYKEDPTVNELERRMAQLFGMDEALFFPSGS
MANQAAIKLHTNPAEQLICDKWAHVYNYEGGGVSFNSGVSCKLIDGDRGMISAQQVKEAI
NPPDFYHSPLTSLVCLENTTNKGGGACYDMQTIKDIRQVCNEHGLGLHLDGARLMNAIVA
RKQDPREFGNYADTISICLSKGLGTPLGTVLVGKKELMKNAIRVRKVLGGGMRQVGFMAA
AGIYALDHHVDRLEDDHRRASEIASLLSELNYVRKVEPTETNIVIFYLDETLSEEKFMND
LNAKDILISNMGQGKLRLVTHLDYTEEMHRNFLDTLQHYA
>OMIFANIC_02056 hypothetical protein
MKKLLLVLFIISQPISAQNDEAYVDQLVNEFTAKLEERGIPNWYSNKRFCTGSIEMFQME
NGKMCTSKGTYFEVYVLWEEEGTTMIKKIDNCGLFYSIPLKNNELMEFVDTNYPDMQLNH
VKPYKADNITGNPVSRTTVQPCKRSYVFKKNGGEMKQNYSLYDLTTSEEHPNTNYEHNND
RKIVALDAKLDDVIDALAAKFKRQKN
>OMIFANIC_02057 hypothetical protein
MNKLAIILITLICTTTVSAQFLSKKKDLKKFDGFFDFHYSDDSGEIYLEVDKLDTEFLYV
HSLRTGLGSNDIGLDRGQLGGGEVVKFVKSGNKILLIQPNMDYRATSNNELERRSINEAF
AKSVIFGFPIKETIEQTYIIDLTPFLMLDAHGVVQRLKSMKEGTYKLDKSRSALWMERTK
AFPKNVEFEALITYTGVPTGSKLRSVAPNSESVSTIHHHSFVELPDSGYTPREFDPRCGS
YPTTHLDYSTPIWEPIKKRYIMRHRLEKKNPNAAISEAKEPIIYYLDPGTPEPVKSALLE
GAGWWNEAFEAIGYKDAFQVKMLPGDADPMDLRYNVIQWVHRSTRGWSYGSTISDPRTGE
IIKGHVSLGSLRIRQDFMIAQALMNRPFAQSDANVKPMMDMALARIRQLSAHEVGHTIGF
AHNFAASMNNRASVMDYPHPTLSLKNGEIDFSNAYATGIGEWDKVTVAYSYSDAPQGTAE
EEYLNGLLDAAFNTGLRYITDSDARAQGGAHAKAHLWDNGVDATSELLNVLEIRKQAIAN
FSADNIRTGEPLTVLEDVFVPLYFFHRYQTEATVKLIGGMEYDYSLKGHEGVMPRYLSAE
KQKNALKVVSATLKPNHLMIPEDKLKLFPPRAFGYNRSRESFKSDMGVSFDALGAAATAA
DMTLKLLLNPQRANRLVQQKALDPFNLGFSDVLESLPLYTPVKDVSGKYEKELTRTINFV
TLDRLLSLLADSKALPQVKALINDKLNDLSSLVNKKDPLDRELLLMIKQFREDPDEYKTI
STPDIPDGSPIGMDCSGPNYNH
>OMIFANIC_02058 Peptide chain release factor 2
MKRLRNKKKWVEDYEKAVALTDDAEVIYEFFKEGEGEAANVENRFQLAFDTVETLEFKNM
LSAEGDDLSAVLQITAGAGGTESCDWAQMLMRMYLMWAEKNGFKVTELNFQQGDVAGVKT
VTLEIDGDYAFGWLKSENGVHRLVRISPFDSNAKRHTSFASVYVYPLADDSIEIDINPAE
ISWDFARSSGAGGQNVNKVETKAILTHHPSGIVIHNSETRSQLENREKAMQMLKSQLYEI
ELRKQQAQRDEIEAGKMAIEWGSQIRNYVLHPYKLIKDVRTQHETGNVDAVLDGDLNAFL
KAYLMMKGQGEKSKEL
>OMIFANIC_02059 hypothetical protein
MKFNRLPILLGLVLSAVSIAQDLSFEEYNPISTLVVDGSPVLNAKFPFIDIHGHQYRMSG
QDLSPVVAAMDTLNMGIMVNLSGRSGDDLKRSVSNIKDNFPNRFVVFANINFEGVGSPGW
TEKTVAQLEEDVRSGARGLKIYKSLGLRYIDPNGNRVTVDDARLDPIWAKCGELGIPVLI
HTADPKSFWDEFDGDNERWLELKLRPRRKRSATNPAPWEQLIAEQHNMFKKHPNTLFVNA
HMGWYANNLGKLGQLMDEMPNMYVGIGAIIAELGRQPRTARAFFIKYQDRILFGKDSWKP
EEFPTYFRVLESDDEYFPYHKKYHAFWAMYGLDLPDDVLKKVYYKNALRIVPGLDKSLFP
N
>OMIFANIC_02060 hypothetical protein
MDAIEEIIANLQLQPHPEGGYYRETYRSEGTIPVSVLGEPYSGDRNIATGIYFLITSGDF
SAFHKIHQDEMWHYYKGAAMNLHLIAPDGKYTLKKIGNDLTTGEVPQHTVPGGYWFASEV
SEENSFSLMGCTVAPGFDFKDFEMPSGSKLIGLFPQHKNIIDQLTRN
>OMIFANIC_02061 Phosphoglycolate phosphatase
MERPVSTIIFDLGGVLIDWNPEYVFLKEFRGNREKMDWFLNEICAWDWNANQDAGYPLAR
ATEDRIAMFPEFEELIRMYYGRWDEMLGFAHDDTLEILESVVNNPDYRVLALTNWSGETF
PNAIAKFDWLQWFEGILVSGNEGMRKPFPEIYELMLSRYQINPAEAVFIDDSIKNVEGSK
LVGIRGIHFTGASNLIRSFDDLGIRI
>OMIFANIC_02062 hypothetical protein
MKKMKVAVLGPIPRDYIITHNNEEIQKYGCVTHTAIALSNLLGSKGTVFPVTHIRKSDAP
GIEELFRNYSNIDTSFISSEADMGDVIQLKFTDQNNRLETQTAFMKPIMPEDVEALLDCE
VFVCVPVTDFEVPLETLRYIKENSDASIVFDAHGPTTALTTRGERITKFWVDRDLWLPYI
DVLKMNLEEANCSWFQNEYTLEELRNNDEIEIEQLPNFAAHCLRHGLKSLFVTLDARGVM
VYTMENGELKQQLVPSIPVDHVVDTTGCGDSFAGGIAFSMMFAPNNHIQAAQFGNAMGAQ
RTQGKTFDVFKSLKETQAILDKTYS
>OMIFANIC_02063 hypothetical protein
MKAATVAQIRKELKYRSSDELEQLCLRLARFKKENKELLTYLLFESDDESGYVEHVKEHI
RDMFSDINTSSFYYIKKSSRKILRETKKFIRYSSVKETEVELLLFYCNQLKAFRPKIDGN
RMLMNLFDRQVQLIKTKIKGLHEDLQFDYTAELNTLIQKT
>OMIFANIC_02064 Protein YceI
MNIARNFWRFTLLIGIALVLNAFTGPSEDLQKLTAETNHSSLLFSVPIANGITRITGKYN
EYTIDLDYVDKDFTKSVLSATIKAASIDTGIDGRDEHLRSSDFFDVGTYPEITFRSDRIV
ETDIGYTAIGNFTLHGVTKELEIPFVITGMDGENTLGISSRLSIDRTDYGVGNDFKHTSI
ENFISNTIDIEIDFWTKKRKEPKKEE
>OMIFANIC_02065 Arsenate reductase
MTTIYHNPRCRKSRETLHLLEERNESVNTVLYLDDPPTVKELKNILNMLGMKPIELVRKN
EAIWKENFKNKDLSDDDILKAMRNHPKLIERPIVLKNGKAALGRPPENVINIL
>OMIFANIC_02066 hypothetical protein
MKPTITLILFLSTLVALGQPSNSNAEIERDYKVSGEVLEKGSNQPLEYASVSFLDVNGNV
AAGGITDLDGLYSIKVPAGTYTVQFDFISFKTFTLTNQVIDKNTKLPTVYLEIDAESLEE
VVVRAETTEVQIRLDKKIYNIGKDLTTAGATVSDALNNVPSVTVDVEGNIALRGNDNVRI
LINGRPSALAGFGSTDALRQLPAEAIERVEVITSPSARYDAEGTAGILNIVLRKDKTLGL
NGSIITNAGFPWSAGINGNVNLRTKKFNIFNTTGYRYRESPGNAFFENRYFSQNRENPLV
QEDRDYDRVGRNFNSNLGMEYFLNERSSITASGFIRIGNDDDVTTNITNEFNRDNQLAVT
TSRVELEGEEDNNYQLALNYRNKFNNQGHELTADFQYEISDETESADILERLNFPNVTNL
PSEIVTTVEDQTEYLAQIDYVLPIGENAQFEAGYRGNFQETITDFSVLDEVATSGAFIKN
DSLSNIFTFEQNVNALYTQYGNKFGKFSFLLGLRMETTALKGDVSAEDIGSTSDEFELTF
DKDYVGLFPTVNLIYELGERENITLGYNRRINRPRFWFLNPFPSRSSEANIFQGNPGLDP
AYASAFDLGYLKRWDKITLTSSLYYQYETDSFERIQEDTGQLTPNGIPIIRTLPINLSTN
QRIGFEAGILYNPAKWLRFNGSFNFFRFSTEGEFNGIDYGADNTSWFARGSVKVSLPAKI
DWQTNAFYRGPRNNAQTESEGILSFNLAFSKDLFNDNATIGFNVRDLFNSRKRRSFTETE
TFTSESEFQWRERSFNLSFTYRFNQKKQRQRNGREGGFEDEGFEG
>OMIFANIC_02067 hypothetical protein
MFEFDQYLGFLAFLTILTIGFWLMIFLISFIPYWIGGALYENWKLKREARRKEIEEDL
>OMIFANIC_02068 Fumarate hydratase class II
MNYRIEKDTMGEVRVPADKLWGAQTERSRNNFKIGAPASMPLEIVYGFAYLKKAAAYTNC
DLGVLSVEKRDLIASVCDEILQGKHDDQFPLVIWQTGSGTQSNMNVNEVIANRAHQLAGG
TIGEGEKTLTPNDDVNKSQSSNDTFPTGMHIAAYKKIVEVTIPGVEQLHATLKRKSEEFK
DIVKIGRTHLMDATPLTLGQEFSGYASQLEHGLKALQNTLPHLSELALGGTAVGTGINTP
AGYAEKVAGHIAEFTGLPFVSAENKFEALAAHDAIVESHGALKQLAVSLNKIANDIRMMA
SGPRSGIGEIIIPANEPGSSIMPGKVNPTQCEALTMVCAQVMGNDVAISVGGLQGHYELN
VFKPVMAANILQSAQLLGDACVSFDLNCAIGIEPNHETIKKLLNNSLMLVTALNTKIGYY
KAAEIANTAHKNGTTLKEEAINLGYLTAQEFDDWVKPEDMVGN
>OMIFANIC_02069 hypothetical protein
MRLQLVPLVLCLFMMFIVPEQLFAVSIDHTSNTTQSLVIKAFKAKAKKESNKEKLSKAEL
NSATDSKAKATGNKDLANVPRNSSNSRLEEFSYKNIKDVRSNSKKSSKEAATNVEATASV
LSNSFGTGMFYGFALMVVLLNLVCFFLFDEKLFLFYALTLAAIGNLLFLSDGLMPLLGIS
EISNPQAIESLMVLATCSFGAWFASKYLNVFEIFPRMIWITSALLGTSAILTMMCFITSL
SNFGIAANLISYGVMSLYFMAGVYLFSKKNYPKFYVIAMSIPLLFAIDYFVLRNLGLDFL
MTQPSHLKSAVIAEMLMLTYAIVYRMKAIKEENELRQTELRIFLKRQEVMNRKNAMQLME
EVYLENLIMHYDLDGFEIKLLQYISEGKENSKIARKLKTTESEIEAHTKELYNKLEISEH
IQEDYRMVDAQADYIYN
>OMIFANIC_02070 Cytochrome c biogenesis protein CcsA
MQKKLASVLFSTRLTAVLFIVFAAAMAVGTFLDASAETSPTPYTRELIYNAWWFELIMVM
FVINFIGNIFKFRLYKKEKWATLTLHLSFILILVGAFVTRYIGYEGRMSIREGATENTFL
SEHTYLTMFIDGDYEVNGVQMRRNVTPKKLRLSERLDNYFELSTDYNKQEVSVVYRDFIK
NAEEGLIPSEGGDEYLKIVEAGDGSRHEHWLKSGEVANIHNILFALNAPTDGAINIDVDS
TGAYKIRSPFEGTYMRMADQQQGIVLADSVQTLQLRSLYQLAGTAFVFPEGITKGRMGII
KAAEGEKTNKDALVLDVVSNGEAATVELLGGMGSYPNPKKVSVGGLDVFLAYGSKKYELP
FSITLNDFIADKYPGTENSYSAFKSKVTVNNSDTEFYDYDIYMNHVLDEGGYRFFQASFD
PDEKGTVLSVNKDWWGTWITYIGYFLLYLGLMAILFDKNTRFGSLKKLLDKVKKKKTAIS
VLLALFMATYGFSQDATENHQHSQTSELQLDSLIMVNKVSKEHAAKFSKLVIQDEGRMKP
VNTYASELLRKISRRDSYKGLDANQVFLSMTEFPRVWLEVPVIYLKRGNDSLRKVLGVAE
DASRIAMIDLFDAQGNNKLEPYLEEATRKANPNQFEKDFIKTYESVYLLNQALSGGILKI
FPIPNDENNKWVAYPELNEANFKGMDSVATRTILPAYFQSINQARQDGDYTQAEEILDGL
AKFQMKYGSEVMPSKNKVNAELTYNKLDIFNKLYKYFLLIGAVMFVFIILKIFREAKVYD
VFIKICKYITWLFFVLMTLGLAMRWYISGHAPWSDAYESIIYVAWATVFFGLAFGRKSNL
TIASTAFVAAIILWVANQNWLDPSIANLQPVLDSYWLMIHVAVIVASYGPFTLGMILAAT
ALLLMLITTEKNKLRMDLNIKEITVITEMALTVGLVMLTIGNFLGGQWANESWGRYWGWD
PKETWALISIIVYAFVIHMRLVPGLRGRWFFNVMALFAYASIMMTYFGVNFYLTGLHSYA
SGDAPVTPTFVWYIVCFAVLLSLVSYFRYRKFYTKKG
>OMIFANIC_02071 hypothetical protein
MISIVVIGFGNVGSHLCQAFQNAEEVALVQIYNRSEISLPESLQAIAVTHSISGLAKADV
YLLALPDDIISEFSSKLPKSDTLVVHTSGGVSMNSLNRDNHRGVFYPLQSFSKSRKPEFK
KIPICIEAEHHSDLNLLQELGESISEKVVAISSEERGRLHLSAVFVNNFVNHMYHISETM
LEEADLDFDLLKPLIRETAHKIESMSASNAQTGPALRGDTKTLEKHLHLLKDSPYKEIYE
QLTSSIQETYGKKL
>OMIFANIC_02072 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MEKSYKEYLQHITTFVFDVDGVLTDGSIMVTTKGELYRTMNIKDGFALKTAVDRGFNVCI
ISGGTNEGVRSRLSGLGITDIHLGTHQKTKTLKDYLATKNLTTENVLFMGDDIPDLEVMQ
QVGLPCCPQDAVPEIKDICKYISHKKGGKGCVRDIVEQVLKVQGKWIDGQGTSAKYD
>OMIFANIC_02073 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MVYLKIIRPVNLLLIAIVQILIKYVIFDVFEAETAMNDLQFALLLVATLAIAAAGNVVND
IYDVEIDRINKPEKVLVGKTITEKRAFNYFIFLNVIGVVCGFILANQLGKPGLAATFIVI
SALLYIYSTQLKAMLILGNVLISALVSFSLLIVLIFDLYPIAINGLSESQQTASEIVLHY
AIFAFVVNLIREIVKDLEDINGDKNGGINTLAIALGRNRTTMLVFVLAVLTIIGIVAYLY
TFLYNKKILVLYFLFLVVAPLLYFCIKAWDAESKKEYKNLSLILKLVMVTGMCAMICYRF
I
>OMIFANIC_02074 Putative ribosomal N-acetyltransferase YdaF
MKFNREENYTLEDERVLLRPLEGDDFTHLKDFSINEPDLWTYSLTPAAGEENLKAYIDHA
LQQKEKGNSYPFIVWDKQIGAYAGSTRFYDIQPQHYSMQMGYTWYGRDFQGTGLNKHCKF
LLLSFAFETLEAERVEFRADARNDRSIAAMKSIGCTPEGILRSNCVSPDGRRDSIVLSIL
KNEWFTSVKRNLKSKL
>OMIFANIC_02075 Septum formation protein Maf
MVYFGKTKSEIEIISMLKERLRNYNIILASGSPRRQHFFKELDIDFTIDVREVVETYPLH
LRGSEITDYLAKLKASMFNDLTQNDIVVTSDTIVWMEDEAINKPKDFNEARQMLERLSGS
AHEVITSVCFTGADFQKIVNDTTRVCFRELTKEEIEYYLNTYQPFDKAGSYGVQEWIGYV
GIDRLEGSYFNVMGLPTRLVYKTLMELGGT
>OMIFANIC_02076 hypothetical protein
MNRKITTLLCSAVLLSFSSCQNTEKGLSMNSVALIGSKKTKSEEVRNLSQEFKDYWYAGE
AEITSYALKQERYGELREGTAVTVFVTEDFVPEKQVKANRTSDANIPVLKQNSTKKFRTG
IYPYSIMTSTFSPVKSTGHAIKVANSVQEWCGQVYMQINNREAYEFMGHSYFESEGDQKL
TLPKTWLEDELWSLVRINPEELPTGDLLILPSMESLRLRHKEVRAYEAVASLKQGDSLTT
YEVRYPNLKRDLLIYFNSTFPFEIEKWEETNAGWGNKSERLKTSGTRMKRIKSAYWTKNR
NSDEYLRENLGLKP
>OMIFANIC_02077 hypothetical protein
MKEYVPELLQSAIIILFHVIVRWILVRIIRRFAKRSEKVEHRTGLIVKYINLAIIFLIIF
GLILIWGVEFTDVGWVMSSVFAVIGIGFFAQWSILSNITSGIIMFFTFPYKIGDFIIIHD
KEYDFEGTIDDIKGFHIVIKTKSGEIITYPNSLMLQKGVTVIKPDDIDNFLNEEDKNVKE
HPID
>OMIFANIC_02078 Mycothiol S-conjugate amidase
MRNNFITFLLLSLFTIVSLAQKPTKPTSSEIYHNLQKLNFLGSALYVAAHPDDENTRLIS
WLSNDVKARTAYLSMTRGDGGQNLIGPEIRELLGVIRTQELLAARRTDGGEQFFTRAIDF
GYSKHSDETLAIWNKDEVLKDVVRAIRKFKPDVIINRFDHRTPGSTHGHHTSSAILSFEA
FDIVGDKTSYPDLAEQYGIWQPRRLFWNNYWSFYNDPKRYENADMTNIVALNTGTFYQAL
GLSNGEIASLSRSMHKSQGFGSTGRRGEQMEWLEFLKGDLPKEKTNLFEGINTTWSRVEG
GEAIGAILKPLESNFNFEDPSAMLPSLLHAYEMVKMLKDDHWREIKLKQLKKLILDCGGI
FLEVVANTNTVNPNGSYEVTIEAINRSDYPVSLRSIVLPSGKILMNEITNLKPNDGFNFK
ATVVTQKSSTSAPYWLKEKGTLGMYEAASDMIGVPETPVPEQFVFNLTMGRSQLSVVRDA
VYKYNDPVKGEVYQPMEILPEVTTSIPEKVLIFPDNKPKEVPVRIVAGRDSINGMVQLNH
PQGWTVSPGQHTFELPKKGEATTVLFSVTPPRNQSEGYLRPLASFGSRFFDKELVTIDYE
HIPYQRVLMPSEAKAVRIDIEKRGQRIGYIDGAGDAIPESLEYIGYEVITLDPADITSEK
IQNLDAIVVGIRAYNTIPQLGFKQDILMEYVKNGGVMLVQYNTNRRLVTDKLAPYPLELS
RDRVTDENSTVSILAPNHPVLSKPNKITQADFQGWVQERGLYFPNNWDKAFTPILGMNDE
NYPETRGSLLVAEYGDGYYVYTGLSFFRELPAGVSGAYRLFANLLSLGN
>OMIFANIC_02079 Sodium/glucose cotransporter
MRFDNLGQIDWIVLIGTLLFIVLYGTYKARGSRNVEDYLKGGSQARWWTIGLSVMATQAS
AITFLSTPGQAFHDGMGFVQFYFGLPIAMVVICLVFIPIYHKLKVFTAYEYLETRFDLKT
RTLTAVLFLIQRGLAAGITIFAPAIILSAVLEWNLIYLNIIIGVLVIIYTVSGGTKAVSV
TQKQQMAVIMGGMFIAFLIILNYLPLDISFDKALDIAGANGKMEILDFSFDFENRYTVWS
GLIGGSFLALSYFGTDQSQVQRYLSGRSVKQSQMGLIMNGVLKVPLQFFILLIGVMVFVF
YQFNSSPLHFNPAGVKDVMNSEYAVEYQALEDHKRLVENDLRVKQIAYARAEDPTDEKTL
KAEIVQLNRAEDSLRSQSRVLIKKANPNAETNDKDYVFIHFILNTLPKGLIGLLLAVILS
AAMSSTASELNALGSTTAIDLYRRNTPGQTERHYLKASRWFTLLWGIIAICIASIADLFD
NLIQLVNIIGSIFYGNILGVFLLAFFFRYVKGTQVFIAALINQALVIGLFFLDVYEVINL
PYLWLNFVGCLSVMLIAYILQLLKNNSRGNTVTV
>OMIFANIC_02080 hypothetical protein
MKTIKRILLAGLLVVSVSAYANNEKIIAVNNGDVTITKEENRQVDVSILNTENYSYTLYI
YNPNGELVFKEKLGNEASLGRRFDFNSALKGNYKFTFVTDSGNKTTHIVKAGIER
>OMIFANIC_02081 HTH-type transcriptional activator RhaR
MSKDPVLESISPKFGSSLKIHNYLGAANDHAPTWHFHPEMEIAFINGGSGKRHIGNHVSY
YNNGDLIFIGANLPHFGFTDSLTGNKSEVVIQAKEDFLGSQFLDIPEMQQIKQLLYRSKQ
GIVFHEGVRNKIGPQIEALLELPSFEQLLAFLNILKQLAETEDYTLLNVEKVILESKPQD
TKRMDIIFSFVSQEFTRSISLSEIADKVSMTEQAFSRYFKKKTGKTFTQFVNEYRLVHAS
KLLSEQHLSITDICYASGFNNFSHFNKSFKTFTGKSPSKFRDQFKNVVE
>OMIFANIC_02082 hypothetical protein
MKKLLLLVCAVTLGFTAQAQMQTPAPSPFQKLEQKVGLTDVTLEYSRPSMKGRTIYGGLV
PYDKLWRTGANANTKITFSNAVQVGTKILEAGTYAVFTKPGTQNWEVYFYSDASNWGTPE
EWDESKVASKVMAKVYAVPVEVQTFTMSIDNITNNSADLGMTWENTYVGVPIQFFTDKQV
SASIDKVMAGPSSNDYYSAAVYYMEAGKDINKAKMWIDKAIELREQPAFWYHRQQSLIYA
KSGDKEGAVKAARKSLELAEKAGNSDYVALNKKSLKEWGAM
>OMIFANIC_02083 hypothetical protein
MKIYTLKAIQNLPISRQQAWEFLSDPKNLKVITPDYMGFNILSGADRPMYAGQIIQYIVT
PVLGIKTKWVTEITHVKEGSYFVDEQRFGPYSLWHHKHFIKEIDGGVEMEDIIDYKVPFG
IIGQWVHPFLVKPKLNQIFEYRQKKLIELFGEYK
>OMIFANIC_02084 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKKNILLIGGSYGIGQEIANRMKDEANVIIASRSSEAIPDGVTHQEFDVLTDDVSSLNLP
ESLDGLVYCPGSINLRPFKMLRPDAFKNDLEINFMGMVRVVHGLLPKLKNADQASLVFFS
TVAVKVGMPFHTSVAAAKGAVEGFAKALAAEYAPSFRVNVIAPSLTDTPLAGKLLSSEEK
KEKMGERHPLKRVGTVSDIAAIAEFLLNDKSSWMTGQVLGIDGGMSTLNVH
>OMIFANIC_02085 Deoxyribodipyrimidine photo-lyase
MSKKVNVFWFRRDLRLDDNVGFVKALRGKFPVLPVFIFDSHILSELPEDDARVSFIYKHV
QKLRTSLQEHGSSIAIYHGEPLQVFDEIIAQFEIQNVITNHDYEPYATERDEAVKELLGS
ENIGFYSFKDQVIFEKDEVVKDDGDPYVVYTPYMKSWRAKFNASKHLKEHDPSKLMDNLY
QHSRLSNLSLSDMNFTLSDIDVPDYDVSPSLVNNYEKTRNFPATDGTSHLGPHLRFGTVS
IRKMVKNAINSKNDVFWKELIWREFFMQILYHFPETVHNAFRKKYDRIPWRNNEKEFELW
KQGKTGYPLVDAGMRQLNATGYMHNRVRMIVASFLCKHLLIDWRWGEAYFAIKLLDYEQA
SNVGNWQWASGSGVDAAPYFRIFNPTTQLEKFDKDKKYVKTWVEEFGTEAYDEEIVDHKE
ARERALYTYKEAIS
>OMIFANIC_02086 hypothetical protein
MKLSDNEFTNGEITVTYEPKKCIHSENCARGLSDVFRTSVIPWIHLDGADSSIVVEQVKK
CPSGALSYCYNKELATVK
>OMIFANIC_02087 hypothetical protein
MKRTFISLLVSLCCILSLSAQEATNQNTLEDQFTDVIDKSNSYQEFKVIKKFKINQLKKS
VLDSVAAFEATIDTLTSEIVAQKQEISTLNQTLTSTNNDLAASREKEDGIYLFGMLLRKS
TYNAILWSIIGILVLLTGVFVMKFRRSNSITRDAKLKLEETESEFDGHRQRSLEREQQLR
RKLQDELNKQRKV
>OMIFANIC_02088 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MSTFKIEGGHQLKGDIHPQGAKNEALQILCAVLLTPETVIIENIPDIRDVNKLIQILRNL
GVKVEKLEKGKYSFTADNLNLDYLESELFKNEGSSLRGSIMIVGPLLARFGKGYIPRPGG
DKIGRRRLDTHFEGFIKLGADFRYNREEHFYGVDAPNGLSGTYMLLDQASVTGTANIVMA
AVLAKGKTTVYNAACEPYLQQLCKMLNSMGAKIEGIGSNLLIIEGVDSLGGCSHCVLPDM
IEIGSWIGLAAMTRSEITIKNVSWENLGLIPETFRKLGITLEKVGDDIHIPQQDGYEIQS
YIDGSILTVSDAPWPGFTPDLLSIVLVVCTQARGSVLIHQKMFESRLFFVDKLIDMGAKI
ILCDPHRATVIGHDFKSSLKATTMVSPDIRAGISLLIAALSAKGTSTIQNIEQIDRGYEN
IDERLRAIGAHIERVES
>OMIFANIC_02089 hypothetical protein
MIDNLEYNTERPKLIIPEYGRHIQKMVDYAISLEDREERNKIAKSIIAVMGNLNPHLRDV
PDFQHKLWDQLFIISDFKLEVDSPYPVPSEEELSERPEHLGYPQNHPKYRFYGNNIKRMI
DVAIGWEEGDMKDGLVLTIANHMKKCFLNWNKDTVEDDVIFQHLFELSDGKLNLKNSDED
LSASSELLKNKKRYSSSNGKKGKKGGRGGGRKRY
>OMIFANIC_02090 hypothetical protein
MKENNESTEFYTRLKQQLLDDTSWPTPYMFKFIVSASLEKIAEIEAVFNHTDAIINTRDS
SKGNYTSVSIRVTMESPDAVIDKYLEVSKVEGVISL
>OMIFANIC_02091 hypothetical protein
MKTKRIVITGGPGSGKTTLVKKLEGQGFACMHEISRQITKEAKEQGVDQLFLENPLLFSE
KLLEGRLEQFKQAEAFQKEILFYDRGMPDVTSYMDYLGIDYPDHYRETCSNYIYDAVFVL
PPWPDIYIQDNERYESYDEAEKIFTHLVEGYTSYNYNVHEVPTGDVAYRIEYILKHLIGL
H
>OMIFANIC_02092 ATP-dependent DNA helicase RecQ
MRTPGQILNEYYGFTTFRPLQEDIINAVINGNDTVALLPTGGGKSICFQVPALVMNGICV
VISPLVALMNDQVNELKEKGIKAMHLSGGMSFEEVNTALDNAMYGNYSFLYLSPERLQQE
MVQNAIRKMDVCLIAVDEAHCISQWGNDFRPSYKNITILREMHPLVPVIALTATATPEVL
ADTISELKLELPKVFKSSFYRPNLAYKTQKAEDKLYRIQQQLEKNPGSAIIYVRSRSLAV
ETSDQLNSLGISATFYHGGISSEIRQTRLAQWKQGAVFTMVATNAFGMGIDHPGVRFVIH
MQLPESIESYFQEAGRAGRDGNYAEALLLYNDYDKVLVKKQFVDSLPRKKDLKKVYRTLS
NYFRIPYGEGEFSSHAFNFTEFCTTYSLPSNITYNALTTLDRLGVLQLSTQFGRKSTVKF
RVASESLLRYFEEDMRVSVIGKTILRVYGGIFETATPVNLDLIAGKTGQTSEEVVSALQK
MEQDDVAELQLFDTDAVITFLVPREDDKTINRMAIGVRELNDKKTKQVKAMLSYVENNFN
CKSEQLLQYFGEEITERCGICSVCLKEVKPTGKKELKIIAEQILVLLETEDLSSREISER
LTFTEHDIIKVLKALLDSRKIGLNSRNQYFTTA
>OMIFANIC_02093 Methionyl-tRNA formyltransferase
MRDLRIVFMGTPHFAVGVLKKLVESGANIVGVITAPDKPAGRGRKLRGSAVKEYAETEGL
YLLQPKKLKDESFLAELKSLRANLQIIVAFRMLPEVVWAMPEYGTFNLHASLLPEYRGAA
PINWAIINGEKVTGVTTFFIDEKIDTGAIILKKEVVIEEGETAGSLHDKLMEVGSELVLE
TVQLIAEGEVKTEIQPSAKELKGAPKLNNENTKIEWTRPATEIDALIRGLNPYPSAWCYL
ENDGERLKIKIYDVVLKMEEHDHEIGTIISTKKDLHVAVENGFLEIQEIQLPGKRRMKSS
DLLNGYSFDTDAKVV
>OMIFANIC_02094 hypothetical protein
MKRFVIIPLMMFTIICIAQKKKNGTVFIEHPAIDAVESMMSAMVNGDAEAAAPFLAEKFT
YYNGNNSNPDYKGTPRENFLKWTDWYKENLSYTSIARQPGAYPDALVYKDGTIWVQTWDV
VTGMHNETGVKMDRPTHCLFSLNKDNKILVMIEYTSDPWDDIRESSVARKNGTLYNSHDN
INTVRKMMMAIEHSDLDKAYGYFIEKARFRNINKPRGEFATLEEDRAGLEKMLETFSIDS
FDVVGYPDYLEYEINSSKVVMSWWNLRLTHKADKKKIVLPAMYVHYFNDEGEIISETGYY
SMKLFEDQLKEPQVAQN
>OMIFANIC_02095 Oxygen-insensitive NAD(P)H nitroreductase
MNSGIINKLQWRYATKKFDPNKTLSEEKLEILKEAFNLTATSYGLQPLRLIVVSDPEIKE
QLVPISMDQQQVKDASHVLIFCTESTVNSKYIKEHFNRVEDIRDTPREILDPFELYLLQS
FSEKKPEDIEQWMTKQAYLAMGNLLTVCALEDIDACPMEGFDPEKYDELLQLTQKGLRSV
LVMPVGHRADDDMFADLKKVRRGVEKVVISI
>OMIFANIC_02096 8-amino-3,8-dideoxy-alpha-D-manno-octulosonate transaminase
MPGFEVFGDEERKQVNDVLETGILMRYGFDGMRNNQWKAKEFEEAFAERMHSNHCQLVSS
GTSALTVALASAGVGAGDEVIMPTFTFVASFESIMMLGAVPVLVDIDDTLTLDPHAVEAA
ITPRTRCIMPVHMCGSMADLKALKAICENYNLLLLEDACQAIGGSFDGKPLGSYGDLGCF
SFDFVKTITCGEGGAVISNFEQYKIHADQYQDHGHDHEGNDRGAETHPTLGYNFRISELN
AAVGLAQLAKLDDILAVQEKHYGIMRKAISDIPGVTFRRVPETGVENYSFLNFFLPTGET
AQKAHKALLEAGVDGCFYWYTNNWHYINGWEHLRNLKSLGRMPSEIKEHIQDLNNTDFSK
SDHWMSRTISCLVKVGWTEEEVEQRADKMRKVLEGIL
>OMIFANIC_02097 Riboflavin biosynthesis protein RibBA
MITSEKTSSIQLNTIEEAIEDIKKGKVIIVVDDENRENEGDFIAAAEMVTPEMINFMARH
GRGLICAPLTEERCNELDLRMMVENNTVLHHTQFTVSVDLIGQGCTTGISVHDRAKTMKA
LVSDDTKPGDLGRPGHIFPLRAKEGGVLRRTGHTEAAIDFARLAGLKPAGILVEILNEDG
TMARLPQLANVAKKFDLKLVSIEDLVAYRMEHDSLIEKKEDFEINTKFGSYRLRAYQQTT
NDQVHIALSKGSWKNDDPVLVRVNSTLVNNDILGTLTKDADKQLDDMFKVINDEGSGAVV
FINQQAQSLNLLNRLSELKEIQTEDEIAKAPRISMDNRDFGIGAQILHDLGISKIKLISN
SEQTRRVGMIGYGLEIVDYVSY
>OMIFANIC_02098 hypothetical protein
MKILDRYILISFLKTFFSVFIILMFIFVLQTIWLYISELAGKDLDVWVVLKFLWYVSPRL
VPLVLPLTILVTSLMVFGNFSEKYEFAAMKSTGISLQRAMRSLTVFILVLAGIAFLFANN
VIPYSEYKWQNLRRNIAQVSPSMVIAEGQFSQIGNDFNIKVDKKGGDRDQYLNTIIIHKK
TPTRPNGNYTVIVADNGELASEKGSNTLSLILNDGYYFDEIQTKDPTKQRSEPFVKSYFE
QYVINIDLTEFNNTDVDKENELSNHNMYKMSELFVEIDSLSNGYTNDIKTFADNMYFRSG
ISKFKDEKVLETPEADTIEEVIAAYPRPLQTNILNMALNNVRGTLQSVSSKKIEFQIKTK
RLNKHEIALHEKYVLAFACIILFFVGAPLGAIIRKGGMGLPMVVAILLFLTYHFIGIFAK
NSAEDGTLHPFIASWLSTAIMLPLGVWLTYRATTDQGIFDIDSFLQRFRRTPAAEAEMIY
ENLNQQISISEEEKQNLDRLNVAQLKDAVKNHKQYNYSHDFRIAALRKLDEEGYSQEHLH
VSGDLFNKDYDLAEKLVKRFKNLSIYTFITYILSIILPILITVVLVKMQDETATVIVSLI
AIITLVLFYIFLFKTQSTVNRLSKLSKEETVIWAAWLIGMPFYIFLFFYYRKHIQRSLKN
IQ
>OMIFANIC_02099 Outer-membrane lipoprotein carrier protein
MKKLALLLIALISFTVSEAQSAKSLLDEVSSKVKSYDNISIDFKYNLNNAKENVNQDTRG
DVTLKGDKYVLNMLGTTRMFNGSSIYTIVPEDEEVTISAYDASEDKEITPSKMLTFYEKG
YTYKMDITQNVKGRKIQFVRLIPIDSKAEIKDILLGVDVQTKHIYKLIQTDSRGTKYTIT
VNSFKTNQPLSKTLFTFDETKFKRDGYYINRLD
>OMIFANIC_02100 DNA translocase SpoIIIE
MLRSIFVFLNIDNPSFMAKKKASTSKKKKTPRKKVSLALSKQQKILLGSFLFFLGLALIF
SFVSYFFSWQADQSTVGVISERELQAENWLNKFGNNVAHFFVYDGFGIAAFIMAFLVTLT
GIYFFFDYAKRQLLRFWFWGLLVMVWISVFFGFFATTRNLFSGVMGYELNDFLQDYLGLT
GTILLMTFLAIVYLVVRLKMTPEKVGDALKKTKEDIAADFNTAPNSEVINAEGSSAEQTD
YEKEVIQEVVNIDDTGSVPMETVVEEEVVEEPFLKTVVKEETKSSPEKEVAMEIEKVAEE
ETVEENQSKKLVEDFGEFDPTLELSNYKFPTIELLKDYTGGQGITINQEELEENKNRIVN
TLSNYKIGISNIKATVGPTVTLYEIVPEAGVRISKIKNLEDDIALSLSALGIRIIAPIPG
RGTIGIEVPNKKPRIVSMRSVIASPKFQSAEMELPLSLGKTISNETFVVDLVKMPHLLMA
GATGQGKSVGLNAILTSLLYKKHPAEVKFVLVDPKKVELTLFNKIERHYLAKLPDTEEAI
ITDTNKVINTLNSLCIEMDERYDLLKDALCRNIKEYNAKFKQRKLNPNDGHRFLPYIVLV
IDEFADLIMTAGKEVETPIARLAQLARAIGIHLIIATQRPSVNVITGIIKANFPARVAFR
VTSKIDSRTILDSAGADQLIGRGDMLYTQGNDLTRLQCAFVDTPEVADIVDYIGSQKAYA
SAHMLPEYVGEEGGTNLDISVDERDQLFREAAEVLVIAQQGSASLLQRKLKLGYNRAGRI
IDQLEAAGIVGPFEGSKARQVLVPTIEALNQLLNNESNNL
>OMIFANIC_02101 Undecaprenol kinase
MWKTYLGKRLLGFKYATKGAWMLLRNEASIQVQAVVAIGITIAGFYFHISTSEWIAQTLA
IGMVMSIEGLNTAAEEIANFVHPDFHDKIGYIKDVAAGAVFFAAIVAVIVACLIYIPKF
>OMIFANIC_02102 putative thiol peroxidase
MAKITLGGNPAQTIGDLPAVGTKASDFKLTAIDMSTKTMGDFAEHKLLLNIFPSVNTGVC
SASVRKFNEAAANMNNTKVLCISKDLPFAQEQFCAAEGIEDVVMLSDFKTGQFGKDYGVT
AVGSAFDQLLSRAVVIVDESGTVTYTEQVPEIGQEPNYEAALSAL
>OMIFANIC_02103 Malate-2H(+)/Na(+)-lactate antiporter
MEDKDNISEFKIKDQKIVENIELNIWEALIPVVALVGMLFYNVYVFGDDALSGSNQFILL
MGAAVAAIVGTFNKVGYKRMVEEVAENVKSTTGALLILLMVGALAGTWLVSGVIPTMIYY
GLQILNPTIFLASCVIICAIISIATGSSWTTSATVGIALIGIAEALGISLGMTAGAVLSG
AYFGDKMSPLSDTTNLAPAMAGTDLFTHIRYMAYTTVPTITITLIIFIIIGFGLEPEGVA
DTASILASIDLAFNINPWLFVVPVLVIILIIKKTPPLIALLAGTLLGAIAAVFFQPDIVA
TLGGGSSLDFTTGYMGVLNAITIDSAIPTDNEALNDLFSSGGMAGMLGTIWLIICAMVFG
GVMDAIGALARISRALLSLFHTTFGLFASTVFSCLALNVTASDQYLAIVVPGKMYSKAFA
DKGLAPENLSRTLEDSGTVTSVLIPWNTCGAYQSGVLGVPVLDYFAFAIFNWLSPFTTLF
FAAFRIKIHQLTESKATV
>OMIFANIC_02104 hypothetical protein
MRKILLTLIFTHLAVWGWSQVGIGTITPDASSVLDISSSDKGILIPQISLSDVTETMLDG
VNTAATGLLIYNTNAAVTGGTGVGYYYFNGTTWERMISTAEPVDEWTLSGNTGTTSANFF
GTVDNQPLNFRVNNDTAGIIDSTTTNTSYGYLGLDALTSGTANTNLGYRSMESVTSSGGN
TVMGYQALNQQVGPNGFNTAIGMEAMENGTDAHMNVAIGWRAMRADGVGEQNVALGVGAM
EYGEGAIGATAVGRWALANENYGTYSTAIGFRSMFNQIFDNGSASWNSYNTGVGAFTLHS
NNPTATNNGIYNTAIGGRALYANTTGFINTAVGMLALYANTTGSNNTAVGYNSQRMTVDG
VYNTSMGTYSLDANTSGSRNTAIGSVSLSANTTGSWNTAVGVDASQQNVDGTHNTGLGFE
ALKEGTSGSANVGIGNYSLRDNTTGNQNVAVGYNAMRGVAGSSTPLGNTAVGYLSMTGIT
TGNQNTAIGHYALNSVSSGGLNIAVGGGSLEANTVGLRNVGMGFWAMRFNTESSGNIAIG
TQALYNQSFTNGGTEYGSYNVAVGYNALYANQPISTITGRLNTGLGLSAGNTNTEGSYNT
LVGANSDVTAGNFDNATALGYTAQVTASNMVRIGNASVTSIGGYAGWTNVSDGRLKQNVR
EDVSGLDFVLKLRPVTYNLSEQIFENKDYEVLDVSEAKKLRHSGFIAQEVETAANNIGYD
FSGIDAPAGAKDHYGLRYAMFVVPLVKSVQEQQKTIEEQQQEIDDLKNEIRLIKEMLMKK
>OMIFANIC_02105 L-methionine gamma-lyase
MSFKPANKIQDLQYFGEFGGVNPSISDSSTYTFHSAKTMFDTFEGNAEGCYLYSRHSSPS
NLYLGEALAAMEGTETATVAATGMGAIVPAILQICGAGDHIVASRTIYGGTYAFLKNLAP
KFNIKTTFVDITKLDAVEKAVTPETKILFCESVSNPLLEIADIKGLAEISKTNNLKLLVD
NTFSPMSISPAKLGADVVLHSLTKFINGSSDTMGGVICGTQEFIDELRNVNDGTCMLMGA
SMDSMRAASILKNLRTLHIRMKQHSKNAMYLAEKFEDDGFRTVYPGLKSHPGHELIGNLM
NPDYGYGGMLTIDVGSLDKANELMELMQERNLGYLAVSLGFYKTLFSAPGTSTSSEIPEE
EQAEMGLTDGLIRFSIGLDNDIERTYRSMRQCMYHVGLLNPETNKVLMH
>OMIFANIC_02106 Leucine-responsive regulatory protein
MLLDKIDIALLKNLQQDAKQTNKQLSLKLNLSVTAIYERIKKLERSGIIRKYVALVDRTK
VDLGFTVFCHIKLVQHAHKSVVDFEREVVKLTEVLECFHVSGEYDYLLKVVVKDMDQFRN
FMVEKLTTLQHIGSTQSSFTISEVKNTTALSF
>OMIFANIC_02107 Dihydrolipoyl dehydrogenase
MNTYDVAIIGSGPGGYVAAIRCAQLGMKTAIIEKYSTLGGTCLNVGCIPSKALLDSSHHY
EDAMKHFSDHGIEIPGEIKLNFKKMIERKQAVVDQTTKGIDFLMNKNSIDVYQGLGSFKD
ATHITISSEKEEKEIEAKHIIIATGSKPATLPFITIDKERVITSTEALSLTEIPKHMIVI
GGGVIGLELGQVYRRLGSEVSVVEYMDRIIPTMDSAQSKELMKAMKKQGVKFYVSHKVSA
VERKKNEITVTATDKKDKEVTFTGDYCLVSVGRRPFTDGLNADKAGVKVNERGEIAVNDH
LQTNVSNIYAIGDVVRGAMLAHKAEEEGVLVAEIIAGQKPHIDYNLIPGVVYTWPEVASV
GKTEEELKESGVAYKSGQFPMRALGRSRASGDTDGFVKILSDATTDEVLGVHMVGARVAD
LITEAVTAMEFRASAEDIARMSHAHPTYAEAVKEAALAATENRPLHI
>OMIFANIC_02108 hypothetical protein
MKKLSIIFCISLVTAIQLNAQVGVNTNNPKSVLDIEATNSSAPTITDGLIVPRVDVLPAS
NPGADQDGMMVFLTTTINGNKKGHHYWDNTAGEWTYFAGEWVDGYNKTSENLTYVKQAFK
ENQKDVVILDTGQMGMGTDDPDESLEIKLPGDNDIQIASNASRPNAPNFIFFTKNGTFAS
GDFLNDGDVIGSLSGTVWDGSTESDIVVSINSAADGDHVSGDLASRFNFSVTSAGNTSAD
ADGMEMTVRASGNVGIGVDNPTAVLHLKAGTASSNSAPIKFNSGTNLTSPEKGTFEYDGV
HLYFTPGADRKILLKKLSGTATLDFLSLFAGLHTEQTVTVNGATPGSSCNCSPVGAIENG
LTWSCYVSANNTVTIRLSNITGSPIDPVSKNWIVNVIE
>OMIFANIC_02109 hypothetical protein
MRKTTYVLSLFILVFFAQGILAQVGIGTTSPKSMLDIPASNSTSPASTDGILIPRIDNFP
STNPGADQDGMLIFLRTAAPGNPKGFYYWDNTLTDWISYNDEWKDNFVTQSRGDYDGNLI
YANQAGIGGVDVVVLDSGQIGMGTSNLEENLELKIDGDNDIQISSASPPDPPQLVFYTTN
GSFGSPDFMNDEDDIGYMTGKVWTGTGKSLDVANIQMEADGNHNSGSLPTKIEFAVTNPG
QTVLNSNNPEMVIASTGNVGIGINDPSAVLQLKAGSASSNSAPLKLTSGATLSAPETGAM
EYDGTNLYFTPNTIRKVLMTGLVATQNLDFPNINSGNTSELTVTVTGASLGSSCSCAPNT
SIELGLQWSCYVSAANTVTIRLSNVSGIAINPASKSWKVTVIQ
>OMIFANIC_02110 Chromate reductase
MKKIIAFAGSNSSTSINHALVSHVANKIIHHNIKVIKLTDFPLPIFGEDLEKEKGYPETL
SKLLNEIRSQDALIISVNEHNAGISAFFKNVLDWLSRIELKFMEGKKVLLLSTSPGKRGA
LSALQYTESIVPRYSGELVASFAFPSFSANFSVEDNKVINADLASGLDNVIETFLASLE
>OMIFANIC_02111 Aminodeoxychorismate synthase component 1
MKRIQNKHSHVIDETFRKKLLLWAQQFHEVAWLDSNNYQQEHSSYQAILAVDAFTSLKTD
YIDAFQKLDDYQSSINDWLFGYLTYDLKNDIEALSSLNHDGLGFPDLFFFQPKRLFLFSK
NNVEMHYLNMVADEMEADWKEINNIPHDKNSSQSENASVKISLRTSKDSYFKEVNKMLAH
IERGDIYEANFCQEFFSEDIAIDPVKTFDHLNEISRPPFATYLKFGNSYAMSASPERYLK
KVGTSVISQPIKGTARRFKNEELDRAMIEKLKNDPKERSENIMITDLVRNDLSKFAEKGS
VLVEELCAVYSFEQVHQLISTVSCEVSEDVKPATMLKETFPMGSMTGAPKVSAMKIIEDL
EDAKRGLYSGAIGYFAPNNDFDFNVVIRSILYNANKKYVSFSVGGAITAKSSPEDEYEEC
LLKAKAMREALEQPK
>OMIFANIC_02112 tRNA(Ile)-lysidine synthase
MLERLKQHIDKNLPFLKGKKLLIACSGGLDSVVMTYLFKDMGFDIGLAHCNFSLRGSESD
GDEAFVTDLAEKLNIPSYVETFDTREYADTRKLSIQMAARELRYLWFDEILRDFHCDFLL
TAHHADDNLETLFINLSRGTGLRGLTGIPEQSDNLVRPLLPFSRDEILKYAKEERYFWRE
DSSNKEIDYLRNAIHHDVIPPLKRHIPKLLKSLEKTQGHLRESQSLLEDYLVLIRQLVMV
EQEDGYSINISKISNLPNTEALLYELLRPFGFTAWKDISELIHAQSGKFIVSASHRLVKD
RDLLLLTEIPLEDNAEETEILRTTKRIEHPIPLIISSVVTKGVNTDKEIFVDANTLTYPL
KVRRWREGDYFYPIGMQGKKKLSKYFKDEKLSLVAKEKIWLLCSGEQIVWIIGHRADDRY
KVGPETTQIKRIHTS
>OMIFANIC_02113 Thiol:disulfide interchange protein DsbD
MKRIFIIVFAALISNFSIVAQDFLDPVSWEVTTQKESENRYNIILEATIDPGWHLYSQIQ
YGEEFEGPIPTEFSYNSSPESYTLVGGTQEPDVKPVLDPVFEIEVKSFDDKAVFIQPIEV
VNPEGLKIVVEIYYSVCDDEKCLPPDVKSFEVDLASGKSELATAEITEFDLEQTAALTIP
LKGDLGNTSGKKGYFTIFLLGFLGGILALLTPCVFPMIPLTVSFFTKGSRDRKKGLRDAL
LYGFFIFLIYVLLSLPFHLLDTVDEGLLNNISTNIYLNILFFIVFLVFAFSFFGYFEITL
PSSWSTKMDEKATTIGGFVGIFFMALTLAIVSFSCTGPILGGLLGGSLSQDAGAMQLSFG
MGGFGLALALPFALFALFPNWLNSLPSSGGWLNTVKVVLGFAELALAFKFLSNADLVMHW
GVLKREVFMAIWILCSLGMALYLFGIIRFPHDGPKGRKLPKGNIIVGILAIVFTIYLIPG
LTNTKYANLKLLSGLAPPMFYSLYDKGTSAPLGLTAYKDFYEGVEAAKKSGKPIMLDFTG
WACVNCRKMEEHVWSVEEVFKVINEEFILISLYVDDRKPLEKEEQFNFLKPTGGTKPIKT
IGDKWATFQTVNFKNNSQPHYALMDSDYKLLNLPIGYTPDESEYLAWLNSGLKEFNKNK
>OMIFANIC_02114 HTH-type transcriptional regulator DegA
MQKLTLKKIARELDVSISTVSKSLKDSPEISEDTRQKVKAFAKLYNYRPNTIALSLKNRK
TKTIGVIIPEIVHHFFTTVVSGIEKVANEKGYTVIIGLSNESFDKEVTNMEKLANGSIDG
FILSVSRETQLKKDYHHLKESIDHGMPVVLFDRTIPEIECDKVVVDDTQGAKNAVLKLIS
SGCTNIALITTEDHVNVGKLRTSGYQHALEERGIDFSDRLVLKLKDEFNEEGLEGQLNSG
IELFLRSNPDIDAIFAVNEKYALTAMKAARALGKQIPSELKVVGFTDGVLSKYATPSLTT
VSQHGIQLGEKAAELLIRRLEEDDYEPPYQTVVVETRLIERESTSQG
>OMIFANIC_02115 hypothetical protein
MEKPKLSFWQIWNMSFGFLGIQFGFALQNANTSRIFEKLGADIESIPILWIAAPVSGLIV
QPIIGYFSDRTWNRLGRRRPYFLVGAIFASIALFIMPNSPSLWVAAGMLWIMDASINVSM
EPFRAFVGDNLGEKQRTLGFAMQSFFIGIGAVVGSLLPYIFTNWIGLDNTAPEGIIPPSV
KWSFYVGGTVFFLAVLWTVLRSKEYSPEELAEFEKNEKKGQVDDAEYFHNVKNISSQLII
GISMFVIGAVVSYLVYSKGLAKELYILFIGLIVVGILFILNSFLRKSNVNNAFTIILTDM
VNMPKTMRQLAWVQFFSWFALFSMWIYTTQAVTGHVFDTPDPTSKAYNDAADWVTVMFTV
YNGVAAAVAFLLPVVARKTSNKVTHLLALTLGGLGLISIFFVTTKTGLLVSMIGVGVAWA
SILSIPYAMLSGSLPASKMGYFMGVFNFFIVIPQIIAATILGFLVKQIFNNEPVYALIVG
GVGMIIAGLLTLRVTTHKKQEVNG
>OMIFANIC_02116 Beta-phosphoglucomutase
MDKKGFIFDLDGVIVDTARYHYMAWKRLAESLGISFSKVKNEQLKGVSRVRSLEKILNWG
NMELTEAQFNELLELKNNDYLAYIERMDKDEILPDVPRVLSFLKQNDQPIALGSASKNAR
TILKEVDLLEVFDEVIDGTNVTNAKPDPEVFLKAAEGLGMDPSDCIVFEDSVAGIRAANT
GGMMSIGIGDPAVLHEATYVFKDFTEISNEFFSKLISE
>OMIFANIC_02117 Maltose phosphorylase
MNQDYIKPDPWSIIEEGFDAEKVKSSESLFSIGNGAMGQRANFEEDYSGETFQGSYVAGV
YYPDKTRVGWWKNGYPEYFAKVLNAPNWIGLKVSVNGENLDLHHCKEVKNFRRELNMKEG
FYRRSFEVTMQNGTEIAVTSTRILHLDQDELGIINYEVTPLNRNAEIVFSPYLDGGITNE
DSNWDDKFWDTLSVSEADHQAFIRSMTMKTEFHICTYMQSEVYLNKTNATPEYTANLEDR
FVQFNYAISAPQGETASLRKYAGYTVSLDHAPDALVDAAKATLDKGIGNGYENLKKSQAE
AWTSIWEMADITIEGDVEAQQGIRFNIFQLNQTYLGKDARLNIGPKGFTGEKYGGSTYWD
TEAYCLPFYMATKDHEVARNLLVYRHNHLQKAIENAEKLGFTNGAALYPMVTMNGEECHN
EWEITFEEIHRNGAIAFAIYNYVRYTGDHGYVPEKGLEVLIGIARFWHQRANFSTQKNKY
VILGVTGPNEYENNVNNNWYTNFTAKWCIEYAASEIEKVKEEYTSDYERIISKTGVTELE
VSEWMKVASDMYFPFSEEHNIYLQQDSFLDKELITVADLDRSQRPINQQWSWDRILRSPY
IKQADVLQGFYFYEDHFSQEELERHFDFYEPFTVHESSLSPCVHSIQAAKLGRMEQAYTF
YLRTSRLDLDDYNKEVEEGCHITSMAGTWLSIVEGFGGMRVRDDHLEFHPRIPDHWKEYT
FKVNFRGQILKATITRDRNSFELSGEQPLTIKVNGVSKIIEPTTY
>OMIFANIC_02118 Periplasmic alpha-amylase
MVYQKLSNRQLIRYMRKVRITGIFICLFIALFSCADNKKELTAANTEVEIATTKPFSWKA
ANIYFLLTDRFNNGDPSNDVNFDRTRETAVLRGFKGGDLKGITQKIEEGYFTDLGINAIW
MTPVVEQIHDGTDEGTGYTYGYHGYWTKDWTALDPNFGAREDLAELVETAHDNGIRILLD
AVINHTGPVTDGDTVWPEEWVRTSPKCEFKDYESTVSCTLVENLPDIRTESDEVVDLPPQ
LVEKWKVEGRYDEEMAELDNFFEKTGHPRAPRFYIMKWLSDYIHDFGIDGYRVDTVKHTE
EYVWEEFEDVCEDAFNSWKAANPDKVLDDAPFYMVGEIYFYNVNTGRTYDFGDRKVDYFN
DSFDALINFDLRSSADRSYEEVFSSYNQVLQGDLKGYSTLSYMSSHDDSSPFDKDRSKPY
ETAIRLLLAPGAAQVYYGDELARTLIVEGTNGDATLRSFMNWEDIDSNPETAKILVHWQK
LGQFRNDHISVGAGVHYMISESPYVFKRSFAEGDISDEVIVGLDLPVGMKSMSVADVFEN
GIKVRDAYSGETAEVVDGKVSVTTDYNLVLLEEINE
>OMIFANIC_02119 Alpha-amylase
MIKYKLILAIAVFVTGCKTETKKETVIVENSIEEIAPITDSILESAVIYEANIRQYSPEG
TFNAFTRDIPQLKELGVKIIWLMPVFPISEVKRKAFGDKMVEDIDDASEREKYLGSYYAV
SDFRKINPEFGTIEDFRKLLKTAHENDIYVILDWVPNHTGWDHTWITQHPDFYTKNSEGE
ITDPLNDDGTPVGWEDVADLNYDNMEMREAMIADMMYWVEEEGIDGFRCDMAGMVPTDFW
ADAIPKLRSAKDIFMLAEWEDPQLTRNNLFEMAYGWEVHHLLNAIAKEEKGVRDFDNYMN
HSVEKWKNGGYLMNFLTNHDENSWAGSVSERMGDASEAMLALVYCMPGMPLIYSGQEYDL
DHRLKFFEKDSIPKEKGKVWPVLKKLGELKNTIPALSGAKNQGEYTRLQTSPEDVLAFKR
EKNSSELIYVANMSTEEREVVLPLQGKYLESISGNEIEINPNNSILLGPWQYRILVKM
>OMIFANIC_02120 ATP-dependent 6-phosphofructokinase 1
MSGTIKRIAVLTSGGDAPGMNAAIRAVVRSCAYHKLECVGIYRGLQGLIEGDFEVLNARS
VKNIINRGGTFLKSARSKEFRTKEGRQTAYNNLKHAGIDAMVVIGGDGTFTGANIFIQEF
DFPIVGLPGTIDNDINGTDYSIGYDTALNTVVEAIDKIRDTANSHNRLFMIEVMGRDAGD
IALNAGIGAGAEEILIPEEEMGREKLLASLRRSKKSGKTSSIVVVAEGDQIGKNIFGLAD
YIQEHMDEYEVKVTVLGHIQRGGSPSCYDRVLASRLGIGAIDALLRGERDVMIGISHKKV
VSVPFIEAIKGENEIDIELIRVADITSI
>OMIFANIC_02121 Glyceraldehyde-3-phosphate dehydrogenase A
MTKIGINGFGRIGRIAFRIAAQNDNVEVVGVNDLLDVDHLAYLLKYDSVHGKYPGTVGVE
NGNLVIDGKTVRVSAERNPEDLKWDEVGAEIVIDCTGIFTTKETASAHIKAGAKKVVISA
PSKDAPMFVMGVNHNDVKPEDTVVSNASCTTNCLAPMAKVIDDNLGIVEGLMTTVHAATS
TQHTVDSPSRKNYRIGRSAILNIIPTSTGAAVAVTKVIPSLKGKLTGMAFRVPTADVSVV
DLTVRTEKSATYEEVKQLFKDAANGPLAGVVDYVEDPVVSQDFVSDPNTCNFDANAGIAL
NDNFFKLVAWYDNEYGYSAKLIDLAVHIASI
>OMIFANIC_02122 hypothetical protein
MIIIADGGSTKCDWILLDKKGNQVLKTRTRGLNPAVVPRQELYTRIEENNELPTLFKKAS
RVDFYGAGCGTETPRAVLMAVLEDLFPNAEVKVQEDLMAAVYAATTEPGIVCILGTGSNS
CYYDGEKIFTPVPSLGFTLMDEASGNYFGKRLIRDYYYKRMPEQIANAFEQRFDLDADTI
KLNLYQKPNPNTYLASFAEFIFTSKEVNGYFYKLISEGMIRFIDYRIMCYKEAQTVPIHF
IGSIAHYSTDIIRDCMKRYQLELGNVIRRPIDGLLDYYRTHVLKVAESSS
>OMIFANIC_02123 Glucose-6-phosphate isomerase
MSLPKINPTKTKAWNELSDHFNSLKDGKMQQWFKDDHERSSRMSVIWEEFYLDYSKNRVT
DETLTKLLNLAIEVDLRSAIDAQFSGEPINETEGRSVLHTALRDFNNMKPEVRETLQKIK
SFSEKVIEGEWKGATGKSITDVVNIGIGGSDLGPDMVCEALQFYKNHLNVHFVSNVDGDH
VMETIKSLNRETTLFIIVSKTFTTQETLTNAQTIRNWFLEKGSEADISKHFAAVSTNLEA
VADFGIAAENIFPMWNWVGGRFSLWSAVGLSISCAVGYENFEKLLKGAHKMDLHFKDSDF
RQNIPVILALLSVWYNNFFGCESECIVPYSQYLNKLVAYLQQGIMESNGKSVDRNGEQID
YQTGTIVWGSTGTNAQHAFFQLIHQGTKLIPTDFICFSESLYGNLDHQNKLLANCFAQTE
ALLQGTYETEVDNNFKIFEGNKPTNTLLIKKLTPETLGSLIAMYEHKLFVQGIIWNIFSY
DQWGVELGKKLAKNTLGAIETRNPAAAQNSSTKSLINKAL
>OMIFANIC_02124 Competence protein ComM
MLTKVYGSAVFGVDATTITVEVNVDQGVGYHLVGLPDNAIKESNYRIAAALQNNGYKIPG
KKITLNMAPADLRKEGSAYDLTLAMGILVSSGQIQESQPLSDYIIMGELSLDGSLQPIRG
SLPIAIKAKEEGFHHFILPKQNAKEAAIVEGISVYGVDSIKEVIDYFNEDIPLDQTVVDI
EAEFYEHLQNPEFDFSDVKGQESIKRCMEIAAAGGHNIILIGPPGSGKTMLAKRLPSILP
PLSLTEALETTKIHSVAGRTLGNGGIMTSRPFRSPHHTISDVALVGGGTFPQPGEISLAH
NGVLFLDELPEFKRSVLEVMRQPLEDREVTIARARFTVTYPSSFMLVASMNPSPGGYFND
PDAPVTSSPAEMQRYLSKISGPLLDRIDIHIEVTPVPFEKLSEERKGESSLVIRERVTKA
RKIQQVRFRKYEKQHYNAQMGVKQIRKYCPLDKASSELLKNAMERLNLSARAYDRILKVA
RTIADLALSEEIIGNHISEAIQYRSLDRDGWLG
>OMIFANIC_02125 Succinylglutamate desuccinylase
MIKLHSTPLDKTIEITRLIGSHSGTGEGPTLIFTGGIHGNEPAGVFALKSVLDNLKKENP
EFKGSMYAIGGNLNALQKGIRFNKADLNRLWTKEKLAGLKDDKVISFNEELVQQKEIYEI
MQDILEKENGPFYFFDLHTTSGETAPFITVNDSLLNRKFTRLFPVPLILGIEEFLDGPLL
SYINELGYVAFGFEGGQHDSPKSYEYCVAFIYLTLAYTGCLSATDANQEKHFKKLKDVMA
FKNKFFEIIFRQGIEPDDKFIICDGYVNFQKVPKGTTIAINNGNQLETPYRGHIFMPLYQ
GKGEDGYFIIRKTPEFFLKLSAFMRKISFDRLLVALPGVNWSSKNREELVVDLNIARFFT
RKFFHLMGYRSKQKDATHLKLKNREIASKEEDYKDAPWNK
>OMIFANIC_02126 Inosine-5'-monophosphate dehydrogenase
MGEQKVNRSFSEEKKAVFIQHLLDDVEALEIMLEKGQIEKGITRIGAEQEFCLVTKDWRP
ATNNEEILAKIDDPHFTTELARYNLEINLDPIELKDNCFAEVENSLKSLLKKASEAAEEE
NAKIILTGILPTISKTHLSMDYITPNPRYFALNDMLMGLRRSHFQLNLQGVDELSIAHDS
VLFEACNTSFQLHLQIDPDDFISSFNWSQAIAGPILSMCCNSPLLLGRELWDETRIALFR
QSIDTRNISQALKDQEPRVAFGNNWATGTAADIYKENISRYKIILSRELEENSLDILKRG
SIPKLEALNLHSGTIYPWNRACYGVGNGKPHLRIENRYIPSGPSVIDEIANFAFWVGIMR
GRPEKFDDMSKVMDFKEAKSNFIKAARTGRNAIMCWEGKHYTARKLVKKVFLPMAYEGLR
KEGIDEADIKRLLNVIKKRLKGNTGSTWMVTNFRRLTKTLKKDKALRLITKSIYLNQKNG
NPVNKWPDADENDKLAEASYWVGHIMSTMLFTVKKNDLASLATSIMEWNNIHHVPVEDDE
GKLCGILTWTHAHKYNPADHQKGYLVKDIMEEEVISVEATTPIKEAIQIMKENEIGCLPV
VQNEELIGIVTVMDVRPYYHD
>OMIFANIC_02127 putative zinc protease
MYLKKLTKFAAIAFFTVVMFTSCGDKSQSAEESAKLSIEFAKYELENGLDVVLHQDKSDP
IVSVAIQYGVGSNREKTGRTGFAHLFEHMLFQESENVPQDQFFKKIQDAGGTLNGGTWKD
GTIYYEIVPKNALEMVLWLESDRMGYLINTVTESAFYNQQEVVQNEKRQRVDNRPYGHTN
WVLDKNIYPDGHPYNWQVIGELVDLQNATVEDVREFYDRFYGPNNATLVLAGDFEEEDAK
ALIEKYFGEIKKRQDVAPLEPQPVTIAETKRLYHEDNFATAPQLHMVWPTLQQYTDDAYA
LDFLAEILSSGKKAPLYKVLVKEKDITSRTTAYNNSQELAGEFHIIITANEGVDLDEVEA
GISEAMALFETEGVTDRDVERIKAGLETSFYNGISSVLGKSFQLAQYNVFTGDPGFIEKD
IENIKAVTKEDVTRVYNKYIKDKPFVLTSFVPKGQTELIAENSVVAPVVEEEIKENVVKT
VEDSNEEVAKTPSLIDRSTEPAQGPAPQLNVPSSWSSELANGMKVYGIEQNEIPTVNFSL
VMEGGHLLDDKNKNGVANLMTDIMMEGTANKTPEELEEEIEMLGANINMYTTRESIVIRG
NTLVRNFNKTMALVEEILLQPRWDEEEFARLKTRTINDIKRAESNPNAVANRVYNKLLYG
EDHIFAYPTSGTVESVEAITMDDLKSYYNNYFSPSVSTFHVVGKIDKDDALKNLASLDEG
WASKDVSIPEYPAENNRDKASLYFVDIPNSKQSVINIGYIGLSRTDPDFYPLEVMNYKLG
GSFSGNVNLILREEKGYTYGARTRFSGSKIPGTFTASSSVRTNTTGESVQIFKDQIAKYK
EGISEEDLDFTKNALIKSNARRFETQGSLLGMLQEMSMYGLSSDYIANEETIIRNMTLDQ
HKSLANKYLDESKMAYLVVGDAATQYVQFQDMEFDEVMLLDKEGEEVKLEEVAQ
>OMIFANIC_02128 Divalent metal cation transporter MntH
MKRFFKNIGPGTLVAAAFIGPGTVTVCSIAGVTYGFTLLWAMVLSIVATIVLQEMAARLG
IVHNRGLAATVKAEIEKPFIRNLAIGLILAAILIGNAAYEAGNISGGVLGLETIFQDSGA
KIAGIEMNMLSLIIGAIAFLVLYLGNYKVIEKFLISLVLLMSISFLITAVLTKPQISEVL
KGMFIPKFPEESWLTIIALVGTTVVPYNLFLHASLVKEKWKDSTHLKAARIDTYISILLG
GIVSLAIIICAAAVRTSEVNNAADLAMALEPLYGEYATYLLSIGLFAAGITSAITAPLAA
AYVARDCFGWQGDLKSVKFRGVWMVILALGVVFSSIGFKPIEIIRFAQVANGLLLPIIAG
FLLWVVNRTNVLGGYRNNWLQNLLGILILITTIVLGSMSLVKVYQSL
>OMIFANIC_02129 hypothetical protein
MKRWIDINADLGEGTGLDEAIMPLISSCSIACGGHFGTEETMRTAVKLAKKYKVKIGAHP
SFPDKDNFGRKVLTITKKELTQTVYHQILQFLAVCEMEDAEINHIKLHGALYNYAAKDAA
TADAVVEAISNLKFRPKLYVPHGSILHRKAENLLPLVYEAFIDRRYEDDGTLVHRGHLKA
LISDPEEAWEHLIRMIINNEVITLSGKSVSMIANTFCIHGDSPNSVKILEYINTQLESEN
IYLER
>OMIFANIC_02130 Kinase A inhibitor
MKRTIRKFGNSAVLFEWSSNIKDIDYTSLLSLESYLLKAYSDEILETVMAYTSLAVYFEE
GTDPDDFIENFDLQQEWDFFDDTKHNTWVLPVCYSKEFAPDISIVASQNNINEREVIQLH
TSREYLVRFIGFLPGFPYLSGLDHRLFTPRKTNPRKLIERGSVGIGGEQTGIYTMDSPGG
WNIIGRSPLQFFNVLHRPPSLLIPGDKIQFRSIDPHTFERIHQGVIEGTYELERVNHD
>OMIFANIC_02131 KipI antagonist
MIEVHNPGIYCSVQDLGRFGSRRYGVPLSGVMDRPSAVNANALLGNEESAAVLEFANPGP
KLFFNKPAIIAIAGATFQVHINGESIATSQPVLVETNSIVDLGRAQEGVWGYLAVKGGIL
SESVLGSMSFYSGITRFSRITKGHILEIAALSESSSQEVNWGKKLPDYNVNHKIEAWPGP
EYELLSEYNKLALFDNDLKVTPQSNRMASLLVSELAILAPEIITSPVQPGTIQITPSGKI
IALMRDAQTTGGYARILQLSDEGITNLTRIQPGESVQFKLN
>OMIFANIC_02132 hypothetical protein
MPETNQSPGLFKKLDNLFSSFITWVSNVFSSVVKFTKASILSLLIIVFILLLLTKMDQAF
TMFVDLIEANGFKWGLMFSFFMINALALALSHYPIYNYYAANLNNSASFTTWEEVYPFKP
KGSTKGRWLYRLFKVFIFHEKPGGNYKKDDRAHYMRYSIGLLIHAVWILFIIKTFMPKFN
LSEAQTTTTMWAFFALCFVPLLHYIYVRRAVQKAKQVNNTTAIYKRLASRFTFLLILTFA
MVITCLVFGSLFSRIGFFILVFTCYLFMFNYLYFRILRTKLAEVVTLFEVSGSKLTLLIM
RIFKRLLYKSEHYLLLFSFNFIISIVIVIWTTYMAIRVGDLPNGTPILLAYFYTYYFIIA
AIGKFFFAYRKIREQISEENGEAPKHSFRFKLVCFGIFMLLSLFAVGMMTESRTHELELV
DHDNSNDLHEVQFINDIRNIPGNTVFFIASHGGGLKSNAWTLHVLEKLHRETNDQLMDRT
IAFSGASGGSLGLALYTGLSKELSGKFSNDMKLLEERIDIISEGNYTSSDLTLTFGLDSF
RKLWPFNREYPLQDRPYYAMIKYQNYVEDSIHHRLSRQSFRSFWKDVYEKRGYFPSLIMN
TAATTGRRGILWSVKANNFDNIFHFSEDLAELSEYSDGDSSVRPKTLSFYEAVSTTNRFP
VFSPAAKIPGYGHYIDAGAIDNSGLLGCLDLYLYLQSKDNFNFFQNKKVVFIEIINSKTL
YLDNLLKKIEQDPIQKEENETDNIIADLQTALNLDKIPGYVSDFVDRYNQAELIKIFMPH
KVTIGDVESYLNGKIENKSQRQGLINKLKAHNSYLDSITERGNGQEDTDRFFKEWNTYEP
TLSRHLSESSLLFIKEVLDHNSITESIKRIKDHIDN
>OMIFANIC_02133 hypothetical protein
MAKPQNCIPVQDAKDMYNNWKNSRGKDLKAKGYKDVNDFTFSLAEMQEFVAYVAEESSNA
GILNPGIRIYFAATGEDSQSTAAVFLAPTTGTSSNSGNNYNVEPLNRGTNGWPPNAY
>OMIFANIC_02134 hypothetical protein
MELLAALAGSFFLYKTNAAKISKQLVGFLWITFIVEVIAAYAPIAYFSDYKYFSFVKDTV
FEDHKWLYNMYSLFSAVFLTYYFHQHLRNIKWKLILQVTLIAFSVAAIINLIFSGVFFVS
DAQFTLLIGTLILIMSIIMFYFELLQSDLLLQLKRILPMYISVGVMVFSLCVTPVDIFSE
YFSEGNDSFVVLRNNVYLYTNIFMYTTFIIGFIICSKEKTSY
>OMIFANIC_02135 Sensor histidine kinase LiaS
MLQREDILLIITFVIVIFVMVAFVVIFFIAFQRRKNKFIMERLEAEKKFEKELTNSRLEI
QEQTLKNIAWELHDNVGQLLSVANIQLNMLQGHVPEEVKGQIKETKDVVAATVQEVRALS
KTLNTEIIQNNGLIKSVRTELERFNRLNFLHADLKIDGEEATIKGEDEIIIFRILQEFFS
NVIKHAKADNLFVNLCYGENELEIMVKDDGVGFDTSVNRDNSGLHNMKSRANLLGATYEL
TSEPGKGTKLNLVYPLKS
>OMIFANIC_02136 Transcriptional regulatory protein DegU
MKQNEHTVVIVDDHLLLSGSLEKLINSFDGFSVLYHASNGKELQQKLKTHKSQPDIILLD
INMPVMDGFETAAWLTDNHPEIKVLALSMEDDEKVILKMLQKGAKGYLLKDIHPDRLKIA
LQEVMDRGYYHSEKVAATLLHSIQPSYNKEEVKFKQNELTFLQLACSEMTYKEIADVMSL
SPKTIDGYRQELFNRLHIKNRVGLVIYALKNDLIKI
>OMIFANIC_02137 putative RNA pseudouridine synthase
MRSNKNNLLVLYEDNHLLIVNKRPGDIVQGDKTGDKPLSEVVKEYIAEKYNKPGAVFLGV
VHRLDRPTSGIVVFARTSKALSRLNKLFSERETKKVYWAVVENQPPKDNDRLVHFMKRNP
KQNKSYAHIKEVPDSKKAILNYSLVKKLDNYFLLEIDLETGRHHQIRSQLSSIGCVIKGD
LKYGAKRSNKNGSIHLHARSLTFIHPVRKEELTIIAPPPVDPIWDACI
>OMIFANIC_02138 hypothetical protein
MSRLKISIAISAISILSIITINYFIAERYLTISGESQAFFAITVMDYWYRHLFIIPGLAA
FVLAHKSNNGTAKGVALTVALLTMIFSLLDIWKIFV
>OMIFANIC_02139 3-methyl-2-oxobutanoate hydroxymethyltransferase
MKQNGEKISMLTAYDYTMAKIVDGAGIDVILVGDSASNVMAGHETTLPITLDQMIYHASS
VVRAAKRSLIVVDIPFGSYQSDPKEALRSAIRIMKESGAHAIKIEGGKEIKESAKRILNA
GIPVMGHLGLTPQSIYKFGTYTVRAKEEEEANKLKEDAKILEKCGCFAIVLEKVPAKLAA
EVASSLTIPIIGIGAGGGVDGQVLVTHDMLGMTHEFNPRFLRRYLDLYAEMTTAFTQYIE
DVKSRDFPNEEEQY
>OMIFANIC_02140 DNA polymerase I
MSAFGLSNQTDLSRTEAKELIETYYKTYPKLRDYIDDQIHFARENGYVQTVLGRRRYLTG
INGSNAVVRGAAERNAVNAPIQGSAADIIKIAMINIYKKLSEGNFKSKMLLQVHDELVFD
AYKPELEQLQDMIKTEMEGAYKLAVPLVVDIGLGNDWLEAH
>OMIFANIC_02141 hypothetical protein
MMKNTFFALFLITSFNLLAQVGIGNTAPQAALDIQSGSQGVLLPRVALTSVTDNVTVVNP
NGGVLAESTLVYNTGSAGLSTPGFYYWNSSQWIQLADDSPKVYVGKAIITGTGTLVISGL
PFEPSSVSIQAYSNVDAYVLDADNGTSNNDAGIANAFGSMKGYARDNSGSIDQQVIYGGG
SGNSINDISRFASPSHCVGLRYADKNGTSLGVTSASLTSFNSDGFTLNIDSYADSVVILY
EAHK
>OMIFANIC_02142 hypothetical protein
MTIQRTIYLLLGIMYFQSSFSQDEVTSDSIPLSYEMRVYTTTSVAGMEEINIDGMLDDAA
WEAVEWTSDYVEFEPDNASDPTEQTKMKIVYDDKNLYVAFKCYQKDPATIERRMGRRDDF
PGDWVEINIDSYGDDRTGFSFTASVSGVKGDEFISNNGNFDSSWNPIWYLDTNIDEEGWT
AEMRIPLSQLRFGNDDEQVWGIQSTRRYFRNEERSLWQPLPPNPPGWVSEFGELRGIKGI
KPQKQLEIQPYTVAQLDTYEQEPGNPFRDGSDTKLTGGLDAKIGITNDLTVDLTINPDFG
QVDADPGAIALDGFEIFFQERRPFFVENKNVFDFRVGGGADNIFFSRRIGRTPQGSTTAD
SNLGEFDDIPVNTTILGAAKFSGKTKNGWAIGLLESVTDREYAEIKLNDDPTVLNSLEEI
GEPREELVEPLTNYLVARAQKDFNDNNSYVGGIITATNRKLEENMDFLRESAYTGGLDAR
HNWKDRKYYVTGKFTFSTVNGSPEVIESTQTSLTHLFQRVDASHVNVDPTKTSLSGTGGS
FEIGGRSDNGKWRYNTGGNFRSPELELNDIGFLRQADQISQYANVRRLWNNPSTWFRRAN
IGFNQFSQYDFEGNYNRIQYEINSYVNWKNNWWTEFGAAHKPRIYTNTILRGGPRWRWNQ
ENFFFLFSGTDGRKKFSMHAGYVHSDAKQDNFSFRRYVLRFFYQPINSLNLRLVTEFERN
PNKTQYVTESAFNGTPRYILGEIDNESLSTTLRVNYNINPNLTIQYYGQPFIFKAKFSNF
NYVNDPVAKDLSDRVTWYNNDQISFSNDVYSVDEDGDAEVDYEFGNPDFAFVQFRSNLVL
RWEYIPGSEIFLVWSQGITGLGDVNNDFGKIIDNQLLSERPQNTFLIKATYRFVL
>OMIFANIC_02143 50S ribosomal protein L13
MDTLSYKTVSANKNTVNKEWVLVDADGQALGRLASEVAKLLRGKHKPNFTPHVDCGDNVI
IINAEKINLSGNKWEQKTYIRHTGYPGGQRSLTANELFSKNPARVVEKAVKGMLPKNKLG
AQLFRNLKVYVGTEHDQEAQKPKTINLNDIK
>OMIFANIC_02144 30S ribosomal protein S9
METIHKIGRRKTAVARVYLSKGKGNITVNKREMDKYFTTATLQYKVKQPLALTDNEKSFD
INVNVFGGGITGQAEAVRLALSRAMCELNEENRSILKPEGLLTRDPRMVERKKFGQKKAR
KKFQFSKR
>OMIFANIC_02145 30S ribosomal protein S2
MANNKEVKELLDAGVHFGHLTRKWNPNMAPYIYMERNGIHILNLYKTAAKLEEASEAMKK
IAASGRKILFVATKKQAKDIVADRAGKANMPYITERWPGGMLTNFVTIRKAVKKMAMIDR
MKQDGTFNTLSKKERLAVDRTRAKLEKNLGSISDMSRLPGALFIVDTTREHIAVKEAQKL
NIPIFAMVDTNSDPREIDYVIPSNDDASKSIEKIVTRVSEAVIEGLAERKSGKESESEAP
KAETPAPAPAPEAAVETEATVETKAATKTKAAVETEAAKEEE
>OMIFANIC_02146 Elongation factor Ts
MEMVKITAAMVSELRKKTGAGMMDCKKALVEAEGDFDKAIEILRKKGQKIAEKRADRDSS
EGAVIAKINDSKTKGAIVSLNCETDFVSKNDDYVAMAHKMAEIALGTSSKEEFMAADFDG
MTIDEKLTEQTGVIGEKIEIGAYKTLEAPFLGSYIHGNKIAAIVGLSANVENADVLAKDL
AMQVASMGATTLSYKDFDADYIAAETEARIAVIEKDNIELGRLGKTLKNVPQYISRAQLT
DEVLSKAEADIKAALIAEGKPEQILDRIVPGKLERFISDNTTLDQEQCLLDQNFIKDEKL
SVAEYVKTYGDVEVVSFERVSLT
>OMIFANIC_02147 Putative serine protease HhoA
MKKLNYLIIFLIIVSCQPKGLDTKFIASKYYQGVVKVVLFDEVLEKIEKGKGYLSRGSGF
IVTEDGYLFTNKHVVETSVKGYVDYDYYENKIKKSTISVYSEDLVNSNDLIKVYNAGYTV
PVIQVFHGKGENDYNLYKAEVVSIGAGAYDGALLKIVSDMEGNPVKRKFTTVPLGNSDNV
SQGEQLCVYGYPAQFKGSAELMMKDLSTISVGIMSGNDYVFNEDYGYIKTDAEIHPGNSG
GPVFNEENKAIGIATAKGKTTGIGLVGGINGMYYISAIDSKAHSELIENGLTLPKRSSSI
NTINGEQQPIKTVKEINDIIAARTKKKSPPTTTLLGDYYSKSKIFFSHLSPAKNDNLIPN
TTKRHTSFNIDKSAGGKIWFYVDNYPKELNTSKITILIDKANNMGIYEKFKDFSVTVNST
HDIKYFDVDFYQEGQYRVKAYSAELKYINTAYLKLTYFK
>OMIFANIC_02148 Uridylate kinase
MRYKRILLKLSGEALMGTRQYGIDPDRLQEYAKEIKEITDHGVEVAIVIGGGNIFRGLSG
ASRGMDRVQGDHMGMLATVINGLALQSALEDEGIPTRLQSAIKINEVAEPFIRRKAIRHL
EKGRVVIFGGGTGNPYFTTDSAAVLRAIEVGAEVILKGTRVDGIYSSDPEKNTDATKFDD
ISFEDVLQKGLKVMDTTAFTLSQENELPIIVFDMNTRGNLYKVVSGEKIGTKVNL
>OMIFANIC_02149 Ribosome-recycling factor
MNEEIKFLLDSTREVMGNAIKHLEKKFVNIRAGKASPSMVSSVMVDYYGTPTPLNQVANV
NTPDGMTISIQPWEKSLIPEIEKGIMVANLGFNPMNNGESVIINVPPLTEERRTELAKQA
KHEAEESKIGVRNDRKHAMNELKDLDISEDMKSNLEIDIQEMTDNHIKKIDEIYHVKEKE
IMTV
>OMIFANIC_02150 hypothetical protein
MRLTSLVFFVLLPYFLGAQEPAIQTQQDSTATQTKQKKSPFKTGFYPLGFFDVDLRYFIK
YNNYEGIRIGFGGITNERLFEDVKLGGYVARGFKDKDFKFSVGGSVRVNKEHNTWINTYY
FDDIREIGTMKYLTDDRVYSVFEPRLLNVTQFYKYRNIMSNIQHEFSPKVWGEFRVGHSK
IDQIEDYQFLDNNVLYSAFETSEVTAALRISPKTNFITIDDGRVEYFDGLPKISAQVTQS
VPGFGGSDFSYTKFGLKLDYYIKRKDLSSTNILLEGNYATGDVPLTHLFHAYPNSPTKDE
ILQRFSVAGRRSFETMYFGEFFSDQLLTLQVKHSLRRFYFSDSFQPELVFITRHAVGDLS
NPERHIGIPFKTLEEFYSESGLELNRLLFGFGLSFAYRYGFYNLPDFEDNISFKFTFYLK
L
>OMIFANIC_02151 Putative membrane protein YdgH
MDKLFSIGFWSAVARFILRNRTLILVAIAIITVLLASQWKHMRFTYTEANLLPDDHEVNI
EYNKFLAEFGEEGNLIVIGVKDTALFTPNNFKAWNLLSNDLRKASEVDLTLAVGDLQKLQ
KRKDSVGFELVPFIQDTVFSEENLSRYKYELFNKLPFYEGLIYNPDKTSVRTAIYLNKDI
VNTSVRKDFIDQVLIPRIEQFETESGMKVYTSGMPYIRTLNSQNIIDEIGMFIGAALLVT
SLIFFFFFRSFRATFISMVTVIIGVMWAFGILGLLHYEITVLTALIPPLIIVIGIPNCIF
LINKYQQEIKNHGNQAKSLQRVISKVGNATLMTNVTTASGFATFTLTNSQLLKEFGAVAS
INIIAIFLLSLFIIPIVYSYMAVPKYKHLKHLNKQWIAKFVDWMERMVKEHRIAIYVSAI
ALLCASIIGIYNIHISGSLIEDMPKTKEFYSDIKFYESEYEGIMPLEILVDTKRKKGVMK
LATLKRIDELQDYIMDVPEFSKPISVAELVKYSKQAYYNNNPEYYQLPNSQERTFILSYA
KSSADSANLLSSYVDSTGQFARITTFMKDTETERFDRIEEDLKDEITKIFPEERYDVSLT
GKALVFQKGTKYLVRNLIISLSLAVFLIALFMAWMFRSFRMILISLIPNLLPLLITAGLM
GFLGVPIKPSTILVFSIAFGISVDDTIHFLAKYRQELIASDWKIKKSVYAALRETGVSMF
YTSIVLFFGFSVFTISSFGGTVALGALVSATLLCAMLANLLLLPSLLLSLERSIANKETL
RKPALKIIPDNDDDMEDDD
>OMIFANIC_02152 Asparagine--tRNA ligase
MQQSEISKILQSEPSQVEITVKGWVRSFRSNRFIALNDGSTIKNLQCVVDFENFEEELLR
KVTVGAAISLSGTLVESQGQGQVVEIQVSKIEVLGEADPEEVKLTILSPKRHTLETLREQ
AHLRIRTNTFGAIMRTRSKLAFAVHDYFQKNNFHYFHSPIITGSDAEGAGEMFRVSALDP
KNPPLNEHGEVDYKQDFFEKETNLTVSGQLEAETYAMGLGKVYTFGPTFRAENSNTSRHL
AEFWMIEPEMAFYDLDANMDLAEDFIKYVVKYTLENCSDDLEFLENRLLQEEKTKPQAER
SEMTLRDKLRFIIDNNFKRVTYTEAIEILKRSKPNKKKKFKFLIDEWGADLQSEHERYLV
EKHFKCPVILFDYPATIKAFYMRLNDDGKTVRAMDVLFPGIGEIVGGSQREERYDVLLEK
MKAMDISEEELYWYLDLRKFGTCVHSGFGLGFERLVQFVTGMGNIRDVIPYPRTPGNAEF
>OMIFANIC_02153 RNA polymerase sigma-54 factor
MLKQQLNFKLSQKLSPQQIQLMKLIQLPTLAFEQRISQEMEENPALEGGKDEDDNLQDTF
DDDSYDDTYDDGTEVIETDINVDDYLSDDETPSYKLSASNYSPDDEDKQTPYASGTSFNQ
YLLQQLNTYRLDEEAEEIAKFLVGSVDESGYIRREISDIVDDLAFTQNIYTTEEKIEEVL
NIVQDLDPAGVAARDLQECLLIQLKRKESSVEVDLATRIIEDTFDHFSKKHYKKLLHKFD
ITEEQLRNAIHEIEGLNPKPGGTYSGNTRMVEHVVPDFTIKIVDGELELTLNGRNAPELH
VSREYTNMLKGYKESKDKSKSQKDAVLFIKQKLDAAKWFIDAIKQRQQTLYVTMNAIMHH
QKEYFLTGDERKLKPMILKDIADKIDMDVSTVSRVANSKYVDTPYGTKLIKEFFSESMKN
IQGEDVSTREIKKILEITISEEDKRKPLTDDKLAKILKEKGYPIARRTVAKYREQLDLPV
ARLRKEI
>OMIFANIC_02154 hypothetical protein
MNIFLRIGAYIFHPLLMPLLGTFFYFIITPRYVERDLLFAKLMAVCIITFLIPLVTYFLL
KNLHVVSSIQLDDVKERKVPLMLQCLLLLLVIKMVFDPYDSPELYYFFVAILFSAITALL
LVFFKQKISLHQMGIAGVTMFLIALSVHFKVNLLIWIIIMFIANGWVASSRLHTNSHTPV
ELVLGLFIGVIPQLILLNFWL
>OMIFANIC_02155 hypothetical protein
MRFSKRIFSLIIICLLGCVGLAQDSIPKPYDQNYREDQFYIGITYNVITDVPTDVATRGL
SGGLHFGFLRDIPLNERRNVAIAIGAGMSIDRYGQTLFIGEAEDNESIFRILNSEIDYTT
NYFSTYTLEAPVEFRWRTSTESSYKFWRIYTGFRIGYSYYYKSVFKQTNNNINQTDIPEF
EKLRLGASLSFGYNTFNFYVYYSINPFFKDAITVENQTVDFKTVKVGLMFYIL
>OMIFANIC_02156 hypothetical protein
MSKFKKKKGGELPHISTASLPDIVFMLLFFFMVVTVLRDTNLLVQNQLPKADQVEKLKKD
RAVYIYAGKPSSRYQEVFGTEGRIQIGDKYTSIENIGLALEEARRKLLPELQDKVYVALK
VDGETNTGLVSDIKQVLRERNLLKIIYITTPGTELSN
>OMIFANIC_02157 hypothetical protein
MRRATPEVNAGSMADIAFLLLIFFLVTTTIEKDKGIARQLPPIEPPTEAPPLIKEKNLFI
VNVNKDDQLLVEDNLMELKDLRQAAIAFLDNGGAPSGSPEYCNYCKGARSPSSSDNPDKA
VISVQNDRLTSYKMYIAVQNELVAAYNFLRDRESERLYGWKFTELNKAINEGSFKGNEDA
AKEKLEAIQKLFPLKLSEAEPKTKGQ
>OMIFANIC_02158 hypothetical protein
MGLHKILRIVALLLAVAGIVALVMVLVNDTGLDAQLYIAYITLALTVFIVLVYVLKETFS
GNLKKTLMSIGAFIAVVIVAYIMADGVETEMRDGEILSESGSHWVGTGLNTFYILAVIAI
GSMIYSGIKKATAR
>OMIFANIC_02159 hypothetical protein
MKKLFSIMAIAALFFAGTFNANATAVQTMPTNVQTLVTSATVTIIQDDEAAASTEESQGW
HQALKQRFIEGGPGFMGIVLLCLILGLAIAIERIIFLNLSTTNTNKLAQSVEDALNSGGV
EAAKEVCRNTKGPVASIYYQGLDRADESIEAAEKAVIGYGGVQMGQLERNVSWISLFIAL
APMLGFMGTVIGMILAFDKIEAAGDMNPSLVAGGIKVALLTTVFGLIVAIILQIFYNYII
AKIDSIVNSMEDASITLIDMLVDYKNKK
>OMIFANIC_02161 L-asparaginase 1
MKQIPKILLIYTGGTIGMIMDFKTGALENFNFNELLTYVPELNLLDCSISTKSFKKPIDS
SNMNPDYWVRLTTIIEKNYDTYDGFVVLHGSDTMSYTASVISFMTENLAKPIIFTGSQLP
IGDLRTDAKENLITSIQLAALQHKGNPRIAEVCLYFEYKLYRANRTTKINAQHFQAFASL
NYPPLAESGVELSINEEALLIPNRRKKFRVFKELGKGIVLLKMFPGMDAQTFRHIVSYDE
IQGLIIETYGSGNVTTQTWFLSGLKKLIGRGIPVINVTQCSGGSVNMGLYHTSVALKKLG
VISGKDITTEAAVAKLMYLLGHGISSKSFRTIFETSLRGEMS
>OMIFANIC_02162 putative metal-dependent hydrolase YjjV
MLTDTHTHLYSEAFDEDRKAMMERAAEAGVSRFFIPAIDSTYTEAMYDLERQFPDKVFLM
MGLHPTSVKEESYLLELAKVEAAFEKRSFYAVGEIGIDLYWDTSTLEIQKEAFRRQIKLA
KKYQLPIVIHCRESFDEIFEVLETERDEKLFGIFHCFTGTKVQAERAIGFNMKLGIGGVV
TFKNGKIDRFLREIDLKHIVLETDSPYLSPVPFRGKRNESSYLKLITQKVAEIYEMPVAE
IANKTTENSKEVFGV
>OMIFANIC_02163 hypothetical protein
MTTLRKLLESKGFFRIPLRKLKTGHYKVEVKVNGEDGHFILDTGASSSCIGFSSVGRFIM
HTEESEIKAAGAGAINMDTHIAKNNIFSIGKKVKNSMSFVIFDLGHVNEALSQVREDPVQ
GILGADFLKESKAVIDYGRNVLYLK
>OMIFANIC_02164 Oxygen sensor histidine kinase NreB
MKALPKFLFIFIFLLTSRSWSQDIDYYINLSETTADRYEKLIALDSVISKAGKTDLDAFI
SYSLKYIEVAKEMDSIEAAARKMINVHYSLSSVKNEPREALTIIDGILARKYKIQDSYLL
GGLYLKRGGSNYKLNLTDAVEDYKMAIANFTEKDSLYVADAYLFSGQAYSNMGKFVPAGE
SYRKAYNYFEALGDYEYMFYAQQGITTMFSMNGFHEKAMIEREKNIKKIESLGLTHHLPT
EYYNQALDYEKIGNKIKYLEYLFKAKDAIDNSRENNMEISNEMYIYAELVDYYCESGQIP
AAEEYLELINKFHENSQDDLITSSQYLGANAKYHFSRGEYETALEYAKQKLIKAETLKYE
ENILSSHKLLSDIYNAQGAFKKALEHELAYSELKDYIYNKGVANSLAYYQTLYETEKNEK
ELVEQSANIQLLEKDNQTFKKLMIFGGVALLLLFGVILLYRNQLYFKNRQVLQEKFSQEL
IVSQEEERMRISKDLHDGLGQRLLVIKNKMLTSRDDETKNMIDETIEEVRSISRDLHPFQ
LQELGITKALEHTVTQIDENTTLFISSEIDNIDNLFNEEAEVNIYRIVQESLSNVLKHAK
AEASKISVKKMANFVVISIKDNGVGFDFSEKLQNVKSLGLKTLMERTRFLDGQMKVESRF
NNGTTLQFQFPIT
>OMIFANIC_02165 Transcriptional regulatory protein DesR
MKNRSIITADDHPLLLKGLNDFLIEKGYNIIGCGSNGREAYNLITKLKPDIAILDIQMPF
MSGLEIAKKCKTNGIDTKIVLITIHKEKELYNKAQELNIFGYILKEFAIEEIENCIEMVS
EGEPYFSQKIKDMLNSNSAEDKALNVLTPSEKKILKLIARDKTNKEIASLLFISYRTVEK
HRSNIINKLKLEPKTNSLLSWAKEHHDKLQ
>OMIFANIC_02166 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MPLEMKVPSPGESITEVEIAEWLVEDGDYVEKDQAIAEVDSDKATLELPAEASGIITLKA
EEGDAVAVGEVVCLIDTDAPKPVGNDAPAKETKDLEVEVKEEPKESKEADKAKTYATGTP
SPAAKKILDEKGIDAASVTGTGRDGRITKEDAAKAVPSMGSPGPGERESKRKKLSLLRRK
VAERLVAAKNETAMLTTFNEVDMGPIFELRKEYKETFKEKHGVSLGFMSFFTLAVVRALE
LYPDVNSMIDGDYKITYDYKDISIAVSGPKGLMVPVIRNAEDLSFRGVEAEVKRLALRAR
DGEITVDEMTGGTFTISNGGVFGSMLSTPIINPPQSGILGMHNIVERPVVKNGEIVIAPV
MYVALSYDHRIIDGRESVGFLVAVKEALENPLELLMNNDVKKALEL
>OMIFANIC_02167 2-oxoglutarate dehydrogenase E1 component
MDRYSFLNAVHPSFIAELYDKYLQFPDTVEPSWRAFFQGFDFGIENGSLEALGIESPVGE
IPDHLHKEFQVIRLIDGYRTRGHLFTRTNPVRERRKYRPKLDIENFGLSQDDLQTKFQAG
EVIGIGEATLEEIIVHLMRIYCDSIGIEYMYIRKPEEIEWIQKRLNINDNQPNFTKEHKL
HILRKLNEAVSFEHFLHTKYVGQKRFSLEGGESLIPALDTLIENAAEKGVEEFVMGMAHR
GRLSTLTNIFGKSAKDIFSEFDGKDYEQDVFDGDVKYHLGWTSHRETDSGKKINLNIAPN
PSHLETVGAVVQGIARAKQDRHHKDNISKVLPIVVHGDAAIAGQGLVYEVVQMAKLDAYK
TGGTIHIVVNNQVGFTTNYLDGRSSTYCTDVGKVTLSPVMHVNADDAEAVVHAMLFALDF
RMEFGRDVFIDLLGYRKYGHNEGDEPRFTQPKLYKAIAKQKNPRDIYAEKLMQQGVIEEG
FTKQLEQEYKDKLEEKLVDSRKEEKTEITAIMKDEWDGFHYAKEESLVKTFDTSMDIDKL
SEVAEVITKLPEDRKFLRKISRLIESRHRMYFEDNKLDWAMGELLAYGTLLKEGYDVRMT
GQDVERGTFSHRHAVVKVEESEEEIVLLNDLKGDQGNFYIYNSLLSEYGVVGFDYGYAMA
SPKTLTIWEAQFGDFSNGAQIMIDQYISASEDKWKLQNGLVMLLPHGYEGQGAEHSSARM
ERYLQLCATDNMFVADCTTPANFYHLLRRQMIVDFRKPLIVFTPKSLLRHPKVVSTKEDL
ANGSFQMLIDDPDAEAAKVKTLVFLTGKFYYDLLEKKEELGRDDIALVRIEQLFPLPKDE
IRSTIKKYKNATDIVWAQEEPKNMGAYSHMLMHFEPSREWRVCSRKMYAAPASGSSVRSM
QRHQRIIDSVFDPTSNNQ
>OMIFANIC_02168 hypothetical protein
MKFYIKMPIFLFLTVLMCSSFVAVAQEAKPPSQFWRNVRFGGGIGLSFGDGFFSGTLAPS
AIYQFDDRFALGLGLNGTYNNQKNTYSSTIVGGSILSLYNVIPEIQLSAEFEELNVNRSY
DSRLGLEDENYWYPALFLGAGFRTNNVTVGIRYDVLYDEEDSIYANAWMPFFRVYF
>OMIFANIC_02169 (2E,6E)-farnesyl diphosphate synthase
MELLKQYNRSLEEHLENAVAVREPEQLYDPIKYILTLGGKRLRPVLTLLSCDFFGEDYLK
AMNAALAVELFHNFSLIHDDIMDNAPLRRGKETVHEKWDLNTGILSGDAMLILAYRFFEG
YEPMLFRELAKLFSKTAIEVCEGQQYDVDFERRDDVTIEEYIKMIDYKTAVLIGAAMKMG
AIVAGATESCKDSIYEFGRNLGIAFQLQDDYLDAFGNPDTFGKQVGGDIIANKKTFLYLT
ALERSESSEAAELKHLFSISPKDPSEKVNIVKRIFENSGAVDATEKEIASYTDKANTVLD
QIQISEERKENLREFGTWLMRRKV
>OMIFANIC_02170 HTH-type transcriptional repressor KstR2
MLKNCKTLETFSVLKVSFLIFALHMKDKITHKAAEMFITLGFKSVTMDDIANELAISKKT
IYAHFKNKTELVHEVTMSLFSTISCGIDHICDLQKNPIEELYEIKKLVMMHLKNERTSPQ
YQLQKFYPEIHEALKAKHYQKMSECTLGNLKRGVAMGLYRENLDIDFVSRIYFIGVNGIK
DEALFPVQKFPKVRLFEDYLEYHLRGIVTKEGLKTLNKFIKTTMHNA
>OMIFANIC_02171 hypothetical protein
MRNYLVILFLIMGVGASNGQGSKAYQFSLEEAISFALDSNYTAINSRRDIAKAIKLKWET
TATGLPQLNANINYQNSLKQPVTLIPGEFTGGDPGTFVPVVFGVPQVASATATLEQLIFD
GSYLVGLQAAKAFLDYSENADEKTLLEIRKGVINAYGSVLLSEELVAIFQKDKTTVERNL
FETRKVYENGLAEEEDVEQLEITLLQIDTQLNRASRTLDIALQMFKVALGIDMNDSVNLT
QNLDDLTRQNINLNFLNTNLNVEENVDYKIAFNLTEQRSLELKLEKSKALPTLNAFVNYA
TQANSDDFTFLETDQRWFQSSILGVSMNVPIFSSGLRGARTQQARIAVDQAKTVLEETIQ
NIRLEFETAKSNYQFTIENYENSKKNLSLAERIEQKNQVKFTEGIASSFDLRQAQAQLFN
AQQEYFQSMLDVINAKTQLETVLNTPQLKN
>OMIFANIC_02172 Cobalt-zinc-cadmium resistance protein CzcB
MKKSIFILTLTVLLTACSGGDKNKSVDDLIEEGNLENLVVKKDEMRTTQSEIQNDLAKLE
AAIKKLDTTDNAALVTTMTLRDTLFQHFIEIQGNVETNQNVIIYPEYQGVLTRVLVKEGD
RVRKGQVLARIDDGGLGSQLSQLKVQEELARTTFERQERLWQQKIGSEIQYLQAKANYEA
TSNSVKQLESQLGKTSVQAPFSGIIDDVITDQGTVVSQGQALFRIVNLNDMFIKAEVPER
YIKSIVPGKEVSISLPILGESVASKVRQTGNYINPNNRAFTVEVDVPNTTGNIKPNLTAR
LKINDYTNENAILIPLSVISENAEGEQYVYMAVKGDTGNGNSQAIQRTISTGKTQGDYIE
VLEGLSPGETIIIEGARSVKDEQEVKIINQ
>OMIFANIC_02173 Swarming motility protein SwrC
MSAKKKKVNKEFRLSSWAIDNPTIIYVMVGLFLLLGLSAYQNMPRESFPEVNETKIYISI
PYPGNTSEDIERLIVDPLEEKLRNVSNVVEILSTSQEDYGIITVEFDEDIAVEQAKQKVK
DEVDSEKANEDWPLFNGAKVEPNVFDLSLSEEMPILNINITGDYPVVKLKEYAEYLQDEI
EKLPEIKEVDIRGAQELEVEVAVDIYKMMAAQVSFDDILNTIRNENMTMSAGNLITSGQR
RTIRVLGEVDDPSELENFVVKNEKGPIYLRDIAEVRFEEEDKTTYARDFGDNVVMLDVKK
RSGKNMIEAVEKIDNILEEAKANTTIFPPDLSVTKANDQSAKTDNQVSDLVNNIIFGIIL
VVTVLMFFLGFRNALFVGFAIPMSMFMSFMILSLLGYTMNTMILFGLIMGLGMLVDNGIV
VVENVYRLMDEEGMPRIQAAKKGIGEIAFPIIISTATTVAAFIPLGLWPGIMGEFMIFFP
ITLSVVLGSSLFVAIFINSMLVSQFMEVGEKVLTTKQLIRLTLIMVPIGAFIFIVGGQMR
GLGSLMIVVVLLFWIYRFVLKQAAVSFQKRILSRVENSYQRFLAWALRGRKPVLFVIGIF
SLLIFVFAGFIGSMMTQRTSVEFFPDNTPNQIIVYIEYPEGTDIEKTNAITKQIEERVYA
IVRDAEYIEGEDYNFLVESAVSQVGEGAGNPMTDGGSAAEMPNRGKITATMREYKFRKGK
DSEILRKRVQEALRGIYPGVAISVEKDAVGPPAGYPINIEIEGDDYDELIATAETMRNYI
NSKSIAGIDELKIDVNKGKPSMQVVVDREKSGELGVPAGMVGSQLRRSLFGEKAGVYKKD
GEDYDINVRFDKNDRYSTSALFDQNITFRDQASGKIKEVPISAVAEQKNTSSFSAIKHRD
TRRVVTVYSALAPGFTDAGAVVSKIEAEMENYQGLPDTVQIDYTGQIEEETKQMNFLMGA
FFSGLGLIMLILIFQFSSVSKPTIIMLAIFLSFIGVFGGILATGASFVIMMTMMGIISLA
GIVVNNGVVLLDYTQLLIDRRIVEMGLPDNALLPKEEIKEIIVRGGRARLRPVILTAITT
VLGLIPLAIGVNIDFFSMFSEFDANFYLGGDNVIFWGPLAWAVIYGLIIATFLTLIIVPV
LFYIVHRIKLRIRRWRTKSKPAENIVLDEAA
>OMIFANIC_02174 hypothetical protein
MKNIYIKVFFFALIMVVAGCELEEIDNPNAPTVESFDEGASQADIQLLAAGIEAVIRNDL
EFHYDTMSILAREYYDLSGVDPRYTGELLKGPLDNNGFLTTRAFAAWYKVVKGANVLLNA
VENSEAGFSDADKNGYYGYANTMKAYALLMVLNRQYENGIRLDVADPDNLGPIVGYSEAL
TGIRAVLDEGFVNLANSGDAFDYDLSAGFDNFDTPSSFAQFNRAIAVRVALYQGNLAEVR
TLLNGSFFDLNGDLNLGVAHVFGLTGNDIPNAQFHVPNQSGQEFMIHDSWVADSEAGDTR
VDEKSILFETGTVMFDNLSADYQIAVYDSNVDPVFMIRNEELILIYAEAQVDNDPAMAVA
AINRIRNEAGLSDYDGPTDATSLIEEILNQRRYSLLAEGHRLVDLRRLGRLNETYVPLDR
DGDNILDSFPTPFNEGL
>OMIFANIC_02175 TonB-dependent receptor SusC
MKQNNFYHRLFLFFLFVLPSMMLAQTTITGSVNDENGNALPFVNVIEKGTSNGTTTDIDG
NFSIDVSSTPATLVFSSLGLETIEQNVTGSPVNITMAESAQALGEVIVTGLATSTKRENA
ANAVSSINAAELAGIANQSGLDGALYGKFNGAEIKANSGAPGGGISMRLRGVTSIFGDQQ
PLFIVDGVYVDNSTIGLGNNVVSAAAGGGNPSTNQDDASNRIADLDPEDIENVEILKGAS
AAAIYGSRAAGGVVIITTKRGKKGDAKVSFSQVVGLRSPTQLLGLRDWDQSEIEAFGGPS
NFDLRNLRDYEAELFDHTRVSYTTRFTTSGGADKTDYFFGATHKNEPGLVENTGYVKSSI
RLNIGQRFNDWLDLYVTSNYINSKSDRGFFNNGNANRTVGYALAFTYPWENLSPTDGVYP
QGGAGSNVLETVALTTNREEINRFIGSATSNLKIIDGDQNRLKLVLQGGFDQYTLRSTSI
FPRELSYFRDPSSLGGVAISGSTVNTNFNLSAFLVHNLDLNNGLSFTTQFGNFLQDFHRN
TVLTVSTGLNGSQTNLGQASNVGTQQTIIPQKDTGFFAQTEINWDDKIIATGGVRGDKST
NNGDVNKTYYYPKGNLAINIHKFDVFGDDSFLTSLKPRVAYGESGRFSAFADRFSLMNAQ
FIDGIGGGGSGLSVANLRGNPDVGPERQSELEYGLDLGLFDGRIIFEGSVYNKKIDDLLL
RTDVPTSSGFTGAVRNAGELENRGIELNLNAAIIDTEDLQWTANIKWWKNESEITRLDVP
SFTEGGFAASLGTFLIQEGKPATQIVGTYNPADFTAAEIAERDPEGDGFFVYGDAEPDYQ
MSWFNSLSYKGFDLTWIWHWKEGGDAINLTTLLYDLAGTTWDYDDFGLDPSGQLANGPYR
AGQAFVNPDPVIEDAGYIRLREIALYYNFPDKWFDFLDSVKVGLSGRNLINIFDYNSYDP
ESSNFGNNVLANNVEVTPYPASKFVNFHLNVNF
>OMIFANIC_02176 Aspartate--tRNA ligase
MYRTHTNGQLRADDINKEVTLAGWVQKTRDKGFMIWVDLRDRYGITQLIFDEDRSPKPIM
EAASALGREFVVQVTGTVIERESKNPNIPTGEIEILVKELTVLNASLTPPFTIENETDGG
EDLRMKYRYLDIRREAVRENLVFRHKVTMAVRNYLSGKSFVEIETPYLIKSTPEGARDFV
VPSRMNQGQFYALPQSPQTFKQLLMIGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDVLTTFEGLTRHLLKEINGVEVGKFPRMTFDEALRRYGNDKPDIRFGMEFGELNE
VAQHRDFNIFNSAELVVGIAVPGGNSYSRKEIDKLVDWVRRPQIGAKGMVYVRCNEDGSF
KSSVDKFYNQEDLAKWAGVTGAEPGDLICVLSGEIDKTRAQLSALRMELAERMGLRKADE
FAPLWVVDFPLLEWDEETERYHAMHHPFTSPKPGQMELLETDPGKVKANAYDLVLNGNEI
GGGSIRIHDKEIQSKMFDYLGFTPEEARAQFGFLMDAFEYGAPPHGGIAFGLDRLVAILG
GQETIRDFIAFPKNNAGRDVMIDAPAPIDSEQLKELHIKLNF
>OMIFANIC_02177 hypothetical protein
MKYFLSISFLIILGTAIYGFSVREADPKTGEFCIGISIAVLFFLWMPFFIYHRWKNRSMK
DYMLTKENIDKMRKEGRRKKL
>OMIFANIC_02178 Cold shock-like protein CspG
MEGTVKFFNESKGYGFITNDETGKDIFVHVTGLNGEALNEGDKVEYVEEEGRKGMVAAQV
RVIHE
>OMIFANIC_02179 tRNA-specific adenosine deaminase
MINPFDDTYFMKKALQEAEAAYDKGEIPIGAVVVINDRIIARAHNLTETLNDVTAHAEMQ
AITAAANFLGGKYLKDCTLYVTIEPCQMCAGALYWSQISKIIYGARDEQRGCIKMKTKLH
PKTVMKGGILKEESSEILKRFFIEKRNLN
>OMIFANIC_02180 hypothetical protein
MRRSAISICSNIAEGSGRNSSKDQARFTEIAYGSALELLNQLIISSDMGFIEEEELSQLR
VEVSEITSMLNGLRNSQTSKS
>OMIFANIC_02181 1-deoxy-D-xylulose-5-phosphate synthase
MSNTLLDSIQFPSDLRKLQKEKLPQLAAELRDFVIHIVAAKEGHLGASLGVVELTIALHY
VFNTPDDQLVWDVGHQAYGHKILTGRRDQFQTNRKLGGLSGFPRREESEYDTFGTGHSST
AISAALGMAIAAQLTNAAHRQHIAVVGDASIASGMAFEALNHAGVTNTNLLVILNDNAIG
IDPSVGSLKDYLTKVTLDNAPDTDNIFEALNFKYSGPLDGHDIDSLVSELERLKNVEGPK
LLHIITTKGKGLRQAEVDQVKYHAPGKFDAKTGDLFPRDTSGMPPKFQDVFGKSLVELAR
KNEKIVGITPAMPTGSSLKYMMDVFPTRAFDVGIAEQHAVTFAAGLATQGMVVFCNIYST
FLQRAYDQVIHDVCLQDLPVIFCLDRAGIVGEDGATHHGIFDLAYLRCVPNLILAAPSNE
IELRNLLYTAQLGLDHPIAIRYPRGRGNIVDWRKEFTAVEIGKGQMLKEGSEIAILSIGN
MAINVTEAISGILENEKIGHFDMCFVKPLDDSLLHEIFGNYHTVITIEDGVAAGGFGSAV
AEFAAGNSYKNNLRIIGIQDEFPEHGSVEELHHLAGISSDKIREVITSLL
>OMIFANIC_02182 Deoxyguanosinetriphosphate triphosphohydrolase
MMQWEELLSLRKHGDTKKRIRNEENLTRSGFEVDFDRIIFSAAFRSLQDKTQVIPLSKTS
FVHTRLTHSLEVSVVGRSLGRQVGSAIIEKHPYLRKIHGYEVNDFGAIVAAAALAHDIGN
PPFGHSGEKAIGDYFKNGKGRRFMESMSEKEYQDLIDFEGNANGFKILTETKNGVKGGLR
LTYATLGAFTKYPKESLPKKPTAHIADKKFGFFQGDKSFFDEVAKNLGLISRGNSGDLSY
CRHPLAYLVEAADDICYTIIDFEDGINLGWITEETALEYLINLVKDRINTDNYTALTQTK
DRLAYLRSLAIGTLISEAVDVFIANENAMLNGTFEDDLLSHSRYKAQIDDIISESIQKIY
KSSEVVDKEIAGYNILNTLLDGFTTACENHYKGQATHYDSLLLRSLDTPLPAEASVYEYT
MFCCSYISMLTDGNALQLFQKIKGHL
>OMIFANIC_02183 TonB-dependent receptor SusC
MKNLVTLIFLGFVSLTSAQSSGSIVGKLTDKDFNNEPLAFANVVIKGTSTGTTSDFDGLY
ELANVSPGIYTIVYSFVGYETIEIDNVQVEANKVTTVNVPMGASAAALDEIVIRTSTRKE
SEVALLLEQKKATTIKQSIGSEELARKGVGDAAGAVTKISGISRQEGGSNVYVRGLGDRY
LNTTYNGLAMPSNDIEKKNIDLNLFSSDIIQNVSVSKAYASDFYGDFAAGNVNILAKEYS
GNGMINIDLGTGFNSRSVGEDFVKSEGTSKFGFYNRYDNNPFAIVLSHGLDPIDAGSPIR
YTGAFAGGTTIILGKESKLSFFGTASFDNDFEIRRGPAVDFTTVEKKRFPNAEEFEYSTT
TTAMANIIYRIDGDHKLSYNSLFINSSSDQVQYFGTEGQGRNRDAILDTDKGFYQMNVQF
DQDMIFVNQLLGDHTFGENLELDWGAGYNVVDARQPDRRRISIERYDLAFDNDPNTQPSF
FNNIVFDNQRYFQEIEDKEWNGRMNFGITLSEKVKLDIGYNGRSKERNFENIRYGYDFIE
PNTPVTDVFNVDSIFDVENLGVVYNTFVFNPLDPTIGIGSTNLPGNPENTYTGILNIHAG
YASSTFNFGEKWIVVPGLRLESFDQEVTYDVINLLSTDPGFRAADEVYVLPSLNVKYGLN
DDQNLRFSFSKTVSFPEFKEVAPFVYEDVTQRIGGNPDLLNDPSFSEIFNLDLKYEWFLS
ENELLSLAAFAKQINDPVNKVIANDATGTQRFFRTGEKAEVFGVELEVRKNIINGEAENP
MLSAGFNATYMHTEQDLRSSTGLFTTSFDRDTEELQGASPFLINADVNFSPEFKNYKPVA
NLVFSYFSDRIDAIGAGQLGNIIERGVPTLDFIMKNKIGDHFEINAAAKNILDPSIERSR
ETGGELGDIALSKYKRGINLSIQMKYNF
>OMIFANIC_02184 hypothetical protein
MKKLTLILIAVLGAFVWSCESDDTADINIELNSGGGGGGNTTSNEIGGTQTVDLTLEIGQ
EYILTEALIMTAGTTLTIPAGVVIKANPGAGVYIAIAQDARIVAEGTSTTPVVLTSNVPT
PSAGDWGGLIILGRAPINSVAGGNATSTSEIGGLPYGGSNTGDNSGILRYVRVEYSGGAA
DASSENNGFSFYGVGNGTVVEFIQAFEGKDDGIEFFGGTVNASNISVIGAQDDSVDWTEG
FSGILTDVYIEHRVEHDKGIEADGFNTDIGNNSNPVFWSKPTINNLTIIGRGSATGNEAV
RLRAGTQGIFNNVIIQGFEEAFDLDAEGNEPTGQGVLDGDLRVNDVTFIDVIVKMKNDTG
VTFEESDFIFGDGNGTGTDYDSWKSGWTRN
>OMIFANIC_02185 hypothetical protein
MKRIIALLVIVIAANTSFAQECKKTCKKDAYVLADGLIEATLYHDNGVIAQTGYYTEDNT
LQGEWISYDAQGNKTAVAQYDNGEKVGTWLFYQGENMKEVTYSDSKIAEVKTWKIKDSRV
VSY
>OMIFANIC_02186 hypothetical protein
MKQPYLFLIVVLCFLGTTTAQEISDTSFGKGMINFVAKDSSFSVKFAPRFQGRYIIDWEH
DGDNYGSGEQNFLIRRARLKFDGFVFSPKIKYKFELGLSNRDISGANQFNRNTPRYILDA
VIKWNFYENFELWAGQTKLPGNVERVVSSGNLQFINRSILNSRFNIDRDAGIQLRHHADL
GGDFFIREKIAISQGEGRNVTQGNEGGLQYTARLELLPFGKFKSKGDYSQSDLKREPKPK
LMLGATYDFNQDAVKTRSNLGSYMFLSDGSLYMTDQTTIFVDAMFKYKGFSFAGEYANRD
ADNPVAVEADGTPALDSDGLPTGDVVLIGNSVNLQAGYLFKNNYEIAGRFTTAEYDDITG
RAMEEQYTLGVSRYVVGHKLKIQSDFTYGTSGGDADFLQFRIGFDIHL
>OMIFANIC_02187 hypothetical protein
MDNIYLMMIVALAILAVADLVVGVSNDAINFLNSAIGSKAIPFKAIMIIASLGIFVGAIS
SSGLMEVARKGIFVPGEFYFDEIMIIFMAVMITDILLLDFFNTLGLPTSTTVSIVFELLG
AAVVMSLIKISNSDTAVLGDLGNYINTAKAMEIISGILLSVVIAFSVGAIVQYLSRLIFT
FHYEKKIKNFGALFGGVALTAITYFIFMKGLKGTPYYGDMKDILEGNELYIIAGSFVLWT
ALSLLYMNVLKKNILIIVIAVGTFGLALAFSGNDLVNFIGVPMAAFHSYEAWSVSGVEAT
AFSMDVLDKKVPAEPLLLFIAGGVMVVTLWFSKKARTVADTEIGLATQDETKEKFKPNLL
SRAVVKGSTKLATILGAAIPKSTQKRINSSFEVPVVTLPKHKTYELPAFDQIRASVNLMV
AGVLISIATSMKLPLSTTYVTFMVAMGTSLADRAWGRESAVYRVAGVLNVIGGWFFTAFS
AFVAAGTMAYLIYIGKAPMIAVLLLLAVLLLIRNYIAHKKQSNVITEPDKLKKAESNTVQ
GIIEESADNIAKAASRTNKIYSSIINGLAKEDEAKLKKSRLKVDQLSEEVDELRNNIFYY
IKNLDETSVRGSNFYIMVLAYLTDVTQSLEYIAKVSYKHVRNHHKTLRYNQIKDLQQIDS
SFEHLLKDIQSIFKNREFEQLEDILIRKERAFNDISDMIQDQIKRTRTEESSPKNTTLYF
SLLLETKDLVTAMMNLMEEYYKSHKSS
>OMIFANIC_02188 hypothetical protein
MNYGYTELLQLFGSLGLFLFGMMVMSDALMKLAGNKMRSILATMTSNRFFGILTGFFITS
VIQSSSATTLMVVSFSNASLLTLTESISVIMGANIGTTITAWLITILGFKVSMSAIALPL
VGFGFAFTFAKRESLKNWGTFIIGFAVLFIGLQFLKDAVPNINENPEMLEFLTRYTDLGF
WSVLIFLFIGTLLTVIIQSSSATMALTLIMTAQGWIPFELAAAMVLGENIGTTITANIAA
IVSNYHAKRTARAHLLFNIIGVVWVLILFYPFLKMVSWVAQWTGSDSPYLSAAAIPVAIS
LFHTIFNLCNTFLLVWFVKPIARLVERFVPEKLLPEKEIDEPKYLSKKVLKYPETLIVSL
ENESKYLFKKAIFEIVAHSLNIHRSDIKSDEKMKEILKRSTEDMGTDVEDLYHTKVKKIY
GEIIRYASLAQSNFKLSQAQNKHVSEIKIANRKMVEILRNMRELTPNVSMYIESDNQYVR
KEYNRLRKKIAKVLRIIYRFRTKKDKDVYHEKLMRLKNEAKEEIHRTSDSIEKLIREGLV
TVDMGSSLVNDRDNVNDTIKKLISIADLLYGERDPLFEEEIE
>OMIFANIC_02189 hypothetical protein
MNYLLLILAFIIPYSIVAQDLSGEELLNKSIEYHDPYNNWGKFNGTLSVTMDTPKASPRF
SAIKIDLPNDFFYLKSRRDTQETTYAIEKGKCSTSIKDSTLMRRTPCETAVLYKNYYTYL
YGLPMKLKDPGTQIEDEVVLKNFKGKEYLVLKVTYVETVGSDVWFFYFDPKSYAMEIYQF
FKGDPASEGKDTGEYILLSEEQIINGIKMPKTRAWYYNKNDGYLGTDTLGE
>OMIFANIC_02190 putative chromate transport protein
MESKNRLSEIARLFFKLGCFAFGGPAAHIAMMEDEVVTKRKWMSREHFLDLMGATNLIPG
PNSTEMTMHCGYERAGWKGLFVAGICFIFPAVVITGFLAWLYVAYGSLPEIAPFIKGIQP
AVLAIIASAILKLGRKAVKNWELAVLGILILSVSLWGINEIIALLAGGIIGGFYFYLKRK
TVGAKFVTPFFLLFVSAETISKLTTLKIFWTFLKVGSILYGSGYVLFAYLDAELVTNGYL
TRPELMEAIGIGQFTPGPVLSTATFIGYQLGGFGGAIVATLGIFLPSFLFVWILNPLIPR
MQKSKLLRGFLDSVNVAAVAVMLAVLFVMGKEALVDWQSILIAGICTALVFGVKKFSSVW
VIVIGIMLGYILHLL
>OMIFANIC_02191 hypothetical protein
MYKTVWELSMKDIIDMSRHRGYFIDQSQSLNLFMENANFAKLTSMHFYAWKSGLKTGMYY
LRTKSAVDAIKFTLKSETKKEPVPAVAEASVDATSAVSDKPLTPQELREMLAKSRDAEDD
DCLMCGS
>OMIFANIC_02192 D-inositol 3-phosphate glycosyltransferase
MRLWDMIFTVLKHARRTQYVLIDTYSTQNFYYAVTIGNICRLLKIPYIPILHGGNLPERL
RKSKRLSWKLFNGAKQNVAPSGYLLEHFRRSGYNNVAHIPNSIDVELYPFKLRSSVKARL
LWVRSFAEIYNPTLAIKIVEELMNKGIDVELCMVGPEKDGSLERCKKLAGEKSLPVRFTG
RLNKEEWIQLSESYDIFINTTNFDNMPVSVIEAMALGLPVISTKVGGIPFLLEDNKDAIL
VDANDKEGFCNAISMLLKDKEFGIRIARNARKKVEKFDWEEVKQLWFEILKA
>OMIFANIC_02193 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MPQKSNIHFDISERKILLRIFDIVSVLALLYVVGMVFDFDYFKINADHWVWSIVLALYLG
VFATIFELYNLQKASKFEIVVQNIILTSSVTVLFYLLTPYFTPELPENRLQIIYFFIAVN
VALFIWRYAYIVLISAPRFFKRVLIIGSSEDMEKVIRSLQKSDPNYKVIGFINTTKANQP
TLGFDLPREFDLNDVAGTVKEHSISEIVIATQPSSGMTIPLYNQLIALLENGVPIREYTQ
VYEEITHRVPVQHVDKDFYRYFPFSRSNQNKLYLFFHRILDLLFSVIGLLFGLLISPVII
IGNLIGNRGPFFYTQIRVGKNSKHFKIYKLRSMVVDAEKDGAKYAEAKDTRVTKFGRFLR
RSRFDEIPQFINVIKGDMSVIGPRPERPVFVKELSEKIPFYEVRHLVKPGVTGWAQVNAK
YGVTQEDTLEKLQYDLYYIKRRSLFLDISIVIKTLSTIIFFRGQ
>OMIFANIC_02194 hypothetical protein
MNKNYLYFLIFFLNFSAYAQYFTLSEDAEISILTIGPGDNLYDKFGHSAFRVKDPVNNLD
RAYNYGVYDFDTPNFYTKFARGKLLYKLAVSHYEPFLNSYIAQDRWVEEQLLNLTYSENQ
ALFNFLQNNAKPENQYYKYDFFFDNCATKIRDVLVEVLGDKLEYKADLAVEGYTFRELIQ
KNVHNNSWGSLGMDVAIGAVVDRKATSWEYQFLPEYIYKAAAGAKISSSSGTQDLVLETR
KIYDTEERHGGGNFFLSPLFIFGILGLMLVFVTFKNYKNQQRSRFLDLVIFLVTGVIGII
LALLWFATDHSTTANNYNLLWAFPFSIFFFLLIGKRTPKRWLQRYIFFLILLLVLLTFHW
ITGVQKFAIGFIPLFIGLAVRYLFLNDYLKHRSS
>OMIFANIC_02195 hypothetical protein
MLKIYRLKKNLFAVFLLICATISAQTTRKYSNEFMNIGVDAAAFGMANAVVASSQDVNSG
YWNPAGLVNIEDNELSLMHASYFANIASYDYAGFAMPLDDRSAVGLSVIRFGVDDILNTT
QLIDDQGNIDYNRISLFSTADYGVTFSYARKLPLDGLNFGVNAKVIRRVIGDFASSWGFG
LDAGIQFEKNNWRFGLMARDITTTFNAWSIDEEQFATISGAVEGQNQELPETTEITIPKL
QLGIARKFVFHYDFVLQAEMDLNFRFAETNDIVSSSFASVTPALGLEFGYIDMIFVRGGV
GNFQNVTQLDGSDSVNFQPNIGVGFRYKGIQVDYALTDIGDQSAALYSNVFSLKLDWSIF
R
>OMIFANIC_02196 hypothetical protein
MVKQIPNIITSLNLLCGCVAILLALSGDLIAAAFFILAGIIFDFFDGLAARWLNAQSELG
LQLDSLADVVTSGVAPAMVMLQMINVSVTGNPMNITEAIAIGGWNEVVFSYMPLIGLLIA
VAAAYRLAKFNVDTRQTESFIGLPTPANTIFILSFPLILHFQHTEVIESIILNTWFLVAV
TVFSCFIMNAEVRLFALKFKTWDYKSNKIRYIFLALCLVAIVLLKFISLPVMILLYFVLS
LFRKA
>OMIFANIC_02197 Lipopolysaccharide export system ATP-binding protein LptB
MKMESLIEEFGLSHIRKNRGDLLSGGERRRTEIARALATDPHFILLDEPFAGVDPVAVED
IQGIVARLKNKNIGILITDHNVQETLAITDRTYLMFEGSILKHGVPEELAADEMVRKVYL
GQNFELRKKKLSF
>OMIFANIC_02198 hypothetical protein
MKKLLLILAMVGAFMACENPVSKKIKETKETVSNTRKAVKEMEKVQEDMEELKNEEPLTN
EELKEWLPDEINGMKRTGYKAGQTAYLQIAQVEATYQNEDKSKKLKIQVMDGAGEMGAAA
TAGMRILFSQDFEEEDEYKVRRTTKKDGNKVIEEYRKDGSRSEVQFMQDDRFYIQVTGTN
MDLDETWDAIAEMDPEDLG
>OMIFANIC_02199 hypothetical protein
MFQLGKAIVSEDIIEKDFVCNLSACKGACCVEGEAGAPVTESEVETLKKIYPKVKPFLRP
EGIQAIEEQGTHIITPLDELETPLVNGKECAYVTFSDKGIAGCGIEDAFNAGVTDFRKPI
SCHLYPVRVKDYSEFAAVNYHRWPICDAACTLGKELEVPVYKFVKDALIRKFGEHWYAEL
VKVASKLK
>OMIFANIC_02200 hypothetical protein
MTLNAKEIFTASMVLFAVIDIIGNIPIIISLREKAGHIHSEKASIIAAVVLTVFLFVGES
ILKLIGINVNEFAVAGAFVLFFIAIEMLLGITLFKDDGTGPEVATIFPLAFPMLAGPGSL
TTILSLRAEYEIQNVIVAIIINIIVIYIVLKTSARLQRFLGKNGIGIIRKIFGVILLAIA
VKLFTSNIQELFN
>OMIFANIC_02201 hypothetical protein
MKVAIYIFIAIATILIVFNITKLDFENLFTGDSLIAAISILASACVIVLMLLLKASRKIA
GKK
>OMIFANIC_02202 Carboxy-terminal processing protease CtpB
MGIQKKYLPLLLGVAIAAGVFIGSKLDFSDSNEKIFATNSKKDKLNRLIDYIDYEYVDQV
NTDSIVDVTVNGILENLDPHSVYIPVDDYEDNADDMRGNFVGIGISFYPYKDSIAVIRAI
EGGPAAKAGIKGGDRILFADGRPLFGSDIFRDSISAFLKGEINSKVNLTIYRPSEDKMID
VKLKRKRVPLVSVDAAYQLTDEIGYIKVNRFSETTYDEFSKALDELSDEGIETLVLDLRN
NPGGYIYAAEKMVDEFLGKDKLMLITRNKNGEENRSYATRKGDFEKGNVYVLINENSASA
SEIVAGALQDNDKGTIIGRRSFGKGLVQREMALGDGSAVRLTIARYYTPTGRSIQKPYGN
GNGDYYSDYENRYKNGELEDPENIEVADSLRFVTPGGKIVYGGGGIIPDVFVPKDTSVEN
ETLEYISRSGFISYFIFEYLEKNRTFFFGMTFNQFADNFDVPESLKEEFIEYSRFEEAQI
DLRKYDEDLGIALKANIAQQLYGPNAFEYFLNDGDAMLNKVLDLESAEPDKEE
>OMIFANIC_02203 tRNA-specific adenosine deaminase
MTQEKQRKYDIAYLRMAKEWSTLSYCERRQVGALIVKDKMIISDGYNGTPTGFENICEDD
EGYTKWYVLHAEANAISKVASSTQSCAGATLYITMSPCQQCSKLIHQAGIKRLVYHKEYK
DNSGVKFLQKAGVTITHIENL
>OMIFANIC_02204 hypothetical protein
MTDFWLYVKLGLDHVLDLSAYDHILFLVALCAAYSFGAWKRLLLLVTLFTVGHTFSLLLA
HYDIVAVSGSYIEFLIPITILVTAGYNIFNAKRSRPTEAHMLFYLVTIFFGLIHGFGFAR
YYNMMKEDESVAPLLEFALGVEIAQIVIVLITLLAAFFVQGVLRFNKRDWLLIISSIVIG
MTIPMLIDTWPF
>OMIFANIC_02205 Beta-agarase D
MKKLILFLISITVFTNAISQDPDLFRTWYLYEMQATDLAPVYIVSEIDPPIQPYIAILPN
LEFSGEGACNTFSGTYTYQPDELTSMDLAHSMDDCGISIHNNFESDYFFFMEYFWFTIIP
DGNGLSLEIGNPLFGYAVFKDYELSVNEYELSAKIKVYPNPVSDILNITSEKVVIESVSV
YSLAGQQLISPTENFENIDVSSLSEGIYLLEIYTENGRQVQKFIKE
>OMIFANIC_02206 Hydroxyacylglutathione hydrolase GloC
MKIEQIYTGCLAQGAYYIESKGEVAIIDPLREVAPYIERALEDNATIKYIFETHFHADFV
SGHVTLSKETGAPIVYGPSADPSFDAIIAEDGQEFKLGGITITALHTPGHTMESTTYLLK
DPDGKDHAIFSGDTLFLGDVGRPDLAQKAAHMTQEELAGILFDSLRDKIMPLADEVIVYP
AHGAGSACGKNLSKETVGTIGGQKKTNYALRTDMTREEFIKEVTDGLLPPPQYFPLNVKM
NKEGYDDIGEVIQRGSIAMTPEEFEVAANETDAIVLDVRNQKDFVKGHIPRSIFIGIDGG
FAPWVGALIGDVEQSILLITPEGREEETITRLSRVGFDNTLGYLKGSFEAWKNAAKEYDT
ISSISAEEFKKDLEGDIPVYDVRKPGEYNSAHIENAHLTPLDFLNEHLAEFPSEETFYMY
CAGGYRSVIAASILKSRGIHNLIDVADGFKAIKEVGIPIADFSCPTTKN
>OMIFANIC_02207 TonB-dependent receptor SusC
MRLLSFLIFLFFVSTIFSQTTGDIYGTVVDEKNIPVSGASVFLENTETGVQTDFDGNYRI
SGIVPGSFNLVVSYLGYETQTQYNIIVKSKGNPAYNFTLIEAPEALEEVVISSRDKISRP
RETPLSTQTLSAVEIATYPGSNNDVVQVAQTLPGVSPSIGGFRNDLIIRGGAPNETVYYL
DGMEVPNINHFSTQGSAGGPVGLVNVSFISEVTLSTSAFGAQYDNPLSGVLQFKQRNGNN
RNFTGNFRVSASEAALTLEGPLFKKKNETSNTTFLASVRRSYLEFLFEAIGLPFRPNYWD
YQFKLNHKIDTYNSISLIGLGSIDDFSVEAPEDFDAEQQAQLDQAPFINQRTNAIGITWQ
NRFRDGSGFMQTTLSNNTLNNEFTRFTDPENETGEIFNNDALESETKLRYEITKFYGEWK
VKGGFNTQYSMYENNTSDLLNDAFFNTEIDFVKYGLFANATRSFLNNTLDISFGFRMDDD
SFTSEDNLLSTFSPRVSLSYEFSENWKFNVSVGRYFKLPPYTILGFRNNEDQLVNQDINY
TQSDHYVVGIQHYFSPSSSISLEGFYKLYDNYPVSVRDGVSLANKGGGFEILGSEPIEST
GRGRSYGTELQFQQKLANNFYGIFAYTWFYSEFTGFDRDVYLPSVWDSRHLISFTGGYKL
NRNWEVSARYRFAGETPFVPTELEATLANYPEVVLDYGRLGEENLDIFSQLDIRIDKKWN
FDKFSFNLFIEAQNVLSQDNPQPPEYGLGRDANGQILQPRSLVEIEQDSGQIIPSLGIVV
DF
>OMIFANIC_02209 hypothetical protein
MLNRFQLYGQFTLDEFKFDRISDGDDWWGNKFGYQLGLKYLDVFNIDKLDMVLEFNRMRP
YTYTHRDSVSNYAHSNLALAHPLGANFREIIMEFRYRPTRKWHLMSRILYMQYGEDVNGD
NYGKDILQPNITRVGNTGIKLLQGDQVNSTVFHFNVGYQFFHNMFVDGIITARMAESETG
VYDLDSFYAGIGIRINMKRDYWSF
>OMIFANIC_02210 hypothetical protein
MDENKQGKQKRHNQVTFKPYDPNQAWLLPPTLGELIPPNHIVRLVNDAIEGMDIEPIVRT
YEGGGSSSYHP
>OMIFANIC_02211 hypothetical protein
MMPKVLVYGYTEQLYSSRKIAKALGENICFMWLSGMQRPDHNSLNRFRNSRMQQTVKNVF
GQVLLMLIEQGYVRMEDYYVDGTKIESVAGRYTYVWAKNAERYKKGLLDKIAALIEQIEE
DNDKAEKEVGQQTPIAESPIEDSEALKETIVRLNEELQDQLGQNKQLKKKLDKLKEEHLP
KLMKYEEQQDILDGRSSYSKTDPDATFMRTKDDHLGNGQLKPCYNLQLGTEDQFIINYTV
HQTPSDMAAFIDHMDDTLQLLETIEVDSPKRIGADAGYGSEENYEYLEDKNIEAYLKYSG
FYAEEKRKRKNDPFHHTNLHYNEEHDYYVCPMGQHLTYVRSTTQKRKSGYEYTVRYYQAQ
RCEGCPLRGQCHKSKDNRVLKTNPKSLLYRQQAKQRLNSLRGIRMRSKRPIDTEPVFGHI
KQDRNFRRFFLTGLQGVSIETGLLAIAHNIKKWWVNRLLVWSIVPIPPANNAKCAQNPEI
CTQLAHFCTQKAA
>OMIFANIC_02212 hypothetical protein
MEVKYVSFYAQNTFSLPKGISFEISGYFNSPGIWGGNFETEEYWNVDMGIQKKFLDDKLS
VKLGLSDVFLGQRWEARNEFGVLAIHGNGGYDSRRFKVNLTYNFGNDQVKRSRKRSTGME
EEQKRARSGGGSGPG
>OMIFANIC_02213 hypothetical protein
MKNFDWTQFTRKIAIKAPLNVLYDAWTIPAQIERWFLSDATFYNSSGEKIDKNEHITSGS
RYEWQWYLWDPTETGVVKEVNGTDHIQFTFAGECIVDVHLESFKDNTIVSISQREIPTTD
EHKVNIRLGCDRGWSFYLVNLKSIYEGGIDLRNKNSDLKPMLNT
>OMIFANIC_02214 Nitronate monooxygenase
MKNKITELFNIQYPIIQAGMIWNSGWRLASAVSNAGGLGLLGAGSMYPEVLREHIQKCQK
ATDKPFGVNVPMLYPNLEEIIKIIIEEGVKIVFTSAGNPRTYTSRLKEAGITVVHVVSSV
KFALKAQEAGVDALVAEGFEAGGHNGREETTTFTLIPMVKEQINVPLIAAGGIANGIGML
AAMVLGADGVQVGSRFVASEESSSHIAFKKMVVDAKEGDTLLTLKELAPVRMLKNKFFED
VMKLYESNPTKEELKELLGRARAKRGMFEGDLVEGELEIGQIAGLIHDIKPAALIVEEMV
EEFEKAKKKVSEL
>OMIFANIC_02215 Subtilisin NAT
MKKLMLFVIILITQLGYAQTQEALVFFADKENVAASIENPISILTQEAIDRKALHDVPID
ERDVPVTESYITNIKGQPGITVFSKSKWMNAVYVGGTQSQIEDLLNLSFVIGVEFMDPDL
NLFPVPIPVPDKYAQENMQGRIVYDYGAAANQIEMLRGDFLHEQDFTGEGMIIAVLDAGF
PNIAGNPAFAEMISENRLLGTFDFVLDQVPIGGSSTHGAKVLSDMAGFLDGQFVGTAPEA
SYYLFRSEDTGSERPVEEAYWLEALERADSLGVDVVNTSLGYQDFDNPNYDHSYEDLDGV
TTLGARAGNLAFEKGMLLVTSAGNDGNGFTYVGTPGDAPGILTIGAVNSEGEYASFSSIG
PTVDGRIKPDVMAQGADAAVIDHNGNITTNNGTSLSSPIMAGVVACLWQSRPEARNYHVM
QIVRESASLYNNPTDEMGYGIPNFEDAYNALQILGNEEILREGTFALYPNPASDILMVSF
PKEIELAEVIISNLMGQVIRKESISKAGNRIDVSTLSAGLYLATVVSNGKYNTFKIVKQ
>OMIFANIC_02216 tRNA-specific 2-thiouridylase MnmA
MKERVVIGLSGGVDSSVAAYLLKEKGYDVIGLFMKNWHDDSVTISNECPWLEDSNDAMLV
AQKLGIPFQTVDLSSEYKDRIVDYMFREYEMGRTPNPDVLCNREIKFDVFMKIALELGAD
YVATGHYCRKDSIQKDGKIIHRLLAGKDPNKDQSYFLCQLSQEQLAKTLFPIGELLKPEV
REIASEQDLITAEKRDSQGLCFIGKVRLPDFLQQQLAPKEGVIVEVPSEYEGYDSGDPIF
TSEEEKLKYLSSKKKYNPNDGTIVGKHQGAHYFTKGQRKGLAVGGTKEPLFVIDTDVEEN
VIYTGQGKNHPGLYRRGLFVNQEEIHWVREDLSLAVDQTMDVLARIRYRQPLQKATLHQT
VSGLYVIFEKPQSAISEGQFVAWYEGEELLGSGVIS
>OMIFANIC_02217 hypothetical protein
MKSILLLFFGMLFLPASLSAQEEINQFDENNERHGVWKKYFDGTDQLRYEGRFEHGKEVG
TFKFYCPDCKSQPMVIKEFSNSDNTANVQYYTAGGKLVSEGKMDGKDRIGEWFFYHKKSK
GIMSKEQYVSGKLHGKKFTYYPNGKVTEEISYDNGMMQGDNLYYGPDGTLLKKLRYSNDQ
LQGEATYYDAYGNLTIKGYYKNGKKHGLWQYYKDGKVEVEETFPKPKNSN
>OMIFANIC_02218 Membrane protein insertase YidC
MEEKKFDLNSLIGFILIGAILVYMLYLQQPTQEEIDAEKQKSEQIVEEEGKKTEDTPKET
VTLDEGIQEITSVSPGDSLALENLKNRLGSFAYSGTLPSATDVVTIIENDVLELTVSNKG
GYITQAKLKEHTTFTGEPIYLIQDGNNSFNLQFTSENRILNSKDLYFEPSLSDDGDNKVL
TMRLKSSQNAFIEYRYELSPGEYMLGFSLKTQGLDDVMNTSQPIYLDWNLKGYRHAKSIS
YENRYTRLTYEYEDAKHSKLSPTGEDDEVEKKVSWMNFRQHFFSSMLLTDTPFDEVALTS
VDLVEDEEVDTVFTKQYGAKMLLTPKGGSLDYNMNMYYGPTDYQVFKKYDKNLDEAMPLG
WGIFGVINKFIIIPLFGFLSGFLPAGIAIIVLTVLIKLVLSPVQYKQYLSQMKMKILKPE
LDEIRKKYGDNKMKVQQETMKLQNVAGANPLKTGCLPALLQIPVFYALFTFFPTAFDLRQ
KSFLWADDLSSFDTIAEIPYIPFYGDHISLFPILASIAIFIYMMMTMGQSMQAQQQPGMP
NMKFLMYLSPLFMLVFFNNYASGLSLYYLTSNLITIGIMLVIKNFILDEDKIHAKIVELK
KKPKKQNRFQRKMSEMMEQAEQQKKAGKKQR
>OMIFANIC_02219 CTP synthase
MSNTKYIFVTGGVSSSLGKGIIAASLAKLLQARGYRVTIQKLDPYINVDPGTLNPYEHGE
CYVTDDGAETDLDLGHYERFLNVPTSQANNVTTGRIYQSVIEKERRGEFLGKTVQVIPHI
TNEIKERIQILGNSGDYDIVITEIGGTVGDIESLPYIEAVRQLKWELGDDNALVIHLTLV
PFLSAAGELKTKPTQHSVKTLMESGIRADILVCRTEHHLNQDLRKKLALFCNVQEEAVIQ
SIDASTIYDVPNMMLEEGLDDVTLKKLNLQGSPEPNLSQWNEFLTRHKNPKGHVKIGLIG
KYVELQDSYKSILESFIHAGAENELKVDVEYIHSEHIDSNTIRNVVSHLDGILVAPGFGE
RGVEGKIDAVRYARENNLPFFGICLGMQMAVIEYSRNVLGLKNANSTEMDPETPHPVIDL
MEEQKTITHKGGTMRLGSWDCELKEGSIVQQVYNLNKIEERHRHRYEYNDQYREQLETAG
MAATGFNPETGLVEIIELPSHPWFVGVQYHPEYKSTVANPHPLFVAFVKAAYEHSVQ
>OMIFANIC_02220 hypothetical protein
MTAGNKKDASPGLPDPNHLIILANYRMPYGKYKGKYLIDLPEAYYVWFKQKGFPEGKLGH
LMMEMHELKVNGLDGMLRKLIR
>OMIFANIC_02221 hypothetical protein
MKLLFALILSCVFLIPSENDGEKMQWSESRPLSWTDFRGEPNGAADYVASTNSGISLSYS
IGNRSGKYQFDFTVKSNFYPEQSWYRPESASEYILKHEQTHFDISELHARKLRKKLAELL
VTEHVKADADKLYKETEQQRQTMQHKYDDESDHSKFQSAEFEWRDYVASELKKYDSWK
>OMIFANIC_02222 hypothetical protein
MSTSKVTYLGDLRTVCEHLKSGNTYITDAPLDNRGKGETFSPTDTVATGLANCMLTVMGI
KARDLEVVLDKSEAIVTKTMASKPRRIAKIEIIMLLPSNVSEKHRKILENTANTCPVIHS
LHPNIEKQIQYQWNSF
>OMIFANIC_02223 Penicillin-binding protein activator LpoA
MKRHYYIILIGVLMLFCGSISAQQYTHRVEKGETIFSISKKYGVTEEAIYSLNPDAKNGL
RSSTILIIPSDGNAEVQKKVTFKKHRVKRRETLFSIAQRYNISVDDIKKYNKELYSRQLK
KGEKIQIPIFEVVATTVDNTETTLETGIDIQGRHEVLAKETKYGIARKYGITIAELEAMN
PLIGESLQIGTMLNVPKAAVIESATIEDENFEFYEVLPKEGFFRLKVKLGLSQEEIIAMN
PYAADGLKEGMILKIPKENAIGSETKSIIVNLEDGITNLSKKKIAVMLPFQLSKADRDSI
KNNIDLIKDNGALRVALDFYSGVIMAAEFAKDKGISVELDIYDTEGRSEKVRSIIDQNDF
SDIDAVIGPLLRKNVEQAASALKKTDTPIFSPLSNREIKISSNLFQTLPTDEMLAKAMLE
YLRMNAMGKNVIIISDSKKTAQKAALMDAIPGSKTLAPREKGFLYDTDISSRLEDMRENW
VILESVDPVIVANVVGLLNGMPDNLTIRLFTTDKNDAFNYHDVSNMNLAKLNFTFPSVNK
SYNFKDKNAFLVSYKNKYNVLPNRFAVRGFDVTYDVLLRLAIADDVYDANDSNIETEYIE
NKFRYTKKMFSGFQNNALYIIKYNNDLQFEVVE
>OMIFANIC_02224 GMP synthase [glutamine-hydrolyzing]
MHNTVLILDFGSQYTQLIARRVRELNIYCEIHPYHHIPENIEFFKAVILSGSPFSTRSED
APHPDLSAIKGHKPLLGVCYGAQYLAHFNNGNVAPSDIREYGRAKLETIYDHDGLFAGIP
ENTQVWMSHSDTIAELPDHGVRLASTRDVANAAYRIDGEDTYGIQFHPEVYHTTHGKLLL
ENFLVHIAGVKPDWTPAAFVEETVESLSNQIGNGKVILGLSGGVDSTVAAVLLHKAIGPN
LYCIFVNNGLLRKNEFEDVLDQYEHMGLNVRGVDASARFLDVLKGVSDPEAKRKAIGGMF
IDVFDDEAHRVEDVDWLAQGTIYPDVIESVSVNGPSVTIKSHHNVGGLPDFMKLKVVEPL
KMLFKDEVRRVGAELGIDKTLLGRHPFPGPGLAIRILGDITAEKVRILQEVDHIFINGLR
KWDLYDKVWQAGAMLLPIQSVGVMGDERTYERVVALRAVESTDGMTADWVNLPYEFLQET
SNNIINRVKGVNRVVYDISSKPPATIEWE
>OMIFANIC_02225 Putative cysteine ligase BshC
MPIETIPYAETGYFSELICDYLAEKEALRPFYHRFPELSQFESQLLEKKKAFSVSSREIL
VAGLQRQYDNFQISETTRENIESLSKENTFTITTGHQLNLFTGPLYFLYKIFSVINLTEQ
LNKEFSHYHFVPVYWMASEDHDFDEINYFNFHGKKIVWDREDGGAVGDLSTEGLEKVLEI
YKQELGGGEFADQLLTLFSEAYLKYNNLADATRHLGNELFKDHGLVIVDGNDVEFKKTFL
PYAKRELEDQLSFRKVSETSSRLKSLGYQEQVSPREINLFYLKEKLRERIIEQDGHFHIN
NTNIDFNADQLIEELNSNPERFSPNALLRPLYQEALLPNLCYVGGGGELAYWLQLKDYFN
EVQVPYPILLLRNSVMLISEKNIEKLKRLNVSISELFLPTLELENLHTHRLSEIEIDFNK
QREFLKKQFEDMYETAKKTDASFLGAVAAQEKKQLNGLDKLEKRLLKAQRRKLADELERI
TAIQEVLFPGESLQERQMNFSEFYLHNGPGLLSLLKKELDALVNKFSIIRW
>OMIFANIC_02226 hypothetical protein
MIKYTVLLLTFFTLTITAQLQSPSEFLGYAIGTEFSRHSDVVSYFEHVAENSNMVRYQQY
GKTYERRPLTYAIVTSEANMANIDAIRRDNLKNIGLENGSANPEIAIVWLSFNVHGNEAS
STEASMTTLYQLITEKQEWLKNTVVIIDPCINPDGRDRYANWYNQVKATPYNKLQVAAEH
DEPWPGGRPNHYLFDLNRDWVWATQVETSERLKIYNRWMPHVHVDFHEQGINEPYYFAPA
AEPYHEIVSDWQREFQEMVGKNHARYFDKEGWLFFTRERFDLLYPSYGDTYPMFMGAIGM
TYEQAGHGRAGLGVNTDEGYELTLVDRVAHHTTTALSTVEISSENAGNLNREFKKFFQNG
NLKYKSYVLKGQQDNIDALTQLLKKHEIKYGFSSGGTVSGYSYTRNANGSMDAAGALVVS
TNQPKGKMVKALFEPNAKLSEPLTYDITAWSIPHAYGLEAIASTANVSANRELPLYNIYN
QPSASTPGYITSWNSLYDAEFLAELLQNDIRVRFTEKDVSYDGTSFKKGSLIITRSDNRK
NSDFDRLVNELATKHNRQLFASPTSYSDNGYDFGSPEIKLINKQRIAVLMGNGTSSLSYG
AIWHFFEQQLHYPITSINTENFSARVLSGFDVLILPSGWYGEVINESAMDDLKSWIRSGG
KVIAFSNALRTFADKEGFLLSWNEKNQDNNEDSDKNLTPYDQRNRQRVSNFITGSIYRVT
LDPTHPMAFGYNKNYYSLKMGGNSYSFLKNGYNVGYIQGTPVSVSGFSGDNAKAGLENSL
VFGEARMGRGSIIYLVDDVMFRSFWENGKLFLVNSIFFVNNNKFRI
>OMIFANIC_02227 Penicillin-binding protein 4*
MKHLPALLIVLLLSLTTLSKLIAQDLESTIDKLLSEKYQPGEPGATALVARNGQVLYRKA
FGLANLELGTPMRPENVFEIGSITKQFTAVSVLMLLEEDKLSLNDEITKYLPDYPTHGKT
ITIHHLLNHTSGIKSYTGMREFRTKARTDMTPVELIDFFKNEPMDFGPGDAYRYNNSAYI
ILGHIIEIVSGISYADFVESRIFKKLGMKNSLYGSKTKLIKNRAYGYQPAAEGYSNAEYL
SMSLPYAGGSLMSCVDDMLLWQRALHNNILISEESKKLAFTNYTLNNGKAINYGYGFSVD
EISGIPSIEHGGGIFGYETYGVYVPEEDVYVIILSNRNGNGPTDVTVEIAAHAMGKPLPS
REAVSLSEEQMKKWLGTYQFSDDVLRYVTFEDGQMYSQREGSSKLKIYPVSANRFYFEGS
TTNYTFSIKEGKKQALFGSRINREMGYESTKKQAAEKKSISLGASVLKRYVGTYALQPGF
DIVITSEENQIFAQATGQPKFELYAEDETNFFLKAVNASIEFKLNDNGVYDSMVLTQGGQ
TIEGVRSK
>OMIFANIC_02228 hypothetical protein
MDQLRTLKSKNSRIRGIILISLIIFGAGIYFFLTQLGGTSSTAEVFDRYFVPYDPTEELL
VANPESTPNWKMGLDNFANGNYQQALDYFEYAEDGVAYTTVEFYEGMSYLQMQHPDYFDA
AYYLNEVQLENCEFQGRARWYYALTLIRQGNVTSATEILKTIVKERSFNYRNAQSILNMK
LEH
>OMIFANIC_02229 hypothetical protein
MEPKLNYTFKRQSRSFLEWFHGTVKSEKYFTADAIIHLETKFVNS
>OMIFANIC_02230 hypothetical protein
MKYFFAVCLIIIAISCNNSTGKEEHTTKSATAEDSYEAIGLLGDTLRSAEPSEELLQRYL
EKKAIYDSLPDDLDNLIWFGRFTAYKGDYRKAIEIYSEGLKKFPNESRLLRHRGHRYISI
REFDKATKDLGRAAKLIEGKENQTEPDGMPNARNIPVSSMHGNIYYHLGLAYYLKQDMRN
ALEAYKKCLETSTSPDNVVSATHWIYMINRRMGRLETADQYLQNISADMDVIENDAYHTA
CLVYKGIIEADDVYEPGAEESPSGSALKYAIGNWHFYNGERDKARQIFEEIVAGKDWASF
GFIAAESDLNNYF
>OMIFANIC_02231 hypothetical protein
MRRSVYVVFGFILLLSCKSRDVSNDLISPETLIEVQKPSFEIEHMVFFTLKDSTTNAEIS
LFKERLRSLRRIKEVGQIFVAETQDLGDSRALDYDVVMTVSFRNRTEMEVYMDHPFHLIV
KESLKPFLREAPATIDLMPE
>OMIFANIC_02232 hypothetical protein
MQLLQFFSEHGYEIDFGSTAARSERSAPLESSKINTHQLRLNDSLFDEFLKELNPQVVIF
DRYITEEQFGWRVAEVCPNAVRVLDTEDLHFLRKAREVAIKAGKPLEEAGLYTDITKREL
ASILRCDLSLIISETERDLLKNNFSIPEGLLHYLPFLINVDLEVATNLPAFSTRRNFVTI
GNFQHSPNADGVKWLAKEIWPEIRNELPNAEMHVYGAYASRNIADLHNETIGFLIKAWAS
NKKEVMSTSRVCLVPLRFGAGLKGKIVDAMLNGTPSVTTKIGAEGINGDLPFGGVISETT
EGFIQAAVRLYSKENEWEQHQSNGFRIIQERFDKHKFTKLLNDKIFEIQKNVEEHRNKYF
IGQILQHHTLQASKFMSKWIELKNKS
>OMIFANIC_02233 Thiosulfate sulfurtransferase GlpE
MNIQGYESLDTIMERGAKPLSPKAFEAAANETGAIVLDVRNRKEFIKGHIPRSIFIGLDG
TFAPWAGALIADVKQPILLVAPEGREAEVITRLSRVGFDNTLGYLEGGFEAWKKDSQQYD
TVNSIDVNTFEETWQENEEIPVFDIRKASEYNSEHMVSAVNTPLDYINNYIAEFPTDENF
YLYCGGGYRSVIAASILKSRGKHNVIDVAGGITAIKKSGRLPLTDYVCPTTML
>OMIFANIC_02234 Selenocysteine-containing peroxiredoxin PrxU
MENTEEKIKYSMPRIGDMAPDFEAITTKGKIRLSDYAKDKWIVMFSHPADFTPVCTTEMS
GFATRKDEFDALNTELIGLSIDSIHAHLAWVNNVRNNMGVYFDFPIIADLDMHVAKLYGM
LQPNESETAAVRAVFFIDPSKKIRLIMYYPLNVGRNMNEILRALEALQISDEHKVALPLD
WKKGEKVIVPPPKTLAEMEDRIQDDSIEKIDFYLAKKELV
>OMIFANIC_02235 Thiosulfate sulfurtransferase GlpE
MNRIIMFFNTLFSASGQTSNSIELLNTSEFKKAISEPDVQLVDVRTQHEFRSGHLMKAIN
IDFFQPTVFTEKFNRLDRSKPLYIYCRTGVRTQKAAIKLLDMGFKKIYDLRGGLAQWY
>OMIFANIC_02237 hypothetical protein
MYTKKEELWNSISHGLGILLGIAGLVLLLVFDNSKTSYSTFSILLYALSVITLYSASTLY
HAISHVKWKPILRKLDHISIYFLIAGTYTPVALISLEHESGWALFWIVWGIAALGTFLKV
FFTGRFETVSLLLYLLMGWLIAFDFSALVQAQSMLGITLLSLGGAFYTVGILFYVVKKIP
YNHTIWHFFVLAGSVFHFFFIFTDVI
>OMIFANIC_02238 hypothetical protein
MNYLLLFLAVAVGYGIAISMQKKQVKQMSIFLAFSGAFLLSMTINELLPEVFKMPTRRIG
VFIMAGILLQIILEFFSKGAEHGHVHLHIKNRDFPWLLFISLSIHALLEGFPISESNDIL
IGIIVHKIPVAIILSIFFIQAQYSRKVTLSFLFLFALMTPLGNLLSDEVSVLQEYHTEIT
AVVIGIFLHVSTTILYESSRDHKFNMAKLLIIVLGFSIAYFF
>OMIFANIC_02239 Ribosomal RNA large subunit methyltransferase K/L
MQDFRETRMGKNFKMVAKTLYGMEELLATELRQLGASAVEIGTRNVSFEGDTGFMYKANL
CCRTAIKILKPITAFNVFKEEDLYRKVYDISWERYMEANGSLAVDATVFSKEFTHSQYIA
LKTKDAIVDRFRDKEGERPDVDLDHPTLRINIHIDRNICTVSLDSSGASLHKRGYKTEST
LAPINEVLAAGMVLLSGWSGQSNFLDPMCGSGTILAEAAMIACNIPPNLNREEFGFETWP
DFDVDLYELIENSALKKIKEFRFKILGYDNDPIAVKKARHNIKNANLDEFVDITTRDFFE
SKKELEGPMHLIFNPPYDERLQVSDIEAFYGKIGTTLKHGYPGSQAWMITSNMEALKCVG
LRPSKKIKLFNGKLESRFVRYEMYEGSRKAKKQKG
>OMIFANIC_02240 hypothetical protein
MKLKHILLSFISIVLFTSVSVAQETTNDSIPKQEDAYGLRVGADLSKPLRTLLEDGYSGF
EIVGDFRISERFYAAAEIGNEKKERFESNLNSIASGSYVKIGADFNAYNNWLGMENAIYG
GLRYGFSTFSQELLAYGIYTTNQTFPGTFRVDPREYTGLTASWLELQVGVKTEILNNLYL
TINLQLKRKISETTPDNFDNLFIPGFNRTYDFSEFGAGYGYSISYLIPIFKK
>OMIFANIC_02241 hypothetical protein
MTKKIFILFLIFASIAGCTRDDICEEGIATTPLLIITFNDIVEPNQRKAVPSLTVETVET
NSTQVISATTTDSIAIPLRNTGLQTIYRFKNGVGTAAPNTDVITFNYTTEDIYINRACAF
KTVYHDLNARVQDEGSANWILQFEIETTDVIDETETHITIFH
>OMIFANIC_02242 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MRKRKKRVVFENIEIIDAGAKGKSVAKAPDGRVIFVNNAVPGDIATIQTFKKRKAYYEGS
AISFSHYSDKRIDPVCQHFGTCGGCKWQFMDYTHQLFYKQKEVKNNLTRLGGIELPEVEP
IIGSEKTVFYRNKMEFSFSDNKWLTREQIESGEEIENRNALGFHIPGMWDKILDIDECHL
QREPSNAIRNFVKDKAQDLGISFFNTRQQHGMLRTLMIRTSTTGDVMVLVQFFSEEKTKR
EQLLEAIKEKFPEITSLLYVINSKGNDTIYDQQVNCYSGEDHIFEEMEGLRFKINAKSFY
QTNSEQAHELYKITRNFAGLTGKELVYDLYTGTGTIAQFVSKQAAKVVGIEAVPEAIQAA
RENAELNNIKNTEFVVGDMKKVFNDDFVAAHGKPDVIITDPPRDGMHSDVVQQLINLLPE
RIVYVSCNSATQARDLKMMDEHYRVDKVQPVDMFPQTYHVENVVLLEKRK
>OMIFANIC_02243 ECF RNA polymerase sigma-E factor
MASDKKIFDSWLVLESQAGSKKAMSLLVKRWHRKLCRHSCWYTKDIDTARDVVQDSWGII
LRKIYGLRNPDRFGSWAMSIVTRKSLDWIRKNKRVKKNKKHYYEQRSNGSDNDHNFSPGD
TLALVRIKMEELPEAQKMVLHLFYLEEFSIKEISEILEVPIGTVKSRLFKAREQLKTILK
TRNHEK
>OMIFANIC_02244 hypothetical protein
MKNKMSEIDDLIKQTLSEEEAEFYNQLDEQNPFEMIGGLFSGKNRWFMILLNIIMLASFI
AFIYCVVQFLNTENTNELIQWGAAGMLTLLIMTVLKIFAWMQMDKNALLREIKRLEIQIS
SLASKQN
>OMIFANIC_02245 Ornithine aminotransferase 2
MSVAQHTLSQEAMALENKYGAQNYHPLPVVLSRGEGVYVWDVEGKIYYDFLSAYSSVNQG
HCHPKILSALNEQANELTLTSRAFYNDKLGKYEKFTTEYFGYDKLLPINTGAEAVETAIK
LCRKWAYEVKGIDINDAQIVVCKNNFHGRTTTIISFSSDPVARKNFGPYTEGFIKIEYDN
LKELEDVLINNDNVAGFLVEPIQGEAGVYVPSEDYLVKAKALCDKYNVLFIADEVQTGIA
RTGRLLASCGNCNCETKSCEGTPDVKPDILVLGKALSGGVYPVSAVLANNEIMGVIRPGN
HGSTFGGNPLASAVAMAALEVVKDERLAENAERLGIIFREAMNEYIKTSKICKLVRGKGL
LNAVVINDTEDGDTAWEICLRLRDNGLLAKPTHGNIIRFAPPLVMTEDQLKECINIIIST
LKEFE
>OMIFANIC_02246 hypothetical protein
MEKQKLNTTVVYILSIVGFLCCCFAGLGIVPAAIAFFIANGKVKEWKANPENYENGNAMN
TAKIIALVVLIINALYLAWSIYSIYAMGGWEAYMEESRRRMEEMGI
>OMIFANIC_02247 hypothetical protein
MIIQGIDDYMLPCLTKKYLGFDCLGCGMQRAAAFLFKGEFVAAFKMYPAIYPLIVLVFFL
GLNMFLEFKHSEKIKIILILITIIFIVGNFLIKLYYH
>OMIFANIC_02248 hypothetical protein
MKGVGVSTHSDPLTDPINQNYDFRGRPNNGDISVGVMANESTLSGNPYPSALDLFLVFWD
ADNTEIQMFKFWDEDRSINSHYYIDNKGGYGTWIPGSSDYATVHTTGGIYTRPTFLNYDN
GGNPSGGDTGMGLDVSRLYAPIGQGFNIFADIAGDGQIIYKNSHRVYETESGSPFANFRS
SQDNSGRNPNAGIDPSAVNPYDGYPPTLRFYTIFEDSHMRDMVLTFNPESTDGYDRGMDA
RHPMDAAKAEVFFPIIHTDPHPIGTFPYVIQSLPYELTKRVPLTFEVEMSSTRATIMSVD
EINLPSRVYLYDSVDNTYQEITGGNRANIQLTQGDYEDRFFLVFRGRDDTNRSSESNQRT
MEIEANVDFFQNNPVAQLEVSNPEGYNIKSAMIFDMSGKLVLNQNDLGDSTRFTFSTATF
SDGVYIVKLTTSENVVIDYKMTVHNKR
>OMIFANIC_02249 hypothetical protein
MYYFLDVFGYFAAKWNNISLADQIIEDHWYLFKDNPVGMKALAYLYQTLGNNEKAHELYK
EIFILRPNYAQSYRDLALSYADVGDYRKSASIYARYDYLVAEGFIRAEDKEFTPLMEREF
SNLLELHRKELTSTETKKGPSLNSDFEGTRLVFEWNDSEAEFQLQFVNPNDKYYNWEHSL
LADPDLIRIEKLKGYSCKEYLIDGSITGNWKVNLKYLGNKSLTPAYLKATIYHNFGSKSQ
RKEVKVFKLQLKDVNQELFKVQNSLSLVSN
>OMIFANIC_02250 hypothetical protein
MFPTRSVASLLFVLAVYQLGYGQRDYKGVILDKNTNEPIPYVNIGFPKKGVGTVSDEEGL
FHLEIDTRLLGTSEILQFSSLGYSTINRKASELEFSYNEYPIIFMEPKAEQLNPVVVTDA
GLFESGDHIGYKNGGHQYYGYWKDNIALGGELATRIRVKKGLRRLNEFNFEVWGNTSDSV
LVRINFYDTDGANGFPGTNLNSSGRNILYTIPSTPEVATVDLREFDLFVRDDFIVSLELL
KVYGPSKIGLVLAAANNRYTDSFKKYASQDDWQIMIDAAMAYRLESTLFSKKPVKDRSRN
KKKEDKSIITGYVFHGNIALPNVKVTNFSNGISVNTNENGNYQIEAKTGDLLQFNAKGMK
TLTVKILKKKFINIRLERS
>OMIFANIC_02251 Methylmalonyl-CoA carboxyltransferase 12S subunit
MIYSDSADKATRFIANCNQKKIPLVFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVV
PKFTVVIGNSYGAGNYAMCGKAYDPRLIIAWPSAELAVMSGNSAAKVLLQIETASLKKKG
EKITAEKEKELYDKIKERYDNQISPYYAAARLWTDAIIDPLETRKWISMGIEAANHAPIE
KPFNMGVLQV
>OMIFANIC_02252 hypothetical protein
MSFKPGDKVSVLDEDFNGIVIKVEGDMIHIESEEGFPFVFRKDKLIPGNDMEDLRSESLL
EGYSKEPRSKPKKTKLVRSAKRKFIPIFEVDLHIEKLLPSNKGMSKHEIRTFQIDTARKQ
LEFAIRKRIPRMVFIHGVGEGILKVELDYLFGRYDNISFFDADYQQYGIGATEVRIHQNA
RRA
>OMIFANIC_02253 hypothetical protein
MRLKRVFYYIFILFGAAIVIYTQNDGNEHLYLLIIGFCLLMAGLFGVYSLIKTPKPDIDP
FAVQNEEEE
>OMIFANIC_02254 hypothetical protein
MRKAILTILGFAIIVLSVFGAIAIVKSNKRQRPRPQKIVKTVFVDTVRNGIVPISIKANG
NLVAKRRLEIYSEVQGVLRTGAKLFKPGQKYRKGELLLSLNASEFYATVQSQRSNLYNQI
AAIMPDLRLDYPEAFDKWQNYLNDFDVNSSLAPLPVSTSEKETFFINGRNITTSYYNIKN
LEQRLSKYRITAPFEGILTEALVTEGSLVRPGQKLGEFIDTGVYELPVAVNKEYGDLLEV
GKKVTLRTLDNLNEYSGIVSRINGNVSVSSQTIDAFIEVKDEKLREGVYLEANLQAKEEA
DAISISRNLLQGDDKVFTVKDSILDLLDVNPVYFSDKTVVVKGIPDGSLILNKPVPGAYA
GMLVKIYAEKTAKEEPTEKTTGE
>OMIFANIC_02255 putative ABC transporter ATP-binding protein YheS
MINIHNLSVSFQGDYLFEGITFQLTPGDRVGLVGKNGAGKSTLLRIIAGEQEYDEGQIAT
DKKVTIGFLKQDIDFTKGRTVLEEAYEAFSEIKTLEKKLESITMEMSERTDYESESYHQL
MVDMNELQHQYEIIGGYNYQGDTERILKGLGFIREDFNMPTDTFSGGWRMRIELAKLLLQ
NNDILLLDEPTNHLDIESILWLEEFLNNYAGVVMLVSHDRMFLDNITNRTIEISLGKIYD
YNQPYTKYLALRHELRTQQLATQKNQQKHIEHTEKLIEKFRAKASKATMAQSLIKKLDRI
ERIEVDEDDTAVMSLRFPVSVNPGKVVIEAENISKHYGDNHVLSGIDLFVERGSKIAFVG
QNGQGKSTLAKILVNEIDHKGSVKLGHNVQIGYFAQNQVDYLEGSKTVEDTMLDAADEKT
RPKVRNMLGAFLFRGDEVDKYVKVLSGGERNRLALAKLLLQPFNVLVMDEPTNHLDMKSK
NVLKDALKSFGGTLIVVSHDRDFLQGLSNKVYEFKDRKIKEYLGDIDYFLEQRNLQNLRE
AERRSEVAESVKVKTSSGKEDYEQQKKRKSLQNKLSKVESEINKLEREIKEIDIELQINY
NETIARENFFDNYQQRKQNLDKLMQEWTSISEQLDSFA
>OMIFANIC_02256 hypothetical protein
MKGTKLYSIFKGKCPVCHNGDLYKNKNPYLLSETLKMHERCSHCDTKFKIEPSFFYGAMY
VSYGVGIAFAVAAFIISFFLLNLGRLNSFLVITGTLVFFLPVILRLSRNIWINFFFKFDP
EKAS
>OMIFANIC_02257 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MKQVDYIIVGLGIAGITACERLDELGRSFVVFDPGVMNATGTAGGVVNPVVLKRFTPAWR
APEFIEVAKPFYRRLNDTLKGRFLDNKPLYRIFANAQEQNDWMVASDSPVLVPFLSAEVV
TNRYPNVQAPFGYGEVHNSFHIDTVSMIRAYRDYLLSSGRLMSEKFDFEKLQTSSGEHHY
GDHLAKYIIFSEGSSVIDNPKFTYGCLIPKKGEYLVIRSKDLKCDAILKGPFFMIPLGDD
LYQVGATFAHGDFSRDSTEQGKAMLEKAVMKMIICDFEIVDQTYGMRPTIKDRRPILGSI
KGDGVFFFNGLGTRGLLMAPLLSKWLIDHIDNDVDLPSEVDIKRFES
>OMIFANIC_02258 hypothetical protein
MSFKNVVLCGLGLLLGAFTANAQLNVLNAKTPEDIGKKTQAQIAYDNDEPLPYGYTDERD
VLWSRTVWEIIDLDERVNFPLYYPIDTNNIGAERRSLYDVLVKNIKNGNIEDVYSDSYFT
EKRTLKDIEASLIYSDTTDVGIDQYNAEGKVDEEYIRKFALDAGDVEEWRVRGIWYLDKR
QGELKYRLIGLCPVANEARSKAFPDDNIDSKVELFWVWFPGAREVLHNAKAFNRRNTSQP
ISYDHLLNSRRFGALVYKEDNVQGDRAVNEYINDNALMQLLESDRIKEQIRNIEIDLWNY
>OMIFANIC_02259 hypothetical protein
MAQGKLSPRQKMINLMYLVFIAMLALNMSKEVLSAFGLLDKKIEESNVATAARNNAFMES
LATKATDAPEQYAALKAKADEVSTISQELDTYLEGIKTQMMGTLKPEDATDYEVQDKPDF
LDRRFFKGSNLKPEGQEFIEKIDKYRNEMVAVLGDSLYPDIKESILANFSTAPVQNRDGK
SIDWINYNFEGFPLIASKTKLTQIQADIKTTKSELLGKMLSGVQTEALALKNYESFMTVK
KTAFYPGETFDGSIILGRVDPNTIPKREELTLDGRKLERDKDYTIDGGRIVLKVGAGSPG
DHKIEGTLFYGEEGDETEVPVETGFATISKPNAAVISADKMNVVYRGVENPMTVSIPGIP
DNKVSASGTGLSKVTGSKYVMRPGGGREVNISASGTLPDGQRVNTTSVFRIKDIPRPTGT
IRGEDGNGGCVRMQRQGLEIASIGAILPDFDFDINLNVTGFKFKVSGQPTVVVGGRRMNA
QAKGALRRAKRGETVQIFDITANIANNSGYKLKKISPVCIELTN
>OMIFANIC_02260 hypothetical protein
MAQSKSSKKLFNMAYGLGASIVILGALFKILHWEIGPLNGGLLLAIGLITEAIIFAISAF
EPVEDDLDWSLVYPELAGGKGTLKGKKEEPEDAQGLLSKKLDEMLKGAKIDSELMTSLGD
SIRSFEGAAKSMAPTAEAMNSTKKYSEEMALAAAQMESLNSLYKVQVESTSRQAEVNERV
VENAEQLKAQMEHLATNLSSLNGVYGGMLSAMGGKN
>OMIFANIC_02261 Serine/threonine-protein kinase pkn1
MKKLIALTAIVAFLFSCNSGDRGELVGAKGKKWYPQKPYGMTLIPGGSFIMGKSDDDFVA
VNDAPTKTVTVRSFYMDETEITNSEYRQFVEWVRDSTVRLKLAILADEVGATPGDEGIGE
FAFVDQENEEMTPYEQYMYDNYYGLGEDFYAGRKINNDVDLIWDTGEYPDEYYSEVMDTM
YIPAEEAYNGQRTIDVDKLKFQYTYMDIQAAARAKGKQRKDFIKKEEIQIYPDTTVWIKD
FNYSYNEPMHNDYFWHEAYGDYPVVGVNWKQAKAFCAWRTLYKNAYQKSRRRNHVNSFRL
PGEAEWEYAARGGLESATFPWGGPYAKNDRGCFMANFKPLRGDYAADQALYTVEADAYEP
NDYNLYNMAGNVSEWVASSYDPASYNYTSTMNPNVNDDENMRKVVRGGSWKDVAYFLQVS
TRDYEYADSARSYIGFRTVQDYMGTDVVLNQNFGDAR
>OMIFANIC_02262 Formimidoylglutamase
MIEFLSPVSKQVLAHREILPEGVLGKQIKIHTKAGSLPAIDKAGFALLGILENRKDVDYL
GGDISLDSFRKALYGLYPGNWNRVIVDLGDIEKGDTVEDSYFAVRTVVEALLKKNIIPII
LGGSQDVGYAQYRAYDSLGNMVNMVNVDTNFDLGDAEKPISNKSYVGKIIVDKPYNLFNY
STLGYQSYFNSPAEIALMEKLYFDAYRLGEVTADITVVEPIMRDADFVMLDVAAIKSAEL
SYKSNKSPNGFDGREICAIARYAGISNRVSSFGVYELKDYKDAESGAMLVAQILWYFIEG
VNFRITDEDFSNENEYTTYKVPIDDEILVFKKSVKTGRWWIELPFISNVNNKLKRRTLLP
CTYGEYLGATNQEIPERWFKARRKNEV
>OMIFANIC_02263 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGKDFKVTSSFGHIADLPSKELGVDVDGDFTPKYIVSPDK
KSLVKDLKAMAKKADMVWLASDEDREGEAIAWHLAEELDLKDDNTKRIVFHEITKSAILK
AIENPRKIDYNLVNAQQARRVLDRLVGYELSPVLWRKVKGGLSAGRVQSVAVRLIVERER
EIESFTPVASYRIDAEFVTTSGSKFKAKLPKNFETEAEARAFLGKNINATYNVADLVKKP
AKKSPAPPFTTSTLQQEASRKLYFSVGKTMTIAQRLYEAGLITYMRTDSVNLSNDARNAA
QKAIEASFGSQYSNPRNYKGKAKGAQEAHEAIRPTDMSRQSIDGDRDQERLYDLIWKRTI
ASQMSDAQLERTNVKIGVHAQESVSEQFAANGEMIKFDGFLKVYLEGTDLEEEEQDGMLP
NLVIGDALLNKYITATQRYSRPAYRYTEASLVKQLEELGIGRPSTYAPTISTIISRNYVE
KGTIDGTERKYLQLTLEDSELKDKVLSETVGSDKGKLVPTDIGMIVNDFLVEHFGNILDY
NFTAKVEEDFDDIADGKEEWTQMMKDFYTKFHPHVEDVQENAERESGERILGEDPETGKP
ILVRLGKFGPMAQIGAPDDDEKKFASLRPDQQLHLVTFEEVLDLFKLPKTLGIYEGEEIE
VNNGRYGPYVRFGKKFISLPRGMDPLDVTMDDAKVMIDEKKKADAPIYMYEGLPVQKGKG
RFGPFIKWNNMFINVNKKYDFDNLSDADIIELIEDKKQKEIDKLINEWPDEGIRIEKARW
GRFNLIKGKTKVELPKTTKADKITLDQAKEMLDKKAPKKKTTRKKKTTTKKK
>OMIFANIC_02264 hypothetical protein
MEHPIFQKIDASKKVDFGDVLTNSYNLFLKVWQQGAMHTLIMMLFVIPFIILVYVPVIYM
SYASNRYYDPYYYDYGPDYGMAGDNWLPFMIIYFIVLFVLIIIMQSVSLGVMAHFYKVCK
IVDLETGEDEGGYFDYFKNGGFMKIFVLSLATFGIAVAAILLCYLPIFYVMVPLQLMLPI
FAFNPKLSVSDIVKAAFKLGHKHWIYVFGLILIAGNVAQLGIFLCIIGIIFTACIAYLPI
YFFYRDTVGFDDTPASETTLTE
>OMIFANIC_02265 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEEKIIDENKQGEALVLEATNGNTRKLFIESYGCQMNFSDSEIVASILAKQGYNTTKILE
EADLVLVNTCSIRDKAEQTVRKRLEKYNAVKRTNPKMKVGVLGCMAERLKSKFLEEEKIV
DMVVGPDAYKDLPNLLEEVEAGRDAVNVILSKEETYGDIAPVRLGGYGVTAFVSITRGCD
NMCTFCVVPFTRGRERSRDPQSILTEVNDLAEKGYMEITLLGQNVDSYLWYGGGLKKDFK
NASEIQKATATNFAQLLDMVATAQPHMRIRFSTSNPQDMTEDVLHSMAKHKNICNYIHLP
VQSGSTRILKEMNRQHTREEYIALINKIWEIIPDCAISQDIITGFPTETEQDHRETLSLM
EYVKYDFGFMFMYSERPGTTAARKLEDDIPLDVKKRRLTEIVDLQLMHSAYRTKKFVGKT
LEVLIEKESKKSDQHWSGRTQYNTVAVFPKENYKVGDLVMVKVEDCTSATLLGVAVDYAE
>OMIFANIC_02266 Nif-specific regulatory protein
MQNVQAIKQRFGIIGNDPKLNRAIEKAIQVAPTDISVLVTGESGVGKESIPKIIHSLSHR
KHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATATRSGYFEVADGGTIFLDEVGELPLP
TQVRLLRILENGEFLKVGSSKTQKTDVRIVAATNLNMIEAIEKGKFREDLYYRLSTVDIH
LPPLRERAEDIHLLFRKFASDFAQKYKMPTVRLEDDAVSLLQQYRWSGNIRQLRNVAEQL
SVLEADRNIAYQTLRNYLPDMGATLPAVVGDKKRDSDFSSEREILYKVLFDMQRDVNDLK
KLTMELMKSGNVSDVQEEQSSLIDKIYSEEKIHEQHLSTIVDDRPADSSVEVVSIPESAS
ETNHANYDFAEEIEEEENLSLQEKELELIKKSLEKYHGKRKDAAEELGISERTLYRKIKQ
YNL
>OMIFANIC_02267 hypothetical protein
MKKNLTTIVTLVTMILILQGCKVNYSFTGADTGDAETFQVNFFQNQAPLVEPGIARDFTI
LLQDLILNQTSLDLVNNNGDLTYEGEIVQFYTAPITATSQSTAAENRLTVAINVRFFNAD
DSEKDFEQRFSFYFDYAGGTQLTGSRLDDALAVIFERISQDVFNASLANW
>OMIFANIC_02268 hypothetical protein
MHHWPIGDFLNTETYTYLLDKPQNIEDQHMEELEGVIAAYPYFQSARALQLKALKNRNSY
RYNDALRKTAAYTTDRDILFEYITSEEFVQNAISEKIKQHDPSVNEIEVTSEDVTEQVSL
EIEKQLKAEMKKAEAILNPDLFERKLASVENLVEDPGAPAVEKSLDVSLDRDKPLEFEKE
DSHSFGEWLKLTKAVPVKREEDPGKKEQNKKARKFELIEKFIQDNPKIEPERRGEKKKNL
AKAFTQTPETLMTETLARVYVQQKNYKKALQAYNILILKYPEKSGFFADQIRAIKKLINT
EE
>OMIFANIC_02269 hypothetical protein
MSTFTIFLILIIFVAFLLVVVIMVQNPKGGGLSSSFGGGGTQQLGGVKKTTDFLDKSTWT
LAIIMIALILLSSISIMSGSGNSDADIIDTEGIETTLPDPGTTGGGTEEDNSGGETPVE
>OMIFANIC_02270 10 kDa chaperonin
MALKIQPLSDRVLVEPQAAETKTASGIYIPDSAKEKPQQGKVVAVGKGKKDHDMTVKVGD
LVLYGKYSGSELKLDGKDYLIMREDDILAII
>OMIFANIC_02271 60 kDa chaperonin
MAKDIKFDVEARDSIKRGVDALANAVKVTLGPKGRNVIISKSFGAPQVTKDGVTVAKEIE
LEDGLENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
AAVAAITKDLEKQSSKVGSSTEKIKQIAAISSNNDEQIGDLIAQAFEKVGKEGVITVEEA
KGTETYVDVVEGMQFDRGYLSPYFVTDSEKMLTDLENPMILLYDKKISSMKDLLPVLEPV
AQQGKSLLIIAEDVDGEALATLVVNKLRGSLKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGFTLENATPEMLGSAETITIDKDNTTIVNGAGKKADIQTRVGQIKAQIETTTSDY
DREKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALV
RAKSVLEKLTTDTMDEATGIQIVARAIESPLRTIVENAGGEGSVVVNKVNEGKKYFGYDA
KADKYVDMLSAGIIDPKKVTRIALENAASVAGMILTTECALVDIKEDTPPMPPMGGGGMP
GMM
>OMIFANIC_02272 hypothetical protein
MKRLLVVTLVFFTMTAMYGQNKNARAVIEVDGVCGMCKERIEKAAIRTKGVKSAVWSIET
HELSLIYDERKTNLRTIQGNIAAVGHDTKAIKATEEAYLSVHECCRYRDLAVQEDHKNGN
>OMIFANIC_02273 TonB-dependent receptor SusC
MKMLVMIMSLIPVWAFAQQQIEGTIVELNDENKVVGLEGASVYWLDTTVGTITDFDGNFT
IDYESEYEKLVISYVGYETDTLTITEPRVIRHQLRLKSDLGEVVVKSRRKSSSTSYLKSQ
NVINVSSAELLKAACCNLSESFETNPSIDVNFADAVSGTRQIKMLGLTSPYILITTENVP
SIRGASQAYGLSFIPGTWVESIQITKGAGSVINGFESITGQINAELQKPSLDDRLFVNAY
GGLNGRLELNTHLNTTVNDKWSTGLYVHGNLRDTKFDRNDDGFLDTPLAQQINVMNRWQY
TDMEKGFVSFFNFRFLNDEKQTGQLDFDPDTDKFTRNAWGSEIDTRRFEVSGKFGYVNPN
IPYQSAGIQLAYSNHDQESYFGLNQYDITHQSLYANALYNTIIGDSRHKIKTGLSFTYDS
YEELVKTTSYDRVENSVGAFFEYAYDNLGDLNATLGVRVDQHNLLGTFVTPRLHVRYTPW
EKSAIRFSVGRGKRSANIFTENQKFFASSREIVILDQGGDIYGLDPEIAWNYGISYLQGF
NLFGRKADVTLDFYRTDFQNQVVVDWENPREIAFYNLKGDSYANNFQTEFNYDILENVDI
RLAYKYFDVRTTYRNGKLDKPLTPNHRIFANASASTNMKENGSQWKFDATYNWLGEQRFP
STVGNPQQYLLPEFSPTVGTLNIQVTKVFSPTFEIYIGGENITNVKQSNPIVASDAPFDP
AFDTTLVYGPIFGSMYYSGLRFKIE
>OMIFANIC_02274 hypothetical protein
MKQSYTISGMTCEGCKASVMQALNSVKEIQHVDINLEKEEAEITLVRDIPLSDLQKALSS
KYSISERKEANIFQSGMEGLTPDTNKSKFQQLQPLFLIFAYIIAAAFLLNYELLDVGSFM
LDFMGLFFIVFSFFKILDLKGFPDSFRMYDPLAKAIPVYGWLYPFIETALGLMFLLRFET
GIALIATIIILGVTTVGVTRSLLGKQKITCACLGTALKLPMTEATFIENAIMILMAIFMI
IKTFAI
>OMIFANIC_02275 hypothetical protein
MRILLAIIAVSSLALQSCKQETTDTVEGIKYAGALKDIMSGKLDSNIALNELKEVPNLYA
LGAMAGLKGEIQIFNSQPYNSRVTPEFLELDKDFDANATLLVYAQVPEWQEFSIPKAILT
LKQFDDYLEYTAVQAGIDTNQPFSFMIEGYVRKIDWHIVDWDENNTNHSRESHMKSGLNG
VLVEEDVEILGFYSKDHKGIYTHHDANWHMHFNAKDRNLAGHLDDLLLGEYMTLKLPKQ
>OMIFANIC_02276 hypothetical protein
MQKIISIFLTILMLASSSGIAYAQHFCGEFEMLSEITLGEKDLSCGMAMELPGCDDETDE
HDCCDNEYTKVDTDDTFAKASFEFDPGENFIFAFYSVFVLFQVENYPENPDFYKDYSPPP
LERDLQVLYDTFLI
>OMIFANIC_02277 hypothetical protein
MKTFKYVLILTLAIVLFSCADDKKKTDSIEPEVKTVETKFEHKAGDINASFKDDKLTSIF
AEYVVLKTALINTDATAASKAASDLMTAFANQGVSESAMTIVQKIVDLDDIEAQRSAFVG
VTNAVEGMLKDALDSGKVYKQYCPMAFKNTGAYWLSESKEIANPYFGDKMYRCGRIDSII
E
>OMIFANIC_02278 hypothetical protein
MSRAMQIILLVLAVSGLILIRQFAGDIFYDPLIEFFKTDHSTQPLPELMTGKLLLHITIR
YFFNTVLSFLVLWVIFKSRSILKLALFLYITLFLIFVIAFAVMLNTSEAGNHMALFYVRR
FLIQPLFLLLLLPAFYFHKRS
>OMIFANIC_02279 hypothetical protein
MRALLIRYKPVLRFIGLFLGTYMLLSILYGIYLNISEGGSYPPDVITNLVAKQSSDVINS
LGYTARVIPDTTEPTMKLYVEGKFLARIIEGCNAVSIIILFISFIIAFAEKFKKTLLFIF
AGAVLIYAVNILRIVILAITLFEYPEQKELLHGVVFPGMIYGMVFILWMIWIRMLKTLKS
DE
>OMIFANIC_02280 Free methionine-R-sulfoxide reductase
MNFDSLKPEITRIIDRSDLSVDDRLTGVCELIQTSLNYYDWVGFYFANHANRTLHLKAFA
GESTDHTVIPFGKGICGQVAESNENFLVPDVKAQDNYIACSIHVKAEIVVPLFKDGKNIG
QIDIDSHSADAFNTDDERFLEWVNEKVAEII
>OMIFANIC_02281 hypothetical protein
MSNVQVHRNFKLASYFILAAVAVGIFKFITVFSDTDITASENYIRAFLNVLILALLIWLG
LFIAKGRNWARITFAVLTASILVLAPFVVLKEFHTSMTIGILSSLFGIFLFIALLLLYSK
GARHWYADQLDDI
>OMIFANIC_02282 Macrolide export ATP-binding/permease protein MacB
MLIYLRIIRESFNFAINALKNNKLRTFLSLVGVTIGIFSIIAVLAAVDSLKKEIEGSISS
LDNSTIFLGRFSFGPTDVPRWKWEQFPDVTYEEYQFVKRSVPDVLAASYTLNVPSETVKY
EDKSVSNVEIGAVTDEYYEIESLQIANGRFYNESESNSGNPVIVLGDEIAQTLFGSGEAS
IGKKIRLYGRKFTVIGVLKKEGTGLFGGSKDTSVFLPVNIIRKIYGDTNKNLFPFIIIKP
ESGVDNAEFIAMLKQKIRVHRGLKPDEIDTFFVNQLQGFADFIDNITGQMNVIGWLISGF
SLLVGGFGIANIMFVSVKERTNIIGIQKSMGAKNRFILLQFLFEAVILAIIGGLIGLVLV
FIASLIASSFSGDFQFVLSPWNMFIGTAISAAIGLISGILPAISASRLDPVEAIRTGM
>OMIFANIC_02283 Bifunctional purine biosynthesis protein PurH
MSNTKKITSALISVFHKDGLAPIVQKLDKLGVNIYSTGGTQKFINDLGVSVIPVEEVTDY
PSILGGRVKTLHPKVFGGILNRQDNDGDIAEMSQYEIPQLDLVIVDLYPFEKTVASGASE
QDIIEKIDIGGISLIRAAAKNFKDTLCVSSMEDYSEVLQMLDQGNGEISMDDRRRFAAKA
FNISSNYDTAIFNYFNSDHSIASLKISEMHGKVLRYGENPHQKGYFFGDFDAMFDKLHGK
ELSYNNLLDVDAAVNLMAEFQGDLPTFAILKHNNACGIAQRDSVKQAYVDALAGDPVSAF
GGILISNTEIDAQTADEIHKLFCEVVIAPSYSEEALEILKGKKNRILLIQKEAKLPATLT
RTCLNGALVQDRDSVTDSAENLSNATHKKPTDSELEDLLFASKICKHTKSNTIVLAKGKQ
LCASGTGQTSRVDALRQAIEKATSFKFDLNGAVMASDAFFPFPDCVEIAEKAGVTAVIQP
GGSIKDQLSIDYCNENDMSMVFTGTRHFKH
>OMIFANIC_02284 Rod shape-determining protein MreB
MGFFDFLTEEIAIDLGTANTLIIHNDKVVVDAPSIVARDRTTGKIIAVGREANMMQGKTH
ENIKTIRPLKDGVIADFDASEKMISMFIKDIPALKKKWITPSLRMVICIPSGITEVEMRA
VKESAERVNGKEVYLIHEPMAAAIGIGVDIMQPKGNMVVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIIYYMRTQHNLYVGERTAEKIKIQIGAATEDLELPPDDLAVQGRDLLT
GKPKQVQTSYREIAKALDKSILRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRLSQKTDLPVYIAEDPLRAVVRGTGICLKNLNKYKSVLIK
>OMIFANIC_02285 Cell shape-determining protein MreC
MFLLLFTISFLLTINSHSFHSNKVATSANFLSGGIYSMKQNFKDYFNLKTQNKILVEENN
RLRQLLSNTQPDANFYSVDSTNILWKYNYVSARVINNSYSKSKNNLTLDHGIKDSIGIDM
GVISSKGVVGIVNSVSANYATVQSVLNSNSQINAKLKNTDHFGTLVWQNGSPFEATLIDI
PRQVQFNVGDTIVTDGKSTIFPEGILIGSIKDYKLAFNEDYYELTISLFNDMTNLRHVYV
IRNKDAVEIRQLENALENVE
>OMIFANIC_02286 hypothetical protein
MWNNEYLINSVRFITLLLIQVILLNNINLFGYVNPYLYVLFIIVFPFTGNRSLLIFLSFF
LGLMVDIFSDSGGIHAAACSFIAYARPAFLKFSFGVSYEYNMVKISKAPMGERITYISLL
IFTHHLILFSLEIFNFSHILLILKSTLFSGIFSVVLILSAVLLFSRKN
>OMIFANIC_02287 Peptidoglycan D,D-transpeptidase MrdA
MRKLLLLVLVLITGVVFAGRLFYLQVYDTSFQKLSENNAIKVIYDYPQRGYIYDRNGELL
VSNQPSYDVMVIPRDLVAFDTLEFCGLLKMNKEDLVKALEKAKNHSPRLPSPIIPQLTKA
EYAYLSEKMHKYKGFYILKRSLRDYQIDHSANVLGYIAEADNKIIKKNPYYQMGDLLGKQ
GVEMQYEEVLRGVKGVKYIQKDRFNRDIGPYKDKAFDTIPERGKDIKLTIDAVLQEYGEK
LMANKRGGIVALEPATGEILALVAAPNYDPSLLVGRERSKNFTKLWYDTISKPLFDRVLQ
GEYPPGSPFKALTALIGLQEGVIDTEETVSCYGGFRYGRNRKLGCHAHRSPLSMQAGIAN
SCNAYFCTVYKRTIEKYPTPQEGIDNWRNHLLSFGLGDFMGYDLPSGRPGKIPSAKTYNA
VYQYPTYKWYATATISNAIGQGEVLLTPMQMVNFTAAIANRGWYYKPHIIKNISGADTIP
SIYRKKYQTTIDREHFDPVIAGLFDVYNYGTAAHLQVPGIEICGKTGTAENYTRVNGERV
QLTDHSVFIAFAPKDDPKIAIAVFVENGYWGSRWAGRIASLMIEKYIKGEITRKDLETFI
LNGSLEEEYAKPYSDEPFKINQ
>OMIFANIC_02288 Peptidoglycan glycosyltransferase MrdB
MARGRGFVRLDWFTIIIYLALVGIGWINIYSASLDDSATGFFDMSQIYFKQLVWICLSLV
LIIFILALEAKFYERFSSIIYIVSLVTLLGLFVFGKNVNGATSWYVLGGFSIQPSEFAKA
ATALALGKYIGDMQTNIKEFKHQLRAFIIIALPALFILPQPDPGSALVYAAFIFPMYREG
LHFFYLLLGFFLAALFISTLAFGVVWVSLGIVLICGLIYFRNRKRKKTKVINYLMVAAVC
IGFSLSVNYIFNNVFEQRHRDRFNIVLGKETDAKGIGYNTNQSEIAIGSGGWTGKGWTQG
TQTKGNFVPEQQTDYIFSTVGEEWGFLGSIVVVILFVALIVRVLFLAERQKSQFSRVYGY
SVGAILFVHFFVNVGMVTGLLPTVGIPLPFFSYGGSGLWGFTILLFILIRLDASNSYYA
>OMIFANIC_02289 Nuclease
MNRKYLYPLLIILITVALYFAEKYIDRQNEDYPIPVVDSSDEAEFDDRFLPNSTTGKIVR
HAYFNLSYSEKHEQAEWIAYELKQDHLAKTDFERPYFVQDRKIRTGSADWRNYKNSGYDR
GHLCPAGDRRFNYDAYHETFLTSNISPQDHEFNAGIWNRLEQKVRYWARGKEGVFVITGG
VLKNGLKTIGDEEVSVPEEFFKIVVDRNGEEYKAIAFLIPNKESSLSFYEYAVTIDEIEK
KTGIDFLRGLDDKKEDALERELDRNGW
>OMIFANIC_02290 Glutathione transport system permease protein GsiD
MKYTSTSLTKLALRKFRKNFWGVFSLSFLILCVLTAIFAYALAPDDSKNANQMHLSIHSK
QPGFKVQMLTIPSVVEQENGFSSFFLGKKNVATEIPINSFDILSEGIAISEYTSDGTAGL
QKEYPLSVFSKVTSSEDIPKQYISEKKFLLGTDKYGRDLLSRMLIGIRISLAIGFVAVFI
SLVIGITLGAIAGYFGGKVDAAIMWLINVTWSIPTLLLVIAITLALGKGFWQVFIAVGLT
MWVEVARVVRGQVMSVKQMQYVTAARALGYTDFRIIIKHILPNALAPVIIISAANFAGAI
LIESGLSFLGIGAQPPMPSWGGIIKDHYSYIILGKPYLAVIPGLAIMSLVTAFMLIGNAL
RDALDVKT
>OMIFANIC_02291 Tail-specific protease
MRLMKKNLKVLFLAIFVAAASCSFTTKEFEDPDKDKLLIDLITYVLQKGHYNPADMDDTF
SAGVYEDFIEAMDPLKRYFLASDVEEFSVYRDEIDNQIKEKDLTFFNLVYSRYMERLDEA
RDRYKVVLKTPFDYSEDETINVDYDNLEYASSKKELKERWRQQLKFSGISAYYDLMQDKL
DSEERKKEAATSGEEYVPGENDNLSAKELEEKAREQTRTSLNEYFEFTDDLERKDYFAVF
LTTVVEEFDPHTNYFAPPDRDRFDLRMSGKLEGIGARLQKKNDYINVVEIISGGPAWRGE
HIEVGDIIMKVRQADEDESVSVVGMRLDDAVKLIKGPKGTKVTLTIKRVDGTIEEETITR
DVVELEETYAKSTVIEKEKNKFGLINLPQFYFDMNDYKKRNAASDVKEEIIRLKQEGVEG
LVLDLRDNGGGSLRTAVDIAGLFIKDGPVVQVASTGSKKEVLKDRDDEIIWDGPLVILVN
ELSASASEILAAAMQDYKRAIIIGSTQTYGKGTVQNLIDLNQWLRKNDLGDMGALKLTTQ
KFYRVNGGSTQLEGVKSDVIMPDRYSYIEVGERDYDNPLPYDKIEPAKYKIWEGYIDFEE
TIKKSKERMAKSEQLALIEENARWIKNRREEMVVDLNYERYNSGIERRKSETKKFDAIGE
YDNKLSYRSLPFELELMKQDTTLREKRKRWHKSLSKDIYVEEAVNVLQDLKLNNIKAGKL
AEIKN
>OMIFANIC_02292 5'-nucleotidase SurE
MNKKKPLILVTNDDGITAPGIRTLIEVMNSLGDVCVVAPDSPQSGMGHAITVNETLYVDK
VVVDKRARQTEYSCSGTPADCVKLAVNEILGRKPDLCVSGINHGSNSSINVIYSGTMSAA
VEAGTQGIPSIGFSLLDYSLEADFNPVKEYVRKIAEQCLQNGTPEGVVLNVNFPRLTENE
IKGIKVCRQANAHWIENFDKRVNPLGRDYYWLTGEFVNKDKGEDTDEWALRNGYVSVVPV
QFDLTAHHAIKDINSWELS
>OMIFANIC_02293 hypothetical protein
MKKQIGIGFITGIIFNLVGIVICIFIISRMKDLSFAETFSFYKRTDSLWMIITLGALPNL
AVFFGFLRQNRDYRARGVLLATFLTAITAYIIYFN
>OMIFANIC_02294 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLIKALRKNDSKAEFRVWGGDLMEKEDAVLAKHYRDLAFMGFI
EVLFNLFTILRNISFCKKDIEAFHPDALIFIDYPGFNLRIAKWAKKQGYTTHYYISPQIW
AWKEGRIKRIKRDVDHMYVILPFEKDFYEKKHGMPVHFVGHPLIDAIYKRNQVDPNEFRK
ENGLDDRPIIALLPGSRKQEISKMLEVMISVVDNFKDYQFVIGGAPSQDASFYEQFIKSN
QVHLLLNKTYDLLSISFAALVTSGTATLETALFKVPQVVCYKGNWFSYQIAKRVIKLKYI
SLVNLILDKPVVTELIQTEFNSQRLEDELHKIIEPYNRASLFLDYYDLEQALGGKGASKK
TASLIKSTIANPG
>OMIFANIC_02295 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKRIILICLLAAALASCGTSRQSSKTVVIEKNSKNISGKKVNKIVSHAKGFVGTRYKFGG
TTRKGMDCSGLVYVSFQHENITLPRMSREMATRGTRISLNQVSEGDLVFFKTNKNRKVIN
HVGLVVESKRGSVKFIHSTSSRGVIISSLNESYWNDAFVEVRRVI
>OMIFANIC_02296 ComE operon protein 3
MRFVKFAIVRFSLFLVLGIVTGHFLHSVWWFYLLPGFFILFGVLWWLAKRQLFQNVYFAL
VTYSWFFILGLVNYQIRLPQFQPNHYSTHLTESEQSFMLEISEILKPDRFNFKGIAEVRT
ISNHATHGRILFFIPLDSLIDTPVTGDQIFTITDPSEIQSPLNPHQFNYARYMQLNDVYH
QMKLSKSNYRLLSGRSFTIITLVDEYRGKLLQKLDASAFGKEEKGIIEALVLGHRHTIDR
DLYRAYAAAGAIHILAVSGLHVGIIYFILQLLLSPLKFVRKGKTIKVILLVLLLWAYATI
TGLSPSVTRAVTMFTFFGMSQLLNRPTNSINTLFLSFFFLLLWNPKWMFHVGFQLSYSAV
FFILWIQPRLYRLYHPKYYLDKLIWTIITVSLAAQIGVGPLSIYYFNQFPGLFLLSNLVI
LPFISVIVSLGLIIVALLSIDLLPDWFAASYNFVIGLLNDFVKWVSVKDSFLFSEIHFSR
YHLFGSYLVILAFVLLWQRLSRPRIIISLCSILLFVCAVLLDKFETSQSKFIVFHKNRSS
LVGIQQGNSLKVLKRDSVSKFENDYPIKAFSTAININEYSEIILPNAFSFGSKRILVVDS
TGVYPGDEDADIVLLCDSPKIHLERLIDSLSPGLIISDGSNYRSYVDRWRKTCELKKLPF
HHTGDRGAFTLE
>OMIFANIC_02297 Thiol:disulfide interchange protein DsbD
MKHLLLLFSLLVIGSISAQEIKWMSMNEALEAQKKEPKKILMDVYTKWCGPCKLMDKNTF
GNKKVIAFVNENYYAVKFNAEGTEEITYQDFTYTNPNYQPERKGRNATHFFADALRLQGY
PSIVFFKDNGELIQSIPGYKTPQQFEIYLKMIANDDYAELTTMEAWKNYQKSFKGTF
>OMIFANIC_02298 Di-/tripeptide transporter
MTTDKENFFENKVLGHPAGLFVLFFTEMWERFSYYGMRAILVIFLTGALLGDNPGWEWST
EAALSLLGTYAMLVYLTPLLGGWLADNKIGYRMAVVIGALLMTMGHASMAVETPTFLYIG
IALLILGNGFFKPNMTSIISKMYEGHDEKKDGAYNIFYMGVNAGAFLGIMLCGWVGEVVG
WSYGFGLAGVFMLLGMLQFYFAQPLFGNVGDKPKKKELQKLEVVEDPTGTAENEAPKLNN
FRIMDVALIVLFTVSALIFIINDPLSKIGDIQTLNFDLMGMTDSLFFALLAAVTFIVLLI
IRLPRYIRIERDRMIAFAIFCVFTVFFWAAFEQAAGSMPIYIRDFTSRVLEGNAAMGFKI
VDLIVTVVPLLIITYVLWSLFKKTFSRIGLSNIILGFSFVIVWAIVIYKLYVEFQATETE
VKVTWFAILNSLFIIMFAPLFTKWWDSKYNPPASVKYFLGLALLGIGFAFLAFGARNVMA
GAESASLSMAWVVLAYLFHTLGELCLSPMGLSYLSKLIPARMIAFMFGVYYLAIAIGNKL
AHYVGGDIERITEEYSLSTFFLIFTIIPIALGLVALMLHPLLKRMMHGVR
>OMIFANIC_02299 Di-/tripeptide transporter
MDSVFENQKKLFGHPVGLYILFLTEMWERFSYYGMRAILVLYLVAETGDINPGLGWANNN
AIALYGWYTMFVYVASIPGGIIADKLIGQKKAVFVGGLLLVAGHSILAIEEMWAFYSGLI
LIVMGVGMLKPNISTMVGGLYPKNEQNKRDMGFYIFYMGINLGAAAAALAVGYVGENIGW
HYGFGMAGVGMALGQLTYWYGQKYLKHVGNLVIDTRSEEEKKESKNLLVSIFHHTNSIIG
FTFMVLAGAAVWLFADSWSYGLLIIGLAFAVGVGIVVYNDGNKVEKDRILVTYISFLIII
IFWGSFEQAGGLLNVYAKQKTDLSLMGLEVPASWFQSVNAIFILIFATLVGSFWVWWKNR
KRESSSLFKMAVGVIIMGWGFFFMSIASREVGYDAAGEIIAKSGMQWLVLAYLFHTIGEL
CASPVALSFITKLAPERWMAFMMGAYFAATGLGNKLAGFLGESASDMGEFTIFTGIAVFC
TIIGILVILVIKPLKRLTHNAENREGSNNDETEGFELADNN
>OMIFANIC_02300 Dipeptidyl aminopeptidase 4
MKRIFSTPMLLLFLAVGISVQAQQKQITLEEIWGGAFRTQRLDVLRSLENGKEYAVLDYN
RAQGASTVDVYDYASGEKVRTLINSSELEDINYIISYEFNKDETKMLLATQLKQIYRRSS
IGTYYVYDINTKKLTLVSEKQIQEPTFSPDGNKIAFGNNNNLYIKDLTTGIESQITSDGI
KNSIINGITDWVYEEEFGFVRAFDWSKDGRRIAYIRFDETNVPRFSMDVYGDELYPSQQV
FKYPKAGDPNAEVSLHVYDLNSSSTSEVDLSAFNNYYIPRINWTNDPEILSVRVTNRHQN
EVDLVFVNAKDNSSRLVLKEIDDAYVDITDDLTFLNDNSFIWTSEKSGWNHIYHYDRSGK
LINQVTDGDWEVSNFYGFDPATGRIYYQSSEDGSINRGVYSVSQTGKNKVKLSQRTGSNS
ASFSADYSYFINTFSDTQTPYIFTLHQAKNGEQVREIKNNNELRDKVAGYAVSPKEFSTI
SVNGEELNMYMIKPKDFDANKKYPLFMYQYSGPGSQNVANRWGGANDYWHQMLAQQGYII
ACVDGRGTGLKGRDFKKMTQKELGKFEVEDQVAAAEKLGVLPYIDENRIGIWGWSYGGFM
SSNCLFQAPETFSMAIAVAPVTSWRFYDTIYTERYMQTPQENPEGYDNNSPITHVDGLKG
DFLLVHGSADDNVHVQNTMRLVEALVQADKNFEWMVYPDKNHGIYGGNTRLHLYKKMTRF
IQESLGKTESESLVQIKN
>OMIFANIC_02301 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MPVPVSGFSKKSKQEKIEWLVHNYFNDNEDALITLKQYWNNNTRLQELHDDFTENTISNY
YLPFGIAPNFKINGRMYAIPMVIEESSVIAAASNAAKFWLDRGGFNTEVISTIKNGQVHI
DYFGNKELIFRFFADVKPALLASISDIEKNMKVRGGGLLDIELIDTTEALPGYFQLHCTF
ETLDAMGANFINSCLEEIAITFEQKAASHPEFSKNSTTPKVVLSILSNYVPECMVRASVR
CAVEELTENGTDGETFARDFVRAVDIARTEIRRAVTHNKGIMNGIDSVILATGNDFRAVE
AGIHAFAAKEGKYTSLTQANVEDGIFTFSIEIPLALGTVGGLTGLHPLVKFALQLLHNPS
AQELMGIAAVAGLAQNFAAIRSLVTTGIQKGHMKMHLMNILNQLEATSDEKEKAIQHFTK
NTVSHIAAVNFIEKLRR
>OMIFANIC_02302 hypothetical protein
MQTFHSNGKLLLTGEYLVLDGALALAIPTVYGQSLSVSNSERIEVSWTSLDMDEHAWYKG
VFSLKDNKIMSSSMDETSELLLKILRKARQLNPDFLDGEEGYSITTKLNFPRNWGLGTSS
TLINNIAQWAEIDGFKLLSESFGGSGYDIAAAQHESPILYSNKADKPVSTPVRLPWKFTD
RLYFIHLNIKQDSKEGIALYRKITVDKSKVLSAISALTLKIVACEELTEFTTLMEEHETI
ISQLLGLPKVKDKLFPDYPGLVKSLGAWGGDFILVSGDASKMKYFTDKGYPTIIPFTDML
K
>OMIFANIC_02303 Chaperone SurA
MAILNSIRKRGIFLILIIAMALFAFILSDVLTRGGGSSVEDTIATVNGVDIDRQEFAELL
ETTQKSMGPNANTSQAMKLVWDRELRRLLMEEQYEKLGLRVETEQINEALSLYLAGDPTF
QDENGNYSELKMLEYVAQVKANANTNPAALEAWNNYLRNVKQTVLENTYMGMLRGGLSST
VADGEQQYRFENDKVNLDYVYIPYTSIDDESIAISEEEIATYIKGNPKKFEVDPQVDFQY
VLIEETASQEDIDDARTAIIGLLENTTAQNDITNNIDTIPGFRETTNYAEFVNANSDNPY
TDRWYRSEQLPAAIKDTVFDLNEGDVYGPYQVDKTLNLTKVIEKRQLPDSARVRHILIPA
GLNRTDSITRTDEQAKKTADSLLSILKGNRSRFPSMVKAFSSDVSSIVNDGVYEWFDYNQ
MVPAFRDYSFEQNTGDIGIAKTNFGYHIIEVLGQKDFKNVIKIATITKEIEPSEETINNI
FAEATNFEIEAANGDFAEQANTQEIPLRPVNKVGELDSNIPGLGTSRQVVTWAFNEETNI
GDISRFNVPQGYAIVQLTRRSPRGLKSISEASAEVTPILRNQKKAAQIMANSSGTTLQEV
AASQNVTVQTATAVTMAAPTIPGAGNEPKVVGAAFGTEPGQETGFIEGNTGVFKVRVTAL
NKAPDLDNYTPYASQLDTGVSQGLSSNVFNALKESADIEDNRATFY
>OMIFANIC_02304 Hemolysin C
MEFSILIILIMLVLSAFFSGMEIAYISSNKVHIEIEKKQTGFLAGVLKKITKRPSKFIAT
MLVGNNIALVVYGFFMGDLLMQFIPLTGFSGLLVQTMISTLIILLTAEFLPKVFFQIYAN
ELVKVFAVPAYLFYLLFSVISEFVIWISDLVLKVFFKTKGDNVQLSFSKIELGNYISEQM
DTVEKHDVVDSEIQIFRNALEFSEVKSREVMVPRTEVVAVDLTTEIKELAKIFTETGLSK
IIVYKENIDDIVGYVHSFELFKKPASIKKILIPVVFVPGTMFAKDVLNILTRKRKSIAVV
IDEYGGTAGIMTVEDIIEELFGEIEDEHDSVELIEEVLADDHFKFSARLEVDYINERYKI
DLPESENYETLGGMIVNFTEEIPEQNETVVIENIICKIIEVSSTKIELVDLRVNPED
>OMIFANIC_02305 hypothetical protein
MGNKIYRLFEYAYLGMAAFSIYLVITNWADNRSRAYLFAFFTVVAIFMFFFKRNFRKKME
QRNQNR
>OMIFANIC_02306 hypothetical protein
MVTGVMAILLVITLFSCESNYRNIQKLNLKDGAPIGVARNINVKYTDSGKLVANLISPLR
NDYTNMNYPYQEFPEGVEVRYWNEEDELSTVTSDFAVRYDESNIVDLRKNVVLVTSDSLV
LKAEQLYWDQKNQWVFTDQPYRIIFKDGSFNDGAGFDSSEDFTNFLSRRNTGEQIIDRNI
NNENTENNTNGE
>OMIFANIC_02307 Photosystem I assembly protein Ycf3
MKTKAILLSTVLFLAFGGKTMAQEKCATLGSLFIEPAKAKNYDGALPHYDKLVAECPTYS
MATYQYAEKMFKHYIGEGDKSRIADLDKVYQLRMQYYPAKTKEGELMMKMAQVKFDNEMG
TTMEQFTSFDAAFKKDEDEFTSPKSLYTYFSLAVDLFNAGEKPIDNVFDLYDIVIQKIEK
EEGKLATGLTKLIDKQDTGTNLSSKEKRRLNAYEKNLAAYGKVKGSVDGKLGQLADCPNL
IPLYEKDFDAKKNDVNWLRRAAGRLSAKDCDTPLFFQLVQQLHTLEPSAKSAYYLGKLAE
KDGKGSTALEYYNQAAELETNPSDKAKVYYSIAENFRKKGSYGRARSYYLKMVEVKPSAG
IAYLKIANMIAKSANSCGSTTFEKRAIYWKAAEMADRAARVDGSIASNARSTASSYRGRA
PSKTDIFSEGMAGKTVTFNCWVGGSVRVPSL
>OMIFANIC_02308 hypothetical protein
MLKRITVVVFLLVAGLAQAQEGTVSPYSFYGIGTLKFKGTAENRAMGGISVYADSIHLSI
QNPAGVAGLRLVNYSAGVSHKYETIKTEVESQKASTTSIDYLALGIPMGKFGASFGLIPL
TSVGYNLRTQDAGITTTYQGSGGLNKAFFALAYQLTPKLSIGVDANYNFGNIENTAERRE
DNIQYGTSEFNKSDLLGFNFNIGAIYKTMINESLSLISSLTYTPETDLTSENTRVISTFL
VLPSGAISARDERDINVGDTEFTFPSQYTVGLGIGKEKKWFIGGEYTNLKTSNLTNRSFD
IDFVTFTDSSKFRVGGFYIPNYNAIGKYWNRVVYRGGVRFEETGININGEGINEFGISFG
VGLPVGRLFSNINLGFEIGRRGTTDFGLVQENFFNTFISLSLNDRWFEKRYYD
>OMIFANIC_02309 Type III pantothenate kinase
MNLIIDVGNTHNKIAVFSEKQLIHKHVCDKEDTKDTLSLIAGEYPEITDCILAVVGNFEE
ELLSWLNDTYNVLILDNHTDVLFNNGYGTPSTLGVDRIALASAASAIYPDENVLVIDAGS
CITYDFISKENNYIGGAISPGIRMRYKAVHTFTANLPLLEPTPPLTEIGNNTETSIHSGI
MHAVVFEMEGFIAMYKVKYPELTVILTGGDAHFLRDSLKSDIFANSNFLLEGLNFILEHN
KH
>OMIFANIC_02311 hypothetical protein
METDLINEALQFEQQKTTFKTTSDRIVASRKAKDLILSLNEIYKENKDAAIMDLMKRLTE
IKRKIEKRLKGRRDLLV
>OMIFANIC_02312 hypothetical protein
MFGIFKSKSERDKLQKRYEKLMSEAHQLSQTNRKAGDAKYQEAEQVMLQLEKLK
>OMIFANIC_02313 Catabolite control protein A
MKEVTLKQIAENLGISITTVSKALKDYPDVSKKTKAIVKKEAKKLRYKPNVFAVNLRTRE
SKTVGLIIPEVVHHFFSSVINGIIEQAEKKGYLVIILQSNESYKLEKKQIDLLISKRVDG
IMISLANKTVDISHLERVKELEVPLVMFDKISKLLDCSKIIINDREAAYIATKHLIDSGC
KRIAHFRGALLPQNSIDRFLGYKKALEDHGLPYDSSLVYICENVDYEDGINAAKKLLEDH
KDVDGIFAITDLAAIGAISVFNERGIRVPDDISIMGFSNWFISSAITPSLSTVDQPGYEM
GKQTFKLLYKEMKARKKNKEFEKQTVELATRLIKRNST
>OMIFANIC_02314 hypothetical protein
MSIKPRISIIFFNFVINRFQNSEINNRKRFRLLSTNHMDCIKKHCTLGIRNNYTRRPRVT
FR
>OMIFANIC_02315 hypothetical protein
MKFFKILTYLLAGLFSSYKSGSTSSGLGNMKEIKYLPNRKSGLMATVNCRRDKAVNQSSS
PVKESFLSEHFEISHDTISNQTHGISRIVKGIDFHFLTCIINKLKLVARHYLDKGMNYRP
SNRQYPSFLTKKLYIPNGNLQLLNFYVINDYIRHENGTYKSYT
>OMIFANIC_02316 TonB-dependent receptor SusC
MKNKLLTKLLLLPILLIIGGSAYAQNTVSGTVSDINGPVPGVNIIVKGTSNGAQSDFDGN
YTIDDVDSNATLVFSYIGYTTQEVAVSGQSTINVILQEDIEALGEVVVIGYGTTTVRDAT
GSVAAVTSEDFNQGVISSPEQLIQGKTAGVQISQSSGEPGAGVDIRIRGANSVRSNNNPL
FVIDGIPLSGESTAAEGTNVGLGSSSAKNPLAFLNPNDIESISILKDASATAIYGSRGAN
GVVIITTKSGKGSTGGVWDFSSNVSLSTVPEYYDVMTADQYLSESERLGFNVSERDFRSS
TDWQDEIFRTSASSSSNLSYSQSYTGGNVRATFGYNKQNGVVVNSELERITGRLNANQRF
FDGKLKLGLQGTISRVNDETAPLSGSAGFRGDLIGAAISANPTWPTGPDFNTGNQLSPST
IKEYTQNLSFTNRYLVNFSAEYDITNDFSAKVNLGYDNSESSRDAITSPNARNFDQGAFG
NGLGAINELDTESKLLETTLQYDKDFTNSSLDVLVGYSFQDFQRSGRNILGYGFFTDDMN
RMARELLRTADLIESRIDGSYQQYGYAGNISEGIFINRLFPEPMTDFLPVFNGLGVNSLF
VDTFDNTTELQSFFGRINFTLADKYLFTATMRADGSSRFGEDNQYGYFPSGAFAWKINNE
DFIGDSVSTLKLRLGVGITGNQEGLGYGEFVNRERYSGGDPIDDGGSINIPGIVGVAFPN
PELKWEETLQYAVGLDFGFNDDRLYGSVDVYLKETTDLLFRVQSAQPAVQPFIFLNLPDS
KVTNQGIEFALGYDIVETDDWTWNASFNIAYNENLIDQLAGEYNAGTIRGQGLTGAFAQK
LQEGQPLFSFFLREFEGFDSDGQPIQEDIQKFVDKSALPDITGGFSTSVSYKNWSLSTFL
AGQFGHYIYNNTENALQTAGAFNGGRNVPLNVLSTGEALTAAAEVSTRFLEKGDFVRMQN
ATLSYAWPLKEDAFLSSLGLSLTGQNLFVITDYSGLDPEVSVSPGGDDLLNGLPIAGIDY
TSFPRPRTFTLGLNAQF
>OMIFANIC_02317 Starch-binding protein SusD
MKKTLKFKLFPIVSMVMIALVAVSCTDLSLEETDSIITEESSGIFDGVADVDASLTQLYN
DVYGQLGDQANFFALQEVSTDETLVPTRGTDWGDNGIWRQLHAHTWGATHEYILNSWNNL
NQNVFRATQIIDDRSAPNAEQKAEAQFLRAFSMFFVLDMWGVAPFREVDEGADVDPRVLS
SAEAYAFILEDLNAAKNVLPVRGPSDDNNRANRAAANYLFAKLRLNAGRYKGSGGFDNAD
MQAVVDAVDAITADGFALQGGFFDLFKPDVDNETIWYLNTAPGNRMWNGLHYNQVAPDNA
GGGWNGFSTLAEFYDSFEGDPNSNYEGDGIDERRGWVPDATNADDDNLGIGYGFLIGQQY
SASGVPLNNRGGSPLIFSKELPGLSGNPEESGIRIIKYHPSPNDGGSFRNHEIMFRYSDA
HLMKAEAMLRMGGDATAMVNELRALRNASAIGTVTESDLLAERGRELYYEFWRRNDLIRF
GQFTRDWEFKNPESVGADFRNLYPIPVNALLSNPNLVQNEGY
>OMIFANIC_02318 hypothetical protein
MNKDGLSFSYHGAIVDSFVYFCRIIRMNYFTLNKKVFSNGNIRAMKPALGILFLILMQFV
SLSCEEKQTDTLFLQKSPEETGIYFQNKLISTPELNILNYIYYYNGGGVAASDFNNDGLI
DLYFTGNQTADKLYINTREFKFEDVTSDAGINNAGNWTTGVTTVDINHDGLMDIYICKVG
DYHAIQGKNLLYINQGPDKNGIPKFVEDAASYGLEFKGFSTQAAFFDYDLDGDLDMFLMN
HSVNPNLNYGKGEKRFIPDLQSGDKLFENKNGRFADVSEDAGIIQSKIGYGLGISVSDLN
NDGYPDLYIGNDFYENDYLYINRGDKTFDEIIQKNTHAIGHTTHYSMGNDIADINNDGNT
DIISVDMLPEDLVTYKTSGTEFNYQIYQNYIQNGYSYQYMQNTLHLNNGNETFSETGYLS
GIAATEWSWSPLIGDYDNDGLNDLFISNGIPGATNDMDFINFIANESIQKSLGQGMDEKA
MAFIEKIPAKKEVNYFFRNMGNSEFEPMNNTWASISATFSNGAVYADLDNDGDLDIVVNN
INEPAMVLENTLGKTAAANFVSVKLEGRNANKFGIGSRIEIYSDGHKMVKENFTTRGYLS
ATAPIVHFGLGEISEIDSLKIVWPDKTFETHYKLKASQMYTFQQRNAQGNYYEQNQLKSS
SVLVQADPLFSFKHAENRSLEFNRNPLTPFASSNEGPGIVVADINKDGLEDVVVGGAKGQ
PSQLFLQQKDGSFSSSQEDLFESDALSEDIALEFFDANGDEYPDLIILSGGNEFLSGAPL
YPRLYMNNKGVFRKDDTQFKVAVNGSDVKSVDIDNDGDLDICLLSNTLPHQFGRTPQQFI
FENDGNGQFTNITSSFAPELTFLGNCTSQYWIDLNGDSFQDLIVGGDWMPVSVFMNDGKQ
LTLQKDNGLENTNGLWNVVKAADFDDDGDLDIVAGNWGANSRLQANIEEPLRLYSVDAND
NGQDETIITYFYQGEETTLASKDELVKQLPGINKNFLSYADFANADINSLFSEEILQNAN
KKEVYILKSSYFENLGDYTFKQYDLPFKAQISTVNDIAVSDFNKDGKKDLLLVGNNFEIS
TQLSRLDASHGLLLLNESNGKFKEADTRFFDIPGASRDIEFLNYQDDKYLLIARNNDQPV
FLKIKK
>OMIFANIC_02319 hypothetical protein
MNLLKYSLVIFLSSMFLTCSSGSKEEDLTTQTLFSKLSAEETNILFKNVVENRKDFNIFN
YRNFYNGGGVAIGDINNDGLADIYMTANMGANKLFLNEGNFKFKDITESAGVAGVKPWST
GVVMADINNDGLLDIYVSHAGFLKGDNHDNDLYINNGDLTFSEKAKDFNLAASGFTIHSS
FFDYDKDGDLDAYILNNSNIPVNTLGYARQRDVRAEDWDIPETIKGSGDMLLRNDGGTFV
DVSEEAGIFGSLIGFGLGIAISDVNGDLYPDIYITNDFYERDYLYINNQDGTFKEDIKNW
MSHLSLSAMGVDIADINNDGKADYFVTEMLPKEEQRVKSVMEFEGYNVFKLKQSKDFYQQ
YIQNTLQLNNGNGTFSDIAYFSGVSATDWSWSSLIFDMDNDGYRDIFVTNGINHDLTDLD
FMDFFANDIIQNMALTGRKEAIDSIIDKMPQYPLSNVAYHNNGDLTFANKAEDWGLGTPS
YSNGAAYGDLDNDGDLDLVVNNVNMESFIYRNNTRETTNNNYIKLNFTGEGANKFAVGTT
VKLYFKDNVVYQELMPSRGFQSSVEYPMTIGLGEENAIDSIRVIWPDNRTTKLEDIAANQ
VLSLRQNEATETYNISPSQDIQPILTEINNSDVEKHDENTYSDFDFEGLIPRMLSQEGPA
IAVGDVNNDGLEDVFIGGAKQQAGIVYSHIGNGKLRKIKNSIIEDDKLNEDTAASFLDAD
GDGDMDLIVGSGGNQVDEKNNEGIRLYLNDGKGNFSKKILDLPPNIYNVSVIAPNDMDGD
GDTDVFVGMRSIIGIYGADPNHIYLQNNGDGTFVNSAKESLGALRRGGMITDAKWIDVDG
DSQKELITVSDWGTPQIYNVRDSKLERRDSDLNKLKGWWNVISPVDIDNDGDQDFILGNE
GKNLHYKPSDDRVIKMWVNDFDNNGTIEQIITQRINGKDMPIQQKKEILGQLVSLKKENL
KASEFAIRSIQELFSESTIQNSLVKEVNTSATVIAVNNGNGSFNIIELPAQAQLSCVCGV
TCADVNNDGNLDIIMGGNDFELKPQFSRLDANYGSVLLNDGNLNFDWQNYDTSGFFIKEE
IKHIRQFKDAEGNAYIIVAINDEKPRVFGINQ
>OMIFANIC_02320 hypothetical protein
MALINKYLFGLALLVMLCGCSENDLLFELRTPSRSGVDFENKLTENDSLNILDYLYFYNG
GGLAMGDINNDGLPDLYFSANQEQNKLYLNKGNLEFEDITQSAGVRGNSTWNTGAVMADV
NGDGWLDIYVTAVVGINGFKGHNELFINNKDNTFTESAAEFGLDLATYGTTASFFDYDLD
GDLDVYVLNHAVHTEESFGKVQLRYTRNEKSGDRLLRNDGNTFTDVSEEAGIYGGVNAYG
LGLATSDFNRDGYPDIYVGNDFHEDDYFYLNNGDGTFTESLRKYFGHTSRFSMGNDVADI
NHDGLPDLISLDMSPEDEKVLKSSEGDDTYQTLEMRTQQYGYHFQYTRNMLYINQDDNPF
TETALLSGIAATDWSWSALFSDFDQDGEQDLFVSNGIPKRPNDMDFIRFVSSDKIKNRAN
EKRLIDQSALEMMPSGAVSNYIFKGNASIGFTNKTEQWISGNPTVSGATAIGDLDGDGDL
DIVTNNINQPAGLYINKTNDQARYLKIRFDYRKGNSFGIGSKVEAWNDGVLQYKELFPCR
GWQASSEPIIHFGMDDILEVDSLKIIWPDNTYQVLSEVMTNQTLTISPQNSAPYSYLKPA
IDPIFKKVNGNLGLNYRHQDIENNDFDYQKLIPYKVSDRGPIMMTLDSNNDSLTDVLFRG
GTKAEAILFLQNKLGFTKDSSNENMPDSVDFTSPDSYSSQYFVSEDTNGDTLKFEGGYTT
RYDFGNIPPSKVYYPDGKQELLEDLGMVTDAVWNDFDQDGDKDLIVVGEWMSPKFFRNND
GELIEDILTDLPLNGLWQTIIPFDIDKDGDTDYLLGNWGLNSKFTASQNAPMVMYYDDFD
ENGTTETVVATFKNGKYYPLMGLNELSAQMNFLRKKFTTFESFAGKTMTEIFGEEALSKA
TKFEVNTLASGFLRNTDNSFIFTEFPEIMQTAPIMAFECFDFNGDGKESVLAGGNYFGVI
PFHGRYDSFPGALIDSETEIRSAHTVGIDLSLKSVRHLRVIRHNNQPYLLVINNNDDVDV
YEIKR
>OMIFANIC_02321 hypothetical protein
MSMYMKLKDSTTTMRILPFLFLVFLLNSCQEKQELVPVEITPEDYQNAVDHVTEIMIHDI
FSPPQASRIYVYPNIAAYEIISHVDPDYKSLAGQITDFTPIPTTSDSLVNYPMAALIAHM
DLSKALVFSEEKMTSYSDSLNNTWSEKNNLEFEASKEYAMKVVDHMNRWIDADNYKQTRT
MSKFTVDIDDPARWQPTPPAYMDGIEPHWNKIRPLVLDSAAQFKPEPPPPFSMEKNSEFY
KELEEVYEVSEEITKKGDESEEIEIAQFWDCNPYVSVTRGHLMFATKKITPGAHWMGITE
IACKDTDAEFNRTVHAYTKSSIAMFDAFISCWDEKYRSNLIRPETLINQYIDENWKPILQ
TPPFPEYVSGHSVVSGAAATVLTEIFGDNFSFMDDTELPYGLPVRGFDSFNKAAEEAAVS
RLYGGIHYRAAIDEGLTQGQMVGQWVIQNLQMKQ
>OMIFANIC_02322 hypothetical protein
MKQWLKWILGVSVLGLGIWYFLVKDYQYQVSFTSDQPMGVLFHHILDWENYERSDAEISV
ISKKNYTEILQRVQSADSSFLYTWEIQKSSDDKTRVTAYIKDEKNEFAQKLMVPFGKNDF
IKRSVENVKTVVEAQKLKADAYKFHSIIDSVVQPTYCVFLPLKSSVRQKATTMLEGISSI
MEYIKGNDIPLNGDPFLEITEWNEDDETINFNFCFPIKRLDSMPYHPTLEFKATEALKGI
KGEFNGNYRISDNAWYYLIEYAEKNKIEVEKFPFEIYLNDPHTGGDPRKWKAHIFLPLKK
>OMIFANIC_02323 Glucan 1,4-alpha-glucosidase SusB
MNRKVLLYLSAAIFVMVFTACSAEKTKTTVTSPDGNIEVAFNLSGSGQPSYMVMHKKETV
IDTSYMSFDFKNIPSLKDGFELISSDMKTIESSWDMQWGEQTTVKNHYNELTLYLQETGE
LKRKLNICFRIYDDGLGFRYEIPAMEGVSEVLITDENTEFNLTGDHKVWWIPGDWDIYEH
LYTETNFSEIDAISKRNHPNLSASYIPENAVNTPVTMKSADGLYLSFHEADLTNYAGMTL
KVDNDNLKMESELVGSEILGGKAKVNLPFSTPWRTIQIEERAGDLIESKLTLNLNEPNAI
GDVSYFTPMKYVGIWWEMHIGKSTWDLEGTQDMNTYIEGQRGSSRHGANTENAKKYIDFA
AANGIKGLLVEGWNTGWDQWINTEDREGVFDFMTPYSDYNFEEVMAYAKEKGVEVIMHHE
TSAAPRTYEKQMEVAYNFMKENGMNSVKTGYVGKIIPKGEYHHGQWMVNHYQKVLDDAAA
KKIAINAHEPIKATGKRRTYPNAIAREGLRGQEFNAWATDGGNPPDHLSTVAFTRMLSGP
IDFTPGVFNIKFDEYKKSNQVNTTLAHQLALYVVIYSPIQMVCDLPEHYMVNGEIHPAFK
FITDVGVDWEASKVLDGEIADHVMIARKEKGSGNWFVGGITDENSRKQTVNFNFLDEGTT
YAATIYKDADDAHYDTNPEAYEIQAMEVTNTSNVEIELAPGGGFAISLIKK
>OMIFANIC_02324 hypothetical protein
MTSLQTIHGEAVNLLHRLTTPDGILASTIEADNYKRVWARDSIICGIAGLLLDDETITNG
LKNSLLTLASKQHEHGMIPSNVLPGENSDVSFGSLVGRIDANTWFIIGSCLYYLESNDTQ
TWETLQPAINKCRYFLKSTEFNDKGWIYTPLSGNWADEYPVHGYTLYDNLLRIWGEKLWI
KISGGNLDALNELIEKTSSNFWPSTQTNAKKLYHQGAYRKAISKNAGHYAAFILPGCYDM
RFDAAGNALALLLLRTDDFQKKELRSFIDELKAGLGNSLIPAFWPAITENSPDWHLLQGN
YSYDFKNKPGYFHNGGIWPVWMGLFCMGLTKIGLNDASKDSVTEFERIVQDAKNWDFNEY
IDAVNFGLDGKTQMGYTASGIVFMKAAIDRTSFAEKLHL
>OMIFANIC_02325 hypothetical protein
MGFKPKLSFWQIWNMNVGFFGIQFSFGLQQTAVNPIFSFLGAAHDELPLLNLAGPVTGLL
IQPLIGAISDKTWIPKWGGRRKPFFLIGAIIASLCLFAFPFSPELWFAVGLLWILDAGNN
TAMEPYRAFIGDKLPDEQLTFGYQMQSLFVGAGITIANFSLWLFQKYLSVPVEEGAALCS
TASVTVTAIPDWVYYSFFLGALASIGTVLWSVWKTPEIPPSEEELDEIKEFNRDKPNPLI
QILSVLVVILSVPMAIGFGLRYFLPEMLEDYNILVIVILAIALVWIYILYKQIKNKPHIS
FFKKMGDTLAPFIETTEAIGDMPKMMWTLSGVYFFQWYALFCYWQFITPMLRTSLYGIDN
SDYKKYEGIMEACEAGEVIGSVDQSFAQNIQILSEQALAQTGLMNGTYNLITMLVALALV
PLARRVGSKWVYVLSLVITGFAMLSMPYIKNEYMLLAPMILFGIGWAAMMGIPYSMVSKV
IPEDRRGVYMGIVNMMIVIPMLIQTVSFGPIIKNLLNDNAVNAILFGGVFFIIASILAIR
LKLPKEKEDHL
>OMIFANIC_02326 hypothetical protein
MKNVGIKISLFLVYFVFAALLNSVGILVERSQEVYDVTKGDAALLEPFKDLSIAFVSFII
GSLLPKLGYKRGMLISLGLVFLGCIGMYFGNSFWAVKILFAMTGIGFAIVKVAVYALIGY
VTDSKDDHRRLMSFIETIFMVGIIFMYVVFPLFFDDENDPDAWLRGYIVMAVIVAIAFFI
ILFSKFNLDVEQKNTTVGQDIRAMLNLFKSPLIYIFAIFAFFYVMTEQGIMTWLPTFNKE
TLNINSQLATQMAVILMASFALGRFVTGILVKKVKWIYIAVIGLIGAAVLVLLVLPMANN
IPEMEVTTFGNLPLVSFLFPMIGLFLAPLYPLISSTVLSATEKMHHSALAGILTFVSALG
GTSGSVIIGNLFDLLGGNKVFYLSLIPMTIILIALFVLNKITGKSS
>OMIFANIC_02327 Cytoplasmic trehalase
MIFTLDIASTLEQLLSQEDTDNDKKITIEDRGPGAFTLKAEDGSSHSLKGTYHLSNLLQE
LVIAMDEGKNIATIPIAHLEEPPVERVSRMIRDYFWKGLTRTMDASGIETLLKDSKNETL
DEIAVLTVYVPHGDTMAFDYYSELRKELPLEIVRLPDKITPEYVRTLNDKPGILSLKLEE
KNGTVTGVPFVVPGGRFNEMYGWDSYFESIGLILDGKVELAKAMADNFQYEIEHYGKILN
ANRSYYLTRTQPPFYSSLIAEVYEKTGDKSWLESHLKTAIKEYETVWMVPGKRLTGFGLN
RYLAEGLGKPPEAEAGHFDHVFGKYAKEAGMSLANYENLYSEGKIENAELDLYFVHDRSV
RESGHDTSYRLEGICADIIPVELNAFLYKYETDFAELIKNEFDDAFEYNKKTYSSQYWYH
KAADRKERMDSLLWNDNQELFYDFNIETGAQTDFISATLFTPLWAGICDEKQAKSTVSKG
ISLLKEKGGIASCDEASRGEINEHRPQKQWDYPNGWAPHQMMIWKGLKDYGYHDELQELV
YRWMYMITRNAVDYNGTIPEKYDVVVATHKVFAEYGNVGTEFQYITKEGFGWMNASFQYG
ISLMEEQFIKKLNELVPPEELF
>OMIFANIC_02328 5-dehydro-2-deoxygluconokinase
MNWCPPKNYSKKYMGEKTTDIICVGETLIDFIGTQPEHPISRIKDYHRFLGGSPTNVAMN
MARLGLNVEMVATIGNDGFGEYILKHFTENKVQISLVRRSKSKPTTVIFVSRTTGTPEFV
ALRGADSEILSEQISEEKLKSAKIFHTSCFALSKEPARSSILKGAHKAAEIGCQLSIDIN
YSEKIWPDTEEAKRTITEYCGLKPIVKVSQDDVDRLFGKGMNHDQIFEYLHGLGVDTICL
TLGKKGAKLSEKGSQVLELSALKVEKIMDATGAGDAFWSGFLFAWLKGRSKQKCMEAALQ
MAAIKLQNVGRIPDFADVISDVLNI
>OMIFANIC_02329 Sodium/glucose cotransporter
MGTLEILDYVVIGGYFVLVFAIAWYVTTKEKSGENSANYFLGGRNLGWFAIGASLFASNI
GSEHLIGLSGAGARGAFPEAQFEILAALILLLLGWVFVPFYIKSGVFTMPEFLERRYNKG
SRTYLSLISIISYVLTKISFTIFAGALVFEVLLGIPFWTGAIITVVATGIYTVFGGLKAV
IYTDMVQSIIFILGGICATYFGLEAIGGWDNVLQAIQDNAPEPDTFMSLWRNKEYPWTGV
LLGAPILGVWYWCTDQFIVQRVLSAKNIKVAKQGTIFGGFLKLLPLFIFVVPGIIAYALS
VTEFPDLFTITNPITGETKTTTDAALPALILHVMPIGIKGLVVAGFLAALMSSLSSVFNS
TSTLFTFDFYKEWRPKASERELVNIGRLATVILVIVGLAWIPFMQKLTEGGGIYKYLQSV
QAYISPPIAAAFLLGIFYKKINGRGALTALWVGFVLGIGRLVLEFMSQEGGLVLSDSSLL
GTLVTMNFLHYAIFLFVISICVMVLVSLATQSTSKELDPALTYDYGERKATMFRTKEFVL
TMIIIVCVLILWYVFR
>OMIFANIC_02330 hypothetical protein
MRHVFLVFLLLISTTVSSQILNAESLRKVTDTSGYSGSLSASIALKRNVNDFVTISSDIH
IQYKMKDHLILFKNEVAFQKIEGQDFDNSLISHIRYNYRFHPRIAWEIFLQGQYNKINLI
DFRGLVGTGPRFKLTQSEKYKFYLGTLVMYEHEKVTDGVTPTQKDFRGSTYLSFSMYPTE
HITIISTTYYQPRIDKFNDYRISSQSSLLVGLFKNFALKTSYTFTYDTFPAVGIPNSQYD
FSTGLTYSFD
>OMIFANIC_02331 Alkyl hydroperoxide reductase AhpD
MSYYDPKDLRKFGDITEWSEELGTKYFDYYGKVFEDGALTAREKSLIALAVSHTEQCPYC
IDAYTKDSLQRGVTKEEMMEAIHVGAAIRSGATLVHGVMMMNKVNKLDG
>OMIFANIC_02332 hypothetical protein
MTKIKTQSLHKRHSELAQANRQLEILSNGIFRDGELPTFAEKITETGQFPLRPKKLEVLQ
INVGYMCNQVCEHCHVDAGPDRKEIMTWETMEQCLEVIRNTGAHTLDLTGGAPEMNPNFR
RFVDEASKAGIQDFIVRSNLTIIRANKKYHDLPRFFKEHNVHVVSSMPHWTKGKTDKQRG
DGVFDASIEALKMLNDVGYGLPDSDLRLDLVYNPSGAFLPGDQASMEKDFKKALMEDFGI
QFHNLFAITNLPISRFLDYLIASDNYEDYMYQLVDAYNPSAVANVMCTNTISVSWDGWLY
DCDFNQMLELKVDNKIQHIKDYNESLLNNRNIVISQHCFGCTAGAGSSCQGSVT
>OMIFANIC_02333 putative adenylyltransferase/sulfurtransferase MoeZ
MKLRFLNILLFLLGFQGYAQESLHDLLNIYNTRSIPYISVEELRMTQIHEKVIILDAREH
SEYEISKIEGAHYVGFSDFSSEELMKVIPPTDSLIVVYCSLGIRSEEIGEKLKKSGYSNV
RNLYGGIFEWKNKDYPVLDSEGIETEKVHPYSKAWGKWLLKGEKVYE
>OMIFANIC_02334 hypothetical protein
MNKNLLLIFTRNPELGKVKTRLAKGVGDKAALEIYKFLVAHTHNITKDLPCAKYVYYSEC
IHENDIWDRTNYVKKMQSGADLGMRMKKAFQEGFRDGFENIIIIGSDMLDLTPQDLEMAF
KSLNDNDYVIGPAADGGYYLLGMNVLNSDLFESKSWGTETVLADTLKDLNSYNLKMLEVK
NDVDRLEDIIGIDAFEHFLNNSNESK
>OMIFANIC_02335 Purine nucleoside phosphorylase 1
MIKQIEEAVSFLKGRGFGEPDVGIILGTGLGKILESVSVEAEMSYNHIPYFPTATVEFHT
GRLIFGTLSEKKVILMQGRFHVYEGYSLQDVTFPVRVMHQLGIKKLLVSNAAGAVNLNLK
KGEIMLIDDHINLQGGSPLAFKGVEKLGERFIDMSAPYDSEMNQLMEKIASEKNITLHKG
VYAAVVGPQLETRAEYRYLKIIGADAIGMSTIPEVIVANHLGLSVSALSVITDECDPDDL
QPVEISEILAMAAKAEPDMISIFTELIKELKN
>OMIFANIC_02336 putative methyltransferase YcgJ
MSYLETTHDVYKDAALSPDVGLCCTTNPIWELPGLKIPKIMQEMNYGCGSTVHARDLINN
PKILYVGVGGGMELLQFSYFSRQKGGVIGVDVVDEMLEASRKNFGIAEQQNPWFKREFVE
LRKGDAMNLPVPDNSIDVAAQNCLFNIFKEDDLRKAIQEMYRVLKPHGRLVMSDPTCEQS
MNETLRNDDRLRALCLSGSLPIKEYVKALTDVGFGTIEIRARKPYRILDPKNYPTDELIY
IESIEVAAIKDPMPEDGPCVFTGKAAIYFGAEEYLDDQNGHILLKNQPIAVCDKTANNLA
NLGREDIFISDSTFHYDGGGCC
>OMIFANIC_02337 hypothetical protein
MTDTVKSILMKKILAKIFLLIIALSFQQCTLFSAAGLTSQGQPTKLVTGSLTAVDISDEI
VDHSVWDTLLKKHVDHKGQVDYAGFQQDQPVLRAYLEMLSNIQPAEKWSVEELLAYYINT
YNAYTVQLILDNYPVRSIKDIGGPWTRGIVPIGDKNLSLGGIENGILRKMNEPRIHFAIN
CASISCPKLLNEAFTASKMEAQLERVTAEFINGEKNDLNATYPRLSSIFNWYKKDFVVNG
KVDVIGYINSYSKTQIDPNASIEYKDYDWNLNVKQ
>OMIFANIC_02338 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MISIIIPVYNEAAGIADLLKHLDERSTSGKITEILVVDGGSTDNTIFRANNYINNGSLLP
MSVLTSRKGRASQMNTGAKQAKGEILYFLHADSYPPHGFDTTILNQVEKGNSAGCFRMKF
DTKHPVLTFSQWFTRFNVRACRGGDQSLFISRDLFTSLKGFNEDFDVYEDCEFIGRIYDE
HDFTVVNDYVITSSRKYTKNGTLRLQYHFTVIHFKKWFGASPSELTRYYNKYIVS
>OMIFANIC_02339 hypothetical protein
METKDILLVVLLAIGAIQGIIYGGILWRTRTLHKTAKQFLATILFFFSYRLIAEILHSFG
LGRYDTWYYILLEYNWIYGALIYFFVLSYVTPTFKLKTKHWIHFLPVLIEIIWSFFIKAQ
NFYWDGTRESLSWLGYWGYVVWMRYPTMYIIAGGLIVYYSFKAEKILNYPPVIPGYRIIK
ENTKWIKRVVIALRIFSILFTAIVLIDFLFFDYSYSFFGDPIFVIMAVITYWLGLEGFAR
RNTLAFKKVEILSEKDQFQLEEIANKISNVMTEKKLYKNQELTLAGLSEAIDVKSYLVTK
ALTSIFNKKFNDYINELRFNELKSLIKDPKNDKFTLLSLAFEAGFNSKASFNRTVKKITG
NSPKYLKSEAY
>OMIFANIC_02340 hypothetical protein
MKSVAVKKMVFLLILTINFSVVAQISNDDLQELVGTWKLDMTPQDKTDNNFAMMSITNIT
DSSIEGEFYRSSVAIREGKVNTQRGIIYAALISGDNSGDYNSTFYYEDGILYGTTHAVDR
GFLAVWTATKKE
>OMIFANIC_02341 hypothetical protein
MKYILALSIFFVFQSCTSQNYKMNGVSFVASRNPVDQAHIDPVIQVQANFASIMPFGFIR
SLNNPEIIYNTERQWFGETFDGAAQYIEMLHGNKIKVMLKPQIWIWRGEFTGYLKMSSEE
HWQELEDSYSKFILEYASLAQSTKVDLFCIGTELEQFIVHRPKYWEKLISEIKTIYKGKL
TYAANWDEYKRVPFWNQLDFIGVDAYFPISESVTPSISEAREGWQRWKEEMEGVSNTHNR
NILFTEYGYRSMDYSGKEPWQTSRDQNNVNLAAQANLLTALYEEIWNESWFAGGYIWKWF
IDHEMAGGEDNDRFTPQNKPAGMVVQYYYSDE
>OMIFANIC_02342 hypothetical protein
MRKIQFILLLLIGLNAVDGLAQSTAKFFDEADSFFKTFVSNGRIDYARIHESPTQLNSLL
ELAKNINVRESNQAVFKAFWINTYNLTVIKGIIDNYPLESPLDVKGFFDITQYDLAGESI
TLNDIENRKLRAIFDDPRIHFVLVCGAQGCPPIISEAYFPSKLGAQLQRQTRGALNDPKF
VRVADGKVALSEIFKWYREDFVKNGQTEVDFINKFRKEIIPADSEITYYPYNWKLNSK
>OMIFANIC_02343 Assimilatory nitrate reductase electron transfer subunit
MEHIVIIGNGISGVTAARHIRKLSDKRITIISAETEHFFSRTALMYIYMGHMKYEHTKPY
EDWFWEKNKIELKRAYVNEVMHEEKQLLLEDGAKISYDKLIIAVGSKSNKFGWPGQDLDG
VQGLYSYQDLETLEQYAPNKKVCKRAVIVGGGLIGIELAEMLHTRGIPVTFLVRESSFWN
GILPNGESEMINRHIKNHHIDLRLGVNLKEILADENGRARAVVVAETAEEIPCDLVGLTA
GVSPNVDFLKGSGIELGRGVKVNRYLETNVPDVYAIGDCAEQHEAIGKRRTIEAVWYTGR
MMGETIAQTICGNRIQYNPGNWFNSAKFFDIEYQTYGWVNSNERLPDYEEHFHWIHEDDT
KCLTIATHKETGKFLGINTFGIRMRHEVFDSWLSDDRSTDYVVQHLAQANFDPEFYRSFE
SQILEAYNNQTINA
>OMIFANIC_02344 Putative electron transport protein YccM
MSTVQRNMSLTGEPPKTLNTVQKIATIIGMFGLAILLLASFNVTFPNKAVWLSISLLSIT
GGIILFARGAYANELEGIKNHGVWFKSVSSRGFLAWITGIALTGFYIVLYFYAEYLGLNA
NGENTGVISLFDPLSRLLNGNPASQWFVYGTLYTIAIFAFGIKFIWKYRHNRYERIRTMS
VMFFQTAFAFLIPEFMARLNTSEAYNLPYYDLKSVWPLNYYLFDGYSLDGLLSSGNLGLY
MLLFGVASIFIITPILTYKYGKRWYCSWVCGCGGLAETAGDPFRHLSDKSMFAWKVERWV
VHSVLVFAVVMTTALVSTYLGNDSNAYWLTKDVFLIGAGVFLTLIFAGIWFFKRDALKKD
ARYGAVGYFVIIIALLGIHYGSGNSNIFIFEAAVLRQWYGFLIGAIFSGVIGTGFYPIFG
SRVWCRFGCPMAAILGLQQRLFSRFRITTNGGQCISCGNCSTYCEMGIDVRAYAQKGENI
VRASCVGCGICSAVCPRGVLKLENGPMESRIDSNQVLLGNDVDLIALVNKK
>OMIFANIC_02345 putative glycosyltransferase
MPPSIKVIIPAFNEADSIGKVIHDIPVSVSEVIVVSNGSTDETEEVAKKAGATVLTEDRK
GYGYACLKAMDHIANSQPHPDIVVFLDGDYSDYPEQLDEIIAPIIENDIDFVIGARVKEL
RESGSMTMPQIFGNWLATSLMRLFFRSKFTDLGPFRAIKYDKLVGLSMEDKTYGWTVEMQ
LKALKRKYTYEEVPVKYRNRIGVSKVSGTVKGAIFAGIKILSWIFKYSFKK
>OMIFANIC_02346 Beta-monoglucosyldiacylglycerol synthase
MILETVVMVIYSVALILIFLYALAQLNLLFNYLRSRRKKADQCEKFDLTIPEEVPHVTIQ
LPVYNELYVIERLLNNMAEIQYPKDKLEIQVLDDSTDESFEKTSNQIVELQKTGLDIKHV
TRKNREGYKAGALKEGLKTAKGEFIAIFDADFLPKKTWLLNTIPYFKDEEIGVVQTRWGH
LNRDYSLLTRVQAFALDAHFTLEQVGRNSRGHFINFNGTAGVWRKECIIDAGNWEGDTLT
EDLDLSYRAQLKDWKFKYLEEVETPAELPVVISAARSQQFRWNKGGAENFQKMAKQVLRK
GNIPFKTKVHSILHLLNSTMFLNILIVAILSIPMLYIKNEYEHLKIYFFIMSFFVISTLI
FFFCYWFTFKNIYGGGIKQFLKYTGMFFTFFSIAMGFSLHNSIAVLEGHLGKKSEFIRTP
KFNISSLKDSWRGNKYLKKKLSPNVIIEGLLMLYFAFGMYSAFIVGDQGGDFGLFPFHLM
LFVGFGFVFFKSLTSKV
>OMIFANIC_02347 hypothetical protein
MILFISGTLQDLEAQEIESQNMKHQVGLQHDNDFFLLTDRYYSFGLFLNYTYRPEKGIFK
KSNEQLNFTLGAEAFTPDDTKTEEITEMDRPYAGYLGLNSGWTLVNNNNFYNLQLELGIA
GKSSGAGAFQRWYHNAVVVSEPQSWIGELSDSFHMNLYADYAKEWQLALNPFGVHLALRS
QFAYGTKDQFIQPEIVAYFGRRNKMGSSIGYGQIGDTERELFFAFRAGYRFVAYNGLLEG
NYWGDDSVFLVDSLETVIQIGFDFQHRFKKNDYKFGYRFHSDETEASQTHQYVILSYARS
F
>OMIFANIC_02348 hypothetical protein
MIRQPKGVHLILFLFIFFSTELLSQEISESEDEEPFYKRQIELHHDNDFLLFTDWYYTTG
SFINYRILLNELEEERNRKQLTFSISQEYYTPSNITETNVRLFDRPYAGYSAVTSALAFT
NENRLLEFTFQMGASGPISGAEGFQSWFHSSNESGNPSWIGQIEDAVHMNLYASYTRDWQ
LLDDSFGVHMALTPKIALGTKDIYIENQGAFYFGKRKDLRRTMAYHQIGRIQPEFFFVVK
CTYRYVLYDALLEGFITGDSSIYVLDPVDHFFTYGVEGFFRKKRMEYKVGYNYASPRVGT
TLLHTWITLSIARNF
>OMIFANIC_02349 Aminopeptidase YwaD
MKEDVTYLAADSLMGRETGTSYEMLAGSYLADRFRDLGLEAKGSDGYMQEFTFKPSTNPH
QEAEVVDKTVDSTLTGRNVIAYLDNKAPTTVIIGAHYDHLGMGGQGSLYREGEAIHNGAD
DNASGVAVLLKLAGELKDTNTNNNYLFIAFSGEEMGLLGSNYFVKNPTIDLADVSYMMNM
DMVGRLNDENTLAVHGVGTSPVWKQALFANNDLGLNIAEHESGIGPSDHTSFYIMDIPVL
HFFTGQHSDYHKPSDDADKLNYTGMETISKYILNIISDLNDNEKLAFRKTKNESEDVPRF
KVTLGVVPDYLYTGEGMRIDGVSEDRPAIKAGIQKGDIVKKMGEFEVTDMMSYMKSLSKF
EEGQTVMVMIDRDGEMLEMEVTF
>OMIFANIC_02350 Dipeptidyl-peptidase 5
MRYLLSLLLLSVIISCKSDSKNERVEQATSEEIVQTSNDSLIYPEEKHFKSIRQITFGGD
NAEAYWSFDDKQIVFQSNNAAWGMECDQMFLMNIDETFEDKKPPMISTGMGRTTCAYFLP
DNKHIVYASTHLADENCPEVPLRKNGRYVWPVYDSFDIFVADLEGNITAQLTSEPGYDAE
ATVSPQGDKIVFTSTRSGDLELYTMNIDGSDVKQITDELGYDGGAFFSPDGTKLIFRSSR
PKTPEEIKEYKDLLAQGLVQPTEMELYICNADGSELRQLTKLGNANWSPFFHPSGEKILF
SSNFEAERGFPFNLYLIDIDGKNLERVTHGETFDAFPVFSNDGKYLAFSSNRNNGGTRDT
NLFIAEWQD
>OMIFANIC_02351 Alpha-(1->6)-mannopyranosyltransferase A
MPLALGLLAAILYGSFAFGLVRSDFLKLISLYVSLFFLTYTLIRMYGWNFWLLVLIGIVF
RLVLLPSLPNLTQDFYRFLWDGQLVAHGTNPYLFTPEMFINDPSLATTKIANAGELFAGM
SELNASHFSNYPPVNQLFFAISTLLGGKSIMASLVVMRALLILADLGILYFGKKLLEALN
LPVKQIFWYFLNPFIIIELTGNLHFEGVMLFFLIVSLYLLHKKRWFPAAILFALSISVKL
IPLIFLPLFYHYFVDKGLFSKGFWTLKKFFWTVIGTVVLTFLPFYSSEFVSNFAKTISLW
FQDFEFNASVFYIIRWVGFQINGWDPIQTAGKILPIIVIVFVLALAFFRKNRSTKDLVTV
MLFAISFYLLLSTTVHPWYVATPLLLCLFTKYRFPILWSGMVFLSYSAYGPEGFSENLWL
VAIEYTVVIGFTVWEIFKKNPKVQLTS
>OMIFANIC_02352 23S rRNA pseudouridine(2604) synthase
MSKQGKQGRRKPTGKEDGKRKGPFRKNTGPKTGRTASKQPSKNTSEGIRLNKYIANSGIC
SRREADTYIATGLVTVNGKIINEMGYKVKLEDDVRFDGRRINPEPNTYVLLNKPKAVATT
TSESKGLTVMDLISNATTARVKPIGRLGRNATGLLLFTNDDKLVNKLHKKGMERLFHIEL
DKNLKADDLQKIKEGLKIGGKEVMVEEVSYVANAPKKEVGLKIKHMGNSVIRDIFSHLGY
DVLKVDCVTIAHLTKKDLPRGRWRMLSQSEIELFSML
>OMIFANIC_02353 Aliphatic nitrilase
MNSSLKVALAQIAPVWLNKSETLKRIEEQMLEAVENKAELIVFGEGLVPGYPFWLALTGG
AEWNTRLNKELHAHYVSNSVCIEDGDLNRICELAKEYKIAVYLGIIERPSDRGGHSIYAS
LVYINSEGNIRSVHRKLQPTYDERLTWSPGDGHGLVVHKLKDFTLGGLNCWENWMPLPRA
SLYAQGEDLHVAVWPGSDHNTRDITRFIARESRSYVISVSSLMFKKDFPKETPHLEAILQ
NAPKVLANGGSCIAGPDGEWILEPVLNYSGNLYSILDFNRVLEERQNFDPVGHYSRPDVT
KLVVNRERQSTVEFGDFTDEESNETK
>OMIFANIC_02354 hypothetical protein
MLSRRQKLFLLKFFSLFSVVRGYNILVIILAQYLTSIYILAPDLPLRKVLFDPNLLMLVL
ASSAAIAGGYIINNFYDREKDLINRPHKTMLDRLVSQRTKLSTYFILNFISVIFASYVSF
RAVIFFSLYIFGIWYYSHRLKRFPFIGNITAAVLAVIPFFAVFIYYKNFDLVIFVHATFL
FLVISMRELVKDLENLKGDFAQNYRTIPVVYGEQTSKRMLTLLAALTLIPVSFLLTKFDI
GYMYLYFYASIPGLVLFLIFLWVSARKLHYILLHTILKLVIVIGVFSIVLIDVDVLLNRI
L
>OMIFANIC_02355 hypothetical protein
MKSYTHMRGPLFYSKILLFGEYGIIKDSKGLSIPYNFYNGALKIDEHHTPSTHKSNQNLK
RFLDYLENLMETQPHLVSFDLDRLKKDIDAGLYFDSSIPQGYGVGSSGALVAAIYDKYAK
DKITVLENLTRDKLLQLKGIFAEMESFFHGKSSGLDPLNSYLSLPILINSKDNIEPAGIP
SQTESGTGAVFLLDSGSTGETAPMVQIFMENMKQEGFRAMLKDQFVKHTDACVEDFLNGD
VKSLFGNIKQLSKVVLENFKPMIPKEFHTLWKKGIDSNSYYLKLCGSGGGGYMLGFTEDL
DRAKEALKDYKLEVVYNF
>OMIFANIC_02356 hypothetical protein
MKKPLILLLMGIFISHISTYSQSHTWNGNGGDNDWFNPSNWIQNSVPDASSDVLISSDAE
VEIFIGTAEANQIQIENNSTLTLDNTLELGSEMNIGALGTFVFMGGTFSGGTIENNGLIR
FESLTVKTVINATLNNNQLFEVNNSNQIQLNNVEINNSTGAIIDIASVGGFLSQGGNPSV
LNNEGFLNKLPDGVNPNGNFYVILNINNTGVIDIPENETLLCLGGNITLNNLNTGLIRGK
GTFDITANFNNSGLVAPGGEGVVGTFHITNIFNLSPPGALLIDIGAEASEHDVIEIFGSP
QLEGDIFVECQATLSVGDEFPIITATQGIGTCNFPQFVYADLFASSYEFEVICDPDTVYL
KFVREVILNNEDFTSGDIDFYTSPNPAKDIIEVILPSELFQLHQSLEIDIINAVGQQIDV
LTISTEKQSFDTSNLTSGIYFLILKTKGRRLSTTKMVKL
>OMIFANIC_02357 hypothetical protein
MTETQFLPDSYTQQPEQGSVSWKSPSNIALIKYWGKYGEQLPQNASVSFTLSNCFTETKL
SYASKDSKGYDFEVYLDGQREPGFEPKILQFFERVENYLAFLQNYSFRIETSNSFPHSSG
IASSASGMSALALCLMDMERSMSGAEMTDDFFNHKASFLARLGSGSACRSIEGPLVVWGE
HPVIDGSSNLFGIKYPLDVHENFNNYQDTILLVDKGEKQVSSTIGHGLMQDHPYAERRFA
TANSNLSKLRLVFGNGDMDAFIEIVESEALQLHAMMMTSLPYFILMKPNTLEIINRIWQY
RKQTGSKICFTLDAGANVHVLYPEAEMTDVSSFIQSNLAQFCKNGSYINDHAGLGASRL
>OMIFANIC_02358 Arabinose operon regulatory protein
MNFNIFNSLILAGVIQGLLFGVVFLFNKKYRAKSTYYLIAWIVSYSLSNLQYYLLDTGIV
DFEGFYDYVYIAWPLLMPALIIMYCHTLLYPKRKISWGERLLFVPFILGFILGVSYKIFR
AMEFKHEGLSVFFIELTPIGELLAILFSMIAIIYMLITVHRFQKKESYSVNKVSLQLNWF
KITLILLFITTLIWAYSEIMYGDSDDISYFYPLWIIVAFLIYWLGHLGMYKYGINEQRKQ
IRKTVHDRYSITEVLPQKNEHITAMKQFLEGDRNFLDPNISLEAVATHLGISSGHLSKVI
NTELRTSFKDYLNKLRIKEAKLYLKDPDFSNYTLVAIGLEAGFNSKSAFNASFKKITGLT
PSQFRQE
>OMIFANIC_02359 hypothetical protein
MKRLCYFLLMISTPLFSQVGIGTITPNASLEIQSTNQATPASTDGLLIPKVDEFPVTNPG
PGQDGMLVYATGSGSVSKGFYYWDNGTTAWVLATGAKNINDLSDGITNSSGGSLFLGTDA
GINDDGTDNRNVGVGYQSLYSNTAGLGNTANGWSALYYNTTGNHNTAVGSAALANNLTGG
LNTANGYYALVGNTTGIENTASGFYALYNNNIGSKNTAYGSRSLFNNSTGIENTAIGYGA
LYNTVGNNNVALGYNAGQNSAGSNKLFIENSNADSNSALIYGEFDNDILRTNGTLQIGNP
ASGGFAFPMSDGTANQVLQTDGAGAMTWVDPNASGAERIDDLSDGLTDATGSSIFLGIGA
GANDDGTANRNTGIGFNVLNTNVDGFSNIAFGHRSLFSNVTGNYNLAIGADALYNTTGTR
NVGVGHQTMLSNTSGNYNVALGANAGHYVEGNNNVFVGRSAGYVGTTHTKNGSVFIGNEA
GFSEANSNRLYIENSNADANNALIYGEFDTNILRANGTFQIGNPSGTGYALPSVDGTINQ
VLQTDGAGAMAWVDPSATVIHDINDLVDGKSDNDGTDDGSSIFLGVDAGLNDDATNNGNV
GIGYKAMQINTTGTYNTTYGYQALFSNISGNWNVANGASSLFSNTTGGGNTANGGVALYS
NTIGIQNTANGFRALHNNTSGNNNTANGKNALTDNTTGSNNTAIGAEALWASSGNNNVAL
GYQSLYFNATGSNNVAIGYDAGYNETGSNKLYIENSNSASPLIYGEFDNDILGINGSLGV
GTQAPEVPFHVKEEGVSGVQTIVAAIDSNTSNRPVLQFSESSTIDLNAGMSLEYDGRGSG
DANRMVFNGVGGSPLFEFRNGGNLTLRDGDLIIRGTGTDREIKLDDDAGNPDRVLMRQTG
TQDIYVGDIDNNGGDTYIRAGGSTELSIISGTGFVGVNTLTPGWELEVNGDAAKPGGGSW
INASDRRLKKNINRYHDGLEQLLQIEPVTYQYNSVSGFDQTKEHVGVIAQDLQKIDPSMV
TTYTRENEQYLAVDNSAMTYMLINAVKEQQLEIDTLKQELEELKNLIKTTHNE
>OMIFANIC_02360 hypothetical protein
MSSLKILFVLVLILNFNNMEAQQNIDLPDFGLSFTIPNGWTGGEQGDYIILGHSTIPGMM
ILFENGSKDANELKELAMQGIYETGLQLSPKGGFTISSENRVEGMYEGIYNGGAVSSYAV
GLINGLGKGMSILILTSTDKFSEIHRKEVEKLANSVKFYEARDSEATVHWKNKLIGRQLK
YMFTDSNSDSSGGFSGTSTTRIINLCSNGEFTYYYNSNSSYAVGDPVDGISTGNQIGSGV
IESTKDKTGSYKIYSAGNSSYLELIFSDDTEMEFEIGINGEGSTTLNGERYFTLDLEGCQ
>OMIFANIC_02361 Melibiose operon regulatory protein
MNFNIWNTLILAGVIQGFIFGVVVITNRKFRSRANFFLAGLIVTYSLSNLQYVLFDFGYF
TRFEFYSTIFLQWALLMPALLLYYGRSLLGMPLSRLWRWIWACPFLISVAMNMGFKIEFN
SIEVSGATTDFFDTTLLVSEYLAMVFNSAVLIYLMIATHKHRKQLTFRKDTIVDRLKWFQ
RTLLLILIATILWAVLESQFEMGSSYDFFYPLWILIAVLIYWLGHLGIYKYGISEQRKKI
RKAVYERYSVSEVLQTNEHIATMEQFIKLERNYLDPGLSLEMVASHLNLSAGHLSKVINT
ELKMSFKDYLNELRIEEAKRYLKDPEFEKYTLAAIGLEAGFNSRSAFNASFKKITGLTPS
QFQQQE
>OMIFANIC_02362 hypothetical protein
MKRFFLITLLITSTMTAQVGIGTETPNATLEIKSTNEATPAINDGLLIPKVEEFPLTNPG
AGQDGMLVYATGAGTISKGFYYWDHGTTAWVQATGAKSINELNDGKSDNDGSNNGSSIFF
GINSGQNDDVSDNQNVGIGANSLSSNTSGYDNTGIGYSTLLDNNTGYQNTAVGHSALESN
TTGYSNTAVGSLALEANSTGISNTALGRRAMEFKTGGNNNTAIGTLALRANTTGNINTIV
GSAAGFNVEGDGNVIIGVGRTLSGTRTISNSVFIGKYAGNPETNSDRLYIENSESATPLI
YGEFDNDVLGFNADVGINTQSPSASLHVNHQNGSSTEGFVISNVIDADEWRMYMQWNSNT
LSMFFNNTNVGNFDDVSGTYSAVSDRRLKKNIEPLGTVLEKVNQLEVVDYNFIHQQESKK
YTGLIAQEVEVLFPNLVVPPNEESENYTMDYSAFGVIAIKAIQEQQEEIDHLKKELEQLR
NFIKSWQNE
>OMIFANIC_02363 hypothetical protein
MYRYIALLRGINVGGHKKLPMAELRTLFESLGFVDVQSYIQSGNVVFSSEEKVSGEVISE
AIKGEYGWKVPVLIKTPDEINGILDNCPFPKEAKEKSYFMFLFQPPSTENIKTTLSFQYP
DEEYVITPQCVYFYCSQGYGRAKLSGNLFEQKLKVSVTARNYRTMTKLIELAS
>OMIFANIC_02364 hypothetical protein
MFSGSICAQGEDRHRWKDRVVVIHGTSEEDTQVAAQIKLLEDDKEAMEDLKLVIHIETIS
EIHYHCTDEVVVASREKPIVSPFKVELYGLDGGLKFSSNELLPLSRFYEIIDSMPMRKSE
LRKRNKG
>OMIFANIC_02365 Ferredoxin--NADP reductase
MRHDYDLLIIGGGAAGFFTAINTAHMNRDLKIAILERGKEVLTKVKVSGGGRCNVTHAEF
MPDELVKKYPRGEKELLGPFHRFMTGDTITWFEERGVALKIEEDGRMFPISDSSQTIIDC
FMNETKRLGIEILKQRAVKAIGKGNSHWEVETSAAVYSASKVVIATGSNPKIWKLLEDLG
HTIVPPVPSLFTFNINDKRITNLSGIATEAWVTILDDEGKALLSSDGPLLITHWGMSGPA
ILKLSAWGARVLKPMNYKFMIRVNWVPDSTADVLTDMMKTLKLEIARKKVSGTAQFGLPK
RLWNSMVGASGIDDDETWADITKEKIAELVNEITGGMYQVDGKSTFKEEFVTAGGVELKE
INFKTFESKLLPGMFFAGEVLNIDAITGGFNFQNAWTGGYLAAKAITE
>OMIFANIC_02366 D-xylose-proton symporter
MKDITKWSITVALAGFLFGFDTVVISGANQPIRELWNTSPLFHGTFIMSMALWGTVLGSL
FGGIPTKYLGRKKTLFWIGILFFISALGSGLAPDPYSFSFFRFIGGIGVGVSSVAAPIYI
SEITTAENRGRLGALYQFNLVFGILIAFVSNWLLKGVDGANDWRWMLGVEAIPALLYTLM
VIKVPNSPRWLVIQKKDYDSALDVLKRIYSGADAQKHLEEIVADANLPKTSDQLFQKKYN
RVLWLGFLIAFFNQLSGINFVLYYAPEILEQAGLGGEESLFNSIAIGIVNLVFTIIGLRL
IDKLGRRQLILIGSVGYILSLLMVGICFQMSLSSTTLLIFICMFIASHAIGQGAVIWVFI
SEIFPNRVRAYGQSWGTSTHWVFAAIITLVTPFFIDKTEGIFKDNLEIIYYFFAGMMVLQ
LLWAIFKMPETKGVSLEDLEKKLIGDEE
>OMIFANIC_02367 Fructoselysine 6-kinase
MKNDVPMVVCFGEVLWDVFPNKVLLGGAPLNVAMRLHSLGAKVQMISSVGDDEFGKEAVS
QILDHGLSVSGIHISESKPTGTVQVSLTKGIASYSISEDVAWDHIIISEDNRLKISNADA
LVFGSLALRTDHNSNLLKELLESTRFAIFDLNLRPPYYSDDLLKELMQRADLIKMNDEEL
NYVCAILNIEDESLDERIHQIAERTYSDSICVTLGPEGAILFQNKTITRHPGFKVNVSDT
VGAGDSFFAGLIYELLSGSGPGEALSTGCALGALVASKEGANCEVTSEEITRLMQPDTL
>OMIFANIC_02368 Cyclic 2,3-diphosphoglycerate synthetase
MKKRVLIMGAAGRDFHNFNTVYRDNDDFEVVAFTATQIPNILGRKYPAALAGSLYPDGIP
IFDEKELENLIAELKVDDVVFSYSDIPYDYVMHKSAIVNTAGANFVLLGCKETSLSSTKP
LISVGATRTGCGKSQTSRRIVEVLMEKGLKVVAVRHPMPYGDLEAQKVQRYAVLEDLEKH
DCTVEEMEEYEPHIVRGNVIYSGVDYEAILRAAENDPDGCDVIVWDGGNNDFPFYKSDLH
ITVTDPHRAGHGLQYYPGEITLRMSDAVIINKIDTARPEDVEKIRNILAETLPEATVIDA
ASPVRVDSAEIIRNKKVLVVEDGPTLTHGGMMIGAGMVAARKYGAAEMVDPRPYLVGQLK
DTFDKYPGIGTLLPAMGYGDEQLKDLETTINNCECDAVIIGTPIDLNRIINIKKPSVRVY
YDLQSIGTPRLEDVINKFVDEKVNINDVPDRPSLVARL
>OMIFANIC_02369 hypothetical protein
MFSKANLVSTLVLTIWGVGGGYLLWGILADPFFTDHVVTDGLMKDPPDMVHLIIGCLIQA
FAFSSIYQRFGSGSYGAGSGLSMGIWIAIMVGLGEGLVDFATSNILDLHGTFVNCVIYLI
FFGIMGLLAGLIYGKMARPTTA
>OMIFANIC_02370 O-acetyltransferase OatA
MHNSRIDKLTKEYRPELNGLRGLAVLLVLFYHLEFEWMKGGFLGVDIFLVISGYFISRNI
LVDVQLNLFTYSRFYTKRIRRLFPALLLTIILTMAAGYMLFAPGDYQRLGLSSFFSTVSA
SNFFFWSEAGYFDGSTIAKPLLHMWSLSLEEQFYLIWPFLLVTAFGLYRKRLLFFILTGV
LLSLFSAEILFAVDRSAVFYLIPFRMFEFMLGAACIWFERASYAKLNKFKHDFLFSLGLV
LMILPSIYFSQHTKLPGFLSLIPCGGAMFVIIGGKKAFLNRLLSNKIVEYIGKASYSIYL
VHWPLIVFYTYVTLTDFSIYEQVVLGLLSIGLGFLMWHYIENTFRYPRKKNMKFDPAWII
VLVIVTGICLFSKVTYESGGFVSRFTGELFMSNEELLENRKNYWMETYSNNGILKGELDE
GHVIVLGNSHAIDLIYALRFNGFDGKITSLQSGSRCYNFGSPEQKIDSDFCKTRKSQNLK
AQEWGQVDAVYVHDDWPILDIPDFRIAIREIKSKTNAPIYVFGPKIRYTENVPDIVRMSK
SIVPEVINEYARKYSELATKQKINNALANEFESNIYYHENQIRYIDLLHLQGGKELDEFE
IVAPDNLEFLYFDGGHLTQRGSKQLGKRMKTNHPYLFDTKMIMNE
>OMIFANIC_02371 hypothetical protein
MELPVAYIPLDISEPIWSHFFTVAPLVIVGTKEGVGYDMAPKHMAMPLGFKNYFGFVCTP
EHRTYHNVLNFDEFSVSYLLPKQIIQAAISASPRSDDISKSDKIVSALPTVNGTKTDTLL
MEDAYVRLECKLHKIIDGFGENCIITGEIIAASVHPEYLRVSEKDERDQLAAHPLLAYIA
DGRFASVNDTFNFPFPKNFSR
>OMIFANIC_02372 Carboxypeptidase G2
MTSATNIAKDIQKYLGKHETEMLDFLKKIVAMESPSQSVRSLHEIFLVLSKALNSVGYYT
LHVPGHKSGGYLYARPKQRKKGIPVQLLVGHCDTVWPLDTLQDIKIEKKGKRLKGPGVYD
MKAGITQMLFALKTIMELNLETEVIPVILINSDEEIGSHESTHMISRLAKISERAYVLEP
PLGLDGKLKTGRKGIGRFNITVKGKAAHAGLDPTKGVNAIVELSHQVQKLFGMNDLNRGI
TVNVGMIEGGISANVIAPTSKAVVDVRVENIEDGEYITDQILSLKPTLPDVTLKIEGGIG
RPPMEKNERNEQLWNKAKELGKELGMTLEDATVGGGSDANTTSQHTATLDGLGTPGDGAH
ADHEFIFHERLKERTALLVLLLLSKPIKK
>OMIFANIC_02373 hypothetical protein
MDYRFLYTSLCRIADLVEKPFDIGKLPRDQWATGDYVVVKIKDPGGIHLQIELPSGRMRG
IIGGDLLIGALGERFATLEATGSWREVRDDLRLHVLTAAGLLGKCTSKSVFLPQMMEVKY
KGHVQRESKKVCMEDFVEHVPDMPYVTPTVLFVGTSMSAGKTTSARIVTHLLKLAGLKVV
GAKLTGAGRYKDILAIRDVGADAVYDFVNVGLPSSIFPREEFKEKVKQITNRMAREQADI
AVVEIGASPLEPYNGDLAINAIRDQIKCVILSASDPYAVYGLMKAFDIVPDIVTGKSTNT
LAGQAMVEKLCGVPAINMIDSTAMPEIRDILTKSTGIKI
>OMIFANIC_02374 hypothetical protein
MEMKTTAVSILVIIFISMTQVINAQGRWSGEFRPGFNIPLNDLGEEDLGLGFGFEAKIAY
KMMPHLKIYGGWGWNAFETDTQDVNKMVDLDEMSFTFGLDLRLPMTDPPVTYFIYGGGVL
GQIKLKDNQNTFNESSDYGLGWQLGGGLEFALTDYWSLKPDVRYRSLSRDIQINNVMTDV
DLQYFAVGLGVCGRF
>OMIFANIC_02375 hypothetical protein
MNIFVARLNYQTDDDSLRDLFEGYGEVSSAKVVMDRETGRSRGFGFVDMPNEEEAKAAIE
DLNETDFDERTIVVKEANPSETGSGDRSGGGRGGYGGGGYRGGGGGYGGGGYNRGGGENS
EESSDSHY
>OMIFANIC_02377 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MYLSVSSEKTHMNSAKTYIQEHKDRFINELIELLKIPSISADSAYEKDVHKMAEAVKASL
EKAGCDLVEVCETPGYPIVYAEKMVDPDLPTILVYGHYDVQPPDPLDLWDSPPFEPIIKK
TDLHPDGAIFARGSSDDKGQMYMHVKAMEYMTSTGQLPCNVKFMIEGEEEVGSVSLGWFV
ERNHDKLANDVILISDTGMIAPEIPSITTGLRGLSYVEVEVTGPNRDLHSGLYGGAVANP
INILTKMIASLHDENNHITIPGFYDDVEVLTSEERAKMAEAPFDKEAYKNALDIEDIYGE
TGYTTNERNSIRPTLDVNGIWGGYTGEGAKTVIASQAFAKISMRLVPDQNWEEITELFKN
HFESIAPKGVRVKVKPHHGGQAYVTPIDSLGYQAASKAYESTFGKTPIPQRSGGSIPIVA
LFEEELKSKTILMGFGLDSDAIHSPNEHFGIRNYLKGIETIPQFYHFYTEMSK
>OMIFANIC_02378 hypothetical protein
MSLERTLKQRSNSQCELCSNPEELSVYEVPSSPKRGEEASILICSTCNKQIGEQESMDPN
HWRCLNDSMWSTVPAVQVMAWRLLHKLKGEGWPQDLLDMMYLDEDMQDWAEADGDGKDIS
DQLVHRDSNGVVLQAGDSVVLIKDLKVKGSSMVAKQGTAVRRISLDHENAEYIEGKVDGQ
QIVIITKYVKKI
>OMIFANIC_02379 Methicillin resistance regulatory protein MecI
MPLSNSEEQLMQILWKQKKAFMKDLIEAYPDPKPAATTIATLLKRMQDKHFVDYEQQGRS
RKYFPLVKKKDYFSKHVNGLIKNFFNDSATQFASFFTESTDLSKEELEELKKIIDQQIKK
K
>OMIFANIC_02380 hypothetical protein
MEMYVLKSALCLAIFFAFYKTLLESTSVHVFKRFYLLGALLLSAGIPLITFTTYVEMPAG
TADLTSAALLEGGIVEEAAFNWSVLLWSVYGLGVLYFGTRFFKNLHDIFRKIRFNPKKRT
RNIITVFLNEKIVPHTFFRYIFLNRKRFEDNSIPREVMDHEITHARELHSIDIILVEIMA
VIFWFNPILHYIKHSVKLNHEFLADNSVLRNGVDTTTYQKILLAYSSDAGSPILANAINY
SFIKKRFKVMKTNTSKKTMWVRTLLLLPIIALTLLSFSSREEIPIERKEIPIETEINSTE
DFVQTSATREEMKEYNKLARKYNNMSKDNMFIKKKELNRMEYIYQKMSPKQRADAEPFPN
FPPPPPPPNVSDAPEPVKVIKGVSDTDDNIPPPPPPPPAPDAPIIDLSEVISQGATFYLN
DKKISTARAKEIVKDSDAIKTVRVMEGKNGKPEVRIWNK
>OMIFANIC_02381 hypothetical protein
MLQRFFIFCSGADTDILEQCSPGERTKYAGIGATVFFTAVMATIASAYALYTVFDNYYTA
VFFGLIWGLLIFNLDRFIVSTLKKRDSFFDELIQASPRIFLAIIIAIVIAKPLELKIFEK
EINQVLLEEKNTMTLENKDQLALQYQPSIEALNSEIDALKQEVIDKETAVNQYYETYISE
AEGREGTLLVGKGPVYKEKREKHDTELSALQELRTANAAKIAAAETQVAELSQQYQLKVS
ETQPVIDGFDGLMARVNALNKLPIIPSLFIFLLFLAIETSPILAKLLSPKGAYDLKLAEQ
EGAVASWVAQQKSQRDVLVTTDRDVNNRVYADIAEEQEIYDYKRKIARELMQMQADAFYK
KQKSVL
>OMIFANIC_02382 Aldose 1-epimerase
MTCNFVESEIPFYHFTDDALSCKIVPAFGGSIQELVVKEKAIIKGVSIDKEGFEKYKEFC
NSAILFPFPNRVAQGSYTFGDKHFHLDRNDSKYGNAIHGFAFTQCPEVISQSDTSLVLRF
THTESPGYTFPYILELEYSISPNGLKLQFKVSNTGKDLMPFGLGWHPYFVTDDQEKFSLH
FEADKKYLTNANMIPDHSNPVNDSKFNPSNMEVDNAYRLTNSQILLRSHDRELKLIVPEQ
SYLQLYNPIDKRSFAVEPMSCVPDAFNNKIGLKTLSPGSVFKWNIQLEFGIS
>OMIFANIC_02383 Putative mannose-6-phosphate isomerase YvyI
MKTYPIKFNPILKEKIWGGTKIVSEFKKGNSNRPIGESWEISGVDGNISTVVNGYYSGMT
LNELQSTFTSEFLGEENYSRFGKDFPLLIKFLDAASDLSIQVHPDDEMARERHGGYGKTE
MWYVMDHEEDASVIMGLKDQQTDLPAKELDTPAIETVFKREKVKNGDTFSIPAGMVHALG
AGVMVAEIQQTSDITYRIFDWNRKDSEGKQRQLHIDLAQEAIKNCDDTKSVSYNASPNSV
VKTVSNEFFTTNLVDVRSKYIRDLSEVNSFVIYMCVEGRISITVDNHTEIIRTGETVLLP
ANSSQAIFYGPKARLLEVYVDPLMHTPMEAAA
>OMIFANIC_02384 Dodecaprenyl-phosphate galacturonate synthase
MKTGIIIPCYNEEKRLNSRAFIDFINENQDYHLCFVNDGSKDNTLGVLQNMKMAAPYGIS
IVDVKKNVGKASAVRAGVRYLYNKKDIANIGFIDADLSTDFRDFKDLVNTLKSNENMSVV
FGSRNSGGDGIKRDFVRNLLSKTIKTFILFILGLPIRDTQCGAKVFSRSIVPVVYGDAFV
SRWLFDVEIFLRLKKYLGKKNVMNHIIEQPLMRWVHVDDSKLGLKDSLEIPARLLHIWTT
YNLLPKQRLVQPAPELISNMEIFETAPMTIAA
>OMIFANIC_02385 hypothetical protein
MENRSNKYLIVALVFGIAFHGTSMFFTLESTYDALIHVFFGNHYATSWFEPWNESWYTGF
TVMGYPPLVHQAIALLSGLGGLKFGMFVIAITGVILFITGVYRFTLLLTSNRTIGGYAAI
LAVFSSSFVETLHLFGQLPSIIGISILLHALPEIYLWLKTGKYWYLVTSFSLLSITVTSH
HVTPIFGMVFFIFPLIGMVLMDASRERVSGWEQITLKVFVKSFYTHLKRILVFGLGSLVL
IIICILPYWINTKDNPITQVPIPHGSRDNFIEVSSSGLVFFLIPWGVLLILLPYLFYRYY
SKRYLFFGLSFSLLTLLGTGGTTPLPLKILGENAFNILTLDRFTLWASIMALPMFGEFTY
RFVEGDLKRYMQNKWGAVYHRLSGGILLTVFLFMTVFSMSLGYFRPSQPKKIDTLPLVNF
LNQDQHDKWRYLPLGFGDQMAWLSTQTKASTIDGNYHSARRLPELTSRAVERLENSKFRG
VEGLGSLQQFLTIPEKYHLKYVFSNDKFYDPILYFTGWHRLQRLENGIMVWEREGVSPMP
SKISKKEVPLYQKLMWGIIPILTVIIAFFLNINQLWKRSFKIGNHEQPVYMAFKKEFFKY
NSQLMAVSRIWAVTISVLVLFGVYSFYMKNATQISPENTVIAYYDALDFKEFEKSYGLIN
PKSEKTLDQYMLEISVTDGLLSSYAKLDAIEVKMLSETDSTATAEAKMKWITPLETYNKS
VKHQLRKIKGKWFLEPSDIDVDIPPDQLFIRKKANYFKHGRRRISSEQTYHEDVLKQPAI
EVLSASLVYANNSYHIVGEIQNIDNIPADVSMRGTLYSKDNRELTTYNAKDILKHKLLPK
ETSVFRIDFEDAIWSEETKSLPATFNPKQFTPVTIKDDISSFNLQVEANIATTDLHNDLA
IADLILNEGKAEGIIYNSGIENATIPQLLVSFRDRNRKLIWVEKKYLEESVRAQRKYRFE
YIIPKISSIDLLSSSLQYVFVNGLPNNEISKKLIPERKETQYYLELQEAISPFRFIDFNL
NYYVGNPR
>OMIFANIC_02386 hypothetical protein
MILSRKHIILFSVLLLLQLLFSSMIFQKLPPSDSLIMITRGELLIKNDQFIAGDPISIDY
RITLADTIGKNESTYTVHLLVISAYGSSLLQGQITETGMNFVIPEEIARKSGDLDLRLIH
NKRLLDSKTITITSKTNSGVIMENYLGPPSMTAGAKDFSMMVVMPTDEFDNLLPDSTLVS
MREQIDETIISTDLYVVNGYAWKNIYSTEKAEKVFVSAECLGVNSKEMETKIRPSYPVDF
GIFAMRTHNYADGNQIVSLSTSLIKDVFGNIIADGTVVTFTIITSDGHKLSTSGAILNGV
AEAQILHPDHSVSWKIKGVISGIAESERITIEFESITRYLKVHFSKDGGKLFVGPLTSYM
DQLAPDGTEVSLYTGDRFITRKSSLNGVVVFDLRQHEFELAENEITVNALGLSRTLKLKS
E
>OMIFANIC_02387 hypothetical protein
MKKNRFIYRVLILTAFLLINALLLFGIGEVYSYLNSGADKAGIFHGDLRGDINYHPEIKW
DITTNKGLEISPTVVKDIVDDYKLAWFIRNNALYSLEDTGIADLYTANAREELYNLIELN
KKTGVSIESTTLSHNLQIDFFSADGKIISFIDKDVTGFSRVTKHDEFVYEANNTASYKVI
MLLEDGFWRIRHLVRTSSEETETMIRETIPLIEPIAGINYYPQDSAWDTFGEKFNEATIK
KELTLIKDLGLNTIRIFVNYKDFGGADVRGGKLNKLSRLLDLSNAEDINVIITLFDFYGD
YSIKEWTATREHAKTIVNSVKEHPALLGWDVKNEPDLDFDNRNSNVVKSWLTQMLRYIKY
IDPEHPVTVGWSNPESALNLVNEVDYISFHYYEDVKLLGSAISRIRSNTSKPMVLQEFGL
STNYSFWSPFGNDEKDQAEYYEAFYKIQKRDSIHYLSWTLFDFEIIPKIISGNSPWRKIK
QSNFGLVTISGAKKPAFTIIKSNH
>OMIFANIC_02388 D-inositol-3-phosphate glycosyltransferase
MKLGIVTSYPPSKVTLNEYAFHLLKQFRNHNRVTEVVLYTDVSEAETGLNSEIDGCKVSV
VKCWKFNSAKNVITIARAIKNSRPDAILYNLQFMKFGDRKIPAALGLFSPWLTKLMKIPT
IVLLHNIMEAVDLNSAGFTQSKWKNAVYNRIGTFLTSIVLKADRVAVTINDYVSKLEGKY
LAKNVVLIPHGTFEIPDTPTYETESGPLKIMTFGKFGTYKKVESLIRAVEIVRKEIKQPL
EIVIAGTDNPNTPGYLEGVKNSFSEVPMLTFTGYVEEEVVPRIFSESAMVVFPYTSTTGS
SGVLHQAGSYGKAVVMPNLGDLSRLVKDEGYRGEFFEPTSDESLAAAIKNLVTDEAYRLE
IAKANYAAATSFPMSKIADMYVDEFHAIGIKEINRNKIAA
>OMIFANIC_02389 hypothetical protein
MISFAKKIPFQLKSEQIFMLSGLLVNAGNYAYNLILGRYLGPTEFADAAILITLLLVLSF
VAMTYQLAVAKFTLEFDSESSVRFVKWMYRNAIILGVILGCGMVVFASDLQKLFHTVSSE
MFTIFGCVIPLYFAMSVNRGRFQGNSNFVQLSGTYQFEMITRLVVTFFILFFFQISSSVG
VAIGIAVSMIAGLFPFKSMAGFRKVKGKISAANQKRILSFLIISASYEGTLIICNNSDIL
LVKHFFEAYDAGLYASLALIGRVVYFITWMFVMLLLPKVIQYRKEGLNTIPILSKYLFYI
TLLCIAIVSFTFIFPDFAVRILFGEGFLEISPLLGWYALATGLFAISNVFAYYFLSLDHY
RPILFAAVMGIVQIILILFFHNNLFEVVLMQITAMGVLLALQVGYFRRFAR
>OMIFANIC_02390 hypothetical protein
MALKITKTDDVYELQGRLCSSQAHEVRNFFISKLQIDGNLNISLCKLDDLDLSGAMMLER
LKEEANKSGKMVQVFSGPNRKILGPFLMIDQTVLSAA
>OMIFANIC_02391 hypothetical protein
MKLVVNNSMNKLRVVYKNNNYTIDNTLSIVHNLYTKDLLKRVN
>OMIFANIC_02392 Beta-barrel assembly-enhancing protease
MKATFTALLSLCFAMISAQEMNPGFDLLEAGKYQDAEEFFFEVIREYPENKTARLCYGRA
IGLNGKPELARDVFARLLELYPADLELKLNFAESLLWNKEFENAKKYYEVLIVQNENSFP
ILLGYANTLSNLKQYNMALEYIERALKIESSNPNALISRKYIRLGLASKQVENNQSDKAL
ALLNQNLEEFPNDQDTRLSMINLHLLNNNLDEAEAEYLTLKDSITALTGLSLISHKRRKE
KLALQWASKANKLAEISHDSTKILMAHERYIQALIWNKKYSKAKESVEKLEDLYPRSTTV
KSLKAMHGMYTGKISNSIQVYKDLLAKDSTSFDGNLGIANAYRAQGNFKKAHKYASKTLQ
FYPNQKDALSLLGILEKSMAPVSVNTVSYSKDNGNNEAVSIGSYLELPISANTKGSLGYT
YRTTENLDNGAMAYNTNITFGVKQRIINNTWLEGSLGFLKANAETNSYSDVNGSLFVSSR
PLPKQYLKIGYGRELQNFNATLIDEKIFMNNFMVNYNMGTNFGLGWYTGYTYTSQTDDNV
RNLLFTSLYYQFTDRPLLKGGLNYQFLGFKDQVPELYFSPSKYQAVEIFFDLSGSSGKWN
YSLNGAGGFQFVDEDKASSLFRFEGKAGYQISGRLLINAYSKYSNIASETATGFKFTEVG
LSIRWQFLKAPVFRSN
>OMIFANIC_02393 Transcriptional regulatory protein YpdB
MKCIIIDDEAAARAIIAHLCSQVESIEIVEEFPNAIQAIKFLNKNHVDLVFLDIHMPDFT
GFDFIDTVKNPPKIILTTSDKNFAINAFEYDCIVDYLVKPVTLPRFLKSIQKAENFVSSV
TSKSEVSSETEKELPNKELYVNIDRRLIKIDFEKIYLIEAKGDYILIKTDDKNYTVHSSL
KKIEDKLPESLFLKVHRSYIINIKKIIDIEDNSVLIAKDVIPISRSNRPELMKRLNLL
>OMIFANIC_02394 hypothetical protein
MSEPNLSLIEELSGNDMEFRKKLIGIIKSELPAEIAVYRDCVMSDHVQAAAIVHKLKHKI
SILGMFDGYQVAEDYEEELKEGRWEGHEKFNELLEKMSQFIIEL
>OMIFANIC_02395 Phytochrome-like protein cph1
MSKEQELILKRALERERAARKLAEKILEDKSAELFSLTRQLKVSNKKLERLVQEKTSELK
GVFENIVDAYVVIDLLGNVLKMNVAAENLLGYSLDNDIDINLSKLVHKEEVENVSEAFKI
LYDNGAITDFNVRILTKTGKQKLVHINASIIYDAENNPIAAQGIVRDITKEKEAQEQLIE
SENRLATLVSNLDSGLLLESEDRKIALTNKKFCDLFGIPVPPEALIGQDCSNAAEETKSL
FKDPENFVLGIEELLENRVIILGDELIMASGKILERDYIPIFVDKEYKGHLWAYRDVTLT
KRYRKSLEAQREKYSNIIANMNLGLLEVNNDDEILMVNQRFEQMSGYLEHELLGKKGAEI
LLKKSAQQILLEANNERIKGKSNSYEVTAITKSGEERTWLISGAPNFNINGEVIGSIGVH
LDITEMKNLEKQKEVLLRQLEKSNDELQEYAHVVSHDLKSPLRSIYALVDWIKEDNLGKF
NEETQHNLTLIENTLEKMEKLISDVLSYSSIFSAEEIEDKVNLNTVVKDICDILFIPKHI
EIKIKTKLPTIKANGIRMQQLFQNLISNAVRYNNKEKGLIEIDFENKEKEYLFRITDNGM
GIKKEYHDKIFQMFQSLTDEKDSSGIGLSIVKKIVTANGGSIWLESKEGEGTTFYFTLKK
Q
>OMIFANIC_02396 hypothetical protein
MKGIIFTEFLELVETKFGIGMVDQIIAQSNLESKGIYTSVGTYSFSEMLSLVTNLSNNSG
ISIDDLFLVYGEHLFAVLKTSYPGLIESYKDPIEMLSSIEDHIHVEVRKIYPKAELPTFT
VEDRTENSIVLLYKSSRAMYSFGLGLMNKTFENFGTTAEIIMEKLNERGTEVRFSITKNE
>OMIFANIC_02397 Polar-differentiation response regulator DivK
MKNLKIMLIEDDQIEVMKLMRAIKKIGGEHHFVEAKNGENALELLSHQENIPDLIFLDLN
MPRLNGLEFLKILKSDEILRYIPIVILTTSSNRKDVLECYKIGVAGYILKPLKYDEYVNK
INKTLDYWSSNELIKA
>OMIFANIC_02398 hypothetical protein
MNFQDITAFKQLAENHSISLKFLFPNLIFSTIAAPDMSLNGSFFEADPHHEDLERAANRL
RKFQDQHPNALLANGYLEQRSFYNTPAFEREHDGLKEFRNIHLGTDFWIPAGTAVHTPLS
GIVVISHNNNFHKDYGPTIVLRHELDGFVFYSLYGHLSLSSLELTEKGKTLEQGDKLGTI
GDENENGHWVPHLHFQLITDLLGNTDNFNGVAFPSEIEKWKKLCPDPDLLFTEHLPSGA
>OMIFANIC_02399 Cycloserine biosynthesis protein DcsG
MVDITVLTDYRYYKPEKITPYIQNILDEYRYLKVAMEELGYSVTRTYWDNSDYDWTQTKA
ILFRTVWDYFERIDEFQIWLEKVRAQTLLINPFSLVQWNIDKHYLRDLSEKGIVIVPTHY
VDKGSYQTLAEVCDINSWKHVVIKPAISGAAFHTYKIMASELAANEELFRKLVMERDMLV
QEYLSTISINGEASLMVFNGEFTHAILKRAKIGDFRVQDDFGGTIHPYEPTPEEIAFAES
VFNACDILPAYGRADIVWDEEGNHLLSELEIIEPELWVRNNPSSAKIFAKGVKRMMES
>OMIFANIC_02400 HTH-type transcriptional repressor NsrR
MLTKSSKYAVRAISYLVVNSSENQKILVKDISNDLQLPKPFLSKILQRLSAKDYISSSKG
RGGGFYVTEDQLDHSILDIIIEVEGKDRLKRCALDFDNCDEAHPCVIHHMIASEKGGLWK
AYKEIKLKDLKS
>OMIFANIC_02401 hypothetical protein
MIFAAAILISCGGKEDKKEDSIKLSGKKEIKKEPAKSEASSDEVPASERITLDNKGVGEV
KDMPLGDEIDQEMVARGAELFKTNCTACHKVDKRFIGPSPKGILNRRSPEWIMNMILDPQ
LMVEQDRCAKDLLIEFNGAAMANQSITLDEARDILEYFRTL
>OMIFANIC_02402 Immunogenic protein MPB70
MKTNNLKFLLISCISILFLLGCKNENKQDNSTVGSDTTSENKEEGQAFIEDDEAVPNVLQ
IAIGSPDHTTLVAAVQAADLENVLVNAGPLMVFAPTNAAFDALPDGTVDNLLKPENKGDL
ALILKHHVTPGNYSKDFLKKFKKLGQASDLNTTVEVKDGEVYVGGAKILASIPAGNGIVH
VVDAVILPPAN
>OMIFANIC_02403 Nitrous-oxide reductase
MKKSNYFFVTVLALSLIMSGCQQGTNKSSNGALASSAAEKVYVAPGEQDEFYAFLSGGYS
GNLTVYGLPSGRMFKEIPVFSQFPTSGYGYSEETKPMLNTSHGFIPWDDLHHPDISQTNG
ELDGRWIFVNGNNTPRIARISLATFETEEIIEIPNSAGNHSSAFITENTEYVIAGTRFAV
PVPQRDMPINEYKGNFKGALSFISVDQESGRLDLKFQIMMPGFNYDLSHPGRGASHGWHF
FSTYNTEEANSLMEVNSSQNDKDFIAAINWKKFEEYVNNGGGSKMATNYAHNVYDDRTHT
GTSTMVKEVVTVDPTQVPGAVFFLPTPKSPHGCDVDPSGEYIIGAGKLSADLTIHSFTKM
LEAIENEKFDGEAYGIPILKYEDVMAGVVKSGGLGPLHTEFDGKGNAYTTFFISSEVVKW
ELGTWEVIDRKPTYYSVGHLMIPGGNSRKPFGKYVVAMNKITKDRYLPTGPEMEHSAQIY
DISGEKMQLLYDFPTHGEPHYAAGCPAELLASKSQKIYRLDENEHPYAVANPSEARVERD
GNEVHIYMSTIRSHFTPDNIEGVKVGDKVYFHITNHEQDFDVPHGFSIIGQNTSELLIMP
GQTKSSLWEPKQVGVWPFYCTDFCSALHQEMQGYVRVSPASSNIELSWSLGED
>OMIFANIC_02404 hypothetical protein
MKKASIIMMVGPLFLMGLYVFPLWTIMLGAPQYPDPLGMNIHIDGIQGVNEFDIQNIDGL
NHYIGMKTLPKPEEMWEFSTFPLVIGIMIGLGVLIGLLGFFKKVNYKWFIGWFIFMSILG
VLGMYDFNAWMVDYGTNLDPNAIMKLANPDGTPMTYKPPLFGHTKMLNFDVTSLPATGAW
LMFTGMLLTIVASVVGWRNRKAPHVKNPVKSQHHE
>OMIFANIC_02405 hypothetical protein
MNKFLLIPLVATLLCCAIGPSKIAYGEQACHFCRMTIVDKQHAAQLITDKGKVFNFDASE
CMINYITGIDRENIGLLLVTDYNNPESLIEVETATFIISEDMPSPMGANLSAIGTLAEAQ
QLIQDKQGKLYNWNELLQYFKNL
>OMIFANIC_02406 hypothetical protein
MFSIEKQIKETSFEGLSVQKIFKNENAETLLITLEKNYEFPEHSSPRDAFLVMLEGSVIF
TIQNTDYALNCSDSFTFPAEEPHKVYAKENSKFLIIR
>OMIFANIC_02407 hypothetical protein
MLAGKSVPAKTIEVCKKCTYSEIGKAVEAANDYDTVLVRKGTYKEVNILIDKPLVLKGEN
YPVIDGELKGEIITITSDDVTVDGLFIINVGTSYTVDYAAVRVIKSKNFLIQNLVLEKLF
FGIYLEKSENGRVYHNNIIGDAEEEYNSGNGIQLWYSKNIEIEQNIISHVRDGIYLEFAD
DCIIKNNISSNNVRYGLHFMFSNNDIYSNNTFENNGAGVAVMFSKEIKMYNNVFRDNWGS
AAYGMLLKEINDSEIMGNTFQENTVGINIEGSNRITYSNNDFIRNGWAIKSRGACYANLF
TENNFLYNSFDLSYNSKLNDNKFEKNYWSNYAGYDLDKDGIGDVPYRPVKLFSYVVNRTP
EAIILLRSLFTDIIDFSEKVSPVFTPDNLLDIQPKMKQIVHDRN
>OMIFANIC_02408 ABC-type transporter ATP-binding protein EcsA
MIEIRGLYKKYGKNEVLKGVDLAIEEKKIVAVLGPNGSGKTTFIKSILGMVLPSKGDIIM
EGKSIKKEWKYRNNIDYLPQIANFPNNLTVKELINMIKDLRQKKSADDGALVELFKLEPF
LNKKLGNLSGGTKQKVNILLTFMFDSPIIILDEPTSGLDPISLIRLKELIDTEKKKGKTI
IITSHIMNFVEEVADEIVFLLEGKIYFKGSISELKEKTNQPDFEHAIASILTQSYA
>OMIFANIC_02409 hypothetical protein
MLKILKYSFYDLMRSRWSYVYFVFYLVLGFVLLFLNNNVSKAVITLMNVIIILVPLIGTI
FGVMYYYNSKEFTGLLLAQPIKRSLIFLGQYLGVALSLSMSLIIGLGIPFILYGIFRSDA
IWDFSLLLITGTFLTLIFTALSFNIALSNENRIKGFGYAILLWLFMAVIYDGIFLMSLMI
FEDYPLDTFSLTATMFNPIDLSRVLILLKLDISALMGYTGALFQKFFGTNFGMFLSIGIL
ILWVVIPAWFIERKANRKDF
>OMIFANIC_02410 hypothetical protein
MKFVLYALLAIITLNSYAQTEVEDKEAILQVLKQQETAWNNYNLEGFMEGYWKSDSLKFF
GSGGVTHGWTQTLERYKKGYPDKSYSGTLNFKIEQISPIENNSYYVMGRYFLTREAGDAE
GIFMIIFKNIDGDWKIISDTSCG
>OMIFANIC_02411 hypothetical protein
MNIEEFRDYCLSKKGVTESFPFDEHTLVFKVMGKMFALTGLERIPKQVNLKCDPERSVRL
REEYDGLIYGAYHMSKVLWNTVEIESNVPRDLIYELIDHSYELVVDGLTKKLKEELRNL
>OMIFANIC_02412 hypothetical protein
MKNLSLILCLLTFPMVFGQDYVRVDATIELYPETFENIEDLAAMISRDFSTDEEKVRGIY
SWIIRNVAYDPDEYKKFNYNFKNYRERNSKEEKVREQTINRTLSKGIAVCEGYAMLFEKL
CNMQGISNYLVRGDIKTHFNDIGRPFEKIHMWNVAVIDGQGYLFDPTWGAGKYQGKFIRE
PSYFYYKTPPELFIKTHYPELQEDTFLGSMVPRDVYAKWPLIIIEEMTQDDIEMPLTGII
DPETSLGQIEFGIRWDTSVAVSYSFGNEKVEVATSDDNGLLHFAIPFELGQRNLLIYFND
EPAIAYKIK
>OMIFANIC_02413 hypothetical protein
MELLFLGLAVGAIVAYFVFVRFNTSRRKRKSHAQSIVLMERIRTVCKLITVEGDFSEIYH
YENLKSKWVNLLLGKKKALVVIEAKAYVGFDLSQLKMDADVPTRTVRLSNFPKPKLMTVE
TDFKYYDKKNGWANPFTASDLTEINKEAKNHIVEKVPGSGLLEEASKHALETVELIEKLV
ETINWKLDYSDLLLDEKDPKSLSETDEES
>OMIFANIC_02414 Kynurenine formamidase
MIASLQHNNITYNVDLSKPLDISIPLDGTSRNPIAWYLDKPVIEPVTNEDWTGSVSKGAA
INFNNIRFNPHAHGTHTECLGHITEEFHSVQKSLKNYFYIATVISVAPELKNGDMVISRK
QLKGILKGNSSEALVIRTLPNTTSKKSRKYSHTNWPYLEESAAKFIREIGVEHLLVDLPS
VDKEKDAGKLKAHKAFWNYPEDPRLKATITEFVYVSNRISDGTYLLNLQTAPFVNDATPS
RPLLYKITYL
>OMIFANIC_02415 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MVDALCRELVLRREEQEDEIQTIYFGGGTPSLLTSEELNQIFNTLKNNFKISANPEITLE
ANPDDLSVEKVRELAQSPVNRLSIGIQSFFEEDLKLMNRAHNAHEALESISVAKGHFDNF
SIDLIYGIPGMSEERWLENLDQALDLEVPHLSCYALTVEPKTALKAFIDKGVVPPVDDNA
AQRHHTILLEKTEQSGYENYEFSNFGKPGYFSRNNMAYWHGKSYLGIGPSAHSYDGNYRS
WNVANNSKYINSIMAGELPYEREKLTVKDKYNEYVMTRLRTAGGISVTEVEALFGFKYRE
YLLQQAEIHMSNHLLFRDQDTIGVSKKGKFLSDGIAADLFLVNLDF
>OMIFANIC_02416 hypothetical protein
MFNTLRLLVIDPGKLLREYLEGKRKRYYKPVAFFILMTVIYLVTRAVINYDPFGNTTIQV
DDNTQSQLLTQARNFMLLNIDKLLFVFVFTMGLLLKLFFYKKRSLAEFIAISFYLIGIYT
VLTTLNMFYIHYVNPNFQFLAMLAMLVYFCYALVSFFQKGKIIVLIKSLFIFVVGFISYG
MIGFAISFCIIYLKQM
>OMIFANIC_02417 Crossover junction endodeoxyribonuclease RuvC
MANVVNSEKIILGIDPGTTIMGFGLIKVVSKKMQFLQLNELKLSKYDDHYVRLKHIFERT
VELIDSFHPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRQVPITEYSPKKIKMAIT
GNGNASKEQVAKMLQSLLELKELPKNLDSTDGLAAAVCHFYNAGRVDVGKSYTGWSAFVK
QNEDRVD
>OMIFANIC_02418 hypothetical protein
MSHLSNKAKHYGLIALKVLILAATFWFIYSRLSSLDNTAWDTFRTALSGLNLFYILFFLL
LAVLNWLLEIRKWQMLVAKIEKIRLQDAVKQCLSALSAGLWTPNRIGEYGIKPLYFPKQQ
RKKIMALNLLSNLSQMLATILFGLPGLLYFLYRYNIEVPAWKPLSLLFLIAAMLMAGYYF
RKRQLLIQGLSLENLVGFTRRILLRIRWQVILLSVTRYVVFASSFYFLLRFFGTDIEFLN
AAPLITSMYLIASVLPSFFFSEVAIKGGVALWIFSVAGYDEIPVLCTAMAMWILNFVLPA
IIGAFFVGKFKLVSQ
>OMIFANIC_02419 Beta-monoglucosyldiacylglycerol synthase
MIVVHILAIATLIYFLAIFYLTYGVYKLRRFKQMADTTVNQFSIVIPFRNEADRIIPLLI
SLNELEYPRDKFEVILVDDDSTDSSVMVIEEHLQNSTLDWKIKPNKRKTASPKKDAITTA
ITSSRNDWIVTTDADCIIPNQWLKRIDSFIQKQDPVMVCGPVSFQASRLWSLSSQYQIVE
GIALQGVSMGGFGHESPLLCNGANLAYKKEIFQQACGYTGNSEIASGDDIFLMESLRRKH
PERIRFIKDRAVIVKTPVMKNWRDIIQQRIRWGSKTSRQRNWTAKGIAIIITVSNLILGI
ALLSLPFNWQSKDLIIQIGCSKIVLDLYFMAQTHLFLRQKLNFLMIIVLAVIYPFISSYI
AIRSIFGGYTWKGREFRH
>OMIFANIC_02420 hypothetical protein
MKRLLLIFGFVIASCAFTFGQQQYTVDGQTYSLKTEVEGTIQLLWNTIGEDYRYFIKKGN
DIAELKNTRSENGYSEEYKDVLKLFTNDSPGDIDNTKLTLASLKKYFRSYNKRVDPSYDD
SIENIEIKLRLGPFAGVSNAIFTQNESNAILFAAGADLEVVDEVKLRRHSVVLRFKQTFE
NSEFSYNASQFSLNYRFKFVKTENVDVFVNGKFVAYTYSTRDFEVTTMNNGITTTRIESA
SGGDINAPATFGLGTDVKLGKGQLFFTYNDIFGLGVDSNGEFPLDISVGYKFGL
>OMIFANIC_02421 hypothetical protein
MKIPLSILFLLFITTSCQFFETEKISTETFYEEELKTINWNDVDQYPVFASCEQFSDKNE
QRDCFSRELISSLSQAAWDSAIGLHQELHDTIWLRIDVSETAELKVREIQIDSALMRTYP
LMKQALLDRIDSVKLIAPAYKRGIPVRTEFSLPIVVETESL
>OMIFANIC_02422 hypothetical protein
MYLLLTPLLSLALPFIKLESIQDTIPKAQHSEQIDEAIQVMELLPKMIPGEHDGKKVNVE
FALPIIFEVE
>OMIFANIC_02423 Penicillinase repressor
MKQLTRAEEDIMQILWDLDEANVAGIIDELPDPKPAYNTVSTIVRIMESKGFVAYRKEGR
GHIYFPKVKKSEYSNQSINKLVDGYFQGSFKSMVSFFMKKNDISINELEGILKEINKEDK
S
>OMIFANIC_02424 hypothetical protein
MDIILIIIGFLLMLIGIAGSILPVIPGTPISWCGLIVLYLSPSLPFDWTFIIITGIVAIV
IYILDYIIPAVGTKKFGGSRAGAWGTIIGLFVGILAPIPFGILIGPFLGALVGEMAFNQT
HGQKAVWAAFGSFVGFLASTFMKLFATCVFLLLFCWKVWEYRGLLF
>OMIFANIC_02425 Lipoprotein signal peptidase
MIHRRKMLYIGLLIAAVLIIDQALKFYVKTSFPLDGGFKMLGLDWAQIKFTENYGMAFGL
ELGGKAGKIILGVFRILAGSGLLYYTYKSLIQEKRFSFVVSLALITAGAIGNIIDGLFYG
VIFSESTGNTTAEFLPKEGGYSTFFDGHVVDMFYFPIIETYWPDWVPFVGGELFKFNNYI
FNFADLSITIGVVWIILLGAFSKKFSL
>OMIFANIC_02426 Putative NAD(P)H nitroreductase YdjA
MLEVIKARRAVFPAQYNSEVISKEEIQTILEAANWAPTHRRTEPWRFKVFYGESQHMLGE
FLAQKYKATSEKYSEFKFRKILDKTKQSGCIIAICMQRDPLESVPEWEEIASTAMAVQNM
WLMAQSMQIGAYWSTPAYKQYFGEHVPLADGERCLGFFFMGKINGELQEGERKTQIADKT
IWL
>OMIFANIC_02427 hypothetical protein
MKQLLGSLKISVNDQLYLKDPESSQLGRKIIEYSILLIDEIGFDGLTFKKLGLSIGSNES
SVYRYFENKHKLLLYLTSWYWGWIEYQLVFETHNISDNSEKLKNAVEIICRPIVEDSTYS
HINEVLLNKIVINEFSKSYLTKEVDAENKEGYFAIYKRLVHRLEEMIREQDHSYQYPTSL
ASTIIETALHQQFLKDHFKSITDCDKNTSPADFLIDLIFKLLNK
>OMIFANIC_02428 Alpha-hemolysin translocation ATP-binding protein HlyB
MSPWQRLINMLQLDKKDILQVFYYAVFAGIVNLSLPLGIQAIINLIQGAQISTSWIILVI
LVTLGVAFAGALQLMQIRIIENIQQKIFTRSSFEFAYRFPKIKMSELRDFYPPELANRFF
DTLTVQKGLSKILVDFPAALLQIIFGLLLLSFYHPFFIIYGILLLLLIYVVFKFTAKRGM
ETSLKESKNKYKVAHWIQEVARSIVSFKLSGKTNLAMTKNDDLVADYLESRESHFRILVI
QFIQMIGFKVLVTAGLLLIGGILVLNQEMNIGQFVAAEIIIILVISSVEKLILGLESIYD
ILTSLEKIGQVVDKDLEPQDGEIIFDISKEFNIQLDHVNYHVDNGRKKILNDISLDINTS
SRILIEGKSGSGKSTLLRLIAGIIQPTDGNIYVNDISLGAVQLNNYRASIGQSLTEESPF
EGTLLENITFGNKNITPEAIHWAIDNVGLTDFVKEQPKGLNTIIYPEGKQIPYTVTKKIL
LARSIVTKPRLLILKDPLDQFEKEEEIRIMSFLTDSKQSWGLIVISHNPGWKNQCSQSLR
LEKGRIIN
>OMIFANIC_02429 hypothetical protein
MLNITNNKLNKTVDISGFRSGQRVFHKRHFKYFNRFLKIFAGITFVILFLPWTQNITGKG
YLTTLKPNQRPQTIQSPIPGKIEKWYVQEGDFVSKGDTILFISEVKNEYFDPQLVERTGQ
QIVAKELSVGSYKEKVKALDAQIGALYRERTLKLEQARNKLMQAKLKVQSDSIDLQAAST
NLKIAETQFNRTLTLQQEGLKAMTDVEAKRLKLQETQAKLISQENKLLASKNEVINASVE
IGRVNASFSEKISKANSDKFTAQSNQFDAEGQVTKLENSRTNYQIRNDLYYIRAPQSGFI
NKALKGGLGETFKEGEKLVAIMPSDIEMAVETYIDPIDMPLIKIGEQVRIQFDGWPAIVF
SGWPNVSYGTYGGKVVAIENYISENGKYRILIAPDSADHEWPSDLRVGSGANTLALLNDV
PIWFELWRKLNGFPPDYYQPEPDMKTAQKDK
>OMIFANIC_02430 hypothetical protein
MKTRFFIFLLLAFLSANGQTSDSLVLGFREYLGYVKKFHPVLKQANLTIDMAQAEVMKAR
GGFDPKVELDYNRKKFKGTEYYDLLNATFKIPTWYGIELKANFEENEGNFINPERTVPVD
GLYSAGVSFSLGQGLLMNERMATLKKAKIFRDQTEADREILVNDILYQASLAYFEWFRAY
NEVRIFDDILDNALQRFEGIKRSSEVGDMAAIDTVEAKISYQNRSLSLEQARIKYLKRSL
ELSNFLWLNNNIPLELQPDVIPSDTIEAEIDMTLNVTGTPLSAFTLETHPKLRSLNYKID
GLEIDRRLKGNKLLPVIDLNYNFISETPETVNSFNTAEYKGGLRLAVPLFLRKERGDYKL
AKLKVADANFELSATQLTLQNKITALYNELESLETQNRLISEIVVNYEQLLTAEERKFSF
GESSIFLVNTREQKLIESKLKQVSIQNTFLKTKARLFNTLVLPAENL
>OMIFANIC_02431 hypothetical protein
MKKAIIILGCVIGAMAFISADKNDPANNNSLSLEGVWELEHQFLYEDNEVKDTIMNLNGY
RQVKVYTKGKVMWTRFNPADSNEWFGYGSYEVKDGMLEEQLEYASDAMMRIVDTVQVFRF
ELDLGKERYSQIVRDSNGDLESSENYIRIE
>OMIFANIC_02432 hypothetical protein
MKKIVLIALLIGFIAPMIAQEPEPLDEIIVTSVNYRYLSAVENSKAPIPVWSVEKEAAMF
DVTDSDVFLDDFNTYHVTFRIPDGVLVAAYDQDGEIIKTIERYKNIQMPDEVKLAIKDKY
PNYEVVKDIFKVTYSLKKGANKEYRVKLKNGDKIIRVTIDDAGNFM
>OMIFANIC_02433 Thiol:disulfide interchange protein DsbD
MRKLALILLIAFISVPFATVTAQDSINWIDITDLEEEMSRNPKPVFFDVYTDWCGWCKRM
DKTTFRNKKVVDAINTNFHAVKFDAEMKETFTFQGHEFKFIDSGRRGHNELAAALLNNRM
SYPSYVALNEKFERITIIKGYQTVQQFMPILTYLSNKHYLQQTWEEYKSSLKSD
>OMIFANIC_02434 hypothetical protein
MKKTSFFTVVLCLVNSVIFSQTTHTISGQISDTNDQGIPFANVLLMKASDSTLVKGSLTN
EDGAYSINEIPTGTYYVQGTYLGFQSSRTDNFELRSHLELPVIILTEGEALGEVVVQARK
PLYTQKVDRLVINVENSIVSSGGTALEVLERSPGVVINRQSNDISVVGKEGVVVMINGKI
SYVPTSSLVQLLDGMSADNIESIELITTPPANFDAEGNAGFINIVMKKNSDLGLNGSYSL
SAGYGKGATSNDNINFNYRKNDFNLFGSYSFLLDKRDQIIKTSREFRQDGDLISNASVTD
REPTQRNHNVRLGADYQVSDKTILGVILTGFDNKWTMDALNNSMDAVNGMPVGFVELANT
ERNQLKHFGGNFNIKHDFTENQFISMDVDYLFYEFDNPTDYTNRFFDGSNTFLRTELLES
RKETPLTTLVGKLDYSNRPTDKFKFELGVKGIKNDFENDVSVANQIDGVFVFDPSLTNFS
VLDESILAGYVSGEYTIDEKTNVKAGVRYEYTDSKLDTDTEGTVVDRQYGIWFPSVFLSR
QWTEDLSMNLSYSKRITRPTFNDLAPFVIFFEPNTFISGNASLQPAISNAYKYDINFKNY
FLSFSYTDQDSSIANFQERIDPETGRLIFEAANLDYTRTFSIIAGIPVKISDWWRTQNNL
TFVNQQVRSFYLEEPVEQELGIFSVNSTHSFKISDSFSAELSGFYNGPGFFGNARYDEVY
GINLGLQKKFSDKWGTLKFSINDILDSVEFNGGTDLPEQNILTRNTFDFNNRTFTLTYSR
NFGNKELRSARNRETGSEEERRRIN
>OMIFANIC_02435 hypothetical protein
MPQLLMNSKTTLLLILILFLSLNGFAMRCGDAYQNATYAVEHTEKALGSNNLEHLKQYAL
RAKEAIEKVYVDTETCGCTEANNASYDTLDHLDKALSKDKYEVARFYVKSALSTTKSVLI
SLDLCNEPDPTYTLMVDENNLVSQEQELLAQQQQLIQKQKALEAQLKTQKELQQQLQREK
ERKLTVQKKIKFEAEGSLLELETVINRFIRIMECDQYEPISSEAYTRTLEQLEVESIKAT
KTFYSIKAREMADRLIAVLAGCD
>OMIFANIC_02436 hypothetical protein
MKSIAVKISATTIIYFILIVAFALRLYNLNYAGLWNDELYTANMANPGRSISNVIFRLKL
DIHPPLHNILSNLWSRIFSYNDTSLRVFNVLIGVFGAFSIYKLAKLLFNSKVALYAMLLV
VVNSFLIQYSQEVRAYALLFLLSNFSYFFYVKLTRGLLTRKNIIGYGLVTTALIYTHYFG
LFVVASQVIILFLVVKWKDIKANLLRYGLAFVIPGLLFLFWAPTMYKHLTKTLGSWRVKP
TPEILIEYFQGFFNDYIISSIALILFFLTGLYFLLKLFIKLPKVKDFVGKRSKELLIIFL
WALIYFLIPYLKSTFSSSMMGLKYFIAMTGPIIIMLAFYIDRIKGSQIRNGIVNGLIIYS
VLVLFLKSNPYYHSATSYREIAQEAKAINNDAPVLYLCKDGFYFDYYLHQNNFMDRREDF
VSFLTLVKKDSPKEYFVFLDLRLTPEKFKNGVPVIPGYEEVSSKTFRNAANIKTVQLVHY
KKTDQSI
>OMIFANIC_02437 Decaprenyl-phosphate phosphoribosyltransferase
MKAIFQLLRLNQWIKNLFVFLPVFFSGNLLNRELLVDSCFAFLTFCFTTSMIYILNDYKD
VEKDRMHPVKKHRPLASGKLSKRTALLLFVPLIIGLGLVVFYRFDLNDTWPLIVYFVLNL
LYTFGLKSIPILDVGIIAVGFVLRVVLGGLVTGIIVSKWAFLLTFALALVLALGKRRGEL
LSTDGSSRRSLKGYNLSFLDAALTSTVTITIVCYIMYSVSPAVENSLGFKHVYITSVFVI
LGVLRYLQQTFVYSSTESPTRLLYKDLFIQVTILLWISTFALIIYFK
>OMIFANIC_02438 Decaprenylphosphoryl-beta-D-ribose oxidase
MQKKKEISNWGNFPTSISSEQWILNSKDPGITFNQTEKIIPRGNGRCYGDASLGENIVST
RYLTNFLELDEDTLEMECESGVLFSDLLDLLIPKGLFLPVTPGTKFITVGGAVAADVHGK
NHHKDGCFSSYVISFQLLTSDHKIINCSKEENSELFWQTIGGMGLTGIILRVRFRLLQIE
TSYISQESIKAKNLDEIFDLFEDSKDWKYTVAWIDCLQKKKNLGRSVLLRGEHASIDDLD
QNKRKRPLLVENKKSFSIPFFFPAFTLNWWTVKIFNLLYYYKQRSKKKSAVVSYNTFFYP
LDSIEGWNKIYGKKGFIQYQFVVPLETSKEVLREILELIAVSRQASFLAVLKLFGENSPE
AINSFPMKGYTLALDFKVTQKTLELVPKMDAIILKHKGRIYRAKDCVSDPRLTNYLQLPE
SNFESLQSIRINSKI
>OMIFANIC_02439 Decaprenylphosphoryl-2-keto-beta-D-erythro-pentose reductase
MIVLGANSEISREFVELMIQKEGLKKVYLFSSNVDTLESFGQHLKVKYGIDAGIYHYDLL
ELPDFDFSQLDYNLVFCASGYLGSQPDIDLSHKMDNDKILKINYSKLVLALNAISMDLIK
KQTGTIIALSSVAGERGRKSNFIYGSAKAGFTVYLSGLRNYLFSHKIHVLTVKPGFMNTK
MTAGLDLPKRLTISPEKAAKLIYKGYKRRKNTIYIAAIWRYIMFIIRNIPEFIFKKMSL
>OMIFANIC_02440 hypothetical protein
MSKLFLYDFDGTISRKDTLFDFLRFTIRKDKLYFGYLVLTPIFVLTFLRLSKRSFAKERL
ISHFLKGKTRAELAQMSEKFLNNMLTEKKFRTSALASIKDDKKEGAVYIVSASLDIWLKD
IANHLGVHLICTWAKFENNVFTGKFLGPNCNNEEKPRRVQSEISLEEYNSITYYGDSKGD
LAMKEIVDHFEYRKFE
>OMIFANIC_02441 hypothetical protein
MTDSKFMKKILLLVLLFTATVSFAQVKLQGVVKDSISGSPLELANVIAIDQNTSTMESYA
VTNPEGRYVLRLGRNGTYKLQVSYIGMKAVETTINTTEEDITRNFELSADNTLDEVNITY
EMPVSVSGDTLTYNADSFNTGTERKLEDVLENLPGVEINEEGQIEVEGKVVNKLMVNGKD
FFDGDSKLASKNIPSKAVDKIQVLRNYSEVGQLSRVSNNQDNVALNIKLKEGKEKFWFGN
VTAGGGFSPEDELYLLQPKLFYYSPKFSLNFIGDLNNTGEVALTRRDIRGFGGGFRLPSR
TSGTNINLGDNSLNFLTNQGNALEIESKLAATNFNYSPNQALDISGFFIFNSSRILSKET
SFVQYTDSDLGIPDEATEQRSRERSDQGLLKLSASYSPNVNNQLDYDVLGRFSNDTQVQN
LFSSVVGNTSQFEEVKPFSINQNINYYYTLNETNIFAFEAQHLIKDEDPFYSALLENDPT
NNDAMDPDERDAFDNTADALGLNTTLNNYNLGQNRRIKSNQVDAKLDWYNILNDRSNINF
TLGTILSRQEFNSDIFQFLENGARFNPTPTINDGRAGNDTEYNFSDVYLGVHYRVKAGKF
TITPGFSVHAYANKNSQFNETFEDNFFRLLPDFETRIQLKKSESLTFNYNMQNQFTDVTR
LAQGLVLNNFNSIQFGNPELQNALSHNLSLFYRSFNLFNYTNVFARVAYSKNIDQIRSLT
NFENVIRTSTFFNSDFADETFTAFGRVQRTFGKIRASLNANFNYSKINQFIQGRRSVNEG
FTQSYTPGVRTNFRYAPNVSVRYRYSISTNNQGTNETKFITNAPSIEFDAYILKAFTFRT
NYTYNSLSDEDGEINSFQSWDASLSYRKDRDAKWEYEIQATNLLNIDSQIRNSANNLSVF
TSETFIQPRFVTFRFVYTL
>OMIFANIC_02442 hypothetical protein
MKKFIILFLFLPFLSFAQEGRIGKVFEAVNAEIARSGEFQQFQIFNQQTRSSSNDYAESV
NDGVILEMDQEMINNLRRQSPARMSLTLPFRSTGETVALDLIQVEVFSPSLTAVTDTGID
LANTVDFGVHYRGVIAGNQNSLVSISIFETQVIGFISNSEGNFTLGRLSDSSSDHILYKD
TDLRQAQSFECFTEDDNEGYTAEQLSNPGNRDPGDVIEIYIEAGSTVAGSFGGDLPNTVA
FLTGVFAQCYALYANDGISARTSSMFVWTELDPYTGTNTTTKLNQFKANLPQNGFDGDLG
HLVEVQNIGGQAAGFSGLCAANTDDSLCVSGFLGTSFNTIPTYSFNVYLIAHEMGHLMGS
RHTHACVWNGDNTAIDGCAGFTEGGCPLPGLPAGGGTIMSYCNNTGVGVNFNEGFGPQPT
AVILNNIDAVGNCLVPIGTLVPPTAVCTNYTAVLDTNGTVTIVPADVDGGSYDDLGITNY
TIDIDTFDCDDLGDNDVLLTVTDGDGLSHTCIAIVKVVDETDPVVTDCPADFTEVIPQGT
QYELLDYTGTVTATDNCPSVTISQDPDPGTLLDEGVYTITLTGEDEDGNEGSCSFELTVE
FILANYDASLLSSLALYPNPAFEYVQLSNPQNLELERIAIYDITGRLIQQEDLTDMGTEV
SIDVSALAASTYFVIISNDESQVAKQLIKK
>OMIFANIC_02443 hypothetical protein
MKRLSITVISAFLLFLSCKSKDGLLMESECGKCEDAVIRNYGDPALDGCGWVVDVSSTIY
KPENLPEQYKIDSLDVMIGYKVLDSVNCGLIRNAHPGISITEIKKKN
>OMIFANIC_02444 Lipopolysaccharide assembly protein B
MSHLKKLSTFIMMIALLLVISCKSSEESKVTFPENDIPIGETSQEALKEFMEGLKLYDQG
DFIKSRPHFRKAIELDPDFVSGHMYTAYTSNSVKDWSENRDKFLAMRDKANEAEIIMMDL
IEADLDNDTAKELELSKALVEKYPNSARAMDNLAGYYVGMDEVEKAREHWMKAHELDQDF
IPVISSLGASYLFTSPKDFNKAEKYMQMVVDKLPESSQARIGLGDCYRAQGDLGKALASY
KKAAELDTENEVAHSKAGHANTFMGNYELARQNFKDARKVSEFGTGSYNFEAYTYLYEGD
YKKALAFLQEGAEMFDKMDIPESNKNGAKMGCARDCAMIAMHYGDADHLKELVAMMKPMS
NQFSEEADDPITTLYQKANMHYWDAMASVTEGDYEAAAAKADMIKAAMETVNDPNKLRSY
HRVHAFVNYKKGDYDKALEHMAELNEDNVYIKFWKAKAHKMKGNDEKSMELFKEIANNNF
NSVAYALILNQAKEMTAAVN
>OMIFANIC_02445 Putative short-chain fatty acid transporter
MITKLGNYFSEGFKKFMPNSFVFALILTLIATLAAILWVEASFIETVESWYKGFWILLEF
GMQVTLILITGYSIALSSVANKGINFIARYIRTPKQVYVFVIIIGFLFSLISWGWLVITA
VLGRELAMRVKGLNYYYLIACVYFSGGLWVCGLSSSIPLLLNTENNFLLEQQVLTTTLPT
SLTLGSILNLSIIAMYFVMGPLLFWLLAPKKVIDLPGLLHKKSGAEPSIKSEAKDSSLEM
PALSDKLNNSWILQYVVAAMGLVYIVYYFSTKGIDLNLNVMIFIFIILGLFLHKTPIRYG
IAMQRASANISGILFQYPFYAAIMGIMLYTGLGERLADMMASVATVDSYPFFAFLSGGVV
NFAIPSAGGEFAVIGPSILTAVKEIGAGLDPGQVNVMVAKASLSVAYGESLTNLLQPFFL
LIVLPIMGKGIKVQARDVMGYLIIPFVVIFIILALLVTYIPIL
>OMIFANIC_02446 hypothetical protein
MKNLFLAILSGLILLTACSKDESFEPIDEQSNEVVYVFDQNMDVADFSNVTIDKIQEISN
NRGPGYNEGFAHSSGFYKPQCKDPMILSWFANLDDTGCHGTAELQIIRPNFTMHLAMETE
CINAEGNKAVYGAIITEVIEISGNIPPITEMWRLYFEVTDNYQMGSGGFDHDQISNRLIL
ASPRSVSLCNVYPPNHPMWSSEGHSDVMSPGFVKVTDLTE
>OMIFANIC_02447 hypothetical protein
MKKKKFNPIREIVADMHVDGVRFNEQVLAALKAQELNRTTLLRGTAEIKS
>OMIFANIC_02448 hypothetical protein
MLRTYNKYGIIIAISLIAYFLFMKLFGLHQYPALSIFNALLFGGGIYRAIQTHMRDRPDY
KYQDLWQAGFMSGAIATIIFTAFMAVYMYQIDTVFASEILTGWGLNYNAGVLVMLFSMVL
MGMSTSIVCVLTYMQRFKKSWNPTKPL
>OMIFANIC_02449 hypothetical protein
MTRIYCIICLLITLTTAVSQEGIEGTVDNYTSGEAEIYSGIKTPIKIGTIDENGTFQILL
DNTYKDQLISSVDADNAKDSQWKTSLPNLERSYGSCYNGELDIKGGDQTMIALSQLGVFS
VANFEEQKLYGKIMYASDLEFAKAIMSFGQFKVKKGYQLDWYYFESEASVKGSCSLEFYP
SGDETSFTQTSNYDLEFKPGWNLVKYEIEEVFTDESGKEYIMKDHSMVLDSLPDDVQIIF
LE
>OMIFANIC_02450 hypothetical protein
MNHFPGKSLIFYFGGMSLFFKTGFPLKNYFSFKSESVKINSFTTRDILIKTIN
>OMIFANIC_02451 tRNA pseudouridine synthase C
MSTSHSHIVPLLTPTQRLQEYGVGLFDAIPTKSALKKALKKKQIQVNGEIATTATIIKGG
ETILFTPLEVHGSDKKLNLKLKVLFEDDYLAATYKPSGILVSGNSFRTIANALPQNLIKS
EQADAVTPQPVHRLDYATTGILMVGKTAESIRRLNKLFEEKEIEKTYFAVSIGSMESRGT
IKEPIGGKEAITYFEKVATVDSSRFKYLNLVRLQPKTGRRHQLRIHLAGLGNPILGDKDY
TPEPFILKGKGMYLHAFSIMFVHPFTNEPLRLTAPLPGRFKKIFKKLL
>OMIFANIC_02452 hypothetical protein
MKHLIKQLLVLIIMFSVVSVYAQNKRSLNNYREPSKEGINVFESPKDTAVIKAFDGVRVR
IGGSSTLQFQAIDHENGRPAESTIMPGSPWFSDDGMGGNANLPLKEIGSNFNLATANLDL
DVELHDGLRMHLRTYLSSRHHPEAWVKGGYIQVDNLNWIQEGLLGDVMDKVTVKIGHMEV
NYGDQHFRRSDNAQSIYNPFVGNTLLDGFAQEVGGEFYYRNNGWLAMVGLYNGKLNQAVS
NPETTSPTLVGKLGWDKQLSDDLRLRLTGSVYNTAHTARVYLYGADRGGSRYYFVMEDAN
ASSGGRGYFTSGRIDPGFTNEVTAIMINPFVKYQGLEFFGLFETTTGRADSEFDASGNNT
DRNWTHIMAEVLYRFGNNENFYVGGRYNTASGEMRGMTSDVTINRFNIGAGVFFTKNVLA
KIEYVNQEYSDFPEGSQFNEGKFNGVVIESVISF
>OMIFANIC_02453 hypothetical protein
MRILKSLVAILLILIQVNTLQAQSAAEIEPEMALKSLACDPLTSSFVIQGTSSLHDWEMI
SNACNGKLEYNDGDNSINLEHINIKVGVTTLKSGKRIMDKKCYNALKHENYPNIIYRFKK
INSISKNGNSKYKASLNGSLDIAGVVKPVNIDVDIELKDGILNIKGSKPMKMTDYDVEPP
TALLGTLKTGNDITIVFNLNFIVL
>OMIFANIC_02454 hypothetical protein
MKKNDSLFMVARTALGLFLILYALNRFFHFLPSSYGAMPEVTQDFLDSVAIYLPALYIFE
IIIGLFLIFNKWTAFILIVLAPLSVAFLIFSISNGEFSKAWPAYVVGLINVLLIVRRWDS
YKPLFK
>OMIFANIC_02455 hypothetical protein
MKAKKISFYVLVLSTGIFFSLNSCQKEPTSINPDNDQQFYVLNSADASIVSNDIGTISIS
NVKPGISQRRPSKSTNGHIRTHSGLAYSFSAKENSGGVHGQTQTISGWPGVIESMHVRSN
CITVIDNRAFYGGVITQIEVGPYQPFTVGWEVYFAVEDNGEGNNAESDRYGIAIFLLPPG
LDVNEVLPIEFIEYYGIETWCDVWPIEYEEGQIPFLDGLAPTNVQVK
>OMIFANIC_02456 hypothetical protein
MFIKRKFNLKYSALLVIIVVLISGFTTPERTGKRIIKYLMSGKVEKIEKYLMEKSEFIDF
VNSMSRKPGQEQINKMLENYEEAQEAYLLDFVSLNDEAWGDLQVDRIEYEYQIGKPGKDE
TISWPESKDYEPKNSPDEQLKVNFSFHLKSDNKKYLGSLDMINYKGKWKLFHLLKPFTIT
EVD
>OMIFANIC_02457 hypothetical protein
MSFKSSLVVCLLIINITFSFSQDVDKNPPWANYITALLTNYDGQNLMIMKGQFFYRTEFQ
SKPNIMKMSFLATDPDEQSDPIFFDALGYVYIKSDEGYIKTYFDTVLFPLIPFLSQADEF
KSDVDVELGIDPLPDSWPLLSLVTKYNIGHFEGKDHLVKKSQFRREDGSLVWTKYSAIDP
DNLGNSIVFDKYGRLKMIITPQGTIQYNYFYSEDSADQISDFPMYAKHEPNMGEMMVGLL
ISLFGGLGG
>OMIFANIC_02458 hypothetical protein
MVMKRVWILSLIVLFISSELYTQEREVKVKVYKTWVTTIDGGKIKGYLRSADGEGIIVNT
SRDLMGQDIVKLPATELSEIKIRKKSSVLIGTVIGFTVGASFGAVLNDSDDSGSGWDLTP
DYWDALAVGGTAAIGAGLGALAGSGRRSFEINGNLETYNEQLSLLQKYSYLVE
>OMIFANIC_02459 hypothetical protein
MLYRILKWLFYPAVNGYFRGISIKGRSNILESGPIIFVANHNSAFMDPILLGIHIKQSLY
FLARGEAFKSKLSSAIFNFLNMIPVYRPEITPDEIHKNKEVFERCFDHLQKGKTLLIFPE
GFSKTVRNLRRLKTGAARIALGAEDQKDFNLNVQIVPIGINYSDPHTFRSDVFINFGRPI
EIAKFKEDYLKNEKDTVLKLTKDIKERLKELLVIVKDEKLSKLVIQIETLYRNRFKDPTD
IYEEATESFKLSKDIAMAVNFIQKESPGKMNDLRSEIDRYFKKLDQLKLRDEQIKTGKNR
LRLPWNVFYFIFGAPICVYGFLANILPYTTVRLLSAKIRIREDFIGSLKLALGAFVFLIF
YILETVFFGWMINWYWSILFALSLYPAGLFTINYIGNFYLFQSDFRYARLFKRRRDLIEQ
LKLTRLELMKALEELRKLDLRNIN
>OMIFANIC_02460 hypothetical protein
MRRTYFISFLIILFISCSSGGDKKLTFGSLDLYYTSDITTYEAEDVGDYFSGIGFGIGDT
KEVVKLSKSNDRYMVQFVMPDGQVKLENIWKRYGQGISQNVLKGAPVDVDLCDENFNSLK
FLGSD
>OMIFANIC_02461 hypothetical protein
MKKQTILMLVVLGLVPILAFTQVQVGSDILSPGDGDILGLSMNEDGTRVAIGTPLYDGVR
GRLRVYSYNGSEWTQTGQDIIGETAVDFTGFSADLDAPGDRLIVGSPNHNTNQGRVVVYD
YDGANWVQVGSTILGANPSDCGRNVSISNSGTVIAVGESGTNNGTGRVRVFDFDGSDWVL
KGQELNGQEGGSAFGFSLDLNDTGDRIAIGSPNFEEGSIRMFEFDGNAWNPLGQEISGDA
MVDRFGEYVSISGSGYRIAVGAPGSDIAGENSGLVRVFDYNGQQWQVVGQDIFGPSGISW
FGLVSLTNSGNALAATKGGANDAFIYEFENNGWVQKAQLSDAASVAFNGNATRFAAGGFE
LTRIYDLSGVLGTEQMEHQQGVTLYPNPANDLIYITGNDDSLDFEIYSMQGSMVAKGKAD
EEINVSHLPSGIYIVKLFDRKAASYHRVLIQ
>OMIFANIC_02462 hypothetical protein
MKTKILFLIVGLICLTTNSQIQFDEHIIGPIVLPRVVKAADIDGDSDLDVIAGTSGNWSI
VWYENMDGQGNYGPKNGINTTIGADSHSLHIADLDGDNDMDILVANNINHILFWFENTDG
LGNFGPEQYISTEAASPSSVYASDLDNDGDMDVLSASTSDNKIAWYENDGLGSFGPQQII
TTNALGANSVYTADMDGDGDMDVLSASTSDNKIAWYENDGIGSFGPQQIISLEAEQPGSV
YACDIDRDGDVDVLSASWADNKIAWYENGGLGSFGPQQIISTNAEGAGSVYADDLDDDGD
MDVLSVSYSDKKIAWYENDGLGSFGPQQIISIDDEVPTSVYADDLDGDGDMDVLSAWPEA
YKIAWFENLGPLGIEDHNSTRFNIYPIPTKGILNFESNTTIIQIDIYNQLGQLVFSANDT
NTIDISSLDQGLYYCKVLDENGTTGSKKILKQ
>OMIFANIC_02463 hypothetical protein
MKTKFTLLLAAILVMLNITCSKDDVPEDNIDLTGSMSAIVNGELIEFQIAERNKWSLYLP
GNAGKGCYLNFTEIYGKIYGEHIIVLLFKDTLRVGTYDLPDSAYSDLTNNKSYSQKNYCD
GYPDGEVIDCGGSLTITSRDTYRIKGTFWFNARTNKWSCEQTDEYVEVRQGKFDIYRGGN
AAYPLCRP
>OMIFANIC_02464 hypothetical protein
MKTKNIKWFAYILTSLMLLQSCNTYKKVSVSSDETITSNTNSAQQTEERSDVFVRVFDMQ
GKKIEKGKIITISDTSLELFRKRESTTIDVRSIGFIKTKRSIGHNFLVGAVAGTLLGIAT
VTIDEDYSWSDDGRWVFLVPTVIGAIEGGLWSFFKNSKTIIIKGDLAKWQTLKTNWESSQ
EFIIK
>OMIFANIC_02465 hypothetical protein
MKQFYLLMAGLIGMVSFSNAQVTIDVDANDPWEGFMNVFEIDCSTFVFNSGWAVEDLKTE
INTGANTITLKPNFNTYCDDPTDPFWVNQTTGEGNKCMDANTLVADNTLLGQEITFQGFV
VSNDLDAGYTTKAYIKVFNADFSVLKEESAPLVAGENFVLNYTNVETEDANVQYGFQVLG
RNANCADEPTLGSVVVTQFTLGVDDVNAVNISVFPNPTTDQLNISANETITNITIYNLLG
QVVLQQTQDTSNVTLDVSQLPTGNYIARVATDSGSQNLKVVKR
>OMIFANIC_02466 hypothetical protein
MKKNLLRLFFLIFTTSLLGQANKVTVSNATDGQRLIVDGKEIMVNGMNWDYIPIGETIAT
TTYQFWNQPDDIIKDALDAEMALLKNMGVNVIRQYVGVPPKWVQYIYENYGIYTMINHTF
GRYGLTIGGAWQPNTDYSDPRVREILKKEVTQMANDFKDTPGILLFMLGNENNYGLFWDG
AETEDIPMEDRRSTKRARPMYKLFNEGSLWIKEVVNDRPVAICNGDLLFLDIIAEECTDI
DIFGTNMYRGTSFGDAFERVKNEYGKPLLLAEFGSDAFNAVQNQEDQQAQAHYMVENWKE
IYANAAGLGKTGNSLGGFTFQFSDGWWKFGQTKNLDAHDNNASWENGGYKFDHVEGENNM
NEEWFGICAKGPTNERGLYTLYPRAAYYALKEAHQYDPYTMGATMGSLEEHFGKIQIIDA
VLRARGDKALAGGGGGSGGGGKIRLSTLRAEITTFNTGGKRITTPEDPVPNDPNTYPNQL
GFDNMESYFIGVEGNPMPGLRANVVANVLGNVAANPINEIFYENRGRPILVESSTGENQL
ITDNNRVAIYQADFSWNSKYVNMTGFYRTGHYHWGYEGDFFGLYPEANYGPNLDIYNGLT
PFGFEFEGKKELKGLKVAFGPELWWGANPAILAKYSTTIGDYAVTGIFHEDISEPRQAVT
SIAIPQPRTRRATLFTSRKFGKWEVGVGGIWAGQPLNDREYQIVQTDANGNQQVLVNTID
GNDNWGGKAKVTYTGGKLNWYASGAAQGLVANGGPDATRTFTGWRLKDTGSGNQYNFLTG
LTYTIGNLQIAPNFMWQEPIVDPIPIGAPAPARSRNILDDPFVVRANRKTTAGEILLTWD
PTPGSWFYEWDNDRAEDAPFAASLGFNYRSLSTTQDASIGFFEGIRDPIAFDGAPPAEDL
WEFNGRVVSKLSTEFGLVANFYGGNGQANGPDDRVIYRYGGDIRAIYKKIKLTTEVKIDD
WGPFDYHRDFNLTYPFQFMADLSTTVGKPNWFILPNTRLGIRYIYRTTDNFSPRFEFQNP
IDQGFPNGNEWEIRTYVHINIGK
>OMIFANIC_02467 hypothetical protein
MKKILSKRTLVYLLPAVLLAFIVGCQPDDNNLPEASFPDIAEVFLDVFSPGLQYDAFGTS
NVTAFDVDNDVAYQSSASLRFDVPNTSDPNGGFAGGVFTVEGGRNLTAYNVLTFYAKASK
GENVDIIGFGLTFQGERYRTDALGLQVGTDWQQYFIPIPNGAKLDREGGMLWLAEAADDG
SSYQLWIDEVKFENLNTIIQESAAILEGQDQVISDNVGDTFAITDASVTSNLPNGLRQTV
SAAPAYFEYTSSNEAVATVDETGLVTVVGEGLAFITATLNGAVVQGSLQVGMEDLPPSPN
VDDSNADAVSMPVGFESTTLNYDLQGFEGADSAIEDNPDPSGINPTGRVVRTTKTNGAQF
FAGTLLNLEEPIDFSTSEIFTMKTWSPKADIPVRLALENQAIGGDSQIFIDVNTTVTDQW
EELVYNFTGQIDSSIAYDRVIVFFEFIPELAGDGSTYYYDDLYIAGSDPVNGGGGGGGGD
NLLSNGDFEGGDTDWFGNAFNIQCDGGNCFNFAEILVAGNPFDVNLSQSVEIVQGESYTL
KFDASTDPVTANRTILAGIGLNEAPFTADTEVVNLTDTTQTFEFTFTASFGLPNSRVLFD
MGAETGVVVIDNVSLVQN
>OMIFANIC_02468 Beta-glucanase
MKLKLGIAITLLCGVLLTTIWSCETDDEVGYEGAELRLVFEDNFDGAEGESINTDNWNFE
IGNGENGWGNQELQYYTDRPENVSLDGQGNMVITARRESFQGFEFTSARITTKDKVEQKY
GRFEARIKMPGGRGIWPAFWMLGANIEVEEDNDPNTVPWPFVGEIDITELRGQEPSKTIG
SIHGPGYSGGGAISGEYELEGERFDKDFYVFAIEWHPDYIDFFLDDVRFNQITRDDLPQG
VEEWPFNESPFFMLMNVAVGGSFVGFPVDATPFPQEMVVDYVRVYDIID
>OMIFANIC_02469 hypothetical protein
MTKEPIYIGSTPASNDKSEIKGELTTIDNETYYKISNCHLMRPFFMSLVSDSNHWMFISS
NGALSAGRKNSDHALFPYYTDDKITESVEITGSKTVIRVRKHDKIFIWEPFSERYEGVYA
ITRNLYKNSYGNKVIFEEHNKDLGLTYQYQWNSSNIYGFVRKSTLINNDDTTVELKVLDG
VQNIIPFGVGEATQNGTSNLVDAYKRSELMPDSGLGIFALSAIIVDKAEPSEALKCNVVW
SLGIENPKYLLSSLQLDNFRNGETLHQEEDIKAEKGAYFVESDISLSAGSETQWMVVANV
NQNVCDITEISEKIKSDSGLMQEVQDDIDLGTARLLQLAGSSDAMQLSTDKLRNLRHFSN
TLFNIMRGGIFDNNYEIEKWDFEKYLANANKKVTKKAQDVLSELPDTFSVSYLKTLAYSS
DDKNFRRLSLEYMPLKFSRRHGDPSRPWNKFSINTRSEVDGSKILDYEGNWRDIFQNWEA
LSLSFPEFLESMIHKFLNATTFDGYNPYRVTKGGFDWEAIEEDDPWSYIGYWGDHQIIYL
LKLLEILEDHDPGKLGSYFGQDLFVYANVPYKIKSYEDLLRNPKDTIDFDFEADEKINIK
RSQLGADGALLRDENFFIYKVNFIEKILATVLAKVSNFIPEAGIWMNTQRPEWNDANNAL
VGNGVSMVTLCYLRRFLKFFGKIIDTASLMETEISEELLEFFNSVTDTLKTHESLLSGSI
GDTDRKSVLDGLGIAASNFRNQVYEQAFTSNKKSIQLHSISDFIDVTLRYLDHTIDANKR
DDNMYHAYNLMTVKGNGVSISYLEEMLEGQVAALSSGHLNPDECLALLDGLKNSALFRDD
QYSYLLYPNKELPRFLEKNIIPETAVNKSQLLTQLLEDGNGQIIKRDITGKYHFNGNFNN
ANRLDEALDTLDELTYGKLVTKERQLLLDMFEEVFNHKAFTGRSGTFFGYEGLGSIYWHM
VSKLLLAVQECCLKAIEKGASDTVVGKLLEHYYEINEGIGVHKPPELYGAFPTDPYSHTP
SGKGAQQPGMTGQVKEDILSRFGELGVFVKEGKLYFNPCLLRKTELLTEPEDFNYVDVSH
QKQQIRIPEDAMCFTYGQVPVVYLISETEGLEVHKRDGSVEKFNTLSLNADTSEHVFNRS
GEVIRIDVHIPKGYLK
>OMIFANIC_02470 hypothetical protein
MSTIRNILVLAGLIILVVSCENATPHKEEQKMQKSITAEDILGNPDYLAISYGGYRMKSR
DSQPTLKELKEDLRILHAMDIKVLRTYNVQLPHASNVLKAIRELKTEDTGFEMYVMLGAW
IDCLNAWTDLEPDHNVESPDNAAEIDRAVALANEYPDVVKVLAVGNEAMVRWATSYYVQP
EVILKWVTHLQDLKAKGKLSKELWITCSDDFASWGGGDESYHTEDLEKIMHAVDYISMHT
YPYHNSHYNPDFWLVPEYQESLTKLQKIDSAMTRAKKFVINQYNAVSNHMKSLGIDKPIH
IGETGWATTSNGYYGPDGSRATDEYKQALFYKYMREWTNANNISCFYFEAFDEPWKDSHN
RLGSENHFGLFTVDGQAKYPLWDMVDRGLFKGLSRGGNPITKTYDGIEENLQLEVFPPPS
RALIPVNH
>OMIFANIC_02471 Glucuronoxylanase XynC
MKGLSKYGLIILLTTIMACKSEKKSEKSLEVEVYETSQKGNKLTRISDFPESKDSLVIQL
RPEKELQTITGFGGAFTESSAYLLNKLSKKQRDTILQAYFSKDGANYSLTRTHMNSCDFS
LSNYSYASVENDMELENFTIDEDRDDLIPMIKDAMAFSEDGFKIFASPWTAPPWMKDNKD
WVGGKLLPEYYDTWALFFSKYVDAYKEEGIELWGFTVENEPLGNGNNWESMHFTPKEMTD
FVEFHLGPKLEADGKGDLVIMGYDQNREHLNEWVDEMYRDENSSKYFDGTAIHWYASTYE
VFPDALQYAHNKAPDKYLIEAEGCIDAQVPVWQDDGWYWKKEATDWGYDWAPEEDKHLHP
KYSPVNRYARDIIGCLNNWVDGWVDWNMVLDKQGGPNWFKNWCIAPVIVDPDSDEVYFTP
LYYTMAHFSKYMRPGAKVIDVDKPDIEKFMVTAATNPDNSIAVVIFNEEPVARDYTLVLN
GKSVNLRIDGQAIQSIVIPPSSE
>OMIFANIC_02472 Glucuronide carrier protein 
MSQYKTSAKDKVPFIQKAAFGSGHLVNNLMPGALAIFMFFLLTAFGMDPFLAGLLGGLPR
LVDAISDPIMGYISDNTNTRWGRRRPYIFIGAILTGLLFILLWQMDETNTQDYNFWYFLI
LSAVFILANTTFSTPLIGLGYEMTSDYNERTRLMGLANIVGQIAWMVVPWFWVLIADENL
FETQAEGVRKLSIIVGVIAIIFGVLPAIFCRGIDSSKIENREEISFKNMLGIFKNLFKGI
IQVFKHKPFLRLCGATFLVFNGFQIVASFSFFIILFYLFNGDYAAAGSWPAWFSTILAAI
TAFIVIPIVAWMANKWGKKNAFIISTFISIIGYGLKWWGFNPDNPYLMFLPLPMMAFGLG
CLFTLMMSMTADICDKDELDNGMPRKEGTFGAIYWWTVKLGQALALIVGGAVLKWVGFDG
NAATQSLETMVQLRIADIVIPAITAALAIIVMWNYGLSEEKARKIKEELEERRGKL
>OMIFANIC_02473 hypothetical protein
MSAKVLIILVGIVLIGVAVLSSLSKKDSKTTLINPKVGIPMGVLGVLMVIFGSYSSDVGY
VSSQMEQISTGNKMELEGPVNSVKVISPIEADSVDCRILSMGVYPKGHEKDIWVVLKPSD
NKYYPQSDHTNTSYKRDGEWQVVTRFGGDKEEKYELIVYETDASASMFFSNTILDWKNKE
SYPGLEETDLPSGATEVDRITVYLRKNCRGVF
>OMIFANIC_02474 putative symporter YjmB
MNKTTTHRKVALGQKIAFGLGMLANQMFPAILVIFMVVLVKDLGFPGWMWGLIFFAPRIF
DAITDPIMGYISDNTKSKWGRRRQYVFIGGLLMGIAYIFMWQLYKENSLEYNFWYFFLWS
LVFYLGLTIFSVPYVAMGYEMSDDFHERTNIMAVAQWIGQWAWVIAPWFWVIMYDQDWFP
SAEVGARELAIWVAIPCAICAIVPAIFIKSESTLDKDYEPLNVSNIGKSLKKILTSFVEA
FKIKEFRKLCIATFLIFNSFNTVAALTFFVIVYKLFNGDAEASGLWVSLFGCLGALGTTF
IVIPTVAWMSKKIGKKNTFLVSQGISVIGYIMLWFLFVPGKPWMYTLALPLFSFGIGSLF
TIMMSMTADVIDIDELNSGLRREGIFGAIYWWMVKVGFAIAGGLSGVIIAIVGFNPELPT
IDQQGAVDGLHAFFCFFPMAGTLLAIWVMKSYDVTEQRANEIRAKIESRKKFPNQEN
>OMIFANIC_02475 hypothetical protein
MSYRGEHNFLLKNTDFTSYEGVNFSKYSFEELKKLWRETLENGMHGLCFSMYEDGQNPGD
IISEEQVERRIKIIKPYTKWVRSFSCIEGNEYVPRIAHKHGLKTMVGAWLGDEMDKNEQE
IEALIALAREGVVDIAAVGNEVLYRNDLNEEQLLDYIRRVKEAIPGTPVGYVDAYYEFTL
HPRIVDACDVILSNCYPYWEGTDINDSLNHMQQMYGQAAQAAKGKRVIITETGWPSQGTN
LRGAYPSAENAMKYFINSQLWSAKDNIDMFYFSSFDESWKVGPEGDVGAYWGLWDKHEEL
KF
>OMIFANIC_02476 hypothetical protein
MPISPTLKSLITVVLILSHAFCVAQELPPIANYPSNVYGADNQNWMISQSDDNYIYVANN
KGLLEYNGARWTLYPTPNETILRSVKSIGNRIYTGCYMDFGYWEYDNKGNLNYTSLVQKQ
EFDMIVDEQIWNIINHDEWILFQSLNRIYLYHVIDESISFLEVENTITKLFEIENDFYFQ
VSNEGLFAIENKKSKLISDDAVLKENVLVNIFMRNDDMVFLTASKGFYTITNEIVQPWSV
PADSVLEGLSIYSSIRLSNGDMILGTIANGIIVLTKDGEFRYQIDQSSGLGDNTALSLFE
DVQENIWVGLDNGIDCVNTKAPFKNYFNRNGRLGTTYASTIHNGFLYIGTNQGLFYKTYN
SNEALTLVQGTEGQVWNLRIAKGELFCGHNFGTFLISDGNAQQISNIQGAWDIREIPGED
DLLLQGGYVGLYVLERQNGSWGLRNKISGFDISSKHFEISDSGEILVSHEYKGVYRLIPN
HDFTEIEEFSEITSVQKGSHSSLASFNGAIYYAYREGIFKYDETSKEFIKDESLSGIFGG
DQYITGKLIADETGKLWVFTKDALIYIFAERLNNTLKTNRISIPVAQRTALDGYENIAHL
DHQKYLIGTSSGYLLMDLDSRPQHFNQISINRVISGSRSGETTSMDLITEGEFPAAQNYF
TFEYSSPDYNKLHTTQYQYKLAGIYDQWSSWSTNSSISFDNLPHGSYEFMVRAKGDGESN
NIASYSFVINKPWYVSNIAMAIYTIAIILLFIGINSFYRRYYRKQRQRLLEENTRELKLK
ELATQKEIIELKNQSLNQDIESRNRELAVSTMNLIKKNSILNDIKTELENISDPSKIRNV
IKVINKNLNNEDDWKFFEEAFNHADKDFFKKVKELHPDLTPNDLRFCVYLRLNLSSKEIS
PLLNISPRSVEIKRYRLRKKIELPRNANLNDYFISL
>OMIFANIC_02477 hypothetical protein
MRNVLILLISVICIVGCMDIGKYDNPEYGTLDIRKIESSQDINGYPCKKGKVTFYENDSL
MNFVLYEDFVINNDMIPADSDITMYWNGKPEFIYLSKETEIQGYIPTAKRIAYWHVSFYN
NGKLHLFSLKDDTHIAGVPCQKGDDLRLFPNGDLWECTLSEDFEIEGKKFSSGAHLIFDE
KGQVYNFSLSRYNEIKDRLKIHEFTKRFYSNKL
>OMIFANIC_02478 hypothetical protein
MKIPVIRESYFLNIVILIFSLFVGGFGLLFGLAHLLDPSAHEPSREPVAGLIFVIGLCLL
GVVFLLIAFLALKGIIYKIKHRHQERN
>OMIFANIC_02479 hypothetical protein
MKTKNHTKIRAHDAIVGILYLASALLAYFVDVKWIFVAVAVAGLQIISPLTKFCPVYFVL
NKLMPESDPIQGGS
>OMIFANIC_02480 hypothetical protein
MRNTLYLLAFLIGTIQLSIAQGQLQAGINGGIPTSETGVSTNFALAMDLVFLTEITGRFD
AGISTGYIIAFGEELPPGSINIELFDITFIPFAASGRFELASNFRVGADLGYAIGTNRFG
RSGLYIAPQASYSFTENIAIITAYRVVTQNDSVGAFHMVSAGVLFGFNI
>OMIFANIC_02481 hypothetical protein
MVMLCNIGVIEGQPSDKIYKAIVKMTDGSTVKGWLYHVSEEGIYLQKGKTTNDNRSFFLD
KTRIEKIKLIRKGERLLWAGIGSVAFASPLAIEQGVINKCQSVGCEGGTGLAVVGAGLFG
AVAGSAIFPKRMKFEIDGKEALFARHLSNIKKYAYQKE
>OMIFANIC_02482 hypothetical protein
MIKFFRRIRQRLLSENKFSKYFLYAIGEIILVVIGILIALQINNWNEDRQAAKQEQLYLN
RLLVENREDLETFSSNIVYLKGGIGTIKGLSTALKSNAMSDSSVVAAAHAYFETGSIFPI
FSSSTSTFDDLWSTGNLKIIRNSSLRDKLVKHYAEHKAVSQRIQIGNEWAYPIDGKISAD
LNIMRLEPNSSFLFPDETLNDKAAELRLNRVAYLNMAAAHYWLNMDAIDQLEKLIEETSQ
IIGLLEEELN
>OMIFANIC_02483 hypothetical protein
MLMIFFIGFAVSAQTDDDDKSSNEPSSKISLLELIQSTTDNYVITHEHVSSISQVRNVYL
RQAINGIGIYGTESSIHISPLGVKIAEHNKFLADVNNKLESNSQSLTAVQAVQRVAAQMG
YGTPSLQVMKTAEGANQKTLFNEGGISMESIPVQLMYYYQKDDGIRLSWNLSIAELDGTN
WYNFMVDANTGVILEKTNWIDECTIEHEHDDEGSTLDDNANLFDIPDYNTNVVSYNEADG
IGSYRVFAVPIESPYYGSRSLQVNPANSTASPFGWHDTDGAIGAEFTITRGNNVHAFRQS
DSYSPDAGANLIFDYALDFTLDPTTGDNLDSSITNLFYFNNIIHDIMYQYGFNEAAGNFQ
ENNYGNGGVGTDYVKARAHFGVLCNAFFGTPVDGGNGSMEMYLCDNAIPNKDGDFDNLVI
AHEYGHGISNRLTGGAGDSDCLDNDEQMGEGWSDFYGLMLTMTSTDTGTTARGIANYLFD
YGANGGGIRTRMYTTDMTVNEYTYDRIKATGSSPHRLGEVWATMLWDLTWGLIDQYGFDS
DLYNGTGGNNIALTLVTEALKLQPCSPGFVDGRDAILAADAAIYGGVNECLIWSTFARRG
LGFSADQGDTDDRTDGTEAFDVPFPPVAVCKADFSVQLDANGEVSIDVSDINDGSTVTCE
PISLSISKSDFTCSDIGPNVITLTISDAFGNETTCTTTVTVEDNIPPVISCVPDDTKSTD
PGLCSYTVQGTEFDATFTDNCLNGSITNNLNNTDSIAGEVLDFGETTVVWTVDDGNGQTD
ECEVTITVIDTEDPVLMTVQDPMIIWPPNHKYQTFDVNSFFVSVLDNCTPLTADDVYIAS
VSSDEEENAPGGGDGNTTDDIVIAQDCKSVDLRRERQGNGNGRVYTINMMVMDASGNTGS
SSSQVYVPKNFGGIATDDGIAYQEDCMLNRAPIVLGNNELPNTIDFDIDFWPNPSDSSFN
LKVSSNDTAVQINIVVYDVNGRTLQSNSFDPKDTYQFGSELTAGIYFTKITQANKSKVIK
IVKH
>OMIFANIC_02484 hypothetical protein
MKRIHLLLIVTLCFITQNIEAQDLLDGLKQVADMHNEEHGNDSNNNQDLSEEEQRQAEEF
WKEKTKDAMDFINGIDKPYHQCLALMGLYSYHFLKLSVAAEEEEDCKMKYDWYGTMLLMN
ISGTFLLPCTEGFYNLPEEDQISIFHDFLNSLYQCNFSGDPLVWTPLAKKAPKIAKDIHI
GFDQPFCSNDEGANYYSLKKVYYLLFEWEAVVANTLAIGKKMEALGCGG
>OMIFANIC_02485 Endonuclease MutS2
MEKGDLVETVDDAIKGVVLKVENGTVTLLTEDDFEMQFEIGELVVTNTKISDSELLPEDT
AVLLAEKESSKPRKNTRIKPKLRSQPAMEVDLHIHKLVNSTKHMANHDMLTIQLDTAKRQ
LDFAIRKRIQRVVFIHGVGDGILKAELEYLFRRYENLKYYDANFQKYGRGATEVYIFQSK
SP
>OMIFANIC_02486 hypothetical protein
MKKYLMIFAMSLFLSACNDGEVILTSFNFGDANLEFCGGPGDYVFFKINNQAAESIALQL
GTTDVLFFESDTLEVNLDGNANKVTYRSFNDVVMANYFCDNIPPTTPGVISNFVGTDGLA
TLFITAIFDDNDGIPFENTDDPMKEGFGDFDNDGLPNFYDDDDDGDNVPTISEIGDDPNN
LMNTDGEDNVDYLDEDDDNDGVLTRYEVSNENDLDPRDDITDPSVGPDYLNPAVSNEIIV
DKFRVHTYNVRSDVRIRIDNLVLVSENEQITRETLSLGTIEDIVNSDITLTPDFPD
>OMIFANIC_02487 Cysteine desulfurase IscS
MKKVYFDSAATTQLRNEVIHCMSEVLKTEYGNPSSTHSYGRSSKSLLETARKEIAGFLNV
SASEIIFTAGGTEADNLALQSAVVSLGVTRIISSKIEHHAVLHTIEILQERFNLKVEHVR
LTPTGCIDYDDLERLLKSSSEKTLVSLMHVNNEVGTLIDLKRVALLCKEYSALFHSDTVQ
SVGHFMLDFEDIPIDFAAVSAHKFHGPKGVGFAFVRKSSGLQPIIFGGEQERGLRAGTEP
VYAIAGMAEALRISFQNLDKERAYVLGLKEYFIQKLKENIPGVHFNGGCEDPANSTYTLI
NVCLPLSEEKAMMLLFQLDLKGIACSKGSACQSGSNTGSHVLAQLLSSEDLKKPSVRFSF
SSFNTKEEVDYVIECLKEFVAS
>OMIFANIC_02488 TonB-dependent receptor SusC
MLLKTSRLILFLLFFGSSLSIFSQNATIKGIIFDDQNMPLAGVNVTYGTSGTQTDLNGVY
VLEIPADADIQLVFSYVGFKDVRLNLVLTTNEDYEFNVAMKTDVEVIGTVIIDTRRRKKV
QGLEPISPEVARRMVGANAGIENVLQSLPGVNSNNELSTQYAVRGGNYDENLVYVNEIEV
YRPFLIRSGQQEGLSFVNTDLTSSVDFSAGGFQAKFGDKLSSVLDIRYKKPVSFNATADL
SLLGASTSVGGTSKNGRFTGIVGLRYRDNSLFVDAKQTETNFRPRFADAQAYLTYKVSNK
FELGILGNVAINQYDYEPLTRQTNFGTLADPVALLVFYEGQEEDRYNTYFGAIKGTYAVS
ERYTAKFIGSVYQTTEQEYFDILAQYRLGEVNTNIGDENLGEVEFSEGIGSQLTHARNDL
DALIVNFEHKGIVALDENEDTTLEYGVKYTHEDIRDRVQEYEIIDSAGFSIRPPLPDFAN
DQPYNPFTSPIVPFTTIRATNNVQTDRLSGYVQWSKKTELGTNDLWLNAGVRAHNWTVNG
DGIESTTQTVFSPRAQVTLKPDWDMDMLFRLSGGVYHQPPFYRELRDSTGTVRPGVKAQQ
SIHVVLGNDYSFDMWGRQFTLNSEVYYKKLTDVNPYTLENVRIRYRARNNAEAYAVGLDL
RLAGEFVPGTESWVSFGFLKTEENIDDRGFIFRPTDQRLKFGVLFQDYVKVIPDLKMYLN
LVYNTGLPGGSPSYADPYDFQTRLPDYKRADLGVSYVIVNSDKLRDSGWLKPFKELSLGA
EIFNIFDVRNSITNTFVRDVYTKVQYSIPNFLTPRVYNVRLTMKF
>OMIFANIC_02489 Murein DD-endopeptidase MepM
MLFTPRFYRITNSLKAMRLLFFTFLLGGFTHAQSSLPQDYFDDPLKIPIILSGSFGELRS
NHFHSGLDIKTQQREGIPVYAPADGVVTRIKVSHYGYGKALYIAHPNGYSTVYAHLQRYE
GVIQEYVKSRQYARETYEVELFPDAGKLKVNRGDIIGYTGNSGSSGGPHLHFEIRDGSSR
PMNPMLFGIEIPDGKKPLVNTVFAYPLDEKSHIDQSQNRVKLRLILQKDGTYKTENISAF
GRIGFGISTYDQQDGASNKNGVYKIKTTFNGRENFNVTFDKFSFGETRYLNRFIDYHYWR
TNKSRVQKLFRESNNPLSIITKEENSGYLSIEDGLDAAYTIEIMDFKGNKVNITVPIKGK
NGEILKPKEVNKTDDYIYADQATSISKGKFNIYIPANSLYEDSYLNIEAKGDILVFHEDN
IPIHKNISITVDASNYKKEDLNTLYLGRLNYKGEPYYHTTYRKGNKLTAKTRTFGSFTLV
SDTTAPSIKPANFADGKWISKNNTLKVKIEDDLSGIGSYRATINGKYILMEYNYKKDVLT
YNFNDNIISETENNLKVNVVDNAGNNATFEATFFRK
>OMIFANIC_02490 hypothetical protein
MSTISEVVDSLENRISKLLHRHQKLKEANLNLESQIQVLKSQQNQSYSEIEDLQAKCNSL
KLANSMLGSDQHKRETKLKINALVREIDDCISQLSE
>OMIFANIC_02491 hypothetical protein
MSNQLKIKLSIADRVYPLTINPTQEEGLRKAAKKIEEMIKRFEKSYAVRDKQDVLAMSAL
QFAAQVEQKAIDKDIDSQHIEEKLIALNQLLHEHLS
>OMIFANIC_02492 hypothetical protein
MNLARNIHTIMKQEAQRKDLFQLKKAYLACGRGDMVMPGKPYIS
>OMIFANIC_02493 hypothetical protein
MKRLKSTYVLVFAIVLLVSCTQDTEDNFDIDTTSSALLLNTQQPLLTDDATVHGLYIGAV
LSETTDSRGKIWINIGNDGNYNALIELVSGENLTFELNPGETLQSSEYLFFEFEGTAGSF
IFDTSDINQPRLRELSLFNENYFAQVVRSRSNMASVETATFSETGNPAFSGTWSLIADGS
VSNPNGNNGEGITSVLVVISGEDYEDFEFDSFNATACLGNNDYVPTLNSFGVNGYIISDY
QTTMFANGMTKWNLSYDPMGSTYMNYQLCDTATSGTFFWSSLDGVVTRYGEIILD
>OMIFANIC_02494 Cytidylate kinase
MRTITIAIDGYSSTGKSTVARQLADWLDYLYVDSGAMYRAVTLFALRKGLISETDFNKEA
LIETLSAIELEFRKNSEGKSEIHLNGENVEKQIRTLEVSEHVSPVATVPEVRRKLVKLQH
AIGENKGVVMDGRDIGTVVFPNAELKIFMNASAKVRAQRRYEELLERGDSITFQEVLDNV
TERDHIDTHREDSPLVKAKDAIEIDNTETNIEDQFHIILQLAKDRIAGRI
>OMIFANIC_02495 hypothetical protein
MHHKVFYVLALLLSVSTLAQVGGRATYQFLNLVNSPRQAALGGKTVTNYDYDVTQALFNP
ASINPAMDNQLSLNYTNYIGDINYGTAAYAYMWDRRTQVLHAGVTYINYGQFDGYDEFGN
PTSSFTGGEVALSVGHARNIAFTNFHVGANLKLISSTLEQYSSFGGAIDIGVMYVYEDWD
LHITGVARNIGTQFTPYDTVYEPLPFELIFGISQTLQNIPIRWHVTFENMQRWNVAFSNP
NREIEDLEGNVQEENINFIDNALRHTILGIELFPKGGFNIRLGYNLRRAEELRILERRAF
AGLSAGFSLRLNKLTLSYSYAKYSTAASTSNFGLNINLQ
>OMIFANIC_02496 hypothetical protein
MKALMVLMALFFAATSIAQDPDPDIFNQNWYLYEIYDSDQNEYFYIEGYQPYGGEPMIPQ
ISPYVFIDEALNFNGLGICNTFEGVLEYDMSINSFRTASVTLTTDSCGAFEDMDEPYIIG
PFGFVDPDPNFYTIIGPQVTDDSDGFQTLTYGTQPFIGYTYRNTPILGINEFIADNIQIY
PNPAKNKINLVFEIGNLEVIYLLDVNGRVIIKASPDLGSYSMDISNIKNGMYFLEVHTDD
GKVRRKILKK
>OMIFANIC_02497 Lon protease 2
MAKTKLTSVDSLSFQDLTEDADLIPLMTPEDEDAMNKEDLPQVLPILPLRNTVLFPGVVI
PITAGRDKSIKLINETNKGSKVIGVVSQKEESKEEPEINDINRVGTVAQILRVLKMPDGN
TTVIIQGKKRFEVNEIITTDPYMTATISEVEEARPAKDNEEFKAIIDSIKEMALEIIKDS
PNIPSEAAFAIKNIESTSFLINFVSSNLNISVEEKQKLLEINDLKERALETLRYMNIEIQ
KLSLRQDIQSKVESDISQQQREYFLHQQMKTIQEELGGTSTEAEIEEMRSRGKTKQWNED
VGEHFNKELAKMQRMNPQVAEYSIQRNYLELILDLPWNEYSKDQFDLKRARKILDRDHSG
LEDVKKRIIEYLAVLKLRNDMKSPILCLYGPPGVGKTSLGKSVAEALGREYVRMSLGGLR
DEAEIRGHRKTYIGAMPGRIVQSIKKAGTSNPVFVLDEIDKLSMGHQGDPSSAMLEVLDP
EQNSSFYDNFLELGYDLSKVMFIATSNSLSTIQPALRDRMEIINVSGYTIEEKVEIAKKH
LLPKQLKEHGLTPEHLKIAKPLLEKIVEGYTRESGVRGLEKQVAKMVRHAAMKIAMEEEY
NPKVTNAMIVEVLGAPRLERDKYENNEVAGVVTGLAWTRVGGDILFVESILSKGKGQLTM
TGNLGKVMKESATIALEFIKSNAEKLGLDPLIFGKYNVHIHVPEGATPKDGPSAGVTMLT
SLVSLFTQRKVKKSLAMTGEITLRGKVLPVGGIKEKILAAKRARIKEIMLSEGNRTDIKE
IKPEYLKGLTFHYVKDMDEVLDVAITNQKVKDAKKL
>OMIFANIC_02498 ECF RNA polymerase sigma factor SigW
MSLTSQNINTLLVLCKQGNQLAQLEVYNRYQQAMYNVSVRIVKNSAEAEDIMQESFITAF
NKLDTFKGDASFGAWLKRIVINNSLTQYRKNSRFTVVSEDSISEEAHQDEFDLTEDDRSQ
INAKKLLDCMNELHESYNRILNLHFIEGYDYEEICEILNISYANCRTMISRAKESLRKKL
TQVI
>OMIFANIC_02499 hypothetical protein
MKKDTIDNLFESLEGSFDVHQTPVGHEKRFLDRLNAQQDSKSQRNWWKPLSIAASIVVIL
GLGFSILKSPGPSGELASVSPEMEQTQNFFVLAINSEIEKLKSFETPDTKKLIDDALIQI
SNLEEEYQQLKIDLVESGNDKRVIYAMISNFQSRIDLLEHVVVIVEDFKNLKTNENEITI
>OMIFANIC_02500 hypothetical protein
MKMKLLFKSLIILLLLPMMATANDKFKGKYTKTKTLNKEYTVNANAGLRVSNSYGNIDIT
SWNENRTVIEVTITTNGNNEDKVQKRLDDIDVDFSASASQVTAKTTFKGGKSSSWSLWGN
KSNVQMEINYVIKVPVTNSVDLGNDYGSISLNRLEGNAKISCDYGQIVIGDLMADDNLLN
FDYTNNSTIDYMKSGRINADYSGFTLDRAEKIELNADYTNSEIVEVGDLNYNSDYGKLVV
NKVGKLMGRGSYLPNKIGTVTRSLNLNTDYGSISVEKLASSVKEVVIKSDYTGVKLGYDA
GFNFDFVVKLSYAGFNEGDDLEITYSHKSNTNRTYEGYHGTKNSGNTININSSYGGVSLK
KQ
>OMIFANIC_02501 hypothetical protein
MEELVLRNNNGQKTINMNKLFKFSLVIALIIFGCGDIMAQWGKKVVGNGNVTTRTVNTGN
YDAIRGLGSMDIHLQKGSEGTITVKTDENLQEYVIVEVVNGALKIRTKKNTYLKTKKGIH
VYVPFDDISEVSLTGSGDIDTEDTINSDDLEIKITGSGDVNLDVSANTVEATVTGSGDIE
VSGNTTNLEVRVTGSGDFDGDELRSENTEASVSGSGDVSVYASKYLKARVSGSGDIRYNG
NPEKRDTKASGSGTIKSN
>OMIFANIC_02502 hypothetical protein
MKKFQLGSWLSLFFLVLPFTACDDEPLEGEFPQEETVIAEEGQFVATIGGQAWTASMASA
FFNDDNTLVITGELDATGQSISLTVEDGGVNTFDLSAGVGTVNTAVYIDADQTNPFISAA
ALGGFGLLTITEVDIDEMTISGTFSFEGVRIALDADGNPVTDGDGNPVIENVSISNGAFN
SIPYTEGVSGGGGGGGTTDDFFAKVDGEDFTPETVNTERNLISDVPMINIIALNSSGEKI
RIDIPESLGVGTFAMEQLSDGTKLIAQYNPGLGTEDLSSDPGTIEILEFNTLTGRIVANF
EFTATDPLGIDNTVVEITQGNFEVLYEPGESNPNNSMSASIDGASWTANFADAFEFDFSG
TETVTARGYNSDTGESIEVTFPKSLEPGSYDFVSTAVPGESIARFYTEPGGTEFTSTDGS
IIVIANELETGGTIEAAFLFLAEDLSGEDTTTFNITNGQFLMELP
>OMIFANIC_02503 hypothetical protein
MAAFFMANLNKGSKKLLNAWAFYDWANSVYSLVIASAVFPIFYQALFSSAGVETVTVFGG
EIRSTPLISYTTAAAFLTVSVLSPILSGIADYVGNKKVFMQFFCYLGSVSCIALYFFDLD
HIYLSLTFYYFGLIGFWASLVFYNSYLPDIAFKEQQDSISAKGFSMGYIGSVILLIFNLI
MVLNPQWFGLGEGDEASMKAMRISFITVGIWWMSFSQYTFFHLPKGVSSGHKVTRRVIFN
GFKELRGVYNSLSENIRLKRYLGAFFVYSMAVQTVMLVATYFGEKEICWCEGCEDISCSE
KTIGLILSILIIQLVAVLGAYLTSRASFKYGNIPTLIVINIIWLAICVVAFFIETPFQFY
STAGAVGLVMGGIQALSRSTYSKFLPQTEDTTSFFSFYDVAEKIGIVVGMIIYGFIDQIT
GSMRNSVLFLVLFFATGVILLLRVPKNLPE
>OMIFANIC_02504 Beta-barrel assembly-enhancing protease
MKFKKTLSLLGILVFIVACATNPFTGKKTMALVPNSQIFPMAFQQYDQFLAENNVVTGTA
EANKIKKIGQEIAIASERWLNANGYAGYLKDYQWEYNLVNDPAVNAWCMPGGKIVFYTGI
LPIAQNDAGIAAVMGHEVAHALANHGQQRMSAAQYQGLVAVAGNVALSKDPKAQEDFNKY
YGIGSTVGVMLPFSRNHESEADRIGLTLMAMAGYEPLEAAELWKRMKANGGQAPPEFLST
HPSSQTRINNITSWATEAKAEARKFGVTSFKRR
>OMIFANIC_02505 hypothetical protein
MKNLLLFLALSATVFLTSCEGDPGPPGEPGINILGQVFEVTVNFTPGNGFSQVVDFPSNV
EVFESDAVLVYLLEDVIPGAGGTIDVWSQLPQTFFIGDNTLVYSFDHTFLDVRLFLDGNF
DLNTLGPTFTDNQTFRIAIVPSEFADANMSMAELLQTINLEGTDIQTIGN
>OMIFANIC_02506 Peptide methionine sulfoxide reductase MsrB
MKQIVLIALCAMFMSCNTKAQKREKEETIFPVTKTEAEWKSELTEMEYYVLREAGTERAF
TSELNKNYEPGTYVCAACQTPLFKSEHKFDSGTGWPSFDREIKGNVMYDTDYKLGYGRTE
ELCASCGGHLGHIFNDGPKDTTGKRHCINGVALDFIPKN
>OMIFANIC_02507 Peptide methionine sulfoxide reductase MsrB
MTQKQYAIQKTEEQWLEELGPERYRILRLKGTERPFTGEYNLNFDKGAYACGACKTQLFD
SSSKFDSGCGWPSFDDAIEGTVEYIRDTSHGMVRTEILCSNCGSHLGHVFNDGPTETGQR
YCVNSLSVDFQNKED
>OMIFANIC_02508 hypothetical protein
MKRYLLILGLGAFLLTSCATRVVTTTPAASSKVVVIKKAPRNHKVVVVNGKRYYRWNGNH
YRKTRNGYVLVKLR
>OMIFANIC_02509 Dihydrolipoyl dehydrogenase
MSKYDIIVLGSGPGGYVTAIRASQLGLKTAIIEKENLGGVCLNWGCIPTKALLKSAQVFE
YLKHAEDYGLTVKDADKDFGKVVARSRGVADGMSKGVQFLMKKNKIDVIEGFGKLKPGKK
VDVDGKEYTADHIIIATGARSRELPGLPQDGKKVIGYREAMTLKEQPKSMIVVGSGAIGV
EFSNFYNTMGTEVTIVEFLPNLVPLEDEEVSKQFERIFKKSGIKVMTNSSVESVDTSGKK
VKATVKTKKGEEVLEADVVLSAVGIASNIENIGLEDVGIVTDKGKIMVNDWYQTNIPGYY
AIGDVVPGPALAHVASAEGITCVEKIAGIHVEAIDYGNIPGCTYTSPEIASVGMTEAQAK
DAGYDLKVGKFPFSASGKASAAGTKDGFVKVIFDAKYGEWLGCHMIGAGVTDMIAEAVVA
RKLETTGHEVLKAIHPHPTMSEAVMEAVADAYDEVIHL
>OMIFANIC_02510 3-dehydroquinate dehydratase
MKIIIINGPNLNLLGKRETDIYGDHSFEDFFEILKDKYDWFEIDYFQSNIEGELIDKIQE
VGFSYDGIILNAAAYTHTSVGIRDAVSAVNSPVIEVHISNTASREEFRHDSYITPVAQGL
IMGFGLQSYELALQSFIN
>OMIFANIC_02511 hypothetical protein
MKKLLLLLTILICSYTMTAQGFGAAISGGYLSEIEGFGATADLIYEIDEKWGVSTDATYS
VADAGSTRAKWFIIDLNGRYKVYDEAYILAGGEYLNITLKQGGLGLGAVTTTEFETSNGE
FGFNAGAGYKYNIIDNVNVFTEVKYVIIDPAGYFHARLGLQFDF
>OMIFANIC_02512 hypothetical protein
MNKYKFVDLPLNITTQMMKKILMLAAIAVLSFTTAQAQGVSFGAKAGVNFASLTGDDADM
LELEGRTGFHIGAVANISISELFAVQPEIVYSTQGFTLEEMGVEGTGKLDYINIPVMADF
TVAEGFSLQGGPQIGINVTDEFEAEGETETLDAESTDFGAAIGAQYRSALGLFVQARYTI
GLSNVAGDDEDDVDLKNGVISISAGWFF
>OMIFANIC_02513 hypothetical protein
MKKYILLVIAIGLFSFTAQAQGIDFGVKAGVNFANITDASGLSNRTGFVAGFFVGGKLND
NIGIQADLLYSQQGAEFEFGDFNLDYVNLPVLLKYYVSERFNIQGGPQFGIVVNDDVNAT
ILGEIIDDLGTSDFDISAVIGLGYDLPMGLRVSGRYNIGLSDVPDDSRYSTSGKNSVVTL
AVGYSFL
>OMIFANIC_02514 Tyrosine recombinase XerD
MNWQNLRTDYLNYLRLERGLSENSISNYTLDIRKLEEWVTSNNITESPVSIREETMQKFV
YDIAIEMNARSQSRIISGLRGFFNYLVFEDYRKDNPMDLIESPKIGRKLPDTLSLTEIDA
LISTIDLSKPQGERNRSIIETLYGCGLRVSELTHLKLSDLYFDEGFIKVTGKGDKQRLVP
IGLQTIRYIEIYRKEVRVHQNIQPEAADTLFLNRRGKALTRAMIFTIVKRLAEKAGIRKN
ISPHTFRHSFATHLLENGADLRAIQQMLGHESITTTEVYTHIDKRHLKEVINRYHPRKSD
>OMIFANIC_02515 Aldo/keto reductase
MKILKYANGDPMQAIGLGTWKATGDTVKYAVKEAVNAGMLHFDTAAVYQNETEIGEALSE
LFSEGVITRDEIFITSKLWNNAHLPEDVLPALKESLHKLQLDYLDLYLIHWPVAFKRDVF
FPANASDYIPLEDCPISETWRQMEVAKDVGLAKHIGVSNFSVKKLKELKMTAIQQPEMNQ
VELHPLLQQNDLWEYCNSEGILLTAYSPLGSGDRDSSMKGEDEPNLMDIDEVLDIARKHN
ITAAQVLISWHLHRGSAVIPKSTSASHIASNYAAGDIKLDTEDMKIIAGLDRNYRYITGK
FFEAPEVGYVNIYDE
>OMIFANIC_02516 Ribonuclease Y
MDNIVAYIIAAVIGLAVGFIIAKFFERNNASRLIKQAKKTAASIVKEAKVESEALKKDKI
LQAKEKFLELKAEHEKVILNRDKKIGEVEKRIRDKESQVSSELAKTKRLNTEVDNKRKEY
EERLNYLHKKQSEVEKVHRNQIEQLEVISSLSADDAKAQLIESLREEAKTDAMAYIQSSL
EEAKLTAQQEAKKIIINSIQRIGTEEAIENCVSVFNLESDDVKGRIIGREGRNIRAIESA
TGVEIIVDDTPEAIILSCFDSVRREVARLSLHKLVTDGRIHPARIEEIVRKTTKQIEEEI
IEVGKRTVIDLGIHGLHPELIKSVGRMKYRSSYGQNLLHHSREVAKLCGVMASELGLNPK
LAKRAGLLHDIGKVPEAETEVPHAILGMQWAEKYGEKPDVCNAIGAHHDEIEMTNLLSPI
VQVCDAISGARPGARRQVLDSYIQRLKDLEAIAFGFNGVNKAFAIQAGRELRVMVESEKV
SDEKAAQLSFEISQKIQTDMTYPGQVKVTVIRETRAVNIAK
>OMIFANIC_02517 hypothetical protein
MEDKIKYEMEFPVHVSPSLLYQYISTPSGMSEWYADNVNSRGEYFTFIWEGSEEKAKLLG
KKNGERIKFRWEEDVDTNYYFELRIQVDEITKDVSLMVTDFADDEEEVEEGKLLWTNMIS
NLKHILGST
>OMIFANIC_02519 hypothetical protein
MIQVIKLNFQVVNESKSHLMRIAQHPADVSRVFEGGGYKSVTRDVFRILSVH
>OMIFANIC_02520 hypothetical protein
MKNTATNFPRKEKLRKSVPHTFNELVQLKKQGDRGAFNEQLLKMLPEVRNFINRRLDAAI
HKGHFPKSKYKAEDFIDQLFIEVYGSIGDVENENEFYIWLFKKTNDLLDKTIAKEEFEDA
IFKNIDEYSNTEWKQMAEKFSAEADGDLIMREDLEDVSYHKSKHSLKQIFSEDDEKALID
KLDKNLSEEDVNRFTDLVLQNFPQPMHTVFELFTKQEFTLSQISEIMQRSVDEVEELLKE
ARAILYNSLSAYFPDE
>OMIFANIC_02521 hypothetical protein
MALNFNHFAAEANQFLKEYTKELMLEGDTEKAGRILSSILHGLREIIATQESLQLIAQFP
MFLKAVYVNGWTIHKKPKIKTMEQFIDLVRKFDGVTGLNDFKSDELAEQYINATFLLLRR
YVSLGEMEDIRSELPKDLKNMVYQRIMF
>OMIFANIC_02522 hypothetical protein
MGDAKKCIKKEKTIFNPRDSENQPTNYMKKFKFPTAQTILLLIAGMVTLLTWVVPAGQYD
TLAYSKAENSFVRTHKDGTESLPATQETLEALNVLIPIEKFTSGDIYKPINIPDTYREVE
AKPQGFGAFVQSPVKGIIEAADIIFLVLFIGGLIGIMNRTGAFDAGISWMAQMLKGREYI
LIILVTTLIAAGGTTFGLAEETMAFYPILIPVFIAAGYDAMVGLACIFLGSAIGSMCSTI
NPFSTIIASDSAGINWTSGIEARILVLLLCLTITIVYILRYAKRVKKDPSRSIIFEQKEK
IEDMFGLTTAQTDTKLTNRLRLIILIFSASFIVMVIGVSMLDWWFVEMTAVFLVGAILIG
IVGKIRESDFVEAFSNGAGALLGVAFIIGIARGVSVIMTDGLISDTMLYNASALTTGMEK
GVFANVMFLVYNGLSFFIPSSSGMAVLTMPIMAPLADTANVGREVVVNAYMYGMGLFFLI
NPTGLILAALAIVKVGFNKWIKFIMPLFWMLLLTIIGFLTVSVYI
>OMIFANIC_02523 hypothetical protein
MKKHILTVFIALFTLSLGYAQGFIVENFTVDIYISEEGYFDVVEKYDVNFTQDKHGIYRT
IQTKYDMLTSEGKKEKRTIRIDNIEVPGHKSDINNKFSRKLEGWVKIKIGDANKYVFGPQ
QYEIRYRVTNAFLYEERDTRFYWNLKPNQWYAPFNSIDFRIHLPENTTVDGANIFVYSGN
TGNTMPSKDFTTDYTGNVFSGTSKEGVISSYGQAVTVLVNFNPGSIAEVKPFFPFWTKYG
FTIIMALLISGFYLLWKKFGKDTRVTTTTSYYPPEGMDPAMAGFLINDREDTADLISLIP
YWGHRGHIRMEEIDNKGWFSKDDVKIIKLKDIPGDAPNYERKIFDGLFSGGKDEVLVSSL
KNKFHTTMSSAKTQLRKAAQIYYFPKSRKARGCIWGALFVLLLLFVPLSLYLWGFLGAIL
MFVTFILLFILNIFMIKKNKKGDVVFSELKGFREFIKTAEENKLKMLLKESKVYFESTMG
YALAFGTFKVWARKFEAMKLEPPSWYTSHTHGHFNMNQFSKSFSSAITSTQSTMVSSPSS
SGSGGGGSSGGGFGGGGGGSW
>OMIFANIC_02524 Diapolycopene oxygenase
MPKAIVIGSGIAGLASALRIRKLGYEVDVFEKNSYPGGKLHAISQDGYRFDLGPSLFTMP
QFVEEIFQLYKLDPALYFQYSRKDTVCNYFWTDGSRFSVNADQDLFVKEAADFFGESQTN
IKTYLRRNRKKYELTAGIFLENSLHKLKTYLSAETIKAMLQLHSLDLMQSLNDVNKKNFR
NPKLVQLFNRYATYNGSSPYQTPGIMSLIPHLEMHYGTFIPKGGMHRISMSLFELAEDQG
ICFHFNEKVDEIVLEDGKAKGVTTSKTNYSADILVSNMDIYPTYKRLLPELKPPTKTLQQ
ERSSSALIFYWGIKGTFKELDLHNIFFSDDYKGEFKSIFKDKTLSDDPTVYVNITTKDVP
GDAPPGCENWFVMINAPGDYGQDWSTLKKKARSLILEKLSACLKRAVEPLIVTEQVLDPV
GIEENTSSYRGALYGAASNSRFAAFLRHPNFTRQVQNLYFCGGSVHPGGGIPLCLLSAKI
VGDLVPDMNSNQEYA
>OMIFANIC_02525 hypothetical protein
MHGFLWSLHRDHHRKDHDSWFERNDTFFIFYAVVSMSFILLAGNSEFWYGYPIGFGIMAY
GATYFLVHDIFIHQRFKIFRNANNWYARGVRRAHKIHHKHLGKEDGECFGMLWVPFKYFK
K
>OMIFANIC_02526 hypothetical protein
MLFLIVIILSIPAVQTKIAKKVTDNLNETYGTTISIERIGLNWKGEVDIREVYIEDHHED
TLIYAKQLQTNILSVPNLIKGKLEFGTIDLTDSKLYVKTYKDETDDNLYIFTEKFNTGEP
STEPFFLIGNDVSLINTRFKISDENLEEPHILAIDNINLRARDFEINGPDIDVDILALSM
LTDFGIPVENLSADFSYSLDEMRFKDLKLDTGDSQITGDVVLDYSENGMADFNNNVVIRA
TLENSVVSTNDLNNFYNEFGPNQFINVTGDLEGILNDFKFKNVNISTSSSRIRGSFYFRN
LLKNDEVFTIVATDHIITTDYFDLRRLMPRLLGDVLPKEIKPLGRFTLGGTSTITNTELA
TSSTLDSRIGSLETNLEMGNTTDIENAYYKGDVILNEFDLGKITGTESVGSVTADLEFDG
RGFTQETVDTQLRGTIASLDFEGYSYKRISVSGNLKNPIFDGDLVINDPNLQMEFKGLID
VSKQFNQYDFEADVEFAELNKLNLFKRDSVSVFAGRIIMDMDGTTINDAEGTIEFVQTFY
QNEDDDFFFDDFLITSLFEGPVRSIEINSPDIINGSIKGEFLIEDVPNLFRNGVGSIYAN
FIPNEVTDDQYIDYEFEVYNKLVEVFVPQLKLGENTRVRGSVSSNESEFKLDFRSPEILV
LDNYLGKVNIQVDNDNPLYNTYISVDSVDTGRYQVSDINVINKTLLDTLYIRSRFKGGNK
KRDLFNFSLYHTINPEGRSVVGVKTSDITYKDNVWLINKNNNKLNKITFSDNFKYVKIDS
LVLNHDDEYIRFAGVVRDTTYKDLKLQFQDVNFGNIAPDIDSLDLQGIVNGRLNFLQKGG
AYYPRSNVTVDDVVINDVAFGDLTIDIRGNKDLTKYNINTSLINENVKSISAVGEIDVAP
DNPQISMNVELERFNLQAFSPFGGDVITNIRGYATGGAKVVGNYKSPDILGRIVLEESGL
KIPYLNTDFNLAENTQVIVTKEKFDISRTTITDTKYKTSGTLIGNATHRNFGDWELDLNI
NTDRLLVLDTPPDEEALYYGTAFISGTADIKGPAEELVIDVIGTTEKGTTFKIPLSDTES
IGDDSFIKFLSPEEKAARISGETFVSEEVKGLSLNFELDINENAEVEVVVDQVNNSRLKG
RGAGILLLEINTLGKFRMWGDFLVIEGTYDFRYGGLVQKAFTVEPGGNITWDGSPERANL
DLTAKYTTAANPSVLLDNPSVNRKIPVDVLIDLTGELIQPNINFEIGFPNASSIVRSELD
YKLQNQEQREKQALFLLASNSFVNDNLRGSGAFSGTIAESVSSLVNDIFAGQDSKFKVGL
DYTPGQNTPDQNIADQVGITLSTNINERIIINGKVGVPVGGVNESAVAGDIEVQWLVNED
GTLRINFFNRQADIQFIGEDQIFEQGAGVSYSVDFDTFRELVFKLFNRKLSLESEEEALP
VTPDDNSVPEDFNQTAIKEKEN
>OMIFANIC_02527 2-iminobutanoate/2-iminopropanoate deaminase
MKKIINTSKAPAPIGPYNQAVLKGDMLFTSGQIAIIPETGELLTGTIAEETRQVMENMKA
VLEAANMTFEQVLKTSIFISDMKNFSEINEVYASYFKEDTAPARETVEVANLPKYVNVEI
SMIASH
>OMIFANIC_02528 LPS-assembly protein LptD
MNNYSKSYKGILLNMSLLFNRAQVHIFMLISFLIGICNSYGQDIPSKNEVNIQSTKEADT
TTISITGPVTPINEVVQDTIKPDTVQPKPEMLDDVVDYYGEDYVYIDRKNNKVYMYNQAY
IVYGDMRIDAGLIILDLNNNEVSAKGIDSAGVYSQRPIFEQATNIAEPDSLRFNTETKKA
IVYNTRTEQDGIITIAETTKKENDSVYFLRKVKFTTSKNLEDPEYYFYTRKAKFVPKKKV
VTGLTNMYIADVPTPIGLPFAFFPLTEDRTSGFIIPTIGDDNSRGFFFQNGGYYFAINDY
VDLTVLGDYYTNGSYGLRGESSYSLRYKFNGNVSVRYENLLNSERGFPDFSQSSVYNIRW
NHTQDAKSNPTSRFSASVNLGSSRYFRQSINQVNNASALVNTLSSSVSYDKTFEGEPQVN
ITIAGTHQQNTNTQEINMSLPNLNASVSRIFPFAPKSGVKKGILQNINFQYDLSAENRIS
TVDSLFFKSEMFDDAQIGARHSIPVSTNFKILDYLSASMSTGVQETWTLQTTSESYDPDA
NEGSGAVVRDTLQGFDRYLTYNFSTSLGTTLYGMYDFEKEGEDKKIKAIRHVMRPSISYN
INPGFDQYYEDYNIPSADPEVNDQVVSYSRFQNTLFGAPGRDFSSSIGVSLSNTLEAKVR
DKDTTATEPRKIVLLNNLNFNTAYNLSADSLNLSPVRFTGSIPIVKKLDFNFNGSLDPYA
LDNNNNRIDEFNIDNGGSLFRLTNANVSFNYSFSSRDFEGDGDDDPDINDETFRNGGRPD
DLFGDATSLNERATAITRDEETDRERNVDWYNFSIPWDLRVAYTMTYANNRRQSEISSQS
IMFSSNLELSPRWSVGISSGYDFKNKGVTLTQLRFVRDLESWELRFNWTPIGSINTNWYF
FIGIRSGVLSDIKYDQRRVPDRNL
>OMIFANIC_02529 N-acetylmuramoyl-L-alanine amidase AmiA
MRTKILILFVLALGSFLFYSFTGRYNNATEPFVVVLDAGHGGKDPGNRGNGYKEKDIALN
VILEIGKILEKVEGIKVIYTRKTDVFLELHERAAIANKADADVFVSVHCNSHHTQAYGAE
TFVMGLSKSKQNLNTAKKENEVIFLEDNYEEKYVGFDPNSPESFIGLTILQEEYLDQSIM
LAGLIQNNMVNNLKRRDRSVKQDVFWVLHNTYMPSVLVELGFLTHNSEGPYINSKKGRNA
MAKEIANGIVTYRKNLLLATNDSQNPIITQEEIDKAMDEAEEKIYEDVIFKVQLLASKKK
IETFAYNFNGLKDVNRHKEDGLYKYYYGKTSDYNKIRLMQTFAKDNGYPTCYVVAFKDGK
KLKLSEVLKSEDK
>OMIFANIC_02530 hypothetical protein
MKLSRELKTGIFAIVVILLFIFGYSYLKGTNLLDNQRSYFVKYNNVEGLAIGAPVTINGL
QVGKVQGIDFLNGDGDLLVTFSVEKDFKFSRKSIVQIYSSGFIGGNNLGILVKYDPKDIA
QRGDTLQGDIQQGILDQVTGKLAPLEAKIESTLTSLDTLLIGVNEVLDKESKANLKRTIS
NLSATVAEFRGASASINSLLRDNKEKLNNSIANLDNTTANFSKLSDSLAEIEVGKMVKEL
ESTVSRFNGIATQIESGEGSVGKLLKDEELYENLTGASLQIEKLLEDMRLNPKRYVHFSL
FGKRQKPYEPPTESQDE
>OMIFANIC_02531 Lactate utilization protein B
MMQYLPNILFLIALTAGIGYFTMNIRKVIRNIKIGQEIGEINHKKERWGNVVRIALGQSK
MVVRPVAGLMHIIVYVGFVIINIEVLEIIIDGLFGTHRIFAFLGPVYDILIASFEVLALL
VLLAVIVFWIRRNVQRIKRFLSPEMKGWPKNDANYILYFEVVLMLLFLTMNAADHQLQQM
GLEHYSQAGMFPVSDFMLPLFSDMSTDSLILVERIAWWLHILGILVFLNYLYFSKHLHII
LAFPNVFFGKIIPKGQFNNLESVTKEVKLMMDPNADPFAAPPEGAEAPAKFGASDVLDLN
RVQLLNAYTCTECGRCTSECPANQTGKKLSPRKIMMDTRDRLEEVGKNLNKNGEFKPDGK
QLLDDYISREELWACTTCNACVEACPVSIDPLSIIMDMRQYLVMEQSAAPAELNVAMTNI
ENNGAPWPYNQMDRLNWKNEN
>OMIFANIC_02532 hypothetical protein
MKKEEAEKLLHEKVEQGEQISPVLPEGVKNYLIDIDGTITEDVPNEQPERMATCKPFPDA
RKTCNKWYDEGHLICYFTSRTEDHREITETWLKKHGFKYHSLLMGKPRGGNYHWVDNHLV
KATRYKGKFTDLIEKQVTIQVFDD
>OMIFANIC_02533 Lactate utilization protein A
MSETIQVPTMAEFTAQGKQPEVLFWVGCAGSFDDRAKKITKAFVKLLHNAKVDFAVLGTE
ESCSGDPAKRAGNEFLFQMQAMMNIQVLNGYEIKKIVTACPHCFNTLKNEYPGLGGNYEV
LHHTQFLKTLLDEGRLRVEGGKFKGKRITFHDPCYLGRANNEYEAPRELLHKLEVELVEM
KRCKSRGLCCGAGGAQMFKEPEKGDKDVNIERTEEALETKPEIIAAGCPFCNTMMTDGIK
ASEKEAEIAVMDVAEMIANAEDI
>OMIFANIC_02534 hypothetical protein
MVTEFKNLPDNSRIWIYQANRKLSDLEVSEIKEKTREFLSQWTAHGADLEAGYEVKYNRF
IVIGLNQSNASASGCSIDASVRFIQSLENAYQVDLLDKMNVTFYNGEFIAHKSLSDFKKM
AKARSVSPNTIVFNNLVNTKAEYEEHWKVPAKESWHSRFLA
>OMIFANIC_02535 Beta-hexosaminidase
MKKLLVTSLFTFIILSVHGQQINPLIDVNDFENQKKWVDSIYNKMSLQEKVGQLFMTVVF
SSDPKSTTNKTKELIRDYYLGGVIFSKGGPYRQAKLNNEFQELADVPLMVGMDAEWGLAM
RLDSTYAYPWNMTLGAITDNKIVEKVGNRIGKHSKRLGVHVNFAPVVDINTNPKNPIIGN
RSFGEDRDNVTSKALAFMKGMQDAGIMANAKHFPGHGDTDTDSHKTLPTISFSKERLDSI
ELHPYRQLINEGLSSVMVAHLNVPSLEKRDGYPSSISETIVSDILKGELGFNGLIFTDAL
NMKGASNFKEPGEIDLAAFLAGNDVLLISEDIPKAHELLVSAYREGVITEARLGHSVKKI
LYAKYLVGLNNYEPVNTNYLFEDLNSVIDDALHEVAMEQALTILKNDQAILPIKDIEKKK
IAYVNLGDANGRPFLDQLRKYAKVDWVKANTLNSYLNKLEKYNYVIIGFHKSNDNPWQDY
HFTDKELVWLYEIARTNTVILDVFARPYAMLDLNATGNIEGIIMSYQNSQVSQELSAQLI
FGAREANGKLPVSLGEEFPLNTHFRTKSLKRLQYGTPESVGVNSYKLEKIDSLAKAGLWG
GMMPGAQILVARKGKVIYSKNFGHHTQDKKNRVGSTDVYDVASLTKILATLPMVMSLVDR
DIINMDTKLSEMLPEYSQSNKANINLRDMLSHYARLRAWIPFYVNTIDSVTKRPSNKYYS
SVASEDYSVEVARDLYIRKDYKDSIYEAIKESELRSRLSYKYSDLPFYILKKYLEEFYGT
PLEKLSQRDLYGPLGANFTTYRPLEKFSKNNIVPTEIDDYFRMQKVHGYVHDQGAAMLGG
VSGHAGLFSNANDVAKIMQMYLWSGFYGGKRYFKPETLDIFNTCYYCEDDVRRGVGFDKP
QLGDIGPTCGCVSMTSFGHSGFTGTFTWADPDEEIVYVFLSNRTYPSADNRKLIGSNLRS
NIQEAIYEAIDYNLED
>OMIFANIC_02536 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGIALTEHGHEVHFITYKQPVRLDLISHHIHFHEVSVNEY
PLFHYQPYELALSSKLVNVVKQYGIELLHVHYAIPHAYAGYMAKKMLEAEGITLPMVTTL
HGTDITLVGNHPFYKPAVTFSINKSDIVTSVSQSLKEDTHRLFDIKNEIIVVPNFIDMEK
HINPYTDCQRDLMAEPHERIITHVSNLRPVKRVKDAIEIFDRILKKMPARLLIVGEGPEK
EACEALCVEKGIDEKVAFLGNSNEVDKILCFSDLFLLPSEKESFGLAALEAMASGVPVVS
SNTGGLPEVNIHGVSGYLSEVGNIDEMASNAISILSSDDTLAKFKIQAKEMAQRFDTARI
VPQYEAVYEKALQLVI
>OMIFANIC_02537 hypothetical protein
METHYVDLHCHPSLKPYSKSFKYHPPKRNELDAGRKNSIWHYSPPTVLEKFVNRIVTLTK
FTQTDMTALAKAKTKVVIVSLYPFEKHFLSKRLIGWKGITDLLVNLAASISQKRIDHVLR
HSDYFEDLQSEYDFYLQLHNQVQRIDDITYTYRVIRNFQDLETNTERETETQKIINILIT
IEGGHAFNSGLDMHQNTGDPLEIRKNVAKVKGWVHRPLFLTFAHHFYNELCGHARSISIG
ALRDNQNRGLNSGITELGFKVINQLLDNTDGNRIPLDVKHMSRDSRKTYYGLLDTAYTNQ
AIPVIASHGAANGMRSIIETDTTDYPDRAHLFNDIDINFYDDEFIRIARSNGIFGIQLDE
RRIGSPKAIKKSKIYFPNKRKQLRKKSLLVWRQIEHVAEVLDKEGLFCWGIQSIGSDFDG
IVNPIKGFWTAENIKDLGEELVNRANDYLSEHKDHLKNFNRISAEAIVARVLRDNAMDFI
KNHY
>OMIFANIC_02538 hypothetical protein
MKKLMLTIIAMLTFTLTIHAQGIADNAIGLRLGDSDGFGTEVNYQRALGENNRLELGLGW
RSSNDVTAIKLAALYQWVWVLDGNLNWYVGAGGGVGQVDFDDDFPGDPDAETFLFAAGDI
GIEYDFDIPLLLSLDFRPEFGFGDYRDDVDFDIALGIRYQF
>OMIFANIC_02539 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MEATLAAFEYRFIGDFYYDDLHKTMYATDASVYRKLPLAVAYPRNEKGIKQLIAFAIQQN
TSLIPRTAGTSLAGQCVGEGIIVDVSKYFTEILALDVKNKTVTVQPGVIRDELNEYLKPH
GIFFGPNTSTSNRCMIGGMAGNNSSGTTSIKYGVTRDKVLKMKTILSSGEEAIFEPLSKE
AFITKSLDPSLEGKIYNLIHAELSSESTKNEIRSEFPKAEIHRRNTGYALDSLLDTDVFS
DSSRQINICDLLCGSEGTLAFTTEITLKLDDLPPAETAMIVSQYHNLSDCLNDVLIAMKH
ELYTCELMDDIILDCTRNNKLYDSYRFFVEGNPRALLLLELRANSKEDLDKKSDLLLGDL
ESSRRSYSRPVLEGDQIDMALELRKAGLGLLGNMVGDKKAVACIEDTAVALSDLPEYIEE
FTALMSSYNQSAVYYAHAGAGELHLRPILNLKKKEGVEYFRKITTDVAKLVKKYRGSFSG
EHGDGIVRGEFLPKLIGEKNYELVCKIKQVFDPHSIFNPGKIVDPWSMDTYFRYNADREE
PEIETFMDFEDSKGILRLAENCNGSGDCRKTEGSSGMMCPSYHATRDEKDTTRGRANILR
EVLTNGTGINTFDSKDLKASLDLCVSCKACASECPSNVNIAAVKAEFQYQYNRSNRISLS
TKLIARSSKYNRMASRFPKLSNWLFRNRFSSTIIKKIGGIAPERTIPVISIRSFNKLSQL
PVYEDVKISKEVCLFVDEFSNYLEAEIALDAFSLLTKLGYKVLIVDHLDSARALISKGFL
EEAKKVVDDNINYFKDRISENTPLLGIEPSAILGFRDEYLRLADDKPSAKLISEHTYLIE
EFIAAELAAGRINSDQFTTEEKKIKIHSHCHQKALSNQKVTFDILNIPKNYKPTIIASGC
CGMAGGFGYEKQHYEISMKIGGLKLFPAINKCDANVIISANGTSCRHQIMDGTQRKALHP
VTILNEALLDL
>OMIFANIC_02540 Chorismate synthase
MAGNSFGTIFKLTTFGESHGEAIGGIIDGCPAGLSLDLEAIQAEMQRRKPGQSSIVTQRK
EEDEVQLLSGIFEGKTTGTPIGFVIQNTNQKSRDYSHIKDTYRPSHADFTYDKKYGIRDY
RGGGRSSARETACRVVAGAIAKQLLKNVTITAYVSAVGELQLTKPYSELDFSQIEKNPVR
TADVDMAVQMEEYIKQIRKEGDTIGGTISCVIENMPVGLGEPVFGKLHAEMGKAMLSINA
VKGFEYGSGFTGTRLKGSQHNDIFNEDGSTQTNFSGGVQGGISNGEDFYFNVAFKPVATI
MQNQQTINSDGESVEMSGKGRHDPCVVPRAVPIVEAMAALVLADFWLLNKLSKI
>OMIFANIC_02541 Proton/glutamate-aspartate symporter
MKNLALHWQILIGMLLGLVFGFIMLQTSWGAGFIGDWISPIGTIFIKLLKLIAIPLILAS
LIKGISDLKDISKFRNIGLRTIITYVFTTVIAISIGLMLVNLMQPGDGVSEETIAKLTET
YAGDSGVQSKIAEATKQKESGPLQFLVDMVPDNALRAMSENALMLQVIVFSIFLGISLLL
IGEKRAKPLKDFFDSLNYVVLKMVDLIMLSAPYAVFALLANVVVTSGDPDLLYALLKYAG
TVVLGLILMIVFYLTIVGTYTKKNPLWFLKEISPAQLLAFSTSSSAATLPVTMERVEEHI
GVDKEVSSFVLPVGATINMDGTSLYQAVAAVFISQALAFDLTFGDQLTIVLTALLASIGS
AAVPGAGMVMLVIVLESIGFPADRFPIALALIFAVDRPLDMCRTVVNVTGDATVSMIVAK
SVGKLGKPRVEDWDEHYEEVK
>OMIFANIC_02542 hypothetical protein
MLRLLIFYFLFISFQFNAQVGINTTSPSPASILDINSTQDNIHFGGLLPPRVPSITNRNS
ISTSFSDIGLLVFVDEVQCLQIWNGTTWEDIHCLNEVSLQGVFQNFDLNTSWGYSSDIPF
FDNGNDGYFGITNSANGGFSNISTLTNNFLGVLDLDDEGVNGTSGFATITFNTIDITGAG
SGVTLSFSYEFFEFDTGDDAFYTITIDGVPQTEVQLINGLADLSISGNVSVNIPPGSNSV
GLSFRIRQDGAGDYAGFDNFAIVPN
>OMIFANIC_02543 Small-conductance mechanosensitive channel
MKSAADYLKIAKDLLFEYGPRILAAIALLLIGLWVIGMITRGIRKTLRRREMEETLQKFL
SNLIGWILKVMLFIAVLSQLGIESTSFIAVLGAAGLAVGLALQGSLSNFAGGVLIMLFRP
FKVGDVISAQGELGSVKEIEIFTTKLLTPQNRLVILPNGALSNGTITNYTAEGFQKIFLT
IGVSYDADIKQTKEVLLEAIRKQENVLADPPPLVEVSGLGDSSVDFAVRCSVKNEDFWPV
QFNLIATIKEELDVAGIEIPYPHQVEIHKQG
>OMIFANIC_02544 Glutathione synthetase
MNVCFIMYPWEEVDPDNDSSLAMIHEFVKRGHGMAVTTPANLTIRDSVAYAFCKCVKRTE
KISKSLKSFHGNTQFYDEMLPLAGFDVIILRSNPPLDMIMLNFLDSVKDDVFIMNDLDGI
RRANNKMYTAVFEDDDNEIIPRTHVTKNKEYLKSVIKEGPDKMILKPLNGYGGSGVILIE
KRAMKSINSLLDFYIDNKDGTSNYVILQDYIEGADQGDVRILMLNGQPIGAMRRVPGEED
HRSNVSAGGSVQKHSLTKQEKELCRRIGPKLVKDGLYFVGIDVIGGMLVEVNVMSPGGIT
YMNRVYKTKVQEKVIDFIEDKVLERVTAFERRQKLRKHVSDA
>OMIFANIC_02545 hypothetical protein
MIRLPVSEIITRIKNEECFEAVAEDYSFTLKIDEYVPYVCGAVHDGDQFRRELWDNCYHT
QYERWFEEDPCTREMVKSHPILIAGCDSRFEYDLNRDPENAIFEDAWGKKLWKEPLSREM
VDKSLAKHTAFYSVVHALIELLEQKFGTIVVYDVHSYNWRRWDREVPVINLGTSNIDNER
FGGMVELWRKSLSELQLPGVPETTSKINDTFFGNGYFLKYITKTFKNTLVLATEFKKIYC
DELQQIIFPEVVAAIEEQLRVKLKEHAEAFYKEHN
>OMIFANIC_02546 hypothetical protein
MAFTDTILANHPNLVHIDGNLNKLVQKIELLNYINPINIEQEKRNFFSSKYNINPRFHYR
KIDFNAHKLQQELFSQDIDSIEDEEARNFYRDVIYDYSGLIQCIESIGKGSKFYFNSLKS
FGTPTEKDVENAKFILHFEDEEYDQEMFPVFSAVEAAEYFQEFTRKYDFQFNLKYSTKLS
AAAMVQNSTQTLVLKKNHRFSANQLKVLANHEIGVHMVTTFNGLAQPLKIFHNGFPKNLE
TQEGMAVFSEYMSGCLTLYRLKELSYRVLATDSLRKGLDFCGTFDLLHNQYKLNREEAYT
ISLRAHRGGGFTKDYLYLTGLKKIYDAYHRGENLDPLLAGKVTYEYVSIVDSWLEIGLAE
ENRYENFAFQKNENANSKLEFILQNLK
>OMIFANIC_02547 hypothetical protein
MTKAEKHKIVLFDGLCNLCNGAVKFMIRHDGDDRFRFAALQEEVGRELTAKYNIDSSKVD
SIILIDNGKAHIKSTAALHIALYLKGLWPLFHGALIFPLFFRDFVYDIIAKYRYKWFGKK
DSCMIPTPELQNKFL
>OMIFANIC_02548 Endonuclease MutS2
MVRIDRKTLQDLEFPSVLQQISEFCITEPGREKVLEIAPFKDANDIAPELHRVKEFSASF
DNENSVPNHGFEPIFKELHMLNIENSTLEIGAFRRILTVCNTTKDLLAFFRKYKEFYEFL
SAFSDEVDYTSSISAEINKVIDRYGEIKNNASEELNAIRKRLSVIKGQINSSFTKSLNRY
SKSDYLDEIRETVVDNRRVLAVKSMHRRKVKGMVMGQSRTGSIVYIEPQETLEFANEFSN
LIYEEREEIKRILKALTEFVRPYRETLGSYQDYLSRIDMLYAKAKYANIIGGELPLLTSE
KRIYLKNAFHPLLLISNKKIKAKTYPQTIELDPGKRIIVISGPNAGGKSITLKTVGLVQL
MLQSGMLVPVDPLSEFCTFGRVLTDIGDNQSIENHLSTYSYRLKMMNQFLKKCKSDTLFL
IDEFGTGSDPELGGALAETFLEVFYEREAFGIITTHYTNLKLLANELPNAVNANMQFDSR
SLEPMYKLHLGEAGSSFTFEVAQKNGIPYSLINKAKKKIERGKVRFDRTIANLQKERSKV
RKTAASLETTEKKARKESKQLEEINIRLQQKLESYQELYDSNQKLLTLGKKVDVLAERYF
NNKKKRQLIDELVKLVMIENSKRKKIHPKKKRVVKAKEKKVQQEVEKKVEVIRRKKKKKK
EEAIKAPPPKPKVALKVGDQVRMIDGRAVGTIDSIEKNHAIVNYGMFTADVKMDELEKV
>OMIFANIC_02549 Uracil-DNA glycosylase
MDVKIEQSWKGVLGEEFEKDYFKQLTAFVKHEYTSGKCFPPGSRIFSAFDHTPFEDVQVV
ILGQDPYHGPGQANGLCFSVQDGITKPPSLINIFRELQNDIQASIPENGNLEGWADQGVL
LLNATLTVRAHQAGSHQNKGWELFTDAAIRVISEQRENIVFLLWGGYAKKKGAKIDKSKH
LVLTSGHPSPLSANRGLWFGNKHFSKTNTYLKEIGKEPINWQL
>OMIFANIC_02550 hypothetical protein
MTIFLIILGALLVTNFLLLQFSCNDVTEPETPEEE
>OMIFANIC_02551 hypothetical protein
MKNFHIGGVPEHFNLPWYLTLRDKSYTKEGINLRWKDYYDGTGAMAKALREKEIDMAVIL
TEGIIRDICNGNDCSIVQVFVQSPLIWGIHVAKNSDFKNISDLKGKTAAISRYGSGSHLM
AYVNAENEGWDTEADLKFKVIKNLDGALEGLPNGKGDYFMWEKFTTKPYVDNGPFRLLGE
CPTPWPCFVIAVRNDVLSSDLKEIRTILRIINNTTADFKNIPGIDSMISNRYDQKLEDVR
EWLSLTEWSQQNLTNVQVDRIQQKLLQLELIDSILPAERLLFRDI
>OMIFANIC_02552 Uridine phosphorylase
MRIPESELILNPDGSIYHLHLLPEDLADTVITVGDPDRVNLISARFDTLEVKKQHREFRS
HTGTYKGKRLTVISTGIGPDNIDIVCNELDALVNIDLKNRSIKSQLRSLEIIRVGTSGGL
QPDVAVDSIVSGGIGIGFDNLLHFYGGNKEFLDYNFAKAFITHMNWNPDNAKPYVVHSDP
GLLEKFSSEDILQGITTTNVGFYGPQGRVMRLPLHDPDMNAKIASFEYEGRKITNLEMET
AAIYGMSRMLGHKALSLNIILANRANGTFSASPRKAIERLVTKTLDILVQ
>OMIFANIC_02553 hypothetical protein
MDLQDQLKNLFPDHVPSEEPKKEEKPTVWLQDDPLICKYEKRKGKPTTVIEGYNGATSDF
KQLAKELKQLLSVGGSFKNEQIIIQGDYRDRIMEFLKAKGFKVKRVGG
>OMIFANIC_02554 hypothetical protein
MNNIPSVDLADFLSDDPERKKKFVNEIGRAYEEIGFVSLKNHFLSDALVDKLYREVKAFF
ALPVEAKAKYEIEGLGGQRGYVSFGKEHAKGKKEGDLKEFWHFGQEPSVDANLPEEYPSN
VQVAELPDFNSTGMEAYRKLEKTAIYVLRALSLYIGLEETYFDHWVTNGNSILRPIHYPP
ITEEPKGAVRAGAHGDINLITLLMGASTGGLQVLRMDGEWIDAVPEEDELVINVGDMLER
HTNNKLRSTIHRVVNPPREQWDTPRYSIPFFMHPRSDMKLNCLEECIDADHPKAYEDITA
GEFLHQRLVEIGLIKK
>OMIFANIC_02555 2-oxoisovalerate dehydrogenase subunit beta
MAHTTVSSISFDYDPGDLDNSVLISLYKKMMKPRLIEEKMLILLRQGKISKWFSGIGQEA
IAAGVTAVLDKDEYILPMHRNLGVFTGREIPLHRLFSQWQGKANGFTKGRDRSFHFGTQE
FKIVGMISHLGPQFGVADGIALGNLLKKNNQVCAVFTGEGGTSEGDIHEALNVASVWQLP
VLFCIENNGYGLSTPTSEQYKCEHLADRGKGYGMETHIIDGNNILEVYTKLKTIVESMRK
EPRPVLIEFKTFRMRGHEEASGTKYVPQELMDRWAAKDPIRNYAEFLRNADILTEEAEVE
IKKEIVHEINENLDIAFAEDTIQSTESKELIDVFKEHIYQEVTPNNKTQELRLVDAISEG
LKQSMVRHDDLVILGQDIAEYGGVFKITEGFLEQFGKDRIRNTPICESAIVGATMGLSIT
GIKSVMEMQFGDFATSGFNPIVNHLAKSQYRWGQNADVVIRMPCGAGVGAGPFHSQTNEA
WFTHTPGLKVVYPAFPYDAKGLLATSIEDPNPVLFFEHKALYRSIRQEVPTDYYTLPLGE
AALLREGNDVTIITYGAGVHWALEELQTLESLSADLLDLRTLAPLDIDAIYRSVRKTGKA
IILQEDSQFGGIASDISAMIVENCFESLDAPVKRVASLDMPVPFAANLEQLYLSKRKFRQ
ELIALLEY
>OMIFANIC_02556 hypothetical protein
MKKTILLAILAAVFFSCGTPKTVQESRKIIKGYWSLDNITYSESGTFNVQLLDDTSKECF
EGSNWRFIPNNNTGNYTIEDSNCPTGERYFIFAIQEIDPTTGLYDFLLKPTNEKKKSEDN
RGFRLRLAKLTGSSMQWEQTVSLEGKPFTIYMNFSKLSE
>OMIFANIC_02557 putative lipoprotein YiaD
MKHILKNIAIIATLVLFVGSFGSCEATKNANNKQKGAVIGAAGGAILGAIIGNNVGKGGN
SEAGAVIGGVVGGAAGVIIGDRMDKQAQKIEEEIPGAKVERVDDGIVVTFDENSGVYFAT
NKYNINEASQTTLDKLAGVLVEYPDTDVLVVGHTDSTGADEYNMTLSKNRANAVTNYFTQ
NKGLNPSRFTTNWYGETSPVADNNTAEGRAQNRRVNIAIVPNEKMIKDAEKQAEGN
>OMIFANIC_02558 Kynurenine 3-monooxygenase
MTTSEAYDVIIIGGGLAGLCCALHLQKYELKILLIEKQSYPKHKVCGEYVSNEVLPYLGW
LNIDPKAHGAVPINQFEISTRHGETIESGLPLGGFGMSRYALDTLLYNEVVPKSEVVIDT
VTSVEFQDNIFVVNTQSKKSFQAPYAVGAFGKRSILDKQMDRKFVNERTHWMAVKAHYDY
SFPENKVALHNFEGGYCGLSQTETGAVNACYLTTLKSFRACDSLEEFQQKVMSENSRLKD
FFENAIPLFEKPLTISQISFAKKSIIEDHIFMLGDSAGLIHPLCGNGMAMAIHSAKLFSE
LYLKEIRNKNGNRDSLEHAYKKAWKANFAERLRTGSRIQRLLLNNTAASFAYTAVNRFPS
ILPYIIKKTHGTALV
>OMIFANIC_02559 hypothetical protein
MIAFSSKHRSEEKEIMDDFQFQGTEMEALLTDLKRINKWLGGNKITLNGIQKLVEAGPGN
RRISILDIGCGDGEMLRVCANKLKQPNITFSYTGIDANKFIIDEAILRNKDYPNIQFKTM
DVFSREFEDLEYDIALCTLFLHHFKDKDIRRLVEKIASNAKVGIVINDLERSKLAFVLFK
IVSTLFVRTKTARNDGLVSIARAFKRKELIAFSKSVKAEHFIKWKWAFRYQWIIKRV
>OMIFANIC_02560 Alpha-pyrone synthesis polyketide synthase-like Pks11
MSVKIKSVAKQLPQYTRNIDEILPYVAAWLEGQDDRFKRKVLKIFEGAGVDRRYSIMDAE
DIFLNTSFEERNEIYCREMKILGSQCLQKALDKAGWRPTDVDYIITVSCTGIMIPSVDAY
LINELKLRQDVVRLPVTEMGCAAGISGMIYAHNFLKANPGKRAAVIALESPMATFQQEDY
SMVNIVSAAIFGDGAACVLMSSSEEDEGPRIVDEAMYHFYDATHMMGFKLVNTGLQMILD
ITVPEKIAEHFPHIIHPFLERNGKTIEDIDHLIFHPGGKKIVQTVEDLFGSLGKNIDDTK
EVLKLYGNMSSATVLYVLERFMDKNIPKGEMGIMLSFGPGFSAQRILLEF
>OMIFANIC_02561 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MQKRQTAVILGGSSGLGLASARKLAETGFDICIVHRTRKSDLPAFTKAVAEMESFGSKIT
SFNKDALKSETINEVIGQLAENSVGLLLHSIAKGSLKPLTSENALNNQDIEITLHAMGYS
WYEWTKALLDANKFASKVRNLAFTSEGNSKVWPGYAAVSAAKATLEAMMRSMAVEYAKFG
ITSNCIQAGATETPSFKMIPGSEKLAEAAKKRNPFRRLTTAEDVANAVYLMSREEAGWIN
GTVIKADGGESLS
>OMIFANIC_02562 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MEAKSVISKLPYSKPFLFVDAIEKLDDNGIAGYYTFHKDEYFYEGHFKDNPITPGVILTE
CMAQIGLVCFGIHLLKDELDKGINIAMSSTEIDFLKPVFPEEKVKVISQKIYFRFNKLKC
KVKMLNSQGEVVCNGTISGMLILKGS
>OMIFANIC_02563 3-oxoacyl-[acyl-carrier-protein] synthase 1
MKHRVVVTGLGIVSPNGVGVKAFHNAIKVGKSGVRFFPELEKLNFSCQIGAKPEVSEEQK
RKYFSELQLKNFNSSGILYGVMAGMEAMEDAGIEAAGKDSEPLWDLGIVFGTGTSGVEKF
RESVYLLDAGKVKRLGSTTVAQTMASGVSAYLGGKIGAGNQVTTNSSACATGTEAIIMGY
EAITSGKAKQMLCGSCSDDGPVVWGGFDAMKVLTWKHNEEPERGSQPMSAAASGFVPGSG
AGAMMLESLESARERGATIYAEVLGGNVNNGGQRQQGSMTAPNSIAVQRCIRSALESATI
KATEIDYINGHLTATVKDPTEIKNWSEALKRKGSDFPYINSLKGMIGHGLAASGSMEAVS
VILQLYHSFVFPNSNCEQLHPEIAEILDRERIPTELINTTLKTVAKASFGFGDVNACVIF
RQNSN
>OMIFANIC_02564 Acyl carrier protein
MTSEEIYAKLQPIIATYLPEDVSADNINRDADLTQELNINSAHLVDVVLDVEDAFDIELS
NNDLETLRTVNDAIAIVEKKVKK
>OMIFANIC_02565 hypothetical protein
MESLFSAENLITLALLTLLQAVLGLDNLLYISLESKRAPLEKQRRVRQIGIGGAVILRIV
LLFVLLKVIELFQDSLFGIHATGVFEGDFNLHSLIVLFGGVFIMYTAVREIMHMMRLEAD
DHMEHKPKSVGMIITSIVIMNLVFSFDSILGAIALTDVFWVMATAIIIGGLLMIYMAGRV
TEFLKKNRMYEVLGLFILLIVGVMLLSEGGHLAHMKLFGNEITPMTKTTFYFVIAVLVIV
DVVQGRYQKKLNRQL
>OMIFANIC_02566 Ribosomal RNA large subunit methyltransferase I
MFNVSLPNIEPKRLAVKLTPVGERSVRSGHPWLFSNSIVKINKEGSAGDLAIIFGNRSNE
VIGVGLYDPDSPIRIKMLTNNGPVTITSEFFSDRIARAYSIRLPLLASSTNSYRLIFGEN
DRFPGFIADMYANVLVVKLYSEIWLPYLKEILKVLIEVSSAVCVVLRLSRKLQEKNDHGL
YDGLVLYGTLENENVLFVEYGVNFSANVIHGHKTGYFLDHRNNRKRVGELAKGKSVLDVF
SYTGGFSVHALVNGAKEVTSLDISKQALEVASYNASLNEYTGTHQTIAGDAFEIMEQLIS
EGKTYDIVVIDPPSFAKRASEIKKAEKKYAQLSKLGTSLTAMRGILVLASCSSRISSEVF
FSINEKSLNESGRNYTLLDKTAHDIDHPVTFPEGAYLKTGYYQF
>OMIFANIC_02567 hypothetical protein
MACMVMTFANHGYCQSENQSKFFIGFNAGYNRGLGFQATITAQDPIESLPVDLRLGAGYT
SLDPGSSADARRIFINNATNGVPEEKARAFDYRLDILAPISLFSLEQSYVYFGPRYSSFR
ANFKYIGGNEDFDVTSRQFGAGLGAESHFKMNDKLNLVVTAGVDYFFDNTLKGHDTSYSP
DDDNVNPRNDNQNNDVEFTYSDADDAINQPDIMPRLLVGINYQL
>OMIFANIC_02568 hypothetical protein
MRHQNDYLLGSYMDPEDELENESEEGFENEFENDLPEASEGDGAIGGADNGIRIDPRT
>OMIFANIC_02569 hypothetical protein
MTFKTFVKECNEKEVLKMLSIYIVSCWVLLQVLAVTWDPMGLPKISNTYLIIILLLGFPF
YIYYIWHLKLAKAEKLKKVRISKKGKPKKSGFYKMYFSSMAVISGLCAVAAAFIIQNNFA
RNRILPEAVSTDKIAIMKFGNNTGDKVNDIIGKMTSDWIMHGITQYELGQVVSPEILGDY
LGILNSETEEADEKEVLTQYFKPAKVIVGNYYLNKDELLFQCSIMDGNYDKTYISFEPIT
CDQGDPLVCIESLKQKILGYLITEVNPALSLEETPPKFEAYQYFIDAEANFGDNELHLEL
LNKAIEADPDYFEPKVMRVAYYYNNGDYEKADSLKNTIVPNSRSSARQINVLQTYNALLE
GNNRSIYTHTLSEYKLAPFHMITNTGAMVVALQYVNKPEEVDSIFRMVTMEGMNLENCTQ
CKFRIYTQSLANIELKKYDEAITLLEPLTNVLDDMYLQRALMAALVRSGNIATLESQLER
LKISNSNSYMQSALSFIAKEFLLLNDNERAREYFDRSSSLPNDEVDNSREAEAFYYLKEF
DKAEPLFEQLHRSDPDDITTMARLAVCYHRNTKTKQALQLIEKISGTRSAYQFGSVDYAL
AQYYANIDNKSLSLQYLMKSIADGNTYTLMTFQNDPHFLPYLNDPEFNKIMTFWY
>OMIFANIC_02570 Low-affinity gluconate transporter
MDSTLLIAIFAGIAVLLILILKFRIHAFVALLISSILVGIIAGMNPGCIVKTVQEGMGNT
LGFVAVVVGLGAMFGAILEHSGGAEAIASFLLKRTGNKGASWALMATGFIIAIPVFFDVA
FIILVPLIYSLQRKSGKSLLLYGIPLLAGLAITHAFIPPTPGPVAVADILNADLGWVIVF
GAIVGIPTAIISGPLFARYIAKRIHVVAPELFEATTDDQPRPSVGMIAAIIGLPIVLIVC
NTVLNSPMANGWVSETVKEWMEMIGHPFTALILANLIAWYLLGIRRKTSREKLLKITTKS
MGPAGIIILLTGAGGVFKEMLITTGTGDMMAAYFSELGLSTLLFAFIVAALVRILQGSAT
VAMITAAGVTAPLLLGSTGDIEKALLVIAIASGASIMSHVNDSGFWLVSKYLGLSEKQTF
RSWTIMTTILALVGISTVSVLSLLI
>OMIFANIC_02571 6-phosphogluconate dehydrogenase, decarboxylating
MKPVYVIMGVSGSGKTTVGKLLADKLRLPFFDADNFHPKSNVKKMSSGIPLTDEDRQPWL
KTLSEKVTKWMREKGAVLACSALKESYRQILSSGNDIRWVVLNGSYDTILNRMQDRQGHY
MGADMLKSQFEALELPDYGLLLDVDKSPILLVSEILKDAISTKKSTLGIIGLGVMGRNLA
HNVLSHGISVSVYNRPDGDEVDMVTDFLAEADTPLAHGFITYPEFIQSLKIPRKILLMIP
AGPIVDSVLLKIQPHLSTGDILMDGGNSHFEDTMRRFEYYKKLGIEYMGIGISGGSEGAL
KGPSMMAGGSTEAYRKIQPVLETITAKDIKQKPCAAHLGPNGAGHFVKMVHNGIEYAEMQ
LLAEVYSLLRLDKDNVSVSKILAEWSETELSSYLLGIAADILVYKDGDEFLIDKISDKAS
NKGTGGWSTKAAVDLGIPATMMSNALFARYLSSFKELREKVSQDSLKIDRSIEIKTLKEA
YQFARLINHYQGFDLIMKASYEFGWKIDPAEIARIWTNGCIIKSELIYRLHDRFSKNTDL
WADKELISDLNRMEGSAHSIINFGMDQRISLPCLSAALQFWYGITTGKSTANLIQAQRDY
FGAHTYERTDTNGPHTTNWTSNG
>OMIFANIC_02572 6-deoxy-6-sulfogluconolactonase
MNFRKGAFVCLIFTTLITSCKKEPAITMTAELEFKSRALLGEGAFWNHESQELFWVDILG
KSVNIYNPKNKSNRSFPLPFRVGTVVPQTDSTAVVALENGIYILNLNNRLLTNLSNVEED
IPTNRFNDGKCDPNGNLWVGSMQLDETLPEASLYKVAPDGTTWKMRDNITISNGIVWTKN
GRTMYYIDTPTAKIRAYDFNMESSTISNERTVVEVAPEVGYPDGMAIDEEDMLWVGLWNG
NAVARFNPKNGELIQKIEVPAHNVTACAFGGPDLDILYITTARKDMTDEEIEKYPLAGSI
FSIKPGVKGVNSQFFGTIK
>OMIFANIC_02573 hypothetical protein
MTKRTKWWWNGAVGAFLFGSGLSIAMECSHLKHSGEPWYLWIAGGTVGIGIVLSGVVLLI
RAGILNNELQQEKRN
>OMIFANIC_02574 Protein YceI
MIFILYIHRSPFIDHISDTMRHAICIFYIVLGVFYTAQSQSIEIDEANALVSFLFVDDDV
EGTLSEFEFTGSIDLDAMDTSVFSGSVLMETLDTDNWFRDRHLRSKKYFNNKNFPRMSFT
STSISGSGDEFVVRGDLTIKGIKKPVAFTFRKLPGKLLGTSVINASHFDILIHNDTERNM
TKITITLPYIVN
>OMIFANIC_02575 hypothetical protein
MSKKSDSPKPGISINPKKSDKAKPGISINPKTSDKSKPGISINPK
>OMIFANIC_02576 hypothetical protein
MKHFLLVTVQTESLIKLLEIIIWPLTLFLIILMFRKQFRNAMERMGSFKADATGISMSFE
PKLDAAKKIFSALKPEGVSKSATSLHERTTFTGTPKEQLGQMKAELHTSLVELAQEANLD
SNGKSTSALNRELAQKSIVKNESYHLIEALLEVINAAPAAISQAQVSEIQEMYNSI
>OMIFANIC_02577 hypothetical protein
MSELSNAFGLVIGVGNDLPASAEDAKAIYNILVDNELAGYKEENISLLVEEEATNTNITK
ALDDLVANTDEESSVFMYYSGHGGTYTDNDIIELEQGGVGLKPEEENRSHYYLVPNNFDP
KNFRDTWVLASDLKDKLRSLKSRRLILFLDCCHAEGMTKAGPELQSKSLKDRIRNPEGLV
HKIDDGRGISIVSSCRADELSWILGDEPNSLFTTCLLEVLKGEHKDVYQEPFIRMTEVVQ
YVMKRVPERKPVQRPFVNLQLYDDFILSSVPNMLRNRVRSSDAVEGGTDKSTSAEVVTSF
REEGSPNLVLFVHGFSGEAAGTFGEIPRLLMGNNDMDGWDLMPLGYTQHVKPEMGKTVWA
SENDILRIADYLRSAIEYKFDSYQRIAVIGHSLGGLVVQQALVDLDPKQMKRISHVMCFA
TPSNGISSESLKKLCDAENSALQHDGNFISSLRKEWDTKFEAGCPFEFKAIAATNDEFVP
VASSLEAFDEGSRITLDGNHYSLVNQSNEENDTYQLILQTLTGNTFHSEYTNQEEVNIAL
GQYDAVIKELLPKKDELNLKGLRNLIFALEGMDRTEEALEILQDHPLAKENSDLMGILGG
RFKRKYLQTLSDADGQKAIEYYTKGLALAEAASNAGQVYYLSINLAFLSLVCDEDHQAMQ
EYAQQALEATAKDAFDNLWKLATMAEAHLYMGQLEESKVYYKKAGEMAGIREKISIHTNA
YAAYTSLMHTENPEDDFIKFLKINFLS
>OMIFANIC_02578 hypothetical protein
MKYTPDMLKFSSDNLPQMNFRKAVKKPIPIECAQIDEPFEVETMEGTLKGKKGDWLMRGV
DGEVYPCDREIFEKTYDLQ
>OMIFANIC_02579 hypothetical protein
MTDNTIFFSYSRDNSDFVLGLAKELKDAGANVWLDQMDIKPGTRWDKSIETALKESGTLL
VVLSKSAVASHNVMDEVSYALEEGKTVVPILLEECDVPFRLRRLQFADFIQSRESGMQTL
FKALHIGEDTANKPTGDPVRESPPKKPAASVSKQASSSKKSNKATLLYVIGGILAVLVIL
YSTGVINLEDSSDDLMVNVVEASANDEEAWKNAQSLNTAKAYLDYAAKYSEDGEYVQEAY
DAMDVVYNSRGIIEYSEGSGSEKENFFLIYKGGLDDERNTPDKGNYIISLEDWPVNLDLM
GTDSGETGNIKKNQIATVEQVHLAGDKVYCTIKYHQE
>OMIFANIC_02580 hypothetical protein
MKTFKNLITIISVIALIFSFTLVSSCREDAKKEETQTETTSTKTPVETKAKTPATNEAIA
KNPAHGQPGHRCDIPVGAPLNSPATNTNSGSPVNNSSSNNATGKVNPPHGQPGHRCDVKV
GDPL
>OMIFANIC_02581 hypothetical protein
MLHRINPEHILFLDIETVPQHATYDQLQETIQQLWEQKTEYQRKDDFTPEEFYDRAGIWA
EFGKVICISVGFFNLKGDKRTFRVTSYHGEEIDILKEFKNLLETHFNRPHHLLCAHNGKE
FDFPYIARRMIINGIPLPSKLNLFGKKPWEVPHLDTMELWKFGDYKTFTSLKLMAHILGI
PSPKDDIDGSQVRNVYYDEKDIDRIIQYCEKDTITVAQIFLKLRNESILEEDEILSV
>OMIFANIC_02582 6-aminohexanoate-dimer hydrolase
MKYLKKIITGLLVLTLLLVGTLYATDTDYLLKAVRTIYLNGHTTAFLDDYNYFDNSVIEA
GEPLAWPDHKDYNSVSETEELTKINAELGTVAYLIIKNDSIWFENYYDGYGKDSKSNSFS
MVKSMVSGMMGMAISDGYIKGLNQPVGDFFPEFSEGLAAKMTVGDLSSMASGTNWDEAYY
SPFSITTRAYFDDDLDKVILGLKVVEEPGQKFKYASGDTQLLAMVIEKATGKPLSEYFSE
SFWKPLGANADAPWQVDSEENGMVKAYCCVAGNARDFARFGKLYKDHGNWRGKQLLDSSF
VAMSVRPRFEGSPQYGYGWWLYDSPDGKSFFMMRGHLGQYVIVNPEDNVMIIRLGHSKSA
DAGVGVFTRDIDIYIVEGYKMLGAGS
>OMIFANIC_02583 Methylated-DNA--protein-cysteine methyltransferase
MMSACIKSPVGILNISGDRNGISEVMFTDDLAETSGKIPDELSEAVTQLNEYFGKKRKKF
SLKLNPEGTEFQKKVWDALLNVEFGKTQTYQQIANKLGDPKVIRAAASANGKNPIAIIIP
CHRIIGSDGSLTGYAGGLHRKKWLLEHESPVVQATLFYLLL
>OMIFANIC_02584 Magnesium and cobalt efflux protein CorC
MTLLIVYAILSIIFSFLCSILEAALLSFTPTFLRMKDLEGRGYARTLTELKKDIDQPLIA
ILTINTIAHTVGAILVGVQAEKLPYKVEILGVNIVGIVSALMTLLILIVSEIIPKTIGAT
YWKRLGRFTAISLKIIIAPLKYTGILWMLLLTTKLIGKSAHVSTMSREEFIAITDAAEQE
GVFEESESAVIKNLLIFKSVEARDVMTPFPVVVMEDEETSLEDFYEAHNNLRFSRIPVYR
EKTHNITGFVLKDDVLEEIVQEHGSKVMGDIRRDIFVVEAEQPIPELFEKFIKQRGHIAL
VVDDFGNTIGIVTMEDIIETLLGLEIMDESDAIEDMQMAARKNWERRAKRMGIDLTDKKP
EDEDASG
>OMIFANIC_02585 hypothetical protein
MKNIRLLFILLFPLISAWAQQANPKEAFLEKWDNSKNYLLAIAEAMPEDYYDFMPTERQM
SFEEQLIHIKGNMDWLSNQYFNAGMATRENIQIPDTKAEILKLIGAAFDSTRDIIASASE
ESLEETVEFFSGPKSRLQILNLLQDHVTHHRGQLVVYLNLKEIKPPRYIGW
>OMIFANIC_02586 Delta-aminolevulinic acid dehydratase
MYPLRRNRRLRTSEAIRSLVRETVITPDDFLVPLFIVEGKGVKEEIPSMPGYYRYSQDLL
PAEVKKLWSLGLKAVLLFVKVDDSLKDNTGKEALNPDGLMQRAIKTIKNAVPDMLVMTDV
ALDPFSSFGHDGIVSEGKIINDHTNAVLAEMALSHAKAGADFVAPSDMMDGRIFEIRTLL
EDEGFHDTGIMSYSAKYASAFYGPFRDALDSAPGFGDKKTYQMDPANRDEAIKETLMDIE
EGADIVMVKPGLCYLDIVRDVRDSVDVPVAVYQVSGEYAMLKAAVEKGWLDHDSVMLEQI
TAIKRAGAHIIASYFAKDVVKLIS
>OMIFANIC_02587 Oxygen-dependent coproporphyrinogen-III oxidase
MKEQFVSYIRELQNTITSRLEELDGKATFVQDKWQRPEGGGGRTRVIENGNVFEKGGVNI
SEVHGKLPESMQQYFGVNDADFFACGLSLVLHPENPFVPTVHANWRYFELYDEKGEIATQ
WFGGGQDLTPYYLFEEDAMHFHKVCKQACDGHNPNFYPKFKERCDEYFFNSHRGEARGIG
GLFFDYLKETDKMTMKQWYDFVTDVGDSFLEAYVPIVEKRKNIQYNTENRDWQEIRRGRY
VEFNLVHDKGTLFGLKTNGRIESILMSLPPYVQWRYDHHPAEGSEEEKLITVLKNPADWV
>OMIFANIC_02588 Sulfate transporter CysZ
MLKNIIKGLRAYGGTFKLISQLGLWKYFGVPILISVLTAIGIGFAAYGFSDNIGGLISRA
WIWDWGSETFRTISDILGGIMIVTLGLILYKHIVMALSAPFMSPVSEKIEAHLTGMQRDH
RKTSFMAQLWRGIKVNGRNLLMELFLSILIFIIGFIPIIGVISTVLLFLVQSYYAGFGNM
DYTLERHFGYSKSIRFVSDHRGLAIGNGIVFILMLFIPVLGIIFVLPLSVTAATTETVKV
LYPSEK
>OMIFANIC_02589 hypothetical protein
MKIWARIRQMSLKELFRFGILFLKNPLLISPTLKASKETMRICDSHFGKLHHRNGKENAF
RHALWNLKICEKCQKTLKISQKSSKWAEKVTNLYENVTKNESLEDAMDLHNNSVGRMLFL
TISGLKMAKKVDILLKMMQKAVKITKMEELQSLKDQLVYISD
>OMIFANIC_02590 Uroporphyrinogen decarboxylase
MIKNDLFLKALQGKVVERPPVWMMRQAGRYLPEFMQIKAKYDFFTRCQTPELASEITVQP
IRRYNMDAAILFSDILVIPQAMNIDVEMKTGVGPWLPEPIRDVRDLDRVIVPNIEETLGY
VMEAIAMTKEKLNDEIPLIGFAGSPWTILCYCVEGQGSKNFALAKEFCFTQADAAHQLLQ
KITDTTIAYLKEKVKAGVNAVQVFDSWGGMLSPTDYQEFSWKYIQQIIDALKDETHVIAF
GKGCWFALDTMAKSGASALGVDWTCSPRNARYLTGGNITLQGNFDPSRLFSPPDEIKKMV
KQMIDEFGKDRYIVNLGHGILPTVPVKNAAAFIEAVKEYKA
>OMIFANIC_02591 hypothetical protein
MRKVLSTKKLTLVQKELLLNSGISLIEYDAISISPLDFELPESIRHAIFTSNNAVEIVFN
SRKNSPKIDKVYCVGAKTSRKLTDLGQNVVKTADNASKLSHFILNSFENEDFYFFCGSLR
RDEIIEYLKSSKNRLFEVKTYKTELKRKIFGQIFDGIMFFSPSAVASFTLVNKLSESNAF
CIGETTAAEAKKHTKNVYVSNNTSIESVIAKTVKILKKND
>OMIFANIC_02592 Porphobilinogen deaminase
MSKVIRIGTRDSKLALWQANLVKSKLDNLGYNTELIAVKSTGDLDLTKPLYELGITGIFT
KTLDIAMLNGTIDIAVHSMKDVPTLLPEGIVQTAVLERASAQDILVTRGELDESKNCTIA
TGSLRRKAQWLSRYPHHNVVGLRGNVNSRLKKLADSDWQGAIFARAGLERIDILPPDFIP
LDWMIPAPAQGAMVVVALRDDDFMIEATKQLNHYISAICTRLEREFLQVLEGGCTAPIGA
HAEIINKDILFKGVLLSLDGQTKLEIEKIIIPDHLESAGRTMALEILDNGGKELMKLIKE
SQ
>OMIFANIC_02593 Glutamyl-tRNA reductase
MKTNGAMNSASASEQNFYALGLSYKKADAEIRGHFSVTDAAQIAILEQAKNEGITSLSVI
STCNRTELYGIASNPFQLIKLLCAHTNGTIEEFEQVAYVYKNKQAVSHLFKVATGLDSQI
LGDFEIISQLRNGMKRSKDIGILNAFMERLANAVIQASKRIKNETELSSGATSVSFAAVQ
YIMARVPYISEKNILLFGIGKIGRNTCENLIKHTRNNHITLVNRTKLKAEKIAGKFDLIV
KDYAAIECEIAQTDVLIVATGAQKPTINKALLHLKKPLLILDLSIPKNVSADVLENEHVN
LVHLDELAKVTDSTLAHRESQIPAAEKIIAEVENEFNAWAENRIFAPTLKALKLKLSEIK
EGEINFHKRKLNDFNEEQAAIVSDRIIHKITTHFANHLKNNETATSESIELIKQVFQLPT
NEA
>OMIFANIC_02594 Regulatory protein PchR
MEKSIAQSIYDETLVDSDIFVLKFTNETADNKLFKREVSSSYIQFHFCVKGAASFSFNNG
NYRLPISDETSLLLYNPQRDMPIEVAVSPRSWVLSLLLPIDNLHALFSRDAGYISFLSDE
NKGRKYYKDAPISPSMAIVINQLLNYNLHSSVKQLYFKAKSYELLSLYFNRPADVNIEQC
PFLVDEDNVAKIKRAKEIILRRMAEPPSLQQLADEVQLPINRLKEGFKQVYGDTVFSFLF
DHKMEYARQLLATGSHNVNEVGLKIGYSTASHFIAAFKKKYGTTPKRFVMALSN
>OMIFANIC_02595 Ferrochelatase
MKGVLLVNLGSPDSTDPKDVKKYLDEFLMDPRVIDVPKWARTLLVRGIILNTRPKKSAEA
YSKIWWEEGSPLIVISERLQKKIQDRINIPVSLAMRYGSMTLKNGLQELVDQGVKEVLVI
PLYPQFAMATTETINVKVEELQKEFFPQLEITSMPSFYNKPEYVEVLSKSISEKLDGLDY
EHLLFSYHGVPERHIRKSDITKSHCKIDGECCKTSSPAHQYCYRHQCYETTRLVAEKLDL
KEGTYSTTFQSRLGFDPWLQPYTDRTIERMGKAGVKKLAIVTPAFVSDCLETLEEIAMEG
EEIFHEVGGEDFTTIPCLNDRDDFAALMADWIEKWRIVDIKTAIA
>OMIFANIC_02596 Multidrug export protein MepA
MARNRSAELGTKPISSLLIQQAVPASIGILVMSLNMIVDTIFVGRWIGPLAISAITVVIP
VTFFIGAIGLAVGIGGSSVLSRALGAGDRDKALRVFGNQTTITFFTSAILAVLGLVFQYQ
LINFFGADDSFRDIALTYYRIVLYGIVMLAMCMMGNNVIRAEGKPKFAMYAMMLPAIGNI
FMDWILIRVFDMGMEGAAWATFISYAICFAFILWFFIVKSELRLKLECFFLKRKIVNEIN
ALSFVTLARQGTIAVLTILLNNVLIRYGDSLDIAAYGIISRMLMFALFPVIGVNQGFLPI
AGYNYGAKKFGRVKESINTSIKASGAFAIFIFALIMIFPEQIVTIFISNSESLDAATLAD
NQEILRRTPSALRWVFAATPVIVIQLIGASYFQAIGKAIPALLLSLTKQGFFLIPLLLIL
PPFLGVFGVWIAFPIADILSTILTGYFLNRAVKRDLNSPVKAKDEIVSNLAQND
>OMIFANIC_02597 hypothetical protein
MLELKDFKDVSDRKSLINILKEKLPEEFLMDIMSSVTYEEDLLKLQAELVDFQQWVAKEG
KRVCIIFEGRDAAGKGGAIRRFTEHLNPRSMRVVALTKPTNVEKGQWYFRRYIKVLPDPG
EIVFFDRSWYNRAVVEPVMGFCNQEEYDKFMVQVPEFEHMLYEDGVDIIKFWFSISKDEQ
LRRFEARLKNPLKQWKFSPVDRVGQRKWDDYTFYKEQMFSRTHTSFCPWMIIKTNNKKEA
RLESIRYVLSQFRYEGKGDSGTNLFPDPNVAQRYHRMIKQIDI
>OMIFANIC_02598 Thymidylate kinase
MAYQLSSKELKILNSKKGIKQLIITEGHSVTKAVRYIKYEARVKSLQEELIKLQQWVSDN
NKKVVILFEGRDAAGKGGAIRRITQHLNPREFSIVALPKPTEEEQSQWYFQRYINKLPQN
GKIVFFDRSWYNRAVVEPVNGFCTENEYNIFMNQVNEFERMIIESGIHLIKIYFSITKEE
QARRFEDIKKSPVKKWKFSAVDRDALRLWDRYTDFKSTMFDQTNTERAPWYIIKANKKTK
ARIESMEKILELIPYIPKDADLITHISSDQTASDTKE
>OMIFANIC_02599 Xyloglucanase Xgh74A
MLLYHPKTSLLFICFFLGIFTESATSQTYDSELYDALEYRLVGPFRGGRSAAVTGVPGKA
NLFYFGAAGGGIWKTTNGGREWENISDGYFGGSIGSIEVAESDANVIYVGGGEKTVRGNV
SSGYGIWKTEDAGKTWKKAGLEKSRHVPRIAIHPKDHNTVYAAVLGNIYKPTQERGVYKS
TDGGSTWKRTLFANENAGAVDLIMDPNNPRILYASTWNVRRTPYSLSSGGDGSALWKSTD
SGESWKEISKNEGFPKDTLGIIGVTVSPANSDRVWAIVEHKEEGGVYRSEDGGKTWKQVN
KERKLRQRAWYYTRIYADPKDEDVMYILNVRYHKSTDGGKTYETYNAPHGDHHDLWIAPE
NPMRMIIGDDGGAQVTYDGGETWSTYYNQPTSQFYRVTTDNSFPYRIYAAQQDNSTIRIA
HRNEGRSIDEDDWERTAGGESAHIAVDPENNDIVYGGSYDGFLTRYNHKNGTVRSVSVWP
DNPMGHGAEDMKYRFQWNFPIFFSPHDPNKLYTASNHLHVTTNEGESWKVISPDLTRNDP
SKLGSSGGPITQDNTSVEYYCTIFAAAESPVTAGVLWTGSDDGLVHLSRDGGNTWDNVTP
KGMPEWMMINSIEPSLHDAGTCYIAGTKYKTGDFAPYLYKTSDYGKTWKKITNGIPSEHF
TRVLREDPKRKGLLYAGTETGMYISFDDGANWMSFQLNLPIVPITDLALKDNNLIVATQG
RSLWIIDDLTVIHQLAGAGNNENYLFKPKDSYRMGGGSRSGSLTSGTNHPGGVMTYFYVK
DPAEKEIKLSYLNSRGDTIKTFSSKGIKDKLKVKKGSNYHTWDMRGKGAERLEGMILWWA
STNAPKAIPGQYKVVLQVGDEVQNQPFTVLADKNSETDQAGMQRQFDFITDINNTVDNAH
KSIKKIRKINKQLGAFQKQYKENEEVKDLVEKAKKLSEDFSEIEKALYQTKNRSGQDPLN
FPIKLTNKLAHLNSLVSMDDFPPTEQDVAVKNELTQQINAELVKFDKLVSQEIAEFNRQF
NTMSLDYLFIEDEKE
>OMIFANIC_02600 hypothetical protein
MEYNYIKSLHLIFVITWFAGLFYIVRLFVYQIEAYHKTSPEKEIIGDQLKIMVRRLWYII
TWPSMILATGFAIWLVVLRSFYLTDAWMQVKLGFVVLLIIYHIKCHMIYIDLQRDKVKYS
SNFMRIFNEGATLILFAVVFLVILKNSINWIYGTLGIILFAILIMLGFKLYKRIREK
>OMIFANIC_02601 Sporulation kinase D
MAFYKRSLRNRIFFSMIVLIVLASVLIAVVTIFQYREEAEDYHRERLQRKEANIRENIDY
VLQNTTYPVETDQIPLIFKEKIYEIKDIHKLELYLYDLDGNLLKSSKASFFRDTTHTTIP
SYALEALESSSDKHYVEQFTEDGQDYQSSYSLITDLYFKPLAILNLPYIEDDGFMNKELK
ESLSRLGLAYLVMLLIAIALAYFLSKYITRSLNDVSEKILETRLNRRNKKITVDDRTTEE
ISTLVKAYNGMIDELESSAAQLAANEREAAWREMAKQVAHEIKNPLTPMRLTVQSFQRKF
DPSDPNVEKKLEEYSNTLIQQIDTMSSIASAFSTYAKMPAQQDETLNVVQITKLALDIFN
EGYIYYFPEEKELIARFDRTQLIRVVTNLIKNSIQAIEQGGVEEPRIEVKVFSEGDHAVI
TVMDNGIGVSQENLEKIFEPKFTTKTSGMGLGLAMVKKIVETYNGNITFESDENETTTFK
VSFPKS
>OMIFANIC_02602 Short-chain-enoyl-CoA hydratase
MKNYENVLVDSNNGITIITINRPTKLNALNKETIKQLHDAFKEADEDNETQVIIITGSGE
KAFVAGADISEFADYSVSQGAELASQGQALLFDYVAHLSTPVIAAVNGFALGGGLELAMS
AHFRIASDNARMGLPEVSLGVIPGYGGTQRLPQLVGKGRAFEMIMTAGMISADQALQYGL
VNHVTAQEGLMPLAEKLAGKILNNSSVAISAAITAINAGYEDGENGFDEEITQFGKCFGT
ADFQEGTQAFLQKRKAEFPGK
>OMIFANIC_02603 hypothetical protein
MSQPIKGRGAQRKAHNRFFELKHEIRDEFLNYCQKEDELASSNDTNYIEVFPKSFVNKIN
SPDVGMGYSANPYQGCEHGCVYCYARNSHEYWGYGAGIDFEQNIMVKKNAPELLEEFIRK
KSWDGNTIVFSGNTDAYQPIERKLQITRECLKVLLKWKHPVGIITKNSLVLRDLDLLKDM
AKLNTVGVHISITSLSEDTRRLLEPRTTSVKQRLKTVEALSSHGIPVNVMIAPIIPSLNS
HEIIPIVKKVAELGARSVAHTVVRLNGQIALLFEDWLKKTIPNKADRILNQIAECHGGNL
NDSKWGRRMRGDGVIAKQIGDTVALAKKKFLQGSGMPKLDRNHYLQLKDPQMKLF
>OMIFANIC_02604 TonB-dependent receptor SusC
MVYFLRESYALKSKLFLVLCLFVGLFYGVSTAYSQSSIKENILKVNGKISTEAGAPLMNA
DIHIKNTFIATQSDEDGEFEIDLMAGDVLVVSAFLMKTSEITVRSGDYISINLAANAELL
DDILLSQKKKQEERVSTPFQNVKSDSRGFPKQSLLNKDFWPGDISVYESLVRNPLLSGRP
GGGLSFQRSRGQINPSPALVILDDVPVDQSVLQQLDPDQVQSVSMVRSLAGSIKYGSLGA
GGVIYVKTKNTFNFDDNEGGKSRSALATDNEYSENLLSIEESFEDSSYIAQLKSAQSFEQ
AKDIYDQHTVSLGVSSLLYYLEASDFFTQWDPLYSHHILSQLFRLSNNNPKVLLGIAYQC
EQLGRHRQAAYVYQELMLMRPDHVQSYLDLAQVYTQIGNYKLASSLYRQMLYNTIPNLDF
RPIEFQIITEYRRFLSKFRSKVKFQGLPNELLIPNSRKTVRIVFEWTNPLTEFELQFVSP
DKKFYNWRHSAFDNKGFIESELASGFSTKDFVIENAARGDWIININRLSEDNENIPTFVK
YTIYKNYGLQNETTETKIVPLNKVDMKVTLDAISG
>OMIFANIC_02605 GTPase Era
MAHKAGFVNIIGNPNVGKSTLMNAFVGERLSIITSKAQTTRHRILGIVNGEDFQVILSDT
PGIIKPAYQLQQSMMEFVKSAFEDADVLLYLVELGEKQLKDEAFFSKIKNSTIPVLLLIN
KIDKGDEEQLAEALKLWQDQVPNAEIFAISALENFGVAEVFQRIVELLPESPPFYPKDQL
TDKPERFFVNEIIREKILMHYKKEIPYSVEIDTEEFFEDEKIIRIRAVIMVERESQKGII
IGHKGAALKRVGVEARKDLETFFGKQIHLETYVKVNKNWRSDKRQLRRFGYNQ
>OMIFANIC_02606 hypothetical protein
MSLPNEVVLRPRFKIELERSNEDALQAFELLKKTSKDFVITRVDDHVFLKIPRDKQHYWS
PQLDLEIVTFEEGKSQLHGVFGPKPTVWTMFMFLHFAVASLFIGFGIWAYTRASLDEPFS
VQLLLMGFMVLAWFVLYFAGRMGKAAGKDEMHLLYNFMKETLDIE
>OMIFANIC_02607 GTPase Der
MLQNSSSMSIVAIVGRPNVGKSTFFNRLIQRREAIVDATSGVTRDRHYGKSDWNGKDFSL
IDTGGYVVGSDDIFEAEIDKQVELAIDEADAIIFMVDVETGITGMDEEVAQLLRKSQKPV
FLAVNKVDSANRLHDAVEFYSLGFEKYYPISGINGSGSGDLLDDLVKVLPETGEREEDSL
PRFAVVGRPNAGKSSFINALIGEERFVVTDIAGTTRDSIDTKYNRFGFEFNLVDTAGIRK
KSKVKEDLEFYSVMRSVRAIEHCDVVLLVFDATRGFDGQVQNIFWLAERNNKGVVILVNK
WDLVEGKDNQTTNEFETYIRKQCEPFTDVPIVFISSLTKQRIFKAIETAVDVYKNRSRRI
KTSELNDIMLPIIKATPPPALKGKYVKIKFCTQLPTPHPCFAFFANLPQYVKEPYKRFLE
NKLREHFNFTGVPVTIYIRKK
>OMIFANIC_02608 hypothetical protein
MFSRIIVKRKQKPLGINRLLFSLYIPFFANAIKFYPKIISLHEPHTYLNKKIDHVVNKPT
>OMIFANIC_02609 hypothetical protein
MNFKTTCLVISLVVSGFVMNAQIQEPFSVRYSENLNGDFTIIANNVISRTPTGNYNGNAN
NQDFTNNVYVDIDNDPNTFNSSNANFSDPSTGGACVTIFRAFLYWAAADAEQPNGSDNQP
NWNFNDVKLMLPGETTYTTVTADDVIFRGRTSHFSNDPYICVKDITPQVLALPNKFGSYQ
VANVEAAEGLMAHDQDVGTAGGWQIVFVYESPNVPAKNITLFDGYAHVTNIINNFDINFS
GFQTTPGGNVNANIVLGALEGDRNLSGDRLQIRNVANNFVDITAPQRNANNFFNSRITDN
NGDFVDRNPVSINTLGFDAAVFPLDNPGNSVIGNNQTSATLRLTSNQEIYGLYLLGLAVE
IYRPSLNPLVVTQTSGTNPTNPGDTLGFNFNIQNNGNDNALNVTLATVIPPQATLIPITN
LPAGVTYTYDPVSGDLVFNVADGMLNVGDPPIDIDFELEINDECYFLEDDCTLSFDLQFT
ATYVGEQNPGQVISVSTADPNSCSAVPYSVNINQPIVNWATAPGALDVTVSCDDTAALNQ
AQSLEPVPDKCNFILNKTSGPFVAGSCPSVGTYTNTWNFTDACGVTIADYVQTITVTDNE
DPTASNPPAINVVCAGDIPAPDPSVVTDAADNCSTPVVAFVSDVSDNQPCPETITRTYSV
TDACGNAIIVTQLIIVSDDILPTASNPPSINVQCIGDIPAPDPAVVTDAADNCSNPVVAF
VSEVSDNQSCPETITRTYSVTDDCGNSINVTQQIIVSDDILPTASNPATINVQCAGDIPA
PDPAVVTDATDNCSTPVVNFVSDVSDNQGCPETITRTYSVTDDCGNSITVSQLIIVLDDI
LPTASNPADINVLCAGDIPAPDPAVVTDEADNCATPVVTFVSDESDNQGCPETITRTYSV
TDDCGNSITVTQLIMVLDDVLPTASNPPSIGVECIEDVPAPDPTVVSDASDNCSTPVVAF
VSDVSDNQSCPETITRTYSVTDDCGNTINVTQDIVIRDVTAPILVTNLQPEINITCEEIP
EIPDLDFTDNCTASVLVEYDEEMEIVTEIDYDIIRTWVVADDCDNRNTYQQRIRVRPTFE
VDVVSLEICPEDDPVNLETLISNTSDLNGNWSGEDIDILDGTVFDPADHEMGEYQFEYTF
IENECEWATTFNVSIGASCIELPCIQSRDDITISKLVSANNDGFNDFFEVNYILNPNANE
SCDITVQVEIFNRWGVRVYKDNNYNNDWYGVSPSGSFGDATLLPTGTYYYVVTLRNSGYD
PIQGFILLGTE
>OMIFANIC_02610 hypothetical protein
MRRTKNILSILLLLIVVCTGYAQQVPQFSQYMYNTISINPAYAGSREVMVINLLNRNQWL
GVDGAPVTQTFSGHTSIPGSNVGLGLSVINDKLGFERTTYLSTDVSYKIDLDPYDEYKLT
FGLKAGFRKYSIDPELLNDPLYNNDPFLSNADYKWDPNIGVGLYFRGESFYLGLSAPRIL
TYQGNSEYFSLDRVTYFANGGYVMDLNKNLLFKPAFIIKYTNGAPLSFDFSAMFLINQNF
WLGASYRLQDSFGALVNFKVAKGISIGYAYDYVTSGLNTATFGSHEIMLNFEFLFPKPRC
VCKDLYN
>OMIFANIC_02611 hypothetical protein
MALTAFLFISEAVPAQFDIPEKPPKSQQTAVYDYVGLLSEYDANALKRKLVDYADTTSTQ
IVIAIISSTNGEDISFLGAKWGQKWGIGQADEDNGILILLAKDDRTVDINTGYGIEYRIT
DRMAEQVINRYMIPEFKKGNYYAGLDNATTVMMQMLAGEFKGEPTTNFPYGRVIIIVLFL
LFWFIMIRASRKGRGGRNGGSGGGMGSLWDIIILSNAGRTGGSWGSGSGGSFGGGGSFGG
GFGGGGFGGGGASGSW
>OMIFANIC_02612 hypothetical protein
MSKLEDFLMPQEEAEVINAIRSAEKNTSGEIRVHLEAHSNMDAFERAAEVFDFLHMNNTK
LSNGVLIYVAVEDRTLVIMGDTGINEVVAPDFWESTKDVIVSQFKLGDVKQGLVDGILMA
GEQLKQHFPYGGGSGNELTDNISVG
>OMIFANIC_02613 hypothetical protein
MKKWLPVIVIVGLLVIGGFYAVNLNNALVELNEDASSQWGNVESSYQRRADLIPNIVKTA
KGYAEFEQETLTMVIEARSKATSVTIDPSNITPAQLEQFQEVQSGLTSALARLLAVFERY
PDLKANENFKELINELERTENRINVERNRYNEKVLPYNTKIKKIPANMFAGMLGFDERAY
FEAKEGTDEAPVVEF
>OMIFANIC_02614 HTH-type transcriptional repressor BluR
MHVELPEKRYYGIGEVARAFNVNTSLLRFWEKEFDVLQPKKNAKGNRKFTQDDIKNLELI
YHLVKERGFTLDGAKIHLKENRKKTLDNFEIIRKLETVKAELLKIKNQL
>OMIFANIC_02615 Murein DD-endopeptidase MepM
MSKVKYYYDSETLSYRKIESKKGRKFGIFLLSLLGMFLSGFLLLLVYINLPYVETPKEKE
LKRELINMELQFELLNKKMEQAELVLTEVADRDNNLYRVYFEANPIPEEQRKAGFGGINR
YKDLEGFDNSRLIIGTSRRLDILTKQIVVQSRSLDEVAKMAEEKEQLLAAIPAIQPVKNE
DLTRVASGFGYRTDPFTKARKFHWGMDFTARRGTPIYASGDGVVKRADNTASGYGKHIRI
DHGYGYESLYAHLYDYKVRRGQRVKRGDLIGFVGSTGRSEAPHLHYEIFKDNERINPINF
YYGNLTPEEFAILLQNAQQENQSLD
>OMIFANIC_02616 Alanine--tRNA ligase
MKSQEVRSKFLDFFESKSHEIVRSAPMVIKDDPTLMFTNAGMNQFKEYFLGNSTPKNERV
ADTQKCLRVSGKHNDLEEVGMDTYHHTMFEMLGNWSFGNYFKKEAIEWAWELLTEVYGID
EDKLYVTIFEGDEDEGLERDQDAFDYWKQFIKEDRILNGSKHDNFWEMGDQGPCGPCSEI
HVDIRSEEDKAKVSGADLVNKDHPQVVEIWNLVFMQFNRKADSSLEKLPAQHVDTGMGFE
RLCMVLQDKQSNYDTDVFSPLIREIEAISNNKYGKDEKIDVAIRVIADHVRAVAFSIADG
QLPSNSGAGYVIRRILRRAIRYGFTFLNKKEPFIFRLTETLVKQLGGAFPELVSEKNLIT
NVIREEEHSFLRTLDQGLVLLENIIGEGKNKEISGKKVFELYDTYGFPKDLTGLILRERG
YSYNEKEFDEELQKQKERSRAAGKVETGDWVILSDDSEEEFIGYDSLEANVKITRYRKTE
SQKEGELYQLVFNLTPFYPEGGGQVGDKGYLEAQDGEVVYVVDTRNENNLIIHFVKNLPR
DPKGSFKAVVDAKQRARTASNHSATHLLHQALRNILGEHVSQKGSMVHSRYLRFDFSHFS
KVSEDELRQVEDFVNARIRESIALEERRNIPYQQAIDEGALAFFGEKYGDTVRAIKFGKS
MELCGGTHVGNTSDVWHFIITSESAIASGVRRIEAITGDAAKSYFVDRSDAYKKVQRALN
NTKDPIGAIEKIQEENNSLQKQIQLLLKDKAKDMKGDIKNELQEVNGIQFIAREVALDAG
GMKDLAFELGSEIENLFLLFGSNHDGKALLACYISRELVASKDLNAGTIVRELGKYIQGG
GGGQPFFATAGGKNPDGISEALSAAREYIS
>OMIFANIC_02617 hypothetical protein
MKLQTQIPIRKESNQIDYDSRVLLLGSCFTENIGAKLDYYKFQNLQNPFGILFHPKPIER
LIRRAVKLVQFVESDIFEQDGQWRCMEVHSLVSHPDKITYLKLLNEKLAEFTEYLKNATH
VIITYGSAWGYRYHKTNEIAGNCHKIPQKEFRKEIASVQDVSECMNNIAEAIHGLNPSAS
LIYTVSPVRHLKDGFIENTRSKSHLIAGIHALTDRDTAISYFPSYEMMMDEMRDYRFYTE
DMLHPNKTAVEIIWDRFEGVWIDPQTEPLRKEIASIQSGLAHKPFNPNSESYREFQLDLQ
QKISRIQDVLPHLEF
>OMIFANIC_02618 hypothetical protein
MKFMVTLFLALSISLQAQVPAPRSTQSTNTGPYWTKSGDYDYTLYDGNGNKLTNVKDLKY
LSTDTLSVLDKNARDIYLLADFKNASDGSSGKASILQKNVGTNFYITNPYSFSFFVDDTA
RTGPFCNIEGSYIYYVSEEGSTYRLPDIRKFSNWGSNTAEKLSYTAINTYWYRDADNKEY
GIIKEGKTLDYSKVTPEKDGNDMVITVSGVKTYRLPGYYTMASFVYKPVEMYTPAREETV
STGCVKGDCQNGWGKYQYDNGYYDGFWLDGMKNGYGLYRWNDTGDYIGNWANDQMEGYGV
YTADNDDSIKGVFRNGQLNGIGVTKTGDKWEQGIFNDGNLESKHTFYSTGNDTGCTAGDC
QDKYGRYKWSNGDSFTGFFRNGNMYIGTYKFANGDKYSGMFNNDNQYHGMGRFWFNNGAY
YGGQWLNGKYSGRGYYSEKDTSPKVGQWKDGELVKSLN
>OMIFANIC_02619 hypothetical protein
MKTLRRSLYYATLCLALVLTACSSDDDNETNNNEGNNGGSGELFIAKIDGNDFAASQDPA
TLIGATKSTANGMTLITGQGSTNTGEFINFGIFDYNGPGTYITGNNLTNPNYLRYGELVG
QTAMVWGSDLATFAAGIGPGELVVTVDADGKLEGTFTFEGYNAQDMTTKMVTQGQFNVTI
D
>OMIFANIC_02620 hypothetical protein
MKTSIGMYTLVCVVFLMSTIALAQRAEAPDFRYDVGGKINDMTLTQGGTMVVATNDGLVG
IKPGTNDLLFNFQDYGKVKPEELIFVPNAPYLVVGQTGFGAMTTKKAVIDYISGKKLFST
EDNGWKLIWTCDVMMPQNKLVVSGQRRAADKYANAVAIYNLESGEQEHYFTMKGSETISG
RPLLLKGGLILPTTKALKKINIESGSEDWSIKVDDIKWMVADETEKEIYGFEISANGSNT
KVHKIGSNGSLLWEDAHKVKGHVSNFEILPQGLAIVSNVDNSGKSGLAKLASSRSESKIG
FLSASNGEDLWDKAPKTKGYVQHFYIMEDGILFGIYEGGINKISFDGKTLFKKPLKTGEN
ILTMANTSQGLIYITSEDANIVNLSTGDQVWKKPLKYKRADAVSSTYDEKNSRYLISADK
NLFSVDANTGDVSTLAESKFDGKESPTGVEVRNGGILLTSDQNMMMLDWNGKTNWHEYHR
APGKSAFGAILMGVTAVAAAATATAAYAEANAHRNKLGYYTSKGESYADLGDAMSMATGA
SVAEMLRRFKATAATENAQFILTKLDEGVGLVKLNKDTGAKEKEIVLKDKKPVYEVDEFG
GVLYYKADNNSIFAYDLKK
>OMIFANIC_02621 hypothetical protein
MGFYDFWPVLIEDQKYKATALFSLFGFFRYFGFNLAQKFCL
>OMIFANIC_02622 Response regulator protein VraR
MNLKVAIVDDNSFLIHAIKEKLSFFEDVIIKTTALNGSELLERLGENHNIDVILMDIEMP
VLNGIEATQLVKQKYPQIKVIMLTAFDNDENIFNAIKAGADGYLLKEINPEDLYNGIRET
LNGGAAMNPSIALKTLKLLRNPIDIDNPRDQEEISLSKREIEVLEQLSKGLSYTAIADNL
FLSPSTVRKHIENIYKKLQVHSKIEAVQKAKNHNII
>OMIFANIC_02623 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKVADQISDALIDNFLAFDPQSKVACETLVTTGQVVLAGEVKSNI
YLDVQKIARDVINRIGYTKGEYQFDGNSCGVLSAIHEQSEDINRGVDRATKEEQGAGDQG
MMFGYATRETDDYMPLALDLSHKILKELAVMRRENKDITYLRPDSKSQVTIEYNNDNKPV
RIDSIVLSTQHDDFDENEERMLEKIKNDIISILIPRVKSQLKPEIQALFNDNIKYHINPT
GKFVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNMVA
AGICDEILVQVSYAIGVVEPMGIFVDTYGTSKVDMTNGEIASKISEIFDMRPSAIEDRLK
LRQPMYSETAAYGHMGRKNEIVHKTFKTPDNTETTLTVELFTWEKLDYVDKVKAAFGI
>OMIFANIC_02624 hypothetical protein
MKLIKLLLVFILCFPITVCAQTEEKVIFPDDYFGIYKGTLSITSSRGPSTYPMEFHLLPS
DTIGKYIYTIVYGEGDMRQERKYTLVTKDAAMGEFVVDENNGIVLDDKVVGNRMYSLFEV
QGTILTTFITFEKDHMIFEIAAAQRENSNISTAKNEGQTEVISYPVTTVQRAVLIKQ
>OMIFANIC_02625 Bifunctional aspartokinase/homoserine dehydrogenase 1
MQVLKFGGTSVANSENISKVVNILSSKSETDQVIAVVSALGGMTDTLQRAGELANLKDEH
YLQLWASIQERHLDTAAELNLDEKAKDHLKEGLNELKKILQGIYLINEFSEKTQDKVLGF
GELLSSFIISESLKTKVSDSQLKDSRDLIITDSNYTRAQVDPELTSKNISEFFSSNGKKV
TIMPGFVSRSTEGVSTTLGRGGSDYTAAIIAASLRASVLEIWTDVSGMFTANPRMVKQAF
PLEEISYHEAMELSHFGAKVLYPPTIRPVLELNIPILIKNTFEPGAPGTLINREGNLDFG
PVKGISHLPNISLLTLEGTWMVGIPGSSKRLFEALSNEKINVILITQASSEHSICIAVQS
ADAERAAHAINEEFLFENSLGKINKAVIEDDQAIIAVIGDNMKNHQGISGRMFSSLGKNN
VNIRAIAQGASERNISAVIDARDVKKALNTLHYKFFERQVRTLNLFIVGVGNVGRRLLDQ
IRQQKDHLYDHLYLNVRVTGLSNSRKMIFNEHGIDLDHWQDALDKGDKRSETEWFETIRD
LNLQNSIFIDITANEAVANSYAAYLRENISIIACNKIACSSEYSNYIELKNLARHYNAPF
LFETNVGAGLPVINTLNNLINSGDQITSIQAVLSGSLNFVFNNFNAETTFFDVVKQAQDE
GYTEPDPRIDLSGVDVARKILILARESGHKIDMEDIENVSFLPKPSMESDTVADFYQTLK
DEAAHFDELFAKADKNGNRLKYVAEFNNGMARVGLQEVGKDHPFYNLDGKDNIVLYYTDR
YTDQPLIIKGAGAGAEVTASGLFGDIISLGKK
>OMIFANIC_02626 Homoserine kinase
MDQIRIFSPATVANVSCGYDAMAFALDTLGDEMVIRKNDSGQVVITRVDGAELPFETNKN
SAGVVASQMLTDAGSPFGVDIEIIKKYKPGSGLGSSAASSSGTAFAVNKFLDGKYSKLEL
LQFARLGEEVACGSPIADNVAAALYGGFVLIRSYDPLDIISIPTPSELVVTVIHPQIEVN
TEDARKILPEQIPMKTAIAQWSNVGGLISGLHTADFDLIGRSLTDHVAEPHRKIFIPHFD
QLKDNAMASGALGAGISGSGPSVFALSKGEDLAQKVASAWDEIYKNSGIDYKIYVSKINK
NGVQILND
>OMIFANIC_02627 Threonine synthase
MQYFSLHKKAAVVSFREAVIRGLAPDRGLYYPTEIKPLAESFIQSIEAFSDHEIAFEVIK
QFVGDDIPLPDLHRIVKEVLTFDFPLVEIEPGIFSLELFHGPTLAFKDVGARFMARCLGY
FNRDESKAEKVTVLVATSGDTGGAVANGFYEVDGVEVVILYPSGKVSDIQEKQLTTLGKN
IRALEVSGNFDDCQAMVKKAFLDEDFEGKVKLTSANSINVARWLPQMFYYFIAYKKLKKE
GKPIVFSVPSGNFGNICAGMMAQKIGLPVAHFITGTNANNIVPQYLKTGDYTSRETIATI
ANAMDVAAPSNFIRIEELHNHNIENLRNNLSGYSYSDKETRAAMNSLFSEFDYIADPHGA
IGYSALKDYIKETGFDGLGVFLETAHPVKFLDVIPKEITEKIILPQAIANIVHKEKIAGK
ISTYSQLKSSLLSG
>OMIFANIC_02628 Pyrroline-5-carboxylate reductase
MDRKVAIIGCGNLGIAILEGLLDSEYTAPANITVTRRNISALKEFENRGVVVTSDNSAAF
RNAEVVLVALKPHNILSILEDLRDEIVQDKHILVSLATGVTIEQLGMATSRELSIFRAMP
NTAAFVNESLTCICANTGDEKTLGTVRQLFDGIGKIQIIDEELMEAATVLGACGIAYVLR
FMRAMVQGGIQIGFSSQVASFIVNQTVNGASRLLIENEAHPEEEIDKVTTPKGCTIEGLN
EMEHHGFSSALIKGIVTSFEKIEK
>OMIFANIC_02629 hypothetical protein
MKVTLDRINDDFLFDAKGASNVSVHIDSKVEDVVNGASPMELLLMAVGGCNAIDIVSILK
KQRQEITGYHIDVEGRRKEVRQAKPFEAIHVNIHLEGKVDPAKAKRAAQLSFEKYCSVSI
TLEGSVEVTYEVYVNGEKV
>OMIFANIC_02630 Methionine synthase
MSAFIEALKKRILVLDGAMGTMLQQYQFTEEDFRGKRFKDFHKPLKGNNDLLSITQPEAI
AEIHRKYFNAGADIVETNTFSGTTVAMADYDMEDLVYELNFESAKIAKEVAAELTKNEPD
KPRFVAGAMGPTNKTASLSPDVNDPGFRAISFDELRIAYKQQAEALVDGGVDILLVETIF
DTLNAKAALFAIEELKEERNLDIPVMVSGTITDASGRTLSGQTAEAFLISISHIPLVSVG
FNCALGAKQLTPHLEVIANRTEIAVSAYPNAGLPNAFGEYDESPAQMALQIEEYLDKKLI
NIIGGCCGTTPPHIEAIAELAAKYEPRPLELNQINA
>OMIFANIC_02631 Methionine synthase
MSETPGEIRYLKLSGLEPLVITPESNFINVGERTNVAGSRKFLRLIKEEQFEEALAVARH
QVEGGAQIIDVNMDDGLIDGKKAMVKFLNLIVAEPDISRVPIMIDSSKWEIIEAGLQVVQ
GKCVVNSISLKEGEEEFLRQAKLIRRYGAAVIVMAFDETGQADTLERRIEIAERSYNLLV
DKLRFPPEDIIFDLNIFPVATGMEEHRRNALDFIEGTRWVKKNLPHCSVSGGVSNVSFSF
RGNDVVREAMHSVFLYHAIQAGMNIGIVNPAMLEVYDDIPKDLLEHVEDVILDRRGDATE
RLLDFAETVKGERKQKVADLSWRELPLQDRITRALVKGIDAFIETDVEEARKVVNKPIEV
IEGHLMTGMNVVGDLFGSGKMFLPQVVKSARVMKRAVAYLLPFIEEDKDAISSSNGKILM
ATVKGDVHDIGKNIVSVVLGCNNYEIIDLGVMVPPEKIIATAKEEAVDIIGLSGLITPSL
DEMVFLAKEMQRQDFKVPLLIGGATTSKAHTAVKIDPQYSSAVVHVNDASRAVTVVGDLL
QKDKQEGYKADLKKEYAEFRENFLDRQQKKEFVSLEDARKNKLRIDWYTAEIFLPNEPGI
HEIKDLPLEVLESYIDWTPFFRSWDLYGRFPRILEDDVVGTQATELYSDARKMLQRIFSE
KLLKAKAVFGLFEANTVNDDDIEVSVASKGTVETKIFRTLRQQSRKAEGRPNIALADFIA
PKTTGLTDYIGCFCVSAGFGTQELAEKYESEHDDYNSIMIKALADRLAEAFAEYLHEQVR
KKYWGYASEEKLNNEELIKENYRGIRPAPGYPACPDHLEKKTIWEILKVEEAIGVSLTES
LAMWPAASVSGYYFGQPESRYFGLGKIKSDQVKDFAQRKGISEAKAFKWLQSSIAE
>OMIFANIC_02632 5,10-methylenetetrahydrofolate reductase
MKVTEHIAKGNGKTQFSFEILPPLKGQNIQSIFDSIDPLMEFKPPFIDVTYHREEYVYKE
MENGLLQKKIVKKRPGTVGICAAIQNKYQVDAIPHILCGGFTKEDTENFLIDLDFLGIDN
VMALRGDAVKTETYFTPEKEGHNYALGLVQQIAALNRGEYLDEDIQNQAQTDFCIGVAGY
PEKHIEAPNMDSDIHFLKKKLKHGASYIVTQMFFDNEKFFNFVNKCREEGITAPIIPGLK
PISTKKQLNLIPHRFFTDLPEELIKEVLKCSNNQEVREVGVEWCVQQSKELIAEKVPFLH
YYSMGRSDNIRSIAEQLF
>OMIFANIC_02633 HTH-type transcriptional regulator CymR
MLSRKTKYGLKALTFLARQETYDPVQISVVSKSENISHKFLETILLILRKAGYLGSKKGK
GGGYYLMKDPSEIPIAAVYRILEGPIAMVPCVSLNFYEKCDDCPDEQTCSVHKLMIRVRD
NTLQIFENTTLADLIEK
>OMIFANIC_02634 Phosphoadenosine phosphosulfate reductase
MLKITSENIHLFNQNLRYEEPKDIISFVLEVAERPIVTTSFGPFSAVLLHAVTSLESTIK
VIWCDTGYNTDDTYRHAKKLMDLLALNIEIYTPKYTTAFLNNTMGRPDIENPKHSAFSEK
VKLEPFKRALDAHRPDVWFTNIRKGQTAHRNTLDILSITEEGILKVSPFFYYSDDALRKY
LSENKLPSEYNYYDPIKALENRECGIHFRN
>OMIFANIC_02635 L-threonine dehydratase catabolic TdcB
MLPTRDELLRVHERIKPFIHFTPVLQSSLLNEITGANVFFKCENFQKMGAFKMRGAMNAI
LQLSEEEKKAGVVTHSSGNFGQAVALAARNAGVTAYIVMPANAPSVKKKAVKDYGGLVTE
CESTLKARVAESERIQREHGATPLHPSNQIEVILGNATAAMELLSEHPDLDFVFTPIGGG
GLVAGTALATHYFGTNCKTIGGEPYEADDAYRSLQSGKIESNITTNTIADGLRTELGSVN
FPIIKALVPEIIRVTEEEIVQALRLIWERMKIIVEPSCAVPFAALLKEKDRFKGNDIGII
ISGGNVDLSNLPFAK
>OMIFANIC_02636 hypothetical protein
MSRQILLFLLLSVPIFAQEKNPNRDFYEVFYGYGTLLRHNTNISHLVGAHPEIITLSFNR
KTFGEKLWQRQFNYPDWGVSFQYLDFRTEDLGRNYSALAFYNFYFLKRKLRLQFAQGISY
NSNPFDLESNPKNIAYGNHLLSATTFALLYTQPKIFKDFGLNIGMSLVHQSNGSLKAPNT
GTNVFVLTVGMSYDPSDTGKVEYIEIEDEKVKEPVRWNFAVRGGINSSDYFNLGQHPFLV
LSGYADKRLSYLSTVQLGAEVFFAEYLREEIKYVSVAFPNRNIDPDTDYKRIGLFAGHEF
RIGDLGIVTQLGYYVYYPYQNESRLYSRVGGKYYFNKKWFGALSIKSHGANAEAIELGFG
VRI
>OMIFANIC_02637 hypothetical protein
MKKLFIIVIVLCFACDSADAPDCFRTNGAIISLNYDVATFTKIRIEDNVNLSLMQGDIQE
VQVEAGENLIDEIKVDVLNNTLVVRNKNTCDLVRDYETINVFVTAPEIVEIRNGSVGDVV
GKGILEYDTLKLISDTSGGIENVRKSGDFYLNVNCVRFVTRANGFSRFFISGSAREATLE
FADEIPYFEGPEFLVDDLRVFQRSANIMKVNPINSIKGEIRGTGDIIAVNRPKIVDVEEY
YTGRLIFED
>OMIFANIC_02638 hypothetical protein
MRNSFCLFIILLSFQLSVSQQKETFPYSIGVDIFTGSILEHNPDIAHLITDHPTGLIVQY
NRKTYGWNEPEGRWNYPDWGFTFSYQDMKNPYLGENYGLYAHFNWYFLKRSISLTMGQGI
AYNTNPYDPETNFQNNAYGSHFLSSTYMKLNYVKERLFDGVGIHAGFGIMHYSNANFKAP
NNSTNTLFFNVGVSYQPDAINFPTYIPVGSWRSINYKERIKYNAVIRTGKNEADVNGLGQ
FPFYTFSFFADKRINYKSTFQVGVDFFFSNFLIELIRYREVAFPIDGLTGDEDYRRVGVF
LGHELRFSRSAFVSQLGYYVYWPYEFENRVYNRLGIKRYFFKDQFFGVITVKAHWAKAEA
VEFGVGVRI
>OMIFANIC_02639 hypothetical protein
MRMMKRLILLVLVSLPLWGCDSGNAWDCIQDSGELVQQEYDVDLFKKIQVWERVQLIIQQ
GNQQSVRVQTGANLIDEIQVVVEDSTLKISNRNSCNYVRDYDVTKVFVSSPDIREIRSSS
GLPVKSLGTLGFDELSLISNDPENLEVYHHDGDFDLDLDVILLRVQSNGLSNFFLRGKAQ
YMGIRFDDGDPRLEGADLIVNNINVFQRSTNKIIVNPQVSIIGEIRGLGDIIALNRPPIV
EVEEFFRGRLIFQ
>OMIFANIC_02640 ABC transporter ATP-binding protein NatA
MSITVENISKEYGAQKALDTVSFSIAKGEIVGFLGPNGAGKSTLMKILTTYLQPSEGSAE
VNGYSIFDAQKGVQQSVGYLPEHNPLYLDMYVREYLNFNADIYNIPKSDIEIIIEKTGLL
PEAHKKIGSLSKGYRQRVGLATALLHNPDVLILDEPTTGLDPNQLIEIRELIKSVGKEKT
VLLSTHIMQEVEAICDRVIIINHGKIVLDKRLDELKSGEQQIVEVEFDYRVETVALQKLD
KVAKVDNPTGFVYHIHFDTKEDMRGKVFDFAHDNGLKILQLHQKNTTLEKLFIDLTTEK
>OMIFANIC_02641 P-protein
MKIAIQGIEGSFHDEAVQKLFPNENVELIKCEAFDHVTQCVKEGKAEYGLLAIENTIAGS
ILPNYNLINADEFEIFDEVFLNIQMYLMALETESIIDIFEVHSHPVALLQCKDYLRKFPP
QFKIIEGKDTASEAKRIKENNIQGAAAIAGKQVADRYGLKILDSNIQDIKENETRFVLMG
KRGSSFNKKIPNKATIKFQLGSEVGTLSKALQLLAGYDINLTKIQSLPVVGVPWRYAFFV
DITFTDLQKFYDATEELNRTVKEFKIVGTYTQNKENAPSKLTNVNADGK
>OMIFANIC_02642 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENKKELRNWLNDMNLNHPLVIAGPCSAETEEQVVKIAHQLKDTDATVLRAGIWKPRTRP
GNFEGVGALGLKWLQRAREETGMMITTEVANPAHVDLAQKHDVDILWIGARTTVSPFIVQ
EIAEALRGTDKPVLIKNPVNPDLGLWLGAVERFHKSGIKNLGVIHRGFSTYEKTRYRNNP
EWQIPIDLQNRFPDLPLILDPSHIAGNRDIIFDLCQTALDLNYDGLMIETHHDPENAWSD
AAQQITPKTLDQITIDLRIRKEEGDAVEFRNRLSTLRTKIDVVDHKLLEILGKRMKISDE
IGQLKKENNVAILQTKRWNEILGKMILEGEDQKLSEEFILRIFKAIHQESINHQKKVISS
>OMIFANIC_02643 ECF RNA polymerase sigma factor SigM
MLLENDEILMQGLQEGNNACLGKLYERYKTILLNYFINVTQDRDAANDLLMEVFERIYKY
RGGFDASRKFKPWMYQMSNNLLHDYRNKLSKHKSLENSKEEISYQQSYTFQQIDRGIILK
DAMGRLSETERKVISMYYLLEIPYSEIAQIEGVSVNSIRIRVCRALKNLNAIITNSGIKE
L
>OMIFANIC_02644 hypothetical protein
MKTEQELLKIMDHVDGYVMKEAESDLKEEIKSLKQCASGIKDLPYEKVSEKTDERFQKFM
ESISDTSKTNTSRGLRTISIITAFAAGLALLLIFNPFQNKEILADFNAMKSNPDKLSFVY
ELTLEKLSEGEIEEVKLLLANEENPNIKVALLDLLENYTPDHVKSEELFLNLNRSSTPSV
QMAMLNAMEATDISDIRSDLDAFRNTVGLEETVKNRILQLLNNAKPKNLK
>OMIFANIC_02645 hypothetical protein
MMKKNLLLLGLFVSICGAAQNDLPDMSAIDTLIVKSYWGEVNVNGVTGNKSGLKVVHTDS
QAKRKMIDNSASGQYYDMKVNGKTLRLAARSPKGFESLDFILSIPNRIFVQVEMIKGGEI
VLQNLLHGIEVNHRNGSFKGRNIGDYALVNLANGSIDIKFNSVNRSRPISLVTMNGGITV
SLPKTVRRDVRLISRKNGYLWSDFDLTGVLPVARLNVRSYSKEPIDGTVKINGGGKLLFL
STENGPIEILKD
>OMIFANIC_02646 hypothetical protein
MKKILITIFAVFAFVQVNTAQNYEYQLVTVIESIVPNGVGRSRMITANDARDYKEFTSTR
TEDENGRNKSNRSDIRVKGFDETKLLNFYNIGGIRFQNIAANDALVMSKINTMAEEGWEL
AFVTSGVESAGGKGDNNGIYITRYVFRKAK
>OMIFANIC_02647 Small ribosomal subunit biogenesis GTPase RsgA
MKGTVYKSTGSWYTVKAENGKFFECRIKGKFRIEGIKSTNPVAVGDHVYFDVETKGDETV
GIIHTIDERENYIIRRSVKLSKQTHIIAANIDVAFLLITLNNPVTFTTFIDRFLVTAEAY
DIEAVLLFNKIDSCSEEELLEIKYLAALYRKIGYTCLGISAKTGKNIDKVKTLMDRKVCM
FSGHSGVGKSTLINTLEPGLNLRTLEISEQHQQGQHTTTFAEMYDLSFGAKIIDTPGIKG
FGVVQMDDEELGDYFPEFFRLKQECKFNNCLHVEEPRCAVKKAIEDEEIAWSRYKSYLQI
LTGDDDTYR
>OMIFANIC_02648 D-aminoacyl-tRNA deacylase
MRAVIQRVKEASVSVDAKVISEIGSGFLILLGVETEDTPEDISWLAGKIARLRVFSDDRG
AMNKSIQESGGDIIVVSQFTLHASTKKGNRPSFIKAARPDMAVPMYETFVSEMAQLIGKD
VYTGEFGAMMDVSLVNDGPVTIVIDSKIKE
>OMIFANIC_02649 hypothetical protein
MDFKHSQQAVDQWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKDSDKTKDL
GEELADVIFVVLCLANQTGIDLEEAFYKKLDKKTKRDHDRHHGNKKLN
>OMIFANIC_02650 hypothetical protein
MLKRVINHKGFWRSVISLAIAFAVLFTIIKWAIEGFSMAYFSEQNPLYFFGGVVAAGLVY
GFFVTFGKFRARLKKEDRKK
>OMIFANIC_02651 3-phosphoshikimate 1-carboxyvinyltransferase
MLSRDHAYADNHPVIEVSGSKSESNRLLILQALYPNVGISNLSDSDDTRLLQQALANSNS
REIDVHHAGTAMRFLTSYLAIQDGRTVVLTGSDRMKQRPISILVDALRNLGAKIEYIGET
GFPPLKIQGTVLQTTEVKIESGTSSQYISSLLLIAPSLPNGLKIKMKGNVTSRPYIDMTC
HLLRGIGCQVDMSENSIQIYPLVKPDPVNVVVESDWSSASYFYSVVSLSENLSVTLRSYK
HNSLQGDAAVSNIYKSLGVDTRFDEMNNRIVLAKNEKPVTKKLTLDLARTPDIAQTIAVS
CFGHGIACELTGLHTLKIKETDRLAALKNELEKLGGKVEITKDSLLLSPAERMNGGIVIN
TYDDHRMAMAFAPLALKHSIGIEDPEVVSKSFPSFWEAIARTGIRTEIQR
>OMIFANIC_02652 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MGMKLSNFNFDLPADLLAEYPAPNRDEARLMVLNRKDHSIEHKMFKDLIDYFEEDDVLVL
NNTKVFPARLFGNKEKTGARIEVFLLRELNPETRLWDVLVDPARKIRIGNKLYFGEDESL
VAEVIDNTTSRGRTLRFLFDGSYEEFRSKLTELGETPLPKYIKRDVEPEDAERYQTIFAK
EEGAVAAPTAGLHFSKHLLKRLEIKGINFAEVTLHVGLGTFSPVEVEDLSKHKMDSEEII
IPQKAVDIINDGITQKRRICSVGTTVMRALESSVSSNNTLNAYSGWTNKFIFPPYDFSIA
NSMVTNFHTPKSTLLMMVSAFAGHEFIKEAYAEAIKEKYRFYTYGDAMLII
>OMIFANIC_02653 Protease 1
MKKALLYFFLFAIFISSYAQDEDNYLPVSWEQNIQTSVTPIELPLLDLSHIQQEDMINDR
DKSLPWRYGIKRDIPLDIQEQGVLTELPNGDKIWQVAIKSTGAINLSINFDQFYIPGGGR
LHFYNDDRTDVSKTYSRASNRPNKRLGAWFVSGEIIWIEYYQPFNVAEKASLVVEGLIHG
YRMGEVNAYVNAMRGLNDSGDCNYDVNCPIGEDFDDKKDLVKKAVTLLNLGNGYLCSAVL
MNNTARDKTPYLLTANHCLDFSDPALWSVRFNWVSPNPVCGTENESGDIETNFTMSGAAL
KAKNTTTDFALVELYNEIPGSWDVTFAGWDNSDDLPLFEVGIHHPNGDIMKICRDDSGAI
KENANGTEVWLIKGVSVGNGDGWEIGTTESGSSGSPLFNEDGRVIGQLYAGQSFCNGIQN
NGDYDIYGRLGVSWAAGSTADSRLMEWLDPGGTGQTNMDGMQNILSVPENEITGQLEIYP
NPASSEITVMNSRYPNLVYKFYTVTGQQLSYGSVSSTMNTINVESYARGVYFLHLIDEDS
GAAITKKIIISR
>OMIFANIC_02654 Dual-specificity RNA methyltransferase RlmN
MSLEKKDIRALSKEQLQEFFISLGDKKFRGDQVYEWLWNKGVHKFEDMTNISKNTRAQLE
EHFVINHIEVDSLQKSKDGTIKNAVKLHDGLVVESVLIPTSSRTTACVSSQVGCSLNCRF
CATARLKRMRNLNPDEIYDQVVAIDRESRLYFDRPLSNIVFMGMGEPLMNYKNVLASVEK
ITSDEGLGMSPKRITVSTSGVPKMIRKLADDEVKFNLAVSLHSAIQEKREQIMPFAKQFT
LEDLRDSLEYWYAKTKKRISYEYVVWRGINDTDADIKALVQFCKYAPSKVNLIEYNPIDD
GEFQQASDEAIDRYISALEANRIPVTVRRSRGKDIDAACGQLANKS
>OMIFANIC_02655 hypothetical protein
MTKITKNNLGKRIAKYSALSLAIAGVADATGQIVYTDVDPDFVGGLGDSFAIDFDGDSVD
DVTILQSNNGNYELVQANTVGPNGVVANSNGYLYASNLNYGDPIDAALTFYSGGASFCAG
VGYAGSAFCGEGEGYLGVRFDAGGGTTHYAWVRVDIADSSNFIVLDYAFESTPDTTIDAG
DTGPLGIEDQAFNGFNYYIADNKLNLSATTAMEQVTIHNIIGQQVIDRQLTSTSEVIDIA
AMKSGIYLATVSIEGVRKTIKFVR
>OMIFANIC_02656 hypothetical protein
MNKKRQEIDFSNMPLSSSLGHLAYGDLAFTAWRKLKKEHNLDGENEKE
>OMIFANIC_02657 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MKKNKLLLIGWDAADWKIIGPMLAQGLMPSLKKLIDNGVYGNMSTMNPPYSPMLWSTVAT
GKTPDKHGVLGFVEVVPNKKALRPVTANSRKARAIWNILHHEGYTSNVVGWWPSFPAEPI
NGVVVTDKFQRVSADPKQQRGMQDGTIHPEHLKDDLKELRMFPWEITHEHFLPFMPDAAK
IDQDDKNNGLIPFSKILTQNVSLHNASTYLLRETEWDFMAVYFDMIDHFCHSFMKYHPPK
LDGVRQEFYDLYKGVVTGAYRFQDMMLGRVLSLIDDDTTVIIMSDHGFESGNKRILAMPK
VAAAPALDHRQFGIFVASGPNIKKNEKIFGASLIDVAPTILHHFGLPVGKDMDGKIIMDM
YQNPSTPSYIDSWEDVKGDFAELEKEERDDILSDEETMEQLIELGYIERPDDKIETSIHK
TKCELKHNLARVYLGKKDYEKAKSILLELLEEKPPINLAPYYVDIMTVYIGLEDYESAET
YLEAFKKVKTPVNYNIYFIEADILLGNGYTKKALKVLEEARDLKPNAEVHYRIGNIQFIL
QNFQIAKECFEQAIELDQDRAKYHKAMSDTMLELQEYEEAAEYAFTSIELVKYYPAAHYA
LGRALEKLGDLENAKLAYETSARLTAKTYSYREEKALENIEEKIKTPLELRDKNNFKYRD
NQIIIVSGLPRSGTSLMMQMMDKGGVECLVDDKREADESNPKGYYEFEPVMSLHKDNTWM
DQAQNKAVKIVAPLLNHIDGKYRYKVVFMTRDLDEVLKSQQKMIGKNPDVLPVKLYNKYR
NLLKFVDSWKENEPGIELIYIDYGDVLENPSKALNDIESFIGIPLNKKEMTKCIDKSLHR
NRVTSTEA
>OMIFANIC_02658 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MKIVSQIKLPIENEMELFEKKFSGAMSSKVSLLNRITHYVVNRKGKQMRPMFVFLIAKMT
NNGEVNERTYRGASVIELIHTATLVHDDVVDDSYRRRGFFSINALWKNKIAVLVGDYLLS
KGLLLSIDNDDFDLLKIISVAVREMSEGELLQIEKARSLDITEQVYFEIIRQKTATLIAA
CCAMGAKSVNAPDAEVERMREFGELIGTAFQIKDDLFDYGDEKIGKPTGIDIKEQKMTLP
LIHAINKASSEDKRWLINSVKNHNKDRKRVKEVIDFVKEKGGLEYAEVQMREYRQRALEI
LSAYPDSEYKSSLELMVNYVIDRKK
>OMIFANIC_02659 ECF RNA polymerase sigma factor SigW
MKLISLHKNYAALIKKVAKGNRKAQHELFELFSPKMLSVCRQYLKQNEVAEEIMLNGFYK
VFTKIDSYSGQGSFEGWIRRIMVNESLSELRRQKKLFFKDESVIENSMEHSAYIESELEV
EEIQKLIDALPDGYKTVFVLYAVEGYKHSEIGELLQISEGTSKSQLSRARSMLQAMINKQ
NTMNYGTL
>OMIFANIC_02660 hypothetical protein
MAPFKIEDNIREKMQERELQPSEGAWAKLEARLGEEKNSGLNRNTWYAIAAGFIGILILA
SVFFNSNSLTNEGEIVQEDTYVEELNSGNDNEFKELISEPDTSEDELAIDEKVLEEKDNA
KIVPVLQKIIAKKEPKEQNEIKIDQKIIAASEVEEQPEQVNETRLIEDQPTDNRGFVESK
VNEVVAEVENRIKTNSTVTPEEVDALLMEAQREISNQRILNSQTKKVDAAALLEDVEFEM
ERSFRDKVFDALGDGYNKIKTAVAERNN
>OMIFANIC_02661 hypothetical protein
MRLITFCTVITVWVLSMPFTWAQDTQVTERIEILEATKDRIVDEEKDALKASVEGINQRL
ENGDITEAEANELKQKMAEKHALNIENRVAIIDNKIELLERNQDMEVLNEDGDRFVIEIG
NDGEDDNSFIYIGKQNKARKYDRRTTSDFVFAFGLNNVIVDGELGDDIYKVGGSRFAEFG
WAWKTRVFKESNWLRVKYGFSFQFNGLKPTDNRYYVDTGLQTELQTFASDLDKSKFRLDN
LVFPVHFEFGPSKKIDKDTYFRYSTRKKLKVGLGGYAGLKLSSRQKLRYDDMGQEVERKE
KGNFNTNNFIYGVSAYLGWGDVGLYAKYDLNTIFKDNPVEQRNISLGLRFDLE
>OMIFANIC_02662 DNA primase
MISKTTIDNVFETARVEEVIGDFVQLKKSGSNFKGLSPFTDERTPSFMVSPVKQIWKDFS
SGKGGNVVAFLMEHEHFTYPEAIKYLAKKYGIEIEETEQTDEQKQLANERESLYLVSEFA
KDYFVSTLHKTEEGKAIGLTYFKERGFTEETIKKFELGYSPNEWSAFTDTAIKKGYKLEF
LEKTGLTIVKEEKQFDRFKGRVIFPIKSMSGRILGFGGRILTSDKKAAKYLNSPESDIYH
KSKVLYGIYQAKQTIAKEDNCFLVEGYTDVIQFNQTGIANVVSSSGTALTPEQIRLINRL
TRNITVLFDGDAAGLRASLRGVDLILEQGMNVKVCTFPEGEDPDSFARENSLEMLRSYLE
DNSQDFINFKASLLASEAKDDPIRKAETIRDMVVSISKIPDAIKQEVYIKECSRIMDISE
EVLFNTLAQMLQKERRDAAKRAPQPPLETMGVVPSEKQSVQKVDIQFELERKIIELLLLY
GTEEEEFEDLILETTDTGEIAFTPEKIQTKVFEKIYLDLQDDEIEFMNEGFRELYYEIIN
KLNQEQDLQIDALVNQLQPEKAETVTHILMEEEKYSLHNWERKEIYVKQKNHAISQVVSE
TILNLRRHLVNSKIEELAKSPVKNGEYEDKSVLENISDYTILRDVLSEKLRRVL
>OMIFANIC_02663 Transcriptional activator protein ExaE
MKKIFIADHHPVTRKGIACMLKKNDNFEIIGKANNGDELYKSLQEEKPDILIMEIDMPHI
NGINALRGIKSEFPEVRVLIFSTHPEEIYALRSIKSGAAGYVPKTASTKVFMKALKQIAK
GGIFLNEDLTSTFTSRNVGETSAISRYKKLSSREIEVLNLLSSGKRNKDIANALNINEKT
VSTYKTRLLKKLKVDNLADLIHQSRMFQFG
>OMIFANIC_02664 NH(3)-dependent NAD(+) synthetase
MQTEKVVDHIVNWLRDYAVNANMKGFVIGISGGIDSAVTSTLCARTGLELLCLEMPIHQA
ESQVNRAMNHIAWLQKNYDKVKMLQINLTPVFDGLIESLPPIEDEESRFMSLANTRARLR
MTCLYYFAALKKYLVAGTGNKVEDFGVGFYTKYGDGGVDLSPIADLMKSEVYEIARFLGI
NQEIIDAAPTDGLWGDNRTDEDQIGASYDELEWAMKMQDDGKDATHFDGREKEVMSIYLK
LNRANQHKMRPIPLCEIPPQLKK
>OMIFANIC_02665 hypothetical protein
MKYFGLLSIILIMISCSNKSSVEKKIEAIPMDIEILRFDKEFASADISDLPEMKKRFPVF
FPEQFHDSIWEGRMTDSLQRELSNAVAEAFPSEIIIEDQLVPLFKHIDYYFPEFEAPTVV
TITSDVDYQNKAIVADTLLVLGLDTYLGAEHEFYVNVKKYVAKNLKPSQIGPDVATSYAR
QLISQPRQRNFLAQMIYFGKELYLKDIWLPEIPDAEKIGYSDAEIIWANENEEDIWRYFI
ENELLYSTDPKLPGRFINAAPFSKFYLEIDNESPGMIGRYIGWQIVRSYMKNNDVTVPQL
MIIPTDEIFKNSKYKPAK
>OMIFANIC_02666 hypothetical protein
MAKHTSEIKINVSLDENKIPEALRWSAPDGGVDNSPSKALLLSVWDHKAQEALRIDLWTK
DMPLDEMKVFFHQTLMAMSHTFQRATGDEKMAATMRDFCDYFAEKLELKKQ
>OMIFANIC_02667 hypothetical protein
MSLLFVYNANSGAMNAILDSMHKVLSPSTYDCKLCELTYSTFSERSAWKDFRDKSTLDMR
FLHKDEFQKEYRSKWLPKYEFPVVLASAGKGLEIFISSEDFEGLDSQQALIDLIQERLSL
Y
>OMIFANIC_02668 putative GTP-binding protein EngB
MKIVSAEFVVSNSDVAKCPDNKLPEYAFIGRSNVGKSSLINMLMQRKNLAKTSGKPGKTQ
LINHFIINGNWYLVDLPGYGYARVSKKAKKTFQKFITQYFQKRKQLVLAFVLVDCRHEPQ
PIDLEFMQWLGENQLPFAIVFTKADKLKPNALKANIEAYQKKLLETWESLPTYFITSSSK
GYGREQLLDYIEAVNKEINALG
>OMIFANIC_02669 2-hydroxy-6-oxo-6-(2'-aminophenyl)hexa-2,4-dienoic acid hydrolase
MTNHFREEGKFNYLEVGEGTPIIVLHGLMGGLSNFDGVTDFFPEKGYQILIPELPIYTMP
ILKTNVKRFAEYVSEFIEHKGFGDVILLGNSLGGHIGLLCTKLYPEKVKALVITGSSGLY
ESAMGESYPKRGDRDYIQKKAENVFYDPKIATKEIVDEVYASVNDRNKLIRTLSIAKSAI
RHNMSKDLPNMKTPTCIIWGKQDNVTPPEVAIEFHDLLPDSDLYWIDKCGHAAMMEHPDE
FNELLYAWIQKRGF
>OMIFANIC_02670 Transcriptional regulator MraZ
MVKVIYIWVYYHRIRNNLMLNLIGTYECKADVKGRVMVPAALKKQLAAVAQNGFVIKRAV
FQPCLELYPMNEWQTLMQKMGQLNRFNRKNNDFIRRFTAGVKTVELDNTGRLNIPKDLAS
FAGVDKEIVISSAINIVEIWDKKNYEQAIDDAANDFADLAEDVMGDASNADDGIS
>OMIFANIC_02671 Ribosomal RNA small subunit methyltransferase H
MLATQTMEYHKPVLLKETVDGLNIQPNGVYVDVTFGGGGHSKEIIKRLGEEGKLIAFDQD
TDALENAIDDPRFLLINENFRFLKRFLRFYGYKQVDGILGDFGVSSHQFDVAERGFSTRF
EADLDMRMNQNSEFSAYDVINSYEQHQLRSVLSSYGELRSAAGMARMIIEAREKEPIKSS
EQLKKALGRFLPKHKENKILAQVFQAIRIEVNQELEALKEFLLQTQDVLKPGGRLSLISY
HSLEDRLVKRYMRNGLFEGEPEKDVFGRSEVPFKPVGKFVLPSEEEIRENPRARSAKLRI
AEKL
>OMIFANIC_02672 hypothetical protein
MKNSFYNVVKGKFLVSDDAFRNWRFIIFLSFLALIMIASSHSADKKVHKIAELSNEVKEL
KSEYVDIRMKLMQTKLESRIIKAMSARGLKPSVTPPQKIRITSIKE
>OMIFANIC_02673 Stage V sporulation protein D
MATEDKNILNRLYFIAGCMFVFAFAVGFKLMNIQFVEGEKYRDLAQKNTTRNFEITANRG
NVYADDGSLLATSVPKYEIRFDAVTVSSEDFKEQLVPLSKELSRMFGKPASYYQQRFRKA
RADKNRYLLVAKNLGYSDYIKVKGFPLFNKGPYKGGFIMDQSTVREHPMGKIGERLVGSQ
KRNEPGVYEVGFEGAFNEYLQGKNGRRLKQKIAKGQWKPVSDNNEIEPQDGFDVVSTINV
NIQDIAHHALLKQMEIYEAEHGSVIVMEVKSGEIKAVSNLGRTSEGTYYEKLNYAVGESH
EPGSTFKVMAMMAALEDKMIDTSTVIDTKNGSKRFYGRNITDSRRGGYGEISAAKTLEVS
SNIGLATIIDEAYAKNPQKFIDRLHSWNLNNKIGIPIIGEGTPEIPGPGHSKWSKNALPS
IAYGYNLSLTPLQTLAFYNAIANDGVMVKPRFIKEIRAWNQEVETFETEIINDKICSDKT
LKEIQDILLNIVKRGTGESLYSEYFSMAGKTGTARTEYWLEGWEKDRKYISSFAGYFPAE
NPKYSCIVVIHKPSTKKGYYGADVTGPVFKRIAQKIFTDSPLIAEVSGVDKEDLAIIEDF
QDFYKKTQTSPTNVPDVQGMAGMDAVSLLENLGMRVEIKGNGTVEGQSIEPGAAFRNRQI
IVLTLR
>OMIFANIC_02674 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MILLKDILYKVPIEKTVGNTAVAIHNLEFDSREVELNDVFIAIRGSQSDGHDFIKMATDK
GALAVICESLPELIINGITYVQVADSQKAMALMASNFYGNPSESLKLIGVTGTNGKTTVT
SLLYDLFKAAGFETGLLSTVRILVGDKEFTATHTTPDSLTINKYLREMVDAGVEFCFMEV
SSHGVHQKRTEGLSFKGGIFTNLSHDHLDYHNSFKEYRDVKKSFFDHLPKTAFALTNADD
KNGPVMLQNTKAKKFTYALKTYADYKGQILENQFNGLLLKINNNEIWVKLIGTFNAYNML
AIYATAELLGLETIEVLQLMSTLESVAGRFQYTVSEGMNITAIVDYAHTPDALKNVLETI
NSIRTGNEELITVVGCGGDRDMDKRPKMGSIAASLSTKVIFTSDNPRSESPEEIIEQIEA
GVPPEHYKRTLSITDRKQAIKTACQMANRNDIILVAGKGHEAYQEINGERFDFDDFKIVN
QFITALNM
>OMIFANIC_02675 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFEYLEKNFDIPGAGLFGFITFRAALAVILSLVIATFFGKKIIGFLQRKQMGETIR
DLGLDGQNEKAGTPTMGGIIIILATLVPVLLLAKLDNIYVIMLIVTTLWMGTIGFIDDYL
KKFKNDKKGLPGKFKVIGQVGLGIFVGAVMYMHPDVTVRLEKENSGVSTEITTEAAAREF
YPEEKSLLTTIPFVKKNEFNYESLISWAGEGAKDYIWLIFIPILIFIITAVSNGANLTDG
IDGLAAGSSAIIAITLALFAWVSGNLIFSDYLNIMYIPNTGEMTIFITAFVGALIGFLWY
NAYPAQVFMGDTGSLTIGGVIAVIAIAVRKELLIPILCGIFLMENLSVVMQVSWFKYTKK
KHGEGRRIFRMSPLHHHYQVKGFHESKIVTRFWIVGIFLAILTIVTLKIR
>OMIFANIC_02676 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MQRLVVIGAGESGVGTAILGKKEGFEVFVSDFGKVKDRYKEVLKHHEIEWEEEMHSEDKI
LNADLVMKSPGIPDMAPIVQKLIEKGIKVISEIEFAGSYTDALLVGITGTNGKTTTATLT
YKLLKDGEMNVGLGGNIGRSFAGMVAEKAYENYVLELSSFQLDGIENYRNHIAVILNIVP
DHLDRYEYDFSKYAAAKFRIIMNQTEKDYFIFDADDATIAKWLSENEIRSQKIPFSVTKT
LDKGAFIEDEKLIIKLNNKEEIMPIATLGLQGQHNIKNAMAASTVATLLKIRKATIRESM
ESFQGVEHRLERVLKINNVMYINDSKATNVNATFYALDSMETPTVWIVGGVDKGNDYAEL
LPLVNEKVKAIICLGLDNEKIISQFGSCVDIIVETDSMMGAVEIAYKLTDRGDTVLLSPA
CASFDLFKNYEDRGRQFKDAVRKL
>OMIFANIC_02677 putative peptidoglycan glycosyltransferase FtsW
MQGIFKNIKGDKAIWAVAGLLALFSFLPVYSASSNLAYLYGDGSTLPYLLKHLAHLLLGF
AILYGVHKIPYHYFRGLSIIALPVVIVLLLVTMAQGTTIEGANASRWIRVPFVGVTFQTS
TLAAVVLLTYVARYLSKIKDREITFKESLLPLWLPVFLVLALILPANFSTTAIIFSMVVA
LVFVGGYPLKYLGVVLGAGIIMLALFVLTAKAFPGLFDNRVDTWMSRIENFTDNTDTEAD
YQIEKAKIAIASGGVTGLGPGKSIQKNFLPQSSSDFIYAIIVEEFGMLGAMFLMFLYLLL
LFRLVIVAHKASSAFGKLVVIGVGLPIVFQALINMAVAVELFPVTGQTLPLISSGGTSIW
MTCLALGMVLSVSAKREAKLKEMEGLENPLDILSETI
>OMIFANIC_02678 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MRPYRFIISGGGTGGHIYPAIAIANELKRRHSDAEFLFVGAKDRMEMEKVPQAGYNIVGL
WISGIQRKLSLKNLMFPFKLISSLFKAKAIVRKFKPDVAIGTGGYASAPLLRVASMRNVP
CLIQEQNSYAGITNKWLKNKVQKICVAYEGMEAFFPSEKLVLTGNPVREDLLDISKNRIE
AQSFFNLEPHRKTLIVLGGSLGARKINTLIDNSLDFLMSVGVQVIWQCGKFYEEEYKDRS
GGLVQVHAFLNRMDLAYAAADIIISRAGALSVSELCLVGKPVIFIPSPNVAEDHQTKNAT
AISEKEAAILLRESEASEKFESVFTGLLHSEEKQRTLSLNIANLARPNATREIVDEIEKL
IKEL
>OMIFANIC_02679 UDP-N-acetylmuramate--L-alanine ligase
MRDLGHIQALYFIGIGGIGMSALARFVKLQGKEVYGYDKTETQLTQELEMEGIRVTYQDS
VSEIPMIIKNNKNSLVVYTPAVPKDNTLLNWFRSEGFTVIKRAQFLGEVTRNTLCLAVAG
THGKTTTSAILGHLLADCDMPVTAFLGGITENYNSNFISKGTEITVVEADEFDRSFLSLN
PDIACVTSMDADHLDIYGDEHTIESAFQEFANLIPSRDKLLHKKGLPLQGKTVAVEETAD
FEARNVRIEDGCYQFDLKTPSETIKDLQFILPGHHNLQNAVTALGMAILAGSPTHCLPKA
LSNFKGVQRRFSYLIKREDLVLIDDYAHHPTEIDALSQAVNELYPDDLKLIVFQPHLYSR
TKDFIDGFAESLSNFDEVILLDIYPARELPIEGVTSSWLGGKIRGVDTKVVSKKELPAAI
KASGCRIKLIVGAGDIGSEAQKLMKYLNDED
>OMIFANIC_02680 Cell division protein FtsQ
MKINMWVIKFVVILVLMVFLLGFSQRRNNERKLEKISIEFIDENEPFITHDAVNKLLIQN
VDSVTSIVKETLVLNEMEQRLLGNPMIRDADVFVTVDGALGARIEQRNPIARVASTPDYY
LDEDGKKMPLSAVYTARVPLITGKSQSDLTEVTQLLLEIEKDDFMKSGIVGLHIENDGNI
ILRLRKHDLKVRFGKPKDIARKFQNLKAFYKKTKQDNLINNYDLIDLQFGNQVVATKK
>OMIFANIC_02681 Cell division protein FtsA
MEHENIAVGLDIGTTKIVAMIGRQNEYGKMEILGIGKSKSLGVHRGVVNNITQTIQSIQQ
AVQDAEASSGMKISEVVVGIAGQHIRSLQHSDYITRSNSDEVIDEDDIDRLCNQVHKLVM
LPGEEIIHVLPQDFKVDGQAEIKEPIGMYGGRLEANFHVVVGQVSSIRNIGRCVKSAGLE
LSGITLEPLASANAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITE
DIKEGCSIIEKQAELLKIKFGSAWPGENKDNEIVSIPGLRGREPKEITLKNLSKIIHARV
VEIIEQVYLEIKNYGHEEQKKKLIAGIVLTGGGAQLKHLKQLVEYISGMDTRVGYPNEHL
AGDSDSETTSPMFATAVGLVLDSLNSRDHEAQMKVAVESEANASGDSMVQDGDEEEIVDN
TPKERKRFFDKWAEKFKEFLDNAE
>OMIFANIC_02682 Cell division protein FtsZ
MSSNTEFDNISFDLPKNQSNVIKVIGVGGGGSNAINHMFSQGIKGVDFVICNTDSQALEN
SPVPIKIQLGVSLTEGLGAGANPKIGEQSAVESMEEIKNMLTTNTKMIFITAGMGGGTGT
GAAPIIAKMAKELDILTVGIVTIPFQFEGKIRNEQAQIGVENLRQNVDSLIVINNNKLRE
VYGNLGFKAGFSKADEVLATAARGIAEVITHHYTQNIDLRDAKTVLANSGTAIMGSASAT
GANRAGEAITKALDSPLLNDNKIKGAKNVLLLIVSGGEEITIDEIGEISDHIQDEAGHSA
NIIMGVGEDDALDGAIAITVIATGFNAEQQDEIVNTETKKIIHTLEDEQKAEQVLTPEPT
ATPVEIPVSGSEQKNKVEEAPVIRHTLFEEEEEEVIVKRPEAKKIVSDEIPFEGYIETSE
LIKNIDVTYKEIDIHHLMEFEQVIINEIDVNDFVIVEQKEETIVSSEEKPVEVSLDEQEE
QILMFDLPAFAGEEASEAPEKKEPEIEVATTSVEEIEVKDAIEVVPVTEISEEGVKRYSL
DDYQEMETMLNEAKPGEDEEVDEEVAFSTKTVESPETDKTDENEPADPLNTPISKLLKDR
TEERKKMMKEFNYKFRNSASKIDDIEKQPAYKRAGIDLDETENSDDTNISRTSVNTDDDD
IELRSNNSFLHDNVD
>OMIFANIC_02683 hypothetical protein
MSLQQKIMEAMKIAMKEKNSLALQSLRAVKSAILLAQTQEGAKEELSEAEEIKLLQKLVK
QRKDSAAIFSEQGREDLAAPELAEAKVIEQFLPEQMSEEEVAKIVDDIIAKTGASSMKDM
GKVMGMANQALAGQADGKTISGIVKARLSN
>OMIFANIC_02685 putative phospholipid ABC transporter permease protein MlaE
MIWLIERNTMKGPALIPSRAESFFNEIGDISYFALRFFREVFTRPFEFRELLRQCYNMGN
RSLLLVGVTGFILGLVFTLQSRPTLMEFGAESWMPSMVSISIVREIGPVIIALICAGRIG
SGIGAELGSMRVTEQIDAMEVSGTNPFKYLVVTRIVATTLMLPLLIVFGDTVALFGSALV
ENLKGEVSFTLYFNEVFDALKYSDIIPATIKSFFFGFAIGLVGCYKGYFCSKGTVGVGEA
SNAAVVYTSMLLFIIDFIAVFVTDIFFEVQ
>OMIFANIC_02686 putative ribonucleotide transport ATP-binding protein mkl
MTDAIDIKPILELRALIKSFGDNHVLKGFNLQLFEGENLVVMGKSGSGKSVMIKCLVGLM
EADEGVIRIKGQDITILGQVELDILRTEIGFLFQGSALYDSMTVRENLEFPLRRHKTKLK
ITESNEELVLEALENVGLADAIDLMPAELSGGMKRRVALARALILKPAIILYDEPTTGLD
PITSKEIINLMRTIQKKYKTSSLIITHDVDCARVIADRIILLVDGINYIEGTYQKLIQSE
DPKVKAFFKT
>OMIFANIC_02687 hypothetical protein
MQKTVTQKIRLGVFVILGTTLLVSALYFIGNRQNLFGSNIELHAEFTNVNGLQLGNNVRY
SGINSGTVKGIEMIGPSRIMISMVIEEKIAKRINKNAVATIGSDGLVGSMLINILPQEGE
SRPIKSGDTIKSYTKIGANDILTTLSVTNENAAILTSDLLKITTKIIDGKGTIGMLINDT
LMADNLKESVNQLKKASMGANNAINQLNTIISSVDFDKSAAGVLLTDSVSGIKVKSIIDD
LDASTTNIKQVSENLDTYLNEIKESEGAFNQLIKDEKFAKNLDSTLLNIKEATFRLNENM
EALKHNFLFRGYFRKQERLKTKATRDSIKNLENEN
>OMIFANIC_02688 hypothetical protein
MKIEHLEERITDYKASIETVVEKKTLWKSVLKGLIKDTFDTIVARYDIGWKVQELSWIYT
NEAVNISFDSFPPELIDCTNRVPAYQFIRGGSLVFSQTYNGDIFVFILFPYIESKPGEGD
MQELGTFNPGEITEKFIVEKVDEFLKAMIRWELPNKKNKVGFS
>OMIFANIC_02689 Hypoxic response protein 1
MASTPVSSIMTKNVVCVTPDQKLIDVKHIYEKIKFHHHIPVTENDKLVGMVSLIDFMYRI
KGAGLDDSNKIYHELTVKDIMSPNPYAVAPETSIDEIAEVLVKGRYRAIPIVESEKIAGI
ISTADVIKYYLHKD
>OMIFANIC_02690 hypothetical protein
MKTKTVIELLTLSASLYHIAKDTHVLEKLHEYSEKGKDNINRVASEPLLDEDGNELELMD
KIIYKAGEMKEELELKIEELVAAFYKKINVAHLDEIKALNEKLEKADRTVALLEARLNKL
EMKT
>OMIFANIC_02691 putative protein kinase UbiB
MGVLSGIGRKFKSVSRYNQILKVLLKYGFEDLVQHLEERDQYAFLRKMVPKSSRKHALMY
NKWEKMRLVCEELGPTFVKFGQILSNRPDLIPLDLTFELEKLQDNVPPMTEEMAKKVVEE
ELGETVGNLFAWFEPKSFASASMAQVHKVTLHTGKRVALKVQRPGIKEVIEEDIKVMYRV
AGILEKRVPSIKNFDPVGLVRNFEASILKELDFINESINVQRFYNNWYQDRSKDQYACSP
KVYQEFTTSKVLAMEFMSGTKIDRLARLKEKGHDKKVIARRLTKSFFKQIFEYGFFHADP
HPGNLLVMPNSKIGYLDFGMMGSILPRDIQVFGKLFLAIKRKEVNKIIKALQMLSSDMVV
DDMRSLEYDITEFVEKYYTRDTHKNEMSTVLLDLKDIIIKNGLVVPSHFFLFARSLVTLE
GVVQKLDPKLDQFDMVKPYLSSAVSKGFDPLKLGEKVFNSIYELSSYMEEFPRDLKNAIR
RINSGQVKVDLTHKGIDPMVHTINRVTKQLVSAFVMVALIIGASLLVTFNIGPLWGDYSL
FGIICAIAAVIIAIGMLRDISKGDYDRR
>OMIFANIC_02692 hypothetical protein
MKDHENSHLMDKVADALRKAAVEIEEFQVKSALGKAEAQDKYEEVKKKFNRFIHDSKSKM
KTGKEKLDELHTKLDELRVQLALGKAESRDAFIEQKRKLLSLLHQIEVKIKTHEKLRKLY
AILLIEIEIFKVQLEILEEKFEEGTEGAKAAFEKGKKEFNEFIENLKSKKAKEEETQWEH
FQGEISEAFDHFKQAFKKA
>OMIFANIC_02693 hypothetical protein
MKITRAIQNLKCGGCANTVRKGLEGISGISEISVDNDTSEVTFNYETTENFNEAHKKLIS
LGYPFEDDDNPLMTRAKSYVSCAIGRMSPSETENKTEV
>OMIFANIC_02694 putative copper-transporting ATPase PacS
MEHCSHCGESCKDETIYLEEMPFCCNGCKTVYELLHENDLSYYYELEKTPGVSPREFEHK
FDFLDNEAIAEKLLEFRDGHTSVVSFLIPSIHCSSCIWVLENLNKLQPAVLASQVNFPEK
TIRITFNSEKYSLKNLVKLLGRIGYEPYISLEDSKKKKRYIDRSLIYKLGVAGFAFGNIM
FLSFPEYFEVSEFWLDRFKPMFRWLMFTFSVPVVFYSAQDYFISAVKGLRSKILNIDVPI
ALGIIVLFIRSTMEIVFDWGTGFFDSLTGLVFFLLVGKFFQQKTYSYLSFERDYKSYFPI
AVTRLKKNSSEEIEEEQVEVYDVKQGDRILVRNNELLPVDAILIKGNALIDYSFVTGESE
LVTRKSGDKLFAGGKQQAGVLEVEVLKPVEQSYLTQLWSNEVFDADRQSPFQSFTDSISK
RFTIAILTIAFVATLFWLLYDPYKAFNVFTAVLIVACPCAIALSAPFTLGNLLRIFGRMK
FYVKEASVIEKMASIDTVVFDKTGTLTSGNGSSMTYEGIALTQEEEEILTSTLRASNHPL
SRSLYEMLDVHNIKTLDAFEEHAGEGMTASVDNQLIKIGSYNFVSEGSGLDDRPFESIDK
TAVHISSNNLYKGCYIFQNEYRDGMNEVMDQLSEDKELIVLSGDNDGDRERLSRLIPEGT
KMYFNQKPEDKLRFIDSLQGKGKKVMMVGDGLNDAGALQQSEIGVAIAENVNVFTPACDG
ILDASMFGSMVDFFRLSKSGIRIIKWSFVLSLVYNVVGLGFAVTGHLAPVVAAILMPLSS
ISIVVFTTIATRFYGDRFLKK
>OMIFANIC_02695 hypothetical protein
MSFFEAGAQVTFTALSQIGMSIIYVLLGISVIVALGFFVAFIISVRKGQYDDTYTPSVRM
LFEDEVVKDTSVDQPIETNDKH
>OMIFANIC_02696 Cbb3-type cytochrome c oxidase subunit CcoN1
MELEKFYYDNKIVKSFLYATIFWGIIGMSVGLLLAFMFLFPNLTDGISWLSFGRLRPLHT
NAVIFAFVGNAIFAGVYYSLQRLLKARMWSNFLSKFNFWGWQLIIVAAAITLPLGYTTSK
EYAELEWPIDIAIALVWVAFGVNMIGTILKRRQRHLYVAIWFYLATFVTVAVLHIFNSLE
LPVSALKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYKLSI
VHFWSLIFIYIWAGPHHLLYTALPDWAQNLGVAFSVMLIAPSWGGMINGLLTLRGAWDKV
RTSPVLKFMVVAITGYGMATFEGPMLSLKNVNAIAHFTDWIIAHVHVGALAWNGFLAFGM
IYWLVPKLFKTTLWSKGWANAHFWIGTLGIIMYALPMYVAGFVQAFMWKQFNPDGTLVYG
NFLETVSEIIPMYWMRAIGGSLYIVGAVLMLVNVVKTIRSGSSVTDELAEAAPLKRVTKR
RTAKEGYHTWLERRPVKLTLYATVAILIGGMVQIIPSIMVEDYVPKITSVKPYTPLELEG
RDIYIRESCNACHSQMVRPFRSEVERYGEYSKSGEYVYDHPFLWGSKRTGPDLFRVGGKY
SDNWHFNHFYDPQTTSSGSIMPSYKWLIKNELDKSMTEKKMEAMVTLGVPYTEEEIARAQ
EWMLEQGTQIEENLFSDPDFAKTYEADKQAAASGGQEFIDMRNREVVALIAYLQRLGTDI
KVQSNEEITANK
>OMIFANIC_02697 hypothetical protein
MLKFIKGNLENIDGVAIYPIISLLIFFVFFLLLFWWVFTAKKKYIEEVSNIPLEEDNTNT
NNQL
>OMIFANIC_02698 Cbb3-type cytochrome c oxidase subunit CcoP
MKTFASYLRVIGFMVIAFLLLEFTIDSGDQMAIEKYPVIWGVLSMLFLFAVAIEVISESL
RSILYRGLSPEAQEKFLENEKSRKAGQFAGIKRLYNRLAGSKPLEEEGEIVLDHNYDGIR
ELDNKLPPWWLYGFYITIIFAGVYLARYHIFDGVTTSEEFEIEMEDARLAVEEYKKTAKD
LVDVNTVALLTDPADLSAGKAIFTQSCVVCHKADGGGGIGPNLTDEYWILGGGIKNVFNT
ISEGGRDGKGMVSWKSELKPAEMAQVASYLLTFQGTTPAEPKDPEGEIWVDPDVTPPADE
VIEVVVDSTAAEIGMVEN
>OMIFANIC_02699 Putative electron transport protein YccM
METPEDERFRDSIATISEEGKRAWIYPKKPSGWFYEKRKLVSYVLLAILFATPFIKIGGN
QFILINVLERRFNIFGFPFWPQDFHIFVIMMIIGVVFIIFFTVAFGRIFCGWMCPQTIFM
EMVFRRVEYWIEGDRGKQIRLDKQKWNLEKIRKRLSKWFLFFVISFFIANIFLAYLISSD
KLIEYITEGPLENISTLISLLIFTAVFYFVFAWFREQVCIIACPYGRLQGVLLDNKSIVV
AYDHKRGEKEKGRALFKKNEDRASTGKGDCIDCFQCVHVCPTGIDIRNGTQLECVNCTAC
IDACDHMMEKVNLPKGLIRYASEDNIEKKAKFKYNARLKGYSAVLVILIGVFIGMLFLRN
DVEARVLRLPGQLYERMENNIISNVYTYKLVNKTTEDITDVRFELLSHEGSIRLVKNQNF
EIGKQGLEEGTLFIEINASDLTGDKDKVKIGVYSGDELIETTKTAFLGPRSYN
>OMIFANIC_02700 hypothetical protein
MKINWGGGLVIGMILFIGFIMFMVITMMTNKEYDHDLVNEAYYEKDLQYQKEIDAEENTK
TLSEKIESKKVAEGWLITFPKEIDPNRIKGKVFLYRPSNKRLDFNIPIVISNAQLLIPDE
RLLDGRWNITLDWEYEGSHYMYKESIVY
>OMIFANIC_02701 hypothetical protein
MLWSGFILGLLGSFHCVGMCGPIAFVLPLDHKNSSRRFIQIILYHSGRIFTYSLIGLLFG
MLGRGLYLFGLQQKISVITGVLMIVAVILTALSIRTTRFTNPIYKTVSKVKNKLGKALKR
KSSDTFLTIGFLNGFLPCGLVYMAVFGAIAAGGLLNSSLYMILFGLGTVPLMTTAVYFGN
FLTGKIRQRIRKVIPVFVVIVGVLFILRGLGLGIPYVSPKPMTEKINAEMECHSVIHSEK
IIEYKTQSISL
>OMIFANIC_02702 hypothetical protein
MNALNIPLVDWGNGVIMIGVFALVVVILVAVTISFMSQGGKKEDE
>OMIFANIC_02703 hypothetical protein
MNKILGIGSRIDHPDHGKGVVSNVTAKMYWVTFIDKGLETIEVDEEFEVIDAAEDEVDTV
SFYEVEKSLRDILKKWSDASEIVPIADKFRGGTMILKPKDISLSQKEIPIDTFFHKIVML
RDRLRVLEQKINSSKTLDDIDKVDLQQYITRCYGSLTTFNVLFKNNSQNFKGESSKK
>OMIFANIC_02704 Protein MtfA
MLLLQVDENATWLAPYAYGVVIVIVAIAIFRAFENWYAGRYNKPLFRHYLVYKKLKPEQV
KILEEEFLFYQNLSEKYKRQFRHRVATFISDKKFVGRESLEITDRIKILIASVGCMLSFG
RKNYEYGLIEYILVYPGEFYSTVNDEHHKGEFNPREKALVLSWKHFEDGYKTNNDNFNLG
IHEFMHAMQLEAKQRSDIDSSRFARQFQNILRRLTNEEVKHRLDETRYFREYAFTNQYEF
MAVLAEYFIESPEDFKTHFPTLYKYTQNLLNFRYAGY
>OMIFANIC_02705 Ferredoxin--NADP reductase
MKNEIDVLIIGAGPIGIACALECKKRDLSYVVVEKGALTNSLYNYPLNMTFFSTSEKLEI
DDIPFISANPKPNRDEALEYYRRVATSNKLNINLYETIESVKKADGRFQVISNKRNYTAN
NLIVSTGFYDIPKLLDVPGEALPKVSHYFKEAHPYVMQKTIVVGASNSAVDAALEIWRKG
GDVTMVIRGPGIGERVKYWVKPDIENRISEGSIKALFNAEITEVREDEVTIKTPDGIKIL
ENDYVVALTGYRPNFDFLKSIGVELSSDGNYFPSYNPETMESNVPGLYLAGVICGGMETH
KWFIENSRVHASIIANSIAASINTPHT
>OMIFANIC_02706 hypothetical protein
MFLSNLEIETLKHFNMKRLRHIATLLLLLITAGISAQNMAVYVSDAGNFSSGPWQIAKFD
ENGSFEGALMNNDDGIVWPQDIIFLDSEEAVLISNLSTAGIISKHEWDTGNFIENFAEGL
GGPTRMKIGPDDKLYVLQWSNTNNKVLRYELDGTFIDEFSEVGVVQSIGIDWDSNGDFYV
SSYSGSTIRKFNGTNGADMGDFISTGLQGPTNIFFEPGGDLIVFNYNSGIIKRFDSDGNF
VEDLISGVNGCEGFAFFPNGDLLIGVGSDGSVRRYDSSYNFIENFVEPGVVLTPNAIVIR
DDIPLSVRENTLEIVMVTPTIGTSFELSDQALTAFDTFYVHNSQGKLIATIKSGDGRIWN
ASHLNEGIYFLTASKDGQRSVQKIVVKAK
>OMIFANIC_02707 HTH-type transcriptional activator RhaS
MQEAPSFDTWTSIFLIAVAMGLFLFLLIVSGKNRKNYPIAFLMLVFSIMLFQYVLYWTRY
ETVFPYLMLVPQVCYLTTGPLLLLYFLNLYKNNIRFNYLLHFLPAGIMLIPNIFLWMKYL
GWTDKDIPLLWSVQNPWIFAAHMGFYTLLIVRLVHTNRSKTTEFLRLRHRWATTLVSLYS
LFLLAYVSFFILVKLPFFNNQWDYAISITMSFSIYAIGFFIFKQPQVFDGEFYRQLFIPL
QNKKQSFEQSLLNELYTNVTNYMETKKPYIENELRLVHLADRLGFSTHLLSKVINDKSGK
NFNQFINDYRLAEAEQLLREASDLSIQNIYFEVGFNNKATFYSAFRKKYGCTPTQFKDNA
AKS
>OMIFANIC_02708 Ribulose-phosphate 3-epimerase
MSAIIAPSILAADFANLQRDCELVNNSQADWFHLDVMDGVFVPNISFGMPVIKAIAKHAN
KTLDTHLMIVDPDRYIKTFAGLGVNVLTVHYEACTHLHRTLQAIKAEGMQAGVALNPHTN
VSLIEDTLKDIDLVCVMSVNPGFGGQSFIENTYKKVRTLKKMIMEQGASTKIEIDGGVTN
KNAVQLVEAGADVLVAGSYVFRSDDPTATIAGLKELAS
>OMIFANIC_02709 Blue light- and temperature-regulated antirepressor BluF
MYTICYVSSARVNITEDELTDLFGITEKNNIGKNITGILLYESGKFLQVLEGEETVLKNL
YEKIEADSRHNNIFVILNQKCKRRIFEKYASRFSIVKSKEELQTIEIYLNQIEDSPNLKY
VKGLLEPFLL
>OMIFANIC_02710 hypothetical protein
MLRTICYVSTASPSLNKEGLSELYKEVILKNTLFNITGILLYSDGNFMQIMEGEADELGA
LYQNIENDSRHHHLIKLTESNISQRIFENYSNGFTIVNNESEVFKLNLYLKWLKENFEGD
VERLFKIVKPFLKYI
>OMIFANIC_02711 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKTFAFLEQAHERPPSAEEIAKELDMTINDVKESMKNSGRHV
SMDAPLVEGEDSNLYDVLRSGESPNPDRTLLHESLRTEIERALETLTPREADVIRLYFGL
GDQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>OMIFANIC_02712 Aerobic respiration control sensor protein ArcB
MSTLISRLFARNDESALYEEVCNDPRRAILVYLYDLASNSVHLSELQTQISDTVFDKDPF
FADMQLVQNYLMLENYLIRKDPKFIGSALDLRTRVHDNFPELVNSGSFKLLLENESNQGA
LLARVYLNLLLNRILQDHPDNSDARDWLERIAIRFPDKSKLNIVERINLLRRLKEASYEM
YHELVEVLGVKVTERYYFDSYTELGNIYKNLKGIKDVNDVIPNGQDVPKGIPVRKLITLE
DSKDPQSSDTISNAQYKSILENILDGFILIDKKMRIVEANNTAMQIMGLRPNTLKFQNLK
EFLPEEISSGLQQDLNRHDSSIPSVILGKRHETILTTKDGKHEDYEISITNNYDSEKKTY
SVLLTNISHKKHMLDAIRDAKVNAERTAKAKSTFLSNMSHEIRTPLNVILGLSEMIKKGV
SEENEVLLKNIEGIDFSAQNLLSIVNDILDFSKIEAGKLTIQSIDFNLRKVVENLSDGFE
IKAKEKGLTLVSEMGQNIPDIVIGDQYRLNQILTNLIGNAIKFTKDGQISIGVKMISEYN
DEVKLQFKVKDTGIGISKENLSKIFDSFFQVENREEMEMSGTGLGLAITKELIKLQDGDF
TATSELGVGSEFKFTLPFTRSKLKSLNDSIKTFVRQDKKLEGLKVLVAEDNKMNQFYIKQ
LLTNLNVSVDIAENGQEAIEIFEQDKSNYDLILMDMHMPVMNGIEAITKIRKTNKDLIKK
VPIVACSADVFPEARKSAIKAGIDFYLTKPLSEDAVKEVLFWLISDEEFDPNKNLDNITT
SSKTKEKESRSVDMNLLKETFDNDEEFIASLLEVFIQTTPEDYKSMRHCIDREYYSRASS
LAHKMKSSFQNLGMTVHGHHLQQIESNIIKTESIEEAKKHLTAFSQMYTKALLEVNLLLI
ELKHK
>OMIFANIC_02713 Polyribonucleotide nucleotidyltransferase
MIPKVFKEVIDLGDGREITIETGKLAKQAHGSVVVQSGNCMLLCTVVSNYEQKDLDFLPL
TVDYREKFAASGRYPGGFFKREARPSDGEILTMRLVDRVLRPLFPKDYHSETQVMIQLMS
HDEHVMPDAMAGLAASAAIQLSDFPFECAISEVRVGRVDGKLVINPTREQLAESDLDMII
GASADSVMMVEGEMKEISEEEMVEAIEFAHEAIKVQVAAQMRLAEAFGRKEVREYEEDPE
DVDLEKKIHDMAYDKVYAIAKAGSSKHERGEAFSAIKEEILATFSEEELEENEDLIKKYY
RKAEKEAIRDLTLNEGLRLDGRKPDEVRPIWCEVDYLPSTHGSSIFTRGETQALATVTLG
TSREANQIDMPSFEGEETFYLHYNFPPFCTGEARPIRGTSRREIGHGNLAQRALKGMIPE
DCPYTVRVVSEVLESNGSSSMATVCSGTMALMDAGVQMVKPVSGIAMGLISDTESGKYAV
LSDILGDEDHLGDMDFKVTGTADGITACQMDIKVKGLSYEILVNALKQARDGRLHILDKL
TETIAQPNPDVKPHAPKMVTTIIPNEFIGALIGPGGKVIQELQKETKTTIVINEDPVTEE
GIVEILGTDQTGIDAVLAKIDSITFKPEVGSVYEVKVIKILDFGAVVEYVEAPGNEVLLH
VSELAWDRTENVTDVVNMGDVFDVKYFGIDSRTRKEKVSRKALFPKPEGYKERPPRSDNR
GRDNRGRDNRGRDNRNRDNKKRD
>OMIFANIC_02714 30S ribosomal protein S15
MYLTPEVKKDIFKKHGKSENDTGSAEGQIALFTHRIDHLTKHLKANHKDYNSERSLVKLV
GKRRSLLDYLMKKDIMRYRAIVKELGLRK
>OMIFANIC_02715 hypothetical protein
MKTYLKKTALFSFLAVGLMLFSCSNDDDSQDNQEVNFSAENTARAAQTDNIVEGSFNVME
AAYVETEEGRSNNISFFPSCAEIVINPSGNGGTITITFSEGCQLNNGAVVSGGIFIEYGP
FEAGSRIIEYTYQDFTYNNNNVAGGGEVIRQIANQNGNPQSSATETITVSFPGTSVTATR
EGNRIIEWVEGVGSGTWVDNVYEINGSWNTEFSNGFTRSGEVTTTLVKKLSCIYLVSGVL
EIQQEGFTGTIDWGDGECDNQATLIINGQEFPIIL
>OMIFANIC_02716 hypothetical protein
MKKNLFISGILSVLMFSLVFTSCSKDEATEVETSNNSDLVFVEESQEVSKADAASDGVIH
MLETAYTEIEEDSGRTVSLFPDCVTITLSSENGVTFVTLDFGFGCELQNGAVVSGIVNIT
YGPVQNGTRTITYTFQNFTWNGNEVAGGATIFRERNNANGNPQSTVHADLQISFQGGLVL
QKDGTRVREWIEGVGSGTWTDNVWLVTGNREVNSNTGFSHYGIITEALRREATCPHFVSG
IVEITRNGNQGILNFGDGTCDNIAILTVNGVDYTIILN
>OMIFANIC_02717 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAWFKRTKKGIQTPTEEKKDVPKGLWYKSPTGKIVDSEELEKNYYVSPEDGYHVRIGSKE
YFEILFDNNEYKELDKNIQSKDPLHFEDNKKYTDRLKDAQEKTGLKDAVRTAVGKSMGED
IVIACMDFSFIGGSMGSVVGEKIARAADHALKNKLPFIIISKSGGARMMEAALSLMQLAK
TSAKLAQLANAKIPYISLSTDPTTGGTTASFAMLGDINISEPGALIGFAGPRVVRDTTGK
DLPEGFQTAEFVLEHGFLDYITHRKDLKRNINLYLDLILNRPLREKTA
>OMIFANIC_02718 Fructose-bisphosphate aldolase class 2
MSHNITPGVATGTEVQKIHQYAKDKGFAMPAVNVIGSNSMNTVMETAAELNSPVIIQFSN
GGAHFNAGKGLSNENQRAAIAGAVAGAKHTHEMARVYGATVIMHTDHCAKKLLPWVDGML
DAGERFYKENGKSLYSSHMLDLSEEPIEENIEICKRYLERMSKMDMTLEIELGITGGEED
GVDNTDVDSSRLYTQPEEVAYAYEELMKVSDQFTVAAAFGNVHGVYKPGNVQLTPVILKN
SQEYVQKKYGTGHNPIDFVFHGGSGSTVDEIREAIGYGVVKMNIDTDLQFAFNEGIRDYM
TGNIGYLKTQIGNPDGDDIPNKKYYDPRKWLREGELTFKKRLIKAFEDLNNINTL
>OMIFANIC_02719 hypothetical protein
MIKTLTKISLISGFLILFYSCNAVKRVGEDDFLLTENEIYVDSVRVKDEKVMSQLVQRPN
SKVFGIPFGIFIYNIANPTPDSTFQKWLHKNPKREQRLVNLLSGKQVDELGNSYIGINKW
FERTGSEPVIIDAVRTSKSLERLKNYYSSFGWFNVEGDYRIVPNEKKEKRAIVEYSLNLH
KPYIIDSITTQISSPVVDSLFRLSAQNSFIEQGKQFANNDFNNERDRLTIQFRNSGLYYF
DQDYITFEADTVNTDHKANITYIIPDRRIRIEDSTHTEPFKVHNINEVRVVTDYTFENRN
RTLSDSVIYEGYKIYSYDPQKFRPKAITDAISITPNSIFKDIDRTLTYNQISDLRIFKYP
NINYLEDPADSTGTGLIASILLTPREKYSWQIDFDVIPIPSPIQQFGLGFSSTFLIRNVF
RGAETLGISARGSVGSSKDAADSESTFFNISDVGADAKLTFPRILFPINTEGFIEKYMSP
STSVSLGINAQNNIGLDRQNFNGIFDYRWRPSNIKTYTFELANVQYVRNLNTNNYFNVYR
NSFDILNEVARDIENTNLGSIDPDYYTTDENGTLTLNLPDGADNFISDIDNGNINTTPDN
TVTVNNISERKDRLTENNLIFATSFQWLRDTRENIFDNNFSRFRWKVETAGNMLSGISKL
AGIEQNEAGQFRTFGVAFSQYLKLESDYIKHWDLKNGNIFAIRAFAGIAIPYGNSNSIPF
TRSYFAGGANDNRGWGPYDLGPGSSGSADEFNEANFKIALNAEYRYTILGDFKGAFFIDA
GNIWNAFDNVEDEASRFTDLGDLSELAIASGLGLRYDFSFFVLRFDGGFKTYNPQRPEGE
RWFKEYNFANIVYNIGINYPF
>OMIFANIC_02720 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MISKSQIKLITGLQQKKYRDKSGLFVAEGPKVIRELINEGLNLHLLFATDTIDSFPENTE
LISKNELQKISFLKTANTALAVFEIPQEKEIKETGLVLVLDAVRDPGNLGTIIRLCDWFG
IKQLVCSIDTVDCYNPKVVQSTMGSIARVQVNYIKLEEFIDNSAMPVYGAVMDGDSVYSR
QLPSEGILVMGNEANGISSAVEQLLDYRITIPRFGDIQATESLNVATATAIMLSEFRRVT
GR
>OMIFANIC_02721 hypothetical protein
MKKLLIVLAVLLFAESAQAQLFSKERLANLENFDKRFLTWGYFLGFNSYDFKFEYDNQFT
DQNTDILMEGQAGFNVGLIGDMRVNRYVNLRLEPGLYYTQRNLIFPNFEEEKDYLREVKS
TYIHVPLLVKISTKRLNNIKPFIVGGISTSLNLSSNEDNPEDNFEGQFRTTKTTSYYELG
FGVDLYLYFFKFTPSIRGVFAFGNELVPDDDPNSPWTGNITSMATRGIFVNFTFQ
>OMIFANIC_02722 Demethylmenaquinone methyltransferase
MINLNYHRNQVNKLKLSQVGISLKKSVALQLYFMEAGIGVMKENVTPYKDSDLTKKKQVE
QMFDTISGNYDGLNRVISLGADVKWRKKVVKMIADSNPSSILDIATGTGDLAIKFTEKST
ADKVVGLDISEGMLSVARKKTENSDLADRVSFIKGDSEALPFSDNSFDAITVSFGIRNFE
NLEKGLSEIYRVLSPKGLFVILETSVPKNFPWKQGYFVYTRGIMPVIGKIFSKDKVAYNY
LSESASVFPHGEVLNNILKKIGFKEVKNMPQTFGVATIYSATK
>OMIFANIC_02723 Trk system potassium uptake protein TrkA
MKIIIAGAGEVGFHLAKLLSFESQDITLIDTNRESLAYADTHLDIRVIKGDATSLSILKD
AKVERTDLVIGVTSSETTNITVCVLAKQLGAKRTIARISNTEFIENKEVVDFTKFGIDEL
ISPESLAANEIELLLNQSAFNDTYEFDEGALTMVGLHLSRTAAFVGKTVKEIGQEYSELD
YVPIAIQRYGTQYTLIPRGDTQFKEGDQVYFTTTEAGVDYIYKLSGIVKEDIRNVMILGG
SAIGRQTARYLCENSFKVKLIETDKEKAFEIADDIPSCLVINGDGRNVELLEEEAIKDMD
AFISVTGNSETNIMSCLVAKSRGVRKTIALVENMDYFQLSHSIGIDTLINKKLLAANNIF
RYVRKGEIVAMTKLNNMNAELVEFLVTPSSEVCNKTVREIEFPRSAVIGGVIRDGEGLIA
LGGFEIKSGDRIVVCSLPQSIKKVEKLFV
>OMIFANIC_02724 Trk system potassium uptake protein TrkH
MSSFSKLNYKIIFHLMGLLLLVNGGFILLSSVVSFAYDDGVGFPMVYSGLTVLAVGTILM
LVTRNHQKEIQKREGYLIVTFGWIMMSLAGTLPYLFTGTIPGFTNAFFETMSGYTTTGAS
ILNDIESVPKGVLFWRSVTHWIGGMGIIVLAIAILPLLGIGGMQLFAAEAPGPGGDKLHP
RITDTAKRLWIIYFGYTAAETILLKVAGMSFFDAINHSLSTLSTGGFSTKNASVAYWNDT
PVIQYIIMIFMFLAGTNFVLSYFAFKTKFSKVFRDEEFKLYGYFIIGLTIVASAMIYFQA
DPSASTVDHPLVWGELESAIRHGLFQVLAIVTTTGFSTADYTLWTPFLTIFFFGLMFLGG
SSGSTAGGVKIVRHLIMIKNGIIEFRRTLHPNAILPVRYNRKAVQQPIVFNILAFFILYM
LSFIVGVLVFSWLGLDFSTALGAAASTLGNVGPALGDLGPTGNYAILPDIAKWWSTFLML
IGRLELFTVLILFTPFFWRNR
>OMIFANIC_02725 Formate-dependent phosphoribosylglycinamide formyltransferase
MAKILLLGSGELGKEFVIAAQRIGQTVIAVDSYENAPAMQVAHDCEVINMLDGDALDAIV
TKHNPDFIVPEIEAIRTERFYDYEAKGFTVVPSAKAANYTMNRKAIRDLAAQELGLKTAP
YRYATSSEELAQAISEIGIPCVVKPLMSSSGKGQSTVRTEADIEKAWRYSQEGSRGDVAE
VIVEGFIDFDYEITLLTVTQREGPTLFCPPIGHRQEGGDYRESWQPAKMLDEDLETAQQM
ADRVTEALGGAGIWGVEFFVSDEGVYFSELSPRPHDTGMVTLGNTQNFNEFELHLKAVLG
LPIPEISLERIGASSVILATGHSEQPTFTGIEQLSAAPKSDFRLFGKPTSRPNRRMGVVV
TYDALSADISEVIQRAKDLSSKVTVNL
>OMIFANIC_02726 Aspartate aminotransferase
MNPKLSDRVNNMATSATLAMAAKARELRAEGRDIIGLSLGEPDFTVPEFVKDAAIQAVKD
DYHAYTPVDGYVDLKQAIITKFKRDNQLEYTLPQIVVSTGAKQSIANLAQVLINEGDEVL
LPAPYWVSYSDIGKVAGGKGVPIATGIENDFKVTPEALEAAITPKSKMLIYSSPCNPSGS
VYSKAELRALADVLVKYPDIIVVSDEIYEHINFTGEHASMAQFPDMYDRTVTVNGVSKAY
AMTGWRIGYIGAPEYIARACNKMQGQVTSGANCIAQRATIAALENPPSKIQYMVDAFRNR
RKLVLDLLSEIPGIKTNEPEGAFYVFPDISFYFGKTIQGVHIENASDFALLLLDKANVAT
VTGEAFGSPNCIRISYAASEEDITEAMKRIKTVLS
>OMIFANIC_02727 NADPH-dependent stearoyl-CoA 9-desaturase
MSKLLNVNTPHINFSRVDSAKFFRTLNKRVNNYFKENNISRNGNWKLHLKSIVMFSLYLA
PYFLLLSLDFPWWAQILLAVVMGVGMAGVGMNVMHDANHGAYSSKKWINKIMGSSMYILA
GNVYNWQVQHNVLHHTYTNIHGHDEDLEAGRVLRFSKHAKWYKLHKFQHYYSVFLYGLLT
LNWVLTADFLQTKRYLAKKLAYGKMPSPVKQWSVLIITKMIYVGVWIVLPILFFNIAWWK
ILIGFFIMHYVAGLILSIVFQLAHVVEDAEVMLPDPSGTMKNTWAIHQLFTTVNFSTKNK
IVNWFTGGLNHQVEHHIFPNISHVHYTKISKIVRNTAKEFNLPYNEYRTTRKALIAHFKH
LKQMGANPAISA
>OMIFANIC_02728 Ribosomal RNA small subunit methyltransferase G
MELIEKYFPELTETQINQFRQLSDLYKDWNTKINVVSRKDIEELYLRHVLHSLGIAKVQA
FLPEAQILDVGTGGGFPGIPLAILFPEANFHLVDSIGKKIKVVREVKDALNLQNVRITND
RVETITDRYDFIVSRAVAQMETFVRWVKDNVAKKSRHDLKNGILYLKGGDLGEELSGFPK
ATIYPLRSFFEEDFFETKSVVHLPLKFKP
>OMIFANIC_02729 hypothetical protein
MSKKAITTVAFSLLTVLAFAQTIVSTTPEDKKVILEEFTGINCVFCPDGHAIAQAIQDNN
PGNVFLVNIHTGSFANPGSGQPDFRTSFGAAIAGQSNLTGYPAGTVNRHFFPGQSQGGGT
AMSRSQWANASNQILAQPAYLNLGVEAEIDVQTNELTVHVEVYYTGNSPFSTNKLNVALL
QNNTLGPQTGGGMGNEYVHMHRLVHMVTGQWGIDINSTTTGSFIDETFTYTIPADYRDVP
VELADLELVAFVTETTQEIISGNGAFPTYTGITIANDAFLKDISDIIDQCGSEIAPEITI
QNLGSNTLTSLDIEYSVNGGTVESYTWTGNLTSLQSEKVELPAIPYTVQSTNTVSISLPS
DDNNANNDGTVDFDEAVGGTGTVYLTLNTDNWGSEVRWNLYDEAGNSLYSGGPYPNNTQI
NETFELAEGCYTFDLRDTYGDGGGVTFLEDSNGVQLFFTNGNYGSGVTSNFSSDGVLGIG
DQNLSSFALYPNPANTELHLVGIGTADITVYNILGSQIMVVNDATDKVSLDVSSLQAGTY
FVKLTSNEGTITKKFIVNR
>OMIFANIC_02730 hypothetical protein
MKRNILVVLLLIVTTLAQAQFTVETHEGDPIVQGQTVFFNVVTYPEASLDFYVFNQGTEP
INMKVEFVSAVNTDGSGMEICFGECYTGTIPGTSYPIDDVVVIQPGSSQTSNGDHFYNSD
PGNGTDALEYAFRFYMVDAGGNEVGDDLTFNYVYDPLLGVNDVNILEASIFPTVTYSDVN
VESKDAVAVSIYDVQGRLIKQTKLEAGTNTLNLSDLRSMIYLVQLTDEAGRKKTIKIVKR
>OMIFANIC_02731 hypothetical protein
MNKLFIACAFFCVCVAQAQEKGYFFGGLETNTQWLLDDEDLKLTESSPGFIAPEEQFRAN
TYVQLNYSYGKFTAGVQYESYLPKALLGFSPDFDGSNGIATYYVNYKTETLDITGGYFYE
QFGNGLILRSWEDRQLGLNNALHGVKIGFTPTPYLELKGVYGQQRVGFDLSEGVIQGLDA
NVDLSTALKIDEVGITAGASYVGRYQDNGTNDTIPSTVNAYGGRLDLVAGNFFGGVEAVV
KDEDVIANEEVIPSNRLYDGTALQVNLGYARKGFGSNATFRRLENFSFYADRLAEGNQFN
QQVIGFIPALTKQQDYLLTNIYVYNPQPRLLTEGFEQRAGEVGSQFDVYFSFPSESFLGK
YKTKIASNFSYWGGLDATFNDDLSYDAEFIGSGDRYFRDFSIEVKNRWNSKWSTILTFQD
VIIDKGVSLGGPLGVQGDIKATIAVAEATYRFGNGKSIRMVGQHLWSDDDRKDWAGAVME
YNASSRLAFYIADAWNYGGEGEIHYYNIGGSYSKGITRFSMNYGRQRGGLICVGGVCRFV
PESNGLSASLVVTF
>OMIFANIC_02732 Thiol-disulfide oxidoreductase ResA
MLSKTPNPIKYFMKYPILAVFFISTFAFCQNELPVTDLTTLDGKTITVSEMIGDDDVAII
SLWATWCVPCLKELDAISEVYADWQDETNVNLYAVSVDDSRTVKRVKPLINGKGWEYDIF
LDTNNDFKRALGASTVPLTLLVKNNVIVYRHSGYNPGAEYELYEKVKEYSN
>OMIFANIC_02733 hypothetical protein
MKKIKISLVSALIVLVSIISGCSKTEDFSAFVDQGGSNEDPVASSLLFRKSSLRNQQVTF
TLTDENGEDISDLAVFYVDGEALDANVFSSPDTGMFEVYAEFDDNGNTQTTETETFNIII
PKQKIAVEDYTGTWCGYCPRVTASIEAIHEVTDDIAVVAIHNDDEMAIPIEEDLRNEFGV
FGFPAGRINRTVKWENPQDPQDVISIAGVDTDLAIAITSSVTGNNLNVKVTVASENDIQN
TKLVVYLVEDNIIADQVNYYDNDPTSPYYQQGNPIVDFVHNDVLRAALTDAFGNAVSSTA
ALEDYNASYQIALSPEFVVANLKIVAMIVEQDNTALNAQYVKVGEEKPFE
>OMIFANIC_02734 1-pyrroline-5-carboxylate dehydrogenase 2
MGKGFYDVPIAVNEPILSYAPGSPEREEVLKTYKEMYNSTVEVPLFINGREVTTENKVTI
SPPHEHKHSLGVYYQASQQHIEEAIETAVEARKNWAAMPWENRAGIFLRAAELIAGPYRA
RLNAATMLGQSKTIHQAEIDSACEIIDFLRFNVQFMTEIYAEQPESTSGAWNRLEYRPLE
GFVYAITPFNFTAIAGNLPTSAALMGNVVIWKPSHSQMYSAKVLLDIFREAGVPDGVINM
VMGNAAMITDTILASPDFSGVHFTGSTDVFKGIWQKIGNNIHTYKTYPRIVGETGGKDFI
VAHKSSDPKQVATAISRGAFEFQGQKCSAASRCYISKSIWDDVKNFVTEDLKSFKMGSPE
DMDNFITAVIHEASFDKLARYIDEAKAASNAEIIAGGTYDKSEGYFIRPTVIVTEDPKYT
TMCTELFGPVLTIYVFEDDAWEDTLHLVDGTSEYALTGAVFSEDRYALEKAVRILENAAG
NFYINDKPTGAVVGQQPFGGARASGTNDKAGSKLNLYRWISPRMVKETFVSPVDYRYPFL
G
>OMIFANIC_02735 hypothetical protein
MCTLTLMPQTDGGLIITSNRDEAPNRETLLPELYQINGSDLLYPKDMLAGGTWIGVSDRK
RFVCLMNGGFKAHERKSEYRMSRGIIVTNLLSAEDFLKAVDSYDFQDIEPFTIVAVDWSV
KLRIYELIWDGANYHLTEKPLAPAIWSSSLLYSEEMKRKREAWFSDFLFDNLSPSENELL
DFHKNAGEGNPETNLIMDRIFVKTKSITQVMVKDSIEMYYEDLQNKKTIRIDF
>OMIFANIC_02736 Protein ApaG
MVQQVTKGIKISVTTQYEGYLGHEHNASYAFSYTITIENNSKDTVQLISRYWNIKDALNN
TQVVTGQGVIGIKPVLAPGEIHTYSSGCMLLAPVGAMNGAYTMINFSNKTAFKVDIPSFK
LHAYFAMN
>OMIFANIC_02737 hypothetical protein
MSSDQPTPSEKPESSDKLQVTDKPVQAKGRKAMKYRASECRNCGHPLELTDRYCSYCSQL
NTTKNLQLKDFFGEFIGSIITYDSKFRFTLKDLLFRPGIITRNYVNGQRLKYANPFRFFL
SVSIIYFILQGLISTFTGNSQLIKESPSIGNTGIIVDPDGDNPLLSTPDIDSLRVDSVIS
KNKNLARLDSILANNNIDLKKNELDSILSQENIDINEVNVDSMVNAFDFLPFIRGNKEPS
YDLIAEETLDTMSWFNRNFKRFVLYRDFYKTTEIKNPLIALDSMNHENTGYNRWAYSKNE
SIERIENNPREFFQYLLEKTPFFLFFFTPIYACFFWLIYSKKKYTYMEHMIFIFHIFSFV
FLAGIICMIPDSIIAGGDDNIVFSVVLTFIGPIYFYKALRNFYKQNRLITIIKFILLNWI
FWIGATVAALLFFAITAAMY
>OMIFANIC_02738 hypothetical protein
MGRLFITIITLLLFNPLLFAQANEIPAPEYISTIQFKGSTSQSQLPIIRLGERLRLSFDA
LNGNEDDFYYKITHHNFDWTESDLSKGEYLVGFDDVRIETYENSLNTLQIFSHYFLDIPN
RETRAINKSGNYLISIYDDDGMIVFSRKFMVIENLVGVAAEVRRSRDLNFIREKQSVNFS
INSPTLTLINPKQTVNVLVMQNSNLKTAITDLKPQYTIGSELIYRYDKESSFWGGNEFLN
FDNKDVRAASNGVRKVDLRDLYENYLFTDITRADRPYTFNPDINGNFVVRNINAPDPTIE
AEYVVIHFGLQYYEDIGDKEIHIYGNFNNWTIDGSTYMRYDEPSDTYRLSRLFKQGFYNY
KYVLVDRDGSVDEGAISGNFWQTENDYTILVYYRELGGRFDRIIGMGMTNSTNITNN
>OMIFANIC_02739 Na(+)-translocating NADH-quinone reductase subunit A
MSKDIKIRKGLNIRLKGEAEKTLSNAPRSRTFAIRPSDFHLITPKMVLKEGAKLQAGDTI
FYSKSNEAIKFVSPVSGTLTEIERGAKRVIKKLLIEGDQQDSYKDFGAIDPSSASPESIR
EFLLTAGCWPFIKQRPYDVIAKPDSEPKAIFISGYSTAPLAADLDFILQGKEKELQAALT
ALSKLTDGQVHVCIGNSDSPLSGMNDVTIHKVKGPHPAGNVGTQIAKIDPVNKGEIIWTV
SSQDLVIIGELILSGKFNAERIIALAGSSVKSPKYYKTKIGSEVSTFVYDSGLDEENVRV
ISGDVLTGTAISPKGHLGFYNSTVSIIPEGDDYEFFGWNKPVFNKISPTRALTFSWMLPN
KKFELNTNTNGEHRAFVVTGNYEEVFPLDIYPLQILKACMVEDLDQMEALGMYEVAPEDF
SLTEFVCVSKQPHQQIIRKGLDLMYKEIG
>OMIFANIC_02740 Na(+)-translocating NADH-quinone reductase subunit B
MGLKQKLHRQKEKYKGTKMAPAFNALHTFLYLPNDITHGGTHVKGADDLKRTMNIVIMAL
VPCLLFGMFNAGYQHYAAIDETLRAAPWQNFFTWDNLIMGLWTILPLVIVSYGVGLAIEF
LFAVIKGHEVEEGYLVTGMLVPLIVPVDIPLWMLAVAVAFGVVIGKEVFGGTGMNILNPA
LTIRAFLFFAYPTWMTGDKVWIHGAVARDKAIAAGENIDAISGETILGFYAKSGQELTVQ
AANGAEIATTYGERADALYSLQDMFWGFIPGSVGETSKALIIFGALFLIFTKIGSWRIIF
STLVGAVAMGLIFNGVAELGWISESSKFYGLMTVPYWQHLIIGSILFGAVYMATDPVTAS
QTNKGKWIYGFLIGFISIMIRVFNPAYPEGVFLAILLMNVFAPTIDHYVLQGNIKRRAKR
LKLKTA
>OMIFANIC_02741 Na(+)-translocating NADH-quinone reductase subunit C
MALDTEKNSYTVIFSIIMVIVVGSILAGFANGLKPTIKANERYEKQQNILYAMGINENEG
PNDVEFIPTDRVEAEFVKYIKKQFVIQGDEVIEDDQAYLIDIKKESAKAKDGDYQRRLPL
FLGEKDGEEIYVMPVRGKGLWDAIWGFVAVDRTMKIQGVYFDHKAETPGLGAEIKQRFFM
DDFTGESFLDDGVYSGIKVAKGNNDPKNEDKTDQEVDALAGATITGDGLSVMLQKDVKMY
VSYFKKLK
>OMIFANIC_02742 hypothetical protein
MTVALSVIVQPLASVITTEYVPAERLNKSSVVSPPGLHRKVYGGVPPVTVRSRDPELSPK
HKTLVTAIPELIGPGSLTVVVAVAVQSVASSVTVTVYTPAGMPVMVCVVCPPGLQE
>OMIFANIC_02743 hypothetical protein
MTNGQEIIDGTDPVDPCDFVLASQNTTPTAAWEALDCDGDGVTNGQEIIDGTDPLDPCDL
IAANQDTTPTAAWNDLDCDGDGVTNGDEIIDGTDPTDPCDFMLSSQSVPTTQAWEDLDCD
GDGVSNGQEIIDGTDPLDPCDLIAANQDTTPTAAWEALDCDGDGVTNGQEIIDGTDPVDP
CDFVLASQDTTPTAAWEALDCDGDGVTNGQEIIDGTDPLDECDLVVANQTLPPSQQWIDG
DCDGDGVTNGDEVIDGTDPTDPCDFQLSSQTVPTTQEWEDLDCDGDGVTNGQEIIDGTDP
LDFCDLVVANQTVPPTQAWEDADCDGDGVTNGQEVIDGTDPVDPCDFVLASQTLPPTQEW
LDLDCDGDGVTNGDELNDGTDPLDPCDLNFMSQTVPPSQEWNDGDCDGDGVTNGNEIIDG
TDPVDPCDFMLENATLPQTMEWEALDCDGDGVTNGQELIDGTDPLDECDLVYTNQTVPPS
QEWLDGDCDGDGVTNGQEVVDGTDPVDPCEFILANQTLPPSQEWLDADCDGDGVTNGDEL
NDGTDPLDPCDLDWMSQTVPPSQEWLDGDCDGDGVTNGQEVIDGTDPTDPCDYDPLSQDL
STTSEEWDALDCDGDGVTNRDEINDGTDPLDLCDFVLSSQTLEPSQEWLDADCDDDGLTN
GEEVEIGTDPLNPDTDGDGVLDGQEVEDGTDPLDLCDFIYESQTFPPSQEWLETDCDGDG
VLNGQEVDDGTDPTDPCDFLVESQDLTIVTDEWLELDCDDDGIKNGDELGDDNDNGIVDY
LEPNNGDPNSEDNLDVFDIMTPNGDGLNDVFVIRGIHRYPNNTLEIFNRWGVKVYGVEGY
GQDDKFFRGISEGRVTIDQGERLPVGTYYYVLTYVNDEGQTKQLAGPLYINRR
>OMIFANIC_02744 hypothetical protein
MPAEPMLGRPNIKPMKKFYVTVIALLCLGFYSESAHGQQDAQYTQYMYNPLSVNPAYAGS
RDVLSIVGLYRSQWVGLDGAPTTLNFSVHSPIGKKVGIGVNVTRDEIFISDETYIDVDFT
YTLNTSDKGRLALGLKGGAHLLNIDSSKLNTGPFNNGDTETQINIDNKFSPQIGAGAYYY
TEKFYLGASVPNILETEHFDESSNTNNSSATAEERVNFYMLTGYVFDVSDGLKFKPALLT
KIVQGSPLQVDMSANFLIQDKLTLGAAYRWSAALSALVGFQVTDQVMIGFAYDRETTELQ
QYNDGSYEIFLRFELFKREEGMKNPRFF
>OMIFANIC_02745 Outer membrane porin F
MTLRSKYFLLIVAGLLLTANVTIAQDGDTSANTKEAKGDAHFNDFAFMDARDAYIKAVES
GYRSVNVLSRLGDSYYFNGEYADAAKWYGALFAYSEDIDSEYIYRYAQSLKTIGKYATAD
RIMDKLNEVASTDDRGELFSEERNYLKLIELQSGRFNVFNVPFNSELSDFAPSLNGGEII
FTSNRKTRTASQRLHDWNDQPFSELYSITVSGDGVPNRYRSKVNSRYHESSAVFSKDGQT
MYFTRNNYTNRKRGKDGAGKTLLKLYRSKRTAKGWGEAEELPFNSDDFSNGHPALSADGK
HLIFASDRPGGEGQSDLYKVSIDGDSFGEPESLGDAVNTEGRETFPFIDTNGDLYFASDG
HVGLGGLDVFVAEMNSEGNYEKGFNIGDPINSKADDFSFVINSTTGLGYFASNREGGKGE
DDIYSFEQTAQLIKNCRQSLSGEVRDEDTDDLIANAKVVLLDSDNNVLEETKSDMNGAFS
FDVIECSTGYAIRASKPDFSTSEKSFVTTGEYESDVKKTLYLLSEEDNELRDAKIGEDLG
VLLNLNPIYFDLSQSYIRPDAQIELLKVVEAMQKFPNLKIDVRSHTDSRSSDAFNMKLSD
ARAKSTINYLVGAGVSPDRVTGRGYGESQLLNRCANGVQCSEADHQLNRRSEFIIVQK
>OMIFANIC_02746 hypothetical protein
MKKLFVSLAALAMVFAVYSCRETEKKAEEMSEEVENVVEDAKEEAEEVMEEAEETVDSMT
NAADEVIEEVKETMEN
>OMIFANIC_02747 hypothetical protein
MERNVPVEAKRFKKVREEQHHTQQSFAELLGIGSTTADIERGKTKISGKAVMELLRQFRI
NPLWLFGNSFSQYVDLSGGDVSPKVVTIDSNDNDTILLVNQKAAAGYPHNIQDVEWYDSL
PAFSIPLPEYRNATYRGFQVEGDSMLPNIRPNEWVLGKAVPNITEASDSRIYIVVLHDSV
LVKKLQKIPNTPDRVRLLSLNPEYLPIDVEVKDIQELWMVNSKLTFGLDEPSDSSLLRQL
QASMEELKGQIRHLNT
>OMIFANIC_02748 hypothetical protein
MSFPRLYSFLERLQKNNSKEWMDRHRKEYIEVRDFFIDWLDKMNDKLASIDDDYYNTPGK
KAINRINNNLMFHPNRPVYKDHFGAGLDQLSKQGDFYIELGINESFLGGGYWHPSSDILK
RIRNAIDYNGEELKAILNKPSFKKLFGEMVDDNPLKTAPKGFSSDHEHIDLLRRRSFAVV
HYVSREHVLVPDFEDKVVNIYKEMLPFRRYLNEAVTVE
>OMIFANIC_02749 3-deoxy-D-manno-octulosonic acid transferase
MRTLYSILTHISFGFLWISRFFSKKMQLFMKGRVHVLENISNAIKPDDKTIWFHCASLGE
YEQGLPIMEGIKSRYPEYKIVLTFFSPSGYEIKKDSPVADVVCYLPLDTVKNAKRFVKIV
HPALAIFVKYEFWPNYLFELEKLNIPSLLVSGLFRKKQSFFKPHGVFMRRALRTIDYFFV
QNESSESLLRSIGIENVKISGDTRFDRVSQQIEQDNSLPYLDTFKGDSVCIVCGSTWPED
ENILLPFINESGSNVKFIIAPHIIDPGKIESFRKKISKSSLLFSERDSENLLQASVFIVD
TIGLLTRIYSYADIAYVGGAMGNSGLHNILEPATFGVPIVIGKNFKKFPEALRLQSLAAL
FSASTSEEISDIMNKLVSDKNFRTQTGMIAGHFVNSNTGATSIIMNHIESLHSDGLI
>OMIFANIC_02750 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLKGQYEKIKDRVDSSLLEVVESAAFVNGPEVHKFQKELEDYLGVKHVIPCANGTDAL
QIAMMGLELKPGDEVITADFTFAATVEVIALLGLTPVLVDVDPVNFNIDVEEIRKAITPR
TKAIVPVHLFGLAAPMDEIMALAEEHDLFVIEDNAQGIGATYTSKDGKKTKAGVIGHVAS
TSFFPSKNLGCYGDGGAIFTNDDELAHTIRGIVNHGMYVRYHHDVVGVNSRLDSMQATVL
RAKLPHLDEYNMSRREAARKYTAAFAGVHNIITPTGVCDEGVPVCDTCDCHVFHQYTLRV
LNCDRDALVQHLNEQGIPCGVYYPIPLHLQKAYRDERYKEEDFDVTNQLVKEVISLPMHT
ELDDDQIEFITTAVINFVTS
>OMIFANIC_02751 UDP-glucose 4-epimerase
MKRILVTGGLGYIGSHTVVELQAAGYKVVIIDNLSNSTMDVLDGIAAISSERPDTEILDL
RDKEKVHTFFNDYNNIEGIIHFAASKAVGESVENPLLYYENNVGSLVYLLKECRDRGIEN
FIFSSSCTVYGQPDTLPITEDAPVKPAISPYGNTKQISEEIIRDLSHASNLRAISLRYFN
PIGAHGSAEIGELPKGVPQNLVPYITQTAAGIREELSVFGNDYPTPDGSCIRDYIHIVDL
AKAHVIALQRLISKENTDDFEIFNVGTGKGSSVLEVIHAFEEVTGNKLNYKIVDRRPGDV
ISVYADTGKANRVLGWKAEKTMEEALASAWAWEKKVRGIQ
>OMIFANIC_02752 Malonyl CoA-acyl carrier protein transacylase
MKAYLFPGQGAQFTGMGLDLYENSEKAKDLFNQANEILGFEITKIMFEGSAEELKETKVT
QPAIFLHSTILAEVLGDAFQPDMVAGHSLGELSALVANKTLAFDDGLSLVSKRAQAMQKA
CEQQPSTMAAVLGLEDEVVERICEETSGIVVAANYNCPGQLVISGEIEAVNKACESLTEA
GARRALLLPVGGAFHSPLMEPAREELAAAIEATRFAAPACPVYQNVNASAVTDPSEIKKN
LMLQLTAPVKWTQTVQQMIKDGGTSFIEVGPGNVLQGLMRKIDRSVETGKAEL
>OMIFANIC_02753 hypothetical protein
METTIRSIAELHSLVLEGITPLAGGDINEVYLLQTSSGNLVVKLNNAERFPKMFETEKAG
LELLSSTNTFRIPEVIANGETENTSYLLLEYILPGSKSTGFWTDFGVNLARLHKNRSDLY
GWKHNNYIGSLFQSNAFTIKASDFYINERLRPQVNLARQNGYLTEDLTRFFKRVSEIIPN
EPPALIHGDLWNGNYMVDKEGRPVLIDPSVSYSHREMDLAMMQLFGGFPSEVFLVYNEEL
PLESGWEERVSLWQLYYLLVHLNLFGAGYLGQVRSAISKYS
>OMIFANIC_02754 Dihydrofolate reductase type 3
MITMIAAAGENNELGLNNMLVWHLPDDFRRFKQLTTGHHIIMGRKTFESFPNPLPNRTHI
VISRNGDYQAEGVTVVHSVEEAIEKSAPDPQPFIIGGGEIYAQGMVIAKKIELTRVHGTF
DADTFFPDIPETDWELVEEHYHPIDDRHDYAFTYETWVRKS
>OMIFANIC_02755 hypothetical protein
MFSKNKKSEGLDHEQRLQYEYARKRVIQKKRLMRHFIIFLAGSVLLIIINPVLGIGDEFF
IKDWFVWAILIWAFLFLIHLFNVFVMNKFMGKEWEDQQLERLKEKQTKRIAELQKEVDGD
LLLPKEEVKKNEDQNSTSQETE
>OMIFANIC_02756 Isopenicillin N epimerase
MEDFRKEFPVINDYTYLNTASCGLLSRSLVQWRHEHDIKLMEGGSVFRDTHKQHIIEIRS
QLAGFFSTSEDTVALVPNFSFGMNTILEGLAKGLKILLLKGDYPSINWPVEFRSFEVCYA
EIDENLESNIERAIAEHRPDVFAFSYVQYISGILIDTEFLSRLKAYHPELLLISDATQFL
GTTDFNFTESPIDVMGASAYKWLLAGYGNGLFMIKPEAQSRIHPKTIGFNSADATFGNRD
RISFVGRMEPGHQDTLNYGSLAESVTYLEKLGMDTIEAHLNTLIQKAKEEFIKRDLLEES
VTQRERHSTIFNLKADKELSDRLKASNIICSLRGKGIRVSFHFYNSLKDLDALLAVIDG
>OMIFANIC_02757 hypothetical protein
MKAIWNNQVIAESNDTVVIENNHYFPPESLNKDFINGSDTHTRCPWKGEASYYTLSVDGE
ENRDAAWYYPETSHAAKPIEGYVAFWKGVEITE
>OMIFANIC_02758 Histidine N-alpha-methyltransferase
MNTTTETFLDTSFKKDVYTGLTTFPKYLLSRYIYDKKGDKLFQDIMELEEYYLTNSEFEI
LSIHKDVISGFFKGNGNGFDLIELGAGDGKKTKVLLTHLSGQNFNFVYKPIDISQNAIDS
LTKTLNEELPKVRVDAEKGEYFEVLERLHQYDERKKVIMVLGSNIGNLLHPRAINFLSHL
RETMNDDDLVFMGFDQKKNPQTVLDAYNDPKGVTAEFNKNLLHRINSELGGNFDVDKFKH
WEVYDPESGTAKSYLVATEETTVRIEAIDLTVKFDAWESIHTEISQKYDDKIVKWLAEES
GLSIVTSFTDSRNYYKDYLFRKK
>OMIFANIC_02759 Hercynine oxygenase
MIQTKNIVSFFLETRAYTESLCKPLEIEDYVVQPVIDVSPPKWHLGHTTWFFEEFILKPH
KQGYNLFHEDFAFVFNSYYESVGKRVVRSDRGNLSRPGVAKVYDYRHYVTNEMKEFLSSG
TINEEILSVLEIGIHHEKQHQELLITDIKYILGNNPLLPAYNDQFNEDPIESQNPEWISM
EEGIYEIGHNGEDFCYDNELGRHKVYLHEYSIANKLVTNSEFIDFIESGGYSNFKQWHAE
GWDWVQQQNITQPMYWHRIQNEWHHYTLNGLQKVDPGAPLSHISYFEAFAFAEWKGCRLP
TEFEWEAAQGAFQWGLRWEWTESAYLPYPGYAKAEGAIGEYNGKFMVNQKVLRGGSVATP
DNHTRHTYRNFFQTNLRWQFTGLRLAK
>OMIFANIC_02760 hypothetical protein
MVDKIGSFFEENFNMELIQSLDLQPGRYRTSMIFRITSEGTVTDVKANNYRGIEEIEKEA
IRVALMLPGMKPGTQRGKVVGVIYGLPIVFDIEPEGKKQRKKRVKN
>OMIFANIC_02761 hypothetical protein
MRQILFILLLTAGGLCYAQDGEINDDKLTR
>OMIFANIC_02762 hypothetical protein
MKNILLLFCLLVSAGSFAQEWGSIDKNKLTMREVAPIWPGCESESSAERDNCFNNKLATH
IAKNFKYPAAEYKNNIQGRVVVTFVVNEKGLIDIKSVTGGNKGLQEEAKRNIMSIPEMAK
PGMLAGKPRAIEYTVPITFKTGK
>OMIFANIC_02763 Thymidylate synthase 2
MQQYHDLVNHILEHGSVKSDRTGTGTKSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELL
WFLNGDTNVKYLQENGVRIWNEWADENGNLGPVYGHQWRNWNNEDIDQISEIVNTIRTNP
DSRRMLVTAWNPSVLPDTSKPFSENVASGKAALPPCHAFFQFYIADGKLSCQLYQRSADV
FLGVPFNIASYALFTMMMAQVCGYEPGDFIHTFGDAHIYSNHLEQLELQLSRNPRPLPKM
LLNPDVKDIFGFKFDDFKLINYDPHPHIKGAVAV
>OMIFANIC_02764 Putative nucleoside permease NupX
MHKILLLFLFVFSFGNQYGQELEQSWKFSAIENDAGESIVPVNSEVDFLKFNNGAFTYEL
AAKDSLKASGDYVLQNNLLVFFYSKPSDTIRRYRISEHTDSTLVFSENEVFYKFTSEPAD
NASAVVPVKKKRIAIDPNQGLGVTAYSVFRGAIGMIFLLFVCYFLSSNRRKINWRLVFSG
LALQLIFAVLVLKVPFVATIFEWFSEKVVAFLALADVGANFVLGAWPDLAEIFEVKFDEN
GNIMKESFTIGYMFAFKVLPTIVFFSAFTSLLYYLGILQKIVYAFAWIMSKTMRLSGAES
LAAAANIFIGQTEAPLVVKPYLEKMTKSEMLCLMVGGMATIAGGVLAAFIAFLGGDSDAE
RVIFAKHLLTASIMSAPAAIIIAKMLYPEVESVNTKLNIAREKIGSNVLDAISKGTTDGI
KLAVNVGAMLLVFTSLMAVLNWISADLFGASTGLNDKITAATDGRYTELSMQYILGNVFA
PIAWIIGVPAEDITVVGQLLGEKTILNEFFAYASLSDLKNAGAITNYRSIVIATYALCGF
ANFASIGIQIGGIGVLAPSQRKVLAAFGVKALIGGTVAALLTATIAGMLIG
>OMIFANIC_02765 hypothetical protein
MSLVRLNIKGISYSQTQNGAYALILSEVDGERKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKNFADHFDITVKQVIIHKLVDGVFYSSIICERDTIEEIIDARTSDAIALALRFKA
PIFTYKNILDKAGIYLKTQKKSEDISVEEEAVIEELLTGDDKESVGPKVSEDYTKFSLKE
LNEMLDQAVTDENYEKAAAIRDEISKR
>OMIFANIC_02766 Caffeyl-CoA reductase-Etf complex subunit CarE
MVLVYTESEGGKFKKIAHEAVSYAKGIADMLGTSVTAVAVNADDASELGNYGASKVLNVA
NDSLHNFNAGAYADVVSEAAKNEGANVVVLTSSANSKFMAPLVAVNLNAGYVPNVNSLPE
SATPFKVNHSVFTNKAFASTEITTNVKVIGLAKNAYGVLENSTSVNVEAFAPEVSNGDSE
TVSVDKATDKVTIADAEIVVSAGRGMKGPENWGMIEELAETLGAATACSKPVSDMGWRPH
AEHVGQTGKPVATNLYIAIGISGAIQHLAGINASKVKVVINNDPEAPFFKAADYGIVGDA
FEVVPQLTEKLKAFKAQNA
>OMIFANIC_02767 Electron transfer flavoprotein subunit beta
MKIAVCISHVPDTTSKINFTDGDTKFDTNGVQFVINPNDEFGLTRAMWFKEKQGASVHVL
NVGGPETEPTLRKALAIGADEAIRVNTAATDGFSVAKQLANVIAEGGYDLVIGGRESIDY
NGGMVPGMIAKLNGANFVNTCIGLEIDGTEATAIREIDGGKETIKTSLPLVIGGQKGLVE
ESDLRIPNMRGIMQARSKPLHIKEPLDTAAETRSVQFQKPDPKGAVKLVDNVDDLVNLLH
NEAKVI
>OMIFANIC_02768 hypothetical protein
MISHSIPSLASSSAALYASFIIFPNETIVTSFPSRLISATPSGIKYSPSGTSPLSPYICS
LSIKITGSSSRMALFNNPLASAGLLGITTFSPGQFAYQLSKAWECVAANCPADAVGPRNT
IGILNCPPLICRILAALLMIWSIPTNEKLNVINSMIGRLPFMALPTPIPVNPNSEMGVSI
TRLAPNSSNIPLLAL
>OMIFANIC_02769 Transcription termination/antitermination protein NusA
MENLALIESFSEFKDDKLIDRVTLMAILEDVFRNALKKKYGSDENFDIIINPDKGDLEIW
RNRVVVADGEVEDENEEISLSEAQKIEEDFEIGEDVSEEVKLIDLGRRSILALRQNLISK
IHEHDNTNIYKQFKELEGEIYTAEVHHIRHRAVILLDDEGNEIILPKDKQIPSDFFRKGD
NVRGIIESVELKGNKPSIIMSRANPVFLEKLFEQEIPEVFDGLITVKKVVRIPGEKAKVA
VDSYDDRIDPVGACVGMKGSRIHGIVRELGNENIDVINYTNNLNLFITRALSPARVTAIN
IDEESKRAEVILKPEEVSKAIGRGGHNIRLAGQLTGYEIDVLREGAEEDVELREFSDEIE
EWIIAEFHKIGLDTAKSVLEHDLDDLVKRTDLEQETIQEVINILKEEFEE
>OMIFANIC_02770 Translation initiation factor IF-2
MAEVKTMRLSKVLREFNISLDRAVEFLSSKGYEVEARPTTKITAEEYEVLFDEFQTDKSK
KVASKEVGEEKRKEKEELRIAREKELEDKEKKQASRVIKAEAKLDGPKQVGKIELDDKKP
KKEEVKEEESPVEAKEEVVAEAPKTKAKTTAKKKKEKVVEAEAPAEEEVVEEKKIVETAY
QKLDGPNFTGKKIDLSKFKKPEKKKEEKKEDSKDKEKKSRRRRISKEPSKGGGSHRDNRG
RRGRSNVPKEEPSEEEVQKQVRETLEKLQGKSSKGKGAKYRREKRDIHRQKSEEELAQQE
ADSTVLKVTEFVTVSEVATMMNVPVTQVISACMSLGMMVTMNQRLDAETLTIVADEFGYQ
VEFVTADIEEAIHEEEDSPEDLEPRAPIVTVMGHVDHGKTSLLDYIREENVIAGESGGIT
QHIGAYGVTLENNQKIAFLDTPGHEAFTAMRARGAQVTDLAIIVIAADDDIMPQTKEAIS
HAQAAGVPIVFAINKVDKPTANPEKIKEGLANMNLLVEDWGGKIQSHDISAKTGEGVNDL
LEKVLLEAELLELKANPNRNAYGTVVEAFLDKGRGYVSTILVQGGTLNIGDYVLAGQHSG
KVKAMQDERGKKIKKAGPSTPVSILGLDGAPQAGDKFNVFEDEREAKDIANKRMQLQREQ
SVRTQRHITLDEIGRRIALGDFKELNIILKGDVDGSVEALTDSFLKLSTEEIQVNIIHKG
VGAITESDVLLASASDAVIIGFNVRPMGNARQIADKEEIDIRTYSIIYDAINDLKDAMEG
MLSPELREEITGTAEIRETFKISKVGTIAGCMVTIGKIYRNSGIRLIREGVVVFTGELES
LKRFKDDVKEVAKGYDCGMQIKNYNDIKEGDIIEAFQEVEVKKKL
>OMIFANIC_02771 hypothetical protein
MKRLILPFVCMLLLSFSESESGLTKEEREMAISEMTNSHDHLMIALHGLSEAQLNYKMTP
ESWSIAECVEHIAISEDTFSGMLLGLLKTKADPANRDKVSVEDKDLIAMMVDRSNKVKTQ
KPFEPTGKYGSHEATVKAFKAARLKNIDFVNSSDADFRNRVQEFPFGTVDAYQVVLFMSA
HSERHIRQIEEIKYSTDFPKK
>OMIFANIC_02772 hypothetical protein
MRLSIIPKIFISSILIVFASEIAVAQQATVKVNQDSQIPRLLKLKKSLEKDNKLSDGYTI
QLYYGELNKANSVIKKYRNLYAAWPASIEYETPNYKVWVGNYSTRLEADRALIEIQREFS
SAFILKPERKKSK
>OMIFANIC_02773 Cytochrome c-554(547)
MIKVKFRNLPTQLSLLLLALLLTFSTTTYAQEESAEAATEVAPATGEGDAAAGKTLFNAN
CAACHKLYKKGVGPALFGVGDKYDKEWLYSWIRNSQELIKSGDAKAIAIYEEYNQSVMTA
FPALSDEDIDNIIAYTYTPKPEPTVATTGTTNVGGDGEGPTNNIILAALALIFLLLVVML
ILVNKTLRRIAEANGVEYEEGEKRLPIWKAFAQNQFLVFVTSVFLLLASAYFAYGWMMQV
GIDQGYAPVQPIHYSHKIHAGANQIDCNYCHSSARKSKHSGIPSLNVCMNCHKNIAEYNG
EEDLENGYTKEFYTNEIKKLYKAVGWDENNQAYTGEEEPVKWVRIHNLPDFAYFNHSQHV
TVAGIECQKCHGPVEEMEIMYQFSPLTMGWCINCHRETNVDLKGNEYYQKIHEELSKKYG
VDQLTIAQMGGLECGKCHY
>OMIFANIC_02774 Menaquinone reductase, iron-sulfur cluster-binding subunit
MNNISDTNMASNKKYWKSVEELNENSSIVETLKQNEFVEEIPTDDFLGDKDTLEASSTTR
RDFLKYVGFTTAAASLAACEGPVIKSIPYVVAPDEIVPGVANYYATSMGDGFDFANVLVK
TREGRPIKIERNDMAGNSEVNARVQASVLSLYDKNRLMAPKVAGEEVSWEDFDAGCIATM
SQMTGKDVVLLTQTFASPTTAKLIQEFTTQYPNVRQVIYDTVSSSEAADAFQTKYGSRGL
ADYDFSKADVIVSVGADILGDWQGGGYSAGYIENRVPKNGKMSRHIQFEANMTLSGANAD
KRVPVKPSLHKQVLMALTGGSMSGLPDNVAEAVRSAKAELDSAGAKGVIVTGLQDVAAQS
AVLNYNESKGSMAMDTDKPRLTSMGNTAEVTAVMNGVISGSIKGLITVGVDPVYSFPNAA
FADAYKNLEMSLAFAMKEDATASLAKMVAATPHYLESWGDIQTKKGSFGLAQPTIRPLFN
TRQFQECLLKWTENEKSYYEYLRENWETNILAGESWNKAVQDGVFEGDVELEMLETTPAA
NVMETGTSEGALLPNSQEGSMELTLYTKTSIGDGQQANNPWLQEMPDPISRAAWDNYLTV
SAADATSLGLENFNVANGALNGSYANVTMGDVTIENIPVIIQPGQAVGSVGLALGYGKSA
AIQSEMQTGVNAYALYNNFNSVQNVSVSKAGGIHEFACVQLQNTMMGRDIIRETTLEIFN
TRDAEEWNAIPMVSKDHLEIPVTSPDADLWDSFDRSIGHHFNLSIDLNACTGCGACVIAC
NAENNVPVVGKDEIRKSRSMHWLRIDRYYSSQESFAVDFDKKENISGLGSSLSEFAELEQ
ASENPQVAFQPVMCQHCNHAPCETVCPVAATSHGRQGQNHMAYNRCVGTRYCANNCPYKV
RRFNWFLYAENDEFDYHMNNDLGRMVLNPDVVVRSRGVMEKCSMCIQMTQKTILDAKRDG
RSIKDGEFKTACSSACNTGAIVFGDVNDHESEIYKKKHDDRMYHLLEAVGTKPNVVYQAQ
VRNTKEA
>OMIFANIC_02775 50S ribosomal protein L21
MASHYEAPIRKPLVLGEKSYHDVSVDVAAPVEGKANRAWWIVFGISLAAFLWGVGCIIYT
ISTGIGVWGLNPTVNWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAINRSAEAMTI
FSVIQAGLFPIIHMGRPWLAYWVLPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMIRDRAITPFTKRVYSILSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSFDFATSVIPGWHTTIFPPYFVAGAIFSGFAMVQTLLIIMRKVSHLEDYITIQHIELM
NIVIMITGSIVGVAYITELFIAWYSGVEYEQYAFLNRATGPYWWAYWAMMTCNVFSPQFM
WFKKLRTSIMFSFFISIVVNIGMWFERFVIIVTSLHRDYLPSSWTMFSPTFVDIGIFIGT
VGFFFVLFLLYARTFPVIAQAEVKSILKGSGESYKRLRAEHGDDVKHYKIPEVSDRTVRS
GDSDEGRALEDNSEKVNNLLSGIGTFDPETQTADDLKLISGVGPKMEEKLHQLGIFTFDQ
VSRMTDREYDLLDSIIEEFPGRAKRDDWAGQASKLKNNS
>OMIFANIC_02776 hypothetical protein
MASKVIHAIYNDDDILLNAVKQVRSEHYHIEEIYTPFPVHGLEKAMGLADTRIAITSFLY
GLLGLAVAIIMMNYIMIQDWPQDIGGKPSFSYIENMPAFVPIMFEMTVFFAAHLMVITFY
MRSKLWPFKKAENPDVRTTDDHFLMAVDTGNHDVEKMTKFLYNTGALEISLIENDEDDH
>OMIFANIC_02777 hypothetical protein
MTKTTINMKKAIHISIVIIASLAMVSCFDSNSPNYQYMNNMYEPVGYETYGEYEIFENEM
EAKLPAEGSIPRGWMPYEYENSTAGLEQARAELKMTLPVTEEHLERGEELYEIYCAVCHG
TKGDGQGILMQREKFLGIPSYADPGRNITEGSIYHVQMYGLNSMGSYASQTNELERWQIT
QHVMNLMAALKGEPALELSSDSEGEAEVAGDMTEGEAETVETEETN
>OMIFANIC_02778 hypothetical protein
MYTLPNKLKLFAIIFMVVGAVGIVSGFLMAPKTTSEVKEMMADGHGDGHEGDHAVADESH
SVAQAEEAHDDEAHYEHVLHQMQNRPWSALYIASFFFFMIALGTLAFYAIQYAAQAGWSP
VLFRVMEGITAYLPVASVIIIVLLLLSAFHMNHIFHWMDPELVNPESEHYDKLIAGKSGF
LNVPFFLIRALIFLGGWNLYRYISRRNSLRDDNAEDNRWFKKNFKASAGFLVFFIVTESM
MSWDWIMSFDPHWFSTLFGWYVFAGMMVSAITVIAMVTIVLKSQGYLEHVNDSHIHDLAK
YMFGFSIFWTYLWFSQFMLIWYSNIPEEVTYFVTRIEDYNLLFFGMVVMNFVFPVLMLMN
SDYKRVNWFVILTGIVILVGHYIDVFNMVMPATVGASWFVGLPEIGAVMFFFGLFVLVVF
SALTKAPLLVKHNPFIKESKHFHY
>OMIFANIC_02779 Alternative cytochrome c oxidase subunit 2
MTAFLVVLVIILFGVAVMQMSRIFKMSRQQSNTSEIANDKDNNTHGWLMLAFVLFIYALC
IYSFYEWGDVMLPRSASEHGVEIDQLWLISMIIIFVVGIITQWLLHYFAFKYRGEKSQKA
TFYADNDRLEFIWTIIPVIVLAGLIIYGLFTWTDIMNIDTDDDPLVVELYAYQFDWRARY
GGEDNTLGEANVRLIEGINQLGVDASDPYAQDDVIVNELHLPKGRKILFKMRSQDVLHSA
YMPHFRAQMNCVPGMITQFSFTPTLTTEEMRATDEMRDKVQKINKIRTENNIALAAAGEE
QLEMYEFDYLLLCNKICGNSHYNMQMKIIVEDEEDFNAWMKEQQTLATVLKQ
>OMIFANIC_02780 Alternative cytochrome c oxidase subunit 1
MSAHAEAHVVDHHDDHGHHHKETFVTKYIFSQDHKMISKQYLITGLFMGIIGIAMSILFR
LQLAWPEEPFTVLEIFLGKWAEGGVMDPSVYLALVTIHGTIMVFFVLTAGLSGTFSNLLI
PLQIGARDMASGFLNMISYWLFFLSSVIMVFSLFVEAGPASAGWTIYPPLSALPQAIPGS
GAGMTLWLVSMAIFIASSLLGSLNYIVTVLNLRTKGMSMTRLPLTIWAFFVTAIIGVVSF
PVLLSAALMLIMDRSFGTSFFLSDIYIAGEVLHNQGGSPVLFEHLFWFLGHPEVYIVLLP
ALGITSEVIATNARKPIFGYRAMVASILAIAFLSTIVWGHHMFISGMNPFLGSVFTFTTL
LIAIPSAVKAFNYITTLWKGNLQLNPAMLFSIALVSTFITGGLTGIILGDSALDINVHDT
YFVVAHFHLVMGISALYGLFAGVYHWFPKMFESRMMNKNLGYVHFWVTAVGAYGVFFPMH
FIGMAGLPRRYYNNTNFPYFDDLTDVNVVITIFAIITSAAQLVFLYNFIHSMFYGKKGPQ
NPWKSNTLEWTAPIKHIHGNWDGPIPHVHRWAYDYSKLNMDESDYVIPGQDYAPQHLPLQ
ENEEEMHH
>OMIFANIC_02781 putative FMN/FAD exporter YeeO
METLKKIFRYLPQAVAGKEQDFTSGSIRKAIFLLSVPMVLEMMMESVFFLVDAYFVSSLG
ANAIATVGLTESVLTLVYAIAIGLSMGVTAIVARRIGEKNVPGASKAAVQSIFLGIVLAA
LVSVIGIIFPKEILGLMGGEPELIAQGYGYTQILLGGNVTIMLLFIINAIFRGAGDASVA
MKVLIFSNLLNIILDPMFIFGFGPIPAFGVKGAAIATTIGRGSAVILQLVILFYGWSRIK
VRLKDIVFRAGIMLNLIRVSLGGIGQFIIGTSSWVFLMRIMAEFGSEVLAGYTIAIRVLM
FTLMPSWGMSNAAATLVGQNLGAEKPERAETSVWKTGKYNAWFMAAVSIFYLICAEMILK
IFSDDPSVIENGALSLRIIAAGYVFYAYGMVIIQAFNGAGNTRTPTIINFFCFWLFQLPF
AYLAAIVFNWGVTGVLVAITTAEVLIAVFGIVWFRKGKWKSVQV
>OMIFANIC_02782 Holliday junction ATP-dependent DNA helicase RuvB
MNEHLDPTGEHLTPQELDIEKKLRPLTFDDFTGQDQALENLRIFVQAANLRDEALDHTLF
HGPPGLGKTTLAHILANELEVAIKVTSGPVLDKPGDLAGLLTNLEERDVLFIDEIHRLSP
IVEEYLYSAMEDYKIDIMIETGPNARTVQINLNPFTLVGATTRSGLLTAPMRARFGIASR
LNYYSNDVLTTIVQRSAGILKMPISMEAAIEIAGRSRGTPRIANALLRRVRDFAQIKGDG
NIDIKIAKYALEALHVDTHGLDEMDNKILTTLIDKFKGGPVGITTLATAVSESSETIEEV
YEPFLIQQGFIVRTPRGREVTEAAYKHLGKLKGGTQGGLF
>OMIFANIC_02783 Putative cytochrome P450 132
MPKKQKTYNYPERLPLLKFFLNAEAIRKNPIPFHRQFFNSYGDTFSVKLGRKKHIMLSRD
KEVVQYILQKNHKNYYKSTIQTKYLSKYLGMGLLTANGEFWLKQRRLIQPAFHKKKMDSL
VDIMQQTIEDELENLPSDATTDVFNVMNQLAFNVVANSLFNLSVTGNELKRLQKIIQEIQ
LFLVKEVRLPHKGWWFKLSGQVRKHKLLAEESRSIIRKIIEDRKASNETHDDLLDMLLAT
RYEDTGEPMSTKQLIDEISILFVAGHETTANALAFTSFLLAKHQDIQRKVFEEVSAARDA
MSGSLEQIKMLPFTKAVIDESMRLYPPAWITDRENLEDDTIKEYHIRENTLVGVSFYELH
RNPKYWESPDEFIPERFMGDRRKETTGIYFPFGAGPRMCIGMGFAIYEMVLAVSHMVYHN
ELSTKVTEAKVNPLITLKPIDLFVHFKTRGH
>OMIFANIC_02784 Epoxyqueuosine reductase
MNSNHRKYTKIIKNEASRLGFLSCGISKAEFLEEEAPRLEKWLKNNMHGQMGYMENHFDK
RLDPTKLVPGSKSVVSLLLNYFPKEQQRSDSYKISKYAYGTDYHFVIKDKLKQLLYFIQQ
EIGDVQGRAFVDSAPVLDKAWAARSGLGWMGKHSNLLTKQLGSFYFIAELIIDLELEYDN
PITDHCGSCTACIDACPTKAIVEPYVVDGSKCISYFTIELKNEIPRDYSGSFDDWMFGCD
VCQDVCPWNRFSKAHSEPLFNPKPELLQMSKKDWEEITEEVFQKIFQKSAVKRTGFQGLT
RNINYLKD
>OMIFANIC_02785 NADP-dependent malic enzyme
MSKQSKRREALLYHARPRPGKIKVVPTKKYATQRDLSLAYSPGVAEPCLEIEKDVNNAYR
YTNKGNLVAVISNGTAVLGLGNIGPEASKPVMEGKGLLFKIFADIDVFDIEVNTENIDAF
IETVKNIAPTFGGINLEDIKAPEAFEIERRLKEELDIPVMHDDQHGTAIISAAALLNALE
IAEKEIEKVNIVISGAGAAAVSCTRLYKAFGANSENIVMLDSKGVIRKDREDLTKEKAEF
ATERKIDTLEEAMKDADVFVGLSIADIVNPEMLLSMADTPIVFAMANPDPEIGYRLAVDT
RDDIIMATGRSDHPNQVNNVLGFPFIFRGALDVRASKINEAMKMAAVKALADLAKEPVPE
QVNIAYGETRLTFGKDYIIPKPFDPRLIAAVPPAVAKAAMESGVATSEIADWETYKDELY
ERMGSDNKIIRLMYNRARMHPKRIVFAEADSLDVLKAAQIVFEEGIGIPILLGRRNVIHE
LMKEIEFEEEGIQVIDPKSDEQLEKVSDYAKIHWNKRKRNGITFYDAKRLMRERNYFAAM
MVNEGDADGMISGYTRAYPTVLRPVLETIGRFESVKRVATTNLMLTKRGPMFLSDTSINI
DPNAHELAKIAQMTNYTMKLFGLAPVIAMISYTNFGSSKDPHARKVKEAVALLHKSNPDM
HVDGELQVDFALNPTLLKENFPFSKLAGKKVNALIFPNLDSANSNYKLLKELNAVESIGP
IMLGMKKPVHILQLGASVEEIVNMAAVAVIDAQQKEKRDEEEVVKKA
>OMIFANIC_02786 Holliday junction ATP-dependent DNA helicase RuvA
MITHIQGRLVEKNPTEVIVDCNGVGYFINISLHTFSQLPSGENVKLYTHLLVREDSHTLY
GFSGKTEREIFRLLLSVSGIGASIARTMLSSLSPQQVMEAIASEDVATIQSVKGIGTKTA
QRAVLDLKDKIIKVYGLDDVSVISSNTNKNEALSALETLGFARKQTEKVCDKILKEQPEA
SVEEIIKQALKNL
>OMIFANIC_02787 hypothetical protein
MGAKHYDYKKGFFKLLFILGIIFGSLSTVQAQDTTSTGFEMGRLELPNPQSIQDLYRYDP
ITDRYIYTQAIGDLDITYPIILTPEEYQELILKEQMKAYFKDKIDAQDGRKEGSEELQKN
LLPTFYVNSNFFETVFGGNTIEVIPQGSVEMDLGILYTKQDNPSFSPRNRRNLSFDFDQR
ISLSLLGKVGTRLQVTANYDTQSTFDFQNQIKLEYTPTEDDIIQKIEVGNVNMPLNSSLI
QGAQSLFGVKTQLQFGKTTITGVFSEQQSETRSVVAEGGATVTDFEVFALEYDENRHFFL
AHYFRDNYDRVLERYPFINSNVQITRAEVWITNRSNRTENVRNIVALQDIGEANPENIGL
DVPPGGFINRPPNSLADNGNNDFNPFGIDDPSIQSILNPAIRDIATVRQGFSGVAVNEGI
DYVTLENARRLQPNEYRLNSQLGYISLNQRLNNDEVLGVSFQYTVNGKVYQVGEFSNDGV
EATGPTIQGEQGLPPEGGLPQNLVVKLLKSNITNVNEPLWDIMMKNIYGLGAFQLEQEDF
RLNIFYTDPSPLNYIIPAPGTAEFPAVDLPEDVDDTILLNVFNLDRLNFNSDPQQGGDGF
FDFLPGITVDTQNGQIIFTSVEPFGEYLFNKLDNTPGGPENYNIPSTYNANQNKYVFREL
YTSTKTIAEQEQSDKNKFQLKGTYKSTGADGIPIGAFNVPPGSVTVTAGGRVLVEGVDYT
VNYQLGRVQILDPALLNSNTPIQITTENNTLFGQQTKRFTGLNVEHQFNENFQIGATYLN
LNERPLTQKSSYNVEPINNTIFGFNANFSTEVPFLTRLVNKLPNIDTDVESNLSVRGEFA
YLLPGAPKVADFDGKATVYVDDFEASQTELDVKAPLSWFLSSTPIGFGGEQANGNLAYNY
NRAKLAWYTIDPIFYSSQRPEGIDDEDLSSPFTRRVFRDEIFPNQDIIQGQTQALFSLDL
AYYPSERGPYNYNPELGGGNDLPNPDTRFAGISRQLTTTDFERSNVEYIQFWLMDPFIYE
ENSGNPGGLLRFNLGNISEDVLKDGRKQYENGLPEDGGITNTTPTAWGKVPTNQSLVYTF
DTEGEQRTNQDIGYDGINDAAEATMFPEFAGLPDPSGDNYLYFLQAEGNILERYLQYNGV
EGNSPVEVGDTNRGSTPQPDVEDINRDNTMNTVDSYFEYDIEIRSDMLDPATNDYVTDVK
ELDVTLQNNETIPVRWVQFKIPISEPDRAVNGIADYRSIRFMRMYLSGFSQNTILRFGAL
DLVRGDYRRYIQTLDITGEDPEMDDTIFENEAVNIEQNENRIPIPYVLPPGVIREELNNN
NNIIRQNEQSLALRVTGLEPGDGRGVYKNFNVDMRQYENLEMFIHAESLLNETALGDGDM
VAFMRLGNDLNQNFYEIQIPLNPTAFNVSSAEDIWPIENRLNLPLRLLQEAKTRTLGDPN
NNPTELQFFDQSELDPGSVDGPENDLRIGILGNPSFGAVRVVMLGLKNSTTNDISGEVWF
NELRLSELKNQGGWAAVASMDANLADFANVSATAGKSTIGFGSIEQGPNQRSREDAQQYD
VVTNVNLGQLLPQKWGVQLPFNYGRSEELITPQFDPEFDDIELDARLDNTTDAAERDRIK
EQAEDYTRRQSINFIGVRKDRTSEKPPMPYDISNFTFSYSYNQVDHRDFEIEEALDQNVR
VGGTYNYNFIQKPFEPFVKNDSLFTGKYWKFLKDLNINYLPTNISVSSNIIRQYNEQKFR
EINLARNLKPVPQLFQRNFLFDWQYTINYNLTKSLRFNFNASNNRIINNYITPELLDDGN
VIYNVDNTIGIWDGFFDVGEPNQHFQSLQVNYDLPFDKFPFLKFIRATYSYQGDFQWQDG
SDLLSNIPFPIGGEDPEFFDLGNSVQNASTHRINSNLDMNTFYKYIGLTKIEAGDRGAGR
GGSSGPGRGGNEKGGKASKGGDDGKNNKKAEDPRLGSGGGAAGGGAGGRTGLSGGAKAAN
TLIGIATSIKKIQINYQENNGIYLPGYTRSIGMLGTLKPTAGFVFGSQREVRELAARKGW
LTLYPEFNEQYTEVENRQLDWQVNTEILPDLKIDFNGNRIYSENYAENYIVEDGLYRSLT
PYASGNFSISTLLISTAFSSSDEFGSAPFDDFRSNRIIIANRLAEDFYGTTGFPRDEEGF
PVGFGKTSQDVLLPAFLSAYKGSDASSEKTGIFRDVPLPNWDLKYTGFMKLDWFKKRFKR
FSIQHGYRAGYTVNQFQTNLDYDPVNPTATDQAGNFKPQTFLTNVNLTEQFSPLIRVDFE
MKNSVKILAELRKDRALSLSFANNLMTEIQGDEIVIGLGYRIKDLRIGTNFGGKKKILKS
DLNFKLDLSRRDNKTIIRYLDIENNQTTAGQTIYGIQFTADYALSKNLTALFYYDHTFSE
YAISTAFPQTTIRSGITLRYNFGN
>OMIFANIC_02788 Glycine cleavage system H protein
MSVPSDLKYTKDHEWVRVDGEIATVGITDFAQGELGDIVYVEVETVDETLDKDEVFGTVE
AVKTVSDLFLPLSGEIIEFNEGLESEPEIVNSDPYGEGWMVKIKFSNPGELDELLDDAGY
KEIIGA
>OMIFANIC_02789 hypothetical protein
MMRVIKKLSGRRNLLLLGVIYTLIITFASLAPDRGVSTFDILFLDKYVHVVMHWLLTFIW
LSYFFLGDQNHFSSKMVILALITCFFYGIVVEAFQHWFTETRTFDFFDIIANAIGDLLGL
LSFMMIRKKMNYES
>OMIFANIC_02790 hypothetical protein
MEVKKNPKFDLGKRSLIFFQIGMIFMLFLTWQALEIKSYDTGEAERDLLDVSDALEEIIP
VTEPLTAPPPPPPAQTVTAVIIQVEDEADIEETVIESTETDENAEIAEIEEIDEVVLEEE
IINVPFHVIENVPIFPGCENLSNNNERKACMSEKVQKFVQNKFNTDLAGELGLEGRQRIH
VQFRIDHKGKVVDVRARAPHPRLEKEAVDVVSSLPDMQPGKQSGKPVGVQYALPILFEVK
TD
